Orange Book 33rd Edition

APPROVED
DRUG
PRODUCTS
WITH
THERAPEUTIC
EQUIVALENCE
EVALUATIONS
33rd EDITION
THE PRODUCTS IN THIS LIST HAVE BEEN APPROVED UNDER SECTION 505 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION

CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF PHARMACEUTICAL SCIENCE OFFICE OF GENERIC DRUGS
2013
APPROVED DRUG PRODUCTS
with
THERAPEUTIC EQUIVALENCE EVALUATIONS
The products in this list have been approved under section 505 of the Federal Food, Drug, and Cosmetic Act. This volume is current through December 31, 2012.
33rd EDITION
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

OFFICE OF PHARMACEUTICAL SCIENCE
OFFICE OF GENERIC DRUGS
2013
FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH APPROVED DRUG PRODUCTS with Therapeutic Equivalence Evaluations
CONTENTS
PAGE
PREFACE TO THIRTY THIRD EDITION..................iv
1 INTRODUCTION...................................................................................................................vi
1.1 Content and Exclusion......................................................................................................vi
1.2 Therapeutic Equivalence-Related Terms .........................................................................vi
1.3 Statistical Criteria for Bioequivalence ............................................................................. viii
1.4 Reference Listed Drug.......................................................................................................x
1.5 General Policies and Legal Status ...................................................................................xi
1.6 Practitioner/User Responsibilities.....................................................................................xi
1.7 Therapeutic Equivalence Evaluations Codes ................................................................. xiii
1.8 Description of Special Situations .....................................................................................xx
1.9 Therapeutic Equivalence Code Change for a Drug Entity............................................. xxii
1.10 Change of the Therapeutic Equivalence Evaluation for a Single Product .................... xxiii
1.11 Discontinued Section.................................................................................................... xxiii
1.12 Changes to the Orange Book ....................................................................................... xxiii
1.13 Availability of the Edition............................................................................................... xxiv
2 2.1 2.2 2.3 HOW TO USE THE DRUG PRODUCTS LISTS ..............................................................2-1
Key Sections for Using the Drug Product Lists ........2-1
Drug Product Illustration ......2-3
Therapeutic Equivalence Evaluations Illustration ....2-4
DRUG PRODUCT LISTS

Prescription Drug Product List .....3-1
OTC Drug Product List ..4-1
Drug Products with Approval under Section 505 of the Act Administered
by the Center for Biologics Evaluation and Research List ........5-1
Discontinued Drug Product List .......6-1
Orphan Products Designations and Approvals List .....7-1
Drug Products Which Must Demonstrate in vivo Bioavailability
Only if Product Fails to Achieve Adequate Dissolution ....8-1
APPENDICES A. Product Name Index .......A-1 B. Product Name Index Listed by Applicant .....B-1
C. Uniform Terms .........C-1
PATENT AND EXCLUSIVITY INFORMATION ADDENDUM .............AD1
A. Patent and Exclusivity Lists .......ADA1 B. Patent and Exclusivity Terms ........ADB1

APPROVED DRUG PRODUCTS
with
Therapeutic Equivalence Evaluations
PREFACE TO THIRTY THIRD EDITION

The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act). Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation [DESI] review [e.g., Donnatal Tablets and Librax Capsules] or pre-1938 drugs [e.g., Phenobarbital Tablets]) are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Inclusion of products on the List is independent of any current regulatory action through administrative or judicial means against a drug product. In addition, the List contains therapeutic equivalence evaluations for approved multisource prescription drug products. These evaluations have been prepared to serve as public information and advice to state health agencies, prescribers, and pharmacists to promote public education in the area of drug product selection and to foster containment of health care costs. Therapeutic equivalence evaluations in this publication are not official FDA actions affecting the legal status of products under the Act. Background of the Publication. To contain drug costs, virtually every state has adopted laws and/or regulations that encourage the substitution of drug products. These state laws generally require either that substitution be limited to drugs on a specific list (the positive formulary approach) or that it be permitted for all drugs except those prohibited by a particular list (the negative formulary approach). Because of the number of requests in the late 1970s for FDA assistance in preparing both positive and negative formularies, it became apparent that FDA could not serve the needs of each state on an individual basis. The Agency also recognized that providing a single list based on common criteria would be preferable to evaluating drug products on the basis of differing definitions and criteria in various state laws. As a result, on May 31, 1978, the Commissioner of the Food and Drug Administration sent a letter to officials of each state stating FDA's intent to provide a list of all prescription drug products that are approved by FDA for safety and effectiveness, along with therapeutic equivalence determinations for multisource prescription products. The List was distributed as a proposal in January l979. It included only currently marketed prescription drug products approved by FDA through new drug applications (NDAs) and abbreviated new drug applications (ANDAs) under the provisions of Section 505 of the Act. The therapeutic equivalence evaluations in the List reflect FDA's application of specific criteria to the multisource prescription drug products on the List approved under Section 505 of the Act. These evaluations are presented in the form of code letters that indicate the basis for the evaluation made. An explanation of the code appears in the Introduction. A complete discussion of the background and basis of FDA's therapeutic equivalence evaluation policy was published in the Federal Register on January 12, 1979 (44 FR 2932). The final rule, which includes FDA's responses to the public comments on the proposal, was published in the Federal Register
iv
on October 31, 1980 (45 FR 72582). The first publication, October 1980, of the final version of the List incorporated appropriate corrections and additions. Each subsequent edition has included the new approvals and made appropriate changes in data. On September 24, 1984, the President signed into law the Drug Price Competition and Patent Term Restoration Act (1984 Amendments). The 1984 Amendments require that FDA, among other things, make publicly available a list of approved drug products with monthly supplements. The Approved Drug Products with Therapeutic Equivalence Evaluations publication and its monthly Cumulative Supplements satisfy this requirement. The Addendum to this publication identifies drugs that qualify under the 1984 Amendments for periods of exclusivity (during which ANDAs or applications described in Section 505(b)(2) of the Act for those drugs may not be submitted for a specified period of time and, if allowed to be submitted, would be tentatively approved) and provides patent information concerning the listed drugs which also may delay the approval of ANDAs or Section 505(b)(2) applications. The Addendum also provides additional information that may be helpful to those submitting a new drug application to the Agency. The Agency intends to use this publication to further its objective of obtaining input and comment on the publication itself and related Agency procedures. Therefore, if you have comments on how the publication can be improved, please send them to the Director, Division of Labeling and Program Support, HFD-610, Office of Generic Drugs, Center for Drug and Evaluation and Research, 7620 Standish Place, Rockville, MD 20855. Comments received are publicly available to the extent allowable under the Freedom of Information regulations.
1. INTRODUCTION
1.1 Content and Exclusion The List is composed of four parts: (1) approved prescription drug products with therapeutic equivalence evaluations; (2) approved over-the-counter (OTC) drug products for those drugs that may not be marketed without NDAs or ANDAs because they are not covered under existing OTC monographs; (3) drug products with approval under Section 505 of the Act administered by the Center for Biologics Evaluation and Research; and (4) a cumulative list of approved products that have never been marketed, are for exportation, are for military use, have been discontinued from marketing, or have had their approvals withdrawn for other than safety or efficacy reasons subsequent to being discontinued from marketing.1 This publication also includes indices of prescription and OTC drug products by trade or established name (if no trade name exists) and by applicant name (holder of the approved application). All established names for active ingredients generally conform to official compendial names or United States Adopted Names (USAN) as prescribed in (21 CFR 299.4(e)). The latter list includes applicants names as abbreviated in this publication; in addition, a list of uniform terms is provided. An Addendum contains drug patent and exclusivity information for the Prescription, OTC, Discontinued Drug Product Lists, and for the Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research. The publication may include additional information that the Agency deems appropriate to disseminate. Prior to the 6th Edition, the publication had excluded OTC drug products and drug products with approval under Section 505 of the Act administered by the Center for Biologics Evaluation and Research because the main purpose of the publication was to provide information to states regarding FDA's recommendation as to which generic prescription drug products were acceptable candidates for drug product selection. The 1984 Amendments required the Agency to begin publishing an up-to-date list of all marketed drug products, OTC as well as prescription, that have been approved for safety and efficacy and for which new drug applications are required. Under the 1984 Amendments, some drug products are given tentative approvals. The Agency will not include drug products with tentative approval in the List. Tentative approval lists are available at ANDA (Generic) Drug Approvals. When the tentative approval becomes a full approval through a subsequent action letter to the application holder, the Agency will list the drug product and the final approval date in the appropriate approved drug product list. Distributors or repackagers of products on the List are not identified. Because distributors or repackagers are not required to notify FDA when they shift their sources of supply from one approved manufacturer to another, it is not possible to maintain complete information linking product approval with the distributor or repackager handling the products. 1.2 Therapeutic Equivalence-Related Terms Pharmaceutical Equivalents. Drug products are considered pharmaceutical equivalents if they contain the same active ingredient(s), are of the same
1 Newly approved products are added to parts 1, 2, or 3, of the List, depending on the dispensing requirements (prescription or OTC) or approval authority, unless the Orange Book staff is otherwise notified before publication.
vi
dosage form, route of administration and are identical in strength or concentration (e.g., chlordiazepoxide hydrochloride, 5mg capsules). Pharmaceutically equivalent drug products are formulated to contain the same amount of active ingredient in the same dosage form and to meet the same or compendial or other applicable standards (i.e., strength, quality, purity, and identity), but they may differ in characteristics such as shape, scoring configuration, release mechanisms, packaging, excipients (including colors, flavors, preservatives), expiration time, and, within certain limits, labeling. Pharmaceutical Alternatives. Drug products are considered pharmaceutical alternatives if they contain the same therapeutic moiety, but are different salts, esters, or complexes of that moiety, or are different dosage forms or strengths (e.g., tetracycline hydrochloride, 250mg capsules vs. tetracycline phosphate complex, 250mg capsules; quinidine sulfate, 200mg tablets vs. quinidine sulfate, 200mg capsules). Data are generally not available for FDA to make the determination of tablet to capsule bioequivalence. Different dosage forms and strengths within a product line by a single manufacturer are thus pharmaceutical alternatives, as are extended-release products when compared with immediate-release or standard-release formulations of the same active ingredient. Therapeutic Equivalents. Drug products are considered to be therapeutic equivalents only if they are pharmaceutical equivalents and if they can be expected to have the same clinical effect and safety profile when administered to patients under the conditions specified in the labeling. FDA classifies as therapeutically equivalent those products that meet the following general criteria: (1) they are approved as safe and effective; (2) they are pharmaceutical equivalents in that they (a) contain identical amounts of the same active drug ingredient in the same dosage form and route of administration, and (b) meet compendial or other applicable standards of strength, quality, purity, and identity; (3) they are bioequivalent in that (a) they do not present a known or potential bioequivalence problem, and they meet an acceptable in vitro standard, or (b) if they do present such a known or potential problem, they are shown to meet an appropriate bioequivalence standard; (4) they are adequately labeled; (5) they are manufactured in compliance with Current Good Manufacturing Practice regulations. The concept of therapeutic equivalence, as used to develop the List, applies only to drug products containing the same active ingredient(s) and does not encompass a comparison of different therapeutic agents used for the same condition (e.g., propoxyphene hydrochloride vs. pentazocine hydrochloride for the treatment of pain). Any drug product in the List repackaged and/or distributed by other than the application holder is considered to be therapeutically equivalent to the application holder's drug product even if the application holder's drug product is single source or coded as non-equivalent (e.g., BN). Also, distributors or repackagers of an application holder's drug product are considered to have the same code as the application holder. Therapeutic equivalence determinations are not made for unapproved, off-label indications. FDA considers drug products to be therapeutically equivalent if they meet the criteria outlined above, even though they may differ in certain other characteristics such as shape, scoring configuration, release mechanisms, packaging, excipients (including colors, flavors, preservatives), expiration date/time and minor aspects of labeling (e.g., the presence of specific pharmacokinetic information) and storage conditions. When such differences are important in the care of a particular patient, it may be appropriate for the prescribing physician to require that a particular brand be dispensed as a medical necessity. With this limitation, however, FDA believes that products classified as therapeutically equivalent can be substituted with the full expectation that the substituted product will produce the same clinical effect and safety profile as the prescribed product. Bioavailability. This term means the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes
vii
available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action. Bioequivalent Drug Products. This term describes pharmaceutical equivalent or pharmaceutical alternative products that display comparable bioavailability when studied under similar experimental conditions. Section 505 (j)(8)(B) of the Act describes one set of conditions under which a test and reference listed drug (see Section 1.4) shall be considered bioequivalent: the rate and extent of absorption of the test drug do not show a significant difference from the rate and extent of absorption of the reference drug when administered at the same molar dose of the therapeutic ingredient under similar experimental conditions in either a single dose or multiple doses; or the extent of absorption of the test drug does not show a significant difference from the extent of absorption of the reference drug when administered at the same molar dose of the therapeutic ingredient under similar experimental conditions in either a single dose or multiple doses and the difference from the reference drug in the rate of absorption of the drug is intentional, is reflected in its proposed labeling, is not essential to the attainment of effective body drug concentrations on chronic use, and is considered medically insignificant for the drug. Where these above methods are not applicable (e.g., for drug products that are not intended to be absorbed into the bloodstream), other in vivo or in vitro test methods to demonstrate bioequivalence may be appropriate. Bioequivalence may sometimes be demonstrated using an in vitro bioequivalence standard, especially when such an in vitro test has been correlated with human in vivo bioavailability data. In other situations, bioequivalence may sometimes be demonstrated through comparative clinical trials or pharmacodynamic studies. 1.3 Statistical Criteria for Bioequivalence Under the Drug Price Competition and Patent Term Restoration Act of 1984, manufacturers seeking approval to market a generic drug product must submit data demonstrating that the drug product is bioequivalent to the pioneer (innovator) drug product. A major premise underlying the 1984 law is that bioequivalent drug products are therapeutically equivalent, and therefore, interchangeable. Bioavailability refers to the rate and extent to which the active ingredient or therapeutic ingredient is absorbed from a drug product and becomes available at the site of drug action (Federal Food, Drug and Cosmetic Act, section 505(j)(8)). Bioequivalence refers to equivalent release of the same drug substance from two or more drug products or formulations. This leads to an equivalent rate and extent of absorption from these formulations. Underlying the concept of bioequivalence is the thesis that, if a drug product contains a drug substance that is chemically identical and is delivered to the site of action at the same rate and extent as another drug product, then it is equivalent and can be substituted for that drug product. Methods used to define bioequivalence can be found in 21 CFR 320.24, and include (1) pharmacokinetic (PK) studies, (2) pharmacodynamic (PD) studies, (3) comparative clinical trials, and (4) in-vitro studies. The choice of study used is based on the site of action of the drug and the ability of the study design to compare drug delivered to that site by the two products. The standard bioequivalence (PK) study is conducted using a two-treatment crossover study design in a limited number of volunteers, usually 24 to 36
viii
adults. Alternately, a four-period, replicate design crossover study may also be used. Single doses of the test and reference drug products are administered and blood or plasma levels of the drug are measured over time. Pharmacokinetic parameters characterizing rate and extent of drug absorption are evaluated statistically. The PK parameters of interest are the resulting area under the plasma concentration-time curve (AUC), calculated to the last measured concentration (AUC(0-t)) and extrapolated to infinity (AUC(0-inf)), for extent of absorption; and the maximum or peak drug concentrations (Cmax), for rate of absorption. Crossover studies may not be practical in drugs with a long half-life in the body, and a parallel study design may be used instead. Alternate study methods, such as in-vitro studies or equivalence studies with clinical or pharmacodynamic endpoints, are used for drug products where plasma concentrations are not useful to determine delivery of the drug substance to the site of activity (such as inhalers, nasal sprays and topical products applied to the skin). The statistical methodology for analyzing these bioequivalence studies is called the two one-sided test procedure. Two situations are tested with this statistical methodology. The first of the two one-sided tests determines whether a generic product (test), when substituted for a brand-name product (reference) is significantly less bioavailable. The second of the two onesided tests determines whether a brand-name product when substituted for a generic product is significantly less bioavailable. Based on the opinions of FDA medical experts, a difference of greater than 20% for each of the above tests was determined to be significant, and therefore, undesirable for all drug products. Numerically, this is expressed as a limit of test-product average/reference-product average of 80% for the first statistical test and a limit of reference-product average/test-product average of 80% for the second statistical test. By convention, all data is expressed as a ratio of the average response (AUC and Cmax) for test/reference, so the limit expressed in the second statistical test is 125% (reciprocal of 80%). For statistical reasons, all data is log-transformed prior to conducting statistical testing. In practice, these statistical tests are carried out using an analysis of variance procedure (ANOVA) and calculating a 90% confidence interval for each pharmacokinetic parameter (Cmax and AUC). The confidence interval for both pharmacokinetic parameters, AUC and Cmax, must be entirely within the 80% to 125% boundaries cited above. Because the mean of the study data lies in the center of the 90% confidence interval, the mean of the data is usually close to 100% (a test/reference ratio of 1). Different statistical criteria are sometimes used when bioequivalence is demonstrated through comparative clinical trials pharmacodynamic studies, or comparative in-vitro methodology. The bioequivalence methodology and criteria described above simultaneously control for both differences in the average response between test and reference, as well as the precision with which the average response in the population is estimated. This precision depends on the within-subject (normal volunteer or patient) variability in the pharmacokinetic parameters (AUC and Cmax) of the two products and on the number of subjects in the study. The width of the 90% confidence interval is a reflection in part of the withinsubject variability of the test and reference products in the bioequivalence study. A test product with no differences in the average response when compared to the reference might still fail to pass the bioequivalence criteria if the variability of one or both products is high and the bioequivalence study has insufficient statistical power (i.e., insufficient number of subjects). Likewise, a test product with low variability may pass the bioequivalence criteria, when there are somewhat larger differences in the average response. This system of assessing bioequivalence of generic products assures that these substitutable products do not deviate substantially in in-vivo performance from the reference product. The Office of Generic Drugs has conducted two surveys to quantify the differences between generic and brand name products. The first survey included 224 bioequivalence studies submitted
ix
in approved applications during 1985 and 1986. The observed average differences between reference and generic products for AUC was 3.5% (JAMA, Sept. 4, 1987, Vol. 258, No. 9). The second survey included 127 bioequivalence studies submitted to the agency in 273 ANDAs approved in 1997. The three measures reviewed include AUC(0-t), AUC(0-inf), and Cmax. The observed average differences between the reference and generic products were + 3.47% (SD 2.84) for AUC(0-t), + 3.25% (SD 2.97) for AUC(0-inf), and + 4.29% (SD 3.72) for Cmax (JAMA, Dec. 1, 1999, Vol. 282, No. 21). The primary concern from the regulatory point of view is the protection of the patient against approval of products that are not bioequivalent. The current practice of carrying out two one-sided tests at the 0.05 level of significance ensures that there is no more than a 5% chance that a generic product that is not truly equivalent to the reference will be approved. 1.4 Reference Listed Drug A reference listed drug (21 CFR 314.94(a)(3)) means the listed drug identified by FDA as the drug product upon which an applicant relies in seeking approval of its ANDA. FDA has identified in the Prescription Drug Product and OTC Drug Product Lists those reference listed drugs to which the in vivo bioequivalence (reference standard) and, in some instances, the in vitro bioequivalence of the applicant's product is compared. By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. Such variations could result if generic drugs were compared to different reference listed drugs. However, in some instances when listed drugs are approved for a single drug product, a product not designated as the reference listed drug and not shown to be bioequivalent to the reference listed drug may be shielded from generic competition. A firm wishing to market a generic version of a listed drug that is not designated as the reference listed drug may petition the Agency through the Citizen Petition procedure (see 21 CFR 10.25(a) and CFR 10.30). When the Citizen Petition is approved, the second listed drug will be designated as an additional reference listed drug and the petitioner may submit an Abbreviated New Drug Application citing the designated reference listed drug. Section 1.7, Therapeutic Equivalence Evaluations Codes products meeting necessary bioequivalence requirements explains the (AB, AB1, AB2, AB3... coding system for multisource drug products listed under the same heading with two reference listed drugs. In addition, there are two situations in which two listed drugs that have been shown to be bioequivalent to each other may both be designated as reference listed drugs. The first situation occurs when the in vivo determination of bioequivalence is self-evident and a waiver of the in vivo bioequivalence may be granted. The second situation occurs when the bioequivalence of two listed products may be determined through in vitro methodology. The reference listed drug is identified by the symbol "+" in the Prescription and Over-the-Counter (OTC) Drug Product Lists. These identified reference listed drugs represent the best judgment of the Division of Bioequivalence at this time. The Prescription and OTC Drug Product Lists identify reference drugs for oral dosage forms, Injectables, ophthalmics, otics, and topical products. It is recommended that a firm planning to conduct an in vivo bioequivalence study, or planning to manufacture a batch of a drug product for which an in vivo waiver of bioequivalence will be requested, contact the Division of Bioequivalence, Office of Generic Drugs, to confirm the appropriate reference listed drug.
1.5 General Policies and Legal Status The List contains public information and advice. It does not mandate the drug products which is purchased, prescribed, dispensed, or substituted for one another, nor does it, conversely, mandate the products that should be avoided. To the extent that the List sets forth FDA's evaluations of the therapeutic equivalence of drug products that have been approved, it contains FDA's advice to the public, to practitioners and to the states regarding drug product selection. These evaluations do not constitute determinations that any product is in violation of the Act or that any product is preferable to any other. Therapeutic equivalence evaluations are a scientific judgment based upon evidence, while generic substitution may involve social and economic policy administered by the states, intended to reduce the cost of drugs to consumers. To the extent that the List identifies drug products approved under Section 505 of the Act, it sets forth information that the Agency is required to publish and that the public is entitled to under the Freedom of Information Act. Exclusion of a drug product from the List does not necessarily mean that the drug product is either in violation of Section 505 of the Act, or that such a product is not safe or effective, or that such a product is not therapeutically equivalent to other drug products. Rather, the exclusion is based on the fact that FDA has not evaluated the safety, effectiveness, and quality of the drug product. 1.6 Practitioner/User Responsibilities
Professional care and judgment should be exercised in using the List. Evaluations of therapeutic equivalence for prescription drugs are based on scientific and medical evaluations by FDA. Products evaluated as therapeutically equivalent can be expected, in the judgment of FDA, to have equivalent clinical effect and no difference in their potential for adverse effects when used under the conditions of their labeling. However, these products may differ in other characteristics such as shape, scoring configuration, release mechanisms, packaging, excipients (including colors, flavors, preservatives), expiration date/time, and, in some instances, labeling. If products with such differences are substituted for each other, there is a potential for patient confusion due to differences in color or shape of tablets, inability to provide a given dose using a partial tablet if the proper scoring configuration is not available, or decreased patient acceptance of certain products because of flavor. There may also be better stability of one product over another under adverse storage conditions, or allergic reactions in rare cases due to a coloring or a preservative ingredient, as well as differences in cost to the patient. FDA evaluation of therapeutic equivalence in no way relieves practitioners of their professional responsibilities in prescribing and dispensing such products with due care and with appropriate information to individual patients. In those circumstances where the characteristics of a specific product, other than its active ingredient, are important in the therapy of a particular patient, the physician's specification of that product is appropriate. Pharmacists must also be familiar with the expiration dates/times and labeling directions for storage of the different products, particularly for reconstituted products, to assure that patients are properly advised when one product is substituted for another. Multisource and single-source drug products. FDA has evaluated for therapeutic equivalence only multisource prescription drug products approved under Section 505 of the Act, which in most instances means those pharmaceutical equivalents available from more than one manufacturer. For such products, a therapeutic equivalence code is included and, in addition, product information is highlighted in bold face and underlined. Those products with approved applications that are single-source (i.e., there is only one approved product available for that active ingredient, dosage form, route of administration, and strength) are also included on the List, but no
xi
therapeutic equivalence code is included with such products. Any drug product in the List repackaged and/or distributed by other than the application holder is considered to be therapeutically equivalent to the application holder's drug product even if the application holder's drug product is single source or coded as non-equivalent (e.g., BN). Also, although not identified in the List, distributors or repackagers of an application holder's drug product are considered to have the same code as the application holder. The details of these codes and the policies underlying them are discussed in Section 1.7, Therapeutic Equivalence Evaluations Codes. Products on the List are identified by the names of the holders of approved applications (applicants) who may not necessarily be the manufacturer of the product. The applicant may have had its product manufactured by a contract manufacturer and may simply be distributing the product for which it has obtained approval. In most instances, however, the manufacturer of the product is also the applicant. The name of the manufacturer is permitted by regulation to appear on the label, even when the manufacturer is not the marketer. Although the products on the List are identified by the names of the applicants, circumstances, such as changing corporate ownership, have sometimes made identification of the applicant difficult. The Agency believes, based on continuing document review and communication with firms, that the applicant designations on the List are, in most cases, correct. To relate firm name information on a product label to that on the List, the following should be noted: the applicant's name always appears on the List. This applies whether the applicant (firm name on the Form FDA 356h in the application) is the marketer (firm name in largest letters on the label) or not. However, the applicant's name may not always appear on the label of the product. If the applicant is the marketer, its name appears on the List and on the label; if the applicant is not the marketer, and the Agency is aware of a corporate relationship (e.g., parent and subsidiary) between the applicant and the marketer, the name of the applicant appears on the List and both firm names may appear on the label. Firms with known corporate relationships are displayed in Appendix B. If there is no known corporate relationship between the applicant and the marketer, the applicant's name appears on the List; however, unless the applicant is the manufacturer, packager, or distributor, the applicant's name may not appear on the label. In this case, the practitioner, from labeling alone, will not be able to relate the marketed product to an applicant cited in the List, and hence to a specific approved drug product. In such cases, to assure that the product in question is the subject of an approved application, the firm named on the label should be contacted. To relate trade name (proprietary name) information on a product label to that on the List, the following should be noted: if the applicant is the marketer, its name appears on the List and on the label; if the Agency is aware of a corporate relationship between the applicant and the marketer, the trade name (proprietary name) of the drug product (established drug name if no trade name exists) appears on the List. If a corporate relationship exists between an application holder and a marketer and both firms are distributing the drug product, the FDA reserves the right to select the trade name of either the marketer or the application holder to appear on the List. If there is no known corporate relationship between the applicant and the marketer, the established drug name appears on the List. Every product on the List is subject at all times to regulatory action. From time to time, approved products may be found in violation of one or more provisions of the Act. In such circumstances, the Agency will commence appropriate enforcement action to correct the violation, if necessary, by securing removal of the product from the market by voluntary recall, seizure, or other enforcement actions. Such regulatory actions are, however,
xii
independent of the inclusion of a product on the List. The main criterion for inclusion of a product is that it has an application with an effective approval that has not been withdrawn for safety or efficacy reasons. FDA believes that retention of a violative product on the List will not have any significant adverse health consequences, because other legal mechanisms are available to the Agency to prevent the product's actual marketing. FDA may however, change a product's therapeutic equivalence rating if the circumstances giving rise to the violation change or otherwise call into question the data upon which the Agency's assessment of whether a product meets the criteria for therapeutic equivalence was made.
1.7 Therapeutic Equivalence Evaluations Codes The coding system for therapeutic equivalence evaluations is constructed to allow users to determine quickly whether the Agency has evaluated a particular approved product as therapeutically equivalent to other pharmaceutically equivalent products (first letter) and to provide additional information on the basis of FDA's evaluations (second letter). With few exceptions, the therapeutic equivalence evaluation date is the same as the approval date. The two basic categories into which multisource drugs have been placed are indicated by the first letter as follows: A Drug products that FDA considers to be therapeutically equivalent to other pharmaceutically equivalent products, i.e., drug products for which: (1) there are no known or suspected bioequivalence problems. These are designated AA, AN, AO, AP, or AT, depending on the dosage form; or (2) actual or potential bioequivalence problems have been resolved with adequate in vivo and/or in vitro evidence supporting bioequivalence. These are designated AB. B Drug products that FDA at this time, considers not to be therapeutically equivalent to other pharmaceutically equivalent products, i.e., drug products for which actual or potential bioequivalence problems have not been resolved by adequate evidence of bioequivalence. Often the problem is with specific dosage forms rather than with the active ingredients. These are designated BC, BD, BE, BN, BP, BR, BS, BT, BX, or B*. Individual drug products have been evaluated as therapeutically equivalent to the reference product in accordance with the definitions and policies outlined below: "A" CODES Drug products that are considered to be therapeutically equivalent to other pharmaceutically equivalent products. "A" products are those for which actual or potential bioequivalence problems have been resolved with adequate in vivo and/or in vitro evidence supporting bio-equivalence. Drug products designated with an "A" code fall under one of two main policies: (1) for those active ingredients or dosage forms for which no in vivo bioequivalence issue is known or suspected, the information necessary to show bioequivalence between pharmaceutically equivalent products is presumed and considered self-evident based on other data in the
xiii
application for some dosage forms (e.g., solutions) or satisfied for solid oral dosage forms by a showing that an acceptable in vitro dissolution standard is met. A therapeutically equivalent rating is assigned such products so long as they are manufactured in accordance with Current Good Manufacturing Practice regulations and meet the other requirements of their approved applications (these are designated AA, AN, AO, AP, or AT, depending on the dosage form, as described below); or (2) for those DESI drug products containing active ingredients or dosage
forms that have been identified by FDA as having actual or potential
bioequivalence problems, and for post-1962 drug products in a dosage
form presenting a potential bioequivalence problem, an evaluation of
therapeutic equivalence is assigned to pharmaceutical equivalents only
if the approved application contains adequate scientific evidence
establishing through in vivo and/or in vitro studies the bioequivalence
of the product to a selected reference product (these products are
designated as AB).
There are some general principles that may affect the substitution of pharmaceutically equivalent products in specific cases. Prescribers and dispensers of drugs should be alert to these principles so as to deal appropriately with situations that require professional judgment and discretion. There may be labeling differences among pharmaceutically equivalent products that require attention on the part of the health professional. For example, pharmaceutically equivalent powders to be reconstituted for administration as oral or injectable liquids may vary with respect to their expiration time or storage conditions after reconstitution. An FDA evaluation that such products are therapeutically equivalent is applicable only when each product is reconstituted, stored, and used under the conditions specified in the labeling of that product. The Agency will use notes in this publication to point out special situations such as potential differences between two drug products that have been evaluated as bioequivalent and otherwise therapeutically equivalent, when they should be brought to the attention of health professionals. These notes are contained in Section 1.8, Description of Special Situations. For example, in rare instances, there may be variations among therapeutically equivalent products in their use or in conditions of administration. Such differences may be due to patent or exclusivity rights associated with such use. When such variations may, in the Agency's opinion, affect prescribing or substitution decisions by health professionals, a note will be added to Section 1.8. Also, occasionally a situation may arise in which changes in a listed drug product after its approval (for example, a change in dosing interval) may have an impact on the substitutability of already approved generic versions of that product that were rated by the Agency as therapeutically equivalent to the listed product. When such changes in the listed drug product are considered by the Agency to have a significant impact on therapeutic equivalence, the Agency will change the therapeutic equivalence ratings for other versions of the drug product unless the manufacturers of those other versions of the product provide additional information to assure equivalence under the changed conditions. Pending receipt of the additional data, the Agency may add a note to Section 1.8, or, in rare cases, may even change the therapeutic equivalence rating. In some cases (e.g., Isolyte S w/ Dextrose 5% in Plastic Container and Plasma-Lyte 148 and Dextrose 5% in Plastic Container), closely related products are listed as containing the same active ingredients, but in somewhat different amounts. In determining which of these products are pharmaceutically equivalent, the Agency has considered products to be
xiv
pharmaceutically equivalent with labeled strengths of an ingredient that do not vary by more than 1%. Different salts and esters of the same therapeutic moiety are regarded as pharmaceutical alternatives. For the purpose of this publication, such products are not considered to be therapeutically equivalent. There are no instances in this List where pharmaceutical alternatives are evaluated or coded with regard to therapeutic equivalence. Anhydrous and hydrated entities, as well as different polymorphs, are considered pharmaceutical equivalents and must meet the same standards and, where necessary, as in the case of ampicillin/ampicillin trihydrate, their equivalence is supported by appropriate bioavailability/bioequivalence studies. The codes in this book are not intended to preclude health care professionals from converting pharmaceutically different concentrations into pharmaceutical equivalents using accepted professional practice. Where package size variations have therapeutic implications, products so packaged have not been considered pharmaceutically equivalent. For example, some oral contraceptives are supplied in 21-tablet and 28-tablet packets; the 28-tablet packets contain 7 placebo or iron tablets. These two packaging configurations are not regarded as pharmaceutically equivalent; thus, they are not designated as therapeutically equivalent. Preservatives may differ among some therapeutically equivalent drug products. Differences in preservatives and other inactive ingredients do not affect FDA's evaluation of therapeutic equivalence except in cases where these components may influence bioequivalence or routes of administration. The specific sub-codes for those drugs evaluated as therapeutically equivalent and the policies underlying these sub-codes follow: AA Products in conventional dosage forms not presenting bioequivalence problems Products coded as AA contain active ingredients and dosage forms that are not regarded as presenting either actual or potential bioequivalence problems or drug quality or standards issues. However, all oral dosage forms must, nonetheless, meet an appropriate in vitro bioequivalence standard that is acceptable to the Agency in order to be approved. AB, AB1, AB2, AB3... Products meeting necessary bioequivalence requirements Multisource drug products listed under the same heading (i.e., identical active ingredients(s), dosage form, and route(s) of administration) and having the same strength (see Section 1.2, Therapeutic Equivalence-Related Terms, Pharmaceutical Equivalents) generally will be coded AB if a study is submitted demonstrating bioequivalence. In certain instances, a number is added to the end of the AB code to make a three character code (i.e., AB1, AB2, AB3, etc.). Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the same heading. Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against. For example, Adalat CC (Miles) and Procardia XL (Pfizer), extendedrelease tablets, are listed under the active ingredient nifedipine. These drug products, listed under the same heading, are not bioequivalent to each other. Generic drug products deemed by FDA to be bioequivalent to Adalat CC and Procardia XL have been approved, Adalat CC and Procardia XL have been assigned ratings of AB1 and AB2, respectively. The generic
xv
drug products bioequivalent to Adalat CC would be assigned a rating of AB1 and those bioequivalent to Procardia XL would be assigned a rating of AB2. (The assignment of an AB1 or AB2 rating to a specific product does not imply product preference.) Even though drug products of distributors and/or repackagers are not included in the List, they are considered therapeutically equivalent to the application holder's drug product if the application holder's drug product is rated either with an AB or threecharacter code or is single source in the List. Drugs coded as AB under a heading are considered therapeutically equivalent only to other drugs coded as AB under that heading. Drugs coded with a three-character code under a heading are considered therapeutically equivalent only to other drugs coded with the same three-character code under that heading. AN Solutions and powders for aerosolization Uncertainty regarding the therapeutic equivalence of aerosolized products arises primarily because of differences in the drug delivery system. Solutions and powders intended for aerosolization that are marketed for use in any of several delivery systems are considered to be pharmaceutically and therapeutically equivalent and are coded AN. Those products that are compatible only with a specific delivery system or those products that are packaged in and with a specific delivery system are coded BN, unless they have met an appropriate bioequivalence standard. Solutions or suspensions in a specific delivery system will be coded AN if the bioequivalence standard is based upon in vitro methodology, if bioequivalence needs to be demonstrated by in vivo methodology then the drug products will be coded AB.
AO Injectable oil solutions The absorption of drugs in injectable (parenteral) oil solutions may vary substantially with the type of oil employed as a vehicle and the concentration of the active ingredient. Injectable oil solutions are therefore considered to be pharmaceutically and therapeutically equivalent only when the active ingredient, its concentration, and the type of oil used as a vehicle are all identical.
AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions It should be noted that even though injectable (parenteral) products under a specific listing may be evaluated as therapeutically equivalent, there may be important differences among the products in the general category, Injectable; Injection. For example, some injectable products that are rated therapeutically equivalent are labeled for different routes of administration. In addition, some products evaluated as therapeutically equivalent may have different preservatives or no preservatives at all. Injectable products available as dry powders for reconstitution, concentrated sterile solutions for dilution, or sterile solutions ready for injection are pharmaceutical alternative drug products. They are not rated as therapeutically equivalent (AP) to each other even if these pharmaceutical alternative drug products are designed to produce the same concentration prior to injection and are similarly labeled. Consistent with accepted professional practice, it is the responsibility of the prescriber, dispenser, or individual administering the product to be familiar with a product's labeling to assure that it is given only by the route(s) of administration stated in the labeling. Certain commonly used large volume intravenous products in glass containers are not included on the List (e.g., dextrose injection 5%,
xvi
dextrose injection 10%, sodium chloride injection 0.9%) since these products are on the market without FDA approval and the FDA has not published conditions for marketing such parenteral products under approved NDAs. When packaged in plastic containers, however, FDA regulations require approved applications prior to marketing. Approval then depends on, among other things, the extent of the available safety data involving the specific plastic component of the product. All large volume parenteral products are manufactured under similar standards, regardless of whether they are packaged in glass or plastic. Thus, FDA has no reason to believe that the packaging container of large volume parenteral drug products that are pharmaceutically equivalent would have any effect on their therapeutic equivalence. The strength of parenteral drugs products is defined as the total drug content of the container. Until recently the strength of liquid parenteral drug products in the Orange Book have not been displayed. The concentration of the liquid parenteral drug product in the Orange Book has been shown as xmg/ml. The amount of dry powder or freeze dried powder in a container has always been identified as the strength. With the finalization of the Waxman-Hatch amendments that characterized each strength of a drug product as a listed drug, it became evident that the format of the Orange Book should be changed to reflect each strength of a parenteral solution. To this end the OGD has started to display the strength of all new approvals of parenteral solutions. Previously we would have displayed only the concentration of an approved parenteral solution, e.g. 50mg/ml. If this drug product had a 20 ml and 60 ml container approved the two products would be shown as 1Gm / 20ml (50mg/ml) and 3Gm / 60ml (50mg/ml).
AT Topical products There are a variety of topical dosage forms available for dermatologic, ophthalmic, otic, rectal, and vaginal administration, including creams, gels, lotions, oils, ointments, pastes, solutions, sprays and suppositories. Even though different topical dosage forms may contain the same active ingredient and potency, these dosage forms are not considered pharmaceutically equivalent. Therefore, they are not considered therapeutically equivalent. All solutions and DESI drug products containing the same active ingredient in the same topical dosage form for which a waiver of in vivo bioequivalence has been granted and for which chemistry and manufacturing processes are adequate to demonstrate bioequivalence, are considered therapeutically equivalent and coded AT. Pharmaceutically equivalent topical products that raise questions of bioequivalence, including all post-1962 non-solution topical drug products, are coded AB when supported by adequate bioequivalence data, and BT in the absence of such data.
"B" CODES Drug products that FDA, at this time, considers not to be therapeutically equivalent to other pharmaceutically equivalent products. "B" products, for which actual or potential bioequivalence problems have not been resolved by adequate evidence of bioequivalence, often have a problem with specific dosage forms rather than with the active ingredients. Drug products designated with a "B" code fall under one of three main policies: (1) the drug products contain active ingredients or are manufactured in dosage forms that have been identified by the Agency as having documented bio-equivalence problems or a significant potential for
xvii
such problems and for which no adequate studies demonstrating bioequivalence have been submitted to FDA; or (2) (3) the quality standards are inadequate or FDA has an insufficient basis to determine therapeutic equivalence; or the drug products are under regulatory review.
The specific coding definitions and policies for the "B" sub-codes are as follows:
B* Drug products requiring further FDA investigation and review to determine therapeutic equivalence The code B* is assigned to products previously assigned an A or B code when FDA receives new information that raises a significant question regarding therapeutic equivalence that can be resolved only through further Agency investigation and/or review of data and information submitted by the applicant. The B* code signifies that the Agency will take no position regarding the therapeutic equivalence of the product until the Agency completes its investigation and review. BC Extended-release dosage forms (capsules, injectables and tablets) Extended-release tablets are formulated in such a manner as to make the contained medicament available over an extended period of time following ingestion. Although bioavailability studies have been conducted on these dosage forms, they may be subject to bioavailability differences, primarily because firms developing extended-release products for the same active ingredient rarely employ the same formulation approach. FDA, therefore, does not consider different extended-release dosage forms containing the same active ingredient in equal strength to be therapeutically equivalent unless equivalence between individual products in both rate and extent has been specifically demonstrated through appropriate bioequivalence studies. Extended-release products for which such bioequivalence data have not been submitted are coded BC, while those for which such data are available have been coded AB.
BD Active ingredients and dosage forms with documented bioequivalence problems The BD code denotes products containing active ingredients with known bioequivalence problems and for which adequate studies have not been submitted to FDA demonstrating bioequivalence. Where studies showing bioequivalence have been submitted, the product has been coded AB.
BE Delayed-release oral dosage forms Where the drug may be destroyed or inactivated by the gastric juice or where it may irritate the gastric mucosa, the use of enteric coatings is indicated. Such coatings are intended to delay the release of the medication until the tablet has passed through the stomach. Drug products in delayed-release dosage forms containing the same active ingredients are subject to significant differences in absorption. Unless otherwise specifically noted, the Agency considers different delayed-release products containing the same active ingredients as presenting a potential bioequivalence problem and codes these products BE in the absence of in vivo studies showing bioequivalence. If adequate in vivo studies have
xviii
demonstrated the bioequivalence of specific delayed-release products, such products are coded AB.
BN Products in aerosol-nebulizer drug delivery systems This code applies to drug solutions or powders that are marketed only as a component of, or as compatible with, a specific drug delivery system. There may, for example, be significant differences in the dose of drug and particle size delivered by different products of this type. Therefore, the Agency does not consider different metered aerosol dosage forms containing the same active ingredient(s) in equal strengths to be therapeutically equivalent unless the drug products meet an appropriate bioequivalence standard, such products are coded AB.
BP Active ingredients and dosage forms with potential bioequivalence problems FDA's bioequivalence regulations (21 CFR 320.33) contain criteria and procedures for determining whether a specific active ingredient in a specific dosage form has a potential for causing a bioequivalence problem. It is FDA's policy to consider an ingredient meeting these criteria as having a potential bioequivalence problem even in the absence of positive data demonstrating inequivalence. Pharmaceutically equivalent products containing these ingredients in oral dosage forms are coded BP until adequate in vivo bioequivalence data are submitted, such products are coded AB. Injectable suspensions containing an active ingredient suspended in an aqueous or oleaginous vehicle have also been coded BP. Injectable suspensions are subject to bioequivalence problems because differences in particle size, polymorphic structure of the suspended active ingredient, or the suspension formulation can significantly affect the rate of release and absorption. FDA does not consider pharmaceutical equivalents of these products bioequivalent without adequate evidence of bioequivalence, such products would be coded AB.
BR Suppositories or enemas that deliver drugs for systemic absorption The absorption of active ingredients from suppositories or enemas that are intended to have a systemic effect (as distinct from suppositories administered for local effect) can vary significantly from product to product. Therefore, FDA considers pharmaceutically equivalent systemic suppositories or enemas bio-equivalent only if in vivo evidence of bioequivalence is available. In those cases where in vivo evidence is available, the product is coded AB. If such evidence is not available, the products are coded BR.
BS Products having drug standard deficiencies If the drug standards for an active ingredient in a particular dosage form are found by FDA to be deficient so as to prevent an FDA evaluation of either pharmaceutical or therapeutic equivalence, all drug products containing that active ingredient in that dosage form are coded BS. For example, if the standards permit a wide variation in pharmacologically active components of the active ingredient such that pharmaceutical equivalence is in question, all products containing that active ingredient in that dosage form are coded BS.
xix
BT Topical products with bioequivalence issues This code applies mainly to post-1962 dermatologic, ophthalmic, otic, rectal, and vaginal products for topical administration, including creams, ointments, gels, lotions, pastes, and sprays, as well as suppositories not intended for systemic drug absorption. Topical products evaluated as having acceptable clinical performance, but that are not bioequivalent to other pharmaceutically equivalent products or that lack sufficient evidence of bioequivalence, will be coded BT.
BX Drug products for which the data are insufficient to determine therapeutic equivalence The code BX is assigned to specific drug products for which the data that have been reviewed by the Agency are insufficient to determine therapeutic equivalence under the policies stated in this document. In these situations, the drug products are presumed to be therapeutically inequivalent until the Agency has determined that there is adequate information to make a full evaluation of therapeutic equivalence.
1.8 Description of Special Situations Certain drugs listed in the Orange Book present special situations that merit further discussion. Following is a description of those special situations: Amino Acid and Protein Hydrolysate Injections. These products differ in the amount and kinds of amino acids they contain and, therefore, are not considered pharmaceutical equivalents. For this reason, these products are not considered therapeutically equivalent. At the same time, the Agency believes that it is appropriate to point out that where nitrogen balance is the sole therapeutic objective and individual amino acid content is not a consideration, pharmaceutical alternatives with the same total amount of nitrogen content may be considered therapeutically equivalent. Follitropin Alfa and Beta. Based on available data derived from physico chemical tests and bioassay, follitropin alfa and follitropin beta are indistinguishable. Gaviscon. Gaviscon is an OTC product which has been marketed since September 1970. The active ingredients in this product, aluminum hydroxide and magnesium trisilicate, were reviewed by the Agency's OTC Antacid Panel and were considered to be safe and effective ingredients (Category I) by that Panel. However, the tablet failed to pass the antacid test which is required of all antacid products. The Agency, therefore, placed the tablet in Category III for lack of effectiveness. A full NDA with clinical studies was submitted by Marion Laboratories, Inc., and approved by FDA on December 9, 1983. Gaviscons activity in treating reflux acidity is made possible by the physical-chemical properties of the inactive ingredients, sodium bicarbonate and alginic acid. Therefore, all ANDAs which cite Gaviscon tablets as the listed drug must contain the inactive ingredients sodium bicarbonate and alginic acid. A full NDA will be required to support the effectiveness of the drug product if different inactive ingredients are to be substituted for sodium bicarbonate or alginic acid or if different proportions of these ingredients are to be used. Levothyroxine Sodium. Because there are multiple reference listed drugs of levothyroxine sodium tablets and some reference listed drugs' sponsors have conducted studies to establish their drugs' therapeutic equivalence to other reference listed drugs, FDA has determined that its usual practice of assigning two or three character TE codes may be potentially confusing and inadequate for these drug products. Accordingly, FDA provides the following explanation and chart of therapeutic equivalence evaluations for levothyroxine
xx
sodium drug products. Levothyroxine Sodium (Mylan ANDA 76187) tablets have been determined to be therapeutically equivalent to corresponding strengths of Unithroid (Jerome Stevens NDA 021210) tablets. Levo-T (Alara NDA 021342), Levothyroxine Sodium (Mylan ANDA 76187), Unithroid (Jerome Stevens NDA 021210), and Levothyroxine Sodium (Merck KGAA ANDA 76752)tablets have been determined to be therapeutically equivalent to corresponding strengths of Synthroid (Abbott NDA 021402) tablets. Levo-T (Alara NDA 021342), Unithroid (Jerome Stevens NDA 021210), Levothyroxine Sodium (Mylan ANDA 076187), and Levothyroxine Sodium (Merck KGAA ANDA 76752) tablets have been determined to be therapeutically equivalent to corresponding strengths of Levoxyl (King Pharms NDA 021301) tablets. Levothyroxine Sodium (Mylan ANDA 76187) tablets have been determined to be therapeutically equivalent to corresponding strengths of Levothroid (Lloyd NDA 021116) tablets. The chart outlines TE codes for all 0.025mg products. Other product strengths may be similar. Therapeutic equivalence has been established between products that have the same AB+number TE code. More than one TE code may apply to some products. One common TE code indicates therapeutic equivalence between products. Trade Name
UNITHROID LEVOTHYROXINE SODIUM LEVOXYL SYNTHROID LEVO-T
Applicant
STEVENS J MYLAN KING PHARMS ABBOTT ALARA PHARM
Potency
0.025MG 0.025MG 0.025MG 0.025MG 0.025MG
TE Code
AB1 AB1 AB1 AB1 AB1
Appl No
021210 076187 021301 021402 021342
Product No
001 001 001 001 001
SYNTHROID LEVOTHYROXINE SODIUM LEVO-T UNITHROID LEVOTHYROXINE SODIUM
ABBOTT MYLAN ALARA PHARM STEVENS J MERCK KGAA
0.025MG 0.025MG 0.025MG 0.025MG 0.025MG
AB2 AB2 AB2 AB2 AB2
021402 076187 021342 021210 076752
001 001 001 001 001
LEVOXYL LEVO-T UNITHROID LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM
KING PHARMS ALARA PHARM STEVENS J MYLAN MERCK KGAA
0.025MG 0.025MG 0.025MG 0.025MG 0.025MG
AB3 AB3 AB3 AB3 AB3
021301 021342 021210 076187 076752
001 001 001 001 001
LEVOTHROID LEVOTHYROXINE SODIUM
LLOYD MYLAN
0.025MG 0.025MG
AB4 AB4
021116 076187
001 001
Patent Certification(s) Reference Listed Drug based upon a suitability petition. An abbreviated new drug application that refers to a Reference Listed Drug (RLD) approved pursuant to a suitability petition must demonstrate that the proposed product is bioequivalent to the RLD, and it must include appropriate patent certification(s) and an exclusivity statement with respect to the listed drug which served as the basis for the approved suitability petition. This concept also applies to an ANDA applicant that cites a RLD that was based upon an NDA that is still covered by patent (s) and/or
xxi
exclusivity, e.g. a second RLD that was selected when the in vivo determination of bioequivalence of the original RLD is self evident and the waiver of the in vivo determination of bioequivalence may be granted. Waived exclusivity. If a new drug application (NDA) submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (Act) qualifies for exclusivity under sections 505(c)(3)(D) and 505(j)(5)(D), the exclusivity is listed in the Patent and Exclusivity Section of the Orange Book. If a drug product has received this exclusivity, the FDA will delay the approval of a 505(b)(2) application or an abbreviated new drug application (ANDA) under section 505(j) of the Act until the expiration of the exclusivity. If the listed drug is also protected by one or more patents, the approval date for the 505(b)(2) application or ANDA will be determined by the latest expiring patent or exclusivity listed in the Orange Book. However, the holder of the NDA may waiver its exclusivity as to any or all 505(b)(2) and ANDA applications referencing the protected drug product. If an NDA sponsor waivers its right to the exclusivity protection, qualified 505(b)(2) or ANDA applications may be approved without regard to the NDA holder's exclusivity. An NDA for which the holder has waived its exclusivity as to all 505(b)(2) and ANDA applications will be coded with a W in the Patent and Exclusivity Section of the Orange Book and be referred to this section. The applicant referencing this listed drug should indicate in the exclusivity statement that the holder of the listed drug has waived its exclusivity.
1.9 Therapeutic Equivalence Code Change for a Drug Entity The Agency will use the following procedures when, in response to a petition or on its own initiative, it is considering a change in the therapeutic equivalence code for approved multi-source drug products. Such changes will generally occur when the Agency becomes aware of new scientific information affecting the therapeutic equivalence of an entire category of drug products in the List (e.g., information concerning the active ingredient or the dosage form), rather than information concerning a single drug product within the category. These procedures will be used when a change in therapeutic equivalence code is under consideration for all drug products found in the Prescription Drug Product List under a specific drug entity and dosage form. The change may be from the code signifying that the drug does not present a bioequivalence problem (e.g., AA) to a code signifying a bioequivalence problem (e.g., BP), or vice versa. This procedure does not apply to a change of a particular product code (e.g., a change from BP to AB or from AB to BX). Before making a change in a therapeutic equivalence code for an entire category of drugs, the Agency will announce in the Introduction to the Cumulative Supplement that it is considering the change and will invite comment. Comments, along with scientific data, may be sent to the Director, Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, HFD-650, 7620 Standish Place, Rockville, MD 20855. The comment period will generally be 60 days in length, and the closing date for comments will be listed in the description of the proposed change for each drug entity. The most useful type of scientific data submission is an in vivo bioavailability/bioequivalence study conducted on batches of the subject drug products. These submissions should present a full description of the analytical procedures and equipment used, a validation of the analytical methodology, including the standard curve, a description of the method of calculating results, and a description of the pharmacokinetic and statistical models used in analyzing the data. Anecdotal or testimonial information is the least useful to the Agency, and such submissions are discouraged. Copies
xxii
of supporting reports published in the scientific literature or unpublished material, however, are welcome.
1.10 Change of the Therapeutic Equivalence Evaluation for a Single Product The aforementioned procedure does not apply to a change in a single drug product code. For example, a change in a single drug product's code from BP to AB as a result of the submission of an acceptable bioequivalence study ordinarily will not be the subject of notice and comment. Likewise, a change in a single drug product's code from AB to BX (e.g., as a result of new information raising a significant question as to bioequivalence) does not require notice and comment. The Agency's responsibility to provide the public with the Agency's most current information related to therapeutic equivalence may require a change in a drug product's code prior to any formal notice and opportunity for the applicant to be heard. The publication in the Federal Register of a proposal to withdraw approval of a drug product will ordinarily result in a change in a product's code from AB to BX if this action has not already been taken. 1.11 Discontinued Section Those drug products in the Discontinued Section of the Orange Book in which a determination has already been made that the products were not withdrawn for safety or efficacy reasons have **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** following the product strength. Those drug products are only reflective of citizen petitions determinations made since 1995. The identification of these drug products in the Discontinued Section of the Orange Book should avoid the submission of multiple citizen petitions for the same drug product. FR notices no longer applicable are removed from the Annual Edition (i.e., there is a currently marketed Reference Listed Drug and no applicable patent or exclusivity). FR Safety or Effectiveness Determinations List lists products that have current and removed notices. The list is updated quarterly. Notices issued during the year are added to the Electronic Orange Book Query in the month they become effective. Generally, approved products are added to the Discontinued Section of the Orange Book when the applicant holder notifies the Orange Book staff of the products not marketed status. Products may also be added if annual reports indicate the product is no longer marketed or other Agency administrative action (e.g., Withdrawal of an Application). Changes to the Orange Book are not affected by the drug registration and listing requirements of Section 510 of the Act. 1.12 Changes to the Orange Book Every effort is made to ensure the Annual Edition is current and accurate. Applicant holders are requested to inform the FDA Orange Book Staff (OBS) of any changes or corrections. Please inform the OBS when products are no longer marketed. Notification of the Orange Book staff to include the newly approved product in the Discontinued Drug Product List rather than parts 1, 2 or 3 of the List (as discussed in Section 1.1) must occur by the end of the month in which the product is approved to ensure that the product is not included in the active portions of the next published Orange Book update We can be contacted by email at drugproducts@fda.hhs.gov. FAX: 240-276-8974; mail to: FDA/CDER Orange Book Staff Office of Generic Drugs, HFD-610 7620 Standish Place Rockville, MD 20855 Send Changes by
xxiii
1.13 Availability of the Edition Commencing with the 25th edition, the Annual Edition and current monthly Cumulative Supplement are available in a Portable Document Format (PDF) at the EOB home page, Electronic Orange Book Query, by clicking on Publications. The PDF annual format duplicates previous paper versions except for the Orphan Products Designations and Approvals List. An annual subscription of the PDF format may be obtained from the U.S. Government Printing Office, 866-512-1800.
xxiv
2. HOW TO USE THE DRUG PRODUCT LISTS

2.1 Key Sections for Using the Drug Product Lists
This publication contains illustrations, along with Drug Product Lists, indices, and lists of abbreviations and terms which facilitate their use. Illustrations. The annotated Drug Product Illustration, see Section 2.2, and the Therapeutic Equivalence Evaluations Illustration, see Section 2.3, are offered to provide further clarification. These depict the format found in the Prescription Drug Product List (the only list in which therapeutic equivalence evaluation codes are displayed). Drug Product Lists. The Prescription and OTC Drug Product Lists, arranged alphabetically by active ingredient(s), contain product identification information (active ingredients, dosage forms, routes of administration, product names, application holders, strengths) for single and multiple ingredient drug products. Also shown are the application number and drug product number (FDA internal computer data use only) and approval dates for those drug products approved on or after January 1, 1982. The application number preceded by N is a New Drug Application (NDA or commonly the innovator). The application number preceded by an A is an Abbreviated New Drug Application (ANDA or commonly the generic). The Discontinued Product List, arranged alphabetically by active ingredient(s), contains product identification information (dosage form, product name, strength, and application number). If a prescription drug product is available from more than one source (multisource), a therapeutic equivalence code will appear in front of the applicant's name. If a product is therapeutically equivalent to one or more products or to an appropriate reference, it will be designated with a code beginning with "A" and the entry will be underlined and printed in bold font for emphasis. Active ingredient headings for multiple ingredient (combination) drug products are arranged alphabetically. For purposes of this publication, this alphabetical sort takes precedence over United States Pharmacopeia official monograph order (i.e., Reserpine, Hydralazine Hydrochloride, Hydrochlorothiazide). For example, product information labeled as Reserpine, Hydrochlorothiazide and Hydralazine Hydrochloride appears under the active ingredient heading Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine. A cross-reference to the product information (for prescription and OTC products) appears for each additional active ingredient in the product. For combination drug products, the ingredient strengths are separated by semicolons and appear in the same relative sequence as the ingredients in the heading. Available strengths of the dosage form from an applicant appear on separate lines. To use the Drug Product Lists, determine by alphabetical order the ingredient under which the product information is listed, using the Product Name Index, if necessary. Then, find the ingredient in the applicable Drug Product List. Proceed to the dosage form and route of administration and compare products within that ingredient heading only. Therapeutic equivalence or inequivalence for prescription products is determined on the basis of the therapeutic equivalence codes provided within that specific dosage form and route heading. The OTC Drug Product List, Discontinued Drug Product List, and
2-1
Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research List have their data arranged similarly. The Discontinued Drug Product List contains approved products that have never been marketed, have been discontinued from marketing, are for military use, or have had their approvals withdrawn for other than safety or efficacy reasons subsequent to being discontinued from marketing. All products having a "@" in the 12th Cumulative Supplement of the 32nd Edition List have been added to the Discontinued Drug Product List appearing in the 33rd Edition. In addition, approved drug products that are not in the commercial distribution channel e.g., approved drug products in applications for export only are also listed in the Discontinued Section of the Orange Book. Product Name Index (Prescription and OTC Drug Product Lists). This is an index of drug products by established or trade name. The second term of each entry indicates the active ingredient name under which product information can be found in the appropriate Drug Product List. For those drug products with multiple active ingredients, only the first active ingredient (in alphabetical order) will appear. OTC products are so designated. Product Name Index Listed by Applicant (Prescription and OTC Drug Product Lists). This is an index that cross-references applicants to drug products. The bolded and underlined entry represents the applicant name abbreviation used in this publication. Each complete applicant name that is represented by the abbreviated name is marked with an asterisk (*). Listed under each complete applicant name is the first alphabetically arranged ingredient under which product information can be found in the appropriate Drug Product List. OTC products are so designated. To use the Drug Product Lists, determine by alphabetical order the ingredient under which the product information is listed, using the Product Name Index, if appropriate. Uniform Terms. To improve readability, uniform terms are used to designate dosage forms, routes of administration, and abbreviations used to express strengths. These terms are listed in Appendix C. In some cases, the terms used may differ from those used in product labels and other labeling.
2-2
2.2
DRUG PRODUCT ILLUSTRATION
SINGLE INGREDIENT
ACTIVE INGREDIENT DOSAGE FORM; ROUTE OF ADMINISTRATION TRADE OR GENERIC NAMES
MEPERIDINE HYDROCHLORIDE INJECTABLE;INJECTION HEXANON AP AP AP AP + PAGE PHARMA + + + 25MG/ML 50MG/ML 75MG/ML 100MG/ML N013111 N013111 N013111 N013111 001 002 003 004 AUG AUG AUG JAN 22, 22, 22, 04, 1983 1983 1983 1989
REFERENCE LISTED DRUG
THERAPEUTIC EQUIVALENCE (TE) CODE FOR MULTISOURCE PRODUCT
MEPERIDINE HCL AP GREENBERG PHARM AP AP AP HOLOVAC LLC JOHNSON MED RHONDA PHARM
25MG/ML 50MG/ML 75MG/ML 100MG/ML
A064890 A064890 A064890 A064890
001 002 003 004
FEB FEB FEB MAR
29, 29, 29, 08,
1987 1987 1987 1992
SINGLE SOURCE PRODUCT (NO TE CODE) AP
10MG/ML A099225 001 DEC 12, 1995 25MG/ML A099226 001 NOV 27, 1993 150MG/ML A079444 001 OCT 31, 1999
APPLICANT AVAILABLE STRENGTH(S) OF A PRODUCT APPLICANTION NUMBER AND PRODUCT NUMBER PRODUCT NUMBER IS FOR FDA INTERNAL COMPUTER DATA USE ONLY APPROVAL DATE
MULTIPLE INGREDIENTS WITH PRODUCT INFORMATION ALPHABETICALLY SORTED BY ACTIVE INGREDIENT
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE TABLET;ORAL HYDROCHLOROTHIAZIDE, RESERPINE AND HYDRALAZINE HCL MADISON 25MG;15MG;0.1MG A069808 001 JAN 18, 1982
PRODUCT INFORMATION
THIS EXAMPLE IS FOR PURPOSE OF ILLUSTRATION ONLY. PRESCRIPTION DRUG PRODUCT LIST.
IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE
2.3
THERAPEUTIC EQUIVALENCE EVALUATIONS ILLUSTRATION
DRUG PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN "A") UNDER AN INGREDIENT AND DOSAGE FORM HEADING ARE CONSIDERED THERAPEUTICALLY EQUIVALENT ONLY TO OTHER PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN A") AND NOT TO THOSE CODED BP (OR ANY CODE BEGINNING WITH "B") AND ANY PRODUCTS NOT LISTED. DRUG PRODUCTS CODED BP (OR ANY CODE BEGINNING WITH A "B") ARE NOT CONSIDERED THERAPEUTICALLY EQUIVALENT TO ANY OTHER PRODUCT. FOR A COMPLETE EXPLANATION OF THE TE CODES REFER TO SECTION 1.7 OF THE INTRODUCTION.
SULFASALAZINE TABLET; ORAL FAZINE AB PRODUCTS CONSIDERED THERAPEUTICALLY EQUIVALENT TO EACH OTHER AB PARKLAND SULAZINE URSA 500MG A042222 001 500MG A042999 001
SULFASALAZINE PRODUCTS CONSIDERED NOT THERAPEUTICALLY EQUIVALENT TO ANY OTHER PRODUCTS LISTED BP BROWN 500MG A041297 001
SULFASALAZINE TABLET; ORAL FAZINE AB PARKLAND PRODUCTS CONSIDERED NOT THERAPEUTICALLY EQUIVALENT TO EACH OTHER BP SULFASALAZINE BROWN SOUTH 500MG 500MG A041297 001 A067627 001
500MG
A042999 001
NOTE: BOLD FONT EQUIVALENT.
AND
UNDERLINING
DENOTES
MULTISOURCE
PRODUCTS
WHICH
ARE
CONSIDERED
THERAPEUTICALLY
THIS EXAMPLE IS FOR PURPOSES OF ILLUSTRATION ONLY. PRESCRIPTION DRUG PRODUCT LIST.
IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE
33RD EDITION - 2013 - APPROVED DRUG PRODUCTS LIST
PRESCRIPTION DRUG PRODUCT LIST

ABACAVIR SULFATE
SOLUTION; ORAL
ZIAGEN + VIIV HLTHCARE TABLET; ORAL ABACAVIR SULFATE APOTEX INC AUROBINDO PHARMA LTD MYLAN PHARMS INC ZIAGEN + VIIV HLTHCARE
3 - 1 (of 428)
XX
EQ 20MG BASE/ML
N020978
001
Dec 17, 1998
AB AB AB AB
EQ 300MG BASE EQ 300MG BASE EQ 300MG BASE EQ 300MG BASE
A201570 A077844 A091294 N020977
001 001 001 001
Dec 17, 2012 Dec 17, 2012 Jun 18, 2012 Dec 17, 1998
ABACAVIR SULFATE; LAMIVUDINE

TABLET; ORAL EPZICOM XX + VIIV HLTHCARE
EQ 600MG BASE;300MG
N021652
001
Aug 02, 2004
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

TABLET; ORAL TRIZIVIR XX + VIIV HLTHCARE
EQ 300MG BASE;150MG;300MG
N021205
001
Nov 14, 2000
ABIRATERONE ACETATE
TABLET; ORAL ZYTIGA XX + JANSSEN BIOTECH
250MG
N202379
001
Apr 28, 2011
ACAMPROSATE CALCIUM
TABLET, DELAYED RELEASE; ORAL CAMPRAL XX + FOREST LABS 333MG
N021431
001
Jul 29, 2004
ACARBOSE
TABLET; ORAL ACARBOSE EMCURE PHARMS LTD AB AB AB IMPAX LABS AB AB AB MYLAN AB AB AB ROXANE AB AB AB STRIDES ARCOLAB LTD AB AB AB WATSON LABS AB AB AB PRECOSE AB + BAYER HLTHCARE AB AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
A202271 A202271 A202271 A078441 A078441 A078441 A091053 A091053 A091053 A078470 A078470 A078470 A090912 A090912 A090912 A077532 A077532 A077532 N020482 N020482 N020482
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 004 001 002
Feb Feb Feb May May May Jan Jan Jan May May May Jul Jul Jul May May May
07, 07, 07, 14, 14, 14, 06, 06, 06, 07, 07, 07, 27, 27, 27, 07, 07, 07,
2012 2012 2012 2009 2009 2009 2011 2011 2011 2008 2008 2008 2011 2011 2011 2008 2008 2008
May 29, 1997 Sep 06, 1995 Sep 06, 1995
ACEBUTOLOL HYDROCHLORIDE
CAPSULE; ORAL ACEBUTOLOL HYDROCHLORIDE AMNEAL PHARM AB EQ 200MG BASE
A075047
001
Dec 30, 1999

ACEBUTOLOL HYDROCHLORIDE
CAPSULE; ORAL ACEBUTOLOL HYDROCHLORIDE AMNEAL PHARM EQ MYLAN EQ EQ WATSON LABS EQ EQ SECTRAL PROMIUS PHARMA EQ + EQ
3 - 2 (of 428)
AB AB AB AB AB AB AB
400MG 200MG 400MG 200MG 400MG
BASE BASE BASE BASE BASE
A075047 A074288 A074288 A074007 A074007 N018917 N018917
002 001 002 001 002 001 003
Dec Apr Apr Oct Oct
30, 24, 24, 18, 18,
1999 1995 1995 1995 1995
200MG BASE 400MG BASE
Dec 28, 1984 Dec 28, 1984
ACETAMINOPHEN
SOLUTION; IV (INFUSION)
OFIRMEV
XX + CADENCE PHARMS
1000MG/100ML (10MG/ML)
N022450
001
Nov 02, 2010
ACETAMINOPHEN; BUTALBITAL
CAPSULE; ORAL
PHRENILIN FORTE
XX + VALEANT
650MG;50MG
A088831
001
Jun 19, 1985
TABLET; ORAL
BUTALBITAL AND ACETAMINOPHEN
300MG;50MG XX + NEXGEN PHARMA BUTAPAP 325MG;50MG XX + MIKART 650MG;50MG XX +
A090956 A089987 A089988
001 001 001
Aug 23, 2011 Oct 26, 1992 Oct 26, 1992
ACETAMINOPHEN; BUTALBITAL; CAFFEINE

CAPSULE; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE WEST WARD 500MG;50MG;40MG ESGIC-PLUS + MIKART 500MG;50MG;40MG BUTALBITAL, ACETAMINOPHEN AND CAFFEINE + MIKART 325MG;50MG;40MG + NEXGEN PHARMA 300MG;50MG;40MG
AA AA XX XX
A040261 A040085 A089007 A040885
001 001 001 001
Oct 28, 1998 Mar 28, 1996 Mar 17, 1986 Nov 16, 2009
SOLUTION; ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
325MG/15ML;50MG/15ML;40MG/15ML XX + MIKART TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE LANNETT HOLDINGS INC 325MG;50MG;40MG AA MALLINCKRODT AA 325MG;50MG;40MG MIKART AA 325MG;50MG;40MG MIRROR PHARMS AA 325MG;50MG;40MG AA 500MG;50MG;40MG VINTAGE PHARMS AA 325MG;50MG;40MG AA 500MG;50MG;40MG WATSON LABS AA 500MG;50MG;40MG WEST WARD AA 325MG;50MG;40MG AA 500MG;50MG;40MG ESGIC-PLUS AA + MIKART 500MG;50MG;40MG FIORICET AA + WATSON PHARMS 325MG;50MG;40MG BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 750MG;50MG;40MG XX + MIKART
A040387
001
Jan 31, 2003
A200243 A087804 A089175 A040864 A040883 A040511 A040513 A040267 A089718 A040336 A089451 A088616 A040496
001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Jan Jan Dec Dec Aug Aug Jul Jun Aug
13, 24, 21, 01, 23, 27, 25, 30, 12, 18,
2012 1985 1987 2008 2008 2003 2003 1998 1995 1999
May 23, 1988 Nov 09, 1984 Dec 23, 2003

ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE; ORAL BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE NEXGEN PHARMA INC 325MG;50MG;40MG;30MG VINTAGE PHARMS 325MG;50MG;40MG;30MG WEST WARD 325MG;50MG;40MG;30MG FIORICET W/ CODEINE + WATSON LABS INC 325MG;50MG;40MG;30MG PHRENILIN WITH CAFFEINE AND CODEINE VALEANT 325MG;50MG;40MG;30MG BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE NEXGEN PHARMA INC 300MG;50MG;40MG;30MG
3 - 3 (of 428)
AB AB AB AB AB XX
A076560 A075929 A075618 N020232 A074911 A076560
001 001 001 001 001 002
Jun 10, 2004 Apr 22, 2002 Mar 23, 2001 Jul 30, 1992 Aug 22, 2001 Jul 19, 2012
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE

CAPSULE; ORAL ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE AA + MIKART 356.4MG;30MG;16MG WRASER PHARMS LLC AA 356.4MG;30MG;16MG TABLET; ORAL ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE BOCA PHARMA AA 712.8MG;60MG;32MG AA + MIKART 712.8MG;60MG;32MG
A040109 A040688
001 001
Aug 26, 1997 Apr 03, 2007
A040701 A040316
001 001
Apr 03, 2007 Apr 28, 1999
ACETAMINOPHEN; CODEINE PHOSPHATE

SOLUTION; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE HI TECH PHARMA 120MG/5ML;12MG/5ML MIKART 120MG/5ML;12MG/5ML + PHARM ASSOC 120MG/5ML;12MG/5ML VINTAGE PHARMS 120MG/5ML;12MG/5ML WOCKHARDT 120MG/5ML;12MG/5ML SUSPENSION; ORAL
CAPITAL AND CODEINE
+ VALEANT PHARMS LLC 120MG/5ML;12MG/5ML TABLET; ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE AMNEAL PHARMS NY 300MG;30MG + MALLINCKRODT INC 300MG;15MG 300MG;30MG 300MG;60MG MIKART 300MG;30MG RANBAXY 300MG;30MG 300MG;60MG TEVA 300MG;15MG 300MG;30MG + 300MG;60MG VINTAGE 300MG;15MG 300MG;30MG VINTAGE PHARMS 300MG;60MG TYLENOL W/ CODEINE NO. 3 + JANSSEN PHARMS 300MG;30MG TYLENOL W/ CODEINE NO. 4 JANSSEN PHARMS 300MG;60MG ACETAMINOPHEN AND CODEINE PHOSPHATE + MIKART 650MG;30MG + 650MG;60MG
AA AA AA AA AA
A040119 A089450 A087508 A091238 A087006
001 001 001 001 001
Apr 26, 1996 Oct 27, 1992 Nov 10, 2011
XX
A086024
001
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA XX XX
A040779 A040419 A040419 A040419 A089238 A085868 A087083 A088627 A088628 A088629 A089990 A089805 A089828 A085055 A085055 A089231 A089363
001 001 002 003 001 001 001 001 001 001 001 001 001 003 004 001 001
May May May May Feb
29, 31, 31, 31, 25,
2008 2001 2001 2001 1986
Mar Mar Mar Sep Sep Sep
06, 06, 06, 30, 30, 30,
1985 1985 1985 1988 1988 1988
Mar 03, 1986 Sep 09, 1991
ACETAMINOPHEN; HYDROCODONE BITARTRATE

CAPSULE; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN MIKART AA 500MG;5MG AA 500MG;5MG
A081067 A089008
001 001
Nov 30, 1989 Feb 21, 1986

SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN BOCA PHARMA 325MG/15ML;7.5MG/15ML MALLINCKRODT 500MG/15ML;7.5MG/15ML + MIKART 325MG/15ML;7.5MG/15ML + 500MG/15ML;7.5MG/15ML PHARM ASSOC 500MG/15ML;7.5MG/15ML VINTAGE PHARMS 500MG/15ML;7.5MG/15ML VISTAPHARM 325MG/15ML;7.5MG/15ML HYDROCODONE BITARTRATE AND ACETAMINOPHEN + MIKART 300MG/15ML;10MG/15ML + PHARM ASSOC 325MG/15ML;10MG/15ML
3 - 4 (of 428)
AA AA AA AA AA AA AA XX XX
A040894 A040418 A040482 A081051 A040182 A040520 A200343 A040881 A040834
001 001 001 001 001 001 001 001 001
Jul Jun Sep Aug Mar Oct Jan
19, 27, 25, 28, 13, 30, 25,
2011 2001 2003 1992 1998 2003 2012
Feb 25, 2010 Apr 18, 2008
TABLET; ORAL ANEXSIA MALLINCKRODT AA 500MG;5MG AA 750MG;10MG ANEXSIA 5/325 MALLINCKRODT AA 325MG;5MG ANEXSIA 7.5/325 MALLINCKRODT AA 325MG;7.5MG ANEXSIA 7.5/650 MALLINCKRODT AA 650MG;7.5MG CO-GESIC UCB INC AA 500MG;5MG HYDROCODONE BITARTRATE AND ACETAMINOPHEN AMNEAL PHARMS NY AA 325MG;5MG AA 325MG;10MG AA 500MG;5MG AA 500MG;7.5MG AA 500MG;10MG AA 650MG;7.5MG AA 650MG;10MG AA 750MG;7.5MG AUROLIFE PHARMA LLC AA 325MG;5MG AA 325MG;7.5MG AA 325MG;10MG BOCA PHARMA AA 300MG;5MG AA 300MG;7.5MG AA 300MG;10MG MALLINCKRODT AA 325MG;10MG AA 500MG;5MG AA 500MG;7.5MG AA 500MG;10MG AA 650MG;10MG AA + 660MG;10MG AA 750MG;7.5MG AA + MIKART 300MG;5MG AA + 300MG;7.5MG AA + 300MG;10MG AA 325MG;7.5MG AA + 500MG;2.5MG AA + 500MG;7.5MG AA + 650MG;7.5MG AA + 650MG;10MG SUN PHARM INDS INC AA 325MG;5MG AA 325MG;7.5MG AA 325MG;10MG AA 500MG;5MG AA 500MG;7.5MG AA 500MG;10MG
A089160 A040468 A040409 A040405 A089725 A087757 A040736 A040746 A040729 A040748 A040813 A040754 A040757 A040769 A201013 A201013 A201013 A090415 A090415 A090415 A040400 A040084 A040201 A040201 A040084 A040084 A040084 A040658 A040556 A040556 A040432 A089698 A089699 A089689 A081223 A090118 A090118 A090118 A090265 A090265 A090265
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 003 001 002 001 002 004 003 001 001 002 001 001 001 001 001 001 001 002 003 001 002 003
Apr 23, 1987 Oct 31, 2002 Oct 20, 2000 Sep 08, 2000 Sep 30, 1987 May 03, 1982 Aug Aug Aug Aug Feb Aug Aug Aug Apr Apr Apr Jan Jan Jan Jul Jun Feb Feb Oct Jul Jun Jan Mar Jun Jan Aug Aug Jun May Dec Dec Dec Dec Dec Dec 25, 25, 25, 25, 23, 25, 25, 28, 11, 11, 11, 24, 24, 24, 26, 01, 27, 27, 16, 29, 01, 19, 24, 23, 22, 25, 25, 29, 29, 23, 23, 23, 23, 23, 23, 2006 2006 2006 2006 2007 2006 2006 2006 2012 2012 2012 2011 2011 2011 2000 1995 1998 1998 1996 1996 1995 2006 2006 2004 2003 1989 1989 1988 1992 2008 2008 2008 2008 2008 2008

TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN SUN PHARM INDS INC AA 650MG;7.5MG AA 650MG;10MG AA 660MG;10MG AA 750MG;7.5MG VINTAGE PHARMS AA 325MG;5MG AA 325MG;7.5MG AA 325MG;10MG AA 500MG;2.5MG AA 500MG;5MG AA 500MG;7.5MG AA 500MG;10MG AA 650MG;7.5MG AA 650MG;10MG AA 660MG;10MG AA 750MG;7.5MG WATSON LABS AA 500MG;2.5MG AA 500MG;5MG AA 500MG;7.5MG AA 500MG;10MG AA 650MG;7.5MG AA 650MG;10MG AA 660MG;10MG AA 750MG;7.5MG AA + 750MG;10MG WATSON LABS FLORIDA AA 660MG;10MG LORTAB UCB INC AA 500MG;5MG AA + 500MG;10MG NORCO AA + WATSON LABS 325MG;5MG AA + 325MG;7.5MG AA + 325MG;10MG HYDROCODONE BITARTRATE AND ACETAMINOPHEN MIKART 325MG;2.5MG XX 650MG;5MG XX ZYDONE 400MG;5MG XX + VINTAGE PHARMS LLC 400MG;7.5MG XX + 400MG;10MG XX +
3 - 5 (of 428)
A090380 A090380 A090380 A090380 A040655 A040656 A040355 A040144 A089971 A040144 A040356 A040155 A040143 A040358 A040157 A081079 A089883 A081080 A040148 A040094 A040094 A040094 A081083 A040094 A040495 A087722 A040100 A040099 A040148 A040148 A040846 A040849 A040288 A040288 A040288
001 002 003 004 001 001 001 002 001 001 001 001 001 001 001 001 001 001 002 001 002 003 001 004 001 001 001 001 003 001 001 001 001 002 003
Dec Dec Dec Dec Jan Jan May Apr Dec Feb May Apr Feb May Apr Aug Dec Aug Feb Sep Sep Aug Aug Mar May
23, 23, 23, 23, 19, 19, 31, 25, 02, 22, 31, 14, 22, 31, 12, 30, 01, 30, 14, 29, 29, 08, 30, 22, 28,
2008 2008 2008 2008 2006 2006 2000 1997 1988 1996 2000 1997 1996 2000 1996 1991 1988 1991 1997 1995 1995 2000 1991 1999 2003
Jul 09, 1982 Jan 26, 1996 Jun 25, 1997 Sep 12, 2000 Feb 14, 1997 Jun 09, 2010 Jun 09, 2010 Nov 27, 1998 Nov 27, 1998 Nov 27, 1998
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

CAPSULE; ORAL OXYCODONE AND ACETAMINOPHEN DURAMED PHARMS BARR 500MG;5MG MALLINCKRODT 500MG;5MG VINTAGE PHARMS 500MG;5MG WATSON LABS 500MG;5MG ROXILOX ROXANE 500MG;5MG TYLOX + JANSSEN PHARMS 500MG;5MG SOLUTION; ORAL ROXICET + ROXANE 325MG/5ML;5MG/5ML TABLET; ORAL OXYCET MALLINCKRODT 325MG;5MG
AA AA AA AA AA AA
A040289 A040257 A040106 A040234 A040061 A088790
001 001 001 001 001 001
Mar Aug Jul Oct
16, 04, 30, 30,
1999 1998 1996 1997
Jul 03, 1995 Dec 12, 1984
AA
A089351
001
Dec 03, 1986
AA
A087463
001
Dec 07, 1983

TABLET; ORAL OXYCODONE AND ACETAMINOPHEN ACTAVIS TOTOWA 325MG;7.5MG 325MG;10MG ALVOGEN INC 325MG;7.5MG 325MG;10MG AMNEAL PHARMS NY 325MG;5MG 325MG;10MG 500MG;7.5MG 650MG;10MG COASTAL PHARMS 325MG;2.5MG 325MG;5MG 325MG;7.5MG 325MG;10MG 500MG;7.5MG 650MG;10MG MALLINCKRODT 325MG;7.5MG 325MG;10MG 500MG;7.5MG 650MG;10MG VINTAGE PHARMS 325MG;5MG WATSON LABS 325MG;5MG 325MG;7.5MG 325MG;10MG 500MG;7.5MG 650MG;10MG PERCOCET + VINTAGE PHARMS LLC 325MG;2.5MG + 325MG;5MG + 325MG;7.5MG + 325MG;10MG + 500MG;7.5MG + 650MG;10MG ROXICET ROXANE 325MG;5MG OXYCODONE AND ACETAMINOPHEN + MIKART 300MG;2.5MG + 300MG;5MG + 300MG;7.5MG + 300MG;10MG + 400MG;2.5MG + 400MG;5MG + 400MG;7.5MG + 400MG;10MG 500MG;10MG ROXICET 5/500 + ROXANE 500MG;5MG
3 - 6 (of 428)
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA XX XX XX XX XX XX XX XX XX XX
A040800 A040800 A202677 A202677 A040777 A040778 A040789 A040789 A090177 A090177 A090177 A090177 A090177 A090177 A040545 A040545 A040550 A040550 A040105 A040171 A040535 A040535 A040371 A040371 A040330 A040330 A040434 A040434 A040341 A040341 A087003 A040608 A040608 A040608 A040608 A040679 A040687 A040698 A040692 A040676 A089775
001 002 001 002 001 001 001 002 001 002 003 004 005 006 001 002 001 002 001 001 001 002 001 002 001 002 001 002 001 002 001 001 002 003 004 001 001 001 001 001 001
Apr Apr Jul Jul Nov Nov Nov Nov Oct Oct Oct Oct Oct Oct Jun Jun Jun Jun Jul Oct Sep Sep Dec Dec Jun Jun Nov Nov Jul Jul
03, 03, 26, 26, 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 30, 30, 30, 30, 30, 30, 05, 05, 29, 29, 25, 25, 23, 23, 26, 26,
2012 2012 2012 2012 2007 2007 2007 2007 2008 2008 2008 2008 2008 2008 2004 2004 2004 2004 1996 1997 2003 2003 2000 2000 1999 1999 2001 2001 1999 1999
Dec Dec Dec Dec May Apr Apr Apr Apr
30, 30, 30, 30, 16, 27, 27, 27, 19,
2005 2005 2005 2005 2006 2006 2006 2006 2006
Jan 12, 1989
ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE

TABLET; ORAL ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE GAVIS PHARMS AB 650MG;EQ 25MG BASE AB + WATSON LABS 650MG;EQ 25MG BASE
A076202 A074699
001 001
Aug 02, 2002 Mar 24, 2000
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

TABLET; ORAL TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN ALVOGEN INC AB 325MG;37.5MG AMNEAL PHARMS AB 325MG;37.5MG CARACO AB 325MG;37.5MG
A202076 A090485 A077184
001 001 001
Mar 30, 2012 Dec 09, 2009 Dec 16, 2005

ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
TABLET; ORAL TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN MICRO LABS LTD INDIA 325MG;37.5MG MYLAN 325MG;37.5MG PAR PHARM 325MG;37.5MG WATSON LABS 325MG;37.5MG ZYDUS PHARMS USA INC 325MG;37.5MG ULTRACET + JANSSEN PHARMS 325MG;37.5MG
3 - 7 (of 428)
AB AB AB AB AB AB
A201952 A077858 A076475 A076914 A090460 N021123
001 001 001 001 001 001
Dec Sep Apr Jul Sep
14, 26, 21, 26, 06,
2012 2008 2005 2006 2012
Aug 15, 2001
ACETAZOLAMIDE
CAPSULE, EXTENDED RELEASE; ORAL ACETAZOLAMIDE HERITAGE PHARMS INC 500MG ZYDUS PHARMS USA INC 500MG DIAMOX + DURAMED PHARMS BARR 500MG TABLET; ORAL ACETAZOLAMIDE LANNETT 250MG MUTUAL PHARM 125MG TARO 125MG 250MG + WATSON LABS 250MG
AB AB AB
A090779 A040904 N012945
001 001 001
Jul 14, 2011 Dec 10, 2008
AB AB AB AB AB
A084840 A089752 A040195 A040195 A088882
001 001 001 002 001
Jun May May Oct
22, 28, 28, 22,
1988 1997 1997 1985
ACETAZOLAMIDE SODIUM
INJECTABLE; INJECTION ACETAZOLAMIDE SODIUM BEDFORD AP SAGENT STRIDES AP AP + X GEN PHARMS
EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL
A040089 A200880 A040784
001 001 001
Feb 28, 1995 May 09, 2012 Dec 10, 2008
ACETIC ACID, GLACIAL

SOLUTION; IRRIGATION, URETHRAL ACETIC ACID 0.25% IN PLASTIC CONTAINER B BRAUN 250MG/100ML BAXTER HLTHCARE 250MG/100ML HOSPIRA 250MG/100ML SOLUTION/DROPS; OTIC ACETIC ACID TARO 2% VINTAGE 2% + WOCKHARDT 2% VOSOL HI TECH PHARMA 2%
AT AT AT
N018161 N018523 N017656
001 001 001
Feb 19, 1982
AT AT AT AT
A088638 A040607 A040166 N012179
001 001 001 001
Sep 06, 1984 Feb 24, 2005 Jul 26, 1996
ACETIC ACID, GLACIAL; ALUMINUM ACETATE

SOLUTION/DROPS; OTIC ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE XX + BAUSCH AND LOMB 2%;0.79%
A040063
001
Feb 25, 1994
ACETIC ACID, GLACIAL; HYDROCORTISONE

SOLUTION/DROPS; OTIC ACETASOL HC ACTAVIS MID ATLANTIC 2%;1% HYDROCORTISONE AND ACETIC ACID TARO 2%;1% VINTAGE 2%;1% VOSOL HC + HI TECH PHARMA 2%;1%
AT AT AT AT
A087143 A088759 A040609 N012770
001 001 001 001
Jan 13, 1982 Mar 04, 1985 Feb 06, 2006

ACETOHEXAMIDE
TABLET; ORAL ACETOHEXAMIDE XX WATSON LABS XX +
3 - 8 (of 428)
250MG 500MG
A071893 A071894
001 001
Nov 25, 1987 Nov 25, 1987
ACETOHYDROXAMIC ACID
TABLET; ORAL
LITHOSTAT
XX + MISSION PHARMA
250MG
N018749
001
May 31, 1983
ACETYLCHOLINE CHLORIDE
FOR SOLUTION; OPHTHALMIC
MIOCHOL-E
XX + BAUSCH AND LOMB
20MG/VIAL
N020213
001
Sep 22, 1993
ACETYLCYSTEINE
INJECTABLE; INTRAVENOUS ACETADOTE AP + CUMBERLAND PHARMS 6GM/30ML (200MG/ML) ACETYLCYSTEINE INNOPHARMA INC AP 6GM/30ML (200MG/ML) SOLUTION; INHALATION, ORAL ACETYLCYSTEINE BEDFORD AN 10% AN 20% HOSPIRA AN 10% AN 20% INNOPHARMA INC AN 20% AN + LUITPOLD 10% AN + 20%
N021539 A200644
001 001
Jan 23, 2004 Nov 07, 2012
A072323 A072324 A073664 A074037 A203853 A072489 A072547
001 001 001 001 001 001 001
Apr Apr Aug Aug Jun Jul Jul
30, 30, 30, 30, 21, 28, 28,
1992 1992 1994 1994 2012 1995 1995
ACITRETIN
CAPSULE; ORAL SORIATANE STIEFEL LABS INC XX XX XX XX +
10MG 17.5MG 22.5MG 25MG
N019821 N019821 N019821 N019821
001 003 004 002
Oct Aug Aug Oct
28, 06, 06, 28,
1996 2009 2009 1996
ACLIDINIUM BROMIDE
POWDER, METERED; INHALATION
TUDORZA PRESSAIR
XX + FOREST LABS INC 0.375MG/INH
N202450
001
Jul 23, 2012
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE

CAPSULE; ORAL
SEMPREX-D
XX + UCB INC
8MG;60MG
N019806
001
Mar 25, 1994
ACYCLOVIR
CAPSULE; ORAL ACYCLOVIR APOTEX INC AB DAVA PHARMS INC AB MYLAN AB AB RANBAXY AB STASON AB TEVA AB WATSON LABS AB
200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG
A075677 A074833 A074727 A074977 A074975 A075090 A074578 A075101
001 001 001 001 001 001 001 001
Sep Apr Apr Apr Sep Jan Apr Apr
28, 22, 22, 13, 30, 26, 22, 15,
2005 1997 1997 1998 1998 1999 1997 1998

ACYCLOVIR
CAPSULE; ORAL ZOVIRAX AB + GLAXOSMITHKLINE CREAM; TOPICAL ZOVIRAX XX + VALEANT INTL OINTMENT; TOPICAL
ZOVIRAX
XX + VALEANT INTL SUSPENSION; ORAL ACYCLOVIR ACTAVIS MID ATLANTIC HI TECH PHARMA ZOVIRAX + GLAXOSMITHKLINE TABLET; ORAL ACYCLOVIR APOTEX INC CARLSBAD DAVA PHARMS INC MYLAN
3 - 9 (of 428)
200MG
N018828
001
Jan 25, 1985
5%
N021478
001
Dec 30, 2002
5%
N018604
001
Mar 29, 1982
AB AB AB
200MG/5ML 200MG/5ML 200MG/5ML
A074738 A077026 N019909
001 001 001
Apr 28, 1997 Jun 07, 2005 Dec 22, 1989
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
RANBAXY TEVA ZOVIRAX GLAXOSMITHKLINE +
400MG 800MG 400MG 800MG 400MG 800MG 400MG 400MG 800MG 800MG 400MG 800MG 400MG 800MG 400MG 800MG
A077309 A077309 A075382 A075382 A074946 A074946 A074976 A075211 A074976 A075211 A074980 A074980 A074556 A074556 N020089 N020089
001 002 001 002 001 002 001 001 002 002 001 002 002 003 001 002
Sep Sep Apr Apr Nov Nov Apr Sep Apr Sep Sep Sep Apr Apr
29, 29, 30, 30, 19, 19, 13, 28, 13, 28, 30, 30, 22, 22,
2005 2005 1999 1999 1997 1997 1998 1998 1998 1998 1998 1998 1997 1997
Apr 30, 1991 Apr 30, 1991
ACYCLOVIR SODIUM
INJECTABLE; INJECTION ACYCLOVIR SODIUM BEDFORD AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP + FRESENIUS KABI USA EQ 50MG BASE/ML AP + EQ 500MG BASE/VIAL HIKMA MAPLE AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE EQ 500MG BASE/VIAL XX + HIKMA MAPLE EQ 1GM BASE/VIAL XX
A074596 A074596 A074930 A075015 A074913 A074913 A074885 A074885
002 001 001 001 001 002 001 002
Apr Apr May Apr Oct Oct
22, 22, 13, 30, 15, 15,
1997 1997 1998 1998 1997 1997
Dec 19, 1997 Dec 19, 1997
ACYCLOVIR; HYDROCORTISONE
CREAM; TOPICAL
XERESE
XX + VALEANT INTL
5%;1%
N022436
001
Jul 31, 2009
ADAPALENE
CREAM; TOPICAL ADAPALENE FOUGERA PHARMS AB DIFFERIN AB + GALDERMA LABS LP
0.1% 0.1%
A090824 N020748
001 001
Jun 30, 2010 May 26, 2000

ADAPALENE
GEL; TOPICAL ADAPALENE GLENMARK GENERICS PLIVA HRVATSKA DOO TOLMAR DIFFERIN + GALDERMA LABS LP + LOTION; TOPICAL
DIFFERIN
+ GALDERMA LABS LP
3 - 10 (of 428)
AB AB AB AB AB
0.1% 0.1% 0.3% 0.1% 0.3%
A091314 A090962 A200298 N020380 N021753
001 001 001 001 001
Jul 01, 2010 Jun 02, 2010 Jun 14, 2012 May 31, 1996 Jun 19, 2007
XX
0.1%
N022502
001
Mar 17, 2010
ADAPALENE; BENZOYL PEROXIDE

GEL; TOPICAL
EPIDUO
XX + GALDERMA LABS LP
0.1%;2.5%
N022320
001
Dec 08, 2008
ADEFOVIR DIPIVOXIL
TABLET; ORAL
HEPSERA
XX + GILEAD
10MG
N021449
001
Sep 20, 2002
ADENOSINE
INJECTABLE; INJECTION ADENOCARD + ASTELLAS ADENOSINE AKORN BEDFORD FRESENIUS KABI USA GLAND PHARMA LTD HIKMA MAPLE LUITPOLD STRIDES ARCOLAB LTD WOCKHARDT ADENOSCAN + ASTELLAS
AP AP AP AP AP AP AP AP AP XX
3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML
N019937 A078076 A076404 A077133 A077283 A076500 A090010 A078686 A090220 N020059
002 001 001 001 001 001 001 001 001 001
Oct 30, 1989 Oct Jun Apr Jun Jun Apr May Jul 31, 16, 27, 14, 16, 28, 13, 20, 2008 2004 2005 2007 2004 2009 2009 2009
May 18, 1995
ALBENDAZOLE
TABLET; ORAL
ALBENZA
XX + COREPHARMA
200MG
N020666
001
Jun 11, 1996
ALBUMIN HUMAN
INJECTABLE; INJECTION
OPTISON
XX + GE HEALTHCARE
10MG/ML
N020899
001
Dec 31, 1997
ALBUMIN IODINATED I-125 SERUM

INJECTABLE; INJECTION JEANATOPE XX ISO TEX XX XX +
100UCI/10ML (10UCI/ML) 500uCi/0.5ML 1,000uCi/ML
N017836 N017836 N017836
003 001 002
Jun 08, 2004

MEGATOPE
XX + ISO TEX XX +
0.5mCi/VIAL 1mCi/VIAL
N017837 N017837
001 002

ALBUTEROL SULFATE
AEROSOL, METERED; INHALATION PROAIR HFA BX + TEVA GLOBAL EQ 0.09MG BASE/INH PROVENTIL-HFA BX + 3M EQ 0.09MG BASE/INH VENTOLIN HFA BX + GLAXOSMITHKLINE EQ 0.09MG BASE/INH SOLUTION; INHALATION ACCUNEB AN + DEY AN + ALBUTEROL SULFATE APOTEX INC AN AN AN AN + BAUSCH AND LOMB AN + DEY HI TECH PHARMA AN AN LANDELA PHARM AN NEPHRON AN AN AN AN NOVEX AN RITEDOSE CORP AN TEVA PHARMS AN WATSON LABS AN AN WATSON LABS INC AN WOCKHARDT AN SYRUP; ORAL ALBUTEROL SULFATE ACTAVIS MID ATLANTIC AMNEAL PHARMS HI TECH PHARMA + TEVA VINTAGE VISTAPHARM
3 - 11 (of 428)
N021457 N020503 N020983
001 001 001
Oct 29, 2004 Aug 15, 1996 Apr 19, 2001
EQ 0.021% BASE EQ 0.042% BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 0.021% BASE 0.042% BASE 0.083% BASE 0.5% BASE 0.083% BASE 0.083% BASE 0.5% BASE 0.083% BASE 0.021% BASE 0.042% BASE 0.083% BASE 0.5% BASE 0.5% BASE 0.083% BASE 0.083% BASE 0.021% BASE 0.042% BASE 0.083% BASE 0.083% BASE
N020949 N020949 A078623 A078623 A075717 A075050 A072652 A075063 A074543 A077569 A076355 A076355 A074880 A075664 A076391 A077839 A075343 A077772 A077772 A076370 A075394
002 001 001 002 001 001 001 001 001 001 002 001 001 001 001 001 001 001 002 001 001
Apr 30, 2001 Apr 30, 2001 Apr Apr Feb Jun Feb Feb Jan Apr Mar Jun Sep Jun Apr Dec Nov Sep Sep Nov Nov 05, 05, 02, 18, 21, 09, 15, 04, 31, 28, 17, 26, 01, 16, 09, 25, 25, 24, 22, 2010 2010 2007 1998 1992 1999 1998 2006 2010 2004 1997 2001 2003 2008 1999 2007 2007 2003 1999
AA AA AA AA AA AA
EQ EQ EQ EQ EQ EQ
2MG 2MG 2MG 2MG 2MG 2MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A074454 A079241 A074749 A073419 A078105 A077788
001 001 001 001 001 001
Sep May Jan Mar Dec Jun
25, 12, 30, 30, 27, 26,
1995 2010 1998 1992 2006 2007
TABLET; ORAL ALBUTEROL SULFATE MUTUAL PHARM AB AB MYLAN AB AB + WATSON LABS AB
AB AB AB AB
EQ 2MG EQ 4MG EQ 2MG EQ 4MG EQ 2MG TABLET, EXTENDED RELEASE; ORAL ALBUTEROL SULFATE MYLAN EQ 4MG EQ 8MG VOSPIRE ER DAVA PHARMS INC EQ 4MG + EQ 8MG
A072637 A072637 A072894 A072894 A072764
002 001 002 001 001
Dec Dec Jan Jan Aug
05, 05, 17, 17, 28,
1989 1989 1991 1991 1991
BASE BASE BASE BASE
A078092 A078092 A076130 A076130
002 001 002 003
Jan 29, 2007 Jan 29, 2007 Sep 26, 2002 Sep 26, 2002
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

AEROSOL, METERED; INHALATION
COMBIVENT
XX + BOEHRINGER INGELHEIM EQ 0.09MG BASE/INH;0.018MG/INH
N020291
001
Oct 24, 1996

SOLUTION; INHALATION ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE APOTEX CORP EQ 0.083% BASE;0.017% NEPHRON EQ 0.083% BASE;0.017% RITEDOSE CORP EQ 0.083% BASE;0.017% TEVA PHARMS EQ 0.083% BASE;0.017% WATSON LABS EQ 0.083% BASE;0.017% EQ 0.083% BASE;0.017% DUONEB + DEY EQ 0.083% BASE;0.017% SPRAY, METERED; INHALATION COMBIVENT RESPIMAT + BOEHRINGER INGELHEIM EQ 0.1MG BASE/INH;0.02MG/INH
3 - 12 (of 428)
AN AN AN AN AN AN AN
A077117 A076749 A202496 A076724 A077063 A077559 N020950
001 001 001 001 001 001 001
Dec Dec Oct Dec Dec Dec
31, 31, 01, 31, 31, 31,
2007 2007 2012 2007 2007 2007
Mar 21, 2001
XX
N021747
001
Oct 07, 2011
ALCAFTADINE
SOLUTION/DROPS; OPHTHALMIC LASTACAFT XX + ALLERGAN 0.25%
N022134
001
Jul 28, 2010
ALCLOMETASONE DIPROPIONATE
CREAM; TOPICAL ACLOVATE + FOUGERA PHARMS 0.05% ALCLOMETASONE DIPROPIONATE FOUGERA PHARMS 0.05% GLENMARK GENERICS 0.05% TARO 0.05% OINTMENT; TOPICAL ACLOVATE + FOUGERA PHARMS 0.05% ALCLOMETASONE DIPROPIONATE FOUGERA PHARMS 0.05% GLENMARK GENERICS 0.05% TARO 0.05%
AB AB AB AB
N018707 A076973 A079061 A076587
001 001 001 001
Dec 14, 1982 Jul 12, 2005 Jun 23, 2009 Sep 15, 2005
AB AB AB AB
N018702 A076884 A079227 A076730
001 001 001 001
Dec 14, 1982 Jul 18, 2005 Jul 30, 2009 Jul 29, 2004
ALCOHOL; DEXTROSE
INJECTABLE; INJECTION ALCOHOL 5% AND DEXTROSE 5% AP + B BRAUN 5ML/100ML;5GM/100ML ALCOHOL 10% AND DEXTROSE 5% 10ML/100ML;5GM/100ML XX + B BRAUN
N004589 N004589
004 006
ALENDRONATE SODIUM
SOLUTION; ORAL FOSAMAX XX + MERCK TABLET; ORAL ALENDRONATE SODIUM APOTEX AB AB AB AB AUROBINDO PHARMA AB AB AB AUSTARPHARMA LLC AB AB AB AB CADISTA PHARMS AB AB
EQ 70MG BASE/75ML
N021575
001
Sep 17, 2003
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 35MG BASE 70MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE
A077982 A077982 A077982 A077982 A090124 A090124 A090124 A090258 A090258 A090258 A090258 A090557 A090557
001 002 003 004 001 002 003 001 002 003 004 001 002
Aug Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Feb Feb
04, 04, 04, 04, 04, 04, 04, 24, 24, 24, 24, 18, 18,
2008 2008 2008 2008 2008 2008 2008 2009 2009 2009 2009 2010 2010

ALENDRONATE SODIUM
TABLET; ORAL ALENDRONATE SODIUM CADISTA PHARMS AB EQ AB EQ DR REDDYS LABS LTD AB EQ AB EQ AB EQ AB EQ MYLAN AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ SUN PHARMA GLOBAL AB EQ AB EQ AB EQ AB EQ TEVA PHARMS AB EQ AB EQ AB EQ AB EQ AB EQ WATSON LABS AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ FOSAMAX MERCK AND CO INC AB EQ AB EQ AB EQ AB EQ AB + EQ TABLET, EFFERVESCENT; ORAL
BINOSTO
XX + MISSION PHARMA EQ
3 - 13 (of 428)
35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 35MG BASE 70MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 40MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 35MG BASE 40MG BASE 40MG BASE 70MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 40MG BASE 70MG BASE
A090557 A090557 A079109 A079109 A079049 A079049 A076584 A076584 A076584 A078638 A076584 A078638 A090022 A090022 A090022 A090022 A075710 A075710 A075710 A075710 A075710 A076768 A076768 A076768 A076984 A076768 A076984 A076768 A076984 N020560 N020560 N020560 N020560 N020560
003 004 001 002 001 002 001 002 003 001 004 002 001 002 003 004 001 002 003 004 005 001 002 003 001 004 002 005 003 003 001 004 002 005
Feb Feb Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Feb Feb Feb Feb Feb Aug Aug Aug Aug Aug Aug Aug Aug Apr Sep Oct Sep Oct
18, 18, 04, 04, 04, 04, 04, 04, 04, 04, 04, 04, 10, 10, 10, 10, 06, 06, 06, 06, 06, 04, 04, 04, 04, 04, 04, 04, 04, 25, 29, 20, 29, 20,
2010 2010 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 1997 1995 2000 1995 2000
70MG BASE
N202344
001
Mar 12, 2012
ALENDRONATE SODIUM; CHOLECALCIFEROL

TABLET; ORAL FOSAMAX PLUS D XX MERCK XX +
EQ 70MG BASE;2,800 IU EQ 70MG BASE;5,600 IU
N021762 N021762
001 002
Apr 07, 2005 Apr 26, 2007
ALFENTANIL HYDROCHLORIDE
INJECTABLE; INJECTION ALFENTA AP + AKORN ALFENTANIL HOSPIRA AP
EQ 0.5MG BASE/ML EQ 0.5MG BASE/ML
N019353 A075221
001 001
Dec 29, 1986 Oct 28, 1999
ALFUZOSIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ALFUZOSIN HYDROCHLORIDE APOTEX INC AB AUROBINDO PHARMA LTD AB INVAGEN PHARMS AB ORAL 10MG 10MG 10MG A079013 A079060 A090284 001 001 001 Jul 18, 2011 Aug 30, 2012 Jan 17, 2012

ALFUZOSIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ALFUZOSIN HYDROCHLORIDE MYLAN SUN PHARMA GLOBAL TEVA PHARMS TORRENT PHARMS WOCKHARDT LTD UROXATRAL + SANOFI AVENTIS US ORAL 10MG 10MG 10MG 10MG 10MG 10MG A079014 A079057 A079056 A079054 A090221 N021287 001 001 001 001 001 001
3 - 14 (of 428)
AB AB AB AB AB AB
Jul Jul Jul Jul Aug
18, 18, 18, 18, 10,
2011 2011 2011 2011 2012
Jun 12, 2003
ALISKIREN HEMIFUMARATE
TABLET; ORAL TEKTURNA XX NOVARTIS XX +
EQ 150MG BASE EQ 300MG BASE
N021985 N021985
001 002
Mar 05, 2007 Mar 05, 2007
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

TABLET; ORAL TEKAMLO NOVARTIS XX XX XX XX +
EQ EQ EQ EQ
150MG 150MG 300MG 300MG
BASE;EQ BASE;EQ BASE;EQ BASE;EQ
5MG BASE 10MG BASE 5MG BASE 10MG BASE
N022545 N022545 N022545 N022545
001 002 003 004
Aug Aug Aug Aug
26, 26, 26, 26,
2010 2010 2010 2010
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

TABLET; ORAL AMTURNIDE NOVARTIS XX XX XX XX XX +
EQ EQ EQ EQ EQ
150MG 300MG 300MG 300MG 300MG
BASE;EQ BASE;EQ BASE;EQ BASE;EQ BASE;EQ
5MG BASE;12.5MG 5MG BASE;12.5MG 5MG BASE;25MG 10MG BASE;12.5MG 10MG BASE;25MG
N200045 N200045 N200045 N200045 N200045
001 002 003 004 005
Dec Dec Dec Dec Dec
21, 21, 21, 21, 21,
2010 2010 2010 2010 2010
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

TABLET; ORAL TEKTURNA HCT XX NOVARTIS XX XX + XX +
EQ EQ EQ EQ
150MG 150MG 300MG 300MG
BASE;12.5MG BASE;25MG BASE;12.5MG BASE;25MG
N022107 N022107 N022107 N022107
001 002 003 004
Jan Jan Jan Jan
18, 18, 18, 18,
2008 2008 2008 2008
ALISKIREN HEMIFUMARATE; VALSARTAN

TABLET; ORAL VALTURNA XX NOVARTIS XX +
EQ 150MG BASE;160MG EQ 300MG BASE;320MG
N022217 N022217
001 002
Sep 16, 2009 Sep 16, 2009
ALITRETINOIN
GEL; TOPICAL
PANRETIN
XX + EISAI INC
EQ 0.1% BASE
N020886
001
Feb 02, 1999
ALLOPURINOL
TABLET; ORAL ALLOPURINOL APOTEX INC AB AB CARACO AB AB IPCA LABS LTD AB AB
100MG 300MG 100MG 300MG 100MG 300MG
A077353 A077353 A078390 A078390 A090637 A090637
001 002 001 002 001 002
Sep Sep Aug Aug Mar Mar
08, 08, 30, 30, 16, 16,
2005 2005 2007 2007 2011 2011

ALLOPURINOL
TABLET; ORAL ALLOPURINOL MUTUAL PHARM AB AB MYLAN AB AB NORTHSTAR HLTHCARE AB AB VINTAGE PHARMS AB AB WATSON LABS AB AB LOPURIN DR REDDYS LA AB AB ZYLOPRIM PROMETHEUS LABS AB AB +
3 - 15 (of 428)
100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG
A071449 A071450 N018659 N018659 A078253 A078253 A075798 A075798 N018832 N018877 A071586 A071587 N016084 N016084
001 001 001 002 001 002 001 002 002 001 001 001 001 002
Jan Jan Oct Oct Sep Sep Jun Jun Sep Sep
09, 09, 24, 24, 11, 11, 27, 27, 28, 28,
1987 1987 1986 1986 2007 2007 2003 2003 1984 1984
Apr 02, 1987 Apr 02, 1987
ALLOPURINOL SODIUM
INJECTABLE; INJECTION ALLOPURINOL SODIUM BEDFORD LABS AP ALOPRIM AP + MYLAN INSTITUTIONAL
EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL
A076870 N020298
001 001
Aug 26, 2004 May 17, 1996
ALMOTRIPTAN MALATE
TABLET; ORAL AXERT JANSSEN PHARMS XX XX +
EQ 6.25MG BASE EQ 12.5MG BASE
N021001 N021001
001 002
May 07, 2001 May 07, 2001
ALOSETRON HYDROCHLORIDE
TABLET; ORAL LOTRONEX XX PROMETHEUS LABS XX +
EQ 0.5MG BASE EQ 1MG BASE
N021107 N021107
002 001
Dec 23, 2003 Feb 09, 2000
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
INFUVITE ADULT
XX + SANDOZ
2 IU/ML;40MG/ML;12MCG/ML;40 N021163 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1 .2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
001
May 18, 2000
INJECTABLE; IV (INFUSION)
INFUVITE ADULT
2 IU/ML;40MG/ML;12MCG/ML;40 N021559 XX + SANDOZ IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1 .2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
001
Jun 16, 2003
ALPRAZOLAM
CONCENTRATE; ORAL
ALPRAZOLAM
XX + ROXANE TABLET; ORAL ALPRAZOLAM ACTAVIS ELIZABETH AB AB
1MG/ML
A074312
001
Oct 31, 1993
0.25MG 0.5MG
A074342 A074342
001 002
Oct 31, 1993 Oct 31, 1993

ALPRAZOLAM
TABLET; ORAL ALPRAZOLAM ACTAVIS ELIZABETH AB AB APOTEX INC AB AB AB AB BOCA PHARMA AB AB AB AB DAVA INTL INC AB AB AB AB MYLAN AB AB AB AB MYLAN PHARMS INC AB AB AB AB SANDOZ AB AB AB AB SUN PHARMA GLOBAL AB AB AB AB VINTAGE AB AB AB AB XANAX PHARMACIA AND UPJOHN AB AB AB + AB TABLET, EXTENDED RELEASE; ALPRAZOLAM ACTAVIS ELIZABETH AB AB AB AB AMNEAL PHARMS NY AB AB AB AB ANCHEN PHARMS AB AB AB AB APOTEX INC AB AB AB AUROBINDO PHARMA USA AB AB
3 - 16 (of 428)
1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG ORAL 0.5MG 1MG 2MG 3MG 0.5MG 1MG 2MG 3MG 0.5MG 1MG 2MG 3MG 0.5MG 2MG 3MG 0.5MG 1MG
A074342 A074342 A077741 A077741 A077741 A077741 A090248 A090248 A090248 A090248 A074174 A074174 A074174 A074174 A074215 A074215 A074215 A074215 A074046 A074046 A074046 A074046 A074112 A074112 A074112 A074909 A090082 A090082 A090082 A090082 A078491 A078491 A078491 A078491 N018276 N018276 N018276 N018276
003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 001 002 003 004 001 002 003 004 001 002 003 004
Oct Oct Jan Jan Jan Jan Sep Sep Sep Sep Oct Oct Oct Oct Jan Jan Jan Jan Oct Oct Oct May Dec Dec Dec Mar Jun Jun Jun Jun Sep Sep Sep Dec
31, 31, 19, 19, 19, 19, 17, 17, 17, 17, 19, 19, 19, 19, 27, 27, 27, 27, 19, 19, 19, 07, 29, 29, 29, 25, 17, 17, 17, 17, 25, 25, 25, 12,
1993 1993 2007 2007 2007 2007 2010 2010 2010 2010 1993 1993 1993 1993 1994 1994 1994 1994 1993 1993 1993 1997 1995 1995 1995 1998 2010 2010 2010 2010 2008 2008 2008 2008
Nov 27, 1985
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002
Feb Feb Feb Feb May May May May Sep Sep Sep Sep Nov Nov Nov Jun Jun
13, 13, 13, 13, 30, 30, 30, 30, 29, 29, 29, 29, 12, 12, 12, 07, 07,
2007 2007 2007 2007 2008 2008 2008 2008 2011 2011 2011 2011 2008 2008 2008 2011 2011

ALPRAZOLAM
TABLET, EXTENDED RELEASE; ORAL ALPRAZOLAM AUROBINDO PHARMA USA 2MG AB AB 3MG BARR AB 0.5MG AB 1MG AB 2MG AB 3MG COREPHARMA AB 0.5MG AB 1MG AB 2MG AB 3MG IMPAX LABS AB 0.5MG AB 1MG AB 2MG AB 3MG MYLAN AB 0.5MG AB 1MG AB 2MG AB 3MG TEVA PHARMS AB 0.5MG AB 1MG AB 2MG AB 3MG WATSON LABS FLORIDA AB 0.5MG AB 1MG AB 2MG AB 3MG ZYDUS PHARMS USA INC 0.5MG AB AB 1MG AB 2MG AB 3MG XANAX XR PHARMACIA AND UPJOHN 0.5MG AB AB 1MG AB 2MG AB + 3MG TABLET, ORALLY DISINTEGRATING; ORAL ALPRAZOLAM ACTAVIS ELIZABETH AB 0.25MG AB 0.5MG AB 1MG AB 2MG PAR PHARM AB 0.25MG AB 0.5MG AB 1MG AB 2MG NIRAVAM UCB INC AB 0.25MG AB 0.5MG AB + 1MG AB 2MG
3 - 17 (of 428)
A090871 A090871 A077725 A077725 A077725 A077725 A077996 A077996 A077996 A077996 A077968 A077968 A077968 A077968 A077391 A077391 A077391 A077391 A077979 A077979 A077979 A077979 A077198 A077198 A077198 A077198 A078489 A078489 A078489 A078489 N021434 N021434 N021434 N021434
003 004 001 002 004 003 001 002 003 004 004 003 002 001 002 003 004 001 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Jun Jun Jul Jul Jul Jul Jan Jan Jan Jan May May May May Jan Jan Jan Jan Feb Feb Feb Feb May May May May Oct Oct Oct Oct Jan Jan Jan Jan
07, 07, 31, 31, 31, 31, 31, 31, 31, 31, 24, 24, 24, 24, 26, 26, 26, 26, 28, 28, 28, 28, 13, 13, 13, 13, 17, 17, 17, 17, 17, 17, 17, 17,
2011 2011 2006 2006 2006 2006 2007 2007 2007 2007 2007 2007 2007 2007 2006 2006 2006 2006 2007 2007 2007 2007 2010 2010 2010 2010 2008 2008 2008 2008 2003 2003 2003 2003
A078561 A078561 A078561 A078561 A078088 A078088 A078088 A078088 N021726 N021726 N021726 N021726
001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar Jan Jan Jan Jan Jan Jan Jan Jan
16, 16, 16, 16, 09, 09, 09, 09, 19, 19, 19, 19,
2010 2010 2010 2010 2009 2009 2009 2009 2005 2005 2005 2005
ALPROSTADIL
INJECTABLE; INJECTION ALPROSTADIL BEDFORD AP TEVA PARENTERAL AP CAVERJECT PHARMACIA AND UPJOHN AP
0.5MG/ML 0.5MG/ML 0.01MG/VIAL
A074815 A075196 N020379
001 001 001
Jan 20, 1998 Apr 30, 1999 Jul 06, 1995

ALPROSTADIL
INJECTABLE; INJECTION CAVERJECT AP + PHARMACIA AND UPJOHN AP + EDEX ACTIENT PHARMS AP AP AP + PROSTIN VR PEDIATRIC AP + PHARMACIA AND UPJOHN CAVERJECT PHARMACIA AND UPJOHN XX CAVERJECT IMPULSE PHARMACIA AND UPJOHN XX XX EDEX XX + ACTIENT PHARMS XX + XX + SUPPOSITORY; URETHRAL MUSE MEDA PHARMS XX XX XX XX +
3 - 18 (of 428)
0.02MG/VIAL 0.04MG/VIAL 0.01MG/VIAL 0.02MG/VIAL 0.04MG/VIAL 0.5MG/ML 0.005MG/VIAL 0.01MG/VIAL 0.02MG/VIAL 0.01MG/VIAL 0.02MG/VIAL 0.04MG/VIAL
N020379 N020379 N020649 N020649 N020649 N018484 N020379 N021212 N021212 N020649 N020649 N020649
002 004 002 003 004 001 003 001 002 005 006 007
Jul 06, 1995 May 19, 1997 Jun 12, 1997 Jun 12, 1997 Jun 12, 1997
Jun 27, 1996 Jun 11, 2002 Jun 11, 2002 Jul 30, 1998 Jul 30, 1998 Jul 30, 1998
0.125MG 0.25MG 0.5MG 1MG
N020700 N020700 N020700 N020700
001 002 003 004
Nov Nov Nov Nov
19, 19, 19, 19,
1996 1996 1996 1996
ALTRETAMINE
CAPSULE; ORAL
HEXALEN
XX + EISAI INC
50MG
N019926
001
Dec 26, 1990
ALVIMOPAN
CAPSULE; ORAL
ENTEREG
XX + CUBIST PHARMS
12MG
N021775
001
May 20, 2008
AMANTADINE HYDROCHLORIDE
CAPSULE; ORAL AMANTADINE HYDROCHLORIDE BANNER PHARMACAPS 100MG SANDOZ 100MG + USL PHARMA 100MG SYRUP; ORAL AMANTADINE HYDROCHLORIDE + CAROLINA MEDCL 50MG/5ML + HI TECH PHARMA 50MG/5ML + MIKART 50MG/5ML + PHARM ASSOC 50MG/5ML + SILARX 50MG/5ML + VINTAGE 50MG/5ML + WOCKHARDT 50MG/5ML TABLET; ORAL
+ USL PHARMA 100MG
AB AB AB
A078720 A071293 A070589
001 001 001
May 29, 2008 Feb 18, 1987 Aug 05, 1986
AA AA AA AA AA AA AA
A075819 A074170 A074028 A074509 A076352 A077992 A075060
001 001 001 001 001 001 001
Sep Oct Jun Jul Sep Dec Dec
11, 28, 28, 17, 10, 12, 24,
2002 1994 1993 1995 2004 2006 1998
XX
A076186
001
Dec 16, 2002
AMBENONIUM CHLORIDE
TABLET; ORAL
MYTELASE
XX + SANOFI AVENTIS US
10MG
N010155
002

AMBRISENTAN
TABLET; ORAL LETAIRIS XX GILEAD XX +
3 - 19 (of 428)
5MG 10MG
N022081 N022081
001 002
Jun 15, 2007 Jun 15, 2007
AMCINONIDE
CREAM; TOPICAL AMCINONIDE AB + FOUGERA PHARMS TARO PHARM INDS AB LOTION; TOPICAL
AMCINONIDE
XX + FOUGERA PHARMS OINTMENT; TOPICAL AMCINONIDE AB + FOUGERA PHARMS TARO PHARM INDS AB
0.1% 0.1%
A076065 A076229
001 001
May 15, 2003 May 31, 2002
0.1%
A076329
001
Nov 06, 2002
0.1% 0.1%
A076096 A076367
001 001
Nov 19, 2002 Mar 19, 2003
AMIFOSTINE
INJECTABLE; INJECTION AMIFOSTINE SUN PHARMA GLOBAL AP ETHYOL AP + MEDIMMUNE
500MG/VIAL 500MG/VIAL
A077126 N020221
001 001
Mar 14, 2008 Dec 08, 1995
AMIKACIN SULFATE
INJECTABLE; INJECTION AMIKACIN SULFATE + BEDFORD + HOSPIRA TEVA PARENTERAL
AP AP AP AP
EQ EQ EQ EQ
50MG BASE/ML 250MG BASE/ML 250MG BASE/ML 250MG BASE/ML
A063313 A063315 A063264 A064045
001 001 001 002
Apr Apr Nov Sep
11, 11, 30, 28,
1994 1994 1994 1993
AMILORIDE HYDROCHLORIDE
TABLET; ORAL AMILORIDE HYDROCHLORIDE AB + PAR PHARM 5MG SIGMAPHARM LABS LLC AB 5MG MIDAMOR PADDOCK LLC AB 5MG
A070346 A079133 N018200
001 001 001
Jan 22, 1986 Jan 30, 2009
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

TABLET; ORAL AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE BARR AB EQ 5MG ANHYDROUS;50MG AB + MYLAN EQ 5MG ANHYDROUS;50MG
A071111 A073209
001 001
May 10, 1988 Oct 31, 1991
AMINO ACIDS
INJECTABLE; INJECTION AMINO ACIDS B BRAUN XX XX AMINOSYN 10% HOSPIRA XX AMINOSYN 10% (PH6) HOSPIRA XX AMINOSYN 3.5% HOSPIRA XX AMINOSYN 5% HOSPIRA XX
15%(300GM/2000ML) 15%(150GM/1000ML) 10% (10GM/100ML) 10% (10GM/100ML) 3.5% (3.5GM/100ML) 5% (5GM/100ML)
A091112 A091112 N017673 N017673 N017789 N017673
002 001 003 008 004 001
Apr 13, 2012 Apr 13, 2012
Nov 18, 1985

AMINO ACIDS
INJECTABLE; INJECTION AMINOSYN 7% HOSPIRA 7% (7GM/100ML) AMINOSYN 7% (PH6) HOSPIRA 7% (7GM/100ML) AMINOSYN 8.5% HOSPIRA 8.5% (8.5GM/100ML) AMINOSYN 8.5% (PH6) HOSPIRA 8.5% (8.5GM/100ML) AMINOSYN II 10% HOSPIRA 10% (10GM/100ML) AMINOSYN II 10% IN PLASTIC CONTAINER HOSPIRA 10% (10GM/100ML) AMINOSYN II 15% IN PLASTIC CONTAINER HOSPIRA 15% (15GM/100ML) AMINOSYN II 7% HOSPIRA 7% (7GM/100ML) AMINOSYN II 8.5% HOSPIRA 8.5% (8.5GM/100ML) AMINOSYN-HBC 7% HOSPIRA 7% (7GM/100ML) AMINOSYN-HF 8% HOSPIRA 8% (8GM/100ML) AMINOSYN-PF 10% HOSPIRA 10% (10GM/100ML) AMINOSYN-PF 7% HOSPIRA 7% (7GM/100ML) AMINOSYN-RF 5.2% HOSPIRA 5.2% (5.2GM/100ML) BRANCHAMIN 4% IN PLASTIC CONTAINER BAXTER HLTHCARE 4% (4GM/100ML) CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER BAXTER HLTHCARE 15% (15GM/100ML) FREAMINE HBC 6.9% B BRAUN 6.9% (6.9GM/100ML) FREAMINE III 10% B BRAUN 10% (10GM/100ML) FREAMINE III 8.5% B BRAUN 8.5% (8.5GM/100ML) HEPATAMINE 8% B BRAUN 8% (8GM/100ML) HEPATASOL 8% BAXTER HLTHCARE 8% (8GM/100ML) NEPHRAMINE 5.4% B BRAUN 5.4% (5.4GM/100ML) PREMASOL 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 10% (10GM/100ML) PREMASOL 6% IN PLASTIC CONTAINER BAXTER HLTHCARE 6% (6GM/100ML) PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER + BAXTER HLTHCARE 20% (20GM/100ML) RENAMIN W/O ELECTROLYTES BAXTER HLTHCARE 6.5% (6.5GM/100ML) TRAVASOL 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 10% (10MG/100ML) TRAVASOL 10% W/O ELECTROLYTES BAXTER HLTHCARE 10% (10GM/100ML) TRAVASOL 5.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 5.5% (5.5GM/100ML) TRAVASOL 5.5% W/O ELECTROLYTES
BAXTER HLTHCARE 5.5% (5.5GM/100ML)
3 - 20 (of 428)
XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX
N017673 N017673 N017673 N017673 N019438 N020015 N020041 N019438 N019438 N019374 N020345 N019492 N019398 N018429 N018684 A020512 N016822 N016822 N016822 N018676 A020360 N017766 A075880 A075880 N020849 N017493 N018931 N017493 N018931 N017493
002 006 004 007 005 001 001 003 004 001 001 002 001 001 001 001 006 005 004 001 001 001 002 001 001 007 003 006 001 004
Aug 23, 1984 Jun 19, 2003 Jun 19, 2003 Aug 26, 1998 Oct 15, 1982 Aug 23, 1984 Aug 03, 1982 Apr 04, 1996 Sep 28, 1984 Aug 30, 1996 May 17, 1983 Nov 18, 1985 Apr 03, 1986 Dec 19, 1991 Dec 19, 1991 Apr 03, 1986 Apr 03, 1986 Jul 12, 1985 Apr 04, 1996 Oct 17, 1986 Sep 06, 1985 Nov 18, 1985

AMINO ACIDS
INJECTABLE; INJECTION TRAVASOL 8.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 8.5% (8.5GM/100ML) TRAVASOL 8.5% W/O ELECTROLYTES BAXTER HLTHCARE 8.5% (8.5GM/100ML) TROPHAMINE + B BRAUN 6% (6GM/100ML) TROPHAMINE 10% + B BRAUN 10% (10GM/100ML)
3 - 21 (of 428)
XX XX XX XX
N018931 N017493 N019018 N019018
002 005 001 003
Aug 23, 1984
Jul 20, 1984 Sep 07, 1988
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION PROCALAMINE XX B BRAUN
3%;26MG/100ML;3GM/100ML;54MG/100ML;41MG N018582 /100ML;150MG/100ML;200MG/100ML;120MG/10 0ML
001
May 08, 1982
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.75%;33MG/100ML;10GM/100ML;51MG/100ML; N020678 002 Mar 26, 1997 261MG/100ML;217MG/100ML;112MG/100ML CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.75%;33MG/100ML;25GM/100ML;51MG/100ML; N020678 005 Mar 26, 1997 261MG/100ML;217MG/100ML;112MG/100ML CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.75%;33MG/100ML;5GM/100ML;51MG/100ML;2 N020678 001 Mar 26, 1997 61MG/100ML;217MG/100ML;112MG/100ML CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;10GM/100ML;51MG/100ML; N020678 009 Mar 26, 1997 261MG/100ML;297MG/100ML;77MG/100ML CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;20GM/100ML;51MG/100ML; N020678 011 Mar 26, 1997 261MG/100ML;297MG/100ML;77MG/100ML CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;25GM/100ML;51MG/100ML; N020678 012 Mar 26, 1997 261MG/100ML;297MG/100ML;77MG/100ML CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;5GM/100ML;51MG/100ML;2 N020678 008 Mar 26, 1997 61MG/100ML;297MG/100ML;77MG/100ML CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;10GM/100ML;51MG/100ML;261 N020678 016 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;15GM/100ML;51MG/100ML;261 N020678 017 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;20GM/100ML;51MG/100ML;261 N020678 018 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;25GM/100ML;51MG/100ML;261 N020678 019 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;35GM/100ML;51MG/100ML;261 N020678 021 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
AMINO ACIDS; DEXTROSE

INJECTABLE; INJECTION CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;10GM/100ML N020734 XX
002
Sep 29, 1997

INJECTABLE; INJECTION CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;25GM/100ML N020734 CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;5GM/100ML N020734 CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;10GM/100ML N020734 CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;20GM/100ML N020734 CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;25GM/100ML N020734 CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;5GM/100ML N020734 CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 5%;10GM/100ML N020734 CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER BAXTER HLTHCARE 5%;15GM/100ML N020734 CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 5%;20GM/100ML N020734 CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 5%;25GM/100ML N020734 CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER BAXTER HLTHCARE 5%;35GM/100ML N020734
3 - 22 (of 428)
XX XX XX XX XX XX XX XX XX XX XX
005 001 008 010 011 007 014 015 016 017 018
Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
INJECTABLE; INJECTION FREAMINE III 8.5% W/ ELECTROLYTES XX B BRAUN 8.5%;110MG/100ML;230MG/100ML;10MG/100ML N016822 ;440MG/100ML;690MG/100ML
007
Jul 01, 1988
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
AMINOSYN 3.5% M
XX HOSPIRA
3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N017789 234MG/100ML
003
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
FREAMINE III 3% W/ ELECTROLYTES
XX B BRAUN 3%;54MG/100ML;40MG/100ML;150MG/100ML;20 N016822 0MG/100ML;120MG/100ML
003
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 10% W/ ELECTROLYTES XX HOSPIRA 10%;102MG/100ML;45MG/100ML;522MG/100ML; N019437 410MG/100ML AMINOSYN II 8.5% W/ ELECTROLYTES XX HOSPIRA 8.5%;102MG/100ML;45MG/100ML;522MG/100ML N019437 ;410MG/100ML
004
Apr 03, 1986
005
Apr 03, 1986
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER XX BAXTER HLTHCARE 3.5%;51MG/100ML;131MG/100ML;218MG/100ML N020177 ;35MG/100ML TRAVASOL 3.5% W/ ELECTROLYTES XX BAXTER HLTHCARE 3.5%;51MG/100ML;131MG/100ML;218MG/100ML N017493 ;35MG/100ML
001
Oct 23, 1995
003
3 - 23 (of 428)
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER XX BAXTER HLTHCARE 5.5%;102MG/100ML;522MG/100ML;431MG/100M L;224MG/100ML TRAVASOL 5.5% W/ ELECTROLYTES XX BAXTER HLTHCARE 5.5%;102MG/100ML;522MG/100ML;431MG/100M L;224MG/100ML TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER XX BAXTER HLTHCARE 8.5%;102MG/100ML;522MG/100ML;594MG/100M L;154MG/100ML TRAVASOL 8.5% W/ ELECTROLYTES XX BAXTER HLTHCARE 8.5%;102MG/100ML;522MG/100ML;594MG/100M L;154MG/100ML
N020173
001
Oct 27, 1995
N017493
001
N020173
002
Oct 27, 1995
N017493
002
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE

AMINOSYN 7% W/ ELECTROLYTES
HOSPIRA 7%;102MG/100ML;522MG/100ML;410MG/100ML N017789 XX AMINOSYN 8.5% W/ ELECTROLYTES
HOSPIRA 8.5%;102MG/100ML;522MG/100ML;410MG/100M N017673 XX L
002
005
AMINOCAPROIC ACID
INJECTABLE; INJECTION AMINOCAPROIC ACID LUITPOLD 250MG/ML AMINOCAPROIC ACID IN PLASTIC CONTAINER + HOSPIRA 250MG/ML SYRUP; ORAL AMICAR + CLOVER PHARMS 1.25GM/5ML AMINOCAPROIC ACID MIKART 1.25GM/5ML TABLET; ORAL AMICAR CLOVER PHARMS 500MG AMINOCAPROIC MIKART 500MG AMICAR + CLOVER PHARMS 1GM
AP AP
A071192 A070010
001 001
Dec 01, 1987 Mar 09, 1987
AA AA
N015230 A074759
002 001 Sep 02, 1998
AB AB XX
N015197 A075602 N015197
001 001 002 May 24, 2001 Jun 24, 2004
AMINOHIPPURATE SODIUM
AMINOHIPPURATE SODIUM
XX + MERCK
20%
N005619
001
AMINOLEVULINIC ACID HYDROCHLORIDE

SOLUTION; TOPICAL
LEVULAN
XX + DUSA
20%
N020965
001
Dec 03, 1999
AMINOPHYLLINE
INJECTABLE; INJECTION AMINOPHYLLINE + HOSPIRA INTL MEDICATION LUITPOLD PHARMA SERVE NY TABLET; ORAL
AMINOPHYLLINE
+ WEST WARD
AP AP AP AP
A087242 A087209 A087600 A087392
001 001 001 001
Oct 26, 1983 Feb 01, 1982 Dec 15, 1983
XX
100MG
A084540
001

AMINOPHYLLINE
TABLET; ORAL
AMINOPHYLLINE
XX + WEST WARD
3 - 24 (of 428)
200MG
A085003
001
AMINOSALICYLIC ACID
GRANULE, DELAYED RELEASE; ORAL
PASER
4GM/PACKET XX + JACOBUS
A074346
001
Jun 30, 1994
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION AMIODARONE HYDROCHLORIDE + AKORN 50MG/ML + BIONICHE PHARMA 50MG/ML + CLARIS LIFESCIENCES 50MG/ML + FRESENIUS KABI USA 50MG/ML + GLAND PHARMA LTD 50MG/ML HIKMA FARMACEUTICA 50MG/ML + HOSPIRA 50MG/ML WOCKHARDT 50MG/ML 50MG/ML NEXTERONE BAXTER HLTHCARE 50MG/ML NEXTERONE + BAXTER HLTHCARE 150MG/100ML (1.5MG/ML) + 360MG/200ML (1.8MG/ML) TABLET; ORAL AMIODARONE HYDROCHLORIDE APOTEX CORP 200MG BARR 200MG MURTY PHARMS 200MG 400MG MYLAN 200MG SANDOZ 200MG 400MG TARO 100MG 200MG 400MG TEVA PHARMS 200MG ZYDUS PHARMS USA INC 200MG CORDARONE + WYETH PHARMS INC 200MG PACERONE UPSHER SMITH 100MG 200MG AMIODARONE HYDROCHLORIDE TARO 300MG
AP AP AP AP AP AP AP AP AP AP XX XX
A076232 A076217 A076394 A075761 A077161 A077234 A075955 A077610 A077834 N022325 N022325 N022325
001 001 001 001 001 001 001 001 001 001 002 003
Jul Oct Apr Oct Apr Feb Oct Oct Oct
05, 15, 25, 15, 20, 25, 18, 30, 30,
2006 2002 2003 2002 2005 2008 2002 2008 2008
Dec 24, 2008 Nov 16, 2010 Nov 16, 2010
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB XX
A078578 A075389 A077069 A077069 A075188 A075315 A075315 A075424 A075424 A076362 A074739 A079029 N018972 A075135 A075135 A076362
001 001 001 002 001 001 002 002 001 001 001 001 001 002 001 002
Nov Jan Apr Apr Feb Dec Jun Dec Mar Nov Nov Sep
06, 25, 08, 08, 24, 23, 30, 18, 30, 29, 30, 16,
2008 2001 2005 2005 1999 1998 2000 2002 2001 2002 1998 2008
Dec 24, 1985 Apr 12, 2005 Apr 30, 1998 Dec 02, 2003
AMITRIPTYLINE HYDROCHLORIDE
TABLET; ORAL AMITRIPTYLINE HYDROCHLORIDE CARACO AB 10MG AB 25MG AB 50MG AB 75MG AB 100MG AB 150MG MUTUAL PHARM AB 10MG AB 25MG AB 50MG
A040816 A040816 A040816 A040816 A040816 A040816 A089398 A089399 A089400
002 001 003 004 005 006 001 001 001
Jun Jun Jun Jun Jun Jun Jul Jul Jul
27, 27, 27, 27, 27, 27, 14, 14, 14,
2008 2008 2008 2008 2008 2008 1987 1987 1987

TABLET; ORAL AMITRIPTYLINE HYDROCHLORIDE MUTUAL PHARM 75MG 100MG 150MG MYLAN 10MG 25MG 50MG 75MG 100MG 150MG SANDOZ 10MG + 25MG 50MG 75MG 100MG 150MG VINTAGE PHARMS 10MG 25MG 50MG 75MG 100MG 150MG
3 - 25 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A089401 A089402 A089403 A086009 A086009 A086009 A086009 A086009 A086009 A085969 A085966 A085968 A085971 A085967 A085970 A040218 A040218 A040218 A040218 A040218 A040218
001 001 001 002 003 001 004 005 006 001 001 001 001 001 001 001 002 003 004 005 006
Jul 14, 1987 Jul 14, 1987 Jul 14, 1987
Sep Sep Sep Sep Sep Sep
11, 11, 11, 11, 11, 11,
1997 1997 1997 1997 1997 1997
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

TABLET; ORAL CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE XX MYLAN PHARMS INC EQ 12.5MG BASE;5MG XX + EQ 25MG BASE;10MG
A071297 A071297
002 001
Dec 10, 1986 Dec 10, 1986
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE

TABLET; ORAL PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE XX MYLAN 10MG;2MG XX 10MG;4MG XX + 25MG;2MG XX + 25MG;4MG XX + 50MG;4MG
A071443 A071443 A071443 A071443 A071443
002 003 004 005 001
Nov Nov Nov Nov Nov
10, 10, 10, 10, 10,
1988 1988 1988 1988 1988
AMLEXANOX
PASTE; DENTAL
APHTHASOL
XX + ULURU
5%
N020511
001
Dec 17, 1996
AMLODIPINE BESYLATE
TABLET; ORAL AMLODIPINE BESYLATE ALKEM AB AB AB AMNEAL PHARMS NY AB AB AB APOTEX AB AB AB AUROBINDO PHARMA AB AB AB CARACO AB
2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE
A078925 A078925 A078925 A078477 A078477 A078477 A076719 A076719 A076719 A078021 A078021 A078021 A078231
001 002 003 001 002 003 001 002 003 001 002 003 001
May May May Jan Jan Jan May May May Jul Jul Jul Nov
04, 04, 04, 16, 16, 16, 23, 23, 23, 17, 17, 17, 30,
2009 2009 2009 2008 2008 2008 2007 2007 2007 2007 2007 2007 2007

AMLODIPINE BESYLATE
TABLET; ORAL AMLODIPINE BESYLATE CARACO AB AB DR REDDYS LABS LTD AB AB AB EPIC PHARMA LLC AB AB AB HIKMA PHARMS AB AB AB INVAGEN PHARMS AB AB AB LUPIN AB AB AB MACLEODS PHARMS LTD AB AB MATRIX LABS LTD AB AB AB MYLAN AB AB AB ORCHID HLTHCARE AB AB AB PURACAP PHARM AB AB AB RANBAXY AB AB AB ROXANE AB AB AB SECAN PHARMS AB AB TEVA AB AB AB TORRENT PHARMS AB AB AB UPSHER SMITH AB AB AB VINTAGE AB AB AB WATSON LABS AB AB AB AB AB AB WOCKHARDT AB
3 - 26 (of 428)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 2.5MG BASE 5MG BASE 5MG BASE 10MG BASE 10MG BASE 2.5MG BASE
A078231 A078231 A076692 A076692 A076692 A078552 A078552 A078552 A077771 A077771 A077771 A077955 A077955 A077955 A078043 A078043 A078043 A201380 A201380 A078224 A078224 A078224 A076418 A076418 A076418 A078453 A078453 A078453 A078131 A078131 A078131 A077974 A077974 A077974 A077262 A077262 A077262 A090752 A090752 A076846 A076846 A076846 A078573 A078573 A078573 A077759 A077759 A077759 A078414 A078414 A078414 A077073 A077671 A077073 A077671 A077073 A077671 A078500
002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001
Nov Nov Jul Jul Jul Apr Apr Apr Apr Apr Apr Aug Aug Aug Jul Jul Jul Apr Apr Feb Feb Feb Oct Oct Oct Jul Jul Jul Sep Sep Sep Jul Jul Jul Jul Jul Jul Apr Apr Jun Jun Jun Sep Sep Sep Jul Jul Jul Apr Apr Apr Sep Jul Sep Jul Sep Jul Sep
30, 30, 20, 20, 20, 08, 08, 08, 12, 12, 12, 28, 28, 28, 12, 12, 12, 13, 13, 27, 27, 27, 03, 03, 03, 02, 02, 02, 04, 04, 04, 09, 09, 09, 09, 09, 09, 15, 15, 28, 28, 28, 22, 22, 22, 09, 09, 09, 07, 07, 07, 26, 19, 26, 19, 26, 19, 06,
2007 2007 2007 2007 2007 2009 2009 2009 2011 2011 2011 2007 2007 2007 2007 2007 2007 2012 2012 2008 2008 2008 2005 2005 2005 2009 2009 2009 2007 2007 2007 2007 2007 2007 2007 2007 2007 2011 2011 2007 2007 2007 2008 2008 2008 2007 2007 2007 2010 2010 2010 2007 2007 2007 2007 2007 2007 2007

AMLODIPINE BESYLATE
TABLET; ORAL AMLODIPINE BESYLATE WOCKHARDT AB AB WORLD GEN AB AB AB ZYDUS PHARMS USA AB AB AB NORVASC PFIZER AB AB AB +
3 - 27 (of 428)
EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE
A078500 A078500 A077516 A077516 A077516 A078226 A078226 A078226 N019787 N019787 N019787
002 003 001 002 003 001 002 003 001 002 003
Sep Sep Jul Jul Jul Jul Jul Jul
06, 06, 11, 11, 11, 09, 09, 09,
2007 2007 2007 2007 2007 2007 2007 2007
EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE
Jul 31, 1992 Jul 31, 1992 Jul 31, 1992
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

TABLET; ORAL CADUET XX PFIZER XX XX XX XX XX XX XX XX XX XX +
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
2.5MG BASE;EQ 10MG BASE 2.5MG BASE;EQ 20MG BASE 2.5MG BASE;EQ 40MG BASE 5MG BASE;EQ 10MG BASE 5MG BASE;EQ 20MG BASE 5MG BASE;EQ 40MG BASE 5MG BASE;EQ 80MG BASE 10MG BASE;EQ 10MG BASE 10MG BASE;EQ 20MG BASE 10MG BASE;EQ 40MG BASE 10MG BASE;EQ 80MG BASE
N021540 N021540 N021540 N021540 N021540 N021540 N021540 N021540 N021540 N021540 N021540
009 010 011 001 002 003 004 005 006 007 008
Jul Jul Jul Jan Jan Jan Jan Jan Jan Jan Jan
29, 29, 29, 30, 30, 30, 30, 30, 30, 30, 30,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

CAPSULE; ORAL AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE AUROBINDO PHARMA LTD EQ 2.5MG BASE;10MG AB AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG AB EQ 5MG BASE;40MG AB EQ 10MG BASE;20MG AB EQ 10MG BASE;40MG DR REDDYS LABS INC AB EQ 2.5MG BASE;10MG AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG AB EQ 5MG BASE;40MG AB EQ 10MG BASE;20MG AB EQ 10MG BASE;40MG LUPIN PHARMS AB EQ 2.5MG BASE;10MG AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG AB EQ 5MG BASE;40MG AB EQ 10MG BASE;20MG AB EQ 10MG BASE;40MG MYLAN AB EQ 2.5MG BASE;10MG AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG AB EQ 5MG BASE;40MG AB EQ 10MG BASE;20MG AB EQ 10MG BASE;40MG PAR PHARM AB EQ 2.5MG BASE;10MG AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG
A202239 A202239 A202239 A202239 A202239 A202239 A077183 A077183 A077183 A090149 A077183 A090149 A078466 A078466 A078466 A078466 A078466 A078466 A077375 A077375 A077375 A079047 A077375 A079047 A078381 A078381 A078381
001 002 003 004 005 006 001 002 003 001 004 002 001 002 003 005 004 006 001 002 003 001 004 002 001 002 003
Sep Sep Sep Sep Sep Sep Apr Apr Apr Jul Apr Jul Feb Feb Feb Jul Feb Jul May May May Jul May Jul Jul Jul Jul
05, 05, 05, 05, 05, 05, 15, 15, 15, 05, 15, 05, 05, 05, 05, 05, 05, 05, 21, 21, 21, 05, 21, 05, 29, 29, 29,
2012 2012 2012 2012 2012 2012 2010 2010 2010 2011 2010 2011 2010 2010 2010 2011 2010 2011 2010 2010 2010 2011 2010 2011 2010 2010 2010

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
CAPSULE; ORAL AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE PAR PHARM AB EQ 5MG BASE;40MG AB EQ 10MG BASE;20MG AB EQ 10MG BASE;40MG TEVA PHARMS AB EQ 2.5MG BASE;10MG AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG AB EQ 5MG BASE;40MG AB EQ 10MG BASE;20MG AB EQ 10MG BASE;40MG WATSON LABS AB EQ 2.5MG BASE;10MG AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG AB EQ 10MG BASE;20MG WATSON LABS INC AB EQ 5MG BASE;40MG AB EQ 10MG BASE;40MG LOTREL NOVARTIS AB EQ 2.5MG BASE;10MG AB EQ 5MG BASE;10MG AB EQ 5MG BASE;20MG AB EQ 5MG BASE;40MG AB EQ 10MG BASE;20MG AB + EQ 10MG BASE;40MG
3 - 28 (of 428)
A078381 A078381 A078381 A077179 A077179 A077179 A077179 A077179 A077179 A077890 A077890 A077890 A077890 A090364 A090364 N020364 N020364 N020364 N020364 N020364 N020364
005 004 006 001 002 003 005 004 006 001 002 003 004 001 002 002 003 004 007 005 006
Jul Jul Jul May May May Jul May Jul Oct Oct Oct Oct Jul Jul Mar Mar Mar Apr Jun Apr
29, 29, 29, 18, 18, 18, 05, 18, 05, 14, 14, 14, 14, 05, 05, 03, 03, 03, 11, 20, 11,
2010 2010 2010 2007 2007 2007 2011 2007 2011 2010 2010 2010 2010 2011 2011 1995 1995 1995 2006 2002 2006
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

TABLET; ORAL TRIBENZOR XX DAIICHI SANKYO XX XX XX XX +
EQ EQ EQ EQ EQ
5MG BASE;12.5MG;20MG 5MG BASE;12.5MG;40MG 5MG BASE;25MG;40MG 10MG BASE;12.5MG;40MG 10MG BASE;25MG;40MG
N200175 N200175 N200175 N200175 N200175
001 002 003 004 005
Jul Jul Jul Jul Jul
23, 23, 23, 23, 23,
2010 2010 2010 2010 2010
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

TABLET; ORAL EXFORGE HCT NOVARTIS AB AB AB AB AB +
5MG;12.5MG;160MG 5MG;25MG;160MG 10MG;12.5MG;160MG 10MG;25MG;160MG 10MG;25MG;320MG
N022314 N022314 N022314 N022314 N022314
001 002 003 004 005
Apr Apr Apr Apr Apr
30, 30, 30, 30, 30,
2009 2009 2009 2009 2009
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

TABLET; ORAL AZOR DAIICHI SANKYO XX XX XX XX +
EQ EQ EQ EQ
5MG BASE;20MG 5MG BASE;40MG 10MG BASE;20MG 10MG BASE;40MG
N022100 N022100 N022100 N022100
001 002 003 004
Sep Sep Sep Sep
26, 26, 26, 26,
2007 2007 2007 2007
AMLODIPINE BESYLATE; TELMISARTAN

TABLET; ORAL TWYNSTA XX BOEHRINGER INGELHEIM XX XX XX +
EQ EQ EQ EQ
N022401 N022401 N022401 N022401
001 003 002 004
Oct Oct Oct Oct
16, 16, 16, 16,
2009 2009 2009 2009

AMLODIPINE BESYLATE; VALSARTAN
TABLET; ORAL EXFORGE XX NOVARTIS XX XX + XX +
3 - 29 (of 428)
EQ EQ EQ EQ
N021990 N021990 N021990 N021990
002 004 003 005
Jun Jun Jun Jun
20, 20, 20, 20,
2007 2007 2007 2007
AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN

TABLET; ORAL AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE TEVA PHARMS AB 5MG;12.5MG;160MG AB 5MG;25MG;160MG AB 10MG;12.5MG;160MG AB 10MG;25MG;160MG AB 10MG;25MG;320MG
A200435 A200435 A200435 A200435 A200435
001 002 005 003 004
Sep Sep Sep Sep Sep
25, 25, 25, 25, 25,
2012 2012 2012 2012 2012
AMMONIA N-13
INJECTABLE; INTRAVENOUS AMMONIA N 13 HOUSTON CYCLOTRON XX
3.75-260mCi/ML
A203543
001
Dec 14, 2012
AMMONIA, N-13
INJECTABLE; INTRAVENOUS
AMMONIA N 13
XX + FEINSTEIN
30MCI-300MCI/8ML (3.75-37.5MCI/ML)
N022119
001
Aug 23, 2007
AMMONIUM CHLORIDE
AMMONIUM CHLORIDE IN PLASTIC CONTAINER
XX + HOSPIRA 5MEQ/ML
A088366
001
Jun 13, 1984
AMMONIUM LACTATE
CREAM; TOPICAL AMMONIUM LACTATE PERRIGO NEW YORK TARO WATSON LABS INC LAC-HYDRIN + RANBAXY LOTION; TOPICAL AMMONIUM LACTATE PERRIGO NEW YORK TARO WATSON LABS INC LAC-HYDRIN + RANBAXY
AB AB AB AB
EQ 12% BASE EQ 12% BASE EQ 12% BASE EQ 12% BASE
A075774 A075883 A076829 N020508
001 001 001 001
May 01, 2002 Apr 10, 2003 Feb 07, 2006 Aug 29, 1996
AB AB AB AB
EQ 12% BASE EQ 12% BASE EQ 12% BASE EQ 12% BASE
A075570 A076216 A075575 N019155
001 001 001 001
Jun 23, 2004 May 28, 2004 Jun 11, 2002 Apr 24, 1985
AMOXAPINE
TABLET; ORAL AMOXAPINE WATSON LABS XX XX XX XX +
25MG 50MG 100MG 150MG
A072688 A072689 A072690 A072691
001 001 001 001
Aug Aug Aug Aug
28, 28, 28, 28,
1992 1992 1992 1992
AMOXICILLIN
CAPSULE; ORAL AMOXICILLIN AM ANTIBIOTICS AB AB AUROBINDO AB
250MG 500MG 250MG
A062058 A062058 A065271
001 002 001
Nov 09, 2005

AMOXICILLIN
CAPSULE; ORAL AMOXICILLIN AUROBINDO AB DAVA PHARMS INC AB AB HIKMA PHARMS AB AB RANBAXY AB AB SANDOZ AB AB TEVA AB AB + AMOXIL DR REDDYS LABS INC AB AB FOR SUSPENSION; ORAL AMOXICILLIN AUROBINDO AB AB DAVA PHARMS INC AB AB HIKMA AB AB AB AB RANBAXY AB AB SANDOZ AB AB AB AB TEVA AB AB AB + AB + WOCKHARDT AB AMOXICILLIN PEDIATRIC TEVA AB AMOXIL DR REDDYS LABS INC AB AB AB AB AB LAROTID DR REDDYS LABS INC AB AB TABLET; ORAL AMOXICILLIN AUROBINDO AB AB DAVA PHARMS INC AB HIKMA AB RANBAXY AB AB SANDOZ AB AB TEVA AB AB +
3 - 30 (of 428)
500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG
A065271 A062884 A062881 A065291 A065291 A065016 A065016 A064076 A064076 A061926 A061926 A062216 A062216
002 001 001 001 002 001 002 001 002 001 003 001 004
Nov Feb Feb Feb Feb Apr Apr Sep Sep
09, 25, 25, 05, 05, 08, 08, 30, 30,
2005 1988 1988 2007 2007 1999 1999 1994 1994
200MG/5ML 400MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 200MG/5ML 250MG/5ML 400MG/5ML 200MG/5ML 400MG/5ML 125MG/5ML 200MG/5ML 250MG/5ML 400MG/5ML 125MG/5ML 200MG/5ML 250MG/5ML 400MG/5ML 400MG/5ML 50MG/ML 50MG/ML 125MG/5ML 200MG/5ML 250MG/5ML 400MG/5ML 125MG/5ML 250MG/5ML
A065334 A065334 A062927 A062927 A065322 A065325 A065322 A065325 A065113 A065113 A065387 A065378 A065387 A065378 A061931 A065119 A061931 A065119 A065319 A061931 A062226 A062226 N050760 A062226 N050760 A062226 A062226
001 002 001 002 002 002 001 001 001 002 001 001 002 002 001 001 002 002 002 003 005 001 001 002 002 003 004
Dec Dec Nov Nov Jun Jun Jun Jun Nov Nov Mar Mar Mar Mar
28, 28, 25, 25, 19, 19, 19, 19, 29, 29, 26, 26, 26, 26,
2006 2006 1988 1988 2006 2006 2006 2006 2002 2002 2007 2007 2007 2007
Dec 04, 2002 Dec 04, 2002 Jun 18, 2007 Dec 01, 1982
Apr 15, 1999 Apr 15, 1999
500MG 875MG 875MG 875MG 500MG 875MG 500MG 875MG 500MG 875MG
A065256 A065256 A065344 A065255 A065059 A065059 A065228 A065228 A065056 A065056
001 002 001 001 001 002 001 002 001 002
Nov Nov Jan Mar Nov Nov Jul Jul Sep Sep
09, 09, 15, 29, 24, 24, 13, 13, 18, 18,
2005 2005 2009 2006 2000 2000 2005 2005 2000 2000

AMOXICILLIN
TABLET; ORAL AMOXIL DR REDDYS LABS INC AB 500MG AB 875MG TABLET, CHEWABLE; ORAL AMOXICILLIN DAVA PHARMS INC AB 125MG AB 250MG RANBAXY AB 125MG AB 250MG TEVA AB 125MG AB + 250MG AMOXIL DR REDDYS LABS INC AB 125MG AB 200MG AB 250MG AB 400MG AMOXICILLIN RANBAXY 200MG XX 400MG XX TABLET, EXTENDED RELEASE; ORAL
MOXATAG
775MG XX + SHIONOGI INC TABLET, FOR SUSPENSION; ORAL AMOXICILLIN AUROBINDO PHARMA AB 200MG AB 400MG
3 - 31 (of 428)
N050754 N050754
002 001
Jul 10, 1998 Jul 10, 1998
A064139 A064139 A065021 A065021 A064013 A064013 N050542 N050761 N050542 N050761 A065060 A065060
001 002 001 002 002 001 002 001 001 002 001 002
Jan Jan Dec Dec Sep Dec
29, 29, 23, 23, 11, 22,
1996 1996 1999 1999 1995 1992
Apr 15, 1999 Apr 15, 1999 Nov 29, 2000 Nov 29, 2000
N050813
001
Jan 23, 2008
A065324 A065324
001 002
Jan 17, 2007 Jan 17, 2007
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE

CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET; ORAL
PREVPAC
XX + TAKEDA PHARMS USA 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30M N050757 G
001
Dec 02, 1997
AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE

CAPSULE, TABLET, CAPSULE, DELAYED RELEASE, TABLET; ORAL
OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN
XX + GASTROENTERO 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20M N050824 G
001
Feb 08, 2011
AMOXICILLIN; CLAVULANATE POTASSIUM

FOR SUSPENSION; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM HIKMA PHARMS 200MG/5ML;EQ 28.5MG BASE/5ML 400MG/5ML;EQ 57MG BASE/5ML 600MG/5ML;EQ 42.9MG BASE/5ML RANBAXY 200MG/5ML;EQ 28.5MG BASE/5ML 400MG/5ML;EQ 57MG BASE/5ML 600MG/5ML;EQ 42.9MG BASE/5ML SANDOZ 200MG/5ML;EQ 28.5MG BASE/5ML 400MG/5ML;EQ 57MG BASE/5ML SANDOZ INC 200MG/5ML;EQ 28.5MG BASE/5ML 400MG/5ML;EQ 57MG BASE/5ML 600MG/5ML;EQ 42.9MG BASE/5ML TEVA 200MG/5ML;EQ 28.5MG BASE/5ML + 400MG/5ML;EQ 57MG BASE/5ML + 600MG/5ML;EQ 42.9MG BASE/5ML WOCKHARDT 250MG/5ML;EQ 62.5MG BASE/5ML AUGMENTIN '125' DR REDDYS LABS INC 125MG/5ML;EQ 31.25MG BASE/5ML
A065191 A065191 A065373 A065132 A065132 A065207 A065066 A065066 A065098 A065098 A065358 A065089 A065089 A065162 A065431 N050575
002 001 001 001 002 002 001 002 001 002 001 001 002 001 001 001
Jan Jan Nov Mar Mar Jan Jun Jun Dec Dec Aug May May Mar Nov
25, 25, 09, 19, 19, 30, 05, 05, 16, 16, 13, 25, 25, 12, 25,
2005 2005 2007 2003 2003 2007 2002 2002 2002 2002 2007 2004 2004 2004 2008
Aug 06, 1984

AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION; ORAL AUGMENTIN '200' DR REDDYS LABS INC AUGMENTIN '250' + DR REDDYS LABS INC AUGMENTIN '400' DR REDDYS LABS INC AUGMENTIN ES-600 DR REDDYS LABS INC
3 - 32 (of 428)
AB AB AB AB
200MG/5ML;EQ 28.5MG BASE/5ML 250MG/5ML;EQ 62.5MG BASE/5ML 400MG/5ML;EQ 57MG BASE/5ML
N050725 N050575 N050725 N050755
001 002 002 001
May 31, 1996 Aug 06, 1984 May 31, 1996 Jun 22, 2001
AB AB AB
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
AB AB AB AB AB AB AB AB AB AB
AB AB
600MG/5ML;EQ 42.9MG BASE/5ML SUSPENSION; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM AUROBINDO PHARMA LTD 200MG/5ML;EQ 28.5MG BASE/5ML 400MG/5ML;EQ 57MG BASE/5ML 600MG/5ML;EQ 42.9MG BASE/5ML TABLET; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM APOTEX 250MG;EQ 125MG BASE 500MG;EQ 125MG BASE APOTEX INC 875MG;EQ 125MG BASE AUROBINDO PHARMA LTD 250MG;EQ 125MG BASE 500MG;EQ 125MG BASE 875MG;EQ 125MG BASE RANBAXY 500MG;EQ 125MG BASE 875MG;EQ 125MG BASE SANDOZ 250MG;EQ 125MG BASE 500MG;EQ 125MG BASE 875MG;EQ 125MG BASE SANDOZ INC 500MG;EQ 125MG BASE 875MG;EQ 125MG BASE TEVA 500MG;EQ 125MG BASE + 875MG;EQ 125MG BASE AUGMENTIN '250' DR REDDYS LABS INC 250MG;EQ 125MG BASE AUGMENTIN '500' DR REDDYS LABS INC 500MG;EQ 125MG BASE AUGMENTIN '875' DR REDDYS LABS INC 875MG;EQ 125MG BASE TABLET, CHEWABLE; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM RANBAXY 200MG;EQ 28.5MG BASE 400MG;EQ 57MG BASE SANDOZ 200MG;EQ 28.5MG BASE 400MG;EQ 57MG BASE TEVA 200MG;EQ 28.5MG BASE + 400MG;EQ 57MG BASE AUGMENTIN '125' DR REDDYS LABS INC 125MG;EQ 31.25MG BASE AUGMENTIN '200' DR REDDYS LABS INC 200MG;EQ 28.5MG BASE AUGMENTIN '250' DR REDDYS LABS INC 250MG;EQ 62.5MG BASE AUGMENTIN '400' DR REDDYS LABS INC 400MG;EQ 57MG BASE TABLET, EXTENDED RELEASE; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM SANDOZ 1GM;EQ 62.5MG BASE AUGMENTIN XR + DR REDDYS LABS INC 1GM;EQ 62.5MG BASE
A201090 A201090 A201091
001 002 001
Dec 20, 2011 Dec 20, 2011 Dec 20, 2011
A065333 A065333 A065317 A091569 A091569 A091568 A065109 A065102 A065189 A065064 A065063 A065117 A065093 A065101 A065096 N050564 N050564 N050720
001 002 003 001 002 001 001 001 001 001 001 001 001 001 001 001 002 001
Feb Feb Oct Jan Jan Jan Nov Sep Aug Mar Mar Nov Nov Oct Oct
24, 24, 20, 20, 20, 20, 04, 17, 23, 15, 14, 27, 21, 30, 29,
2009 2009 2008 2012 2012 2012 2002 2002 2005 2002 2002 2002 2002 2002 2002
Aug 06, 1984 Aug 06, 1984 Feb 13, 1996
A065161 A065161 A065065 A065065 A065205 A065205 N050597 N050726 N050597 N050726
001 002 001 002 001 002 001 001 002 002
Dec Dec Apr Apr Feb Feb
03, 03, 18, 18, 09, 09,
2003 2003 2002 2002 2005 2005
Jul 22, 1985 May 31, 1996 Jul 22, 1985 May 31, 1996
A090227 N050785
001 001
Apr 21, 2010 Sep 25, 2002
3 - 33 (of 428)
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

CAPSULE, EXTENDED RELEASE; ORAL ADDERALL XR 10
SHIRE 2.5MG;2.5MG;2.5MG;2.5MG N021303 ADDERALL XR 15
SHIRE 5MG;5MG;5MG;5MG N021303 ADDERALL XR 25
+ SHIRE 7.5MG;7.5MG;7.5MG;7.5MG N021303 ADDERALL XR 5
SHIRE 1.25MG;1.25MG;1.25MG;1.25MG N021303 DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
ACTAVIS ELIZABETH 1.25MG;1.25MG;1.25MG;1.25MG A077302 2.5MG;2.5MG;2.5MG;2.5MG A077302 3.75MG;3.75MG;3.75MG;3.75MG A077302 5MG;5MG;5MG;5MG A077302 6.25MG;6.25MG;6.25MG;6.25MG A077302 7.5MG;7.5MG;7.5MG;7.5MG A077302 TABLET; ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE BARR 1.25MG;1.25MG;1.25MG;1.25MG A040422 1.875MG;1.875MG;1.875MG;1.875MG A040422 2.5MG;2.5MG;2.5MG;2.5MG A040422 3.125MG;3.125MG;3.125MG;3.125MG A040422 3.75MG;3.75MG;3.75MG;3.75MG A040422 5MG;5MG;5MG;5MG A040422 + 7.5MG;7.5MG;7.5MG;7.5MG A040422 COREPHARMA 1.25MG;1.25MG;1.25MG;1.25MG A040444 2.5MG;2.5MG;2.5MG;2.5MG A040444 5MG;5MG;5MG;5MG A040444 7.5MG;7.5MG;7.5MG;7.5MG A040444 SANDOZ 1.25MG;1.25MG;1.25MG;1.25MG A040439 2.5MG;2.5MG;2.5MG;2.5MG A040439 5MG;5MG;5MG;5MG A040439 7.5MG;7.5MG;7.5MG;7.5MG A040439 TEVA PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A040472 2.5MG;2.5MG;2.5MG;2.5MG A040472 5MG;5MG;5MG;5MG A040472 7.5MG;7.5MG;7.5MG;7.5MG A040472
AB AB AB AB AB AB AB AB AB AB AB AB
001 006 002 004 003 005 001 002 003 004 005 006
Oct 11, 2001

May 22, 2002
Oct 11, 2001
May 22, 2002
Oct 11, 2001
May 22, 2002
Jun Jun Jun Jun Jun Jun 22, 22, 22, 22, 22, 22, 2012
2012
2012
2012
2012
2012
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 005 002 006 007 003 004 001 002 003 004 004 001 002 003 001 002 003 004
Feb Mar Feb Mar Mar Feb Feb Jun Jun Jun Jun Sep Jun Jun Jun Sep Sep Sep Sep
11, 19, 11, 19, 19, 11, 11, 19, 19, 19, 19, 27, 14, 14, 14, 30, 30, 30, 30,
2002 2003 2002 2003 2003 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2003 2003 2003 2003
AMPHETAMINE SULFATE
TABLET; ORAL AMPHETAMINE SULFATE XX ARBOR PHARMS INC XX +
5MG 10MG
A200166 A200166
001 002
Aug 09, 2012 Aug 09, 2012
AMPHOTERICIN B
INJECTABLE; INJECTION AMPHOTERICIN B + X GEN PHARMS 50MG/VIAL INJECTABLE, LIPID COMPLEX; INJECTION ABELCET + SIGMA TAU 5MG/ML AMPHOTEC + ALKOPHARMA USA 50MG/VIAL + 100MG/VIAL
AP
A063206
001
Apr 29, 1992
XX XX XX
N050724 N050729 N050729
001 001 002
Nov 20, 1995 Nov 22, 1996 Nov 22, 1996

AMPHOTERICIN B
INJECTABLE, LIPOSOMAL; INJECTION
AMBISOME
XX + ASTELLAS 50MG/VIAL
3 - 34 (of 428)
N050740
001
Aug 11, 1997
AMPICILLIN SODIUM
INJECTABLE; INJECTION AMPICILLIN SODIUM ANTIBIOTICE AP AP AP AP AUROBINDO PHARMA AP AP AP AP AP AP HANFORD GC AP AP AP AP AP IBI AP AP AP AP AP AP + SANDOZ AP + AP + AP + AP AP + AP AP +
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
A090354 A090354 A090354 A090354 A065499 A065499 A065499 A065499 A065499 A065493 A063145 A063146 A062772 A063140 A063142 A062797 A062719 A062719 A062719 A062797 A061395 A061395 A061395 A061395 A062738 A061395 A062738 A061395
001 002 003 004 001 002 003 004 005 001 001 001 001 001 001 001 001 003 002 002 001 002 003 004 001 005 002 006
Dec Dec Dec Dec Aug Aug Aug Aug Aug Aug Apr Apr Apr Apr Apr Jul May May May Jul
28, 28, 28, 28, 17, 17, 17, 17, 17, 17, 15, 15, 15, 15, 15, 12, 12, 12, 12, 12,
2009 2009 2009 2009 2010 2010 2010 2010 2010 2010 1993 1993 1993 1993 1993 1993 1987 1987 1987 1993
Feb 19, 1987 Feb 19, 1987
AMPICILLIN SODIUM; SULBACTAM SODIUM

INJECTABLE; INJECTION AMPICILLIN AND SULBACTAM ACS DOBFAR EQ EQ EQ AUROBINDO PHARMA EQ EQ EQ EQ EQ BIONICHE PHARMA EQ EQ HANFORD GC EQ EQ EQ HIKMA MAPLE EQ EQ EQ HOSPIRA INC EQ EQ EQ EQ EQ
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL
001 002 001 001 001 002 002 001 001 002 001 002 001 001 002 001 001 001 002 002 001
Dec Dec Dec Sep Sep Sep Sep Sep Jun Jun Nov Nov Nov Mar Mar Mar Dec Dec Dec Dec Dec
22, 22, 23, 20, 20, 20, 20, 20, 29, 29, 30, 30, 25, 19, 19, 19, 21, 21, 21, 21, 21,
2009 2009 2009 2010 2010 2010 2010 2010 2007 2007 2005 2005 2005 2002 2002 2002 2011 2011 2011 2011 2011

INJECTABLE; INJECTION AMPICILLIN AND SULBACTAM IBI EQ EQ EQ SANDOZ EQ EQ EQ EQ EQ UNASYN PFIZER EQ + EQ + EQ + EQ
3 - 35 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP
1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL
A065222 A065222 A065314 A065241 A065310 A065241 A065310 A065240 A062901 N050608 N050608 N050608
001 002 001 001 001 002 002 001 001 002 001 005
Nov Nov Nov Jul Jul Jul Jul Jul Nov Dec Dec Dec
29, 29, 27, 25, 25, 25, 25, 25, 23, 31, 31, 10,
2005 2005 2006 2006 2006 2006 2006 2006 1988 1986 1986 1993
AMPICILLIN/AMPICILLIN TRIHYDRATE
CAPSULE; ORAL AMPICILLIN TRIHYDRATE DAVA PHARMS INC AB AB + SANDOZ AB AB FOR SUSPENSION; ORAL AMPICILLIN TRIHYDRATE DAVA PHARMS INC XX XX +
EQ EQ EQ EQ
250MG 500MG 250MG 500MG
BASE BASE BASE BASE
A062883 A062882 A064082 A064082
001 001 001 002
Feb Feb Aug Aug
25, 25, 29, 29,
1988 1988 1995 1995
EQ 125MG BASE/5ML EQ 250MG BASE/5ML
A062982 A062982
001 002
Feb 10, 1989 Feb 10, 1989
ANAGRELIDE HYDROCHLORIDE
CAPSULE; ORAL AGRYLIN SHIRE LLC EQ ANAGRELIDE HYDROCHLORIDE BARR EQ EQ IMPAX LABS EQ EQ IVAX SUB TEVA PHARMS EQ + EQ MYLAN EQ EQ MYLAN PHARMS INC EQ EQ WATSON LABS EQ EQ
AB AB AB AB AB AB AB AB AB AB AB AB AB
0.5MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE
N020333 A076530 A076530 A076910 A076910 A076468 A076468 A076811 A076811 A077613 A077613 A076417 A076417
001 001 002 001 002 001 002 001 002 001 002 001 002
Mar 14, 1997 Apr Apr Apr Apr Apr Apr Apr Apr Jun Jun Apr Apr 18, 18, 18, 18, 18, 18, 18, 18, 27, 27, 18, 18, 2005 2005 2005 2005 2005 2005 2005 2005 2006 2006 2005 2005
ANASTROZOLE
TABLET; ORAL ANASTROZOLE ACCORD HLTHCARE INC APOTEX INC DR REDDYS LABS LTD FRESENIUS KABI ONCOL IMPAX LABS INC KUDCO IRELAND MYLAN NATCO PHARMA LTD ROXANE SANDOZ SANTOS BIOTECH
AB AB AB AB AB AB AB AB AB AB AB
1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG
A090568 A200654 A090732 A090088 A091242 A091331 A091051 A079220 A078485 A079007 A078944
001 001 001 001 001 001 001 001 001 001 001
Jun May Jun Jun May Jan Jun Jun Jun Jun Jun
28, 11, 28, 28, 31, 05, 28, 28, 28, 28, 28,
2010 2012 2010 2010 2012 2011 2010 2010 2010 2010 2010

ANASTROZOLE
TABLET; ORAL ANASTROZOLE SUN PHARM INDS LTD TEVA PHARMS THREE RIVERS PHARMS WATSON LABS ZYDUS PHARMS USA INC ARIMIDEX + ASTRAZENECA
3 - 36 (of 428)
AB AB AB AB AB AB
A091177 A078058 A091164 A078984 A078921 N020541
001 001 001 001 001 001
Jul Jun Jun Jun Jun
15, 28, 28, 28, 28,
2011 2010 2010 2010 2010
Dec 27, 1995
ANIDULAFUNGIN
ERAXIS
XX + VICURON 50MG/VIAL XX + 100MG/VIAL
N021632 N021632
001 002
Feb 17, 2006 Nov 14, 2006
APIXABAN
TABLET; ORAL ELIQUIS BRISTOL MYERS SQUIBB XX XX +
2.5MG 5MG
N202155 N202155
001 002
Dec 28, 2012 Dec 28, 2012
APOMORPHINE HYDROCHLORIDE
INJECTABLE; SUBCUTANEOUS
APOKYN
XX + US WORLDMEDS
30MG/3ML (10MG/ML)
N021264
002
Apr 20, 2004
APRACLONIDINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC APRACLONIDINE HYDROCHLORIDE AKORN INC AT EQ 0.5% BASE IOPIDINE AT + ALCON EQ 0.5% BASE IOPIDINE EQ 1% BASE XX + ALCON
A077764 N020258 N019779
001 001 001
Mar 12, 2009 Jul 30, 1993 Dec 31, 1987
APREPITANT
CAPSULE; ORAL APREPITANT SANDOZ AB AB AB EMEND MERCK AB AB AB +
40MG 80MG 125MG 40MG 80MG 125MG
A090999 A090999 A090999 N021549 N021549 N021549
001 002 003 003 001 002
Sep 24, 2012 Sep 24, 2012 Sep 24, 2012 Jun 30, 2006 Mar 26, 2003 Mar 26, 2003
ARFORMOTEROL TARTRATE
SOLUTION; INHALATION
BROVANA
XX + SUNOVION
EQ 0.015MG BASE/2ML
N021912
001
Oct 06, 2006
ARGATROBAN
INJECTABLE; INJECTION ACOVA AP + PFIZER 250MG/2.5ML (100MG/ML) ARGATROBAN HIKMA PHARM CO LTD AP 250MG/2.5ML (100MG/ML) INJECTABLE; IV (INFUSION) ARGATROBAN IN SODIUM CHLORIDE XX + EAGLE PHARMS 50MG/50ML (1MG/ML)
N020883 N203049
001 001
Jun 30, 2000 Jan 05, 2012
N022434
001
Jun 29, 2011

ARGATROBAN
ARGATROBAN IN SODIUM CHLORIDE
XX + SANDOZ 125MG/125ML (1MG/ML)
3 - 37 (of 428)
N022485
001
May 09, 2011
ARGININE HYDROCHLORIDE
R-GENE 10
XX + PHARMACIA AND UPJOHN 10GM/100ML
N016931
001
ARIPIPRAZOLE
INJECTABLE; INTRAMUSCULAR
ABILIFY
XX + OTSUKA 9.75MG/1.3ML (7.5MG/ML) SOLUTION; ORAL
ABILIFY
XX + OTSUKA TABLET; ORAL ABILIFY XX OTSUKA XX + XX + XX XX XX
N021866
001
Sep 20, 2006
1MG/ML
N021713
001
Dec 10, 2004
N021436 N021436 N021436 N021436 N021436 N021436
006 005 001 002 003 004
Nov Nov Nov Nov Nov Nov
15, 15, 15, 15, 15, 15,
2002 2002 2002 2002 2002 2002
TABLET, ORALLY DISINTEGRATING; ORAL

ABILIFY
XX + OTSUKA 10MG XX 15MG
N021729 N021729
002 003
Jun 07, 2006 Jun 07, 2006
ARMODAFINIL
TABLET; ORAL ARMODAFINIL MYLAN PHARMS INC AB AB AB NUVIGIL CEPHALON AB AB AB + ARMODAFINIL WATSON LABS INC XX XX
A200043 A200043 A200043 N021875 N021875 N021875 A200156 A200156
001 002 003 001 003 004 002 004
Jun 01, 2012 Jun 01, 2012 Jun 01, 2012 Jun 15, 2007 Jun 15, 2007 Jun 15, 2007 Aug 29, 2012 Aug 29, 2012
ARSENIC TRIOXIDE
TRISENOX
XX + CEPHALON
1MG/ML
N021248
001
Sep 25, 2000
ARTEMETHER; LUMEFANTRINE
TABLET; ORAL
COARTEM
XX + NOVARTIS
20MG;120MG
N022268
001
Apr 07, 2009
ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

INJECTABLE; INJECTION ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE HOSPIRA AP 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML) SEPTOCAINE AP + DEPROCO 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)
A079138
001
Jun 18, 2010
N020971
001
Apr 03, 2000

ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION ARTICAINE HYDROCHLORIDE WITH EPINEPHRINE XX PIERREL 4%;EQ 0.009MG BASE/1.8ML (EQ 0.005MG BASE/ML) XX + 4%;EQ 0.018MG BASE/1.8ML (EQ 0.01MG BASE/ML)
SEPTOCAINE
4%;EQ 0.0085MG BASE/1.7ML (4%;EQ XX + DEPROCO 0.005MG BASE/ML)
3 - 38 (of 428)
N022466 N022466
001 002
Feb 26, 2010 Feb 26, 2010
N022010
001
Mar 30, 2006
ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
INFUVITE PEDIATRIC
XX + SANDOZ 80MG/VIAL;0.02MG/VIAL;400 N021265 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/ VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL XX INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) + SANDOZ 80MG/VIAL;0.02MG/VIAL;400 N021646 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/ VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL
001
Feb 21, 2001
001
Jan 29, 2004
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
FOR SOLUTION; IV (INFUSION) M.V.I. PEDIATRIC 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/ N018920 XX + HOSPIRA VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
001
Sep 21, 2000
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
M.V.I.-12 (WITHOUT VITAMIN K)
XX + HOSPIRA 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML; N008809 0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0 .36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML
006
Sep 09, 2004
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K
INJECTABLE; IV (INFUSION) M.V.I. ADULT 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15M N021625 XX + HOSPIRA G/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIA L;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL ;10MG/VIAL;0.15MG/VIAL XX M.V.I. ADULT (PHARMACY BULK PACKAGE) + HOSPIRA 200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5 N021643 ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5 ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0 .15MG/5ML
001
Jan 30, 2004
001
Feb 18, 2004
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
FOR SOLUTION; ORAL ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM AA NOVEL LABS INC 4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM A090145 001 Jan 25, 2012
3 - 39 (of 428)
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
FOR SOLUTION; ORAL MOVIPREP AA + SALIX PHARMS
4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM N021881
001
Aug 02, 2006
ASENAPINE MALEATE
TABLET; SUBLINGUAL SAPHRIS XX ORGANON SUB MERCK XX +
N022117 N022117
001 002
Aug 13, 2009 Aug 13, 2009
ASPIRIN; BUTALBITAL; CAFFEINE

CAPSULE; ORAL FIORINAL AA + WATSON LABS INC 325MG;50MG;40MG LANORINAL LANNETT AA 325MG;50MG;40MG TABLET; ORAL BUTALBITAL, ASPIRIN AND CAFFEINE AA + WEST WARD 325MG;50MG;40MG
N017534 A086996
005 002
Apr 16, 1986 Oct 11, 1985
A086162
002
Feb 16, 1984
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

CAPSULE; ORAL BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE NEXGEN PHARMA INC 325MG;50MG;40MG;30MG STEVENS J 325MG;50MG;40MG;30MG WATSON LABS 325MG;50MG;40MG;30MG FIORINAL W/CODEINE + WATSON LABS INC 325MG;50MG;40MG;30MG
AB AB AB AB
A075231 A074951 A074359 N019429
001 001 001 003
Nov 30, 2001 Aug 31, 1998 Aug 31, 1995 Oct 26, 1990
ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE

CAPSULE; ORAL
SYNALGOS-DC
XX + CARACO
356.4MG;30MG;16MG
N011483
004
Sep 06, 1983
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

TABLET; ORAL NORGESIC MEDICIS AB 385MG;30MG;25MG NORGESIC FORTE AB + MEDICIS 770MG;60MG;50MG ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE SANDOZ AB 385MG;30MG;25MG AB 770MG;60MG;50MG STEVENS J AB 385MG;30MG;25MG AB 770MG;60MG;50MG
N013416 N013416 A074654 A074654 A074988 A074988
003 004 001 002 001 002
Oct 27, 1982 Oct 27, 1982 Dec Dec Apr Apr 31, 31, 30, 30, 1996 1996 1999 1999
ASPIRIN; CARISOPRODOL
TABLET; ORAL CARISOPRODOL AND ASPIRIN HERITAGE PHARMS INC 325MG;200MG MIRROR PHARMS 325MG;200MG PROSAM LABS 325MG;200MG SANDOZ 325MG;200MG SOMA COMPOUND + MEDA PHARMS 325MG;200MG
AB AB AB AB AB
A089594 A040832 A040252 A040116 N012365
001 001 001 001 005
Mar Jan Dec Apr
31, 07, 10, 25,
1989 2010 1997 1996
Jul 11, 1983
ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE

TABLET; ORAL CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE MIRROR PHARMS AB 325MG;200MG;16MG
A040860
001
Jan 07, 2010

ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
TABLET; ORAL CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE PROSAM LABS AB 325MG;200MG;16MG SANDOZ AB 325MG;200MG;16MG SOMA COMPOUND W/ CODEINE AB + MEDA PHARMS 325MG;200MG;16MG
3 - 40 (of 428)
A040283 A040118 N012366
001 001 002
Dec 29, 1998 Apr 16, 1996 Jul 11, 1983
ASPIRIN; DIPYRIDAMOLE
CAPSULE, EXTENDED RELEASE; ORAL AGGRENOX AB + BOEHRINGER INGELHEIM 25MG;200MG ASPIRIN AND DIPYRIDAMOLE BARR AB 25MG;200MG
N020884 A078804
001 001
Nov 22, 1999 Aug 14, 2009
ASPIRIN; METHOCARBAMOL
TABLET; ORAL
METHOCARBAMOL AND ASPIRIN
XX + STEVENS J 325MG;400MG
A081145
001
Jan 31, 1995
ASPIRIN; OXYCODONE HYDROCHLORIDE

TABLET; ORAL OXYCODONE AND ASPIRIN COASTAL PHARMS AA WATSON LABS AA PERCODAN AA + ENDO PHARMS
325MG;4.8355MG 325MG;4.8355MG 325MG;4.8355MG
A091670 A090084 N007337
001 001 007
Mar 16, 2011 Mar 22, 2011 Aug 05, 2005
ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE

TABLET; ORAL OXYCODONE AND ASPIRIN XX WATSON LABS
325MG;4.5MG;0.38MG
A040255
001
Feb 27, 1998
ATAZANAVIR SULFATE
CAPSULE; ORAL REYATAZ XX BRISTOL MYERS SQUIBB XX XX XX +
EQ EQ EQ EQ
100MG 150MG 200MG 300MG
BASE BASE BASE BASE
N021567 N021567 N021567 N021567
001 002 003 004
Jun Jun Jun Oct
20, 20, 20, 16,
2003 2003 2003 2006
ATENOLOL
TABLET; ORAL ATENOLOL AUROBINDO PHARMA AB AB AB CARACO AB AB AB DAVA PHARMS INC AB AB AB IPCA LABS LTD AB AB AB IPR AB AB AB MUTUAL PHARM AB AB AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
A078512 A078512 A078512 A078210 A078210 A078210 A074099 A073542 A073543 A077877 A077877 A077877 A073646 A072303 A072304 A074499 A073475 A073476
001 002 003 001 002 003 001 001 001 001 002 003 001 001 001 001 001 001
Oct Oct Oct Jul Jul Jul Apr Dec Dec Dec Dec Dec Jul Jul Jul Jul Mar Mar
31, 31, 31, 10, 10, 10, 28, 19, 19, 27, 27, 27, 31, 15, 15, 30, 30, 30,
2007 2007 2007 2007 2007 2007 1992 1991 1991 2006 2006 2006 1992 1988 1988 1997 1993 1993

ATENOLOL
TABLET; ORAL ATENOLOL MYLAN AB AB AB AB AB AB NORTHSTAR HLTHCARE AB AB AB SANDOZ AB AB AB TEVA AB AB AB UNIQUE PHARM LABS AB AB AB WATSON LABS AB AB ZYDUS PHARMS USA AB AB AB TENORMIN ASTRAZENECA AB AB AB +
3 - 41 (of 428)
25MG 25MG 50MG 50MG 100MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
A073457 A074126 A073456 A074126 A073457 A074126 A078254 A078254 A078254 A074052 A073025 A073026 A074056 A074056 A074056 A077443 A077443 A077443 A073352 A073353 A076900 A076900 A076900 N018240 N018240 N018240
002 003 001 001 001 002 001 002 003 001 001 001 003 001 002 001 002 003 001 001 001 002 003 004 001 002
Apr Aug Jan Mar Jan Mar Sep Sep Sep May Sep Sep Jul Jan Jan Sep Sep Sep Dec Dec Jan Jan Jan
26, 26, 24, 23, 24, 23, 25, 25, 25, 01, 17, 17, 19, 18, 18, 13, 13, 13, 27, 27, 28, 28, 28,
1999 1998 1992 1994 1992 1994 2009 2009 2009 1992 1991 1991 2004 1995 1995 2006 2006 2006 1991 1991 2005 2005 2005
Apr 09, 1990
ATENOLOL; CHLORTHALIDONE
TABLET; ORAL ATENOLOL AND CHLORTHALIDONE IPR AB 50MG;25MG AB 100MG;25MG MUTUAL PHARM AB 50MG;25MG AB 100MG;25MG MYLAN AB 50MG;25MG AB 100MG;25MG WATSON LABS AB 50MG;25MG AB 100MG;25MG TENORETIC 100 AB + ASTRAZENECA 100MG;25MG TENORETIC 50 ASTRAZENECA AB 50MG;25MG
A072301 A072302 A073581 A073582 A074203 A074203 A073665 A073665 N018760 N018760
001 001 001 001 001 002 001 002 001 002
May May Apr Apr Oct Oct Jul Jul
31, 31, 29, 29, 31, 31, 02, 02,
1990 1990 1993 1993 1993 1993 1992 1992
Jun 08, 1984 Jun 08, 1984
ATOMOXETINE HYDROCHLORIDE
CAPSULE; ORAL STRATTERA LILLY XX XX XX XX XX + XX XX
10MG 18MG 25MG 40MG 60MG 80MG 100MG
N021411 N021411 N021411 N021411 N021411 N021411 N021411
002 003 004 005 006 007 008
Nov Nov Nov Nov Nov Feb Feb
26, 26, 26, 26, 26, 14, 14,
2002 2002 2002 2002 2002 2005 2005

ATORVASTATIN CALCIUM
TABLET; ORAL ATORVASTATIN CALCIUM APOTEX INC AB AB AB AB DR REDDYS LABS LTD AB AB AB AB MYLAN PHARMS INC AB AB AB AB RANBAXY LABS LTD AB AB AB AB SANDOZ INC AB AB AB AB LIPITOR PFIZER AB AB AB AB +
3 - 42 (of 428)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A090548 A090548 A090548 A090548 A091650 A091650 A091650 A202357 A091226 A091226 A091226 A091226 A076477 A076477 A076477 A076477 A077575 A077575 A077575 A077575 N020702 N020702 N020702 N020702
001 002 003 004 001 002 003 001 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
May May May May Jul Jul Jul Jul May May May May Nov Nov Nov Nov May May May May Dec Dec Dec Apr
29, 29, 29, 29, 17, 17, 17, 17, 29, 29, 29, 29, 30, 30, 30, 30, 29, 29, 29, 29, 17, 17, 17, 07,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2011 2011 2011 2011 2012 2012 2012 2012 1996 1996 1996 2000
ATOVAQUONE
SUSPENSION; ORAL
MEPRON
XX + GLAXOSMITHKLINE LLC
750MG/5ML
N020500
001
Feb 08, 1995
ATOVAQUONE; PROGUANIL HYDROCHLORIDE

TABLET; ORAL ATOVAQUONE AND PROGUANIL HYDROCHLORIDE GLENMARK GENERICS AB 250MG;100MG MALARONE AB + GLAXOSMITHKLINE 250MG;100MG MALARONE PEDIATRIC GLAXOSMITHKLINE 62.5MG;25MG XX
A091211 N021078 N021078
001 001 002
Jan 12, 2011 Jul 14, 2000 Jul 14, 2000
ATRACURIUM BESYLATE
INJECTABLE; INJECTION ATRACURIUM BESYLATE + BEDFORD 10MG/ML HOSPIRA INC 10MG/ML SAGENT PHARMS 10MG/ML ATRACURIUM BESYLATE PRESERVATIVE FREE + BEDFORD 10MG/ML HOSPIRA INC 10MG/ML SAGENT PHARMS 10MG/ML
AP AP AP AP AP AP
A074901 A090761 A091489 A074900 A090782 A091488
001 001 001 001 001 001
Jul 18, 1997 Oct 18, 2012 Feb 17, 2012 Jul 18, 1997 Oct 18, 2012 Feb 17, 2012
ATROPINE
ATROPEN
+ MERIDIAN MEDCL TECHN + + +
XX XX XX XX
EQ EQ EQ EQ
0.25MG SULFATE/0.3ML 0.5MG SULFATE/0.7ML 1MG SULFATE/0.7ML 2MG SULFATE/0.7ML
N017106 N017106 N017106 N017106
004 003 002 001
Sep 17, 2004 Jun 19, 2003 Jun 19, 2003

ATROPINE SULFATE
INJECTABLE; IM-IV-SC ATROPINE SULFATE ANSYR PLASTIC SYRINGE XX HOSPIRA 0.05MG/ML XX + 0.1MG/ML
3 - 43 (of 428)
N021146 N021146
002 001
Jul 09, 2001 Jul 09, 2001
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE

TABLET; ORAL MOTOFEN XX + VALEANT
0.025MG;1MG
N017744
002
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE

SOLUTION; ORAL DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE + ROXANE 0.025MG/5ML;2.5MG/5ML TABLET; ORAL DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE LANNETT 0.025MG;2.5MG MYLAN 0.025MG;2.5MG PAR PHARM 0.025MG;2.5MG LOMOTIL + GD SEARLE LLC 0.025MG;2.5MG LONOX SANDOZ 0.025MG;2.5MG
AA
A087708
001
May 03, 1982
AA AA AA AA AA
A085372 A085762 A040357 N012462 A085311
001 001 001 001 002
May 02, 2000
ATROPINE SULFATE; EDROPHONIUM CHLORIDE

ENLON-PLUS
XX + MYLAN INSTITUTIONAL
0.14MG/ML;10MG/ML
N019678
001
Nov 06, 1991
ATROPINE; PRALIDOXIME CHLORIDE

DUODOTE
XX + MERIDIAN MEDCL 2.1MG/0.7ML;600MG/2ML
N021983
001
Sep 28, 2006
AURANOFIN
CAPSULE; ORAL
RIDAURA
XX + PROMETHEUS LABS
3MG
N018689
001
May 24, 1985
AVANAFIL
TABLET; ORAL STENDRA XX VIVUS XX XX +
50MG 100MG 200MG
N202276 N202276 N202276
001 002 003
Apr 27, 2012 Apr 27, 2012 Apr 27, 2012
AXITINIB
TABLET; ORAL INLYTA XX PFIZER XX +
1MG 5MG
N202324 N202324
001 002
Jan 27, 2012 Jan 27, 2012
AZACITIDINE
INJECTABLE; IV-SC
VIDAZA
XX + CELGENE
100MG/VIAL
N050794
001
May 19, 2004
AZATHIOPRINE
TABLET; ORAL AZASAN AAIPHARMA LLC AB
25MG
A075252
002
Feb 03, 2003

AZATHIOPRINE
TABLET; ORAL AZASAN AAIPHARMA LLC AB AB AB AZATHIOPRINE MYLAN AB ROXANE AB ZYDUS PHARMS USA AB AB AB AB IMURAN AB + PROMETHEUS LABS
3 - 44 (of 428)
A075252 A075252 A075252 A075568 A074069 A077621 A077621 A077621 A077621 N016324
001 003 004 001 001 002 001 003 004 001
Jun 07, 1999 Feb 03, 2003 Feb 03, 2003 Dec Feb Sep Mar Sep Sep 13, 16, 05, 15, 05, 05, 1999 1996 2008 2007 2008 2008
AZATHIOPRINE SODIUM
AZATHIOPRINE SODIUM
XX + BEDFORD
EQ 100MG BASE/VIAL
A074419
001
Mar 31, 1995
AZELAIC ACID
CREAM; TOPICAL
AZELEX
XX + ALLERGAN GEL; TOPICAL
FINACEA
XX + BHP DERMATOLOGY
20%
N020428
001
Sep 13, 1995
15%
N021470
001
Dec 24, 2002
AZELASTINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AZELASTINE HYDROCHLORIDE ALCON PHARMA 0.05% APOTEX INC 0.05% SUN PHARMA GLOBAL 0.05% OPTIVAR + MEDA PHARMS 0.05% SPRAY, METERED; NASAL ASTELIN + MEDA PHARMS EQ 0.125MG BASE/SPRAY ASTEPRO + MEDA PHARMS EQ 0.1876MG BASE/SPRAY AZELASTINE HYDROCHLORIDE APOTEX INC EQ 0.125MG BASE/SPRAY EQ 0.1876MG BASE/SPRAY SUN PHARMA GLOBAL EQ 0.125MG BASE/SPRAY
AT AT AT AT
A202305 A078621 A078738 N021127
001 001 001 001
May 31, 2012 Aug 03, 2009 Jun 21, 2010 May 22, 2000
AB AB AB AB AB
N020114 N022371 A077954 A201846 A090423
001 001 001 001 001
Nov 01, 1996 Aug 31, 2009 Apr 30, 2009 Aug 31, 2012 May 23, 2012
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

SPRAY, METERED; NASAL
DYMISTA
XX + MEDA PHARMS
EQ 0.125MG BASE/SPRAY;0.05MG/SPRAY
N202236
001
May 01, 2012
AZILSARTAN KAMEDOXOMIL
TABLET; ORAL EDARBI TAKEDA PHARMS USA XX XX +
EQ 40MG MEDOXOMIL EQ 80MG MEDOXOMIL
N200796 N200796
001 002
Feb 25, 2011 Feb 25, 2011
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

TABLET; ORAL EDARBYCLOR XX TAKEDA PHARMS USA
EQ 40MG MEDOXOMIL;12.5MG
N202331
001
Dec 20, 2011

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
TABLET; ORAL
EDARBYCLOR
XX + TAKEDA PHARMS USA
3 - 45 (of 428)
EQ 40MG MEDOXOMIL;25MG
N202331
002
Dec 20, 2011
AZITHROMYCIN
FOR SUSPENSION; ORAL AZITHROMYCIN PLIVA AB AB TEVA PHARMS AB AB ZITHROMAX PFIZER AB AB + ZITHROMAX XX + PFIZER
EQ EQ EQ EQ
100MG 200MG 100MG 200MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A065246 A065246 A065419 A065419 N050710 N050710 N050693
002 001 001 002 001 002 001
Jul Jul Jun Jun
05, 05, 24, 24,
2006 2006 2008 2008
EQ 100MG BASE/5ML EQ 200MG BASE/5ML EQ 1GM BASE/PACKET
Oct 19, 1995 Oct 19, 1995 Sep 28, 1994
XX
AP AP AP AP AP AP
XX
FOR SUSPENSION, EXTENDED RELEASE; ORAL

ZMAX
+ PFIZER GLOBAL EQ 2GM BASE/BOT INJECTABLE; INJECTION AZITHROMYCIN FRESENIUS KABI USA EQ 500MG BASE/VIAL GLAND PHARMA LTD EQ 500MG BASE/VIAL HOSPIRA EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL SAGENT STRIDES EQ 500MG BASE/VIAL ZITHROMAX + PFIZER EQ 500MG BASE/VIAL SOLUTION/DROPS; OPHTHALMIC AZASITE + INSPIRE 1%
N050797
001
Jun 10, 2005
A065179 A065501 A065500 A065511 A065506 N050733
001 001 001 001 001 001
Dec Nov Jun Jun Mar
13, 09, 26, 26, 24,
2005 2009 2009 2009 2009
Jan 30, 1997
N050810
001
Apr 27, 2007
TABLET; ORAL AZITHROMYCIN APOTEX CORP AB AB AB MYLAN AB AB AB PLIVA AB AB AB SANDOZ AB AB AB TEVA AB AB AB WOCKHARDT AB AB AB ZITHROMAX PFIZER AB AB AB +
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A065507 A065509 A065508 A065365 A065366 A065360 A065225 A065223 A065218 A065211 A065212 A065209 A065153 A065193 A065150 A065404 A065405 A065302 N050711 N050784 N050730
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003 001 001 001
Jul Jul Jul May May Jan Nov Nov Nov Nov Nov Nov Nov Nov Nov Feb Feb Feb
13, 13, 13, 30, 30, 08, 14, 14, 14, 14, 14, 14, 14, 14, 14, 11, 11, 11,
2011 2011 2011 2007 2007 2007 2005 2005 2005 2005 2005 2005 2005 2005 2005 2008 2008 2008
EQ 250MG BASE EQ 500MG BASE EQ 600MG BASE
Jul 18, 1996 May 24, 2002 Jun 12, 1996
AZTREONAM
FOR SOLUTION; INHALATION
CAYSTON
XX + GILEAD
75MG/VIAL
N050814
001
Feb 22, 2010

AZTREONAM
INJECTABLE; INJECTION AZACTAM AP + BRISTOL MYERS SQUIBB 1GM/VIAL AP + 2GM/VIAL AZTREONAM BEDFORD AP 1GM/VIAL AP 2GM/VIAL FRESENIUS KABI USA AP 1GM/VIAL AP 2GM/VIAL AZACTAM IN PLASTIC CONTAINER XX + BRISTOL MYERS SQUIBB 20MG/ML 40MG/ML XX + AZTREONAM FRESENIUS KABI USA 500MG/VIAL XX
3 - 46 (of 428)
N050580 N050580 A065286 A065286 A065439 A065439 N050632 N050632 A065439
002 003 001 002 002 003 002 001 001
Dec 31, 1986 Dec 31, 1986 Mar Mar Jun Jun 23, 23, 18, 18, 2011 2011 2010 2010
May 24, 1989 May 24, 1989 Jun 18, 2010
BACITRACIN
INJECTABLE; INJECTION BACIIM X GEN PHARMS BACITRACIN FRESENIUS KABI USA + PHARMACIA AND UPJOHN SAGENT STRIDES BACITRACIN
PHARMACIA AND UPJOHN
AP AP AP AP XX
50,000 UNITS/VIAL 50,000 UNITS/VIAL 50,000 UNITS/VIAL 50,000 UNITS/VIAL 10,000 UNITS/VIAL
A064153 A065116 A060733 A090211 A060733
001 001 002 001 001
May 09, 1997 Dec 03, 2002 May 11, 2010
OINTMENT; OPHTHALMIC
BACITRACIN
XX + FERA PHARMS
500 UNITS/GM
A061212
001
POWDER; FOR RX COMPOUNDING

BACI-RX
X GEN PHARMS 5,000,000 UNITS/BOT XX
A061580
001
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

OINTMENT; OPHTHALMIC NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE AKORN AT 400 UNITS/GM;1%;EQ 3.5MG A065213 BASE/GM;10,000 UNITS/GM AT + BAUSCH AND LOMB 400 UNITS/GM;1%;EQ 3.5MG A064068 BASE/GM;10,000 UNITS/GM OINTMENT; TOPICAL
CORTISPORIN
400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 N050168 XX + MONARCH PHARMS UNITS/GM
001 001
Jul 25, 2012 Oct 30, 1995
002
May 04, 1984
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

OINTMENT; OPHTHALMIC NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC AKORN AT 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM AT + BAUSCH AND LOMB 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM FERA PHARMS AT 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
A065088 A064064 A060764
001 001 002
Feb 06, 2004 Oct 30, 1995
BACITRACIN ZINC; POLYMYXIN B SULFATE

OINTMENT; OPHTHALMIC BACITRACIN ZINC AND POLYMYXIN B SULFATE AKORN AT 500 UNITS/GM;10,000 UNITS/GM AT + BAUSCH AND LOMB 500 UNITS/GM;10,000 UNITS/GM FERA PHARMS AT 500 UNITS/GM;10,000 UNITS/GM
A064028 A064046 A065022
001 001 001
Jan 30, 1995 Jan 26, 1995 Feb 27, 2002
3 - 47 (of 428)
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
XX + FERA PHARMS 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
A062166
002
BACLOFEN
INJECTABLE; INTRATHECAL GABLOFEN CNS THERAPS INC AP AP AP LIORESAL AP + MEDTRONIC AP + AP + GABLOFEN CNS THERAPS INC XX TABLET; ORAL BACLOFEN CARACO AB AB IMPAX LABS AB AB IVAX SUB TEVA PHARMS AB AB + LANNETT AB AB MYLAN AB AB MYLAN PHARMS INC AB AB NORTHSTAR HLTHCARE AB AB PROSAM LABS AB AB USL PHARMA AB AB VINTAGE PHARMS AB AB WATSON LABS AB AB
0.05MG/ML 0.5MG/ML 2MG/ML 0.05MG/ML 0.5MG/ML 2MG/ML 1MG/ML
N022462 N022462 N022462 N020075 N020075 N020075 N022462
001 002 003 003 001 002 004
Nov 19, 2010 Nov 19, 2010 Nov 19, 2010 Nov 07, 1996 Jun 17, 1992 Jun 17, 1992 Jun 22, 2012
10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG
A077984 A077862 A078146 A077971 A072234 A072235 A078220 A077241 A077181 A077121 A090334 A090334 A078504 A078401 A077089 A077088 A074584 A074584 A077156 A077068 A072824 A072825
001 002 001 002 001 001 001 001 001 002 001 002 001 001 001 001 001 002 001 001 001 001
Aug Aug Oct Oct Jul Jul Jul Dec Jul Jul Feb Feb Sep Sep Oct Oct Aug Aug Aug Aug Sep Sep
14, 14, 26, 26, 21, 21, 06, 20, 29, 29, 18, 18, 18, 18, 31, 31, 19, 19, 30, 30, 18, 18,
2006 2006 2007 2007 1988 1988 2007 2005 2005 2005 2010 2010 2009 2009 2007 2007 1996 1996 2005 2005 1991 1991
BALSALAZIDE DISODIUM
CAPSULE; ORAL BALSALAZIDE DISODIUM APOTEX INC MYLAN ROXANE COLAZAL + SALIX PHARMS TABLET; ORAL
GIAZO
+ SALIX PHARMS
AB AB AB AB
750MG 750MG 750MG 750MG
A077883 A077807 A077806 N020610
001 001 001 001
Dec 28, 2007 Dec 28, 2007 Dec 28, 2007 Jul 18, 2000
XX
1.1GM
N022205
001
Feb 03, 2012
BECLOMETHASONE DIPROPIONATE
QVAR 40
0.04MG/INH XX + TEVA BRANDED PHARM QVAR 80 0.08MG/INH XX + TEVA BRANDED PHARM
N020911 N020911
002 001
Sep 15, 2000 Sep 15, 2000

AEROSOL, METERED; NASAL
QNASL
XX + TEVA BRANDED PHARM
3 - 48 (of 428)
0.08MG/ACTUATION
N202813
001
Mar 23, 2012
BECLOMETHASONE DIPROPIONATE MONOHYDRATE

BECONASE AQ
XX + GLAXOSMITHKLINE
EQ 0.042MG DIPROP/SPRAY
N019389
001
Jul 27, 1987
BEDAQUILINE FUMARATE
TABLET; ORAL
SIRTURO
XX + JANSSEN THERAP
EQ 100MG BASE
N204384
001
Dec 28, 2012
BENAZEPRIL HYDROCHLORIDE
TABLET; ORAL BENAZEPRIL HYDROCHLORIDE APOTEX INC 5MG 10MG 20MG 40MG AUROBINDO PHARMA 10MG 20MG 40MG BIOKEY 5MG 10MG 20MG 40MG IVAX SUB TEVA PHARMS 5MG 10MG 20MG 40MG MYLAN 5MG 10MG 20MG 40MG PRINSTON INC 5MG 10MG 20MG 40MG RANBAXY 5MG 10MG 20MG 40MG SANDOZ 5MG 10MG 20MG 40MG TEVA 5MG 10MG 20MG 40MG WATSON LABS FLORIDA 5MG 10MG 20MG 40MG ZYDUS PHARMS USA 5MG 10MG 20MG 40MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A077128 A077128 A077128 A077128 A078212 A078212 A078212 A076820 A076820 A076820 A076820 A076333 A076333 A076333 A076333 A076430 A076430 A076430 A076430 A076118 A076118 A076118 A076118 A076344 A076344 A076344 A076344 A076402 A076402 A076402 A076402 A076211 A076211 A076211 A076211 A076267 A076267 A076267 A076267 A078848 A078848 A078848 A078848
001 002 003 004 001 002 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar May May May Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb May May May May
08, 08, 08, 08, 22, 22, 22, 03, 03, 03, 03, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 23, 23, 23, 23,
2006 2006 2006 2006 2008 2008 2008 2006 2006 2006 2006 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2008 2008 2008 2008

TABLET; ORAL LOTENSIN US PHARMS HOLDINGS I AB AB AB AB +
3 - 49 (of 428)
5MG 10MG 20MG 40MG
N019851 N019851 N019851 N019851
001 002 003 004
Jun Jun Jun Jun
25, 25, 25, 25,
1991 1991 1991 1991
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

TABLET; ORAL BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE IVAX SUB TEVA PHARMS 5MG;6.25MG AB AB 10MG;12.5MG AB 20MG;12.5MG AB 20MG;25MG MYLAN AB 5MG;6.25MG AB 10MG;12.5MG AB 20MG;12.5MG AB 20MG;25MG RANBAXY AB 5MG;6.25MG AB 10MG;12.5MG AB 20MG;12.5MG AB 20MG;25MG SANDOZ AB 5MG;6.25MG AB 10MG;12.5MG AB 20MG;12.5MG AB 20MG;25MG WATSON LABS FLORIDA AB 5MG;6.25MG AB 10MG;12.5MG AB 20MG;12.5MG AB 20MG;25MG LOTENSIN HCT US PHARMS HOLDINGS I 5MG;6.25MG AB AB 10MG;12.5MG AB 20MG;12.5MG AB + 20MG;25MG
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 004 003
Feb Feb Feb Feb Feb Feb Feb Feb Sep Sep Sep Sep Feb Feb Feb Feb Feb Feb Feb Feb May May May May
11, 11, 11, 11, 11, 11, 11, 11, 08, 08, 08, 08, 11, 11, 11, 11, 11, 11, 11, 11, 19, 19, 19, 19,
2004 2004 2004 2004 2004 2004 2004 2004 2005 2005 2005 2005 2004 2004 2004 2004 2004 2004 2004 2004 1992 1992 1992 1992
BENDAMUSTINE HYDROCHLORIDE
POWDER; IV (INFUSION)
TREANDA
XX + CEPHALON XX +
N022249 N022249
002 001
May 01, 2009 Mar 20, 2008
BENDROFLUMETHIAZIDE; NADOLOL
TABLET; ORAL CORZIDE KING PHARMS 5MG;40MG + 5MG;80MG NADOLOL AND BENDROFLUMETHAZIDE MYLAN 5MG;40MG 5MG;80MG NADOLOL AND BENDROFLUMETHIAZIDE IMPAX LABS 5MG;40MG 5MG;80MG
AB AB AB AB AB AB
N018647 N018647 A078688 A078688 A077833 A077833
001 002 001 002 001 002
May 25, 1983 May 25, 1983 Feb 15, 2008 Feb 15, 2008 Mar 30, 2007 Mar 30, 2007
BENZONATATE
CAPSULE; ORAL BENZONATATE BANNER PHARMACAPS AA AA MIKART AA
100MG 200MG 100MG
A081297 A081297 A040851
001 002 001
Jan 29, 1993 Oct 30, 2007 Nov 09, 2009

BENZONATATE
CAPSULE; ORAL BENZONATATE MIKART AA ORIT LABS LLC AA AA SUN PHARM INDS INC AA AA THE PHARMA NETWORK AA AA ZYDUS PHARMS USA AA AA TESSALON AA + PFIZER AA + BENZONATATE MIKART XX
3 - 50 (of 428)
200MG 100MG 200MG 100MG 200MG 100MG 200MG 100MG 200MG 100MG 200MG 150MG
A040851 A040682 A040682 A040587 A040587 A040627 A040749 A040597 A040597 N011210 N011210 A040851
003 001 002 001 002 001 001 001 002 001 003 002
Nov Jul Jul Mar Mar Mar Jul Jun Jun
09, 30, 30, 19, 19, 30, 25, 08, 08,
2009 2007 2007 2008 2008 2007 2007 2007 2007
Jun 25, 1999 Nov 09, 2009
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

GEL; TOPICAL BENZACLIN VALEANT INTL 5%;EQ 1% BASE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE MYLAN PHARMS INC 5%;EQ 1% BASE PERRIGO ISRAEL 5%;1.2% DUAC + STIEFEL 5%;1.2% BENZACLIN + VALEANT INTL 5%;EQ 1% BASE ACANYA + DOW PHARM SCI 2.5%;1.2%
AB AB AB AB BT XX
N050756 A065443 A090979 N050741 N050756 N050819
001 001 001 001 002 001
Dec 21, 2000 Aug 11, 2009 Jun 26, 2012 Aug 26, 2002 Apr 20, 2007 Oct 23, 2008
BENZOYL PEROXIDE; ERYTHROMYCIN

GEL; TOPICAL BENZAMYCIN AB + VALEANT INTL 5%;3% ERYTHROMYCIN AND BENZOYL PEROXIDE TOLMAR AB 5%;3% BENZAMYCIN PAK 5%;3% XX + VALEANT INTL
N050557 A065112 N050769
001 001 001
Oct 26, 1984 Mar 29, 2004 Nov 27, 2000
BENZPHETAMINE HYDROCHLORIDE
TABLET; ORAL BENZPHETAMINE HYDROCHLORIDE COREPHARMA 50MG EMCURE PHARMS LTD 50MG IMPAX LABS 50MG KVK TECH 50MG MALLINCKRODT INC 50MG MIKART 25MG 50MG PADDOCK 50MG TEDOR PHARM 50MG DIDREX + PHARMACIA AND UPJOHN 50MG
AA AA AA AA AA AA AA AA AA AA
A040714 A202061 A040845 A090968 A040773 A090473 A090473 A040578 A040747 N012427
001 001 001 001 001 001 002 001 001 002
Oct Jan Nov Jul Apr Sep Sep Apr Mar
29, 27, 18, 20, 25, 15, 15, 17, 30,
2007 2012 2008 2010 2007 2010 2010 2006 2007
BENZTROPINE MESYLATE
INJECTABLE; INJECTION BENZTROPINE MESYLATE FRESENIUS KABI USA AP HIKMA FARMACEUTICA AP LUITPOLD AP
1MG/ML 1MG/ML 1MG/ML
A090233 A090287 A091152
001 001 001
Jul 28, 2009 Aug 31, 2009 Mar 29, 2010

INJECTABLE; INJECTION COGENTIN AP + OAK PHARMS AKORN TABLET; ORAL BENZTROPINE MESYLATE COREPHARMA AA AA AA EXCELLIUM AA AA AA INVAGEN PHARMS AA AA AA PLIVA AA AA AA PROSAM LABS AA AA AA AA + USL PHARMA AA + AA + VINTAGE AA AA AA
3 - 51 (of 428)
1MG/ML
N012015
001
0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG
001 001 001 001 002 003 001 002 003 001 001 001 001 001 001 001 002 003 001 001 003
Feb Feb Feb Nov Nov Nov Mar Mar Mar Aug Aug Aug Feb Feb Feb Dec Dec Dec Aug Aug Aug
27, 27, 27, 28, 28, 28, 29, 29, 29, 10, 10, 10, 14, 14, 14, 12, 12, 12, 27, 27, 27,
1989 1989 1989 2012 2012 2012 2010 2010 2010 1988 1988 1988 2008 2008 2008 1996 1996 1996 2007 2007 2007
BENZYL ALCOHOL
LOTION; TOPICAL ULESFIA XX + SHIONOGI INC
5%
N022129
001
Apr 09, 2009
BENZYLPENICILLOYL POLYLYSINE
INJECTABLE; INJECTION PRE-PEN XX + ALLERQUEST
60UMOLAR
N050114
001
BEPOTASTINE BESILATE
SOLUTION/DROPS; OPHTHALMIC BEPREVE XX + ISTA PHARMS 1.5%
N022288
001
Sep 08, 2009
BERACTANT
SUSPENSION; INTRATRACHEAL SURVANTA 25MG/ML XX + ABBVIE
N020032
001
Jul 01, 1991
BESIFLOXACIN HYDROCHLORIDE
SUSPENSION/DROPS; OPHTHALMIC BESIVANCE XX + BAUSCH AND LOMB EQ 0.6% BASE
N022308
001
May 28, 2009
BETAINE HYDROCHLORIDE
FOR SOLUTION; ORAL CYSTADANE XX + RARE DIS THERAP
1GM/SCOOPFUL
N020576
001
Oct 25, 1996
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE

INJECTABLE; INJECTION BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE LUITPOLD AB 3MG/ML;EQ 3MG BASE/ML
A090747
001
Jul 31, 2009

BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
INJECTABLE; INJECTION CELESTONE SOLUSPAN AB + SCHERING
3 - 52 (of 428)
3MG/ML;EQ 3MG BASE/ML
N014602
001
BETAMETHASONE DIPROPIONATE
CREAM; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ + FOUGERA PHARMS EQ TARO EQ CREAM, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE FOUGERA PHARMS EQ GLENMARK GENERICS EQ PERRIGO NEW YORK EQ TARO EQ TOLMAR EQ DIPROLENE AF + MERCK SHARP DOHME EQ GEL, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE + FOUGERA PHARMS EQ TARO EQ LOTION; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ EQ + FOUGERA PERRIGO NEW YORK EQ TEVA EQ LOTION, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE FOUGERA PHARMS EQ TARO EQ DIPROLENE + MERCK SHARP DOHME EQ OINTMENT; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ + FOUGERA EQ TARO EQ OINTMENT, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ FOUGERA PHARMS EQ TARO EQ DIPROLENE + MERCK SHARP DOHME EQ
AB AB AB
0.05% BASE 0.05% BASE 0.05% BASE
A070885 N019137 A073552
001 001 001
Feb 03, 1987 Jun 26, 1984 Apr 30, 1992
AB AB AB AB AB AB
0.05% 0.05% 0.05% 0.05% 0.05%
A076215 A078930 A076592 A076543 A076603 N019555
001 001 001 001 001 001
Dec Sep Dec Dec Jan
09, 23, 09, 09, 23,
2003 2008 2003 2003 2004
0.05% BASE
Apr 27, 1987
AB AB
0.05% BASE 0.05% BASE
A075276 A076508
001 001
May 13, 2003 Dec 02, 2003
AB AB AB AB
0.05% 0.05% 0.05% 0.05%
BASE BASE BASE BASE
A070281 A070275 A072538 A071467
001 001 001 001
Jul Aug Jan Aug
31, 12, 31, 10,
1985 1985 1990 1987
AB AB AB
0.05% BASE 0.05% BASE 0.05% BASE
A077111 A077477 N019716
001 001 001
May 21, 2007 May 21, 2007 Aug 01, 1988
AB AB AB
0.05% BASE 0.05% BASE 0.05% BASE
A071012 N019141 A074271
001 001 001
Feb 03, 1987 Sep 04, 1984 Sep 15, 1994
AB AB AB AB
0.05% BASE 0.05% BASE 0.05% BASE 0.05% BASE
A074304 A075373 A076753 N018741
001 001 001 001
Aug 31, 1995 Jun 22, 1999 Oct 12, 2004 Jul 27, 1983
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE

OINTMENT; TOPICAL CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE TOLMAR AB 0.064%;0.005% TACLONEX AB + LEO PHARMA AS 0.064%;0.005% SUSPENSION; TOPICAL TACLONEX 0.064%;0.005% XX + LEO PHARM
A201615 N021852
001 001
Jan 14, 2013 Jan 09, 2006
N022185
001
May 09, 2008

BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
CREAM; TOPICAL CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ 0.05% BASE;1% FOUGERA PHARMS EQ 0.05% BASE;1% TARO EQ 0.05% BASE;1% LOTRISONE + MERCK SHARP DOHME EQ 0.05% BASE;1% LOTION; TOPICAL CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE FOUGERA PHARMS EQ 0.05% BASE;1% TARO EQ 0.05% BASE;1% LOTRISONE + SCHERING CORP EQ 0.05% BASE;1%
3 - 53 (of 428)
AB AB AB AB
A076002 A075502 A075673 N018827
001 001 001 001
Aug 02, 2002 Jun 05, 2001 May 29, 2001 Jul 10, 1984
AB AB AB
A076516 A076493 N020010
001 001 001
Jun 16, 2005 Jul 28, 2004 Dec 08, 2000
BETAMETHASONE VALERATE
AEROSOL, FOAM; TOPICAL BETAMETHASONE VALERATE PERRIGO AB LUXIQ AB + STIEFEL CREAM; TOPICAL BETAMETHASONE VALERATE AB + FOUGERA BETA-VAL TEVA AB DERMABET TARO AB VALNAC ACTAVIS MID ATLANTIC AB LOTION; TOPICAL BETAMETHASONE VALERATE AB + FOUGERA STI PHARMA LLC AB BETA-VAL TEVA AB OINTMENT; TOPICAL BETAMETHASONE VALERATE ACTAVIS MID ATLANTIC AB AB + FOUGERA
EQ 0.12% BASE EQ 0.12% BASE
A078337 N020934
001 001
Nov 26, 2012 Feb 28, 1999
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE
N018861 N018642 A072041 A070050
001 001 001 001
Aug 31, 1983 Mar 24, 1983 Jan 06, 1988 Oct 10, 1984
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE
N018866 A070052 A070072
001 001 001
Aug 31, 1983 Jul 31, 1985 Jun 27, 1985
EQ 0.1% BASE EQ 0.1% BASE
A070051 N018865
001 001
Oct 10, 1984 Aug 31, 1983
BETAXOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC BETAXOLOL HYDROCHLORIDE AKORN EQ BAUSCH AND LOMB EQ NOVEX EQ WOCKHARDT EQ BETOPTIC + ALCON EQ SUSPENSION/DROPS; OPHTHALMIC BETOPTIC S + ALCON EQ
AT AT AT AT AT
0.5% 0.5% 0.5% 0.5%
BASE BASE BASE BASE
A075386 A075630 A075446 A078694 N019270
001 001 001 001 001
Jun Apr Sep Nov
30, 12, 28, 16,
2000 2001 2000 2009
0.5% BASE
Aug 30, 1985
XX
0.25% BASE
N019845
001
Dec 29, 1989
TABLET; ORAL BETAXOLOL HYDROCHLORIDE EPIC PHARMA 10MG AB 20MG AB + KVK TECH 10MG AB 20MG AB
A075541 A075541 A078962 A078962
001 002 001 002
Oct Oct Jun Jun
22, 22, 27, 27,
1999 1999 2008 2008

BETHANECHOL CHLORIDE
TABLET; ORAL BETHANECHOL CHLORIDE AMNEAL PHARM AA AA AA AA EMCURE USA AA AA AA AA IMPAX LABS AA AA AA AA LANNETT AA AA AA AA PHARMAX AA AA AA AA SUN PHARM INDS INC AA AA AA AA UPSHER SMITH AA AA AA AA WOCKHARDT AA AA AA AA DUVOID WELLSPRING PHARM AA AA AA URECHOLINE AA + ODYSSEY PHARMS AA + AA + AA +
3 - 54 (of 428)
5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG
A040855 A040855 A040855 A040855 A091256 A091256 A091256 A091256 A040739 A040741 A040740 A040721 A040703 A040704 A040678 A040677 A040725 A040726 A040727 A040728 A040897 A040897 A040897 A040897 A040633 A040634 A040635 A040636 A040532 A040533 A040534 A040518 A086262 A086263 A085882 A089095 A088440 A088441 A089096
001 002 003 004 001 002 003 004 001 001 001 004 001 001 003 001 001 001 001 001 001 002 003 004 001 001 001 001 001 001 001 001 001 001 003 001 001 001 001
Nov Nov Nov Nov May May May May Nov Nov Nov Nov Mar Mar Mar Mar Oct Oct Oct Oct Apr Apr Apr Apr Jun Jun Jun Jun Sep Sep Sep Sep
21, 21, 21, 21, 04, 04, 04, 04, 01, 01, 01, 01, 27, 27, 27, 27, 26, 26, 26, 26, 22, 22, 22, 22, 01, 01, 01, 01, 29, 29, 29, 29,
2007 2007 2007 2007 2010 2010 2010 2010 2006 2006 2006 2006 2008 2008 2008 2008 2007 2007 2007 2007 2009 2009 2009 2009 2005 2005 2005 2005 2003 2003 2003 2003
Dec May May Dec
19, 29, 29, 19,
1985 1984 1984 1985
BEXAROTENE
CAPSULE; ORAL
TARGRETIN
XX + EISAI INC GEL; TOPICAL
TARGRETIN
XX + EISAI INC
75MG
N021055
001
Dec 29, 1999
1%
N021056
001
Jun 28, 2000
BICALUTAMIDE
TABLET; ORAL BICALUTAMIDE ACCORD HLTHCARE INC ACTAVIS TOTOWA FRESENIUS KABI ONCOL KUDCO IRELAND MYLAN
AB AB AB AB AB
50MG 50MG 50MG 50MG 50MG
A078917 A078634 A079045 A077995 A079185
001 001 001 001 001
Jul Aug May Jul Jul
06, 28, 13, 06, 06,
2009 2009 2010 2009 2009

BICALUTAMIDE
TABLET; ORAL BICALUTAMIDE ROXANE SANDOZ SUN PHARMA GLOBAL SYNTHON PHARMS TEVA ZYDUS PHARMS USA INC CASODEX + ASTRAZENECA
3 - 55 (of 428)
A078285 A078575 A079110 A077973 A076932 A079089 N020498
001 001 001 001 001 001 001
Mar Jul Jul Jul Jul Jul
24, 06, 06, 06, 06, 06,
2011 2009 2009 2009 2009 2009
Oct 04, 1995
BIMATOPROST
SOLUTION/DROPS; OPHTHALMIC
LUMIGAN
XX + ALLERGAN 0.01% XX + 0.03% SOLUTION/DROPS; TOPICAL
LATISSE
XX + ALLERGAN
N022184 N021275
001 001
Aug 31, 2010 Mar 16, 2001
0.03%
N022369
001
Dec 24, 2008
BIPERIDEN HYDROCHLORIDE
TABLET; ORAL
AKINETON
XX + ABBVIE
2MG
N012003
001
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
FOR SOLUTION; TABLET, DELAYED RELEASE; ORAL
HALFLYTELY
XX + BRAINTREE 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM N021551 ;N/A,5.6GM
003
Jul 16, 2010
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE

CAPSULE; ORAL
PYLERA
XX + APTALIS PHARMA US
140MG;125MG;125MG
N050786
001
Sep 28, 2006
BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE

TABLET, CHEWABLE, TABLET, CAPSULE; ORAL
HELIDAC
262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,5 N050719 XX + PROMETHEUS LABS 00MG
001
Aug 15, 1996
BISOPROLOL FUMARATE
TABLET; ORAL BISOPROLOL FUMARATE AUROBINDO PHARMA AB AB MYLAN AB AB SANDOZ AB AB TEVA PHARMS AB AB UNICHEM PHARMS (USA) AB AB ZEBETA TEVA WOMENS AB AB +
A077910 A077910 A075831 A075831 A075643 A075643 A075644 A075644 A078635 A078635 N019982 N019982
001 002 001 002 001 002 001 002 001 002 002 001
Dec Dec Dec Dec Nov Nov Jun Jun Aug Aug
27, 27, 14, 14, 16, 16, 26, 26, 18, 18,
2006 2006 2005 2005 2000 2000 2001 2001 2009 2009
Jul 31, 1992 Jul 31, 1992

BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
TABLET; ORAL BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE MYLAN AB 2.5MG;6.25MG AB 5MG;6.25MG AB 10MG;6.25MG SANDOZ AB 2.5MG;6.25MG AB 5MG;6.25MG AB 10MG;6.25MG UNICHEM AB 2.5MG;6.25MG AB 5MG;6.25MG AB 10MG;6.25MG WATSON LABS AB 2.5MG;6.25MG AB 5MG;6.25MG AB 10MG;6.25MG ZIAC TEVA WOMENS AB 2.5MG;6.25MG AB 5MG;6.25MG AB + 10MG;6.25MG
3 - 56 (of 428)
A075768 A075768 A075768 A075579 A075579 A075579 A079106 A079106 A079106 A075469 A075469 A075469 N020186 N020186 N020186
001 002 003 001 002 003 001 002 003 001 002 003 003 001 002
Sep Sep Sep Sep Sep Sep Jul Jul Jul Sep Sep Sep
25, 25, 25, 25, 25, 25, 28, 28, 28, 25, 25, 25,
2000 2000 2000 2000 2000 2000 2010 2010 2010 2000 2000 2000
Mar 26, 1993 Mar 26, 1993 Mar 26, 1993
BIVALIRUDIN
ANGIOMAX
XX + MEDICINES CO
250MG/VIAL
N020873
001
Dec 15, 2000
BLEOMYCIN SULFATE
INJECTABLE; INJECTION BLEOMYCIN SULFATE BEDFORD AP AP AP + FRESENIUS KABI USA AP + HOSPIRA AP AP PHARMACHEMIE BV AP TEVA PARENTERAL AP AP
EQ EQ EQ EQ EQ EQ EQ EQ EQ
15 30 15 30 15 30 15 15 30
UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS
BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
A065042 A065042 A065185 A065185 A065031 A065031 A065201 A065033 A065033
002 001 001 002 001 002 001 001 002
Oct Oct Jan Jan Mar Mar Dec Jun Jun
17, 17, 28, 28, 10, 10, 13, 27, 27,
2001 2001 2008 2008 2000 2000 2007 2000 2000
BOCEPREVIR
CAPSULE; ORAL
VICTRELIS
XX + MERCK SHARP DOHME
200MG
N202258
001
May 13, 2011
BORTEZOMIB
INJECTABLE; INTRAVENOUS, SUBCUTANEOUS
VELCADE
XX + MILLENNIUM PHARMS 3.5MG/VIAL
N021602
001
May 13, 2003
BOSENTAN
TABLET; ORAL TRACLEER ACTELION PHARMS LTD XX XX +
62.5MG 125MG
N021290 N021290
001 002
Nov 20, 2001 Nov 20, 2001
BOSUTINIB MONOHYDRATE
TABLET; ORAL BOSULIF WYETH PHARMS INC XX XX +
N203341 N203341
001 002
Sep 04, 2012 Sep 04, 2012

BRETYLIUM TOSYLATE
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
XX + B BRAUN 100MG/100ML XX + 200MG/100ML XX + 400MG/100ML
3 - 57 (of 428)
N019121 N019121 N019121
001 002 003
Apr 29, 1986 Apr 29, 1986 Apr 29, 1986
BRIMONIDINE TARTRATE
SOLUTION/DROPS; OPHTHALMIC ALPHAGAN P + ALLERGAN 0.15% BRIMONIDINE TARTRATE AKORN 0.2% ALCON PHARMS LTD 0.15% 0.2% + BAUSCH AND LOMB 0.2% SANDOZ 0.2% ALPHAGAN P + ALLERGAN 0.1%
AT AT AT AT AT AT XX
N021262 A076439 N021764 A076254 A076260 A078075 N021770
001 001 001 001 001 001 001
Mar 16, 2001 Mar May Sep May Jan 14, 22, 16, 28, 30, 2006 2006 2003 2003 2008
Aug 19, 2005
BRIMONIDINE TARTRATE; TIMOLOL MALEATE

COMBIGAN
XX + ALLERGAN 0.2%;0.5%
N021398
001
Oct 30, 2007
BRINZOLAMIDE
SUSPENSION/DROPS; OPHTHALMIC
AZOPT
XX + ALCON PHARMS LTD 1%
N020816
001
Apr 01, 1998
BROMFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC BROMFENAC SODIUM COASTAL PHARMS AT 0.09% PHARMAFORCE AT 0.09% BROMDAY 0.09% XX + ISTA PHARMS INC
A201211 A202030 N021664
001 001 002
May 11, 2011 Jan 09, 2013 Oct 16, 2010
BROMOCRIPTINE MESYLATE
CAPSULE; ORAL BROMOCRIPTINE MESYLATE MYLAN AB ZYDUS PHARMS USA INC AB PARLODEL AB + US PHARMS HOLDINGS I TABLET; ORAL BROMOCRIPTINE MESYLATE LEK PHARMS AB MYLAN AB PADDOCK LLC AB PARLODEL AB + US PHARMS HOLDINGS I CYCLOSET XX + VEROSCIENCE
A077226 A078899 N017962
001 001 002
Apr 04, 2005 Jul 30, 2008 Mar 01, 1982
EQ 2.5MG BASE EQ 2.5MG BASE EQ 2.5MG BASE EQ 2.5MG BASE EQ 0.8MG BASE
A074631 A076962 A077646 N017962 N020866
001 001 001 001 001
Jan 13, 1998 Sep 24, 2004 Oct 01, 2008
May 05, 2009
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

SYRUP; ORAL
BROMFED-DM
XX + WOCKHARDT
2MG/5ML;10MG/5ML;30MG/5ML
A088811
001
Jun 07, 1985

BUDESONIDE
CAPSULE; ORAL BUDESONIDE MYLAN AB 3MG ENTOCORT EC AB + ASTRAZENECA 3MG POWDER, METERED; INHALATION PULMICORT FLEXHALER ASTRAZENECA 0.08MG/INH XX 0.16MG/INH XX + SPRAY, METERED; NASAL
RHINOCORT
XX + ASTRAZENECA SUSPENSION; INHALATION BUDESONIDE APOTEX AN AN TEVA PHARMS AN AN WATSON LABS INC AN AN PULMICORT RESPULES ASTRAZENECA AN AN PULMICORT RESPULES XX + ASTRAZENECA
3 - 58 (of 428)
A090410 N021324
001 001
May 16, 2011 Oct 02, 2001
N021949 N021949
001 002
Jul 12, 2006 Jul 12, 2006
0.032MG/INH
N020746
001
Oct 01, 1999
0.25MG/2ML 0.5MG/2ML 0.25MG/2ML 0.5MG/2ML 0.25MG/2ML 0.5MG/2ML 0.25MG/2ML 0.5MG/2ML 1MG/2ML
A078202 A078202 A077519 A077519 A078404 A078404 N020929 N020929 N020929
001 002 001 002 001 002 001 002 003
Mar Mar Nov Nov Jul Jul
30, 30, 18, 18, 31, 31,
2009 2009 2008 2008 2012 2012
Aug 08, 2000 Aug 08, 2000 Aug 08, 2000
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE

SYMBICORT
0.08MG/INH;0.0045MG/INH XX + ASTRAZENECA 0.16MG/INH;0.0045MG/INH XX +
N021929 N021929
001 002
Jul 21, 2006 Jul 21, 2006
BUMETANIDE
INJECTABLE; INJECTION BUMETANIDE + BEDFORD HIKMA MAPLE HOSPIRA TABLET; ORAL BUMETANIDE IVAX SUB TEVA PHARMS
AP AP AP
0.25MG/ML 0.25MG/ML 0.25MG/ML
A074441 A079196 A074332
001 001 001
Jan 27, 1995 Apr 30, 2008 Oct 31, 1994
AB AB AB AB AB AB
SANDOZ +
0.5MG 1MG 2MG 0.5MG 1MG 2MG
A074225 A074225 A074225 A074700 A074700 A074700
001 002 003 001 002 003
Apr Apr Apr Nov Nov Nov
24, 24, 24, 21, 21, 21,
1995 1995 1995 1996 1996 1996
BUPIVACAINE
EXPAREL
266MG/20ML (13.3MG/ML) XX + PACIRA PHARMS INC
N022496
002
Oct 28, 2011
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION BUPIVACAINE HYDROCHLORIDE HOSPIRA 0.25% 0.25% 0.25% 0.25% 0.5% 0.5%
AP AP AP AP AP AP
A070583 A070586 A070590 N018053 A070584 A070597
001 001 001 002 001 001
Feb 17, 1987 Mar 03, 1987 Feb 17, 1987 Feb 17, 1986 Mar 03, 1987

INJECTABLE; INJECTION BUPIVACAINE HYDROCHLORIDE HOSPIRA 0.5% 0.5% 0.75% 0.75% 0.75% SAGENT AGILA 0.25% 0.5% BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE INTL MEDICATED 0.25% 0.5% 0.75% SAGENT AGILA 0.25% 0.5% 0.75% MARCAINE HYDROCHLORIDE + HOSPIRA 0.25% + 0.5% MARCAINE HYDROCHLORIDE PRESERVATIVE FREE + HOSPIRA 0.25% + 0.5% + 0.75% SENSORCAINE FRESENIUS KABI USA 0.25% 0.25% 0.5% 0.5% 0.75% 0.75% INJECTABLE; SPINAL BUPIVACAINE HYDROCHLORIDE HOSPIRA 0.75% MARCAINE + HOSPIRA 0.75% SENSORCAINE FRESENIUS KABI USA 0.75%
3 - 59 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A070609 N018053 A070585 A070587 N018053 A091503 A091503 A076012 A076012 A076012 A091487 A091487 A091487 N016964 N016964 N016964 N016964 N016964 A070552 N018304 A070553 N018304 A070554 N018304
001 001 001 001 003 001 002 001 002 003 002 001 003 001 006 012 005 009 001 001 001 002 001 003
Mar 03, 1987 Mar 03, 1987 Mar 03, 1987 Oct 18, 2011 Oct 18, 2011 Jan Jan Jan Oct Oct Oct 09, 09, 09, 18, 18, 18, 2002 2002 2002 2011 2011 2011
May 21, 1986 May 21, 1986 May 21, 1986
AP AP AP
A071810 N018692 A071202
001 001 001
Dec 11, 1987 May 04, 1984 Apr 15, 1987
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE

INJECTABLE; INJECTION BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE + HOSPIRA 0.5%;0.005MG/ML 0.5%;0.005MG/ML BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE + HOSPIRA 0.25%;0.005MG/ML 0.25%;0.005MG/ML
AP AP XX XX
A071168 A071170 A071165 A071167
001 001 001 001
Jun 16, 1988 Jun 16, 1988 Jun 16, 1988 Jun 16, 1988
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

INJECTABLE; INJECTION BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE SEPTODONT 0.5%;0.0091MG/ML BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE + HOSPIRA 0.5%;0.0091MG/ML MARCAINE HYDROCHLORIDE W/ EPINEPHRINE + HOSPIRA 0.25%;0.0091MG/ML + 0.5%;0.0091MG/ML MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE + HOSPIRA 0.25%;0.0091MG/ML + 0.5%;0.0091MG/ML + 0.75%;0.0091MG/ML
AP AP AP AP AP AP AP
A077250 N022046 N016964 N016964 N016964 N016964 N016964
001 001 004 008 013 007 010
Sep 27, 2006 Jul 13, 1983

BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION SENSORCAINE FRESENIUS KABI USA AP AP AP AP AP
3 - 60 (of 428)
0.25%;0.0091MG/ML 0.25%;0.0091MG/ML 0.5%;0.0091MG/ML 0.5%;0.0091MG/ML 0.75%;0.0091MG/ML
A070966 A070967 A070968 N018304 N018304
001 001 001 004 005
Oct Oct Oct Sep Sep
13, 13, 13, 02, 02,
1987 1987 1987 1983 1983
BUPRENORPHINE
FILM, EXTENDED RELEASE; TRANSDERMAL BUTRANS XX PURDUE PHARMA LP 5MCG/HR XX 10MCG/HR XX + 20MCG/HR
N021306 N021306 N021306
001 002 003
Jun 30, 2010 Jun 30, 2010 Jun 30, 2010
BUPRENORPHINE HYDROCHLORIDE
INJECTABLE; INJECTION BUPRENEX + RECKITT BENCKISER EQ 0.3MG BASE/ML BUPRENORPHINE HYDROCHLORIDE BEDFORD EQ 0.3MG BASE/ML HOSPIRA EQ 0.3MG BASE/ML LUITPOLD EQ 0.3MG BASE/ML TABLET; SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE BARR EQ 2MG BASE EQ 8MG BASE ETHYPHARM EQ 2MG BASE EQ 8MG BASE ROXANE EQ 2MG BASE + EQ 8MG BASE
AP AP AP AP
N018401 A076931 A074137 A078331
001 001 001 001 Mar 02, 2005 Jun 03, 1996 Mar 27, 2007
AB AB AB AB AB AB
A090360 A090360 A090622 A090622 A078633 A078633
001 002 001 002 001 002
May May Sep Sep Oct Oct
07, 07, 24, 24, 08, 08,
2010 2010 2010 2010 2009 2009
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

FILM; SUBLINGUAL SUBOXONE XX RECKITT BENCKISER XX XX + XX TABLET; SUBLINGUAL SUBOXONE XX RECKITT BENCKISER XX +
EQ EQ EQ EQ
2MG BASE;EQ 0.5MG BASE 4MG BASE;EQ 1MG BASE 8MG BASE;EQ 2MG BASE 12MG BASE;EQ 3MG BASE
N022410 N022410 N022410 N022410
001 003 002 004
Aug Aug Aug Aug
30, 10, 30, 10,
2010 2012 2010 2012
EQ 2MG BASE;EQ 0.5MG BASE EQ 8MG BASE;EQ 2MG BASE
N020733 N020733
001 002
Oct 08, 2002 Oct 08, 2002
BUPROPION HYDROBROMIDE
TABLET, EXTENDED RELEASE; ORAL APLENZIN XX VALEANT INTL 174MG XX + 348MG XX 522MG
N022108 N022108 N022108
001 002 003
Apr 23, 2008 Apr 23, 2008 Apr 23, 2008
BUPROPION HYDROCHLORIDE
TABLET; ORAL BUPROPION HYDROCHLORIDE APOTEX INC AB 75MG AB 100MG MYLAN AB 75MG AB 100MG SANDOZ AB 75MG AB 100MG
A076143 A076143 A075491 A075491 A075584 A075584
001 002 001 002 001 002
Jan Jan Apr Apr Feb Feb
17, 17, 17, 17, 07, 07,
2006 2006 2000 2000 2000 2000

TABLET; ORAL BUPROPION HYDROCHLORIDE TEVA AB 75MG AB 100MG WELLBUTRIN GLAXOSMITHKLINE AB 75MG AB + 100MG TABLET, EXTENDED RELEASE; ORAL BUPROPION HYDROCHLORIDE ACTAVIS AB1 100MG AB1 150MG AB1 200MG ANCHEN PHARMS AB1 100MG AB1 150MG AB1 200MG IMPAX LABS AB1 100MG AB1 150MG AB1 200MG MYLAN AB1 100MG AB1 150MG AB1 200MG SANDOZ AB1 100MG AB1 150MG AB1 200MG SUN PHARMA GLOBAL AB1 100MG AB1 150MG AB1 200MG WATSON LABS FLORIDA AB1 100MG AB1 150MG AB1 200MG WOCKHARDT LTD AB1 100MG AB1 150MG AB1 200MG WELLBUTRIN SR GLAXOSMITHKLINE AB1 100MG AB1 150MG AB1 + 200MG BUPROPION HYDROCHLORIDE ACTAVIS AB2 150MG ANCHEN PHARMS AB2 150MG IMPAX LABS AB2 150MG MYLAN AB2 150MG WATSON LABS FLORIDA AB2 150MG ZYBAN AB2 + GLAXOSMITHKLINE 150MG BUPROPION HYDROCHLORIDE ACTAVIS AB3 150MG AB3 300MG ANCHEN PHARMS AB3 150MG AB3 300MG IMPAX LABS AB3 150MG MYLAN AB3 150MG AB3 300MG WATSON LABS AB3 150MG AB3 300MG WOCKHARDT LTD AB3 150MG WELLBUTRIN XL VALEANT INTL AB3 150MG AB3 + 300MG
3 - 61 (of 428)
A075310 A075310 N018644 N018644
001 002 002 003
Nov 29, 1999 Nov 29, 1999 Dec 30, 1985 Dec 30, 1985
A077455 A077455 A077455 A091459 A091459 A091459 A075913 A075913 A076711 A090325 A090325 A090325 A075932 A075932 A075932 A078866 A078866 A078866 A079095 A079095 A079095 A201331 A201331 A201331 N020358 N020358 N020358 A077475 A091520 A075914 A090941 A079094 N020711 A077285 A077285 A077284 A077284 A077415 A090942 A090942 A077715 A077715 A202189 N021515 N021515
001 002 003 001 002 003 001 002 001 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 002 003 004 001 001 001 001 001 003 001 002 001 002 001 001 002 001 002 001 001 002
Jul Mar Jul Jun Jun Jun Jan Mar Dec Apr Apr Apr Nov Mar Jun Apr Apr Apr Mar Mar Mar Aug Aug Aug
19, 12, 19, 09, 09, 09, 28, 22, 03, 08, 08, 08, 25, 22, 22, 06, 06, 06, 24, 24, 24, 30, 30, 30,
2010 2008 2010 2011 2011 2011 2004 2004 2004 2010 2010 2010 2003 2004 2005 2010 2010 2010 2009 2009 2009 2012 2012 2012
Oct 04, 1996 Oct 04, 1996 Jun 14, 2002 Mar Jun May May Mar 12, 09, 27, 03, 24, 2008 2011 2004 2010 2009
May 14, 1997 Nov Aug Dec Dec Nov Jul Jul Nov Jun Nov 26, 15, 14, 14, 26, 14, 14, 26, 13, 21, 2008 2008 2006 2006 2008 2010 2010 2008 2007 2012
Aug 28, 2003 Aug 28, 2003

TABLET, EXTENDED RELEASE; ORAL BUPROPION HYDROCHLORIDE BX IMPAX LABS 300MG FORFIVO XL XX + EDGEMONT PHARMS LLC 450MG
3 - 62 (of 428)
A077415 N022497
002 001
Dec 15, 2006 Nov 10, 2011
BUSPIRONE HYDROCHLORIDE
TABLET; ORAL BUSPIRONE HYDROCHLORIDE DR REDDYS LABS LTD AB 5MG AB 10MG AB 15MG AB 30MG MYLAN AB 5MG AB 5MG AB 7.5MG AB 10MG AB 10MG AB 15MG AB 15MG AB 30MG PROSAM LABS AB 30MG TEVA AB 5MG AB 10MG AB + 15MG AB 30MG WATSON LABS AB 5MG AB 10MG AB 15MG
A078246 A078246 A078246 A078246 A075272 A075467 A075467 A075272 A075467 A075272 A075467 A076008 A078302 A075022 A075022 A075022 A075022 A074253 A074253 A074253
001 002 003 004 001 001 002 002 003 003 004 001 001 001 002 003 004 001 002 003
Feb Feb Feb Feb Mar Feb Mar Mar Feb Mar Feb Jun Dec Feb Feb Feb Mar Mar Mar Mar
27, 27, 27, 27, 01, 28, 28, 01, 28, 28, 28, 28, 17, 28, 28, 28, 25, 28, 28, 13,
2009 2009 2009 2009 2002 2002 2001 2002 2002 2001 2002 2001 2007 2002 2002 2002 2004 2001 2001 2002
BUSULFAN
BUSULFEX
XX + OTSUKA PHARM TABLET; ORAL
MYLERAN
XX + ASPEN GLOBAL
6MG/ML
N020954
001
Feb 04, 1999
2MG
N009386
001
BUTABARBITAL SODIUM
ELIXIR; ORAL
BUTISOL SODIUM
XX + MEDA PHARMS TABLET; ORAL
BUTISOL SODIUM
XX + MEDA PHARMS XX +
30MG/5ML
A085380
001
30MG 50MG
N000793 N000793
004 003
BUTENAFINE HYDROCHLORIDE
CREAM; TOPICAL
MENTAX
XX + MYLAN MENTAX-TC XX + MYLAN
1% 1%
N020524 N021408
001 001
Oct 18, 1996 Oct 17, 2002
BUTOCONAZOLE NITRATE
CREAM; VAGINAL BUTOCONAZOLE NITRATE PERRIGO ISRAEL AB GYNAZOLE-1 AB + KV PHARM
2% 2%
A200923 N019881
001 001
May 18, 2012 Feb 07, 1997

BUTORPHANOL TARTRATE
INJECTABLE; INJECTION BUTORPHANOL TARTRATE BEDFORD AP 2MG/ML CLARIS LIFESCIENCES AP 2MG/ML HIKMA FARMACEUTICA AP 1MG/ML AP 2MG/ML AP 2MG/ML BUTORPHANOL TARTRATE PRESERVATIVE FREE BEDFORD AP 1MG/ML AP 2MG/ML CLARIS LIFESCIENCES AP 1MG/ML AP 2MG/ML HOSPIRA AP 1MG/ML AP 2MG/ML STADOL AP + APOTHECON 2MG/ML STADOL PRESERVATIVE FREE AP + APOTHECON 1MG/ML AP + 2MG/ML SPRAY, METERED; NASAL BUTORPHANOL TARTRATE AB + MYLAN 1MG/SPRAY NOVEX AB 1MG/SPRAY ROXANE AB 1MG/SPRAY
3 - 63 (of 428)
A075046 A075697 A078400 A078247 A078400 A075045 A075045 A075695 A075695 A074626 A074626 N017857 N017857 N017857
001 001 001 001 002 001 002 001 002 001 002 004 001 002
Aug Oct May Apr May Aug Aug Oct Oct Jan Jan
12, 23, 01, 29, 01, 12, 12, 23, 23, 23, 23,
1998 2001 2009 2009 2009 1998 1998 2001 2001 1997 1997
A075759 A075499 A075824
001 001 001
Aug 08, 2001 Dec 04, 2002 Mar 12, 2002
CABAZITAXEL
JEVTANA KIT
60MG/1.5ML (40MG/ML)
N201023
001
Jun 17, 2010
CABERGOLINE
TABLET; ORAL CABERGOLINE IMPAX LABS INC IVAX SUB TEVA PHARMS + PAR PHARM WATSON LABS
AB AB AB AB
0.5MG 0.5MG 0.5MG 0.5MG
A077843 A077750 A076310 A078035
001 001 001 001
Jul Mar Dec Apr
03, 07, 29, 21,
2007 2007 2005 2008
CABOZANTINIB S-MALATE
CAPSULE; ORAL COMETRIQ XX EXELIXIS XX +
N203756 N203756
001 002
Nov 29, 2012 Nov 29, 2012
CAFFEINE CITRATE
SOLUTION; INTRAVENOUS CAFCIT + BEDFORD LABS CAFFEINE CITRATE FRESENIUS KABI USA LUITPOLD PADDOCK LLC SAGENT PHARMS SUN PHARMA GLOBAL SOLUTION; ORAL CAFCIT + BEDFORD LABS CAFFEINE CITRATE FRESENIUS KABI USA LUITPOLD PADDOCK LLC
AP AP AP AP AP AP
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) EQ EQ EQ EQ EQ 30MG 30MG 30MG 30MG 30MG BASE/3ML BASE/3ML BASE/3ML BASE/3ML BASE/3ML (EQ (EQ (EQ (EQ (EQ 10MG 10MG 10MG 10MG 10MG BASE/ML) BASE/ML) BASE/ML) BASE/ML) BASE/ML)
N020793 A077997 A077906 A077233 A090827 A090077
001 001 001 001 001 001
Sep 21, 1999 Jul May Sep Aug Sep 20, 15, 21, 29, 30, 2007 2007 2006 2012 2009
AA AA AA AA
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) EQ 30MG BASE/3ML (EQ 10MG BASE/ML) EQ 30MG BASE/3ML (EQ 10MG BASE/ML) EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
N020793 A078002 A090064 A077304
002 001 001 001
Apr 12, 2000 Jan 31, 2008 Nov 20, 2009 Sep 21, 2006

CAFFEINE CITRATE
SOLUTION; ORAL CAFFEINE CITRATE SAGENT PHARMS AA SUN PHARMA GLOBAL AA
3 - 64 (of 428)
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
A091102 A090357
001 001
Aug 29, 2012 Sep 30, 2009
CAFFEINE; ERGOTAMINE TARTRATE

SUPPOSITORY; RECTAL MIGERGOT XX + G AND W LABS
100MG;2MG
A086557
001
Oct 04, 1983
TABLET; ORAL CAFERGOT AA + SANDOZ 100MG;1MG ERGOTAMINE TARTRATE AND CAFFEINE MIKART AA 100MG;1MG WEST WARD AA 100MG;1MG
A084294 A040590 A040510
001 001 001 Sep 16, 2005 Sep 17, 2004
CALCIPOTRIENE
AEROSOL, FOAM; TOPICAL SORILUX XX + STIEFEL LABS INC CREAM; TOPICAL CALCIPOTRIENE TOLMAR AB DOVONEX AB + LEO PHARMA AS OINTMENT; TOPICAL CALCIPOTRIENE XX + GLENMARK GENERICS SOLUTION; TOPICAL CALCIPOTRIENE FOUGERA PHARMS G AND W LABS INC HI TECH PHARMA TOLMAR DOVONEX + LEO PHARM
0.005%
N022563
001
Oct 06, 2010
0.005% 0.005%
A200935 N020554
001 001
May 30, 2012 Jul 22, 1996
0.005%
A090633
001
Mar 24, 2010
AT AT AT AT AT
0.005% 0.005% 0.005% 0.005% 0.005%
A078305 A078468 A077579 A077029 N020611
001 001 001 001 001
May Mar Nov Nov
06, 24, 19, 20,
2008 2011 2009 2009
Mar 03, 1997
CALCITONIN SALMON
INJECTABLE; INJECTION MIACALCIN XX + NOVARTIS SPRAY, METERED; NASAL CALCITONIN-SALMON APOTEX INC AB PAR PHARM AB MIACALCIN AB + NOVARTIS
200 IU/ML
N017808
002
Mar 29, 1991
200 IU/SPRAY 200 IU/SPRAY 200 IU/SPRAY
A076396 A076979 N020313
001 001 002
Nov 17, 2008 Jun 08, 2009 Aug 17, 1995
CALCITONIN SALMON RECOMBINANT

SPRAY, METERED; NASAL FORTICAL XX + UPSHER SMITH
200 IU/SPRAY
N021406
001
Aug 12, 2005
CALCITRIOL
CAPSULE; ORAL CALCITRIOL ROXANE AB TEVA AB AB ROCALTROL VALIDUS PHARMS AB
0.25MCG 0.25MCG 0.5MCG 0.25MCG
A076917 A075765 A075765 N018044
001 001 002 001
Mar 27, 2006 Oct 12, 2001 Oct 12, 2001

CALCITRIOL
CAPSULE; ORAL ROCALTROL + VALIDUS PHARMS INJECTABLE; INJECTION CALCIJEX + ABBVIE + CALCITRIOL AKORN FRESENIUS KABI USA FRESENIUS MEDCL LUITPOLD
3 - 65 (of 428)
AB
0.5MCG
N018044
002
AP AP AP AP AP AP AP AP AP AP AP AP AP
0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.001MG/ML 0.002MG/ML
N018874 N018874 A078066 A078066 A075836 A075836 A075766 A075766 A075746 A075746 A076206 A077102 A075823
001 002 001 002 001 002 001 002 001 002 001 001 002
Sep 25, 1986 Sep 25, 1986 Jan Jan Dec Dec Feb Feb Sep Sep Sep Feb Mar 29, 29, 31, 31, 20, 20, 26, 26, 17, 08, 31, 2008 2008 2002 2002 2003 2003 2003 2003 2003 2006 2003
ROCKWELL MEDCL SAGENT PHARMS TEVA PARENTERAL OINTMENT; TOPICAL

VECTICAL
XX + GALDERMA LABS LP SOLUTION; ORAL CALCITRIOL ROXANE AA ROCALTROL AA + VALIDUS PHARMS
3MCG/GM
N022087
001
Jan 23, 2009
1MCG/ML 1MCG/ML
A076242 N021068
001 001
Jul 18, 2003 Nov 20, 1998
CALCIUM ACETATE
CAPSULE; ORAL CALCIUM ACETATE PADDOCK LLC AB ROXANE AB PHOSLO GELCAPS AB + FRESENIUS MEDCL SOLUTION; ORAL PHOSLYRA XX + FRESENIUS MEDCL TABLET; ORAL CALCIUM ACETATE PADDOCK LLC AB ELIPHOS AB + CYPRESS PHARM
EQ 169MG CALCIUM EQ 169MG CALCIUM EQ 169MG CALCIUM
A091312 A077728 N021160
001 001 003
Jun 01, 2012 Feb 26, 2008 Apr 02, 2001
EQ 169MG CALCIUM/5ML
N022581
001
Apr 18, 2011
EQ 169MG CALCIUM EQ 169MG CALCIUM
A091561 A078502
001 001
Apr 13, 2011 Nov 25, 2008
CALCIUM CHLORIDE
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
XX + HOSPIRA 100MG/ML
N021117
001
Jan 28, 2000
CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION; IRRIGATION BSS PLUS AT + ALCON
0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/M N018469 L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M L 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/M N020079 L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M L
001
AT
ENDOSOL EXTRA + AKORN
001
Nov 27, 1991
3 - 66 (of 428)
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
XX + GAMBRO RENAL PRODS N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 5GM/1000ML;0.157GM/1000ML;2.21GM/1000ML ;7.07GM/1000ML PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER XX + GAMBRO RENAL PRODS N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 5GM/1000ML;0.314GM/1000ML;2.21GM/1000ML ;7.07GM/1000ML PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER XX + GAMBRO RENAL PRODS 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; 3.05GM/1000ML;0.314GM/1000ML;2.21GM/100 0ML;7.07GM/1000ML PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER XX + GAMBRO RENAL PRODS 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; 3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML; 6.46GM/1000ML PRISMASOL BGK 2/0 IN PLASTIC CONTAINER XX + GAMBRO RENAL PRODS N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.0 3GM/1000ML;0.157GM/1000ML;3.09GM/1000ML ;6.46GM/1000ML PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER XX + GAMBRO RENAL PRODS 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML; 2.03GM/1000ML;0.157GM/1000ML;3.09GM/100 0ML;6.46GM/1000ML PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.4 XX + GAMBRO RENAL PRODS 4GM/1000ML;0.314GM/1000ML;3.09GM/1000ML ;6.46GM/1000ML PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; XX + GAMBRO RENAL PRODS 3.05GM/1000ML;0.314GM/1000ML;3.09GM/100 0ML;6.46GM/1000ML PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44 XX + GAMBRO RENAL PRODS GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46 GM/1000ML PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2 XX + GAMBRO RENAL PRODS .03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6 .46GM/1000ML
N021703
010
Oct 10, 2008
N021703
011
Oct 10, 2008
N021703
013
Oct 10, 2008
N021703
006
Oct 25, 2006
N021703
002
Oct 25, 2006
N021703
003
Oct 25, 2006
N021703
015
Oct 10, 2008
N021703
004
Oct 25, 2006
N021703
014
Oct 10, 2008
N021703
001
Oct 25, 2006
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION; IRRIGATION
NAVSTEL
XX + ALCON PHARMS LTD
0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/M N022193 L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M L
001
Jul 24, 2008
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER
XX + B BRAUN 37MG/100ML;5GM/100ML;31MG/100ML;120MG/1 N019864 00ML;330MG/100ML;88MG/100ML
001
Jun 10, 1993
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER
35MG/100ML;5GM/100ML;30MG/100ML;74MG/10 N019867 XX + B BRAUN 0ML;640MG/100ML;500MG/100ML;74MG/100ML
001
Dec 20, 1993
3 - 67 (of 428)
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE
PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER
XX + BAXTER HLTHCARE 37MG/100ML;5GM/100ML;30MG/100ML;119MG/1 N017390 00ML;161MG/100ML;94MG/100ML;138MG/100ML
001
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

SOLUTION; INTRAPERITONEAL
DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER
+ B BRAUN 510MG/100ML;30GM/100ML;200MG/100ML;9.4G M/100ML;11GM/100ML + 510MG/100ML;30GM/100ML;200MG/100ML;9.2G M/100ML;9.6GM/100ML DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER + B BRAUN 510MG/100ML;50GM/100ML;200MG/100ML;9.4G M/100ML;11GM/100ML + 510MG/100ML;50GM/100ML;200MG/100ML;9.2G M/100ML;9.6GM/100ML
XX XX
N018807 N018807
003 001
Aug 26, 1983 Aug 26, 1983
XX XX
N018807 N018807
004 002
Aug 26, 1983 Aug 26, 1983
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

SOLUTION; INTRAPERITONEAL DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 N018379 67MG/100ML;392MG/100ML 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 N018883 67MG/100ML;392MG/100ML DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N018883 38MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER FRESENIUS MEDCL 18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N020171 38MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 N018379 67MG/100ML;392MG/100ML 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 N018883 67MG/100ML;392MG/100ML DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N018883 38MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER FRESENIUS MEDCL 18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N020171 38MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;5 N018379 67MG/100ML;392MG/100ML DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; N018379 567MG/100ML;392MG/100ML 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; N018883 567MG/100ML;392MG/100ML DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; N018883 538MG/100ML;448MG/100ML DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER FRESENIUS MEDCL 18.4MG/100ML;4.25GM/100ML;5.08MG/100ML; N020171 538MG/100ML;448MG/100ML DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N018379 38MG/100ML;448MG/100ML DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N018379 38MG/100ML;448MG/100ML
AT AT
002 001 Nov 30, 1984
AT
004
Nov 30, 1984
AT
001
Aug 19, 1992
AT AT
003 002 Nov 30, 1984
AT
005
Nov 30, 1984
AT
002
Aug 19, 1992
AT
007
Jun 24, 1988
AT AT
001 003 Nov 30, 1984
AT
006
Nov 30, 1984
AT
003
Aug 19, 1992
AT
004
Jul 07, 1982
AT
005
Jul 07, 1982
3 - 68 (of 428)

SOLUTION; INTRAPERITONEAL DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; 538MG/100ML;448MG/100ML DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 67MG/100ML;392MG/100ML DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 67MG/100ML;392MG/100ML DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; 567MG/100ML;392MG/100ML DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 67MG/100ML;392MG/100ML DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 67MG/100ML;392MG/100ML DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;5 67MG/100ML;392MG/100ML DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; 567MG/100ML;392MG/100ML DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML 25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER BAXTER HLTHCARE 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; 538MG/100ML;448MG/100ML 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; 538MG/100ML;448MG/100ML INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER FRESENIUS 18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER FRESENIUS 18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER FRESENIUS 18.4MG/100ML;4.25GM/100ML;5.08MG/100ML; 538MG/100ML;448MG/100ML DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER B BRAUN 26MG/100ML;1.5GM/100ML;5MG/100ML;530MG/ 100ML;450MG/100ML DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER B BRAUN 26MG/100ML;2.5GM/100ML;5MG/100ML;530MG/ 100ML;450MG/100ML
AT
N018379
008
Jun 24, 1988
AT
N018379
006
Jul 07, 1982
AT
N017512
001
AT
N017512
003
AT
N017512
002
AT
N020183
001
Dec 04, 1992
AT
N017512
007
Jul 09, 1984
AT
N017512
008
Jul 09, 1984
AT
N017512
010
Nov 18, 1985
AT
N017512
009
Jul 09, 1984
AT AT
N017512 N020163
004 001 Dec 04, 1992
AT AT
N017512 N020163
005 002 Dec 04, 1992
AT
N017512
011
Nov 18, 1985
AT AT
N017512 N020163
006 003 Dec 04, 1992
AT
N020374
001
Jun 13, 1994
AT
N020374
002
Jun 13, 1994
AT
N020374
004
Jun 13, 1994
XX
N018460
007
Jan 29, 1986
XX
N018460
005
Nov 02, 1983
3 - 69 (of 428)

SOLUTION; INTRAPERITONEAL DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER B BRAUN 26MG/100ML;4.25GM/100ML;5MG/100ML;530MG /100ML;450MG/100ML DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER BAXTER HLTHCARE 18.3MG/100ML;4.25GM/100ML;5.08MG/100ML; 538MG/100ML;448MG/100ML INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER FRESENIUS 18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;5 38MG/100ML;448MG/100ML
XX
N018460
009
Jan 29, 1986
XX
N020183
002
Dec 04, 1992
XX
N020183
003
Dec 04, 1992
XX
N020183
004
Dec 04, 1992
XX
N020374
003
Jun 13, 1994
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INTRATHECAL
ELLIOTTS B SOLUTION
XX + QOL MEDCL
0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9 N020577 MG/ML;7.3MG/ML;0.2MG/ML
001
Sep 27, 1996
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER
20MG/100ML;5GM/100ML;30MG/100ML;380MG/1 N018258 XX + B BRAUN 00ML;600MG/100ML
001
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

INJECTABLE; INJECTION DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER HOSPIRA AP 33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N018254 00ML DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER B BRAUN AP 33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N020000 00ML BAXTER HLTHCARE AP 33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N016695 00ML
001
001 001
Apr 17, 1992
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

INJECTABLE; INJECTION DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER HOSPIRA 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 00ML;310MG/100ML DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER B BRAUN 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 00ML;310MG/100ML LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 00ML;310MG/100ML POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN BAXTER HLTHCARE 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ 100ML;310MG/100ML POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN BAXTER HLTHCARE 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ 100ML;310MG/100ML 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ 100ML;310MG/100ML HOSPIRA 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ 100ML;310MG/100ML 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ 100ML;310MG/100ML
AP
N017608
001
AP
N019634
003
Feb 24, 1988
AP
N016679
001
AP
PLASTIC CONTAINER Apr 05, 1985 N019367 006 PLASTIC CONTAINER Apr 05, 1985 N019367 004 N019367 N019685 N019685 005 002 008 Apr 05, 1985 Oct 17, 1988 Oct 17, 1988
AP AP AP AP
3 - 70 (of 428)

INJECTABLE; INJECTION POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ N019367 007 100ML;310MG/100ML POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ N019367 008 100ML;310MG/100ML HOSPIRA Oct 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ N019685 004 100ML;310MG/100ML DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER B BRAUN 10MG/100ML;2.5GM/100ML;15MG/100ML;300MG N019634 001 Feb /100ML;160MG/100ML POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER BAXTER HLTHCARE 20MG/100ML;5GM/100ML;105MG/100ML;600MG/ N019367 002 Apr 100ML;310MG/100ML 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ N019367 003 Apr 100ML;310MG/100ML POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER BAXTER HLTHCARE 20MG/100ML;5GM/100ML;105MG/100ML;600MG/ N019367 001 Apr 100ML;310MG/100ML
AP
05, 1985
AP AP
05, 1985 17, 1988
XX
24, 1988
XX XX
05, 1985 05, 1985
XX
05, 1985
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
TPN ELECTROLYTES IN PLASTIC CONTAINER
XX + HOSPIRA 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML; N018895 16.1MG/ML
001
Jul 20, 1984
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
ISOLYTE E IN PLASTIC CONTAINER
35MG/100ML;30MG/100ML;74MG/100ML;640MG/ N019718 XX + B BRAUN 100ML;500MG/100ML;74MG/100ML SOLUTION; IRRIGATION BALANCED SALT AKORN AT AT B BRAUN BSS + ALCON
001
Sep 29, 1989
0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6 A075503 .4MG/ML;1.7MG/ML 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6 A091387 .4MG/ML;1.7MG/ML 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6 N020742 .4MG/ML;1.7MG/ML
001 001
Sep 27, 2006 Feb 03, 2010
AT
001
Dec 10, 1997
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE
PLASMA-LYTE R IN PLASTIC CONTAINER
36.8MG/100ML;30.5MG/100ML;74.6MG/100ML; N017438 XX + BAXTER HLTHCARE 640MG/100ML;496MG/100ML;89.6MG/100ML
001
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

SOLUTION; PERFUSION, CARDIAC CARDIOPLEGIC IN PLASTIC CONTAINER BAXTER HLTHCARE AT 17.6MG/100ML;325.3MG/100ML;119.3MG/100M A075323 L;643MG/100ML PLEGISOL IN PLASTIC CONTAINER AT + HOSPIRA 17.6MG/100ML;325.3MG/100ML;119.3MG/100M N018608 L;643MG/100ML
001
Apr 21, 2000
001
Feb 26, 1982
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

INJECTABLE; INJECTION RINGER'S IN PLASTIC CONTAINER B BRAUN AP 33MG/100ML;30MG/100ML;860MG/100ML
N020002
001
Apr 17, 1992

INJECTABLE; INJECTION RINGER'S IN PLASTIC CONTAINER BAXTER HLTHCARE AP 33MG/100ML;30MG/100ML;860MG/100ML HOSPIRA AP 33MG/100ML;30MG/100ML;860MG/100ML SOLUTION; IRRIGATION RINGER'S IN PLASTIC CONTAINER B BRAUN AT 33MG/100ML;30MG/100ML;860MG/100ML BAXTER HLTHCARE AT 33MG/100ML;30MG/100ML;860MG/100ML HOSPIRA AT 33MG/100ML;30MG/100ML;860MG/100ML
3 - 71 (of 428)
N016693 N018251
001 001
N018156 N018495 N017635
001 001 001
Feb 19, 1982
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

INJECTABLE; INJECTION LACTATED RINGER'S IN PLASTIC CONTAINER B BRAUN AP 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML BAXTER HLTHCARE AP 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML HOSPIRA AP 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML SOLUTION; IRRIGATION LACTATED RINGER'S IN PLASTIC CONTAINER AT + B BRAUN 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML BAXTER HLTHCARE AT 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML AT + 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML AT + 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML AT + HOSPIRA 20MG/100ML;30MG/100ML;600MG/100ML;310MG /100ML
N019632 N016682 N017641
001 001 001
Feb 29, 1988
N018681 N018494 N018921 N019933 N019416
001 001 001 001 001
Dec 27, 1982 Feb 19, 1982 Apr 03, 1984 Aug 29, 1989 Jan 17, 1986
CALFACTANT
SUSPENSION; INTRATRACHEAL
INFASURF PRESERVATIVE FREE
XX + ONY 35MG/ML
N020521
001
Jul 01, 1998
CANDESARTAN CILEXETIL
TABLET; ORAL ATACAND ASTRAZENECA XX XX XX XX +
4MG 8MG 16MG 32MG
N020838 N020838 N020838 N020838
001 002 003 004
Jun Jun Jun Jun
04, 04, 04, 04,
1998 1998 1998 1998
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE

TABLET; ORAL ATACAND HCT ASTRAZENECA AB 16MG;12.5MG AB 32MG;12.5MG AB + 32MG;25MG CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE APOTEX INC AB 16MG;12.5MG AB 32MG;12.5MG MYLAN LABS AB 16MG;12.5MG AB 32MG;12.5MG AB 32MG;25MG
N021093 N021093 N021093 A202884 A202884 A090704 A090704 A090704
001 002 003 001 002 001 002 003
Sep 05, 2000 Sep 05, 2000 May 16, 2008 Dec Dec Dec Dec Dec 04, 04, 04, 04, 04, 2012 2012 2012 2012 2012
CAPECITABINE
TABLET; ORAL XELODA XX HOFFMANN LA ROCHE
150MG
N020896
001
Apr 30, 1998

CAPECITABINE
TABLET; ORAL
XELODA
XX + HOFFMANN LA ROCHE
3 - 72 (of 428)
500MG
N020896
002
Apr 30, 1998
CAPREOMYCIN SULFATE
CAPASTAT SULFATE
XX + AKORN
EQ 1GM BASE/VIAL
N050095
001
CAPSAICIN
PATCH; TOPICAL
QUTENZA
XX + NEUROGESX
8%
N022395
001
Nov 16, 2009
CAPTOPRIL
TABLET; ORAL CAPOTEN PAR PHARM AB AB AB AB + CAPTOPRIL APOTEX AB AB AB AB MYLAN AB AB AB AB PRINSTON INC AB AB AB AB SANDOZ AB AB AB AB STASON AB AB AB AB TEVA AB AB AB AB AB AB AB AB WATSON LABS AB AB AB AB AB AB AB AB WEST WARD AB AB
12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 12.5MG 25MG 25MG 50MG 50MG 100MG 100MG 12.5MG 12.5MG 25MG 25MG 50MG 50MG 100MG 100MG 12.5MG 25MG
N018343 N018343 N018343 N018343 A074737 A074737 A074737 A074737 A074434 A074434 A074434 A074434 A074477 A074477 A074477 A074477 A074363 A074363 A074363 A074363 A074677 A074677 A074677 A074677 A074322 A074483 A074322 A074483 A074322 A074483 A074322 A074483 A074386 A074451 A074386 A074451 A074386 A074451 A074386 A074451 A074505 A074505
005 002 001 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 004 002 001 003 001 001 002 002 003 003 004 004 001 001 002 002 003 003 004 004 001 002
Jan 17, 1985
Oct Oct Oct Oct Feb Feb Feb Feb Feb Feb Feb Feb Nov Nov Nov Nov May May May May Feb Feb Feb Feb Feb Feb Feb Feb May Feb May Feb May Feb May Feb Feb Feb
28, 28, 28, 28, 13, 13, 13, 13, 13, 13, 13, 13, 09, 09, 09, 09, 30, 30, 30, 30, 13, 13, 13, 13, 13, 13, 13, 13, 23, 13, 23, 13, 23, 13, 23, 13, 13, 13,
1998 1998 1998 1998 1996 1996 1996 1996 1996 1996 1996 1996 1995 1995 1995 1995 1997 1997 1997 1997 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996

CAPTOPRIL
TABLET; ORAL CAPTOPRIL WEST WARD AB AB WOCKHARDT AB AB AB AB
3 - 73 (of 428)
50MG 100MG 12.5MG 25MG 50MG 100MG
A074505 A074505 A074532 A074532 A074532 A074532
003 004 001 002 003 004
Feb Feb Mar Mar Mar Mar
13, 13, 28, 28, 28, 28,
1996 1996 1997 1997 1997 1997
CAPTOPRIL; HYDROCHLOROTHIAZIDE
TABLET; ORAL CAPOZIDE 25/15 APOTHECON 25MG;15MG CAPOZIDE 25/25 + APOTHECON 25MG;25MG CAPOZIDE 50/15 + APOTHECON 50MG;15MG CAPOZIDE 50/25 APOTHECON 50MG;25MG CAPTOPRIL AND HYDROCHLOROTHIAZIDE MYLAN 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG TEVA 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG
N018709 N018709 N018709 N018709 A074896 A074896 A074896 A074896 A074827 A074827 A074827 A074827
001 002 004 003 001 002 004 003 001 002 004 003
Oct 12, 1984 Oct 12, 1984 Oct 12, 1984 Oct 12, 1984 Dec Dec Dec Dec Dec Dec Dec Dec 29, 29, 29, 29, 29, 29, 29, 29, 1997 1997 1997 1997 1997 1997 1997 1997
CARBACHOL
SOLUTION; INTRAOCULAR
MIOSTAT
XX + ALCON
0.01%
N016968
001
CARBAMAZEPINE
CAPSULE, EXTENDED RELEASE; ORAL CARBAMAZEPINE APOTEX INC AB 100MG AB 200MG AB 300MG NOSTRUM AB 100MG AB 200MG AB 300MG TEVA PHARMS AB 100MG AB 200MG AB 300MG CARBATROL SHIRE AB 100MG AB 200MG AB + 300MG EQUETRO VALIDUS PHARMS INC 100MG XX 200MG XX 300MG XX + SUSPENSION; ORAL CARBAMAZEPINE WOCKHARDT AB TEGRETOL AB + NOVARTIS
A078986 A078986 A078986 A076697 A076697 A076697 A078592 A078592 A078592 N020712 N020712 N020712 N021710 N021710 N021710
001 002 003 001 002 003 001 002 003 003 001 002 001 002 003
Nov Nov Nov May May May Sep Sep Sep
25, 25, 25, 20, 20, 20, 20, 20, 20,
2011 2011 2011 2011 2011 2011 2012 2012 2012
Sep 30, 1997 Sep 30, 1997 Sep 30, 1997 Dec 10, 2004 Dec 10, 2004 Dec 10, 2004
100MG/5ML 100MG/5ML
A075714 N018927
001 001
Jun 05, 2002 Dec 18, 1987

CARBAMAZEPINE
SUSPENSION; ORAL TERIL TARO TABLET; ORAL CARBAMAZEPINE APOTEX INC TARO TORRENT PHARMS EPITOL TEVA TEGRETOL + NOVARTIS CARBAMAZEPINE TORRENT PHARMS
3 - 74 (of 428)
AB
100MG/5ML
A076729
001
Sep 20, 2004
AB AB AB AB AB XX XX XX
A075948 A074649 A077272 A070541 N016608 A077272 A077272 A077272
001 001 002 001 001 001 003 004
Feb 27, 2002 Oct 03, 1996 Dec 07, 2005 Sep 17, 1986
Dec 07, 2005 Dec 07, 2005 Dec 07, 2005
AB AB AB AB XX
AB AB AB AB AB AB
TABLET, CHEWABLE; ORAL CARBAMAZEPINE TARO PHARM INDS TORRENT PHARMS EPITOL TEVA TEGRETOL + NOVARTIS CARBAMAZEPINE + TARO PHARM INDS TABLET, EXTENDED RELEASE; CARBAMAZEPINE TARO
100MG 100MG 100MG 100MG 200MG ORAL 100MG 200MG 400MG 100MG 200MG 400MG
A075687 A075712 A073524 N018281 A075687
001 001 001 001 002
Oct 24, 2000 Jul 05, 2001 Jul 29, 1992
Jul 29, 2002
A078115 A078115 A078115 N020234 N020234 N020234
001 002 003 001 002 003
Mar 31, 2009 Mar 31, 2009 Mar 31, 2009 Mar 25, 1996 Mar 25, 1996 Mar 25, 1996
TEGRETOL-XR NOVARTIS +
CARBIDOPA
TABLET; ORAL
LODOSYN
XX + ATON
25MG
N017830
001
CARBIDOPA; ENTACAPONE; LEVODOPA

TABLET; ORAL CARBIDOPA, LEVODOPA AND ENTACAPONE SUN PHARMA GLOBAL AB 25MG;200MG;100MG AB 37.5MG;200MG;150MG WOCKHARDT LTD AB 12.5MG;200MG;50MG AB 18.75MG;200MG;75MG AB 25MG;200MG;100MG AB 31.25MG;200MG;125MG AB 37.5MG;200MG;150MG AB 50MG;200MG;200MG STALEVO 100 ORION PHARMA AB 25MG;200MG;100MG STALEVO 125 ORION PHARMA AB 31.25MG;200MG;125MG STALEVO 150 ORION PHARMA AB 37.5MG;200MG;150MG STALEVO 200 AB + ORION PHARMA 50MG;200MG;200MG
A079085 A079085 A090786 A090833 A090833 A090833 A090833 A090833 N021485 N021485 N021485 N021485
001 002 001 001 002 003 004 005 002 006 003 004
May May Nov Nov Nov Nov Nov Nov
10, 10, 20, 20, 20, 20, 20, 20,
2012 2012 2012 2012 2012 2012 2012 2012
Jun 11, 2003 Aug 29, 2008 Jun 11, 2003 Aug 02, 2007

CARBIDOPA; ENTACAPONE; LEVODOPA
TABLET; ORAL STALEVO 50 AB + ORION PHARMA STALEVO 75 ORION PHARMA AB
3 - 75 (of 428)
12.5MG;200MG;50MG 18.75MG;200MG;75MG
N021485 N021485
001 005
Jun 11, 2003 Aug 29, 2008
CARBIDOPA; LEVODOPA
TABLET; ORAL CARBIDOPA AND LEVODOPA ACTAVIS ELIZABETH 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB APOTEX INC 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB MYLAN 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB SUN PHARM INDS 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB TEVA 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB SINEMET MERCK SHARP DOHME AB 10MG;100MG AB 25MG;100MG AB + 25MG;250MG TABLET, EXTENDED RELEASE; ORAL CARBIDOPA AND LEVODOPA APOTEX 25MG;100MG AB 50MG;200MG AB IMPAX LABS 25MG;100MG AB 50MG;200MG AB MYLAN 25MG;100MG AB 50MG;200MG AB SUN PHARM INDS 25MG;100MG AB 50MG;200MG AB SINEMET CR MERCK SHARP DOHME AB 25MG;100MG AB + 50MG;200MG TABLET, ORALLY DISINTEGRATING; ORAL CARBIDOPA AND LEVODOPA IMPAX LABS 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB MYLAN 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB SUN PHARM INDS 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB PARCOPA UCB INC 10MG;100MG AB 25MG;100MG AB 25MG;250MG AB +
001 002 003 001 002 003 001 002 003 001 002 003 001 001 001 001 003 002
Sep Sep Sep Jun Jun Jun Sep Sep Sep Oct Oct Oct Aug Aug Aug
03, 03, 03, 02, 02, 02, 28, 28, 28, 28, 28, 28, 28, 28, 28,
1993 1993 1993 2008 2008 2008 2009 2009 2009 2008 2008 2008 1992 1992 1992
A076212 A076212 A076521 A076521 A075091 A075091 A077828 A077828 N019856 N019856
001 002 001 002 002 001 001 002 002 001
Jun Jun May May Apr Sep Aug Aug
16, 16, 14, 14, 21, 30, 23, 23,
2004 2004 2004 2004 2000 1999 2007 2007
Dec 24, 1992 May 30, 1991
A090631 A090631 A090631 A078893 A078893 A078893 A078690 A078690 A078690 A076699 A076699 A076699
001 002 003 001 002 003 001 002 003 001 002 003
Jun Jun Jun Sep Sep Sep Jul Jul Jul
08, 08, 08, 18, 18, 18, 31, 31, 31,
2010 2010 2010 2008 2008 2008 2009 2009 2009
Aug 27, 2004 Aug 27, 2004 Aug 27, 2004

CARBINOXAMINE MALEATE
SOLUTION; ORAL CARBINOXAMINE MALEATE BOCA PHARMA AA CYPRESS PHARM AA AA + MIKART TABLET; ORAL CARBINOXAMINE MALEATE BOCA PHARMA AA CYPRESS PHARM AA INVAGEN PHARMS AA LYNROSE LABS AA AA + MIKART
3 - 76 (of 428)
A040814 A090418 A040458
001 001 001
Feb 26, 2008 May 04, 2010 Apr 25, 2003
4MG 4MG 4MG 4MG 4MG
A040639 A090417 A090435 A090756 A040442
002 001 001 001 001
May Aug Apr May Mar
30, 23, 15, 27, 19,
2008 2010 2010 2011 2003
CARBOPLATIN
INJECTABLE; INJECTION CARBOPLATIN BEDFORD AP AP AP CIPLA LTD AP AP AP FRESENIUS KABI USA AP AP AP ONCO THERAPIES LTD AP AP AP PLIVA AP AP AP SANDOZ AP AP AP AP + WATSON LABS AP + AP + INJECTABLE; IV (INFUSION) CARBOPLATIN ACTAVIS TOTOWA AP AP AP AP AKORN AP AP AP AP BEDFORD LABS AP AP AP AP BIONICHE PHARMA USA AP AP AP CIPLA LTD AP AP AP AP EBEWE PHARMA AP AP
50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Oct Oct Oct Jan Jan Jan Oct Oct Oct May May May Nov Nov Nov Mar Mar Mar Oct Oct Oct
14, 14, 14, 27, 27, 27, 14, 14, 14, 29, 29, 29, 16, 16, 16, 18, 18, 18, 14, 14, 14,
2004 2004 2004 2006 2006 2006 2004 2004 2004 2012 2012 2012 2004 2004 2004 2005 2005 2005 2004 2004 2004
50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) 600MG/60ML (10MG/ML) 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) 600MG/60ML (10MG/ML) 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) 600MG/60ML (10MG/ML) 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) 600MG/60ML (10MG/ML) 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML)
001 002 003 004 001 002 003 002 001 002 003 004 001 002 003 001 002 003 004 001 002
Feb Feb Feb Feb Jul Jul Jul Jul Oct Oct Oct Jan Apr Apr Apr Jan Jan Jan Jan May May
06, 06, 06, 06, 29, 29, 29, 28, 15, 15, 15, 20, 24, 24, 24, 18, 18, 18, 18, 08, 08,
2012 2012 2012 2012 2009 2009 2009 2010 2004 2004 2004 2006 2007 2007 2007 2007 2007 2007 2007 2008 2008

CARBOPLATIN
INJECTABLE; IV (INFUSION) CARBOPLATIN EBEWE PHARMA AP 450MG/45ML (10MG/ML) FRESENIUS KABI ONCOL 150MG/15ML (10MG/ML) AP AP 50MG/5ML (10MG/ML) AP 450MG/45ML (10MG/ML) FRESENIUS KABI USA AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 600MG/60ML (10MG/ML) HOSPIRA AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 600MG/60ML (10MG/ML) ONCO THERAPIES LTD AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 600MG/60ML (10MG/ML) AP + PHARMACHEMIE 50MG/5ML (10MG/ML) AP + 150MG/15ML (10MG/ML) AP + 450MG/45ML (10MG/ML) AP + 600MG/60ML (10MG/ML) PHARMACHEMIE BV AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) PLIVA LACHEMA AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 600MG/60ML (10MG/ML) SUN PHARMA GLOBAL AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP + TEVA PARENTERAL 50MG/5ML (10MG/ML) AP + 150MG/15ML (10MG/ML) AP + 450MG/45ML (10MG/ML) AP + 600MG/60ML (10MG/ML) CARBOPLATIN 1GM/100ML (10MG/ML) XX + ONCO THERAPIES LTD
3 - 77 (of 428)
A078280 A077432 A077432 A077432 A077266 A077266 A077247 A077266 A077266 A076517 A076517 A076517 A077059 A091063 A091063 A091063 A091063 A077269 A077269 A077269 A077269 A077679 A077679 A077679 A078631 A078631 A078631 A078631 A077926 A077926 A077926 A077139 A077139 A077139 A077139 A091478
003 002 001 003 001 002 003 003 004 001 002 003 001 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 001 002 003 004 001
May Sep Sep Sep Feb Feb Oct Feb Feb Oct Oct Oct Nov Nov Nov Nov Nov Oct Oct Oct Dec Feb Feb Feb Dec Dec Dec Dec Sep Sep Sep Sep Sep Sep Sep
08, 29, 29, 29, 15, 15, 21, 15, 15, 14, 14, 14, 23, 09, 09, 09, 09, 14, 14, 14, 28, 25, 25, 25, 02, 02, 02, 02, 19, 19, 19, 21, 21, 21, 21,
2008 2006 2006 2006 2006 2006 2004 2006 2006 2004 2004 2004 2004 2011 2011 2011 2011 2004 2004 2004 2007 2009 2009 2009 2008 2008 2008 2008 2008 2008 2008 2005 2005 2005 2005
Nov 23, 2011
CARBOPROST TROMETHAMINE
HEMABATE
XX + PHARMACIA AND UPJOHN
EQ 0.25MG BASE/ML
N017989
001
CARFILZOMIB
POWDER; INTRAVENOUS
KYPROLIS
XX + ONYX PHARMS
60MG/VIAL
N202714
001
Jul 20, 2012
CARGLUMIC ACID
TABLET; ORAL
CARBAGLU
XX + ORPHAN EUROPE
200MG
N022562
001
Mar 18, 2010
CARISOPRODOL
TABLET; ORAL CARISOPRODOL ADVENT PHARMS AA AUROBINDO PHARMA AA
350MG 350MG
A040576 A040792
001 001
Jun 07, 2005 Aug 06, 2009

CARISOPRODOL
TABLET; ORAL CARISOPRODOL COREPHARMA MIRROR PHARMS MUTUAL PHARM PROSAM LABS SUN PHARM INDS LTD VINTAGE PHARMS WATSON LABS WEST WARD SOMA MEDA PHARMS SOMA + MEDA PHARMS
3 - 78 (of 428)
AA AA AA AA AA AA AA AA AA XX
A040397 A040823 A089346 A040188 A040755 A040245 A087499 A040124 N011792 N011792
001 001 001 001 001 001 001 001 001 004
Sep Oct Oct Mar Feb Sep Apr Jan
21, 22, 17, 07, 27, 08, 20, 24,
2000 2008 1991 1997 2007 1997 1982 1996
Sep 13, 2007
CARMUSTINE
IMPLANT; INTRACRANIAL
GLIADEL
XX + ARBOR PHARMS INC INJECTABLE; INJECTION
BICNU
XX + BRISTOL
7.7MG
N020637
001
Sep 23, 1996
100MG/VIAL
N017422
001
CARTEOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC CARTEOLOL HYDROCHLORIDE ALCON 1% BAUSCH AND LOMB 1% NOVEX 1% OCUPRESS + NOVARTIS 1%
AT AT AT AT
A075476 A075546 A076097 N019972
001 001 001 001
Jan 03, 2000 Jan 20, 2000 Feb 06, 2002 May 23, 1990
CARVEDILOL
TABLET; ORAL CARVEDILOL APOTEX INC AB AB AB AB AUROBINDO PHARMA AB AB AB AB BEXIMCO USA AB AB AB AB CARACO AB AB AB AB DR REDDYS LABS LTD AB AB AB AB GLENMARK GENERICS AB AB AB AB HIKMA AB
3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG
A078165 A078165 A078165 A078165 A078332 A078332 A078332 A078332 A078384 A078384 A078384 A078384 A077346 A077346 A077346 A077346 A076649 A076649 A076649 A076649 A078251 A078251 A078251 A078251 A077887
001 002 003 004 001 002 003 004 001 002 003 004 004 001 002 003 001 002 003 004 001 002 003 004 001
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 07,
2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007

CARVEDILOL
TABLET; ORAL CARVEDILOL HIKMA AB AB AB LUPIN AB AB AB AB MYLAN AB AB AB AB PLIVA HRVATSKA DOO AB AB AB AB RANBAXY AB AB AB AB SANDOZ AB AB AB AB TARO AB AB AB AB TEVA AB AB AB AB WATSON LABS AB AB AB AB WOCKHARDT AB AB AB AB ZYDUS PHARMS USA INC AB AB AB AB COREG SMITHKLINE BEECHAM AB AB AB + AB
3 - 79 (of 428)
6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG
A077887 A077887 A077887 A078217 A078217 A078217 A078217 A077316 A077316 A077316 A077316 A078240 A078240 A078240 A078240 A076989 A076989 A076989 A076989 A078227 A078227 A078227 A078227 A077780 A077780 A077780 A077780 A076373 A076373 A076373 A076373 A077474 A077474 A077474 A077474 A078786 A078786 A078786 A078786 A077614 A077614 A077614 A077614 N020297 N020297 N020297 N020297
002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 004 001 002 003 004 003 002 001
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Dec Dec Dec Dec Sep Sep Sep Sep May Sep Sep Sep
07, 07, 07, 05, 05, 05, 05, 05, 05, 05, 05, 30, 30, 30, 30, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 22, 22, 22, 22, 05, 05, 05, 05, 29, 14, 14, 14,
2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2009 2009 2009 2009 2007 2007 2007 2007 1997 1995 1995 1995
CARVEDILOL PHOSPHATE
CAPSULE, EXTENDED RELEASE; ORAL COREG CR XX SB PHARMCO 10MG XX 20MG XX + 40MG XX 80MG
N022012 N022012 N022012 N022012
001 002 003 004
Oct Oct Oct Oct
20, 20, 20, 20,
2006 2006 2006 2006

CASPOFUNGIN ACETATE
CANCIDAS
XX + MERCK 50MG/VIAL XX + 70MG/VIAL
3 - 80 (of 428)
N021227 N021227
001 002
Jan 26, 2001 Jan 26, 2001
CEFACLOR
CAPSULE; ORAL CEFACLOR HIKMA AB AB + YUNG SHIN PHARM AB AB FOR SUSPENSION; ORAL CEFACLOR YUNG SHIN PHARM AB AB AB AB TABLET, EXTENDED RELEASE; CEFACLOR TEVA XX XX +
EQ EQ EQ EQ
250MG 500MG 250MG 500MG
BASE BASE BASE BASE
A065350 A065350 A065146 A065146
001 002 001 002
Apr Apr Jan Jan
03, 03, 22, 22,
2007 2007 2004 2004
EQ 125MG EQ 187MG EQ 250MG EQ 375MG ORAL
A065412 A065412 A065412 A065412
001 002 003 004
Feb Feb Feb Feb
17, 17, 17, 17,
2012 2012 2012 2012
A065058 A065058
001 002
Sep 04, 2002 Sep 04, 2002
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL CEFADROXIL AUROBINDO PHARMA HIKMA LUPIN ORCHID HLTHCARE SANDOZ + TEVA PHARMS
AB AB AB AB AB AB
EQ EQ EQ EQ EQ EQ
500MG 500MG 500MG 500MG 500MG 500MG
BASE BASE BASE BASE BASE BASE
A065352 A065311 A065392 A065309 A062291 A065282
001 001 001 001 001 001
Jan Feb May Sep
25, 07, 29, 18,
2007 2006 2007 2006
Jan 20, 2006
FOR SUSPENSION; ORAL CEFADROXIL HIKMA PHARMS AB AB LUPIN AB AB + ORCHID HLTHCARE AB AB RANBAXY AB AB TEVA PHARMS AB AB CEFADROXIL RANBAXY XX TABLET; ORAL CEFADROXIL HIKMA AB ORCHID HLTHCARE AB CEFADROXIL XX + TEVA PHARMS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A091036 A091036 A065396 A065396 A065307 A065307 A065115 A065115 A065278 A065278 A065115
001 002 001 002 002 003 002 003 001 002 001
Nov Nov Feb Feb Oct Oct Mar Mar Jan Jan
28, 28, 21, 21, 16, 16, 26, 26, 20, 20,
2012 2012 2008 2008 2006 2006 2003 2003 2006 2006
EQ 125MG BASE/5ML
Mar 26, 2003
EQ 1GM BASE EQ 1GM BASE EQ 1GM BASE
A065260 A065301 A062774
001 001 001
Mar 30, 2006 Sep 18, 2006 Apr 08, 1987
CEFAZOLIN SODIUM
INJECTABLE; INJECTION CEFAZOLIN SODIUM ACS DOBFAR AP AP AP AUROBINDO PHARMA AP
EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL
A065303 A065303 A065306 A065395
001 002 001 001
Oct Oct Oct Aug
22, 22, 22, 08,
2008 2008 2008 2008

CEFAZOLIN SODIUM
INJECTABLE; INJECTION CEFAZOLIN SODIUM AUROBINDO PHARMA AP EQ HIKMA FARMACEUTICA AP EQ AP EQ AP EQ HOSPIRA INC AP EQ AP EQ AP EQ AP EQ SANDOZ AP EQ AP EQ AP EQ AP EQ STERI PHARMA AP EQ AP EQ AP EQ AP EQ AP EQ AP EQ KEFZOL ACS DOBFAR AP EQ AP EQ AP EQ ANCEF IN PLASTIC CONTAINER EQ XX + BAXTER HLTHCARE EQ XX + CEFAZOLIN AND DEXTROSE EQ XX + B BRAUN EQ XX CEFAZOLIN SODIUM EQ XX + SAMSON MEDCL EQ XX +
3 - 81 (of 428)
1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 10MG BASE/ML 20MG BASE/ML 1GM BASE/VIAL 2GM BASE/VIAL 100GM BASE/VIAL 300GM BASE/VIAL
A065395 A065047 A065047 A065143 A065226 A065226 A065244 A065247 A062831 A062831 A065345 A062831 A063214 A063216 A063207 A063208 A063209 A063209 A061773 A061773 A061773 A063002 A063002 N050779 N050779 A065141 A065141
002 001 002 001 001 002 001 001 001 002 001 003 001 001 001 001 001 002 002 003 004 001 002 002 003 001 002
Aug Sep Sep Oct Apr Apr Aug Aug Dec Dec May Sep Dec Dec Dec Dec Dec Apr
08, 18, 18, 18, 21, 21, 12, 12, 09, 09, 09, 25, 27, 27, 27, 27, 27, 30,
2008 2001 2001 2004 2005 2005 2005 2005 1988 1988 2007 1992 1991 1991 1991 1991 1991 1999
Mar 28, 1991 Mar 28, 1991 Jul 27, 2000 Jan 13, 2012 Nov 29, 2006 Nov 29, 2006
CEFDINIR
CAPSULE; ORAL CEFDINIR AUROBINDO PHARMA LUPIN ORCHID HLTHCARE + SANDOZ TEVA PHARMS
AB AB AB AB AB
300MG 300MG 300MG 300MG 300MG
A065434 A065264 A065418 A065330 A065368
001 001 001 001 001
Jan May Jul Apr May
07, 19, 18, 06, 09,
2008 2006 2007 2007 2007
FOR SUSPENSION; ORAL CEFDINIR AUROBINDO PHARMA AB AB LUPIN AB AB ORCHID HLTHCARE AB AB SANDOZ AB AB + TEVA PHARMS AB AB
125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML
A065473 A065473 A065259 A065259 A065429 A065429 A065337 A065337 A065332 A065332
001 002 001 002 001 002 001 002 001 002
Dec Dec May May Jul Jul Apr Apr May May
14, 14, 31, 07, 18, 18, 06, 06, 04, 04,
2007 2007 2006 2007 2007 2007 2007 2007 2007 2007
CEFDITOREN PIVOXIL
TABLET; ORAL SPECTRACEF XX VANSEN PHARMA XX +
200MG 400MG
N021222 N021222
001 002
Aug 29, 2001 Jul 21, 2008

CEFEPIME HYDROCHLORIDE
INJECTABLE; INJECTION CEFEPIME HYDROCHLORIDE ACS DOBFAR AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL HOSPIRA INC AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 2GM BASE/VIAL SANDOZ AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL MAXIPIME AP + HOSPIRA INC EQ 500MG BASE/VIAL AP + EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER B BRAUN EQ 1GM BASE/VIAL XX EQ 2GM BASE/VIAL XX CEFEPIME IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) XX + BAXTER HLTHCARE EQ 2GM BASE/100ML (EQ 20MG BASE/ML) XX +
3 - 82 (of 428)
A065441 A065441 A065369 A065369 A202268 A065369 A202268 A090291 A090291 A090291 N050679 N050679 N050679 N050821 N050821 N050817 N050817
001 002 001 002 001 003 002 001 002 003 001 002 003 001 002 001 002
Mar Mar Jun Jun Jul Jun Jul Dec Dec Dec
20, 20, 18, 18, 30, 18, 30, 21, 21, 21,
2008 2008 2007 2007 2012 2007 2012 2010 2010 2010
Jan 18, 1996 Jan 18, 1996 Jan 18, 1996 May 06, 2010 May 06, 2010 Aug 05, 2008 Aug 05, 2008
CEFIXIME
CAPSULE; ORAL
SUPRAX
XX + LUPIN LTD SUSPENSION; ORAL SUPRAX LUPIN PHARMS XX XX + TABLET; ORAL
SUPRAX
XX + LUPIN PHARMS TABLET, CHEWABLE; ORAL SUPRAX XX LUPIN LTD XX XX +
400MG
N203195
001
Jun 01, 2012
100MG/5ML 200MG/5ML
A065129 A065355
001 001
Feb 23, 2004 Apr 10, 2007
400MG
A065130
001
Feb 12, 2004
100MG 150MG 200MG
A065380 A065380 A065380
001 002 003
Oct 25, 2010 Oct 25, 2010 Oct 25, 2010
CEFOTAXIME SODIUM
INJECTABLE; INJECTION CEFOTAXIME HIKMA AP AP AP AP WOCKHARDT AP CEFOTAXIME SODIUM AUROBINDO PHARMA AP AP AP AP HOSPIRA INC AP AP AP AP AP AP LUPIN AP
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL
A065072 A065072 A065072 A065071 A065197 A065517 A065517 A065517 A065516 A065290 A065290 A065293 A065290 A065293 A065292 A065124
001 002 003 001 001 001 002 003 001 001 002 001 003 002 001 001
Nov Nov Nov Nov Aug Nov Nov Nov Nov Aug Aug Aug Aug Aug Aug Sep
20, 20, 20, 20, 29, 06, 06, 06, 06, 11, 11, 10, 11, 10, 10, 24,
2002 2002 2002 2002 2006 2009 2009 2009 2009 2006 2006 2006 2006 2006 2006 2003

CEFOTAXIME SODIUM
INJECTABLE; INJECTION CEFOTAXIME SODIUM LUPIN AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL WOCKHARDT AP EQ 500MG BASE/VIAL AP EQ 2GM BASE/VIAL CLAFORAN AP + SANOFI AVENTIS US EQ 500MG BASE/VIAL AP + EQ 1GM BASE/VIAL AP + EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL AP + EQ 2GM BASE/VIAL AP + EQ 10GM BASE/VIAL CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER EQ 20MG BASE/ML XX + SANOFI AVENTIS US EQ 40MG BASE/ML XX +
3 - 83 (of 428)
A065124 A065124 A065197 A065197 N050547 A062659 N050547 A062659 N050547 N050547 N050596 N050596
002 003 002 003 001 001 002 002 003 004 002 004
Sep Sep Jun Jun
24, 24, 20, 20,
2003 2003 2008 2008
Jan 13, 1987 Jan 13, 1987 Dec 29, 1983 May 20, 1985 May 20, 1985
CEFOTETAN DISODIUM
INJECTABLE; INJECTION CEFOTETAN + FRESENIUS KABI USA + + WEST-WARD PHARM CORP
AP AP AP AP AP AP XX XX
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER + B BRAUN EQ 1GM BASE/VIAL + EQ 2GM BASE/VIAL
A065374 A065374 A065375 A091031 A091031 A091030 A065430 A065430
001 002 001 001 002 001 001 002
Aug Aug Aug Oct Oct Oct
09, 09, 09, 26, 26, 26,
2007 2007 2007 2011 2011 2011
Aug 09, 2007 Aug 09, 2007
CEFOXITIN SODIUM
INJECTABLE; INJECTION CEFOXITIN ACS DOBFAR AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL ANTIBIOTICOS BRASIL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL HIKMA FARMACEUTICA AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL HIKMA MAPLE AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL HOSPIRA INC AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER B BRAUN AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL MEFOXIN IN PLASTIC CONTAINER EQ 20MG BASE/ML XX + BIONICHE PHARMA EQ 40MG BASE/ML XX +
A065414 A065414 A065415 A065467 A065467 A065464 A065238 A065238 A065239 A065051 A065051 A065050 A065313 A065313 A065312 A065214 A065214 A063182 A063182
001 002 001 001 002 001 001 002 001 001 002 001 001 002 001 001 002 001 002
Jun Jun May Aug Aug Aug Mar Mar Mar Sep Sep Sep Jan Jan Feb
12, 12, 19, 31, 31, 31, 12, 12, 02, 11, 11, 11, 23, 23, 13,
2009 2009 2010 2011 2011 2011 2010 2010 2010 2000 2000 2000 2006 2006 2006
Mar 10, 2006 Mar 10, 2006 Jan 25, 1993 Jan 25, 1993
CEFPODOXIME PROXETIL
FOR SUSPENSION; ORAL CEFPODOXIME PROXETIL AUROBINDO PHARMA LTD AB AB
A065409 A065409
001 002
Jun 08, 2007 Jun 08, 2007

FOR SUSPENSION; ORAL CEFPODOXIME PROXETIL RANBAXY AB AB SANDOZ AB AB + TABLET; ORAL CEFPODOXIME PROXETIL AUROBINDO PHARMA AB AB ORCHID HLTHCARE AB AB RANBAXY AB AB SANDOZ AB AB +
3 - 84 (of 428)
EQ EQ EQ EQ
50MG BASE/5ML 100MG BASE/5ML 50MG BASE/5ML 100MG BASE/5ML
A065082 A065082 A090031 A090031
001 002 001 002
May May Jan Jan
31, 31, 14, 14,
2002 2002 2009 2009
BASE BASE BASE BASE BASE BASE BASE BASE
A065370 A065370 A065388 A065388 A065083 A065083 A065462 A065462
001 002 001 002 001 002 001 002
Jun Jun Nov Nov Aug Aug May May
11, 11, 14, 14, 20, 20, 28, 28,
2007 2007 2007 2007 2003 2003 2008 2008
CEFPROZIL
FOR SUSPENSION; ORAL CEFPROZIL APOTEX INC AB AB AUROBINDO PHARMA AB AB LUPIN AB AB + ORCHID HLTHCARE AB AB SANDOZ AB AB TEVA PHARMS AB AB TABLET; ORAL CEFPROZIL APOTEX INC AB AB AUROBINDO PHARMA LTD AB AB LUPIN AB AB + ORCHID HLTHCARE AB AB SANDOZ AB AB TEVA AB AB WOCKHARDT AB AB
125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML
A065351 A065351 A065381 A065381 A065261 A065261 A065284 A065284 A065257 A065257 A065236 A065236
001 002 001 002 001 002 002 001 001 002 001 002
Feb Feb Jan Jan Dec Dec Dec Dec Dec Dec Dec Dec
29, 29, 30, 30, 19, 19, 30, 30, 08, 08, 08, 08,
2012 2012 2007 2007 2005 2005 2005 2005 2005 2005 2005 2005
A065327 A065327 A065340 A065340 A065276 A065276 A065267 A065267 A065235 A065235 A065208 A065208 A065428 A065428
001 002 001 002 001 002 001 002 001 002 001 002 001 002
Mar Mar May May Dec Dec Dec Dec Nov Nov Dec Dec Jun Jun
26, 26, 24, 24, 08, 08, 19, 19, 14, 14, 06, 06, 14, 14,
2008 2008 2007 2007 2005 2005 2005 2005 2005 2005 2005 2005 2007 2007
CEFTAROLINE FOSAMIL
POWDER; IV (INFUSION) TEFLARO XX CEREXA XX +
N200327 N200327
001 002
Oct 29, 2010 Oct 29, 2010
CEFTAZIDIME
INJECTABLE; INJECTION CEFTAZIDIME ACS DOBFAR AP AP
500MG/VIAL 1GM/VIAL
A062640 A062640
001 002
Nov 20, 1985 Nov 20, 1985

CEFTAZIDIME
INJECTABLE; INJECTION CEFTAZIDIME ACS DOBFAR AP AP AUROBINDO PHARMA AP AP AP AP WOCKHARDT AP FORTAZ AP + COVIS PHARMA AP + AP + AP + TAZICEF HOSPIRA AP AP AP AP AP AP CEFTAZIDIME IN DEXTROSE B BRAUN XX XX +
3 - 85 (of 428)
2GM/VIAL 6GM/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 6GM/VIAL 1GM/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 6GM/VIAL 500MG/VIAL 1GM/VIAL 1GM/VIAL 2GM/VIAL 2GM/VIAL 6GM/VIAL CONTAINER EQ 1GM BASE EQ 2GM BASE
A062640 A062640 A065481 A065481 A065481 A065482 A065196 N050578 N050578 N050578 N050578 A062662 A062662 A064032 A062662 A064032 A062662 N050823 N050823
003 004 001 002 003 001 001 001 002 003 004 001 002 001 003 002 004 001 002
Nov Feb May May May May Oct Jul Jul Jul Jul Mar Mar Oct Mar Oct Mar
20, 03, 28, 28, 28, 28, 15, 19, 19, 19, 19, 06, 06, 31, 06, 31, 06,
1985 1992 2010 2010 2010 2010 2008 1985 1985 1985 1985 1986 1986 1993 1986 1993 1986
Jun 13, 2011 Jun 13, 2011
CEFTAZIDIME SODIUM
FORTAZ IN PLASTIC CONTAINER
XX + COVIS PHARMA EQ 20MG BASE/ML XX + EQ 40MG BASE/ML
N050634 N050634
002 003
Apr 28, 1989 Apr 28, 1989
CEFTIBUTEN DIHYDRATE
CAPSULE; ORAL
CEDAX
XX + PERNIX THERAP FOR SUSPENSION; ORAL
CEDAX
XX + PERNIX THERAP
EQ 400MG BASE
N050685
002
Dec 20, 1995
EQ 90MG BASE/5ML
N050686
001
Dec 20, 1995
CEFTRIAXONE SODIUM
INJECTABLE; IM-IV CEFTRIAXONE AKORN INC AP AP AP AP AUROBINDO PHARMA AP AP AP AP BEDFORD AP AP AP AP FRESENIUS KABI USA AP HIKMA FARMACEUTICA AP AP AP AP HOSPIRA INC AP
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL
001 002 003 004 001 002 003 004 001 002 003 004 001 001 002 003 004 001
Jan Jan Jan Jan Jul Jul Jul Jul Aug Aug Aug Aug Feb Jan Jan Jan Jan Aug
11, 11, 11, 11, 31, 31, 31, 31, 18, 18, 18, 18, 15, 10, 10, 10, 10, 02,
2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2006 2008 2008 2008 2008 2005

CEFTRIAXONE SODIUM
INJECTABLE; IM-IV CEFTRIAXONE HOSPIRA INC AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL LUPIN AP EQ 250MG BASE/VIAL AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP + SANDOZ EQ 250MG BASE/VIAL AP + EQ 500MG BASE/VIAL AP + EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL STERI PHARMA AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL TEVA AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL TEVA PHARMS AP EQ 250MG BASE/VIAL AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL WOCKHARDT AP EQ 250MG BASE/VIAL AP EQ 500MG BASE/VIAL AP EQ 2GM BASE/VIAL INJECTABLE; INJECTION CEFTRIAXONE ACS DOBFAR AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL AUROBINDO PHARMA AP EQ 10GM BASE/VIAL BEDFORD AP EQ 10GM BASE/VIAL HOSPIRA INC AP EQ 1GM BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL LUPIN AP EQ 10GM BASE/VIAL AP + SANDOZ EQ 10GM BASE/VIAL AP + SANDOZ INC EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL STERI PHARMA AP EQ 10GM BASE/VIAL STRIDES ARCOLAB LTD AP EQ 10GM BASE/VIAL TEVA AP EQ 10GM BASE/VIAL WOCKHARDT AP EQ 1GM BASE/VIAL CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER AP + B BRAUN EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL ROCEPHIN AP + HOFFMANN LA ROCHE EQ 500MG BASE/VIAL AP + EQ 1GM BASE/VIAL CEFTRIAXONE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/ML XX EQ 40MG BASE/ML XX
3 - 86 (of 428)
002 003 004 001 002 003 004 001 002 003 004 001 002 001 002 001 002 003 004 001 002 003
Aug Aug Aug Sep Sep Sep Sep May May May May Feb Feb Jun Jun Mar Mar Mar Mar Apr Apr Apr
02, 02, 02, 30, 30, 30, 30, 09, 09, 09, 09, 28, 28, 29, 29, 15, 15, 15, 15, 12, 12, 12,
2005 2005 2005 2003 2003 2003 2003 2005 2005 2005 2005 2007 2007 2006 2006 2007 2007 2007 2007 2007 2007 2007
A065329 A065329 A065329 A065328 A065504 A065475 A065231 A202563 A065231 A202563 A065232 A065263 A065168 A065204 A065204 A065269 A091068 A065274 A065180 N050796 N050796 A063239 A063239 A065224 A065224
001 002 003 001 001 001 001 001 002 002 001 001 001 001 002 001 001 001 001 001 002 002 003 001 002
Jul Jul Jul Jul Jul Aug Aug Aug Aug Aug Aug Sep May May May Feb Jan May May
24, 24, 24, 24, 31, 18, 02, 20, 02, 20, 02, 12, 17, 03, 03, 28, 07, 01, 12,
2008 2008 2008 2008 2008 2008 2005 2012 2005 2012 2005 2006 2005 2005 2005 2007 2013 2006 2006
Apr 20, 2005 Apr 20, 2005 Aug 13, 1993 Aug 13, 1993 Aug 23, 2005 Aug 23, 2005
CEFUROXIME AXETIL
FOR SUSPENSION; ORAL CEFTIN GLAXOSMITHKLINE AB AB +
N050672 N050672
001 002
Jun 30, 1994 Apr 29, 1997

CEFUROXIME AXETIL
FOR SUSPENSION; ORAL CEFUROXIME AXETIL RANBAXY AB AB TABLET; ORAL CEFTIN GLAXOSMITHKLINE AB AB AB + CEFUROXIME AXETIL ALKEM LABS LTD AB AB APOTEX AB AB AUROBINDO PHARMA LTD AB AB AB LUPIN AB AB ORCHID HLTHCARE AB AB AB RANBAXY AB AB AB TEVA AB AB WOCKHARDT AB AB AB
3 - 87 (of 428)
A065323 A065323
001 002
Feb 05, 2008 Feb 05, 2008
EQ 125MG BASE EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 125MG 250MG 500MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 250MG 500MG 125MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N050605 N050605 N050605 A065496 A065496 A065069 A065069 A065308 A065308 A065308 A065135 A065135 A065359 A065359 A065359 A065118 A065118 A065118 A065190 A065190 A065166 A065166 A065166
001 002 003 001 002 001 002 001 002 003 001 002 001 002 003 001 002 003 001 002 001 002 003
Dec 28, 1987 Dec 28, 1987 Dec 28, 1987 Jun Jun Oct Oct Mar Mar Mar Jul Jul Feb Feb Feb Apr Apr Apr Oct Oct Jul Jul Jul 07, 07, 02, 02, 29, 29, 29, 25, 25, 15, 15, 15, 25, 25, 25, 18, 18, 29, 29, 29, 2010 2010 2002 2002 2006 2006 2006 2003 2003 2008 2008 2008 2003 2003 2003 2004 2004 2005 2005 2005
CEFUROXIME SODIUM
INJECTABLE; IM-IV CEFUROXIME SODIUM HIKMA FARMACEUTICA STERI PHARMA TEVA PHARMS ZINACEF + COVIS PHARMA CEFUROXIME SODIUM HOSPIRA INC INJECTABLE; INJECTION CEFUROXIME AND DEXTROSE + B BRAUN + CEFUROXIME SODIUM HIKMA FARMACEUTICA HOSPIRA INC
AB AB AB AB AP
EQ 750MG BASE/VIAL EQ 750MG BASE/VIAL EQ 750MG BASE/VIAL EQ 750MG BASE/VIAL EQ 750MG BASE/VIAL IN DUPLEX CONTAINER EQ 750MG BASE/VIAL EQ 1.5GM BASE/VIAL EQ EQ EQ EQ EQ EQ EQ EQ EQ 1.5GM 7.5GM 1.5GM 1.5GM 7.5GM 1.5GM 7.5GM 1.5GM 7.5GM BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
A065048 A064125 A064192 N050558 A065483
001 001 002 002 001
Jan 09, 2004 May 30, 1997 Apr 16, 1998 Oct 19, 1983 Oct 15, 2008
AP AP AP AP AP AP AP AP AP AP AP AP AP XX
N050780 N050780 A065048 A065046 A065483 A065503 A065484 A064125 A064124 A064192 A064191 N050558 N050558 A065251
001 002 002 001 002 001 001 002 001 001 001 003 004 001
Feb 21, 2001 Feb 21, 2001 Jan Jan Oct Oct Oct May May Apr Apr 09, 09, 15, 15, 15, 30, 30, 16, 16, 2004 2004 2008 2008 2008 1997 1997 1998 1998
STERI PHARMA TEVA PHARMS
ZINACEF + COVIS PHARMA EQ 1.5GM BASE/VIAL + EQ 7.5GM BASE/VIAL CEFUROXIME SODIUM IN PLASTIC CONTAINER + SAMSON MEDCL EQ 75GM BASE/VIAL
Oct 19, 1983 Oct 23, 1986 Dec 30, 2009

CEFUROXIME SODIUM
CEFUROXIME SODIUM IN PLASTIC CONTAINER
XX + SAMSON MEDCL EQ 225GM BASE/VIAL ZINACEF IN PLASTIC CONTAINER XX + COVIS PHARMA EQ 15MG BASE/ML XX + EQ 30MG BASE/ML
3 - 88 (of 428)
A065251 N050643 N050643
002 001 002
Dec 30, 2009 Apr 28, 1989 Apr 28, 1989
CELECOXIB
CAPSULE; ORAL CELEBREX XX GD SEARLE XX XX XX +
50MG 100MG 200MG 400MG
N020998 N020998 N020998 N020998
004 001 002 003
Dec Dec Dec Aug
15, 31, 31, 29,
2006 1998 1998 2002
CEPHALEXIN
CAPSULE; ORAL CEPHALEXIN ALKEM AB AB AUROBINDO PHARMA LTD AB AB BELCHER PHARMS AB AB FACTA FARMA AB AB HIKMA AB AB LUPIN AB AB ORCHID HLTHCARE AB AB RANBAXY AB AB STEVENS J AB SUN PHARM INDS (IN) AB AB TEVA AB AB YUNG SHIN PHARM AB AB KEFLEX SHIONOGI INC AB AB KEFLEX XX + SHIONOGI INC FOR SUSPENSION; ORAL CEPHALEXIN FACTA FARMA AB AB + HIKMA PHARMS AB AB LUPIN AB AB ORCHID HLTHCARE AB AB RANBAXY AB AB TEVA AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG 250MG 500MG 250MG 500MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001 002 001 002 001 002 002 003 005
Dec Dec Nov Nov Jul Jul
20, 20, 16, 16, 15, 15,
2010 2010 2005 2005 1988 1988
Jan Jan Nov Nov Jun Jun Sep Sep Mar Jun Jun Feb Feb Feb Feb
24, 24, 25, 25, 28, 28, 16, 16, 17, 11, 11, 13, 13, 24, 24,
2006 2006 2005 2005 2005 2005 1999 1999 1988 1987 1987 1987 1987 2005 2005
May 12, 2006
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062117 A062117 A065444 A065444 A065234 A065234 A065326 A065326 A065081 A065081 A062703 A062703
002 003 001 002 001 002 001 002 001 002 001 002
Aug Aug Aug Aug Jul Jul Jul Jul Feb Feb
28, 28, 17, 17, 10, 10, 27, 27, 13, 13,
2009 2009 2005 2005 2006 2006 2001 2001 1987 1987

CEPHALEXIN
FOR SUSPENSION; ORAL CEPHALEXIN YUNG SHIN PHARM AB AB TABLET; ORAL CEPHALEXIN TEVA XX XX +
3 - 89 (of 428)
A065336 A065336
001 002
Jul 25, 2007 Jul 25, 2007
A063023 A063024
001 001
Jan 12, 1989 Jan 12, 1989
CETIRIZINE HYDROCHLORIDE
SYRUP; ORAL CETIRIZINE HYDROCHLORIDE AMNEAL PHARMS 5MG/5ML APOTEX INC 5MG/5ML AUROBINDO PHARMA 5MG/5ML CYPRESS PHARM 5MG/5ML DR REDDYS LABS LTD 5MG/5ML PERRIGO R AND D 5MG/5ML SILARX 5MG/5ML SUN PHARM INDS INC 5MG/5ML TARO 5MG/5ML TEVA PHARMS 5MG/5ML VINTAGE 5MG/5ML WOCKHARDT 5MG/5ML ZYRTEC + MCNEIL CONSUMER 5MG/5ML
AA AA AA AA AA AA AA AA AA AA AA AA AA
A090766 A078412 A090751 A078488 A078870 A078398 A078876 A090191 A076601 A077279 A078496 A078757 N020346
001 001 001 001 001 001 001 001 001 001 001 001 001
Oct Jun Dec Oct Apr Jun May Nov Jun May Sep Aug
07, 18, 16, 06, 27, 17, 11, 12, 20, 27, 25, 28,
2009 2008 2009 2008 2009 2008 2012 2009 2008 2008 2009 2009
Sep 27, 1996
CETRORELIX
CETROTIDE
XX + EMD SERONO XX +
EQ 0.25MG BASE/ML EQ 3MG BASE/ML
N021197 N021197
001 002
Aug 11, 2000 Aug 11, 2000
CEVIMELINE HYDROCHLORIDE
CAPSULE; ORAL CEVIMELINE APOTEX INC AB EVOXAC AB + DAIICHI SANKYO CO
30MG 30MG
A091260 N020989
001 002
Aug 25, 2011 Jan 11, 2000
CHENODIOL
TABLET; ORAL
CHENODIOL
XX + NEXGEN PHARMA
250MG
A091019
001
Oct 22, 2009
CHLORAMBUCIL
TABLET; ORAL
LEUKERAN
XX + ASPEN GLOBAL INC
2MG
N010669
002
CHLORAMPHENICOL SODIUM SUCCINATE

XX + FRESENIUS KABI USA EQ 1GM BASE/VIAL
A062365
001
Aug 25, 1982
CHLORDIAZEPOXIDE HYDROCHLORIDE
CAPSULE; ORAL CHLORDIAZEPOXIDE HYDROCHLORIDE BARR AB 5MG AB 10MG AB 25MG
A084768 A083116 A084769
001 001 001

CAPSULE; ORAL CHLORDIAZEPOXIDE HYDROCHLORIDE USL PHARMA AB 10MG WATSON LABS AB 5MG AB 10MG AB 25MG LIBRIUM VALEANT PHARM INTL AB 5MG AB 10MG AB + 25MG
3 - 90 (of 428)
A084623 A086383 A086294 A086382 A085461 A085472 A085475
001 001 001 001 001 001 001
CHLORHEXIDINE GLUCONATE
SOLUTION; DENTAL CHLORHEXIDINE GLUCONATE HI TECH PHARMA JOHN O BUTLER CO LYNE NOVEX TEVA WOCKHARDT XTTRIUM PERIDEX + 3M PERIOGARD COLGATE
AT AT AT AT AT AT AT AT AT
0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12%
A074356 A076434 A074291 A075561 A074522 A075006 A077789 N019028 A073695
001 001 001 001 001 001 001 001 001
May Nov Dec Nov Dec Mar Jun
07, 29, 28, 14, 15, 03, 18,
1996 2005 1995 2000 1995 2004 2009
Aug 13, 1986 Jan 14, 1994
TABLET; DENTAL PERIOCHIP XX + DEXCEL PHARMA
2.5MG
N020774
001
May 15, 1998
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION CHLOROPROCAINE HYDROCHLORIDE BEDFORD 2% 3% HOSPIRA 2% 3% NESACAINE FRESENIUS KABI USA 2% NESACAINE-MPF + FRESENIUS KABI USA 2% + 3% NESACAINE + FRESENIUS KABI USA 1%
AP AP AP AP AP AP AP XX
A040273 A040273 A087447 A087446 N009435 N009435 N009435 N009435
001 002 001 001 002 006 007 001
Sep Sep Apr Apr
09, 09, 16, 16,
1998 1998 1982 1982
May 02, 1996 May 02, 1996
CHLOROQUINE PHOSPHATE
TABLET; ORAL ARALEN AA + SANOFI AVENTIS US CHLOROQUINE PHOSPHATE IMPAX LABS AA AA IPCA LABS LTD AA AA NATCO PHARMA LTD AA AA AA + WEST WARD AA
EQ 300MG BASE EQ EQ EQ EQ EQ EQ EQ EQ 150MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG BASE BASE BASE BASE BASE BASE BASE BASE
N006002 A080880 A040516 A090610 A090249 A091621 A090612 A083082 A083082
001 001 001 001 001 001 001 001 002
Aug Dec Dec Jan Jan
29, 03, 03, 21, 21,
2003 2009 2009 2011 2011
Sep 17, 1999

CHLOROTHIAZIDE
SUSPENSION; ORAL DIURIL XX + SALIX PHARMS TABLET; ORAL CHLOROTHIAZIDE AB + MYLAN AB WEST WARD AB AB
3 - 91 (of 428)
250MG/5ML
N011870
001
250MG 500MG 250MG 500MG
A084388 A084217 A086028 A087736
001 001 001 001
Jul 14, 1982 Jul 14, 1982
CHLOROTHIAZIDE SODIUM
INJECTABLE; INJECTION CHLOROTHIAZIDE SODIUM FRESENIUS KABI USA AP SUN PHARMA GLOBAL AP DIURIL AP + LUNDBECK INC
A090896 A091546 N011145
001 001 005
Oct 16, 2009 Jul 26, 2011
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE

SOLUTION; ORAL ZUTRIPRO XX + CYPRESS PHARM
4MG/5ML;5MG/5ML;60MG/5ML
N022439
001
Jun 08, 2011
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX

CAPSULE, EXTENDED RELEASE; ORAL TUSSICAPS XX HI TECH PHARMA CO EQ 4MG MALEATE;EQ 5MG BITARTRATE XX + EQ 8MG MALEATE;EQ 10MG BITARTRATE SUSPENSION, EXTENDED RELEASE; ORAL HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX TRIS PHARMA INC AB EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX CORNERSTONE THERAP AB EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML TUSSIONEX PENNKINETIC AB + UCB INC EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML
A077273 A077273
002 001
Sep 24, 2007 Sep 24, 2007
A091632
001
Oct 01, 2010
A091671
001
Jun 29, 2012
N019111
001
Dec 31, 1987
CHLORPROMAZINE HYDROCHLORIDE
+ HIKMA MAPLE 25MG/ML TABLET; ORAL CHLORPROMAZINE HYDROCHLORIDE SANDOZ 10MG 25MG 50MG + 100MG 200MG USL PHARMA 10MG 25MG 50MG 100MG 200MG
XX
A083329
001
BP BP BP BP BP BP BP BP BP BP
A080439 A080439 A080439 A080439 A080439 A083386 A084112 A084113 A084114 A084115
001 002 003 004 005 001 001 001 001 001
CHLORPROPAMIDE
TABLET; ORAL CHLORPROPAMIDE MYLAN AB AB
100MG 250MG
A088549 A088549
002 001
Jun 01, 1984 Jun 01, 1984

CHLORPROPAMIDE
TABLET; ORAL CHLORPROPAMIDE PLIVA AB AB WATSON LABS AB AB DIABINESE PFIZER AB AB +
3 - 92 (of 428)
100MG 250MG 100MG 250MG 100MG 250MG
A088921 A088922 A088852 A088826 N011641 N011641
001 001 001 001 003 006
Apr Apr Sep Sep
12, 12, 26, 26,
1985 1985 1984 1984
CHLORTHALIDONE
TABLET; ORAL CHLORTHALIDONE MYLAN AB AB + PLIVA AB AB THALITONE XX + MONARCH PHARMS
A086831 A086831 A088902 A088903 N019574
002 001 001 001 001
Sep 19, 1985 Sep 19, 1985 Dec 20, 1988
CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE

TABLET; ORAL CLORPRES MYLAN XX XX XX +
15MG;0.1MG 15MG;0.2MG 15MG;0.3MG
A071325 A071325 A071325
003 002 001
Feb 09, 1987 Feb 09, 1987 Feb 09, 1987
CHLORZOXAZONE
TABLET; ORAL CHLORZOXAZONE BARR AA WATSON LABS AA AA AA PARAFON FORTE DSC AA + JANSSEN R AND D CHLORZOXAZONE MIKART XX XX
500MG 500MG 500MG 500MG 500MG 375MG 750MG
A089895 A040137 A081040 A089859 N011529 A040861 A040861
001 001 001 001 002 001 002
May Aug Aug May
04, 09, 22, 04,
1988 1996 1989 1988
Jun 15, 1987 Jun 01, 2010 Jun 01, 2010
CHOLESTYRAMINE
POWDER; ORAL CHOLESTYRAMINE PAR PHARM AB AB AB + SANDOZ AB CHOLESTYRAMINE LIGHT PAR PHARM AB AB AB + SANDOZ AB PREVALITE UPSHER SMITH AB AB
4GM 4GM 4GM 4GM 4GM 4GM 4GM 4GM
RESIN/SCOOPFUL RESIN/PACKET RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL
A077204 A077204 A074557 A074557 A077203 A077203 A074558 A074558 A073263 A073263
002 001 001 002 001 002 001 002 002 001
Aug Aug Aug Aug Aug Aug Aug Aug
26, 26, 15, 15, 26, 26, 15, 15,
2005 2005 1996 1996 2005 2005 1996 1996
EQ 4GM RESIN/SCOOPFUL EQ 4GM RESIN/PACKET
Oct 30, 1997 Feb 22, 1996
CHOLINE C-11
CHOLINE C-11
XX + MCPRF
4-33.1mCi/ML
N203155
001
Sep 12, 2012

CHOLINE FENOFIBRATE
CAPSULE, DELAYED RELEASE; ORAL TRILIPIX XX ABBVIE EQ 45MG FENOFIBRIC ACID XX + EQ 135MG FENOFIBRIC ACID
3 - 93 (of 428)
N022224 N022224
001 002
Dec 15, 2008 Dec 15, 2008
CHORIOGONADOTROPIN ALFA
OVIDREL
XX + EMD SERONO
EQ 0.25MG /0.5ML
N021149
002
Oct 06, 2003
CHROMIC CHLORIDE
CHROMIC CHLORIDE IN PLASTIC CONTAINER
XX + HOSPIRA EQ 0.004MG CHROMIUM/ML
N018961
001
Jun 26, 1986
CICLESONIDE
AEROSOL, METERED; INHALATION ALVESCO XX TAKEDA GMBH 0.08MG/INH XX + 0.16MG/INH AEROSOL, METERED; NASAL
ZETONNA
XX + TAKEDA GMBH SPRAY, METERED; NASAL
OMNARIS
XX + TAKEDA GMBH
N021658 N021658
002 003
Jan 10, 2008 Jan 10, 2008
0.037MG/INH
N202129
001
Jan 20, 2012
0.05MG/INH
N022004
001
Oct 20, 2006
CICLOPIROX
CREAM; TOPICAL CICLOPIROX FOUGERA PHARMS G AND W LABS INC GLENMARK PHARMS PERRIGO TARO LOPROX + MEDICIS GEL; TOPICAL CICLOPIROX FOUGERA PHARMS GLENMARK GENERICS PADDOCK LLC LOPROX + MEDICIS SHAMPOO; TOPICAL CICLOPIROX FOUGERA PHARMS PERRIGO TARO WATSON LABS INC LOPROX + MEDICIS SOLUTION; TOPICAL CICLOPIROX ACTAVIS MID ATLANTIC APOTEX CORP G AND W LABS HI TECH PHARMA MYLAN PHARMS INC PERRIGO NEW YORK TARO PHARM INDS
AB AB AB AB AB AB
0.77% 0.77% 0.77% 0.77% 0.77% 0.77%
A076435 A078463 A090273 A077364 A076790 N018748
001 001 001 001 001 001
Dec Dec Nov Mar Apr
29, 20, 10, 03, 12,
2004 2010 2009 2006 2005
Dec 30, 1982
AB AB AB AB
0.77% 0.77% 0.77% 0.77%
A077896 A091595 A078266 N020519
001 001 001 001
Jun 10, 2008 Feb 29, 2012 Jan 07, 2009 Jul 21, 1997
AT AT AT AT AT
1% 1% 1% 1% 1%
A090146 A078594 A090269 A090490 N021159
001 001 001 001 001
May Feb Feb Nov
25, 16, 23, 24,
2010 2010 2011 2009
Feb 28, 2003
AT AT AT AT AT AT AT
8% 8% 8% 8% 8% 8% 8%
A078046 A078172 A078233 A078270 A078567 A077623 A078144
001 001 001 001 001 001 001
Sep Sep Sep Sep Sep Sep Sep
18, 18, 18, 18, 18, 18, 18,
2007 2007 2007 2007 2007 2007 2007

CICLOPIROX
SOLUTION; TOPICAL CICLOPIROX TEVA PHARMS TOLMAR VERSAPHARM WATSON LABS PENLAC + SANOFI AVENTIS US SUSPENSION; TOPICAL CICLOPIROX FOUGERA PHARMS PERRIGO NEW YORK TARO LOPROX + MEDICIS
3 - 94 (of 428)
AT AT AT AT AT
8% 8% 8% 8% 8%
A078079 A077687 A078975 A078124 N021022
001 001 001 001 001
Sep Sep Feb Sep
18, 18, 17, 18,
2007 2007 2010 2007
Dec 17, 1999
AB AB AB AB
0.77% 0.77% 0.77% 0.77%
A076422 A077676 A077092 N019824
001 001 001 001
Aug 06, 2004 Dec 15, 2006 Aug 10, 2005 Dec 30, 1988
CIDOFOVIR
INJECTABLE; INJECTION CIDOFOVIR EMCURE PHARMS LTD AP MYLAN LLC AP VISTIDE AP + GILEAD SCIENCES INC
EQ 75MG BASE/ML EQ 75MG BASE/ML EQ 75MG BASE/ML
A202501 A201276 N020638
001 001 001
Jul 26, 2012 Jun 27, 2012 Jun 26, 1996
CILASTATIN SODIUM; IMIPENEM

INJECTABLE; INJECTION IMIPENEM AND CILASTATIN ACS DOBFAR AP EQ AP EQ HOSPIRA INC AP EQ AP EQ AP EQ PRIMAXIN MERCK AP EQ AP + EQ AP EQ AP + EQ AP EQ
BASE/VIAL;250MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;250MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;250MG/VIAL BASE/VIAL;250MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;500MG/VIAL
A090577 A090577 A090825 A090825 A091007 A062756 N050587 A062756 N050587 N050630
001 002 001 002 001 001 001 002 002 001
Dec Dec Nov Nov Nov Jan Nov Jan Nov Dec
21, 21, 16, 16, 16, 08, 26, 08, 26, 14,
2011 2011 2011 2011 2011 1987 1985 1987 1985 1990
CILOSTAZOL
TABLET; ORAL CILOSTAZOL APOTEX INC AB AB BIOKEY AB AB BRECKENRIDGE PHARM AB AB COREPHARMA AB AB MYLAN AB AB MYLAN PHARMS INC AB AB PLIVA HRVATSKA DOO AB AB ROXANE AB AB SANDOZ AB AB
001 002 001 001 001 002 001 001 002 001 001 002 001 002 001 002 001 001
Dec Dec Sep Sep Sep Sep Mar Nov Apr Apr Nov Nov Oct Oct May May Nov Nov
10, 10, 24, 24, 28, 28, 11, 23, 20, 20, 23, 23, 29, 29, 17, 17, 08, 23,
2004 2004 2012 2012 2009 2009 2005 2004 2006 2006 2004 2004 2007 2007 2005 2005 2005 2004

CILOSTAZOL
TABLET; ORAL CILOSTAZOL TEVA AB AB PLETAL AB + OTSUKA AB +
3 - 95 (of 428)
50MG 100MG 50MG 100MG
A077027 A077027 N020863 N020863
001 002 001 002
Nov 24, 2004 Nov 24, 2004 Jan 15, 1999 Jan 15, 1999
CIMETIDINE
TABLET; ORAL CIMETIDINE APOTEX AB AB AB AB DAVA PHARMS INC AB AB AB IVAX SUB TEVA PHARMS AB AB AB AB MYLAN AB AB AB AB PLIVA AB AB AB AB TEVA AB AB AB AB WATSON LABS AB AB AB AB TAGAMET GLAXOSMITHKLINE AB AB AB AB +
200MG 300MG 400MG 800MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG
A074890 A074890 A074890 A074890 A074340 A074340 A074339 A074424 A074424 A074424 A074424 A074246 A074246 A074246 A074246 A074568 A074568 A074568 A074566 A074151 A074151 A074151 A074463 A074349 A074349 A074349 A074316 N017920 N017920 N017920 N017920
001 002 003 004 001 002 001 001 002 003 004 001 002 003 004 001 002 003 001 001 002 003 001 001 002 003 001 002 003 004 005
Dec Dec Dec Dec Jun Jun Jun Jul Jul Jul Jul May May May May Feb Feb Feb Feb May May May May Aug Aug Aug Feb
18, 18, 18, 18, 23, 23, 23, 28, 28, 28, 28, 17, 17, 17, 17, 27, 27, 27, 27, 17, 17, 17, 17, 30, 30, 30, 28,
1998 1998 1998 1998 1995 1995 1995 1995 1995 1995 1995 1994 1994 1994 1994 1997 1997 1997 1997 1994 1994 1994 1994 1996 1996 1996 1996
Dec 14, 1983 Apr 30, 1986
CIMETIDINE HYDROCHLORIDE
INJECTABLE; INJECTION CIMETIDINE HYDROCHLORIDE DAVA PHARMS INC EQ SOLUTION; ORAL CIMETIDINE HYDROCHLORIDE + HI TECH PHARMA EQ NOVEX EQ PHARM ASSOC EQ TEVA EQ WOCKHARDT EQ
AP
300MG BASE/2ML
A074428
001
Apr 25, 1996
AA AA AA AA AA
300MG 300MG 300MG 300MG 300MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A074664 A075560 A074553 A074610 A074757
001 001 001 001 001
Oct Mar Jan Sep Oct
28, 15, 27, 26, 17,
1997 2000 1997 1996 1997
CINACALCET HYDROCHLORIDE
TABLET; ORAL SENSIPAR XX AMGEN
EQ 30MG BASE
N021688
001
Mar 08, 2004

TABLET; ORAL SENSIPAR XX AMGEN XX +
3 - 96 (of 428)
N021688 N021688
002 003
Mar 08, 2004 Mar 08, 2004
CIPROFLOXACIN
FOR SUSPENSION; ORAL CIPRO BAYER HLTHCARE + INJECTABLE; INJECTION CIPRO + BAYER HLTHCARE + CIPRO IN DEXTROSE 5% IN + BAYER HLTHCARE + CIPROFLOXACIN CLARIS LIFESCIENCES
XX XX
250MG/5ML 500MG/5ML
N020780 N020780
001 002
Sep 26, 1997 Sep 26, 1997
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) PLASTIC CONTAINER 200MG/100ML 400MG/200ML
N019847 N019847 N019857 N019857 A078062 A078062 A076717 A076717 A077245 A077245 A078252 A078252 A078024 A078024 A078431 A077753 A077753
002 001 001 002 001 002 001 002 002 001 001 002 001 002 001 001 002
Dec 26, 1990 Dec 26, 1990 Dec 26, 1990 Dec 26, 1990 Apr Apr Dec Dec Aug Aug Mar Mar Mar Mar Nov Mar Mar 29, 29, 22, 22, 28, 28, 18, 18, 18, 18, 18, 18, 18, 2008 2008 2009 2009 2006 2006 2008 2008 2008 2008 2009 2008 2008
200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) HIKMA FARMACEUTICA 200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) HOSPIRA 400MG/40ML (10MG/ML) 200MG/20ML (10MG/ML) CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ACS DOBFAR INFO SA 200MG/100ML 400MG/200ML CLARIS LIFESCIENCES 200MG/100ML 400MG/200ML HIKMA FARMACEUTICA 400MG/200ML HOSPIRA 200MG/100ML 400MG/200ML
CIPROFLOXACIN HYDROCHLORIDE
OINTMENT; OPHTHALMIC CILOXAN + ALCON PHARMS LTD EQ 0.3% SOLUTION/DROPS; OPHTHALMIC CILOXAN + ALCON PHARMS LTD EQ 0.3% CIPROFLOXACIN HYDROCHLORIDE AKORN INC EQ 0.3% APOTEX EQ 0.3% BAUSCH AND LOMB EQ 0.3% FDC LTD EQ 0.3% HITECH PHARMA EQ 0.3% NEXUS PHARMS EQ 0.3% PHARMAFORCE EQ 0.3% SOLUTION/DROPS; OTIC CETRAXAL + WRASER PHARMS EQ 0.2%
XX
BASE
N020369
001
Mar 30, 1998
AT AT AT AT AT AT AT AT
N019992 A076555 A075928 A076754 A077568 A076673 A077689 A078598
001 001 001 001 001 001 001 001
Dec 31, 1990 Dec Jun Jun Jun Jan Dec Jan 11, 09, 09, 30, 21, 13, 16, 2008 2004 2004 2008 2005 2006 2008
XX
BASE
N021918
001
May 01, 2009
TABLET; ORAL CIPRO BAYER HLTHCARE AB EQ 100MG AB EQ 250MG AB + EQ 500MG AB EQ 750MG CIPROFLOXACIN HYDROCHLORIDE APOTEX AB EQ 250MG AB EQ 500MG
N019537 N019537 N019537 N019537 A076896 A076896
001 002 003 004 001 002
Apr Oct Oct Oct
08, 22, 22, 22,
1996 1987 1987 1987
Nov 04, 2004 Nov 04, 2004

TABLET; ORAL CIPROFLOXACIN HYDROCHLORIDE APOTEX EQ 750MG AUROBINDO PHARMA EQ 250MG EQ 500MG EQ 750MG CARLSBAD EQ 250MG EQ 500MG EQ 750MG DR REDDYS LABS LTD EQ 100MG EQ 250MG EQ 500MG EQ 750MG HIKMA EQ 250MG EQ 500MG EQ 750MG IVAX SUB TEVA PHARMS EQ 250MG EQ 500MG EQ 750MG MYLAN EQ 100MG EQ 250MG EQ 250MG EQ 500MG EQ 500MG EQ 750MG EQ 750MG RANBAXY EQ 250MG EQ 500MG EQ 750MG TARO EQ 100MG EQ 250MG EQ 500MG EQ 750MG UNIQUE PHARM LABS EQ 250MG EQ 500MG EQ 750MG WATSON LABS EQ 100MG EQ 250MG EQ 500MG EQ 750MG
3 - 97 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A076896 A077859 A077859 A077859 A076126 A076126 A076126 A075593 A075593 A075593 A075593 A076558 A076558 A076558 A076089 A076089 A076089 A075817 A075685 A075817 A075685 A075817 A075685 A075817 A075747 A075747 A075747 A076912 A076912 A076912 A076912 A076639 A076639 A076639 A076794 A076794 A076794 A076794
003 001 002 003 002 003 004 002 003 004 001 002 003 004 002 003 004 001 002 002 003 003 001 004 001 002 003 001 002 003 004 001 002 003 001 002 003 004
Nov Apr Apr Apr Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Feb Oct Oct Oct Sep Sep Sep Feb Jun Jun Jun
04, 26, 26, 26, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 25, 09, 09, 09, 09, 09, 09, 09, 09, 09, 18, 06, 06, 06, 10, 10, 10, 10, 09, 09, 09,
2004 2007 2007 2007 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2007 2004 2004 2004 2004 2004 2004 2004 2004 2004 2005 2004 2004 2004 2004 2004 2004 2005 2004 2004 2004
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE

SUSPENSION/DROPS; OTIC
CIPRO HC
EQ 0.2% BASE;1%
N020805
001
Feb 10, 1998
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL CIPRO XR + BAYER HLTHCARE 212.6MG;EQ + 425.2MG;EQ CIPROFLOXACIN EXTENDED RELEASE ANCHEN PHARMS 212.6MG;EQ 425.2MG;EQ DR REDDYS LABS LTD 212.6MG;EQ 425.2MG;EQ MYLAN 212.6MG;EQ 425.2MG;EQ WATSON LABS FLORIDA 212.6MG;EQ 425.2MG;EQ
287.5MG BASE 574.9MG BASE 287.5MG 574.9MG 287.5MG 574.9MG 287.5MG 574.9MG 287.5MG 574.9MG BASE BASE BASE BASE BASE BASE BASE BASE
N021473 N021473 A078166 A078166 A077701 A077701 A078183 A078183 A077417 A077809
001 002 002 001 002 001 001 002 001 001
Dec 13, 2002 Aug 28, 2003 Nov Nov Oct Mar Mar Mar Nov Nov 27, 27, 31, 26, 22, 22, 30, 30, 2007 2007 2007 2007 2007 2007 2010 2010

CIPROFLOXACIN; DEXAMETHASONE
CIPRODEX
3 - 98 (of 428)
0.3%;0.1%
N021537
001
Jul 18, 2003
CISATRACURIUM BESYLATE
INJECTABLE; INJECTION CISATRACURIUM BESYLATE SANDOZ INC AP EQ 2MG BASE/ML CISATRACURIUM BESYLATE PRESERVATIVE FREE SANDOZ INC AP EQ 2MG BASE/ML AP EQ 10MG BASE/ML NIMBEX AP + ABBVIE EQ 2MG BASE/ML NIMBEX PRESERVATIVE FREE AP + ABBVIE EQ 2MG BASE/ML AP + EQ 10MG BASE/ML
A200159 A200154 A200154 N020551 N020551 N020551
001 001 002 001 003 002
Feb 03, 2012 Feb 03, 2012 Feb 03, 2012 Dec 15, 1995 Dec 15, 1995 Dec 15, 1995
CISPLATIN
INJECTABLE; INJECTION CISPLATIN BEDFORD + FRESENIUS KABI USA ONCO THERAPIES LTD PHARMACHEMIE
AP AP AP AP
A075036 A074735 A091062 A074656
001 001 001 001
Nov Jul Apr May
07, 16, 18, 16,
2000 1999 2012 2000
CITALOPRAM HYDROBROMIDE
CAPSULE; ORAL CITALOPRAM HYDROBROMIDE XX MYLAN PHARMS INC EQ 10MG BASE XX EQ 20MG BASE XX + EQ 40MG BASE SOLUTION; ORAL CELEXA + FOREST LABS CITALOPRAM HYDROBROMIDE AUROBINDO PHARMA LTD ROXANE SILARX
A077668 A077668 A077668
001 002 003
Feb 28, 2007 Feb 28, 2007 Feb 28, 2007
AA AA AA AA
EQ 10MG BASE/5ML EQ 10MG BASE/5ML EQ 10MG BASE/5ML EQ 10MG BASE/5ML
N021046 A077812 A077043 A077629
001 001 001 001
Dec 22, 1999 Aug 28, 2006 Dec 13, 2004 Jun 15, 2006
TABLET; ORAL CELEXA FOREST LABS AB AB AB + CITALOPRAM HYDROBROMIDE AMNEAL PHARMS NY AB AB AB APOTEX INC AB AB AB AUROBINDO AB AB AB CARACO AB AB AB COREPHARMA AB AB AB DR REDDYS LABS LTD AB
EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N020822 N020822 N020822 A077289 A077289 A077289 A077046 A077046 A077046 A077031 A077031 A077031 A077032 A077032 A077032 A077036 A077036 A077036 A077038
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001
Apr 27, 2000 Jul 17, 1998 Jul 17, 1998 Nov Nov Nov Nov Nov Nov Oct Oct Oct Nov Nov Nov Oct Oct Oct Oct 30, 30, 30, 24, 24, 24, 28, 28, 28, 12, 12, 12, 28, 28, 28, 28, 2006 2006 2006 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004

TABLET; ORAL CITALOPRAM HYDROBROMIDE DR REDDYS LABS LTD EQ AB EQ AB EPIC PHARMA EQ AB EQ AB EQ AB GLENMARK GENERICS EQ AB EQ AB EQ AB INVAGEN PHARMS EQ AB EQ AB EQ AB MYLAN EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB MYLAN PHARMS INC EQ AB EQ AB EQ AB NATCO PHARMA LTD EQ AB EQ AB PLIVA EQ AB EQ AB EQ AB TEVA PHARMS EQ AB EQ AB EQ AB TORRENT PHARMS EQ AB EQ AB EQ AB WATSON LABS EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB
3 - 99 (of 428)
20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 10MG 20MG 20MG 40MG 40MG 10MG 20MG 40MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 10MG 20MG 20MG 40MG 40MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A077038 A077038 A077045 A077045 A077045 A077654 A077654 A077654 A077534 A077534 A077534 A077039 A077042 A077039 A077042 A077039 A077042 A077037 A077037 A077037 A077141 A077141 A077232 A077232 A077232 A077048 A077048 A077048 A078216 A078216 A078216 A077034 A077044 A077034 A077044 A077034 A077044
002 003 003 002 001 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 002 001 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003
Oct Oct Apr Apr Apr Feb Feb Feb Oct Oct Oct Feb Nov Feb Nov Feb Nov Nov Nov Nov Apr Apr Oct Oct Oct Nov Nov Nov Mar Mar Mar Jun Nov Jun Nov Jun Nov
28, 28, 29, 29, 29, 27, 27, 27, 03, 03, 03, 03, 05, 03, 05, 03, 05, 05, 05, 05, 10, 10, 31, 31, 31, 16, 16, 16, 27, 27, 27, 30, 05, 30, 05, 30, 05,
2004 2004 2005 2005 2005 2009 2009 2009 2006 2006 2006 2005 2004 2005 2004 2005 2004 2004 2004 2004 2008 2008 2005 2005 2005 2004 2004 2004 2007 2007 2007 2005 2004 2005 2004 2005 2004
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE

SOLUTION; IRRIGATION RENACIDIN XX + UNITED GUARDIAN
6.602GM/100ML;198MG/100ML;3.177GM/100ML N019481
001
Oct 02, 1990
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE

FOR SOLUTION; ORAL PREPOPIK XX + FERRING PHARMS AS
12GM/PACKET;3.5GM/PACKET;10MG/PACKET
N202535
001
Jul 16, 2012
CITRIC ACID; UREA C-13

FOR SOLUTION, TABLET, FOR SOLUTION; ORAL IDKIT:HP XX + EXALENZ BIOSCIENCE N/A,4GM;75MG,N/A
N021314
001
Dec 17, 2002
CLADRIBINE
INJECTABLE; INJECTION CLADRIBINE BEDFORD AP FRESENIUS KABI USA AP
1MG/ML 1MG/ML
A075405 A076571
001 001
Feb 28, 2000 Apr 22, 2004

CLADRIBINE
INJECTABLE; INJECTION CLADRIBINE ONCO THERAPIES LTD AP LEUSTATIN AP + JANSSEN PHARMS
3 - 100 (of 428)
1MG/ML 1MG/ML
A200510 N020229
001 001
Oct 06, 2011 Feb 26, 1993
CLARITHROMYCIN
FOR SUSPENSION; ORAL BIAXIN ABBVIE AB AB + CLARITHROMYCIN RANBAXY AB AB SANDOZ AB AB TABLET; ORAL BIAXIN AB + ABBVIE AB + CLARITHROMYCIN APOTEX CORP AB AB AUROBINDO AB AB MYLAN AB AB RANBAXY AB AB ROXANE AB AB SANDOZ AB AB TEVA AB AB WOCKHARDT AB AB TABLET, EXTENDED RELEASE; BIAXIN XL AB + ABBVIE CLARITHROMYCIN TEVA AB WATSON LABS FLORIDA AB
125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML
N050698 N050698 A065382 A065382 A065283 A065283
001 002 001 002 002 003
Dec 23, 1993 Dec 23, 1993 Aug Aug Sep Sep 30, 30, 04, 04, 2007 2007 2007 2007
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG ORAL 500MG 500MG 500MG
N050662 N050662 A065384 A065384 A065489 A065489 A065195 A065195 A065174 A065174 A065178 A065178 A065144 A065136 A065155 A065155 A065266 A065266
001 002 001 002 001 002 001 002 001 002 002 001 001 001 001 002 001 002
Oct 31, 1991 Oct 31, 1991 Aug Aug Jul Jul Mar Mar Sep Sep May May Oct Aug May May May May 20, 20, 25, 25, 11, 11, 24, 24, 25, 25, 18, 25, 31, 31, 31, 31, 2007 2007 2012 2012 2005 2005 2004 2004 2004 2004 2005 2005 2005 2005 2006 2006
N050775 A065154 A065145
001 001 001
Mar 03, 2000 May 18, 2005 Jun 24, 2004
CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

TIMENTIN
XX + GLAXOSMITHKLINE EQ 1GM BASE/VIAL;EQ 30GM BASE/VIAL XX EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL XX + EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL XX + EQ 200MG BASE/VIAL;EQ 3GM BASE/VIAL TIMENTIN IN PLASTIC CONTAINER XX + GLAXOSMITHKLINE EQ 100MG BASE/100ML;EQ 3GM BASE/100ML
N050590 A062691 N050590 N050590 N050658
003 001 001 002 001
Aug Dec Apr Apr
18, 19, 01, 01,
1987 1986 1985 1985
Dec 15, 1989
CLEMASTINE FUMARATE
SYRUP; ORAL CLEMASTINE FUMARATE NOVEX AA SILARX AA AA + TEVA
EQ 0.5MG BASE/5ML EQ 0.5MG BASE/5ML EQ 0.5MG BASE/5ML
A075703 A074884 A073399
001 001 001
Nov 27, 2000 Dec 17, 1997 Jun 30, 1994

CLEMASTINE FUMARATE
SYRUP; ORAL CLEMASTINE FUMARATE WOCKHARDT AA TABLET; ORAL CLEMASTINE FUMARATE SANDOZ AB AB + TEVA
3 - 101 (of 428)
EQ 0.5MG BASE/5ML
A074863
001
Mar 13, 1998
2.68MG 2.68MG
A073459 A073283
001 001
Oct 31, 1993 Jan 31, 1992
CLEVIDIPINE BUTYRATE
EMULSION; INTRAVENOUS
CLEVIPREX
XX + MEDICINES CO XX +
25MG/50ML (0.5MG/ML) 50MG/100ML (0.5MG/ML)
N022156 N022156
001 002
Aug 01, 2008 Aug 01, 2008
CLINDAMYCIN HYDROCHLORIDE
CAPSULE; ORAL CLEOCIN HYDROCHLORIDE PHARMACIA AND UPJOHN EQ AB AB EQ AB + EQ CLINDAMYCIN HYDROCHLORIDE AUROBINDO PHARMA AB EQ AB EQ COREPHARMA AB EQ AB EQ LANNETT AB EQ AB EQ AB EQ MYLAN PHARMS INC AB EQ AB EQ AB EQ RANBAXY AB EQ AB EQ TEVA AB EQ AB EQ WATSON LABS AB EQ AB EQ ZYDUS PHARMS USA AB EQ AB EQ AB EQ
75MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 75MG BASE 150MG BASE 300MG BASE 75MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 75MG BASE 150MG BASE 300MG BASE
N050162 N050162 N050162 A065442 A065442 A065194 A065194 A065242 A065242 A065243 A091225 A091225 A091225 A065061 A065061 A063029 A063029 A063083 A063083 A065217 A065217 A065217
001 002 003 001 002 001 002 001 002 001 001 002 003 001 002 001 002 001 002 001 002 003
Apr 14, 1988 Aug Aug Mar Mar Aug Aug Aug May May May Feb Feb Sep Aug Jul Mar Jan Jan Jan 26, 26, 22, 22, 12, 12, 12, 31, 31, 31, 02, 02, 20, 05, 31, 18, 31, 31, 31, 2009 2009 2004 2004 2005 2005 2005 2011 2011 2011 2001 2001 1989 2005 1991 2003 2005 2005 2005
CLINDAMYCIN PALMITATE HYDROCHLORIDE

FOR SOLUTION; ORAL CLEOCIN AA + PHARMACIA AND UPJOHN EQ 75MG BASE/5ML CLINDAMYCIN PALMITATE HYDROCHLORIDE LYNE AA EQ 75MG BASE/5ML PADDOCK LABS AA EQ 75MG BASE/5ML
A062644 A201821 A090902
001 001 001
Apr 07, 1986 Aug 28, 2012 Jul 07, 2010
CLINDAMYCIN PHOSPHATE
AEROSOL, FOAM; TOPICAL CLINDAMYCIN PHOSPHATE PERRIGO UK FINCO AT EVOCLIN AT + STIEFEL LABS INC CREAM; VAGINAL CLEOCIN AB + PHARMACIA AND UPJOHN CLINDAMYCIN PHOSPHATE FOUGERA PHARMS AB
1% 1%
A090785 N050801
001 001
Mar 31, 2010 Oct 22, 2004
EQ 2% BASE EQ 2% BASE
N050680 A065139
002 001
Mar 02, 1998 Dec 27, 2004

CREAM; VAGINAL CLINDESSE + KV PHARM GEL; TOPICAL CLEOCIN T + PHARMACIA AND UPJOHN CLINDAMYCIN PHOSPHATE FOUGERA PHARMS CLINDAGEL + GALDERMA LABS LP
3 - 102 (of 428)
XX
EQ 2% BASE
N050793
001
Nov 30, 2004
AB AB BT
EQ 1% BASE EQ 1% BASE EQ 1% BASE
N050615 A064160 N050782
001 001 001
Jan 07, 1987 Jan 28, 2000 Nov 27, 2000
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX
AB AB
XX
AT AT AT AT
INJECTABLE; INJECTION CLEOCIN PHOSPHATE PHARMACIA AND UPJOHN EQ 150MG BASE/ML + EQ 150MG BASE/ML CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER + PHARMACIA AND UPJOHN EQ 6MG BASE/ML EQ 12MG BASE/ML + EQ 18MG BASE/ML + CLINDAMYCIN PHOSPHATE BEDFORD EQ 150MG BASE/ML FRESENIUS KABI USA EQ 150MG BASE/ML EQ 150MG BASE/ML HIKMA MAPLE EQ 150MG BASE/ML HOSPIRA EQ 150MG BASE/ML EQ 150MG BASE/ML EQ 150MG BASE/ML SAGENT STRIDES EQ 150MG BASE/ML EQ 150MG BASE/ML CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER SANDOZ INC EQ 6MG BASE/ML EQ 12MG BASE/ML EQ 18MG BASE/ML CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% + ABRAXIS PHARM EQ 900MG BASE/100ML LOTION; TOPICAL CLEOCIN T + PHARMACIA AND UPJOHN EQ 1% BASE CLINDAMYCIN PHOSPHATE FOUGERA PHARMS EQ 1% BASE SOLUTION; TOPICAL CLEOCIN T + PHARMACIA AND UPJOHN EQ 1% BASE CLINDA-DERM PADDOCK LLC EQ 1% BASE CLINDAMYCIN PHOSPHATE FOUGERA EQ 1% BASE FOUGERA PHARMS EQ 1% BASE PERRIGO NEW YORK EQ 1% BASE TARO PHARM INDS EQ 1% BASE WOCKHARDT EQ 1% BASE SUPPOSITORY; VAGINAL CLEOCIN + PHARMACIA AND UPJOHN 100MG SWAB; TOPICAL CLEOCIN PHARMACIA AND UPJOHN EQ 1% BASE CLINDAMYCIN PHOSPHATE PERRIGO NEW YORK EQ 1% BASE VERSAPHARM EQ 1% BASE CLINDETS PERRIGO EQ 1% BASE
A062803 N050441 N050639 N050639 N050639 A065206 A065346 A065347 A062889 A062800 A062801 A062943 A090108 A090109 A201692 A201692 A201692 N050635
001 001 001 002 003 001 001 001 001 001 001 001 001 001 001 002 003 001
Oct 16, 1987
Aug 30, 1989 Aug 30, 1989 Apr 10, 1991 Sep Mar May Apr Jul Jul Sep Sep Sep 24, 29, 09, 25, 24, 24, 29, 30, 30, 2004 2007 2007 1988 1987 1987 1988 2011 2011
May 31, 2012 May 31, 2012 May 31, 2012 Dec 22, 1989
N050600 A065067
001 001
May 31, 1989 Jan 31, 2002
N050537 A063329 A064159 A065254 A064050 A065184 A063304
001 001 001 001 001 001 001 Sep 30, 1992 Jun Feb Nov Mar Jul 05, 14, 30, 31, 15, 1997 2006 1995 2004 1997
N050767
001
Aug 13, 1999
N050537 A065049 A065513 A064136
002 001 001 001
Feb 22, 1994 May 25, 2000 Jun 17, 2010 Sep 30, 1996

CLINDAMYCIN PHOSPHATE; TRETINOIN
GEL; TOPICAL VELTIN BX + STIEFEL GSK ZIANA BX + MEDICIS
3 - 103 (of 428)
1.2%;0.025% 1.2%;0.025%
N050803 N050802
001 001
Jul 16, 2010 Nov 07, 2006
CLOBAZAM
SUSPENSION; ORAL
ONFI
XX + LUNDBECK LLC TABLET; ORAL ONFI XX LUNDBECK LLC XX XX +
2.5MG/ML
N203993
001
Dec 14, 2012
5MG 10MG 20MG
N202067 N202067 N202067
001 002 003
Oct 21, 2011 Oct 21, 2011 Oct 21, 2011
CLOBETASOL PROPIONATE
AEROSOL, FOAM; TOPICAL CLOBETASOL PROPIONATE PERRIGO ISRAEL AB1 0.05% OLUX AB1 + STIEFEL LABS INC 0.05% CLOBETASOL PROPIONATE PERRIGO ISRAEL AB2 0.05% OLUX E AB2 + STIEFEL LABS INC 0.05% CREAM; TOPICAL CLOBETASOL PROPIONATE FOUGERA AB1 0.05% TARO AB1 0.05% TEVA PHARMS AB1 0.05% CORMAX HI TECH PHARMA AB1 0.05% TEMOVATE AB1 + FOUGERA PHARMS 0.05% CLOBETASOL PROPIONATE (EMOLLIENT) FOUGERA PHARMS AB2 0.05% TARO AB2 0.05% EMBELINE E HI TECH PHARMA AB2 0.05% TEMOVATE E AB2 + FOUGERA PHARMS 0.05% GEL; TOPICAL CLOBETASOL PROPIONATE FOUGERA PHARMS AB 0.05% PERRIGO AB 0.05% TARO AB 0.05% EMBELINE HI TECH PHARMA AB 0.05% TEMOVATE AB + FOUGERA PHARMS 0.05% LOTION; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC 0.05% AB TARO AB 0.05% CLOBEX AB + GALDERMA LABS LP 0.05% OINTMENT; TOPICAL CLOBETASOL PROPIONATE FOUGERA PHARMS AB 0.05% TARO AB 0.05%
A077763 N021142 A201402 N022013
001 001 001 001
Mar 10, 2008 May 26, 2000 Aug 14, 2012 Jan 12, 2007
A074392 A074249 A074087 A074220 N019322 A075430 A075633 A075325 N020340
001 001 001 001 001 001 001 001 001
Sep 30, 1996 Jul 08, 1996 Feb 16, 1994 May 16, 1997 Dec 27, 1985 May 26, 1999 May 17, 2000 Dec 24, 1998 Jun 17, 1994
A075368 A075027 A075279 A076141 N020337
001 001 001 001 001
Feb 15, 2000 Oct 31, 1997 May 28, 1999 Apr 12, 2002 Apr 29, 1994
A078223 A200302 N021535
001 001 001
Dec 04, 2008 Jul 02, 2012 Jul 24, 2003
A074407 A074248
001 001
Feb 23, 1996 Jul 12, 1996

OINTMENT; TOPICAL
CLOBETASOL PROPIONATE TEVA PHARMS AB EMBELINE HI TECH PHARMA AB TEMOVATE AB + FOUGERA PHARMS SHAMPOO; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC AB PERRIGO ISRAEL AB CLOBEX AB + GALDERMA LABS SOLUTION; TOPICAL CLOBETASOL PROPIONATE FOUGERA PHARMS AT TARO AT AT TOLMAR AT WOCKHARDT AT EMBELINE HI TECH PHARMA AT TEMOVATE AT + FOUGERA PHARMS SPRAY; TOPICAL CLOBETASOL PROPIONATE PADDOCK LLC AT CLOBEX AT + GALDERMA LABS LP
3 - 104 (of 428)
0.05% 0.05% 0.05%
A074089 A074221 N019323
001 001 001
Feb 16, 1994 Mar 31, 1995 Dec 27, 1985
0.05% 0.05% 0.05%
A078854 A090974 N021644
001 001 001
Jun 07, 2011 Aug 09, 2012 Feb 05, 2004
0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%
A075391 A075224 A075363 A076977 A075205 A074222 N019966
001 001 001 001 001 001 001
Feb Nov Dec Aug Nov
08, 16, 29, 05, 13,
1999 1998 2000 2005 1998
Dec 06, 1995 Feb 22, 1990
0.05% 0.05%
A090898 N021835
001 001
Jun 16, 2011 Oct 27, 2005
CLOCORTOLONE PIVALATE
CREAM; TOPICAL CLODERM XX + PROMIUS PHARMA LLC
0.1%
N017765
001
CLOFARABINE
INJECTABLE; IV (INFUSION) CLOLAR XX + GENZYME 20MG/20ML (1MG/ML)
N021673
001
Dec 28, 2004
CLOFAZIMINE
CAPSULE; ORAL LAMPRENE XX + NOVARTIS
50MG
N019500
002
Dec 15, 1986
CLOMIPHENE CITRATE
TABLET; ORAL CLOMID AB + SANOFI AVENTIS US CLOMIPHENE CITRATE PAR PHARM AB SEROPHENE EMD SERONO AB
50MG 50MG 50MG
N016131 A075528 N018361
002 001 001 Aug 30, 1999 Mar 22, 1982
CLOMIPRAMINE HYDROCHLORIDE
CAPSULE; ORAL ANAFRANIL MALLINCKRODT LLC AB AB + AB
25MG 50MG 75MG
N019906 N019906 N019906
001 002 003
Dec 29, 1989 Dec 29, 1989 Dec 29, 1989

CAPSULE; ORAL CLOMIPRAMINE HYDROCHLORIDE MYLAN AB 25MG AB 50MG AB 75MG SANDOZ AB 25MG AB 50MG AB 75MG TARO AB 25MG AB 50MG AB 75MG TEVA AB 25MG AB 50MG AB 75MG
3 - 105 (of 428)
A074947 A074947 A074947 A074364 A074364 A074364 A074694 A074694 A074694 A074958 A074958 A074958
001 002 003 001 002 003 001 002 003 001 002 003
Apr Apr Apr Mar Mar Mar Dec Dec Dec Aug Aug Aug
30, 30, 30, 29, 29, 29, 31, 31, 31, 26, 26, 26,
1998 1998 1998 1996 1996 1996 1996 1996 1996 1997 1997 1997
CLONAZEPAM
TABLET; ORAL CLONAZEPAM ACCORD HLTHCARE INC AB 0.5MG AB 1MG AB 2MG ACTAVIS ELIZABETH AB 0.5MG AB 1MG AB 2MG APOTEX AB 0.5MG AB 1MG AB 2MG CARACO AB 0.5MG AB 1MG AB 2MG MYLAN AB 0.5MG AB 1MG AB 2MG MYLAN PHARMS INC AB 0.5MG AB 1MG AB 2MG SANDOZ AB 0.5MG AB 1MG AB 2MG TEVA AB 0.5MG AB 1MG AB 2MG VINTAGE PHARMS AB 0.5MG AB 1MG AB 2MG WATSON LABS AB 0.5MG AB 1MG AB 2MG KLONOPIN ROCHE AB 0.5MG AB + 1MG AB 2MG TABLET, ORALLY DISINTEGRATING; ORAL CLONAZEPAM BARR AB 0.125MG AB 0.25MG AB 0.5MG AB 1MG AB 2MG PAR PHARM AB 0.125MG
A077147 A077147 A077147 A074869 A074869 A074869 A075468 A075468 A075468 A075423 A075423 A075423 A075150 A075150 A075150 A074940 A074940 A074940 A074979 A074979 A074979 A074569 A074569 A074569 A077856 A077856 A077856 A074964 A074964 A074964 N017533 N017533 N017533
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
May May May Oct Oct Oct Oct Oct Oct Apr Apr Apr Oct Oct Oct Oct Oct Oct Aug Aug Aug Sep Sep Sep Jun Jun Jun Dec Dec Dec
02, 02, 02, 31, 31, 31, 06, 06, 06, 27, 27, 27, 05, 05, 05, 30, 30, 30, 29, 29, 29, 10, 10, 10, 28, 28, 28, 30, 30, 30,
2005 2005 2005 1996 1996 1996 2000 2000 2000 2001 2001 2001 1998 1998 1998 1997 1997 1997 1997 1997 1997 1996 1996 1996 2006 2006 2006 1997 1997 1997
A077194 A077194 A077194 A077194 A077194 A077171
001 002 003 004 005 001
Aug Aug Aug Aug Aug Aug
10, 10, 10, 10, 10, 03,
2005 2005 2005 2005 2005 2005

CLONAZEPAM
TABLET, ORALLY DISINTEGRATING; ORAL CLONAZEPAM PAR PHARM AB 0.25MG AB 0.5MG AB + 1MG AB 2MG
3 - 106 (of 428)
A077171 A077171 A077171 A077171
002 003 004 005
Aug Aug Aug Aug
03, 03, 03, 03,
2005 2005 2005 2005
CLONIDINE
FILM, EXTENDED RELEASE; TRANSDERMAL CATAPRES-TTS-1 BOEHRINGER INGELHEIM 0.1MG/24HR CATAPRES-TTS-2 BOEHRINGER INGELHEIM 0.2MG/24HR CATAPRES-TTS-3 + BOEHRINGER INGELHEIM 0.3MG/24HR CLONIDINE AVEVA 0.1MG/24HR 0.2MG/24HR 0.3MG/24HR BARR 0.1MG/24HR 0.2MG/24HR 0.3MG/24HR MYLAN TECHNOLOGIES 0.1MG/24HR 0.2MG/24HR 0.3MG/24HR
N018891 N018891 N018891 A076157 A076157 A076157 A079090 A079090 A079090 A076166 A076166 A076166
001 002 003 001 002 003 001 002 003 001 002 003
Oct 10, 1984 Oct 10, 1984 Oct 10, 1984 Aug Aug Aug Aug Aug Aug Jul Jul Jul 18, 18, 18, 20, 20, 20, 16, 16, 16, 2009 2009 2009 2010 2010 2010 2010 2010 2010
CLONIDINE HYDROCHLORIDE
INJECTABLE; INJECTION CLONIDINE HYDROCHLORIDE FRESENIUS KABI USA AP 1MG/10ML (0.1MG/ML) AP 5MG/10ML (0.5MG/ML) HIKMA FARMACEUTICA AP 1MG/10ML (0.1MG/ML) AP 5MG/10ML (0.5MG/ML) LUITPOLD AP 1 MG/10 ML (0.1 MG/ML) AP 5 MG/10 ML (0.5 MG/ML) DURACLON MYLAN INSTITUTIONAL AP 1 MG/10 ML (0.1 MG/ML) AP + 5 MG/10 ML (0.5 MG/ML) TABLET; ORAL CATAPRES BOEHRINGER INGELHEIM 0.1MG AB AB 0.2MG AB + 0.3MG CLONIDINE HYDROCHLORIDE ACTAVIS ELIZABETH AB 0.1MG AB 0.2MG AB 0.3MG ALEMBIC PHARMS LTD AB 0.1MG AB 0.2MG AB 0.3MG DAVA PHARMS INC AB 0.1MG AB 0.2MG AB 0.3MG IMPAX LABS AB 0.1MG AB 0.2MG AB 0.3MG MUTUAL PHARM AB 0.1MG AB 0.2MG AB 0.3MG MYLAN AB 0.1MG
A200673 A200673 A200300 A200300 A091104 A091104 N020615 N020615
001 002 001 002 001 002 001 002
Jul Jul Jan Jan Oct Oct
08, 08, 26, 26, 08, 08,
2011 2011 2011 2011 2009 2009
Oct 02, 1996 Apr 27, 1999
001 002 003 001 001 001 001 002 003 001 001 001 001 002 003 001 001 001 002 Dec Dec Dec Dec Dec Dec Apr Apr Apr Aug Aug Aug Sep Sep Sep Jul 16, 16, 16, 06, 06, 06, 05, 05, 05, 27, 27, 27, 04, 04, 04, 09, 1986 1986 1986 2011 2011 2011 1988 1988 1988 2009 2009 2009 1987 1987 1987 1987

TABLET; ORAL CLONIDINE HYDROCHLORIDE MYLAN AB 0.2MG AB 0.3MG UNICHEM AB 0.1MG AB 0.2MG AB 0.3MG VINTAGE AB 0.1MG AB 0.2MG AB 0.3MG WATSON LABS AB 0.3MG TABLET, EXTENDED RELEASE; ORAL
KAPVAY
0.1MG XX + SHIONOGI INC 0.2MG XX
3 - 107 (of 428)
A070317 A070317 A078895 A078895 A078895 A077901 A077901 A077901 A070963
003 001 001 002 003 001 002 003 001
Jun Jun Aug Aug Aug Mar Mar Mar Jul
09, 09, 26, 26, 26, 09, 09, 09, 08,
1987 1987 2009 2009 2009 2007 2007 2007 1986
N022331 N022331
003 004
Sep 28, 2010 Sep 28, 2010
CLOPIDOGREL BISULFATE
TABLET; ORAL CLOPIDOGREL BISULFATE APOTEX INC AUROBINDO PHARMA LTD DR REDDYS LABS INC DR REDDYS LABS LTD GATE PHARMS MYLAN PHARMS INC ROXANE SUN PHARMA GLOBAL TEVA TEVA PHARMS TORRENT PHARMS LTD WOCKHARDT LTD ZYDUS PHARMS USA INC PLAVIX SANOFI AVENTIS US +
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
75MG BASE 75MG BASE 75MG BASE 300MG BASE 300MG BASE 75MG BASE 300MG BASE 75MG BASE 75MG BASE 75MG BASE 300MG BASE 75MG BASE 75MG BASE 300MG BASE 75MG BASE
A076274 A090540 A076273 A091023 A091216 A077665 A077665 A078004 A090494 A076999 A090625 A090844 A202266 A202266 A201686 N020839 N020839
001 001 001 001 001 001 002 001 001 001 001 001 001 002 001 001 002
May May Jan May May May May May May May May May Aug Nov Oct
17, 17, 14, 17, 17, 17, 17, 17, 17, 17, 17, 17, 14, 20, 10,
2012 2012 2008 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
Nov 17, 1997 Sep 20, 2007
CLORAZEPATE DIPOTASSIUM
TABLET; ORAL CLORAZEPATE DIPOTASSIUM MYLAN AB 3.75MG AB 7.5MG AB 15MG RANBAXY AB 3.75MG AB 7.5MG AB 15MG TARO AB 3.75MG AB 7.5MG AB 15MG WATSON LABS AB 3.75MG AB 7.5MG AB 15MG GEN-XENE ALRA AB 3.75MG AB 7.5MG AB 15MG TRANXENE LUNDBECK LLC AB 3.75MG AB 7.5MG
002 003 001 001 002 003 003 002 001 001 001 001 001 001 001 006 007
Jul Jul Jul Sep Sep Sep Apr Apr Apr Feb Feb Feb
17, 17, 17, 29, 29, 29, 27, 27, 27, 09, 09, 09,
1987 1987 1987 2004 2004 2004 2000 2000 2000 1988 1988 1988
Apr 26, 1988 Apr 26, 1988 Apr 26, 1988

TABLET; ORAL TRANXENE AB + LUNDBECK LLC
3 - 108 (of 428)
15MG
N017105
008
CLOTRIMAZOLE
CREAM; TOPICAL CLOTRIMAZOLE FOUGERA PHARMS GLENMARK PHARMS + TARO SOLUTION; TOPICAL CLOTRIMAZOLE TARO TEVA MYCELEX + BAYER HLTHCARE
AB AB AB
1% 1% 1%
A078338 A090219 A072640
001 001 001
Sep 02, 2008 Aug 03, 2010 Aug 31, 1993
AT AT AT
1% 1% 1%
A074580 A073306 N018181
001 001 001
Jul 29, 1996 Feb 28, 1995
TROCHE/LOZENGE; ORAL CLOTRIMAZOLE PADDOCK LLC AB AB + ROXANE
10MG 10MG
A076763 A076387
001 001
Oct 28, 2005 Jul 29, 2004
CLOZAPINE
TABLET; ORAL CLOZAPINE CARACO AB 25MG AB 50MG AB 100MG IVAX SUB TEVA PHARMS 25MG AB AB 50MG AB 50MG AB 100MG AB 100MG MYLAN AB 25MG AB 100MG CLOZARIL NOVARTIS AB 25MG AB + 100MG CLOZAPINE IVAX SUB TEVA PHARMS 12.5MG XX 200MG XX TABLET, ORALLY DISINTEGRATING; ORAL FAZACLO ODT JAZZ PHARMS III 12.5MG XX 25MG XX 100MG XX + 150MG XX 200MG XX
A075713 A075713 A075713 A074949 A074949 A076809 A074949 A076809 A075417 A075417 N019758 N019758 A074949 A076809
001 003 002 001 004 003 002 002 001 002 001 002 003 001
Nov Aug Nov Nov Apr Dec Nov Dec May May
15, 19, 15, 26, 25, 16, 26, 16, 27, 27,
2002 2005 2002 1997 2005 2005 1997 2005 1999 1999
Sep 26, 1989 Sep 26, 1989 Jul 31, 2003 Dec 16, 2005
N021590 N021590 N021590 N021590 N021590
004 001 002 005 006
May Feb Feb Jul Jul
30, 10, 10, 09, 09,
2007 2004 2004 2010 2010
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

TABLET; ORAL
STRIBILD
XX + GILEAD SCIENCES INC
150MG;150MG;200MG;300MG
N203100
001
Aug 27, 2012
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE

SYRUP; ORAL PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE VINTAGE AA 10MG/5ML;5MG/5ML;6.25MG/5ML A040660 PROMETH VC W/ CODEINE AA + ACTAVIS MID ATLANTIC 10MG/5ML;5MG/5ML;6.25MG/5ML A088764
001 001
Dec 07, 2006 Oct 31, 1984

CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE + ACTAVIS MID ATLANTIC 10MG/5ML;6.25MG/5ML HI TECH PHARMA 10MG/5ML;6.25MG/5ML PHARM ASSOC 10MG/5ML;6.25MG/5ML SUN PHARM INDS INC 10MG/5ML;6.25MG/5ML TRIS PHARMA INC 10MG/5ML;6.25MG/5ML WOCKHARDT 10MG/5ML;6.25MG/5ML PROMETHAZINE WITH CODEINE VINTAGE 10MG/5ML;6.25MG/5ML
3 - 109 (of 428)
A088763 A040151 A089647 A090180 A200386 A088875 A040650
001 001 001 001 001 001 001
Oct Aug Dec Mar Jun Dec
31, 26, 22, 17, 29, 17,
1984 1997 1988 2010 2012 1984
Jan 31, 2006
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE

SYRUP; ORAL
TRIACIN-C
XX + STI PHARMA LLC
10MG/5ML;30MG/5ML;1.25MG/5ML
A088704
001
Mar 22, 1985
CODEINE SULFATE
SOLUTION; ORAL
CODEINE SULFATE
XX + ROXANE TABLET; ORAL CODEINE SULFATE ROXANE XX XX XX +
30MG/5ML
N202245
001
Jun 30, 2011
15MG 30MG 60MG
N022402 N022402 N022402
001 002 003
Jul 16, 2009 Jul 16, 2009 Jul 16, 2009
COLCHICINE
TABLET; ORAL
COLCRYS
0.6MG
N022352
001
Jul 29, 2009
COLCHICINE; PROBENECID
TABLET; ORAL COL-PROBENECID AB + WATSON LABS 0.5MG;500MG PROBENECID AND COLCHICINE MIRROR PHARMS AB 0.5MG;500MG
A084279 A040618
001 001 May 13, 2008
COLESEVELAM HYDROCHLORIDE
FOR SUSPENSION; ORAL WELCHOL XX DAIICHI SANKYO XX + TABLET; ORAL
WELCHOL
XX + DAIICHI SANKYO
1.875GM/PACKET 3.75GM/PACKET
N022362 N022362
001 002
Oct 02, 2009 Oct 02, 2009
625MG
N021176
001
May 26, 2000
COLESTIPOL HYDROCHLORIDE
GRANULE; ORAL COLESTID PHARMACIA AND UPJOHN 5GM/SCOOPFUL + 5GM/PACKET COLESTIPOL HYDROCHLORIDE IMPAX LABS 5GM/PACKET 5GM/SCOOPFUL FLAVORED COLESTID
PHARMACIA AND UPJOHN 5GM/SCOOPFUL 5GM/PACKET TABLET; ORAL
COLESTID + PHARMACIA AND UPJOHN 1GM
AB AB AB AB XX XX
N017563 N017563 A077277 A077277 N017563 N017563
003 004 002 001 002

001
Sep 22, 1995 Sep 22, 1995 May 02, 2006 May 02, 2006
AB
N020222
001
Jul 19, 1994

COLESTIPOL HYDROCHLORIDE
TABLET; ORAL COLESTIPOL HYDROCHLORIDE IMPAX LABS AB 1GM
3 - 110 (of 428)
A077510
001
Oct 24, 2006
COLISTIMETHATE SODIUM
INJECTABLE; INJECTION COLISTIMETHATE SODIUM EMCURE PHARMS LTD FRESENIUS KABI USA PADDOCK LLC X GEN PHARMS COLY-MYCIN M + JHP PHARMS
AP AP AP AP AP
EQ EQ EQ EQ
150MG 150MG 150MG 150MG
BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
A202359 A065364 A065177 A064216 N050108
001 001 001 001 002
Sep Apr Mar Feb
28, 17, 19, 26,
2012 2008 2004 1999
EQ 150MG BASE/VIAL
COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE

COLY-MYCIN S
XX + JHP PHARMS
EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML
N050356
001
CONIVAPTAN HYDROCHLORIDE
VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
XX + ASTELLAS 20MG/100ML (0.2MG/ML)
N021697
002
Oct 08, 2008
COPPER
INTRAUTERINE DEVICE; INTRAUTERINE
PARAGARD T 380A
XX + TEVA WOMENS 309MG/COPPER
N018680
001
Nov 15, 1984
CORTICORELIN OVINE TRIFLUTATE

ACTHREL
XX + FERRING
EQ 0.1MG BASE/VIAL
N020162
001
May 23, 1996
CORTICOTROPIN
INJECTABLE; INJECTION H.P. ACTHAR GEL XX + QUESTCOR PHARMS
80 UNITS/ML
N008372
008
CORTISONE ACETATE
TABLET; ORAL
CORTISONE ACETATE
XX + WEST WARD
25MG
A080776
002
COSYNTROPIN
INJECTABLE; INJECTION CORTROSYN AP + AMPHASTAR PHARMS INC COSYNTROPIN BIONICHE PHARMA AP SANDOZ AP SOLUTION; INTRAVENOUS COSYNTROPIN SANDOZ XX
0.25MG/VIAL 0.25MG/VIAL 0.25MG/VIAL
N016750 A090574 A202147
001 001 001 Dec 17, 2009 Jun 29, 2012
0.25MG/ML (0.25MG/ML)
N022028
001
Feb 21, 2008
CRIZOTINIB
CAPSULE; ORAL XALKORI XX PFIZER XX +
200MG 250MG
N202570 N202570
001 002
Aug 26, 2011 Aug 26, 2011

CROFELEMER
TABLET, DELAYED RELEASE; ORAL FULYZAQ XX + SALIX PHARMS 125MG
3 - 111 (of 428)
N202292
001
Dec 31, 2012
CROMOLYN SODIUM
CONCENTRATE; ORAL CROMOLYN SODIUM PACK PHARMS LLC AA 100MG/5ML GASTROCROM AA + MEDA PHARMS 100MG/5ML SOLUTION; INHALATION CROMOLYN SODIUM BAUSCH AND LOMB AN 10MG/ML DEY AN 10MG/ML NOVEX AN 10MG/ML AN + TEVA PHARMS 10MG/ML WATSON LABS AN 10MG/ML WOCKHARDT AN 10MG/ML SOLUTION/DROPS; OPHTHALMIC CROLOM BAUSCH AND LOMB AT 4% CROMOLYN SODIUM AKORN 4% AT ALCON 4% AT NOVEX 4% AT OPTICROM AT + ALLERGAN 4%
A202583 N020479
001 001
Oct 27, 2011 Feb 29, 1996
A075585 A074209 A075333 A075271 A076469 A075346
001 001 001 001 001 001
Dec Apr Apr Jan Jun Oct
21, 26, 30, 18, 17, 25,
2000 1994 2002 2000 2005 1999
A074443 A074706 A075282 A075615 N018155
001 001 001 001 001
Jan 30, 1995 Apr 29, 1998 Jun 16, 1999 Jan 26, 2001 Oct 03, 1984
CROTAMITON
CREAM; TOPICAL EURAX XX + RANBAXY LOTION; TOPICAL CROTAN SUMMERS AT EURAX AT + RANBAXY
10%
N006927
001
10% 10%
A087204 N009112
001 003
CUPRIC CHLORIDE
INJECTABLE; INJECTION CUPRIC CHLORIDE IN PLASTIC CONTAINER XX + HOSPIRA EQ 0.4MG COPPER/ML
N018960
001
Jun 26, 1986
CYANOCOBALAMIN
INJECTABLE; INJECTION CYANOCOBALAMIN AP + LUITPOLD VIBISONE AP + FRESENIUS KABI USA SPRAY, METERED; NASAL NASCOBAL XX + PAR PHARM
1MG/ML 1MG/ML
A080737 A080557
001 003
0.5MG/SPRAY
N021642
001
Jan 31, 2005
CYCLOBENZAPRINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL AMRIX TEVA AB 15MG AB + 30MG CYCLOBENZAPRINE HYDROCHLORIDE MYLAN AB 15MG AB 30MG
N021777 N021777 A090738 A090738
001 002 001 002
Feb 01, 2007 Feb 01, 2007 Apr 18, 2011 Apr 18, 2011

TABLET; ORAL CYCLOBENZAPRINE HYDROCHLORIDE AUROBINDO PHARMA 5MG 10MG INVAGEN PHARMS 5MG 10MG JUBILANT CADISTA 5MG 10MG KVK TECH 5MG 10MG MUTUAL PHARM 5MG 10MG MYLAN PHARMS INC 5MG 10MG + ORIT LABS LLC 10MG PLIVA 10MG PROSAM LABS 5MG 10MG RANBAXY 5MG 7.5MG 10MG SANDOZ 5MG 10MG VINTAGE PHARMS 5MG 10MG WATSON LABS 5MG 7.5MG 10MG
3 - 112 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A078643 A078643 A090478 A090478 A077563 A077563 A078048 A078048 A073541 A073541 A073144 A073144 A078218 A074421 A077291 A077209 A078722 A078722 A078722 A072854 A072854 A077797 A077797 A071611 A071611 A071611
001 002 001 002 001 002 001 002 002 001 002 001 001 001 001 001 001 002 003 002 001 001 002 002 003 001
Sep Sep Jul Jul Apr Apr Feb Feb Apr May Feb May Apr Sep Feb Oct May May May Feb Nov Feb Feb Feb Feb May
26, 26, 23, 23, 19, 19, 28, 28, 06, 23, 03, 30, 18, 29, 03, 04, 12, 12, 12, 03, 19, 28, 28, 03, 03, 03,
2008 2008 2010 2010 2006 2006 2011 2011 2006 1995 2006 1991 2008 1995 2006 2005 2008 2008 2008 2006 1991 2007 2007 2006 2006 1989
CYCLOPENTOLATE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AKPENTOLATE AKORN AT 1% AT 2% CYCLOGYL AT + ALCON 1% AT + 2% PENTOLAIR BAUSCH AND LOMB AT 1% CYCLOGYL 0.5% XX + ALCON
A040164 A040165 A084110 A084108 A040075 A084109
001 001 001 001 001 001
Jan 13, 1997 Jan 13, 1997
Apr 29, 1994
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE

SOLUTION/DROPS; OPHTHALMIC CYCLOMYDRIL XX + ALCON 0.2%;1%
A084300
001
CYCLOPHOSPHAMIDE
INJECTABLE; INJECTION CYCLOPHOSPHAMIDE + BAXTER HLTHCARE + + CYTOXAN + BAXTER HLTHCARE + + TABLET; ORAL CYCLOPHOSPHAMIDE ROXANE
AP AP AP AP AP AP
500MG/VIAL 1GM/VIAL 2GM/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL
A040745 A040745 A040745 N012142 N012142 N012142
001 002 003 003 004 005
May 21, 2008 May 21, 2008 May 21, 2008
Aug 30, 1982 Aug 30, 1982
XX
25MG
A040032
001
Aug 17, 1999

CYCLOPHOSPHAMIDE
TABLET; ORAL CYCLOPHOSPHAMIDE XX + ROXANE
3 - 113 (of 428)
50MG
A040032
002
Aug 17, 1999
CYCLOSERINE
CAPSULE; ORAL SEROMYCIN XX + PURDUE GMP
250MG
A060593
001
CYCLOSPORINE
CAPSULE; ORAL CYCLOSPORINE IVAX SUB TEVA PHARMS AB1 AB1 AB1 SANDOZ AB1 AB1 WATSON LABS INC AB1 AB1 GENGRAF ABBVIE AB1 AB1 AB1 NEORAL NOVARTIS AB1 AB1 + CYCLOSPORINE APOTEX AB2 AB2 SANDIMMUNE NOVARTIS AB2 AB2 + SANDIMMUNE BX NOVARTIS EMULSION; OPHTHALMIC RESTASIS XX + ALLERGAN INJECTABLE; INJECTION CYCLOSPORINE BEDFORD AP LUITPOLD AP SANDIMMUNE AP + NOVARTIS SOLUTION; ORAL CYCLOSPORINE ABBVIE AB1 IVAX SUB TEVA PHARMS AB1 NOVEX AB1 WATSON LABS AB1 NEORAL AB1 + NOVARTIS CYCLOSPORINE WOCKHARDT AB2 SANDIMMUNE AB2 + NOVARTIS
25MG 50MG 100MG 25MG 100MG 25MG 100MG 25MG 50MG 100MG 25MG 100MG 25MG 100MG 25MG 100MG 50MG
A065110 A065110 A065110 A065017 A065017 A065044 A065044 A065003 A065003 A065003 N050715 N050715 A065040 A065040 N050625 N050625 N050625
003 001 002 002 001 002 001 001 002 003 001 002 001 002 001 002 003
Mar Mar Mar Jan Jan Dec Dec
29, 29, 29, 13, 13, 20, 20,
2005 2005 2005 2000 2000 2000 2000
May 12, 2000 May 12, 2000 May 12, 2000 Jul 14, 1995 Jul 14, 1995 May 09, 2002 May 09, 2002 Mar 02, 1990 Mar 02, 1990 Nov 23, 1992
0.05%
N050790
001
Dec 23, 2002
A065004 A065151 N050573
001 001 001
Oct 29, 1999 Oct 07, 2003 Nov 14, 1983
100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML
A065025 A065078 A065167 A065054 N050716 A065133 N050574
001 001 001 001 001 001 001
Mar Mar Jan Dec
03, 25, 05, 18,
2000 2005 2005 2001
Jul 14, 1995 Sep 17, 2004 Nov 14, 1983
CYPROHEPTADINE HYDROCHLORIDE
SYRUP; ORAL CYPROHEPTADINE HYDROCHLORIDE AA + LYNE 2MG/5ML
A040668
001
Jun 28, 2006

TABLET; ORAL CYPROHEPTADINE HYDROCHLORIDE COREPHARMA 4MG + IVAX SUB TEVA PHARMS 4MG PAR PHARM 4MG STASON PHARMS 4MG
3 - 114 (of 428)
AA AA AA AA
A040537 A087056 A087129 A040644
001 001 001 001
Sep 30, 2003
May 30, 2006
CYSTEAMINE BITARTRATE
CAPSULE; ORAL CYSTAGON XX MYLAN XX +
N020392 N020392
001 002
Aug 15, 1994 Aug 15, 1994
CYSTEAMINE HYDROCHLORIDE
CYSTARAN
XX + SIGMA TAU EQ 0.44% BASE
N200740
001
Oct 02, 2012
CYTARABINE
INJECTABLE; INJECTION CYTARABINE BEDFORD AP 100MG/VIAL AP 500MG/VIAL AP 1GM/VIAL AP 2GM/VIAL AP + FRESENIUS KABI USA 100MG/ML AP + HOSPIRA 20MG/ML AP + 20MG/ML AP + 20MG/ML AP 100MG/ML ONCO THERAPIES LTD AP 20MG/ML AP 20MG/ML AP 20MG/ML AP 100MG/ML CYTOSAR-U TEVA PARENTERAL AP 100MG/VIAL AP + 500MG/VIAL AP + 1GM/VIAL AP + 2GM/VIAL INJECTABLE, LIPOSOMAL; INJECTION
DEPOCYT
10MG/ML XX + PACIRA PHARMS INC
001 001 001 002 001 001 001 001 001 001 001 001 001 001 002 004 003
Aug Aug Aug Aug Jan Jun Aug Feb Nov Dec Dec Dec Jan Dec Dec Dec Dec
02, 02, 31, 31, 15, 04, 31, 28, 22, 13, 13, 13, 30, 30, 30, 30, 30,
1989 1989 1994 1994 2004 1990 1990 1994 1999 2011 2011 2011 2012 1998 1998 1998 1998
N021041
001
Apr 01, 1999
DABIGATRAN ETEXILATE MESYLATE

CAPSULE; ORAL PRADAXA BOEHRINGER INGELHEIM XX XX +
N022512 N022512
001 002
Oct 19, 2010 Oct 19, 2010
DACARBAZINE
INJECTABLE; INJECTION DACARBAZINE BEDFORD AP AP FRESENIUS KABI USA AP AP HOSPIRA AP TEVA PARENTERAL AP AP +
200MG/VIAL 500MG/VIAL 100MG/VIAL 200MG/VIAL 200MG/VIAL 200MG/VIAL 500MG/VIAL
A075812 A075812 A075371 A075371 A075940 A075259 A075259
001 002 001 002 001 002 001
Jun Oct Aug Aug Oct Aug Sep
15, 31, 27, 27, 18, 27, 22,
2001 2002 1999 1999 2001 1998 2000

DACARBAZINE
INJECTABLE; INJECTION DTIC-DOME AP + BAYER HLTHCARE AP +
3 - 115 (of 428)
N017575 N017575
001 002
DACTINOMYCIN
INJECTABLE; INJECTION COSMEGEN AP + LUNDBECK LLC DACTINOMYCIN BEDFORD AP
0.5MG/VIAL 0.5MG/VIAL
N050682 A090304
001 001 Mar 16, 2010
DALFAMPRIDINE
TABLET, EXTENDED RELEASE; ORAL
AMPYRA
10MG XX + ACORDA
N022250
001
Jan 22, 2010
DALFOPRISTIN; QUINUPRISTIN
SYNERCID
XX + KING PHARMS 350MG/VIAL;150MG/VIAL
N050748
001
Sep 21, 1999
DALTEPARIN SODIUM
INJECTABLE; SUBCUTANEOUS FRAGMIN XX EISAI INC XX XX XX XX XX XX XX XX XX +
2,500IU/0.2ML (12,500IU/ML) 5,000IU/0.2ML (25,000IU/ML) 7,500IU/0.3ML (25,000IU/ML) 10,000IU/ML (10,000IU/ML) 10,000IU/0.4ML (25,000IU/ML) 12,500IU/0.5ML (25,000IU/ML) 15,000IU/0.6ML (25,000IU/ML) 18,000IU/0.72ML (25,000IU/ML) 95,000IU/9.5ML (10,000IU/ML) 95,000IU/3.8ML (25,000IU/ML)
N020287 N020287 N020287 N020287 N020287 N020287 N020287 N020287 N020287 N020287
001 003 005 004 002 009 010 011 007 006
Dec Mar Apr Jan May May May May Apr Apr
22, 18, 04, 30, 01, 01, 01, 01, 04, 04,
1994 1996 2002 1998 2007 2007 2007 2007 2002 2002
DANAZOL
CAPSULE; ORAL DANAZOL BARR AB AB AB + LANNETT AB AB AB
50MG 100MG 200MG 50MG 100MG 200MG
A074582 A074582 A074582 A078214 A078214 A077246
003 002 001 001 002 001
May May Aug Apr Apr Sep
29, 29, 09, 19, 19, 28,
1998 1998 1996 2007 2007 2005
DANTROLENE SODIUM
CAPSULE; ORAL DANTRIUM JHP PHARMS AB AB AB + DANTROLENE SODIUM IMPAX LABS AB AB AB INJECTABLE; INJECTION DANTRIUM AP + JHP PHARMS DANTROLENE SODIUM US WORLDMEDS AP
25MG 50MG 100MG 25MG 50MG 100MG
N017443 N017443 N017443 A076856 A076856 A076856
001 003 002 001 002 003 Mar 01, 2005 Mar 01, 2005 Mar 01, 2005
20MG/VIAL 20MG/VIAL
N018264 A078378
001 001 Jul 24, 2007

DAPSONE
GEL; TOPICAL
ACZONE
XX + ALLERGAN TABLET; ORAL DAPSONE
XX JACOBUS XX +
3 - 116 (of 428)
5%
N021794
001
Jul 07, 2005
25MG 100MG
A086841 A086842
001
001
DAPTOMYCIN
CUBICIN
XX + CUBIST 500MG/VIAL
N021572
002
Sep 12, 2003
DARIFENACIN HYDROBROMIDE
TABLET, EXTENDED RELEASE; ORAL ENABLEX XX WARNER CHILCOTT LLC EQ 7.5MG BASE XX + EQ 15MG BASE
N021513 N021513
001 002
Dec 22, 2004 Dec 22, 2004
DARUNAVIR ETHANOLATE
SUSPENSION; ORAL
PREZISTA
XX + JANSSEN PRODS TABLET; ORAL PREZISTA XX JANSSEN PRODS XX XX XX XX +
EQ 100MG BASE/ML
N202895
001
Dec 16, 2011
EQ EQ EQ EQ EQ
75MG BASE 150MG BASE 400MG BASE 600MG BASE 800MG BASE
N021976 N021976 N021976 N021976 N021976
004 005 003 002 006
Dec Dec Oct Feb Nov
18, 18, 21, 25, 09,
2008 2008 2008 2008 2012
DASATINIB
TABLET; ORAL SPRYCEL BRISTOL MYERS SQUIBB XX XX XX XX XX XX +
20MG 50MG 70MG 80MG 100MG 140MG
N021986 N021986 N021986 N021986 N021986 N021986
001 002 003 005 004 006
Jun Jun Jun Oct May Oct
28, 28, 28, 28, 30, 28,
2006 2006 2006 2010 2008 2010
DAUNORUBICIN CITRATE
DAUNOXOME
XX + GALEN (UK) EQ 2MG BASE/ML
N050704
002
Apr 08, 1996
DAUNORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION CERUBIDINE + BEDFORD EQ DAUNORUBICIN HYDROCHLORIDE + BEDFORD EQ FRESENIUS KABI USA EQ TEVA PARENTERAL EQ DAUNORUBICIN HYDROCHLORIDE FRESENIUS KABI USA EQ
AP AP AP AP XX
20MG BASE/VIAL 5MG BASE/ML 20MG BASE/VIAL 5MG BASE/ML 5MG BASE/VIAL
A064103 N050731 A065000 A065035 A065034
001 001 001 001 001
Feb 03, 1995 Jan 30, 1998 May 25, 1999 Jan 24, 2000 Nov 20, 2001
DECITABINE
DACOGEN
XX + EISAI INC
50MG/VIAL
N021790
001
May 02, 2006

DEFERASIROX
TABLET, FOR SUSPENSION; ORAL EXJADE XX NOVARTIS 125MG XX 250MG XX + 500MG
3 - 117 (of 428)
N021882 N021882 N021882
001 002 003
Nov 02, 2005 Nov 02, 2005 Nov 02, 2005
DEFERIPRONE
TABLET; ORAL
FERRIPROX
XX + APOPHARMA INC
500MG
N021825
001
Oct 14, 2011
DEFEROXAMINE MESYLATE
INJECTABLE; INJECTION DEFEROXAMINE MESYLATE BEDFORD AP AP FRESENIUS KABI USA AP AP HOSPIRA AP AP WATSON LABS AP AP DESFERAL AP + NOVARTIS AP +
500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL
A078086 A078086 A078718 A078718 A076019 A076019 A076806 A076806 N016267 N016267
001 002 001 002 001 002 001 002 001 002
May May Sep Sep Mar Mar Mar Mar
30, 30, 15, 15, 17, 17, 31, 31,
2007 2007 2009 2009 2004 2004 2006 2006
May 25, 2000
DEGARELIX ACETATE
POWDER; SUBCUTANEOUS FIRMAGON XX FERRING XX +
N022201 N022201
001 002
Dec 24, 2008 Dec 24, 2008
DELAVIRDINE MESYLATE
TABLET; ORAL RESCRIPTOR VIIV HLTHCARE XX XX +
100MG 200MG
N020705 N020705
001 002
Apr 04, 1997 Jul 14, 1999
DEMECLOCYCLINE HYDROCHLORIDE
TABLET; ORAL DEMECLOCYCLINE HYDROCHLORIDE AMNEAL PHARM AB 150MG AB + 300MG BARR AB 150MG AB 300MG IMPAX LABS AB 150MG AB 300MG VERSAPHARM AB 150MG AB 300MG
A065425 A065425 A065171 A065171 A065094 A065094 A065389 A065389
001 002 001 002 001 002 001 002
Feb Feb Dec Dec Mar Mar Dec Dec
27, 27, 13, 13, 22, 22, 01, 01,
2008 2008 2004 2004 2004 2004 2008 2008
DESFLURANE
LIQUID; INHALATION
SUPRANE
XX + BAXTER HLTHCARE
99.9%
N020118
001
Sep 18, 1992
DESIPRAMINE HYDROCHLORIDE
TABLET; ORAL DESIPRAMINE HYDROCHLORIDE ACTAVIS TOTOWA AB 10MG AB 25MG AB 50MG
A074430 A071601 A071588
001 001 001
Feb 09, 1996 Jun 05, 1987 Jun 05, 1987

TABLET; ORAL DESIPRAMINE HYDROCHLORIDE ACTAVIS TOTOWA 75MG 100MG 150MG SANDOZ 10MG 25MG 50MG 75MG 100MG 150MG NORPRAMIN SANOFI AVENTIS US 10MG 25MG 50MG 75MG + 100MG 150MG
3 - 118 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 001 002 001 001 001 001 001 001 007 001 003 004 005 006
Oct Oct Feb May May May Jun Jun Jun
05, 05, 09, 24, 24, 24, 20, 20, 20,
1987 1987 1996 1988 1988 1988 1988 1988 1988
Feb 11, 1982
DESIRUDIN RECOMBINANT
INJECTABLE; SUBCUTANEOUS IPRIVASK XX + CANYON
15MG/VIAL
N021271
001
Apr 04, 2003
DESLORATADINE
SYRUP; ORAL CLARINEX XX + MERCK SHARP DOHME TABLET; ORAL CLARINEX + MERCK SHARP DOHME DESLORATADINE BELCHER PHARMS DR REDDYS LABS LTD LUPIN PHARMS MYLAN PHARMS INC ORCHID HLTHCARE PERRIGO R AND D SANDOZ SUN PHARM INDS
0.5MG/ML
N021300
001
Sep 01, 2004
AB AB AB AB AB AB AB AB AB
5MG
N021165 A078355 A078365 A078352 A078351 A078357 A078361 A078364 A078359
001 001 001 001 001 001 001 001 001
Dec 21, 2001 Apr Mar Oct Feb Feb Dec Dec Nov 19, 08, 25, 10, 19, 22, 03, 16, 2012 2011 2010 2012 2010 2011 2010 2010
AB AB AB AB
5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG TABLET, ORALLY DISINTEGRATING; ORAL CLARINEX MERCK SHARP DOHME 2.5MG 5MG + DESLORATADINE REDDYS 2.5MG 5MG
N021312 N021312 A078367 A078367
002 001 001 002
Jul 14, 2005 Jun 26, 2002 Jul 12, 2010 Jul 12, 2010
DESLORATADINE; PSEUDOEPHEDRINE SULFATE

TABLET, EXTENDED RELEASE; ORAL CLARINEX D 24 HOUR AB + MERCK SHARP DOHME 5MG;240MG DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR DR REDDYS LABS LTD AB 5MG;240MG CLARINEX-D 12 HOUR 2.5MG;120MG XX + MERCK SHARP DOHME
N021605 A078366 N021313
001 001 001
Mar 03, 2005 Apr 26, 2011 Feb 01, 2006
DESMOPRESSIN ACETATE
INJECTABLE; INJECTION DDAVP AP + SANOFI AVENTIS US
0.004MG/ML
N018938
001
Mar 30, 1984

INJECTABLE; INJECTION DESMOPRESSIN ACETATE HOSPIRA AP TEVA PARENTERAL AP SOLUTION; NASAL DDAVP AB + SANOFI AVENTIS US DESMOPRESSIN ACETATE SUN PHARM INDS AB
3 - 119 (of 428)
0.004MG/ML 0.004MG/ML
A075220 A074888
001 001
Aug 28, 2000 Oct 15, 1997
0.01%
N017922 A077212
001 001 Apr 12, 2012
AB AB AB AB XX
0.01% SPRAY, METERED; NASAL DDAVP (NEEDS NO REFRIGERATION) + SANOFI AVENTIS US 0.01MG/SPRAY DESMOPRESSIN ACETATE + BAUSCH AND LOMB 0.01MG/SPRAY DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) APOTEX INC 0.01MG/SPRAY MINIRIN + FERRING 0.01MG/SPRAY STIMATE (NEEDS NO REFRIGERATION) + CSL BEHRING 1.5MG/SPRAY
N017922 A074830 A076703 N021333 N020355
003 001 001 001 002
Aug 07, 1996 Jan 25, 1999 Jan 27, 2005 Sep 16, 2002 Oct 24, 2007
TABLET; ORAL DDAVP SANOFI AVENTIS US AB AB + DESMOPRESSIN ACETATE APOTEX INC AB AB TEVA PHARMS AB AB WATSON LABS AB AB DESMOPRESSIN ACETATE FERRING XX XX +
0.1MG 0.2MG 0.1MG 0.2MG 0.1MG 0.2MG 0.1MG 0.2MG 0.1MG 0.2MG
N019955 N019955 A077414 A077414 A077122 A077122 A076470 A076470 N021795 N021795
001 002 001 002 001 002 001 002 001 002
Sep 06, 1995 Sep 06, 1995 Mar Mar Jan Jan Jul Jul 07, 07, 25, 25, 01, 01, 2006 2006 2006 2006 2005 2005
May 08, 2008 May 08, 2008
DESOGESTREL; ETHINYL ESTRADIOL

TABLET; ORAL-28 CYCLESSA AB + ORGANON USA INC DESOGEN ORGANON USA INC DESOGESTREL AND ETHINYL DURAMED PHARMS BARR WATSON LABS EMOQUETTE VINTAGE PHARMS LLC KARIVA BARR MIRCETTE + TEVA BRANDED PHARM ORTHO-CEPT + JANSSEN PHARMS VELIVET DURAMED PHARMS BARR VIORELE GLENMARK GENERICS
0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0. N021090 025MG 0.15MG;0.03MG ESTRADIOL 0.15MG;0.03MG 0.15MG,N/A;0.02MG,0.01MG 0.15MG;0.03MG 0.15MG;0.03MG 0.15MG,N/A;0.02MG,0.01MG 0.15MG,N/A;0.02MG,0.01MG 0.15MG;0.03MG N020071 A075256 A076916 A076915 A076675 A075863 N020713 N020301
001
Dec 20, 2000
002 002 001 001 001 001 001 002 001
Dec 10, 1992 Aug 12, 1999 Dec 29, 2008 Jul 29, 2005 Feb 25, 2011 Apr 05, 2002 Apr 22, 1998 Dec 14, 1992 Feb 24, 2004
0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0. A076455 025MG 0.15MG,N/A;0.02MG,0.01MG A091346
AB
001
Apr 02, 2012

DESONIDE
AEROSOL, FOAM; TOPICAL
VERDESO
+ STIEFEL LABS INC CREAM; TOPICAL DESONIDE + PERRIGO NEW YORK TARO DESOWEN GALDERMA LABS LP
3 - 120 (of 428)
XX
0.05%
N021978
001
Sep 19, 2006
AB AB AB
0.05% 0.05% 0.05%
N017010 A073548 N019048
001 001 001
Jun 30, 1992 Dec 14, 1984
GEL; TOPICAL DESONATE XX + BHP DERMATOLOGY LOTION; TOPICAL DESONIDE FOUGERA PHARMS AB DESOWEN AB + GALDERMA LABS LP OINTMENT; TOPICAL DESONIDE FOUGERA PHARMS AB AB + PERRIGO NEW YORK TARO AB DESOWEN GALDERMA LABS LP AB
0.05%
N021844
001
Oct 20, 2006
0.05% 0.05%
A075860 A072354
001 001
Mar 19, 2002 Jan 24, 1992
0.05% 0.05% 0.05% 0.05%
A075751 N017426 A074254 A071425
001 001 001 001
Mar 12, 2001 Aug 03, 1994 Jun 15, 1988
DESOXIMETASONE
CREAM; TOPICAL DESOXIMETASONE FOUGERA PHARMS PERRIGO NEW YORK TOPICORT + TARO TOPICORT + TARO GEL; TOPICAL DESOXIMETASONE PERRIGO NEW YORK VERSAPHARM TOPICORT + TARO
AB AB AB XX
0.25% 0.25% 0.25% 0.05%
A078369 A076510 A073193 A073210
001 001 001 001
Jun 29, 2010 Jul 01, 2003 Nov 30, 1990 Nov 30, 1990
AB AB AB
0.05% 0.05% 0.05%
A077552 A090727 A074904
001 001 001
Jan 09, 2006 Mar 10, 2011 Jul 14, 1998
OINTMENT; TOPICAL DESOXIMETASONE FOUGERA PHARMS AB TOPICORT AB + TARO TOPICORT XX + TARO PHARMS NORTH
0.25% 0.25% 0.05%
A078657 A074286 N018594
001 001 001
Sep 28, 2012 Jun 07, 1996 Jan 17, 1985
DESVENLAFAXINE SUCCINATE
PRISTIQ
XX + WYETH PHARMS INC EQ 50MG BASE XX + EQ 100MG BASE
N021992 N021992
001 002
Feb 29, 2008 Feb 29, 2008
DEXAMETHASONE
CONCENTRATE; ORAL
DEXAMETHASONE INTENSOL
XX + ROXANE 1MG/ML ELIXIR; ORAL DEXAMETHASONE LYNE AA 0.5MG/5ML
A088252
001
Sep 01, 1983
A090891
001
Jul 12, 2011

DEXAMETHASONE
ELIXIR; ORAL DEXAMETHASONE AA + STI PHARMA LLC VINTAGE PHARMS AA AA + WOCKHARDT IMPLANT; INTRAVITREAL
OZURDEX
XX + ALLERGAN
3 - 121 (of 428)
0.5MG/5ML 0.5MG/5ML 0.5MG/5ML
A084754 A091188 A088254
001 001 001
May 11, 2011 Jul 27, 1983
0.7MG
N022315
001
Jun 17, 2009
XX
XX
AB AB BP BP BP BP BP BP BP BP BP BP BP
SOLUTION; ORAL
DEXAMETHASONE
+ ROXANE 0.5MG/5ML SUSPENSION/DROPS; OPHTHALMIC
MAXIDEX
+ ALCON 0.1% TABLET; ORAL
DEXAMETHASONE ECR 1.5MG ROXANE 1.5MG DEXAMETHASONE PAR PHARM 0.5MG 0.75MG 1.5MG 4MG + 6MG ROXANE 0.5MG 0.75MG 1MG 2MG 4MG + 6MG
A088248
001
Sep 01, 1983
N013422
001
A040700 A084610 A088148 A088160 A088237 A088238 A088481 A084611 A084613 A088306 A087916 A084612 A088316
001 001 001 001 001 001 001 001 001 001 001 001 001
Aug 15, 2008
Apr Apr Apr Apr Nov
28, 28, 28, 28, 28,
1983 1983 1983 1983 1983
Sep 15, 1983 Aug 26, 1982 Sep 15, 1983
DEXAMETHASONE SODIUM PHOSPHATE

INJECTABLE; INJECTION DEXAMETHASONE SODIUM PHOSPHATE FRESENIUS KABI USA EQ 4MG PHOSPHATE/ML + EQ 10MG PHOSPHATE/ML + EQ 10MG PHOSPHATE/ML + HIKMA MAPLE EQ 10MG PHOSPHATE/ML + LUITPOLD EQ 4MG PHOSPHATE/ML PFIZER EQ 4MG PHOSPHATE/ML EQ 10MG PHOSPHATE/ML SOLUTION/DROPS; OPHTHALMIC, OTIC DEXAMETHASONE SODIUM PHOSPHATE + ALCON PHARMS LTD EQ 0.1% PHOSPHATE BAUSCH AND LOMB EQ 0.1% PHOSPHATE
A084916 A040491 A040572 A087702 A087440 A040803 A040802
001 001 001 001 001 001 001
Apr Apr Sep Jul Aug Aug
11, 22, 07, 21, 29, 29,
2003 2005 1982 1982 2008 2008
AT AT
A088771 A040069
001 001
Jan 16, 1985 Jul 26, 1996
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

OINTMENT; OPHTHALMIC MAXITROL AT + FALCON PHARMS 0.1%;EQ 3.5MG NEOMYCIN AND POLYMYXIN B SULFATES AND BAUSCH AND LOMB AT 0.1%;EQ 3.5MG FERA PHARMS AT 0.1%;EQ 3.5MG SUSPENSION; OPHTHALMIC NEOMYCIN AND POLYMYXIN B SULFATES AND ALCON PHARMS LTD AT 0.1%;EQ 3.5MG SUSPENSION/DROPS; OPHTHALMIC DEXASPORIN BAUSCH AND LOMB AT 0.1%;EQ 3.5MG MAXITROL ALCON AT 0.1%;EQ 3.5MG
BASE/GM;10,000 UNITS/GM DEXAMETHASONE BASE/GM;10,000 UNITS/GM BASE/GM;10,000 UNITS/GM DEXAMETHASONE BASE/ML;10,000 UNITS/ML
N050065 A064063 A062938
002 001 001 Jul 25, 1994 Jul 31, 1989
A062721
001
Nov 17, 1986
BASE/ML;10,000 UNITS/ML BASE/ML;10,000 UNITS/ML
A064135 A062341
001 001
Sep 13, 1995 May 22, 1984

SUSPENSION/DROPS; OPHTHALMIC MAXITROL AT + FALCON PHARMS 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
3 - 122 (of 428)
N050023
002
DEXAMETHASONE; TOBRAMYCIN
TOBRADEX
XX + ALCON
0.1%;0.3%
N050616
001
Sep 28, 1988
SUSPENSION/DROPS; OPHTHALMIC TOBRADEX AB + ALCON 0.1%;0.3% TOBRAMYCIN AND DEXAMETHASONE BAUSCH AND LOMB AB 0.1%;0.3% TOBRADEX ST 0.05%;0.3% XX + ALCON PHARMS LTD
N050592 A064134 N050818
001 001 001
Aug 18, 1988 Oct 27, 1999 Feb 13, 2009
DEXCHLORPHENIRAMINE MALEATE
SYRUP; ORAL
2MG/5ML XX + WOCKHARDT
A088251
001
Mar 23, 1984
DEXLANSOPRAZOLE
CAPSULE, DELAYED RELEASE; ORAL DEXILANT XX TAKEDA PHARMS 30MG XX + 60MG
N022287 N022287
001 002
Jan 30, 2009 Jan 30, 2009
DEXMEDETOMIDINE HYDROCHLORIDE
PRECEDEX
XX + HOSPIRA
EQ 100MCG BASE/ML (EQ100MCG BASE/ML)
N021038
001
Dec 17, 1999
DEXMETHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL FOCALIN XR NOVARTIS 5MG XX 10MG XX 15MG XX 20MG XX 25MG XX 30MG XX 35MG XX 40MG XX + TABLET; ORAL DEXMETHYLPHENIDATE HYDROCHLORIDE TEVA PHARMS AB 2.5MG AB 5MG AB 10MG FOCALIN NOVARTIS AB 2.5MG AB 5MG AB + 10MG
N021802 N021802 N021802 N021802 N021802 N021802 N021802 N021802
001 002 004 003 008 005 007 006
May May Aug May Apr Oct Apr Aug
26, 26, 01, 26, 21, 23, 21, 11,
2005 2005 2006 2005 2011 2009 2011 2010
A077107 A077107 A077107 N021278 N021278 N021278
003 001 002 001 002 003
Jan 29, 2007 Jan 29, 2007 Jan 29, 2007 Nov 13, 2001 Nov 13, 2001 Nov 13, 2001
DEXRAZOXANE HYDROCHLORIDE
INJECTABLE; INJECTION DEXRAZOXANE HYDROCHLORIDE BEDFORD EQ EQ MYLAN INSTITUTIONAL EQ EQ
AP AP AP AP
250MG 500MG 250MG 500MG
BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
A076068 A076068 A200752 A200752
001 002 001 002
Sep Sep Oct Oct
28, 28, 19, 19,
2004 2004 2011 2011

DEXRAZOXANE HYDROCHLORIDE
INJECTABLE; INJECTION ZINECARD AP + PHARMACIA AND UPJOHN AP + TOTECT XX + APRICUS PHARMS
3 - 123 (of 428)
N020212 N020212 N022025
001 002 001
May 26, 1995 May 26, 1995 Sep 06, 2007
DEXTROAMPHETAMINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL DEXEDRINE AMEDRA PHARMS AB 5MG AB 10MG AB + 15MG DEXTROAMPHETAMINE SULFATE ACTAVIS ELIZABETH AB 5MG AB 10MG AB 15MG BARR AB 5MG AB 10MG AB 15MG MALLINCKRODT AB 5MG AB 10MG AB 15MG SOLUTION; ORAL DEXTROAMPHETAMINE SULFATE 5MG/5ML XX + OUTLOOK PHARMS TABLET; ORAL DEXTROAMPHETAMINE SULFATE BARR AA 5MG AA + 10MG MALLINCKRODT AA 5MG AA 10MG MIKART AA 5MG AA 10MG DEXTROAMPHETAMINE SULFATE MIKART 2.5MG XX 7.5MG XX 15MG XX 20MG XX 30MG XX
N017078 N017078 N017078 A203901 A203901 A203901 A076137 A076137 A076137 A076353 A076353 A076353
001 002 003 001 002 003 001 002 003 001 002 003 Nov Nov Nov Jan Jan Jan May May May 30, 30, 30, 18, 18, 18, 06, 06, 06, 2012 2012 2012 2002 2002 2002 2003 2003 2003
A040776
001
Jan 29, 2008
A040361 A040361 A040436 A040436 A090533 A090533 A090533 A090533 A090533 A090533 A090533
001 002 001 002 002 004 001 003 005 006 007
Jan Jan Jan Jan Oct Oct Oct Oct Oct Oct Oct
31, 31, 29, 29, 25, 25, 25, 25, 25, 25, 25,
2001 2001 2002 2002 2011 2011 2011 2011 2011 2011 2011
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE

SYRUP; ORAL PROMETH W/ DEXTROMETHORPHAN + ACTAVIS MID ATLANTIC 15MG/5ML;6.25MG/5ML PROMETHAZINE DM VINTAGE 15MG/5ML;6.25MG/5ML PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE AMNEAL PHARMS 15MG/5ML;6.25MG/5ML HI TECH PHARMA 15MG/5ML;6.25MG/5ML TRIS PHARMA INC 15MG/5ML;6.25MG/5ML PROMETHAZINE W/ DEXTROMETHORPHAN WOCKHARDT 15MG/5ML;6.25MG/5ML
AA AA AA AA AA AA
A088762 A040649 A090575 A040027 A091687 A088864
001 001 001 001 001 001
Oct 31, 1984 Feb 14, 2006 Feb 08, 2011 Jul 31, 1996 Jun 28, 2012 Jan 04, 1985
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE

CAPSULE; ORAL NUEDEXTA XX + AVANIR PHARMS
20MG;10MG
N021879
001
Oct 29, 2010

DEXTROSE
INJECTABLE; INJECTION DEXTROSE 10% IN PLASTIC CONTAINER + B BRAUN 10GM/100ML + BAXTER HLTHCARE 10GM/100ML + HOSPIRA 10GM/100ML DEXTROSE 20% IN PLASTIC CONTAINER + BAXTER HLTHCARE 20GM/100ML + HOSPIRA 20GM/100ML DEXTROSE 30% IN PLASTIC CONTAINER + BAXTER HLTHCARE 30GM/100ML + HOSPIRA 30GM/100ML DEXTROSE 40% IN PLASTIC CONTAINER + BAXTER HLTHCARE 40GM/100ML + HOSPIRA 40GM/100ML DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 50MG/ML + 5GM/100ML + 5GM/100ML + BAXTER HLTHCARE 50MG/ML + 50MG/ML + 5GM/100ML + 5GM/100ML + HOSPIRA 50MG/ML + 50MG/ML + 5GM/100ML + 5GM/100ML DEXTROSE 50% IN PLASTIC CONTAINER + BAXTER HLTHCARE 50GM/100ML + 50GM/100ML HOSPIRA 500MG/ML + 50GM/100ML + 50GM/100ML DEXTROSE 60% IN PLASTIC CONTAINER + BAXTER HLTHCARE 60GM/100ML DEXTROSE 70% IN PLASTIC CONTAINER + BAXTER HLTHCARE 70GM/100ML + 70GM/100ML + HOSPIRA 70GM/100ML + 70GM/100ML DEXTROSE 25% + HOSPIRA 250MG/ML
3 - 124 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX
N019626 N016694 N018080 N017521 N018564 N017521 N019345 N017521 N018562 N016730 N016730 N019626 N016673 N020179 N016673 N020179 N016367 N019222 N019466 N019479 N017521 N020047 N019445 N018563 N019894 N017521 N017521 N020047 N018561 N019893 N019445
004 001 001 004 001 003 001 002 001 002 001 002 003 002 001 001 002 001 001 001 001 001 001 001 001 005 006 003 001 001 002
Feb 02, 1988
Mar 23, 1982
Jan 26, 1985
Mar 23, 1982
Feb 02, 1988 Oct 30, 1985 Dec 07, 1992 Dec 07, 1992 Jul 13, 1984 Jul 15, 1985 Sep 17, 1985
Jul Jun Mar Dec
02, 03, 23, 26,
1991 1986 1982 1989
Mar 26, 1982 Mar Jul Mar Dec 26, 02, 23, 26, 1982 1991 1982 1989
Nov 23, 1998
DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE

PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
XX BAXTER HLTHCARE 5GM/100ML;32MG/100ML;128MG/100ML;234MG/ N017385 100ML
001
DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE

NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
XX HOSPIRA 5GM/100ML;21MG/100ML;128MG/100ML;234MG/ N017610 100ML
001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
INJECTABLE; INJECTION ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML;26MG/1 N019873 XX 00ML;320MG/100ML
001
Jun 10, 1993
3 - 125 (of 428)
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE; INJECTION IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER XX HOSPIRA 5GM/100ML;53MG/100ML;100MG/100ML;100MG/ N019515 100ML;180MG/100ML;280MG/100ML;16MG/100M L
001
May 08, 1986
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER
XX BAXTER HLTHCARE 5GM/100ML;31MG/100ML;141MG/100ML;20MG/1 N017484 00ML;12MG/100ML;260MG/100ML
001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE; INJECTION IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER XX HOSPIRA 5GM/100ML;30MG/100ML;141MG/100ML;15MG/1 N019513 00ML;260MG/100ML;25MG/100ML
001
May 08, 1986
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

INJECTABLE; INJECTION ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;30MG/100ML;97MG/100ML;220MG/1 N019844 XX 00ML;140MG/100ML
001
Jun 10, 1993
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER XX B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;370MG/1 N019843 00ML;530MG/100ML;500MG/100ML NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER XX HOSPIRA 5GM/100ML;30MG/100ML;37MG/100ML;222MG/1 N017609 00ML;526MG/100ML;502MG/100ML PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER XX BAXTER HLTHCARE 5GM/100ML;30MG/100ML;37MG/100ML;368MG/1 N017451 00ML;526MG/100ML;502MG/100ML
001
Aug 09, 1993
001
001
DEXTROSE; POTASSIUM CHLORIDE

INJECTABLE; INJECTION DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;75MG/100ML DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;150MG/100ML DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;224MG/100ML DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;300MG/100ML POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;75MG/100ML POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;150MG/100ML 5GM/100ML;150MG/100ML POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;300MG/100ML 5GM/100ML;300MG/100ML POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;224MG/100ML POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;220MG/100ML
AP AP AP AP AP AP AP AP AP AP XX
N017634 N017634 N017634 N017634 N018744 N018744 N019699 N018744 N019699 N018371 N018744
004 001 003 002 001 002 004 004 006 003 003 Nov 09, 1982 Nov 09, 1982 Nov 09, 1982 Sep 29, 1989 Nov 09, 1982 Sep 29, 1989

POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
XX HOSPIRA 5GM/100ML;149MG/100ML POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
XX HOSPIRA 5GM/100ML;298MG/100ML
3 - 126 (of 428)
N018371 N018371
001
002
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER XX B BRAUN 5GM/100ML;150MG/100ML;130MG/100ML;280MG N019870 /100ML;91MG/100ML
001
Jun 10, 1993
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER XX BAXTER HLTHCARE 5GM/100ML;205MG/100ML;100MG/100ML;120MG N018840 /100ML;220MG/100ML
001
Jun 29, 1983
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

INJECTABLE; INJECTION DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ BAXTER HLTHCARE Apr 13, 1982 AP 5GM/100ML;75MG/100ML;200MG/100ML N018037 006 Apr 13, 1982 AP 5GM/100ML;150MG/100ML;200MG/100ML N018037 007 DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K) BAXTER HLTHCARE AP 5GM/100ML;224MG/100ML;200MG/100ML N018037 004 DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ BAXTER HLTHCARE Apr 13, 1982 AP 5GM/100ML;150MG/100ML;200MG/100ML N018037 008 DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) BAXTER HLTHCARE AP 5GM/100ML;300MG/100ML;200MG/100ML N018037 001 DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ BAXTER HLTHCARE Apr 13, 1982 AP 5GM/100ML;224MG/100ML;200MG/100ML N018037 005 DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ BAXTER HLTHCARE Apr 13, 1982 AP 5GM/100ML;300MG/100ML;200MG/100ML N018037 009 DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ BAXTER HLTHCARE AP 5GM/100ML;75MG/100ML;200MG/100ML N018037 002 DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) BAXTER HLTHCARE AP 5GM/100ML;150MG/100ML;200MG/100ML N018037 003 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 AP 5GM/100ML;75MG/100ML;330MG/100ML N018629 005 Mar 23, 1982 AP 5GM/100ML;150MG/100ML;330MG/100ML N018629 002 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 AP 5GM/100ML;224MG/100ML;330MG/100ML N018629 003 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 AP 5GM/100ML;150MG/100ML;330MG/100ML N018629 004 Mar 23, 1982 AP 5GM/100ML;300MG/100ML;330MG/100ML N018629 006 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 AP 5GM/100ML;224MG/100ML;330MG/100ML N018629 007 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 AP 5GM/100ML;300MG/100ML;330MG/100ML N018629 008 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 AP 5GM/100ML;75MG/100ML;330MG/100ML N018629 001 DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER BAXTER HLTHCARE AP 5GM/100ML;300MG/100ML;450MG/100ML N018008 010 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 AP 5GM/100ML;75MG/100ML;200MG/100ML N019630 008 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 AP 5GM/100ML;75MG/100ML;330MG/100ML N019630 014 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 AP 5GM/100ML;75MG/100ML;450MG/100ML N019630 020

3 - 127 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
INJECTABLE; INJECTION POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN Feb 17, 5GM/100ML;75MG/100ML;900MG/100ML N019630 026 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN Feb 17, 5GM/100ML;150MG/100ML;200MG/100ML N019630 010 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
B BRAUN Feb 17, 5GM/100ML;150MG/100ML;330MG/100ML N019630 016 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN Feb 17, 5GM/100ML;150MG/100ML;450MG/100ML N019630 022 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN Feb 17, 5GM/100ML;150MG/100ML;900MG/100ML N019630 028 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN Feb 17, 5GM/100ML;300MG/100ML;200MG/100ML N019630 012 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN Feb 17, 5GM/100ML;300MG/100ML;330MG/100ML N019630 018 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN Feb 17, 5GM/100ML;300MG/100ML;450MG/100ML N019630 024 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN Feb 17, 5GM/100ML;300MG/100ML;900MG/100ML N019630 030 POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 5GM/100ML;75MG/100ML;450MG/100ML N018008 005 Apr 28, 5GM/100ML;150MG/100ML;450MG/100ML N018008 006 HOSPIRA Jul 05, 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 009 Mar 28, 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 005 POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 5GM/100ML;75MG/100ML;900MG/100ML N019308 004 Apr 05, 5GM/100ML;150MG/100ML;900MG/100ML N019308 002 HOSPIRA Mar 24, 5GM/100ML;74.5MG/100ML;900MG/100ML N019691 002 Mar 24, 5GM/100ML;149MG/100ML;900MG/100ML N019691 004 POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER HOSPIRA Mar 28, 5GM/100ML;224MG/100ML;450MG/100ML N018362 006 POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA Mar 24, 5GM/100ML;224MG/100ML;900MG/100ML N019691 006 POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 5GM/100ML;150MG/100ML;450MG/100ML N018008 007 HOSPIRA Jul 05, 5GM/100ML;149MG/100ML;450MG/100ML N018362 010 Mar 28, 5GM/100ML;298MG/100ML;450MG/100ML N018362 007 POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 5GM/100ML;150MG/100ML;900MG/100ML N019308 005 Apr 05, 5GM/100ML;300MG/100ML;900MG/100ML N019308 003 HOSPIRA Mar 24, 5GM/100ML;149MG/100ML;900MG/100ML N019691 005 Mar 24, 5GM/100ML;298MG/100ML;900MG/100ML N019691 008 POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 5GM/100ML;224MG/100ML;450MG/100ML N018008 008 HOSPIRA 5GM/100ML;224MG/100ML;450MG/100ML N018362 002 POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 5GM/100ML;224MG/100ML;900MG/100ML N019308 006 HOSPIRA Mar 24, 5GM/100ML;224MG/100ML;900MG/100ML N019691 007 POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 5GM/100ML;300MG/100ML;450MG/100ML N018008 009 HOSPIRA 5GM/100ML;298MG/100ML;450MG/100ML N018362 003 POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 5GM/100ML;300MG/100ML;900MG/100ML N019308 007 HOSPIRA Mar 24, 5GM/100ML;298MG/100ML;900MG/100ML N019691 009 POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;150MG/100ML;450MG/100ML N018008 004 HOSPIRA Mar 28, 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 008 Mar 28, 5GM/100ML;149MG/100ML;450MG/100ML N018362 004 POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 5GM/100ML;150MG/100ML;900MG/100ML N019308 001
1988 1988
1988
1988 1988 1988 1988 1988 1988 1982 1982 1983 1988 1985 1985 1988 1988 1988 1988 1982 1983 1988 1985 1985 1988 1988 1982
1985 1988 1982
1985 1988
1988 1988 1985

3 - 128 (of 428)
INJECTABLE; INJECTION POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA Mar 24, 1988 AP 5GM/100ML;74.5MG/100ML;900MG/100ML N019691 001 Mar 24, 1988 AP 5GM/100ML;149MG/100ML;900MG/100ML N019691 003 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;37MG/100ML;200MG/100ML N019630 031 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;37MG/100ML;450MG/100ML N019630 037 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;37MG/100ML;900MG/100ML N019630 043 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;110MG/100ML N019630 001 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;200MG/100ML N019630 007 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;330MG/100ML N019630 013 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;450MG/100ML N019630 019 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;900MG/100ML N019630 025 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;75MG/100ML;200MG/100ML N019630 032 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;75MG/100ML;450MG/100ML N019630 038 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;75MG/100ML;900MG/100ML N019630 044 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER B BRAUN 3.3GM/100ML;75MG/100ML;300MG/100ML N019630 049 May 07, 1992 XX POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;75MG/100ML;110MG/100ML N019630 002 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;110MG/100ML;200MG/100ML N019630 033 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;110MG/100ML;450MG/100ML N019630 039 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;110MG/100ML;900MG/100ML N019630 045 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER B BRAUN 3.3GM/100ML;110MG/100ML;300MG/100ML N019630 050 May 07, 1992 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;110MG/100ML;110MG/100ML N019630 003 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;110MG/100ML;200MG/100ML N019630 009 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;110MG/100ML;330MG/100ML N019630 015 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;110MG/100ML;450MG/100ML N019630 021 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;110MG/100ML;900MG/100ML N019630 027 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;150MG/100ML;200MG/100ML N019630 034 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;150MG/100ML;450MG/100ML N019630 040 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;150MG/100ML;900MG/100ML N019630 046 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER B BRAUN 3.3GM/100ML;150MG/100ML;300MG/100ML N019630 051 May 07, 1992 XX POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;150MG/100ML;110MG/100ML N019630 004 Feb 17, 1988 XX POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;220MG/100ML;200MG/100ML N019630 035 Feb 17, 1988 XX

INJECTABLE; POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA POTASSIUM HOSPIRA
3 - 129 (of 428)
XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX
INJECTION CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 10GM/100ML;220MG/100ML;450MG/100ML N019630 041 Feb 17, CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 10GM/100ML;220MG/100ML;900MG/100ML N019630 047 Feb 17, CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 3.3GM/100ML;220MG/100ML;300MG/100ML N019630 052 May 07, CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;110MG/100ML N019630 005 Feb 17, CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;200MG/100ML N019630 011 Feb 17, CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;330MG/100ML N019630 017 Feb 17, CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;450MG/100ML N019630 023 Feb 17, CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;900MG/100ML N019630 029 Feb 17, CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 10GM/100ML;300MG/100ML;200MG/100ML N019630 036 Feb 17, CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 10GM/100ML;300MG/100ML;450MG/100ML N019630 042 Feb 17, CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 10GM/100ML;300MG/100ML;900MG/100ML N019630 048 Feb 17, CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 3.3GM/100ML;300MG/100ML;300MG/100ML N019630 053 May 07, CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;110MG/100ML N019630 006 Feb 17, CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER 5GM/100ML;74.5MG/100ML;225MG/100ML N018365 002 Jul 05, 5GM/100ML;149MG/100ML;225MG/100ML N018365 006 Mar 28, CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;74.5MG/100ML;300MG/100ML N018876 001 Jan 17, 5GM/100ML;149MG/100ML;300MG/100ML N018876 006 Mar 28, CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER 5GM/100ML;224MG/100ML;225MG/100ML N018365 008 Mar 28, CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;224MG/100ML;300MG/100ML N018876 007 Mar 28, CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER 5GM/100ML;149MG/100ML;225MG/100ML N018365 001 5GM/100ML;298MG/100ML;225MG/100ML N018365 009 Mar 28, CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;298MG/100ML;300MG/100ML N018876 008 Mar 28, CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;149MG/100ML;300MG/100ML N018876 002 Jan 17, CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER 5GM/100ML;224MG/100ML;225MG/100ML N018365 003 Jul 05, CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;224MG/100ML;300MG/100ML N018876 003 Jan 17, CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER 5GM/100ML;298MG/100ML;225MG/100ML N018365 004 Jul 05, CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;298MG/100ML;300MG/100ML N018876 004 Mar 28, CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER 5GM/100ML;74.5MG/100ML;225MG/100ML N018365 005 Mar 28, 5GM/100ML;149MG/100ML;225MG/100ML N018365 007 Mar 28, CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;74.5MG/100ML;300MG/100ML N018876 005 Mar 28, 5GM/100ML;149MG/100ML;300MG/100ML N018876 009 Mar 28,
1988 1988 1992 1988 1988 1988 1988 1988 1988 1988 1988 1992 1988 1983 1988 1986 1988 1988 1988
1988 1988 1986 1983 1986 1983 1988 1988 1988 1988 1988

DEXTROSE; SODIUM CHLORIDE
INJECTABLE; INJECTION DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;900MG/100ML BAXTER HLTHCARE 10GM/100ML;900MG/100ML DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML;450MG/100ML BAXTER HLTHCARE 2.5GM/100ML;450MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;200MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;330MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;450MG/100ML HOSPIRA 5GM/100ML;450MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;900MG/100ML HOSPIRA 5GM/100ML;900MG/100ML DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;200MG/100ML DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;330MG/100ML DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;450MG/100ML DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;900MG/100ML DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;110MG/100ML DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;200MG/100ML DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;330MG/100ML DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;450MG/100ML DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML;110MG/100ML DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML;200MG/100ML DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML;330MG/100ML DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML;900MG/100ML DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER B BRAUN 3.3GM/100ML;300MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;110MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;225MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;300MG/100ML
3 - 130 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX XX XX XX XX XX XX XX XX XX XX
N019631 N016696 N019631 N016697 N019631 N019631 N019631 N017607 N019631 N017585 N016689 N016687 N016683 N016678 N019631 N019631 N019631 N019631 N019631 N019631 N019631 N019631 N019631 N019631 N017606 N017799
015 001 004 001 007 008 009 001 010 001 001 001 001 001 011 012 013 014 001 002 003 005 016 006 001 001
Feb 24, 1988
Feb 24, 1988
Feb 24, 1988 Feb 24, 1988 Feb 24, 1988
Feb 24, 1988
Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Jan 19, 1990 Feb 24, 1988
DIATRIZOATE MEGLUMINE
SOLUTION; URETHRAL CYSTOGRAFIN XX BRACCO CYSTOGRAFIN DILUTE XX BRACCO
30% 18%
N010040 N010040
018 022 Nov 09, 1982
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

INJECTABLE; INJECTION MD-76R AP + MALLINCKRODT
66%;10%
N019292
001
Sep 29, 1989

INJECTABLE; INJECTION RENOGRAFIN-76 AP + BRACCO SOLUTION; ORAL, RECTAL GASTROGRAFIN AA + BRACCO MD-GASTROVIEW MALLINCKRODT AA
3 - 131 (of 428)
66%;10%
N010040
001
66%;10% 66%;10%
N011245 A087388
003 001
DIATRIZOATE MEGLUMINE; IODIPAMIDE MEGLUMINE

SOLUTION; INTRAUTERINE
SINOGRAFIN
XX + BRACCO
52.7%;26.8%
N011324
002
DIAZEPAM
CONCENTRATE; ORAL
DIAZEPAM INTENSOL
+ ROXANE GEL; RECTAL DIASTAT VALEANT DIASTAT ACUDIAL VALEANT +
XX
5MG/ML
A071415
001
Apr 03, 1987
XX XX XX
2.5MG/0.5ML (5MG/ML) 10MG/2ML (5MG/ML) 20MG/4ML (5MG/ML)
N020648 N020648 N020648
001 007 006
Jul 29, 1997 Sep 15, 2005 Sep 15, 2005
INJECTABLE; INJECTION DIAZEPAM AP + HOSPIRA AP WATSON LABS AP SOLUTION; ORAL

DIAZEPAM
XX + ROXANE TABLET; ORAL DIAZEPAM BARR AB AB DAVA PHARMS INC AB IVAX SUB TEVA PHARMS AB AB AB MYLAN AB AB AB VINTAGE PHARMS AB AB AB WATSON LABS AB AB AB VALIUM ROCHE AB AB AB +
A071583 A072079 A070296
001 001 001
Oct 13, 1987 Dec 20, 1988 Feb 12, 1986
5MG/5ML
A070928
001
Apr 03, 1987
001 001 001 001 001 001 002 003 001 001 002 003 001 001 001 002 004 006
Nov Nov Sep Dec Dec Dec Sep Sep Sep Mar Mar Mar Feb Feb Feb
01, 01, 26, 10, 10, 10, 04, 04, 04, 31, 31, 31, 03, 03, 03,
1985 1985 1985 1986 1986 1986 1985 1985 1985 2006 2006 2006 1987 1987 1987
DIAZOXIDE
SUSPENSION; ORAL
PROGLYCEM
XX + TEVA GLOBAL
50MG/ML
N017453
001

DICLOFENAC EPOLAMINE
PATCH; TOPICAL
FLECTOR
XX + INST BIOCHEM
3 - 132 (of 428)
1.3%
N021234
001
Jan 31, 2007
DICLOFENAC POTASSIUM
CAPSULE; ORAL
ZIPSOR
XX + DEPOMED INC FOR SOLUTION; ORAL
CAMBIA
XX + NAUTILUS NEUROSCIENC TABLET; ORAL CATAFLAM + NOVARTIS DICLOFENAC POTASSIUM APOTEX MYLAN SANDOZ TEVA
25MG
N022202
001
Jun 16, 2009
50MG
N022165
001
Jun 17, 2009
AB AB AB AB AB
N020142 A076561 A075463 A075229 A075219
002 001 001 001 001
Nov 24, 1993 Mar Jul Nov Aug 18, 26, 20, 06, 2004 1999 1998 1998
DICLOFENAC SODIUM
GEL; TOPICAL
SOLARAZE
+ FOUGERA PHARMS 3% VOLTAREN + NOVARTIS 1% SOLUTION; TOPICAL
PENNSAID
+ MALLINCKRODT 1.5% SOLUTION/DROPS; OPHTHALMIC DICLOFENAC SODIUM AKORN 0.1% ALCON PHARMS LTD 0.1% APOTEX INC 0.1% BAUSCH AND LOMB 0.1% NEXUS PHARMS 0.1% VOLTAREN + NOVARTIS 0.1% TABLET, DELAYED RELEASE; ORAL DICLOFENAC SODIUM ACTAVIS ELIZABETH 50MG 75MG CARLSBAD 25MG 50MG 75MG MYLAN PHARMS INC 50MG 75MG + SANDOZ 25MG + 50MG + 75MG UNIQUE PHARM LABS 25MG 50MG 75MG TABLET, EXTENDED RELEASE; ORAL DICLOFENAC SODIUM ACTAVIS ELIZABETH 100MG DEXCEL LTD 100MG MYLAN 100MG VALEANT INTL 100MG VOLTAREN-XR + NOVARTIS 100MG
XX XX
N021005 N022122
001 001
Oct 16, 2000 Oct 17, 2007
XX
N020947
001
Nov 04, 2009
AT AT AT AT AT AT
A077845 A078031 A077600 A078792 A078553 N020037
001 001 001 001 001 001
Apr Feb Nov Dec Dec
17, 06, 13, 28, 28,
2008 2008 2008 2007 2007
Mar 28, 1991
A074514 A074514 A075185 A075185 A075185 A075281 A075281 A074376 A074376 A074394 A090066 A090066 A077863
001 002 002 003 001 002 003 001 002 001 001 002 003
Mar Mar Nov Nov Nov Feb Feb Sep Sep Nov Dec Dec Jun
26, 26, 13, 13, 13, 12, 12, 28, 28, 30, 01, 01, 08,
1996 1996 1998 1998 1998 2002 2002 1995 1995 1995 2010 2010 2007
AB AB AB AB AB
A075910 A076201 A076152 A075492 N020254
001 001 001 001 001
Jan Nov Dec Feb
07, 06, 13, 11,
2002 2002 2001 2000
Mar 08, 1996

DICLOFENAC SODIUM; MISOPROSTOL
TABLET, DELAYED RELEASE; ORAL ARTHROTEC GD SEARLE LLC 50MG;0.2MG + 75MG;0.2MG DICLOFENAC SODIUM AND MISOPROSTOL WATSON LABS INC 50MG;0.2MG 75MG;0.2MG
3 - 133 (of 428)
AB AB AB AB
N020607 N020607 A201089 A201089
001 002 001 002
Dec 24, 1997 Dec 24, 1997 Jul 09, 2012 Jul 09, 2012
DICLOXACILLIN SODIUM
CAPSULE; ORAL DICLOXACILLIN SODIUM SANDOZ AB AB + TEVA AB AB DICLOXACILLIN SODIUM
SANDOZ XX
EQ EQ EQ EQ
250MG 500MG 250MG 500MG
BASE BASE BASE BASE
A061454 A061454 A062286 A062286 A061454
001 003 001 002 002
Jun 03, 1982 Jun 03, 1982
EQ 125MG BASE
DICYCLOMINE HYDROCHLORIDE
CAPSULE; ORAL BENTYL + APTALIS PHARMA US 10MG DICYCLOMINE HYDROCHLORIDE LANNETT 10MG MYLAN 10MG WATSON LABS 10MG WEST WARD 10MG INJECTABLE; INJECTION BENTYL + APTALIS PHARMA US 10MG/ML BENTYL PRESERVATIVE FREE + APTALIS PHARMA US 10MG/ML DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE) BEDFORD 10MG/ML SYRUP; ORAL BENTYL + APTALIS PHARMA US 10MG/5ML DICYCLOMINE HYDROCHLORIDE MIKART 10MG/5ML TABLET; ORAL BENTYL + APTALIS PHARMA US 20MG DICYCLOMINE HYDROCHLORIDE LANNETT 20MG MYLAN 20MG WATSON LABS 20MG WEST WARD 20MG
AB AB AB AB AB
N007409 A084285 A040319 A085082 A040204
003 001 001 001 001
Oct 15, 1984
Sep 07, 1999 Jun 19, 1986 Feb 28, 1997
AP AP AP
N008370 N008370 A040465
001 002 001
Oct 15, 1984 Oct 15, 1984 Jun 30, 2003
AA AA
N007961 A040169
002 001
Oct 15, 1984 Mar 24, 2005
AB AB AB AB AB
N007409 A040230 A040317 A085223 A040161
001 001 001 001 001
Oct 15, 1984 Feb Sep Jul Oct 26, 07, 30, 01, 1999 1999 1986 1996
DIDANOSINE
CAPSULE, DELAYED REL PELLETS; ORAL DIDANOSINE AUROBINDO PHARMA AB 125MG AB 200MG AB 250MG AB 400MG BARR AB 200MG AB 250MG AB 400MG MYLAN PHARMS INC AB 125MG AB 200MG AB 250MG
A090094 A090094 A090094 A090094 A077167 A077167 A077167 A090788 A090788 A090788
001 002 003 004 001 002 003 001 002 003
Sep Sep Sep Sep Dec Dec Dec Apr Apr Apr
24, 24, 24, 24, 03, 03, 03, 08, 08, 08,
2008 2008 2008 2008 2004 2004 2004 2010 2010 2010

DIDANOSINE
CAPSULE, DELAYED REL PELLETS; ORAL DIDANOSINE MYLAN PHARMS INC 400MG VIDEX EC BRISTOL MYERS SQUIBB 125MG 200MG 250MG + 400MG FOR SOLUTION; ORAL DIDANOSINE AUROBINDO PHARMA 10MG/ML VIDEX + BRISTOL MYERS SQUIBB 10MG/ML TABLET, CHEWABLE; ORAL DIDANOSINE AUROBINDO 100MG 150MG + 200MG
3 - 134 (of 428)
AB AB AB AB AB
A090788 N021183 N021183 N021183 N021183
004 001 002 003 004
Apr 08, 2010 Oct Oct Oct Oct 31, 31, 31, 31, 2000 2000 2000 2000
AA AA
A078112 N020156
001 001
Mar 08, 2007 Oct 09, 1991
XX XX XX
A077275 A077275 A077275
001 002 003
Aug 14, 2012 Aug 14, 2012 Aug 14, 2012
DIENOGEST; ESTRADIOL VALERATE

TABLET; ORAL, ORAL-28
NATAZIA
XX + BAYER HLTHCARE
N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A N022252
001
May 06, 2010
DIETHYLPROPION HYDROCHLORIDE
TABLET; ORAL DIETHYLPROPION HYDROCHLORIDE AVANTHI INC 25MG COREPHARMA 25MG LANNETT HOLDINGS INC 25MG TENUATE + WATSON PHARMS 25MG TABLET, EXTENDED RELEASE; ORAL DIETHYLPROPION HYDROCHLORIDE LANNETT HOLDINGS INC 75MG TENUATE DOSPAN + WATSON PHARMS 75MG
AA AA AA AA
A201212 A040828 A200177 N011722
001 001 001 002
Dec 22, 2010 Nov 05, 2008 Jul 18, 2011
AB AB
A091680 N012546
001 001
Oct 24, 2011
DIFLORASONE DIACETATE
CREAM; TOPICAL DIFLORASONE DIACETATE AB1 + FOUGERA PHARMS TARO AB1 DIFLORASONE DIACETATE BX + FOUGERA PHARMS OINTMENT; TOPICAL DIFLORASONE DIACETATE FOUGERA PHARMS AB AB + TARO
0.05% 0.05% 0.05%
A075187 A075508 A076263
001 001 001
Mar 30, 1998 Apr 24, 2000 Dec 20, 2002
0.05% 0.05%
A075374 A075331
001 001
Apr 27, 1999 May 14, 1999
DIFLUNISAL
TABLET; ORAL DIFLUNISAL EMCURE PHARMS USA AB AB + TEVA
500MG 500MG
A202845 A073673
001 001
Mar 08, 2012 Jul 31, 1992
DIFLUPREDNATE
EMULSION; OPHTHALMIC
DUREZOL
0.05%
N022212
001
Jun 23, 2008

DIGOXIN
ELIXIR; ORAL DIGOXIN + ROXANE INJECTABLE; INJECTION DIGOXIN HIKMA MAPLE SANDOZ LANOXIN + COVIS PHARMA LANOXIN PEDIATRIC + COVIS PHARMA TABLET; ORAL DIGOXIN CARACO IMPAX LABS STEVENS J WEST WARD LANOXIN COVIS PHARMA +
3 - 135 (of 428)
XX
0.05MG/ML
N021648
001
Aug 26, 2004
AP AP AP XX
0.25MG/ML 0.25MG/ML 0.25MG/ML 0.1MG/ML
A083391 A040481 N009330 N009330
001 001 002 004
Aug 21, 2003
A076363 A076363 A078556 A078556 A076268 A076268 A077002 A077002 N020405 N020405
001 002 001 002 001 002 002 001 002 004
Jan Jan Jul Jul Jul Jul Oct Oct
31, 31, 20, 20, 26, 26, 30, 30,
2003 2003 2009 2009 2002 2002 2007 2007
Sep 30, 1997 Sep 30, 1997
DIHYDROERGOTAMINE MESYLATE
INJECTABLE; INJECTION D.H.E. 45 + VALEANT 1MG/ML DIHYDROERGOTAMINE MESYLATE BEDFORD LABS 1MG/ML PADDOCK LLC 1MG/ML SPRAY, METERED; NASAL MIGRANAL + VALEANT 0.5MG/INH
AP AP AP
N005929 A040453 A040475
001 001 001 Jun 09, 2003 Apr 28, 2003
XX
N020148
001
Dec 08, 1997
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL DILACOR XR WATSON LABS AB2 120MG AB2 180MG AB2 + 240MG DILTIAZEM HYDROCHLORIDE APOTEX AB2 120MG AB2 180MG AB2 240MG MYLAN AB2 120MG AB2 180MG AB2 240MG WATSON LABS FLORIDA AB2 120MG AB2 180MG AB2 240MG CARDIZEM CD VALEANT INTL AB3 120MG AB3 180MG AB3 240MG AB3 300MG AB3 + 360MG CARTIA XT WATSON LABS FLORIDA AB3 120MG
N020092 N020092 N020092 A074943 A074943 A074943 A075124 A075124 A075124 A074852 A074852 A074852 N020062 N020062 N020062 N020062 N020062 A074752
001 002 003 003 002 001 002 003 001 001 002 003 001 002 003 004 005 002
May 29, 1992 May 29, 1992 May 29, 1992 Dec Dec Aug Mar Mar Mar Oct Oct Oct Aug Dec Dec Dec Aug 19, 19, 06, 18, 18, 18, 10, 10, 10, 10, 27, 27, 27, 24, 2000 2000 1998 1998 1998 1998 1997 1997 1997 1992 1991 1991 1991 1999
Jul 09, 1998

CAPSULE, EXTENDED RELEASE; ORAL CARTIA XT WATSON LABS FLORIDA AB3 180MG AB3 240MG AB3 300MG DILT-CD APOTEX AB3 120MG AB3 180MG AB3 240MG AB3 300MG DILTIAZEM HYDROCHLORIDE ACTAVIS ELIZABETH AB3 120MG AB3 180MG AB3 240MG AB3 300MG ACTAVIS INC AB3 360MG SUN PHARMA GLOBAL AB3 120MG AB3 180MG AB3 240MG AB3 300MG AB3 360MG VALEANT INTL AB3 120MG AB3 180MG AB3 240MG AB3 300MG DILTIAZEM HYDROCHLORIDE ACTAVIS ELIZABETH AB4 120MG AB4 180MG AB4 240MG AB4 300MG AB4 360MG AB4 420MG NESHER PHARMS AB4 120MG AB4 180MG AB4 240MG AB4 300MG AB4 360MG AB4 420MG SUN PHARMA GLOBAL AB4 120MG AB4 180MG AB4 240MG AB4 300MG AB4 360MG DILTZAC APOTEX INC AB4 120MG AB4 180MG AB4 240MG AB4 300MG AB4 360MG TAZTIA XT WATSON LABS FLORIDA AB4 120MG AB4 180MG AB4 240MG AB4 300MG AB4 360MG TIAZAC VALEANT INTL AB4 120MG AB4 180MG AB4 240MG AB4 300MG
3 - 136 (of 428)
A074752 A074752 A074752 A076151 A076151 A076151 A076151 A074984 A074984 A074984 A074984 A202463 A090492 A090492 A090492 A090492 A090492 A075116 A075116 A075116 A075116 A091022 A091022 A091022 A091022 A091022 A091022 A076563 A076563 A076563 A076563 A076563 A076563 A090421 A090421 A090421 A090421 A090421 A076395 A076395 A076395 A076395 A076395 A075401 A075401 A075401 A075401 A075401 N020401 N020401 N020401 N020401
001 003 004 001 002 003 004 001 002 003 004 001 001 002 003 004 005 001 002 003 004 001 002 003 004 005 006 002 003 004 005 006 001 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004
Jul 09, 1998 Jul 09, 1998 Jul 09, 1998 May May May May Dec Dec Dec Dec Dec Oct Oct Oct Oct Oct Dec Dec Dec Dec Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Nov Nov Nov Nov Nov Feb Feb Feb Feb Feb Apr Apr Apr Apr Apr Sep Sep Sep Sep 20, 20, 20, 20, 20, 20, 20, 20, 07, 28, 28, 28, 28, 28, 23, 23, 23, 23, 28, 28, 28, 28, 28, 28, 12, 12, 12, 12, 12, 12, 15, 15, 15, 15, 15, 01, 01, 01, 01, 01, 10, 10, 10, 10, 10, 11, 11, 11, 11, 2004 2004 2004 2004 1999 1999 1999 1999 2012 2011 2011 2011 2011 2011 1999 1999 1999 1999 2012 2012 2012 2012 2012 2012 2006 2006 2006 2006 2006 2006 2010 2010 2010 2010 2010 2006 2006 2006 2006 2006 2003 2003 2003 2003 2003 1995 1995 1995 1995

CAPSULE, EXTENDED RELEASE; ORAL TIAZAC VALEANT INTL AB4 360MG AB4 + 420MG DILTIAZEM HYDROCHLORIDE BC + MYLAN 120MG DILTIAZEM HYDROCHLORIDE MYLAN 60MG XX 90MG XX INJECTABLE; INJECTION DILTIAZEM HYDROCHLORIDE AGILA SPECLTS + BEDFORD HIKMA FARMACEUTICA HIKMA MAPLE HOSPIRA INTL MEDICATION TAYLOR PHARMA DILTIAZEM HYDROCHLORIDE + HOSPIRA + TEVA PARENTERAL TABLET; ORAL CARDIZEM VALEANT INTL
3 - 137 (of 428)
N020401 N020401 A074910 A074910 A074910
005 006 003 001 002
Sep 11, 1995 Oct 16, 1998 May 02, 1997 May 02, 1997 May 02, 1997
AP AP AP AP AP AP AP XX XX
5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 100MG/VIAL 10MG/ML
A075375 A074617 A202651 A078538 A074941 A075749 A075086 A075853 A074894
001 001 001 001 001 001 001 001 002
Sep Feb Aug Dec Apr Nov Apr
30, 28, 09, 17, 15, 21, 09,
1999 1996 2012 2008 1998 2001 1998
Dec 17, 2002 Apr 19, 2002
+ DILTIAZEM HYDROCHLORIDE DAVA PHARMS INC 30MG 60MG 90MG 120MG MYLAN 30MG 60MG 90MG 120MG TEVA 30MG 60MG 90MG 120MG TABLET, EXTENDED RELEASE; ORAL CARDIZEM LA VALEANT INTL 120MG 180MG 240MG 300MG 360MG + 420MG DILTIAZEM HYDROCHLORIDE WATSON LABS FLORIDA 120MG 180MG 240MG 300MG 360MG 420MG
30MG 60MG 90MG 120MG
N018602 N018602 N018602 N018602 A074093 A074093 A074093 A074093 A072838 A072838 A072838 A072838 A074185 A074185 A074185 A074185
001 002 003 004 001 002 003 004 004 003 002 001 001 002 003 004
Nov Nov Dec Dec Nov Nov Nov Nov Nov Nov Nov Nov May May May May
05, 05, 08, 08, 05, 05, 05, 05, 05, 05, 05, 05, 31, 31, 31, 31,
1982 1982 1986 1986 1992 1992 1992 1992 1992 1992 1992 1992 1995 1995 1995 1995
N021392 N021392 N021392 N021392 N021392 N021392 A077686 A077686 A077686 A077686 A077686 A077686
001 002 003 004 005 006 006 005 004 003 002 001
Feb Feb Feb Feb Feb Feb Mar Mar Mar Mar Mar Mar
06, 06, 06, 06, 06, 06, 15, 15, 15, 15, 15, 15,
2003 2003 2003 2003 2003 2003 2010 2010 2010 2010 2010 2010
DIMENHYDRINATE
INJECTABLE; INJECTION DIMENHYDRINATE FRESENIUS KABI USA AP
50MG/ML
A040519
001
Jun 23, 2004

DIMENHYDRINATE
INJECTABLE; INJECTION DIMENHYDRINATE AP + WATSON LABS
3 - 138 (of 428)
50MG/ML
A080615
001
DIMERCAPROL
BAL
XX + AKORN
10%
N005939
001
DIMETHYL SULFOXIDE
SOLUTION; INTRAVESICAL DIMETHYL SULFOXIDE BIONICHE PHARMA AT RIMSO-50 AT + BIONICHE PHARMA
50% 50%
A076185 N017788
001 001
Nov 29, 2002
DINOPROSTONE
GEL; ENDOCERVICAL
PREPIDIL
0.5MG/3GM
N019617
001
Dec 09, 1992
INSERT, EXTENDED RELEASE; VAGINAL

CERVIDIL
10MG XX + FERRING CONTROLLED SUPPOSITORY; VAGINAL
PROSTIN E2
XX + PHARMACIA AND UPJOHN 20MG
N020411
001
Mar 30, 1995
N017810
001
DIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE; ORAL
XX + BARR 50MG ELIXIR; ORAL
XX + PHARM ASSOC 12.5MG/5ML INJECTABLE; INJECTION DIPHENHYDRAMINE HYDROCHLORIDE APP PHARMS 50MG/ML BIONICHE PHARMA 50MG/ML + HIKMA MAPLE 50MG/ML HOSPIRA 50MG/ML WATSON LABS 50MG/ML DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE INTL MEDICATION 50MG/ML WATSON LABS 50MG/ML DIPHENHYDRAMINE HYDROCHLORIDE + WATSON LABS 10MG/ML
A080738
001
A087513
001
Feb 10, 1982
A040466 A040498 A080817 A040140 A080873 A084094 A080873 A080873
001 001 002 001 002 001 003 001
May 28, 2002 Jul 12, 2005 Nov 20, 1998
DIPIVEFRIN HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AKPRO AKORN AT 0.1% DIPIVEFRIN HYDROCHLORIDE FALCON PHARMS AT 0.1% PROPINE AT + ALLERGAN 0.1%
A074382 A073636 N018239
001 001 001
Sep 29, 1995 Jun 30, 1994
DIPYRIDAMOLE
INJECTABLE; INJECTION DIPYRIDAMOLE AP + BEDFORD CLARIS LIFESCIENCES AP
5MG/ML 5MG/ML
A074939 A075769
001 001
Apr 13, 1998 Nov 27, 2002

DIPYRIDAMOLE
INJECTABLE; INJECTION DIPYRIDAMOLE FRESENIUS KABI USA AP HIKMA MAPLE AP TABLET; ORAL DIPYRIDAMOLE BARR AB AB AB GLENMARK GENERICS AB AB AB IMPAX LABS AB AB AB LANNETT AB AB AB MURTY PHARMS AB AB AB PROSAM LABS AB AB AB PUREPAC PHARM AB WATSON LABS AB ZYDUS PHARMS USA INC AB AB AB PERSANTINE BOEHRINGER INGELHEIM AB AB AB +
3 - 139 (of 428)
5MG/ML 5MG/ML
A074956 A074521
001 001
Sep 30, 1998 Oct 18, 1996
001 001 001 001 001 001 001 002 003 001 002 003 001 002 003 001 002 003 001 001 001 002 003 003 004 005
Oct Oct Oct Feb Feb Feb Jul Jul Jul Apr Apr Apr Feb Feb Feb Apr Apr Apr Jul Jun Jan Jan Jan
03, 03, 03, 05, 05, 05, 18, 18, 18, 23, 23, 23, 13, 13, 13, 21, 21, 21, 12, 07, 28, 28, 28,
1990 1990 1990 1991 1991 1991 2007 2007 2007 2008 2008 2008 2007 2007 2007 2006 2006 2006 1990 1996 2008 2008 2008
Dec 22, 1986 Feb 06, 1987 Feb 06, 1987
DISOPYRAMIDE PHOSPHATE
CAPSULE; ORAL DISOPYRAMIDE PHOSPHATE TEVA AB EQ 100MG AB EQ 150MG WATSON LABS AB EQ 100MG AB EQ 150MG NORPACE GD SEARLE LLC AB EQ 100MG AB + EQ 150MG CAPSULE, EXTENDED RELEASE; ORAL NORPACE CR AB + GD SEARLE LLC EQ 150MG NORPACE CR GD SEARLE LLC EQ 100MG XX
A070101 A070102 A070173 A070174 N017447 N017447
001 001 001 001 001 002
Feb Feb May May
22, 22, 31, 31,
1985 1985 1985 1985
BASE BASE
N018655 N018655
002 001
Jul 20, 1982 Jul 20, 1982
DISULFIRAM
TABLET; ORAL ANTABUSE ODYSSEY PHARMS AB AB + DISULFIRAM SIGMAPHARM LABS LLC AB AB VINTAGE PHARMS AB AB
250MG 500MG 250MG 500MG 250MG 500MG
A088482 A088483 A091619 A091619 A091563 A091563
001 001 001 002 001 002
Dec 08, 1983 Dec 08, 1983 Mar Mar Dec Dec 28, 28, 31, 31, 2011 2011 2012 2012

DIVALPROEX SODIUM
CAPSULE, DELAYED REL PELLETS; ORAL DEPAKOTE + ABBVIE EQ 125MG DIVALPROEX SODIUM DR REDDYS LABS LTD EQ 125MG MYLAN EQ 125MG ZYDUS PHARMS USA INC EQ 125MG TABLET, DELAYED RELEASE; ORAL DEPAKOTE ABBVIE EQ 125MG EQ 250MG + EQ 500MG DIVALPROEX SODIUM ANCHEN PHARMS EQ 500MG AUROBINDO PHARMA LTD EQ 125MG EQ 250MG EQ 500MG DR REDDYS LABS LTD EQ 125MG EQ 250MG EQ 500MG LUPIN EQ 125MG EQ 250MG EQ 500MG MYLAN EQ 125MG EQ 125MG EQ 250MG EQ 250MG EQ 500MG EQ 500MG NU PHARM EQ 125MG EQ 250MG EQ 500MG ORCHID HLTHCARE EQ 125MG EQ 250MG EQ 500MG SANDOZ EQ 125MG EQ 250MG EQ 500MG SUN PHARM INDS EQ 125MG EQ 250MG EQ 500MG TEVA EQ 125MG EQ 250MG EQ 500MG UNICHEM LABS LTD EQ 125MG EQ 250MG EQ 500MG UPSHER SMITH EQ 125MG EQ 250MG EQ 500MG VINTAGE EQ 125MG EQ 250MG EQ 500MG WATSON LABS FLORIDA EQ 500MG WOCKHARDT EQ 125MG EQ 250MG EQ 500MG ZYDUS PHARMS USA INC EQ 125MG EQ 250MG EQ 500MG
3 - 140 (of 428)
AB AB AB AB
VALPROIC ACID VALPROIC ACID VALPROIC ACID VALPROIC ACID
N019680 A078979 A090407 A078919
001 001 001 001
Sep 12, 1989 Jan 23, 2009 Mar 28, 2011 Jan 27, 2009
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
VALPROIC ACID VALPROIC ACID VALPROIC ACID VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID
N018723 N018723 N018723 A078411 A090554 A090554 A090554 A078755 A078755 A078755 A078790 A078790 A078790 A077254 A090062 A077254 A090062 A077254 A090062 A077615 A077615 A077615 A078853 A078853 A078853 A078290 A078290 A078290 A078597 A078597 A078597 A076941 A076941 A076941 A079163 A079163 A079163 A078182 A078182 A078182 A090210 A090210 A090210 A079080 A077296 A077296 A077296 A077100 A077100 A077100
003 001 002 001 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 003 002 001 001 002 003 003 002 001 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 003 001 002 003
Oct 26, 1984 Mar 10, 1983 Mar 10, 1983 Nov Apr Apr Apr Jul Jul Jul Jul Jul Jul Jul Mar Jul Mar Jul Mar Jul Jul Jul Nov Nov Nov Jul Jul Jul Jul Jul Jul Jul Jul Jul Apr Apr Apr Jul Jul Jul Nov Nov Nov Feb Jul Jul Jul Mar Mar Mar 03, 21, 21, 21, 29, 29, 29, 29, 29, 29, 29, 17, 29, 17, 29, 17, 29, 29, 29, 25, 25, 25, 29, 29, 29, 29, 29, 29, 29, 29, 29, 05, 05, 05, 29, 29, 29, 30, 30, 30, 25, 31, 31, 31, 05, 05, 05, 2008 2011 2011 2011 2008 2008 2008 2008 2008 2008 2008 2009 2008 2009 2008 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2011 2011 2011 2008 2008 2008 2009 2009 2009 2011 2008 2008 2008 2009 2009 2009

DIVALPROEX SODIUM
TABLET, EXTENDED RELEASE; DEPAKOTE ER ABBVIE AB AB + DIVALPROEX SODIUM ANCHEN PHARMS AB AB DR REDDYS LABS LTD AB IMPAX LABS AB AB MYLAN AB AB REDDYS AB TEVA PHARMS AB WOCKHARDT AB AB ZYDUS PHARMS USA INC AB AB ORAL EQ 250MG VALPROIC ACID EQ 500MG VALPROIC ACID EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 250MG 500MG 250MG 500MG 500MG 500MG 250MG 500MG 250MG 500MG VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID N021168 N021168 A078445 A078445 A090161 A078791 A078791 A077567 A077567 A090070 A078700 A078705 A078705 A078239 A078239
3 - 141 (of 428)
002 001 001 002 001 001 002 001 002 001 001 002 001 001 002
May 31, 2002 Aug 04, 2000 Feb Aug Mar May Aug Jan Jan Mar Aug Feb Aug Feb Aug 26, 04, 15, 06, 04, 29, 29, 12, 03, 10, 04, 27, 04, 2009 2009 2012 2009 2009 2009 2009 2012 2009 2009 2009 2009 2009
DOBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION DOBUTAMINE HYDROCHLORIDE BEDFORD EQ 12.5MG BASE/ML HOSPIRA EQ 12.5MG BASE/ML + EQ 12.5MG BASE/ML WATSON LABS EQ 12.5MG BASE/ML DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% + HOSPIRA EQ 50MG BASE/100ML + EQ 100MG BASE/100ML + EQ 200MG BASE/100ML DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER + BAXTER HLTHCARE EQ 50MG BASE/100ML + EQ 100MG BASE/100ML + EQ 200MG BASE/100ML + EQ 400MG BASE/100ML + HOSPIRA EQ 50MG BASE/100ML + EQ 100MG BASE/100ML + EQ 200MG BASE/100ML + EQ 400MG BASE/100ML
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A074277 A074086 A074292 A074114 N020269 N020269 N020269 N020255 N020255 N020255 N020255 N020201 N020201 N020201 N020201
001 001 001 001 001 002 003 001 003 004 005 003 002 001 006
Oct Nov Feb Nov
31, 29, 16, 30,
1994 1993 1995 1993
Oct 19, 1993 Oct 19, 1993 Oct 19, 1993 Oct Oct Oct Oct Oct Oct Oct Jul 19, 19, 19, 19, 19, 19, 19, 07, 1993 1993 1993 1993 1993 1993 1993 1994
DOCETAXEL
INJECTABLE; INJECTION DOCETAXEL ACCORD HLTHCARE AP AP AP AP APOTEX INC AP AP AP + HOSPIRA INC AP + AP + SANDOZ AP AP AP TAXOTERE AP + SANOFI AVENTIS US AP + DOCEFREZ XX + SUN PHARMA GLOBAL
20MG/ML (20MG/ML) 20MG/0.5ML (40MG/ML) 80MG/2ML (40MG/ML) 80MG/4ML (20MG/ML) 20MG/0.5ML (40MG/ML) 80MG/2ML (40MG/ML) 20MG/2ML (10MG/ML) 80MG/8ML (10MG/ML) 160MG/16ML (10MG/ML) 20MG/2ML (10MG/ML) 80MG/8ML (10MG/ML) 160MG/16ML (10MG/ML) 20MG/ML (20MG/ML) 80MG/4ML (20MG/ML) 20MG/VIAL
N201195 N201195 N201195 N201195 N022312 N022312 N022234 N022234 N022234 N201525 N201525 N201525 N020449 N020449 N022534
003 001 002 004 001 002 001 002 003 001 002 003 003 004 001
Apr Jun Jun Apr Jan Jan Mar Mar Mar Jun Jun Jun
20, 08, 08, 20, 11, 11, 08, 08, 08, 29, 29, 29,
2012 2011 2011 2012 2012 2012 2011 2011 2011 2011 2011 2011
Aug 03, 2010 Aug 02, 2010 May 03, 2011

DOCETAXEL
DOCEFREZ
XX + SUN PHARMA GLOBAL DOCETAXEL XX ACCORD HLTHCARE
3 - 142 (of 428)
80MG/VIAL 160MG/8ML (20MG/ML)
N022534 N201195
002 005
May 03, 2011 Apr 20, 2012
DOFETILIDE
CAPSULE; ORAL TIKOSYN XX PFIZER XX XX +
0.125MG 0.25MG 0.5MG
N020931 N020931 N020931
001 002 003
Oct 01, 1999 Oct 01, 1999 Oct 01, 1999
DOLASETRON MESYLATE
ANZEMET
+ SANOFI AVENTIS US + + TABLET; ORAL ANZEMET SANOFI AVENTIS US +
XX XX XX
12.5MG/0.625ML (20MG/ML) 100MG/5ML (20MG/ML) 500MG/25ML (20MG/ML)
N020624 N020624 N020624
002 001 003
Sep 11, 1997 Sep 11, 1997 Dec 11, 2001
XX XX
50MG 100MG
N020623 N020623
001 002
Sep 11, 1997 Sep 11, 1997
DONEPEZIL HYDROCHLORIDE
TABLET; ORAL ARICEPT EISAI INC AB 5MG AB + 10MG DONEPEZIL HYDROCHLORIDE ACCORD HLTHCARE AB 5MG AB 10MG ACTAVIS PHARMA AB 5MG AB 10MG APOTEX AB 5MG AB 10MG AUROBINDO AB 5MG AB 10MG CIPLA LTD AB 5MG AB 10MG DR REDDYS LABS LTD AB 5MG AB 10MG HIKMA PHARMS AB 5MG AB 10MG INDICUS PHARMA AB 5MG AB 10MG JUBILANT LIFE AB 5MG AB 10MG MACLEODS PHARMS LTD AB 5MG AB 10MG MYLAN PHARMS INC AB 5MG AB 10MG PLIVA HRVATSKA DOO AB 5MG AB 10MG PRINSTON INC AB 5MG AB 10MG RANBAXY AB 5MG AB 10MG ROXANE AB 5MG AB 10MG
N020690 N020690 A201335 A201335 A090551 A090551 A078841 A078841 A090056 A090056 A077518 A077518 A201001 A201001 A090247 A090247 A201634 A201634 A090768 A090768 A201146 A201146 A090521 A090521 A090425 A090425 A200292 A200292 A076786 A076786 A078662 A078662
002 001 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Nov 25, 1996 Nov 25, 1996 Aug Aug May May Jun Jun May May May May May May May May Jun Jun May May Aug Aug May May May May May May Nov Nov May May 29, 29, 31, 31, 02, 02, 31, 31, 31, 31, 31, 31, 31, 31, 13, 13, 31, 31, 17, 17, 31, 31, 31, 31, 31, 31, 26, 26, 31, 31, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2012 2012 2011 2011 2012 2012 2011 2011 2011 2011 2011 2011 2010 2010 2011 2011

TABLET; ORAL DONEPEZIL HYDROCHLORIDE SANDOZ AB 5MG AB 10MG SUN PHARM INDS AB 5MG AB 10MG TEVA AB 5MG AB 10MG TORRENT PHARMS AB 5MG AB 10MG WOCKHARDT AB 5MG AB 10MG ZYDUS PHARMS USA INC 5MG AB AB 10MG ARICEPT 23MG XX + EISAI INC TABLET, ORALLY DISINTEGRATING; ORAL ARICEPT ODT EISAI INC 5MG + 10MG DONEPEZIL HYDROCHLORIDE BARR 5MG 10MG MACLEODS PHARMS LTD 5MG 10MG SANDOZ 5MG 10MG ZYDUS PHARMS USA INC 5MG 10MG
3 - 143 (of 428)
A090290 A090290 A090493 A090493 A077344 A077344 A090686 A090686 A091267 A091267 A090100 A090100 N022568
001 002 001 002 001 002 001 002 001 002 001 002 001
May May May May May May May May May May Oct Oct
31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 24, 24,
2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2012 2012
Jul 23, 2010
N021720 N021720 A078388 A078388 A201787 A201787 A091198 A091198 A090175 A090175
001 002 002 001 001 002 001 002 001 002
Oct 18, 2004 Oct 18, 2004 Nov Nov Dec Dec May May May May 26, 26, 14, 14, 10, 10, 10, 10, 2010 2010 2012 2012 2011 2011 2011 2011
DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION DOPAMINE HYDROCHLORIDE + HOSPIRA + + + + LUITPOLD + + DOPAMINE HYDROCHLORIDE + B BRAUN + DOPAMINE HYDROCHLORIDE + B BRAUN DOPAMINE HYDROCHLORIDE + BAXTER HLTHCARE + + + HOSPIRA + + DOPAMINE HYDROCHLORIDE + B BRAUN DOPAMINE HYDROCHLORIDE + BAXTER HLTHCARE
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX
40MG/ML 80MG/100ML 80MG/ML 160MG/100ML 40MG/ML 80MG/ML 160MG/ML AND DEXTROSE 5% 80MG/100ML 320MG/100ML AND DEXTROSE 5% IN PLASTIC CONTAINER 160MG/100ML IN DEXTROSE 5% IN PLASTIC CONTAINER 80MG/100ML 160MG/100ML 320MG/100ML 80MG/100ML 160MG/100ML 320MG/100ML AND DEXTROSE 5% IN PLASTIC CONTAINER 40MG/100ML IN DEXTROSE 5% IN PLASTIC CONTAINER 640MG/100ML
N018132 N018132 N018132 N018132 A070799 A070820 A070826 N019099 N019099 N019099 N019615 N019615 N019615 N018826 N018826 N018826 N019099 N019615
001 002 004 003 001 001 001 002 004 003 001 002 003 001 002 003 001 004
Feb Jul Feb Feb Feb Feb
04, 09, 04, 11, 11, 11,
1982 1982 1982 1987 1987 1987
Oct 15, 1986 Oct 15, 1986 Oct 15, 1986 Mar Mar Mar Sep Sep Sep 27, 27, 27, 30, 30, 30, 1987 1987 1987 1983 1983 1983
Oct 15, 1986 Mar 27, 1987

DORIPENEM
INJECTABLE; IV (INFUSION) DORIBAX XX JANSSEN PHARMS 250MG/VIAL 500MG/VIAL XX +
3 - 144 (of 428)
N022106 N022106
002 001
Oct 05, 2010 Oct 12, 2007
DORZOLAMIDE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE ALCON PHARMS LTD EQ APOTEX INC EQ BAUSCH AND LOMB EQ HI TECH PHARMA EQ LUITPOLD EQ SANDOZ EQ TEVA PHARMS EQ TRUSOPT + MERCK EQ
2% 2% 2% 2% 2% 2% 2%
BASE BASE BASE BASE BASE BASE BASE
A078981 A078395 A090143 A077846 A079186 A078748 A078756 N020408
001 001 001 001 001 001 001 001
Apr Oct Jun Oct Nov Nov Dec
13, 28, 25, 28, 18, 06, 04,
2009 2008 2009 2008 2009 2008 2008
2% BASE
Dec 09, 1994
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

SOLUTION/DROPS; OPHTHALMIC COSOPT + MERCK EQ 2% DORZOLAMIDE HYDROCHLORIDE AND ALCON RES EQ 2% APOTEX INC EQ 2% BAUSCH AND LOMB EQ 2% HI TECH PHARMA EQ 2% SANDOZ EQ 2% TEVA PHARMS EQ 2% COSOPT PF + MERCK SHARP DOHME EQ 2%
AT AT AT AT AT AT AT XX
BASE;EQ TIMOLOL BASE;EQ BASE;EQ BASE;EQ BASE;EQ BASE;EQ BASE;EQ
0.5% BASE MALEATE 0.5% BASE 0.5% BASE 0.5% BASE 0.5% BASE 0.5% BASE 0.5% BASE
N020869 A090604 A078201 A090037 A077847 A078749 A078704 N202667
001 001 001 001 001 001 001 001
Apr 07, 1998 Nov Oct Jul Oct Nov Sep 18, 28, 14, 28, 06, 28, 2009 2008 2009 2008 2008 2009
BASE;EQ 0.5% BASE
Feb 01, 2012
DOXAPRAM HYDROCHLORIDE
INJECTABLE; INJECTION DOPRAM AP + BAXTER HLTHCARE DOXAPRAM HYDROCHLORIDE BEDFORD AP WATSON LABS AP
N014879 A076266 A073529
001 001 001 Jan 10, 2003 Jan 30, 1992
DOXAZOSIN MESYLATE
TABLET; ORAL CARDURA AB + PFIZER AB AB AB DOXAZOSIN MESYLATE APOTEX AB AB AB AB DAVA PHARMS INC AB AB AB AB MYLAN AB AB AB AB
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N019668 N019668 N019668 N019668 A075580 A075580 A075580 A075580 A076161 A076161 A076161 A076161 A075509 A075509 A075509 A075509
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Nov Nov Nov Nov Oct Oct Oct Oct Jun Jun Jun Jun Oct Oct Oct Oct
02, 02, 02, 02, 18, 18, 18, 18, 10, 10, 10, 10, 19, 19, 19, 19,
1990 1990 1990 1990 2000 2000 2000 2000 2004 2004 2004 2004 2000 2000 2000 2000

DOXAZOSIN MESYLATE
TABLET; ORAL DOXAZOSIN MESYLATE PLIVA AB AB AB AB TEVA AB AB AB AB WATSON LABS AB AB AB AB TABLET, EXTENDED RELEASE; CARDURA XL PFIZER XX XX +
3 - 145 (of 428)
EQ 1MG EQ 2MG EQ 4MG EQ 8MG EQ 1MG EQ 2MG EQ 4MG EQ 8MG EQ 1MG EQ 2MG EQ 4MG EQ 8MG ORAL
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075750 A075750 A075750 A075750 A075536 A075536 A075536 A075536 A075426 A075426 A075426 A075426
001 002 003 004 001 002 003 004 001 002 003 004
Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct Oct Oct
08, 08, 08, 08, 18, 18, 18, 18, 18, 18, 18, 18,
2001 2001 2001 2001 2000 2000 2000 2000 2000 2000 2000 2000
N021269 N021269
001 002
Feb 22, 2005 Feb 22, 2005
DOXEPIN HYDROCHLORIDE
CAPSULE; ORAL DOXEPIN HYDROCHLORIDE MYLAN AB AB AB AB AB PAR PHARM AB AB + AB AB AB + WATSON LABS AB AB AB AB AB DOXEPIN HYDROCHLORIDE PAR PHARM XX CONCENTRATE; ORAL DOXEPIN HYDROCHLORIDE PHARM ASSOC SILARX + TEVA PHARMS WOCKHARDT
10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE
002 003 001 004 005 001 001 001 001 001 001 001 001 001 001 001
May May May May May Nov Nov Nov Nov Nov Apr Apr Apr Apr Apr
13, 13, 13, 13, 13, 09, 09, 09, 09, 09, 30, 30, 30, 30, 30,
1986 1986 1986 1986 1986 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987
EQ 150MG BASE
Nov 09, 1987
AA AA AA AA
EQ EQ EQ EQ
10MG 10MG 10MG 10MG
BASE/ML BASE/ML BASE/ML BASE/ML
A075924 A074721 A071609 A071918
001 001 001 001
Jan Dec Nov Jul
15, 29, 09, 20,
2004 1998 1987 1988
CREAM; TOPICAL
ZONALON
XX + FOUGERA PHARMS TABLET; ORAL SILENOR SOMAXON XX XX +
5%
N020126
001
Apr 01, 1994
N022036 N022036
001 002
Mar 17, 2010 Mar 17, 2010
DOXERCALCIFEROL
CAPSULE; ORAL DOXERCALCIFEROL ROXANE AB HECTOROL GENZYME CORP AB
0.5MCG 0.5MCG
A091433 N020862
001 002
Sep 23, 2011 Apr 23, 2004

DOXERCALCIFEROL
CAPSULE; ORAL HECTOROL XX GENZYME CORP XX + INJECTABLE; INJECTION HECTOROL XX GENZYME CORP XX +
3 - 146 (of 428)
1MCG 2.5MCG
N020862 N020862
003 001
Jul 13, 2009 Jun 09, 1999
2MCG/ML (2MCG/ML) 4MCG/2ML (2MCG/ML)
N021027 N021027
002 001
Apr 06, 2000 Apr 06, 2000
DOXORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION DOXORUBICIN HYDROCHLORIDE ALVOGEN INC 2MG/ML + BEDFORD 2MG/ML + 10MG/VIAL + 20MG/VIAL + 50MG/VIAL + 200MG/100ML FRESENIUS KABI USA 2MG/ML ONCO THERAPIES LTD 2MG/ML 10MG/VIAL 50MG/VIAL PHARMACHEMIE 2MG/ML 10MG/VIAL 20MG/VIAL 50MG/VIAL 200MG/100ML SANDOZ INC 2MG/ML SUN PHARM INDS 2MG/ML TEVA PARENTERAL 2MG/ML 200MG/100ML INJECTABLE, LIPOSOMAL; INJECTION
DOXIL
+ JANSSEN R AND D 20MG/10ML (2MG/ML) + 50MG/25ML (2MG/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
001 001 001 002 003 001 001 001 001 002 001 001 002 003 004 001 001 001 002
Nov Mar Mar Mar Mar Sep Oct Feb Oct Oct Feb May May May Feb Jul Feb Jul Jul
08, 17, 17, 17, 17, 13, 26, 14, 28, 28, 28, 21, 21, 21, 28, 18, 15, 28, 28,
2012 1989 1989 1989 1989 1994 1995 2012 2011 2011 1995 1990 1990 1990 1995 2012 2012 1995 1995
XX XX
N050718 N050718
001 002
Nov 17, 1995 Jun 13, 2000
DOXYCYCLINE
CAPSULE; ORAL DOXYCYCLINE IMPAX LABS INC MYLAN MYLAN PHARMS INC PAR PHARM + RANBAXY
AB AB AB AB AB AB AB AB AB AB AB AB AB AB
WATSON LABS MONODOX AQUA PHARMS
EQ 150MG BASE 40MG EQ 150MG BASE EQ 50MG BASE EQ 100MG BASE EQ 150MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE EQ 50MG BASE EQ 100MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE 40MG
A200065 A090855 A202778 A065055 A065055 A065055 A065053 A065053 A065053 A065041 A065041 N050641 N050641 N050641 N050805
001 001 001 001 002 003 001 003 002 001 002 002 003 001 001
Feb Jul Jun Dec Dec Jul Nov Sep Nov Apr Apr
17, 01, 08, 01, 01, 15, 22, 10, 22, 28, 28,
2011 2010 2012 2000 2000 2005 2000 2003 2000 2000 2000
+ ORACEA AB + GALDERMA LABS LP FOR SUSPENSION; ORAL DOXYCYCLINE IVAX SUB TEVA PHARMS AB
Feb 10, 1992 Oct 18, 2006 Dec 29, 1989 May 26, 2006
EQ 25MG BASE/5ML
A065454
001
Jul 16, 2008

DOXYCYCLINE
FOR SUSPENSION; ORAL VIBRAMYCIN AB + PFIZER TABLET; ORAL DOXYCYCLINE HERITAGE PHARMS INC AB AB AB AB LANNETT AB AB AB AB MYLAN AB AB AB AB PAR PHARM AB AB AB AB + RANBAXY AB AB AB
3 - 147 (of 428)
EQ 25MG BASE/5ML
N050006
001
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
50MG BASE 75MG BASE 100MG BASE 150MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 50MG BASE 75MG BASE 100MG BASE
001 002 003 004 001 003 002 004 001 002 003 001 001 003 002 004 001 002 003
Dec Dec Dec Dec Dec Jul Dec Jul Nov Nov Nov Jun Dec Dec Dec Jul May May May
20, 20, 20, 20, 08, 30, 08, 30, 07, 07, 07, 07, 15, 30, 15, 14, 31, 31, 31,
2011 2011 2011 2011 2005 2008 2005 2008 2006 2006 2006 2007 2000 2002 2000 2005 2006 2006 2006
DOXYCYCLINE CALCIUM
SUSPENSION; ORAL
VIBRAMYCIN
XX + PFIZER
EQ 50MG BASE/5ML
N050480
001
DOXYCYCLINE HYCLATE
CAPSULE; ORAL DOXYCYCLINE HYCLATE IVAX SUB TEVA PHARMS AB AB MUTUAL PHARM AB AB WATSON LABS FLORIDA AB AB WEST WARD AB AB VIBRAMYCIN PFIZER AB AB + DOXYCYCLINE HYCLATE XX + WEST WARD CAPSULE, DELAYED RELEASE; DOXYCYCLINE HYCLATE MEDICIS + INJECTABLE; INJECTION DOXY 100 + FRESENIUS KABI USA DOXYCYCLINE + BEDFORD PFIZER DOXY 200 + FRESENIUS KABI USA
50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE
A062500 A062500 A062675 A062676 A062031 A062031 A062396 A062396 N050007 N050007 A065103
001 002 001 001 002 001 002 001 001 002 001
Sep Sep Jul Jul Oct
11, 11, 10, 10, 13,
1984 1984 1986 1986 1982
Nov 07, 1984 May 07, 1984
EQ 50MG BASE EQ 100MG BASE EQ 20MG BASE ORAL EQ 75MG BASE EQ 100MG BASE
May 13, 2005
XX XX
A065281 A065281
001 002
Dec 21, 2005 Dec 21, 2005
AP AP AP XX
EQ 100MG BASE/VIAL EQ 100MG BASE/VIAL EQ 100MG BASE/VIAL EQ 200MG BASE/VIAL
A062475 A062569 A091406 A062475
001 001 001 002
Dec 09, 1983 Mar 09, 1988 Aug 21, 2012 Dec 09, 1983

DOXYCYCLINE HYCLATE
SYSTEM, EXTENDED RELEASE; ATRIDOX XX + TOLMAR TABLET; ORAL DOXYCYCLINE HYCLATE COREPHARMA AB IVAX SUB TEVA PHARMS AB AB LANNETT AB LARKEN LABS AB MUTUAL PHARM AB MUTUAL PHARMA AB VINTAGE PHARMS AB WATSON LABS INC FL AB AB + WEST-WARD PHARM CORP PERIOSTAT AB + GALDERMA LABS LP PERIODONTAL 50MG N050751
3 - 148 (of 428)
001
Sep 03, 1998
20MG BASE 20MG BASE 100MG BASE 20MG BASE 20MG BASE 100MG BASE 20MG BASE 100MG BASE 100MG BASE 100MG BASE
A065182 A065163 A062505 A065277 A065287 A062677 A065134 A062538 A062421 A065095 N050783
001 001 001 001 001 001 001 001 001 001 001
May May Sep Nov Feb Jul May Apr Feb Jul
13, 13, 11, 10, 28, 10, 13, 07, 02, 02,
2005 2005 1984 2005 2006 1986 2005 1986 1983 2003
EQ 20MG BASE TABLET, DELAYED RELEASE; ORAL DORYX MAYNE PHARMA EQ 75MG BASE AB EQ 100MG BASE AB EQ 150MG BASE AB + DOXYCYCLINE HYCLATE ACTAVIS ELIZABETH EQ 75MG BASE AB EQ 100MG BASE AB IMPAX LABS INC EQ 75MG BASE AB EQ 100MG BASE AB MYLAN EQ 75MG BASE AB EQ 100MG BASE AB MYLAN PHARMS INC EQ 150MG BASE AB
Feb 02, 2001
N050795 N050795 N050795 A090134 A090134 A090505 A090505 A090431 A090431 A091052
001 002 003 001 002 001 002 001 002 001
May 06, 2005 May 06, 2005 Jun 20, 2008 Dec Dec Dec Dec Dec Dec Feb 14, 14, 28, 28, 28, 28, 08, 2011 2011 2010 2010 2010 2010 2012
DRONABINOL
CAPSULE; ORAL DRONABINOL INSYS THERAP AB AB AB SVC PHARMA AB AB AB MARINOL ABBVIE AB AB + AB
2.5MG 5MG 10MG 2.5MG 5MG 10MG 2.5MG 5MG 10MG
A078501 A078501 A078501 A078292 A078292 A078292 N018651 N018651 N018651
001 002 003 001 002 003 001 002 003
Aug Aug Aug Jun Jun Jun
19, 19, 19, 27, 27, 27,
2011 2011 2011 2008 2008 2008
May 31, 1985 May 31, 1985 May 31, 1985
DRONEDARONE HYDROCHLORIDE
TABLET; ORAL MULTAQ XX + SANOFI AVENTIS US
EQ 400MG BASE
N022425
001
Jul 01, 2009
DROPERIDOL
INJECTABLE; INJECTION DROPERIDOL HOSPIRA AP LUITPOLD AP INAPSINE AP + AKORN INC
A071981 A072123 N016796
001 001 001
Feb 29, 1988 Oct 24, 1988

DROSPIRENONE; ESTRADIOL
TABLET; ORAL ANGELIQ XX BAYER HLTHCARE XX +
3 - 149 (of 428)
0.25MG;0.5MG 0.5MG;1MG
N021355 N021355
001 002
Feb 29, 2012 Sep 28, 2005
DROSPIRENONE; ETHINYL ESTRADIOL

TABLET; ORAL DROSPIRENONE AND ETHINYL ESTRADIOL BARR 3MG;0.02MG WATSON LABS 3MG;0.02MG LORYNA SANDOZ 3MG;0.02MG YAZ + BAYER HLTHCARE 3MG;0.02MG TABLET; ORAL-28 DROSPIRENONE AND ETHINYL ESTRADIOL BARR 3MG;0.03MG LUPIN LTD 3MG;0.03MG WATSON LABS 3MG;0.03MG SYEDA SANDOZ 3MG;0.03MG YASMIN + BAYER HLTHCARE 3MG;0.03MG
AB AB AB AB
A078515 A078833 A079221 N021676
001 001 001 001
Mar 30, 2009 Nov 28, 2011 Mar 28, 2011 Mar 16, 2006
AB AB AB AB AB
A077527 A201663 A090081 A090114 N021098
001 001 001 001 001
May 09, 2008 Dec 18, 2012 Sep 07, 2010 Mar 28, 2011 May 11, 2001
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM

TABLET; ORAL
BEYAZ
XX + BAYER HLTHCARE SAFYRAL BAYER HLTHCARE XX
3MG,N/A;0.02MG,N/A;0.451MG,0.451MG 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG
N022532 N022574
001 001
Sep 24, 2010 Dec 16, 2010
DULOXETINE HYDROCHLORIDE
CAPSULE, DELAYED REL PELLETS; ORAL CYMBALTA LILLY EQ 20MG BASE XX EQ 30MG BASE XX EQ 60MG BASE XX +
N021427 N021427 N021427
001 002 004
Aug 03, 2004 Aug 03, 2004 Aug 03, 2004
DUTASTERIDE
CAPSULE; ORAL AVODART AB + GLAXOSMITHKLINE DUTASTERIDE BARR AB
0.5MG 0.5MG
N021319 A090095
001 001
Nov 20, 2001 Dec 21, 2010
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE

CAPSULE; ORAL
JALYN
0.5MG;0.4MG
N022460
001
Jun 14, 2010
DYPHYLLINE
TABLET; ORAL
LUFYLLIN
XX MEDA PHARMS XX +
200MG 400MG
A084566 A084566
001
002
ECHOTHIOPHATE IODIDE
PHOSPHOLINE IODIDE
XX + WYETH PHARMS INC
0.125%
N011963
001

ECONAZOLE NITRATE
CREAM; TOPICAL ECONAZOLE NITRATE + FOUGERA PHARMS PERRIGO NEW YORK PRASCO TARO
3 - 150 (of 428)
AB AB AB AB
1% 1% 1% 1%
A076075 A076479 A076574 A076005
001 001 001 001
Nov Jun Dec Nov
26, 23, 17, 26,
2002 2004 2004 2002
EDETATE CALCIUM DISODIUM

CALCIUM DISODIUM VERSENATE
XX + MEDICIS 200MG/ML
N008922
001
EDROPHONIUM CHLORIDE
INJECTABLE; INJECTION ENLON BIONICHE PHARMA AP 10MG/ML TENSILON AP + VALEANT PHARM INTL 10MG/ML TENSILON PRESERVATIVE FREE AP + VALEANT PHARM INTL 10MG/ML
A088873 N007959 N007959
001 001 002
Aug 06, 1985
EFAVIRENZ
CAPSULE; ORAL SUSTIVA XX BRISTOL MYERS SQUIBB 50MG XX + 200MG TABLET; ORAL
SUSTIVA
XX + BRISTOL MYERS SQUIBB 600MG
N020972 N020972
001 003
Sep 17, 1998 Sep 17, 1998
N021360
002
Feb 01, 2002
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

TABLET; ORAL
ATRIPLA
XX + GILEAD
600MG;200MG;300MG
N021937
001
Jul 12, 2006
EFLORNITHINE HYDROCHLORIDE
CREAM; TOPICAL
VANIQA
XX + SKINMEDICA
13.9%
N021145
001
Jul 27, 2000
ELETRIPTAN HYDROBROMIDE
TABLET; ORAL RELPAX XX PFIZER IRELAND XX +
N021016 N021016
001 002
Dec 26, 2002 Dec 26, 2002
ELTROMBOPAG OLAMINE
TABLET; ORAL PROMACTA XX GLAXOSMITHKLINE XX XX + XX XX
EQ EQ EQ EQ EQ
12.5MG ACID 25MG ACID 50MG ACID 75MG ACID 100MG ACID
N022291 N022291 N022291 N022291 N022291
004 001 002 003 005
Oct Nov Nov Sep Nov
20, 20, 20, 08, 16,
2011 2008 2008 2009 2012
EMEDASTINE DIFUMARATE
EMADINE
XX + ALCON 0.05%
N020706
001
Dec 29, 1997

EMTRICITABINE
CAPSULE; ORAL
EMTRIVA
XX + GILEAD SOLUTION; ORAL
EMTRIVA
XX + GILEAD
3 - 151 (of 428)
200MG
N021500
001
Jul 02, 2003
10MG/ML
N021896
001
Sep 28, 2005
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

TABLET; ORAL
COMPLERA
XX + GILEAD SCIENCES INC
200MG;EQ 25MG BASE;300MG
N202123
001
Aug 10, 2011
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

TABLET; ORAL
TRUVADA
XX + GILEAD
200MG;300MG
N021752
001
Aug 02, 2004
ENALAPRIL MALEATE
TABLET; ORAL ENALAPRIL MALEATE APOTEX AB AB AB AB MYLAN AB AB AB AB AB AB AB AB TARO AB AB AB AB TEVA AB AB AB AB WATSON LABS AB AB AB AB WOCKHARDT USA AB AB AB AB VASOTEC VALEANT INTL AB AB AB AB +
2.5MG 5MG 10MG 20MG 2.5MG 2.5MG 5MG 5MG 10MG 10MG 20MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG
A075178 A075178 A075178 A075178 A075472 A075480 A075472 A075480 A075472 A075480 A075472 A075480 A075657 A075657 A075657 A075657 A075479 A075479 A075479 A075479 A075501 A075501 A075501 A075501 A075483 A075483 A075483 A075483 N018998 N018998 N018998 N018998
002 001 003 004 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 005 001 002 003
Mar Mar Mar Mar Aug Aug Aug Aug Aug Aug Aug Aug Jan Jan Jan Jan Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Jul Dec Dec Dec
23, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 26, 24, 24, 24,
2001 2001 2001 2001 2000 2000 2000 2000 2000 2000 2000 2000 2001 2001 2001 2001 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 1988 1985 1985 1985
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE

TABLET; ORAL ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE APOTEX INC 5MG;12.5MG AB 10MG;25MG AB DR REDDYS LABS LTD 5MG;12.5MG AB
A076486 A076486 A075909
001 002 001
Oct 27, 2004 Oct 27, 2004 Oct 15, 2001

TABLET; ORAL ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE DR REDDYS LABS LTD 10MG;25MG AB MYLAN 5MG;12.5MG AB 10MG;25MG AB TARO PHARM INDS 5MG;12.5MG AB 10MG;25MG AB TEVA 5MG;12.5MG AB 10MG;25MG AB VASERETIC VALEANT INTL AB 5MG;12.5MG AB + 10MG;25MG
3 - 152 (of 428)
A075909 A075624 A075624 A075788 A075788 A075727 A075727 N019221 N019221
002 001 002 001 002 001 002 003 001
Oct Sep Sep Sep Sep Sep Sep
15, 18, 18, 18, 18, 18, 18,
2001 2001 2001 2001 2001 2001 2001
Jul 12, 1995 Oct 31, 1986
ENALAPRILAT
INJECTABLE; INJECTION ENALAPRILAT + BEDFORD HIKMA FARMACEUTICA + HOSPIRA TEVA PARENTERAL
AP AP AP AP
A075634 A078687 A075458 A075578
001 001 001 001
Aug Dec Aug Aug
22, 23, 22, 22,
2000 2008 2000 2000
ENFLURANE
LIQUID; INHALATION ENFLURANE PIRAMAL CRITICAL AN ETHRANE AN + BAXTER HLTHCARE
99.9% 99.9%
A074396 N017087
001 001
Jul 29, 1994
ENFUVIRTIDE
INJECTABLE; SUBCUTANEOUS FUZEON XX + ROCHE
90MG/VIAL
N021481
001
Mar 13, 2003
ENOXAPARIN SODIUM
INJECTABLE; INTRAVENOUS, SUBCUTANEOUS ENOXAPARIN SODIUM SANDOZ INC AB 300MG/3ML (100MG/ML) LOVENOX SANOFI AVENTIS US AB 300MG/3ML (100MG/ML) INJECTABLE; SUBCUTANEOUS ENOXAPARIN SODIUM (PRESERVATIVE FREE) AMPHASTAR PHARM AP 30MG/0.3ML (100MG/ML) AP 40MG/0.4ML (100MG/ML) AP 60MG/0.6ML (100MG/ML) AP 80MG/0.8ML (100MG/ML) AP 100MG/ML (100MG/ML) AP 120MG/0.8ML (150MG/ML) AP 150MG/ML (150MG/ML) SANDOZ AP 30MG/0.3ML (100MG/ML) AP 40MG/0.4ML (100MG/ML) AP 60MG/0.6ML (100MG/ML) AP 80MG/0.8ML (100MG/ML) AP 100MG/ML (100MG/ML) AP 120MG/0.8ML (150MG/ML) AP 150MG/ML (150MG/ML) LOVENOX (PRESERVATIVE FREE) SANOFI AVENTIS US AP 30MG/0.3ML (100MG/ML) AP 40MG/0.4ML (100MG/ML) AP 60MG/0.6ML (100MG/ML) AP 80MG/0.8ML (100MG/ML)
A078660 N020164
001 009
Nov 28, 2011 Jan 23, 2003
A076684 A076684 A076684 A076684 A076684 A076684 A076684 A077857 A077857 A077857 A077857 A077857 A077857 A077857 N020164 N020164 N020164 N020164
001 002 003 004 005 006 007 002 003 004 005 001 006 007 001 002 003 004
Sep Sep Sep Sep Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Mar Jan Mar Mar
19, 19, 19, 19, 19, 19, 19, 23, 23, 23, 23, 23, 23, 23, 29, 30, 27, 27,
2011 2011 2011 2011 2011 2011 2011 2010 2010 2010 2010 2010 2010 2010 1993 1998 1998 1998

ENOXAPARIN SODIUM
INJECTABLE; SUBCUTANEOUS LOVENOX (PRESERVATIVE FREE) AP + SANOFI AVENTIS US 100MG/ML (100MG/ML) AP 120MG/0.8ML (150MG/ML) AP 150MG/ML (150MG/ML)
3 - 153 (of 428)
N020164 N020164 N020164
005 007 008
Mar 27, 1998 Jun 02, 2000 Jun 02, 2000
ENTACAPONE
TABLET; ORAL COMTAN AB + ORION PHARMA ENTACAPONE SUN PHARMA GLOBAL AB WOCKHARDT LTD AB
200MG 200MG 200MG
N020796 A090690 A078941
001 001 001
Oct 19, 1999 Jul 16, 2012 Aug 16, 2012
ENTECAVIR
SOLUTION; ORAL
BARACLUDE
XX + BRISTOL MYERS SQUIBB TABLET; ORAL BARACLUDE BRISTOL MYERS SQUIBB XX XX +
0.05MG/ML
N021798
001
Mar 29, 2005
0.5MG 1MG
N021797 N021797
001 002
Mar 29, 2005 Mar 29, 2005
ENZALUTAMIDE
CAPSULE; ORAL
XTANDI
XX + ASTELLAS
40MG
N203415
001
Aug 31, 2012
EPINASTINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC ELESTAT + ALLERGAN 0.05% EPINASTINE HYDROCHLORIDE APOTEX 0.05% CYPRESS PHARM 0.05% LUITPOLD 0.05% SUN PHARM INDS 0.05%
AT AT AT AT AT
N021565 A090919 A090870 A090951 A091626
001 001 001 001 001
Oct 16, 2003 Oct Mar Oct Oct 31, 14, 31, 31, 2011 2011 2011 2011
EPINEPHRINE
INJECTABLE; IM-SC ADRENACLICK BX + AMEDRA PHARMS BX + AUVI-Q BX + SANOFI AVENTIS US BX TWINJECT 0.15 BX + AMEDRA PHARMS TWINJECT 0.3 BX + AMEDRA PHARMS INJECTABLE; INTRAMUSCULAR EPIPEN BX + MERIDIAN MEDCL TECHN EPIPEN JR. BX + MERIDIAN MEDCL TECHN
EQ 0.15MG/DELIVERY EQ 0.3MG/DELIVERY EQ 0.15MG/DELIVERY EQ 0.3MG/DELIVERY EQ 0.15MG/DELIVERY EQ 0.3MG/DELIVERY
N020800 N020800 N201739 N201739 N020800 N020800
003 004 002 001 002 001
Nov 25, 2009 Nov 25, 2009 Aug 10, 2012 Aug 10, 2012 May 28, 2004 May 30, 2003
0.3MG/DELIVERY 0.15MG/DELIVERY
N019430 N019430
001 002
Dec 22, 1987 Dec 22, 1987
INJECTABLE; INTRAMUSCULAR, INTRAOCULAR, SUBCUTANEOUS ADRENALIN 1MG/ML XX + JHP PHARMS
N204200
001
Dec 07, 2012

EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
LIGNOSPAN FORTE
XX + DEPROCO LIGNOSPAN STANDARD XX + DEPROCO
3 - 154 (of 428)
EQ 0.02MG BASE/ML;2% EQ 0.01MG BASE/ML;2%
A088389 A088390
001 001
Jan 22, 1985 Jan 22, 1985
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE

INJECTABLE; INJECTION CITANEST FORTE DENTAL AP + DENTSPLY PHARM 0.005MG/ML;4% PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE SEPTODONT INC AP 0.005MG/ML;4%
N021383 A078959
001 001 Aug 30, 2011
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE

INJECTABLE; INJECTION LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE EASTMAN KODAK AP 0.01MG/ML;2% AP 0.02MG/ML;2% HOSPIRA AP 0.005MG/ML;0.5% AP 0.005MG/ML;1.5% AP 0.005MG/ML;1.5% AP 0.005MG/ML;2% AP 0.01MG/ML;1% AP 0.01MG/ML;2% AP 0.01MG/ML;2% AP 0.02MG/ML;2% OCTOCAINE AP + SEPTODONT 0.01MG/ML;2% AP + 0.02MG/ML;2% XYLOCAINE W/ EPINEPHRINE AP + FRESENIUS KABI USA 0.005MG/ML;0.5% AP + 0.005MG/ML;1% AP + 0.005MG/ML;1.5% AP + 0.005MG/ML;2% AP + 0.01MG/ML;1% AP + 0.02MG/ML;2%
A040057 A040057 A089635 A088571 A089645 A089651 A089644 A078772 A089646 A078772 A084048 A084048 N006488 N006488 N006488 N006488 N006488 N006488
002 001 001 001 001 001 001 001 001 002 001 002 012 018 017 019 004 005
Feb Feb Jun Sep Jun Jun Jun May Jun May
26, 26, 21, 13, 21, 21, 21, 12, 21, 12,
1993 1993 1988 1985 1988 1988 1988 2008 1988 2008
Nov 13, 1986 Nov 13, 1986
EPIRUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION ELLENCE PFIZER INC 50MG/25ML (2MG/ML) + 200MG/100ML (2MG/ML) EPIRUBICIN HYDROCHLORIDE ACTAVIS TOTOWA 10MG/5ML (2MG/ML) 50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML) AKORN INC 50MG/25ML (2MG/ML) BEDFORD 200MG/100ML (2MG/ML) 50MG/25ML (2MG/ML) BIONICHE PHARMA USA 50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML) CIPLA LTD 50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML) EBEWE PHARMA 50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML) FRESENIUS KABI ONCOL 200MG/100ML (2MG/ML) 50MG/25ML (2MG/ML) FRESENIUS KABI USA 150MG/75ML (2MG/ML) 50MG/25ML (2MG/ML) 10MG/5ML (2MG/ML)
N050778 N050778 A065445 A065445 A065445 A090163 A065289 A065289 A065371 A065371 A065361 A065361 A065339 A065339 A065411 A065411 A065408 A065408 A065408
002 001 001 002 003 001 002 001 001 002 001 002 001 002 001 002 003 002 001
Sep 15, 1999 Sep 15, 1999 Sep Sep Sep Jun Jun Jun Nov Nov Oct Oct Dec Dec Aug Aug Oct Oct Oct 18, 18, 18, 24, 27, 27, 28, 28, 22, 22, 22, 22, 20, 20, 15, 15, 15, 2008 2008 2008 2009 2007 2007 2007 2007 2007 2007 2009 2009 2007 2007 2007 2007 2007

INJECTABLE; INJECTION EPIRUBICIN HYDROCHLORIDE FRESENIUS KABI USA 200MG/100ML (2MG/ML) HISUN PHARM HANGZHOU 50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML) HOSPIRA 200MG/100ML (2MG/ML) 50MG/25ML (2MG/ML) 10MG/5ML (2MG/ML) 150MG/75ML (2MG/ML) MUSTAFA NEVSAT 200MG/100ML (2MG/ML) 50MG/25ML (2MG/ML) ONCO THERAPIES LTD 50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML) TEVA PARENTERAL 50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML) INJECTABLE; IV (INFUSION)
+ HOSPIRA 50MG/VIAL
3 - 155 (of 428)
A065408 A090075 A090075 A065343 A065343 A065343 A065343 A090266 A090266 A091599 A091599 A065331 A065331
004 001 002 004 002 001 003 002 001 001 002 001 002
Oct Mar Mar Apr Apr Apr Apr Apr Apr Mar Mar Aug Aug
15, 25, 25, 19, 19, 19, 19, 15, 15, 12, 12, 09, 09,
2007 2010 2010 2007 2007 2007 2007 2011 2011 2012 2012 2007 2007
XX
N050807
001
Sep 15, 2006
EPLERENONE
TABLET; ORAL EPLERENONE APOTEX AB AB SANDOZ AB AB INSPRA GD SEARLE LLC AB AB +
A078482 A078482 A078510 A078510 N021437 N021437
001 002 001 002 001 002
Jul Jul Aug Aug
30, 30, 01, 01,
2008 2008 2008 2008
Sep 27, 2002 Sep 27, 2002
EPOPROSTENOL SODIUM
INJECTABLE; INJECTION EPOPROSTENOL SODIUM TEVA PARENTERAL AP AP FLOLAN AP + GLAXOSMITHKLINE LLC AP + VELETRI ACTELION PHARMS LTD XX XX +
EQ 0.5MG BASE/VIAL EQ 1.5MG BASE/VIAL EQ 0.5MG BASE/VIAL EQ 1.5MG BASE/VIAL EQ 0.5MG BASE/VIAL EQ 1.5MG BASE/VIAL
A078396 A078396 N020444 N020444 N022260 N022260
001 002 001 002 002 001
Apr 23, 2008 Apr 23, 2008 Sep 20, 1995 Sep 20, 1995 Jun 28, 2012 Jun 27, 2008
EPROSARTAN MESYLATE
TABLET; ORAL EPROSARTAN MESYLATE MYLAN PHARMS INC AB AB TEVETEN ABBVIE AB AB +
A202012 A202012 N020738 N020738
001 002 005 006
Nov 16, 2011 Nov 16, 2011 Dec 22, 1997 May 27, 1999
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE

TABLET; ORAL TEVETEN HCT ABBVIE XX XX +
600MG;12.5MG 600MG;25MG
N021268 N021268
001 002
Nov 01, 2001 Nov 01, 2001
EPTIFIBATIDE
INTEGRILIN
XX + SCHERING
2MG/ML
N020718
001
May 18, 1998

EPTIFIBATIDE
INTEGRILIN
XX + SCHERING
3 - 156 (of 428)
75MG/100ML
N020718
002
May 18, 1998
ERGOCALCIFEROL
CAPSULE; ORAL DRISDOL + SANOFI AVENTIS US ERGOCALCIFEROL ORIT LABS LLC SIGMAPHARM LABS LLC STRIDES ARCOLAB LTD SUN PHARM INDS INC VITAMIN D BANNER PHARMACAPS
AA AA AA AA AA AA
50,000 IU 50,000 50,000 50,000 50,000 IU IU IU IU
N003444 A040833 A091004 A090455 A040865 A080704
001 001 001 001 001 001 May Jul Aug Dec 20, 14, 03, 29, 2009 2010 2010 2009
50,000 IU
ERGOLOID MESYLATES
TABLET; ORAL ERGOLOID MESYLATES MUTUAL PHARM AB HYDERGINE AB + NOVARTIS TABLET; SUBLINGUAL ERGOLOID MESYLATES WATSON LABS XX
1MG 1MG
A081113 N017993
001 001
Oct 31, 1991
0.5MG
A087233
001
ERGOTAMINE TARTRATE
TABLET; SUBLINGUAL
ERGOMAR
XX + ROSEDALE THERAPEUTIC
2MG
A087693
001
Feb 24, 1983
ERIBULIN MESYLATE
SOLUTION; INTRAVENOUS
HALAVEN
XX + EISAI INC
1MG/2ML (0.5MG/ML)
N201532
001
Nov 15, 2010
ERLOTINIB HYDROCHLORIDE
TABLET; ORAL TARCEVA OSI PHARMS XX XX XX +
N021743 N021743 N021743
001 002 003
Nov 18, 2004 Nov 18, 2004 Nov 18, 2004
ERTAPENEM SODIUM
INJECTABLE; INTRAMUSCULAR, IV (INFUSION)
INVANZ
XX + MERCK EQ 1GM BASE/VIAL
N021337
001
Nov 21, 2001
ERYTHROMYCIN
CAPSULE, DELAYED REL PELLETS; ORAL ERYC + HOSPIRA 250MG WARNER CHILCOTT LLC 250MG ERYTHROMYCIN ARBOR PHARMS INC 250MG GEL; TOPICAL ERYGEL + MERZ PHARMS 2% ERYTHROMYCIN FOUGERA PHARMS 2% PERRIGO 2%
AB AB AB
N050536 A062338 A062746
001 001 001 Dec 22, 1986
AT AT AT
N050617 A064184 A063211
001 001 001
Oct 21, 1987 Sep 30, 1997 Jan 29, 1993

ERYTHROMYCIN
OINTMENT; OPHTHALMIC ERYTHROMYCIN AKORN AT BAUSCH AND LOMB AT AT + FERA PHARMS OINTMENT; TOPICAL
AKNE-MYCIN
XX + DOW PHARM SCIENCES SOLUTION; TOPICAL C-SOLVE-2 FOUGERA PHARMS ERYTHRA-DERM PADDOCK LLC ERYTHROMYCIN + FOUGERA PHARMS PERRIGO NEW YORK WOCKHARDT ERYTHRO-STATIN HI TECH PHARMA SWAB; TOPICAL ERYTHROMYCIN + FOUGERA PHARMS + PERRIGO VERSAPHARM
3 - 157 (of 428)
0.5% 0.5% 0.5%
A064030 A064067 A062447
001 001 001
Jul 18, 1996 Jul 29, 1994 Sep 26, 1983
2%
N050584
001
Jan 10, 1985
AT AT AT AT AT AT
2% 2% 2% 2% 2% 2%
A062468 A062687 A064187 A063038 A062825 A064101
001 001 001 001 001 001
Jul 03, 1985 Feb 05, 1988 Sep 30, 1997 Jan 11, 1991 Oct 23, 1987 Oct 22, 1996
AT AT AT
2% 2% 2%
A065320 A064126 A090215
001 001 001
Jul 25, 2006 Jul 03, 1996 May 12, 2010
TABLET; ORAL
ERYTHROMYCIN
ARBOR PHARMS INC XX XX +
250MG 500MG
A061621 A061621
001
002
TABLET, COATED PARTICLES; ORAL

PCE ARBOR PHARMS INC 333MG XX 500MG XX + TABLET, DELAYED RELEASE; ORAL
ERY-TAB
250MG XX + ARBOR PHARMS INC 333MG XX + 500MG XX +
N050611 N050611
001 002
Sep 09, 1986 Aug 22, 1990
A062298 A062298 A062298
001 003 002
Mar 29, 1982
ERYTHROMYCIN ETHYLSUCCINATE
GRANULE; ORAL E.E.S. ARBOR PHARMS INC AB ERYPED ARBOR PHARMS INC AB ERYPED XX + ARBOR PHARMS INC SUSPENSION; ORAL
E.E.S. 200 ARBOR PHARMS AB E.E.S. 400 AB + ARBOR PHARMS PEDIAMYCIN ARBOR PHARMS AB PEDIAMYCIN 400 ARBOR PHARMS AB
EQ 200MG BASE/5ML EQ 200MG BASE/5ML EQ 400MG BASE/5ML
N050207 N050207 N050207
001 003 002

Mar 30, 1987
INC INC INC
EQ 200MG BASE/5ML EQ 400MG BASE/5ML EQ 200MG BASE/5ML
A061639 A061639 A062304 A062304
001 002 001 002
INC EQ 400MG BASE/5ML TABLET; ORAL E.E.S. 400 BX + ARBOR PHARMS INC EQ 400MG BASE ERYTHROMYCIN ETHYLSUCCINATE BX + ARBOR PHARMS INC EQ 400MG BASE
A061905 A061904
002 001
Aug 12, 1982

ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
GRANULE; ORAL
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
XX + BARR EQ 200MG BASE/5ML;EQ 600MG BASE/5ML
3 - 158 (of 428)
A062759
001
May 20, 1988
ERYTHROMYCIN LACTOBIONATE
INJECTABLE; INJECTION ERYTHROCIN HOSPIRA AP AP + AP +
EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
A062638 N050609 A062638
001 001 002
Oct 31, 1986 Sep 24, 1986 Oct 31, 1986
ERYTHROMYCIN STEARATE
TABLET; ORAL
ERYTHROCIN STEARATE
XX + ARBOR PHARMS INC
EQ 250MG BASE
A060359
001
ESCITALOPRAM OXALATE
SOLUTION; ORAL ESCITALOPRAM OXALATE AMNEAL PHARMS AUROBINDO PHARMA LTD HETERO LABS LTD III TARO LEXAPRO + FOREST LABS
AA AA AA AA AA
EQ EQ EQ EQ
5MG 5MG 5MG 5MG
A202227 A079062 A202221 A079121 N021365
001 001 001 001 001
Mar Apr Jun May
14, 02, 12, 03,
2012 2012 2012 2012
EQ 5MG BASE/5ML
Nov 27, 2002
TABLET; ORAL ESCITALOPRAM OXALATE ACCORD HLTHCARE AB AB AB APOTEX INC AB AB AB AUROBINDO PHARMA LTD AB AB AB HIKMA PHARMS AB AB AB INVAGEN PHARMS AB AB AB IVAX SUB TEVA PHARMS AB AB AB JUBILANT ORGANOSYS AB AB AB LUPIN LTD AB AB AB MACLEODS PHARMS LTD AB AB AB STI PHARMA LLC AB AB AB TORRENT PHARMS LTD AB AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE 5MG BASE 10MG BASE 20MG BASE
A202389 A202389 A202389 A078777 A078777 A078777 A090432 A090432 A090432 A078766 A078766 A078766 A078604 A078604 A078604 A076765 A076765 A076765 A202280 A202280 A202280 A078169 A078169 A078169 A202210 A202210 A202210 A077512 A077512 A077512 A090939 A090939 A090939
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 14, 14, 14, 12, 12, 12, 11, 11, 11, 11, 11, 11, 12, 12, 12, 11, 11, 11,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012

TABLET; ORAL ESCITALOPRAM OXALATE ZYDUS PHARMS USA INC AB AB AB LEXAPRO FOREST LABS AB AB AB +
3 - 159 (of 428)
EQ 5MG BASE EQ 10MG BASE EQ 20MG BASE EQ 5MG BASE EQ 10MG BASE EQ 20MG BASE
A077734 A077734 A077734 N021323 N021323 N021323
001 002 003 001 002 003
Sep 11, 2012 Sep 11, 2012 Sep 11, 2012 Aug 14, 2002 Aug 14, 2002 Aug 14, 2002
ESMOLOL HYDROCHLORIDE
INJECTABLE; INJECTION BREVIBLOC + BAXTER HLTHCARE 10MG/ML ESMOLOL HYDROCHLORIDE BEDFORD LABS 10MG/ML BIONICHE PHARMA 10MG/ML FRESENIUS KABI USA 10MG/ML BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER + BAXTER HLTHCARE 2GM/100ML BREVIBLOC IN PLASTIC CONTAINER + BAXTER HLTHCARE 1GM/100ML
AP AP AP AP XX XX
N019386 A076323 A076474 A076573 N019386 N019386
006 001 001 001 005 004
Feb 25, 2003 Aug 10, 2004 May 02, 2005 May 02, 2005 Jan 27, 2003 Feb 16, 2001
ESOMEPRAZOLE MAGNESIUM
CAPSULE, DELAYED REL PELLETS; ORAL NEXIUM XX ASTRAZENECA EQ 20MG BASE XX + EQ 40MG BASE FOR SUSPENSION, DELAYED RELEASE; ORAL NEXIUM XX ASTRAZENECA EQ 2.5MG BASE/PACKET XX EQ 5MG BASE/PACKET XX EQ 10MG BASE/PACKET XX EQ 20MG BASE/PACKET XX + EQ 40MG BASE/PACKET
N021153 N021153
001 002
Feb 20, 2001 Feb 20, 2001
N021957 N021957 N022101 N021957 N021957
003 004 001 001 002
Dec Dec Feb Oct Oct
15, 15, 27, 20, 20,
2011 2011 2008 2006 2006
ESOMEPRAZOLE MAGNESIUM; NAPROXEN

TABLET, DELAYED RELEASE; ORAL VIMOVO XX ASTRAZENECA LP EQ 20MG BASE;375MG XX + EQ 20MG BASE;500MG
N022511 N022511
002 001
Apr 30, 2010 Apr 30, 2010
ESOMEPRAZOLE SODIUM
NEXIUM IV
XX + ASTRAZENECA XX +
N021689 N021689
001 002
Mar 31, 2005 Mar 31, 2005
ESTAZOLAM
TABLET; ORAL ESTAZOLAM PAR PHARM AB AB TEVA AB AB + WATSON LABS AB AB
A074826 A074826 A074921 A074921 A074818 A074818
001 002 001 002 001 002
Jul Jul Jul Jul Aug Aug
03, 03, 10, 10, 19, 19,
1997 1997 1997 1997 1997 1997

ESTRADIOL
CREAM; VAGINAL
ESTRACE
XX + WARNER CHILCOTT US 0.01% FILM, EXTENDED RELEASE; TRANSDERMAL CLIMARA BAYER HLTHCARE AB 0.0375MG/24HR AB 0.06MG/24HR ESTRADIOL MYLAN TECHNOLOGIES AB 0.0375MG/24HR AB 0.06MG/24HR VIVELLE NOVARTIS AB1 0.05MG/24HR AB1 0.1MG/24HR VIVELLE-DOT NOVARTIS AB1 0.05MG/24HR AB1 + 0.1MG/24HR CLIMARA BAYER HLTHCARE AB2 0.025MG/24HR AB2 0.05MG/24HR AB2 0.075MG/24HR AB2 + 0.1MG/24HR ESTRADIOL MYLAN TECHNOLOGIES AB2 0.025MG/24HR AB2 0.05MG/24HR AB2 0.075MG/24HR AB2 0.1MG/24HR ALORA BX WATSON LABS 0.025MG/24HR BX 0.05MG/24HR BX 0.075MG/24HR BX 0.1MG/24HR ESTRADERM BX NOVARTIS 0.05MG/24HR BX + 0.1MG/24HR VIVELLE-DOT BX NOVARTIS 0.025MG/24HR BX 0.0375MG/24HR BX 0.075MG/24HR MENOSTAR 0.014MG/24HR XX + BAYER HLTHCARE MINIVELLE NOVEN 0.0375MG/24HR XX 0.05MG/24HR XX 0.075MG/24HR XX 0.1MG/24HR XX + GEL; TRANSDERMAL DIVIGEL UPSHER SMITH 0.1% (0.5GM/PACKET) XX 0.1% (1GM/PACKET) XX + 0.1% (0.25GM/PACKET) XX GEL, METERED; TRANSDERMAL
ELESTRIN
0.06% (0.87GM/ACTIVATION) XX + MEDA PHARMS ESTROGEL 0.06% (1.25GM/ACTIVATION) XX + ASCEND INSERT, EXTENDED RELEASE; VAGINAL ESTRING XX + PHARMACIA AND UPJOHN 0.0075MG/24HR SPRAY; TRANSDERMAL EVAMIST XX + KV PHARM
3 - 160 (of 428)
A086069
001
Jan 31, 1984
N020375 N020375 A075182 A075182 N020323 N020323 N020538 N020538 N020375 N020375 N020375 N020375 A075182 A075182 A075182 A075182 N020655 N020655 N020655 N020655 N019081 N019081 N020538 N020538 N020538 N021674 N203752 N203752 N203752 N203752
005 006 004 005 002 004 006 008 004 001 003 002 003 006 002 001 004 001 002 003 002 003 009 005 007 001 001 003 002 004
May 27, 2003 May 27, 2003 Jul 20, 2006 Jul 20, 2006 Oct 28, 1994 Oct 28, 1994 Jan 08, 1999 Jan 08, 1999 Mar Dec Mar Dec Jan Feb Jan Feb Apr Dec Dec Dec 05, 22, 23, 22, 26, 24, 26, 24, 05, 20, 20, 20, 1999 1994 1998 1994 2005 2000 2005 2000 2002 1996 1996 1996
Sep 10, 1986 Sep 10, 1986 May 03, 2002 Jan 08, 1999 Jan 08, 1999 Jun 08, 2004 Oct Oct Oct Oct 29, 29, 29, 29, 2012 2012 2012 2012
N022038 N022038 N022038
002 003 001
Jun 04, 2007 Jun 04, 2007 Jun 04, 2007
N021813 N021166
001 002
Dec 15, 2006 Feb 09, 2004
N020472
001
Apr 26, 1996
1.53MG/SPRAY
N022014
001
Jul 27, 2007

ESTRADIOL
TABLET; ORAL ESTRADIOL BARR LABS INC AB AB AB + MYLAN AB AB AB USL PHARMA AB AB AB WATSON LABS AB AB AB TABLET; VAGINAL
VAGIFEM
XX + NOVO NORDISK INC
3 - 161 (of 428)
0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG
A040197 A040197 A040197 A040326 A040326 A040326 A040297 A040297 A040297 A040114 A040114 A040114
001 002 003 001 002 003 001 002 003 003 001 002
Oct Oct Oct Apr Apr Apr Apr Apr Apr Mar Mar Mar
22, 22, 22, 21, 21, 21, 17, 17, 17, 14, 14, 14,
1997 1997 1997 1999 1999 1999 2002 2002 2002 1996 1996 1996
10MCG
N020908
002
Nov 25, 2009
ESTRADIOL ACETATE
INSERT, EXTENDED RELEASE; VAGINAL FEMRING XX WARNER IRELAND EQ 0.05MG BASE/24HR XX + EQ 0.1MG BASE/24HR TABLET; ORAL FEMTRACE XX WARNER CHILCOTT LLC XX XX +
N021367 N021367
001 002
Mar 20, 2003 Mar 20, 2003
0.45MG 0.9MG 1.8MG
N021633 N021633 N021633
001 002 003
Aug 20, 2004 Aug 20, 2004 Aug 20, 2004
ESTRADIOL CYPIONATE
INJECTABLE; INJECTION DEPO-ESTRADIOL AO + PHARMACIA AND UPJOHN ESTRADIOL CYPIONATE WATSON LABS AO
5MG/ML 5MG/ML
A085470 A085620
003 001
ESTRADIOL HEMIHYDRATE
EMULSION; TOPICAL
ESTRASORB
XX + MEDICIS
0.25%
N021371
001
Oct 09, 2003
ESTRADIOL VALERATE
INJECTABLE; INJECTION DELESTROGEN + JHP PHARMS + + ESTRADIOL VALERATE LUITPOLD SANDOZ
AO AO AO AO AO AO AO AO AO AO
N009402 N009402 N009402 A090920 A090920 A040628 A040628 A040628 A083547 A083714
002 004 003 001 002 001 002 003 001 001 Jan Jan Oct Oct Oct 19, 19, 04, 04, 04, 2010 2010 2007 2007 2007
WATSON LABS
ESTRADIOL; LEVONORGESTREL
FILM, EXTENDED RELEASE; TRANSDERMAL CLIMARA PRO XX + BAYER HLTHCARE 0.045MG/24HR;0.015MG/24HR
N021258
001
Nov 21, 2003

ESTRADIOL; NORETHINDRONE ACETATE
FILM, EXTENDED RELEASE; TRANSDERMAL COMBIPATCH XX NOVARTIS 0.05MG/24HR;0.14MG/24HR XX + 0.05MG/24HR;0.25MG/24HR TABLET; ORAL ACTIVELLA NOVO NORDISK INC 0.5MG;0.1MG + 1MG;0.5MG ESTRADIOL AND NORETHINDRONE ACETATE BARR 1MG;0.5MG BRECKENRIDGE PHARM 0.5MG;0.1MG 1MG;0.5MG TEVA PHARMS USA 0.5MG;0.1MG
3 - 162 (of 428)
N020870 N020870
001 002
Aug 07, 1998 Aug 07, 1998
AB AB AB AB AB AB
N020907 N020907 A079193 A078324 A078324 A200747
002 001 001 002 001 001
Dec 28, 2006 Nov 18, 1998 May Jun Apr Mar 11, 09, 17, 08, 2010 2011 2008 2012
ESTRADIOL; NORGESTIMATE
TABLET; ORAL ESTRADIOL AND NORGESTIMATE BARR AB 1MG,1MG;N/A,0.09MG PREFEST AB + TEVA WOMENS 1MG,1MG;N/A,0.09MG
A076812 N021040
001 001
Apr 29, 2005 Oct 22, 1999
ESTRAMUSTINE PHOSPHATE SODIUM

CAPSULE; ORAL
EMCYT
EQ 140MG PHOSPHATE
N018045
001
ESTROGENS, CONJUGATED
CREAM; TOPICAL, VAGINAL
PREMARIN
XX + WYETH PHARMS INC INJECTABLE; INJECTION
PREMARIN
XX + WYETH PHARMS INC TABLET; ORAL
PREMARIN
XX WYETH PHARMS INC XX XX + XX + XX +
0.625MG/GM
N020216
001
25MG/VIAL
N010402
001
0.3MG 0.45MG 0.625MG 0.9MG 1.25MG
N004782 N004782 N004782 N004782 N004782
003 006 004 005 001
Jul 16, 2003 Jan 26, 1984
ESTROGENS, CONJUGATED SYNTHETIC A

CREAM; VAGINAL
SYNTHETIC CONJUGATED ESTROGENS A
0.625MG/GM XX + TEVA WOMENS TABLET; ORAL CENESTIN TEVA BRANDED PHARM XX XX XX XX XX +
N021788
001
Nov 28, 2008
0.3MG 0.45MG 0.625MG 0.9MG 1.25MG
N020992 N020992 N020992 N020992 N020992
001 005 002 003 004
Jun Feb Mar Mar Mar
21, 05, 24, 24, 13,
2002 2004 1999 1999 2000
ESTROGENS, CONJUGATED SYNTHETIC B

TABLET; ORAL ENJUVIA XX TEVA WOMENS XX XX XX XX +
0.3MG 0.45MG 0.625MG 0.9MG 1.25MG
N021443 N021443 N021443 N021443 N021443
001 002 003 005 004
Dec Dec May Apr May
20, 20, 10, 27, 10,
2004 2004 2004 2007 2004

ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
TABLET; ORAL-28
PREMPHASE 14/14
+ WYETH PHARMS INC PREMPRO + WYETH PHARMS INC + + +
3 - 163 (of 428)
XX XX XX XX XX
0.625MG,0.625MG;N/A,5MG 0.3MG;1.5MG 0.45MG;1.5MG 0.625MG;2.5MG 0.625MG;5MG
N020527 N020527 N020527 N020527 N020527
002 005 004 001 003
Nov 17, 1995 Jun Mar Nov Jan 04, 12, 17, 09, 2003 2003 1995 1998
ESTROGENS, ESTERIFIED
TABLET; ORAL MENEST XX MONARCH PHARMS XX XX XX +
0.3MG 0.625MG 1.25MG 2.5MG
A084951 A084948 A084950 A084949
001 001 001 001
ESTRONE
ESTRONE
XX + WATSON LABS
5MG/ML
A085239
001
ESTROPIPATE
TABLET; ORAL ESTROPIPATE BARR AB AB AB MYLAN AB AB WATSON LABS AB AB AB AB OGEN .625 PHARMACIA AND UPJOHN AB OGEN 1.25 PHARMACIA AND UPJOHN AB OGEN 2.5 AB + PHARMACIA AND UPJOHN OGEN 5 PHARMACIA AND UPJOHN AB ORTHO-EST SUN PHARM INDS (IN) AB AB
0.75MG 1.5MG 3MG 0.75MG 1.5MG 0.75MG 1.5MG 3MG 6MG 0.75MG 1.5MG 3MG 6MG 0.75MG 1.5MG
A040135 A040135 A040135 A040359 A040359 A081213 A081214 A081215 A081216 A083220 A083220 A083220 A083220 A089567 A089582
001 002 003 001 002 001 001 001 001 001 002 003 004 001 001
Nov Nov Nov Aug Aug Sep Sep Sep Sep
27, 27, 27, 26, 26, 23, 23, 23, 23,
1996 1996 1996 1999 1999 1993 1993 1993 1993
Feb 27, 1991 Jul 17, 1991
ESZOPICLONE
TABLET; ORAL LUNESTA XX SUNOVION PHARMS INC XX XX +
1MG 2MG 3MG
N021476 N021476 N021476
001 002 003
Dec 15, 2004 Dec 15, 2004 Dec 15, 2004
ETHACRYNATE SODIUM
EDECRIN
XX + ATON
EQ 50MG BASE/VIAL
N016093
001

ETHACRYNIC ACID
TABLET; ORAL EDECRIN XX + ATON
3 - 164 (of 428)
25MG
N016092
001
ETHAMBUTOL HYDROCHLORIDE
TABLET; ORAL ETHAMBUTOL HYDROCHLORIDE BARR AB 400MG LUPIN AB 100MG AB 400MG WEST WARD AB 100MG AB + 400MG MYAMBUTOL STI PHARMA LLC AB 100MG AB 400MG
A076057 A078939 A078939 A075095 A075095 N016320 N016320
001 001 002 001 002 001 003
Nov Jun Jun Nov Nov
26, 17, 17, 30, 30,
2001 2009 2009 1999 1999
ETHANOLAMINE OLEATE
INJECTABLE; INJECTION ETHAMOLIN XX + QOL MEDCL
50MG/ML
N019357
001
Dec 22, 1988
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE

TABLET; ORAL-28 KELNOR BARR AB ZOVIA 1/35E-28 WATSON LABS AB ZOVIA 1/50E-28 XX + WATSON LABS
0.035MG;1MG 0.035MG;1MG 0.05MG;1MG
A076785 A072721 A072723
001 001 001
May 23, 2005 Dec 30, 1991 Dec 30, 1991
ETHINYL ESTRADIOL; ETONOGESTREL

RING; VAGINAL NUVARING XX + ORGANON USA INC
0.015MG;0.12MG
N021187
001
Oct 03, 2001
ETHINYL ESTRADIOL; LEVONORGESTREL

TABLET; ORAL INTROVALE SANDOZ AB 0.03MG;0.15MG LEVONORGESTREL AND ETHINYL ESTRADIOL LUPIN LTD AB 0.02MG,0.01MG;0.1MG,N/A AB 0.03MG;0.15MG WATSON LABS AB 0.02MG,0.01MG;0.1MG,N/A LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL WATSON LABS AB 0.03MG,0.01MG;0.15MG,N/A LOSEASONIQUE TEVA BRANDED PHARM AB 0.02MG,0.01MG;0.1MG,N/A QUASENSE WATSON LABS AB 0.03MG;0.15MG SEASONALE AB + TEVA BRANDED PHARM 0.03MG;0.15MG SEASONIQUE AB + TEVA BRANDED PHARM 0.03MG,0.01MG;0.15MG,N/A LEVONORGESTREL AND ETHINYL ESTRADIOL 0.02MG;0.09MG XX + WATSON LABS TABLET; ORAL-28 ALTAVERA SANDOZ AB ENPRESSE-28 DURAMED PHARMS BARR AB
A079064 A091674 A091440 A200407 A078834 N022262 A077101 N021544 N021840 A079218
001 001 001 001 001 001 001 001 001 001
Sep 27, 2010 Oct 26, 2011 Oct 23, 2012 Oct 25, 2011 May 31, 2011 Oct 24, 2008 Sep 06, 2006 Sep 05, 2003 May 25, 2006 Jun 06, 2011
0.03MG;0.15MG
A079102
001 002
Aug 03, 2010 Jul 16, 2001
0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A075809 25MG

TABLET; ORAL-28 KURVELO LUPIN LTD AB LEVONEST NOVAST LABS LTD AB
3 - 165 (of 428)
0.03MG;0.15MG
A091408
001 001
Oct 17, 2012 Dec 29, 2010
AB AB AB AB
AB AB AB
AB1 AB1 AB1 AB1 AB2 AB2
0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A090719 25MG LEVONORGESTREL AND ETHINYL ESTRADIOL FAMY CARE LTD 0.03MG;0.15MG A091663 LEVORA 0.15/30-28 WATSON LABS 0.03MG;0.15MG A073594 MARLISSA GLENMARK GENERICS 0.03MG;0.15MG A091452 MYZILRA VINTAGE PHARMS LLC 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A077502 25MG NORDETTE-28 + TEVA BRANDED PHARM 0.03MG;0.15MG N018782 PORTIA-28 BARR 0.03MG;0.15MG A075866 TRIVORA-28 + WATSON LABS 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A074538 25MG AVIANE-28 DURAMED PHARMS BARR 0.02MG;0.1MG A075796 FALMINA NOVAST LABS LTD 0.02MG;0.1MG A090721 LEVONORGESTREL AND ETHINYL ESTRADIOL + WATSON LABS 0.02MG;0.1MG A076625 ORSYTHIA VINTAGE PHARMS LLC 0.02MG;0.1MG A077099 LESSINA-28 BARR 0.02MG;0.1MG A075803 LEVONORGESTREL AND ETHINYL ESTRADIOL + WATSON LABS 0.02MG;0.1MG A077681
001 001 001 001
Dec 21, 2012 Dec 13, 1993 Feb 29, 2012 Nov 23, 2011
001 002 002
Jul 21, 1982 May 23, 2002 Dec 18, 1997
001 001 001 001 002 001
Apr 30, 2001 Mar 28, 2012 Nov 18, 2004 May 11, 2011 Mar 20, 2002 May 31, 2006
ETHINYL ESTRADIOL; NORELGESTROMIN

FILM, EXTENDED RELEASE; TRANSDERMAL
ORTHO EVRA
XX + JANSSEN PHARMS 0.75MG;6MG
N021180
001
Nov 20, 2001
ETHINYL ESTRADIOL; NORETHINDRONE

TABLET; ORAL-21 NORETHIN 1/35E-21 WATSON LABS 0.035MG;1MG NORETHINDRONE AND ETHINYL ESTRADIOL WATSON LABS 0.035MG;1MG NORINYL 1+35 21-DAY WATSON LABS 0.035MG;1MG NORTREL 1/35-21 BARR 0.035MG;1MG NORETHINDRONE AND ETHINYL ESTRADIOL WATSON LABS 0.035MG;0.4MG NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) WATSON LABS 0.035MG,0.035MG;0.5MG,1MG NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) WATSON LABS 0.035MG,0.035MG;0.5MG,1MG NORTREL 7/7/7 BARR 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M G
AB AB AB AB XX XX XX XX
A071480 A070685 N017565 A072693 A078379 A071043 A071041 A075478
001 001 001 001 001 001 001 001
Apr 12, 1988 Jan 29, 1987
Feb 28, 1992 Feb 23, 2010 Apr 01, 1988 Sep 24, 1991 Aug 30, 2002
TABLET; ORAL-28 ALYACEN 1/35 GLENMARK GENERICS AB
0.035MG;1MG
A091634
001
Jan 19, 2012

TABLET; ORAL-28 ALYACEN 7/7/7 GLENMARK GENERICS AB ARANELLE BARR BALZIVA-28 BARR BREVICON 28-DAY WATSON LABS BRIELLYN GLENMARK GENERICS CYCLAFEM 1/35 VINTAGE PHARMS LLC CYCLAFEM 7/7/7 VINTAGE PHARMS LLC DASETTA 1/35 NOVAST LABS LTD DASETTA 7/7/7 NOVAST LABS LTD
3 - 166 (of 428)
0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A091636 G 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG A076783 0.035MG;0.4MG 0.035MG;0.5MG 0.035MG;0.4MG 0.035MG;1MG A076238 N017743 A090538 A076337
001
Jan 19, 2012
AB AB AB AB AB AB
001 001 001 001 001 001
Sep 29, 2004 Apr 22, 2004
Mar 22, 2011 Nov 12, 2010 Nov 16, 2010
0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A076338 G 0.035MG;1MG A090948
AB AB
001 001
Dec 22, 2011 Dec 22, 2011
0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A090946 G A078376 N017735 A071481 A078323 A070686 A076393 A070687 N017565 A072695 A072696 A075478
AB AB
AB AB AB AB XX XX XX
GILDAGIA VINTAGE PHARMS 0.035MG;0.4MG MODICON 28 + JANSSEN PHARMS 0.035MG;0.5MG NORETHIN 1/35E-28 WATSON LABS 0.035MG;1MG NORETHINDRONE AND ETHINYL ESTRADIOL WATSON LABS 0.035MG;0.4MG 0.035MG;0.5MG 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M G 0.035MG;1MG NORINYL 1+35 28-DAY WATSON LABS 0.035MG;1MG NORTREL 0.5/35-28 BARR 0.035MG;0.5MG NORTREL 1/35-28 BARR 0.035MG;1MG NORTREL 7/7/7 BARR 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M G ORTHO-NOVUM 1/35-28 + JANSSEN PHARMS 0.035MG;1MG ORTHO-NOVUM 7/7/7-28 + JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M G OVCON-35 + WARNER CHILCOTT LLC 0.035MG;0.4MG PHILITH NOVAST LABS LTD 0.035MG;0.4MG TRI-NORINYL 28-DAY + WATSON LABS 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG WERA NOVAST LABS LTD 0.035MG;0.5MG NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) WATSON LABS 0.035MG,0.035MG;0.5MG,1MG NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) WATSON LABS 0.035MG,0.035MG;0.5MG,1MG OVCON-50 + WARNER CHILCOTT LLC 0.05MG;1MG
001 001 001 001 001 001 001 002 001 001 002
Nov 06, 2012
Apr 12, 1988 Feb 04, 2010 Jan 29, 1987 Feb 04, 2010 Jan 29, 1987
Feb 28, 1992 Feb 28, 1992 Aug 30, 2002
N017919 N018985
002 002 Apr 04, 1984
N017716 A090947 N018977 A091204 A071044 A071042 N017576
001 001 002 001 001 001 001 Dec 22, 2011 Apr 13, 1984 Mar 27, 2012 Apr 01, 1988 Sep 24, 1991

TABLET, CHEWABLE; ORAL FEMCON FE + WARNER CHILCOTT LLC 0.035MG;0.4MG NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE BARR 0.035MG;0.4MG WATSON LABS 0.035MG;0.4MG NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE + WATSON LABS INC 0.025MG;0.8MG
3 - 167 (of 428)
AB AB AB XX
N021490 A078965 A078892 N022573
001 001 001 001
Nov 14, 2003 Aug 05, 2010 Sep 26, 2011 Dec 22, 2010
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

TABLET; ORAL FEMHRT + WARNER CHILCOTT LLC 0.005MG;1MG LOESTRIN 24 FE + WARNER CHILCOTT 0.02MG;1MG NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL BARR 0.005MG;1MG NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE WATSON LABS 0.02MG;1MG FEMHRT WARNER CHILCOTT LLC 0.0025MG;0.5MG LO LOESTRIN FE + WARNER CHILCOTT LLC 0.01MG,0.01MG;1MG,N/A TABLET; ORAL-21 JUNEL 1.5/30 BARR 0.03MG;1.5MG JUNEL 1/20 BARR 0.02MG;1MG LOESTRIN 21 1.5/30 WARNER CHILCOTT LLC 0.03MG;1.5MG LOESTRIN 21 1/20 WARNER CHILCOTT LLC 0.02MG;1MG MICROGESTIN 1.5/30 WATSON LABS 0.03MG;1.5MG MICROGESTIN 1/20 WATSON LABS 0.02MG;1MG TRI-LEGEST 21 BARR 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG TABLET; ORAL-28 ESTROSTEP FE + WARNER CHILCOTT LLC 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG GILDESS FE 1.5/30 VINTAGE PHARMS LLC 0.03MG;1.5MG GILDESS FE 1/20 VINTAGE PHARMS LLC 0.02MG;1MG JUNEL FE 1.5/30 BARR 0.03MG;1.5MG JUNEL FE 1/20 BARR 0.02MG;1MG LOESTRIN FE 1.5/30 + WARNER CHILCOTT LLC 0.03MG;1.5MG LOESTRIN FE 1/20 WARNER CHILCOTT 0.02MG;1MG MICROGESTIN FE 1.5/30 WATSON LABS 0.03MG;1.5MG MICROGESTIN FE 1/20 WATSON LABS 0.02MG;1MG NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL WATSON LABS 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG TRI-LEGEST FE BARR 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG
AB AB AB AB XX XX
N021065 N021871 A076221 A078267 N021065 N022501
002 001 001 001 001 001
Oct 15, 1999 Feb 17, 2006 Nov 06, 2009 Sep 01, 2009 Jan 14, 2005 Oct 21, 2010
AB AB AB AB AB AB XX
A076381 A076380 N017875 N017876 A075548 A075647 A076405
001 001 001 001 002 002 001
May 30, 2003 May 30, 2003
Jul 30, 2003 Jul 30, 2003 Oct 26, 2007
N020130 A077075 A077077 A076064 A076081 N017355 N017354 A075548 A075647 A076629 A076105
002 001 001 001 001 001 001 001 001 001 001
Oct 09, 1996 Apr 28, 2005 May 20, 2005 Sep 18, 2003 Sep 18, 2003
Feb 05, 2001 Feb 05, 2001 Mar 18, 2010 Oct 26, 2007

ETHINYL ESTRADIOL; NORGESTIMATE
TABLET; ORAL NORGESTIMATE AND ETHINYL ESTRADIOL GLENMARK GENERICS 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, 0.25MG TABLET; ORAL-28 MONO-LINYAH NOVAST LABS LTD 0.035MG;0.25MG NORGESTIMATE AND ETHINYL ESTRADIOL GLENMARK GENERICS 0.035MG;0.25MG LUPIN PHARMS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, 0.25MG WATSON LABS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, 0.25MG 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, 0.25MG 0.035MG;0.25MG ORTHO CYCLEN-28 + JANSSEN PHARMS 0.035MG;0.25MG ORTHO TRI-CYCLEN + JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, 0.25MG ORTHO TRI-CYCLEN LO + JANSSEN PHARMS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, 0.25MG PREVIFEM VINTAGE PHARMS LLC 0.035MG;0.25MG SPRINTEC BARR 0.035MG;0.25MG TRI LO SPRINTEC BARR 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, 0.25MG TRI-LINYAH NOVAST LABS LTD 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, 0.25MG TRI-PREVIFEM VINTAGE PHARMS LLC 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, 0.25MG TRI-SPRINTEC BARR 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, 0.25MG
3 - 168 (of 428)
AB
A200494
001
Jun 17, 2011
AB AB AB AB AB AB AB AB
A090523 A200538 A200541 A090479 A076626 A076627 N019653 N019697
001 001 001 001 001 001 002 001
May 23, 2012 Apr 05, 2012 Jun 25, 2012 Mar 09, 2011 Aug 17, 2006 Aug 17, 2006 Dec 29, 1989 Jul 03, 1992
AB
N021241
001
Aug 22, 2002
AB AB AB
A076334 A075804 A076784
001 001 001
Jan 09, 2004 Sep 25, 2002 Jun 29, 2009
AB
A090524
001
May 30, 2012
AB
A076335
001
Mar 26, 2004
AB
A075808
001
Dec 29, 2003
ETHINYL ESTRADIOL; NORGESTREL

TABLET; ORAL-21 CRYSELLE DURAMED PHARMS BARR LOW-OGESTREL-21 + WATSON LABS TABLET; ORAL-28 CRYSELLE DURAMED PHARMS BARR ELINEST NOVAST LABS LTD LO/OVRAL-28 WYETH PHARMS LOW-OGESTREL-28 WATSON LABS OGESTREL 0.5/50-28 + WATSON LABS
AB AB
0.03MG;0.3MG 0.03MG;0.3MG
A075840 A075288
001 001
Nov 30, 2001 Jul 28, 1999
AB AB AB AB XX
0.03MG;0.3MG 0.03MG;0.3MG 0.03MG;0.3MG 0.03MG;0.3MG 0.05MG;0.5MG
A075840 A091105 N017802 A075288 A075406
002 001 001 002 002
Nov 30, 2001 Mar 28, 2012
Jul 28, 1999 Dec 15, 1999

ETHIONAMIDE
TABLET; ORAL TRECATOR XX + WYETH PHARMS INC
3 - 169 (of 428)
250MG
N013026
002
ETHOSUXIMIDE
CAPSULE; ORAL ETHOSUXIMIDE BANNER PHARMACAPS VERSAPHARM ZYDUS PHARMS USA INC ZARONTIN + PARKE DAVIS SYRUP; ORAL ETHOSUXIMIDE MIKART PHARM ASSOC TEVA PHARMS ZARONTIN + PARKE DAVIS
AB AB AB AB
250MG 250MG 250MG 250MG
A040430 A040686 A200892 N012380
001 001 001 001
Oct 28, 2002 May 28, 2008 Sep 25, 2012
AA AA AA AA
250MG/5ML 250MG/5ML 250MG/5ML 250MG/5ML
A040506 A040253 A081306 A080258
001 001 001 001
Dec 22, 2003 Nov 22, 2000 Jul 30, 1993
ETHOTOIN
TABLET; ORAL PEGANONE XX + LUNDBECK LLC
250MG
N010841
001
ETIDRONATE DISODIUM
TABLET; ORAL DIDRONEL PROCTER AND GAMBLE AB AB + ETIDRONATE DISODIUM MYLAN AB AB
200MG 400MG 200MG 400MG
N017831 N017831 A075800 A075800
001 002 001 002 Jan 24, 2003 Jan 24, 2003
ETODOLAC
CAPSULE; ORAL ETODOLAC APOTEX AB AB TARO AB AB + TEVA AB TABLET; ORAL ETODOLAC APOTEX INC AB AB MYLAN AB AB PROSAM LABS AB AB SANDOZ AB AB TARO PHARM INDS AB AB + TEVA AB AB TABLET, EXTENDED RELEASE; ETODOLAC TARO AB AB AB
200MG 300MG 200MG 300MG 300MG
A075419 A075419 A075078 A075078 A075126
001 002 001 002 002
Jul Jul Apr Apr Sep
28, 28, 30, 30, 16,
2000 2000 1998 1998 1999
400MG 500MG 400MG 500MG 400MG 500MG 400MG 500MG 400MG 500MG 400MG 500MG ORAL 400MG 500MG 600MG
A076004 A076004 A075104 A075104 A074819 A074819 A074903 A074903 A075074 A075074 A075009 A075009
001 002 001 002 001 002 001 002 001 002 001 002
Dec Dec Feb Nov Feb Apr Apr Apr Mar Apr Nov Dec
03, 03, 06, 20, 28, 28, 11, 19, 11, 25, 26, 28,
2002 2002 1998 1998 1997 1998 1997 1999 1998 2000 1997 1999
A076174 A076174 A076174
001 002 003
Mar 13, 2003 Mar 13, 2003 Mar 13, 2003

ETODOLAC
TABLET, EXTENDED RELEASE; ORAL ETODOLAC TEVA AB 400MG AB 500MG AB + 600MG
3 - 170 (of 428)
A075665 A075665 A075665
003 002 001
Feb 05, 2001 Jul 31, 2000 Jul 31, 2000
ETOMIDATE
INJECTABLE; INJECTION AMIDATE + HOSPIRA ETOMIDATE BEDFORD LUITPOLD MYLAN INSTITUTIONAL STRIDES ARCOLAB LTD
AP AP AP AP AP
2MG/ML 2MG/ML 2MG/ML 2MG/ML 2MG/ML
N018227 A074593 A078867 A091297 A078289
001 001 001 001 001
Sep 07, 1982 Nov Dec Jun Jan 04, 22, 20, 02, 1996 2009 2012 2009
ETONOGESTREL
IMPLANT; IMPLANTATION
IMPLANON
XX + ORGANON USA INC NEXPLANON XX + ORGANON USA INC
68MG/IMPLANT 68MG/IMPLANT
N021529 N021529
001 002
Jul 17, 2006 May 31, 2011
ETOPOSIDE
CAPSULE; ORAL
ETOPOSIDE
XX + MYLAN INJECTABLE; INJECTION ETOPOSIDE ACCORD HLTHCARE INC BEDFORD + FRESENIUS KABI USA PHARMACHEMIE TEVA PARENTERAL
50MG
A075635
001
Sep 19, 2001
AP AP AP AP AP AP
20MG/ML 20MG/ML 20MG/ML 20MG/ML 20MG/ML 20MG/ML
A074513 A074290 A074983 A074227 A074284 A074529
001 001 001 001 001 001
Mar Jul Sep Feb Feb Jul
14, 17, 30, 22, 10, 24,
1996 1995 1998 1996 1994 1996
ETOPOSIDE PHOSPHATE
ETOPOPHOS PRESERVATIVE FREE
XX + BRISTOL MYERS SQUIBB EQ 100MG BASE/VIAL
N020457
001
May 17, 1996
ETRAVIRINE
TABLET; ORAL INTELENCE XX JANSSEN R AND D XX XX +
25MG 100MG 200MG
N022187 N022187 N022187
003 001 002
Mar 26, 2012 Jan 18, 2008 Dec 22, 2010
EVEROLIMUS
TABLET; ORAL AFINITOR NOVARTIS XX XX XX XX + ZORTRESS NOVARTIS XX XX XX +
2.5MG 5MG 7.5MG 10MG 0.25MG 0.5MG 0.75MG
N022334 N022334 N022334 N022334 N021560 N021560 N021560
003 001 004 002 001 002 003
Jul Mar Mar Mar
09, 30, 30, 30,
2010 2009 2012 2009
Apr 20, 2010 Apr 20, 2010 Apr 20, 2010

EVEROLIMUS
TABLET, FOR SUSPENSION; ORAL AFINITOR DISPERZ XX NOVARTIS PHARM 2MG XX 3MG XX + 5MG
3 - 171 (of 428)
N203985 N203985 N203985
001 002 003
Aug 29, 2012 Aug 29, 2012 Aug 29, 2012
EXEMESTANE
TABLET; ORAL AROMASIN AB + PHARMACIA AND UPJOHN EXEMESTANE ROXANE AB
25MG 25MG
N020753 A077431
001 001
Oct 21, 1999 Apr 01, 2011
EXENATIDE SYNTHETIC
FOR SUSPENSION, EXTENDED RELEASE; SUBCUTANEOUS
BYDUREON
XX + AMYLIN 2MG/VIAL INJECTABLE; SUBCUTANEOUS
BYETTA
XX + AMYLIN XX +
N022200
001
Jan 27, 2012
300MCG/1.2ML (250MCG/ML) 600MCG/2.4ML (250MCG/ML)
N021773 N021773
001 002
Apr 28, 2005 Apr 28, 2005
EZETIMIBE
TABLET; ORAL
ZETIA
XX + MSD INTL GMBH
10MG
N021445
001
Oct 25, 2002
EZETIMIBE; SIMVASTATIN
TABLET; ORAL VYTORIN XX MSD INTL XX XX XX +
10MG;10MG 10MG;20MG 10MG;40MG 10MG;80MG
N021687 N021687 N021687 N021687
001 002 003 004
Jul Jul Jul Jul
23, 23, 23, 23,
2004 2004 2004 2004
EZOGABINE
TABLET; ORAL POTIGA GLAXOSMITHKLINE XX XX XX XX +
50MG 200MG 300MG 400MG
N022345 N022345 N022345 N022345
001 002 003 004
Jun Jun Jun Jun
10, 10, 10, 10,
2011 2011 2011 2011
FAMCICLOVIR
TABLET; ORAL FAMCICLOVIR APOTEX AB AB AB AUROBINDO PHARMA LTD AB AB AB MACLEODS PHARMS LTD AB AB AB MYLAN AB AB AB ROXANE AB AB AB
125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jul Jul Jul Mar Mar Mar Jan Jan Jan Mar Mar Mar Mar Mar Mar
22, 22, 22, 21, 21, 21, 12, 12, 12, 24, 24, 24, 21, 21, 21,
2011 2011 2011 2011 2011 2011 2012 2012 2012 2011 2011 2011 2011 2011 2011

FAMCICLOVIR
TABLET; ORAL FAMCICLOVIR TEVA PHARMS AB AB AB WATSON LABS AB AB AB FAMVIR NOVARTIS AB AB AB +
3 - 172 (of 428)
125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG
A077487 A077487 A077487 A078278 A078278 A078278 N020363 N020363 N020363
001 002 003 001 002 003 003 001 002
Aug Aug Aug Mar Mar Mar
24, 24, 24, 21, 21, 21,
2007 2007 2007 2011 2011 2011
Dec 11, 1995 Apr 26, 1996 Jun 29, 1994
FAMOTIDINE
FOR SUSPENSION; ORAL FAMOTIDINE LUPIN LTD AB NAVINTA LLC AB PEPCID AB + SALIX PHARMS INJECTABLE; INJECTION FAMOTIDINE BEDFORD AP AP FRESENIUS KABI USA AP AP + HIKMA MAPLE AP + PFIZER AP FAMOTIDINE PRESERVATIVE BEDFORD AP BEN VENUE AP CLARIS LIFESCIENCES AP FRESENIUS KABI USA AP AP + HIKMA MAPLE AP + PFIZER AP FAMOTIDINE PRESERVATIVE CLARIS LIFESCIENCES AP FAMOTIDINE PRESERVATIVE AP + BAXTER HLTHCARE SUSPENSION; ORAL FAMOTIDINE NOVEL LABS INC AB TABLET; ORAL FAMOTIDINE ALEMBIC PHARMS LTD AB AB APOTEX AB AB CARLSBAD AB AB DR REDDYS LABS LTD AB AB IVAX SUB TEVA PHARMS AB AB MYLAN AB AB PERRIGO AB AB TEVA AB
A090440 A091020 N019527
001 001 001
Jun 29, 2010 May 27, 2010 Feb 02, 1987
10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML FREE 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML FREE (PHARMACY BULK) 10MG/ML FREE IN PLASTIC CONTAINER 0.4MG/ML
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Apr Apr Apr Apr Apr Jun Apr Apr Nov Apr Apr Apr Jun
16, 16, 16, 16, 30, 25, 16, 17, 27, 16, 16, 30, 25,
2001 2001 2001 2001 2002 2008 2001 2001 2002 2001 2001 2002 2008
Nov 27, 2002 May 10, 2001
40MG/5ML
A201695
001
Dec 17, 2012
001 002 001 002 001 002 001 002 001 002 001 002 002 001 001
May May Jul Jul Apr Apr Apr Apr Apr Apr Apr Apr Jul Jul Apr
22, 22, 23, 23, 16, 16, 16, 16, 16, 16, 16, 16, 27, 27, 16,
2009 2009 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2005 2005 2001

FAMOTIDINE
TABLET; ORAL FAMOTIDINE TEVA AB WATSON LABS AB AB WOCKHARDT AB AB PEPCID MARATHON PHARMS AB AB +
3 - 173 (of 428)
A075311 A075062 A075062 A075786 A075786 N019462 N019462
002 002 001 001 002 001 002
Apr Apr Apr Apr Apr
16, 16, 16, 16, 16,
2001 2001 2001 2001 2001
Oct 15, 1986 Oct 15, 1986
FAMOTIDINE; IBUPROFEN
TABLET; ORAL
DUEXIS
XX + HORIZON PHARMA
26.6MG;800MG
N022519
001
Apr 23, 2011
FEBUXOSTAT
TABLET; ORAL ULORIC TAKEDA PHARMS USA XX XX +
40MG 80MG
N021856 N021856
001 002
Feb 13, 2009 Feb 13, 2009
FELBAMATE
SUSPENSION; ORAL FELBAMATE AMNEAL PHARMS AB FELBATOL AB + MEDA PHARMS TABLET; ORAL FELBAMATE AMNEAL PHARMS AB AB FELBATOL MEDA PHARMS AB AB +
600MG/5ML 600MG/5ML
A202385 N020189
001 003
Dec 16, 2011 Jul 29, 1993
400MG 600MG 400MG 600MG
A201680 A201680 N020189 N020189
001 002 001 002
Sep 13, 2011 Sep 13, 2011 Jul 29, 1993 Jul 29, 1993
FELODIPINE
TABLET, EXTENDED RELEASE; ORAL FELODIPINE AUROBINDO PHARMA LTD 2.5MG AB AB 5MG AB 10MG GLENMARK GENERICS AB 2.5MG AB 5MG AB 10MG MUTUAL PHARM AB 2.5MG AB 5MG AB 10MG MYLAN AB 2.5MG AB 5MG AB + 10MG TORRENT PHARMS LTD AB 2.5MG AB 5MG AB 10MG VINTAGE PHARMS LLC AB 2.5MG AB 5MG AB 10MG WOCKHARDT LTD AB 2.5MG AB 5MG AB 10MG
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jan Jan Jan Dec Dec Dec Nov Nov Nov Apr Apr Apr Nov Nov Nov Oct Oct Oct Aug Aug Aug
17, 17, 17, 17, 17, 17, 02, 02, 02, 17, 17, 17, 28, 28, 28, 28, 28, 28, 15, 15, 15,
2013 2013 2013 2010 2010 2010 2004 2004 2004 2008 2008 2008 2011 2011 2011 2011 2011 2011 2012 2012 2012

FELODIPINE
TABLET, EXTENDED RELEASE; ORAL PLENDIL ASTRAZENECA AB 2.5MG AB 5MG AB 10MG
3 - 174 (of 428)
N019834 N019834 N019834
004 001 002
Sep 22, 1994 Jul 25, 1991 Jul 25, 1991
FENOFIBRATE
CAPSULE; ORAL ANTARA (MICRONIZED) LUPIN ATLANTIS 43MG + 130MG FENOFIBRATE (MICRONIZED) DR REDDYS LABS SA 43MG 130MG IMPAX LABS 67MG 134MG 200MG MYLAN PHARMS INC 43MG 67MG 130MG 134MG 200MG TEVA 67MG 134MG + 200MG LIPOFEN CIPHER PHARMS INC 50MG + 150MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB XX XX
N021695 N021695 A090859 A090859 A075868 A075868 A075868 A202579 A202676 A202579 A202676 A202676 A075753 A075753 A075753 N021612 N021612
001 003 001 002 001 002 003 001 001 002 002 003 001 002 003 001 003
Nov 30, 2004 Nov 30, 2004 Mar Mar Oct Oct Oct Jan Oct Jan Oct Oct Sep Apr Apr 01, 01, 27, 27, 27, 10, 23, 10, 23, 23, 03, 09, 09, 2012 2012 2003 2003 2003 2013 2012 2013 2012 2012 2002 2002 2002
Jan 11, 2006 Jan 11, 2006
TABLET; ORAL FENOFIBRATE IMPAX LABS AB AB LUPIN LTD AB AB MYLAN AB AB MYLAN PHARMS INC AB AB RANBAXY AB AB TEVA AB AB + VALEANT INTL AB AB TRICOR ABBVIE AB AB + TRIGLIDE BX + SKYEPHARMA AG FENOFIBRATE RANBAXY XX FENOGLIDE SANTARUS XX XX + TRIGLIDE SKYEPHARMA AG XX
54MG 160MG 48MG 145MG 54MG 160MG 48MG 145MG 54MG 160MG 54MG 160MG 48MG 145MG 48MG 145MG 160MG 107MG 40MG 120MG 50MG
A076509 A076509 A090856 A090856 A076520 A076520 A202856 A202856 A076635 A076635 A076433 A076433 A090715 A090715 N021656 N021656 N021350 A076635 N022118 N022118 N021350
001 002 001 002 001 003 001 002 001 003 001 002 001 002 001 002 002 002 001 002 001
Mar Mar Dec Dec Oct Oct Dec Dec Oct Oct May May Apr Apr
26, 26, 23, 23, 25, 25, 07, 07, 31, 31, 13, 13, 05, 05,
2008 2008 2011 2011 2007 2007 2012 2012 2005 2005 2005 2005 2012 2012
Nov 05, 2004 Nov 05, 2004 May 07, 2005 Oct 31, 2005 Aug 10, 2007 Aug 10, 2007 May 07, 2005

FENOFIBRIC ACID
TABLET; ORAL FIBRICOR XX AR HOLDING CO INC XX +
3 - 175 (of 428)
35MG 105MG
N022418 N022418
001 002
Aug 14, 2009 Aug 14, 2009
FENOLDOPAM MESYLATE
INJECTABLE; INJECTION CORLOPAM AP + HOSPIRA FENOLDOPAM MESYLATE BEDFORD LABS AP SANDOZ AP
N019922 A076582 A077155
001 001 001
Sep 23, 1997 Oct 12, 2004 Feb 15, 2005
FENOPROFEN CALCIUM
CAPSULE; ORAL
NALFON
XX + XSPIRE XX TABLET; ORAL FENOPROFEN CALCIUM IVAX SUB TEVA PHARMS AB AB + MYLAN
N017604 N017604
003 004
Jul 21, 2009
A072557 A072267
001 001
Aug 29, 1988 Aug 17, 1988
FENTANYL
FILM, EXTENDED RELEASE; TRANSDERMAL DURAGESIC-100 JANSSEN PHARMS 100MCG/HR DURAGESIC-12 JANSSEN PHARMS 12.5MCG/HR DURAGESIC-25 + JANSSEN PHARMS 25MCG/HR DURAGESIC-50 JANSSEN PHARMS 50MCG/HR DURAGESIC-75 JANSSEN PHARMS 75MCG/HR FENTANYL-100 AVEVA 100MCG/HR LAVIPHARM LABS 100MCG/HR MALLINCKRODT INC 100MCG/HR MYLAN TECHNOLOGIES 100MCG/HR NOVEN 100MCG/HR PAR PHARM INC 100MCG/HR WATSON LABS 100MCG/HR FENTANYL-12 MYLAN TECHNOLOGIES 12.5MCG/HR FENTANYL-25 AVEVA 25MCG/HR LAVIPHARM LABS 25MCG/HR MALLINCKRODT INC 25MCG/HR MYLAN TECHNOLOGIES 25MCG/HR NOVEN 25MCG/HR PAR PHARM INC 25MCG/HR WATSON LABS 25MCG/HR FENTANYL-50 AVEVA 50MCG/HR LAVIPHARM LABS 50MCG/HR MALLINCKRODT INC 50MCG/HR MYLAN TECHNOLOGIES 50MCG/HR NOVEN 50MCG/HR PAR PHARM INC 50MCG/HR
N019813 N019813 N019813 N019813 N019813 A077449 A077051 A077154 A076258 A077775 A077062 A076709 A076258 A077449 A077051 A077154 A076258 A077775 A077062 A076709 A077449 A077051 A077154 A076258 A077775 A077062
001 005 004 003 002 004 004 004 004 004 004 004 005 001 001 001 001 001 001 001 002 002 002 002 002 002
Aug 07, 1990 Feb 04, 2005 Aug 07, 1990 Aug 07, 1990 Aug 07, 1990 Oct Aug Feb Jan Oct Aug Aug 20, 04, 09, 28, 16, 20, 20, 2008 2006 2011 2005 2009 2007 2007
Jan 23, 2007 Oct Aug Feb Jan Oct Aug Aug Oct Aug Feb Jan Oct Aug 20, 04, 09, 28, 16, 20, 20, 20, 04, 09, 28, 16, 20, 2008 2006 2011 2005 2009 2007 2007 2008 2006 2011 2005 2009 2007

FENTANYL
FILM, EXTENDED RELEASE; TRANSDERMAL FENTANYL-50 WATSON LABS 50MCG/HR FENTANYL-75 AVEVA 75MCG/HR LAVIPHARM LABS 75MCG/HR MALLINCKRODT INC 75MCG/HR MYLAN TECHNOLOGIES 75MCG/HR NOVEN 75MCG/HR PAR PHARM INC 75MCG/HR WATSON LABS 75MCG/HR SPRAY; SUBLINGUAL SUBSYS INSYS THERAP 0.1MG 0.2MG + 0.4MG 0.6MG 0.8MG
3 - 176 (of 428)
A076709 A077449 A077051 A077154 A076258 A077775 A077062 A076709
002 003 003 003 003 003 003 003
Aug 20, 2007 Oct Aug Feb Jan Oct Aug Aug 20, 04, 09, 28, 16, 20, 20, 2008 2006 2011 2005 2009 2007 2007
XX XX XX XX XX
N202788 N202788 N202788 N202788 N202788
001 002 003 004 005
Jan Jan Jan Jan Jan
04, 04, 04, 04, 04,
2012 2012 2012 2012 2012
FENTANYL CITRATE
FILM; BUCCAL ONSOLIS XX MEDA PHARMS XX + XX XX XX
EQ EQ EQ EQ EQ
0.2MG 0.4MG 0.6MG 0.8MG 1.2MG
N022266 N022266 N022266 N022266 N022266
001 002 003 004 005
Jul Jul Jul Jul Jul
16, 16, 16, 16, 16,
2009 2009 2009 2009 2009
AP AP AP AP
XX XX
INJECTABLE; INJECTION FENTANYL CITRATE HOSPIRA EQ 0.05MG BASE/ML FENTANYL CITRATE PRESERVATIVE FREE + BAXTER HLTHCARE EQ 0.05MG BASE/ML HOSPIRA EQ 0.05MG BASE/ML SUBLIMAZE PRESERVATIVE FREE + AKORN EQ 0.05MG BASE/ML SPRAY, METERED; NASAL LAZANDA ARCHIMEDES EQ 0.1MG BASE + EQ 0.4MG BASE
N019115 N019101 A072786 N016619
001 001 001 001
Jan 12, 1985 Jul 11, 1984 Sep 24, 1991
N022569 N022569
001 002
Jun 30, 2011 Jun 30, 2011
TABLET; BUCCAL FENTANYL CITRATE WATSON LABS AB AB AB AB AB FENTORA CEPHALON AB AB AB + AB AB TABLET; SUBLINGUAL ABSTRAL PROSTRAKAN INC XX XX XX XX + XX XX
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A079075 A079075 A079075 A079075 A079075 N021947 N021947 N021947 N021947 N021947
001 002 003 004 005 001 002 003 004 005
Jan Jan Jan Jan Jan Sep Sep Sep Sep Sep
07, 07, 07, 07, 07, 25, 25, 25, 25, 25,
2011 2011 2011 2011 2011 2006 2006 2006 2006 2006
EQ EQ EQ EQ EQ EQ
0.1MG 0.2MG 0.3MG 0.4MG 0.6MG 0.8MG
N022510 N022510 N022510 N022510 N022510 N022510
001 002 003 004 005 006
Jan Jan Jan Jan Jan Jan
07, 07, 07, 07, 07, 07,
2011 2011 2011 2011 2011 2011

FENTANYL CITRATE
TROCHE/LOZENGE; TRANSMUCOSAL ACTIQ CEPHALON AB EQ 0.2MG BASE AB + EQ 0.4MG BASE AB EQ 0.6MG BASE AB EQ 0.8MG BASE AB EQ 1.2MG BASE AB EQ 1.6MG BASE FENTANYL CITRATE MALLINCKRODT AB EQ 0.2MG BASE AB EQ 0.4MG BASE AB EQ 0.6MG BASE AB EQ 0.8MG BASE AB EQ 1.2MG BASE AB EQ 1.6MG BASE PAR PHARM AB EQ 0.2MG BASE AB EQ 0.4MG BASE AB EQ 0.6MG BASE AB EQ 0.8MG BASE AB EQ 1.2MG BASE AB EQ 1.6MG BASE
3 - 177 (of 428)
N020747 N020747 N020747 N020747 N020747 N020747 A078907 A078907 A078907 A078907 A078907 A078907 A077312 A077312 A077312 A077312 A077312 A077312
001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006
Nov Nov Nov Nov Nov Nov Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
04, 04, 04, 04, 04, 04, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30,
1998 1998 1998 1998 1998 1998 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
FERRIC HEXACYANOFERRATE(II)
CAPSULE; ORAL
RADIOGARDASE (PRUSSIAN BLUE)
XX + HEYL CHEMISCH 500MG
N021626
001
Oct 02, 2003
FERUMOXSIL
SUSPENSION; ORAL
GASTROMARK
XX + AMAG PHARMS INC
EQ 0.175MG IRON/ML
N020410
001
Dec 06, 1996
FERUMOXYTOL
FERAHEME
XX + AMAG PHARMS INC
EQ 510MG IRON/17ML (EQ 30MG IRON/ML)
N022180
001
Jun 30, 2009
FESOTERODINE FUMARATE
TABLET, EXTENDED RELEASE; ORAL TOVIAZ XX PFIZER 4MG XX + 8MG
N022030 N022030
001 002
Oct 31, 2008 Oct 31, 2008
FEXOFENADINE HYDROCHLORIDE
SUSPENSION; ORAL ALLEGRA + SANOFI AVENTIS US 30MG/5ML FEXOFENADINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 30MG/5ML TABLET; ORAL FEXOFENADINE HYDROCHLORIDE BARR 30MG 60MG 180MG DR REDDYS LABS LTD 30MG 60MG 180MG MYLAN 30MG 60MG 180MG
AB AB
N021963 A201311
001 001
Oct 16, 2006 Jul 25, 2012
A076191 A076191 A076191 A076502 A076502 A076502 A077081 A077081 A077081
001 002 003 001 002 003 002 003 001
Aug Aug Aug Apr Apr Apr Apr Apr Apr
31, 31, 31, 11, 11, 11, 11, 11, 16,
2005 2005 2005 2006 2006 2006 2008 2008 2007

TABLET; ORAL FEXOFENADINE HYDROCHLORIDE TEVA AB 30MG AB 60MG AB 180MG
3 - 178 (of 428)
A076447 A076447 A076447
001 002 003
Sep 01, 2005 Sep 01, 2005 Sep 01, 2005
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE BARR 60MG;120MG AB IMPAX PHARMS 60MG;120MG AB
A076236 A076298
001 001
Apr 14, 2005 Nov 12, 2010
FIDAXOMICIN
TABLET; ORAL DIFICID XX + OPTIMER PHARMS
200MG
N201699
001
May 27, 2011
FINASTERIDE
TABLET; ORAL FINASTERIDE ACCORD HLTHCARE INC ACTAVIS TOTOWA AUROBINDO PHARMA DR REDDYS LABS INC DR REDDYS LABS LTD GEDEON RICHTER USA HETERO DRUGS LTD MYLAN SUN PHARMA GLOBAL TEVA ZYDUS PHARMS USA INC PROPECIA + MERCK PROSCAR + MERCK
A090121 A077914 A078341 A076436 A076437 A077251 A090061 A077578 A090507 A076511 A078900 N020788 N020180
001 001 001 001 001 001 001 001 001 001 001 001 001
Feb Mar Oct Jul Feb Dec Jun Dec Aug Dec Dec
23, 28, 30, 28, 28, 22, 07, 18, 16, 15, 28,
2010 2007 2007 2006 2007 2006 2010 2006 2011 2006 2009
Dec 19, 1997 Jun 19, 1992
FINGOLIMOD
CAPSULE; ORAL GILENYA XX + NOVARTIS
0.5MG
N022527
001
Sep 21, 2010
FLAVOXATE HYDROCHLORIDE
TABLET; ORAL FLAVOXATE HYDROCHLORIDE EPIC PHARMA AB 100MG IMPAX PHARMS AB 100MG AB + PADDOCK LLC 100MG
A076835 A076234 A076831
001 001 001
Nov 30, 2005 Aug 28, 2003 Dec 16, 2004
FLECAINIDE ACETATE
TABLET; ORAL FLECAINIDE ACETATE AMNEAL PHARM AB AB AB APOTEX INC AB AB AB BARR AB AB AB
A075442 A075442 A075442 A079164 A079164 A079164 A075882 A075882 A075882
001 002 003 001 002 003 001 002 003
Jul Jul Jul Jul Jul Jul Oct Oct Oct
31, 31, 31, 09, 09, 09, 28, 28, 28,
2001 2001 2001 2009 2009 2009 2002 2002 2002

FLECAINIDE ACETATE
TABLET; ORAL FLECAINIDE ACETATE RANBAXY AB AB AB ROXANE AB AB AB TAMBOCOR MEDICIS AB AB AB +
3 - 179 (of 428)
A076421 A076421 A076421 A076278 A076278 A076278 N018830 N018830 N018830
001 002 003 001 002 003 004 001 003
Mar Mar Mar Jan Jan Jan
28, 28, 28, 14, 14, 14,
2003 2003 2003 2003 2003 2003
Aug 23, 1988 Oct 31, 1985 Jun 03, 1988
FLORBETAPIR F-18
AMYVID
XX + AVID RADIOPHARMS INC XX + XX +
10-50ML (13.5-51MCI/ML) 10-30ML (13.5-51MCI/ML) 10ML (13.5-51MCI/ML)
N202008 N202008 N202008
003 002 001
Apr 06, 2012 Apr 06, 2012 Apr 06, 2012
FLOXURIDINE
INJECTABLE; INJECTION FLOXURIDINE AP + BEDFORD FRESENIUS KABI USA AP
A075387 A075837
001 001
Apr 16, 2000 Feb 22, 2001
FLUCONAZOLE
FOR SUSPENSION; ORAL DIFLUCAN PFIZER AB 50MG/5ML AB + 200MG/5ML FLUCONAZOLE AUROBINDO PHARM AB 50MG/5ML AB 200MG/5ML IVAX SUB TEVA PHARMS 50MG/5ML AB AB 200MG/5ML RANBAXY AB 50MG/5ML AB 200MG/5ML ROXANE AB 50MG/5ML AB 200MG/5ML TARO PHARM INDS AB 50MG/5ML AB 200MG/5ML INJECTABLE; INJECTION DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER AP + PFIZER 200MG/100ML (2MG/ML) AP + 400MG/200ML (2MG/ML) DIFLUCAN IN SODIUM CHLORIDE 0.9% AP + PFIZER 200MG/100ML (2MG/ML) AP + 400MG/200ML (2MG/ML) DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER AP + PFIZER 200MG/100ML (2MG/ML) AP + 400MG/200ML (2MG/ML) FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ACS DOBFAR INFO SA AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER AGILA SPECLTS 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) AP HIKMA FARMACEUTICA 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) AP
N020090 N020090 A079150 A079150 A077523 A077523 A076332 A076332 A076246 A076246 A076918 A076918
001 002 001 002 001 002 001 002 001 002 001 002
Dec 23, 1993 Dec 23, 1993 Sep Sep Sep Sep Jul Jul Jul Jul Dec Dec 18, 18, 12, 12, 29, 29, 29, 29, 18, 18, 2009 2009 2007 2007 2004 2004 2004 2004 2006 2006
N019950 N019950 N019950 N019950 N019950 N019950 A079104 A079104 A076888 A076888 A078764 A078764
003 005 001 006 002 004 001 002 001 002 001 002
Sep 29, 1992 Jul 08, 1994 Jan 29, 1990 Jan 29, 1990 Jan 29, 1990 Jan 29, 1990 Jul 30, 2009 Jul 30, 2009 Mar Mar Jan Jan 25, 25, 30, 30, 2005 2005 2012 2012

FLUCONAZOLE
INJECTABLE; INJECTION FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) FLUCONAZOLE IN SODIUM CHLORIDE 0.9% BEDFORD AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) CLARIS LIFESCIENCES AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) FRESENIUS KABI USA AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) HIKMA FARMACEUTICA AP 200MG/100ML (2MG/ML) TEVA PARENTERAL AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) BEDFORD LABS AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) CLARIS LIFESCIENCES AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) HIKMA FARMACEUTICA AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) HOSPIRA AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) TEVA PHARMS AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) FULCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER CLARIS LIFESCIENCES AP 200MG/100ML (2MG/ML) AP 400MG/200ML (2MG/ML) FLUCONAZOLE IN SODIUM CHLORIDE 0.9% BEDFORD 100MG/50ML (2MG/ML) XX TABLET; ORAL DIFLUCAN PFIZER AB AB AB AB + FLUCONAZOLE APOTEX AB AB AB AB AUROBINDO PHARMA AB AB AB AB GLENMARK GENERICS AB AB AB AB HARRIS PHARM AB AB AB AB IVAX SUB TEVA PHARMS AB AB AB AB MYLAN AB
3 - 180 (of 428)
001 002 001 003 001 002 001 002 001 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 002
Jul 29, 2004 Jul 29, 2004 Jul Jul May May Jul Jul Aug Jul Jul Jul Jul Jul Jul May May Jan Jan Jul Jul Jan Jan 29, 29, 26, 26, 29, 29, 23, 29, 29, 29, 29, 30, 30, 26, 26, 30, 30, 29, 29, 13, 13, 2004 2004 2010 2010 2004 2004 2005 2004 2004 2004 2004 2008 2008 2010 2010 2012 2012 2004 2004 2005 2005
May 26, 2010 May 26, 2010 Sep 26, 2008
50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG
N019949 N019949 N019949 N019949 A076665 A076665 A076665 A076665 A077731 A077731 A077731 A077731 A077253 A077253 A077253 A077253 A078423 A078423 A078423 A078423 A076077 A076077 A076077 A076077 A076351
001 002 004 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001
Jan Jan Jun Jan Jul Jul Jul Jul Oct Oct Oct Oct Jan Jan Jan Jan Mar Mar Mar Mar Jul Jul Jul Jul Jul
29, 29, 30, 29, 29, 29, 29, 29, 07, 07, 07, 07, 25, 25, 25, 25, 07, 07, 07, 07, 29, 29, 29, 29, 29,
1990 1990 1994 1990 2004 2004 2004 2004 2008 2008 2008 2008 2006 2006 2006 2006 2011 2011 2011 2011 2004 2004 2004 2004 2004

FLUCONAZOLE
TABLET; ORAL FLUCONAZOLE MYLAN AB AB AB TARO AB AB AB AB TEVA AB AB AB AB UNIQUE PHARM LABS AB AB AB FLUCONAZOLE BX DR REDDYS LABS INC BX BX BX
3 - 181 (of 428)
002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004
Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Sep Sep Sep Jul Jul Jul Jul
29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 28, 28, 29, 29, 29, 29,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2005 2005 2005 2004 2004 2004 2004
FLUCYTOSINE
CAPSULE; ORAL ANCOBON VALEANT AB AB + FLUCYTOSINE SIGMAPHARM LABS LLC AB AB
250MG 500MG 250MG 500MG
N017001 N017001 A201566 A201566
001 002 001 002 Jun 28, 2011 Jun 28, 2011
FLUDARABINE PHOSPHATE
INJECTABLE; INJECTION FLUDARABINE PHOSPHATE ACTAVIS TOTOWA AP BIONICHE PHARMA USA AP FRESENIUS KABI USA AP AP AP + HOSPIRA ONCO THERAPIES LTD AP AP AP + SANDOZ TEVA PARENTERAL AP AP +
50MG/VIAL 50MG/2ML (25MG/ML) 50MG/2ML (25MG/ML) 50MG/VIAL 50MG/VIAL 50MG/2ML (25MG/ML) 50MG/VIAL 50MG/2ML (25MG/ML) 50MG/VIAL 50MG/2ML (25MG/ML)
A078610 A090724 A078393 A078544 A077790 A200647 A200648 N022137 A076349 A076661
001 001 001 001 001 001 001 001 001 001
Feb Sep Oct Oct Apr Dec Oct Sep Aug Apr
11, 27, 15, 15, 06, 21, 16, 21, 28, 28,
2009 2010 2007 2007 2007 2011 2012 2007 2003 2004
FLUDEOXYGLUCOSE F-18
INJECTABLE; INTRAVENOUS FLUDEOXYGLUCOSE F18 + FEINSTEIN PETNET FLUDEOXYGLUCOSE F 18 + WEILL MEDCL COLL FLUDEOXYGLUCOSE F18 + FEINSTEIN
AP AP XX XX
20-200mCi/ML 20-200mCi/ML 10-100mCi/ML 20-300mCi/ML
N021870 A079086 N021768 N021870
001 001 001 002
Aug 19, 2005 Feb 25, 2011 Aug 05, 2004 Nov 21, 2008
FLUDROCORTISONE ACETATE
TABLET; ORAL FLUDROCORTISONE ACETATE BARR AB 0.1MG AB + IMPAX LABS 0.1MG
A040425 A040431
001 001
Jan 21, 2003 Mar 18, 2002

TABLET; ORAL FLUDROCORTISONE ACETATE WEST-WARD PHARM CORP 0.1MG AB
3 - 182 (of 428)
A091302
001
Jul 22, 2011
FLUMAZENIL
INJECTABLE; INJECTION FLUMAZENIL BEDFORD LABS AP AP CLARIS LIFESCIENCES AP AP FRESENIUS KABI USA AP AP HIKMA FARMACEUTICA AP AP HIKMA MAPLE AP AP PFIZER AP AP SAGENT PHARMS AP AP SANDOZ AP AP ROMAZICON AP + HOFFMANN LA ROCHE AP
0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML)
A076256 A076256 A076755 A076755 A076955 A076955 A078527 A078527 A076787 A076787 A078595 A078595 A090584 A090584 A077071 A077071 N020073 N020073
002 001 002 001 002 001 001 002 002 001 001 002 001 002 002 001 001 002
Oct Oct Oct Oct Oct Oct Mar Mar Oct Oct May May Aug Aug May May
12, 12, 12, 12, 12, 12, 23, 23, 12, 12, 13, 13, 28, 28, 03, 03,
2004 2004 2004 2004 2004 2004 2009 2009 2004 2004 2008 2008 2012 2012 2005 2005
Dec 20, 1991 Dec 20, 1991
FLUNISOLIDE
AEROBID
+ ROCHE PALO 0.25MG/INH AEROSPAN HFA + ACTON PHARMS EQ 78MG BASE/INH SPRAY, METERED; NASAL FLUNISOLIDE + BAUSCH AND LOMB 0.025MG/SPRAY HI TECH PHARMA CO 0.025MG/SPRAY FLUNISOLIDE + APOTEX INC 0.029MG/SPRAY
XX XX
N018340 N021247
001 001
Aug 17, 1984 Jan 27, 2006
AB AB XX
A074805 A077704 A077436
001 001 001
Feb 20, 2002 Aug 03, 2006 Aug 09, 2007
FLUOCINOLONE ACETONIDE
CREAM; TOPICAL FLUOCINOLONE ACETONIDE FOUGERA AT AT G AND W LABS AT AT TARO AT SYNALAR AT + MEDIMETRIKS PHARMS AT + AT + IMPLANT; INTRAVITREAL
RETISERT
XX + BAUSCH AND LOMB OIL; TOPICAL DERMA-SMOOTHE/FS AT + HILL DERMAC AT +
0.01% 0.025% 0.01% 0.025% 0.025% 0.01% 0.025% 0.025%
A088170 A088169 A089526 A089525 A087104 N012787 N012787 N012787
001 001 001 001 001 004 002 005
Dec Dec Jul Jul Apr
16, 16, 26, 26, 27,
1982 1982 1988 1988 1982
0.59MG
N021737
001
Apr 08, 2005
0.01% 0.01%
N019452 N019452
002 001
Nov 09, 2005 Feb 03, 1988

OIL; TOPICAL FLUOCINOLONE ACETONIDE IDENTI PHARMS INC AT AT OIL/DROPS; OTIC DERMOTIC AT + HILL DERMAC FLUOCINOLONE ACETONIDE IDENTI PHARMS INC AT OINTMENT; TOPICAL FLUOCINOLONE ACETONIDE FOUGERA G AND W LABS TARO SYNALAR + MEDIMETRIKS PHARMS SHAMPOO; TOPICAL CAPEX + GALDERMA LABS LP SOLUTION; TOPICAL FLUOCINOLONE ACETONIDE FOUGERA TARO SYNALAR + MEDIMETRIKS PHARMS
3 - 183 (of 428)
0.01% 0.01%
A201759 A201764
001 001
Oct 17, 2011 Oct 17, 2011
0.01% 0.01%
N019452 A091306
003 001
Nov 09, 2005 Oct 17, 2011
AT AT AT AT
0.025% 0.025% 0.025% 0.025%
A088168 A089524 A040041 N013960
001 001 001 001
Dec 16, 1982 Jul 26, 1988 Sep 15, 1994
XX
0.01%
N020001
001
Aug 27, 1990
AT AT AT
0.01% 0.01% 0.01%
A088167 A089124 N015296
001 001 001
Dec 16, 1982 Sep 11, 1985
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN

CREAM; TOPICAL TRI-LUMA XX + GALDERMA LABS LP
0.01%;4%;0.05%
N021112
001
Jan 18, 2002
FLUOCINONIDE
CREAM; TOPICAL FLUOCINONIDE FOUGERA AB1 G AND W LABS INC AB1 AB1 + TARO TEVA AB1 FLUOCINONIDE EMULSIFIED FOUGERA PHARMS AB2 AB2 + TARO TEVA AB2 VANOS XX + MEDICIS GEL; TOPICAL FLUOCINONIDE FOUGERA TARO TEVA LIDEX + MEDICIS OINTMENT; TOPICAL FLUOCINONIDE FOUGERA PHARMS TARO TEVA LIDEX + MEDICIS SOLUTION; TOPICAL FLUOCINONIDE FOUGERA
0.05% 0.05% 0.05% 0.05% BASE 0.05% 0.05% 0.05% 0.1%
A073030 A073085 N019117 A072488 A076586 A072494 A072490 N021758
001 001 001 001 001 001 001 001
Oct Feb Jun Feb
17, 14, 26, 06,
1994 1992 1984 1989
Jun 23, 2004 Jan 19, 1989 Feb 07, 1989 Feb 11, 2005
AB AB AB AB
0.05% 0.05% 0.05% 0.05%
A072933 A074935 A072537 N017373
001 001 001 001
Dec 30, 1994 Jul 29, 1997 Feb 07, 1989
AB AB AB AB
0.05% 0.05% 0.05% 0.05%
A074905 A075008 A073481 N016909
001 001 001 002
Aug 26, 1997 Jun 30, 1999 Dec 27, 1991
AT
0.05%
A072934
001
Feb 27, 1995

FLUOCINONIDE
SOLUTION; TOPICAL FLUOCINONIDE G AND W LABS INC TARO TEVA LIDEX + MEDICIS
3 - 184 (of 428)
AT AT AT AT
0.05% 0.05% 0.05% 0.05%
A071535 A074799 A072511 N018849
001 001 001 001
Dec 02, 1988 Dec 31, 1996 Feb 07, 1989 Apr 06, 1984
FLUORESCEIN SODIUM
INJECTABLE; INTRAVENOUS AK-FLUOR 10% AKORN AP FLUORESCITE AP + ALCON PHARMS LTD AK-FLUOR 25% AKORN XX
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) EQ 500MG BASE/5ML (EQ 100MG BASE/ML) EQ 500MG BASE/2ML (EQ 250MG BASE/ML)
N022186 N021980 N022186
001 001 002
Aug 08, 2008 Mar 28, 2006 Aug 08, 2008
FLUOROMETHOLONE
FML
XX + ALLERGAN
0.1%
N017760
001
Sep 04, 1985
FML
0.1% XX + ALLERGAN FML FORTE ALLERGAN 0.25% XX
N016851 N019216
002 001
Jul 28, 1982 Apr 23, 1986
FLUOROMETHOLONE ACETATE
FLAREX
XX + ALCON 0.1%
N019079
001
Feb 11, 1986
FLUOROURACIL
CREAM; TOPICAL EFUDEX + VALEANT PHARM INTL FLUOROURACIL SPEAR PHARMS TARO CARAC + VALEANT BERMUDA FLUOROPLEX + AQUA PHARMS INJECTABLE; INJECTION
FLUOROURACIL + BIONICHE PHARMA + + + EBEWE PHARMA + FRESENIUS KABI USA + + + ONCO THERAPIES LTD
AB AB AB XX XX
5% 5% 5% 0.5% 1%
N016831 A077524 A090368 N020985 N016988
003 001 001 001 001

Apr 11, 2008 Mar 05, 2010 Oct 27, 2000
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
SANDOZ + TEVA PARENTERAL
500MG/10ML (50MG/ML) 1GM/20ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML) 500MG/10ML (50MG/ML) 500MG/10ML (50MG/ML) 1GM/20ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML) 500MG/10ML (50MG/ML) 1GM/20ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML) 500MG/10ML (50MG/ML)
002 001 002 001 001 002 001 001 002 001 002 001 002 001 002 001
Apr Apr Apr Apr Aug Sep Sep Sep Sep Jul Jul Jul Jul May May Jan
26, 26, 26, 26, 11, 30, 30, 30, 30, 17, 17, 17, 17, 02, 02, 27,
2007 2007 2007 2007 2008 1998 1998 1998 1998 2012 2012 2012 2012 2011 2011 2000

FLUOROURACIL
INJECTABLE; INJECTION FLUOROURACIL + TEVA PARENTERAL + SOLUTION; TOPICAL EFUDEX + VALEANT PHARM INTL + FLUOROURACIL TARO
3 - 185 (of 428)
AP AP
2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML)
A040334 A040334
001 002
Feb 25, 2000 Feb 25, 2000
AT AT AT AT
2% 5% 2% 5%
N016831 N016831 A076526 A076526
001 002 001 002 Nov 05, 2003 Nov 05, 2003
FLUOXETINE HYDROCHLORIDE
CAPSULE; ORAL FLUOXETINE HYDROCHLORIDE ALEMBIC PHARMS LTD AB EQ AUROBINDO PHARMA AB EQ DR REDDYS LABS INC AB EQ HERITAGE PHARMS INC AB EQ IVAX SUB TEVA PHARMS EQ AB MYLAN AB EQ PAR PHARM AB EQ RANBAXY AB EQ SANDOZ AB EQ TEVA AB EQ WOCKHARDT AB EQ PROZAC AB + ELI LILLY AND CO EQ FLUOXETINE HYDROCHLORIDE ALEMBIC PHARMS LTD AB1 EQ AB1 EQ AUROBINDO PHARMA AB1 EQ AB1 EQ BARR AB1 EQ AB1 EQ BEIJING DOUBLE CRANE EQ AB1 AB1 EQ CARLSBAD AB1 EQ AB1 EQ DR REDDYS LABS INC AB1 EQ AB1 EQ HERITAGE PHARMS INC AB1 EQ AB1 EQ IVAX SUB TEVA PHARMS EQ AB1 AB1 EQ LANDELA PHARM AB1 EQ AB1 EQ MALLINCKRODT AB1 EQ AB1 EQ MYLAN AB1 EQ AB1 EQ MYLAN PHARMS INC AB1 EQ AB1 EQ PLIVA AB1 EQ AB1 EQ SANDOZ AB1 EQ AB1 EQ TEVA AB1 EQ AB1 EQ WOCKHARDT AB1 EQ
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A090223 A078619 A075465 A201336 A075245 A075207 A076922 A076990 A075049 A075452 A078143 N018936 A090223 A090223 A078619 A078619 A074803 A074803 A076165 A076165 A076022 A076022 A075465 A075465 A201336 A201336 A075245 A075245 A075464 A075464 A075658 A075658 A075207 A075207 A075577 A075577 A076001 A076001 A075049 A075049 A075452 A075452 A078143
003 003 003 003 003 003 003 001 003 003 003 003 001 002 001 002 002 001 001 002 001 002 001 002 001 002 002 001 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001
Mar Jan Aug Oct Sep May Dec Dec Jan Jan Jan
19, 31, 02, 01, 28, 25, 16, 13, 29, 29, 16,
2009 2008 2001 2012 2004 2007 2004 2004 2002 2002 2008
40MG BASE 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
Jun 15, 1999 Mar Mar Jan Jan Jan Aug Feb Feb Jan Jan Jan Jan Oct Oct Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Aug Jan Jan Jan Jan 19, 19, 31, 31, 30, 02, 01, 01, 30, 30, 29, 29, 01, 01, 31, 31, 30, 30, 29, 29, 30, 30, 29, 29, 29, 29, 02, 29, 29, 29, 16, 2009 2009 2008 2008 2002 2001 2002 2002 2002 2002 2002 2002 2012 2012 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2001 2002 2002 2002 2008

CAPSULE; ORAL FLUOXETINE HYDROCHLORIDE WOCKHARDT AB1 EQ 20MG BASE PROZAC ELI LILLY AND CO AB1 EQ 10MG BASE AB1 EQ 20MG BASE FLUOXETINE HYDROCHLORIDE MYLAN AB2 EQ 10MG BASE AB2 EQ 20MG BASE SANDOZ AB2 EQ 10MG BASE AB2 EQ 20MG BASE TEVA AB2 EQ 10MG BASE AB2 EQ 20MG BASE SARAFEM ELI LILLY AND CO AB2 EQ 10MG BASE AB2 + EQ 20MG BASE CAPSULE, DELAYED REL PELLETS; ORAL FLUOXETINE HYDROCHLORIDE BARR AB EQ 90MG BASE DR REDDYS LABS LTD AB EQ 90MG BASE PROZAC WEEKLY AB + LILLY EQ 90MG BASE SOLUTION; ORAL FLUOXETINE HYDROCHLORIDE AUROBINDO PHARM AA EQ 20MG BASE/5ML LANNETT AA EQ 20MG BASE/5ML MALLINCKRODT AA EQ 20MG BASE/5ML NOVEX AA EQ 20MG BASE/5ML AA + PHARM ASSOC EQ 20MG BASE/5ML SILARX AA EQ 20MG BASE/5ML TEVA AA EQ 20MG BASE/5ML WOCKHARDT AA EQ 20MG BASE/5ML TABLET; ORAL FLUOXETINE HYDROCHLORIDE DR REDDYS LABS INC AB EQ 10MG BASE MYLAN AB EQ 10MG BASE TEVA AB EQ 10MG BASE FLUOXETINE HYDROCHLORIDE EDGEMONT PHARMS LLC EQ 60MG BASE XX EQ 20MG BASE XX + MYLAN SARAFEM WARNER CHILCOTT LLC EQ 10MG BASE XX EQ 15MG BASE XX EQ 20MG BASE XX +
3 - 186 (of 428)
A078143 N018936 N018936 A078045 A078045 A077469 A077469 A076287 A076287 N018936 N018936
002 006 001 001 002 001 002 001 002 007 008
Jan 16, 2008 Dec 23, 1992 Dec 29, 1987 Nov Nov Nov Nov May May 17, 17, 17, 17, 20, 20, 2008 2008 2008 2008 2008 2008
Jul 06, 2000 Jul 06, 2000
A076237 A078572 N021235
001 001 001
Mar 24, 2010 Mar 22, 2010 Feb 26, 2001
A079209 A076458 A075920 A075292 A076015 A077849 A075506 A075514
001 001 001 001 001 001 001 001
Mar May Jan Feb Jan Feb Aug Aug
20, 14, 29, 07, 30, 09, 02, 29,
2009 2004 2002 2002 2002 2007 2001 2002
A076006 A075755 A075872 N202133 A075755 N021860 N021860 N021860
001 001 001 001 002 001 002 003
Jan 30, 2002 Aug 02, 2001 Jan 29, 2002 Oct 06, 2011 Aug 02, 2001 May 19, 2006 May 19, 2006 May 19, 2006
FLUOXETINE HYDROCHLORIDE; OLANZAPINE

CAPSULE; ORAL OLANZAPINE AND FLUOXETINE HYDROCHLORIDE PAR PHARM AB EQ 25MG BASE;EQ AB EQ 25MG BASE;EQ AB EQ 25MG BASE;EQ AB EQ 50MG BASE;EQ AB EQ 50MG BASE;EQ SANDOZ AB EQ 25MG BASE;EQ AB EQ 25MG BASE;EQ AB EQ 25MG BASE;EQ AB EQ 50MG BASE;EQ AB EQ 50MG BASE;EQ TEVA PHARMS AB EQ 25MG BASE;EQ AB EQ 25MG BASE;EQ
3MG BASE 6MG BASE 12MG BASE 6MG BASE 12MG BASE 3MG BASE 6MG BASE 12MG BASE 6MG BASE 12MG BASE 6MG BASE 12MG BASE
A077742 A077742 A077742 A077742 A077742 A078901 A078901 A078901 A078901 A078901 A077528 A077528
001 002 003 004 005 005 001 003 002 004 001 002
Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov Jun Jun
02, 02, 02, 02, 02, 16, 16, 16, 16, 16, 19, 19,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012

FLUOXETINE HYDROCHLORIDE; OLANZAPINE
CAPSULE; ORAL OLANZAPINE AND FLUOXETINE HYDROCHLORIDE TEVA PHARMS AB EQ 50MG BASE;EQ AB EQ 50MG BASE;EQ SYMBYAX LILLY AB EQ 25MG BASE;EQ AB EQ 25MG BASE;EQ AB EQ 25MG BASE;EQ AB + EQ 50MG BASE;EQ AB EQ 50MG BASE;EQ
3 - 187 (of 428)
6MG BASE 12MG BASE 3MG BASE 6MG BASE 12MG BASE 6MG BASE 12MG BASE
A077528 A077528 N021520 N021520 N021520 N021520 N021520
003 004 001 002 004 003 005
Jun 19, 2012 Jun 19, 2012 Apr Dec Dec Dec Dec 09, 24, 24, 24, 24, 2007 2003 2003 2003 2003
FLUOXYMESTERONE
TABLET; ORAL
FLUOXYMESTERONE
XX + USL PHARMA
10MG
A088342
001
Oct 21, 1983
FLUPHENAZINE DECANOATE
INJECTABLE; INJECTION FLUPHENAZINE DECANOATE BEDFORD AO CLARIS LIFESCIENCES AO AO + FRESENIUS KABI USA
A074531 A075918 A071413
001 001 001
Aug 30, 1996 Aug 17, 2001 Jul 14, 1987
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
XX + PHARM ASSOC 5MG/ML ELIXIR; ORAL
XX + PHARM ASSOC 2.5MG/5ML INJECTABLE; INJECTION
XX + FRESENIUS KABI USA 2.5MG/ML TABLET; ORAL FLUPHENAZINE HYDROCHLORIDE LANNETT AB 1MG AB 2.5MG AB 5MG AB 10MG MYLAN AB 1MG AB 2.5MG AB 5MG AB + 10MG SANDOZ AB 1MG AB 2.5MG AB 5MG AB 10MG
A074725
001
Sep 16, 1996
A040146
001
Aug 21, 1996
A089556
001
Apr 16, 1987
A089740 A089741 A089742 A089743 A089804 A089804 A089804 A089804 A089583 A089584 A089585 A089586
001 001 001 001 002 003 004 001 001 001 001 001
Aug Aug Aug Aug Aug Aug Aug Aug Oct Oct Oct Oct
25, 25, 25, 25, 12, 12, 12, 12, 16, 16, 16, 16,
1988 1988 1988 1988 1988 1988 1988 1988 1987 1987 1987 1987
FLURANDRENOLIDE
CREAM; TOPICAL
CORDRAN SP
+ AQUA PHARMS + LOTION; TOPICAL
CORDRAN
+ AQUA PHARMS TAPE; TOPICAL
CORDRAN
+ WATSON PHARMS
XX XX
0.025% 0.05%
N012806 N012806
003 002
XX
0.05%
N013790
001
XX
0.004MG/SQ CM
N016455
001

FLURAZEPAM HYDROCHLORIDE
CAPSULE; ORAL FLURAZEPAM HYDROCHLORIDE MYLAN PHARMS INC 15MG + 30MG WATSON LABS 15MG 30MG 30MG WEST WARD 15MG 30MG
3 - 188 (of 428)
A070345 A070345 A071205 A071068 A072369 A071107 A071108
002 001 001 001 001 001 001
Nov Nov Nov Nov Mar Dec Dec
27, 27, 25, 25, 30, 08, 08,
1985 1985 1986 1986 1989 1986 1986
FLURBIPROFEN
TABLET; ORAL ANSAID PHARMACIA AND UPJOHN AB AB + FLURBIPROFEN CARACO AB AB MYLAN AB AB TEVA AB
50MG 100MG 50MG 100MG 50MG 100MG 100MG
N018766 N018766 A075058 A075058 A074358 A074358 A074431
002 003 001 002 001 002 001
Oct 31, 1988 Oct 31, 1988 Apr Apr Jun Jun May 27, 27, 20, 20, 31, 2001 2001 1994 1994 1995
FLURBIPROFEN SODIUM
SOLUTION/DROPS; OPHTHALMIC FLURBIPROFEN SODIUM BAUSCH AND LOMB AT 0.03% OCUFEN AT + ALLERGAN 0.03%
A074447 N019404
001 001
Jan 04, 1995 Dec 31, 1986
FLUTAMIDE
CAPSULE; ORAL FLUTAMIDE + IVAX SUB TEVA PHARMS MYLAN PAR PHARM WATSON LABS INC FL
AB AB AB AB
125MG 125MG 125MG 125MG
A075780 A076224 A075298 A075820
001 001 001 001
Sep May Sep Sep
19, 09, 18, 18,
2001 2003 2001 2001
FLUTICASONE FUROATE
VERAMYST
0.0275MG/INH
N022051
001
Apr 27, 2007
FLUTICASONE PROPIONATE
FLOVENT HFA
XX + GLAXO GRP LTD 0.044MG/INH XX + 0.11MG/INH XX + 0.22MG/INH CREAM; TOPICAL CUTIVATE + FOUGERA PHARMS FLUTICASONE PROPIONATE FOUGERA PHARMS G AND W LABS PERRIGO NEW YORK TOLMAR LOTION; TOPICAL CUTIVATE + FOUGERA PHARMS FLUTICASONE PROPIONATE GLENMARK GENERICS
N021433 N021433 N021433
003 002 001
May 14, 2004 May 14, 2004 May 14, 2004
AB AB AB AB AB
0.05% 0.05% 0.05% 0.05% 0.05%
N019958 A076451 A077055 A076793 A076633
001 001 001 001 001
Dec 18, 1990 May Jun May May 14, 30, 14, 14, 2004 2006 2004 2004
AB AB
0.05% 0.05%
N021152 A090759
001 001
Mar 31, 2005 May 02, 2011

OINTMENT; TOPICAL CUTIVATE + FOUGERA PHARMS FLUTICASONE PROPIONATE FOUGERA PHARMS G AND W LABS PERRIGO NEW YORK POWDER; INHALATION
FLOVENT DISKUS 100
+ GLAXOSMITHKLINE FLOVENT DISKUS 250 + GLAXOSMITHKLINE FLOVENT DISKUS 50 + GLAXOSMITHKLINE SPRAY, METERED; NASAL FLONASE + GLAXOSMITHKLINE FLUTICASONE PROPIONATE APOTEX INC HI TECH PHARMA ROXANE WOCKHARDT
3 - 189 (of 428)
AB AB AB AB
0.005% 0.005% 0.005% 0.005%
N019957 A076300 A077168 A076668
001 001 001 001
Dec 14, 1990 May 14, 2004 Mar 03, 2006 May 14, 2004
XX XX XX
0.1MG/INH 0.25MG/INH 0.05MG/INH
N020833 N020833 N020833
002 003 001
Sep 29, 2000 Sep 29, 2000 Sep 29, 2000
AB AB AB AB AB
0.05MG/SPRAY 0.05MG/SPRAY 0.05MG/SPRAY 0.05MG/SPRAY 0.05MG/SPRAY
N020121 A077538 A077570 A076504 A078492
001 001 001 001 001
Oct 19, 1994 Sep Jan Feb Jan 12, 16, 22, 09, 2007 2008 2006 2012
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

ADVAIR HFA
XX + GLAXOSMITHKLINE 0.045MG/INH;EQ 0.021MG BASE/INH XX + 0.115MG/INH;EQ 0.021MG BASE/INH XX + 0.23MG/INH;EQ 0.021MG BASE/INH POWDER; INHALATION
ADVAIR DISKUS 100/50
XX + GLAXOSMITHKLINE ADVAIR DISKUS 250/50 XX + GLAXOSMITHKLINE ADVAIR DISKUS 500/50 XX + GLAXOSMITHKLINE
N021254 N021254 N021254
001 002 003
Jun 08, 2006 Jun 08, 2006 Jun 08, 2006
0.1MG/INH;EQ 0.05MG BASE/INH 0.25MG/INH;EQ 0.05MG BASE/INH 0.5MG/INH;EQ 0.05MG BASE/INH
N021077 N021077 N021077
001 002 003
Aug 24, 2000 Aug 24, 2000 Aug 24, 2000
FLUVASTATIN SODIUM
CAPSULE; ORAL FLUVASTATIN SODIUM MYLAN PHARMS INC AB AB TEVA PHARMS AB AB LESCOL NOVARTIS AB AB + TABLET, EXTENDED RELEASE; LESCOL XL
XX + NOVARTIS
EQ EQ EQ EQ
20MG 40MG 20MG 40MG
BASE BASE BASE BASE
A090595 A090595 A078407 A078407 N020261 N020261
001 002 001 002 001 002
Apr Apr Jun Jun
11, 11, 12, 12,
2012 2012 2012 2012
EQ 20MG BASE EQ 40MG BASE ORAL

80MG
Dec 31, 1993 Dec 31, 1993
N021192
001
Oct 06, 2000
FLUVOXAMINE MALEATE
CAPSULE, EXTENDED RELEASE; ORAL LUVOX CR JAZZ PHARMS 100MG XX 150MG XX + TABLET; ORAL FLUVOXAMINE MALEATE APOTEX AB AB AB
N022033 N022033
001 002
Feb 28, 2008 Feb 28, 2008
25MG 50MG 100MG
A075902 A075902 A075902
001 002 003
May 07, 2001 May 07, 2001 May 07, 2001

FLUVOXAMINE MALEATE
TABLET; ORAL FLUVOXAMINE MALEATE BARR AB AB AB CARACO AB AB AB MYLAN AB AB AB SANDOZ AB AB AB + TEVA AB AB AB LUVOX ANI PHARMS AB AB AB
3 - 190 (of 428)
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jan Jan Jan Feb Feb Feb Nov Nov Nov Nov Nov Nov Sep Sep Sep
25, 25, 25, 23, 23, 23, 29, 29, 29, 29, 29, 29, 10, 10, 10,
2001 2001 2001 2006 2006 2006 2000 2000 2000 2000 2000 2000 2002 2002 2002
Dec 20, 2007 Dec 20, 2007 Dec 20, 2007
FOLIC ACID
FOLIC ACID
+ FRESENIUS KABI USA TABLET; ORAL FOLIC ACID + AMNEAL PHARM CONTRACT PHARMACAL EXCELLIUM INVAGEN PHARMS JUBILANT CADISTA VINTAGE + WATSON LABS WEST WARD
XX
5MG/ML
A089202
001
Feb 18, 1986
AA AA AA AA AA AA AA AA
A040625 A085061 A040796 A090035 A040514 A040756 A080680 A080600
001 001 001 001 001 001 001 001
Jul 21, 2005 Jan Jun Jun Jun 12, 09, 14, 04, 2009 2009 2005 2010
FOLLITROPIN ALFA/BETA
FOLLISTIM AQ
+ ORGANON USA INC + + + + GONAL-F + EMD SERONO GONAL-F RFF + EMD SERONO GONAL-F RFF PEN + EMD SERONO + +
XX XX XX XX XX XX XX XX XX XX XX
75 IU/0.5ML 150 IU/0.5ML 300 IU/0.36ML 600 IU/0.72ML 900 IU/1.08ML 450 IU/VIAL 1,050 IU/VIAL 75 IU/VIAL 300 IU/0.5ML 450 IU/0.75ML 900 IU/1.5ML
N021273 N021273 N021211 N021211 N021211 N020378 N020378 N021765 N021684 N021684 N021684
001 002 001 002 004 005 004 002 001 002 003
Aug Aug Mar Mar Feb
26, 26, 23, 23, 11,
2005 2005 2004 2004 2005
Mar 26, 2004 Feb 28, 2001 Mar 25, 2004 May 25, 2004 May 25, 2004 May 25, 2004
FOMEPIZOLE
INJECTABLE; INJECTION ANTIZOL AP + PALADIN LABS
1.5GM/1.5ML (1GM/ML)
N020696
001
Dec 04, 1997

FOMEPIZOLE
INJECTABLE; INJECTION FOMEPIZOLE BIONICHE PHARMA USA LUITPOLD MYLAN LLC NAVINTA LLC
3 - 191 (of 428)
AP AP AP AP
1.5GM/1.5ML 1.5GM/1.5ML 1.5GM/1.5ML 1.5GM/1.5ML
(1GM/ML) (1GM/ML) (1GM/ML) (1GM/ML)
A079033 A078368 A078639 A078537
001 001 001 001
Apr Dec Mar Mar
07, 14, 03, 06,
2009 2007 2008 2008
FONDAPARINUX SODIUM
INJECTABLE; SUBCUTANEOUS ARIXTRA + GLAXOSMITHKLINE + + + FONDAPARINUX SODIUM DR REDDYS LABS LTD
AP AP AP AP AP AP AP AP
2.5MG/0.5ML 5MG/0.4ML 7.5MG/0.6ML 10MG/0.8ML 2.5MG/0.5ML 5MG/0.4ML 7.5MG/0.6ML 10MG/0.8ML
N021345 N021345 N021345 N021345 A091316 A091316 A091316 A091316
001 002 003 004 001 002 003 004
Dec May May May Jul Jul Jul Jul
07, 28, 28, 28, 11, 11, 11, 11,
2001 2004 2004 2004 2011 2011 2011 2011
FORMOTEROL FUMARATE
POWDER; INHALATION
FORADIL
XX + NOVARTIS SOLUTION; INHALATION
PERFOROMIST
XX + MYLAN SPECLT
0.012MG/INH
N020831
001
Feb 16, 2001
0.02MG/2ML
N022007
001
May 11, 2007
FORMOTEROL FUMARATE; MOMETASONE FUROATE

DULERA
XX + MERCK SHARP DOHME 0.005MG/INH;0.1MG/INH XX + 0.005MG/INH;0.2MG/INH
N022518 N022518
001 002
Jun 22, 2010 Jun 22, 2010
FOSAMPRENAVIR CALCIUM
SUSPENSION; ORAL
LEXIVA
XX + VIIV HLTHCARE TABLET; ORAL
LEXIVA
XX + VIIV HLTHCARE
EQ 50MG BASE/ML
N022116
001
Jun 14, 2007
EQ 700MG BASE
N021548
001
Oct 20, 2003
FOSAPREPITANT DIMEGLUMINE
POWDER; INTRAVENOUS
EMEND
XX + MERCK AND CO INC XX +
N022023 N022023
001 002
Jan 25, 2008 Nov 12, 2010
FOSCARNET SODIUM
INJECTABLE; INJECTION FOSCARNET SODIUM HOSPIRA AP FOSCAVIR AP + CLINIGEN HLTHCARE
2.4GM/100ML 2.4GM/100ML
A077174 N020068
001 001
May 31, 2005 Sep 27, 1991
FOSFOMYCIN TROMETHAMINE
FOR SUSPENSION; ORAL
MONUROL
XX + ZAMBON SPA
EQ 3GM BASE/PACKET
N050717
001
Dec 19, 1996

FOSINOPRIL SODIUM
TABLET; ORAL FOSINOPRIL SODIUM APOTEX INC AB AB AB AUROBINDO PHARMA LTD AB AB AB INVAGEN PHARMS AB AB AB SANDOZ AB AB AB TEVA AB AB AB + WATSON LABS AB AB AB AB AB AB WATSON LABS FLORIDA AB AB AB
3 - 192 (of 428)
A076906 A076906 A076906 A091163 A091163 A091163 A077222 A077222 A077222 A076483 A076483 A076483 A076139 A076139 A076139 A076987 A077531 A076987 A077531 A076987 A077531 A076620 A076620 A076620
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003
May May May Mar Mar Mar Apr Apr Apr Apr Apr Apr Nov Nov Nov Dec Aug Dec Aug Dec Aug Oct Oct Oct
17, 17, 17, 30, 30, 30, 20, 20, 20, 23, 23, 23, 25, 25, 25, 23, 31, 23, 31, 23, 31, 15, 15, 15,
2005 2005 2005 2011 2011 2011 2005 2005 2005 2004 2004 2004 2003 2003 2003 2004 2006 2004 2006 2004 2006 2004 2004 2004
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE

TABLET; ORAL FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE AUROBINDO PHARMA AB 10MG;12.5MG AB 20MG;12.5MG INVAGEN PHARMS AB 10MG;12.5MG AB 20MG;12.5MG MYLAN AB 10MG;12.5MG AB 20MG;12.5MG RANBAXY AB 10MG;12.5MG AB 20MG;12.5MG SANDOZ AB 10MG;12.5MG AB 20MG;12.5MG WATSON LABS FLORIDA AB 10MG;12.5MG AB 20MG;12.5MG
A079245 A079245 A090228 A090228 A077705 A077705 A076739 A076739 A076961 A076961 A076608 A076608
001 002 001 002 001 002 001 002 001 002 001 002
Jul Jul Jul Jul Aug Aug Dec Dec Sep Sep Dec Dec
09, 09, 09, 09, 14, 14, 17, 17, 28, 28, 03, 03,
2009 2009 2009 2009 2006 2006 2004 2004 2005 2005 2004 2004
FOSINOPRIL; HYDROCHLOROTHIAZIDE
TABLET; ORAL FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE EMCURE PHARMS INDIA AB 10MG;12.5MG AB 20MG;12.5MG
A079025 A079025
001 002
Sep 17, 2010 Sep 17, 2010
FOSPHENYTOIN SODIUM
INJECTABLE; INJECTION FOSPHENYTOIN SODIUM APOTEX INC BEDFORD + FRESENIUS KABI USA HIKMA FARMACEUTICA HIKMA MAPLE HOSPIRA LUITPOLD
PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN
NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML
A078126 A077481 A078052 A078765 A077989 A078158 A078277 A090099
001 001 001 001 001 001 001 001
Aug Aug Aug Dec Aug Aug Aug May
06, 06, 06, 02, 06, 06, 06, 13,
2007 2007 2007 2009 2007 2007 2007 2010

FOSPHENYTOIN SODIUM
INJECTABLE; INJECTION FOSPHENYTOIN SODIUM PFIZER STRIDES ARCOLAB SUN PHARMA GLOBAL WOCKHARDT
3 - 193 (of 428)
AP AP AP AP
EQ EQ EQ EQ
50MG 50MG 50MG 50MG
PNENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN
NA/ML NA/ML NA/ML NA/ML
A078476 A078736 A078417 A078137
001 001 001 001
Mar Jun Mar Aug
18, 08, 18, 06,
2008 2010 2008 2007
FROVATRIPTAN SUCCINATE
TABLET; ORAL FROVA XX + ENDO PHARMS
EQ 2.5MG BASE
N021006
001
Nov 08, 2001
FULVESTRANT
INJECTABLE; INTRAMUSCULAR FASLODEX 50MG/ML XX + ASTRAZENECA
N021344
001
Apr 25, 2002
FUROSEMIDE
INJECTABLE; INJECTION FUROSEMIDE FRESENIUS KABI USA AP HOSPIRA AP AP INTL MEDICATION AP AP + LUITPOLD WOCKHARDT AP SOLUTION; ORAL FUROSEMIDE AA + ROXANE WOCKHARDT AA FUROSEMIDE ROXANE XX TABLET; ORAL FUROSEMIDE DAVA PHARMS INC AB AB AB EXCELLIUM AB AB AB IPCA LABS LTD AB AB AB IVAX SUB TEVA PHARMS AB AB MYLAN AB AB AB ROXANE AB AB AB SANDOZ AB AB AB VINTAGE PHARMS AB AB AB WATSON LABS AB AB AB
N018902 A075241 N018667 N018025 N018579 A077941
001 001 001 001 001 001
May 22, 1984 May 28, 1999 May 28, 1982 Nov 30, 1983 Mar 22, 2007
10MG/ML 10MG/ML 40MG/5ML
A070434 A070655 A070433
001 001 001
Apr 22, 1987 Oct 02, 1987 Apr 22, 1987
N018415 N018415 N018415 A077293 A077293 A077293 A078010 A078010 A078010 N018413 N018413 N018487 N018487 A070082 N018823 N018823 A070086 N018569 N018569 N018569 A076796 A076796 A076796 A070412 A070449 A071379
001 002 003 001 002 003 001 002 003 001 002 001 002 001 001 002 001 002 001 005 001 002 003 001 001 001
Jul Jul Nov Nov Nov Nov Sep Sep Sep Nov Nov
27, 27, 26, 09, 09, 09, 18, 18, 18, 30, 30,
1982 1982 1984 2005 2005 2005 2006 2006 2006 1983 1983
Oct Nov Nov Jan
29, 10, 10, 24,
1986 1983 1983 1986
Aug Mar Mar Mar Feb Nov Jan
14, 26, 26, 26, 26, 22, 02,
1984 2004 2004 2004 1986 1985 1987

FUROSEMIDE
TABLET; ORAL FUROSEMIDE WATSON LABS AB AB AB LASIX SANOFI AVENTIS US AB AB AB +
3 - 194 (of 428)
A070450 A070528 A071594 N016273 N016273 N016273
001 001 001 002 001 003
Nov 22, 1985 Jan 07, 1986 Feb 09, 1988
GABAPENTIN
CAPSULE; ORAL GABAPENTIN ACTAVIS ELIZABETH AB AB AB ALKEM AB AB AB AMNEAL PHARMS NY AB AB AB APOTEX INC AB AB AB AUROBINDO PHARM AB AB AB HIKMA AB AB AB INVAGEN PHARMS AB AB AB MARKSANS PHARMA AB AB AB MYLAN AB AB AB RANBAXY AB AB AB SUN PHARM INDS LTD AB AB AB TEVA PHARMS AB AB AB WATSON LABS AB AB AB NEURONTIN PFIZER PHARMS AB AB AB + SOLUTION; ORAL GABAPENTIN ACELLA PHARMS LLC AA AMNEAL PHARMS AA
100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG
A075350 A075350 A075350 A090858 A090858 A090858 A078428 A078428 A078428 A075360 A075360 A075360 A078787 A078787 A078787 A078150 A078150 A078150 A090705 A090705 A090705 A090007 A090007 A090007 A090158 A090158 A090158 A076606 A076606 A076606 A077242 A077242 A077242 A075435 A075435 A075435 A075485 A075485 A075485 N020235 N020235 N020235
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 003 002 001 001 002 003
Sep Sep Sep Dec Dec Dec Jul Jul Jul Apr Apr Apr Jan Jan Jan Sep Sep Sep Dec Dec Dec Jul Jul Jul Feb Feb Feb Oct Oct Oct Aug Aug Aug Oct Oct Oct May May May
12, 12, 12, 17, 17, 17, 25, 25, 25, 06, 06, 06, 31, 31, 31, 25, 25, 25, 30, 30, 30, 21, 21, 21, 14, 14, 14, 07, 07, 07, 24, 24, 24, 08, 08, 08, 11, 11, 11,
2003 2003 2003 2010 2010 2010 2007 2007 2007 2005 2005 2005 2008 2008 2008 2007 2007 2007 2009 2009 2009 2011 2011 2011 2011 2011 2011 2005 2005 2005 2006 2006 2006 2004 2004 2004 2007 2007 2007
Dec 30, 1993 Dec 30, 1993 Dec 30, 1993
250MG/5ML 250MG/5ML
A076403 A202024
001 001
May 01, 2012 Mar 23, 2012

GABAPENTIN
SOLUTION; ORAL GABAPENTIN HI TECH PHARMA AA NEURONTIN AA + PARKE DAVIS TABLET; ORAL GABAPENTIN ACTAVIS ELIZABETH AB AB APOTEX INC AB AB AB AB AB AUROBINDO PHARMA LTD AB AB GLENMARK GENERICS AB AB HIKMA PHARMS AB AB INVAGEN PHARMS AB AB IVAX SUB TEVA PHARMS AB AB AB AB AB MYLAN PHARMS INC AB AB SUN PHARM INDS LTD AB AB ZYDUS PHARMS USA INC AB AB NEURONTIN PFIZER PHARMS AB AB + GRALISE BX + DEPOMED INC BX +
3 - 195 (of 428)
250MG/5ML 250MG/5ML
A078974 N021129
001 001
Feb 18, 2011 Mar 02, 2000
600MG 800MG 100MG 300MG 400MG 600MG 800MG 600MG 800MG 600MG 800MG 600MG 800MG 600MG 800MG 100MG 300MG 400MG 600MG 800MG 600MG 800MG 600MG 800MG 600MG 800MG 600MG 800MG 300MG 600MG
A075694 A075694 A077894 A077894 A077894 A077661 A077661 A200651 A200651 A077662 A077662 A078782 A078782 A202764 A202764 A076017 A076017 A076017 A076017 A076017 A090335 A090335 A077525 A077525 A078926 A078926 N020882 N020882 N022544 N022544
001 002 001 002 003 004 005 001 002 001 002 001 002 001 002 001 002 003 004 005 001 002 001 002 001 002 001 002 001 002
Oct Oct Oct Oct Oct Sep Sep Oct Oct Aug Aug Jul Jul Oct Oct Apr Apr Apr Apr Apr Jun Jun Aug Aug Feb Feb
21, 21, 10, 10, 10, 13, 13, 06, 06, 18, 18, 21, 21, 16, 16, 28, 28, 28, 29, 29, 01, 01, 24, 24, 11, 11,
2004 2004 2006 2006 2006 2006 2006 2011 2011 2006 2006 2011 2011 2012 2012 2004 2004 2004 2005 2005 2010 2010 2006 2006 2011 2011
Oct 09, 1998 Oct 09, 1998 Jan 28, 2011 Jan 28, 2011
GABAPENTIN ENACARBIL
TABLET, EXTENDED RELEASE; ORAL HORIZANT XX GLAXO GRP LTD 300MG XX + 600MG
N022399 N022399
002 001
Dec 13, 2011 Apr 06, 2011
GADOBENATE DIMEGLUMINE
MULTIHANCE
+ BRACCO + + + MULTIHANCE MULTIPACK + BRACCO +
XX XX XX XX XX XX
2.645GM/5ML (529MG/ML) 5.29GM/10ML (529MG/ML) 7.935GM/15ML (529MG/ML) 10.58GM/20ML (529MG/ML) 26.45GM/50ML (529MG/ML) 52.9GM/100ML (529MG/ML)
N021357 N021357 N021357 N021357 N021358 N021358
001 002 003 004 001 002
Nov Nov Nov Nov
23, 23, 23, 23,
2004 2004 2004 2004
Nov 23, 2004 Nov 23, 2004

GADOBUTROL
GADAVIST
+ BAYER HLTHCARE + + + +
3 - 196 (of 428)
XX XX XX XX XX
4.5354GM/7.5ML (604.72MG/ML) 6.0472GM/10ML (604.72MG/ML) 9.0708GM/15ML (604.72MG/ML) 18.1416GM/30ML (604.72MG/ML) 39.3068GM/65ML (604.72MG/ML)
N201277 N201277 N201277 N201277 N201277
001 002 003 004 005
Mar Mar Mar Mar Mar
14, 14, 14, 14, 14,
2011 2011 2011 2011 2011
GADODIAMIDE
OMNISCAN
XX + GE HEALTHCARE XX +
287MG/ML 28.7GM/100ML (287MG/ML)
N020123 N022066
001 002
Jan 08, 1993 Sep 05, 2007
GADOFOSVESET TRISODIUM
SOLUTION; INTRAVENOUS ABLAVAR XX LANTHEUS MEDCL XX +
2440MG/10ML (244MG/ML) 3660MG/15ML (244MG/ML)
N021711 N021711
001 002
Dec 22, 2008 Dec 22, 2008
GADOPENTETATE DIMEGLUMINE
MAGNEVIST
XX + BAYER HLTHCARE XX +
469.01MG/ML 469.01MG/ML
N019596 N021037
001 001
Jun 02, 1988 Mar 10, 2000
GADOTERIDOL
PROHANCE
XX + BRACCO PROHANCE MULTIPACK XX + BRACCO
279.3MG/ML 279.3MG/ML
N020131 N021489
001 001
Nov 16, 1992 Oct 09, 2003
GADOVERSETAMIDE
OPTIMARK
+ MALLINCKRODT 1654.5MG/5ML (330.9MG/ML) + 3309MG/10ML (330.9MG/ML) + 4963.5MG/15ML (330.9MG/ML) + 6618MG/20ML (330.9MG/ML) + 16.545GM/50ML (330.9MG/ML) OPTIMARK IN PLASTIC CONTAINER + MALLINCKRODT 3309MG/10ML (330.9MG/ML) + 4963.5MG/15ML (330.9MG/ML) + 6618MG/20ML (330.9MG/ML) + 9927MG/30ML (330.9MG/ML)
XX XX XX XX XX XX XX XX XX
N020937 N020937 N020937 N020937 N020975 N020976 N020976 N020976 N020976
001 002 003 004 001 002 003 004 001
Dec Dec Dec Dec Dec Dec Dec Dec Dec
08, 08, 08, 08, 08, 08, 08, 08, 08,
1999 1999 1999 1999 1999 1999 1999 1999 1999
GADOXETATE DISODIUM
EOVIST
XX + BAYER HLTHCARE
1.8143GM/10ML (181.43MG/ML)
N022090
001
Jul 03, 2008
GALANTAMINE HYDROBROMIDE
CAPSULE, EXTENDED RELEASE; ORAL GALANTAMINE HYDROBROMIDE BARR EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE IMPAX LABS EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE
AB AB AB AB AB AB
A078189 A078189 A078189 A078484 A078484 A078484
001 002 003 001 002 003
Sep Sep Sep May May May
15, 15, 15, 27, 27, 27,
2008 2008 2008 2009 2009 2009

CAPSULE, EXTENDED RELEASE; ORAL GALANTAMINE HYDROBROMIDE MYLAN EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE SUN PHARMA GLOBAL EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE WATSON LABS EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE RAZADYNE ER + JANSSEN PHARMS EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE SOLUTION; ORAL GALANTAMINE HYDROBROMIDE ROXANE 4MG/ML RAZADYNE + JANSSEN PHARMS 4MG/ML TABLET; ORAL GALANTAMINE HYDROBROMIDE APOTEX INC EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE AUROBINDO PHARMA LTD EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE BARR EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE DR REDDYS LABS LTD EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE MYLAN EQ 4MG BASE EQ 4MG BASE EQ 8MG BASE EQ 8MG BASE EQ 12MG BASE EQ 12MG BASE ROXANE EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE SANDOZ EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE TEVA PHARMS EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE ZYDUS PHARMS USA INC EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE RAZADYNE + JANSSEN PHARMS EQ 4MG BASE EQ 8MG BASE EQ 12MG BASE
3 - 197 (of 428)
A090900 A090900 A090900 A090178 A090178 A090178 A079028 A079028 A079028 N021615 N021615 N021615
001 002 003 001 002 003 001 002 003 001 002 003
Jan Jan Jan Feb Feb Feb Dec Dec Dec
24, 24, 24, 02, 02, 02, 15, 15, 15,
2011 2011 2011 2011 2011 2011 2008 2008 2008
Apr 01, 2005 Apr 01, 2005 Apr 01, 2005
AA AA
A078185 N021224
001 001
Jan 30, 2009 Jun 22, 2001
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Sep Sep Sep Mar Mar Mar Aug Aug Aug Sep Sep Sep May Aug May Aug May Aug Feb Feb Feb Jun Jun Jun Jul Jul Jul Feb Feb Feb
27, 27, 27, 29, 29, 29, 28, 28, 28, 11, 11, 11, 29, 28, 29, 28, 29, 28, 11, 11, 11, 22, 22, 22, 09, 09, 09, 17, 17, 17,
2011 2011 2011 2011 2011 2011 2008 2008 2008 2008 2008 2008 2009 2008 2009 2008 2009 2008 2009 2009 2009 2009 2009 2009 2009 2009 2009 2011 2011 2011
Feb 28, 2001 Feb 28, 2001 Feb 28, 2001

GALLIUM CITRATE GA-67
INJECTABLE; INJECTION GALLIUM CITRATE GA 67 BS LANTHEUS MEDCL BS MALLINCKRODT
3 - 198 (of 428)
2mCi/ML 2mCi/ML
N017478 N018058
001 001
GALLIUM NITRATE
GANITE
XX + GENTA
25MG/ML
N019961
002
Jan 17, 1991
GANCICLOVIR
GEL; OPHTHALMIC
ZIRGAN
XX + BAUSCH AND LOMB IMPLANT; IMPLANTATION
VITRASERT
0.15%
N022211
001
Sep 15, 2009
4.5MG
N020569
001
Mar 04, 1996
GANCICLOVIR SODIUM
INJECTABLE; INJECTION CYTOVENE AP + ROCHE PALO GANCICLOVIR FRESENIUS KABI USA AP
N019661 A090658
001 001
Jun 23, 1989 Jun 21, 2010
GANIRELIX ACETATE
GANIRELIX ACETATE INJECTION
XX + ORGANON USA INC EQ 250MCG BASE/0.5ML
N021057
001
Jul 29, 1999
GATIFLOXACIN
SOLUTION/DROPS; OPHTHALMIC GATIFLOXACIN APOTEX CORP AT 0.3% ZYMAR AT + ALLERGAN 0.3% ZYMAXID 0.5% XX + ALLERGAN
A079084 N021493 N022548
001 001 001
Aug 19, 2011 Mar 28, 2003 May 18, 2010
GEMCITABINE HYDROCHLORIDE
INJECTABLE; INJECTION GEMCITABINE HYDROCHLORIDE ACCORD HLTHCARE EQ EQ EQ ACTAVIS TOTOWA EQ EQ DR REDDYS LABS LTD EQ EQ EMCURE PHARMS LTD EQ EQ FRESENIUS KABI ONCOL EQ EQ EQ FRESENIUS KABI USA EQ HAMELN RDS GMBH EQ EQ HOSPIRA EQ EQ + HOSPIRA INC EQ ONCO THERAPIES LTD EQ
200MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 200MG BASE/VIAL 1GM BASE/VIAL 200MG BASE/VIAL 1GM BASE/VIAL 200MG BASE/VIAL 1GM BASE/VIAL 200MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 200MG BASE/VIAL 1GM BASE/VIAL 200MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 200MG BASE/VIAL
001 002 003 001 002 001 002 001 002 001 002 003 003 001 002 001 002 001 001
Jul Jul Jul Jul Jul Jul Jul Sep Sep Jul Jul May May Sep Sep Jul Jul Nov Jul
25, 25, 25, 25, 25, 25, 25, 11, 11, 25, 25, 16, 16, 10, 10, 25, 25, 15, 25,
2011 2011 2011 2011 2011 2011 2011 2012 2012 2011 2011 2011 2011 2012 2012 2011 2011 2010 2011

INJECTABLE; INJECTION GEMCITABINE HYDROCHLORIDE ONCO THERAPIES LTD EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL SUN PHARMA GLOBAL EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL TEVA PHARMS EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL WATSON LABS EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL GEMZAR + LILLY EQ 200MG BASE/VIAL + EQ 1GM BASE/VIAL GEMCITABINE HYDROCHLORIDE + HOSPIRA INC 200MG/5.26ML (38MG/ML) + 1GM/26.3ML (38MG/ML) + 2GM/52.6ML (38MG/ML)
3 - 199 (of 428)
AP AP AP AP AP AP AP AP AP AP XX XX XX
A200145 A200145 A078433 A078433 A077983 A077983 A078759 A078759 N020509 N020509 N200795 N200795 N200795
002 003 001 002 002 001 001 002 001 002 001 002 003
Jul Jul Jul Jul Jan Jan Jul Jul
25, 25, 25, 25, 25, 25, 25, 25,
2011 2011 2011 2011 2011 2011 2011 2011
May 15, 1996 May 15, 1996 Aug 04, 2011 Aug 04, 2011 Aug 04, 2011
GEMFIBROZIL
TABLET; ORAL GEMFIBROZIL APOTEX BLU CARIBE DAVA PHARMS INC HIKMA PHARMS IMPAX PHARMS INVAGEN PHARMS NORTHSTAR HLTHCARE SUN PHARM INDS INC TEVA WATSON LABS LOPID + PFIZER PHARMS
A075034 A078012 A074270 A078599 A078207 A077836 A079072 A079239 A074256 A074442 N018422
001 001 001 001 001 001 001 001 001 001 003
Jul Mar Sep Aug Jun Jul Sep Dec Oct Apr
20, 26, 27, 16, 01, 27, 13, 29, 31, 28,
1998 2007 1993 2010 2007 2006 2010 2008 1993 1995
Nov 20, 1986
GEMIFLOXACIN MESYLATE
TABLET; ORAL
FACTIVE
XX + CORNERSTONE THERAP
EQ 320MG BASE
N021158
001
Apr 04, 2003
GENTAMICIN SULFATE
CREAM; TOPICAL GENTAMICIN SULFATE + FOUGERA PERRIGO NEW YORK TARO INJECTABLE; INJECTION GENTAMICIN SULFATE + FRESENIUS KABI USA +
AT AT AT
A062531 A062307 A062427
001 001 001
Jul 05, 1984 May 26, 1983
EQ 10MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML HOSPIRA EQ 10MG BASE/ML EQ 10MG BASE/ML EQ 40MG BASE/ML GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER + B BRAUN EQ 0.8MG BASE/ML + EQ 1.2MG BASE/ML + EQ 1.4MG BASE/ML + EQ 1.6MG BASE/ML + EQ 1.8MG BASE/ML + EQ 2MG BASE/ML
A062356 A062356 A062366 A062420 A062612 A062420 A062814 A062814 A062814 A062814 A062814 A062814
001 002 001 001 004 002 001 002 003 004 005 006
Mar Mar Aug Aug Feb Aug Aug Aug Aug Aug Aug Aug
04, 04, 04, 15, 20, 15, 28, 28, 28, 28, 28, 28,
1982 1982 1983 1983 1986 1983 1987 1987 1987 1987 1987 1987

GENTAMICIN SULFATE
INJECTABLE; INJECTION GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER + B BRAUN EQ 2.4MG BASE/ML + EQ 40MG BASE/100ML + EQ 60MG BASE/100ML + EQ 70MG BASE/100ML + EQ 80MG BASE/100ML + EQ 90MG BASE/100ML + EQ 100MG BASE/100ML + EQ 120MG BASE/100ML HOSPIRA EQ 1.2MG BASE/ML EQ 1.4MG BASE/ML EQ 1.6MG BASE/ML EQ 1.8MG BASE/ML EQ 2MG BASE/ML EQ 60MG BASE/100ML EQ 70MG BASE/100ML EQ 80MG BASE/100ML EQ 90MG BASE/100ML EQ 100MG BASE/100ML ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 0.8MG BASE/ML EQ 1.2MG BASE/ML EQ 1.6MG BASE/ML EQ 2MG BASE/ML EQ 2.4MG BASE/ML EQ 40MG BASE/100ML EQ 60MG BASE/100ML EQ 80MG BASE/100ML EQ 100MG BASE/100ML EQ 120MG BASE/100ML OINTMENT; OPHTHALMIC GENTAMICIN SULFATE + AKORN EQ 0.3% BASE FERA PHARMS EQ 0.3% BASE OINTMENT; TOPICAL GENTAMICIN SULFATE FOUGERA EQ 0.1% BASE + PERRIGO NEW YORK EQ 0.1% BASE TARO EQ 0.1% BASE SOLUTION/DROPS; OPHTHALMIC GENOPTIC ALLERGAN EQ 0.3% BASE GENTAK AKORN EQ 0.3% BASE GENTAMICIN SULFATE AKORN EQ 0.3% BASE + BAUSCH AND LOMB EQ 0.3% BASE FALCON PHARMS EQ 0.3% BASE FERA PHARMS EQ 0.3% BASE
3 - 200 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
007 008 009 010 011 012 013 014 001 002 003 004 005 006 007 008 009 010 001 007 008 009 010 003 004 002 005 006
Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
28, 28, 28, 28, 28, 28, 28, 28, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 07, 07, 07, 07, 07, 07, 07, 07, 07, 07,
1987 1987 1987 1987 1987 1987 1987 1987 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1982 1982 1982 1982 1982 1982 1982 1982 1982 1982
AT AT
A064093 A065024
001 001
Aug 31, 1995 Jul 30, 2004
AT AT AT
A062533 A062351 A062477
001 001 001
Oct 05, 1984 Feb 18, 1982 Dec 23, 1983
AT AT AT AT AT AT
A062452 A064163 A062635 A064048 A062196 A065121
001 001 001 001 001 001
Oct 10, 1984 Oct 12, 2001 Jan 08, 1987 May 11, 1994 Jan 30, 2004
GENTAMICIN SULFATE; PREDNISOLONE ACETATE

PRED-G
XX + ALLERGAN
EQ 0.3% BASE;0.6%
N050612
001
Dec 01, 1989
PRED-G
XX + ALLERGAN EQ 0.3% BASE;1%
N050586
001
Jun 10, 1988

GLATIRAMER ACETATE
COPAXONE
XX + TEVA
3 - 201 (of 428)
20MG/ML
N020622
002
Feb 12, 2002
GLIMEPIRIDE
TABLET; ORAL AMARYL AB + SANOFI AVENTIS US AB AB GLIMEPIRIDE ACCORD HLTHCARE AB AB AB AUROBINDO PHARMA LTD AB AB AB CARLSBAD AB AB AB COREPHARMA AB AB AB DR REDDYS LABS LTD AB AB AB INVAGEN PHARMS AB AB AB MICRO LABS USA AB AB AB AB MYLAN AB AB AB AB AB AB TEVA AB AB AB VINTAGE AB AB AB AB WATSON LABS AB AB AB WATSON LABS FLORIDA AB AB AB GLIMEPIRIDE MICRO LABS USA XX XX
1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 8MG 1MG 1MG 2MG 2MG 4MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 1MG 2MG 4MG 3MG 6MG
N020496 N020496 N020496 A078181 A078181 A078181 A202759 A202759 A202759 A077911 A077911 A077911 A077274 A077274 A077274 A077091 A077091 A077091 A077295 A077295 A077295 A091220 A091220 A091220 A091220 A077486 A077624 A077486 A077624 A077486 A077624 A076802 A076802 A076802 A077370 A077370 A077370 A077370 A077280 A077280 A077280 A076995 A076995 A076995 A091220 A091220
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 004 006 001 001 002 002 003 003 001 002 003 001 002 003 004 001 002 003 001 002 003 003 005
Nov 30, 1995 Nov 30, 1995 Nov 30, 1995 Aug Aug Aug Jun Jun Jun Sep Sep Sep Oct Oct Oct Oct Oct Oct Oct Oct Oct Jun Jun Jun Jun Feb Nov Feb Nov Feb Nov Oct Oct Oct Dec Dec Dec Dec Feb Feb Feb Apr Apr Apr 23, 23, 23, 29, 29, 29, 22, 22, 22, 06, 06, 06, 06, 06, 06, 06, 06, 06, 29, 29, 29, 29, 10, 28, 10, 28, 10, 28, 06, 06, 06, 23, 23, 23, 23, 03, 03, 03, 27, 27, 27, 2007 2007 2007 2012 2012 2012 2009 2009 2009 2005 2005 2005 2005 2005 2005 2005 2005 2005 2012 2012 2012 2012 2006 2005 2006 2005 2006 2005 2005 2005 2005 2005 2005 2005 2005 2006 2006 2006 2010 2010 2010
Jun 29, 2012 Jun 29, 2012
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE

TABLET; ORAL DUETACT AB + TAKEDA PHARMS USA
2MG;30MG
N021925
001
Jul 28, 2006

GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
TABLET; ORAL DUETACT TAKEDA PHARMS USA AB 4MG;30MG PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE SANDOZ AB 2MG;30MG AB 4MG;30MG
3 - 202 (of 428)
N021925 A201049 A201049
002 001 002
Jul 28, 2006 Jan 04, 2013 Jan 04, 2013
GLIMEPIRIDE; ROSIGLITAZONE MALEATE

TABLET; ORAL
AVANDARYL
XX + SB PHARMCO XX XX XX XX
1MG;4MG 2MG;4MG 2MG;8MG 4MG;4MG 4MG;8MG
N021700 N021700 N021700 N021700 N021700
001 002 004 003 005
Nov Nov Mar Nov Mar
23, 23, 30, 23, 30,
2005 2005 2007 2005 2007
GLIPIZIDE
TABLET; ORAL GLIPIZIDE ACCORD HLTHCARE INC AB AB APOTEX AB AB CARACO AB AB IVAX SUB TEVA PHARMS AB AB MYLAN AB AB AB AB SANDOZ AB AB WATSON LABS AB AB AB AB GLUCOTROL PFIZER AB AB + TABLET, EXTENDED RELEASE; GLIPIZIDE WATSON LABS AB AB AB GLUCOTROL XL PFIZER AB AB AB +
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 5MG 10MG 10MG 5MG 10MG 5MG 5MG 10MG 10MG 5MG 10MG ORAL 2.5MG 5MG 10MG 2.5MG 5MG 10MG
A074550 A074550 A075795 A075795 A077820 A077820 A074497 A074497 A074226 A074438 A074226 A074438 A074305 A074305 A074223 A074370 A074223 A074370 N017783 N017783
001 002 001 002 001 002 001 002 001 001 002 002 001 002 001 001 002 002 001 002
Sep Sep Jun Jun Jul Jul Aug Aug May Jun May Jun Apr Apr Feb Nov Feb Nov
11, 11, 13, 13, 11, 11, 31, 31, 10, 20, 10, 20, 07, 07, 27, 22, 27, 22,
1997 1997 2001 2001 2006 2006 1995 1995 1994 1995 1994 1995 1995 1995 1995 1994 1995 1994
May 08, 1984 May 08, 1984
A076467 A076467 A076467 N020329 N020329 N020329
003 001 002 003 001 002
Mar 27, 2006 Sep 08, 2003 Nov 07, 2003 Aug 10, 1999 Apr 26, 1994 Apr 26, 1994
GLIPIZIDE; METFORMIN HYDROCHLORIDE

TABLET; ORAL GLIPIZIDE AND METFORMIN HYDROCHLORIDE CARACO AB 2.5MG;250MG AB 2.5MG;500MG AB 5MG;500MG COREPHARMA AB 2.5MG;250MG AB 2.5MG;500MG AB 5MG;500MG HERITAGE PHARMS INC AB 2.5MG;250MG
A077620 A077620 A077620 A077507 A077507 A077507 A078728
001 002 003 001 002 003 001
Jan Jan Jan Oct Oct Oct Jun
11, 11, 11, 27, 27, 27, 23,
2008 2008 2008 2005 2005 2005 2010

TABLET; ORAL GLIPIZIDE AND METFORMIN HYDROCHLORIDE HERITAGE PHARMS INC AB 2.5MG;500MG AB 5MG;500MG MYLAN AB 2.5MG;250MG AB 2.5MG;500MG AB 5MG;500MG TEVA PHARMS AB 2.5MG;250MG AB 2.5MG;500MG AB + 5MG;500MG ZYDUS PHARMS USA INC 2.5MG;250MG AB AB 2.5MG;500MG AB 5MG;500MG
3 - 203 (of 428)
A078728 A078728 A078083 A078083 A078083 A077270 A077270 A077270 A078905 A078905 A078905
002 003 001 002 003 001 002 003 001 002 003
Jun Jun Apr Apr Apr Oct Oct Oct Jan Jan Jan
23, 23, 12, 12, 12, 28, 28, 28, 31, 31, 31,
2010 2010 2007 2007 2007 2005 2005 2005 2011 2011 2011
GLUCAGON HYDROCHLORIDE RECOMBINANT

GLUCAGEN
XX + NOVO NORDISK
EQ 1MG BASE/VIAL
N020918
001
Jun 22, 1998
GLUCAGON RECOMBINANT
GLUCAGON
XX + LILLY
1MG/VIAL
N020928
001
Sep 11, 1998
GLUTAMINE
FOR SOLUTION; ORAL
NUTRESTORE
XX + EMMAUS MEDCL
5GM/PACKET
N021667
001
Jun 10, 2004
GLYBURIDE
TABLET; ORAL GLYBURIDE AUROBINDO PHARMA AB AB AB COREPHARMA AB AB AB HERITAGE PHARMS INC AB AB AB TEVA AB AB AB + GLYBURIDE (MICRONIZED) DAVA PHARMS INC AB AB AB AB HIKMA AB AB AB MYLAN AB AB AB TEVA AB AB AB AB
1.25MG 2.5MG 5MG 1.25MG 2.5MG 5MG 1.25MG 2.5MG 5MG 1.25MG 2.5MG 5MG 1.5MG 3MG 4.5MG 6MG 1.5MG 3MG 6MG 1.5MG 3MG 6MG 1.5MG 3MG 4.5MG 6MG
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 004 001 002 003 001 002 003 001 002 003 004
Oct Oct Oct Jun Jun Jun Feb Feb Feb Aug Aug Aug Dec Dec Dec Dec Jul Jul Jul Jun Jun Aug Apr Apr Apr Apr
18, 18, 18, 27, 27, 27, 28, 28, 28, 29, 29, 29, 22, 22, 22, 22, 31, 31, 31, 26, 26, 17, 20, 20, 20, 20,
2007 2007 2007 2002 2002 2002 2011 2011 2011 1995 1995 1995 1997 1997 1997 1997 2003 2003 2003 1998 1998 1999 1999 1999 1999 1999

GLYBURIDE
TABLET; ORAL GLYNASE PHARMACIA AND UPJOHN AB AB AB + DIABETA BX SANOFI AVENTIS US BX BX +
3 - 204 (of 428)
1.5MG 3MG 6MG 1.25MG 2.5MG 5MG
N020051 N020051 N020051 N017532 N017532 N017532
001 002 004 001 002 003
Mar 04, 1992 Mar 04, 1992 Sep 24, 1993 May 01, 1984 May 01, 1984 May 01, 1984
GLYBURIDE; METFORMIN HYDROCHLORIDE

TABLET; ORAL GLUCOVANCE BRISTOL MYERS SQUIBB AB AB + AB GLYBURIDE AND METFORMIN ACTAVIS ELIZABETH AB AB AB AUROBINDO PHARMA AB AB AB COREPHARMA AB AB AB HERITAGE PHARMS INC AB AB AB IVAX SUB TEVA PHARMS AB AB AB
1.25MG;250MG 2.5MG;500MG 5MG;500MG HYDROCHLORIDE 1.25MG;250MG 2.5MG;500MG 5MG;500MG 1.25MG;250MG 2.5MG;500MG 5MG;500MG 1.25MG;250MG 2.5MG;500MG 5MG;500MG 1.25MG;250MG 2.5MG;500MG 5MG;500MG 1.25MG;250MG 2.5MG;500MG 5MG;500MG
N021178 N021178 N021178 A076716 A076716 A076716 A077870 A077870 A077870 A076731 A076731 A076731 A079009 A079009 A079009 A076345 A076345 A076345
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jul 31, 2000 Jul 31, 2000 Jul 31, 2000 Jun Jun Jun Nov Nov Nov Nov Nov Nov Jun Jun Jun Feb Feb Feb 28, 28, 28, 14, 14, 14, 19, 19, 19, 03, 03, 03, 18, 18, 18, 2005 2005 2005 2007 2007 2007 2004 2004 2004 2009 2009 2009 2004 2004 2004
GLYCINE
SOLUTION; IRRIGATION AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE AT 1.5GM/100ML GLYCINE 1.5% IN PLASTIC CONTAINER B BRAUN AT 1.5GM/100ML HOSPIRA AT 1.5GM/100ML
N017865 N016784 N018315
001 001 001
GLYCOPYRROLATE
INJECTABLE; INJECTION GLYCOPYRROLATE HIKMA FARMACEUTICA AP LUITPOLD AP ROBINUL AP + BAXTER HLTHCARE SOLUTION; ORAL CUVPOSA XX + MERZ PHARMS TABLET; ORAL GLYCOPYRROLATE BOCA PHARMA AA AA COREPHARMA AA AA DR REDDYS LABS LTD AA AA EXCELLIUM AA
A090963 A089335 N017558
001 001 001
Sep 21, 2011 Jul 23, 1986
1MG/5ML
N022571
001
Jul 28, 2010
A090020 A090020 A040568 A040568 A040847 A040847 A090195
001 002 001 002 001 002 001
Oct Oct Dec Dec Mar Mar Sep
19, 19, 22, 22, 21, 21, 21,
2011 2011 2004 2004 2008 2008 2012

GLYCOPYRROLATE
TABLET; ORAL GLYCOPYRROLATE EXCELLIUM AA NEXGEN PHARMA AA PAR PHARM AA AA RANBAXY AA AA VINTAGE AA AA WEST WARD AA AA ROBINUL AA + SHIONOGI INC ROBINUL FORTE AA + SHIONOGI INC
3 - 205 (of 428)
2MG 1.5MG 1MG 2MG 1MG 2MG 1MG 2MG 1MG 2MG 1MG 2MG
A090195 A091522 A040653 A040653 A040844 A040844 A040821 A040821 A040836 A040836 N012827 N012827
002 001 001 002 001 002 001 002 001 002 001 002
Sep Mar Aug Aug Aug Aug Dec Dec Mar Mar
21, 12, 31, 31, 18, 18, 29, 29, 05, 05,
2012 2012 2006 2006 2009 2009 2008 2008 2009 2009
GONADOTROPIN, CHORIONIC
INJECTABLE; INJECTION CHORIONIC GONADOTROPIN AP + FERRING AP + FRESENIUS KABI USA PREGNYL AP + ORGANON USA INC
10,000 UNITS/VIAL 10,000 UNITS/VIAL 10,000 UNITS/VIAL
N017016 N017067 N017692
007 002 001
GOSERELIN ACETATE
IMPLANT; IMPLANTATION
ZOLADEX
XX + ASTRAZENECA XX +
N019726 N020578
001 001
Dec 29, 1989 Jan 11, 1996
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

SOLUTION/DROPS; OPHTHALMIC NEOMYCIN AND POLYMYXIN B SULFATES AND AT + BAUSCH AND LOMB 0.025MG/ML;EQ UNITS/ML LUITPOLD AT 0.025MG/ML;EQ UNITS/ML NEOSPORIN AT + MONARCH PHARMS 0.025MG/ML;EQ UNITS/ML GRAMICIDIN 1.75MG BASE/ML;10,000 1.75MG BASE/ML;10,000
A064047 A065187
001 001
Jan 31, 1996 Oct 28, 2005
1.75MG BASE/ML;10,000
A060582
001
GRANISETRON
FILM, EXTENDED RELEASE; TRANSDERMAL SANCUSO XX + PROSTRAKAN INC 3.1MG/24HR
N022198
001
Sep 12, 2008
GRANISETRON HYDROCHLORIDE
INJECTABLE; INJECTION GRANISETRON HYDROCHLORIDE AKORN INC EQ EQ EQ BEDFORD LABS EQ EQ EQ CIPLA LTD EQ EQ EQ CLARIS LIFESCIENCES EQ EQ
AP AP AP AP AP AP AP AP AP AP AP
0.1MG BASE/ML (EQ 0.1MG BASE/ML) 1MG BASE/ML (EQ 1MG BASE/ML) 4MG BASE/4ML (EQ 1MG BASE/ML) 0.1MG BASE/ML (EQ 0.1MG BASE/ML) 4MG BASE/4ML (EQ 1MG BASE/ML) 1MG BASE/ML (EQ 1MG BASE/ML) 0.1MG BASE/ML (EQ 0.1MG BASE/ML) 1MG BASE/ML (EQ 1MG BASE/ML) 4MG BASE/4ML (EQ 1MG BASE/ML) 0.1MG BASE/ML (EQ 0.1MG BASE/ML) 1MG BASE/ML (EQ 1MG BASE/ML)
A079119 A079078 A079078 A077913 A077186 A077187 A078262 A078258 A078258 A078197 A078198
001 001 002 001 001 001 001 001 002 001 001
Sep Sep Sep Jun Jun Jun Dec Jun Jun Dec Jun
10, 14, 14, 26, 30, 30, 31, 30, 30, 31, 30,
2009 2009 2009 2008 2008 2008 2007 2008 2008 2007 2008

INJECTABLE; INJECTION GRANISETRON HYDROCHLORIDE CLARIS LIFESCIENCES EQ 4MG BASE/4ML (EQ 1MG BASE/ML) DR REDDYS LABS INC EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) EBEWE PHARMA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) FRESENIUS KABI USA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) HIKMA MAPLE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) LUITPOLD EQ 1MG BASE/ML (EQ 1MG BASE/ML) SAGENT AGILA EQ 4MG BASE/4ML (EQ 1MG BASE/ML) SAGENT STRIDES EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) SANDOZ EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) + TEVA PARENTERAL EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) + EQ 1MG BASE/ML (EQ 1MG BASE/ML) + EQ 4MG BASE/4ML (EQ 1MG BASE/ML) WOCKHARDT USA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE DR REDDYS LABS INC EQ 1MG BASE/ML (EQ 1MG BASE/ML) + FRESENIUS KABI USA EQ 1MG BASE/ML (EQ 1MG BASE/ML) GRANISTERON HYDROCHLORIDE HIKMA FARMACEUTICA EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) SOLUTION; ORAL GRANISETRON HYDROCHLORIDE + PEDIATRX EQ 2MG BASE/10ML TABLET; ORAL GRANISETRON HYDROCHLORIDE APOTEX INC EQ 1MG BASE CIPLA LTD EQ 1MG BASE COREPHARMA EQ 1MG BASE DR REDDYS LABS LTD EQ 1MG BASE MYLAN EQ 1MG BASE NATCO PHARMA EQ 1MG BASE ORCHID HLTHCARE EQ 1MG BASE ROXANE EQ 1MG BASE TARO EQ 1MG BASE EQ 1MG BASE + TEVA PHARMS
3 - 206 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
002 001 001 001 001 002 001 001 001 001 002 001 002 001 001 002 001 001 001 001 001 001 002 001 001 002
Jun Jun Jun Apr Jun Jun Dec Jun Dec Sep Apr Apr Apr Apr Apr Apr Dec Jan Jun Feb Jun Jun
30, 30, 30, 29, 30, 30, 31, 30, 31, 22, 09, 09, 09, 30, 30, 30, 31, 03, 30, 29, 30, 30,
2008 2008 2008 2008 2008 2008 2007 2008 2007 2010 2010 2010 2010 2009 2009 2009 2007 2008 2008 2008 2008 2008
Jun 30, 2008 Jun 30, 2008 Dec 23, 2009 Dec 23, 2009
XX
A078334
001
Feb 28, 2008
A078843 A078037 A078260 A078846 A078725 A078969 A078678 A077842 A090817 A078080
001 001 001 001 001 001 001 001 001 001
Feb Feb Dec Feb Jan Jun Feb Dec May Dec
27, 27, 31, 27, 30, 22, 13, 31, 28, 31,
2008 2008 2007 2009 2008 2009 2008 2007 2010 2007
GRISEOFULVIN, MICROSIZE
SUSPENSION; ORAL GRIFULVIN V + VALEANT PHARM NORTH GRISEOFULVIN ACTAVIS MID ATLANTIC IVAX SUB TEVA PHARMS PERRIGO CO TENNESSEE VINTAGE PHARMS
AB AB AB AB AB
125MG/5ML 125MG/5ML 125MG/5ML 125MG/5ML 125MG/5ML
A062483 A065394 A065354 A065200 A065438
001 001 001 001 001
Jan 26, 1984 Jul Sep Mar Oct 06, 10, 02, 08, 2007 2007 2005 2010
TABLET; ORAL GRIFULVIN V AB + VALEANT LUXEMBOURG GRISEOFULVIN SIGMAPHARM LABS LLC AB
500MG 500MG
A062279 A202482
003 001 Oct 22, 2012

GRISEOFULVIN, ULTRAMICROSIZE
TABLET; ORAL GRISEOFULVIN,ULTRAMICROSIZE SIGMAPHARM LABS LLC 125MG 250MG GRIS-PEG PEDINOL 125MG + 250MG
3 - 207 (of 428)
AB AB AB AB
A202545 A202545 N050475 N050475
001 002 001 002
Oct 22, 2012 Oct 22, 2012
GUANABENZ ACETATE
TABLET; ORAL GUANABENZ ACETATE IVAX SUB TEVA PHARMS XX XX +
A074149 A074149
001 002
Apr 07, 1995 Apr 07, 1995
GUANFACINE HYDROCHLORIDE
TABLET; ORAL GUANFACINE HYDROCHLORIDE AMNEAL PHARM EQ 1MG EQ 2MG EPIC PHARMA EQ 1MG EQ 2MG MYLAN EQ 1MG EQ 2MG WATSON LABS EQ 1MG EQ 2MG TENEX PROMIUS PHARMA EQ 1MG + EQ 2MG TABLET, EXTENDED RELEASE; ORAL GUANFACINE HYDROCHLORIDE ACTAVIS ELIZABETH EQ 1MG EQ 2MG EQ 3MG EQ 4MG INTUNIV SHIRE EQ 1MG EQ 2MG EQ 3MG + EQ 4MG
A075109 A075109 A074673 A074673 A074796 A074796 A074145 A074145 N019032 N019032
001 002 001 002 001 002 001 002 001 002
Nov Nov Feb Feb Jan Jan Oct Oct
25, 25, 28, 28, 27, 27, 17, 17,
1998 1998 1997 1997 1997 1997 1995 1995
Oct 27, 1986 Nov 07, 1988
A200881 A200881 A200881 A200881 N022037 N022037 N022037 N022037
001 002 003 004 001 002 003 004
Oct Oct Oct Oct Sep Sep Sep Sep
05, 05, 05, 05, 02, 02, 02, 02,
2012 2012 2012 2012 2009 2009 2009 2009
GUANIDINE HYDROCHLORIDE
TABLET; ORAL
GUANIDINE HYDROCHLORIDE
XX MERCK SHARP DOHME 125MG
N001546
001
HALCINONIDE
CREAM; TOPICAL
HALOG
XX + RANBAXY OINTMENT; TOPICAL
HALOG
XX + RANBAXY
0.1%
N017556
001
0.1%
N017824
001
HALOBETASOL PROPIONATE
CREAM; TOPICAL HALOBETASOL PROPIONATE FOUGERA PHARMS G AND W LABS PERRIGO ISRAEL TARO
AB AB AB AB
0.05% 0.05% 0.05% 0.05%
A077001 A078162 A077123 A077227
001 001 001 001
Dec Apr Dec Aug
16, 24, 16, 04,
2004 2007 2004 2005

CREAM; TOPICAL ULTRAVATE + RANBAXY OINTMENT; TOPICAL HALOBETASOL PROPIONATE FOUGERA PHARMS G AND W LABS PERRIGO TARO ULTRAVATE + RANBAXY
3 - 208 (of 428)
AB
0.05%
N019967
001
Dec 27, 1990
AB AB AB AB AB
0.05% 0.05% 0.05% 0.05% 0.05%
A076903 A077721 A076872 A076994 N019968
001 001 001 001 001
Dec Sep Dec Dec
16, 07, 16, 16,
2004 2006 2004 2004
Dec 17, 1990
HALOPERIDOL
TABLET; ORAL HALOPERIDOL MYLAN AB AB AB AB AB AB SANDOZ AB AB AB + AB AB AB ZYDUS PHARMS USA AB AB AB
0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 5MG 10MG 20MG
006 004 001 005 002 003 001 001 001 001 001 001 003 004 005
Jun Jun Jun Jun Jul Jul Nov Nov Nov Nov Mar Mar Nov Nov Nov
10, 10, 10, 10, 16, 16, 17, 17, 17, 17, 11, 11, 29, 29, 29,
1986 1986 1986 1986 2009 2009 1986 1986 1986 1986 1988 1988 2007 2007 2007
HALOPERIDOL DECANOATE
INJECTABLE; INJECTION HALDOL AO + JANSSEN PHARMS AO + HALOPERIDOL DECANOATE BEDFORD AO AO CLARIS LIFESCIENCES AO AO FRESENIUS KABI USA AO AO TEVA PARENTERAL AO AO
EQ 50MG BASE/ML EQ 100MG BASE/ML EQ EQ EQ EQ EQ EQ EQ EQ 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML
N018701 N018701 A074811 A075305 A075440 A075440 A074893 A074893 A075393 A075393
001 002 001 001 001 002 001 002 001 002
Jan 14, 1986 Jan 31, 1997 Jan Sep Feb Feb Dec Dec May May 30, 28, 28, 28, 19, 19, 11, 11, 1998 1998 2000 2000 1997 1997 1999 1999
HALOPERIDOL LACTATE
CONCENTRATE; ORAL HALOPERIDOL PHARM ASSOC SILARX + TEVA PHARMS INJECTABLE; INJECTION HALDOL + JANSSEN PHARMS HALOPERIDOL BEDFORD CLARIS LIFESCIENCES FRESENIUS KABI USA
AA AA AA
A073037 A073364 A071617
001 001 001
Feb 26, 1993 Sep 28, 1993 Dec 01, 1988
AP AP AP AP AP
EQ 5MG BASE/ML EQ EQ EQ EQ 5MG 5MG 5MG 5MG BASE/ML BASE/ML BASE/ML BASE/ML
N015923 A075858 A076791 A076828 A075689
001 001 001 001 001 Jun Aug Aug Mar 18, 25, 25, 09, 2001 2004 2004 2001

HALOPERIDOL LACTATE
INJECTABLE; INJECTION HALOPERIDOL GLAND PHARMA LTD AP PFIZER AP SAGENT PHARMS AP AP TEVA PARENTERAL AP
3 - 209 (of 428)
EQ EQ EQ EQ EQ
5MG 5MG 5MG 5MG 5MG
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A076774 A078347 A091637 A200742 A076035
001 001 001 001 001
Aug Sep Sep Sep Aug
25, 14, 02, 02, 29,
2004 2009 2011 2011 2001
HEPARIN SODIUM
INJECTABLE; INJECTION HEPARIN SODIUM + BAXTER HLTHCARE + + + FRESENIUS KABI USA + + + HOSPIRA HOSPIRA INC
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
1,000 UNITS/ML N017037 5,000 UNITS/ML N017037 10,000 UNITS/ML N017037 1,000 UNITS/ML N017029 5,000 UNITS/ML N017651 10,000 UNITS/ML N017029 20,000 UNITS/ML N017029 5,000 UNITS/ML A088100 1,000 UNITS/ML A090571 5,000 UNITS/ML A090571 10,000 UNITS/ML A090571 SAGENT PHARMS 1,000 UNITS/ML A090808 5,000 UNITS/ML A090808 10,000 UNITS/ML A090808 20,000 UNITS/ML A090809 SANDOZ 1,000 UNITS/ML A091682 5,000 UNITS/ML A091659 5,000 UNITS/ML A091682 10,000 UNITS/ML A201002 HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE 200 UNITS/100ML N018609 HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER + B BRAUN 200 UNITS/100ML N019953 HOSPIRA 200 UNITS/100ML N018916 HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 10,000 UNITS/100ML N019339 HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE 200 UNITS/100ML N018609 HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA 200 UNITS/100ML N018916 HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 4,000 UNITS/100ML N019952 HOSPIRA 4,000 UNITS/100ML N019805 HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 5,000 UNITS/100ML N019952 + 10,000 UNITS/100ML N019952 HOSPIRA 5,000 UNITS/100ML N019339 5,000 UNITS/100ML N019805 10,000 UNITS/100ML N019339 HEPARIN SODIUM IN PLASTIC CONTAINER N017029 + FRESENIUS KABI USA 1,000 UNITS/ML N017029 + 5,000 UNITS/ML N017029 + 10,000 UNITS/ML N017029 + 20,000 UNITS/ML HEPARIN SODIUM PRESERVATIVE FREE + FRESENIUS KABI USA 1,000 UNITS/ML N017029 + HOSPIRA 10,000 UNITS/ML A089522 SAGENT PHARMS 1,000 UNITS/ML A090810
001 002 003 001 006 003 004 001 001 002 003 001 002 003 001 001 001 002 001 001 001 010 003 002 011 001 001 004 005 004 002 002 013 014 015 016 010 001 001
Apr Aug Aug Aug Jun Jun Jun Jun Jun Jun Jun Jun
28, 31, 31, 31, 30, 30, 30, 30, 08, 08, 08, 08,
1983 2009 2009 2009 2010 2010 2010 2010 2011 2011 2011 2011
Apr 28, 1982 Jul 20, 1992 Jun 23, 1989 Mar 27, 1985 Apr 28, 1982 Jun 23, 1989 Jul 20, 1992 Jan 25, 1989 Jul Jul Mar Jan Mar Dec Dec Dec Dec 20, 20, 27, 25, 27, 05, 05, 05, 05, 1992 1992 1985 1989 1985 1985 1985 1985 1985
Apr 28, 1986 May 04, 1987 Jun 30, 2010

HEPARIN SODIUM
3 - 210 (of 428)
INJECTABLE; INJECTION HEPARIN SODIUM XX PFIZER 1,000 UNITS/ML N201370 001 XX 5,000 UNITS/ML N201370 002 XX 10,000 UNITS/ML N201370 003 HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER XX HOSPIRA 5,000 UNITS/100ML N019339 001 HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER XX HOSPIRA 5,000 UNITS/100ML N018916 006 HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER XX HOSPIRA 5,000 UNITS/100ML N018916 007 XX 10,000 UNITS/100ML N018916 008 HEPARIN SODIUM PRESERVATIVE FREE XX PFIZER 1,000 UNITS/ML N201370 004
Jul 21, 2011 Jul 21, 2011 Jul 21, 2011 Mar 27, 1985 Jan 31, 1984 Jan 31, 1984 Jan 31, 1984 Jul 21, 2011
HEXACHLOROPHENE
EMULSION; TOPICAL
PHISOHEX
XX + SANOFI AVENTIS US SPONGE; TOPICAL
PRE-OP AT + DAVIS AND GECK PRE-OP II DAVIS AND GECK AT
3%
N006882
001
480MG 480MG
N017433 N017433
001 002
HEXAMINOLEVULINATE HYDROCHLORIDE
FOR SOLUTION; INTRAVESICAL
CYSVIEW KIT
XX + PHOTOCURE ASA 100MG/VIAL
N022555
001
May 28, 2010
HISTRELIN ACETATE
IMPLANT; SUBCUTANEOUS
SUPPRELIN LA
XX + ENDO PHARM VANTAS XX + ENDO PHARM
50MG 50MG
N022058 N021732
001 001
May 03, 2007 Oct 12, 2004
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE

SYRUP; ORAL HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ACTAVIS MID ATLANTIC 1.5MG/5ML;5MG/5ML AA AA + HI TECH PHARMA 1.5MG/5ML;5MG/5ML WOCKHARDT AA 1.5MG/5ML;5MG/5ML TABLET; ORAL HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE NOVEL LABS INC AB 1.5MG;5MG TUSSIGON AB + KING PHARMS 1.5MG;5MG
A088017 A040613 A088008
001 001 001
Jul 05, 1983 Feb 08, 2008 Mar 03, 1983
A091528 A088508
001 001
Apr 20, 2011 Jul 30, 1985
HYALURONIDASE
AMPHADASE
XX + AMPHASTAR PHARM VITRASE XX + ISTA PHARMS
150 UNITS/ML 200 UNITS/VIAL
N021665 N021640
001 002
Oct 26, 2004 Dec 02, 2004
HYALURONIDASE RECOMBINANT HUMAN

HYLENEX RECOMBINANT
XX + HALOZYME THERAP
150 UNITS/ML
N021859
001
Dec 02, 2005

HYDRALAZINE HYDROCHLORIDE
INJECTABLE; INJECTION HYDRALAZINE HYDROCHLORIDE AKORN 20MG/ML FRESENIUS KABI USA 20MG/ML + LUITPOLD 20MG/ML TABLET; ORAL HYDRALAZINE HYDROCHLORIDE GLENMARK PHARMS LTD 10MG 25MG 50MG 100MG HERITAGE PHARMS INC 10MG 25MG 50MG 100MG HETERO LABS UNIT III 10MG 25MG 50MG 100MG INVAGEN PHARMS 10MG 25MG 50MG 100MG MYLAN 10MG 25MG 50MG 100MG PAR PHARM 10MG 25MG 50MG 100MG + PLIVA 10MG + 25MG + 50MG + 100MG WATSON LABS 25MG 50MG ZYDUS PHARMS USA 10MG 25MG 50MG 100MG HYDRALAZINE HYDROCHLORIDE ALKEM LABS LTD 10MG 25MG 50MG 100MG
3 - 211 (of 428)
AP AP AP
A040730 A040388 A040136
001 001 001
Apr 21, 2009 Mar 13, 2001 Jun 30, 1997
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AB AB AB AB
001 002 003 004 001 003 002 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 001 001 001 001 001 001 001 001 001 002 003 004 001 002 003 004
May May May May Feb
27, 27, 27, 27, 04,
2009 2009 2009 2009 2010
Feb Sep Sep Sep Sep Dec Dec Dec Dec Dec Dec Dec Dec Oct
04, 12, 12, 12, 12, 15, 15, 15, 15, 08, 08, 08, 08, 05,
2010 2008 2008 2008 2008 2008 2008 2008 2008 2010 2010 2010 2010 1982
Sep Dec May May Dec
27, 18, 01, 01, 18,
1983 1985 1984 1984 1985
Feb Feb Feb Feb Dec Dec Dec Dec
26, 26, 26, 26, 07, 07, 07, 07,
2010 2010 2010 2010 2012 2012 2012 2012
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

CAPSULE; ORAL HYDRA-ZIDE XX PAR PHARM XX +
25MG;25MG 50MG;50MG
A088957 A088946
001 001
Oct 21, 1985 Oct 21, 1985
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE

TABLET; ORAL
BIDIL
XX + ARBOR PHARMS INC
37.5MG;20MG
N020727
001
Jun 23, 2005

HYDROCHLOROTHIAZIDE
CAPSULE; ORAL HYDROCHLOROTHIAZIDE ALEMBIC PHARMS LTD APOTEX AUROBINDO PHARMA IPCA LABS LTD IVAX SUB TEVA PHARMS JUBILANT CADISTA LANNETT HOLDINGS INC MYLAN UNICHEM VINTAGE PHARMS WEST WARD MICROZIDE + WATSON LABS
3 - 212 (of 428)
12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG
A200645 A078389 A078164 A079237 A077005 A078391 A091662 A075640 A090510 A075907 A077885 N020504
001 001 001 001 001 001 001 001 001 001 001 001
Nov May Sep Apr Jul Feb Jan Jan Jan Sep Nov
30, 16, 18, 02, 13, 11, 27, 28, 19, 17, 26,
2010 2008 2007 2009 2005 2008 2012 2000 2010 2002 2007
Dec 27, 1996
TABLET; ORAL HYDROCHLOROTHIAZIDE ACCORD HLTHCARE AB AB AB ACTAVIS ELIZABETH AB APOTEX AB AB AUROBINDO PHARMA AB AB CARACO AB AB AB DAVA PHARMS INC AB AB EXCELLIUM AB AB HERITAGE PHARMS INC AB AB IPCA LABS LTD AB AB AB IVAX SUB TEVA PHARMS AB AB + JUBILANT CADISTA AB AB LANNETT AB AB MYLAN PHARMS INC AB AB AB UNICHEM AB AB VINTAGE PHARMS AB AB WATSON LABS AB WEST WARD AB AB ORETIC ABBVIE AB
12.5MG 25MG 50MG 12.5MG 25MG 50MG 25MG 50MG 12.5MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 12.5MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 12.5MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 25MG 50MG 50MG
A202556 A202556 A202556 A040707 A040774 A040774 A040780 A040780 A040857 A040810 A040810 A087059 A087068 A040702 A040702 A085182 A085182 A040807 A040807 A040807 A083177 A083177 A040809 A040809 A084325 A084324 A040770 A040735 A040735 A040907 A040907 A040412 A040412 A081189 A084878 A084878 N011971
001 002 003 001 001 002 001 002 001 001 002 001 001 001 002 002 001 001 002 003 001 002 001 002 001 001 001 002 003 001 002 001 002 001 002 001 002
Sep Sep Sep Feb Oct Oct Jul Jul May Mar Mar
24, 24, 24, 27, 03, 03, 20, 20, 30, 27, 27,
2012 2012 2012 2007 2007 2007 2007 2007 2008 2007 2007
Mar 16, 2007 Mar 16, 2007
Jul 20, 2007 Jul 20, 2007 Jul 20, 2007
Sep 04, 2007 Sep 04, 2007
Jan Jan Jan Aug Aug Mar Mar Jan Jul
23, 23, 23, 15, 15, 29, 29, 24, 12,
2007 2007 2007 2008 2008 2002 2002 1992 2006
HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET; ORAL AVALIDE AB + SANOFI AVENTIS US
12.5MG;150MG
N020758
002
Sep 30, 1997

TABLET; ORAL AVALIDE + SANOFI AVENTIS US 12.5MG;300MG IRBESARTAN AND HYDROCHLOROTHIAZIDE ALEMBIC LTD 12.5MG;150MG 12.5MG;300MG APOTEX INC 12.5MG;150MG 12.5MG;300MG DR REDDYS LABS LTD 12.5MG;150MG 12.5MG;300MG MACLEODS PHARMS LTD 12.5MG;150MG 12.5MG;300MG MYLAN PHARMS INC 12.5MG;150MG 12.5MG;300MG ROXANE 12.5MG;150MG 12.5MG;300MG SANDOZ 12.5MG;150MG 12.5MG;300MG TEVA 12.5MG;150MG 12.5MG;300MG WATSON LABS INC 12.5MG;150MG 12.5MG;300MG
3 - 213 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
N020758 A091370 A091370 A201505 A201505 A203500 A203500 A202414 A202414 A077969 A077969 A090351 A090351 A077446 A077446 A077369 A077369 A091539 A091539
003 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Aug 31, 1998 Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Oct Oct Sep Sep Mar Mar Oct Oct 15, 15, 15, 15, 27, 27, 27, 27, 27, 27, 15, 15, 27, 27, 30, 30, 22, 22, 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
HYDROCHLOROTHIAZIDE; LISINOPRIL
TABLET; ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE APOTEX INC AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG AUROBINDO AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG IVAX SUB TEVA PHARMS 12.5MG;10MG AB AB 12.5MG;20MG AB 25MG;20MG LUPIN AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG MYLAN AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG PRINSTON INC AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG RANBAXY AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG SANDOZ AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG WATSON LABS AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG WEST WARD AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG PRINZIDE MERCK AB 12.5MG;10MG AB 12.5MG;20MG
A076674 A076674 A076674 A077606 A077606 A077606 A075776 A075776 A075776 A077912 A077912 A077912 A076113 A076113 A076113 A076230 A076230 A076230 A076007 A076007 A076007 A076262 A076262 A076262 A076194 A076194 A076194 A076265 A076265 A076265 N019778 N019778
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 003 001 002 001 002 003 003 001
Oct Oct Oct Mar Mar Mar Jul Jul Jul Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
05, 05, 05, 14, 14, 14, 01, 01, 01, 27, 27, 27, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 08, 08, 08,
2004 2004 2004 2006 2006 2006 2002 2002 2002 2006 2006 2006 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002
Nov 18, 1993 Feb 16, 1989

TABLET; ORAL ZESTORETIC ASTRAZENECA AB AB + AB +
3 - 214 (of 428)
12.5MG;10MG 12.5MG;20MG 25MG;20MG
N019888 N019888 N019888
003 001 002
Nov 18, 1993 Sep 20, 1990 Jul 20, 1989
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

TABLET; ORAL HYZAAR MERCK AB 12.5MG;50MG AB 12.5MG;100MG AB + 25MG;100MG LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ALEMBIC PHARMS LTD AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG APOTEX AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG AUROBINDO PHARMA AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG CADISTA PHARMS AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG LUPIN LTD AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG MACLEODS PHARMS LTD AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG MYLAN AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG ROXANE AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG SANDOZ AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG TEVA PHARMS AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG TORRENT PHARMS AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG WATSON LABS AB 12.5MG;50MG AB 12.5MG;100MG AB 25MG;100MG ZYDUS PHARMS USA INC 12.5MG;50MG AB AB 25MG;100MG
N020387 N020387 N020387 A091617 A091617 A091617 A090150 A090150 A090150 A091629 A091629 A091629 A201845 A201845 A201845 A078245 A078245 A078245 A202289 A202289 A202289 A091652 A091652 A091652 A077732 A077732 A077732 A077948 A077948 A077948 A077157 A077157 A077157 A090528 A090528 A090528 A200180 A200180 A200180 A078385 A078385
001 003 002 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 002 001 003 001 003 002 001 002 003 001 003 002 001 002 003 001 002
Apr 28, 1995 Oct 20, 2005 Nov 10, 1998 Feb Feb Feb Oct Aug Oct Oct Oct Jan Sep Sep Sep Oct May Oct Aug Aug Aug Oct Apr Oct Oct Apr Oct Oct Aug Oct Apr Apr Apr Oct Apr Oct Jan Jan Jan Oct Oct 17, 17, 17, 06, 11, 06, 06, 06, 06, 18, 18, 18, 06, 21, 06, 09, 09, 09, 06, 06, 06, 06, 06, 06, 06, 19, 06, 06, 06, 06, 06, 06, 06, 12, 12, 12, 06, 06, 2012 2012 2012 2010 2010 2010 2010 2010 2010 2012 2012 2012 2010 2010 2010 2012 2012 2012 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2011 2011 2011 2010 2010
HYDROCHLOROTHIAZIDE; METHYLDOPA
TABLET; ORAL METHYLDOPA AND HYDROCHLOROTHIAZIDE XX MYLAN 15MG;250MG XX + 25MG;250MG
A070264 A070265
001 001
Jan 23, 1986 Jan 23, 1986

HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE; ORAL DUTOPROL XX ASTRAZENECA 12.5MG;EQ 25MG TARTRATE XX 12.5MG;EQ 50MG TARTRATE XX + 12.5MG;EQ 100MG TARTRATE
3 - 215 (of 428)
N021956 N021956 N021956
001 002 003
Aug 28, 2006 Aug 28, 2006 Aug 28, 2006
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE

TABLET; ORAL LOPRESSOR HCT US PHARMS HOLDINGS I AB AB + METOPROLOL TARTRATE AND MYLAN AB AB AB SUN PHARM INDS AB AB AB
25MG;50MG 25MG;100MG HYDROCHLOROTHIAZIDE 25MG;50MG 25MG;100MG 50MG;100MG 25MG;50MG 25MG;100MG 50MG;100MG
N018303 N018303 A076792 A076792 A076792 A090654 A090654 A090654
001 002 001 002 003 001 002 003
Dec 31, 1984 Dec 31, 1984 Aug Aug Aug Jan Jan Jan 20, 20, 20, 19, 19, 19, 2004 2004 2004 2012 2012 2012
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE

TABLET; ORAL MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE GLENMARK PHARMS AB 12.5MG;7.5MG AB 12.5MG;15MG AB 25MG;15MG TEVA AB 12.5MG;7.5MG AB 12.5MG;15MG AB 25MG;15MG UNIRETIC UCB INC AB 12.5MG;7.5MG AB 12.5MG;15MG AB + 25MG;15MG
A090718 A090718 A090718 A076980 A076980 A076980 N020729 N020729 N020729
001 002 003 001 003 002 001 003 002
Mar Mar Mar Mar Mar Mar
17, 17, 17, 07, 07, 07,
2010 2010 2010 2007 2007 2007
Jun 27, 1997 Feb 14, 2002 Jun 27, 1997
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

TABLET; ORAL BENICAR HCT XX DAIICHI SANKYO XX XX +
12.5MG;20MG 12.5MG;40MG 25MG;40MG
N021532 N021532 N021532
002 003 005
Jun 05, 2003 Jun 05, 2003 Jun 05, 2003
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

TABLET; ORAL INDERIDE-40/25 + AKRIMAX PHARMS 25MG;40MG PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE MYLAN 25MG;40MG + 25MG;80MG PLIVA 25MG;40MG 25MG;80MG WATSON LABS 25MG;40MG 25MG;80MG
N018031 A070946 A070947 A072042 A072043 A070301 A070305
001 001 001 001 001 001 001 Mar Apr Mar Mar Apr Apr 04, 01, 14, 14, 18, 18, 1987 1987 1988 1988 1986 1986
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

TABLET; ORAL ACCURETIC PFIZER PHARMS AB AB AB + QUINAPRIL HYDROCHLORIDE AUROBINDO PHARMA AB
12.5MG;EQ 10MG BASE 12.5MG;EQ 20MG BASE 25MG;EQ 20MG BASE AND HYDROCHLOROTHIAZIDE 12.5MG;EQ 10MG BASE
N020125 N020125 N020125 A078450
001 002 003 001
Dec 28, 1999 Dec 28, 1999 Dec 28, 1999 Aug 24, 2007

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
TABLET; ORAL QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE AUROBINDO PHARMA AB 12.5MG;EQ 20MG BASE AB 25MG;EQ 20MG BASE INVAGEN PHARMS AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG MYLAN AB 12.5MG;EQ 10MG BASE AB 12.5MG;EQ 20MG BASE AB 25MG;EQ 20MG BASE RANBAXY AB 12.5MG;EQ 10MG BASE AB 12.5MG;EQ 20MG BASE AB 25MG;EQ 20MG BASE QUINARETIC GAVIS PHARMS AB 12.5MG;EQ 10MG BASE AB 12.5MG;EQ 20MG BASE AB 25MG;EQ 20MG BASE
3 - 216 (of 428)
A078450 A078450 A201356 A201356 A201356 A077093 A077093 A077093 A078211 A078211 A078211 A076374 A076374 A076374
002 003 001 002 003 001 002 003 001 002 003 001 002 003
Aug Aug Apr Apr Apr Mar Mar Mar Mar Mar Mar
24, 24, 20, 20, 20, 28, 28, 28, 04, 04, 04,
2007 2007 2011 2011 2011 2005 2005 2005 2009 2009 2009
Mar 31, 2004 Mar 31, 2004 Mar 31, 2004
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
TABLET; ORAL ALDACTAZIDE GD SEARLE LLC 25MG;25MG SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE MUTUAL PHARM 25MG;25MG MYLAN 25MG;25MG WATSON LABS 25MG;25MG ALDACTAZIDE + GD SEARLE LLC 50MG;50MG
AB AB AB AB XX
N012616 A089534 A086513 A087398 N012616
004 001 001 001 005
Dec 30, 1982 Jul 02, 1987
Dec 30, 1982
HYDROCHLOROTHIAZIDE; TELMISARTAN
TABLET; ORAL MICARDIS HCT BOEHRINGER INGELHEIM XX XX XX +
12.5MG;40MG 12.5MG;80MG 25MG;80MG
N021162 N021162 N021162
001 002 003
Nov 17, 2000 Nov 17, 2000 Apr 19, 2004
HYDROCHLOROTHIAZIDE; TRIAMTERENE
CAPSULE; ORAL DYAZIDE + GLAXOSMITHKLINE LLC 25MG;37.5MG TRIAMTERENE AND HYDROCHLOROTHIAZIDE DURAMED PHARMS BARR 25MG;37.5MG IVAX SUB TEVA PHARMS 25MG;50MG LANNETT HOLDINGS INC 25MG;37.5MG MYLAN 25MG;37.5MG SANDOZ 25MG;37.5MG + 25MG;50MG TABLET; ORAL MAXZIDE + MYLAN BERTEK 50MG;75MG MAXZIDE-25 MYLAN BERTEK 25MG;37.5MG TRIAMTERENE AND HYDROCHLOROTHIAZIDE APOTEX INC 25MG;37.5MG 50MG;75MG PLIVA 25MG;37.5MG 50MG;75MG SANDOZ 25MG;37.5MG 50MG;75MG WATSON LABS 25MG;37.5MG
N016042 A075052 A074259 A201407 A074701 A074821 A073191
003 001 001 001 001 001 001
Mar 03, 1994 Jun Mar Dec Jun Jun Jul 18, 30, 09, 07, 05, 31, 1999 1995 2011 1996 1997 1991
N019129 N019129 A071251 A071251 A074026 A073467 A073281 A072011 A073449
001 003 002 001 001 001 001 001 001
Oct 22, 1984 May 13, 1988 May Apr Apr Jan Apr Jun Sep 05, 17, 26, 31, 30, 17, 23, 1998 1988 1996 1996 1992 1988 1993

TABLET; ORAL TRIAMTERENE AND HYDROCHLOROTHIAZIDE WATSON LABS AB 50MG;75MG AB 50MG;75MG
3 - 217 (of 428)
A071851 A071969
001 001
Nov 30, 1988 Apr 17, 1988
HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET; ORAL DIOVAN HCT NOVARTIS AB 12.5MG;80MG AB 12.5MG;160MG AB 12.5MG;320MG AB 25MG;160MG AB + 25MG;320MG VALSARTAN AND HYDROCHLOROTHIAZIDE MYLAN PHARMS INC AB 12.5MG;80MG AB 12.5MG;160MG AB 12.5MG;320MG AB 25MG;160MG AB 25MG;320MG
N020818 N020818 N020818 N020818 N020818 A078020 A078020 A078020 A078020 A078020
001 002 004 003 005 001 002 004 003 005
Mar Mar Apr Jan Apr Sep Sep Sep Sep Sep
06, 06, 28, 17, 28, 21, 21, 21, 21, 21,
1998 1998 2006 2002 2006 2012 2012 2012 2012 2012
HYDROCODONE BITARTRATE; IBUPROFEN

TABLET; ORAL HYDROCODONE BITARTRATE AND IBUPROFEN AMNEAL PHARMS NY AB 5MG;200MG AB 7.5MG;200MG TEVA AB 7.5MG;200MG VINTAGE PHARMS AB 5MG;200MG AB 7.5MG;200MG AB 10MG;200MG WATSON LABS FLORIDA AB 5MG;200MG AB 7.5MG;200MG VICOPROFEN AB + ABBVIE 7.5MG;200MG REPREXAIN AMNEAL PHARMS NY 2.5MG;200MG XX 10MG;200MG XX
A076642 A076642 A076023 A077727 A077723 A077723 A077454 A076604 N020716 A076642 A076642
002 001 001 001 001 002 001 001 001 003 004
Mar Oct Apr Nov Nov Nov Jun Dec
18, 12, 11, 06, 06, 06, 23, 31,
2004 2004 2003 2006 2006 2006 2010 2003
Sep 23, 1997 Oct 19, 2007 Oct 19, 2007
HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE

SOLUTION; ORAL
REZIRA
XX + CYPRESS PHARM
5MG/5ML;60MG/5ML
N022442
001
Jun 08, 2011
HYDROCORTISONE
CREAM; TOPICAL ALA-CORT CROWN LABS AT ANUSOL HC SALIX PHARMS AT HYDROCORTISONE ACTAVIS MID ATLANTIC AT AT AT + FOUGERA AT + LYNE AT PERRIGO NEW YORK AT TARO AT AT VINTAGE PHARMS AT SYNACORT MEDICIS AT
1% 2.5% 1% 2.5% 1% 2.5% 2.5% 2.5% 1% 2.5% 2.5% 1%
A080706 A088250 A087795 A089682 A080693 A089414 A040879 A085025 A086155 A088799 A040503 A087458
006 001 001 001 003 001 001 001 001 001 001 001 Jun 06, 1984 May 03, 1983 Mar 10, 1988 Dec 16, 1986 Aug 20, 2010
Nov 09, 1984 Mar 12, 2004

HYDROCORTISONE
CREAM; TOPICAL SYNACORT MEDICIS ENEMA; RECTAL COLOCORT PADDOCK LLC CORTENEMA + ANI PHARMS HYDROCORTISONE TEVA PHARMS LOTION; TOPICAL ALA-CORT CROWN LABS HYDROCORTISONE + FOUGERA PHARMS TARO VINTAGE PHARMS NUTRACORT DOW PHARM STIE-CORT PERRIGO ALA-SCALP
CROWN LABS OINTMENT; TOPICAL
HYDROCORTISONE ACTAVIS MID ATLANTIC + FOUGERA + FOUGERA PHARMS PERRIGO NEW YORK TARO
3 - 218 (of 428)
AT
2.5%
A087457
001
AB AB AB
100MG/60ML 100MG/60ML 100MG/60ML
A075172 N016199 A074171
001 001 001
Dec 03, 1999
May 27, 1994
AT AT AT AT AT AT AT AT XX
1% 2.5% 2.5% 2.5% 1% 2.5% 1% 2.5% 2%
A083201 A040351 A040247 A040417 A080443 A087644 A089066 A089074 A083231
001 001 001 001 003 001 001 001 001

Jul 25, 2000 Jul 23, 1999 Jul 30, 2003
Aug 24, 1982 Nov 25, 1985 Nov 26, 1985
XX
XX
AB AB AB AB AB AB AB AB AB BP
1% 2.5% 1% 2.5% 1% 2.5% HYDROCORTISONE IN ABSORBASE CAROLINA MEDCL 1% POWDER; FOR RX COMPOUNDING HYDRO-RX + X GEN PHARMS 100% SOLUTION; TOPICAL
TEXACORT
+ MISSION PHARMA 2.5% TABLET; ORAL CORTEF PHARMACIA AND UPJOHN 5MG 10MG + 20MG HYDROCORTISONE AMEDRA PHARMS 5MG 10MG 20MG VINTAGE 5MG 10MG 20MG HYDROCORTISONE WEST WARD 20MG
A087796 A081203 A080692 A085027 A086257 A040310 A088138
001 001 001 001 001 001 001
Oct 13, 1982 May 28, 1993
Dec 29, 2000 Sep 06, 1985
A085982
001
A081271
001
Apr 17, 1992
N008697 N008697 N008697 A040646 A040646 A040646 A040761 A040761 A040761 A083365
003 001 002 001 002 003 001 002 003 001 Mar Mar Mar Jul Jul Jul 30, 30, 30, 16, 16, 16, 2007 2007 2007 2007 2007 2007
HYDROCORTISONE ACETATE
AEROSOL, METERED; RECTAL
CORTIFOAM
XX + MEDA PHARMS
10%
N017351
001
Feb 10, 1982

CREAM; TOPICAL
XX + FERNDALE LABS 2.5% MICORT-HC XX + FERNDALE LABS 2% XX 2.5% PASTE; TOPICAL ORABASE HCA XX COLGATE
3 - 219 (of 428)
A040259 A040398 A040396
001 001 001
Jul 29, 1999 Mar 29, 2002 Feb 27, 2001
0.5%
A083205
001
POWDER; FOR RX COMPOUNDING HYDROCORTISONE ACETATE

XX X GEN PHARMS 100%
A085981
001
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

CREAM; TOPICAL
CORTISPORIN
XX + MONARCH PHARMS
0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
N050218
001
Aug 09, 1985
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE

AEROSOL, METERED; TOPICAL EPIFOAM BX MEDA PHARMS 1%;1% PROCTOFOAM HC BX MEDA PHARMS 1%;1% CREAM; TOPICAL PRAMOSONE FERNDALE LABS XX XX LOTION; TOPICAL PRAMOSONE FERNDALE LABS XX XX
A086457 A086195
001 001
0.5%;1% 1%;1%
A083778 A085368
001 001
1%;1% 2.5%;1%
A085980 A085979
001 001
HYDROCORTISONE ACETATE; UREA

CREAM; TOPICAL CARMOL HC FOUGERA PHARMS AT U-CORT TARO AT
1%;10% 1%;10%
A080505 A089472
001 001 Jun 13, 1988
HYDROCORTISONE BUTYRATE
CREAM; TOPICAL HYDROCORTISONE BUTYRATE TARO PHARM INDS AB 0.1% LOCOID AB + PRECISION DERMAT 0.1% LOCOID LIPOCREAM 0.1% XX + PRECISION DERMAT LOTION; TOPICAL
LOCOID
XX + PRECISION DERMAT
A076654 N018514 N020769
001 001 001
Aug 03, 2005 Mar 31, 1982 Sep 08, 1997
0.1%
N022076
001
May 18, 2007
OINTMENT; TOPICAL HYDROCORTISONE BUTYRATE TARO AB 0.1% LOCOID AB + PRECISION DERMAT 0.1% SOLUTION; TOPICAL HYDROCORTISONE BUTYRATE TARO PHARM INDS AT 0.1% LOCOID AT + PRECISION DERMAT 0.1%
A076842 N018652
001 001
Dec 27, 2004 Oct 29, 1982
A076364 N019116
001 001
Jan 14, 2004 Feb 25, 1987

HYDROCORTISONE PROBUTATE
CREAM; TOPICAL
PANDEL
XX + FOUGERA PHARMS
3 - 220 (of 428)
0.1%
N020453
001
Feb 28, 1997
HYDROCORTISONE SODIUM SUCCINATE

INJECTABLE; INJECTION A-HYDROCORT HOSPIRA SOLU-CORTEF + PHARMACIA AND UPJOHN + + +
AP AP AP AP AP
EQ 100MG BASE/VIAL EQ EQ EQ EQ 100MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A040666 N009866 N009866 N009866 N009866
001 001 002 003 004
Apr 06, 2006
HYDROCORTISONE VALERATE
CREAM; TOPICAL HYDROCORTISONE VALERATE PERRIGO NEW YORK + TARO OINTMENT; TOPICAL HYDROCORTISONE VALERATE FOUGERA PHARMS TARO WESTCORT + RANBAXY
AB AB
0.2% 0.2%
A075666 A075042
001 001
May 24, 2000 Aug 25, 1998
AB AB AB
0.2% 0.2% 0.2%
A075085 A075043 N018726
001 001 001
Jul 31, 2001 Aug 25, 1998 Aug 08, 1983
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

SOLUTION/DROPS; OTIC CORTISPORIN + MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE ALCON PHARMS LTD 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML BAUSCH AND LOMB 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML LUITPOLD 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML SUSPENSION/DROPS; OPHTHALMIC NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE + ALCON PHARMS LTD 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML SUSPENSION/DROPS; OTIC CORTISPORIN + MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE ALCON PHARMS LTD 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML LUITPOLD 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML OTICAIR BAUSCH AND LOMB 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML PEDIOTIC MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
AT AT AT AT
N050479 A062423 A064053 A065216
001 001 001 001 Aug 25, 1983 Dec 29, 1995 Oct 31, 2005
XX
A062874
001
May 11, 1988
AT AT AT AT AT
A060613 A062488 A065219 A064065 A062822
001 001 001 001 001 Nov 06, 1985 May 01, 2006 Aug 28, 1996 Sep 29, 1987
HYDROFLUMETHIAZIDE
TABLET; ORAL SALURON AB + SHIRE LLC
50MG
N011949
001
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION DILAUDID + PURDUE PHARM PRODS + + DILAUDID-HP + PURDUE PHARM PRODS
AP AP AP AP
N019034 N019034 N019034 N019034
003 004 005 001
Apr 30, 2009 Apr 30, 2009 Apr 30, 2009 Jan 11, 1984

INJECTABLE; INJECTION HYDROMORPHONE HYDROCHLORIDE AKORN 10MG/ML 10MG/ML BARR 10MG/ML HOSPIRA 10MG/ML HOSPIRA INC 1MG/ML 2MG/ML 4MG/ML 10MG/ML DILAUDID-HP + PURDUE PHARM PRODS 250MG/VIAL SOLUTION; ORAL DILAUDID + PURDUE PHARM PRODS 5MG/5ML HYDROMORPHONE HYDROCHLORIDE ROXANE 5MG/5ML TABLET; ORAL DILAUDID PURDUE PHARM PRODS 2MG 4MG + 8MG HYDROMORPHONE HYDROCHLORIDE ELITE LABS 8MG LANNETT 2MG 4MG 8MG MALLINCKRODT 8MG MALLINCKRODT INC 2MG 4MG ROXANE 4MG 8MG TABLET, EXTENDED RELEASE; ORAL EXALGO MALLINCKRODT INC 8MG 12MG + 16MG 32MG
3 - 221 (of 428)
AP AP AP AP AP AP AP AP XX
A078228 A078261 A076444 A074598 N200403 N200403 N200403 A078591 N019034
001 001 001 001 001 002 003 001 002
Apr Apr Apr Jun Dec Dec Dec Jun
14, 14, 25, 19, 01, 01, 01, 17,
2010 2010 2003 1997 2011 2011 2011 2008
Aug 04, 1994
AA AA
N019891 A074653
001 001
Dec 07, 1992 Jul 29, 1998
N019892 N019892 N019892 A076723 A078439 A078439 A077471 A076855 A078273 A078273 A074597 A074597
003 002 001 001 001 002 001 001 001 002 003 001
Nov 09, 2007 Nov 09, 2007 Dec 07, 1992 Oct Dec Dec Dec Dec Sep Sep May Jul 18, 09, 09, 09, 23, 19, 19, 29, 29, 2005 2009 2009 2009 2004 2007 2007 2009 1998
XX XX XX XX
N021217 N021217 N021217 N021217
001 002 003 004
Mar Mar Mar Aug
01, 01, 01, 24,
2010 2010 2010 2012
HYDROXOCOBALAMIN
CYANOKIT
XX + MERCK SANTE SAS HYDROXOCOBALAMIN XX + WATSON LABS
5GM/VIAL (5GM/KIT) 1MG/ML
N022041 A085998
001 001
Apr 08, 2011
HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE

PAREMYD
XX + AKORN 1%;0.25%
N019261
001
Jan 30, 1992
HYDROXYCHLOROQUINE SULFATE
TABLET; ORAL HYDROXYCHLOROQUINE SULFATE IPCA LABS LTD 200MG MYLAN 200MG SANDOZ 200MG TEVA PHARMS 200MG WATSON LABS 200MG WEST WARD 200MG
AB AB AB AB AB AB
A040766 A040274 A040104 A040081 A040133 A040760
001 001 001 001 001 001
Jun May Nov Sep Nov Aug
14, 29, 30, 30, 30, 15,
2007 1998 1995 1994 1995 2007

TABLET; ORAL HYDROXYCHLOROQUINE SULFATE ZYDUS PHARMS USA INC 200MG AB PLAQUENIL AB + SANOFI AVENTIS US 200MG
3 - 222 (of 428)
A040657 N009768
001 001
Sep 21, 2007
HYDROXYPROGESTERONE CAPROATE
SOLUTION; INTRAMUSCULAR
MAKENA
XX + KV PHARM
1250MG/5ML (250MG/ML)
N021945
001
Feb 03, 2011
HYDROXYPROPYL CELLULOSE
INSERT; OPHTHALMIC
LACRISERT
XX + ATON
5MG
N018771
001
HYDROXYUREA
CAPSULE; ORAL HYDREA + BRISTOL MYERS SQUIBB HYDROXYUREA BARR PAR PHARM DROXIA BRISTOL MYERS SQUIBB
AB AB AB XX XX XX
500MG 500MG 500MG 200MG 300MG 400MG
N016295 A075143 A075340 N016295 N016295 N016295
001 001 001 002 003 004 Oct 16, 1998 Feb 24, 1999 Feb 25, 1998 Feb 25, 1998 Feb 25, 1998
HYDROXYZINE HYDROCHLORIDE
INJECTABLE; INJECTION HYDROXYZINE HYDROCHLORIDE + FRESENIUS KABI USA 25MG/ML + 50MG/ML LUITPOLD 25MG/ML 50MG/ML SYRUP; ORAL HYDROXYZINE HYDROCHLORIDE + HI TECH PHARMA 10MG/5ML + VINTAGE PHARMS 10MG/5ML + WOCKHARDT 10MG/5ML TABLET; ORAL HYDROXYZINE HYDROCHLORIDE AMNEAL PHARM 10MG 25MG 50MG HERITAGE PHARMS INC 10MG 25MG 50MG HETERO LABS UNIT III 10MG 25MG 50MG INVAGEN PHARMS 10MG 25MG 50MG KVK TECH 10MG 25MG 50MG MUTUAL PHARM 10MG 25MG 50MG
AP AP AP AP
A087329 A087329 A087408 A087408
001 002 001 002
AA AA AA
A040010 A040391 A087294
001 001 001
Oct 28, 1994 Apr 10, 2002 Apr 12, 1982
001 002 003 001 002 003 001 002 003 001 002 003 001 001 001 001 001 001
Sep Sep Sep Jun Jun Jun May May May Mar Mar Mar Mar Mar Mar May May May
24, 24, 24, 30, 30, 30, 29, 29, 29, 12, 12, 12, 20, 20, 20, 19, 19, 19,
2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2007 2007 2007 1986 1986 1986

TABLET; ORAL HYDROXYZINE HYDROCHLORIDE MYLAN AB 10MG AB 25MG AB 50MG NORTHSTAR HLTHCARE AB 10MG AB 25MG AB 50MG AB + PLIVA 10MG AB + 25MG AB + 50MG SUN PHARM INDS INC AB 10MG AB 25MG AB 50MG VINTAGE PHARMS AB 10MG AB 25MG AB 50MG WATSON LABS AB 10MG AB 10MG AB 25MG AB 25MG AB 50MG AB 50MG
3 - 223 (of 428)
001 002 003 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 001 001
Jun Jun Jun Mar Mar Mar Jan Jan Jan Jun Jun Jun May May May Mar Sep Mar Sep Mar Sep
07, 07, 07, 31, 31, 31, 10, 10, 10, 10, 10, 10, 27, 27, 27, 18, 15, 18, 15, 18, 15,
2010 2010 2010 2008 2008 2008 1986 1986 1986 2008 2008 2008 2005 2005 2005 1994 1983 1994 1983 1994 1983
HYDROXYZINE PAMOATE
CAPSULE; ORAL HYDROXYZINE PAMOATE BARR AB AB SANDOZ AB AB WATSON LABS AB AB AB VISTARIL PFIZER AB AB + HYDROXYZINE PAMOATE BARR XX
EQ EQ EQ EQ EQ EQ EQ
HCL HCL HCL HCL HCL HCL HCL
A088496 A088487 A087479 A086183 A040156 A081165 A040156 N011459 N011459 A088488
001 001 001 001 001 001 002 002 004 001
Jun 15, 1984 Jun 15, 1984
Jul 15, 1996 Jul 31, 1991 Jul 15, 1996
EQ 25MG HCL EQ 50MG HCL EQ 100MG HCL
Jun 15, 1984
IBANDRONATE SODIUM
BONIVA
+ ROCHE TABLET; ORAL BONIVA + HOFFMANN LA ROCHE IBANDRONATE SODIUM APOTEX INC DR REDDYS LABS LTD MUTUAL PHARM CO INC MYLAN PHARMS INC ORCHID HLTHCARE WATSON LABS INC
XX
EQ 3MG BASE/3ML
N021858
001
Jan 06, 2006
EQ 150MG BASE EQ EQ EQ EQ EQ EQ 150MG 150MG 150MG 150MG 150MG 150MG BASE BASE BASE BASE BASE BASE
N021455 A078948 A078997 A078996 A078995 A078998 A079003
002 001 001 001 001 001 001
Mar 24, 2005 Mar Apr Aug Mar Mar Mar 19, 30, 15, 19, 19, 20, 2012 2012 2012 2012 2012 2012
IBUPROFEN
SOLUTION; INTRAVENOUS CALDOLOR XX CUMBERLAND PHARMS XX +
N022348 N022348
001 002
Jun 11, 2009 Jun 11, 2009

IBUPROFEN
SUSPENSION; ORAL IBUPROFEN AB + ACTAVIS MID ATLANTIC PERRIGO R AND D AB TABLET; ORAL IBUPROFEN AMNEAL PHARMS NY AB AB AB AB AB AB CONTRACT PHARMACAL AB AB AB DR REDDYS LA AB AB AB + DR REDDYS LABS INC AB AB AB MARKSANS PHARMA AB AB AB PERRIGO R AND D AB AB AB SHASUN USA AB AB AB VINTAGE PHARMS AB AB AB AB AB WATSON LABS AB AB IBU-TAB ALRA AB AB
3 - 224 (of 428)
100MG/5ML 100MG/5ML
A074978 A076925
001 001
Mar 25, 1998 Sep 23, 2004
400MG 400MG 600MG 600MG 800MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 300MG 400MG 400MG 600MG 800MG 400MG 600MG 400MG 600MG
001 001 001 002 001 003 001 001 001 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 001 001 001 001 001 001 001
Nov Jun Nov Jun Oct Jun Oct Oct Jul Nov Nov Nov Oct Oct Oct Dec Dec Dec Jul Jul Jul Feb Feb Feb Oct Oct Feb Oct Nov Aug Aug
25, 18, 25, 18, 13, 18, 15, 15, 01, 14, 14, 14, 31, 31, 31, 21, 21, 21, 18, 18, 18, 05, 05, 05, 22, 22, 01, 22, 18, 21, 21,
1986 2007 1986 2007 1987 2007 1986 1986 1988 2001 2001 2001 2001 2001 2001 2010 2010 2010 2005 2005 2005 2009 2009 2009 1986 1986 1988 1986 1987 1985 1985
Aug 11, 1988 Aug 11, 1988
IBUPROFEN LYSINE
INJECTABLE; INTRAVENOUS NEOPROFEN XX + LUNDBECK LLC
EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
N021903
001
Apr 13, 2006
IBUPROFEN; OXYCODONE HYDROCHLORIDE

TABLET; ORAL OXYCODONE HYDROCHLORIDE ACTAVIS ELIZABETH AB AB + BARR LABS INC WATSON LABS AB AND IBUPROFEN 400MG;5MG 400MG;5MG 400MG;5MG
A078769 A078316 A078394
001 001 001
Jan 04, 2008 Nov 29, 2007 Nov 26, 2007
IBUTILIDE FUMARATE
INJECTABLE; INJECTION CORVERT AP + PHARMACIA AND UPJOHN IBUTILIDE FUMARATE BIONICHE PHARMA USA AP AP
N020491 A090643 A090924
001 001 001
Dec 28, 1995 Jan 11, 2010 Jan 11, 2010

IBUTILIDE FUMARATE
INJECTABLE; INJECTION IBUTILIDE FUMARATE LUITPOLD AP
3 - 225 (of 428)
0.1MG/ML
A090240
001
Jan 11, 2010
ICATIBANT ACETATE
FIRAZYR
XX + SHIRE ORPHAN THERAP
N022150
001
Aug 25, 2011
ICODEXTRIN
SOLUTION; INTRAPERITONEAL
EXTRANEAL
XX + BAXTER HLTHCARE 7.5GM/100ML
N021321
001
Dec 20, 2002
ICOSAPENT ETHYL
CAPSULE; ORAL
VASCEPA
XX + AMARIN PHARMA INC
1GM
N202057
001
Jul 26, 2012
IDARUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION IDAMYCIN PFS + PHARMACIA AND UPJOHN 1MG/ML IDARUBICIN HYDROCHLORIDE BEDFORD LABS 1MG/ML 1MG/ML FRESENIUS KABI USA 1MG/ML ONCO THERAPIES LTD 1MG/ML SANDOZ 1MG/ML IDARUBICIN HYDROCHLORIDE PFS TEVA PARENTERAL 1MG/ML
N050734 A065275 A065288 A065440 A200144 A091293 A065036
001 001 001 001 001 001 001
Feb 17, 1997 Dec May Aug Oct Mar 14, 15, 04, 11, 29, 2006 2007 2009 2012 2011
May 01, 2002
IDOXURIDINE
SOLUTION/DROPS; OPHTHALMIC DENDRID AT + ALCON 0.1% HERPLEX AT + ALLERGAN 0.1%
N014169 N013935
001 002
IFOSFAMIDE
INJECTABLE; INJECTION IFEX BAXTER HLTHCARE AP AP IFOSFAMIDE BEDFORD LABS AP AP AP + FRESENIUS KABI USA AP AP + AP ONCO THERAPIES LTD AP AP AP + TEVA PARENTERAL AP +
1GM/VIAL 3GM/VIAL 1GM/20ML(50MG/ML) 3GM/60ML(50MG/ML) 1GM/VIAL 1GM/20ML (50MG/ML) 3GM/VIAL 3GM/60ML (50MG/ML) 1GM/20ML (50MG/ML) 3GM/60ML (50MG/ML) 1GM/20ML (50MG/ML) 3GM/60ML (50MG/ML)
N019763 N019763 A076619 A076619 A076078 A090181 A076078 A090181 A201689 A201689 A076657 A076657
001 002 001 002 001 001 002 002 001 002 001 002
Dec 30, 1988 Dec 30, 1988 Jun Jun May Sep May Sep Nov Nov Apr Apr 29, 29, 28, 22, 28, 22, 26, 26, 04, 04, 2011 2011 2002 2009 2002 2009 2012 2012 2007 2007
IFOSFAMIDE; MESNA
IFOSFAMIDE/MESNA KIT
XX + TEVA PARENTERAL XX +
1GM/20ML;1GM/10ML (50MG/ML;100MG/ML) 3GM/60ML;1GM/10ML (50MG/ML;100MG/ML)
A075874 A075874
001 002
Feb 26, 2002 Feb 26, 2002

ILOPERIDONE
TABLET; ORAL FANAPT XX + NOVARTIS XX XX XX XX XX XX
3 - 226 (of 428)
N022192 N022192 N022192 N022192 N022192 N022192 N022192
001 002 003 004 005 006 007
May May May May May May May
06, 06, 06, 06, 06, 06, 06,
2009 2009 2009 2009 2009 2009 2009
ILOPROST
SOLUTION; INHALATION VENTAVIS XX + ACTELION PHARMS LTD XX +
10MCG/ML (10MCG/ML) 20MCG/ML (20MCG/ML)
N021779 N021779
002 003
Dec 08, 2005 Aug 07, 2009
IMATINIB MESYLATE
TABLET; ORAL GLEEVEC XX NOVARTIS XX +
N021588 N021588
001 002
Apr 18, 2003 Apr 18, 2003
IMIGLUCERASE
INJECTABLE; INJECTION CEREZYME XX GENZYME XX +
200 UNITS/VIAL 400 UNITS/VIAL
N020367 N020367
001 002
May 23, 1994 Sep 22, 1999
IMIPRAMINE HYDROCHLORIDE
TABLET; ORAL IMIPRAMINE HYDROCHLORIDE EXCELLIUM 10MG 25MG 50MG LUPIN LTD 10MG 25MG 50MG MUTUAL PHARM 10MG 25MG 50MG PAR PHARM 10MG 10MG 25MG 50MG PROSAM LABS 10MG 25MG 50MG SANDOZ 10MG 25MG 50MG TOFRANIL MALLINCKRODT INC 10MG 25MG + 50MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 003 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001
Oct Oct Oct Mar Mar Mar Jun Jun Jun Oct Jul Oct Oct Feb Feb Feb
24, 24, 24, 11, 11, 11, 05, 05, 05, 21, 14, 21, 21, 28, 28, 28,
2012 2012 2012 2010 2010 2010 1990 1990 1990 1983 1987 1983 1983 2008 2008 2008
May 22, 1984 May 22, 1984 May 22, 1984
IMIPRAMINE PAMOATE
CAPSULE; ORAL IMIPRAMINE PAMOATE LUPIN LTD AB AB
EQ 75MG HCL EQ 100MG HCL
A090444 A090444
001 002
Apr 16, 2010 Apr 16, 2010

IMIPRAMINE PAMOATE
CAPSULE; ORAL IMIPRAMINE PAMOATE LUPIN LTD AB AB ROXANE AB AB AB AB TOFRANIL-PM AB + MALLINCKRODT INC AB AB AB
3 - 227 (of 428)
125MG HCL 150MG HCL 75MG HCL 100MG HCL 125MG HCL 150MG HCL 75MG HCL 100MG HCL 125MG HCL 150MG HCL
A090444 A090444 A091099 A091099 A091099 A091099 N017090 N017090 N017090 N017090
003 004 001 002 003 004 001 004 003 002
Apr Apr Apr Apr Apr Apr
16, 16, 16, 16, 16, 16,
2010 2010 2010 2010 2010 2010
IMIQUIMOD
CREAM; TOPICAL ALDARA + MEDICIS IMIQUIMOD APOTEX INC FOUGERA PHARMS GLENMARK GENERICS PERRIGO ISRAEL TARO TEVA PHARMS USA TOLMAR ZYCLARA + MEDICIS +
AB AB AB AB AB AB AB AB XX XX
5% 5% 5% 5% 5% 5% 5% 5% 2.5% 3.75%
N020723 A091308 A078548 A201994 A078837 A200173 A200481 A091044 N022483 N022483
001 001 001 001 001 001 001 001 002 001
Feb 27, 1997 Apr Feb Mar Sep Apr Apr Feb 06, 25, 06, 07, 15, 18, 28, 2012 2010 2012 2010 2011 2011 2011
Jul 15, 2011 Mar 25, 2010
INAMRINONE LACTATE
INJECTABLE; INJECTION AMRINONE LACTATE XX + BEDFORD
EQ 5MG BASE/ML
A075513
001
May 09, 2000
INDACATEROL MALEATE
POWDER; INHALATION ARCAPTA NEOHALER XX + NOVARTIS
EQ 75MCG BASE
N022383
001
Jul 01, 2011
INDAPAMIDE
TABLET; ORAL INDAPAMIDE ACTAVIS ELIZABETH AB AB IVAX SUB TEVA PHARMS AB AB MYLAN AB AB + MYLAN PHARMS INC AB AB WATSON LABS AB AB
A074722 A074722 A074299 A074299 A074461 A074461 A075105 A075105 A074585 A074585
001 002 002 001 002 001 001 002 001 002
Jun Jun Apr Jul Mar Mar Jul Jul Sep Sep
17, 17, 29, 27, 26, 27, 23, 23, 26, 26,
1996 1996 1996 1995 1997 1996 1998 1998 1996 1996
INDINAVIR SULFATE
CAPSULE; ORAL CRIXIVAN XX MERCK SHARP DOHME XX XX +
N020685 N020685 N020685
006 003 001
Apr 19, 2000 Mar 13, 1996 Mar 13, 1996

INDIUM IN-111 CHLORIDE
INDICLOR
XX + GE HEALTHCARE INDIUM IN 111 CHLORIDE XX + MALLINCKRODT
3 - 228 (of 428)
2mCi/0.2ML 5mCi/0.5ML
N019862 N019841
001 001
Dec 29, 1992 Sep 27, 1994
INDIUM IN-111 OXYQUINOLINE

INDIUM IN-111 OXYQUINOLINE
XX + GE HEALTHCARE 1mCi/ML
N019044
001
Dec 24, 1985
INDIUM IN-111 PENTETATE DISODIUM

MPI INDIUM DTPA IN 111
1mCi/ML XX + GE HEALTHCARE
N017707
001
Feb 18, 1982
INDIUM IN-111 PENTETREOTIDE KIT

OCTREOSCAN
XX + MALLINCKRODT
3mCi/ML
N020314
001
Jun 02, 1994
INDOCYANINE GREEN
INJECTABLE; INJECTION IC-GREEN AP + AKORN INDOCYANINE GREEN PULSION MEDCL AP
25MG/VIAL 25MG/VIAL
N011525 A040811
001 001 Nov 21, 2007
INDOMETHACIN
CAPSULE; ORAL INDOMETHACIN GLENMARK GENERICS AB 25MG AB 50MG HERITAGE PHARMS INC AB 25MG AB 50MG HETERO LABS UNIT III 25MG AB AB 50MG IVAX SUB TEVA PHARMS 25MG AB AB 50MG MYLAN AB 25MG AB + 50MG SANDOZ AB 25MG AB 50MG ZYDUS PHARMS USA INC 25MG AB AB 50MG CAPSULE, EXTENDED RELEASE; ORAL INDOMETHACIN AMNEAL PHARMS AB 75MG AVANTHI INC AB 75MG HETERO LABS LTD III AB 75MG PADDOCK LLC AB 75MG AB + SANDOZ 75MG INJECTABLE; INJECTION
INDOMETHACIN
EQ 1MG BASE/VIAL XX + FRESENIUS KABI USA SUPPOSITORY; RECTAL
INDOMETHACIN
XX + G AND W LABS SUSPENSION; ORAL
INDOCIN
XX + IROKO PHARMS
A091276 A091276 N018851 N018851 A091240 A091240 A070719 A070756 N018858 A070624 A070673 A070674 A090403 A090403
001 002 001 002 001 002 001 001 001 001 001 001 001 002
Dec Dec May May Apr Apr Feb Feb Apr Sep Apr Apr Nov Nov
22, 22, 18, 18, 12, 12, 12, 12, 20, 04, 29, 29, 15, 15,
2010 2010 1984 1984 2011 2011 1986 1986 1984 1985 1987 1987 2010 2010
A091549 A079175 A201807 A200529 A074464
001 001 001 001 001
Dec Mar Sep Nov May
01, 06, 28, 30, 28,
2010 2009 2012 2010 1998
N022536
001
Mar 17, 2010
50MG
A073314
001
Aug 31, 1992
25MG/5ML
N018332
001
Oct 10, 1985

INDOMETHACIN SODIUM
INJECTABLE; INJECTION INDOCIN AP + LUNDBECK LLC INDOMETHACIN SODIUM BEDFORD AP
3 - 229 (of 428)
N018878 A078713
001 001
Jan 30, 1985 Jul 16, 2008
INGENOL MEBUTATE
GEL; TOPICAL PICATO XX LEO PHARMA AS XX +
0.015% 0.05%
N202833 N202833
001 002
Jan 23, 2012 Jan 23, 2012
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

NOVOLOG MIX 70/30
XX + NOVO NORDISK INC
XX
700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML)

NOVOLOG MIX 70/30 FLEXPEN
+ NOVO NORDISK INC 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
N021172
001
Nov 01, 2001
N021172
004
May 03, 2002
INSULIN ASPART RECOMBINANT

NOVOLOG
XX + NOVO NORDISK INC NOVOLOG FLEXPEN XX + NOVO NORDISK INC NOVOLOG PENFILL XX + NOVO NORDISK INC
1000 UNITS/10ML (100 UNITS/ML) 300 UNITS/3ML (100 UNITS/ML) 300 UNITS/3ML (100 UNITS/ML)
N020986 N020986 N020986
001 003 002
Jun 07, 2000 Jan 19, 2001 Jun 07, 2000
INSULIN DETEMIR RECOMBINANT

LEVEMIR
XX + NOVO NORDISK INC LEVEMIR FLEXPEN XX + NOVO NORDISK INC
1000 UNITS/10ML (100 UNITS/ML) 300 UNITS/3ML (100 UNITS/ML)
N021536 N021536
001 002
Jun 16, 2005 Jun 16, 2005
INSULIN GLARGINE RECOMBINANT

LANTUS
100 UNITS/ML
N021081
001
Apr 20, 2000
INSULIN GLULISINE RECOMBINANT

INJECTABLE; IV (INFUSION)-SC
APIDRA
XX + SANOFI AVENTIS US 1000 UNITS/10ML (100 UNITS/ML) XX + 300 UNITS/3ML (100 UNITS/ML) INJECTABLE; SUBCUTANEOUS APIDRA SOLOSTAR XX SANOFI AVENTIS US
N021629 N021629
001 002
Apr 16, 2004 Dec 20, 2005
300 UNITS/3ML
N021629
003
Feb 24, 2009
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

HUMALOG MIX 50/50
+ LILLY 50 HUMALOG MIX 50/50 KWIKPEN + LILLY 50 HUMALOG MIX 75/25 + LILLY 75 HUMALOG MIX 75/25 KWIKPEN + LILLY 75
XX XX XX XX
UNITS/ML;50 UNITS/ML UNITS/ML;50 UNITS/ML UNITS/ML;25 UNITS/ML UNITS/ML;25 UNITS/ML
N021018 N021018 N021017 N021017
001 002 001 002
Dec 22, 1999 Sep 06, 2007 Dec 22, 1999 Sep 06, 2007

INSULIN LISPRO RECOMBINANT
HUMALOG
XX + LILLY HUMALOG KWIKPEN XX + LILLY
3 - 230 (of 428)
100 UNITS/ML 100 UNITS/ML
N020563 N020563
001 003
Jun 14, 1996 Sep 06, 2007
INSULIN RECOMBINANT HUMAN

HUMULIN R
XX + LILLY
500 UNITS/ML
N018780
004
Mar 31, 1994
IOBENGUANE SULFATE I-123

ADREVIEW
XX + GE HEALTHCARE
10MCI/5ML (2MCI/ML)
N022290
001
Sep 19, 2008
IODIPAMIDE MEGLUMINE
CHOLOGRAFIN MEGLUMINE
XX + BRACCO
52%
N009321
003
IODIXANOL
VISIPAQUE 270
XX + GE HEALTHCARE XX VISIPAQUE 320 XX + GE HEALTHCARE XX
55% 55% 65.2% 65.2%
N020351 N020808 N020351 N020808
001 001 002 002
Mar 22, 1996 Aug 29, 1997 Mar 22, 1996 Aug 29, 1997
IOFLUPANE I-123
DATSCAN
XX + GE HLTHCARE INC
5MCI/2.5ML (2MCI/ML)
N022454
001
Jan 14, 2011
IOHEXOL
OMNIPAQUE 140
XX + GE HEALTHCARE
30.2%
N018956
005
Nov 30, 1988
SOLUTION; INJECTION, ORAL

OMNIPAQUE 350
75.5% XX + GE HEALTHCARE 75.5% XX SOLUTION; INJECTION, ORAL, RECTAL
OMNIPAQUE 180
XX + GE HEALTHCARE 38.8% OMNIPAQUE 240 XX + GE HEALTHCARE 51.8% XX 51.8% OMNIPAQUE 300 64.7% XX + GE HEALTHCARE 64.7% XX
N018956 N020608
004 003
Dec 26, 1985 Oct 24, 1995
N018956 N018956 N020608 N018956 N020608
001 002 001 003 002
Dec 26, 1985 Dec 26, 1985 Oct 24, 1995 Dec 26, 1985 Oct 24, 1995
IOPAMIDOL
INJECTABLE; INJECTION IOPAMIDOL-250 FRESENIUS KABI USA AP IOPAMIDOL-300 FRESENIUS KABI USA AP IOPAMIDOL-370 FRESENIUS KABI USA AP
51% 61% 76%
A074679 A074679 A074679
001 002 003
Apr 02, 1997 Apr 02, 1997 Apr 02, 1997

IOPAMIDOL
INJECTABLE; INJECTION ISOVUE-200 + BRACCO ISOVUE-250 + BRACCO + ISOVUE-300 + BRACCO + ISOVUE-370 + BRACCO + SCANLUX-300 SANOCHEMIA CORP USA SCANLUX-370 SANOCHEMIA CORP USA ISOVUE-M 200 + BRACCO ISOVUE-M 300 + BRACCO
3 - 231 (of 428)
AP AP AP AP AP AP AP AP AP XX XX
41% 51% 51% 61% 61% 76% 76% 61% 76% 41% 61%
N018735 N018735 N020327 N018735 N020327 N018735 N020327 A090394 A090394 N018735 N018735
006 007 002 002 003 003 004 001 002 001 004
Jul 07, 1987 Jul 06, 1992 Oct 12, 1994 Dec 31, 1985 Oct 12, 1994 Dec 31, 1985 Oct 12, 1994 Jun 18, 2010 Jun 18, 2010 Dec 31, 1985 Dec 31, 1985
IOPROMIDE
ULTRAVIST (PHARMACY BULK)
+ BAYER HLTHCARE 49.9% + 62.3% + 76.9% ULTRAVIST 150 + BAYER HLTHCARE 31.2% ULTRAVIST 240 + BAYER HLTHCARE 49.9% ULTRAVIST 300 + BAYER HLTHCARE 62.3% ULTRAVIST 300 IN PLASTIC CONTAINER + BAYER HLTHCARE 62.3% ULTRAVIST 370 + BAYER HLTHCARE 76.9%
XX XX XX XX XX XX XX XX
N021425 N021425 N021425 N020220 N020220 N020220 N020220 N020220
003 001 002 004 003 002 005 001
Mar 12, 2004 Sep 20, 2002 Sep 20, 2002 May 10, 1995 May 10, 1995 May 10, 1995 Nov 18, 2008 May 10, 1995
IOTHALAMATE MEGLUMINE
CONRAY
XX + MALLINCKRODT CONRAY 30
XX + MALLINCKRODT CONRAY 43
XX + MALLINCKRODT SOLUTION; INTRAVESICAL
CYSTO-CONRAY II
XX MALLINCKRODT
60% 30% 43%
N013295 N016983 N013295
001
001
002
17.2%
N017057
002
IOTHALAMATE SODIUM I-125

GLOFIL-125
XX ISOTEX
250-300uCi/ML
N017279
001
IOVERSOL
OPTIRAY 240
XX + MALLINCKRODT OPTIRAY 300 XX + MALLINCKRODT
51% 64%
N019710 N019710
002 004
Dec 30, 1988 Jan 22, 1992

IOVERSOL
OPTIRAY 300
+ MALLINCKRODT OPTIRAY 320 + MALLINCKRODT OPTIRAY 350 + MALLINCKRODT +
3 - 232 (of 428)
XX XX XX XX
64% 68% 74% 74%
N020923 N019710 N019710 N020923
004 001 005 003
May 13, 1999 Dec 30, 1988 Jan 22, 1992 May 28, 1998
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM

HEXABRIX
XX + GUERBET
39.3%;19.6%
N018905
002
Jul 26, 1985
IOXILAN
INJECTABLE; INJECTION OXILAN-300 XX GUERBET OXILAN-350 GUERBET XX
62% 73%
N020316 N020316
001 002
Dec 21, 1995 Dec 21, 1995
IPRATROPIUM BROMIDE
ATROVENT HFA
XX + BOEHRINGER INGELHEIM 0.021MG/INH SOLUTION; INHALATION IPRATROPIUM BROMIDE BAUSCH AND LOMB + DEY LANDELA PHARM NEPHRON NOVEX RITEDOSE CORP TEVA PHARMS WATSON LABS
N021527
001
Nov 27, 2004
AN AN AN AN AN AN AN AN
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
A075835 A074755 A077072 A075562 A075441 A075693 A075313 A076291
001 001 001 001 001 001 001 001
Oct Jan Jul Sep Mar Jan Feb May
15, 10, 19, 27, 28, 26, 07, 09,
2001 1997 2005 2001 2001 2001 2000 2005
SPRAY, METERED; NASAL ATROVENT AB + BOEHRINGER INGELHEIM AB + IPRATROPIUM BROMIDE BAUSCH AND LOMB AB AB DEY AB AB NOVEX AB AB ROXANE AB AB
0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY
N020393 N020394 A076025 A076103 A075552 A075553 A076156 A076155 A076664 A076598
001 001 001 001 001 001 001 001 001 001
Oct 20, 1995 Oct 20, 1995 Mar Mar Mar Mar Apr Apr Nov Nov 31, 31, 31, 31, 18, 18, 05, 05, 2003 2003 2003 2003 2003 2003 2003 2003
IRBESARTAN
TABLET; ORAL AVAPRO SANOFI AVENTIS US AB AB AB + IRBESARTAN ALEMBIC PHARMS LTD AB AB AB APOTEX INC AB AB
N020757 N020757 N020757 A091236 A091236 A091236 A200832 A200832
001 002 003 001 002 003 001 002
Sep 30, 1997 Sep 30, 1997 Sep 30, 1997 Oct Oct Oct Oct Oct 15, 15, 15, 15, 15, 2012 2012 2012 2012 2012

IRBESARTAN
TABLET; ORAL IRBESARTAN APOTEX INC AB AUROBINDO PHARMA LTD AB AB AB CIPLA LTD AB AB AB DR REDDYS LABS LTD AB AB AB HETERO LABS LTD V AB AB AB LUPIN LTD AB AB AB MACLEODS PHARMS LTD AB AB AB MYLAN PHARMS INC AB AB AB PRINSTON INC AB AB AB ROXANE AB AB AB SANDOZ AB AB AB TEVA PHARMS AB AB AB WATSON LABS INC AB AB AB ZYDUS PHARMS USA INC AB AB AB
3 - 233 (of 428)
300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG 75MG 150MG 300MG
A200832 A203081 A203081 A203081 A077205 A077205 A077205 A203161 A203161 A203161 A202910 A202910 A202910 A201531 A201531 A201531 A202254 A202254 A202254 A200461 A200461 A200461 A203071 A203071 A203071 A090201 A090201 A090201 A077466 A077466 A077466 A077159 A077159 A077159 A090720 A090720 A090720 A079213 A079213 A079213
003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Oct Sep Sep Sep Nov Nov Nov Sep Sep Sep Sep Sep Sep Oct Oct Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Oct Oct Oct Sep Sep Sep Mar Mar Mar Oct Oct Oct Sep Sep Sep
15, 27, 27, 27, 14, 14, 14, 27, 27, 27, 27, 27, 27, 15, 15, 15, 03, 03, 03, 27, 27, 27, 27, 27, 27, 15, 15, 15, 27, 27, 27, 30, 30, 30, 12, 12, 12, 27, 27, 27,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION CAMPTOSAR + PFIZER INC 40MG/2ML (20MG/ML) + 100MG/5ML (20MG/ML) IRINOTECAN HYDROCHLORIDE ACCORD HLTHCARE 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) ACTAVIS TOTOWA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) AKORN 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) BEDFORD LABS 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) BIONICHE PHARMA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) CIPLA LTD 40MG/2ML (20MG/ML)
N020571 N020571 A079068 A079068 A078589 A078589 A090726 A090726 A078753 A078753 A090393 A090393 A077219
001 002 001 002 001 002 001 002 001 002 002 003 001
Jun 14, 1996 Jun 14, 1996 Nov Nov Feb Feb Sep Sep Dec Dec May May Feb 21, 21, 27, 27, 16, 16, 24, 24, 13, 13, 20, 2008 2008 2008 2008 2009 2009 2008 2008 2011 2011 2008

INJECTABLE; INJECTION IRINOTECAN HYDROCHLORIDE CIPLA LTD 100MG/5ML (20MG/ML) DR REDDYS LABS LTD 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) EBEWE PHARMA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) EMCURE PHARMS LTD 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) FRESENIUS KABI ONCOL 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) FRESENIUS KABI USA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) HIKMA FARMACEUTICA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) HISUN PHARM HANGZHOU 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) HOSPIRA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) 500MG/25ML (20MG/ML) + JIANGSU HENGRUI MED 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) PLIVA LACHEMA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) SUN PHARMA GLOBAL 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) TEVA PARENTERAL 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) 500MG/25ML (20MG/ML) CAMPTOSAR + PFIZER INC 300MG/15ML (20MG/ML)
3 - 234 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX
A077219 A078953 A078953 A090137 A090137 A200771 A200771 A078188 A078188 A077776 A077776 A091032 A091032 A090016 A090016 A077915 A077915 A078796 A090675 A090675 A078122 A078122 A078805 A078805 A090101 A090101 A090101 N020571
002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001 002 001 002 002 003 001 003
Feb Apr Apr Nov Nov Feb Feb Feb Feb Feb Feb Dec Dec Jan Jan Feb Feb Feb Dec Dec Oct Oct Apr Apr Feb Feb Nov
20, 15, 15, 12, 12, 14, 14, 27, 27, 27, 27, 20, 20, 28, 28, 27, 27, 27, 16, 16, 31, 31, 21, 21, 27, 27, 26,
2008 2010 2010 2009 2009 2012 2012 2008 2008 2008 2008 2010 2010 2009 2009 2008 2008 2008 2011 2011 2008 2008 2008 2008 2008 2008 2008
Aug 05, 2010
IRON DEXTRAN
INJECTABLE; INJECTION DEXFERRUM BP LUITPOLD INFED BP + WATSON LABS (UTAH) PROFERDEX BP NEW RIVER
EQ 50MG IRON/ML EQ 50MG IRON/ML EQ 50MG IRON/ML
N040024 N017441 N017807
001 001 001
Feb 23, 1996
IRON SUCROSE
INJECTABLE; INTRAVENOUS VENOFER LUITPOLD XX XX + XX
EQ 50MG BASE/2.5ML (EQ 20MG BASE/ML) EQ 100MG BASE/5ML (EQ 20MG BASE/ML) EQ 200MG BASE/10ML (EQ 20MG BASE/ML)
N021135 N021135 N021135
002 001 004
Mar 20, 2005 Nov 06, 2000 Feb 09, 2007
ISOCARBOXAZID
TABLET; ORAL MARPLAN XX + VALIDUS PHARMS INC
10MG
N011961
001
ISOFLURANE
LIQUID; INHALATION FORANE AN + BAXTER HLTHCARE ISOFLURANE HALOCARBON PRODS AN HOSPIRA AN
99.9% 99.9% 99.9%
N017624 A075225 A074097
001 001 001 Oct 20, 1999 Jan 25, 1993

ISOFLURANE
LIQUID; INHALATION ISOFLURANE PIRAMAL CRITICAL AN RHODIA AN
3 - 235 (of 428)
99.9% 99.9%
A074416 A074502
001 001
Sep 30, 1994 Jun 27, 1995
ISONIAZID
ISONIAZID
XX + SANDOZ SYRUP; ORAL
ISONIAZID
XX + CAROLINA MEDCL TABLET; ORAL ISONIAZID BARR AA AA MIKART AA AA AA + SANDOZ AA + WATSON LABS AA WEST WARD AA AA
100MG/ML
A040648
001
Jul 05, 2005
50MG/5ML
A088235
001
Nov 10, 1983
A080936 A080937 A040090 A040090 N008678 N008678 A080521 A080212 A087425
001 002 001 002 002 003 001 001 001
Jun 26, 1997 Jun 26, 1997
ISONIAZID; PYRAZINAMIDE; RIFAMPIN

TABLET; ORAL
RIFATER
50MG;300MG;120MG
N050705
001
May 31, 1994
ISONIAZID; RIFAMPIN
CAPSULE; ORAL RIFAMATE AB + SANOFI AVENTIS US RIFAMPIN AND ISONIAZID WESTWARD AB
150MG;300MG 150MG;300MG
A061884 A065221
001 001 Jul 29, 2005
ISOPROTERENOL HYDROCHLORIDE
INJECTABLE; INJECTION ISOPROTERENOL HYDROCHLORIDE INTL MEDICATION AP 0.2MG/ML ISUPREL AP + HOSPIRA 0.2MG/ML
A083724 N010515
001 001
ISOSORBIDE DINITRATE
CAPSULE, EXTENDED RELEASE; ORAL
DILATRATE-SR
XX + SCHWARZ PHARMA 40MG TABLET; ORAL ISORDIL VALEANT INTL AB AB AB AB + ISOSORBIDE DINITRATE PAR PHARM AB AB AB AB SANDOZ AB AB AB
N019790
001
Sep 02, 1988
N012093 N012093 N012093 N012093 A086923 A086925 A087537 A087946 A086221 A086223 A089367
007 002 006 005 001 001 001 001 001 001 001
Jul Jul Jul Jul Mar Mar Oct Jan Jan Jan Apr
29, 29, 29, 29, 12, 12, 02, 12, 07, 07, 07,
1988 1988 1988 1988 1987 1987 1987 1988 1988 1988 1988

TABLET; ORAL ISOSORBIDE DINITRATE WATSON LABS AB AB WEST WARD AB AB AB AB ISORDIL XX + VALEANT INTL TABLET; SUBLINGUAL ISOSORBIDE DINITRATE WATSON LABS AB AB + WEST WARD AB AB TABLET, EXTENDED RELEASE; ISOSORBIDE DINITRATE AB + CARACO COREPHARMA AB
3 - 236 (of 428)
A086034 A086032 A086067 A086066 A088088 A040591 N012093
001 001 001 001 001 001 001
Jan Jan Oct Oct Nov Jan
06, 07, 29, 29, 02, 10,
1988 1988 1987 1987 1987 2007
Jul 29, 1988
2.5MG 5MG 2.5MG 5MG ORAL 40MG 40MG
A086033 A086031 A086054 A086055
001 001 001 001
Feb Sep Oct Nov
26, 29, 29, 02,
1988 1987 1987 1987
A040009 A040723
001 001
Dec 30, 1998 Mar 17, 2008
ISOSORBIDE MONONITRATE
TABLET; ORAL ISOSORBIDE MONONITRATE ACTAVIS ELIZABETH AB AB TEVA AB WEST WARD AB MONOKET KREMERS URBAN PHARMS AB AB + TABLET, EXTENDED RELEASE; ISOSORBIDE MONONITRATE ACTAVIS ELIZABETH AB AB DEXCEL LTD AB KREMERS URBAN PHARMS AB AB AB + NESHER PHARMS AB AB AB TORRENT PHARMS AB AB AB VINTAGE PHARMS AB AB AB WEST WARD AB AB
10MG 20MG 20MG 20MG 10MG 20MG ORAL 30MG 60MG 60MG 30MG 60MG 120MG 30MG 60MG 120MG 30MG 60MG 120MG 30MG 60MG 120MG 30MG 60MG
A075037 A075037 A075147 A075361 N020215 N020215
002 001 001 001 002 001
Oct Oct Nov Oct
30, 30, 27, 05,
1998 1998 1998 2000
Jun 30, 1993 Jun 30, 1993
001 002 001 002 001 003 001 002 003 001 001 002 001 002 003 002 001
Dec Dec Apr Jan Oct Aug Mar Mar Mar Jun Jun Jun Aug Aug Aug Mar Jan
31, 31, 17, 13, 30, 04, 16, 16, 16, 03, 03, 03, 11, 11, 11, 30, 07,
1998 1998 2000 2000 1998 2000 2000 2000 2000 2011 2011 2011 2010 2010 2010 2006 2005
ISOSULFAN BLUE
INJECTABLE; INJECTION ISOSULFAN BLUE MYLAN INSTITUTIONAL AP LYMPHAZURIN AP + COVIDIEN
1% 1%
A090874 N018310
001 001
Jul 20, 2010

ISOTRETINOIN
CAPSULE; ORAL AMNESTEEM MYLAN + + CLARAVIS BARR
3 - 237 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB BX BX BX BX
001 002 003 001 002 003 001 001 002 003 001 002 001 003 001 002 003 004
Nov 08, 2002 Nov 08, 2002 Nov 08, 2002 Apr Apr May Apr 11, 11, 11, 11, 2003 2003 2006 2003
MYORISAN DOUGLAS PHARMS
Jan 19, 2012 Jan 19, 2012 Jan 19, 2012 Dec Dec Jun Dec May May May May 24, 24, 20, 24, 25, 25, 25, 25, 2002 2002 2003 2002 2012 2012 2012 2012
SOTRET RANBAXY
ABSORICA CIPHER
ISRADIPINE
CAPSULE; ORAL ISRADIPINE MIKAH PHARMA AB AB WATSON LABS AB AB + TABLET, EXTENDED RELEASE; DYNACIRC CR GLAXOSMITHKLINE LLC XX XX +
2.5MG 5MG 2.5MG 5MG ORAL 5MG 10MG
A077169 A077169 A077317 A077317
001 002 001 002
Apr Apr Jan Jan
24, 24, 05, 05,
2006 2006 2006 2006
N020336 N020336
001 002
Jun 01, 1994 Jun 01, 1994
ITRACONAZOLE
CAPSULE; ORAL ITRACONAZOLE MYLAN PHARMS INC AB SANDOZ AB SPORANOX AB + JANSSEN PHARMS SOLUTION; ORAL SPORANOX XX + JANSSEN PHARMS TABLET; ORAL
ONMEL
XX + MERZ PHARMS
100MG 100MG 100MG
A200463 A076104 N020083
001 001 001
Jul 20, 2012 May 28, 2004 Sep 11, 1992
10MG/ML
N020657
001
Feb 21, 1997
200MG
N022484
001
Apr 29, 2010
IVACAFTOR
TABLET; ORAL
KALYDECO
XX + VERTEX PHARMS
150MG
N203188
001
Jan 31, 2012
IVERMECTIN
LOTION; TOPICAL
SKLICE
XX + SANOFI PASTEUR INC
0.5%
N202736
001
Feb 07, 2012

IVERMECTIN
TABLET; ORAL
STROMECTOL
3 - 238 (of 428)
3MG
N050742
002
Oct 08, 1998
IXABEPILONE
IXEMPRA KIT
XX + BRISTOL MYERS SQUIBB 15MG/VIAL XX + 45MG/VIAL
N022065 N022065
001 002
Oct 16, 2007 Oct 16, 2007
KANAMYCIN SULFATE
INJECTABLE; INJECTION KANAMYCIN SULFATE XX FRESENIUS KABI USA XX +
EQ 500MG BASE/2ML EQ 1GM BASE/3ML
A065111 A065111
001 002
Dec 17, 2002 Dec 17, 2002
KETAMINE HYDROCHLORIDE
INJECTABLE; INJECTION KETALAR + JHP PHARMS + + KETAMINE HYDROCHLORIDE BEDFORD BIONICHE PHARMA
AP AP AP AP AP AP AP AP AP AP
EQ 10MG BASE/ML EQ 50MG BASE/ML EQ 100MG BASE/ML EQ EQ EQ EQ EQ EQ EQ 50MG BASE/ML 100MG BASE/ML 10MG BASE/ML 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML
N016812 N016812 N016812 A074524 A074524 A076092 A076092 A076092 A074549 A074549
001 002 003 001 002 001 002 003 001 002 Mar Mar Sep Dec Oct Jun Jun 22, 22, 30, 28, 25, 27, 27, 1996 1996 2008 2001 2002 1996 1996
HOSPIRA
KETOCONAZOLE
AEROSOL, FOAM; TOPICAL EXTINA AT + STIEFEL LABS INC KETOCONAZOLE PERRIGO ISRAEL AT CREAM; TOPICAL KETOCONAZOLE FOUGERA PHARMS AB AB + TEVA KETOZOLE TARO AB GEL; TOPICAL XOLEGEL + AQUA PHARMS SHAMPOO; TOPICAL KETOCONAZOLE PERRIGO NEW YORK TOLMAR NIZORAL + JANSSEN PHARMS TABLET; ORAL KETOCONAZOLE APOTEX MUTUAL PHARMA MYLAN PLIVA TARO TEVA
2% 2%
N021738 A091550
001 001
Jun 12, 2007 Aug 25, 2011
2% 2% 2%
A076294 A075581 A075638
001 001 001
Apr 28, 2004 Apr 25, 2000 Dec 18, 2002
XX
2%
N021946
001
Jul 28, 2006
AB AB AB
2% 2% 2%
A076419 A076942 N019927
001 001 001
Jan 07, 2004 Apr 11, 2005 Aug 31, 1990
AB AB AB AB AB AB
200MG 200MG 200MG 200MG 200MG 200MG
A075912 A075314 A075597 A075362 A075319 A075273
001 001 001 001 001 001
Jan Jun Dec Jun Jun Jun
10, 15, 23, 15, 15, 15,
2002 1999 1999 1999 1999 1999

KETOCONAZOLE
TABLET; ORAL NIZORAL AB + ORTHO MCNEIL JANSSEN
3 - 239 (of 428)
200MG
N018533
001
KETOPROFEN
CAPSULE; ORAL KETOPROFEN DORADO PHARMA AB 50MG AB 75MG MYLAN AB 50MG AB 75MG TEVA AB 50MG AB + 75MG KETOPROFEN DORADO PHARMA 25MG XX CAPSULE, EXTENDED RELEASE; ORAL KETOPROFEN MYLAN AB 100MG AB 150MG AB + 200MG WATSON LABS FLORIDA AB 100MG AB 150MG AB 200MG
A074014 A074014 A074035 A074035 A073516 A073517 A074014
002 003 002 003 001 001 001
Jan Jan Dec Dec Dec Dec
29, 29, 31, 31, 22, 22,
1993 1993 1996 1996 1992 1992
Jan 29, 1993
A075679 A075679 A075679 A075270 A075270 A075270
003 002 001 002 003 001
Feb Feb Feb Mar Mar Mar
20, 20, 20, 24, 24, 24,
2002 2002 2002 1999 1999 1999
KETOROLAC TROMETHAMINE
INJECTABLE; INJECTION KETOROLAC TROMETHAMINE + BEDFORD + + CLARIS LIFESCIENCES FRESENIUS KABI USA HIKMA MAPLE
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
HOSPIRA
LUITPOLD PFIZER SANDOZ SUN PHARMA GLOBAL WOCKHARDT
15MG/ML 30MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 15MG/ML 30MG/ML 30MG/ML 15MG/ML 15MG/ML 30MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 30MG/ML
001 002 001 002 001 001 002 001 001 002 002 001 001 002 002 001 002 001 002 001 002 001 002 001 002 001
Apr Apr Apr Jun Jun Jan Jan Nov Jul Nov Jul Jun Jan Jun Jan Jan Jan Jul Jul Oct Oct Oct Oct Mar Mar Mar
26, 26, 26, 29, 29, 11, 11, 03, 21, 03, 21, 05, 27, 05, 27, 14, 14, 16, 16, 06, 06, 06, 06, 27, 27, 27,
1999 1999 1999 2001 2001 2002 2002 1999 2004 1999 2004 1997 1999 1997 1999 2008 2008 2007 2007 2004 2004 2008 2008 2007 2007 2007
SOLUTION/DROPS; OPHTHALMIC ACULAR AT + ALLERGAN 0.5% ACULAR LS AT + ALLERGAN 0.4% KETOROLAC TROMETHAMINE AKORN AT 0.4%
N019700 N021528 A078399
001 001 001
Nov 09, 1992 May 30, 2003 Nov 05, 2009

SOLUTION/DROPS; OPHTHALMIC KETOROLAC TROMETHAMINE AKORN 0.5% ALCON PHARMS LTD 0.4% 0.5% APOTEX INC 0.4% 0.5% SUN PHARMA GLOBAL 0.5% ACULAR PRESERVATIVE FREE + ALLERGAN 0.5% ACUVAIL + ALLERGAN 0.45% SPRAY, METERED; NASAL
SPRIX
+ LUITPOLD TABLET; ORAL KETOROLAC TROMETHAMINE + MYLAN PLIVA TEVA
3 - 240 (of 428)
AT AT AT AT AT AT XX XX
A078434 A078721 A076583 A077308 A076109 A090017 N020811 N022427
001 001 001 001 001 001 001 001
05, 05, 05, 05, 05, 05,
2009 2009 2009 2009 2009 2009
Nov 03, 1997 Jul 22, 2009
XX
15.75MG/SPRAY
N022382
001
May 14, 2010
AB AB AB
10MG 10MG 10MG
A074761 A075284 A074754
001 001 001
May 16, 1997 Jun 23, 1999 May 16, 1997
LABETALOL HYDROCHLORIDE
INJECTABLE; INJECTION LABETALOL HYDROCHLORIDE BEDFORD CLARIS LIFESCIENCES GLAND PHARMA LTD + HOSPIRA + TAYLOR LABETALOL HYDROCLORIDE SAGENT STRIDES
A075303 A076051 A090699 A075239 A075240 A075431 A075524 A079134
001 001 001 001 001 001 001 001
May Jul Apr Nov Nov Nov Nov
28, 05, 03, 29, 29, 29, 29,
1999 2002 2012 1999 1999 1999 1999
5MG/ML TABLET; ORAL LABETALOL HYDROCHLORIDE IVAX SUB TEVA PHARMS 100MG AB AB 200MG AB 300MG PAR FORM AB 100MG AB 200MG AB 300MG SANDOZ AB 100MG AB 200MG AB 300MG WATSON LABS AB 100MG AB 200MG AB 300MG TRANDATE PROMETHEUS LABS AB 100MG AB + 200MG
Feb 03, 2010
A074787 A074787 A074787 A200908 A200908 A200908 A075113 A075113 A075113 A075133 A075133 A075133 N018716 N018716
001 002 003 001 002 003 001 002 003 001 002 003 001 002
Aug Aug Aug Jul Jul Jul Aug Aug Aug Aug Aug Aug
03, 03, 03, 10, 10, 10, 04, 04, 04, 03, 03, 03,
1998 1998 1998 2012 2012 2012 1998 1998 1998 1998 1998 1998
May 24, 1985 Aug 01, 1984
LACOSAMIDE
VIMPAT
XX + UCB INC SOLUTION; ORAL
VIMPAT
XX + UCB INC
200MG/20ML (10MG/ML)
N022254
001
Oct 28, 2008
10MG/ML
N022255
001
Apr 20, 2010

LACOSAMIDE
TABLET; ORAL VIMPAT XX UCB INC XX XX XX +
3 - 241 (of 428)
50MG 100MG 150MG 200MG
N022253 N022253 N022253 N022253
001 002 003 004
Oct Oct Oct Oct
28, 28, 28, 28,
2008 2008 2008 2008
LACTULOSE
FOR SOLUTION; ORAL LACTULOSE XX + CUMBERLAND PHARMS XX + SOLUTION; ORAL CONSTILAC ALRA CONSTULOSE + ACTAVIS MID ATLANTIC LACTULOSE ANI PHARMS FRESENIUS KABI HI TECH PHARMA MORTON GROVE NOVEX PHARM ASSOC ROXANE VINTAGE PHARMS VISTAPHARM SOLUTION; ORAL, RECTAL CHOLAC ALRA ENULOSE + ACTAVIS MID ATLANTIC GENERLAC MORTON GROVE PHARMS LACTULOSE ANI PHARMS FRESENIUS KABI HI TECH PHARMA NOVEX
10GM/PACKET 20GM/PACKET
A074712 A074712
001 002
Dec 10, 1997 Dec 10, 1997
AA AA AA AA AA AA AA AA AA AA AA
10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML
A071054 A070288 A078430 A090503 A074076 A074602 A075911 A074623 A073591 A075993 A074138
001 001 001 001 001 001 001 001 001 001 001
Jul 26, 1988 Aug 15, 1988 Nov Jan Jul Nov Feb Jul May Jul Sep 28, 25, 03, 14, 21, 30, 29, 26, 30, 2007 2012 1995 1996 2002 1996 1992 2001 1992
10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML
A071331 A071548 A074603 A090426 A090502 A074077 A076645
001 001 001 001 001 001 001
Jul 26, 1988 Aug 15, 1988 Oct 31, 1996 Nov Jan Jul Jul 21, 25, 03, 28, 2008 2012 1995 2003
LAMIVUDINE
SOLUTION; ORAL EPIVIR + VIIV HLTHCARE EPIVIR-HBV + GLAXOSMITHKLINE TABLET; ORAL EPIVIR VIIV HLTHCARE + LAMIVUDINE APOTEX AUROBINDO PHARMA LTD EPIVIR-HBV + GLAXOSMITHKLINE
XX XX
10MG/ML 5MG/ML
N020596 N021004
001 001
Nov 17, 1995 Dec 08, 1998
150MG 300MG 150MG 300MG 150MG 300MG 100MG
N020564 N020564 A091606 A091606 A202032 A202032 N021003
001 003 001 002 001 002 001
Nov 17, 1995 Jun 24, 2002 Dec Dec Nov Nov 02, 02, 17, 17, 2011 2011 2011 2011
Dec 08, 1998

LAMIVUDINE; ZIDOVUDINE
TABLET; ORAL COMBIVIR + VIIV HLTHCARE 150MG;300MG LAMIVUDINE AND ZIDOVUDINE AUROBINDO PHARMA LTD 150MG;300MG LUPIN LTD 150MG;300MG TEVA PHARMS 150MG;300MG
3 - 242 (of 428)
AB AB AB AB
N020857 A202418 A090246 A079081
001 001 001 001
Sep 26, 1997 May 15, 2012 May 15, 2012 May 25, 2011
LAMOTRIGINE
TABLET; ORAL LAMICTAL AB + GLAXOSMITHKLINE AB AB AB LAMOTRIGINE ACTAVIS TOTOWA AB AB AB AB ALEMBIC PHARMS LTD AB AB AB AB APOTEX INC AB AB AB AB AUROBINDO PHARMA AB AB AB AB CADISTA PHARMS AB AB AB AB DR REDDYS LABS LTD AB AB AB AB GLENMARK GENERICS AB AB AB AB HIKMA PHARMS AB AB AB AB LUPIN LTD AB AB AB AB MYLAN AB AB AB AB SANDOZ AB AB AB AB
25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG
N020241 N020241 N020241 N020241 A078669 A078669 A078669 A078669 A090607 A090607 A090607 A090607 A078625 A078625 A078625 A078625 A078956 A078956 A078956 A078956 A079132 A079132 A079132 A079132 A076708 A076708 A076708 A076708 A090169 A090169 A090169 A090169 A078134 A078134 A078134 A078134 A078691 A078691 A078691 A078691 A077420 A077420 A077420 A077420 A078645 A078645 A078645 A078645
005 001 002 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Dec Dec Dec Dec Apr Apr Apr Apr Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan May May May May Apr Apr Apr Apr Jun Jun Jun Jun Jan Jan Jan Jan Jan Jan Jan Jan
27, 27, 27, 27, 08, 08, 08, 08, 13, 13, 13, 13, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 12, 12, 12, 12, 19, 19, 19, 19, 01, 01, 01, 01, 27, 27, 27, 27, 27, 27, 27, 27,
1994 1994 1994 1994 2011 2011 2011 2011 2011 2011 2011 2011 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2012 2012 2012 2012 2011 2011 2011 2011 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009 2009 2009

LAMOTRIGINE
TABLET; ORAL LAMOTRIGINE TARO PHARM INDS AB AB AB AB TEVA AB AB AB AB TORRENT PHARMS AB AB AB AB UNICHEM LABS LTD AB AB AB AB WATSON LABS AB AB AB AB ZYDUS PHARMS USA AB AB AB AB LAMOTRIGINE BX UPSHER SMITH BX BX BX LAMOTRIGINE ZYDUS PHARMS USA XX XX TABLET, CHEWABLE; ORAL LAMICTAL CD GLAXOSMITHKLINE AB AB AB + LAMOTRIGINE AUROBINDO PHARMA AB AB DR REDDYS LABS LTD AB AB GLENMARK GENERICS AB AB JUBILANT LIFE AB AB MYLAN AB AB TARO AB AB TEVA AB AB WATSON LABS AB AB AB ZYDUS PHARMS USA INC AB AB
3 - 243 (of 428)
A078525 A078525 A078525 A078525 A076388 A076388 A076388 A076388 A078947 A078947 A078947 A078947 A090170 A090170 A090170 A090170 A077783 A077783 A077783 A077783 A077633 A077633 A077633 A077633 A078310 A078310 A078310 A078310 A077633 A077633
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 003 004 005 001 002 003 004 002 006
Jan Jan Jan Jan Aug Aug Aug Aug Jan Jan Jan Jan Oct Oct Oct Oct Nov Nov Nov Nov Jan Jan Jan Jan Feb Feb Feb Feb
27, 27, 27, 27, 30, 30, 30, 30, 27, 27, 27, 27, 06, 06, 06, 06, 01, 01, 01, 01, 27, 27, 27, 27, 04, 04, 04, 04,
2009 2009 2009 2009 2006 2006 2006 2006 2009 2009 2009 2009 2011 2011 2011 2011 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009 2009 2009
Jan 27, 2009 Jan 27, 2009
N020764 N020764 N020764 A090401 A090401 A076701 A076701 A079099 A079099 A200220 A200220 A076630 A076630 A079204 A079204 A076420 A076420 A076928 A076928 A076928 A078009 A078009
004 001 002 002 003 001 002 001 002 001 002 001 002 001 002 001 002 001 002 003 002 003
Sep 08, 2000 Aug 24, 1998 Aug 24, 1998 Nov Nov Jan Jan Feb Feb Feb Feb Jan Jan Feb Feb Jun Jun Jan Jan Jan Jan Jan 04, 04, 22, 22, 19, 19, 28, 28, 22, 22, 04, 04, 21, 21, 22, 22, 22, 22, 22, 2009 2009 2009 2009 2009 2009 2011 2011 2009 2009 2009 2009 2006 2006 2009 2009 2009 2009 2009

LAMOTRIGINE
TABLET, EXTENDED RELEASE; ORAL LAMICTAL XR SMITHKLINE BEECHAM AB 25MG AB + 50MG AB 100MG AB 200MG AB 250MG AB 300MG LAMOTRIGINE ANCHEN PHARMS AB 25MG AB 50MG AB 100MG AB 200MG AB 250MG AB 300MG WOCKHARDT LTD AB 25MG AB 50MG AB 100MG AB 200MG AB 300MG TABLET, ORALLY DISINTEGRATING; ORAL LAMICTAL ODT SMITHKLINE BEECHAM 25MG XX 50MG XX + 100MG XX 200MG XX
3 - 244 (of 428)
N022115 N022115 N022115 N022115 N022115 N022115 A201374 A201374 A201374 A201374 A201374 A201374 A202498 A202498 A202498 A202498 A202498
001 002 003 004 006 005 001 002 003 004 005 006 001 002 003 004 005
May May May May Jun Apr Dec Dec Dec Dec Dec Dec Jan Jan Jan Jan Jan
29, 29, 29, 29, 21, 14, 26, 26, 26, 26, 26, 26, 04, 04, 04, 04, 04,
2009 2009 2009 2009 2011 2010 2012 2012 2012 2012 2012 2012 2013 2013 2013 2013 2013
N022251 N022251 N022251 N022251
001 002 003 004
May May May May
08, 08, 08, 08,
2009 2009 2009 2009
LANREOTIDE ACETATE
SOMATULINE DEPOT
XX + IPSEN PHARMA XX + XX +
N022074 N022074 N022074
001 002 003
Aug 30, 2007 Aug 30, 2007 Aug 30, 2007
LANSOPRAZOLE
CAPSULE, DELAYED REL PELLETS; ORAL LANSOPRAZOLE DR REDDYS LABS LTD 15MG 30MG MYLAN PHARMS INC 15MG 30MG NATCO PHARMA LTD 15MG 30MG SANDOZ 15MG 30MG TEVA PHARMS 15MG 30MG WOCKHARDT USA 15MG 30MG PREVACID TAKEDA PHARMS USA 15MG + 30MG TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING; ORAL PREVACID TAKEDA PHARMS USA 15MG + 30MG
A091269 A091269 A090763 A090763 A201921 A201921 A090331 A090331 A077255 A077255 A202176 A202176 N020406 N020406
001 002 001 002 001 002 001 002 001 002 001 002 001 002
Oct Oct Nov Nov Dec Dec Apr Apr Nov Nov Sep Sep
15, 15, 10, 10, 18, 18, 23, 23, 10, 10, 14, 14,
2010 2010 2009 2009 2012 2012 2010 2010 2009 2009 2012 2012
May 10, 1995 May 10, 1995
XX XX
N021428 N021428
001 002
Aug 30, 2002 Aug 30, 2002

LANTHANUM CARBONATE
TABLET, CHEWABLE; ORAL FOSRENOL XX SHIRE LLC XX XX +
3 - 245 (of 428)
EQ 500MG BASE EQ 750MG BASE EQ 1GM BASE
N021468 N021468 N021468
002 003 004
Oct 26, 2004 Nov 23, 2005 Nov 23, 2005
LAPATINIB DITOSYLATE
TABLET; ORAL TYKERB XX + SMITHKLINE BEECHAM
EQ 250MG BASE
N022059
001
Mar 13, 2007
LATANOPROST
SOLUTION/DROPS; OPHTHALMIC LATANOPROST AKORN 0.005% ALCON RES 0.005% APOTEX 0.005% BAUSCH AND LOMB 0.005% LUITPOLD 0.005% MYLAN 0.005% XALATAN + PHARMACIA AND UPJOHN 0.005%
A090887 A091449 A077697 A201006 A200925 A201786 N020597
001 001 001 001 001 001 001
Jul Mar Mar Mar Mar Mar
19, 22, 22, 22, 22, 22,
2011 2011 2011 2011 2011 2011
Jun 05, 1996
LEFLUNOMIDE
TABLET; ORAL ARAVA SANOFI AVENTIS US AB AB + LEFLUNOMIDE ALEMBIC PHARMS LTD AB AB APOTEX INC AB AB BARR AB AB HERITAGE PHARMS INC AB AB SANDOZ AB AB TEVA PHARMS AB AB ARAVA XX + SANOFI AVENTIS US
N020905 N020905 A091369 A091369 A077090 A077090 A077083 A077083 A077086 A077086 A077087 A077087 A077084 A077084 N020905
001 002 001 002 001 002 001 002 001 002 001 002 001 002 003
Sep 10, 1998 Sep 10, 1998 Nov Nov Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep 21, 21, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 2011 2011 2005 2005 2005 2005 2005 2005 2005 2005 2005 2005
Sep 10, 1998
LENALIDOMIDE
CAPSULE; ORAL REVLIMID CELGENE XX XX XX XX XX +
2.5MG 5MG 10MG 15MG 25MG
N021880 N021880 N021880 N021880 N021880
005 001 002 003 004
Dec Dec Dec Jun Jun
21, 27, 27, 29, 29,
2011 2005 2005 2006 2006
LEPIRUDIN RECOMBINANT
INJECTABLE; INJECTION REFLUDAN XX + BAYER HLTHCARE
50MG/VIAL
N020807
001
Mar 06, 1998

LETROZOLE
TABLET; ORAL FEMARA + NOVARTIS PHARMS LETROZOLE ACCORD HLTHCARE ACTAVIS TOTOWA APOTEX INC DR REDDYS LABS LTD FRESENIUS KABI ONCOL IMPAX LABS INDICUS PHARMA KUDCO IRELAND MYLAN NATCO PHARMA LTD ROXANE SUN PHARM INDS LTD TEVA PHARMS VINTAGE PHARMS LLC
3 - 246 (of 428)
2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG
N020726 A090934 A090292 A091303 A091191 A090491 A091638 A201804 A091098 A078190 A200161 A090838 A091466 A090289 A090789
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul 25, 1997 Jun Jul Apr Jun Jun Jun Jun Jun Dec Jun Jun Jun Jun Jun 03, 13, 19, 03, 03, 03, 03, 03, 24, 03, 03, 03, 03, 03, 2011 2011 2012 2011 2011 2011 2011 2011 2008 2011 2011 2011 2011 2011
LEUCOVORIN CALCIUM
INJECTABLE; INJECTION LEUCOVORIN CALCIUM AP + BEDFORD EQ 50MG BASE/VIAL AP + EQ 100MG BASE/VIAL TEVA PARENTERAL AP EQ 100MG BASE/VIAL AP EQ 350MG BASE/VIAL LEUCOVORIN CALCIUM PRESERVATIVE FREE AP + BEDFORD EQ 200MG BASE/VIAL AP + EQ 350MG BASE/VIAL FRESENIUS KABI USA AP EQ 200MG BASE/VIAL LUITPOLD AP EQ 50MG BASE/VIAL SAGENT PHARMS AP EQ 50MG BASE/VIAL AP EQ 100MG BASE/VIAL AP EQ 200MG BASE/VIAL AP EQ 350MG BASE/VIAL LEUCOVORIN CALCIUM PRESERVATIVE FREE EQ 10MG BASE/ML XX + BEDFORD EQ 500MG BASE/VIAL XX + FRESENIUS KABI USA TABLET; ORAL LEUCOVORIN CALCIUM BARR AB EQ 5MG BASE AB EQ 25MG BASE ROXANE AB EQ 5MG BASE AB EQ 15MG BASE AB + EQ 25MG BASE LEUCOVORIN CALCIUM ROXANE EQ 10MG BASE XX
A089384 A089717 A081277 A040174 A040056 A040335 A040258 A040338 A200753 A200753 A200753 A200855 A040347 A040286
001 001 001 001 001 001 001 001 001 002 003 001 001 001
Sep Mar Sep Jun May Apr Feb Jan Sep Sep Sep Sep
14, 28, 28, 12, 23, 20, 26, 31, 06, 06, 06, 06,
1987 1988 1993 1997 1995 2000 1999 2001 2012 2012 2012 2012
Apr 25, 2000 Feb 26, 1999
A071198 A071199 A072733 A072735 A072736 A072734
001 001 001 001 001 001
Sep Sep Feb Feb Feb
24, 24, 22, 22, 22,
1987 1987 1993 1993 1993
Feb 22, 1993
LEUPROLIDE ACETATE
INJECTABLE; INJECTION LEUPROLIDE ACETATE + SANDOZ SUN PHARMA GLOBAL TEVA PARENTERAL LUPRON DEPOT + ABBOTT ENDOCRINE + + + +
AP AP AP XX XX XX XX XX
1MG/0.2ML 1MG/0.2ML 1MG/0.2ML 3.75MG/VIAL 7.5MG/VIAL 11.25MG/VIAL 22.5MG/VIAL 30MG/VIAL
A074728 A078885 A075471 N020011 N019732 N020708 N020517 N020517
001 001 001 001 001 001 001 002
Aug 04, 1998 Mar 09, 2009 Oct 25, 2000 Oct Jan Mar Dec May 22, 26, 07, 22, 30, 1990 1989 1997 1995 1997

LEUPROLIDE ACETATE
INJECTABLE; INJECTION LUPRON DEPOT ABBOTT ENDOCRINE LUPRON DEPOT-PED + ABBOTT ENDOCRINE + + + + INJECTABLE; SUBCUTANEOUS
ELIGARD
+ TOLMAR THERAP + + +
3 - 247 (of 428)
XX XX XX XX XX XX
45MG/VIAL 7.5MG/VIAL 11.25MG/VIAL 11.25MG/VIAL 15MG/VIAL 30MG/VIAL
N020517 N020263 N020263 N020263 N020263 N020263
003 002 005 007 006 008
Jun 17, 2011 Apr Jan Aug Jan Aug 16, 21, 15, 21, 15, 1993 1994 2011 1994 2011
XX XX XX XX
7.5MG/VIAL 22.5MG/VIAL 30MG/VIAL 45MG/VIAL
N021343 N021379 N021488 N021731
001 001 001 001
Jan Jul Feb Dec
23, 24, 13, 14,
2002 2002 2003 2004
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE

INJECTABLE, TABLET; INJECTION, ORAL LUPANETA PACK ABBVIE ENDOCRINE 3.75MG/VIAL,N/A;N/A,5MG XX 11.25MG/VIAL,N/A;N/A,5MG XX +
N203696 N203696
001 002
Dec 14, 2012 Dec 14, 2012
LEVALBUTEROL HYDROCHLORIDE
SOLUTION; INHALATION LEVALBUTEROL HYDROCHLORIDE DEY EQ WATSON LABS INC EQ EQ EQ XOPENEX + SUNOVION EQ + EQ + EQ + EQ
AN AN AN AN AN AN AN AN
0.25% BASE 0.0103% BASE 0.021% BASE 0.042% BASE 0.0103% BASE 0.021% BASE 0.042% BASE 0.25% BASE
A078309 A077756 A077756 A077756 N020837 N020837 N020837 N020837
001 003 001 002 003 001 002 004
Mar Apr Apr Apr Jan Mar Mar Jul
20, 09, 09, 09, 30, 25, 25, 18,
2009 2008 2008 2008 2002 1999 1999 2003
LEVALBUTEROL TARTRATE
XOPENEX HFA
EQ 0.045MG BASE/INH XX + SUNOVION
N021730
001
Mar 11, 2005
LEVETIRACETAM
INJECTABLE; IV (INFUSION) KEPPRA + UCB INC LEVETIRACETAM FRESENIUS KABI USA HIKMA FARMACEUTICA HOSPIRA INC LUITPOLD SUN PHARM INDS LTD X GEN PHARMS LEVETIRACETAM IN SODIUM + HQ SPECIALITY PHARMA + +
AP AP AP AP AP AP AP XX XX XX
500MG/5ML (100MG/ML) 500MG/5ML (100MG/ML) 500MG/5ML(100MG/ML) 500MG/ML (100MG/ML) 500MG/5ML (100MG/ML) 500MG/5ML (100MG/ML) 500MG/5ML (100MG/ML) CHLORIDE 500MG/100ML (5MG/ML) 1000MG/100ML (10MG/ML) 1500MG/100ML (15MG/ML)
N021872 A090813 A090981 A202869 A202143 A090754 A091485 N202543 N202543 N202543
001 001 001 001 001 001 001 001 002 003
Jul 31, 2006 May Oct Apr Jan Jun Aug 26, 13, 06, 31, 16, 05, 2010 2011 2012 2012 2010 2011
Nov 09, 2011 Nov 09, 2011 Nov 09, 2011
SOLUTION; ORAL KEPPRA AA + UCB INC LEVETIRACETAM ACTAVIS MID ATLANTIC AA AMNEAL PHARMS AA
N021505 A078976 A090992
001 001 001
Jul 15, 2003 Jan 15, 2009 Oct 27, 2009

LEVETIRACETAM
SOLUTION; ORAL LEVETIRACETAM APOTEX AUROBINDO PHARM CYPRESS PHARM HI-TECH PHARMACAL LUPIN LTD ROXANE SILARX TARO TOLMAR TRIS PHARMA INC VINTAGE PHARMS WOCKHARDT TABLET; ORAL KEPPRA UCB INC
3 - 248 (of 428)
AA AA AA AA AA AA AA AA AA AA AA AA
100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML
A090187 A079063 A079120 A090601 A090893 A078582 A090263 A078774 A079107 A090461 A090079 A090028
001 001 001 001 001 001 001 001 001 001 001 001
Aug Jan Jan Feb Oct Jan Apr Feb Jan Sep Apr Mar
05, 15, 16, 28, 17, 15, 03, 10, 15, 30, 11, 03,
2011 2009 2009 2012 2011 2009 2009 2009 2009 2010 2012 2010
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
+ LEVETIRACETAM ACCORD HLTHCARE
250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 500MG 250MG 500MG 750MG 1GM
N021035 N021035 N021035 N021035 A090843 A090843 A090843 A090843 A201293 A201293 A201293 A201293 A078869 A078869 A078869 A078869 A078993 A078993 A078993 A078993 A077319 A077319 A077319 A090511 A090511 A090511 A090511 A076920 A076920 A076920 A078904 A090515 A090515 A090515 A090515 A078234 A078234 A078234 A090906 A078154 A078154 A078154 A090025
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 001 001 002 003 004 001 002 003 001 001 002 003 001
Nov Nov Nov Jan Feb Feb Feb Feb Jun Jun Jun Jun Mar Mar Mar Mar Jan Jan Jan Jan Mar Mar Mar Aug Aug Aug Aug Jan Jan Jan Jan Oct Oct Oct Oct Jan Jan Jan Nov Jan Jan Jan Jan
30, 30, 30, 06, 14, 14, 14, 14, 14, 14, 14, 14, 13, 13, 13, 13, 15, 15, 15, 15, 20, 20, 20, 18, 18, 18, 18, 15, 15, 15, 15, 08, 08, 08, 08, 15, 15, 15, 05, 15, 15, 15, 15,
1999 1999 1999 2006 2011 2011 2011 2011 2011 2011 2011 2011 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2011 2011 2011 2011 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2010 2009 2009 2009 2009
AJANTA PHARMA
APOTEX INC
AUROBINDO PHARMA
BOCA PHARMA
BRECKENRIDGE PHARM
DR REDDYS LABS LTD
HETERO DRUGS LTD
INVAGEN PHARMS
LOTUS PHARM CO LTD LUPIN

LEVETIRACETAM
TABLET; ORAL LEVETIRACETAM METHAPHARM AB AB AB AB MYLAN AB AB AB AB ORCHID HLTHCARE AB AB AB AB ROXANE AB AB AB AB SANDOZ AB AB AB AB SOLCO HLTHCARE AB AB AB AB TARO AB AB AB AB TEVA PHARMS AB AB AB AB TORRENT PHARMS AB AB AB AB VINTAGE PHARMS AB AB AB AB WATSON LABS INC AB AB AB AB WOCKHARDT AB AB AB AB ZYDUS PHARMS USA INC AB AB TABLET, EXTENDED RELEASE; KEPPRA XR UCB INC AB AB + LEVETIRACETAM ACTAVIS ELIZABETH AB AB ANCHEN PHARMS AB
3 - 249 (of 428)
250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 1GM ORAL 500MG 750MG 500MG 750MG 500MG
A090767 A090767 A090767 A090767 A076919 A076919 A076919 A090261 A078526 A078526 A078526 A090484 A078042 A078042 A078042 A078042 A077324 A077324 A077324 A077324 A078106 A078106 A078106 A078106 A078960 A078960 A078960 A078960 A078101 A078101 A078101 A078101 A078858 A078858 A078858 A078858 A091491 A091491 A091491 A091491 A078797 A078797 A078797 A078797 A079042 A079042 A079042 A079042 A078918 A078918
001 002 003 004 001 002 003 001 001 002 003 001 001 002 003 004 001 002 003 004 001 002 003 004 004 003 002 001 001 002 003 004 001 002 003 004 001 002 003 004 002 003 004 001 001 002 003 004 001 002
Jul Jul Jul Jul Nov Nov Nov Dec Jan Jan Jan Aug Jan Jan Jan Jan Jan Jan Jan Jan Feb Feb Feb Feb Feb Feb Feb Feb Jan Jan Jan Jan Jan Jan Jan Jan Dec Dec Dec Dec Jan Jan Jan Jan Jan Jan Jan Jan Apr Apr
28, 28, 28, 28, 04, 04, 04, 08, 15, 15, 15, 05, 15, 15, 15, 15, 15, 15, 15, 15, 10, 10, 10, 10, 01, 01, 01, 01, 15, 15, 15, 15, 15, 15, 15, 15, 14, 14, 14, 14, 15, 15, 15, 15, 15, 15, 15, 15, 29, 29,
2010 2010 2010 2010 2008 2008 2008 2009 2009 2009 2009 2010 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
N022285 N022285 A091557 A091557 A091360
001 002 001 002 001
Sep 12, 2008 Feb 12, 2009 Sep 12, 2011 Sep 12, 2011 Oct 04, 2011

LEVETIRACETAM
TABLET, EXTENDED RELEASE; ORAL LEVETIRACETAM ANCHEN PHARMS 750MG AB APOTEX INC 500MG AB 750MG AB BOCA PHARMA 500MG AB 750MG AB LUPIN LTD 500MG AB 750MG AB MUTUAL PHARM CO INC 500MG AB 750MG AB MYLAN PHARMS INC 500MG AB 750MG AB PAR PHARM 500MG AB 750MG AB ROUSES POINT PHARMS 500MG AB 750MG AB SANDOZ 500MG AB 750MG AB TEVA PHARMS 500MG AB 750MG AB TORRENT PHARMS LTD 500MG AB 750MG AB VINTAGE PHARMS LLC 500MG AB 750MG AB WATSON LABS FLORIDA 500MG AB 750MG AB
3 - 250 (of 428)
002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Oct Sep Sep May May Sep Sep Sep Sep Dec Dec Sep Sep Aug Aug Nov Nov Sep Sep May May Jul Jul Sep Sep
04, 12, 12, 25, 25, 12, 12, 12, 12, 19, 19, 12, 12, 27, 27, 01, 01, 12, 12, 29, 29, 20, 20, 12, 12,
2011 2011 2011 2012 2012 2011 2011 2011 2011 2011 2011 2011 2011 2012 2012 2012 2012 2011 2011 2012 2012 2012 2012 2011 2011
LEVOBUNOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AKBETA AKORN AT 0.25% AT 0.5% BETAGAN AT + ALLERGAN 0.25% AT + 0.5% LEVOBUNOLOL HYDROCHLORIDE BAUSCH AND LOMB 0.25% AT 0.5% AT FALCON PHARMS 0.25% AT 0.5% AT NOVEX 0.25% AT 0.5% AT
A074779 A074780 N019814 N019219 A074307 A074326 A074851 A074850 A075473 A075475
001 001 001 002 001 001 001 001 001 001
Oct 29, 1996 Oct 29, 1996 Jun 28, 1989 Dec 19, 1985 Mar Mar Oct Oct Aug Aug 04, 04, 28, 28, 03, 03, 1994 1994 1996 1996 2000 2000
LEVOCARNITINE
INJECTABLE; INJECTION CARNITOR + SIGMA TAU LEVOCARNITINE BEDFORD LUITPOLD TEVA PARENTERAL SOLUTION; ORAL CARNITOR + SIGMA TAU CARNITOR SF SIGMA TAU LEVOCARNITINE HI TECH PHARMA LYNE
AP AP AP AP
N020182 A075567 A075861 A075881
001 001 001 001
Dec 16, 1992 Mar 29, 2001 Jun 22, 2001 Mar 29, 2001
AA AA AA AA
1GM/10ML 1GM/10ML 1GM/10ML 1GM/10ML
N019257 N019257 A077399 A076851
001 002 001 001
Apr 10, 1986 Mar 28, 2007 Oct 25, 2007 Aug 10, 2004

LEVOCARNITINE
TABLET; ORAL CARNITOR AB + SIGMA TAU LEVOCARNITINE COREPHARMA AB
3 - 251 (of 428)
330MG 330MG
N018948 A076858
001 001
Dec 27, 1985 Sep 20, 2004
LEVOCETIRIZINE DIHYDROCHLORIDE
SOLUTION; ORAL LEVOCETIRIZINE DIHYDROCHLORIDE SYNTHON PHARMS 2.5MG/5ML XYZAL + UCB INC 2.5MG/5ML TABLET; ORAL LEVOCETIRIZINE DIHYDROCHLORIDE DR REDDYS LABS LTD 5MG GLENMARK GENERICS 5MG HETERO LABS LTD III 5MG SYNTHON PHARMS 5MG TEVA PHARMS 5MG XYZAL + UCB INC 5MG
AA AA
A091263 N022157
001 001
Nov 07, 2011 Jan 28, 2008
AB AB AB AB AB AB
A090392 A090385 A091264 A090229 A090199 N022064
001 001 001 001 001 001
Feb Feb Jun Nov Aug
24, 24, 29, 26, 22,
2011 2011 2012 2010 2011
May 25, 2007
LEVOFLOXACIN
INJECTABLE; INJECTION LEVAQUIN + JANSSEN PHARMS EQ 500MG/20ML (EQ 25MG/ML) + EQ 750MG/30ML (EQ 25MG/ML) LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER + JANSSEN PHARMS EQ 250MG/50ML (EQ 5MG/ML) + EQ 500MG/100ML (EQ 5MG/ML) + EQ 750MG/150ML (EQ 5MG/ML) LEVOFLOXACIN AKORN EQ 500MG/20ML (EQ 25MG/ML) EQ 750MG/30ML (EQ 25MG/ML) SAGENT PHARMS EQ 500MG/20ML (EQ 25MG/ML) EQ 750MG/30ML (EQ 25MG/ML) LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ACS DOBFAR INFO SA EQ 250MG/50ML (EQ 5MG/ML) EQ 500MG/100ML (EQ 5MG/ML) EQ 750MG/150ML (EQ 5MG/ML) HIKMA FARMACEUTICA EQ 250MG/50ML (EQ 5MG/ML) EQ 500MG/100ML (EQ5MG/ML) EQ 750MG/150ML (EQ 5MG/ML) SOLUTION; ORAL LEVAQUIN + JANSSEN PHARMS 250MG/10ML LEVOFLOXACIN HI TECH PHARMA 250MG/10ML SOLUTION/DROPS; OPHTHALMIC LEVOFLOXACIN AKORN 0.5% APOTEX 0.5% HI TECH PHARMA 0.5% NEXUS PHARMS 0.5% QUIXIN + SANTEN 0.5% IQUIX + SANTEN 1.5%
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N020635 N020635 N020635 N020635 N020635 A091644 A091644 A200560 A200560 A090343 A090343 A090343 A091375 A091375 A091375
001 004 002 003 005 001 002 001 002 001 002 003 001 002 003
Dec 20, 1996 Dec 20, 1996 Dec 20, 1996 Dec 20, 1996 Dec 20, 1996 Jun Jun Jun Jun Jul Jul Jul Sep Sep Sep 20, 20, 20, 20, 07, 07, 07, 16, 16, 16, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011
AA AA
N021721 A091678
001 001
Oct 21, 2004 Jun 20, 2011
AT AT AT AT AT XX
A090268 A078282 A076826 A077700 N021199 N021571
001 001 001 001 001 001
Dec Dec Feb Dec
20, 20, 10, 20,
2010 2010 2011 2010
Aug 18, 2000 Mar 01, 2004
TABLET; ORAL LEVAQUIN JANSSEN PHARMS AB
250MG
N020634
001
Dec 20, 1996

LEVOFLOXACIN
TABLET; ORAL LEVAQUIN JANSSEN PHARMS AB AB + LEVOFLOXACIN APOTEX INC AB AB AB AUROBINDO PHARMA LTD AB AB AB CIPLA LTD AB AB AB DR REDDYS LABS INC AB AB AB GLENMARK GENERICS AB AB AB LUPIN AB AB AB MACLEODS PHARMS LTD AB AB AB MYLAN AB AB AB ORCHID HLTHCARE AB AB AB SANDOZ AB AB AB TEVA AB AB AB TORRENT PHARMS AB AB AB WOCKHARDT AB AB AB ZYDUS PHARMS USA INC AB AB AB
3 - 252 (of 428)
500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG
N020634 N020634 A090787 A090787 A090787 A201043 A201043 A201043 A076890 A076890 A076890 A076710 A076710 A076710 A200250 A200250 A200250 A078424 A078424 A078424 A200839 A200839 A200839 A076276 A076276 A077097 A202200 A202200 A202200 A077438 A077438 A077438 A076361 A076361 A076361 A090722 A090722 A090722 A090367 A090367 A090367 A077652 A077652 A077652
002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 001 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Dec 20, 1996 Sep 08, 2000 Sep Sep Sep Jun Jun Jun Mar Mar Mar Jun Jun Jun Jun Jun Jun Jun Jun Jun Mar Mar Mar Jun Jun Jun Jan Jan Jan Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Sep Sep Sep 29, 29, 29, 20, 20, 20, 30, 30, 30, 20, 20, 20, 20, 20, 20, 20, 20, 20, 22, 22, 22, 20, 20, 20, 30, 30, 30, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 07, 07, 07, 2011 2011 2011 2011 2011 2011 2012 2012 2012 2011 2011 2011 2011 2011 2011 2011 2011 2011 2012 2012 2012 2011 2011 2011 2012 2012 2012 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2012 2012 2012
LEVOLEUCOVORIN CALCIUM
POWDER; IV (INFUSION) FUSILEV XX + SPECTRUM PHARMS SOLUTION; IV (INFUSION) FUSILEV XX + SPECTRUM PHARMS
EQ 50MG BASE/VIAL
N020140
001
Mar 07, 2008
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
N020140
002
Apr 29, 2011
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE

INJECTABLE; INJECTION ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN NOVOCOL AP 0.05MG/ML;2%
A084697
001

INJECTABLE; INJECTION SCANDONEST L DEPROCO AP
3 - 253 (of 428)
0.05MG/ML;2%
A088388
001
Oct 10, 1984
LEVONORGESTREL
INTRAUTERINE DEVICE; INTRAUTERINE
MIRENA
52MG XX + BAYER HLTHCARE TABLET; ORAL LEVONORGESTREL PERRIGO R AND D AB AB + WATSON LABS AB WATSON LABS INC AB PLAN B AB + TEVA BRANDED PHARM PLAN B ONE-STEP AB + DURAMED
N021225
001
Dec 06, 2000
0.75MG 0.75MG 0.75MG 1.5MG 0.75MG 1.5MG
A090740 A078665 A078666 A200670 N021045 N021998
001 001 001 001 002 001
Dec Aug Jun Jul
30, 28, 24, 12,
2010 2009 2009 2012
Aug 24, 2006 Jul 10, 2009
LEVORPHANOL TARTRATE
TABLET; ORAL LEVORPHANOL TARTRATE XX ROXANE
2MG
A074278
001
Mar 31, 2000
LEVOTHYROXINE SODIUM** **Refer to Preface Section 1.8 Levothyroxine Sodium for amplifying information**
CAPSULE; ORAL TIROSINT XX INST BIOCHIMIQUE XX INSTITUT BIOCHIMIQUE XX XX XX XX XX XX XX XX + POWDER; INTRAVENOUS LEVOTHYROXINE SODIUM XX + FRESENIUS KABI USA XX + XX + TABLET; ORAL LEVO-T ALARA PHARM --> --> --> --> --> --> --> --> --> --> --> --> + LEVOTHYROXINE SODIUM MERCK KGAA --> -->
N022121 N021924 N021924 N021924 N021924 N021924 N021924 N021924 N021924 N021924
001 002 003 004 010 005 008 006 009 007
Aug Oct Oct Oct Oct Oct Oct Oct Oct Oct
01, 13, 13, 13, 02, 13, 02, 13, 02, 13,
2007 2006 2006 2006 2009 2006 2009 2006 2009 2006
100MCG/VIAL 200MCG/VIAL 500MCG/VIAL
N202231 N202231 N202231
001 002 003
Jun 24, 2011 Jun 24, 2011 Jun 24, 2011
--> --> --> --> --> --> --> --> --> --> --> --> --> -->
AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB2,AB3 AB2,AB3
N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 A076752 A076752
001 002 003 004 005 006 007 012 008 009 010 011 001 002
Mar Mar Mar Mar Mar Mar Mar Dec Mar Mar Mar Mar
01, 01, 01, 01, 01, 01, 01, 08, 01, 01, 01, 01,
2002 2002 2002 2002 2002 2002 2002 2003 2002 2002 2002 2002
0.025MG 0.05MG
Jun 16, 2005 Jun 16, 2005

LEVOTHYROXINE SODIUM**
3 - 254 (of 428)
**Refer to Preface Section 1.8 Levothyroxine Sodium for amplifying information**

TABLET; ORAL LEVOTHYROXINE SODIUM MERCK KGAA --> --> --> --> --> --> --> --> --> MYLAN --> --> --> --> --> --> --> --> --> --> --> --> LEVOXYL KING PHARMS --> --> --> --> --> --> --> --> --> --> --> + SYNTHROID ABBVIE --> --> --> --> --> --> --> --> --> --> --> --> + UNITHROID STEVENS J --> --> --> --> --> --> --> --> --> -->
--> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> -->
AB2,AB3 0.075MG AB2,AB3 0.088MG AB2,AB3 0.1MG AB2,AB3 0.112MG AB2,AB3 0.125MG AB2,AB3 0.15MG AB2,AB3 0.175MG AB2,AB3 0.2MG AB2,AB3 0.3MG AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG
A076752 A076752 A076752 A076752 A076752 A076752 A076752 A076752 A076752 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210
003 004 005 006 007 008 009 010 011 001 002 003 004 005 006 007 012 008 009 010 011 001 002 003 004 005 006 007 008 009 010 011 001 002 003 004 005 006 007 008 009 010 012 011 001 002 003 004 005 006 007 012 008 009
Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Dec Jun Jun Jun Jun May May May May May May May May May May May Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Aug Aug Aug Aug Aug Aug Aug Feb Aug Aug
16, 16, 16, 16, 16, 16, 16, 16, 16, 05, 05, 05, 05, 05, 05, 05, 13, 05, 05, 05, 05, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 21, 21, 21, 21, 21, 21, 21, 08, 21, 21,
2005 2005 2005 2005 2005 2005 2005 2005 2005 2002 2002 2002 2002 2002 2002 2002 2006 2002 2002 2002 2002 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2000 2000 2000 2000 2000 2000 2000 2008 2000 2000
AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3

3 - 255 (of 428)
**Refer to Preface Section 1.8 Levothyroxine Sodium for amplifying information**

TABLET; ORAL UNITHROID STEVENS J --> --> + LEVOTHROID LLOYD AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 +
--> -->
AB1,AB2,AB3 AB1,AB2,AB3
0.2MG 0.3MG
N021210 N021210 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116
010 011 001 002 003 010 004 011 005 012 006 007 008 009
Aug 21, 2000 Aug 21, 2000 Oct Oct Oct Oct Oct Oct Oct Dec Oct Oct Oct Oct 24, 24, 24, 24, 24, 24, 24, 07, 24, 24, 24, 24, 2002 2002 2002 2002 2002 2002 2002 2004 2002 2002 2002 2002
LIDOCAINE
OINTMENT; TOPICAL LIDOCAINE + FOUGERA NOVOCOL INC TARO PATCH; TOPICAL LIDOCAINE WATSON LABS INC LIDODERM + TEIKOKU PHARMA USA
AT AT AT
5% 5% 5%
A080198 A040911 A086724
001 001 001
May 23, 2011
AB AB
5% 5%
A200675 N020612
001 001
Aug 23, 2012 Mar 19, 1999
LIDOCAINE HYDROCHLORIDE
GEL; OPHTHALMIC AKTEN XX + AKORN INJECTABLE; INJECTION LIDOCAINE HYDROCHLORIDE HOSPIRA AP AP AP AP AP AP AP LUITPOLD AP AP PFIZER AP AP AP AP LIDOCAINE HYDROCHLORIDE B BRAUN AP BAXTER HLTHCARE AP LIDOCAINE HYDROCHLORIDE B BRAUN AP BAXTER HLTHCARE AP LIDOCAINE HYDROCHLORIDE HOSPIRA AP LIDOCAINE HYDROCHLORIDE B BRAUN AP
3.5%
N022221
001
Oct 07, 2008
0.5% A088328 1% A083158 1% A088329 2% A040078 2% A083158 2% A088294 20% A083158 1% A080850 2% A083198 0.5% A091056 0.5% A091058 1% A091056 1% A091058 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER 200MG/100ML N019830 200MG/100ML N018461 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER 400MG/100ML N019830 400MG/100ML N018461 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER 400MG/100ML N018388 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER 800MG/100ML N019830
001 001 001 001 002 001 003 001 001 001 001 002 002 002 002 003 003 002 004
May 17, 1984 May 17, 1984 Jun 23, 1995 May 17, 1984
Dec Sep Dec Sep
08, 30, 08, 30,
2010 2010 2010 2010
Apr 08, 1992
Apr 08, 1992
Apr 08, 1992

0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER 800MG/100ML N018461 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER 800MG/100ML N018388 IN PLASTIC CONTAINER 1% A088586 0.5% A088325 1% A088299 2% A088327 LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE FRESENIUS KABI USA 1% A080404 2% A080404 2% N017584 4% N017584 HOSPIRA 1% A080408 1.5% A080408 4% A088295 INTL MEDICATION 20% N017702 PFIZER 2% A090665 LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER HOSPIRA 1% A040302 2% A040302 LIDOPEN MERIDIAN MEDCL TECHN 10% N017549 XYLOCAINE + FRESENIUS KABI USA 0.5% N006488 + 1% N006488 + 1.5% N006488 + 2% N006488 XYLOCAINE 4% PRESERVATIVE FREE + FRESENIUS KABI USA 4% N010417 XYLOCAINE PRESERVATIVE FREE + FRESENIUS KABI USA 1% N016801 + 2% N016801 + 4% N016801 + 10% N016801 + 20% N016801 INJECTABLE; SPINAL
LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
+ HOSPIRA 5% A083914 JELLY; TOPICAL
ANESTACON POLYMEDICA 2% A080429 LIDOCAINE HYDROCHLORIDE AKORN 2% A040433 HI TECH PHARMA 2% A040837 INTL MEDICATION 2% A086283 TEVA PHARMS 2% A081318 XYLOCAINE + OAK PHARMS 2% N008816 SOLUTION; ORAL LIDOCAINE HYDROCHLORIDE HI TECH PHARMA 2% A040014 WOCKHARDT 2% A087872 LIDOCAINE HYDROCHLORIDE VISCOUS VINTAGE 2% A040708 LIDOCAINE VISCOUS ROXANE 2% A088802 INJECTABLE; INJECTION LIDOCAINE HYDROCHLORIDE BAXTER HLTHCARE LIDOCAINE HYDROCHLORIDE HOSPIRA LIDOCAINE HYDROCHLORIDE FRESENIUS KABI USA HOSPIRA
3 - 256 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
004 003 001 001 001 001 002 003 001 002 001 002 001 001 001 001 002 001 008 007 010 002 001 005 001 002 003 004
Feb 22, 1982 Nov 05, 1982 Jul Jul Jul Jul 24, 31, 31, 31, 1985 1984 1984 1984
May 17, 1984 Sep 27, 2010 Sep 28, 1998 Sep 28, 1998
Jan 19, 1988
XX
001
AT AT AT AT AT AT
001 001 001 001 001 001 Feb 12, 2003 Mar 23, 2011 Apr 29, 1993
AT AT AT AT
001 001 001 001
Jul 10, 1995 Nov 18, 1982 Feb 27, 2007 Apr 26, 1985

SOLUTION; ORAL XYLOCAINE VISCOUS + FRESENIUS KABI USA 2% SOLUTION; TOPICAL LARYNG-O-JET KIT INTL MEDICATION 4% LIDOCAINE HYDROCHLORIDE ROXANE 4% VINTAGE 4% WOCKHARDT 4% LTA II KIT HOSPIRA 4% XYLOCAINE 4% PRESERVATIVE FREE + FRESENIUS KABI USA 4%
3 - 257 (of 428)
AT
N009470
001
AT AT AT AT AT AT
A086364 A088803 A040710 A087881 A080409 N010417
001 001 001 001 001 002 Apr 03, 1985 Feb 27, 2007 Nov 18, 1982
LIDOCAINE; PRILOCAINE
CREAM; TOPICAL EMLA + OAK PHARMS 2.5%;2.5% LIDOCAINE AND PRILOCAINE FOUGERA PHARMS 2.5%;2.5% HI TECH PHARMA 2.5%;2.5% TOLMAR 2.5%;2.5% GEL; PERIODONTAL
ORAQIX
+ DENTSPLY PHARM 2.5%;2.5%
AB AB AB AB
N019941 A076453 A076290 A076320
001 001 001 001
Dec 30, 1992 Aug 18, 2003 Sep 25, 2003 Aug 27, 2003
XX
N021451
001
Dec 19, 2003
LIDOCAINE; TETRACAINE
CREAM; TOPICAL
PLIAGLIS
XX + GALDERMA LABS LP PATCH; TOPICAL
SYNERA
XX + ZARS PHARM
7%;7%
N021717
001
Jun 29, 2006
70MG;70MG
N021623
001
Jun 23, 2005
LINACLOTIDE
CAPSULE; ORAL LINZESS FOREST LABS INC XX XX +
145MCG 290MCG
N202811 N202811
001 002
Aug 30, 2012 Aug 30, 2012
LINAGLIPTIN
TABLET; ORAL
TRADJENTA
XX + BOEHRINGER INGELHEIM
5MG
N201280
001
May 02, 2011
LINAGLIPTIN; METFORMIN HYDROCHLORIDE

TABLET; ORAL JENTADUETO XX BOEHRINGER INGELHEIM XX XX +
2.5MG;500MG 2.5MG;850MG 2.5MG;1GM
N201281 N201281 N201281
001 002 003
Jan 30, 2012 Jan 30, 2012 Jan 30, 2012
LINCOMYCIN HYDROCHLORIDE
LINCOCIN
EQ 300MG BASE/ML
N050317
001

LINDANE
LOTION; TOPICAL LINDANE OLTA PHARMS AT AT + WOCKHARDT SHAMPOO; TOPICAL LINDANE OLTA PHARMS AT AT + WOCKHARDT
3 - 258 (of 428)
1% 1%
A087313 A088190
001 001
Aug 16, 1984
1% 1%
A087266 A088191
001 001
Sep 18, 1984
LINEZOLID
FOR SUSPENSION; ORAL ZYVOX XX + PHARMACIA AND UPJOHN INJECTABLE; INJECTION LINEZOLID TEVA PHARMS AP ZYVOX AP + PHARMACIA AND UPJOHN TABLET; ORAL ZYVOX XX + PHARMACIA AND UPJOHN
100MG/5ML
N021132
001
Apr 18, 2000
200MG/100ML 200MG/100ML
A200222 N021131
001 001
Jun 27, 2012 Apr 18, 2000
600MG
N021130
002
Apr 18, 2000
LIOTHYRONINE SODIUM
INJECTABLE; INJECTION LIOTHYRONINE SODIUM X GEN PHARMS AP TRIOSTAT AP + JHP PHARMS TABLET; ORAL CYTOMEL KING PHARMS AB AB AB + LIOTHYRONINE SODIUM COASTAL PHARMS AB AB AB MYLAN AB AB AB SIGMAPHARM LABS LLC AB AB AB
EQ 0.01MG BASE/ML EQ 0.01MG BASE/ML
A076923 N020105
001 001
Aug 17, 2005 Dec 31, 1991
EQ 0.005MG BASE EQ 0.025MG BASE EQ 0.05MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ 0.005MG BASE 0.025MG BASE 0.05MG BASE 0.005MG BASE 0.025MG BASE 0.05MG BASE 0.005MG BASE 0.025MG BASE 0.05MG BASE
N010379 N010379 N010379 A090097 A090097 A090097 A090326 A090326 A090326 A200295 A200295 A200295
001 002 003 001 002 003 001 002 003 001 002 003 Mar Mar Mar Jul Jul Jul Nov Nov Nov 20, 20, 20, 14, 14, 14, 29, 29, 29, 2009 2009 2009 2009 2009 2009 2012 2012 2012
LIOTRIX (T4;T3)
TABLET; ORAL THYROLAR-0.25 FOREST LABS THYROLAR-0.5 FOREST LABS THYROLAR-1 FOREST LABS THYROLAR-2 FOREST LABS THYROLAR-3 + FOREST LABS
XX XX XX XX XX
N016807 N016807 N016807 N016807 N016807
001 005 004 002 003
LIRAGLUTIDE RECOMBINANT
SOLUTION; SUBCUTANEOUS VICTOZA XX + NOVO NORDISK INC
18MG/3ML (6MG/ML)
N022341
001
Jan 25, 2010

LISDEXAMFETAMINE DIMESYLATE
CAPSULE; ORAL VYVANSE XX SHIRE DEVELOPMENT XX XX XX XX XX +
3 - 259 (of 428)
N021977 N021977 N021977 N021977 N021977 N021977
004 001 005 002 006 003
Dec Feb Dec Feb Dec Feb
10, 23, 10, 23, 10, 23,
2007 2007 2007 2007 2007 2007
LISINOPRIL
TABLET; ORAL LISINOPRIL APOTEX INC AB AB AB AB AB AB AUROBINDO AB AB AB AB AB AB IVAX SUB TEVA PHARMS AB AB AB AB AB AB LUPIN AB AB AB AB AB AB MYLAN AB AB AB AB AB AB PRINSTON INC AB AB AB AB AB AB RANBAXY AB AB AB AB AB AB SANDOZ AB AB AB AB AB AB
2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 2.5MG 5MG 5MG 10MG 10MG
A076102 A076102 A076102 A076102 A076102 A076102 A077622 A077622 A077622 A077622 A077622 A077622 A075752 A075752 A075752 A075752 A075752 A075752 A077321 A077321 A077321 A077321 A077321 A077321 A076071 A076071 A076071 A076071 A076071 A076071 A076180 A076180 A076180 A076164 A076164 A076164 A075944 A075944 A075944 A075944 A075944 A075944 A075903 A075994 A075903 A075994 A075903 A075994
001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 001 002 003 001 002 003 004 006 005 001 001 002 002 003 003
Sep Sep Sep Sep Sep Sep Feb Feb Feb Feb Feb Feb Jul Jul Jul Jul Jul Jul Sep Sep Sep Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Feb Jul Jul Jul Jul Jul Jul Jul
30, 30, 30, 30, 30, 30, 22, 22, 22, 22, 22, 22, 01, 01, 01, 01, 01, 01, 09, 09, 09, 09, 09, 09, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 11, 01, 01, 01, 01, 01, 01, 01,
2002 2002 2002 2002 2002 2002 2006 2006 2006 2006 2006 2006 2002 2002 2002 2002 2002 2002 2005 2005 2005 2005 2005 2005 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2003 2002 2002 2002 2002 2002 2002 2002

LISINOPRIL
TABLET; ORAL LISINOPRIL SANDOZ AB AB AB AB AB AB VINTAGE AB AB AB AB AB AB WATSON LABS AB AB AB AB AB AB WEST WARD AB AB AB AB AB AB WOCKHARDT AB AB AB AB AB AB PRINIVIL MERCK AB AB AB AB ZESTRIL ASTRAZENECA AB AB AB AB AB AB +
3 - 260 (of 428)
20MG 20MG 30MG 30MG 40MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 5MG 10MG 20MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG
A075903 A075994 A075903 A075994 A075903 A075994 A075743 A075743 A075743 A075743 A075743 A075743 A076059 A076059 A076059 A076059 A076059 A076059 A076063 A076063 A076063 A076063 A076063 A076063 A078402 A078402 A078402 A078402 A078402 A078402 N019558 N019558 N019558 N019558 N019777 N019777 N019777 N019777 N019777 N019777
004 004 005 005 006 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 006 005 001 002 003 004 005 006 001 002 003 004 005 001 002 003 006 004
Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jun Jul Apr Apr Apr Apr Apr Apr Dec Dec Dec Oct Apr May May May Jan May
01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 27, 01, 19, 19, 19, 19, 19, 19, 29, 29, 29, 25, 29, 19, 19, 19, 20, 19,
2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2003 2002 2007 2007 2007 2007 2007 2007 1987 1987 1987 1988 1993 1988 1988 1988 1999 1988
LITHIUM CARBONATE
CAPSULE; ORAL LITHIUM CARBONATE ALEMBIC LTD AB AB AB APOTEX INC AB GLENMARK GENERICS AB AB AB HETERO DRUGS LTD AB AB AB ROXANE AB AB
A079159 A079159 A079159 A076795 A079139 A079139 A079139 A090702 A090702 A090702 N017812 N017812
001 002 003 001 001 002 003 001 002 003 002 001
Jan Jan Jan Nov Feb Feb Feb Sep Sep Sep Jan
12, 12, 12, 22, 03, 03, 03, 25, 25, 25, 28,
2009 2009 2009 2004 2009 2009 2009 2009 2009 2009 1987

LITHIUM CARBONATE
CAPSULE; ORAL LITHIUM CARBONATE AB + ROXANE WEST WARD AB AB AB TABLET; ORAL LITHIUM CARBONATE AB + ROXANE SUN PHARM INDS INC AB WEST WARD AB TABLET, EXTENDED RELEASE; LITHIUM CARBONATE GLENMARK GENERICS AB AB MYLAN PHARMS INC AB AB ROXANE AB AB + WEST WARD AB LITHOBID AB + NOVEN THERAP
3 - 261 (of 428)
600MG 150MG 300MG 600MG
N017812 A076243 A076243 A078763
003 002 001 001
Jan Feb Jun Apr
28, 24, 27, 15,
1987 2003 2002 2008
300MG 300MG 300MG ORAL 300MG 450MG 300MG 450MG 300MG 450MG 450MG 300MG
N018558 A091027 A078715
001 001 001
Jan 29, 1982 Jun 24, 2010 Dec 28, 2010
A091544 A091616 A202288 A202219 A076832 A076691 A076490 N018027
001 001 001 001 001 001 001 001
Dec Feb Jun Aug Oct Jan Jun
27, 14, 29, 08, 28, 05, 17,
2010 2011 2012 2012 2004 2004 2003
LITHIUM CITRATE
SYRUP; ORAL LITHIUM CITRATE AA + ROXANE WOCKHARDT AA
EQ 300MG CARBONATE/5ML EQ 300MG CARBONATE/5ML
N018421 A070755
001 001
May 21, 1986
LODOXAMIDE TROMETHAMINE
ALOMIDE
XX + ALCON EQ 0.1% BASE
N020191
001
Sep 23, 1993
LOMITAPIDE MESYLATE
CAPSULE; ORAL JUXTAPID XX AEGERION XX XX +
N203858 N203858 N203858
001 002 003
Dec 21, 2012 Dec 21, 2012 Dec 21, 2012
LOMUSTINE
CAPSULE; ORAL
CEENU
XX BRISTOL MYERS SQUIBB XX XX +
10MG 40MG 100MG
N017588 N017588 N017588
001
002
003
LOPERAMIDE HYDROCHLORIDE
CAPSULE; ORAL IMODIUM AB + MCNEIL CONS 2MG LOPERAMIDE HYDROCHLORIDE MYLAN AB 2MG TEVA AB 2MG
N017694 A072741 A073192
001 001 001 Sep 18, 1991 Apr 30, 1992
LOPINAVIR; RITONAVIR
CAPSULE; ORAL
KALETRA
XX + ABBVIE
133.3MG;33.3MG
N021226
001
Sep 15, 2000

LOPINAVIR; RITONAVIR
SOLUTION; ORAL
KALETRA
XX + ABBVIE TABLET; ORAL KALETRA XX ABBVIE XX +
3 - 262 (of 428)
80MG/ML;20MG/ML
N021251
001
Sep 15, 2000
100MG;25MG 200MG;50MG
N021906 N021906
002 001
Nov 09, 2007 Oct 28, 2005
LORAZEPAM
CONCENTRATE; ORAL LORAZEPAM AMNEAL PHARMS HI-TECH PHARMA CO PADDOCK LLC PHARM ASSOC LORAZEPAM INTENSOL + ROXANE
AA AA AA AA AA
A091383 A200169 A079244 A090260 A072755
001 001 001 001 001
Dec Jan Apr Jun
23, 30, 28, 15,
2009 2012 2009 2010
2MG/ML INJECTABLE; INJECTION ATIVAN AP + BAXTER HLTHCARE CORP 2MG/ML AP + 4MG/ML LORAZEPAM HOSPIRA AP 2MG/ML AP 2MG/ML AP 4MG/ML AP 4MG/ML INTL MEDICATION SYS AP 2MG/ML TAYLOR AP 2MG/ML WATSON LABS AP 2MG/ML AP 4MG/ML LORAZEPAM PRESERVATIVE FREE BEDFORD LABS AP 2MG/ML AP 4MG/ML TABLET; ORAL ATIVAN VALEANT INTL AB 0.5MG AB 1MG AB + 2MG LORAZEPAM AMNEAL PHARMS AB 0.5MG AB 1MG AB 2MG EXCELLIUM AB 0.5MG AB 1MG AB 2MG IVAX SUB TEVA PHARMS 0.5MG AB AB 1MG AB 2MG MYLAN AB 0.5MG AB 0.5MG AB 1MG AB 1MG AB 2MG AB 2MG RANBAXY AB 0.5MG AB 1MG AB 2MG SANDOZ AB 0.5MG AB 0.5MG AB 1MG
Jun 28, 1991
N018140 N018140 A074243 A074282 A074243 A074282 A076150 A075025 A074276 A074276 A077074 A077074
001 002 001 001 002 002 001 001 001 002 001 002 Apr May Apr May Nov Jul Apr Apr 12, 27, 12, 27, 15, 23, 15, 15, 1994 1994 1994 1994 2004 1998 1994 1994
Jul 13, 2005 Jul 13, 2005
N017794 N017794 N017794 A078826 A078826 A078826 A078203 A078203 A078203 A077396 A077396 A077396 A071589 A077657 A071590 A077657 A071591 A077657 A076045 A076045 A076045 A071193 A071403 A071194
001 002 003 001 002 003 001 002 003 001 002 003 001 001 001 002 001 003 001 002 003 001 001 001 Jun Jun Jun Jul Jul Jul Dec Dec Dec Oct Mar Oct Mar Oct Mar Aug Aug Aug Apr Apr Apr 23, 23, 23, 30, 30, 30, 13, 13, 13, 13, 16, 13, 16, 13, 16, 29, 29, 29, 15, 21, 15, 2010 2010 2010 2007 2007 2007 2006 2006 2006 1987 2006 1987 2006 1987 2006 2001 2001 2001 1988 1987 1988

LORAZEPAM
TABLET; ORAL LORAZEPAM SANDOZ AB AB AB VINTAGE PHARMS AB AB AB WATSON LABS AB AB AB AB
3 - 263 (of 428)
1MG 2MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 1MG 2MG
A071404 A071141 A071195 A077754 A077754 A077754 A072926 A071118 A072927 A072928
001 001 001 001 002 003 001 001 001 001
Apr Apr Apr May May May Oct Jul Oct Oct
21, 21, 15, 10, 10, 10, 31, 24, 31, 31,
1987 1987 1988 2006 2006 2006 1991 1986 1991 1991
LORCASERIN HYDROCHLORIDE
TABLET; ORAL BELVIQ XX + EISAI INC
10MG
N022529
001
Jun 27, 2012
LOSARTAN POTASSIUM
TABLET; ORAL COZAAR MERCK AB AB AB + LOSARTAN POTASSIUM ACTAVIS INC AB AB AB ALEMBIC PHARMS LTD AB AB AB APOTEX CORP AB AB AB AUROBINDO PHARMA AB AB AB CADISTA PHARMS AB AB AB LUPIN LTD AB AB AB MACLEODS PHARMS LTD AB AB AB MICRO LABS LTD INDIA AB AB AB MYLAN AB AB AB PRINSTON INC AB AB AB ROXANE AB AB AB SANDOZ AB AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG
N020386 N020386 N020386 A090382 A090382 A090382 A090428 A090428 A090428 A090790 A090790 A090790 A090083 A090083 A090083 A201170 A201170 A201170 A078232 A078232 A078232 A202230 A202230 A202230 A091541 A091541 A091541 A091590 A091590 A091590 A091497 A091497 A091497 A077459 A077459 A077459 A077424 A077424
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002
Apr 14, 1995 Apr 14, 1995 Oct 13, 1998 Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Sep Sep Sep Oct Oct Oct May May May Sep Sep Sep Oct Oct Oct Jun Jun Jun Oct Oct Oct Oct Oct 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 18, 18, 18, 06, 06, 06, 30, 30, 30, 24, 24, 24, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2012 2012 2012 2010 2010 2010 2012 2012 2012 2012 2012 2012 2010 2010 2010 2011 2011 2011 2010 2010 2010 2010 2010

LOSARTAN POTASSIUM
TABLET; ORAL LOSARTAN POTASSIUM SANDOZ AB TEVA AB AB AB TORRENT PHARMS AB AB AB UPSHER SMITH AB AB AB WATSON LABS AB AB AB ZYDUS PHARMS USA INC AB AB AB
3 - 264 (of 428)
003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Oct Apr Apr Apr Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06,
2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
LOTEPREDNOL ETABONATE
GEL; OPHTHALMIC
LOTEMAX
XX + BAUSCH AND LOMB OINTMENT; OPHTHALMIC
LOTEMAX
0.5%
N202872
001
Sep 28, 2012
0.5%
N200738
001
Apr 15, 2011
ALREX
0.2% XX + BAUSCH AND LOMB LOTEMAX 0.5% XX + BAUSCH AND LOMB
N020803 N020583
001 001
Mar 09, 1998 Mar 09, 1998
LOTEPREDNOL ETABONATE; TOBRAMYCIN

ZYLET
XX + BAUSCH AND LOMB 0.5%;0.3%
N050804
001
Dec 14, 2004
LOVASTATIN
TABLET; ORAL LOVASTATIN ACTAVIS ELIZABETH AB AB AB APOTEX INC AB AB AB CARLSBAD AB AB AB LUPIN AB AB AB MUTUAL PHARM AB AB AB MYLAN AB AB AB AB AB
10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 10MG 20MG 20MG 40MG
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003
Dec Dec Dec Feb Feb Feb Jun Jun Jun Mar Nov Nov Apr Apr Apr Dec Dec Dec Dec Dec
17, 17, 17, 28, 28, 28, 05, 05, 05, 14, 01, 01, 14, 14, 14, 17, 17, 17, 17, 17,
2001 2001 2001 2007 2007 2007 2002 2002 2002 2008 2007 2007 2006 2006 2006 2001 2001 2001 2001 2001

LOVASTATIN
TABLET; ORAL LOVASTATIN MYLAN AB SANDOZ AB AB AB AB AB AB TEVA AB AB AB MEVACOR MERCK AB AB + TABLET, EXTENDED RELEASE; ALTOPREV ANDRX LABS LLC XX XX XX +
3 - 265 (of 428)
40MG 10MG 10MG 20MG 20MG 40MG 40MG 10MG 20MG 40MG 20MG 40MG ORAL 20MG 40MG 60MG
A075935 A075300 A075636 A075300 A075636 A075300 A075636 A075551 A075551 A075551 N019643 N019643
003 001 001 002 002 003 003 003 002 001 003 004
Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec
17, 17, 17, 17, 17, 17, 17, 17, 17, 17,
2001 2001 2001 2001 2001 2001 2001 2001 2001 2001
Aug 31, 1987 Dec 14, 1988
N021316 N021316 N021316
002 003 004
Jun 26, 2002 Jun 26, 2002 Jun 26, 2002
LOVASTATIN; NIACIN
ADVICOR
+ ABBVIE 20MG;500MG + 20MG;750MG + 20MG;1GM + 40MG;1GM
XX XX XX XX
N021249 N021249 N021249 N021249
001 002 003 004
Dec Dec Dec Apr
17, 17, 17, 27,
2001 2001 2001 2006
LOXAPINE
POWDER; INHALATION
ADASUVE
XX + ALEXZA PHARMS
10MG
N022549
001
Dec 21, 2012
LOXAPINE SUCCINATE
CAPSULE; ORAL LOXAPINE SUCCINATE LANNETT HOLDINGS INC AB AB AB AB MYLAN AB AB AB AB WATSON LABS AB AB AB + AB
A090695 A090695 A090695 A090695 A076762 A076762 A076762 A076762 A072204 A072205 A072206 A072062
001 002 003 004 001 002 003 004 001 001 001 001
Sep Sep Sep Sep Nov Nov Nov Nov Jun Jun Jun Jun
26, 26, 26, 26, 01, 01, 01, 01, 15, 15, 15, 15,
2011 2011 2011 2011 2004 2004 2004 2004 1988 1988 1988 1988
LUBIPROSTONE
CAPSULE; ORAL AMITIZA SUCAMPO PHARMS XX XX +
8MCG 24MCG
N021908 N021908
002 001
Apr 29, 2008 Jan 31, 2006
LUCINACTANT
SURFAXIN
XX + DISCOVERY LABS 8.5ML
N021746
001
Mar 06, 2012

LURASIDONE HYDROCHLORIDE
TABLET; ORAL LATUDA XX SUNOVION PHARMS INC XX + XX XX
3 - 266 (of 428)
N200603 N200603 N200603 N200603
003 001 002 004
Dec Oct Oct Apr
07, 28, 28, 26,
2011 2010 2010 2012
MAFENIDE ACETATE
CREAM; TOPICAL
SULFAMYLON
XX + MYLAN LLC FOR SOLUTION; TOPICAL
SULFAMYLON
XX + MYLAN LLC
EQ 85MG BASE/GM
N016763
001
5%
N019832
003
Jun 05, 1998
MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE

INJECTABLE; INJECTION PLASMA-LYTE 56 IN PLASTIC CONTAINER BAXTER HLTHCARE 32MG/100ML;128MG/100ML;234MG/100ML XX
N019047
001
Jun 15, 1984
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
XX + B BRAUN 30MG/100ML;37MG/100ML;0.82MG/100ML;370M N019696 G/100ML;530MG/100ML;500MG/100ML;12MG/10 0ML
001
Sep 29, 1989
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG /100ML;502MG/100ML PLASMA-LYTE A IN PLASTIC CONTAINER BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG /100ML;502MG/100ML ISOLYTE S IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG /100ML;500MG/100ML NORMOSOL-R IN PLASTIC CONTAINER HOSPIRA 30MG/100ML;37MG/100ML;222MG/100ML;526MG /100ML;502MG/100ML
AP
N017378
001
AP
N017378
002
Nov 22, 1982
XX
N019711
001
Sep 29, 1989
XX
N017586
001
SOLUTION; IRRIGATION PHYSIOLYTE IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG N019024 XX /100ML;500MG/100ML PHYSIOSOL IN PLASTIC CONTAINER HOSPIRA 30MG/100ML;37MG/100ML;222MG/100ML;526MG N017637 XX /100ML;502MG/100ML
001
Jun 08, 1984
002
Jul 08, 1982
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

SOLUTION; INJECTION
NORMOCARB HF 25
XX + DIALYSIS SUPS NORMOCARB HF 35 XX + DIALYSIS SUPS
0.21GM/100ML;2.8GM/100ML;9.07GM/100ML 0.21GM/100ML;3.97GM/100ML;8.3GM/100ML
N021910 N021910
001 002
Jul 26, 2006 Jul 26, 2006
MAGNESIUM SULFATE
INJECTABLE; INJECTION MAGNESIUM SULFATE AP + FRESENIUS KABI USA HOSPIRA AP
500MG/ML 500MG/ML
N019316 A075151
001 001
Sep 08, 1986 Apr 25, 2000

MAGNESIUM SULFATE
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
+ HOSPIRA 1GM/100ML + 2GM/100ML MAGNESIUM SULFATE IN PLASTIC CONTAINER HOSPIRA 2GM/50ML (40MG/ML) + 4GM/50ML (80MG/ML) + 4GM/100ML (40MG/ML) 20GM/500ML (40MG/ML) 40GM/1000ML(40MG/ML)
3 - 267 (of 428)
XX XX XX XX XX XX XX
N020488 N020488 N020309 N020309 N020309 N020309 N020309
001 002 003 002 001 004 005
Jul 11, 1995 Jul 11, 1995 Jan Jun Jun Jan Jan 26, 24, 24, 18, 18, 2007 1994 1994 1995 1995
MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE

SOLUTION; ORAL
SUPREP BOWEL PREP KIT
XX + BRAINTREE LABS
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT
N022372
001
Aug 05, 2010
MAGNESIUM SULFATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION; IRRIGATION TIS-U-SOL BAXTER HLTHCARE AT
AT
20MG/100ML;40MG/100ML;6.25MG/100ML;800M N018508 G/100ML;8.75MG/100ML TIS-U-SOL IN PLASTIC CONTAINER BAXTER HLTHCARE 20MG/100ML;40MG/100ML;6.25MG/100ML;800M N018336 G/100ML;8.75MG/100ML
001
Feb 19, 1982
001
MALATHION
LOTION; TOPICAL MALATHION MYLAN PHARMS INC AT SUVEN LIFE AT OVIDE AT + TARO PHARMS NORTH
0.5% 0.5% 0.5%
A078743 A091559 N018613
001 001 001
Mar 06, 2009 May 23, 2012 Aug 02, 1982
MANGANESE CHLORIDE
INJECTABLE; INJECTION MANGANESE CHLORIDE IN PLASTIC CONTAINER XX HOSPIRA EQ 0.1MG MANGANESE/ML
N018962
001
Jun 26, 1986
MANNITOL
INJECTABLE; INJECTION MANNITOL 10% B BRAUN 10GM/100ML MANNITOL 10% IN PLASTIC CONTAINER B BRAUN 10GM/100ML HOSPIRA 10GM/100ML MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER B BRAUN 10GM/100ML MANNITOL 15% B BRAUN 15GM/100ML MANNITOL 15% IN PLASTIC CONTAINER B BRAUN 15GM/100ML HOSPIRA 15GM/100ML MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45% B BRAUN 15GM/100ML MANNITOL 20% B BRAUN 20GM/100ML 20GM/100ML MANNITOL 20% IN PLASTIC CONTAINER B BRAUN 20GM/100ML HOSPIRA 20GM/100ML
N016080 N020006 N019603 N016080 N016080 N020006 N019603 N016080 N014738 N016080 N020006 N019603
002 002 002 006 003 003 003 005 001 004 004 004 Jul 26, 1993 Jan 08, 1990 Jul 26, 1993 Jan 08, 1990 Jul 26, 1993 Jan 08, 1987

MANNITOL
INJECTABLE; INJECTION MANNITOL 25% FRESENIUS KABI USA 12.5GM/50ML HOSPIRA 12.5GM/50ML INTL MEDICATION 12.5GM/50ML LUITPOLD 12.5GM/50ML MANNITOL 5% B BRAUN 5GM/100ML MANNITOL 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML HOSPIRA 5GM/100ML MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12% B BRAUN 5GM/100ML OSMITROL 10% IN WATER BAXTER HLTHCARE 10GM/100ML OSMITROL 10% IN WATER IN PLASTIC CONTAINER BAXTER HLTHCARE 10GM/100ML OSMITROL 15% IN WATER BAXTER HLTHCARE 15GM/100ML OSMITROL 15% IN WATER IN PLASTIC CONTAINER BAXTER HLTHCARE 15GM/100ML OSMITROL 20% IN WATER BAXTER HLTHCARE 20GM/100ML OSMITROL 20% IN WATER IN PLASTIC CONTAINER BAXTER HLTHCARE 20GM/100ML OSMITROL 5% IN WATER BAXTER HLTHCARE 5GM/100ML OSMITROL 5% IN WATER IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML POWDER; INHALATION ARIDOL KIT + PHARMAXIS LTD N/A,5MG,10MG,20MG,40MG
3 - 268 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A080677 N016269 A083051 A087409 N016080 N020006 N019603 N016080 N013684 N013684 N013684 N013684 N013684 N013684 N013684 N013684
001 006 001 001 001 001 001 007 002 006 004 008 003 007 001 005
Aug 25, 1994 Jan 21, 1982
Jul 26, 1993 Jan 08, 1987
XX
N022368
001
Oct 05, 2010
SOLUTION; IRRIGATION RESECTISOL IN PLASTIC CONTAINER

B BRAUN 5GM/100ML XX
N016772
002
MANNITOL; SORBITOL
SOLUTION; IRRIGATION SORBITOL-MANNITOL IN PLASTIC CONTAINER XX HOSPIRA 540MG/100ML;2.7GM/100ML
N018316
001
MAPROTILINE HYDROCHLORIDE
TABLET; ORAL MAPROTILINE HYDROCHLORIDE XX MYLAN 25MG XX + 50MG XX 75MG
A072285 A072285 A072285
002 001 003
Oct 03, 1988 Oct 03, 1988 Oct 03, 1988
MARAVIROC
TABLET; ORAL SELZENTRY XX VIIV HLTHCARE XX +
150MG 300MG
N022128 N022128
001 002
Aug 06, 2007 Aug 06, 2007
MEBENDAZOLE
TABLET, CHEWABLE; ORAL
MEBENDAZOLE
XX + TEVA PHARMS
100MG
A073580
001
Jan 04, 1995

MECASERMIN RECOMBINANT
INCRELEX
XX + IPSEN INC
3 - 269 (of 428)
40MG/4ML (10MG/ML)
N021839
001
Aug 30, 2005
MECHLORETHAMINE HYDROCHLORIDE
MUSTARGEN
XX + LUNDBECK INC
10MG/VIAL
N006695
001
MECLIZINE HYDROCHLORIDE
TABLET; ORAL ANTIVERT + PFIZER + + MECLIZINE HYDROCHLORIDE AMNEAL PHARMS
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA
12.5MG 25MG 50MG 12.5MG 25MG 50MG 12.5MG 25MG 12.5MG 25MG 12.5MG 25MG 50MG 12.5MG 25MG 50MG 12.5MG 25MG 12.5MG 25MG 25MG
N010721 N010721 N010721 A201451 A201451 A201451 A200294 A200294 A040659 A040659 A202640 A202640 A202640 A087127 A087128 A089674 A084843 A084092 A040179 A040179 A085740
006 004 001 001 002 003 001 002 001 002 001 002 003 001 001 001 002 003 001 002 001
Jan 20, 1982 Feb Feb Feb Apr Apr Jun Jun Sep Sep Sep 23, 23, 23, 13, 13, 04, 04, 17, 17, 17, 2011 2011 2011 2012 2012 2010 2010 2012 2012 2012
EPIC PHARMA LLC JUBILANT CADISTA MYLAN PHARMS INC
PAR PHARM
SANDOZ VINTAGE PHARMS WATSON LABS
Mar May May Jan Jan
31, 22, 22, 30, 30,
1988 1989 1989 1997 1997
MECLOFENAMATE SODIUM
CAPSULE; ORAL MECLOFENAMATE SODIUM MYLAN AB AB + WATSON LABS AB AB
EQ EQ EQ EQ
A071081 A071081 A071468 A071469
002 001 001 001
Sep Sep Apr Apr
03, 03, 15, 15,
1986 1986 1987 1987
MEDROXYPROGESTERONE ACETATE
INJECTABLE; INJECTION DEPO-PROVERA + PHARMACIA AND UPJOHN 150MG/ML MEDROXYPROGESTERONE ACETATE SANDOZ 150MG/ML TEVA PARENTERAL 150MG/ML DEPO-PROVERA + PHARMACIA AND UPJOHN 400MG/ML INJECTABLE; SUBCUTANEOUS
DEPO-SUBQ PROVERA 104
+ PHARMACIA AND UPJOHN 104MG/0.65ML
AB AB AB XX
N020246 A078711 A076553 N012541
001 001 001 003
Oct 29, 1992 May 20, 2009 Jul 28, 2004
XX
N021583
001
Dec 17, 2004
TABLET; ORAL MEDROXYPROGESTERONE ACETATE BARR AB 2.5MG AB 5MG AB 10MG
A040159 A040159 A040159
001 002 003
Aug 09, 1996 Aug 09, 1996 Aug 09, 1996

TABLET; ORAL PROVERA PHARMACIA AND UPJOHN 2.5MG AB AB 5MG AB + 10MG MEDROXYPROGESTERONE ACETATE BP USL PHARMA 10MG
3 - 270 (of 428)
N011839 N011839 N011839 A088484
001 003 004 001 Jul 26, 1984
MEFENAMIC ACID
CAPSULE; ORAL MEFENAMIC ACID LUPIN LTD AB MICRO LABS LTD AB PONSTEL AB + SHIONOGI INC
250MG 250MG 250MG
A091322 A090562 N015034
001 001 003
Jul 22, 2011 Nov 19, 2010
MEFLOQUINE HYDROCHLORIDE
TABLET; ORAL MEFLOQUINE HYDROCHLORIDE BARR 250MG ROXANE 250MG + SANDOZ 250MG WEST WARD 250MG
AB AB AB AB
A076392 A076523 A076175 A077699
001 001 001 001
Dec Oct Feb Apr
29, 01, 20, 21,
2003 2004 2002 2010
MEGESTROL ACETATE
SUSPENSION; ORAL MEGACE + BRISTOL MYERS SQUIBB MEGESTROL ACETATE APOTEX INC PAR PHARM ROXANE TEVA PHARMS WOCKHARDT MEGACE ES + PAR PHARM
N020264 A077404 A075671 A075997 A075681 A076721 N021778
001 001 001 001 001 001 001
Sep 10, 1993 Feb Jul Feb May Nov 16, 25, 15, 05, 01, 2006 2001 2002 2003 2004
Jul 05, 2005
TABLET; ORAL MEGESTROL ACETATE BARR AB AB PAR PHARM AB AB + ROXANE AB AB
A074621 A074621 A072422 A072423 A074458 A074458
002 001 001 001 001 002
Aug Nov Aug Aug Sep Sep
16, 30, 08, 08, 29, 29,
1996 1995 1988 1988 1995 1995
MELOXICAM
SUSPENSION; ORAL MOBIC XX + BOEHRINGER INGELHEIM TABLET; ORAL MELOXICAM APOTEX INC AB AB AUROBINDO PHARMA AB AB BEIJING DOUBLE CRANE AB AB BRECKENRIDGE PHARM AB AB CARACO AB
7.5MG/5ML
N021530
001
Jun 01, 2004
7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG
A077882 A077882 A078008 A078008 A078039 A078039 A077920 A077920 A077937
001 002 001 002 001 002 001 002 001
Jul Jul Oct Oct Dec Dec Jul Jul Jul
20, 20, 02, 02, 14, 14, 19, 19, 19,
2006 2006 2006 2006 2006 2006 2006 2006 2006

MELOXICAM
TABLET; ORAL MELOXICAM CARACO AB CARLSBAD AB AB COREPHARMA AB AB DR REDDYS LABS INC AB AB GLENMARK GENERICS AB AB LUPIN PHARMS AB AB MYLAN AB AB AB AB PURACAP PHARM AB AB STRIDES ARCOLAB LTD AB AB TARO AB AB TEVA PHARMS AB AB UNICHEM AB AB WATSON LABS AB AB ZYDUS PHARMS USA AB AB MOBIC BOEHRINGER INGELHEIM AB AB +
3 - 271 (of 428)
15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 7.5MG 15MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG
A077937 A077918 A077918 A077930 A077930 A077931 A077931 A077932 A077932 A077944 A077944 A077923 A077934 A077923 A077934 A077938 A077938 A077928 A077928 A078102 A078102 A077936 A077936 A077927 A077927 A077929 A077929 A077921 A077921 N020938 N020938
002 001 002 001 002 001 002 001 002 001 002 001 001 002 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Jul Dec Dec Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul May May Nov Nov Jul Jul Dec Dec Jul Jul Jul Jul
19, 07, 07, 19, 19, 25, 25, 19, 19, 19, 19, 19, 20, 19, 20, 19, 19, 13, 13, 07, 07, 19, 19, 20, 20, 19, 19, 19, 19,
2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2009 2009 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006
Apr 13, 2000 Aug 23, 2000
MELPHALAN
TABLET; ORAL
ALKERAN
2MG
N014691
002
MELPHALAN HYDROCHLORIDE
INJECTABLE; INJECTION ALKERAN + GLAXOSMITHKLINE MELPHALAN HYDROCHLORIDE BEDFORD LABS BIONICHE PHARMA USA MYLAN INSTITUTIONAL
AP AP AP AP
EQ 50MG BASE/VIAL EQ 50MG BASE/VIAL EQ 50MG BASE/VIAL EQ 50MG BASE/VIAL
N020207 A090303 A090299 A090270
001 001 001 001
Nov 18, 1992 Oct 28, 2010 Oct 27, 2009 Jun 09, 2009
MEMANTINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL NAMENDA XR XX FOREST LABS 7MG XX 14MG XX 21MG XX + 28MG SOLUTION; ORAL
NAMENDA
XX + FOREST LABS 2MG/ML
N022525 N022525 N022525 N022525
001 002 003 004
Jun Jun Jun Jun
21, 21, 21, 21,
2010 2010 2010 2010
N021627
001
Apr 18, 2005

TABLET; ORAL NAMENDA XX FOREST LABS XX +
3 - 272 (of 428)
5MG 10MG
N021487 N021487
001 002
Oct 16, 2003 Oct 16, 2003
MENOTROPINS (FSH;LH)
INJECTABLE; IM-SC
REPRONEX
XX + FERRING INJECTABLE; SUBCUTANEOUS
MENOPUR
XX + FERRING
75 IU/VIAL;75 IU/VIAL
N021047
001
Aug 27, 1999
75 IU/VIAL;75 IU/VIAL
N021663
001
Oct 29, 2004
MEPENZOLATE BROMIDE
TABLET; ORAL
CANTIL
25MG
N010679
003
MEPERIDINE HYDROCHLORIDE
INJECTABLE; INJECTION DEMEROL + HOSPIRA 25MG/ML + 50MG/ML + 75MG/ML + 100MG/ML MEPERIDINE HYDROCHLORIDE HIKMA MAPLE 25MG/ML 25MG/ML 50MG/ML 50MG/ML 75MG/ML 75MG/ML 100MG/ML 100MG/ML WATSON LABS 50MG/ML 100MG/ML MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE HIKMA MAPLE 10MG/ML + HOSPIRA 10MG/ML INTL MEDICATION 10MG/ML WATSON LABS 10MG/ML SYRUP; ORAL
+ ROXANE 50MG/5ML TABLET; ORAL DEMEROL + SANOFI AVENTIS US 50MG + 100MG MEPERIDINE HYDROCHLORIDE BARR 50MG 100MG CARACO 50MG 100MG EPIC PHARMA 50MG 100MG MALLINCKRODT 50MG 100MG MIKART 50MG 100MG ROXANE 50MG
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N021171 N021171 N021171 N021171 A080445 A080455 A080445 A080455 A080445 A080455 A080445 A080455 A073444 A073445 A081002 A088432 A081309 A073443
001 002 003 004 001 007 002 008 003 009 004 010 001 001 001 001 001 001
Mar 17, 1992 Mar 17, 1992 Jul Aug Aug Mar 30, 16, 30, 17, 1993 1984 1993 1992
XX
A088744
001
Jan 30, 1985
AA AA AA AA AA AA AA AA AA AA AA AA AA
N005010 N005010 A088639 A088640 A040446 A040446 A040331 A040331 A040352 A040352 A040893 A040893 A040110
001 004 001 001 001 002 001 002 001 002 001 003 001 Jul Sep Aug Aug May May Jun Jun Jun Jun Mar 02, 19, 08, 08, 28, 28, 13, 13, 24, 24, 12, 1984 1984 2002 2002 1999 1999 2000 2000 2009 2009 1997

TABLET; ORAL MEPERIDINE HYDROCHLORIDE ROXANE 100MG VINTAGE PHARMS 50MG 100MG WATSON LABS 50MG 100MG MEPERIDINE HYDROCHLORIDE MIKART 75MG 150MG
3 - 273 (of 428)
AA AA AA AA AA XX XX
A040110 A040191 A040191 A040186 A040186 A040893 A040893
002 001 002 001 002 002 004
Mar Dec Dec Jun Jun
12, 17, 17, 30, 30,
1997 1998 1998 1997 1997
Jun 24, 2009 Jun 24, 2009
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION CARBOCAINE + HOSPIRA 1% + 1.5% + 2% ISOCAINE HYDROCHLORIDE + NOVOCOL 3% MEPIVACAINE HYDROCHLORIDE HOSPIRA INC 3% WATSON LABS 1% 2% POLOCAINE FRESENIUS KABI USA 1% 2% POLOCAINE-MPF FRESENIUS KABI USA 1% 1.5% 2% SCANDONEST PLAIN + DEPROCO 3%
N012250 N012250 N012250 A080925 A040806 A088769 A088770 A089407 A089410 A089406 A089408 A089409 A088387
001 005 002 001 001 001 001 001 001 001 001 001 001 Apr 28, 2008 Nov 20, 1984 Nov 20, 1984 Dec 01, 1986 Dec 01, 1986 Dec 01, 1986 Dec 01, 1986 Dec 01, 1986 Oct 10, 1984
MEPROBAMATE
TABLET; ORAL MEPROBAMATE ALEMBIC PHARMS LTD AA AA INVAGEN PHARMS AA AA TARO AA AA AA + WATSON LABS AA +
A090122 A090122 A040797 A040797 A200998 A200998 A083304 A083308
001 002 001 002 001 002 001 001
Feb Feb Feb Feb May May
18, 18, 27, 27, 23, 23,
2009 2009 2008 2008 2011 2011
MERCAPTOPURINE
TABLET; ORAL MERCAPTOPURINE MYLAN PROMETHEUS LABS ROXANE PURINETHOL + TEVA
AB AB AB AB
50MG 50MG 50MG 50MG
A040594 A040461 A040528 N009053
001 001 001 002
Jul 01, 2005 Feb 11, 2004 Feb 13, 2004
MEROPENEM
INJECTABLE; INJECTION MEROPENEM ACS DOBFAR AP AP HOSPIRA INC AP
500MG/VIAL 1GM/VIAL 500MG/VIAL
A091404 A091404 A090940
001 002 001
Oct 26, 2011 Oct 26, 2011 Jun 22, 2010

MEROPENEM
INJECTABLE; INJECTION MEROPENEM HOSPIRA INC AP SANDOZ AP AP MERREM AP + ASTRAZENECA AP +
3 - 274 (of 428)
1GM/VIAL 500MG/VIAL 1GM/VIAL 500MG/VIAL 1GM/VIAL
A090940 A091201 A091201 N050706 N050706
002 001 002 003 001
Jun 22, 2010 Mar 29, 2011 Mar 29, 2011 Jun 21, 1996 Jun 21, 1996
MESALAMINE
APRISO
XX + SALIX PHARMS 375MG PENTASA XX SHIRE 250MG XX + 500MG ENEMA; RECTAL MESALAMINE PERRIGO ISRAEL TEVA ROWASA + MEDA PHARMS SFROWASA MEDA PHARMS
N022301 N020049 N020049
001 001 002
Oct 31, 2008 May 10, 1993 Jul 08, 2004
AB AB AB AB
4GM/60ML 4GM/60ML 4GM/60ML
A076751 A076841 N019618 N019618
001 001 001 002
Sep 17, 2004 Sep 30, 2004 Dec 24, 1987 Jun 20, 2008
XX
XX XX XX
4GM/60ML SUPPOSITORY; RECTAL CANASA APTALIS PHARMA US 1GM TABLET, DELAYED RELEASE; ORAL ASACOL + WARNER CHILCOTT LLC 400MG ASACOL HD + WARNER CHILCOTT LLC 800MG LIALDA + SHIRE 1.2GM
N021252
002
Nov 05, 2004
N019651 N021830 N022000
001 001 001
Jan 31, 1992 May 29, 2008 Jan 16, 2007
MESNA
INJECTABLE; INTRAVENOUS MESNA BEDFORD FRESENIUS KABI USA MYLAN INSTITUTIONAL SAGENT AGILA TEVA PARENTERAL MESNEX + BAXTER HLTHCARE TABLET; ORAL MESNEX + BAXTER HLTHCARE
AP AP AP AP AP AP
A075739 A075811 A076488 A090913 A075764 N019884
001 001 001 001 001 001
Jan Apr Mar Apr Apr
09, 26, 08, 13, 27,
2004 2001 2012 2010 2001
Dec 30, 1988
XX
400MG
N020855
001
Mar 21, 2002
MESTRANOL; NORETHINDRONE
TABLET; ORAL-28
NORINYL 1+50 28-DAY
XX + WATSON LABS
0.05MG;1MG
N016659
001
METAPROTERENOL SULFATE
SOLUTION; INHALATION METAPROTERENOL SULFATE AN + DEY AN + NOVEX AN AN
0.4% 0.6% 0.4% 0.6%
A071786 A070804 A075402 A075403
001 001 001 001
Aug Aug Feb Feb
05, 17, 28, 28,
1988 1987 2001 2001

SOLUTION; INHALATION METAPROTERENOL SULFATE WOCKHARDT AN AN SYRUP; ORAL METAPROTERENOL SULFATE NOVEX AA AA + SILARX TABLET; ORAL METAPROTERENOL SULFATE PAR PHARM AB AB + WATSON LABS AB AB
3 - 275 (of 428)
0.4% 0.6%
A075586 A075586
001 002
May 30, 2002 May 30, 2002
10MG/5ML 10MG/5ML
A075235 A073632
001 001
Jan 27, 2000 Jul 22, 1992
10MG 20MG 10MG 20MG
A072024 A072025 A073013 A072795
001 001 001 001
Jun Jun Jan Jan
28, 28, 31, 31,
1988 1988 1991 1991
METARAMINOL BITARTRATE
INJECTABLE; INJECTION METARAMINOL BITARTRATE XX + FRESENIUS KABI USA
EQ 10MG BASE/ML
A080722
001
METAXALONE
TABLET; ORAL METAXALONE SANDOZ AB SKELAXIN AB + KING PHARMS
800MG 800MG
A040445 N013217
001 003
Mar 31, 2010 Aug 30, 2002
METFORMIN HYDROCHLORIDE
SOLUTION; ORAL RIOMET XX + RANBAXY TABLET; ORAL GLUCOPHAGE BRISTOL MYERS SQUIBB AB AB AB + METFORMIN HYDROCHLORIDE ALKEM AB AB AB ALVOGEN AB AB AB AMNEAL PHARMS NY AB AB AB APOTEX AB AB AB AB AB AB AUROBINDO AB AB AB CARACO AB AB AB DR REDDYS LABS INC AB AB
500MG/5ML
N021591
001
Sep 11, 2003
500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 500MG 850MG 850MG 1GM 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG
N020357 N020357 N020357 A091184 A091184 A091184 A076033 A076033 A076033 A077880 A077880 A077880 A075984 A090666 A075984 A090666 A075984 A090666 A077095 A077095 A077095 A075967 A075967 A075967 A077787 A077787
001 002 005 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002
Mar 03, 1995 Mar 03, 1995 Nov 05, 1998 Nov Nov Nov Jan Jan Jan Jun Jun Jun Apr Dec Apr Dec Apr Dec Jan Jan Jan Jan Jan Jan Aug Aug 01, 01, 01, 24, 24, 24, 05, 05, 05, 23, 07, 23, 07, 23, 07, 14, 14, 14, 29, 29, 29, 23, 23, 2010 2010 2010 2002 2002 2002 2006 2006 2006 2002 2011 2002 2011 2002 2011 2005 2005 2005 2002 2002 2002 2006 2006

TABLET; ORAL METFORMIN HYDROCHLORIDE DR REDDYS LABS INC AB 1GM GLENMARK GENERICS AB 500MG AB 850MG AB 1GM GRANULES INDIA AB 500MG AB 850MG AB 1GM INDICUS PHARMA AB 500MG AB 850MG AB 1GM IVAX SUB TEVA PHARMS 500MG AB AB 850MG AB 1GM MARKSANS PHARMA AB 500MG AB 850MG AB 1GM MUTUAL PHARMA AB 500MG AB 850MG AB 1GM MYLAN AB 500MG AB 500MG AB 850MG AB 850MG AB 1GM AB 1GM MYLAN PHARMS INC AB 500MG AB 850MG AB 1GM PROVIDENT PHARM AB 500MG AB 850MG AB 1GM SANDOZ AB 500MG AB 500MG AB 850MG AB 850MG AB 1GM AB 1GM TEVA AB 500MG AB 850MG AB 1GM TORRENT PHARMS AB 500MG AB 850MG AB 1GM WATSON LABS AB 500MG AB 850MG AB 1GM WATSON LABS FLORIDA AB 500MG AB 850MG AB 1GM ZYDUS PHARMS USA AB 500MG AB 850MG AB 1GM METFORMIN HYDROCHLORIDE IVAX SUB TEVA PHARMS 625MG XX 750MG XX TABLET, EXTENDED RELEASE; ORAL
FORTAMET
AB + ANDRX LABS LLC 1GM
3 - 276 (of 428)
A077787 A078170 A078170 A078170 A090564 A090564 A090564 A079148 A079148 A079148 A075972 A075972 A075972 A090888 A090888 A090888 A076038 A076038 A076038 A075973 A075976 A075973 A075976 A075973 A075976 A075969 A075969 A075969 A077853 A077853 A077853 A075965 A075985 A075965 A075985 A075965 A075985 A075978 A075978 A075978 A077711 A077711 A077711 A075979 A075979 A075979 A075961 A075961 A075961 A077064 A077064 A077064 A075972 A075972
003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 005 004
Aug May May May Apr Apr Apr Nov Nov Nov Jan Jan Jan Mar Mar Mar Feb Feb Feb Jan Jan Jan Jan Jan Jan Jan Jan Jan Jul Jul Jul Jan Jan Jan Jan Jan Jan Jan Jan Nov Jan Jan Jan Jan Jan Jan Jan Jan Jan Apr Apr Apr
23, 23, 23, 23, 22, 22, 22, 25, 25, 25, 24, 24, 24, 12, 12, 12, 21, 21, 21, 25, 24, 25, 24, 25, 24, 29, 29, 29, 28, 28, 28, 25, 25, 25, 25, 25, 25, 25, 25, 05, 24, 24, 24, 24, 24, 24, 25, 25, 25, 18, 18, 18,
2006 2008 2008 2008 2010 2010 2010 2008 2008 2008 2002 2002 2002 2012 2012 2012 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2006 2006 2006 2002 2002 2002 2002 2002 2002 2002 2002 2002 2007 2007 2007 2002 2002 2002 2002 2002 2002 2005 2005 2005
Jan 24, 2002 Jan 24, 2002
N021574
002
Apr 27, 2004

TABLET, EXTENDED RELEASE; GLUCOPHAGE XR AB + BRISTOL MYERS SQUIBB METFORMIN HYDROCHLORIDE ALVOGEN AB AMNEAL PHARMS NY AB APOTEX AB AUROBINDO PHARMA LTD AB BARR AB IMPAX LABS AB LUPIN LTD AB MYLAN AB MYLAN PHARMS INC AB NOSTRUM PHARMS LLC AB SUN PHARM INDS (IN) AB TEVA AB TORRENT PHARMS AB WATSON LABS FLORIDA AB ZYDUS PHARMS USA AB GLUCOPHAGE XR BRISTOL MYERS SQUIBB AB1 METFORMIN HYDROCHLORIDE ALVOGEN AB1 AMNEAL PHARMS NY AB1 APOTEX AB1 AUROBINDO PHARMA LTD AB1 IMPAX LABS AB1 INVENTIA HLTHCARE AB1 MYLAN AB1 NOSTRUM PHARMS LLC AB1 SANDOZ AB1 SUN PHARM INDS (IN) AB1 TEVA AB1 TORRENT PHARM AB1 WATSON LABS FLORIDA AB1 WATSON LABS INC AB1 ZYDUS PHARMS USA AB1 FORTAMET ANDRX LABS LLC AB2 METFORMIN HYDROCHLORIDE LUPIN LTD AB2 MYLAN PHARMS INC AB2 GLUMETZA BX SANTARUS BX + ORAL 750MG 750MG 750MG 750MG 750MG 750MG 750MG 1GM 750MG 1GM 750MG 750MG 750MG 750MG 750MG 750MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 1GM N021202 A078321 A078596 A076706 A079118 A076863 A076985 A090692 A077113 A200690 A076756 A077336 A076864 A079226 A076869 A077078 N021202 A078321 A078596 A076706 A079118 A076249 A201991 A076650 A076756 A076873 A077336 A076269 A090014 A076172 A076818 A077060 N021574 A090692 A200690 N021748 N021748
3 - 277 (of 428)
004 002 002 002 002 001 001 002 001 002 002 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Apr 11, 2003 Apr Jan Dec Jul Oct Sep Jun Sep Aug Dec Feb Apr Feb Apr Apr 17, 03, 29, 20, 14, 13, 29, 08, 01, 12, 09, 12, 18, 12, 21, 2008 2008 2005 2012 2004 2005 2011 2005 2012 2011 2006 2005 2010 2005 2005
Oct 13, 2000 Apr Jan Dec Jul Jul Jan Sep Jul Dec Feb Jun Dec Jun Dec Apr 17, 03, 14, 20, 30, 18, 13, 26, 14, 09, 18, 30, 16, 14, 20, 2008 2008 2004 2012 2004 2012 2005 2006 2004 2006 2004 2009 2004 2004 2005
Apr 27, 2004 Jun 29, 2011 Aug 01, 2012 Jun 03, 2005 Jun 03, 2005
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

TABLET; ORAL ACTOPLUS MET TAKEDA PHARMS USA 500MG;EQ 15MG BASE + 850MG;EQ 15MG BASE PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE MYLAN 500MG;EQ 15MG BASE 850MG;EQ 15MG BASE TABLET, EXTENDED RELEASE; ORAL ACTOPLUS MET XR TAKEDA PHARMS USA 1GM;EQ 15MG BASE + 1GM;EQ 30MG BASE
AB AB AB AB
N021842 N021842 A090406 A090406
001 002 001 002
Aug 29, 2005 Aug 29, 2005 Feb 25, 2011 Feb 25, 2011
XX XX
N022024 N022024
001 002
May 12, 2009 May 12, 2009

METFORMIN HYDROCHLORIDE; REPAGLINIDE
TABLET; ORAL PRANDIMET XX NOVO NORDISK INC XX +
3 - 278 (of 428)
500MG;1MG 500MG;2MG
N022386 N022386
001 002
Jun 23, 2008 Jun 23, 2008
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE

TABLET; ORAL AVANDAMET SB PHARMCO XX XX XX XX +
500MG;EQ 2MG BASE 500MG;EQ 4MG BASE 1GM;EQ 2MG BASE 1GM;EQ 4MG BASE
N021410 N021410 N021410 N021410
002 003 004 005
Oct Oct Aug Aug
10, 10, 25, 25,
2002 2002 2003 2003
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL KOMBIGLYZE XR XX BRISTOL MYERS SQUIBB 500MG;EQ 5MG BASE XX 1GM;EQ 2.5MG BASE XX + 1GM;EQ 5MG BASE
N200678 N200678 N200678
001 003 002
Nov 05, 2010 Nov 05, 2010 Nov 05, 2010
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

TABLET; ORAL JANUMET MERCK SHARP DOHME XX XX + TABLET, EXTENDED RELEASE; JANUMET XR MERCK SHARP DOHME XX XX XX +
500MG;EQ 50MG BASE 1GM;EQ 50MG BASE ORAL 500MG;EQ 50MG BASE 1GM;EQ 50MG BASE 1GM;EQ 100MG BASE
N022044 N022044
001 002
Mar 30, 2007 Mar 30, 2007
N202270 N202270 N202270
001 002 003
Feb 02, 2012 Feb 02, 2012 Feb 02, 2012
METHACHOLINE CHLORIDE
PROVOCHOLINE
XX + METHAPHARM
100MG/VIAL
N019193
001
Oct 31, 1986
METHADONE HYDROCHLORIDE
CONCENTRATE; ORAL METHADONE HYDROCHLORIDE ROXANE VISTAPHARM METHADONE HYDROCHLORIDE ROXANE METHADOSE + MALLINCKRODT INJECTABLE; INJECTION DOLOPHINE HYDROCHLORIDE + MYLAN INSTITUTIONAL
AA AA AA AA
10MG/ML 10MG/ML INTENSOL 10MG/ML 10MG/ML
A040180 A040088 A089897 N017116
001 001 001 002
Apr 30, 1998 Nov 30, 1994 Sep 06, 1988
XX
10MG/ML
N021624
001
XX XX XX
AA AA AA AA

MALLINCKRODT 50GM/BOT 100GM/BOT 500GM/BOT SOLUTION; ORAL METHADONE HYDROCHLORIDE + ROXANE 5MG/5ML + 10MG/5ML VISTAPHARM 5MG/5ML 10MG/5ML
N006383 N006383 N006383
002
003
004
A087393 A087997 A090707 A090707
001 001 001 002
Aug 30, 1982 Jun 30, 2010 Jun 30, 2010

TABLET; ORAL DOLOPHINE HYDROCHLORIDE AA + ROXANE 5MG AA + 10MG METHADONE HYDROCHLORIDE MALLINCKRODT 5MG AA 10MG AA 40MG AA 40MG AA + ROXANE SANDOZ AA 10MG AA 40MG THE PHARMANETWORK AA 10MG METHADOSE MALLINCKRODT AA 5MG AA 10MG AA 40MG
3 - 279 (of 428)
N006134 N006134 A040517 A040517 A077142 N017058 A040241 A075082 A090635 A040050 A040050 A074184
002 010 001 002 001 001 002 001 001 001 002 001 Apr 27, 2004 Apr 27, 2004 Jul 12, 2005 May 29, 1998 Mar 25, 1998 Nov 25, 2009 Apr 15, 1993 Apr 15, 1993 Apr 29, 1993
METHAMPHETAMINE HYDROCHLORIDE
TABLET; ORAL DESOXYN AA + LUNDBECK INC 5MG METHAMPHETAMINE HYDROCHLORIDE COASTAL PHARMS AA 5MG
N005378 A091189
002 001 Apr 21, 2010
METHAZOLAMIDE
TABLET; ORAL METHAZOLAMIDE MIKART AB AB + SANDOZ AB AB TEVA PHARMS AB AB
A040062 A040062 A040036 A040036 A040001 A040001
001 002 001 002 001 002
Jan Jan Jun Jun Jun Jun
27, 27, 30, 30, 30, 30,
1994 1994 1993 1993 1993 1993
METHENAMINE HIPPURATE
TABLET; ORAL HIPREX AB + SANOFI AVENTIS US METHENAMINE HIPPURATE COREPHARMA AB UREX CNTY LINE PHARMS AB
1GM 1GM 1GM
N017681 A076411 N016151
001 001 001 Jun 20, 2003
METHIMAZOLE
TABLET; ORAL METHIMAZOLE BOCA PHARMA AB AB CARACO AB AB CEDAR PHARMS AB AB EMCURE PHARMS USA AB AB MYLAN AB AB + SANDOZ AB AB TAPAZOLE KING PHARMS AB
A202068 A202068 A040870 A040870 A040547 A040547 A040734 A040734 A040350 A040350 A040411 A040411 A040320
001 002 001 002 001 002 001 002 001 002 001 002 001
Mar Mar Sep Sep Feb Feb Dec Dec Mar Mar Mar Mar
07, 07, 25, 25, 18, 18, 14, 14, 29, 29, 27, 27,
2012 2012 2007 2007 2005 2005 2007 2007 2000 2000 2001 2001
Mar 31, 2000

METHIMAZOLE
TABLET; ORAL TAPAZOLE KING PHARMS AB
3 - 280 (of 428)
10MG
A040320
002
Mar 31, 2000
METHOCARBAMOL
INJECTABLE; INJECTION METHOCARBAMOL WATSON LABS AP ROBAXIN AP + BAXTER HLTHCARE CORP TABLET; ORAL METHOCARBAMOL AUSTARPHARMA LLC AA AA HETERO DRUGS AA AA LANNETT HOLDINGS INC AA AA SANDOZ AA AA SOLCO HLTHCARE AA AA VINTAGE PHARMS AA AA WATSON LABS AA AA AA AA WEST WARD AA AA ROBAXIN AA + ACTIENT PHARMS ROBAXIN-750 AA + ACTIENT PHARMS
100MG/ML 100MG/ML
A086459 N011790
001 001
001 002 001 002 002 001 001 001 001 001 001 002 001 001 002 001 001 001 004 006
Oct Oct Nov Nov Mar
21, 21, 06, 06, 31,
2011 2011 2009 2009 2003
Jan 29, 2003 Jan 29, 2003
METHOHEXITAL SODIUM
BREVITAL SODIUM
XX + JHP PHARMS XX + XX +
200MG/VIAL 500MG/VIAL 2.5GM/VIAL
N011559 N011559 N011559
004 001 002
Dec 21, 2012
METHOTREXATE SODIUM
INJECTABLE; INJECTION METHOTREXATE PRESERVATIVE FREE FRESENIUS KABI USA EQ 1GM BASE/VIAL PHARMACHEMIE BV EQ 100MG BASE/4ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM + BEDFORD EQ 100MG BASE/4ML (EQ 25MG BASE/ML) + FRESENIUS KABI USA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) + EQ 250MG BASE/10ML (EQ 25MG BASE/ML) + HOSPIRA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM PRESERVATIVE FREE + BEDFORD EQ 50MG BASE/2ML (EQ 25MG BASE/ML) + EQ 250MG BASE/10ML (EQ 25MG BASE/ML) EBEWE PHARMA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) EQ 250MG BASE/10ML (EQ 25MG BASE/ML) EQ 1GM BASE/40ML (EQ 25MG BASE/ML) + HOSPIRA EQ 1GM BASE/40ML (EQ 25MG BASE/ML) + MYLAN INSTITUTIONAL EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
A040266 A200171 A089341 A040263 A040263 N011719 A089340 A089343 A090039 A090039 A090029 N011719 A040767
001 001 001 001 002 010 001 001 001 002 001 012 001
Feb 26, 1999 Feb 27, 2012 Sep Feb Feb Dec Sep Sep Mar Mar Mar Apr Apr 16, 26, 26, 15, 16, 16, 31, 31, 31, 13, 30, 1986 1999 1999 2004 1986 1986 2009 2009 2009 2005 2007

METHOTREXATE SODIUM
INJECTABLE; INJECTION METHOTREXATE SODIUM PRESERVATIVE FREE + MYLAN INSTITUTIONAL EQ 250MG BASE/10ML (EQ 25MG BASE/ML) + EQ 1GM BASE/40ML (EQ 25MG BASE/ML) ONCO THERAPIES LTD EQ 50MG BASE/2ML (EQ 25MG BASE/ML) EQ 100MG BASE/4ML (EQ 25MG BASE/ML) EQ 200MG BASE/8ML (EQ 25MG BASE/ML) EQ 250MG BASE/10ML (EQ 25MG BASE/ML) EQ 1GM BASE/40ML (EQ 25MG BASE/ML) PHARMACHEMIE BV EQ 50MG BASE/2ML (EQ 25MG BASE/ML) EQ 250MG/10ML (EQ 25MG BASE/ML) EQ 1GM BASE/40ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM + BEDFORD EQ 200MG BASE/8ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM PRESERVATIVE FREE + BEDFORD EQ 1GM BASE/VIAL TABLET; ORAL METHOTREXATE SODIUM BARR + DAVA PHARMS INC MYLAN ROXANE TREXALL BARR
3 - 281 (of 428)
AP AP AP AP AP AP AP AP AP AP XX XX
A040768 A040716 A201529 A201529 A201529 A201529 A201530 A040850 A040853 A040843 A089342 A040632
001 001 001 002 003 004 001 001 001 001 001 001
Apr Apr Mar Mar Mar Mar Mar Jan Jan Jan
30, 30, 29, 29, 29, 29, 29, 11, 11, 11,
2007 2007 2012 2012 2012 2012 2012 2010 2010 2010
Sep 16, 1986 Aug 12, 2005
AB AB AB AB XX XX XX XX
2.5MG 2.5MG 2.5MG 2.5MG
BASE BASE BASE BASE
A081099 N008085 A081235 A040054 A040385 A040385 A040385 A040385
001 002 001 001 001 002 003 004
Oct 15, 1990 May 15, 1992 Aug 01, 1994 Mar Mar Mar Mar 21, 21, 21, 21, 2001 2001 2001 2001
5MG BASE 7.5MG BASE 10MG BASE 15MG BASE
METHOXSALEN
CAPSULE; ORAL
8-MOP
+ VALEANT PHARM INTL OXSORALEN-ULTRA
+ VALEANT PHARM INTL INJECTABLE; INJECTION
UVADEX
+ THERAKOS LOTION; TOPICAL
OXSORALEN
+ VALEANT PHARM INTL
XX XX
10MG 10MG
N009048 N019600
001
001 Oct 30, 1986
XX
0.02MG/ML
N020969
001
Feb 25, 1999
XX
1%
N009048
002
METHSCOPOLAMINE BROMIDE
TABLET; ORAL METHSCOPOLAMINE BROMIDE BAYSHORE PHARMS LLC AA 2.5MG AA 5MG BOCA PHARMA AA 2.5MG AA 5MG BRECKENRIDGE PHARM AA 2.5MG AA 5MG PAMINE AA + FOUGERA PHARMS 2.5MG PAMINE FORTE AA + FOUGERA PHARMS 5MG
A200602 A200602 A040624 A040624 A040642 A040642 N008848 N008848
001 002 001 002 001 002 001 002
Sep Sep Dec Dec Dec Dec
24, 24, 28, 28, 06, 06,
2012 2012 2006 2006 2011 2011
Mar 25, 2003
METHSUXIMIDE
CAPSULE; ORAL
CELONTIN
XX PARKE DAVIS XX +
150MG 300MG
N010596 N010596
007
008

METHYCLOTHIAZIDE
TABLET; ORAL METHYCLOTHIAZIDE AB + MYLAN PHARMS INC WATSON LABS AB
3 - 282 (of 428)
5MG 5MG
A087672 A088724
001 001
Aug 17, 1982 Sep 06, 1984
METHYL AMINOLEVULINATE HYDROCHLORIDE

CREAM; TOPICAL
METVIXIA
XX + GALDERMA LABS LP
EQ 16.8% BASE
N021415
001
Jul 27, 2004
METHYLDOPA
TABLET; ORAL METHYLDOPA ACCORD HLTH AB AB IVAX SUB TEVA PHARMS AB AB MYLAN AB AB + WATSON LABS AB
250MG 500MG 250MG 500MG 250MG 500MG 500MG
A070084 A070085 A070098 A070343 A070075 A070076 A070625
001 001 001 001 001 001 001
Oct Oct Feb Feb Apr Apr Jun
15, 15, 20, 20, 18, 18, 06,
1985 1985 1986 1986 1985 1985 1986
METHYLDOPATE HYDROCHLORIDE
INJECTABLE; INJECTION METHYLDOPATE HYDROCHLORIDE AP + LUITPOLD 50MG/ML
A071279
001
Oct 02, 1987
METHYLERGONOVINE MALEATE
INJECTABLE; INJECTION METHERGINE + US PHARMS HOLDINGS I 0.2MG/ML METHYLERGONOVINE MALEATE ERGOJECT 0.2MG/ML LUITPOLD 0.2MG/ML TABLET; ORAL METHERGINE + US PHARMS HOLDINGS I 0.2MG METHYLERGONOVINE MALEATE NOVEL LABS INC 0.2MG
AP AP AP
N006035 A040889 A090193
004 001 001 Sep 13, 2010 Nov 24, 2008
AB AB
N006035 A091577
003 001 May 02, 2011
METHYLNALTREXONE BROMIDE
INJECTABLE; SUBCUTANEOUS RELISTOR SALIX PHARMS XX XX + SOLUTION; SUBCUTANEOUS
RELISTOR
XX + SALIX PHARMS
8MG/0.4ML 12MG/0.6ML (12MG/0.6ML)
N021964 N021964
002 003
Sep 27, 2010 Apr 24, 2008
12MG/0.6ML (12MG/0.6ML)
N021964
001
Apr 24, 2008
METHYLPHENIDATE
FILM, EXTENDED RELEASE; TRANSDERMAL DAYTRANA XX NOVEN PHARMS INC 10MG/9HR (1.1MG/HR) XX 15MG/9HR (1.6MG/HR) XX 20MG/9HR (2.2MG/HR) XX + 30MG/9HR (3.3MG/HR)
N021514 N021514 N021514 N021514
001 002 003 004
Apr Apr Apr Apr
06, 06, 06, 06,
2006 2006 2006 2006
METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL METADATE CD UCB INC AB 10MG AB 50MG
N021259 N021259
003 005
May 27, 2003 Feb 19, 2006

CAPSULE, EXTENDED RELEASE; ORAL METADATE CD AB + UCB INC 60MG METHYLPHENIDATE HYDROCHLORIDE TEVA PHARMS AB 10MG AB 50MG AB 60MG METHYLPHENIDATE HYDROCHLORIDE ACTAVIS AB1 20MG AB1 30MG AB1 40MG BARR LABS INC AB1 20MG AB1 30MG AB1 40MG RITALIN LA NOVARTIS AB1 20MG AB1 30MG AB1 + 40MG METADATE CD UCB INC AB2 20MG AB2 30MG AB2 40MG METHYLPHENIDATE HYDROCHLORIDE TEVA PHARMS AB2 20MG AB2 30MG AB2 40MG RITALIN LA BX NOVARTIS 10MG FOR SUSPENSION, EXTENDED RELEASE; ORAL QUILLIVANT XR 5MG/ML XX + NEXTWAVE PHARMS SOLUTION; ORAL METHYLIN + MALLINCKRODT 5MG/5ML + 10MG/5ML METHYLPHENIDATE HYDROCHLORIDE TRIS PHARMA INC 5MG/5ML 10MG/5ML TABLET; ORAL METHYLPHENIDATE HYDROCHLORIDE MALLINCKRODT 5MG 10MG 20MG SUN PHARM INDS INC 5MG 10MG 20MG UCB INC 5MG 10MG 20MG WATSON LABS 5MG 10MG 20MG RITALIN NOVARTIS 5MG 10MG + 20MG TABLET, CHEWABLE; ORAL METHYLIN MALLINCKRODT 2.5MG 5MG
3 - 283 (of 428)
N021259 A077707 A078873 A078873 A078458 A078458 A078458 A079031 A079031 A079031 N021284 N021284 N021284 N021259 N021259 N021259 A077707 A077707 A078873 N021284
006 001 002 003 001 002 003 001 002 003 001 002 003 001 002 004 002 003 001 004
Feb 19, 2006 Jul 19, 2012 Jul 19, 2012 Jul 19, 2012 Dec Dec Dec Jul Jul Jul 01, 01, 01, 13, 13, 13, 2011 2011 2011 2012 2012 2012
Jun 05, 2002 Jun 05, 2002 Jun 05, 2002 Apr 03, 2001 Jun 19, 2003 Feb 19, 2006 Jul 19, 2012 Jul 19, 2012 Jul 19, 2012 Apr 10, 2004
N202100
001
Sep 27, 2012
AA AA AA AA
N021419 N021419 A091601 A091601
001 002 001 002
Dec 19, 2002 Dec 19, 2002 Jul 23, 2010 Jul 23, 2010
001 002 003 001 002 003 001 001 001 001 002 003 003 006 010
Nov Nov Nov Mar Mar Mar
27, 27, 27, 15, 15, 15,
1998 1998 1998 2012 2012 2012
Aug 29, 1997 Aug 29, 1997 Aug 29, 1997
XX XX
N021475 N021475
001 002
Apr 15, 2003 Apr 15, 2003

TABLET, CHEWABLE; ORAL METHYLIN XX + MALLINCKRODT 10MG TABLET, EXTENDED RELEASE; ORAL CONCERTA JANSSEN PHARMS 27MG AB 36MG AB 54MG AB + METADATE ER AB + UCB INC 20MG METHYLIN ER MALLINCKRODT AB 10MG AB 20MG METHYLPHENIDATE HYDROCHLORIDE MALLINCKRODT INC 27MG AB 36MG AB 54MG AB WATSON LABS 20MG AB RITALIN-SR NOVARTIS AB 20MG CONCERTA JANSSEN PHARMS 18MG XX
3 - 284 (of 428)
N021475
003
Apr 15, 2003
N021121 N021121 N021121 A089601 A075629 A075629 A202608 A202608 A202608 A040410 N018029 N021121
004 002 003 001 001 002 001 002 003 001 001 001
Apr 01, 2002 Aug 01, 2000 Dec 08, 2000 Jun 01, 1988 May 09, 2000 May 09, 2000 Dec Dec Dec Feb 28, 28, 28, 09, 2012 2012 2012 2001
Mar 30, 1982 Aug 01, 2000
METHYLPREDNISOLONE
TABLET; ORAL MEDROL PHARMACIA AND UPJOHN AB AB AB AB + METHYLPREDNISOLONE DURAMED PHARMS BARR AB JUBILANT CADISTA AB AB AB AB SANDOZ AB VINTAGE PHARMS AB WATSON LABS AB
N011153 N011153 N011153 N011153 A088497 A040189 A040189 A040189 A040189 A040194 A040183 A040232
001 004 003 006 001 001 002 003 004 001 001 001 Feb Oct Oct Jul Jul Oct Dec Oct 21, 31, 31, 20, 20, 31, 22, 16, 1984 1997 1997 2007 2007 1997 1998 1997
METHYLPREDNISOLONE ACETATE
INJECTABLE; INJECTION DEPO-MEDROL + PHARMACIA AND UPJOHN 40MG/ML + 80MG/ML METHYLPREDNISOLONE ACETATE SANDOZ 40MG/ML 40MG/ML 80MG/ML 80MG/ML TEVA PARENTERAL 40MG/ML 40MG/ML 80MG/ML 80MG/ML DEPO-MEDROL + PHARMACIA AND UPJOHN 20MG/ML
AB AB AB AB AB AB AB AB AB AB XX
N011757 N011757 A040719 A040794 A040719 A040794 A040557 A040620 A040557 A040620 N011757
001 004 001 001 002 002 001 001 002 002 002 Jan Mar Jan Mar Feb Oct Feb Oct 29, 05, 29, 05, 23, 27, 23, 27, 2009 2009 2009 2009 2005 2006 2005 2006

METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE; INJECTION A-METHAPRED HOSPIRA AP EQ 40MG BASE/VIAL AP EQ 125MG BASE/VIAL HOSPIRA INC AP EQ 40MG BASE/VIAL AP EQ 125MG BASE/VIAL METHYLPREDNISOLONE SODIUM SUCCINATE FRESENIUS KABI USA AP EQ 40MG BASE/VIAL AP EQ 125MG BASE/VIAL AP EQ 1GM BASE/VIAL MUSTAFA NEVSAT AP EQ 40MG BASE/VIAL AP EQ 125MG BASE/VIAL AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL SOLU-MEDROL AP + PHARMACIA AND UPJOHN EQ 40MG BASE/VIAL AP + EQ 125MG BASE/VIAL AP + EQ 500MG BASE/VIAL AP + EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL
3 - 285 (of 428)
A040664 A040665 A040793 A040827 A040583 A040583 A040612 A040888 A040888 A040888 A040888 A040888 N011856 N011856 N011856 N011856 N011856
001 001 001 001 001 002 001 001 002 003 004 005 003 004 005 006 007
Dec Dec Nov Nov Jul Jul Aug Jul Jul Jul Jul Jul
20, 20, 25, 25, 30, 30, 12, 18, 18, 18, 18, 18,
2005 2005 2008 2008 2004 2004 2004 2011 2011 2011 2011 2011
Feb 27, 1985
METHYLTESTOSTERONE
CAPSULE; ORAL
TESTRED
+ VALEANT PHARM INTL TABLET; ORAL ANDROID 10 VALEANT PHARM INTL ANDROID 25 + VALEANT PHARM INTL METHYLTESTOSTERONE IMPAX LABS
XX
10MG
A083976
001
BP BP BP BP
10MG 25MG 10MG 25MG
A086450 A087147 A080767 A084310
001 001 002 001
METIPRANOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC METIPRANOLOL FALCON PHARMS AT 0.3% OPTIPRANOLOL AT + BAUSCH AND LOMB 0.3%
A075720 N019907
001 001
Aug 06, 2001 Dec 29, 1989
METOCLOPRAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION METOCLOPRAMIDE HYDROCHLORIDE HOSPIRA EQ 5MG BASE/ML TEVA PARENTERAL EQ 5MG BASE/ML REGLAN + BAXTER HLTHCARE CORP EQ 5MG BASE/ML SOLUTION; ORAL METOCLOPRAMIDE HYDROCHLORIDE ANI PHARMS EQ 5MG BASE/5ML PHARM ASSOC EQ 5MG BASE/5ML SILARX EQ 5MG BASE/5ML VISTAPHARM EQ 5MG BASE/5ML + WOCKHARDT EQ 5MG BASE/5ML TABLET; ORAL METOCLOPRAMIDE HYDROCHLORIDE IPCA LABS LTD EQ 5MG BASE EQ 10MG BASE MUTUAL PHARM EQ 5MG BASE
AP AP AP
A073118 A073135 N017862
001 001 001
Jan 17, 1991 Nov 27, 1991
AA AA AA AA AA
A071402 A072744 A073680 A075051 A074703
001 001 001 001 001
Jun May Oct Jan Oct
25, 28, 27, 26, 31,
1993 1991 1992 2001 1997
AB AB AB
A078807 A078807 A071536
001 002 002
Jun 12, 2008 Jun 12, 2008 Jan 16, 1997

TABLET; ORAL METOCLOPRAMIDE HYDROCHLORIDE NORTHSTAR HLTHCARE EQ 5MG BASE EQ 10MG BASE PAR PHARM INC EQ 10MG BASE TEVA EQ 5MG BASE EQ 10MG BASE VINTAGE PHARMS EQ 5MG BASE EQ 10MG BASE WATSON LABS EQ 5MG BASE EQ 10MG BASE REGLAN ANI PHARMS EQ 5MG BASE + EQ 10MG BASE TABLET, ORALLY DISINTEGRATING; ORAL METOZOLV ODT SALIX PHARMS EQ 5MG BASE + EQ 10MG BASE
3 - 286 (of 428)
A078374 A078374 A070581 A072801 A070184 A077878 A077878 A072750 A071250 N017854 N017854
001 002 001 001 001 001 002 001 001 002 001
Nov Nov Oct Jun Jul Aug Aug Dec Feb
30, 30, 17, 15, 29, 28, 28, 28, 03,
2007 2007 1985 1993 1985 2006 2006 1995 1988
May 05, 1987
XX XX
N022246 N022246
001 002
Sep 04, 2009 Sep 04, 2009
METOLAZONE
TABLET; ORAL METOLAZONE MYLAN AB AB AB SANDOZ AB AB AB TEVA AB AB AB ZAROXOLYN UCB INC AB AB + AB +
2.5MG 5MG 10MG 2.5MG 5MG 10MG 2.5MG 5MG 10MG 2.5MG 5MG 10MG
A076698 A076698 A076698 A076732 A076466 A076466 A076600 A076833 A075543 N017386 N017386 N017386
001 002 003 001 001 002 001 001 003 001 002 003
Dec Oct Oct Dec Dec Dec Jan Mar Dec
23, 19, 19, 19, 19, 19, 06, 01, 24,
2003 2004 2004 2003 2003 2003 2004 2004 2003
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE; ORAL METOPROLOL SUCCINATE DR REDDYS LABS LTD AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE MYLAN PHARMS INC AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE NESHER PHARMS AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE REDDYS AB EQ 100MG BASE AB EQ 200MG BASE WATSON LABS FLORIDA AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE WOCKHARDT AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE TOPROL-XL ASTRAZENECA AB EQ 25MG TARTRATE AB + EQ 50MG TARTRATE
001 002 001 002 003 004 001 001 001 002 001 001 001 002 001 002 003 004 004 001
Aug Aug Dec Dec Dec Dec Mar May Aug Aug Aug Aug Apr Apr Jul Jul Jul Jul
01, 01, 15, 15, 15, 15, 20, 14, 15, 15, 03, 03, 15, 15, 22, 22, 22, 22,
2012 2012 2011 2011 2011 2011 2008 2008 2012 2012 2009 2009 2010 2010 2010 2010 2010 2010
Feb 05, 2001 Jan 10, 1992

TABLET, EXTENDED RELEASE; ORAL TOPROL-XL ASTRAZENECA AB EQ 100MG TARTRATE AB + EQ 200MG TARTRATE
3 - 287 (of 428)
N019962 N019962
002 003
Jan 10, 1992 Jan 10, 1992
METOPROLOL TARTRATE
INJECTABLE; INJECTION LOPRESSOR + NOVARTIS METOPROLOL TARTRATE BEDFORD LABS FRESENIUS KABI USA HIKMA FARMACEUTICA HOSPIRA
N018704 A076495 A091045 A077761 A074133 A075160 A078085 A090386 A091307 A090317 A077360 A074032
001 001 001 001 001 001 001 001 001 001 001 001
Mar 30, 1984 Jul Oct May Dec Jul Apr Sep Dec Apr Oct Dec 07, 25, 30, 21, 06, 29, 30, 29, 19, 02, 21, 2003 2010 2007 1993 1998 2008 2009 2010 2010 2007 1993
LUITPOLD
SAGENT STRIDES SANDOZ WATSON LABS TABLET; ORAL LOPRESSOR US PHARMS HOLDINGS I AB AB METOPROLOL TARTRATE AUROBINDO PHARMA AB AB AB CARACO AB AB AB IPCA LABS LTD AB AB AB MUTUAL PHARM AB AB AB MYLAN AB AB AB + SANDOZ AB AB TEVA AB AB WATSON LABS AB AB
N017963 N017963 A077739 A077739 A077739 A076670 A074644 A074644 A078459 A078459 A078459 A073654 A073653 A073654 A076704 A076704 A076704 A073288 A073289 A074141 A074141 A074217 A074217
001 002 001 002 003 001 001 002 001 002 003 002 001 001 001 002 003 001 001 001 002 001 002 Sep Sep Sep Jan Dec Dec Jun Jun Jun Jul Dec Dec Jan Jan Jan Mar Mar Jan Jan May May 11, 11, 11, 15, 10, 10, 17, 17, 17, 15, 21, 21, 16, 16, 16, 25, 25, 31, 31, 27, 27, 2007 2007 2007 2004 1996 1996 2008 2008 2008 2009 1993 1993 2004 2004 2004 1994 1994 1995 1995 1994 1994
METRONIDAZOLE
CAPSULE; ORAL FLAGYL AB + GD SEARLE LLC METRONIDAZOLE ALEMBIC LTD AB PAR PHARM AB CREAM; TOPICAL METROCREAM AB + GALDERMA LABS LP METRONIDAZOLE FOUGERA PHARMS AB
375MG 375MG 375MG
N020334 A079065 A076522
001 001 001
May 03, 1995 Jun 23, 2009 Jan 29, 2004
0.75% 0.75%
N020531 A076408
001 001
Sep 20, 1995 May 28, 2004

METRONIDAZOLE
CREAM; TOPICAL METRONIDAZOLE G AND W LABS AB NORITATE XX + VALEANT BERMUDA GEL; TOPICAL METROGEL + GALDERMA LABS LP + METRONIDAZOLE FOUGERA PHARMS G AND W LABS INC TARO TOLMAR
3 - 288 (of 428)
0.75% 1%
A077549 N020743
001 001
Dec 19, 2007 Sep 26, 1997
0.75% 1% 0.75% 0.75% 0.75% 0.75% 1%
N019737 N021789 A077018 A078178 A077819 A077547 A090903
001 001 001 001 001 001 001
Nov 22, 1988 Jun 30, 2005 Jun Jan Jul Jul Jul 06, 19, 18, 13, 22, 2006 2011 2006 2006 2011
AB AB BX
AP AP AP AP AP
AB AB
AB AB
GEL; VAGINAL METROGEL-VAGINAL + MEDICIS 0.75% METRONIDAZOLE TOLMAR 0.75% VANDAZOLE TEVA PHARMS 0.75% INJECTABLE; INJECTION FLAGYL I.V. RTU IN PLASTIC CONTAINER + BAXTER HLTHCARE 500MG/100ML + PFIZER 500MG/100ML METRO I.V. IN PLASTIC CONTAINER + B BRAUN 500MG/100ML METRONIDAZOLE IN PLASTIC CONTAINER CLARIS LIFESCIENCES 500MG/100ML + HOSPIRA 500MG/100ML LOTION; TOPICAL METROLOTION + GALDERMA LABS LP 0.75% METRONIDAZOLE FOUGERA PHARMS 0.75% TABLET; ORAL FLAGYL GD SEARLE LLC 250MG + 500MG METRONIDAZOLE ALEMBIC PHARMS LTD 250MG 500MG MUTUAL PHARM 250MG 500MG PLIVA 250MG 500MG TEVA 500MG WATSON LABS 250MG 250MG 500MG TABLET, EXTENDED RELEASE; ORAL FLAGYL ER + GD SEARLE LLC 750MG METRONIDAZOLE ALEMBIC LTD 750MG
N020208 A077264 N021806
001 001 001
Aug 17, 1992 Oct 31, 2006 May 20, 2005
N018657 N018353 N018900 A078084 N018890
001 002 001 001 002 Sep 29, 1983 Mar 31, 2008 Nov 18, 1983
N020901 A077197
001 001
Nov 24, 1998 May 24, 2006
N012623 N012623 A079067 A079067 A070772 A070773 A070027 A070033 A070044 A070035 N018764 N018764
001 003 001 002 001 001 001 001 001 001 001 002 Mar Mar Jul Jul Nov Dec Feb Dec Sep Dec 13, 13, 16, 16, 06, 06, 08, 20, 17, 20, 2009 2009 1986 1986 1984 1984 1985 1984 1982 1982
N020868 A090222
001 001
Nov 26, 1997 May 05, 2010
METYRAPONE
CAPSULE; ORAL METOPIRONE XX + HRA PHARMA
250MG
N012911
002
Aug 09, 1996

METYROSINE
CAPSULE; ORAL
DEMSER
XX + BIOVAIL TECHNOLOGIES
3 - 289 (of 428)
250MG
N017871
001
MEXILETINE HYDROCHLORIDE
CAPSULE; ORAL MEXILETINE HYDROCHLORIDE TEVA 150MG 200MG + 250MG WATSON LABS 150MG 150MG 200MG 200MG 250MG 250MG
A074377 A074377 A074377 A074711 A074865 A074711 A074865 A074711 A074865
001 002 003 001 001 002 002 003 003
May May May Feb Apr Feb Apr Feb Apr
16, 16, 16, 26, 13, 26, 13, 26, 13,
1995 1995 1995 1997 1998 1997 1998 1997 1998
MICAFUNGIN SODIUM
MYCAMINE
XX + ASTELLAS 50MG/VIAL XX + 100MG/VIAL
N021506 N021506
002 003
Mar 16, 2005 Jun 27, 2006
MICONAZOLE
TABLET; BUCCAL
ORAVIG
XX + VESTIQ PHARMS
50MG
N022404
001
Apr 16, 2010
MICONAZOLE NITRATE
SUPPOSITORY; VAGINAL MICONAZOLE NITRATE ACTAVIS MID ATLANTIC AB MONISTAT 3 AB + INSIGHT PHARMS
200MG 200MG
A073508 N018888
001 001
Nov 19, 1993 Aug 15, 1984
MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE

OINTMENT; TOPICAL
VUSION
XX + STIEFEL LABS INC
0.25%;81.35%;15%
N021026
001
Feb 16, 2006
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION MIDAZOLAM HYDROCHLORIDE BEDFORD AP AP BEN VENUE AP AP CLARIS LIFESCIENCES AP AP FRESENIUS KABI USA AP AP GLAND PHARMA LTD AP AP HIKMA MAPLE AP AP AP AP AP + HOSPIRA AP AP +
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
002 001 002 001 001 002 002 001 001 001 001 001 002 002 001 001 002
Jun Jun Jun Jun Oct Oct Jun Jun Feb Jan Jun Jun Jun Jun Jun Jun Jun
23, 23, 20, 20, 31, 31, 20, 20, 29, 25, 20, 20, 20, 20, 20, 13, 20,
2000 2000 2000 2000 2000 2000 2000 2000 2012 2012 2000 2000 2000 2000 2000 2002 2000

INJECTABLE; INJECTION MIDAZOLAM HYDROCHLORIDE HOSPIRA AP EQ 5MG BASE/ML INTL MEDICATED AP EQ 1MG BASE/ML AP EQ 5MG BASE/ML INTL MEDICATION AP EQ 1MG BASE/ML AP EQ 5MG BASE/ML TAYLOR AP EQ 1MG BASE/ML AP EQ 5MG BASE/ML AP EQ 5MG BASE/ML WOCKHARDT AP EQ 1MG BASE/ML AP EQ 1MG BASE/ML AP EQ 5MG BASE/ML AP EQ 5MG BASE/ML MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE AP + HOSPIRA EQ 1MG BASE/ML AP + EQ 5MG BASE/ML SAGENT STRIDES AP EQ 1MG BASE/ML AP EQ 5MG BASE/ML MIDOZALAM HYDROCHLORIDE SAGENT STRIDES AP EQ 1MG BASE/ML AP EQ 5MG BASE/ML SYRUP; ORAL MIDAZOLAM HYDROCHLORIDE APOTEX INC AA EQ 2MG BASE/ML HI TECH PHARMA AA EQ 2MG BASE/ML PADDOCK LLC AA EQ 2MG BASE/ML RANBAXY AA EQ 2MG BASE/ML AA + ROXANE EQ 2MG BASE/ML
3 - 290 (of 428)
002 001 002 001 002 001 001 002 001 001 002 002 001 002 001 002 001 002
Jun Jan Jan Jul Jul Jun Jun Jun May Nov May Nov Jul Jul Nov Nov
13, 26, 26, 16, 16, 30, 30, 30, 30, 10, 30, 10, 22, 22, 29, 29,
2002 2005 2005 2004 2004 2000 2000 2000 2008 2008 2008 2008 2002 2002 2010 2010
May 04, 2011 May 04, 2011
A077115 A075958 A076379 A076058 A075873
001 001 001 001 001
Sep Sep May Mar Apr
09, 04, 02, 15, 30,
2005 2003 2005 2002 2002
MIDODRINE HYDROCHLORIDE
TABLET; ORAL MIDODRINE HYDROCHLORIDE APOTEX INC AB 2.5MG AB 5MG AB 10MG IMPAX PHARMS AB 2.5MG AB 5MG AB 10MG MYLAN PHARMS INC AB 2.5MG AB + 5MG AB 10MG SANDOZ AB 2.5MG AB 5MG AB 10MG ORVATEN UPSHER SMITH AB 2.5MG AB 5MG AB 10MG
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Sep Sep Sep May May Dec Sep Sep Sep Sep Sep Jul
12, 12, 12, 27, 27, 16, 10, 10, 10, 11, 11, 02,
2006 2006 2006 2004 2004 2005 2003 2003 2003 2003 2003 2004
Nov 03, 2004 Nov 03, 2004 Nov 03, 2004
MIFEPRISTONE
TABLET; ORAL
KORLYM
XX + CORCEPT THERAP MIFEPREX XX + DANCO LABS LLC
300MG 200MG
N202107 N020687
001 001
Feb 17, 2012 Sep 28, 2000

MIGLITOL
TABLET; ORAL GLYSET XX PHARMACIA AND UPJOHN XX XX +
3 - 291 (of 428)
25MG 50MG 100MG
N020682 N020682 N020682
001 002 003
Dec 18, 1996 Dec 18, 1996 Dec 18, 1996
MIGLUSTAT
CAPSULE; ORAL ZAVESCA XX + ACTELION PHARMS LTD
100MG
N021348
001
Jul 31, 2003
MILNACIPRAN HYDROCHLORIDE
TABLET; ORAL SAVELLA XX CYPRESS BIOSCIENCE XX XX + XX
12.5MG 25MG 50MG 100MG
N022256 N022256 N022256 N022256
001 002 003 004
Jan Jan Jan Jan
14, 14, 14, 14,
2009 2009 2009 2009
MILRINONE LACTATE
INJECTABLE; INJECTION MILRINONE LACTATE + BEDFORD EQ 1MG BASE/ML CLARIS LIFESCIENCES EQ 1MG BASE/ML FRESENIUS KABI USA EQ 1MG BASE/ML GLAND PHARMA LTD EQ 1MG BASE/ML HIKMA FARMACEUTICA EQ 1MG BASE/ML HIKMA MAPLE EQ 1MG BASE/ML INTL MEDICATED EQ 1MG BASE/ML MILRINONE LACTATE IN DEXTROSE 5% CLARIS LIFESCIENCES EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) + BAXTER HLTHCARE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) + EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) BEDFORD LABS EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) CLARIS LIFESCIENCES EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) HOSPIRA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) MILRINONE LACTATE IN PLASTIC CONTAINER HIKMA FARMACEUTICA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
001 001 001 001 001 001 001 002 001 001 002 001 002 001 001 002 001 002
May Sep May Oct Dec May Aug
28, 21, 28, 31, 03, 28, 02,
2002 2004 2002 2006 2010 2002 2002
Jul 20, 2005 Aug May May May May Jul May May 18, 28, 28, 21, 21, 20, 28, 28, 2004 2002 2002 2008 2008 2005 2002 2002
Jan 21, 2010 Jan 21, 2010
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL DYNACIN MEDICIS AB EQ AB EQ MINOCIN PRECISION DERMAT AB EQ AB EQ MINOCYCLINE HYDROCHLORIDE AUROBINDO PHARMA EQ AB EQ AB EQ AB IMPAX LABS EQ AB EQ AB EQ AB RANBAXY EQ AB
75MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE
A063067 A063067 N050649 N050649 A065470 A065470 A065470 A065005 A065005 A065005 A065062
002 001 001 002 001 002 003 001 003 002 001
Sep 15, 1999 Jul 31, 1990 May 31, 1990 May 31, 1990 Mar Mar Mar Mar Apr Mar Nov 11, 11, 11, 23, 18, 23, 30, 2008 2008 2008 1999 2001 1999 2000

CAPSULE; ORAL MINOCYCLINE HYDROCHLORIDE RANBAXY AB EQ 75MG BASE AB EQ 100MG BASE TEVA AB EQ 50MG BASE AB EQ 75MG BASE AB + EQ 100MG BASE WATSON LABS AB EQ 50MG BASE AB EQ 75MG BASE AB EQ 100MG BASE CAPSULE, EXTENDED RELEASE; ORAL XIMINO RANBAXY LABS LTD EQ 45MG BASE XX EQ 67.5MG BASE XX EQ 90MG BASE XX EQ 112.5MG BASE XX EQ 135MG BASE XX + INJECTABLE; INJECTION
MINOCIN
EQ 100MG BASE/VIAL XX + REMPEX PHARMS INC POWDER, EXTENDED RELEASE; DENTAL
ARESTIN
+ ORAPHARMA EQ 1MG BASE TABLET; ORAL MINOCYCLINE HYDROCHLORIDE DR REDDYS LABS LTD EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE PAR PHARM EQ 50MG BASE EQ 75MG BASE + EQ 100MG BASE RANBAXY EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE TABLET, EXTENDED RELEASE; ORAL MINOCYCLINE HYDROCHLORIDE AUROBINDO PHARMA LTD EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE BARR LABS INC EQ 45MG BASE EQ 65MG BASE EQ 90MG BASE EQ 115MG BASE EQ 135MG BASE IMPAX LABS INC EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE LUPIN LTD EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE MYLAN PHARMS INC EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE SANDOZ EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE SOLODYN MEDICIS EQ 45MG BASE EQ 65MG BASE EQ 90MG BASE
3 - 292 (of 428)
A065062 A065062 A063011 A063009 A063009 A063181 A063065 A063065
002 003 001 002 001 001 002 001
Nov Nov Mar Aug Mar Dec Jun Dec
30, 30, 02, 12, 02, 30, 10, 30,
2000 2000 1992 2003 1992 1991 1999 1991
N201922 N201922 N201922 N201922 N201922
001 002 003 004 005
Jul Jul Jul Jul Jul
11, 11, 11, 11, 11,
2012 2012 2012 2012 2012
N050444
001
XX
N050781
001
Feb 16, 2001
A065436 A065436 A065436 A065131 A065131 A065131 A065156 A065156 A065156
001 002 003 001 002 003 001 002 003
Dec Dec Dec Apr Apr Apr Jan Jan Jan
26, 26, 26, 16, 16, 16, 06, 06, 06,
2007 2007 2007 2003 2003 2003 2004 2004 2004
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A202261 A202261 A202261 A065485 A065485 A065485 A065485 A065485 A090024 A090024 A090024 A091424 A091424 A091424 A090911 A090911 A090911 A090422 A090422 A090422 N050808 N050808 N050808
001 003 005 001 004 002 005 003 001 002 003 001 003 004 001 002 003 001 002 003 001 004 002
Nov Nov Nov Mar May Mar May Mar Feb Feb Feb Nov Nov Nov Jul Jul Jul Aug Aug Aug
19, 19, 19, 17, 18, 17, 18, 17, 03, 03, 03, 30, 30, 30, 20, 20, 20, 13, 13, 13,
2012 2012 2012 2009 2012 2009 2012 2009 2009 2009 2009 2011 2011 2011 2010 2010 2010 2009 2009 2009
May 08, 2006 Jul 23, 2009 May 08, 2006

TABLET, EXTENDED RELEASE; ORAL SOLODYN MEDICIS AB EQ 115MG BASE AB + EQ 135MG BASE SOLODYN MEDICIS EQ 55MG BASE XX EQ 80MG BASE XX EQ 105MG BASE XX
3 - 293 (of 428)
N050808 N050808 N050808 N050808 N050808
005 003 008 007 006
Jul 23, 2009 May 08, 2006 Aug 27, 2010 Aug 27, 2010 Aug 27, 2010
MINOXIDIL
TABLET; ORAL MINOXIDIL MUTUAL PHARM AB AB PAR PHARM AB AB WATSON LABS AB AB +
2.5MG 10MG 2.5MG 10MG 2.5MG 10MG
A072708 A072709 A071826 A071839 A071344 A071345
001 001 001 001 001 001
Dec Dec Nov Nov Mar Mar
14, 14, 14, 14, 03, 03,
1995 1995 1988 1988 1987 1987
MIRABEGRON
TABLET, EXTENDED RELEASE; ORAL MYRBETRIQ XX APGDI 25MG XX + 50MG
N202611 N202611
001 002
Jun 28, 2012 Jun 28, 2012
MIRTAZAPINE
TABLET; ORAL MIRTAZAPINE APOTEX INC AB AB AB AUROBINDO AB AB AB AB CARACO AB AB AB AB MYLAN AB AB AB MYLAN PHARMS INC AB AB AB SANDOZ AB AB AB TEVA AB AB AB WATSON LABS AB AB AB WATSON LABS FLORIDA AB AB AB REMERON AB + ORGANON USA INC AB
15MG 30MG 45MG 7.5MG 15MG 30MG 45MG 7.5MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG
A077666 A077666 A077666 A076921 A076921 A076921 A076921 A076541 A076541 A076541 A076541 A076122 A076122 A076122 A076176 A076176 A076176 A076219 A076219 A076219 A076119 A076119 A076119 A076312 A076312 A076312 A076336 A076336 A076336 N020415 N020415
001 002 003 001 002 003 004 004 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002
Aug Aug Aug Oct Oct Oct Oct Apr Apr Apr Apr Jun Jun Jun Jun Jun Jun Jun Jun Jun Jan Jan Jun Jun Jun Jun Jun Jun Jun
22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 19, 19, 19, 19, 19, 19, 19, 19, 19, 24, 24, 19, 19, 19, 19, 20, 20, 20,
2007 2007 2007 2004 2004 2004 2004 2004 2004 2004 2004 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
Jun 14, 1996 Jun 14, 1996

MIRTAZAPINE
TABLET; ORAL REMERON ORGANON USA INC 45MG TABLET, ORALLY DISINTEGRATING; ORAL MIRTAZAPINE ACTAVIS ELIZABETH 15MG 30MG 45MG AUROBINDO PHARMA LTD 15MG 30MG 45MG TEVA 15MG 30MG 45MG WATSON LABS 15MG 30MG 45MG REMERON SOLTAB + ORGANON USA INC 15MG 30MG 45MG
3 - 294 (of 428)
AB
N020415
003
Mar 17, 1997
001 002 003 002 003 004 001 002 003 001 002 003 001 002 003
Feb Feb Feb Dec Dec Feb Jun Jun Jun Dec Dec Feb
14, 14, 14, 08, 08, 28, 28, 28, 28, 17, 17, 28,
2011 2011 2011 2005 2005 2006 2005 2005 2005 2003 2003 2006
Jan 12, 2001 Jan 12, 2001 Jan 12, 2001
MISOPROSTOL
TABLET; ORAL CYTOTEC GD SEARLE LLC AB AB + MISOPROSTOL IVAX SUB TEVA PHARMS AB AB NOVEL LABS INC AB AB
0.1MG 0.2MG 0.1MG 0.2MG 0.1MG 0.2MG
N019268 N019268 A076095 A076095 A091667 A091667
003 001 001 002 001 002
Sep 21, 1990 Dec 27, 1988 Jul Jul Jul Jul 10, 10, 25, 25, 2002 2002 2012 2012
MITOMYCIN
FOR SOLUTION; TOPICAL
MITOSOL
XX + MOBIUS THERAP INJECTABLE; INJECTION MITOMYCIN + ACCORD HLTHCARE + + BEDFORD HIKMA MAPLE
0.2MG/VIAL
N022572
001
Feb 07, 2012
A064144 A064144 A064144 A064117 A064117 A064180 A064180
001 002 003 001 002 001 002
Apr Apr Aug Apr Apr Dec Dec
30, 30, 11, 19, 19, 23, 23,
1998 1998 2009 1995 1995 1999 1999
MITOTANE
TABLET; ORAL
LYSODREN
XX + BRISTOL MYERS SQUIBB
500MG
N016885
001
MITOXANTRONE
INJECTABLE; INJECTION MITOXANTRONE HYDROCHLORIDE ONCO THERAPIES LTD AP EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
A201014
001
Dec 11, 2012
MITOXANTRONE HYDROCHLORIDE
INJECTABLE; INJECTION MITOXANTRONE HYDROCHLORIDE BEDFORD AP EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
A076611
001
Apr 11, 2006

INJECTABLE; INJECTION MITOXANTRONE HYDROCHLORIDE BEDFORD EQ EQ FRESENIUS KABI USA EQ EQ EQ + HOSPIRA EQ + EQ + EQ MYLAN INSTITUTIONAL EQ EQ TEVA PARENTERAL EQ EQ EQ
3 - 295 (of 428)
BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML)
A076611 A076611 A077496 A077496 A077496 A076871 A076871 A076871 A078980 A078980 A077356 A077356 A077356
002 003 001 002 003 001 002 003 001 002 001 002 003
Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr
11, 11, 11, 11, 11, 11, 11, 11, 13, 13, 11, 11, 11,
2006 2006 2006 2006 2006 2006 2006 2006 2009 2009 2006 2006 2006
MODAFINIL
TABLET; ORAL MODAFINIL ALEMBIC LTD AB AB AUROBINDO PHARMA LTD AB AB CARLSBAD AB AB HIKMA PHARMS AB AB MYLAN PHARMS INC AB AB ORCHID HLTHCARE AB AB PROVIGIL CEPHALON AB AB +
A202700 A202700 A202566 A202566 A076715 A076715 A090543 A090543 A076594 A076594 A078963 A078963 N020717 N020717
001 002 001 002 001 002 001 002 001 002 001 002 001 002
Oct Oct Sep Sep Nov Nov Sep Sep Jul Jul Sep Sep
18, 18, 27, 27, 01, 01, 26, 26, 16, 16, 26, 26,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
Dec 24, 1998 Dec 24, 1998
MOEXIPRIL HYDROCHLORIDE
TABLET; ORAL MOEXIPRIL HYDROCHLORIDE APOTEX INC AB 7.5MG AB 15MG GLENMARK GENERICS AB 7.5MG AB 15MG PADDOCK LLC AB 7.5MG AB 15MG TEVA AB 7.5MG AB 15MG UNIVASC UCB INC AB 7.5MG AB + 15MG
A078454 A078454 A090416 A090416 A077536 A077536 A076204 A076204 N020312 N020312
001 002 001 002 001 002 001 002 001 002
Jun Jun Mar Mar Nov Nov May May
02, 02, 30, 30, 30, 30, 08, 08,
2008 2008 2010 2010 2006 2006 2003 2003
Apr 19, 1995 Apr 19, 1995
MOMETASONE FUROATE
CREAM; TOPICAL ELOCON + MERCK SHARP DOHME MOMETASONE FUROATE FOUGERA PHARMS G AND W LABS GLENMARK GENERICS TARO TOLMAR
AB AB AB AB AB AB
0.1% 0.1% 0.1% 0.1% 0.1% 0.1%
N019625 A076171 A077447 A078541 A076679 A076591
001 001 001 001 001 001
May 06, 1987 Apr May May Dec Apr 08, 22, 28, 21, 18, 2005 2006 2008 2004 2007

MOMETASONE FUROATE
LOTION; TOPICAL
ELOCON + MERCK SHARP DOHME MOMETASONE FUROATE FOUGERA PHARMS G AND W LABS GLENMARK GENERICS PERRIGO TARO TOLMAR OINTMENT; TOPICAL ELOCON + MERCK SHARP DOHME MOMETASONE FUROATE FOUGERA PHARMS G AND W LABS GLENMARK GENERICS PERRIGO NEW YORK TARO TOLMAR POWDER; INHALATION ASMANEX TWISTHALER SCHERING +
3 - 296 (of 428)
0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1%
N019796 A075919 A077678 A090506 A077180 A076788 A076499
001 001 001 001 001 001 001
Mar 30, 1989 Nov Nov Aug Apr Mar Nov 29, 21, 09, 06, 15, 21, 2007 2007 2010 2005 2006 2007
0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1%
N019543 A077061 A077401 A078571 A076067 A076624 A076481
001 001 001 001 001 001 001
Apr 30, 1987 Mar Jun May Mar Dec Nov 28, 20, 28, 18, 03, 14, 2005 2006 2008 2002 2004 2003
XX XX
0.11MG/INH 0.22MG/INH
N021067 N021067
002 001
Feb 01, 2008 Mar 30, 2005
MOMETASONE FUROATE MONOHYDRATE

SPRAY, METERED; NASAL NASONEX XX + SCHERING PLOUGH
EQ 0.05MG BASE/SPRAY
N020762
001
Oct 01, 1997
MONTELUKAST SODIUM
GRANULE; ORAL MONTELUKAST SODIUM DR REDDYS LABS LTD MYLAN PHARMS INC TEVA PHARMS SINGULAIR + MERCK TABLET; ORAL MONTELUKAST SODIUM ACCORD HLTHCARE APOTEX CORP AUROBINDO PHARMA LTD DR REDDYS LABS LTD GLENMARK GENERICS KUDCO IRELAND MYLAN PHARMS INC ROXANE SANDOZ INC TEVA PHARMS TORRENT PHARMS LTD VINTAGE PHARMS LLC SINGULAIR + MERCK
AB AB AB AB
EQ 4MG BASE/PACKET EQ 4MG BASE/PACKET EQ 4MG BASE/PACKET EQ 4MG BASE/PACKET
A202906 A202776 A090955 N021409
001 001 001 001
Sep 17, 2012 Dec 18, 2012 Aug 03, 2012 Jul 26, 2002
A202717 A201294 A202468 A201582 A090926 A201522 A079103 A090655 A200889 A078605 A201515 A091576 N020829
001 001 001 001 001 001 001 001 001 001 001 001 002
Sep Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug
21, 03, 03, 06, 03, 03, 03, 03, 03, 03, 03, 03,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
EQ 10MG BASE
Feb 20, 1998
TABLET, CHEWABLE; ORAL MONTELUKAST SODIUM APOTEX INC AB AB AUROBINDO PHARMA LTD AB AB
EQ EQ EQ EQ
4MG 5MG 4MG 5MG
BASE BASE BASE BASE
A201508 A201508 A202096 A202096
001 002 001 002
Aug Aug Aug Aug
03, 03, 03, 03,
2012 2012 2012 2012

MONTELUKAST SODIUM
TABLET, CHEWABLE; ORAL MONTELUKAST SODIUM DR REDDYS LABS LTD AB AB KUDCO IRELAND AB AB MYLAN PHARMS INC AB AB ROXANE AB AB SANDOZ INC AB AB TEVA PHARMS AB AB TORRENT PHARMS LTD AB AB VINTAGE PHARMS LLC AB AB SINGULAIR MERCK AB AB +
3 - 297 (of 428)
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 002 001
Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug
06, 06, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
Mar 03, 2000 Feb 20, 1998
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL MORPHINE SULFATE PAR PHARM INC AB 20MG AB 30MG AB 50MG AB 60MG AB 80MG AB 100MG KADIAN ACTAVIS ELIZABETH AB1 20MG AB1 30MG AB1 50MG AB1 60MG AB1 80MG AB1 + 100MG AVINZA KING PFIZER AB2 30MG AB2 45MG AB2 60MG AB2 75MG AB2 90MG AB2 + 120MG MORPHINE SULFATE ACTAVIS ELIZABETH AB2 30MG AB2 45MG AB2 60MG AB2 75MG AB2 90MG AB2 120MG KADIAN 10MG XX + ACTAVIS ELIZABETH 40MG XX 70MG XX 130MG XX 150MG XX 200MG XX +
A200812 A200812 A200812 A200812 A200812 A200812 N020616 N020616 N020616 N020616 N020616 N020616 N021260 N021260 N021260 N021260 N021260 N021260 A079040 A079040 A079040 A079040 A079040 A079040 N020616 N020616 N020616 N020616 N020616 N020616
001 002 003 004 005 006 001 004 002 005 006 003 001 005 002 006 003 004 001 002 003 004 005 006 008 009 010 011 012 007
Nov Nov Nov Nov Nov Nov Jul Mar Jul Mar Oct Jul Mar Dec Mar Dec Mar Mar Jan Jan Jan Jan Jan Jan Apr Jul Jul Jul Jul Feb
10, 10, 10, 10, 10, 10, 03, 09, 03, 09, 27, 03, 20, 18, 20, 18, 20, 20, 16, 16, 16, 16, 16, 16, 20, 09, 09, 09, 09, 27,
2011 2011 2011 2011 2011 2011 1996 2001 1996 2001 2006 1996 2002 2008 2002 2008 2002 2002 2013 2013 2013 2013 2013 2013 2007 2012 2012 2012 2012 2007

MORPHINE SULFATE
INJECTABLE; INJECTION ASTRAMORPH PF FRESENIUS KABI USA AP AP AP AP DURAMORPH PF AP + HIKMA MAPLE AP + MORPHINE SULFATE HOSPIRA AP AP AP AP AP + WATSON LABS AP AP AP AP INFUMORPH XX + HIKMA MAPLE XX + MORPHINE SULFATE XX + HOSPIRA XX + HOSPIRA INC XX + XX + XX + XX + XX + MERIDIAN MEDCL TECHN SOLUTION; ORAL MORPHINE SULFATE MALLINCKRODT INC AA PADDOCK LLC AA ROXANE AA AA AA + VISTAPHARM AA AA MORPHINE SULFATE LANNETT HOLDINGS INC XX TABLET; ORAL MORPHINE SULFATE ROXANE + TABLET, EXTENDED RELEASE; MORPHINE SULFATE CLONMEL HLTHCARE MALLINCKRODT
3 - 298 (of 428)
0.5MG/ML 0.5MG/ML 1MG/ML 1MG/ML 0.5MG/ML 1MG/ML 0.5MG/ML 0.5MG/ML 1MG/ML 1MG/ML 1MG/ML 0.5MG/ML 0.5MG/ML 1MG/ML 1MG/ML 10MG/ML 25MG/ML 5MG/ML 2MG/ML 4MG/ML 8MG/ML 10MG/ML 15MG/ML 15MG/ML
A071050 A071051 A071052 A071053 N018565 N018565 A071849 A073509 A071850 A073510 N019916 A073373 A073375 A073374 A073376 N018565 N018565 N019916 N202515 N202515 N202515 N202515 N202515 N019999
001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 003 004 002 001 002 003 004 005 001
Oct Oct Oct Oct
07, 07, 07, 07,
1986 1986 1986 1986
Sep 18, 1984 Sep 18, 1984 May Sep May Sep Oct Sep Sep Sep Sep 11, 30, 11, 30, 30, 30, 30, 30, 30, 1988 1992 1988 1992 1992 1991 1991 1991 1991
Jul 19, 1991 Jul 19, 1991 Oct Nov Nov Nov Nov Nov Jul 27, 14, 14, 14, 14, 14, 12, 2006 2011 2011 2011 2011 2011 1990
100MG/5ML 100MG/5ML 10MG/5ML 20MG/5ML 100MG/5ML 10MG/5ML 20MG/5ML 20MG/ML
A202348 A201574 N022195 N022195 N022195 A201947 A201947 N201517
001 001 001 002 003 001 002 001
Jul Aug Mar Mar Jan Jan Jan
15, 06, 17, 17, 25, 05, 05,
2011 2012 2008 2008 2010 2012 2012
Jun 23, 2011
XX XX
15MG 30MG ORAL 15MG 15MG 30MG 60MG 100MG 200MG 15MG 30MG 60MG 100MG 200MG 15MG 30MG
N022207 N022207
001 002
Mar 17, 2008 Mar 17, 2008
MYLAN PHARMS INC
NESHER PHARMS
A075407 A076412 A076412 A076412 A076438 A076438 A200824 A200824 A200824 A200824 A200824 A076733 A076720
001 001 002 003 001 002 001 002 003 004 005 001 002
Jan Jul Jul Jul Jul Jul Oct Oct Oct Oct Oct May Dec
28, 31, 31, 31, 03, 03, 18, 18, 18, 18, 18, 19, 23,
2000 2003 2003 2003 2003 2003 2011 2011 2011 2011 2011 2004 2005

MORPHINE SULFATE
TABLET, EXTENDED RELEASE; ORAL MORPHINE SULFATE NESHER PHARMS AB 60MG AB 100MG AB 200MG RANBAXY LABS LTD AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG RHODES PHARMS AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG VINTAGE PHARMS LLC AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG MS CONTIN PURDUE PHARMA LP AB 15MG AB 30MG AB 60MG AB + 100MG AB 200MG
3 - 299 (of 428)
A076720 A077855 A077855 A078761 A078761 A078761 A078761 A078761 A074862 A074862 A074862 A074769 A074769 A075295 A075295 A075295 A075295 A075295 N019516 N019516 N019516 N019516 N019516
001 001 002 001 002 003 004 005 001 002 003 001 002 001 002 003 004 005 003 001 002 004 005
May Sep Sep May May May May May Jul Jul Jul Jul Jul Oct Oct Oct Sep Sep Sep May Apr Jan Nov
19, 27, 27, 11, 11, 11, 11, 11, 07, 07, 07, 02, 02, 28, 28, 28, 15, 15, 12, 29, 08, 16, 08,
2004 2007 2007 2012 2012 2012 2012 2012 1998 1998 1998 1998 1998 1998 1998 1998 2000 2000 1989 1987 1988 1990 1993
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

CAPSULE, EXTENDED RELEASE; ORAL EMBEDA ALPHARMA KING 20MG;0.8MG XX 30MG;1.2MG XX 50MG;2MG XX 60MG;2.4MG XX 80MG;3.2MG XX 100MG;4MG XX +
N022321 N022321 N022321 N022321 N022321 N022321
001 002 003 004 005 006
Aug Aug Aug Aug Aug Aug
13, 13, 13, 13, 13, 13,
2009 2009 2009 2009 2009 2009
MOXIFLOXACIN HYDROCHLORIDE
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
XX + BAYER HLTHCARE 160MG/100ML SOLUTION/DROPS; OPHTHALMIC
MOXEZA
XX + ALCON PHARMS LTD EQ 0.5% BASE VIGAMOX XX + ALCON PHARMS LTD EQ 0.5% BASE TABLET; ORAL
AVELOX
XX + BAYER HLTHCARE
N021277
001
Nov 30, 2001
N022428 N021598
001 001
Nov 19, 2010 Apr 15, 2003
EQ 400MG BASE
N021085
001
Dec 10, 1999
MUPIROCIN
OINTMENT; TOPICAL BACTROBAN + GLAXOSMITHKLINE MUPIROCIN FOUGERA PHARMS GLENMARK PHARMS PERRIGO NEW YORK TARO TEVA
AB AB AB AB AB AB
2% 2% 2% 2% 2% 2%
N050591 A065192 A090480 A065123 A065170 A065085
001 001 001 001 001 001
Dec 31, 1987 Nov Jun Nov Sep Nov 30, 08, 07, 23, 07, 2005 2011 2003 2005 2003

MUPIROCIN
OINTMENT; TOPICAL CENTANY BX PERRIGO NEW YORK
3 - 300 (of 428)
2%
N050788
001
Dec 04, 2002
MUPIROCIN CALCIUM
CREAM; TOPICAL
BACTROBAN
XX + GLAXOSMITHKLINE OINTMENT; NASAL
BACTROBAN
EQ 2% BASE
N050746
001
Dec 11, 1997
EQ 2% BASE
N050703
001
Sep 18, 1995
MYCOPHENOLATE MOFETIL
CAPSULE; ORAL CELLCEPT + ROCHE PALO MYCOPHENOLATE MOFETIL ACCORD HLTHCARE INC APOTEX CORP DR REDDYS LABS LTD MYLAN ROXANE SANDOZ STRIDES ARCOLAB LTD TEVA PHARMS VINTAGE PHARMS LLC
N050722 A090253 A090419 A091315 A065520 A065410 A065379 A090055 A065491 A090111
001 001 001 001 001 001 001 001 001 001
May 03, 1995 May Apr Oct May Jul Oct Jun May Dec 04, 22, 27, 04, 29, 15, 10, 06, 22, 2009 2009 2011 2009 2008 2008 2010 2009 2009
SUSPENSION; ORAL
CELLCEPT
XX + ROCHE PALO TABLET; ORAL CELLCEPT AB + ROCHE PALO MYCOPHENOLATE MOFETIL ACCORD HLTHCARE AB ALKEM LABS LTD AB APOTEX AB MYLAN AB ROXANE AB SANDOZ AB STRIDES ARCOLAB LTD AB TEVA PHARMS AB VINTAGE PHARMS LLC AB
200MG/ML
N050759
001
Oct 01, 1998
N050723 A065416 A091249 A090499 A065521 A065413 A065451 A090456 A065457 A090606
001 001 001 001 001 001 001 001 001 001
Jun 19, 1997 May Nov Apr May Jul Oct Jun May Jul 04, 04, 22, 04, 29, 15, 10, 04, 16, 2009 2011 2009 2009 2008 2008 2010 2009 2010
MYCOPHENOLATE MOFETIL HYDROCHLORIDE

CELLCEPT
XX + ROCHE PALO
500MG/VIAL
N050758
001
Aug 12, 1998
MYCOPHENOLIC ACID
TABLET, DELAYED RELEASE; ORAL MYCOPHENOLIC ACID APOTEX INC AB 180MG MYFORTIC NOVARTIS AB 180MG MYFORTIC 360MG XX + NOVARTIS
A091558 N050791 N050791
001 001 002
Aug 21, 2012 Feb 27, 2004 Feb 27, 2004
NABILONE
CAPSULE; ORAL
CESAMET
XX + MEDA PHARMS
1MG
N018677
001
Dec 26, 1985

NABUMETONE
TABLET; ORAL NABUMETONE APOTEX INC AB AB DR REDDYS LABS LTD AB AB INVAGEN PHARMS AB AB LUPIN LTD AB AB MYLAN PHARMS INC AB AB PAR PHARM AB AB PROSAM LABS AB AB SANDOZ AB AB TEVA AB AB + WATSON LABS AB AB
3 - 301 (of 428)
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Dec Dec Sep Sep Mar Mar Jan Jan Jul Jul Jan Jan Feb Feb Feb Feb May Sep Jun Jun
30, 30, 24, 24, 07, 07, 12, 12, 12, 12, 24, 24, 27, 27, 25, 25, 26, 24, 13, 13,
2011 2011 2008 2008 2008 2008 2011 2011 2010 2010 2003 2003 2009 2009 2002 2002 2000 2001 2011 2011
NADOLOL
TABLET; ORAL CORGARD KING PHARMS AB AB AB + NADOLOL IVAX SUB TEVA PHARMS AB AB AB MYLAN AB AB AB SANDOZ AB AB AB
N018063 N018063 N018063 A074229 A074229 A074255 A074172 A074172 A074172 A074501 A074501 A074501
005 001 002 001 002 001 001 002 003 001 002 003
Oct 28, 1986
Aug Aug Jan Oct Oct Oct Nov Nov Nov
30, 30, 24, 31, 31, 31, 09, 09, 09,
1996 1996 1996 1993 1993 1993 1995 1995 1995
NAFARELIN ACETATE
SYNAREL
XX + GD SEARLE LLC
EQ 0.2MG BASE/SPRAY
N019886
001
Feb 13, 1990
NAFCILLIN SODIUM
INJECTABLE; INJECTION NAFCILLIN SODIUM ANTIBIOTICE AP AP AUROBINDO PHARMA LTD AP AP AP IBI AP AP AP SAGENT PHARMS AP AP AP AP + SANDOZ
1GM BASE 2GM BASE 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 1GM BASE/VIAL
A090560 A090560 A091613 A091613 A091614 A090002 A090002 A090005 A090582 A090582 A090580 A062527
001 002 001 002 001 001 002 001 001 002 001 002
Oct Oct Dec Dec Dec Jun Jun Apr Aug Aug Aug Aug
03, 03, 26, 26, 26, 30, 30, 20, 24, 24, 24, 02,
2011 2011 2012 2012 2012 2011 2011 2011 2012 2012 2012 1984

NAFCILLIN SODIUM
INJECTABLE; INJECTION NAFCILLIN SODIUM + SANDOZ EQ 1GM BASE/VIAL + EQ 2GM BASE/VIAL + EQ 2GM BASE/VIAL + EQ 10GM BASE/VIAL NALLPEN IN PLASTIC CONTAINER + BAXTER HLTHCARE EQ 20MG BASE/ML + EQ 2GM BASE/100ML
3 - 302 (of 428)
AP AP AP AP XX XX
A062732 A062527 A062732 A062527 N050655 N050655
001 003 002 004 001 002
Dec Aug Dec Aug
23, 02, 23, 02,
1986 1984 1986 1984
Oct 31, 1989 Oct 31, 1989
NAFTIFINE HYDROCHLORIDE
CREAM; TOPICAL
NAFTIN
XX + MERZ PHARMS XX + GEL; TOPICAL
NAFTIN
XX + MERZ PHARMS
1% 2%
N019599 N019599
001 002
Feb 29, 1988 Jan 13, 2012
1%
N019356
001
Jun 18, 1990
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION NALBUPHINE HYDROCHLORIDE + HOSPIRA 10MG/ML + 10MG/ML + 20MG/ML + 20MG/ML
AP AP AP AP
A070914 A070915 A070916 A070918
001 001 001 001
Feb Feb Feb Feb
03, 03, 03, 03,
1989 1989 1989 1989
NALOXONE HYDROCHLORIDE
INJECTABLE; INJECTION NALOXONE HYDROCHLORIDE + HOSPIRA + + + INTL MEDICATION +
AP AP AP AP AP AP
0.4MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 1MG/ML
A070172 A070254 A070256 A070257 A070639 A072076
001 001 001 001 001 001
Sep Jan Jan Jan Sep Mar
24, 07, 07, 07, 24, 24,
1986 1987 1987 1987 1986 1988
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE

TABLET; ORAL PENTAZOCINE AND NALOXONE HYDROCHLORIDE GAVIS PHARMS AB EQ 0.5MG BASE;EQ 50MG BASE PENTAZOCINE AND NALOXONE HYDROCHLORIDES RANBAXY AB EQ 0.5MG BASE;EQ 50MG BASE AB + WATSON LABS EQ 0.5MG BASE;EQ 50MG BASE
A075735 A075523 A074736
001 001 001
Jul 11, 2001 Mar 17, 2000 Jan 21, 1997
NALTREXONE
FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
VIVITROL
XX + ALKERMES 380MG/VIAL
N021897
001
Apr 13, 2006
NALTREXONE HYDROCHLORIDE
TABLET; ORAL NALTREXONE HYDROCHLORIDE ACCORD HLTHCARE 50MG BARR 50MG ELITE LABS 50MG MALLINCKRODT 50MG SANDOZ 50MG SUN PHARMA GLOBAL 50MG REVIA + DURAMED 50MG
A091205 A074918 A075274 A076264 A075434 A090356 N018932
001 001 001 002 001 001 001
Aug May May Mar Mar Feb
17, 08, 26, 22, 08, 24,
2011 1998 1999 2002 2000 2012
Nov 20, 1984

NALTREXONE HYDROCHLORIDE
TABLET; ORAL NALTREXONE HYDROCHLORIDE XX MALLINCKRODT 25MG XX 100MG
3 - 303 (of 428)
A076264 A076264
001 003
Mar 22, 2002 Mar 22, 2002
NANDROLONE DECANOATE
XX + PHARMAFORCE
200MG/ML
A091252
001
Aug 30, 2010
NAPHAZOLINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC ALBALON AT + ALLERGAN 0.1% NAPHAZOLINE HYDROCHLORIDE TAYLOR AT 0.1%
A080248 A083590
001 001
NAPROXEN
SUSPENSION; ORAL NAPROSYN AB + ROCHE PALO NAPROXEN ROXANE AB TABLET; ORAL NAPROSYN ROCHE PALO AB AB AB + NAPROXEN AMNEAL PHARMS NY AB AB AB AUROBINDO PHARMA USA AB AB AB DAVA PHARMS INC AB AB AB GLENMARK GENERICS AB AB AB INVAGEN PHARMS AB AB AB MARKSANS PHARMA AB AB AB MYLAN AB AB AB PERRIGO R AND D AB AB AB SANDOZ AB AB AB TEVA AB AB AB WATSON LABS AB
25MG/ML 25MG/ML
N018965 A074190
001 001
Mar 23, 1987 Mar 30, 1994
250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG
N017581 N017581 N017581 A075927 A075927 A075927 A200429 A200429 A200429 A074410 A074410 A074410 A078250 A078250 A078250 A091305 A091305 A091305 A091416 A091416 A091416 A074121 A074121 A074121 A077339 A077339 A077339 A074140 A074140 A074140 A074201 A074201 A074201 A074457
002 003 004 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001
Apr 15, 1982 Dec Dec Dec Nov Nov Nov Apr Apr Apr Mar Mar Mar Aug Aug Aug Feb Feb Feb Dec Dec Dec Apr Apr Apr Dec Dec Dec Dec Dec Dec May 18, 18, 18, 08, 08, 08, 28, 28, 28, 28, 28, 28, 24, 24, 24, 14, 14, 14, 21, 21, 21, 27, 27, 27, 21, 21, 21, 21, 21, 21, 31, 2001 2001 2001 2011 2011 2011 1995 1995 1995 2007 2007 2007 2011 2011 2011 2011 2011 2011 1993 1993 1993 2005 2005 2005 1993 1993 1993 1993 1993 1993 1995

NAPROXEN
TABLET; ORAL NAPROXEN WATSON LABS AB 375MG AB 500MG WESTWARD AB 250MG AB 375MG AB 500MG ZYDUS PHARMS USA AB 250MG AB 375MG AB 500MG TABLET, DELAYED RELEASE; ORAL EC-NAPROSYN AB + ROCHE PALO 375MG AB + 500MG NAPROXEN INVAGEN PHARMS AB 375MG AB 500MG MYLAN PHARMS INC AB 375MG AB 500MG PLIVA AB 375MG AB 500MG SANDOZ AB 375MG AB 500MG TEVA AB 375MG AB 500MG
3 - 304 (of 428)
A074457 A074457 A076494 A076494 A076494 A078620 A078620 A078620
002 003 001 002 003 001 002 003
May May Jan Jan Jan Jun Jun Jun
31, 31, 14, 14, 14, 07, 07, 07,
1995 1995 2004 2004 2004 2007 2007 2007
N020067 N020067 A091432 A091432 A075390 A075390 A075337 A075337 A075061 A075061 A075227 A075227
002 003 001 002 001 002 001 002 001 002 001 002
Oct 14, 1994 Oct 14, 1994 Sep Sep Apr Apr May May Feb Feb Jun Jun 19, 19, 19, 19, 26, 26, 18, 18, 30, 30, 2011 2011 2001 2001 1999 1999 1998 1998 1998 1998
NAPROXEN SODIUM
TABLET; ORAL ANAPROX HOFFMANN LA ROCHE AB ANAPROX DS AB + HOFFMANN LA ROCHE NAPROXEN SODIUM AMNEAL PHARMS NY AB AB AUROBINDO PHARMA LTD AB AB DR REDDYS LABS LTD AB AB GLENMARK GENERICS AB AB HIKMA AB AB TEVA AB AB WATSON LABS AB AB TABLET, EXTENDED RELEASE; NAPRELAN STAT TRADE XX XX XX +
EQ 250MG BASE EQ 500MG BASE EQ 250MG EQ 500MG EQ 250MG EQ 500MG EQ 250MG EQ 500MG EQ 250MG EQ 500MG EQ 250MG EQ 500MG EQ 250MG EQ 500MG EQ 250MG EQ 500MG ORAL BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N018164 N018164 A078432 A078432 A200629 A200629 A078486 A078486 A078314 A078314 A074480 A074480 A074198 A074198 A074455 A074455
001 003 001 002 001 002 001 002 001 002 002 001 001 002 001 002 Sep 30, 1987 Apr Apr Oct Oct Jul Jul Apr Apr Feb May Dec Dec May May 25, 25, 31, 31, 26, 26, 27, 27, 18, 14, 21, 21, 31, 31, 2007 2007 2011 2011 2007 2007 2007 2007 1998 1996 1993 1993 1995 1995
N020353 N020353 N020353
001 002 003
Jan 05, 1996 Jan 05, 1996 Jan 05, 1996
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE

TABLET; ORAL
TREXIMET
XX + SMITHKLINE BEECHAM
500MG;EQ 85MG BASE
N021926
001
Apr 15, 2008

NARATRIPTAN
TABLET; ORAL NARATRIPTAN APOTEX CORP AB AB SUN PHARM INDS LTD AB
3 - 305 (of 428)
EQ 1MG BASE EQ 2.5MG BASE EQ 2.5MG BASE
A091373 A091373 A091552
001 002 001
Apr 22, 2011 Apr 22, 2011 Feb 14, 2011
NARATRIPTAN HYDROCHLORIDE
TABLET; ORAL AMERGE GLAXOSMITHKLINE AB AB + NARATRIPTAN HERITAGE PHARMS INC AB AB MYLAN PHARMS INC AB AB ORCHID HLTHCARE AB AB PADDOCK LLC AB AB ROXANE AB AB SANDOZ AB AB TEVA PHARMS AB AB
EQ 1MG BASE EQ 2.5MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE
002 001 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Feb 10, 1998 Feb 10, 1998 Feb Feb May May Apr Apr Jul Jul Jul Jul Jul Jul Jul Jul 28, 28, 31, 31, 30, 30, 08, 08, 07, 07, 07, 07, 07, 07, 2011 2011 2012 2012 2012 2012 2010 2010 2010 2010 2010 2010 2010 2010
NATAMYCIN
SUSPENSION; OPHTHALMIC
NATACYN
XX + ALCON
5%
N050514
001
NATEGLINIDE
TABLET; ORAL NATEGLINIDE DR REDDYS LABS LTD AB AB PAR PHARM AB AB WATSON LABS AB AB STARLIX NOVARTIS AB AB +
A077461 A077461 A077463 A077463 A077462 A077462 N021204 N021204
001 002 001 002 001 002 001 002
Sep Sep Sep Sep Mar Mar
09, 09, 09, 09, 30, 30,
2009 2009 2009 2009 2011 2011
Dec 22, 2000 Dec 22, 2000
NEBIVOLOL HYDROCHLORIDE
TABLET; ORAL BYSTOLIC XX FOREST LABS XX XX XX +
EQ EQ EQ EQ
2.5MG BASE 5MG BASE 10MG BASE 20MG BASE
N021742 N021742 N021742 N021742
002 003 004 005
Dec Dec Dec Oct
17, 17, 17, 08,
2007 2007 2007 2008
NEDOCROMIL SODIUM
SOLUTION/DROPS; OPHTHALMIC ALOCRIL AT + ALLERGAN 2% NEDOCROMIL SODIUM AKORN AT 2%
N021009 A090638
001 001
Dec 08, 1999 Aug 22, 2012

NEFAZODONE HYDROCHLORIDE
TABLET; ORAL NEFAZODONE HYDROCHLORIDE RANBAXY AB 50MG AB 100MG AB 150MG AB 200MG AB 250MG TEVA AB 50MG AB 100MG AB 150MG AB 200MG AB + 250MG NEFAZODONE HYDROCHLORIDE BX DR REDDYS LABS INC 50MG BX 100MG BX 150MG BX 200MG BX 250MG
3 - 306 (of 428)
001 002 003 004 005 001 002 003 004 005 001 002 003 004 005
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
NELARABINE
ARRANON
250MG/50ML (5MG/ML) XX + SMITHKLINE BEECHAM
N021877
001
Oct 28, 2005
NELFINAVIR MESYLATE
POWDER; ORAL
VIRACEPT
XX + AGOURON TABLET; ORAL
VIRACEPT
XX + AGOURON XX +
EQ 50MG BASE/SCOOPFUL
N020778
001
Mar 14, 1997
N020779 N021503
001 001
Mar 14, 1997 Apr 30, 2003
NEOMYCIN SULFATE
NEO-RX
X GEN PHARMS 100% XX SOLUTION; ORAL
NEO-FRADIN
XX + X GEN PHARMS TABLET; ORAL NEOMYCIN SULFATE OMAN PHARM PRODUCTS AA AA + TEVA X GEN PHARMS AA
A061579
001
EQ 87.5MG BASE/5ML
A065010
001
May 23, 2002
500MG 500MG 500MG
A065468 A060304 A065220
001 001 001
Mar 29, 2010 Jul 28, 2006
NEOMYCIN SULFATE; POLYMYXIN B SULFATE

SOLUTION; IRRIGATION NEOMYCIN AND POLYMYXIN B SULFATE WATSON LABS AT EQ 40MG BASE/ML;200,000 X GEN PHARMS AT EQ 40MG BASE/ML;200,000 AT EQ 40MG BASE/ML;200,000 NEOSPORIN G.U. IRRIGANT AT + MONARCH PHARMS EQ 40MG BASE/ML;200,000
UNITS/ML UNITS/ML UNITS/ML UNITS/ML
A062664 A065106 A065108 A060707
001 001 001 001
Apr 08, 1986 Jan 31, 2006 Jan 31, 2006
NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE

POLY-PRED
XX + ALLERGAN EQ 0.35% BASE;10,000 UNITS/ML;0.5%
N050081
002

NEPAFENAC
NEPAFENAC
XX + ALCON RES LTD 0.3% NEVANAC XX + ALCON PHARMS LTD 0.1%
3 - 307 (of 428)
N203491 N021862
001 001
Oct 16, 2012 Aug 19, 2005
NESIRITIDE RECOMBINANT
FOR SOLUTION; INTRAVENOUS
NATRECOR
XX + SCIOS 1.5MG/VIAL
N020920
001
Aug 10, 2001
NEVIRAPINE
SUSPENSION; ORAL NEVIRAPINE AUROBINDO AA VIRAMUNE AA + BOEHRINGER INGELHEIM TABLET; ORAL NEVIRAPINE APOTEX INC AB AUROBINDO AB CIPLA AB HETERO LABS LTD III AB MICRO LABS LTD AB MYLAN LABS AB MYLAN PHARMS INC AB PRINSTON INC AB SCIEGEN PHARMS INC AB STRIDES AB VIRAMUNE AB + BOEHRINGER INGELHEIM
50MG/5ML 50MG/5ML
A077702 N020933
001 001
May 22, 2012 Sep 11, 1998
A203021 A077521 A077956 A078584 A203080 A078864 A202523 A078644 A203176 A078195 N020636
001 001 001 001 001 001 001 001 001 001 001
May May May May May May May May May May
22, 22, 22, 22, 22, 22, 22, 22, 22, 22,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
200MG TABLET, EXTENDED RELEASE; ORAL VIRAMUNE XR BOEHRINGER INGELHEIM 100MG XX 400MG XX +
Jun 21, 1996
N201152 N201152
002 001
Nov 08, 2012 Mar 25, 2011
NIACIN
TABLET; ORAL NIACIN WOCKHARDT 500MG NIACOR + UPSHER SMITH 500MG TABLET, EXTENDED RELEASE; ORAL NIASPAN ABBVIE 500MG + 750MG + 1GM
AA AA
A081134 A040378
001 001
Apr 28, 1992 May 03, 2000
XX XX XX
N020381 N020381 N020381
002 003 004
Jul 28, 1997 Jul 28, 1997 Jul 28, 1997
NIACIN; SIMVASTATIN
SIMCOR
+ ABBVIE 500MG;20MG + 500MG;40MG + 750MG;20MG + 1GM;20MG + 1GM;40MG
XX XX XX XX XX
N022078 N022078 N022078 N022078 N022078
001 004 002 003 005
Feb Jul Feb Feb Jul
15, 28, 15, 15, 28,
2008 2010 2008 2008 2010
NICARDIPINE HYDROCHLORIDE
CAPSULE; ORAL CARDENE EKR THERAP AB
20MG
N019488
001
Dec 21, 1988

CAPSULE; ORAL CARDENE + EKR THERAP 30MG NICARDIPINE HYDROCHLORIDE BARR 20MG 30MG EPIC PHARMA 20MG 30MG MYLAN 20MG 30MG TEVA 20MG 30MG WATSON LABS 20MG 30MG CAPSULE, EXTENDED RELEASE; ORAL
CARDENE SR
+ EKR THERAP 30MG + 60MG INJECTABLE; INJECTION CARDENE + EKR THERAP 25MG/10ML (2.5MG/ML) NICARDIPINE HYDROCHLORIDE BEDFORD 25MG/10ML (2.5MG/ML) BIONICHE PHARMA USA 25MG/10ML (2.5MG/ML) EXELA PHARMA SCIENCE 25MG/10ML (2.5MG/ML) NAVINTA LLC 25MG/10ML (2.5MG/ML) PHARMAFORCE 25MG/10ML (2.5MG/ML) SUN PHARMA GLOBAL 25MG/10ML (2.5MG/ML) WOCKHARDT 25MG/10ML (2.5MG/ML) INJECTABLE; INTRAVENOUS
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
+ EKR THERAP 40MG/200ML (0.2MG/ML) CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER + EKR THERAP 20MG/200ML (0.1MG/ML) CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER + EKR THERAP 20MG/200ML (0.1MG/ML) CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER + EKR THERAP 40MG/200ML (0.2MG/ML)
3 - 308 (of 428)
N019488 A074439 A074439 A074928 A074928 A074642 A074642 A074540 A074540 A074670 A074670
002 001 002 001 002 001 002 001 002 001 002
Dec 21, 1988 Dec Dec Mar Mar Jul Jul Oct Oct Oct Oct 10, 10, 19, 19, 18, 18, 28, 28, 28, 28, 1996 1996 1998 1998 1996 1996 1996 1996 1996 1996
XX XX
N020005 N020005
001 003
Feb 21, 1992 Feb 21, 1992
N019734 A078714 A090664 N022276 A090125 A090534 N078405 A090671
001 001 001 001 001 001 001 001
Jan 30, 1992 Dec Nov Jul Nov Nov Nov Nov 28, 17, 24, 17, 17, 17, 17, 2009 2009 2008 2009 2009 2009 2009
XX XX XX XX
N019734 N019734 N019734 N019734
004 003 002 005
Nov 07, 2008 Jul 31, 2008 Jul 31, 2008 Nov 07, 2008
NICOTINE
INHALANT; ORAL
NICOTROL
XX + PHARMACIA AND UPJOHN SPRAY, METERED; NASAL
NICOTROL
XX + PFIZER INC
4MG/CARTRIDGE
N020714
001
May 02, 1997
0.5MG/SPRAY
N020385
001
Mar 22, 1996
NIFEDIPINE
CAPSULE; ORAL NIFEDIPINE ACTAVIS ELIZABETH AB CATALENT AB INTERGEL PHARM AB PROCARDIA AB + PFIZER NIFEDIPINE ACTAVIS ELIZABETH XX TABLET, EXTENDED RELEASE; ADALAT CC BAYER HLTHCARE AB1 AB1 +
10MG 10MG 10MG 10MG 20MG ORAL 30MG 60MG
A072579 A073250 A072781 N018482 A072556
001 001 001 001 001
Jan 08, 1991 Oct 08, 1991 Jul 30, 1993
Sep 20, 1990
N020198 N020198
001 002
Apr 21, 1993 Apr 21, 1993

NIFEDIPINE
TABLET, EXTENDED RELEASE; ADALAT CC AB1 + BAYER HLTHCARE AFEDITAB CR WATSON LABS AB1 AB1 NIFEDIPINE MYLAN AB1 AB1 AB1 PAR PHARM AB1 AB1 AB1 VALEANT INTL AB1 AB1 AB1 NIFEDIPINE MATRIX LABS LTD AB2 AB2 AB2 MYLAN AB2 AB2 AB2 OSMOTICA PHARM AB2 AB2 AB2 VALEANT INTL AB2 AB2 PROCARDIA XL PFIZER AB2 AB2 AB2 + ORAL 90MG 30MG 60MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 30MG 60MG 90MG N020198 A075128 A075659 A201071 A201071 A201071 A077899 A077899 A077899 A075269 A075269 A076070 A090602 A090602 A090602 A090649 A090649 A090649 A077127 A077127 A077410 A075289 A075289 N019684 N019684 N019684
3 - 309 (of 428)
003 001 001 001 002 003 001 002 003 001 002 001 001 002 003 001 002 003 001 002 001 002 001 001 002 003
Apr 21, 1993 Mar 10, 2000 Oct 26, 2001 Dec Dec Dec Dec Dec May Dec Dec Aug Sep Sep Sep Jun Jun Jun Nov Nov Oct Feb Sep 03, 03, 03, 13, 13, 25, 04, 04, 16, 13, 13, 13, 21, 21, 21, 21, 21, 03, 06, 27, 2010 2010 2010 2006 2006 2012 2000 2000 2002 2010 2010 2010 2010 2010 2010 2005 2005 2007 2001 2000
Sep 06, 1989 Sep 06, 1989 Sep 06, 1989
NILOTINIB HYDROCHLORIDE MONOHYDRATE

CAPSULE; ORAL TASIGNA XX NOVARTIS XX +
N022068 N022068
002 001
Jun 17, 2010 Oct 29, 2007
NILUTAMIDE
TABLET; ORAL NILANDRON XX + SANOFI AVENTIS US
150MG
N020169
002
Apr 30, 1999
NIMODIPINE
CAPSULE; ORAL NIMODIPINE BANNER PHARMACAPS AB BARR LABS INC AB AB + SUN PHARM INDS INC
30MG 30MG 30MG
A076740 A077811 A077067
001 001 001
Jan 17, 2008 May 02, 2007 Apr 17, 2007
NISOLDIPINE
TABLET, EXTENDED RELEASE; ORAL NISOLDIPINE MYLAN AB 8.5MG AB 17MG AB 25.5MG AB 34MG SULAR AB + SHIONOGI INC 8.5MG
A091001 A091001 A091001 A091001 N020356
001 002 003 004 008
Jan Jan Jan Jan
26, 26, 26, 26,
2011 2011 2011 2011
Jan 02, 2008

NISOLDIPINE
TABLET, EXTENDED RELEASE; ORAL SULAR AB + SHIONOGI INC 17MG AB 25.5MG AB + 34MG NISOLDIPINE 20MG XX + MYLAN 30MG XX + 40MG XX +
3 - 310 (of 428)
N020356 N020356 N020356 A079051 A079051 A079051
007 006 005 001 002 003
Jan 02, 2008 Jan 02, 2008 Jan 02, 2008 Jul 25, 2008 Jul 25, 2008 Jul 25, 2008
NITAZOXANIDE
ALINIA
XX + ROMARK TABLET; ORAL
ALINIA
XX + ROMARK
100MG/5ML
N021498
001
Nov 22, 2002
500MG
N021497
001
Jul 21, 2004
NITISINONE
CAPSULE; ORAL ORFADIN XX RARE DIS XX XX +
2MG 5MG 10MG
N021232 N021232 N021232
001 002 003
Jan 18, 2002 Jan 18, 2002 Jan 18, 2002
NITRIC OXIDE
GAS; INHALATION INOMAX XX INO XX +
100PPM 800PPM
N020845 N020845
002 003
Dec 23, 1999 Dec 23, 1999
NITROFURANTOIN
SUSPENSION; ORAL FURADANTIN AB + SHIONOGI INC NITROFURANTOIN AMNEAL PHARMS AB
25MG/5ML 25MG/5ML
N009175 A201679
001 001 May 11, 2011
NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE; ORAL MACRODANTIN ALMATICA AB AB AB + NITROFURANTOIN IVAX SUB TEVA PHARMS AB AB MYLAN AB AB WATSON LABS AB AB AB
N016620 N016620 N016620 A073671 A073652 A074967 A077025 A073696 A073696 A073696
003 001 002 001 001 001 001 001 002 003 Jan Jan Jul Aug Dec Dec Dec 28, 28, 09, 18, 31, 31, 31, 1993 1993 1997 2004 1992 1992 1992
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

CAPSULE; ORAL MACROBID AB + ALMATICA 75MG;25MG NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) MYLAN AB 75MG;25MG SANDOZ AB 75MG;25MG
N020064 A076648 A077066
001 001 001
Dec 24, 1991 Mar 22, 2004 Apr 05, 2005

NITROGLYCERIN
AEROSOL, METERED; SUBLINGUAL
NITROMIST
XX + NOVADEL 0.4MG/SPRAY FILM, EXTENDED RELEASE; TRANSDERMAL MINITRAN MEDICIS AB1 0.1MG/HR AB1 0.2MG/HR AB1 0.4MG/HR AB1 0.6MG/HR NITRO-DUR AB1 + KEY PHARMS 0.1MG/HR AB1 + 0.2MG/HR AB1 + 0.4MG/HR AB1 + 0.6MG/HR NITROGLYCERIN KREMERS URBAN PHARMS 0.2MG/HR AB1 AB1 0.4MG/HR NITROGLYCERIN HERCON PHARM AB2 0.2MG/HR AB2 0.4MG/HR AB2 0.6MG/HR AB2 + MYLAN TECHNOLOGIES 0.2MG/HR AB2 + 0.4MG/HR AB2 + 0.6MG/HR NITRO-DUR 0.3MG/HR XX + KEY PHARMS 0.8MG/HR XX + NITROGLYCERIN 0.1MG/HR XX + MYLAN TECHNOLOGIES INJECTABLE; INJECTION NITROGLYCERIN + HOSPIRA 5MG/ML + LUITPOLD 5MG/ML NITROGLYCERIN IN DEXTROSE 5% + BAXTER HLTHCARE 10MG/100ML + 20MG/100ML + 40MG/100ML HOSPIRA 10MG/100ML 20MG/100ML 40MG/100ML OINTMENT; INTRA-ANAL
RECTIV
+ APTALIS PHARMA 0.4% OINTMENT; TRANSDERMAL
NITROGLYCERIN
+ FOUGERA 2% SPRAY, METERED; SUBLINGUAL
NITROLINGUAL PUMPSPRAY
+ POHL BOSKAMP 0.4MG/SPRAY TABLET; SUBLINGUAL NITROSTAT PFIZER PHARMS 0.3MG 0.4MG + 0.6MG
3 - 311 (of 428)
N021780
001
Nov 02, 2006
A089771 A089772 A089773 A089774 N020145 N020145 N020145 N020145 A075115 A075115 A089884 A089885 A089886 A074559 A074559 A074559 N020145 N020145 A074559
001 001 001 001 001 002 004 005 001 002 001 001 001 003 002 001 003 006 004
Aug Aug Aug Aug Apr Apr Apr Apr
30, 30, 30, 30, 04, 04, 04, 04,
1996 1996 1996 1996 1995 1995 1995 1995
Aug 10, 2004 Aug 10, 2004 Oct Oct Oct Aug Aug Aug 30, 30, 30, 30, 30, 30, 1998 1998 1998 1996 1996 1996
Apr 04, 1995 Apr 04, 1995 Feb 06, 1998
N018531 A072034 N019970 N019970 N019970 A071846 A071847 A071848
001 001 001 002 003 001 001 001
May 24, 1988 Dec Dec Dec Aug Aug Aug 29, 29, 29, 31, 31, 31, 1989 1989 1989 1990 1990 1990
XX
N021359
001
Jun 21, 2011
XX
A087355
001
Jul 08, 1988
XX
N018705
002
Jan 10, 1997
XX XX XX
N021134 N021134 N021134
001 002 003
May 01, 2000 May 01, 2000 May 01, 2000
NIZATIDINE
CAPSULE; ORAL NIZATIDINE APOTEX AB AB DR REDDYS LABS LTD AB
150MG 300MG 150MG
A076383 A076383 A077314
001 002 001
Jan 23, 2003 Jan 23, 2003 Sep 15, 2005

NIZATIDINE
CAPSULE; ORAL NIZATIDINE DR REDDYS LABS LTD AB GLENMARK GENERICS AB AB MYLAN PHARMS INC AB AB + SANDOZ AB AB TEVA AB AB WATSON LABS AB AB SOLUTION; ORAL AXID AA + BRAINTREE NIZATIDINE AMNEAL PHARMS AA
3 - 312 (of 428)
A077314 A090618 A090618 A075806 A075806 A076178 A076178 A075668 A075668 A075616 A075616
002 001 002 001 002 001 002 001 002 001 002
Sep Jul Jul Jul Jul Jul Jul Sep Sep Jul Jul
15, 15, 15, 05, 05, 05, 05, 12, 12, 09, 09,
2005 2011 2011 2002 2002 2002 2002 2002 2002 2002 2002
15MG/ML 15MG/ML
N021494 A090576
001 001
May 25, 2004 Nov 18, 2009
NOREPINEPHRINE BITARTRATE
INJECTABLE; INJECTION LEVOPHED + HOSPIRA EQ NOREPINEPHRINE BITARTRATE BEDFORD EQ CLARIS LIFESCIENCES EQ TEVA PARENTERAL EQ
AP AP AP AP
N007513 A040462 A040859 A040455
001 001 001 001 Oct 31, 2003 Mar 27, 2012 Mar 03, 2003
NORETHINDRONE
TABLET; ORAL-28 CAMILA BARR AB1 HEATHER GLENMARK GENERICS AB1 NORETHINDRONE LUPIN LTD AB1 NOR-QD AB1 + WATSON LABS (UTAH) ERRIN BARR AB2 MICRONOR AB2 + JANSSEN PHARMS NORETHIDRONE GLENMARK GENERICS AB2
0.35MG 0.35MG 0.35MG 0.35MG 0.35MG 0.35MG 0.35MG
A076177 A090454 A091325 N017060 A076225 N016954 A091209
001 001 001 001 001 001 001
Oct 21, 2002 Apr 23, 2010 Sep 19, 2011
Oct 21, 2002
Jul 21, 2010
NORETHINDRONE ACETATE
TABLET; ORAL AYGESTIN + DURAMED RES NORETHIDRONE ACETATE AMNEAL PHARMS NORETHINDRONE ACETATE BARR GLENMARK GENERICS
AB AB AB AB
5MG 5MG 5MG 5MG
N018405 A200275 A075951 A091090
001 001 001 001
Apr 21, 1982 Jul 30, 2012 May 25, 2001 Jul 21, 2010
NORFLOXACIN
TABLET; ORAL NOROXIN XX + MERCK
400MG
N019384
002
Oct 31, 1986

NORTRIPTYLINE HYDROCHLORIDE
CAPSULE; ORAL NORTRIPTYLINE HYDROCHLORIDE MYLAN EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG AB TARO EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG AB TEVA EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG AB WATSON LABS EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG AB PAMELOR MALLINCKRODT LLC AB EQ 10MG AB EQ 25MG AB EQ 50MG AB + EQ 75MG SOLUTION; ORAL AVENTYL HYDROCHLORIDE AA + RANBAXY EQ 10MG NORTRIPTYLINE HYDROCHLORIDE PHARM ASSOC EQ 10MG AA TARO EQ 10MG AA
3 - 313 (of 428)
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A074234 A074234 A074234 A074234 A075520 A075520 A075520 A075520 A074132 A074132 A074132 A074132 A073553 A073554 A073555 A073556 N018013 N018013 N018013 N018013
001 002 003 004 004 003 001 002 001 002 003 004 001 001 001 001 001 002 004 003
Jul Jul Jul Jul May May May May Mar Mar Mar Mar Mar Mar Mar Mar
26, 26, 26, 26, 08, 08, 08, 08, 27, 27, 27, 27, 30, 30, 30, 30,
1993 1993 1993 1993 2000 2000 2000 2000 1995 1995 1995 1995 1992 1992 1992 1992
BASE/5ML BASE/5ML BASE/5ML
N014685 A075606 A077965
001 001 001 Aug 28, 2000 Jun 20, 2006
NYSTATIN
CREAM; TOPICAL NYSTATIN ACTAVIS MID ATLANTIC FOUGERA PHARMS PERRIGO NEW YORK + TARO VINTAGE
AT AT AT AT AT
100,000 100,000 100,000 100,000 100,000
UNITS/GM UNITS/GM UNITS/GM UNITS/GM UNITS/GM
A062949 A062129 A062225 A064022 A065315
001 001 001 001 001
Jun 13, 1988
Jan 29, 1993 May 31, 2006
OINTMENT; TOPICAL NYSTATIN ACTAVIS MID ATLANTIC AT AT + FOUGERA PHARMS PERRIGO NEW YORK AT POWDER; TOPICAL NYSTATIN AT + COASTAL PHARMS GAVIS PHARMS AT UPSHER SMITH AT X GEN PHARMS AT NYSTOP PADDOCK LLC AT SUSPENSION; ORAL NILSTAT + GLENMARK GENERICS NYSTATIN ACTAVIS MID ATLANTIC FOUGERA HI TECH PHARMA TARO VINTAGE PHARMS
100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM
A062840 A062124 A062472
001 002 001
Nov 13, 1987 Sep 23, 1982 Feb 13, 1984
100,000 100,000 100,000 100,000
UNITS/GM UNITS/GM UNITS/GM UNITS/GM
A065203 A065138 A065183 A065175 A064118
001 001 001 001 001
Jul Jul May Dec
15, 23, 03, 17,
2004 2004 2005 2004
100,000 UNITS/GM
Aug 16, 1996
AA AA AA AA AA AA
100,000 UNITS/ML 100,000 100,000 100,000 100,000 100,000 UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML
N050299 A062349 A062517 A064042 A062876 A065148
001 001 001 001 001 001 Jul Jun Feb Feb Jun 14, 07, 28, 29, 28, 1982 1984 1994 1988 2005

NYSTATIN
SUSPENSION; ORAL NYSTATIN VISTAPHARM AA AA AA + WOCKHARDT TABLET; ORAL NYSTATIN HERITAGE PHARMS INC AA MUTUAL PHARM AA AA + TEVA TABLET; VAGINAL
NYSTATIN
XX + ODYSSEY PHARMS
3 - 314 (of 428)
100,000 UNITS/ML 100,000 UNITS/ML 100,000 UNITS/ML
A064142 A065422 A062512
001 001 001
Jun 25, 1998 Mar 07, 2011 Oct 29, 1984
500,000 UNITS 500,000 UNITS 500,000 UNITS
A062474 A062838 A062506
001 001 001
Dec 22, 1983 Dec 22, 1988 Jan 16, 1984
100,000 UNITS
A062615
001
Oct 17, 1985
NYSTATIN; TRIAMCINOLONE ACETONIDE

CREAM; TOPICAL NYSTATIN AND TRIAMCINOLONE ACETONIDE FOUGERA 100,000 UNITS/GM;0.1% + TARO 100,000 UNITS/GM;0.1% OINTMENT; TOPICAL NYSTATIN AND TRIAMCINOLONE ACETONIDE FOUGERA 100,000 UNITS/GM;0.1% + TARO 100,000 UNITS/GM;0.1%
AT AT
A062599 A062364
001 001
Oct 08, 1985 Dec 22, 1987
AT AT
A062602 A063305
001 001
Oct 09, 1985 Mar 29, 1993
OCTREOTIDE ACETATE
INJECTABLE; INJECTION OCTREOTIDE ACETATE AP + BEDFORD EQ 0.2MG BASE/ML AP + EQ 1MG BASE/ML FRESENIUS KABI USA AP EQ 0.2MG BASE/ML AP EQ 1MG BASE/ML SUN PHARM INDS AP EQ 0.05MG BASE/ML AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.2MG BASE/ML AP EQ 0.2MG BASE/ML AP EQ 0.5MG BASE/ML AP EQ 0.5MG BASE/ML AP EQ 1MG BASE/ML AP EQ 1MG BASE/ML TEVA PARENTERAL AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.2MG BASE/ML AP EQ 0.5MG BASE/ML AP EQ 1MG BASE/ML WOCKHARDT USA AP EQ 0.2MG BASE/ML AP EQ 1MG BASE/ML OCTREOTIDE ACETATE (PRESERVATIVE FREE) AP + BEDFORD EQ 0.05MG BASE/ML AP + EQ 0.1MG BASE/ML AP + EQ 0.5MG BASE/ML FRESENIUS KABI USA AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.5MG BASE/ML MYLAN INSTITUTIONAL AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.5MG BASE/ML WOCKHARDT USA AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML
A076330 A076330 A077450 A077450 A077329 A077372 A077329 A077372 A077330 A077373 A077329 A077372 A077331 A077373 A075957 A075957 A075959 A075957 A075959 A090986 A090986 A076313 A076313 A076313 A077457 A077457 A077457 A079198 A079198 A079198 A090985 A090985
001 002 001 002 001 001 002 002 001 001 003 003 001 002 001 002 001 003 002 001 002 001 003 002 001 002 003 001 002 003 001 002
Apr Apr Feb Feb Mar Aug Mar Aug Mar Aug Mar Aug Mar Aug Oct Oct Nov Oct Nov May May Mar Mar Mar Feb Feb Feb Feb Feb Feb May May
08, 08, 10, 10, 04, 14, 04, 14, 04, 14, 04, 14, 04, 14, 03, 03, 21, 03, 21, 11, 11, 28, 28, 28, 10, 10, 10, 10, 10, 10, 11, 11,
2005 2005 2006 2006 2008 2007 2008 2007 2008 2007 2008 2007 2008 2007 2005 2005 2005 2005 2005 2011 2011 2005 2005 2005 2006 2006 2006 2011 2011 2011 2011 2011

OCTREOTIDE ACETATE
INJECTABLE; INJECTION OCTREOTIDE ACETATE (PRESERVATIVE FREE) WOCKHARDT USA EQ 0.5MG BASE/ML SANDOSTATIN + NOVARTIS EQ 0.05MG BASE/ML + EQ 0.1MG BASE/ML + EQ 0.2MG BASE/ML + EQ 0.5MG BASE/ML + EQ 1MG BASE/ML SANDOSTATIN LAR NOVARTIS EQ 10MG BASE/VIAL EQ 20MG BASE/VIAL + EQ 30MG BASE/VIAL
3 - 315 (of 428)
AP AP AP AP AP AP XX XX XX
A090985 N019667 N019667 N019667 N019667 N019667 N021008 N021008 N021008
003 001 002 004 003 005 001 002 003
May 11, 2011 Oct Oct Jun Oct Jun 21, 21, 12, 21, 12, 1988 1988 1991 1988 1991
Nov 25, 1998 Nov 25, 1998 Nov 25, 1998
OFLOXACIN
SOLUTION/DROPS; OPHTHALMIC OCUFLOX + ALLERGAN 0.3% OFLOXACIN AKORN 0.3% ALCON PHARMS LTD 0.3% BAUSCH AND LOMB 0.3% FDC LTD 0.3% FERA PHARMS 0.3% HI TECH PHARMA 0.3% NOVEX 0.3% SOLUTION/DROPS; OTIC FLOXIN OTIC + DAIICHI 0.3% OFLOXACIN ALCON PHARMS LTD 0.3% APOTEX INC 0.3% BAUSCH AND LOMB 0.3% FERA PHARMS 0.3% HI TECH PHARMA 0.3% TABLET; ORAL OFLOXACIN DR REDDYS LABS LTD 200MG 300MG 400MG TEVA 200MG 300MG + 400MG
N019921 A076407 A076231 A076622 A078559 A076830 A076615 A076513
001 001 001 001 001 001 001 001
Jul 30, 1993 Apr May May Feb Aug May May 15, 14, 14, 25, 31, 14, 14, 2008 2004 2004 2009 2004 2004 2004
AT AT AT AT AT AT
N020799 A078222 A076527 A076128 A090395 A076616
001 001 001 001 001 001
Dec 16, 1997 Mar Sep Mar Aug Mar 17, 28, 17, 11, 17, 2008 2007 2008 2009 2008
AB AB AB AB AB AB
A077098 A077098 A077098 A076182 A076182 A076182
001 002 003 001 002 003
Feb Feb Feb Sep Sep Sep
10, 10, 10, 02, 02, 02,
2006 2006 2006 2003 2003 2003
OLANZAPINE
INJECTABLE; INTRAMUSCULAR OLANZAPINE LUITPOLD AP 10MG/VIAL SANDOZ INC AP 10MG/VIAL ZYPREXA AP + LILLY 10MG/VIAL TABLET; ORAL OLANZAPINE APOTEX INC AB 2.5MG AB 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG AUROBINDO PHARMA LTD 2.5MG AB
A201741 A201588 N021253
001 001 001
Mar 20, 2012 Oct 24, 2011 Mar 29, 2004
A090798 A090798 A090798 A090798 A090798 A090798 A202050
001 002 003 004 005 006 001
Apr Apr Apr Apr Apr Apr Apr
23, 23, 23, 23, 23, 23, 23,
2012 2012 2012 2012 2012 2012 2012

OLANZAPINE
TABLET; ORAL OLANZAPINE AUROBINDO PHARMA LTD 5MG AB AB 7.5MG AB 10MG AB 15MG AB 20MG DR REDDYS LABS LTD AB 2.5MG AB 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG MYLAN AB 2.5MG AB 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG ORCHID HLTHCARE AB 2.5MG AB 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG SUN PHARM INDS AB 2.5MG AB 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG TEVA PHARMS AB 2.5MG AB 5MG AB 7.5MG AB 10MG AB 15MG TORRENT PHARMS LTD AB 2.5MG AB 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG ZYPREXA LILLY AB 2.5MG AB + 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG TABLET, ORALLY DISINTEGRATING; ORAL OLANZAPINE APOTEX INC AB 5MG AB 10MG AB 15MG AB 20MG BARR LABS INC AB 5MG AB 10MG AB 15MG AB 20MG DR REDDYS LABS LTD AB 5MG
3 - 316 (of 428)
A202050 A202050 A202050 A202050 A202050 A076255 A076255 A076255 A076255 A076133 A076133 A076866 A076866 A076866 A076866 A076866 A076866 A202287 A202287 A202287 A202287 A202287 A202287 A091038 A091038 A091038 A091038 A091038 A091038 A076000 A076000 A076000 A076000 A076000 A091434 A091434 A091434 A091434 A091434 A091434 N020592 N020592 N020592 N020592 N020592 N020592
002 003 004 005 006 001 002 003 004 001 002 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 001 002 003 004 005 006 001 002 003 004 005 006
Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Oct Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Oct Oct Oct Oct Oct Apr Apr Apr Apr Apr Apr Sep Sep Sep Sep Sep Sep
23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 24, 24, 24, 23, 23, 23, 23, 23, 23, 30, 30, 30, 30, 09, 09,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2011 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2011 2011 2011 2011 2011 2012 2012 2012 2012 2012 2012 1996 1996 1996 1996 1997 1997
A091265 A091265 A091265 A091265 A077243 A077243 A077243 A077243 A076534
001 002 003 004 001 002 003 004 001
Oct Oct Oct Oct Jan Jan Jan Jan Oct
24, 24, 24, 24, 30, 30, 30, 30, 24,
2011 2011 2011 2011 2012 2012 2012 2012 2011

OLANZAPINE
TABLET, ORALLY DISINTEGRATING; ORAL OLANZAPINE DR REDDYS LABS LTD 10MG 15MG 20MG JUBILANT ORGANOSYS 5MG 10MG 15MG 20MG PAR PHARM 5MG 10MG 15MG 20MG SUN PHARM INDS 5MG 10MG 15MG 20MG TORRENT PHARMS LLC 5MG 10MG 15MG 20MG ZYPREXA ZYDIS + LILLY 5MG 10MG 15MG 20MG
3 - 317 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A076534 A076534 A076534 A200221 A200221 A200221 A200221 A078109 A078109 A078109 A078109 A090881 A090881 A090881 A090881 A091415 A091415 A091415 A091415 N021086 N021086 N021086 N021086
002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Oct Oct Oct Sep Sep Sep Sep Oct Oct Oct Oct Feb Feb Feb Feb Oct Oct Oct Oct Apr Apr Apr Apr
24, 24, 24, 12, 12, 12, 12, 24, 24, 24, 24, 28, 28, 28, 28, 25, 25, 25, 25, 06, 06, 06, 06,
2011 2011 2011 2012 2012 2012 2012 2011 2011 2011 2011 2012 2012 2012 2012 2011 2011 2011 2011 2000 2000 2000 2000
OLANZAPINE PAMOATE
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR ZYPREXA RELPREVV ELI LILLY CO EQ 210MG BASE/VIAL XX EQ 300MG BASE/VIAL XX EQ 405MG BASE/VIAL XX +
N022173 N022173 N022173
001 002 003
Dec 11, 2009 Dec 11, 2009 Dec 11, 2009
OLMESARTAN MEDOXOMIL
TABLET; ORAL BENICAR XX DAIICHI SANKYO XX XX +
5MG 20MG 40MG
N021286 N021286 N021286
001 003 004
Apr 25, 2002 Apr 25, 2002 Apr 25, 2002
OLOPATADINE HYDROCHLORIDE
PATADAY
XX + ALCON PHARMS LTD EQ 0.2% BASE PATANOL EQ 0.1% BASE XX + ALCON SPRAY, METERED; NASAL
PATANASE
N021545 N020688
001 001
Dec 22, 2004 Dec 18, 1996
0.665MG/SPRAY
N021861
001
Apr 15, 2008
OLSALAZINE SODIUM
CAPSULE; ORAL
DIPENTUM
XX + MEDA PHARMS
250MG
N019715
001
Jul 31, 1990
OMACETAXINE MEPESUCCINATE
POWDER; SUBCUTANEOUS
SYNRIBO
XX + IVAX INTL
3.5MG/VIAL
N203585
001
Oct 26, 2012

OMEGA-3-ACID ETHYL ESTERS
CAPSULE; ORAL
LOVAZA
XX + SMITHKLINE BEECHAM
3 - 318 (of 428)
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
N021654
001
Nov 10, 2004
OMEPRAZOLE
CAPSULE, DELAYED REL PELLETS; ORAL OMEPRAZOLE APOTEX AB 10MG AB 20MG AB 40MG DR REDDYS LABS LTD AB 10MG AB 10MG AB 20MG AB 20MG AB 40MG AB 40MG IMPAX LABS AB 10MG AB 20MG AB 40MG KREMERS URBAN PHARMS 10MG AB AB 20MG AB 40MG MYLAN AB 10MG AB 20MG AB 40MG SANDOZ AB 10MG AB 20MG AB 40MG WATSON LABS FLORIDA AB 10MG AB 20MG AB 40MG ZYDUS PHARMS USA INC 10MG AB AB 20MG AB 40MG PRILOSEC ASTRAZENECA AB 10MG AB + 20MG AB + 40MG
A076048 A076048 A076048 A075576 A078490 A075576 A078490 A075576 A078490 A075785 A075785 A075785 A075410 A075410 A075410 A075876 A075876 A075876 A075757 A075757 A076515 A075347 A075347 A075347 A091352 A091352 A091352 N019810 N019810 N019810
001 002 003 003 002 002 003 001 001 001 002 003 001 002 003 001 002 003 001 002 001 001 002 003 001 002 003 003 001 002
Oct Oct Jan Oct Mar Oct Mar Jan Apr Oct Oct Jan Nov Nov Jan May May Jan Jan Jan Jan May May May Nov Nov Nov
22, 22, 21, 22, 16, 22, 16, 21, 17, 22, 22, 21, 01, 01, 23, 29, 29, 21, 28, 28, 21, 30, 30, 30, 19, 19, 19,
2007 2007 2009 2007 2009 2007 2009 2009 2009 2007 2007 2009 2002 2002 2009 2003 2003 2009 2003 2003 2009 2008 2008 2008 2012 2012 2012
Oct 05, 1995 Sep 14, 1989 Jan 15, 1998
OMEPRAZOLE MAGNESIUM
FOR SUSPENSION, DELAYED RELEASE; ORAL PRILOSEC XX ASTRAZENECA EQ 2.5MG BASE/PACKET XX + EQ 10MG BASE/PACKET
N022056 N022056
001 002
Mar 20, 2008 Mar 20, 2008
OMEPRAZOLE; SODIUM BICARBONATE

CAPSULE; ORAL OMEPRAZOLE AND SODIUM BICARBONATE PAR PHARM AB 20MG;1.1GM AB 40MG;1.1GM ZEGERID SANTARUS AB 20MG;1.1GM AB + 40MG;1.1GM FOR SUSPENSION; ORAL ZEGERID SANTARUS 20MG/PACKET;1.68GM/PACKET XX 40MG/PACKET;1.68GM/PACKET XX +
A078966 A078966 N021849 N021849
001 002 001 002
May 25, 2010 May 25, 2010 Feb 27, 2006 Feb 27, 2006
N021636 N021636
001 002
Jun 15, 2004 Dec 21, 2004

ONDANSETRON
FILM; ORAL ZUPLENZ XX VESTIQ PHARMS XX +
3 - 319 (of 428)
4MG 8MG
N022524 N022524
001 002
Jul 02, 2010 Jul 02, 2010
TABLET, ORALLY DISINTEGRATING; ORAL ONDANSETRON AUROBINDO PHARMA 4MG 8MG BARR 4MG 8MG GLENMARK GENERICS 4MG 8MG MYLAN 4MG 8MG RANBAXY 4MG 8MG SANDOZ 4MG 8MG SUN PHARM INDS 4MG 8MG TEVA 4MG 8MG ZOFRAN ODT GLAXOSMITHKLINE 4MG + 8MG
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Apr Apr Jun Jun Jun Jun Jun Jun Feb Feb Aug Aug Aug Aug Jun Jun
12, 12, 25, 25, 27, 27, 25, 25, 24, 24, 13, 13, 02, 02, 25, 25,
2010 2010 2007 2007 2007 2007 2007 2007 2011 2011 2007 2007 2007 2007 2007 2007
Jan 27, 1999 Jan 27, 1999
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION ONDANSETRON HYDROCHLORIDE APOTEX EQ 2MG BASE/ML AUROBINDO PHARMA LTD EQ 2MG BASE/ML BEDFORD EQ 2MG BASE/ML EMCURE PHARMS EQ 2MG BASE/ML FRESENIUS KABI USA EQ 2MG BASE/ML GLAND PHARMA LTD EQ 2MG BASE/ML EQ 2MG BASE/ML HIKMA FARMACEUTICA EQ 2MG BASE/ML HIKMA MAPLE EQ 2MG BASE/ML HOSPIRA EQ 2MG BASE/ML EQ 2MG BASE/ML LANNETT EQ 2MG BASE/ML EQ 2MG BASE/ML LUITPOLD EQ 2MG BASE/ML EQ 2MG BASE/ML PFIZER EQ 2MG BASE/ML PLIVA HRVATSKA DOO EQ 2MG BASE/ML SANDOZ EQ 2MG BASE/ML SUN PHARM INDS (IN) EQ 2MG BASE/ML TEVA EQ 2MG BASE/ML WOCKHARDT EQ 2MG BASE/ML ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER BEDFORD LABS EQ 0.64MG BASE/ML CLARIS LIFESCIENCES EQ 0.64MG BASE/ML + HOSPIRA EQ 0.64MG BASE/ML ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE APOTEX INC EQ 2MG BASE/ML AUROBINDO PHARMA LTD EQ 2MG BASE/ML BEDFORD LABS EQ 2MG BASE/ML EMCURE PHARMS LTD EQ 2MG BASE/ML FRESENIUS KABI USA EQ 2MG BASE/ML
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A077368 A202599 A076967 A090424 A076974 A079224 A090648 A076781 A077365 A077473 A077840 A090116 A090883 A077582 A079039 A078257 A077544 A077430 A077172 A076876 A077577 A078291 A078308 A077348 A077343 A202600 A077011 A078945 A076972
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Dec Dec Dec Apr Dec Sep Jun Dec Dec Dec Jan Apr Aug Dec Nov Apr Dec Jun Dec Nov Dec
26, 21, 26, 16, 26, 25, 15, 26, 26, 26, 19, 14, 05, 26, 18, 23, 26, 27, 26, 22, 26,
2006 2012 2006 2010 2006 2009 2012 2006 2006 2006 2007 2010 2010 2006 2008 2008 2006 2007 2006 2006 2006
Apr 13, 2009 Mar 17, 2008 Feb 01, 2007 Dec Dec Dec Jan Dec 26, 21, 26, 03, 26, 2006 2012 2006 2013 2006

INJECTABLE; INJECTION ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE HIKMA FARMACEUTICA EQ 2MG BASE/ML HIKMA MAPLE EQ 2MG BASE/ML HOSPIRA EQ 2MG BASE/ML LUITPOLD EQ 2MG BASE/ML EQ 2MG BASE/ML PFIZER EQ 2MG BASE/ML SANDOZ EQ 2MG BASE/ML SUN PHARM INDS LTD EQ 2MG BASE/ML TARO PHARMS IRELAND EQ 2MG BASE/ML TEVA EQ 2MG BASE/ML WOCKHARDT EQ 2MG BASE/ML ZOFRAN + GLAXOSMITHKLINE EQ 2MG BASE/ML ZOFRAN PRESERVATIVE FREE + GLAXOSMITHKLINE EQ 2MG BASE/ML SOLUTION; ORAL ONDANSETRON HYDROCHLORIDE AMNEAL PHARMS EQ 4MG BASE/5ML APOTEX EQ 4MG BASE/5ML AUROBINDO PHARMA EQ 4MG BASE/5ML ROXANE EQ 4MG BASE/5ML SILARX EQ 4MG BASE/5ML TARO EQ 4MG BASE/5ML ZOFRAN + GLAXOSMITHKLINE EQ 4MG BASE/5ML TABLET; ORAL ONDANSETRON HYDROCHLORIDE APOTEX EQ 4MG BASE EQ 8MG BASE AUROBINDO PHARMA EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE DR REDDYS LABS LTD EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE GLENMARK GENERICS EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE MYLAN EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE NATCO PHARMA LTD EQ 4MG BASE EQ 8MG BASE PLIVA HRVATSKA DOO EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE SANDOZ EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE SUN PHARM INDS (IN) EQ 4MG BASE EQ 8MG BASE TARO EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE TEVA EQ 4MG BASE EQ 8MG BASE EQ 24MG BASE
3 - 320 (of 428)
A076780 A077541 A077548 A077387 A079032 A078244 A077551 A077173 A078014 A076759 A077716 N020007 N020007
001 001 001 001 001 001 001 001 001 001 001 001 003
Dec Dec Dec Dec Nov Apr Jun Dec Mar Nov Dec
26, 26, 26, 26, 18, 23, 27, 26, 21, 22, 26,
2006 2006 2006 2006 2008 2008 2007 2006 2008 2006 2006
Jan 04, 1991 Dec 10, 1993
A091483 A078127 A078776 A076960 A091342 A077009 N020605
001 001 001 001 001 001 001
Jan Jun Nov Dec Jan Nov
31, 25, 28, 26, 27, 30,
2011 2007 2007 2006 2011 2007
Jan 24, 1997
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 001 002 003 003 002 001 001 002 003 001 002 004 001 002 001 002 003 001 002 003 001 002 001 002 003 001 002 003
Jun Jun Jul Jul Jul Dec Dec Dec Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Mar Mar Mar Jun Jun Jun
25, 25, 31, 31, 31, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 28, 28, 28, 25, 25, 25,
2007 2007 2007 2007 2007 2006 2006 2006 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2011 2011 2011 2007 2007 2007

TABLET; ORAL ZOFRAN GLAXOSMITHKLINE AB EQ AB EQ AB + EQ ONDANSETRON HYDROCHLORIDE DR REDDYS LABS LTD EQ XX
3 - 321 (of 428)
N020103 N020103 N020103 A076183
001 002 003 004
Dec 31, 1992 Dec 31, 1992 Aug 27, 1999 Dec 26, 2006
ORLISTAT
CAPSULE; ORAL
XENICAL
120MG
N020766
001
Apr 23, 1999
ORPHENADRINE CITRATE
INJECTABLE; INJECTION NORFLEX + MEDICIS ORPHENADRINE CITRATE AKORN BEDFORD LABS SAGENT PHARMS WATSON LABS
AP AP AP AP AP AP
30MG/ML
N013055 A040484 A040463 A090585 A084779 A087062
001 001 001 001 001 001 May Mar Aug Mar 24, 04, 30, 15, 2006 2003 2011 1982
AB AB AB AB AB
30MG/ML 30MG/ML 30MG/ML 30MG/ML 30MG/ML TABLET, EXTENDED RELEASE; ORAL ORPHENADRINE CITRATE CNTY LINE PHARMS 100MG GAVIS PHARMS 100MG IMPAX PHARMS 100MG INVAGEN PHARMS 100MG + SANDOZ 100MG
A040249 A040284 A040368 A091158 A040327
001 001 001 001 001
Jan Jun Jun Jul Feb
29, 19, 23, 27, 15,
1999 1998 2000 2012 2000
OSELTAMIVIR PHOSPHATE
CAPSULE; ORAL TAMIFLU ROCHE XX XX XX + FOR SUSPENSION; ORAL
TAMIFLU
XX + ROCHE
N021087 N021087 N021087
003 002 001
Jul 02, 2007 Jul 02, 2007 Oct 27, 1999
EQ 6MG BASE/ML
N021246
002
Mar 21, 2011
OXACILLIN SODIUM
INJECTABLE; INJECTION OXACILLIN SODIUM SAGENT PHARMS AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL AP + SANDOZ EQ 1GM BASE/VIAL AP EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL AP EQ 2GM BASE/VIAL AP + EQ 10GM BASE/VIAL BACTOCILL IN PLASTIC CONTAINER EQ 20MG BASE/ML XX + BAXTER HLTHCARE EQ 40MG BASE/ML XX +
A091246 A091246 A091245 A061490 A062737 A061490 A062737 A061490 N050640 N050640
001 002 001 003 001 004 002 006 001 002
Mar 30, 2012 Mar 30, 2012 Mar 30, 2012 Dec 23, 1986 Dec 23, 1986 May 09, 1991 Oct 26, 1989 Oct 26, 1989
OXALIPLATIN
INJECTABLE; IV (INFUSION) ELOXATIN AP + SANOFI AVENTIS US 50MG/10ML (5MG/ML) AP + 100MG/20ML (5MG/ML)
N021759 N021759
001 002
Jan 31, 2005 Jan 31, 2005

OXALIPLATIN
INJECTABLE; IV (INFUSION) OXALIPLATIN ACTAVIS TOTOWA 50MG/VIAL AP 100MG/VIAL AP EBEWE PHARMA 50MG/10ML (5MG/ML) AP 100MG/20ML (5MG/ML) AP FRESENIUS KABI ONCOL 100MG/20ML (5MG/ML) AP 50MG/10ML (5MG/ML) AP 50MG/VIAL AP 100MG/VIAL AP FRESENIUS KABI USA 50MG/VIAL AP 100MG/VIAL AP HOSPIRA INC 50MG/VIAL AP 100MG/VIAL AP HOSPIRA WORLDWIDE 50MG/10ML (5MG/ML) AP 100MG/20ML (5MG/ML) AP ONCO THERAPIES LTD 50MG/10ML (5MG/ML) AP 50MG/VIAL AP 100MG/20ML (5MG/ML) AP 100MG/VIAL AP SANDOZ 50MG/10ML (5MG/ML) AP 100MG/20ML (5MG/ML) AP 50MG/VIAL AP + SUN PHARMA GLOBAL 100MG/VIAL AP + 50MG/10ML (5MG/ML) AP + TEVA PHARMS 100MG/20ML (5MG/ML) AP + ELOXATIN 200MG/40ML (5MG/ML) XX + SANOFI AVENTIS US
3 - 322 (of 428)
A078803 A078803 A078812 A078812 A078811 A078811 A078810 A078810 A078819 A078819 A078815 A078815 A078813 A078813 A091358 A200979 A091358 A200979 A078817 A078817 A078818 A078818 N022160 N022160 N021759
001 002 001 002 002 001 001 002 001 002 001 002 001 002 001 001 002 002 001 002 001 002 001 002 003
Aug Aug Aug Aug Jun Jun Aug Aug Jun Jun Sep Sep Aug Aug Aug Aug Aug Aug Jan Jan Aug Aug Aug Aug
08, 08, 07, 07, 10, 10, 07, 07, 02, 02, 30, 30, 07, 07, 07, 08, 07, 08, 24, 24, 07, 07, 07, 07,
2012 2012 2009 2009 2010 2010 2009 2009 2010 2010 2009 2009 2009 2009 2012 2012 2012 2012 2011 2011 2009 2009 2009 2009
Nov 17, 2006
OXANDROLONE
TABLET; ORAL OXANDRIN SAVIENT PHARMS AB AB + OXANDROLONE PAR PHARM AB AB UPSHER SMITH AB AB
2.5MG 10MG 2.5MG 10MG 2.5MG 10MG
N013718 N013718 A077827 A077827 A076761 A078033
001 002 001 002 001 001
Nov 05, 2001 Jun Jun Dec Mar 22, 22, 01, 22, 2007 2007 2006 2007
OXAPROZIN
TABLET; ORAL DAYPRO + GD SEARLE OXAPROZIN APOTEX INC CARACO DR REDDYS LABS LTD IVAX SUB TEVA PHARMS SANDOZ TEVA WATSON LABS
N018841 A075987 A075844 A075855 A075846 A075845 A075849 A075848
004 001 001 001 001 001 001 001
Oct 29, 1992 Sep Jan Jan May Jan Jul Feb 02, 03, 31, 13, 31, 03, 09, 2004 2002 2001 2002 2001 2002 2001
OXAZEPAM
CAPSULE; ORAL OXAZEPAM ACTAVIS ELIZABETH AB AB AB IVAX SUB TEVA PHARMS AB
10MG 15MG 30MG 10MG
A072251 A072252 A072253 A070943
001 001 001 001
Apr Apr Apr Aug
14, 14, 14, 03,
1988 1988 1988 1987

OXAZEPAM
CAPSULE; ORAL OXAZEPAM IVAX SUB TEVA PHARMS AB AB + SANDOZ AB AB AB WATSON LABS AB AB AB
3 - 323 (of 428)
A070944 A070945 A071813 A071756 A071814 A072952 A072953 A072954
001 001 001 001 001 001 001 001
Aug Aug Apr Apr Apr Sep Sep Sep
03, 03, 19, 19, 19, 28, 28, 28,
1987 1987 1988 1988 1988 1990 1990 1990
OXCARBAZEPINE
SUSPENSION; ORAL OXCARBAZEPINE AMNEAL PHARMS RANBAXY ROXANE TRILEPTAL + NOVARTIS
AB AB AB AB
A202961 A078734 A201193 N021285
001 001 001 001
Sep 17, 2012 Jun 26, 2009 Oct 03, 2012 May 25, 2001
TABLET; ORAL OXCARBAZEPINE APOTEX INC AB AB AB BRECKENRIDGE PHARM AB AB AB CADISTA PHARMS AB AB AB GLENMARK GENERICS AB AB AB ROXANE AB AB AB SUN PHARM INDS AB AB AB TARO AB AB AB TEVA PHARMS AB AB AB TRILEPTAL NOVARTIS AB AB AB + TABLET, EXTENDED RELEASE; OXTELLAR XR SUPERNUS PHARMS XX XX XX +
150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG ORAL 150MG 300MG 600MG
A077747 A077747 A077747 A078069 A078069 A078069 A090239 A090239 A090239 A077802 A077802 A077802 A077795 A077795 A077795 A077794 A077794 A077794 A077801 A077801 A077801 A078005 A078005 A078005 N021014 N021014 N021014
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Apr Apr Apr Jan Jan Jan Jan Jan Jan Oct Oct Oct Oct Oct Oct Oct Oct Oct Nov Nov Nov Dec Dec Dec
09, 09, 09, 11, 11, 11, 25, 25, 25, 09, 09, 09, 09, 09, 09, 09, 09, 09, 15, 15, 15, 11, 11, 11,
2008 2008 2008 2008 2008 2008 2010 2010 2010 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
Jan 14, 2000 Jan 14, 2000 Jan 14, 2000
N202810 N202810 N202810
001 002 003
Oct 19, 2012 Oct 19, 2012 Oct 19, 2012
OXICONAZOLE NITRATE
CREAM; TOPICAL
OXISTAT
XX + FOUGERA PHARMS
EQ 1% BASE
N019828
001
Dec 30, 1988

OXICONAZOLE NITRATE
LOTION; TOPICAL
OXISTAT
XX + FOUGERA PHARMS
3 - 324 (of 428)
EQ 1% BASE
N020209
001
Sep 30, 1992
OXTRIPHYLLINE
CHOLEDYL SA
400MG XX + WARNER CHILCOTT LLC 600MG XX +
A087863 A086742
001 001
May 24, 1983
OXYBUTYNIN
OXYTROL
XX + WATSON LABS (UTAH) 3.9MG/24HR GEL, METERED; TRANSDERMAL
ANTUROL
XX + WATSON LABS INC 3%
N021351
002
Feb 26, 2003
N202513
001
Dec 07, 2011
OXYBUTYNIN CHLORIDE
GEL; TRANSDERMAL
GELNIQUE
+ WATSON LABS SYRUP; ORAL OXYBUTYNIN CHLORIDE MIKART NOVEX PHARM ASSOC SILARX VINTAGE PHARMS + WOCKHARDT TABLET; ORAL OXYBUTYNIN CHLORIDE PLIVA USL PHARMA + VINTAGE PHARMS
XX
10%(100MG/PACKET)
N022204
001
Jan 27, 2009
AA AA AA AA AA AA
A075039 A074997 A075137 A074520 A076682 A074868
001 001 001 001 001 001
Jan Oct Dec Mar Dec Feb
29, 15, 18, 29, 28, 12,
1999 1997 1998 1996 2004 1997
AB AB AB
5MG 5MG 5MG TABLET, EXTENDED RELEASE; ORAL DITROPAN XL JANSSEN PHARMS 5MG 10MG + 15MG OXYBUTYNIN CHLORIDE IMPAX PHARMS 5MG 10MG 15MG MYLAN 5MG MYLAN PHARMS INC 10MG 15MG OSMOTICA PHARM 5MG 10MG 15MG
A071655 A074625 A075079
001 001 001
Nov 14, 1988 Jul 31, 1996 Oct 31, 1997
N020897 N020897 N020897 A076745 A076745 A076745 A076702 A076644 A076644 A078503 A078503 A078503
001 002 003 002 003 001 001 001 002 001 002 003
Dec 16, 1998 Dec 16, 1998 Jun 22, 1999 May May Nov Nov Nov May Feb Feb Feb 09, 09, 09, 09, 09, 10, 04, 04, 04, 2007 2007 2006 2006 2006 2007 2009 2009 2009
OXYCODONE HYDROCHLORIDE
CAPSULE; ORAL OXYCODONE HYDROCHLORIDE COASTAL PHARMS + LEHIGH VALLEY SOLUTION; ORAL OXYCODONE HYDROCHLORIDE + LEHIGH VALLEY VISTAPHARM
AB AB
5MG 5MG
A203107 N200534
001 001
Jul 26, 2012 Oct 20, 2010
AA AA
100MG/5ML 100MG/5ML
N200535 A202537
001 001
Oct 20, 2010 Jul 30, 2012

SOLUTION; ORAL
XX + VISTAPHARM 5MG/5ML TABLET; ORAL OXYCODONE HYDROCHLORIDE ACTAVIS TOTOWA AB 15MG AB 30MG ALVOGEN INC AB 5MG AB 15MG AB 30MG AUROLIFE PHARMA LLC AB 5MG AB 15MG AB 30MG AVANTHI INC AB 5MG AB 10MG AB 15MG AB 20MG AB 30MG COASTAL PHARMS AB 5MG AB 15MG AB 30MG COREPHARMA AB 5MG AB 15MG AB 30MG MALLINCKRODT INC AB 5MG AB 15MG AB 30MG NESHER PHARMS AB 5MG AB 10MG AB 15MG AB 20MG AB 30MG RHODES PHARMS AB 5MG AB 10MG AB 15MG AB 20MG AB 30MG SUN PHARM INDS INC AB 5MG AB 10MG AB 15MG AB 20MG AB 30MG VINTAGE PHARMS AB 5MG AB 15MG AB 30MG ROXICODONE MALLINCKRODT INC AB 5MG AB + 15MG AB 30MG OXECTA KING PHARMS R AND D 5MG XX 7.5MG XX TABLET, EXTENDED RELEASE; ORAL OXYCONTIN PURDUE PHARMA LP 10MG XX 15MG XX 20MG XX 30MG XX XX + 40MG XX 60MG
3 - 325 (of 428)
N201194
001
Jan 12, 2012
A076636 A076636 A202116 A202116 A202116 A202160 A202160 A202160 A091393 A091393 A091393 A091393 A091393 A091313 A091313 A091313 A090895 A090895 A090895 A076758 A076758 A076758 A077290 A077290 A077290 A077290 A077290 A091490 A091490 A091490 A091490 A091490 A090659 A090659 A090659 A090659 A090659 A077712 A077712 A077712 N021011 N021011 N021011 N202080 N202080
001 002 001 002 003 001 002 003 001 002 003 004 005 001 002 003 001 002 003 003 001 002 001 002 003 004 005 001 002 003 004 005 001 005 002 004 003 003 001 002 003 001 002 001 002
Feb Feb Dec Dec Dec Nov Nov Nov Aug Aug Aug Aug Aug Feb Feb Feb Aug Aug Aug Mar Jun Jun Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar Apr Nov Apr Nov Apr Mar Jan Jan
06, 06, 30, 30, 30, 19, 19, 19, 31, 31, 31, 31, 31, 18, 18, 18, 24, 24, 24, 19, 30, 30, 08, 08, 08, 08, 08, 09, 09, 09, 09, 09, 10, 06, 10, 06, 10, 02, 31, 31,
2004 2004 2011 2011 2011 2012 2012 2012 2009 2009 2009 2009 2009 2011 2011 2011 2009 2009 2009 2007 2004 2004 2005 2005 2005 2005 2005 2011 2011 2011 2011 2011 2009 2012 2009 2012 2009 2009 2007 2007
May 15, 2009 Aug 31, 2000 Aug 31, 2000 Jun 17, 2011 Jun 17, 2011
N022272 N022272 N022272 N022272 N022272 N022272
001 002 003 004 005 006
Apr Apr Apr Apr Apr Apr
05, 05, 05, 05, 05, 05,
2010 2010 2010 2010 2010 2010

TABLET, EXTENDED RELEASE; ORAL OXYCONTIN XX PURDUE PHARMA LP 80MG
3 - 326 (of 428)
N022272
007
Apr 05, 2010
OXYMETHOLONE
TABLET; ORAL
ANADROL-50
XX + MEDA PHARMS
50MG
N016848
001
OXYMORPHONE HYDROCHLORIDE
OPANA
XX + ENDO PHARMS
1MG/ML
N011707
002
AB AB AB AB AB AB
AB AB AB AB XX XX XX XX XX XX XX XX XX XX XX XX
TABLET; ORAL
OPANA ENDO PHARMS 5MG + 10MG OXYMORPHONE HYDROCHLORIDE ROXANE 5MG 10MG TEVA 5MG 10MG TABLET, EXTENDED RELEASE; ORAL OXYMORPHONE HYDROCHLORIDE ACTAVIS 7.5MG 15MG IMPAX LABS 7.5MG 15MG OPANA ER ENDO PHARMS 5MG 7.5MG 10MG 15MG 20MG 30MG + 40MG OXYMORPHONE HYDROCHLORIDE IMPAX LABS 5MG 10MG 20MG 30MG 40MG
N021611 N021611 A090964 A090964 A091443 A091443
001 002 001 002 002 001
Jun 22, 2006 Jun 22, 2006 Sep Sep Feb Feb 27, 27, 15, 15, 2010 2010 2011 2011
A079046 A079046 A079087 A079087 N201655 N201655 N201655 N201655 N201655 N201655 N201655 A079087 A079087 A079087 A079087 A079087
001 002 002 004 001 002 003 004 005 006 007 001 003 005 006 007
Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Jun Jun Jun Jul Jun
13, 13, 21, 21, 09, 09, 09, 09, 09, 09, 09, 14, 14, 14, 22, 14,
2010 2010 2010 2010 2011 2011 2011 2011 2011 2011 2011 2010 2010 2010 2010 2010
OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE

TERRAMYCIN W/ POLYMYXIN B SULFATE
EQ 5MG BASE/GM;10,000 UNITS/GM XX + PFIZER
A061015
001
OXYTOCIN
INJECTABLE; INJECTION OXYTOCIN + BAXTER HLTHCARE CORP + + FRESENIUS KABI USA + PITOCIN + JHP PHARMS OXYTOCIN + FRESENIUS KABI USA
AP AP AP AP AP AP XX
10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML) 10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML) 10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML) 300USP UNITS/30ML (10USP UNITS/ML)
N018243 N018243 N018248 N018248 N018261 N018261 N018248
001 002 001 002 001 002 003
Jan 10, 2007
Jul 27, 2007 Jul 27, 2007

OXYTOCIN
INJECTABLE; INJECTION PITOCIN XX JHP PHARMS
3 - 327 (of 428)
500USP UNITS/50ML (10USP UNITS/ML)
N018261
003
Sep 05, 2012
PACLITAXEL
FOR SUSPENSION; IV (INFUSION)
ABRAXANE
XX + ABRAXIS BIOSCIENCE 100MG/VIAL INJECTABLE; INJECTION PACLITAXEL ACCORD HLTHCARE INC ACTAVIS TOTOWA BEDFORD EBEWE PHARMA FRESENIUS KABI ONCOL + HOSPIRA MYLAN ONCO THERAPIES LTD TEVA PHARMS
N021660
001
Jan 07, 2005
AP AP AP AP AP AP AP AP AP
6MG/ML 6MG/ML 6MG/ML 6MG/ML 6MG/ML 6MG/ML 6MG/ML 6MG/ML 6MG/ML
A075436 A090130 A075190 A078167 A077574 A076131 A075278 A091540 A075184
001 001 001 001 001 001 001 001 001
Nov Dec Jan Dec Nov May Jan Sep Jan
12, 09, 28, 26, 27, 08, 25, 29, 25,
2004 2009 2002 2007 2006 2002 2002 2011 2002
PALIPERIDONE
TABLET, EXTENDED RELEASE; ORAL INVEGA JANSSEN PHARMS 1.5MG XX 3MG XX 6MG XX + 9MG XX
N021999 N021999 N021999 N021999
006 001 002 003
Aug Dec Dec Dec
26, 19, 19, 19,
2008 2006 2006 2006
PALIPERIDONE PALMITATE
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR INVEGA SUSTENNA XX JANSSEN PHARMS 39MG/0.25ML (39MG/0.25ML) XX 78MG/0.5ML (78MG/0.5ML) XX + 117MG/0.75ML (117MG/0.75ML) XX 156MG/ML (156MG/ML) XX 234MG/1.5ML (156MG/ML)
N022264 N022264 N022264 N022264 N022264
001 002 003 004 005
Jul Jul Jul Jul Jul
31, 31, 31, 31, 31,
2009 2009 2009 2009 2009
PALONOSETRON HYDROCHLORIDE
ALOXI
XX + HELSINN HLTHCARE XX +
EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
N021372 N021372
002 001
Feb 29, 2008 Jul 25, 2003
PAMIDRONATE DISODIUM
INJECTABLE; INJECTION PAMIDRONATE DISODIUM AREVA PHARMS AP AP AP BEDFORD AP AP + AP AP + FRESENIUS KABI USA AP AP AP AP AP + HOSPIRA AP + AP +
30MG/VIAL 60MG/VIAL 90MG/VIAL 30MG/VIAL 30MG/10ML 90MG/VIAL 90MG/10ML 30MG/VIAL 30MG/10ML 90MG/VIAL 90MG/10ML 30MG/10ML 60MG/10ML 90MG/10ML
(3MG/ML) (9MG/ML) (3MG/ML) (9MG/ML) (3MG/ML) (6MG/ML) (9MG/ML)
A077433 A077433 A077433 A075290 N021113 A075290 N021113 A075773 A076207 A075773 A076207 A075841 A075841 A075841
001 002 003 001 001 003 002 001 001 002 002 001 002 003
Nov Nov Nov Apr Mar Apr Mar May May May May Jun Jun Jun
26, 26, 26, 30, 04, 30, 04, 06, 17, 06, 17, 27, 27, 27,
2008 2008 2008 2001 2002 2001 2002 2002 2002 2002 2002 2002 2002 2002

INJECTABLE; INJECTION PAMIDRONATE DISODIUM LUITPOLD AP AP MN PHARMS AP AP MUSTAFA NEVZAT AP AP PFIZER AP AP PLIVA LACHEMA AP AP AP SUN PHARMA GLOBAL AP AP TEVA PARENTERAL AP AP
3 - 328 (of 428)
30MG/10ML 90MG/10ML 30MG/VIAL 90MG/VIAL 30MG/10ML 90MG/10ML 30MG/10ML 90MG/10ML 30MG/10ML 60MG/10ML 90MG/10ML 30MG/VIAL 90MG/VIAL 30MG/10ML 90MG/10ML
(3MG/ML) (9MG/ML)
(3MG/ML) (9MG/ML) (3MG/ML) (9MG/ML) (3MG/ML) (6MG/ML) (9MG/ML)
(3MG/ML) (9MG/ML)
001 002 001 002 001 002 001 002 001 002 003 001 002 001 002
Jul Jul Mar Mar Dec Dec Oct Oct Aug Aug Aug Dec Dec Mar Mar
25, 25, 10, 10, 23, 23, 31, 31, 19, 19, 19, 24, 24, 27, 27,
2008 2008 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2002 2002
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
CAPSULE, DELAYED RELEASE; ORAL CREON XX ABBVIE 15,000USP UNITS;3,000USP UNITS;9,500USP UNITS XX 30,000USP UNITS;6,000USP UNITS;19,000USP UNITS XX 60,000USP UNITS;12,000USP UNITS;38,000USP UNITS XX + 120,000USP UNITS;24,000USP UNITS;76,000USP UNITS PANCREAZE XX JANSSEN PHARMS 17,500USP/ UNITS;4,200USP/ UNITS;10,000USP/ UNITS XX 43,750USP/ UNITS;10,500USP/ UNITS;25,000USP/ UNITS XX 70,000USP/ UNITS;16,800USP/ UNITS;40,000USP/ UNITS XX + 61,000USP/ UNITS;21,000USP/ UNITS;37,000USP/ UNITS PERTZYE XX DIGESTIVE CARE INC 30,250USP/UNITS;8,000USP/UNITS;28,750US P/UNITS XX + 60,500USP/UNITS;16,000USP/UNITS;57,500U SP/UNITS ULTRESA XX APTALIS PHARMA US 27,600USP UNITS;13,800USP UNITS;27,600USP UNITS XX 41,400USP UNITS;20,700USP UNITS;41,400USP UNITS XX + 46,000USP UNITS;23,000USP UNITS;46,000USP UNITS ZENPEP XX APTALIS PHARMA US 16,000USP UNITS;3,000USP UNITS;10,000USP UNITS XX 27,000USP UNITS;5,000USP UNITS;17,000USP UNITS XX 55,000USP UNITS;10,000USP UNITS;34,000USP UNITS XX 82,000USP UNITS;15,000USP UNITS;51,000USP UNITS XX 109,000USP UNITS;20,000USP UNITS;68,000USP UNITS XX + 136,000USP UNITS;25,000USP UNITS;85,000USP UNITS
N020725 N020725 N020725 N020725
004 001 002 003
Jul 12, 2011 Apr 30, 2009 Apr 30, 2009 Apr 30, 2009
N022523 N022523 N022523 N022523
001 002 004 003
Apr 12, 2010 Apr 12, 2010 Apr 12, 2010 Apr 12, 2010
N022175 N022175
001 002
May 17, 2012 May 17, 2012
N022222 N022222 N022222
001 002 003
Mar 01, 2012 Mar 01, 2012 Mar 01, 2012
N022210 N022210 N022210 N022210 N022210 N022210
005 001 002 003 004 006
Jun 15, 2011 Aug 27, 2009 Aug 27, 2009 Aug 27, 2009 Aug 27, 2009 Jul 13, 2011

TABLET; ORAL VIOKACE XX APTALIS PHARMA US XX +
3 - 329 (of 428)
39,150USP UNITS;10,440USP UNITS;39,150USP UNITS 78,300USP UNITS;20,880USP UNITS;78,300USP UNITS
N022542 N022542
001 002
Mar 01, 2012 Mar 01, 2012
PANCURONIUM BROMIDE
INJECTABLE; INJECTION PANCURONIUM BROMIDE HOSPIRA AP AP + TEVA PARENTERAL AP +
A072320 A072759 A072760
001 001 001
Jan 19, 1989 Jul 31, 1990 Jul 31, 1990
PANTOPRAZOLE SODIUM
FOR SUSPENSION, DELAYED RELEASE; ORAL
PROTONIX
+ WYETH PHARMS INC EQ 40MG BASE INJECTABLE; IV (INFUSION) PANTOPRAZOLE SODIUM AKORN INC EQ 40MG BASE/VIAL PROTONIX IV + WYETH PHARMS INC EQ 40MG BASE/VIAL TABLET, DELAYED RELEASE; ORAL PANTOPRAZOLE SODIUM ACTAVIS TOTOWA EQ 20MG BASE EQ 40MG BASE APOTEX INC EQ 20MG BASE EQ 40MG BASE AUROBINDO PHARMA LTD EQ 20MG BASE EQ 40MG BASE DR REDDYS LABS LTD EQ 20MG BASE EQ 40MG BASE JUBILANT ORGANOSYS EQ 20MG BASE EQ 40MG BASE KUDCO IRELAND EQ 20MG BASE EQ 40MG BASE MACLEODS PHARMS LTD EQ 20MG BASE EQ 40MG BASE MYLAN PHARMS INC EQ 20MG BASE EQ 40MG BASE RANBAXY LABS LTD EQ 20MG BASE EQ 40MG BASE SUN PHARMA GLOBAL EQ 20MG BASE EQ 40MG BASE TEVA EQ 20MG BASE EQ 40MG BASE TORRENT PHARMS EQ 20MG BASE EQ 40MG BASE WOCKHARDT EQ 20MG BASE EQ 40MG BASE PROTONIX WYETH PHARMS INC EQ 20MG BASE + EQ 40MG BASE
XX
N022020
001
Nov 14, 2007
AP AP
A079197 N020988
001 001
Nov 08, 2012 Mar 22, 2001
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A090797 A090797 A090807 A090807 A202038 A202038 A077619 A077619 A090901 A090901 A078281 A078281 A200821 A200821 A090970 A090970 A200794 A200794 A077058 A077058 A077056 A077056 A090074 A090074 A091231 A091231 N020987 N020987
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 002 001
Feb Feb May May Sep Sep Jan Jan Aug Aug Jan Jan Feb Feb Jan Jan May May Sep Sep Aug Aug Jan Jan Jan Jan
07, 07, 02, 02, 28, 28, 19, 19, 30, 30, 20, 20, 16, 16, 19, 19, 02, 02, 10, 10, 02, 02, 19, 19, 19, 19,
2011 2011 2012 2012 2012 2012 2011 2011 2011 2011 2011 2011 2012 2012 2011 2011 2012 2012 2007 2007 2007 2007 2011 2011 2011 2011
Jun 12, 2001 Feb 02, 2000
PARICALCITOL
CAPSULE; ORAL ZEMPLAR ABBVIE XX XX XX +
1MCG 2MCG 4MCG
N021606 N021606 N021606
001 002 003
May 26, 2005 May 26, 2005 May 26, 2005

PARICALCITOL
INJECTABLE; INJECTION PARICALCITOL SANDOZ CANADA INC AP AP ZEMPLAR AP + ABBVIE AP +
3 - 330 (of 428)
A091108 A091108 N020819 N020819
001 002 002 001
Jul 27, 2011 Jul 27, 2011 Feb 01, 2000 Apr 17, 1998
PAROMOMYCIN SULFATE
CAPSULE; ORAL PAROMOMYCIN SULFATE AA + CARACO HERITAGE PHARMS INC AA
A064171 A065173
001 001
Jun 30, 1997 Dec 14, 2007
PAROXETINE HYDROCHLORIDE
SUSPENSION; ORAL PAROXETINE HYDROCHLORIDE APOTEX INC EQ PAXIL + GLAXOSMITHKLINE EQ TABLET; ORAL PAROXETINE HYDROCHLORIDE APOTEX EQ EQ EQ EQ AUROBINDO PHARMA EQ EQ EQ EQ CARACO EQ EQ EQ EQ MYLAN EQ EQ EQ EQ MYLAN PHARMS INC EQ EQ EQ EQ PROSAM LABS EQ EQ EQ EQ TEVA EQ EQ EQ EQ ZYDUS PHARMS USA EQ EQ EQ EQ PAXIL GLAXOSMITHKLINE EQ EQ EQ + EQ
AB AB
10MG BASE/5ML 10MG BASE/5ML
A077395 N020710
001 001
Dec 05, 2006 Jun 25, 1997
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075356 A075356 A075356 A075356 A078406 A078406 A078406 A078406 A078194 A078194 A078194 A078194 A078902 A078902 A078902 A078902 A075716 A075716 A075716 A075716 A076968 A076968 A076968 A076968 A076618 A076618 A076618 A076618 A077584 A077584 A077584 A077584 N020031 N020031 N020031 N020031
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 005
Jul Jul Jul Jul Jul Jul Jul Jul Jun Jun Jun Jun Mar Mar Mar Mar Mar Mar Mar Mar Jun Jun Jun Jun Aug Aug Aug Aug Mar Mar Mar Mar Dec Dec Dec Dec
30, 30, 30, 30, 25, 25, 25, 25, 29, 29, 29, 29, 13, 13, 13, 13, 08, 08, 08, 08, 21, 21, 21, 21, 15, 15, 15, 15, 07, 07, 07, 07, 29, 29, 29, 29,
2003 2003 2003 2003 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2008 2008 2004 2004 2004 2004 2010 2010 2010 2010 2005 2005 2005 2005 2007 2007 2007 2007 1992 1992 1992 1992

TABLET, EXTENDED RELEASE; ORAL PAROXETINE HYDROCHLORIDE MYLAN EQ 12.5MG BASE EQ 25MG BASE EQ 37.5MG BASE PAXIL CR GLAXOSMITHKLINE EQ 12.5MG BASE EQ 25MG BASE + EQ 37.5MG BASE
3 - 331 (of 428)
AB AB AB AB AB AB
A077873 A077873 A091427 N020936 N020936 N020936
001 002 001 001 002 003
Jun 29, 2007 Jun 29, 2007 Apr 14, 2011 Feb 16, 1999 Feb 16, 1999 Dec 06, 2000
PAROXETINE MESYLATE
TABLET; ORAL PEXEVA XX NOVEN THERAP XX XX XX +
EQ EQ EQ EQ
10MG 20MG 30MG 40MG
BASE BASE BASE BASE
N021299 N021299 N021299 N021299
001 002 003 004
Jul Jul Jul Jul
03, 03, 03, 03,
2003 2003 2003 2003
PASIREOTIDE DIASPARTATE
SOLUTION; SUBCUTANEOUS SIGNIFOR XX NOVARTIS XX XX +
EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML) EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML) EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)
N200677 N200677 N200677
001 002 003
Dec 14, 2012 Dec 14, 2012 Dec 14, 2012
PAZOPANIB HYDROCHLORIDE
TABLET; ORAL
VOTRIENT
XX + GLAXOSMITHKLINE XX
N022465 N022465
001 002
Oct 19, 2009 Oct 19, 2009
PEGADEMASE BOVINE
ADAGEN
XX + SIGMA TAU
250 UNITS/ML
N019818
001
Mar 21, 1990
PEGAPTANIB SODIUM
INJECTABLE; INTRAVITREAL
MACUGEN
XX + VALEANT PHARMS LLC
EQ 0.3MG ACID/0.09ML
N021756
001
Dec 17, 2004
PEGINESATIDE ACETATE
SOLUTION; INTRAVENOUS, SUBCUTANEOUS
OMONTYS
+ AFFYMAX EQ 10MG BASE/ML (EQ 10MG BASE/ML) + EQ 20MG BASE/2ML (EQ 10MG BASE/ML) OMONTYS PRESERVATIVE FREE + AFFYMAX EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML) + EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.5ML) + EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML) + EQ 4MG BASE/0.5ML (EQ 4MG BASE/0.5ML) + EQ 5MG BASE/0.5ML (EQ 5MG BASE/0.5ML) + EQ 6MG BASE/0.5ML (EQ 6MG BASE/0.5ML)
XX XX XX XX XX XX XX XX
N202799 N202799 N202799 N202799 N202799 N202799 N202799 N202799
007 008 001 002 003 004 005 006
Mar 27, 2012 Mar 27, 2012 Mar Mar Mar Mar Mar Mar 27, 27, 27, 27, 27, 27, 2012 2012 2012 2012 2012 2012
PEGVISOMANT
SOMAVERT
XX + PHARMACIA AND UPJOHN 10MG/VIAL XX + 15MG/VIAL XX + 20MG/VIAL
N021106 N021106 N021106
001 002 003
Mar 25, 2003 Mar 25, 2003 Mar 25, 2003

PEMETREXED DISODIUM
ALIMTA
XX + LILLY EQ 100MG BASE/VIAL XX + EQ 500MG BASE/VIAL
3 - 332 (of 428)
N021462 N021462
002 001
Sep 07, 2007 Feb 04, 2004
PEMIROLAST POTASSIUM
ALAMAST
XX + SANTEN 0.1%
N021079
001
Sep 24, 1999
PENBUTOLOL SULFATE
TABLET; ORAL
LEVATOL
XX + ACTIENT PHARMS
20MG
N018976
004
Jan 05, 1989
PENCICLOVIR SODIUM
CREAM; TOPICAL
DENAVIR
XX + DENCO ASSET
1%
N020629
001
Sep 24, 1996
PENICILLAMINE
CAPSULE; ORAL
CUPRIMINE
XX + ATON TABLET; ORAL
DEPEN
XX + MEDA PHARMS
250MG
N019853
001
250MG
N019854
001
PENICILLIN G BENZATHINE
INJECTABLE; INJECTION BICILLIN L-A BC + KING PHARMS PERMAPEN BC PFIZER BICILLIN L-A XX + KING PHARMS
600,000 UNITS/ML 600,000 UNITS/ML 300,000 UNITS/ML
N050141 A060014 N050141
001 001 003
PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE

BICILLIN C-R
XX + KING PHARMS XX + BICILLIN C-R 900/300
XX + KING PHARMS
150,000 UNITS/ML;150,000 UNITS/ML 300,000 UNITS/ML;300,000 UNITS/ML 900,000 UNITS/2ML;300,000 UNITS/2ML
N050138 N050138 N050138
002 001
003
PENICILLIN G POTASSIUM
INJECTABLE; INJECTION PENICILLIN G POTASSIUM HANFORD GC AP 5,000,000 UNITS/VIAL AP 20,000,000 UNITS/VIAL IBI AP 5,000,000 UNITS/VIAL AP 20,000,000 UNITS/VIAL SANDOZ AP 5,000,000 UNITS/VIAL AP 20,000,000 UNITS/VIAL PFIZERPEN AP + PFIZER 5,000,000 UNITS/VIAL AP + 20,000,000 UNITS/VIAL PENICILLIN G POTASSIUM HANFORD GC 1,000,000 UNITS/VIAL XX PENICILLIN G POTASSIUM IN PLASTIC CONTAINER 20,000 UNITS/ML XX + BAXTER HLTHCARE
A065149 A065149 A065448 A065448 A065079 A065079 A060657 A060657 A065149 N050638
002 003 001 002 002 003 002 003 001 001
Jul Jul Aug Aug Aug Aug
23, 23, 18, 18, 30, 30,
2009 2009 2009 2009 2002 2002
Jul 23, 2009 Jun 25, 1990

PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
XX + BAXTER HLTHCARE 40,000 UNITS/ML XX + 60,000 UNITS/ML
3 - 333 (of 428)
N050638 N050638
002 003
Jun 25, 1990 Jun 25, 1990
PENICILLIN G PROCAINE
XX + KING PHARMS XX +
300,000 UNITS/ML 600,000 UNITS/ML
A060101 A060101
002 001
PENICILLIN G SODIUM
INJECTABLE; IM-IV
PENICILLIN G SODIUM
XX + SANDOZ
5,000,000 UNITS/VIAL
A065068
001
Feb 26, 2001
PENICILLIN V POTASSIUM
FOR SOLUTION; ORAL PENICILLIN V POTASSIUM DAVA PHARMS INC AA AA PENICILLIN-VK TEVA AA AA + TABLET; ORAL PENICILLIN V POTASSIUM AUROBINDO PHARMA AB AB DAVA PHARMS INC AB AB SANDOZ AB AB + PENICILLIN-VK TEVA AB AB
A062981 A062981 A060456 A060456
001 002 001 002
Feb 10, 1989 Feb 10, 1989
EQ EQ EQ EQ EQ EQ
250MG 500MG 250MG 500MG 250MG 500MG
A065435 A065435 A062936 A062935 A064071 A064071 A060711 A060711
001 002 001 001 001 002 002 003
Apr Apr Nov Nov Nov Nov
29, 29, 25, 23, 30, 30,
2008 2008 1988 1988 1995 1995
PENTAMIDINE ISETHIONATE
NEBUPENT
XX + FRESENIUS KABI USA
300MG/VIAL
N019887
001
Jun 15, 1989
INJECTABLE; INJECTION PENTAM AP + FRESENIUS KABI USA 300MG/VIAL PENTAMIDINE ISETHIONATE WATSON LABS AP 300MG/VIAL
N019264 A074303
001 001
Oct 16, 1984 Aug 17, 1995
PENTAZOCINE LACTATE
TALWIN
XX + HOSPIRA
EQ 30MG BASE/ML
N016194
001
PENTOBARBITAL SODIUM
NEMBUTAL SODIUM
XX + OAK PHARMS
50MG/ML
A083246
001
PENTOSAN POLYSULFATE SODIUM

CAPSULE; ORAL
ELMIRON
XX + JANSSEN PHARMS
100MG
N020193
001
Sep 26, 1996

PENTOSTATIN
INJECTABLE; INJECTION NIPENT AP + HOSPIRA INC PENTOSTATIN BEDFORD LABS AP
3 - 334 (of 428)
10MG/VIAL 10MG/VIAL
N020122 A077841
001 001
Oct 11, 1991 Aug 07, 2007
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE; PENTOXIFYLLINE APOTEX IMPAX LABS MYLAN PLIVA VALEANT INTL WATSON LABS PENTOXIL UPSHER SMITH TRENTAL + SANOFI AVENTIS US ORAL 400MG 400MG 400MG 400MG 400MG 400MG 400MG 400MG A075191 A075093 A074425 A074874 A075028 A075107 A074962 N018631 001 001 001 001 001 001 001 001 Jun Aug Jul May Jul Sep 09, 10, 08, 25, 20, 04, 1999 1999 1997 1999 1998 1998
Mar 31, 1999 Aug 30, 1984
PERAMPANEL
TABLET; ORAL FYCOMPA EISAI INC XX XX XX XX XX XX +
N202834 N202834 N202834 N202834 N202834 N202834
001 002 003 004 005 006
Oct Oct Oct Oct Oct Oct
20, 22, 22, 22, 22, 22,
2012 2012 2012 2012 2012 2012
PERFLUTREN
DEFINITY
XX + LANTHEUS MEDCL
6.52MG/ML
N021064
001
Jul 31, 2001
PERINDOPRIL ERBUMINE
TABLET; ORAL ACEON XOMA AB AB AB + PERINDOPRIL ERBUMINE APOTEX AB AB AB AUROBINDO PHARMA AB AB AB IVAX PHARMS AB AB AB LUPIN LTD AB AB AB ROXANE AB AB AB
N020184 N020184 N020184 A090463 A090463 A090463 A079070 A079070 A079070 A078138 A078138 A078138 A078263 A078263 A078263 A090072 A090072 A090072
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Dec 30, 1993 Dec 30, 1993 Dec 30, 1993 Aug Aug Aug Nov Nov Nov Nov Nov Nov Jan Jan Jan Nov Nov Nov 30, 30, 30, 10, 10, 10, 10, 10, 10, 27, 27, 27, 10, 10, 10, 2010 2010 2010 2009 2009 2009 2009 2009 2009 2010 2010 2010 2009 2009 2009

PERMETHRIN
CREAM; TOPICAL ELIMITE AB + RENAISSANCE PHARMA PERMETHRIN ACTAVIS MID ATLANTIC AB PERRIGO NEW YORK AB
3 - 335 (of 428)
5% 5% 5%
N019855 A074806 A076369
001 001 001
Aug 25, 1989 Jan 23, 1998 Apr 21, 2003
PERPHENAZINE
TABLET; ORAL PERPHENAZINE SANDOZ AB AB AB AB + VINTAGE PHARMS AB AB AB AB
A089683 A089684 A089685 A089686 A040226 A040226 A040226 A040226
001 001 001 001 001 002 003 004
Dec Dec Dec Dec Dec Dec Dec Dec
08, 08, 08, 08, 31, 31, 31, 31,
1988 1988 1988 1988 1998 1998 1998 1998
PHENDIMETRAZINE TARTRATE
CAPSULE, EXTENDED RELEASE; ORAL BONTRIL BC VALEANT 105MG PHENDIMETRAZINE TARTRATE BC + SANDOZ 105MG TABLET; ORAL BONTRIL PDM + VALEANT 35MG PHENDIMETRAZINE TARTRATE KVK TECH 35MG MIKAH PHARMA 35MG MIKART 35MG SANDOZ 35MG
A088021 N018074
001 001
Sep 21, 1982
AA AA AA AA AA
A085272 A091042 A040762 A089452 A085588
001 001 001 001 001 Aug 31, 2010 Jan 28, 2008 Oct 30, 1991
PHENELZINE SULFATE
TABLET; ORAL NARDIL AB + PARKE DAVIS PHENELZINE SULFATE NOVEL LABS INC AB
N011909 A200181
002 001 Dec 08, 2010
PHENOXYBENZAMINE HYDROCHLORIDE
CAPSULE; ORAL DIBENZYLINE AB + WELLSPRING PHARM 10MG PHENOXYBENZAMINE HYDROCHLORIDE ROXANE AB 10MG
N008708 A201050
001 001 Jul 16, 2012
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL ADIPEX-P AA + TEVA 37.5MG PHENTERMINE HYDROCHLORIDE BARR AA 15MG AA 30MG ELITE LABS AA 15MG AA 30MG KVK TECH AA 15MG AA 30MG AA 30MG AA 37.5MG
A088023 A090591 A090591 A202248 A202248 A040886 A040875 A040886 A040887
001 001 002 001 002 002 001 001 001
Aug 02, 1983 Mar Mar Sep Sep Mar Mar Mar Apr 18, 18, 28, 28, 31, 21, 31, 24, 2010 2010 2012 2012 2008 2008 2008 2008

CAPSULE; ORAL PHENTERMINE HYDROCHLORIDE LANNETT AA 15MG AA 30MG AA 30MG LANNETT HOLDINGS INC 37.5MG AA MUTUAL PHARM AA 30MG AA + SANDOZ 15MG AA + 30MG AA + 30MG TABLET; ORAL ADIPEX-P AA + TEVA 37.5MG PHENTERMINE HYDROCHLORIDE BARR AA 37.5MG CARACO AA 37.5MG ELITE LABS AA 37.5MG KVK TECH AA 37.5MG LANNETT AA 37.5MG MIRROR PHARMS AA 37.5MG MUTUAL PHARM AA 37.5MG VINTAGE PHARMS AA 37.5MG TABLET, ORALLY DISINTEGRATING; ORAL SUPRENZA CITIUS PHARMS 15MG XX 30MG XX 37.5MG XX +
3 - 336 (of 428)
A087022 A087022 A091359 A201961 A040525 A087190 A086945 A087190
002 001 001 001 001 002 001 001
Jan Feb Jul Jul Oct
20, 03, 16, 20, 23,
2012 1983 2010 2011 2003
Jul 20, 1983
A085128 A090470 A040790 A200272 A040876 A040555 A091451 A040526 A040377
001 001 001 001 001 001 001 001 001 Aug Aug Jan Mar Apr Sep Oct Jan 31, 21, 31, 31, 15, 21, 23, 04, 2009 2007 2011 2008 2005 2012 2003 2002
N202088 N202088 N202088
001 002 003
Jun 13, 2011 Jun 13, 2011 Mar 27, 2012
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

CAPSULE, EXTENDED RELEASE; ORAL QSYMIA XX VIVUS EQ 3.75MG BASE;23MG XX EQ 7.5MG BASE;46MG XX EQ 11.25MG BASE;69MG XX + EQ 15MG BASE;92MG
N022580 N022580 N022580 N022580
001 002 003 004
Jul Jul Jul Jul
17, 17, 17, 17,
2012 2012 2012 2012
PHENTERMINE RESIN COMPLEX

XX + LANNETT HOLDINGS INC EQ 15MG BASE XX + EQ 30MG BASE
A040872 A040872
001 002
Jul 28, 2011 Jul 28, 2011
PHENTOLAMINE MESYLATE
INJECTABLE; INJECTION PHENTOLAMINE MESYLATE BEDFORD AP REGITINE AP + NOVARTIS ORAVERSE XX + SEPTODONT HOLDING
5MG/VIAL 5MG/VIAL 0.4MG/1.7ML
A040235 N008278 N022159
001 003 001
Mar 11, 1998
May 09, 2008
PHENYLEPHRINE HYDROCHLORIDE
XX + WEST WARD PHARM CORP 10MG/ML (10MG/ML)
N203826
001
Dec 20, 2012
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE

SYRUP; ORAL PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE VINTAGE AA 5MG/5ML;6.25MG/5ML
A040654
001
Dec 07, 2006

SYRUP; ORAL PROMETH VC PLAIN AA + ACTAVIS MID ATLANTIC 5MG/5ML;6.25MG/5ML PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE AMNEAL PHARMS AA 5MG/5ML;6.25MG/5ML
3 - 337 (of 428)
A088761 A040902
001 001
Nov 08, 1984 Aug 25, 2009
PHENYTOIN
SUSPENSION; ORAL DILANTIN-125 AB + PARKE DAVIS PHENYTOIN TARO AB VISTAPHARM AB AB WOCKHARDT AB TABLET, CHEWABLE; ORAL DILANTIN AB + PFIZER PHARMS PHENYTOIN MYLAN PHARMS INC AB
125MG/5ML 125MG/5ML 125MG/5ML 125MG/5ML 125MG/5ML
N008762 A040521 A040342 A040610 A040420
001 001 001 001 001 Mar Jan Aug Apr 08, 31, 18, 19, 2004 2001 2005 2002
50MG 50MG
A084427 A200691
001 001 Dec 26, 2012
PHENYTOIN SODIUM
CAPSULE; ORAL DILANTIN + PARKE DAVIS 30MG EXTENDED + 100MG EXTENDED EXTENDED PHENYTOIN SODIUM AMNEAL PHARMS NY 100MG EXTENDED MYLAN 100MG EXTENDED SUN PHARM INDS 200MG EXTENDED 300MG EXTENDED SUN PHARM INDS (IN) 100MG EXTENDED TARO 100MG EXTENDED WOCKHARDT 30MG EXTENDED WOCKHARDT USA 100MG EXTENDED PHENYTEK MYLAN 200MG EXTENDED + 300MG EXTENDED INJECTABLE; INJECTION PHENYTOIN SODIUM + HIKMA MAPLE 50MG/ML HOSPIRA 50MG/ML 50MG/ML LUITPOLD 50MG/ML X-GEN PHARMS 50MG/ML
A084349 A084349 A040765 A040298 A040731 A040731 A040621 A040684 A040759 A040732 A040298 A040298
001 002 001 001 001 002 001 001 001 001 002 003 Nov Dec Jun Jun Dec Sep Dec Jan 12, 28, 30, 30, 11, 05, 18, 30, 2008 1998 2008 2008 2006 2006 2007 2008
Dec 06, 2001 Dec 06, 2001
AP AP AP AP AP
A084307 A089521 A089744 A040781 A040573
001 001 001 001 001
Mar Dec Dec Sep
17, 18, 04, 13,
1987 1987 2007 2006
PHYTONADIONE
INJECTABLE; INJECTION PHYTONADIONE BP + INTL MEDICATION VITAMIN K1 BP + HOSPIRA VITAMIN K1 XX + HOSPIRA TABLET; ORAL
MEPHYTON
XX + VALEANT PHARMS
1MG/0.5ML 1MG/0.5ML 10MG/ML
A083722 A087954 A087955
001 001 001 Jul 25, 1983 Jul 25, 1983
5MG
N010104
003

PILOCARPINE HYDROCHLORIDE
GEL; OPHTHALMIC
PILOPINE HS
XX + ALCON SOLUTION; OPHTHALMIC ISOPTO CARPINE XX ALCON RES XX XX +
3 - 338 (of 428)
4%
N018796
001
Oct 01, 1984
1% 2% 4%
N200890 N200890 N200890
001 002 003
Jun 22, 2010 Jun 22, 2010 Jun 22, 2010
TABLET; ORAL PILOCARPINE HYDROCHLORIDE COREPHARMA 5MG IMPAX LABS 5MG 7.5MG LANNETT 5MG 7.5MG ROXANE 5MG 7.5MG SALAGEN EISAI INC 5MG + 7.5MG
A076746 A077248 A077248 A077220 A077220 A076963 A076963 N020237 N020237
001 001 002 001 002 001 002 001 002
Nov Mar Mar Oct May Dec Feb
16, 31, 31, 14, 06, 22, 27,
2004 2006 2006 2005 2009 2004 2007
Mar 22, 1994 Apr 18, 2003
PIMECROLIMUS
CREAM; TOPICAL
ELIDEL
XX + VALEANT BERMUDA
1%
N021302
001
Dec 13, 2001
PIMOZIDE
TABLET; ORAL ORAP XX TEVA XX +
1MG 2MG
N017473 N017473
003 001
Aug 27, 1997 Jul 31, 1984
PINDOLOL
TABLET; ORAL PINDOLOL MYLAN AB AB + WATSON LABS AB AB
5MG 10MG 5MG 10MG
A074019 A074019 A074437 A074437
001 002 001 002
Sep Sep Feb Feb
03, 03, 27, 27,
1992 1992 1995 1995
PIOGLITAZONE HYDROCHLORIDE
TABLET; ORAL ACTOS TAKEDA PHARMS USA AB EQ AB EQ AB + EQ PIOGLITAZONE HYDROCHLORIDE MYLAN PHARMS INC AB EQ AB EQ AB EQ WATSON LABS AB EQ AB EQ AB EQ
15MG BASE 30MG BASE 45MG BASE 15MG 30MG 45MG 15MG 30MG 45MG BASE BASE BASE BASE BASE BASE
N021073 N021073 N021073 A076801 A076801 A076801 A076798 A076798 A076798
001 002 003 001 002 003 001 002 003
Jul 15, 1999 Jul 15, 1999 Jul 15, 1999 Aug Aug Aug Oct Oct Oct 17, 17, 17, 26, 26, 26, 2012 2012 2012 2012 2012 2012
PIPERACILLIN SODIUM
PIPERACILLIN
+ IBI + + +
XX XX XX XX
EQ EQ EQ EQ
2GM BASE/VIAL 3GM BASE/VIAL 4GM BASE/VIAL 40GM BASE/VIAL
A065114 A065114 A065114 A065157
001 002 003 001
Nov Nov Nov Jul
14, 14, 14, 12,
2003 2003 2003 2004

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
INJECTABLE; INJECTION PIPERACILLIN AND TAZOBACTAM AUROBINDO PHARMA LTD EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL HOSPIRA INC EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL IBI EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL SANDOZ EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL ZOSYN + WYETH PHARMS INC EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL + EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL + EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL + EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL ZOSYN IN PLASTIC CONTAINER + WYETH PHARMS INC EQ 40MG BASE/ML;EQ 5MG BASE/ML + EQ 60MG BASE/ML;EQ 7.5MG BASE/ML + EQ 4GM BASE/100ML;EQ 500MG BASE/100ML
3 - 339 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX XX
A065498 A065498 A065498 A065386 A065386 A065386 A065446 A065523 A065523 A065523 A090498 A065362 A065363 A065362 A065363 A065362 A065363 N050684 N050684 N050684 N050684 N050750 N050750 N050750
001 002 003 001 002 003 001 001 002 003 001 001 001 002 002 003 003 001 002 003 004 001 002 003
May May May Sep Sep Sep Sep May May May May Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
23, 23, 23, 15, 15, 15, 15, 31, 31, 31, 31, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22,
2011 2011 2011 2009 2009 2009 2009 2011 2011 2011 2011 2010 2010 2010 2010 2010 2010 1993 1993 1993 1993
Feb 24, 1998 Feb 24, 1998 Feb 24, 1998
PIRBUTEROL ACETATE
MAXAIR
EQ 0.2MG BASE/INH XX + MEDICIS
N020014
001
Nov 30, 1992
PIROXICAM
CAPSULE; ORAL FELDENE PFIZER + PIROXICAM MUTUAL PHARM MYLAN NOSTRUM LABS TEVA WATSON LABS
N018147 N018147 A073535 A074102 A074102 A074116 A074118 A074131 A074131 A074287 A074460 A074287 A074460
002 003 001 001 002 001 001 001 002 001 001 002 002
Apr 06, 1982 Apr 06, 1982 Mar Jul Jul Jun Jun Dec Dec May Sep May Sep 12, 31, 31, 15, 15, 11, 11, 16, 29, 16, 29, 1993 1992 1992 1993 1993 1992 1992 1996 1995 1996 1995
PITAVASTATIN CALCIUM
TABLET; ORAL LIVALO XX KOWA CO XX XX +
N022363 N022363 N022363
001 002 003
Aug 03, 2009 Aug 03, 2009 Aug 03, 2009

PLERIXAFOR
SOLUTION; SUBCUTANEOUS
MOZOBIL
XX + GENZYME
3 - 340 (of 428)
24MG/1.2ML (20MG/ML)
N022311
001
Dec 15, 2008
PODOFILOX
GEL; TOPICAL
CONDYLOX
XX + WATSON PHARMS SOLUTION; TOPICAL CONDYLOX AT + WATSON PHARMS PODOFILOX PADDOCK LLC AT PRECISION DERMAT AT
0.5%
N020529
001
Mar 13, 1997
0.5% 0.5% 0.5%
N019795 A075600 A090184
001 001 001
Dec 13, 1990 Jan 29, 2002 Jul 21, 2010
POLIDOCANOL
SOLUTION; INTRAVENOUS ASCLERA XX CHEMISCH FBRK KRSSLR XX +
N021201 N021201
001 002
Mar 30, 2010 Mar 30, 2010
POLYETHYLENE GLYCOL 3350

FOR SOLUTION; ORAL GLYCOLAX KREMERS URBAN PHARMS 17GM/SCOOPFUL POLYETHYLENE GLYCOL 3350 BRECKENRIDGE PHARM 17GM/SCOOPFUL NEXGEN PHARMA INC 17GM/SCOOPFUL PADDOCK LLC 17GM/SCOOPFUL
AA AA AA AA
A076652 A077736 A077706 A077893
001 001 001 001
Jul 02, 2004 May 26, 2006 Sep 27, 2006 May 26, 2006
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

FOR SOLUTION; ORAL LAX-LYTE WITH FLAVOR PACKS PADDOCK LLC AA 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ BOT NULYTELY AA + BRAINTREE 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ BOT NULYTELY-FLAVORED AA + BRAINTREE 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ BOT PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE MYLAN AA 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ BOT NOVEL LABS INC AA 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ BOT TRILYTE MEDA PHARMS AA 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ BOT
A079232
001
Feb 25, 2010
N019797
001
Apr 22, 1991
N019797
002
Nov 18, 1994
A090409 A090019
001 001
Apr 02, 2010 May 27, 2009
A076491
001
Feb 05, 2004
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS
FOR SOLUTION; ORAL COLYTE AA + MEDA PHARMS AA +
227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53G N018983 M/BOT;21.5GM/BOT 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ N018983 BOT;22.72GM/BOT
010 007
Jan 31, 1989 Jun 12, 1987
AA
COLYTE WITH FLAVOR PACKS + MEDA PHARMS 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ N018983 BOT;22.72GM/BOT
012
Oct 08, 1998
3 - 341 (of 428)
FOR SOLUTION; ORAL COLYTE-FLAVORED AA + MEDA PHARMS AA + GOLYTELY + BRAINTREE
227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53G N018983 M/BOT;21.5GM/BOT 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ N018983 BOT;22.72GM/BOT N019011
008 009
Nov 14, 1991 Nov 14, 1991
AA
AA AA AA
XX
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ BOT;22.74GM/BOT PEG 3350 AND ELECTROLYTES MYLAN 236GM;2.97GM;6.74GM;5.86GM;22.74GM NOVEL LABS INC 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ BOT;22.74GM/BOT 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ BOT;22.72GM/BOT GOLYTELY + BRAINTREE 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC KET;5.53GM/PACKET;21.5GM/PACKET
001
Jul 13, 1984
A090928 A090231 A090186
001 001 001
Jan 28, 2010 Jun 01, 2009 Jun 01, 2009
N019011
002
Jun 02, 1992
POLYMYXIN B SULFATE
INJECTABLE; INJECTION POLYMYCIN B SULFATE SAGENT STRIDES EQ 500,000 UNITS BASE/VIAL POLYMYXIN B SULFATE + BEDFORD EQ 500,000 U BASE/VIAL FRESENIUS KABI USA EQ 500,000 U BASE/VIAL X GEN PHARMS EQ 500,000 U BASE/VIAL POWDER; FOR RX COMPOUNDING
POLY-RX
+ X GEN PHARMS 100,000,000 UNITS/BOT
AP AP AP AP
A090110 A060716 A065372 A063000
001 001 001 001
Jun 29, 2011
Jan 10, 2008 Sep 30, 1994
XX
A061578
001
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE

SOLUTION/DROPS; OPHTHALMIC POLYTRIM + ALLERGAN 10,000 UNITS/ML;EQ 1MG TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE BAUSCH AND LOMB 10,000 UNITS/ML;EQ 1MG FALCON PHARMS 10,000 UNITS/ML;EQ 1MG TAYLOR PHARMA 10,000 UNITS/ML;EQ 1MG
AT AT AT AT
N050567 A064120 A064211 A065006
001 001 001 001
Oct 20, 1988 Feb 14, 1997 Apr 13, 1998 Dec 17, 1998
PONATINIB HYDROCHLORIDE
TABLET; ORAL ICLUSIG XX ARIAD XX +
N203469 N203469
001 002
Dec 14, 2012 Dec 14, 2012
PORACTANT ALFA
CUROSURF
XX + CORNERSTONE THERAP 80MG/ML
N020744
001
Nov 18, 1999
PORFIMER SODIUM
INJECTABLE; INJECTION PHOTOFRIN PINNACLE BIOLGS XX
75MG/VIAL
N020451
001
Dec 27, 1995
POSACONAZOLE
SUSPENSION; ORAL
NOXAFIL
XX + SCHERING
40MG/ML
N022003
001
Sep 15, 2006

POTASSIUM ACETATE
POTASSIUM ACETATE IN PLASTIC CONTAINER
XX + HOSPIRA 2MEQ/ML
3 - 342 (of 428)
N018896
001
Jul 20, 1984
POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL MICRO-K NESHER PHARMS 8MEQ MICRO-K 10 NESHER PHARMS 10MEQ POTASSIUM CHLORIDE PADDOCK LLC 8MEQ 10MEQ WATSON LABS FLORIDA 8MEQ + 10MEQ INJECTABLE; INJECTION POTASSIUM CHLORIDE B BRAUN 2MEQ/ML BAXTER HLTHCARE 2MEQ/ML FRESENIUS KABI USA 2MEQ/ML + HOSPIRA 2MEQ/ML INTL MEDICATION 2MEQ/ML POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 14.9MG/ML + 746MG/100ML HOSPIRA 14.9MG/ML 745MG/100ML POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 29.8MG/ML + 1.49GM/100ML + HOSPIRA 29.8MG/ML 1.49GM/100ML POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.24GM/100ML + HOSPIRA 2.24GM/100ML POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.98GM/100ML + HOSPIRA 2.98GM/100ML POTASSIUM CHLORIDE IN PLASTIC CONTAINER FRESENIUS KABI USA 2MEQ/ML 2MEQ/ML POTASSIUM CHLORIDE + FRESENIUS KABI USA 3MEQ/ML TABLET, EXTENDED RELEASE; KLOR-CON M10 UPSHER SMITH LABS KLOR-CON M20 + UPSHER SMITH LABS POTASSIUM CHLORIDE EURAND WATSON LABS FLORIDA KLOR-CON UPSHER-SMITH LABS + K-TAB ABBVIE POTASSIUM CHLORIDE ABBVIE KLOR-CON M15 UPSHER SMITH LABS ORAL
10MEQ 20MEQ 20MEQ 10MEQ 20MEQ 8MEQ 10MEQ 10MEQ 8MEQ 15MEQ A074726 A074726 A076368 A075604 A075604 N019123 N019123 N018279 N018279 A074726 002 001 001 001 002 001 002 001 002 003 Aug 01, 1988 Jun 06, 2003 Aug 09, 2000 Nov 20, 1998 Aug 18, 2004 Apr 10, 2002 Apr 10, 2002 Apr 17, 1986 Apr 17, 1986
AB AB AB AB AB AB
N018238 N018238 A200185 A200185 A077419 A077419
001 002 001 002 001 002 May 14, 1984 May May Jun Jun 18, 18, 02, 02, 2011 2011 2008 2008
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX
A085870 A085499 A080225 A080205 A083163 N019904 N019904 N020161 N020161 N019904 N019904 N020161 N020161 N019904 N020161 N019904 N020161 A088901 A088908 A080225
001 001 001 001 001 001 005 005 001 002 006 006 002 003 003 004 004 001 001 003
Dec Dec Nov Nov Dec Dec Aug Nov 26, 17, 30, 30, 26, 17, 11, 30, 1989 1990 1992 1992 1989 1990 1998 1992
Dec 26, 1989 Aug 11, 1998 Dec 26, 1989 Aug 11, 1998 Jan 25, 1985 Jan 25, 1985
AB AB AB AB AB BC BC BC BC XX

POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER HOSPIRA 149MG/100ML;450MG/100ML A078446 POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER + BAXTER HLTHCARE 150MG/100ML;450MG/100ML N017648 POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 150MG/100ML;900MG/100ML N019708 BAXTER HLTHCARE 150MG/100ML;900MG/100ML N017648 POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE 300MG/100ML;900MG/100ML N017648 POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA 149MG/100ML;900MG/100ML N019686 POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA 298MG/100ML;900MG/100ML N019686 POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9% BAXTER HLTHCARE 224MG/100ML;900MG/100ML N017648
3 - 343 (of 428)
001 005 004 001 002 001 002 003
Sep 10, 2008 Nov 26, 2002 Sep 29, 1989
Oct 17, 1988 Oct 17, 1988
POTASSIUM CITRATE
TABLET, EXTENDED RELEASE; ORAL POTASSIUM CITRATE COREPHARMA AB 5MEQ AB 10MEQ UROCIT-K MISSION PHARMA AB 5MEQ AB 10MEQ UROCIT-K 15MEQ XX + MISSION PHARMA
A077440 A077440 N019071 N019071 N019071
001 002 001 002 003
Jun 09, 2006 Jun 09, 2006 Aug 30, 1985 Aug 31, 1992 Dec 30, 2009
POVIDONE-IODINE
BETADINE
XX + ALCON PHARMS LTD 5%
N018634
001
Dec 17, 1986
PRALATREXATE
SOLUTION; INTRAVENOUS FOLOTYN XX ALLOS XX +
20MG/ML (20MG/ML) 40MG/2ML (20MG/ML)
N022468 N022468
001 002
Sep 24, 2009 Sep 24, 2009
PRALIDOXIME CHLORIDE
XX + MERIDIAN MEDCL TECHN PROTOPAM CHLORIDE XX + BAXTER HLTHCARE CORP
300MG/ML 1GM/VIAL
N018986 N014134
001 001
Apr 26, 1983
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET; ORAL MIRAPEX BOEHRINGER INGELHEIM 0.125MG AB AB + 0.25MG AB 0.5MG AB 0.75MG AB 1MG AB 1.5MG PRAMIPEXOLE DIHYDROCHLORIDE ACTAVIS PHARMA AB 0.125MG AB 0.25MG AB 0.5MG AB 0.75MG AB 1MG
N020667 N020667 N020667 N020667 N020667 N020667 A091254 A091254 A091254 A091254 A091254
001 002 006 007 003 005 001 002 003 004 005
Jul Jul Feb Jul Jul Jul Nov Nov Nov Nov Nov
01, 01, 12, 30, 01, 01, 30, 30, 30, 30, 30,
1997 1997 1998 2007 1997 1997 2010 2010 2010 2010 2010

TABLET; ORAL PRAMIPEXOLE DIHYDROCHLORIDE ACTAVIS PHARMA 1.5MG ALEMBIC LTD 0.125MG 0.25MG 0.5MG 1MG 1.5MG APOTEX INC 0.125MG 0.25MG 0.5MG 0.75MG 1MG 1.5MG AUROBINDO PHARMA LTD 0.125MG 0.25MG 0.5MG 0.75MG 1MG 1.5MG BARR 0.125MG 0.25MG 0.5MG 1MG 1.5MG BRECKENRIDGE PHARM 0.125MG 0.25MG 0.5MG 1MG 1.5MG GLENMARK GENERICS 0.125MG 0.25MG 0.5MG 1MG 1.5MG MACLEODS PHARMS LTD 0.125MG 0.25MG 0.5MG 1MG 1.5MG MYLAN 0.125MG 0.25MG 0.5MG 0.75MG 1MG 1.5MG SANDOZ 0.125MG 0.25MG 0.5MG 0.75MG 1MG 1.5MG TEVA PHARMS 0.125MG 0.25MG 0.5MG 0.75MG 1MG 1.5MG TORRENT PHARMS 0.125MG 0.25MG
3 - 344 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
006 001 002 003 004 005 001 002 003 006 004 005 001 002 003 004 005 006 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 001 004 005 001 002 003 006 004 005 001 002 003 004 005 006 001 002
Nov Oct Oct Oct Oct Oct Apr Apr Apr Apr Apr Apr Oct Oct Oct Oct Oct Oct Feb Feb Feb Feb Feb Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Sep Sep Sep Sep Sep Oct Oct Oct Apr Oct Oct Jul Jul Jul Oct Jul Jul Oct Oct Oct Oct Oct Oct Oct Oct
30, 08, 08, 08, 08, 08, 30, 30, 30, 30, 30, 30, 26, 26, 26, 26, 26, 26, 19, 19, 19, 19, 19, 08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 20, 20, 20, 20, 20, 08, 08, 08, 09, 08, 08, 06, 06, 06, 08, 06, 06, 08, 08, 08, 08, 08, 08, 08, 08,
2010 2010 2010 2010 2010 2010 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2008 2008 2008 2008 2008 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2012 2012 2012 2012 2012 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010

TABLET; ORAL PRAMIPEXOLE DIHYDROCHLORIDE TORRENT PHARMS 0.5MG 0.75MG 1MG 1.5MG WATSON LABS 0.125MG 0.25MG 0.5MG 1MG 1.5MG ZYDUS PHARMS USA INC 0.125MG 0.25MG 0.5MG 1MG 1.5MG TABLET, EXTENDED RELEASE; ORAL
MIRAPEX ER
+ BOEHRINGER INGELHEIM 0.375MG 0.75MG 1.5MG 2.25MG 3MG 3.75MG 4.5MG
3 - 345 (of 428)
A090865 A090865 A090865 A090865 A078551 A078551 A078551 A078551 A078551 A078920 A078920 A078920 A078920 A078920
003 004 005 006 001 002 003 004 005 001 002 003 004 005
Oct Oct Oct Oct Oct Oct Oct Oct Oct Jul Jul Jul Jul Jul
08, 08, 08, 08, 08, 08, 08, 08, 08, 06, 06, 06, 06, 06,
2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
XX XX XX XX XX XX XX
N022421 N022421 N022421 N022421 N022421 N022421 N022421
001 002 003 006 004 007 005
Feb Feb Feb Jun Feb Jun Feb
19, 19, 19, 17, 19, 17, 19,
2010 2010 2010 2011 2010 2011 2010
PRAMLINTIDE ACETATE
INJECTABLE; SUBCUTANEOUS SYMLIN XX AMYLIN XX XX +
EQ 1.5MG BASE/1.5ML (EQ 1MG BASE/ML) EQ 2.7MG BASE/2.7ML (EQ 1MG BASE/ML) EQ 3MG BASE/5ML (EQ 600MCG BASE/ML)
N021332 N021332 N021332
002 003 001
Sep 25, 2007 Sep 25, 2007 Mar 16, 2005
PRASUGREL HYDROCHLORIDE
TABLET; ORAL EFFIENT ELI LILLY AND CO XX XX +
N022307 N022307
001 002
Jul 10, 2009 Jul 10, 2009
PRAVASTATIN SODIUM
TABLET; ORAL PRAVACHOL BRISTOL MYERS SQUIBB AB AB AB AB + PRAVASTATIN SODIUM APOTEX AB AB AB AB DR REDDYS LABS INC AB AB AB AB GLENMARK GENERICS AB AB AB AB LUPIN PHARMS AB
002 003 004 008 001 002 003 004 001 002 003 004 001 002 003 004 001
Oct Oct Mar Dec Oct Oct Oct Dec Oct Oct Oct Dec May May May Dec Jan
31, 31, 22, 18, 23, 23, 23, 28, 23, 23, 23, 28, 11, 11, 11, 28, 08,
1991 1991 1993 2001 2006 2006 2006 2007 2006 2006 2006 2007 2007 2007 2007 2007 2008

PRAVASTATIN SODIUM
TABLET; ORAL PRAVASTATIN SODIUM LUPIN PHARMS AB AB AB MYLAN AB AB AB AB MYLAN PHARMS INC AB AB AB AB TEVA AB AB AB TEVA PHARMS AB WATSON LABS AB AB AB AB AB AB AB ZYDUS PHARMS USA AB AB AB AB
3 - 346 (of 428)
002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 004 001 003 002 002 003 001 001 002 003 004
Jan Jan Jan Oct Oct Oct Dec May May May May Apr Apr Apr Jan Oct Oct Oct Oct Oct Oct Dec Apr Apr Apr Apr
08, 08, 08, 23, 23, 23, 28, 27, 27, 27, 27, 24, 24, 24, 15, 23, 23, 23, 23, 23, 23, 28, 30, 30, 30, 30,
2008 2008 2008 2006 2006 2006 2007 2010 2010 2010 2010 2006 2006 2006 2008 2006 2006 2006 2006 2006 2006 2007 2008 2008 2008 2008
PRAZIQUANTEL
TABLET; ORAL BILTRICIDE XX + BAYER PHARMA AG
600MG
N018714
001
Dec 29, 1982
PRAZOSIN HYDROCHLORIDE
CAPSULE; ORAL MINIPRESS PFIZER AB AB + AB PRAZOSIN HYDROCHLORIDE IVAX SUB TEVA PHARMS AB MYLAN AB AB AB TEVA PHARMS AB AB
EQ 1MG BASE EQ 2MG BASE EQ 5MG BASE EQ EQ EQ EQ EQ EQ 1MG 1MG 2MG 5MG 2MG 5MG BASE BASE BASE BASE BASE BASE
N017442 N017442 N017442 A071994 A072575 A072575 A072575 A071995 A071745
002 003 001 001 003 002 001 001 001 Sep May May May Sep Sep 12, 16, 16, 16, 12, 12, 1988 1989 1989 1989 1988 1988
PREDNICARBATE
CREAM; TOPICAL DERMATOP E EMOLLIENT AB + VALEANT BERMUDA PREDNICARBATE FOUGERA PHARMS AB OINTMENT; TOPICAL DERMATOP AB + VALEANT BERMUDA PREDNICARBATE FOUGERA PHARMS AB
0.1% 0.1%
N020279 A077287
001 001
Oct 29, 1993 Sep 19, 2006
0.1% 0.1%
N019568 A077236
001 001
Sep 23, 1991 Mar 09, 2007

PREDNISOLONE
SYRUP; ORAL PREDNISOLONE ALPHARMA AA APOTEX INC AA AA AA + HI TECH PHARMA CO PHARM ASSOC AA VINTAGE AA WOCKHARDT AA PRELONE TEVA AA TABLET; ORAL PREDNISOLONE XX + WATSON LABS
3 - 347 (of 428)
15MG/5ML 5MG/5ML 15MG/5ML 15MG/5ML 15MG/5ML 15MG/5ML 15MG/5ML 15MG/5ML
A040323 A040570 A040571 A040401 A040399 A040775 A040313 A089081
001 001 001 001 001 001 001 001
May Aug Aug Feb Mar Sep Sep
13, 25, 25, 27, 05, 21, 10,
1999 2005 2005 2003 2003 2007 2003
Feb 04, 1986
5MG
A080354
001
PREDNISOLONE ACETATE
SUSPENSION; ORAL
FLO-PRED
XX + TARO
EQ 15MG BASE/5ML
N022067
002
Jan 17, 2008
SUSPENSION/DROPS; OPHTHALMIC OMNIPRED ALCON AB 1% PRED FORTE AB + ALLERGAN 1% PRED MILD 0.12% XX + ALLERGAN
N017469 N017011 N017100
001 001 001
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

BLEPHAMIDE S.O.P.
XX + ALLERGAN SUSPENSION; OPHTHALMIC
BLEPHAMIDE
XX + ALLERGAN
0.2%;10%
A087748
001
Dec 03, 1986
0.2%;10%
N012813
002
PREDNISOLONE SODIUM PHOSPHATE

SOLUTION; ORAL ORAPRED + SHIONOGI INC EQ 15MG BASE/5ML PEDIAPRED + SETON PHARM EQ 5MG BASE/5ML PREDNISOLONE SODIUM PHOSPHATE AMNEAL PHARMS EQ 15MG BASE/5ML HI TECH PHARMA EQ 5MG BASE/5ML NESHER PHARMS EQ 15MG BASE/5ML PADDOCK LLC EQ 5MG BASE/5ML PHARM ASSOC EQ 5MG BASE/5ML EQ 15MG BASE/5ML VINTAGE EQ 15MG BASE/5ML WE PHARMS EQ 15MG BASE/5ML WOCKHARDT EQ 5MG BASE/5ML EQ 15MG BASE/5ML PREDNISOLONE SODIUM PHOSPHATE + MISSION PHARMA EQ 25MG BASE/5ML + PHARM ASSOC EQ 10MG BASE/5ML + EQ 20MG BASE/5ML SOLUTION/DROPS; OPHTHALMIC
+ BAUSCH AND LOMB EQ 0.9% PHOSPHATE
AA AA AA AA AA AA AA AA AA AA AA AA XX XX XX
A075117 N019157 A078345 A075183 A076988 A075988 A076123 A076913 A079010 A075250 A075099 A076895 A091396 A078465 A078988
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Dec 14, 2000 May 28, 1986 Mar Mar May May Dec Apr May Jul Jun Oct 10, 26, 24, 25, 23, 25, 26, 12, 28, 04, 2009 2003 2005 2004 2002 2005 2009 2002 2002 2004
Sep 13, 2010 Mar 07, 2008 Jun 09, 2008
XX
A040070
001
Jul 29, 1994

TABLET, ORALLY DISINTEGRATING; ORAL ORAPRED ODT XX SHIONOGI INC EQ 10MG BASE XX EQ 15MG BASE XX + EQ 30MG BASE
3 - 348 (of 428)
N021959 N021959 N021959
001 002 003
Jun 01, 2006 Jun 01, 2006 Jun 01, 2006
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM

SOLUTION/DROPS; OPHTHALMIC SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE ALCON PHARMS LTD AT EQ 0.23% PHOSPHATE;10% BAUSCH AND LOMB AT EQ 0.23% PHOSPHATE;10% VASOCIDIN AT + NOVARTIS EQ 0.23% PHOSPHATE;10%
A073630 A074449 N018988
001 001 001
May 27, 1993 Dec 29, 1995 Aug 26, 1988
PREDNISONE
SOLUTION; ORAL
PREDNISONE
XX + ROXANE PREDNISONE INTENSOL XX + ROXANE
5MG/5ML 5MG/ML
A088703 A088810
001 001
Nov 08, 1984 Feb 20, 1985
TABLET; ORAL PREDNISONE CONTRACT PHARMACAL AB 5MG JUBILANT CADISTA AB 1MG AB 5MG AB 10MG AB 20MG MUTUAL PHARM AB 5MG AB 10MG AB 20MG AB + ROXANE 1MG AB + 2.5MG AB + 5MG AB + 10MG AB + 20MG AB + 50MG VINTAGE PHARMS AB 1MG AB 2.5MG AB 5MG AB 10MG AB 20MG WATSON LABS AB 5MG AB 10MG AB 20MG WEST WARD AB 2.5MG AB 5MG AB 10MG AB 20MG WEST WARD PHARM CORP 1MG AB AB 50MG TABLET, DELAYED RELEASE; ORAL RAYOS HORIZON PHARMA 1MG XX 2MG XX 5MG XX +
001 001 002 001 003 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001
Jun Aug Aug Jun Dec Dec Dec Apr Apr
06, 29, 29, 29, 04, 04, 04, 22, 22,
2005 2001 2001 2005 1985 1985 1985 1982 1982
Dec Dec Jul Jul Feb
21, 21, 12, 12, 12,
2004 2004 2002 2002 2003
Jan 08, 2004 Dec 04, 1985 Nov 01, 2010 Jun 01, 1984
N202020 N202020 N202020
001 002 003
Jul 26, 2012 Jul 26, 2012 Jul 26, 2012
PREGABALIN
CAPSULE; ORAL LYRICA PF PRISM AB
25MG
N021446
001
Dec 30, 2004

PREGABALIN
CAPSULE; ORAL LYRICA PF PRISM AB AB AB AB AB AB AB + PREGABALIN LUPIN LTD AB AB AB AB AB AB AB AB TEVA PHARMS AB AB AB AB AB AB AB AB WATSON LABS INC AB AB AB AB AB AB AB AB SOLUTION; ORAL
LYRICA
XX + PF PRISM
3 - 349 (of 428)
N021446 N021446 N021446 N021446 N021446 N021446 N021446 A091040 A091040 A091040 A091040 A091040 A091040 A091040 A091040 A091219 A091219 A091224 A091224 A091224 A091224 A091224 A091224 A091221 A091221 A091221 A091221 A091221 A091221 A091221 A091221
002 003 004 005 006 007 008 001 002 003 004 005 006 007 008 001 002 001 002 003 004 005 006 001 002 003 004 005 006 007 008
Dec Dec Dec Dec Dec Dec Dec Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
30, 30, 30, 30, 30, 30, 30, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03, 03,
2004 2004 2004 2004 2004 2004 2004 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
20MG/ML
N022488
001
Jan 04, 2010
PRILOCAINE HYDROCHLORIDE
XX + SEPTODONT INC 4%
A079235
001
Sep 29, 2010
PRIMAQUINE PHOSPHATE
TABLET; ORAL
PRIMAQUINE
EQ 15MG BASE
N008316
001
PRIMIDONE
TABLET; ORAL MYSOLINE AB + VALEANT AB PRIMIDONE AMNEAL PHARM AB AB DR REDDYS LABS LTD AB AB IMPAX LABS AB AB
N009170 N009170 A040866 A040866 A040862 A040862 A040717 A040717
003 002 001 002 001 002 001 002 Apr Apr Oct Oct Feb Feb 23, 23, 03, 03, 12, 12, 2008 2008 2008 2008 2008 2008

PRIMIDONE
TABLET; ORAL PRIMIDONE LANNETT AB AB MUTUAL PHARM AB AB VINTAGE PHARMS AB AB WATSON LABS AB WEST WARD AB AB
3 - 350 (of 428)
A084903 A084903 A040626 A040626 A040586 A040586 A083551 A040667 A040667
002 001 001 002 001 002 001 001 002
May 24, 2001 Sep Sep Feb Feb 29, 29, 24, 24, 2005 2005 2005 2005
Jul 27, 2006 Jul 27, 2006
PROBENECID
TABLET; ORAL PROBALAN LANNETT PROBENECID IVAX SUB TEVA PHARMS + MYLAN WATSON LABS
AB AB AB AB
500MG 500MG 500MG 500MG
A080966 A083740 A084211 A084442
001 001 002 004 May 09, 1984 Mar 29, 1983
PROCAINAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION PROCAINAMIDE HYDROCHLORIDE + HOSPIRA 100MG/ML + 500MG/ML INTL MEDICATION 100MG/ML 500MG/ML
AP AP AP AP
A089069 A089070 A088636 A088637
001 001 001 001
Feb Feb Jul Jul
12, 12, 31, 31,
1986 1986 1984 1984
PROCARBAZINE HYDROCHLORIDE
CAPSULE; ORAL
MATULANE
XX + SIGMA TAU
EQ 50MG BASE
N016785
001
PROCHLORPERAZINE
SUPPOSITORY; RECTAL COMPRO PADDOCK LLC AB PROCHLORPERAZINE AB + G AND W LABS
25MG 25MG
A040246 A040058
001 001
Jun 28, 2000 Nov 24, 1993
PROCHLORPERAZINE EDISYLATE
INJECTABLE; INJECTION PROCHLORPERAZINE EDISYLATE BEDFORD AP EQ 5MG BASE/ML AP + HIKMA MAPLE EQ 5MG BASE/ML
A040540 A089903
001 001
May 28, 2004 Aug 29, 1989
PROCHLORPERAZINE MALEATE
TABLET; ORAL PROCHLORPERAZINE MALEATE MYLAN AB EQ AB EQ SANDOZ AB EQ AB + EQ TEVA PHARMS AB EQ AB EQ PROCOMP JUBILANT CADISTA AB EQ AB EQ
A040185 A040185 A040101 A040101 A040120 A040120 A040268 A040268
002 001 001 002 001 002 001 002
Oct Oct Jul Jul Jul Jul
28, 28, 19, 19, 11, 11,
1996 1996 1996 1996 1996 1996
Feb 27, 1998 Feb 27, 1998

PROGESTERONE
CAPSULE; ORAL PROGESTERONE SOFGEN PHARMS AB AB TEVA PHARMS AB AB PROMETRIUM ABBOTT LABS AB AB + GEL; VAGINAL CRINONE WATSON LABS XX XX + INJECTABLE; INJECTION PROGESTERONE FRESENIUS KABI USA HIKMA FARMACEUTICA LUITPOLD + WATSON LABS (UTAH) INSERT; VAGINAL
ENDOMETRIN
+ FERRING
3 - 351 (of 428)
100MG 200MG 100MG 200MG 100MG 200MG
A200456 A200456 A202121 A202121 N019781 N019781
001 002 001 002 001 002
Sep Sep Feb Feb
28, 28, 29, 29,
2012 2012 2012 2012
May 14, 1998 Oct 15, 1999
4% 8%
N020701 N020701
001 002
Jul 31, 1997 Jul 31, 1997
AO AO AO AO
A075906 A091033 A090845 N017362
001 001 001 002
Apr 25, 2001 Oct 28, 2010 Jun 22, 2009
XX
100MG
N022057
001
Jun 21, 2007
PROMETHAZINE HYDROCHLORIDE
INJECTABLE; INJECTION PROMETHAZINE HYDROCHLORIDE HIKMA MAPLE 25MG/ML 50MG/ML HOSPIRA 25MG/ML LUITPOLD 25MG/ML + TEVA PARENTERAL 25MG/ML + 50MG/ML WOCKHARDT 25MG/ML 50MG/ML X-GEN PHARMS 25MG/ML 50MG/ML SUPPOSITORY; RECTAL PROMETHAZINE HYDROCHLORIDE G AND W LABS 12.5MG + 25MG PERRIGO NEW YORK 12.5MG 25MG TARO 12.5MG 25MG WATSON LABS INC 12.5MG 25MG PROMETHEGAN + G AND W LABS 50MG SYRUP; ORAL PROMETHAZINE HYDROCHLORIDE AMNEAL PHARMS 6.25MG/5ML HI TECH PHARMA 6.25MG/5ML SUN PHARM INDS INC 6.25MG/5ML TARO 6.25MG/5ML TRIS PHARMA INC 6.25MG/5ML VINTAGE 6.25MG/5ML PROMETHAZINE PLAIN + WOCKHARDT 6.25MG/5ML
AP AP AP AP AP AP AP AP AP AP
A083312 A083312 A040372 A040515 A040454 A040454 A040785 A040785 A040737 A040737
001 002 001 001 001 002 001 002 001 002
Jun Mar Aug Aug Sep Sep Apr Apr
08, 19, 22, 22, 26, 26, 24, 24,
2000 2003 2002 2002 2008 2008 2008 2008
AB AB AB AB AB AB AB AB XX
A040428 A040428 A040500 A040500 A040603 A040603 A040479 A040479 A087165
002 001 001 002 001 002 001 002 001
Mar Feb Jun Jun Oct Oct Jun Jun
31, 05, 30, 30, 26, 26, 24, 24,
2003 2002 2003 2003 2006 2006 2003 2003
Aug 14, 1987
A040882 A040026 A040891 A040718 A091675 A040643 A087953
001 001 001 001 001 001 001
Dec Sep Mar Apr Jun Apr
30, 25, 13, 04, 28, 26,
2009 1998 2009 2007 2012 2006
Nov 15, 1982

TABLET; ORAL PROMETHAZINE HYDROCHLORIDE AMNEAL PHARMS NY 12.5MG 25MG 50MG EMCURE PHARMS USA 12.5MG 25MG 50MG IMPAX LABS 12.5MG 25MG 50MG KVK TECH 12.5MG 25MG 50MG MYLAN 12.5MG 25MG 50MG SANDOZ 25MG + 50MG SUN PHARM INDS INC 12.5MG 25MG 50MG VINTAGE PHARMS 12.5MG 25MG 50MG WATSON LABS 25MG 50MG ZYDUS PHARMS USA 12.5MG 25MG 50MG
3 - 352 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 003 001 002 003 001 002 001 002 001 001 001 002 003 001 001 001 002 003 001 002 003 001 001 001 002 003
Dec Dec Dec Mar Mar Mar Feb Feb May May Jul Jul Aug Aug Aug
13, 13, 13, 05, 05, 05, 12, 12, 20, 04, 31, 31, 30, 30, 30,
2010 2010 2010 2008 2008 2008 2008 2008 2008 2007 2006 2006 2011 2011 2011
Dec Dec Dec Jul Jul Jul
30, 30, 30, 18, 18, 18,
2008 2008 2008 2006 2006 2006
Nov 18, 2005 Nov 18, 2005 Nov 18, 2005
PROPAFENONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL PROPAFENONE HYDROCHLORIDE PAR PHARM 225MG 325MG 425MG RYTHMOL SR GLAXOSMITHKLINE LLC 225MG 325MG + 425MG TABLET; ORAL PROPAFENONE HYDROCHLORIDE MUTUAL PHARM 150MG 225MG 300MG PLIVA 150MG 225MG 300MG VINTAGE PHARMS 150MG 225MG 300MG WATSON LABS 150MG 225MG RYTHMOL GLAXOSMITHKLINE LLC 150MG 225MG + 300MG
AB AB AB AB AB AB
A078540 A078540 A078540 N021416 N021416 N021416
001 002 003 001 002 003
Oct 18, 2010 Oct 18, 2010 Oct 18, 2010 Sep 04, 2003 Sep 04, 2003 Sep 04, 2003
A075998 A075998 A075998 A076550 A076550 A076550 A075938 A075938 A075938 A075203 A075203 N019151 N019151 N019151
001 002 003 001 002 003 001 002 003 001 002 001 003 002
Nov Nov Nov Apr Apr Apr Oct Oct Oct Oct Oct
29, 29, 29, 23, 23, 23, 17, 17, 17, 24, 24,
2001 2001 2001 2004 2004 2004 2002 2002 2002 2000 2000
Nov 27, 1989 Nov 20, 1992 Nov 27, 1989

PROPANTHELINE BROMIDE
TABLET; ORAL
XX + ROXANE
3 - 353 (of 428)
15MG
A080927
002
PROPARACAINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC ALCAINE ALCON 0.5% OPHTHAINE + APOTHECON 0.5% OPHTHETIC + ALLERGAN 0.5% PROPARACAINE HYDROCHLORIDE BAUSCH AND LOMB 0.5% TAYLOR PHARMA 0.5%
AT AT AT AT AT
A080027 N008883 N012583 A040074 A040277
001 001 001 001 001 Sep 29, 1995 Mar 16, 2000
PROPOFOL
INJECTABLE; INJECTION DIPRIVAN AB + FRESENIUS KABI USA PROPOFOL HOSPIRA AB TEVA PARENTERAL AB
N019627 A077908 A075102
002 001 001
Jun 11, 1996 Mar 17, 2006 Jan 04, 1999
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL INDERAL LA AKRIMAX PHARMS 60MG 80MG 120MG + 160MG PROPRANOLOL HYDROCHLORIDE ACTAVIS ELIZABETH 60MG 80MG 120MG 160MG APTALIS PHARMATECH 60MG 80MG 120MG 160MG MYLAN 60MG 80MG 120MG 160MG PAR PHARM 60MG 80MG 120MG 160MG UPSHER SMITH 60MG 80MG 120MG 160MG ZYDUS PHARMS USA INC 60MG 80MG 120MG 160MG INNOPRAN XL GLAXOSMITHKLINE LLC 80MG 120MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB BX BX
N018553 N018553 N018553 N018553 A078494 A078494 A078494 A078494 A078703 A078703 A078703 A078703 A078022 A078022 A078022 A078022 A078065 A078065 A078065 A078065 A078311 A078311 A078311 A078311 A090321 A090321 A090321 A090321 N021438 N021438
004 002 003 001 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002
Mar Apr Apr Apr Aug Aug Aug Aug Jul Jul Jul Jul Feb Feb Feb Feb Jan Jan Jan Jan Mar Mar Mar Mar Mar Mar Mar Mar
18, 19, 19, 19, 10, 10, 10, 10, 15, 15, 15, 15, 15, 15, 15, 15, 26, 26, 26, 26, 06, 06, 06, 06, 25, 25, 25, 25,
1987 1983 1983 1983 2007 2007 2007 2007 2011 2011 2011 2011 2007 2007 2007 2007 2007 2007 2007 2007 2009 2009 2009 2009 2011 2011 2011 2011
Mar 12, 2003 Mar 12, 2003

INJECTABLE; INJECTION PROPRANOLOL HYDROCHLORIDE + BAXTER HLTHCARE CORP 1MG/ML BEDFORD 1MG/ML FRESENIUS KABI USA 1MG/ML HIKMA FARMACEUTICA 1MG/ML SANDOZ 1MG/ML SOLUTION; ORAL PROPRANOLOL HYDROCHLORIDE + ROXANE 20MG/5ML + 40MG/5ML TABLET; ORAL INDERAL AKRIMAX PHARMS 40MG 60MG + 80MG PROPRANOLOL HYDROCHLORIDE IPCA LABS LTD 10MG 20MG 40MG 60MG 80MG MYLAN 10MG 20MG 40MG 60MG 80MG NORTHSTAR HLTHCARE 10MG 20MG 40MG 60MG 80MG PLIVA 10MG 20MG 40MG 60MG + 80MG VINTAGE PHARMS 10MG 20MG 40MG 60MG 80MG WATSON LABS 10MG 20MG 40MG 80MG
3 - 354 (of 428)
AP AP AP AP AP
N016419 A075792 A075826 A077760 A076400
001 001 001 001 001
Aug Aug Jan Feb
29, 31, 31, 26,
2000 2001 2008 2003
XX XX
A070979 A070690
001 001
May 15, 1987 May 15, 1987
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
N016418 N016418 N016418 A078955 A078955 A078955 A078955 A078955 A070213 A070213 A070213 A070213 A070213 A078213 A078213 A078213 A078213 A078213 A071972 A071973 A071974 A071975 A071976 A070217 A070218 A070219 A070220 A070221 A070175 A070176 A070177 A070178
002 009 004 001 002 003 004 005 002 003 001 005 004 001 002 003 004 005 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Oct 18, 1982
Jun Jun Jun Jun Jun Nov Nov Nov Apr Nov Jan Jan Jan Jan Jan Apr Apr Apr Apr Apr Aug Aug Aug Sep Apr May May May May
02, 02, 02, 02, 02, 19, 19, 19, 08, 19, 10, 10, 10, 10, 10, 06, 06, 06, 06, 06, 01, 01, 01, 24, 14, 13, 13, 13, 13,
2008 2008 2008 2008 2008 1985 1985 1985 2011 1985 2008 2008 2008 2008 2008 1988 1988 1988 1988 1988 1986 1986 1986 1986 1986 1986 1986 1986 1986
PROPYLTHIOURACIL
TABLET; ORAL PROPYLTHIOURACIL BD ACTAVIS ELIZABETH BD + DAVA PHARMS INC BD WEST WARD
50MG 50MG 50MG
A080172 N006188 A080154
001 001 001
PROTAMINE SULFATE
PROTAMINE SULFATE
XX + FRESENIUS KABI USA
10MG/ML
A089454
001
Apr 07, 1987

PROTRIPTYLINE HYDROCHLORIDE
TABLET; ORAL PROTRIPTYLINE HYDROCHLORIDE EPIC PHARMA LLC AB 5MG AB 10MG ROXANE AB 5MG AB 10MG SIGMAPHARM LABS LLC AB 5MG AB 10MG VIVACTIL ODYSSEY PHARMS AB 5MG AB + 10MG
3 - 355 (of 428)
A202220 A202220 A078913 A078913 A090462 A090462 A073644 A073645
001 002 001 002 001 002 001 001
Nov Nov Sep Sep May May
19, 19, 16, 16, 03, 03,
2012 2012 2008 2008 2010 2010
Aug 24, 1995 Aug 24, 1995
PYRAZINAMIDE
TABLET; ORAL PYRAZINAMIDE AB + DAVA PHARMS INC MIKART AB
500MG 500MG
A080157 A081319
001 001
Jun 30, 1992
PYRIDOSTIGMINE BROMIDE
INJECTABLE; INJECTION MESTINON AP + VALEANT PHARM INTL REGONOL SANDOZ AP SYRUP; ORAL MESTINON XX + VALEANT PHARM INTL TABLET; ORAL MESTINON AB + VALEANT PHARMS LLC PYRIDOSTIGMINE BROMIDE COREPHARMA AB IMPAX LABS AB TABLET, EXTENDED RELEASE; MESTINON XX + VALEANT PHARMS LLC
5MG/ML 5MG/ML
N009830 N017398
001 001
60MG/5ML
N015193
001
60MG 60MG 60MG ORAL 180MG
N009829 A040457 A040502
002 001 001 Dec 26, 2002 Apr 24, 2003
N011665
001
PYRIDOXINE HYDROCHLORIDE
INJECTABLE; INJECTION PYRIDOXINE HYDROCHLORIDE XX + FRESENIUS KABI USA 100MG/ML
A080618
001
PYRIMETHAMINE
TABLET; ORAL DARAPRIM XX + COREPHARMA
25MG
N008578
001
QUAZEPAM
TABLET; ORAL DORAL XX + QUESTCOR PHARMS
15MG
N018708
001
Dec 27, 1985
QUETIAPINE FUMARATE
TABLET; ORAL QUETIAPINE FUMARATE ACCORD HLTHCARE INC AB AB AB AB AB AB
EQ EQ EQ EQ EQ EQ
25MG BASE 50MG BASE 100MG BASE 200MG BASE 300MG BASE 400MG BASE
A202152 A202152 A202152 A202152 A202152 A202152
001 002 003 004 005 006
Mar Mar Mar Mar Mar Mar
27, 27, 27, 27, 27, 27,
2012 2012 2012 2012 2012 2012

QUETIAPINE FUMARATE
TABLET; ORAL QUETIAPINE FUMARATE APOTEX INC AB AB AB AB AB AB AUROBINDO PHARMA LTD AB AB AB AB AB AB AB DR REDDYS LABS LTD AB AB AB AB AB AB AB LUPIN LTD AB AB AB AB AB AB MYLAN PHARMS INC AB ROXANE AB AB AB AB AB AB SANDOZ AB AB AB AB AB AB AB SUN PHARMA GLOBAL AB AB AB AB AB AB TEVA PHARMS AB AB AB AB AB AB AB TORRENT PHARMS LTD AB AB AB AB AB
3 - 356 (of 428)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
25MG BASE 50MG BASE 100MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 50MG BASE 100MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 25MG BASE 50MG BASE 100MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 50MG BASE 100MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE 300MG BASE 400MG BASE 25MG BASE 50MG BASE 100MG BASE 200MG BASE 300MG BASE
001 002 003 004 005 006 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 001 001 001 002 003 004 005 001 002 003 004 005 006 007 001 002 003 004 005 006 001 002 003 004 005 006 007 001 002 003 004 005
Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Dec Dec Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar
27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 14, 14, 14, 14, 14, 14, 14, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012

QUETIAPINE FUMARATE
TABLET; ORAL QUETIAPINE FUMARATE TORRENT PHARMS LTD AB SEROQUEL AB + ASTRAZENECA AB AB AB AB + AB TABLET, EXTENDED RELEASE; SEROQUEL XR ASTRAZENECA XX XX XX + XX XX
3 - 357 (of 428)
EQ 400MG BASE EQ 25MG BASE EQ 50MG BASE EQ 100MG BASE EQ 200MG BASE EQ 300MG BASE EQ 400MG BASE ORAL EQ EQ EQ EQ EQ 50MG BASE 150MG BASE 200MG BASE 300MG BASE 400MG BASE
A200363 N020639 N020639 N020639 N020639 N020639 N020639
006 001 007 002 003 005 006
Mar 27, 2012 Sep Oct Sep Sep Jul Oct 26, 04, 26, 26, 26, 04, 1997 2005 1997 1997 2000 2005
N022047 N022047 N022047 N022047 N022047
001 005 002 003 004
May Aug May May May
17, 11, 17, 17, 17,
2007 2008 2007 2007 2007
QUINAPRIL HYDROCHLORIDE
TABLET; ORAL ACCUPRIL PFIZER PHARMS AB AB AB AB + QUINAPRIL HYDROCHLORIDE APOTEX AB AB AB AB INVAGEN PHARMS AB AB AB AB LUPIN AB AB AB AB MYLAN AB AB AB AB AB AB AB AB RANBAXY AB AB AB AB SUN PHARM INDS LTD AB AB AB AB TEVA AB AB AB AB WATSON LABS FLORIDA AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 5MG BASE 10MG BASE 10MG BASE 20MG BASE 20MG BASE 40MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE
N019885 N019885 N019885 N019885 A076240 A076240 A076240 A076240 A078457 A078457 A078457 A078457 A077690 A077690 A077690 A077690 A076036 A076694 A076036 A076694 A076036 A076694 A076036 A076694 A076607 A076607 A076607 A076607 A090800 A090800 A090800 A090800 A075504 A075504 A075504 A075504 A076049 A076049
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002
Nov Nov Nov Nov Jan Jan Jan Jan Aug Aug Aug Aug Jun Jun Jun Jun Jan Dec Jan Dec Jan Dec Jan Dec Dec Dec Dec Dec Jun Jun Jun Jun Aug Aug Aug Aug Jan Jan
19, 19, 19, 19, 26, 26, 26, 26, 24, 24, 24, 24, 20, 20, 20, 20, 28, 23, 28, 23, 28, 23, 28, 23, 15, 15, 15, 15, 18, 18, 18, 18, 24, 24, 24, 24, 14, 14,
1991 1991 1991 1991 2006 2006 2006 2006 2007 2007 2007 2007 2006 2006 2006 2006 2005 2004 2005 2004 2005 2004 2005 2004 2004 2004 2004 2004 2009 2009 2009 2009 2007 2007 2007 2007 2005 2005

TABLET; ORAL QUINAPRIL HYDROCHLORIDE WATSON LABS FLORIDA AB EQ 20MG BASE AB EQ 40MG BASE
3 - 358 (of 428)
A076049 A076049
003 004
Jan 14, 2005 Jan 14, 2005
QUINIDINE GLUCONATE
QUINIDINE GLUCONATE
XX + LILLY
80MG/ML
N007529
002
Feb 10, 1989
TABLET, EXTENDED RELEASE; ORAL QUINIDINE GLUCONATE BX + MUTUAL PHARM 324MG BX WATSON LABS 324MG
A089338 A087810
001 001
Feb 11, 1987 Sep 29, 1982
QUINIDINE SULFATE
TABLET; ORAL QUINIDINE SULFATE MUTUAL PHARM AB AB SANDOZ AB AB AB + WATSON LABS AB + TABLET, EXTENDED RELEASE; QUINIDINE SULFATE
XX + TEVA PHARMS
200MG 300MG 200MG 300MG 200MG 300MG ORAL

300MG
A081030 A081031 A088072 A088072 A083288 A085583
001 001 002 001 001 001
Apr 14, 1989 Apr 14, 1989 Sep 26, 1983
A040045
001
Jun 30, 1994
QUININE SULFATE
CAPSULE; ORAL QUALAQUIN AB + MUTUAL PHARM CO INC QUININE SULFATE MYLAN PHARMS INC AB TEVA PHARMS AB
324MG 324MG 324MG
N021799 A202581 A091661
001 001 001
Aug 12, 2005 Dec 14, 2012 Sep 28, 2012
RABEPRAZOLE SODIUM
TABLET, DELAYED RELEASE; ORAL
ACIPHEX
20MG XX + EISAI INC
N020973
002
Aug 19, 1999
RALOXIFENE HYDROCHLORIDE
TABLET; ORAL
EVISTA
XX + LILLY
60MG
N020815
001
Dec 09, 1997
RALTEGRAVIR POTASSIUM
TABLET; ORAL
ISENTRESS
XX + MERCK SHARP DOHME TABLET, CHEWABLE; ORAL ISENTRESS XX MERCK SHARP DOHME XX +
EQ 400MG BASE
N022145
001
Oct 12, 2007
N203045 N203045
001 002
Dec 21, 2011 Dec 21, 2011
RAMELTEON
TABLET; ORAL
ROZEREM
8MG
N021782
001
Jul 22, 2005

RAMIPRIL
CAPSULE; ORAL ALTACE KING PHARMS AB AB AB AB + RAMIPRIL APOTEX AB AB AB AB AUROBINDO PHARMA LTD AB AB AB AB CIPLA AB AB AB AB DR REDDYS LABS LTD AB AB AB AB INVAGEN PHARMS AB AB AB AB LUPIN AB AB AB AB ROXANE AB AB AB AB SANDOZ AB AB AB AB TEVA PHARMS AB AB AB AB WATSON LABS AB AB AB AB ZYDUS PHARMS USA AB AB AB AB TABLET; ORAL RAMIPRIL MYLAN PHARMS INC AB AB AB AB ZYDUS PHARMS USA INC AB AB AB
3 - 359 (of 428)
1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG
N019901 N019901 N019901 N019901 A079116 A079116 A079116 A079116 A091604 A091604 A091604 A091604 A077004 A077004 A077004 A077004 A078191 A078191 A078191 A078191 A078745 A078745 A078745 A078745 A077626 A077626 A077626 A077626 A077900 A077900 A077900 A077900 A077514 A077514 A077514 A077514 A077470 A077470 A077470 A077470 A076549 A076549 A076549 A076549 A078832 A078832 A078832 A078832
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Jan Jan Jan Jan Jun Jun Jun Jun Jun Jun Jun Jun Aug Aug Aug Aug Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Oct Oct Oct Oct Sep Sep Sep Sep
28, 28, 28, 28, 20, 20, 20, 20, 08, 08, 08, 08, 07, 07, 07, 07, 18, 18, 18, 18, 18, 18, 18, 18, 09, 09, 09, 09, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 24, 24, 24, 24, 02, 02, 02, 02,
1991 1991 1991 1991 2008 2008 2008 2008 2011 2011 2011 2011 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2005 2005 2005 2005 2008 2008 2008 2008
1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG
A090650 A090650 A090650 A090650 A090697 A090697 A090697
001 002 003 004 001 002 003
Jun Jun Jun Jun Sep Sep Sep
30, 30, 30, 30, 24, 24, 24,
2011 2011 2011 2011 2009 2009 2009

RAMIPRIL
TABLET; ORAL RAMIPRIL ZYDUS PHARMS USA INC AB
3 - 360 (of 428)
10MG
A090697
004
Sep 24, 2009
RANITIDINE HYDROCHLORIDE
CAPSULE; ORAL RANITIDINE HYDROCHLORIDE DR REDDYS LABS LTD EQ 150MG BASE EQ 300MG BASE SANDOZ EQ 150MG BASE EQ 300MG BASE + INJECTABLE; INJECTION RANITIDINE HYDROCHLORIDE BEDFORD EQ 25MG BASE/ML BEN VENUE EQ 25MG BASE/ML ZANTAC + COVIS PHARMA EQ 25MG BASE/ML ZANTAC IN PLASTIC CONTAINER + COVIS PHARMA EQ 1MG BASE/ML SYRUP; ORAL RANITIDINE HYDROCHLORIDE ACTAVIS MID ATLANTIC EQ 15MG BASE/ML AMNEAL PHARMS EQ 15MG BASE/ML APOTEX EQ 15MG BASE/ML AUROBINDO PHARM EQ 15MG BASE/ML CYPRESS PHARM EQ 15MG BASE/ML DR REDDYS LABS LTD EQ 15MG BASE/ML HI TECH PHARMA EQ 15MG BASE/ML PHARM ASSOC EQ 15MG BASE/ML SILARX EQ 15MG BASE/ML SUN PHARM INDS INC EQ 15MG BASE/ML TARO EQ 15MG BASE/ML TOLMAR EQ 15MG BASE/ML VINTAGE PHARMS EQ 15MG BASE/ML WOCKHARDT EQ 15MG BASE/ML EQ 15MG BASE/ML ZANTAC + GLAXOSMITHKLINE EQ 15MG BASE/ML TABLET; ORAL RANITIDINE HYDROCHLORIDE AMNEAL PHARMS NY EQ 150MG BASE EQ 300MG BASE APOTEX EQ 150MG BASE EQ 300MG BASE DR REDDYS LABS INC EQ 150MG BASE EQ 300MG BASE GLENMARK GENERICS EQ 150MG BASE EQ 300MG BASE IVAX SUB TEVA PHARMS EQ 150MG BASE EQ 300MG BASE MYLAN EQ 150MG BASE EQ 300MG BASE PAR PHARM EQ 150MG BASE EQ 300MG BASE SANDOZ EQ 150MG BASE EQ 300MG BASE TEVA EQ 150MG BASE EQ 300MG BASE WATSON LABS EQ 150MG BASE EQ 150MG BASE
AB AB AB AB
A075742 A075742 A074655 A074655
001 002 001 002
Nov Nov Oct Oct
29, 29, 22, 22,
2000 2000 1997 1997
AP AP AP XX
A077458 A074777 N019090 N019593
001 001 001 002
Feb 16, 2006 Mar 02, 2005 Oct 19, 1984 Sep 27, 1991
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA
A076124 A078312 A077602 A090623 A078684 A090102 A091078 A077405 A091288 A091091 A077476 A090054 A078890 A079211 A079212 N019675
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Feb Sep Sep Jul Aug May Mar Sep Dec Sep Jun Nov Jul May Feb
21, 02, 17, 28, 27, 26, 22, 21, 09, 20, 13, 15, 01, 26, 23,
2007 2008 2007 2010 2009 2009 2011 2007 2010 2011 2011 2010 2010 2009 2009
Dec 30, 1988
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001
Oct Oct Sep Sep Jul Jul Nov Nov Sep Sep Aug Aug Jan Jan Aug Aug Jul Jul Oct Dec
13, 13, 12, 12, 27, 27, 19, 19, 30, 30, 22, 22, 28, 28, 29, 29, 31, 31, 20, 19,
2006 2006 1997 1997 2005 2005 2008 2008 1998 1998 1997 1997 1999 1999 1997 1997 1997 1997 1997 2005

TABLET; ORAL RANITIDINE HYDROCHLORIDE WATSON LABS EQ EQ WOCKHARDT EQ EQ EQ EQ ZANTAC 150 GLAXOSMITHKLINE EQ ZANTAC 300 + GLAXOSMITHKLINE EQ TABLET, EFFERVESCENT; ORAL ZANTAC 25 + GLAXOSMITHKLINE EQ
3 - 361 (of 428)
300MG 300MG 150MG 150MG 300MG 300MG
A074864 A077426 A075208 A078701 A075208 A078701 N018703 N018703
002 002 001 001 002 002 001 002
Oct Dec Dec Nov Dec Dec
20, 19, 17, 12, 17, 11,
1997 2005 1998 2009 1998 2009
Jun 09, 1983 Dec 09, 1985
XX
25MG BASE
N020251
003
Apr 01, 2004
RANOLAZINE
TABLET, EXTENDED RELEASE; ORAL RANEXA GILEAD 500MG XX 1GM XX +
N021526 N021526
002 001
Jan 27, 2006 Feb 12, 2007
RASAGILINE MESYLATE
TABLET; ORAL AZILECT XX TEVA XX +
N021641 N021641
001 002
May 16, 2006 May 16, 2006
REGADENOSON
LEXISCAN
XX + ASTELLAS
0.4MG/5ML (0.08MG/ML)
N022161
001
Apr 10, 2008
REGORAFENIB
TABLET; ORAL
STIVARGA
XX + BAYER HLTHCARE
40MG
N203085
001
Sep 27, 2012
REMIFENTANIL HYDROCHLORIDE
INJECTABLE; INJECTION ULTIVA XX MYLAN INSTITUTIONAL XX XX +
N020630 N020630 N020630
001 002 003
Jul 12, 1996 Jul 12, 1996 Jul 12, 1996
REPAGLINIDE
TABLET; ORAL PRANDIN NOVO NORDISK INC XX XX XX +
0.5MG 1MG 2MG
N020741 N020741 N020741
001 002 003
Dec 22, 1997 Dec 22, 1997 Dec 22, 1997
RESERPINE
TABLET; ORAL RESERPINE BP SANDOZ BP + SERPALAN BP LANNETT BP
0.1MG 0.25MG 0.1MG 0.25MG
N009838 N009838 N010124 N010124
001 002 001 002

RETAPAMULIN
OINTMENT; TOPICAL
ALTABAX
XX + GLAXO GRP LTD
3 - 362 (of 428)
1%
N022055
001
Apr 12, 2007
RIBAVIRIN
CAPSULE; ORAL REBETOL + MERCK SHARP DOHME RIBASPHERE THREE RIVERS PHARMS RIBAVARIN AUROBINDO PHARMA RIBAVIRIN SANDOZ TEVA ZYDUS PHARMS USA REBETOL + MERCK SHARP DOHME
200MG 200MG 200MG 200MG 200MG 200MG 200MG
N020903 A076203 A079117 A076192 A076277 A077224 N020903
002 001 001 001 001 001 001
Jul 25, 2001 Apr 06, 2004 Sep 17, 2009 Apr 06, 2004 Oct 04, 2004 Oct 28, 2005 Jun 03, 1998

VIRAZOLE
XX + VALEANT PHARM INTL SOLUTION; ORAL
REBETOL
XX + SCHERING TABLET; ORAL COPEGUS ROCHE RIBAVIRIN AUROBINDO PHARMA SANDOZ TEVA THREE RIVERS PHARMS + ZYDUS PHARMS USA
6GM/VIAL
N018859
001
Dec 31, 1985
40MG/ML
N021546
001
Jul 29, 2003
AB AB AB AB AB AB AB AB AB AB XX
N021511 A079111 A077743 A077053 A077456 A077456 A077456 A077094 A077094 A077094 A077094
001 001 001 001 001 002 003 001 002 003 004
Dec 03, 2002 Sep Oct Dec Dec Dec Dec Dec Mar Mar 17, 03, 05, 05, 05, 05, 05, 16, 16, 2009 2006 2005 2005 2005 2005 2005 2007 2007
RIBAVIRIN ZYDUS PHARMS USA
Apr 18, 2008
RIFABUTIN
CAPSULE; ORAL
MYCOBUTIN
150MG
N050689
001
Dec 23, 1992
RIFAMPIN
CAPSULE; ORAL RIFADIN SANOFI AVENTIS US AB AB + RIFAMPIN LANNETT AB AB SANDOZ AB AB VERSAPHARM AB AB RIMACTANE PROSAM LABS AB
A062303 N050420 A065390 A065390 A064150 A064150 A065028 A065028 N050429
001 001 001 002 002 001 001 002 001 Mar Mar Jan May Mar Mar 28, 28, 02, 28, 14, 14, 2008 2008 1998 1997 2001 2001

RIFAMPIN
INJECTABLE; INJECTION RIFADIN + SANOFI AVENTIS US RIFAMPIN BEDFORD PFIZER VERSAPHARM INC
3 - 363 (of 428)
AP AP AP AP
600MG/VIAL 600MG/VIAL 600MG/VIAL 600MG/VIAL
N050627 A064217 A065421 A065502
001 001 001 001
May 25, 1989 Oct 29, 1999 May 22, 2008 Sep 21, 2010
RIFAPENTINE
TABLET; ORAL
PRIFTIN
150MG
N021024
001
Jun 22, 1998
RIFAXIMIN
TABLET; ORAL
XIFAXAN
XX + SALIX PHARMS XX +
200MG 550MG
N021361 N022554
001 001
May 25, 2004 Mar 24, 2010
RILPIVIRINE HYDROCHLORIDE
TABLET; ORAL
EDURANT
XX + JANSSEN PRODS
EQ 25MG BASE
N202022
001
May 20, 2011
RILUZOLE
TABLET; ORAL RILUTEK AB + SANOFI AVENTIS US RILUZOLE IMPAX LABS AB
50MG 50MG
N020599 A076173
001 001
Dec 12, 1995 Jan 29, 2003
RIMANTADINE HYDROCHLORIDE
TABLET; ORAL FLUMADINE AB + CARACO 100MG RIMANTADINE HYDROCHLORIDE COREPHARMA AB 100MG IMPAX LABS AB 100MG
N019649 A075916 A076132
001 001 001
Sep 17, 1993 Nov 02, 2001 Aug 30, 2002
RIMEXOLONE
VEXOL
XX + ALCON 1%
N020474
001
Dec 30, 1994
RISEDRONATE SODIUM
TABLET; ORAL ACTONEL WARNER CHILCOTT LLC AB 5MG AB 30MG AB + 35MG RISEDRONATE SODIUM TEVA PHARMS AB 5MG AB 30MG AB 35MG ACTONEL 150MG XX + WARNER CHILCOTT LLC TABLET, DELAYED RELEASE; ORAL
ATELVIA
35MG XX + WARNER CHILCOTT LLC
N020835 N020835 N020835 A077132 A077132 A077132 N020835
002 001 003 001 002 003 005
Apr 14, 2000 Mar 27, 1998 May 25, 2002 Oct 05, 2007 Oct 05, 2007 Oct 05, 2007 Apr 22, 2008
N022560
001
Oct 08, 2010

RISPERIDONE
INJECTABLE; INTRAMUSCULAR RISPERDAL CONSTA XX JANSSEN PHARMS 12.5MG/VIAL XX + 25MG/VIAL XX 37.5MG/VIAL XX 50MG/VIAL SOLUTION; ORAL RISPERDAL AA + JANSSEN PHARMS 1MG/ML RISPERIDONE AMNEAL PHARMS AA 1MG/ML APOTEX INC AA 1MG/ML AUROBINDO PHARMA AA 1MG/ML DR REDDYS LABS LTD AA 1MG/ML PRECISION DOSE AA 1MG/ML ROXANE AA 1MG/ML TARO AA 1MG/ML TEVA AA 1MG/ML TRIS PHARMA INC AA 1MG/ML VINTAGE AA 1MG/ML WOCKHARDT AA 1MG/ML TABLET; ORAL RISPERDAL JANSSEN PHARMS AB 0.25MG AB 0.5MG AB + 1MG AB 2MG AB 3MG AB 4MG RISPERIDONE AJANTA PHARMA LTD AB 0.25MG AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG APOTEX INC AB 0.25MG AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG AUROBINDO PHARMA AB 0.25MG AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG CIPLA AB 0.25MG AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG DR REDDYS LABS LTD AB 0.25MG AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG
3 - 364 (of 428)
N021346 N021346 N021346 N021346
004 001 002 003
Apr Oct Oct Oct
12, 29, 29, 29,
2007 2003 2003 2003
N020588 A091384 A077719 A078452 A078909 A076797 A076904 A090347 A076440 A079059 A079158 A078744
001 001 001 001 001 001 001 001 001 001 001 001
Jun 10, 1996 May Jul Sep Jul Jun Jul Feb Jan Dec Dec Oct 25, 29, 04, 29, 28, 29, 07, 30, 12, 03, 08, 2011 2009 2009 2009 2010 2009 2011 2009 2012 2010 2009
N020272 N020272 N020272 N020272 N020272 N020272 A201003 A201003 A201003 A201003 A201003 A201003 A077953 A077953 A077953 A077953 A077953 A077953 A078269 A078269 A078269 A078269 A078269 A078269 A077543 A077543 A077543 A077543 A077543 A077543 A076879 A076879 A076879 A076879 A076879 A076879
008 007 001 002 003 004 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006
May Jan Dec Dec Dec Dec Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Sep Sep Oct Oct Oct Oct Oct Oct May May May May May May Oct Oct Oct Oct Oct Oct
10, 27, 29, 29, 29, 29, 24, 24, 24, 24, 24, 24, 15, 15, 15, 15, 15, 15, 08, 08, 08, 08, 08, 08, 18, 18, 18, 18, 18, 18, 24, 24, 24, 24, 24, 24,
1999 1999 1993 1993 1993 1993 2011 2011 2011 2011 2011 2011 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2011 2011 2011 2011 2011 2011 2008 2008 2008 2008 2008 2008

RISPERIDONE
TABLET; ORAL RISPERIDONE MYLAN AB AB AB AB AB AB PLIVA HRVATSKA DOO AB AB AB AB AB AB PRINSTON INC AB AB AB AB AB AB PROSAM LABS AB AB AB AB AB AB SANDOZ AB AB AB AB AB AB TEVA AB AB AB AB AB AB TORRENT PHARMS AB AB AB AB AB AB VINTAGE AB AB AB AB AB AB WATSON LABS AB AB AB AB AB AB WEST WARD PHARMS AB AB AB AB
3 - 365 (of 428)
0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG
001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004
Sep Sep Sep Sep Sep Sep Oct Oct Oct Oct Oct Oct Nov Nov Nov Nov Nov Nov Jun Jun Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct Jun Jun Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec May May May May
15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 29, 29, 29, 29, 29, 29, 17, 17, 17, 17, 17, 17, 16, 16, 16, 16, 16, 16, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 29, 29, 29, 29, 29, 05, 05, 05, 05, 05, 05, 29, 29, 29, 29,
2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2011 2011 2011 2011 2011 2011 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2009 2009 2009 2009

RISPERIDONE
TABLET; ORAL RISPERIDONE WEST WARD PHARMS AB 3MG AB 4MG WOCKHARDT AB 0.25MG AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG ZYDUS PHARMS USA INC 0.25MG AB AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG TABLET, ORALLY DISINTEGRATING; ORAL RISPERDAL JANSSEN PHARMS AB 0.5MG AB + 1MG AB 2MG AB 3MG AB 4MG RISPERIDONE DR REDDYS LABS LTD AB 0.5MG AB 1MG AB 2MG JUBILANT ORGANOSYS AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG MYLAN AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG PAR PHARM AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG RANBAXY AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG SANDOZ AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG TEVA AB 0.5MG AB 1MG AB 2MG WATSON LABS FLORIDA AB 0.5MG AB 1MG AB 2MG AB 3MG AB 4MG
3 - 366 (of 428)
A078740 A078740 A078871 A078871 A078871 A078871 A078871 A078871 A078040 A078040 A078040 A078040 A078040 A078040
005 006 001 002 003 004 005 006 001 002 003 004 005 006
May May Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
29, 29, 09, 09, 09, 09, 09, 09, 16, 16, 16, 16, 16, 16,
2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
N021444 N021444 N021444 N021444 N021444 A077328 A077328 A077328 A090839 A090839 A090839 A090839 A090839 A091537 A091537 A091537 A091537 A091537 A077494 A077494 A077494 A077494 A077494 A077542 A077542 A077542 A078474 A078474 A078116 A078116 A078116 A078116 A078116 A076908 A076908 A076908 A076996 A076996 A076996 A076996 A076996
001 002 003 004 005 001 002 003 001 002 003 004 005 001 002 003 004 005 002 003 004 005 006 001 002 003 001 002 001 002 003 004 005 001 002 003 001 002 003 004 005
Apr Apr Apr Dec Dec Feb Oct Feb Nov Nov Nov Nov Nov Mar Mar Mar Mar Mar Apr Oct Apr Apr Apr Aug Aug Aug Aug Aug Dec Dec Dec Dec Dec Mar Mar Mar Apr Apr Apr Apr Apr
02, 02, 02, 23, 23, 24, 05, 24, 04, 04, 04, 04, 04, 30, 30, 30, 30, 30, 30, 26, 30, 30, 30, 06, 06, 06, 06, 06, 22, 22, 22, 22, 22, 12, 12, 12, 19, 19, 19, 19, 19,
2003 2003 2003 2004 2004 2009 2009 2009 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2009 2009 2009 2009 2009 2010 2010 2010 2010 2010 2009 2009 2009 2009 2009 2012 2012 2012 2011 2011 2011 2011 2011

RISPERIDONE
TABLET, ORALLY DISINTEGRATING; ORAL RISPERIDONE ZYDUS PHARMS USA AB 0.5MG AB 2MG RISPERIDONE PAR PHARM 0.25MG XX
3 - 367 (of 428)
A078516 A078516 A077494
001 003 001
May 01, 2009 May 01, 2009 Apr 30, 2009
RITONAVIR
CAPSULE; ORAL
NORVIR
XX + ABBVIE SOLUTION; ORAL
NORVIR
XX + ABBVIE TABLET; ORAL
NORVIR
XX + ABBVIE
100MG
N020945
001
Jun 29, 1999
80MG/ML
N020659
001
Mar 01, 1996
100MG
N022417
001
Feb 10, 2010
RIVAROXABAN
TABLET; ORAL
XARELTO
XX + JANSSEN PHARMS XX XX +
10MG 15MG 20MG
N022406 N022406 N022406
001 002 003
Jul 01, 2011 Nov 04, 2011 Nov 04, 2011
RIVASTIGMINE
FILM, EXTENDED RELEASE; TRANSDERMAL EXELON XX NOVARTIS 4.6MG/24HR XX + 9.5MG/24HR XX 13.3MG/24HR
N022083 N022083 N022083
001 002 005
Jul 06, 2007 Jul 06, 2007 Aug 31, 2012
RIVASTIGMINE TARTRATE
CAPSULE; ORAL EXELON AB + NOVARTIS AB AB AB RIVASTIGMINE TARTRATE ALEMBIC PHARMS LTD AB AB AB AB DR REDDYS LABS INC AB AB AB AB SUN PHARM INDS AB AB AB AB WATSON LABS AB AB AB AB SOLUTION; ORAL
EXELON
XX + NOVARTIS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE 1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE 1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE 1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE 1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE
N020823 N020823 N020823 N020823 A091689 A091689 A091689 A091689 A077130 A077130 A077130 A077130 A077131 A077131 A077131 A077131 A077129 A077129 A077129 A077129
003 004 005 006 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Apr Apr Apr Apr Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct Oct Oct Jan Jan Jan Jan
21, 21, 21, 21, 12, 12, 12, 12, 31, 31, 31, 31, 22, 22, 22, 22, 08, 08, 08, 08,
2000 2000 2000 2000 2012 2012 2012 2012 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2008 2008
EQ 2MG BASE/ML
N021025
001
Apr 21, 2000

RIZATRIPTAN BENZOATE
TABLET; ORAL MAXALT MERCK AB EQ 5MG BASE AB + EQ 10MG BASE RIZATRIPTAN BENZOATE APOTEX INC AB EQ 5MG BASE AB EQ 10MG BASE AUROBINDO PHARMA LTD EQ 5MG BASE AB AB EQ 10MG BASE GLENMARK GENERICS AB EQ 5MG BASE AB EQ 10MG BASE MYLAN PHARMS INC AB EQ 5MG BASE AB EQ 10MG BASE NATCO PHARMA LTD AB EQ 5MG BASE AB EQ 10MG BASE SANDOZ AB EQ 5MG BASE AB EQ 10MG BASE SUN PHARMA GLOBAL AB EQ 5MG BASE AB EQ 10MG BASE TEVA PHARMS AB EQ 5MG BASE AB EQ 10MG BASE TABLET, ORALLY DISINTEGRATING; ORAL MAXALT-MLT MERCK AB EQ 5MG BASE AB + EQ 10MG BASE RIZATRIPTAN BENZOATE MYLAN PHARMS INC AB EQ 5MG BASE AB EQ 10MG BASE
3 - 368 (of 428)
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Jun 29, 1998 Jun 29, 1998 Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
N020865 N020865 A078173 A078173
001 002 001 002
Jun 29, 1998 Jun 29, 1998 Dec 31, 2012 Dec 31, 2012
ROCURONIUM BROMIDE
INJECTABLE; INJECTION ROCURONIUM BROMIDE BIONICHE PHARMA USA AP AP FRESENIUS KABI USA AP AP HOSPIRA AP AP SAGENT STRIDES AP AP SANDOZ AP AP TAMARANG AP AP TEVA PHARMS AP AP ZEMURON AP + SCHERING AP +
50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML)
A079199 A079199 A078651 A078651 A078519 A078519 A091458 A091458 A079195 A079195 A091115 A091115 A078717 A078717 N020214 N020214
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 003
Nov Nov Dec Dec Nov Nov Jul Jul Dec Dec Aug Aug Nov Nov
26, 26, 29, 29, 26, 26, 28, 28, 05, 05, 27, 27, 26, 26,
2008 2008 2008 2008 2008 2008 2010 2010 2008 2008 2012 2012 2008 2008
Mar 17, 1994 Mar 17, 1994
ROFLUMILAST
TABLET; ORAL
DALIRESP
XX + FOREST RES INST INC
500MCG
N022522
001
Feb 28, 2011
ROMIDEPSIN
ISTODAX
XX + CELGENE
10MG/VIAL
N022393
001
Nov 05, 2009

ROPINIROLE HYDROCHLORIDE
TABLET; ORAL REQUIP AB + GLAXOSMITHKLINE EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ ROPINIROLE HYDROCHLORIDE ALEMBIC LTD AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ APOTEX AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ COREPHARMA AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ GLENMARK GENERICS AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ MYLAN AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ ORCHID HLTHCARE AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ PRINSTON INC AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ ROXANE AB EQ
3 - 369 (of 428)
0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE
N020658 N020658 N020658 N020658 N020658 N020658 N020658 A090429 A090429 A090429 A090429 A090429 A090429 A090429 A079165 A079165 A079165 A079165 A079165 A079165 A079165 A078230 A078230 A078230 A078230 A078230 A078230 A078230 A090135 A090135 A090135 A090135 A090135 A090135 A090135 A078881 A078881 A078881 A078881 A078881 A078881 A078881 A079229 A079229 A079229 A079229 A079229 A079229 A079229 A078110 A078110 A078110 A078110 A078110 A078110 A078110 A077852
001 002 003 004 006 007 005 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001
Sep Sep Sep Sep Jan Jan Sep Mar Mar Mar Mar Mar Mar Mar Feb Feb Feb Feb Feb Feb Feb May May May May May May May Feb Feb Feb Feb Feb Feb Feb May May May May May May May Nov Nov Nov Nov Nov Nov Nov May May May May May May Jul May
19, 19, 19, 19, 27, 27, 19, 24, 24, 24, 24, 24, 24, 24, 07, 07, 07, 07, 07, 07, 07, 20, 20, 20, 20, 20, 20, 20, 25, 25, 25, 25, 25, 25, 25, 05, 05, 05, 05, 05, 05, 19, 28, 28, 28, 28, 28, 28, 28, 05, 05, 05, 05, 05, 05, 11, 05,
1997 1997 1997 1997 1999 1999 1997 2010 2010 2010 2010 2010 2010 2010 2012 2012 2012 2012 2012 2012 2012 2008 2008 2008 2008 2008 2008 2008 2010 2010 2010 2010 2010 2010 2010 2008 2008 2008 2008 2008 2008 2008 2012 2012 2012 2012 2012 2012 2012 2008 2008 2008 2008 2008 2008 2008 2008

TABLET; ORAL ROPINIROLE HYDROCHLORIDE ROXANE AB EQ 0.5MG BASE AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 3MG BASE AB EQ 4MG BASE AB EQ 5MG BASE TEVA AB EQ 0.25MG BASE AB EQ 0.5MG BASE AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 3MG BASE AB EQ 4MG BASE AB EQ 5MG BASE WOCKHARDT AB EQ 0.25MG BASE AB EQ 0.5MG BASE AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 3MG BASE AB EQ 4MG BASE AB EQ 5MG BASE ZYDUS PHARMS USA INC EQ 0.25MG BASE AB AB EQ 0.5MG BASE AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 3MG BASE AB EQ 4MG BASE AB EQ 5MG BASE TABLET, EXTENDED RELEASE; ORAL REQUIP XL AB + SMITHKLINE BEECHAM EQ 2MG BASE AB EQ 4MG BASE AB EQ 6MG BASE AB EQ 8MG BASE AB EQ 12MG BASE ROPINIROLE HYDROCHLORIDE ACTAVIS AB EQ 2MG BASE AB EQ 4MG BASE AB EQ 6MG BASE AB EQ 8MG BASE AB EQ 12MG BASE DR REDDYS LABS LTD AB EQ 2MG BASE AB EQ 4MG BASE AB EQ 6MG BASE AB EQ 8MG BASE AB EQ 12MG BASE MYLAN PHARMS INC AB EQ 2MG BASE AB EQ 4MG BASE AB EQ 6MG BASE AB EQ 8MG BASE AB EQ 12MG BASE SANDOZ INC AB EQ 2MG BASE AB EQ 4MG BASE AB EQ 6MG BASE AB EQ 8MG BASE AB EQ 12MG BASE WATSON LABS INC AB EQ 2MG BASE AB EQ 4MG BASE AB EQ 6MG BASE
3 - 370 (of 428)
002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007
May May May May May May May May May May May May May May May May May May May May Jun Jun Jun Jun Jun Jun Jun
05, 05, 05, 05, 05, 19, 05, 05, 05, 05, 05, 05, 19, 29, 29, 29, 29, 29, 29, 29, 01, 01, 01, 01, 01, 01, 01,
2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2009 2009 2009 2009 2009 2009 2009
N022008 N022008 N022008 N022008 N022008 A090869 A090869 A090869 A090869 A090869 A201576 A201576 A201576 A201576 A201576 A200462 A200462 A200462 A200462 A200462 A201047 A201047 A201047 A201047 A201047 A200431 A200431 A200431
001 003 006 004 005 001 002 003 004 005 001 002 003 004 005 001 003 004 005 006 001 003 004 005 006 001 002 003
Jun Jun Apr Jun Oct May May May May May Jun Jun Jun Jun Jun Oct Oct Oct Oct Oct Jun Jun Jun Jun Jun Jun Jun Jun
13, 13, 10, 13, 31, 17, 17, 17, 17, 17, 06, 06, 06, 06, 06, 15, 15, 15, 15, 15, 06, 06, 06, 06, 06, 06, 06, 06,
2008 2008 2009 2008 2008 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012

TABLET, EXTENDED RELEASE; ORAL ROPINIROLE HYDROCHLORIDE WATSON LABS INC EQ 8MG BASE EQ 12MG BASE WOCKHARDT LTD EQ 2MG BASE EQ 4MG BASE EQ 6MG BASE EQ 8MG BASE EQ 12MG BASE ROPINIROLE HYDROCHLORIDE MYLAN PHARMS INC EQ 3MG BASE
3 - 371 (of 428)
AB AB AB AB AB AB AB XX
A200431 A200431 A091395 A091395 A091395 A091395 A091395 A200462
004 005 001 002 003 004 005 002
Jun Jun Aug Aug Aug Aug Aug
06, 06, 27, 27, 27, 27, 27,
2012 2012 2012 2012 2012 2012 2012
Oct 15, 2012
ROPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION NAROPIN FRESENIUS KABI USA XX XX XX XX +
2MG/ML 5MG/ML 7.5MG/ML 10MG/ML
N020533 N020533 N020533 N020533
001 003 004 005
Sep Sep Sep Sep
24, 24, 24, 24,
1996 1996 1996 1996
ROSIGLITAZONE MALEATE
TABLET; ORAL AVANDIA SB PHARMCO XX XX XX +
N021071 N021071 N021071
002 003 004
May 25, 1999 May 25, 1999 May 25, 1999
ROSUVASTATIN CALCIUM
TABLET; ORAL CRESTOR IPR XX XX XX XX +
5MG 10MG 20MG 40MG
N021366 N021366 N021366 N021366
002 003 004 005
Aug Aug Aug Aug
12, 12, 12, 12,
2003 2003 2003 2003
ROTIGOTINE
FILM, EXTENDED RELEASE; TRANSDERMAL NEUPRO XX UCB INC 1MG/24HR XX 2MG/24HR XX 3MG/24HR XX 4MG/24HR XX 6MG/24HR XX + 8MG/24HR
N021829 N021829 N021829 N021829 N021829 N021829
004 001 005 002 003 006
Apr May Apr May May Apr
02, 09, 02, 09, 09, 02,
2012 2007 2012 2007 2007 2012
RUBIDIUM CHLORIDE RB-82

INJECTABLE; INJECTION CARDIOGEN-82 XX BRACCO
N/A
N019414
001
Dec 29, 1989
RUFINAMIDE
SUSPENSION; ORAL
BANZEL
XX + EISAI INC TABLET; ORAL BANZEL EISAI INC XX XX +
40MG/ML
N201367
001
Mar 03, 2011
200MG 400MG
N021911 N021911
002 003
Nov 14, 2008 Nov 14, 2008

RUXOLITINIB PHOSPHATE
TABLET; ORAL JAKAFI XX INCYTE CORP XX XX XX XX +
3 - 372 (of 428)
EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 15MG BASE 20MG BASE 25MG BASE
N202192 N202192 N202192 N202192 N202192
001 002 003 004 005
Nov Nov Nov Nov Nov
16, 16, 16, 16, 16,
2011 2011 2011 2011 2011
SACROSIDASE
SOLUTION; ORAL
SUCRAID
XX + QOL MEDCL
8,500 IU/ML
N020772
001
Apr 09, 1998
SAFFLOWER OIL; SOYBEAN OIL

LIPOSYN II 10%
XX + HOSPIRA LIPOSYN II 20% XX + HOSPIRA
5%;5% (5GM/100ML) 10%;10% (10GM/100ML)
N018997 N018991
001 001
Aug 27, 1984 Aug 27, 1984
SALMETEROL XINAFOATE
POWDER; INHALATION
SEREVENT
XX + GLAXO GRP LTD
EQ 0.05MG BASE/INH
N020692
001
Sep 19, 1997
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM

QUADRAMET
XX + JAZZ EUSA PHARMA
50mCi/ML
N020570
001
Mar 28, 1997
SAPROPTERIN DIHYDROCHLORIDE
TABLET; ORAL
KUVAN
XX + BIOMARIN PHARM
100MG
N022181
001
Dec 13, 2007
SAQUINAVIR MESYLATE
CAPSULE; ORAL
INVIRASE
XX + HOFFMANN LA ROCHE TABLET; ORAL
INVIRASE
XX + ROCHE
EQ 200MG BASE
N020628
001
Dec 06, 1995
EQ 500MG BASE
N021785
001
Dec 17, 2004
SAXAGLIPTIN HYDROCHLORIDE
TABLET; ORAL ONGLYZA BRISTOL MYERS SQUIBB XX XX +
N022350 N022350
001 002
Jul 31, 2009 Jul 31, 2009
SCOPOLAMINE
TRANSDERM SCOP
XX + NOVARTIS 1MG/72HR
N017874
001
SECOBARBITAL SODIUM
CAPSULE; ORAL
SECONAL SODIUM
XX + MARATHON PHARMS XX +
50MG 100MG
A086101 A086101
001 002
Oct 03, 1983 Oct 03, 1983

SECRETIN SYNTHETIC HUMAN
FOR SOLUTION; INTRAVENOUS
CHIRHOSTIM
XX + CHIRHOCLIN 16MCG/VIAL XX 40MCG/VIAL
3 - 373 (of 428)
N021256 N021256
001 002
Apr 09, 2004 Jun 21, 2007
SELEGILINE
EMSAM
6MG/24HR XX + SOMERSET 9MG/24HR XX 12MG/24HR XX
N021336 N021336 N021336
001 002 003
Feb 27, 2006 Feb 27, 2006 Feb 27, 2006
SELEGILINE HYDROCHLORIDE
CAPSULE; ORAL ELDEPRYL + SOMERSET 5MG SELEGILINE HYDROCHLORIDE APOTEX 5MG DAVA PHARMS INC 5MG TABLET; ORAL SELEGILINE HYDROCHLORIDE + APOTEX INC 5MG DAVA PHARMS INC 5MG MYLAN 5MG STASON 5MG TABLET, ORALLY DISINTEGRATING; ORAL
ZELAPAR
+ VALEANT PHARM INTL 1.25MG
AB AB AB
N020647 A075321 A075352
001 001 001
May 15, 1996 Dec 04, 1998 Nov 30, 1998
AB AB AB AB
A074871 A074641 A074866 A074912
001 001 001 001
Jun Aug Nov Apr
06, 02, 26, 30,
1997 1996 1997 1998
XX
N021479
001
Jun 14, 2006
SELENIUM SULFIDE
LOTION/SHAMPOO; TOPICAL SELENIUM SULFIDE PERRIGO NEW YORK AT WOCKHARDT AT SELSUN AT + CHATTEM
2.5% 2.5% 2.5%
A089996 A088228 N007936
001 001 001
Jan 10, 1991 Sep 01, 1983
SERTACONAZOLE NITRATE
CREAM; TOPICAL
ERTACZO
XX + VALEANT INTL
2%
N021385
001
Dec 10, 2003
SERTRALINE HYDROCHLORIDE
CONCENTRATE; ORAL SERTRALINE HYDROCHLORIDE AUROBINDO PHARMA EQ ZOLOFT + PFIZER EQ TABLET; ORAL SERTRALINE HYDROCHLORIDE APOTEX INC EQ EQ EQ AUROBINDO PHARMA EQ EQ EQ AUSTARPHARMA LLC EQ EQ EQ DR REDDYS LABS LTD EQ EQ
AA AA
20MG BASE/ML 20MG BASE/ML
A078861 N020990
001 001
Oct 31, 2008 Dec 07, 1999
25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE
A076882 A076882 A076882 A077206 A077206 A077206 A078677 A078677 A078677 A076442 A076442
001 002 003 001 002 003 001 002 003 001 002
Feb Feb Feb Feb Feb Feb Mar Mar Mar Apr Apr
06, 06, 06, 06, 06, 06, 04, 04, 04, 30, 30,
2007 2007 2007 2007 2007 2007 2009 2009 2009 2007 2007

TABLET; ORAL SERTRALINE HYDROCHLORIDE DR REDDYS LABS LTD EQ HIKMA PHARMS EQ EQ EQ INVAGEN PHARMS EQ EQ EQ LUPIN EQ EQ EQ MYLAN EQ EQ EQ MYLAN PHARMS INC EQ EQ EQ PROSAM LABS EQ EQ EQ RANBAXY EQ EQ EQ SUN PHARM INDS (IN) EQ EQ EQ TEVA EQ EQ EQ TORRENT PHARMS EQ EQ EQ WATSON LABS EQ EQ EQ WOCKHARDT EQ EQ EQ ZYDUS PHARMS USA EQ EQ EQ ZOLOFT PFIZER EQ EQ + EQ SERTRALINE HYDROCHLORIDE RANBAXY EQ EQ
3 - 374 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB XX XX
100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE
A076442 A077864 A077864 A077864 A077397 A077397 A077397 A077670 A077670 A077670 A076671 A076671 A076671 A078626 A078626 A078626 A078175 A078175 A078175 A077977 A077977 A077977 A078108 A078108 A078108 A076465 A076465 A076465 A077765 A077765 A077765 A077663 A077663 A077663 A078403 A078403 A078403 A077106 A077106 A077106 N019839 N019839 N019839 A077977 A077977
003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 005 001 002 004 005
Apr Aug Aug Aug Feb Feb Feb Feb Feb Feb Feb Feb Feb Jan Jan Jan Jul Jul Jul Feb Feb Feb Feb Feb Feb Aug Aug Aug Feb Feb Feb Feb Feb Feb Jan Jan Jan Feb Feb Feb
30, 10, 10, 10, 06, 06, 06, 06, 06, 06, 06, 06, 06, 31, 31, 31, 21, 21, 21, 06, 06, 06, 06, 06, 06, 11, 11, 11, 06, 06, 06, 06, 06, 06, 08, 08, 08, 06, 06, 06,
2007 2009 2009 2009 2007 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2008 2010 2010 2010 2007 2007 2007 2007 2007 2007 2006 2006 2006 2007 2007 2007 2007 2007 2007 2008 2008 2008 2007 2007 2007
Mar 06, 1996 Dec 30, 1991 Dec 30, 1991 Feb 06, 2007 Feb 06, 2007
SEVELAMER CARBONATE
FOR SUSPENSION; ORAL RENVELA XX GENZYME XX + TABLET; ORAL
RENVELA
XX + GENZYME
800MG/PACKET 2.4GM/PACKET
N022318 N022318
001 002
Aug 12, 2009 Feb 18, 2009
800MG
N022127
001
Oct 19, 2007

SEVELAMER HYDROCHLORIDE
TABLET; ORAL RENAGEL XX GENZYME XX +
3 - 375 (of 428)
400MG 800MG
N021179 N021179
001 002
Jul 12, 2000 Jul 12, 2000
SEVOFLURANE
LIQUID; INHALATION SEVOFLURANE BAXTER HLTHCARE HALOCARBON PRODS SOJOURN PIRAMAL CRITICAL ULTANE + ABBVIE
AN AN AN AN
100% 100% 100% 100%
A075895 A078650 A077867 N020478
001 001 001 001
Jul 02, 2002 Nov 19, 2007 May 02, 2007 Jun 07, 1995
SILDENAFIL CITRATE
FOR SUSPENSION; ORAL REVATIO XX + PFIZER SOLUTION; INTRAVENOUS REVATIO XX + PFIZER TABLET; ORAL REVATIO + PFIZER SILDENAFIL CITRATE APOTEX CORP DR REDDYS LABS LTD MYLAN PHARMS INC TEVA PHARMS TORRENT PHARMS LTD WATSON LABS INC VIAGRA PFIZER IRELAND +
EQ 10MG BASE/ML
N203109
001
Aug 30, 2012
EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML)
N022473
001
Nov 18, 2009
AB AB AB AB AB AB AB XX XX XX
EQ 20MG BASE EQ EQ EQ EQ EQ EQ 20MG 20MG 20MG 20MG 20MG 20MG BASE BASE BASE BASE BASE BASE
N021845 A091379 A202598 A201150 A078380 A091479 A202503 N020895 N020895 N020895
001 001 001 001 001 001 001 001 002 003
Jun 03, 2005 Nov Nov Nov Jan Nov Nov 06, 06, 09, 07, 06, 06, 2012 2012 2012 2013 2012 2012
Mar 27, 1998 Mar 27, 1998 Mar 27, 1998
SILODOSIN
CAPSULE; ORAL RAPAFLO XX + WATSON LABS XX
4MG 8MG
N022206 N022206
001 002
Oct 08, 2008 Oct 08, 2008
SILVER SULFADIAZINE
CREAM; TOPICAL SILVADENE + KING PHARMS SSD DR REDDYS LA THERMAZENE THEPHARMANETWORK LLC SSD AF DR REDDYS LA
AB AB AB BX
1% 1% 1% 1%
N017381 N018578 N018810 N018578
001 001 001 003 Feb 25, 1982 Dec 23, 1985 Jul 11, 1990
SIMVASTATIN
TABLET; ORAL SIMVASTATIN ACCORD HLTHCARE AB AB AB AB
10MG 20MG 40MG 80MG
A078155 A078155 A078155 A078155
002 003 004 001
Feb Feb Feb Feb
26, 26, 26, 26,
2008 2008 2008 2008

SIMVASTATIN
TABLET; ORAL SIMVASTATIN AUROBINDO PHARMA AB AB AB AB AB BLU CARIBE AB AB AB AB AB DR REDDYS LABS INC AB AB AB AB AB IVAX SUB TEVA PHARMS AB AB AB AB AB LUPIN AB AB AB AB AB MICRO LABS LTD AB AB AB AB AB MYLAN PHARMS INC AB AB AB AB AB PROSAM LABS AB AB AB AB AB RANBAXY AB AB AB AB AB WATSON LABS AB AB AB AB AB ZYDUS PHARMS USA AB AB AB AB AB ZOCOR MERCK AB AB
3 - 376 (of 428)
5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG
A077691 A077691 A077691 A077691 A077691 A078034 A078034 A078034 A078034 A078034 A077752 A077752 A077752 A077752 A077752 A076052 A076052 A076052 A076052 A076052 A078103 A078103 A078103 A078103 A078103 A090383 A090383 A090383 A090383 A090383 A090868 A090868 A090868 A090868 A090868 A078735 A078735 A078735 A078735 A078735 A076285 A076285 A076285 A076285 A076285 A076685 A076685 A076685 A076685 A076685 A077837 A077837 A077837 A077837 A077837 N019766 N019766
001 002 003 004 005 001 002 003 004 005 005 001 002 003 004 001 002 003 004 005 005 001 002 003 004 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002
Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Jan Dec Dec Dec Dec Jun Jun Jun Jun Dec Apr May May May May Sep Sep Sep Sep Sep Jun Jun Jun Jun Jun Aug Aug Aug Aug Aug Dec Dec Dec Dec Jun Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec
20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 23, 20, 20, 20, 20, 23, 23, 23, 23, 20, 14, 11, 11, 11, 11, 16, 16, 16, 16, 16, 08, 08, 08, 08, 08, 30, 30, 30, 30, 30, 20, 20, 20, 20, 23, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2008 2006 2006 2006 2006 2006 2006 2006 2006 2006 2009 2007 2007 2007 2007 2011 2011 2011 2011 2011 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006
Dec 23, 1991 Dec 23, 1991

SIMVASTATIN
TABLET; ORAL ZOCOR MERCK AB AB AB +
3 - 377 (of 428)
20MG 40MG 80MG
N019766 N019766 N019766
003 004 005
Dec 23, 1991 Dec 23, 1991 Jul 10, 1998
SIMVASTATIN; SITAGLIPTIN PHOSPHATE

TABLET; ORAL JUVISYNC XX MERCK SHARP DOHME XX XX XX XX XX +
10MG;EQ 10MG;EQ 20MG;EQ 20MG;EQ 40MG;EQ 40MG;EQ
N202343 N202343 N202343 N202343 N202343 N202343
004 001 005 002 006 003
Sep Oct Sep Oct Sep Oct
18, 07, 18, 07, 18, 07,
2012 2011 2012 2011 2012 2011
SINCALIDE
KINEVAC
XX + BRACCO
0.005MG/VIAL
N017697
001
SINECATECHINS
OINTMENT; TOPICAL
VEREGEN
XX + MEDIGENE AG
15%
N021902
001
Oct 31, 2006
SIROLIMUS
SOLUTION; ORAL
RAPAMUNE
XX + WYETH PHARMS INC TABLET; ORAL RAPAMUNE XX WYETH PHARMS INC XX XX +
1MG/ML
N021083
001
Sep 15, 1999
0.5MG 1MG 2MG
N021110 N021110 N021110
004 001 002
Jan 25, 2010 Aug 25, 2000 Aug 22, 2002
SITAGLIPTIN PHOSPHATE
TABLET; ORAL JANUVIA XX MERCK SHARP DOHME XX XX +
N021995 N021995 N021995
001 002 003
Oct 16, 2006 Oct 16, 2006 Oct 16, 2006
SODIUM ACETATE ANHYDROUS

SODIUM ACETATE IN PLASTIC CONTAINER
2MEQ/ML XX + HOSPIRA
N018893
001
May 04, 1983
SODIUM BENZOATE; SODIUM PHENYLACETATE

AMMONUL
XX + UCYCLYD
10%;10% (5GM/50ML;5GM/50ML)
N020645
001
Feb 17, 2005
SODIUM BICARBONATE
SODIUM BICARBONATE
XX + HOSPIRA XX +
0.9MEQ/ML 1MEQ/ML
A077394 A077394
001 002
Nov 09, 2005 Nov 09, 2005

SODIUM CHLORIDE
INJECTABLE; INJECTION BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER FRESENIUS KABI USA 9MG/ML + HOSPIRA 9MG/ML SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 450MG/100ML BAXTER HLTHCARE 450MG/100ML HOSPIRA 450MG/100ML 450MG/100ML SODIUM CHLORIDE 0.9% HIKMA (MAPLE) 9MG/ML SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER + B BRAUN 900MG/100ML + 900MG/100ML + BAXTER HLTHCARE 9MG/ML 9MG/ML + 900MG/100ML + 900MG/100ML + FRESENIUS KABI USA 9MG/ML FRESENIUS MEDCL 900MG/100ML HAEMONETICS 900MG/100ML + HOSPIRA 9MG/ML + 9MG/ML 9MG/ML + 900MG/100ML + 900MG/100ML + 900MG/100ML + TARO PHARMS IRELAND 9MG/ML SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER + MALLINCKRODT 45MG/50ML (9MG/ML) 112.5MG/125ML (9MG/ML) MEDEFIL 9MG/ML SODIUM CHLORIDE 3% IN PLASTIC CONTAINER BAXTER HLTHCARE 3GM/100ML SODIUM CHLORIDE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML SODIUM CHLORIDE IN PLASTIC CONTAINER HOSPIRA 2.5MEQ/ML SOLUTION FOR SLUSH; IRRIGATION SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER BAXTER HLTHCARE 900MG/100ML SOLUTION; IRRIGATION SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE 450MG/100ML SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 900MG/100ML BAXTER HLTHCARE 900MG/100ML 900MG/100ML HOSPIRA 900MG/100ML 900MG/100ML
3 - 378 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX XX XX XX XX
A088911 N018800 N019635 N018016 N018090 N019759 A201850 N017464 N019635 N016677 N020178 N016677 N020178 A088912 A078177 A076316 N018803 N019217 N019465 N016366 N019465 N019480 A077407 N021569 N021569 N202832 N019022 N019022 N018897
001 001 001 001 001 001 001 001 002 004 002 001 001 001 001 001 001 001 002 001 001 001 001 001 002 001 001 002 001
Feb 07, 1985 Oct 29, 1982 Mar 09, 1988
Jun 08, 1988 Jan 20, 2012
Mar 09, 1988 Oct 30, 1985 Dec 07, 1992 Dec Jan Apr Oct Oct Jul Jul 07, 10, 12, 27, 29, 13, 15, 1992 1985 2007 2004 1982 1984 1985
Jul 15, 1985 Sep 17, 1985 Aug 11, 2006 Jul 27, 2006 Jul 27, 2006 Jan 06, 2012 Nov 01, 1983 Nov 01, 1983 Jul 20, 1984
XX
N019319
002
May 17, 1985
AT AT AT AT AT AT
N017864 N016733 N017427 N017867 N017514 N018314
001 001 001 001 001 001
SODIUM FERRIC GLUCONATE COMPLEX

INJECTABLE; INJECTION FERRLECIT AB + SANOFI AVENTIS US 62.5MG/5ML SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE HIKMA PHARMS AB 62.5MG/5ML
N020955 A078215
001 001
Feb 18, 1999 Mar 31, 2011

SODIUM FLUORIDE F-18
XX + HOUSTON CYCLOTRON
3 - 379 (of 428)
10-200mCi/ML
A203544
001
Dec 26, 2012
SODIUM IODIDE I-123

CAPSULE; ORAL SODIUM IODIDE I 123 AA + CARDINAL HLTH 414 AA + MALLINCKRODT AA AA SODIUM IODIDE I 123 XX + CARDINAL HLTH 414
100uCi 200uCi 100uCi 200uCi 400uCi
N018671 N018671 A071909 A071910 N018671
001 002 001 001 003
May May Feb Feb
27, 27, 28, 28,
1982 1982 1989 1989
May 27, 1982
SODIUM IODIDE I-131

CAPSULE; ORAL
SODIUM IODIDE I 131
XX + MALLINCKRODT SODIUM IODIDE I-131 JUBILANT DRAXIMAGE XX SOLUTION; ORAL
HICON
XX + JUBILANT DRAXIMAGE SODIUM IODIDE I 131 XX + MALLINCKRODT
0.8-100mCi 9-100mCi
N016517 N021305
001 006 May 19, 2005
250-1000mCi 3.5-150mCi/VIAL
N021305 N016515
007 001
Dec 05, 2011
SODIUM LACTATE
INJECTABLE; INJECTION SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER BAXTER HLTHCARE AP 1.87GM/100ML SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER B BRAUN AP 1.87GM/100ML SODIUM LACTATE IN PLASTIC CONTAINER XX + HOSPIRA 5MEQ/ML
N016692 N020004 N018947
001 001 001 Apr 21, 1992 Sep 05, 1984
SODIUM NITRITE
SOLUTION; INTRAVENOUS SODIUM NITRITE XX + HOPE PHARMS
N203922
001
Feb 14, 2012
SODIUM NITRITE; SODIUM THIOSULFATE

SOLUTION, SOLUTION; INTRAVENOUS, INTRAVENOUS NITHIODOTE XX + HOPE PHARMS 300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML N201444 (250MG/ML)
001
Jan 14, 2011
SODIUM NITROPRUSSIDE
INJECTABLE; INJECTION NITROPRESS XX + HOSPIRA
25MG/ML
A071961
001
Aug 01, 1988
SODIUM OXYBATE
SOLUTION; ORAL XYREM XX + JAZZ PHARMS
500MG/ML
N021196
001
Jul 17, 2002
SODIUM PHENYLBUTYRATE
POWDER; ORAL BUPHENYL XX + MEDICIS
3GM/TEASPOONFUL
N020573
001
Apr 30, 1996

SODIUM PHENYLBUTYRATE
TABLET; ORAL BUPHENYL AB + MEDICIS SODIUM PHENYLBUTYRATE AMPOLGEN AB
3 - 380 (of 428)
500MG 500MG
N020572 A090910
001 001
May 13, 1996 Nov 18, 2011
SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

TABLET; ORAL VISICOL XX + SALIX PHARMS
0.398GM;1.102GM
N021097
001
Sep 21, 2000
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

TABLET; ORAL MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE NOVEL LABS INC AB 0.398GM;1.102GM OSMOPREP AB + SALIX PHARMS 0.398GM;1.102GM
A079247 N021892
001 001
Dec 30, 2011 Mar 16, 2006
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS

INJECTABLE; INJECTION SODIUM PHOSPHATES IN PLASTIC CONTAINER XX HOSPIRA 142MG/ML;276MG/ML
N018892
001
May 10, 1983
SODIUM POLYSTYRENE SULFONATE

POWDER; ORAL, RECTAL KALEXATE KVK TECH 454GM/BOT KAYEXALATE + SANOFI AVENTIS US 453.6GM/BOT KIONEX PADDOCK LLC 454GM/BOT SODIUM POLYSTYRENE SULFONATE CAROLINA MEDCL 454GM/BOT CEDAR PHARMS 453.6GM/BOT SUSPENSION; ORAL, RECTAL KIONEX PADDOCK LLC 15GM/60ML SODIUM POLYSTYRENE SULFONATE PADDOCK LLC 15GM/60ML ROXANE 15GM/60ML SPS + CAROLINA MEDCL 15GM/60ML
AA AA AA AA AA
A040905 N011287 A040029 A089910 A090313
001 001 001 001 001
Mar 30, 2009
Feb 06, 1998 Jan 19, 1989 Dec 21, 2011
AA AA AA AA
A040028 A090590 A089049 A087859
001 001 001 001
Sep 17, 2007 May 13, 2011 Nov 17, 1986 Dec 08, 1982
SODIUM TETRADECYL SULFATE

INJECTABLE; INJECTION SOTRADECOL BIONICHE PHARMA XX XX +
A040541 A040541
001 002
Nov 12, 2004 Nov 12, 2004
SODIUM THIOSULFATE
SODIUM THIOSULFATE
XX + HOPE PHARMS
12.5GM/50ML (250MG/ML)
N203923
001
Feb 14, 2012
SOLIFENACIN SUCCINATE
TABLET; ORAL VESICARE ASTELLAS XX XX +
5MG 10MG
N021518 N021518
001 002
Nov 19, 2004 Nov 19, 2004

SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION GENOTROPIN BX + PHARMACIA AND UPJOHN GENOTROPIN PRESERVATIVE BX PHARMACIA AND UPJOHN HUMATROPE BX + LILLY BX NORDITROPIN FLEXPRO BX NOVO NORDISK INC BX NUTROPIN BX GENENTECH OMNITROPE BX SANDOZ BX BX BX SAIZEN BX EMD SERONO SEROSTIM BX EMD SERONO BX BX TEV-TROPIN BX + FERRING VALTROPIN BX LG LIFE GENOTROPIN XX + PHARMACIA AND UPJOHN GENOTROPIN PRESERVATIVE PHARMACIA AND UPJOHN XX XX XX XX XX XX XX XX XX XX + HUMATROPE XX + LILLY XX + NORDITROPIN FLEXPRO NOVO NORDISK INC XX NORDITROPIN NORDIFLEX NOVO NORDISK INC XX NUTROPIN XX + GENENTECH NUTROPIN AQ XX + GENENTECH XX + XX + NUTROPIN AQ PEN XX + GENENTECH SAIZEN XX + EMD SERONO ZORBTIVE XX + EMD SERONO
3 - 381 (of 428)
5.8MG/VIAL FREE 1.5MG/VIAL 5MG/VIAL 6MG/VIAL 5MG/1.5ML 10MG/1.5ML 5MG/VIAL 1.5MG/VIAL 5MG/1.5ML 5.8MG/VIAL 10MG/1.5ML 5MG/VIAL 4MG/VIAL 5MG/VIAL 6MG/VIAL 5MG/VIAL 5MG/VIAL 13.8MG/VIAL FREE 0.2MG/VIAL 0.4MG/VIAL 0.6MG/VIAL 0.8MG/VIAL 1MG/VIAL 1.2MG/VIAL 1.4MG/VIAL 1.6MG/VIAL 1.8MG/VIAL 2MG/VIAL 12MG/VIAL 24MG/VIAL 15MG/1.5ML 30MG/3ML 10MG/VIAL 5MG/2ML (2.5MG/ML) 10MG/2ML (5MG/ML) 20MG/2ML (10MG/ML) 10MG/2ML (5MG/ML) 8.8MG/VIAL 8.8MG/VIAL
N020280 N020280 N019640 N019640 N021148 N021148 N020168 N021426 N021426 N021426 N021426 N019764 N020604 N020604 N020604 N019774 N021905 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N019640 N019640 N021148 N021148 N020168 N020522 N020522 N020522 N020522 N019764 N021597
006 004 004 005 008 009 001 002 003 001 004 002 003 002 001 002 001 007 001 002 003 005 008 009 010 011 012 013 006 007 010 007 002 003 001 004 002 003 004
Aug 24, 1995 Aug 24, 1995 Mar 08, 1987 Feb 04, 1999 Mar 01, 2010 Mar 01, 2010 Nov 17, 1993 May Jan May Aug 30, 16, 30, 25, 2006 2008 2006 2008
Oct 08, 1996 Jul 25, 1997 Aug 23, 1996 Aug 23, 1996 Jan 04, 2002 Apr 19, 2007 Oct 23, 1996 Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 1998 1998 1998 1998 1998 1998 1998 1998 1998 1998
Feb 04, 1999 Feb 04, 1999 Mar 01, 2010 Mar 10, 2009 Nov 17, 1993 Jan 03, 2008 Dec 29, 1995 Jan 03, 2008 Apr 22, 2002 Aug 29, 2000 Dec 01, 2003

SORAFENIB TOSYLATE
TABLET; ORAL
NEXAVAR
XX + BAYER HLTHCARE
3 - 382 (of 428)
EQ 200MG BASE
N021923
001
Dec 20, 2005
SORBITOL
SORBITOL 3% IN PLASTIC CONTAINER
BAXTER HLTHCARE 3GM/100ML XX SORBITOL 3.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML XX
N017863 N016741
001
001
SOTALOL HYDROCHLORIDE
XX + ACADEMIC PHARMS TABLET; ORAL BETAPACE BAYER HLTHCARE AB1 AB1 AB1 + AB1 SORINE UPSHER SMITH AB1 AB1 AB1 AB1 SOTALOL HYDROCHLORIDE APOTEX INC AB1 AB1 AB1 AB1 IMPAX PHARMS AB1 AB1 AB1 AB1 MYLAN AB1 AB1 AB1 AB1 AB1 AB1 AB1 AB1 SANDOZ AB1 AB1 AB1 AB1 TEVA AB1 AB1 AB1 AB1 VINTAGE PHARMS AB1 AB1 AB1 AB1 BETAPACE AF BAYER HLTHCARE AB2 AB2 AB2 +
N022306
001
Jul 02, 2009
N019865 N019865 N019865 N019865 A075500 A075500 A075500 A075500 A076140 A076140 A076140 A076140 A075663 A075663 A075663 A075663 A075237 A075725 A075237 A075725 A075237 A075725 A075237 A075725 A075366 A075366 A075366 A075366 A075429 A075429 A075429 A075429 A075563 A075563 A075563 A075563 N021151 N021151 N021151
001 005 002 003 001 004 002 003 001 002 003 004 001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003
Oct Apr Oct Oct Apr Apr Apr Apr Sep Sep Sep Sep Nov Nov Nov Nov May Dec May Dec May Dec May Dec May May May May May May May May Nov Nov Nov Nov
30, 20, 30, 30, 27, 27, 27, 27, 26, 26, 26, 26, 07, 07, 07, 07, 01, 19, 01, 19, 01, 19, 01, 19, 01, 01, 01, 01, 01, 01, 01, 01, 07, 07, 07, 07,
1992 1994 1992 1992 2001 2001 2001 2001 2002 2002 2002 2002 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2003 2003 2003 2003
Feb 22, 2000 Feb 22, 2000 Feb 22, 2000

TABLET; ORAL SOTALOL HYDROCHLORIDE APOTEX AB2 AB2 AB2 EPIC PHARMA INC AB2 AB2 AB2 MYLAN AB2 AB2 AB2 TEVA AB2 AB2 AB2
3 - 383 (of 428)
A076214 A076214 A076214 A077070 A077070 A077070 A077616 A077616 A077616 A076883 A076883 A076883
001 002 003 001 002 003 001 002 003 001 002 003
Aug Aug Aug Nov Nov Nov Feb Feb Feb Jul Jul Jul
27, 27, 27, 04, 04, 04, 07, 07, 07, 26, 26, 26,
2003 2003 2003 2005 2005 2005 2007 2007 2007 2004 2004 2004
SOYBEAN OIL
INJECTABLE; INJECTION INTRALIPID 10% + FRESENIUS INTRALIPID 20% + FRESENIUS + INTRALIPID 30% + FRESENIUS LIPOSYN III 10% + HOSPIRA LIPOSYN III 20% + HOSPIRA LIPOSYN III 30% + HOSPIRA NUTRILIPID 10% + B BRAUN NUTRILIPID 20% + B BRAUN
10% 20% 20% 30% 10% 20% 30% 10% 20%
N017643 N018449 N020248 N019942 N018969 N018970 N020181 N019531 N019531
001 001 001 001 001 001 001 001 002
Aug 07, 1996 Dec 30, 1993 Sep 24, 1984 Sep 25, 1984 Jan 13, 1998 May 28, 1993 May 28, 1993
SPINOSAD
SUSPENSION; TOPICAL NATROBA XX + PARAPRO LLC
0.9%
N022408
001
Jan 18, 2011
SPIRONOLACTONE
TABLET; ORAL ALDACTONE GD SEARLE LLC AB AB AB + SPIRONOLACTONE ACTAVIS ELIZABETH AB AB AB AMNEAL PHARMS AB AB AB MUTUAL PHARM AB AB AB MYLAN AB AB AB SANDOZ AB
N012151 N012151 N012151 A040353 A040353 A040353 A091426 A091426 A091426 A089424 A089424 A089424 A040424 A040424 A040424 A086809
009 008 010 003 001 002 001 002 003 001 002 003 001 002 003 001
Dec 30, 1983 Dec 30, 1982 Dec 30, 1983 Mar Jul Jul Jun Jun Jun Jul Aug Aug Aug Aug Aug 15, 29, 29, 08, 08, 08, 23, 11, 11, 20, 20, 20, 2006 1999 1999 2010 2010 2010 1986 1999 1999 2001 2001 2001

SPIRONOLACTONE
TABLET; ORAL SPIRONOLACTONE VINTAGE AB AB AB
3 - 384 (of 428)
25MG 50MG 100MG
A040750 A040750 A040750
001 002 003
Aug 29, 2006 Aug 29, 2006 Aug 29, 2006
STAVUDINE
CAPSULE; ORAL STAVUDINE AUROBINDO PHARMA AB AB AB AB HETERO DRUGS AB AB AB AB MATRIX LABS LTD AB AB MYLAN AB AB AB AB ZERIT BRISTOL MYERS SQUIBB AB AB AB AB + FOR SOLUTION; ORAL STAVUDINE AUROBINDO PHARMA AA CIPLA LTD AA ZERIT AA + BRISTOL MYERS SQUIBB
003 004 001 002 001 002 003 004 001 002 001 002 003 004 002 003 004 005
Dec Dec Dec Dec Dec Dec Dec Dec Jan Jan Dec Dec Dec Dec Jun Jun Jun Jun
29, 29, 29, 29, 29, 29, 29, 29, 05, 05, 29, 29, 29, 29, 24, 24, 24, 24,
2008 2008 2008 2008 2008 2008 2008 2008 2009 2009 2008 2008 2008 2008 1994 1994 1994 1994
A077774 A078030 N020413
001 001 001
Dec 29, 2008 Mar 20, 2009 Sep 06, 1996
STERILE WATER FOR INJECTION

LIQUID; N/A BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER + HOSPIRA 100% STERILE WATER FOR INJECTION IN PLASTIC CONTAINER 100% + B BRAUN 100% + BAXTER HLTHCARE 100% + FRESENIUS KABI USA 100% 100% + HOSPIRA + 100% + 100% TARO PHARMS IRELAND 100%
N018802 N019633 N018632 N018632 A088400 N018233 N018801 N019869 A077393
001 001 002 001 001 001 001 001 001
Oct 27, 1982 Feb Apr Jun Jan 29, 19, 30, 16, 1988 1988 1982 1984
Oct 27, 1982 Dec 26, 1989 Aug 11, 2006
STERILE WATER FOR IRRIGATION

LIQUID; IRRIGATION STERILE WATER BAXTER HLTHCARE 100% STERILE WATER IN PLASTIC CONTAINER B BRAUN 100% BAXTER HLTHCARE 100% HOSPIRA 100% 100%
AT AT AT AT AT
N017428 N016734 N017866 N017513 N018313
001 001 001 001 001

STREPTOMYCIN SULFATE
XX + X GEN PHARMS
3 - 385 (of 428)
EQ 1GM BASE/VIAL
A064210
001
Jun 30, 1998
STREPTOZOCIN
ZANOSAR
XX + TEVA PARENTERAL
1GM/VIAL
N050577
001
May 07, 1982
STRONTIUM CHLORIDE SR-89

INJECTABLE; INJECTION METASTRON AP + GE HEALTHCARE 1mCi/ML STRONTIUM CHLORIDE SR-89 BIO NUCLEONICS AP 1mCi/ML
N020134 A075941
001 001
Jun 18, 1993 Jan 06, 2003
SUCCIMER
CAPSULE; ORAL
CHEMET
XX + LUNDBECK LLC
100MG
N019998
002
Jan 30, 1991
SUCCINYLCHOLINE CHLORIDE
INJECTABLE; INJECTION ANECTINE + SANDOZ 20MG/ML QUELICIN + HOSPIRA 20MG/ML QUELICIN PRESERVATIVE FREE + HOSPIRA 20MG/ML QUELICIN PRESERVATIVE FREE + HOSPIRA 100MG/ML
AP AP AP XX
N008453 N008845 N008845 N008845
002 006 001 004
SUCRALFATE
SUSPENSION; ORAL
CARAFATE
XX + APTALIS PHARMA US TABLET; ORAL CARAFATE AB + APTALIS PHARMA US SUCRALFATE NOSTRUM LABS AB TEVA AB
1GM/10ML
N019183
001
Dec 16, 1993
1GM 1GM 1GM
N018333 A074415 A070848
001 001 001 Jun 08, 1998 Mar 29, 1996
SUFENTANIL CITRATE
INJECTABLE; INJECTION SUFENTA PRESERVATIVE FREE AP + AKORN EQ 0.05MG BASE/ML SUFENTANIL CITRATE HIKMA MAPLE AP EQ 0.05MG BASE/ML HOSPIRA AP EQ 0.05MG BASE/ML
N019050 A074413 A074534
001 001 001
May 04, 1984 Dec 15, 1995 Dec 11, 1996
SULCONAZOLE NITRATE
CREAM; TOPICAL
EXELDERM
XX + RANBAXY SOLUTION; TOPICAL
EXELDERM
XX + RANBAXY
1%
N018737
001
Feb 28, 1989
1%
N018738
001
Aug 30, 1985

SULFACETAMIDE SODIUM
LOTION; TOPICAL KLARON + SANOFI AVENTIS US SULFACETAMIDE SODIUM FOUGERA PHARMS PERRIGO CO TENNESSEE TARO OINTMENT; OPHTHALMIC CETAMIDE + ALCON SULFACETAMIDE SODIUM FERA PHARMS
3 - 386 (of 428)
AB AB AB AB
10% 10% 10% 10%
N019931 A077015 A078649 A078668
001 001 001 001
Dec 23, 1996 Nov 17, 2006 Mar 23, 2009 May 20, 2009
AT AT
10%
A080021 A080029
001 001
10% SOLUTION/DROPS; OPHTHALMIC BLEPH-10 AT + ALLERGAN 10% SULFACETAMIDE SODIUM ALCON PHARMS LTD AT 10% BAUSCH AND LOMB AT 10%
A080028 A089560 A040066
001 001 001 Oct 18, 1988 Dec 28, 1994
SULFADIAZINE
TABLET; ORAL SULFADIAZINE XX + SANDOZ
500MG
A040091
001
Jul 29, 1994
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION SULFAMETHOXAZOLE AND TRIMETHOPRIM 80MG/ML;16MG/ML XX + TEVA PARENTERAL SUSPENSION; ORAL SULFAMETHOXAZOLE AND TRIMETHOPRIM AUROBINDO PHARMA 200MG/5ML;40MG/5ML 200MG/5ML;40MG/5ML + HI TECH PHARMA VINTAGE 200MG/5ML;40MG/5ML SULFATRIM PEDIATRIC STI PHARMA LLC 200MG/5ML;40MG/5ML TABLET; ORAL BACTRIM MUTUAL PHARM 400MG;80MG BACTRIM DS + MUTUAL PHARM 800MG;160MG SEPTRA MONARCH PHARMS 400MG;80MG SEPTRA DS MONARCH PHARMS 800MG;160MG SULFAMETHOPRIM NOVEL LABS INC 400MG;80MG SULFAMETHOPRIM-DS NOVEL LABS INC 800MG;160MG SULFAMETHOXAZOLE AND TRIMETHOPRIM AMNEAL PHARMS NY 400MG;80MG 800MG;160MG AUROBINDO PHARMA 400MG;80MG 800MG;160MG GLENMARK GENERICS 400MG;80MG 800MG;160MG MUTUAL PHARM 800MG;160MG VINTAGE 400MG;80MG 800MG;160MG VISTA PHARMS 400MG;80MG 800MG;160MG
A073303
001
Oct 31, 1991
AB AB AB AB
A091348 A074650 A077785 N018615
001 001 001 001
Jun 08, 2010 Dec 29, 1997 Jan 24, 2007 Jan 07, 1983
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 001 002 001 001 001 002 001 002 002 001 001 002 001 001 002 Feb 15, 1985 Feb 15, 1985 Jan Jan Feb Feb Dec Dec Aug Jan Jan Oct Oct 27, 27, 16, 16, 22, 22, 25, 25, 25, 07, 07, 2005 2005 2010 2010 2010 2010 1986 2007 2007 2005 2005

TABLET; ORAL SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH SANDOZ AB 800MG;160MG TEVA AB 800MG;160MG SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH TEVA PHARMS AB 400MG;80MG
3 - 387 (of 428)
N018598 A070037 A070030
004 001 001
May 19, 1982 Jun 02, 1987 Jun 02, 1987
SULFANILAMIDE
CREAM; VAGINAL
AVC
XX + MEDA PHARMS
15%
N006530
003
Jan 27, 1987
SULFASALAZINE
SUSPENSION; ORAL
AZULFIDINE
250MG/5ML
A086983
001
TABLET; ORAL
AZULFIDINE AB + PHARMACIA AND UPJOHN 500MG SULFASALAZINE VINTAGE PHARMS AB 500MG WATSON LABS AB 500MG AB 500MG TABLET, DELAYED RELEASE; ORAL AZULFIDINE EN-TABS AB + PHARMACIA AND UPJOHN 500MG SULFASALAZINE VINTAGE PHARMS AB 500MG
N007073 A040349 A085828 A087197
001 001 001 001 Jan 11, 2002
N007073 A075339
002 001
Apr 06, 1983 Jan 11, 2002
SULINDAC
TABLET; ORAL CLINORIL AB + MERCK SULINDAC EPIC PHARMA AB AB MUTUAL PHARM AB AB MYLAN AB AB WATSON LABS AB AB
N017911 A072710 A072711 A072050 A072051 A073039 A073039 A071891 A071795
002 001 001 001 001 002 001 001 001 Mar Mar Apr Apr Jun Jun Apr Apr 25, 25, 17, 17, 22, 22, 03, 03, 1991 1991 1991 1991 1993 1993 1990 1990
SUMATRIPTAN
SPRAY; NASAL
IMITREX
XX + GLAXOSMITHKLINE XX +
5MG/SPRAY 20MG/SPRAY
N020626 N020626
001 003
Aug 26, 1997 Aug 26, 1997
SUMATRIPTAN SUCCINATE
INJECTABLE; SUBCUTANEOUS IMITREX STATDOSE + GLAXOSMITHKLINE SUMATRIPTAN SUCCINATE SUN PHARMA GLOBAL IMITREX + GLAXOSMITHKLINE SUMATRIPTAN SUCCINATE BEDFORD FRESENIUS KABI USA
AB AB AP AP AP AP
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
N020080 A090358 N020080 A079123 A079242 A079240
003 001 001 001 001 002
Dec 23, 1996 Jun 21, 2011 Dec 28, 1992 Feb 06, 2009 Mar 02, 2009 Sep 18, 2009

INJECTABLE; SUBCUTANEOUS SUMATRIPTAN SUCCINATE FRESENIUS KABI USA INJECTALIA JHP PHARMS PAR PHARM SAGENT STRIDES SANDOZ TEVA PARENTERAL WOCKHARDT ALSUMA MERIDIAN MEDCL SUMAVEL DOSEPRO + ZOGENIX INC IMITREX STATDOSE + GLAXOSMITHKLINE
3 - 388 (of 428)
AP AP AP AP AP AP AP AP AP AP BX BX XX
BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML
(EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ
8MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 8MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML)
A079240 A090310 A077871 A077332 A090314 A090641 A078067 A078067 A077907 A078593 N022377 N022239 N020080
001 001 001 001 001 001 002 001 001 001 001 001 002
Sep Aug Jul Oct Jun Jul Feb Feb Feb Feb
18, 11, 09, 09, 10, 28, 06, 06, 06, 06,
2009 2010 2009 2009 2010 2010 2009 2009 2009 2009
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
Jun 29, 2010 Jul 15, 2009 Feb 01, 2006
TABLET; ORAL IMITREX GLAXOSMITHKLINE AB AB AB + SUMATRIPTAN SUCCINATE APOTEX INC AB AB AB AUROBINDO PHARMA AB AB AB DR REDDYS LABS INC AB AB AB MYLAN AB AB AB AB AB AB ORCHID HLTHCARE AB AB AB RANBAXY AB AB AB SANDOZ AB AB AB SUN PHARM INDS AB AB AB TEVA AB AB AB WATSON LABS AB AB AB
EQ 25MG BASE EQ 50MG BASE EQ 100MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 25MG BASE 50MG BASE 50MG BASE 100MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE
N020132 N020132 N020132 A200263 A200263 A200263 A078327 A078327 A078327 A076847 A076847 A076847 A077163 A077744 A077163 A077744 A077163 A077744 A078284 A078284 A078284 A076554 A076554 A076572 A076976 A076976 A076976 A078295 A078295 A078295 A076840 A076840 A076840 A076933 A076933 A076933
002 003 001 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 001 001 002 003 001 002 003 001 002 003 001 002 003
Jun 01, 1995 Jun 01, 1995 Jun 01, 1995 Jun Jun Jun Aug Aug Aug Aug Aug Aug Nov Aug Nov Aug Nov Aug Aug Aug Aug Aug Aug Feb Aug Aug Aug Aug Aug Aug Feb Feb Feb Aug Aug Aug 19, 19, 19, 10, 10, 10, 10, 10, 10, 02, 10, 02, 10, 02, 10, 10, 10, 10, 10, 10, 09, 10, 10, 10, 10, 10, 10, 09, 09, 09, 10, 10, 10, 2012 2012 2012 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009

SUNITINIB MALATE
CAPSULE; ORAL SUTENT XX CPPI CV XX XX XX +
3 - 389 (of 428)
EQ EQ EQ EQ
12.5MG BASE 25MG BASE 37.5MG BASE 50MG BASE
N021938 N021938 N021938 N021938
001 002 004 003
Jan Jan Mar Jan
26, 26, 31, 26,
2006 2006 2009 2006
TACROLIMUS
CAPSULE; ORAL PROGRAF ASTELLAS AB AB AB + TACROLIMUS ACCORD HLTHCARE AB AB AB DR REDDYS LABS LTD AB AB AB MYLAN AB AB AB PANACEA BIOTEC LTD AB AB AB SANDOZ AB AB AB WATSON LABS AB INJECTABLE; INJECTION
PROGRAF
XX + ASTELLAS OINTMENT; TOPICAL PROTOPIC ASTELLAS XX XX +
EQ 0.5MG BASE EQ 1MG BASE EQ 5MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 0.5MG BASE 1MG BASE 5MG BASE 0.5MG BASE 1MG BASE 5MG BASE 0.5MG BASE 1MG BASE 5MG BASE 0.5MG BASE 1MG BASE 5MG BASE 0.5MG BASE 1MG BASE 5MG BASE 5MG BASE
003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001
Aug 24, 1998 Apr 08, 1994 Apr 08, 1994 Aug Aug Aug May May May Sep Sep Sep Sep Sep Sep Aug Aug Aug Jul 31, 31, 31, 12, 12, 12, 17, 17, 17, 28, 28, 28, 10, 10, 10, 01, 2011 2011 2011 2010 2010 2010 2010 2010 2010 2012 2012 2012 2009 2009 2009 2010
EQ 5MG BASE/ML
N050709
001
Apr 08, 1994
0.03% 0.1%
N050777 N050777
001 002
Dec 08, 2000 Dec 08, 2000
TADALAFIL
TABLET; ORAL
ADCIRCA
XX + ELI LILLY CO CIALIS XX LILLY XX XX XX +
20MG 2.5MG 5MG 10MG 20MG
N022332 N021368 N021368 N021368 N021368
001 004 001 002 003
May 22, 2009 Jan Nov Nov Nov 07, 21, 21, 21, 2008 2003 2003 2003
TAFLUPROST
ZIOPTAN
XX + MERCK SHARP DOHME 0.0015%
N202514
001
Feb 10, 2012
TALC
AEROSOL, METERED; INTRAPLEURAL
SCLEROSOL
XX + BRYAN 400MG/SPRAY POWDER; INTRAPLEURAL
TALC
XX + BRYAN
N020587
001
Dec 24, 1997
5GM/BOT
N021388
001
Dec 15, 2003

TALIGLUCERASE ALFA
ELELYSO
XX + PFIZER
3 - 390 (of 428)
200 UNITS/VIAL
N022458
001
May 01, 2012
TAMOXIFEN CITRATE
SOLUTION; ORAL SOLTAMOX DARA BIOSCIENCES XX TABLET; ORAL TAMOXIFEN CITRATE APOTEX AB AB MYLAN AB AB TEVA AB AB + TEVA PHARMS WATSON LABS AB AB WATSON LABS FLORIDA AB AB
EQ 10MG BASE/5ML
N021807
001
Oct 29, 2005
A090878 A090878 A074732 A074732 A075797 A074858 A070929 A070929 A076179 A076179
001 002 002 001 001 001 001 002 001 002
Sep Sep Feb Feb Feb Feb Feb Feb Feb Feb
23, 23, 20, 20, 20, 20, 20, 20, 20, 20,
2011 2011 2003 2003 2003 2003 2003 2003 2003 2003
TAMSULOSIN HYDROCHLORIDE
CAPSULE; ORAL FLOMAX + BOEHRINGER INGELHEIM 0.4MG TAMSULOSIN HYDROCHLORIDE ANCHEN PHARMS 0.4MG IMPAX LABS 0.4MG MYLAN 0.4MG SANDOZ 0.4MG SUN PHARM INDS LTD 0.4MG SYNTHON PHARMS 0.4MG TEVA PHARMS 0.4MG WOCKHARDT 0.4MG ZYDUS PHARMS USA INC 0.4MG
N020579 A202010 A090377 A090408 A078015 A090931 A078801 A077630 A078938 A078225
001 001 001 001 001 001 001 001 001 001
Apr 15, 1997 Jan Mar Apr Apr Jul Apr Apr Apr Apr 04, 02, 27, 27, 15, 27, 27, 27, 27, 2013 2010 2010 2010 2010 2010 2010 2010 2010
TAPENTADOL HYDROCHLORIDE
SOLUTION; ORAL
NUCYNTA
XX + JANSSEN PHARMS TABLET; ORAL NUCYNTA JANSSEN PHARMS XX XX XX +
EQ 20MG BASE/ML
N203794
001
Oct 15, 2012
N022304 N022304 N022304
001 002 003
Nov 20, 2008 Nov 20, 2008 Nov 20, 2008
TABLET, EXTENDED RELEASE; ORAL NUCYNTA ER JANSSEN PHARMS EQ 50MG BASE XX EQ 100MG BASE XX EQ 150MG BASE XX EQ 200MG BASE XX EQ 250MG BASE XX +
N200533 N200533 N200533 N200533 N200533
001 002 003 004 005
Aug Aug Aug Aug Aug
25, 25, 25, 25, 25,
2011 2011 2011 2011 2011
TAZAROTENE
FABIOR
XX + STIEFEL LABS INC CREAM; TOPICAL
AVAGE
XX + ALLERGAN
0.1%
N202428
001
May 11, 2012
0.1%
N021184
003
Sep 30, 2002

TAZAROTENE
CREAM; TOPICAL
TAZORAC
XX + ALLERGAN XX + GEL; TOPICAL
TAZORAC
XX + ALLERGAN XX +
3 - 391 (of 428)
0.05% 0.1%
N021184 N021184
001 002
Sep 29, 2000 Sep 29, 2000
0.05% 0.1%
N020600 N020600
001 002
Jun 13, 1997 Jun 13, 1997
TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT

INJECTABLE; INJECTION PULMOLITE BS PHARMALUCENCE N/A TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT BS DRAXIMAGE N/A
N017776 N017881
001 001 Dec 30, 1987
TECHNETIUM TC-99M BICISATE KIT

INJECTABLE; INJECTION NEUROLITE LANTHEUS MEDCL XX
N/A
N020256
001
Nov 23, 1994
TECHNETIUM TC-99M DISOFENIN KIT

INJECTABLE; INJECTION HEPATOLITE PHARMALUCENCE XX
N/A
N018467
001
Mar 16, 1982
TECHNETIUM TC-99M EXAMETAZIME KIT

CERETEC
XX + GE HEALTHCARE
N/A
N019829
001
Dec 30, 1988
TECHNETIUM TC-99M MEBROFENIN KIT

INJECTABLE; INJECTION CHOLETEC AP + BRACCO N/A TECHNETIUM TC-99M MEBROFENIN PHARMALUCENCE AP N/A
N018963 A078242
001 001
Jan 21, 1987 Jan 29, 2008
TECHNETIUM TC-99M MEDRONATE

DRAXIMAGE MDP-25
XX + JUBILANT DRAXIMAGE
N/A
N018035
002
Feb 27, 2004
TECHNETIUM TC-99M MEDRONATE KIT

INJECTABLE; INJECTION CIS-MDP PHARMALUCENCE AP MDP-BRACCO BRACCO AP
N/A N/A
N018124 N018107
001 001
TECHNETIUM TC-99M MERTIATIDE KIT

TECHNESCAN MAG3
XX + MALLINCKRODT
N/A
N019882
001
Jun 15, 1990
TECHNETIUM TC-99M OXIDRONATE KIT

TECHNESCAN
XX + MALLINCKRODT
N/A
N018321
001

TECHNETIUM TC-99M PENTETATE KIT
INJECTABLE; INJECTION AN-DTPA PHARMALUCENCE AP DTPA DRAXIMAGE AP
3 - 392 (of 428)
N/A N/A
N017714 N018511
001 001 Dec 29, 1989
TECHNETIUM TC-99M PYROPHOSPHATE KIT

INJECTABLE; INJECTION CIS-PYRO PHARMALUCENCE AP TECHNESCAN PYP KIT MALLINCKRODT AP
N/A N/A
N019039 N017538
001 001
Jun 30, 1987
TECHNETIUM TC-99M RED BLOOD CELL KIT

INJECTABLE; INJECTION ULTRATAG XX MALLINCKRODT
N/A
N019981
001
Jun 10, 1991
TECHNETIUM TC-99M SESTAMIBI KIT

INJECTABLE; INJECTION CARDIOLITE + LANTHEUS MEDCL N/A TECHNETIUM TC 99M SESTAMIBI CARDINAL HEALTH 414 N/A DRAXIMAGE N/A PHARMALUCENCE 10-30mCi TECHNETIUM TC-99 SESTAMIBI MALLINCKRODT N/A
AP AP AP AP AP
N019785 A078809 A078806 A079157 A078098
001 001 001 001 001
Dec 21, 1990 Apr 28, 2009 Apr 29, 2009 Jul 10, 2009 Sep 22, 2008
TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

TECHNELITE
XX + LANTHEUS MEDCL 0.0083-2.7 CI/GENERATOR ULTRA-TECHNEKOW FM
0.25-3 CI/GENERATOR XX + MALLINCKRODT
N017771 N017243
001
002
TECHNETIUM TC-99M SUCCIMER KIT

INJECTABLE; INJECTION MPI DMSA KIDNEY REAGENT XX GE HEALTHCARE N/A
N017944
001
May 18, 1982
TECHNETIUM TC-99M SULFUR COLLOID KIT

AN-SULFUR COLLOID
N/A XX + PHARMALUCENCE
N017858
001
TECHNETIUM TC-99M TETROFOSMIN KIT

MYOVIEW
XX + GE HEALTHCARE MYOVIEW 30ML XX + GE HEALTHCARE
N/A N/A
N020372 N020372
001 002
Feb 09, 1996 Jul 07, 2005
TEDUGLUTIDE RECOMBINANT
GATTEX KIT
XX + NPS PHARMS INC
5MG/VIAL
N203441
001
Dec 21, 2012

TELAPREVIR
TABLET; ORAL
INCIVEK
XX + VERTEX PHARMS
3 - 393 (of 428)
375MG
N201917
001
May 23, 2011
TELAVANCIN HYDROCHLORIDE
POWDER; IV (INFUSION) VIBATIV THERAVANCE INC XX XX +
N022110 N022110
001 002
Sep 11, 2009 Sep 11, 2009
TELBIVUDINE
TABLET; ORAL
TYZEKA
XX + NOVARTIS
600MG
N022011
001
Oct 25, 2006
TELITHROMYCIN
TABLET; ORAL KETEK XX SANOFI AVENTIS US XX +
300MG 400MG
N021144 N021144
002 001
Feb 09, 2005 Apr 01, 2004
TELMISARTAN
TABLET; ORAL MICARDIS XX BOEHRINGER INGELHEIM XX XX +
20MG 40MG 80MG
N020850 N020850 N020850
003 001 002
Apr 04, 2000 Nov 10, 1998 Nov 10, 1998
TEMAZEPAM
CAPSULE; ORAL RESTORIL MALLINCKRODT INC AB AB AB AB + TEMAZEPAM ACTAVIS ELIZABETH AB AB MUTUAL PHARM AB AB MYLAN AB AB AB AB NOVEL LABS INC AB AB AB AB SANDOZ AB AB WATSON LABS AB AB
7.5MG 15MG 22.5MG 30MG 15MG 30MG 7.5MG 22.5MG 7.5MG 15MG 22.5MG 30MG 7.5MG 15MG 22.5MG 30MG 15MG 30MG 15MG 30MG
003 001 004 002 001 001 001 002 002 004 003 001 002 001 003 001 001 001 001 001
Oct 25, 1991 Nov 02, 2004
Aug Aug Sep Sep May Jul Jun Jul Jun Apr Jun Apr Jan Jan May May
07, 07, 08, 14, 21, 07, 12, 10, 22, 21, 22, 21, 12, 12, 21, 21,
1987 1987 2009 2009 2010 1986 2009 1986 2012 1987 2012 1987 1988 1988 1993 1993
TEMOZOLOMIDE
CAPSULE; ORAL TEMODAR MERCK SHARP DOHME AB AB AB AB
N021029 N021029 N021029 N021029
001 002 003 005
Aug Aug Aug Oct
11, 11, 11, 19,
1999 1999 1999 2006

TEMOZOLOMIDE
CAPSULE; ORAL TEMODAR MERCK SHARP DOHME AB AB + TEMOZOLOMIDE BARR AB AB AB AB AB AB POWDER; INTRAVENOUS
TEMODAR
3 - 394 (of 428)
N021029 N021029 A078879 A078879 A078879 A078879 A078879 A078879
006 004 001 002 003 005 006 004
Oct 19, 2006 Aug 11, 1999 Mar Mar Mar Mar Mar Mar 01, 01, 01, 01, 01, 01, 2010 2010 2010 2010 2010 2010
100MG/VIAL
N022277
001
Feb 27, 2009
TEMSIROLIMUS
TORISEL
XX + WYETH PHARMS INC
25MG/ML (25MG/ML)
N022088
001
May 30, 2007
TENIPOSIDE
VUMON
XX + BRISTOL MYERS SQUIBB
10MG/ML
N020119
001
Jul 14, 1992
TENOFOVIR DISOPROXIL FUMARATE

POWDER; ORAL
VIREAD
XX + GILEAD SCIENCES INC TABLET; ORAL VIREAD XX GILEAD SCIENCES INC XX XX XX +
40MG/SCOOPFUL
N022577
001
Jan 18, 2012
150MG 200MG 250MG 300MG
N021356 N021356 N021356 N021356
002 003 004 001
Jan Jan Jan Oct
18, 18, 18, 26,
2012 2012 2012 2001
TERAZOSIN HYDROCHLORIDE
CAPSULE; ORAL HYTRIN ABBOTT AB AB + AB AB TERAZOSIN HYDROCHLORIDE APOTEX AB AB AB AB IVAX SUB TEVA PHARMS AB AB AB AB JUBILANT CADISTA AB AB AB AB MYLAN AB AB AB AB
1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE
001 002 003 004 001 002 003 004 002 001 003 004 001 002 003 004 002 003 001 004
Dec Dec Dec Dec Apr Apr Apr Apr Jan Jan Jan Jan Dec Dec Dec Dec Feb Feb Feb Feb
14, 14, 14, 14, 12, 12, 12, 12, 30, 30, 30, 30, 20, 20, 20, 20, 11, 11, 11, 11,
1994 1994 1994 1994 2001 2001 2001 2001 2001 2001 2001 2001 2004 2004 2004 2004 2000 2000 2000 2000

CAPSULE; ORAL TERAZOSIN HYDROCHLORIDE SANDOZ AB EQ AB EQ AB EQ AB EQ TABLET; ORAL HYTRIN ABBOTT EQ XX EQ XX + EQ XX EQ XX
3 - 395 (of 428)
A074823 A074823 A074823 A074823
001 002 003 004
Mar Mar Mar Mar
30, 30, 30, 30,
1998 1998 1998 1998
N019057 N019057 N019057 N019057
001 002 003 004
Aug Aug Aug Aug
07, 07, 07, 07,
1987 1987 1987 1987
TERBINAFINE HYDROCHLORIDE
GRANULE; ORAL LAMISIL NOVARTIS EQ + EQ TABLET; ORAL LAMISIL + NOVARTIS EQ TERBINAFINE HYDROCHLORIDE APOTEX EQ AUROBINDO PHARMA EQ BRECKENRIDGE PHARM EQ DR REDDYS LABS INC EQ GLENMARK GENERICS EQ HARRIS PHARM EQ INVAGEN PHARMS EQ MYLAN EQ EQ ORCHID HLTHCARE EQ TEVA EQ WATSON LABS EQ WOCKHARDT EQ
XX XX
125MG BASE/PACKET 187.5MG BASE/PACKET
N022071 N022071
001 002
Sep 28, 2007 Sep 28, 2007
250MG BASE 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N020539 A078199 A078297 A077714 A076390 A078157 A077919 A077533 A077136 A077195 A078163 A076377 A077137 A078229
001 001 001 001 001 001 001 001 001 001 001 001 001 001
May 10, 1996 Jul Jul Jun Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul 02, 02, 04, 02, 02, 02, 02, 02, 02, 02, 02, 02, 02, 2007 2007 2010 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
TERBUTALINE SULFATE
INJECTABLE; INJECTION TERBUTALINE SULFATE AKORN + BEDFORD FRESENIUS KABI USA HIKMA FARMACEUTICA
AP AP AP AP
A078151 A076770 A076887 A078630
001 001 001 001
Jan Apr May May
07, 23, 26, 20,
2008 2004 2004 2009
TABLET; ORAL TERBUTALINE SULFATE IMPAX LABS AB AB + LANNETT AB AB
2.5MG 5MG 2.5MG 5MG
A075877 A075877 A077152 A077152
001 002 001 002
Jun Jun Mar Mar
26, 26, 25, 25,
2001 2001 2005 2005
TERCONAZOLE
CREAM; VAGINAL TERAZOL 3 + JANSSEN PHARMS TERAZOL 7 + JANSSEN PHARMS TERCONAZOLE FOUGERA PHARMS TARO
AB AB AB AB AB
0.8% 0.4% 0.4% 0.4% 0.8%
N019964 N019579 A076712 A076043 A075953
001 001 001 001 001
Feb 21, 1991 Dec 31, 1987 Feb 18, 2005 Jan 19, 2005 Apr 06, 2004

TERCONAZOLE
CREAM; VAGINAL TERCONAZOLE + NYCOMED US SUPPOSITORY; VAGINAL TERAZOL 3 + JANSSEN PHARMS TERCONAZOLE FOUGERA PHARMS PERRIGO NEW YORK TARO
3 - 396 (of 428)
BX
0.8%
N021735
001
Oct 01, 2004
AB AB AB AB
80MG 80MG 80MG 80MG
N019641 A076850 A077149 A077553
001 001 001 001
May 24, 1988 Jul 12, 2006 Mar 17, 2006 Mar 09, 2007
TERIFLUNOMIDE
TABLET; ORAL AUBAGIO XX SANOFI AVENTIS US XX +
7MG 14MG
N202992 N202992
001 002
Sep 12, 2012 Sep 12, 2012
TERIPARATIDE RECOMBINANT HUMAN

FORTEO
XX + LILLY
0.6MG/2.4ML (0.25MG/ML)
N021318
002
Jun 25, 2008
TESAMORELIN ACETATE
EGRIFTA
XX + EMD SERONO
EQ 2MG BASE/VIAL
N022505
002
Nov 29, 2011
TESTOSTERONE
ANDRODERM
XX + WATSON LABS 2MG/24HR XX + 4MG/24HR GEL; TRANSDERMAL ANDROGEL BX + ABBVIE TESTIM BX + AUXILIUM PHARMS ANDROGEL XX ABBVIE XX XX + TESTOSTERONE XX TEVA PHARMS XX
N020489 N020489
003 004
Oct 20, 2011 Oct 20, 2011
1% (50MG/5GM PACKET) 1% (50MG/5GM PACKET) 1% (25MG/2.5GM PACKET) 1.62% (20.25MG/1.25GM PACKET) 1.62% (40.5MG/2.5GM PACKET) 25MG/2.5GM PACKET 50MG/5GM PACKET
N021015 N021454 N021015 N022309 N022309 N202763 N202763
002 001 001 002 003 001 002
Feb 28, 2000 Oct 31, 2002 Feb 28, 2000 Sep 07, 2012 Sep 07, 2012 Feb 14, 2012 Feb 14, 2012
XX XX XX
XX
XX
GEL, METERED; TRANSDERMAL

ANDROGEL
+ ABBVIE 1% (1.25GM/ACTUATION) + 1.62% (20.25MG/1.25GM ACTIVATION) FORTESTA + ENDO PHARMS 10MG/0.5GM ACTUATION PELLET; IMPLANTATION
TESTOPEL
+ ACTIENT PHARMS 75MG SOLUTION, METERED; TRANSDERMAL
AXIRON
+ ELI LILLY AND CO 30MG/1.5ML ACTUATION
N021015 N022309 N021463
003 001 001
Sep 26, 2003 Apr 29, 2011 Dec 29, 2010
A080911
001
N022504
001
Nov 23, 2010
TABLET, EXTENDED RELEASE; BUCCAL

STRIANT
XX + ACTIENT PHARMS 30MG
N021543
001
Jun 19, 2003

TESTOSTERONE CYPIONATE
INJECTABLE; INJECTION DEPO-TESTOSTERONE AO + PHARMACIA AND UPJOHN AO + TESTOSTERONE CYPIONATE BEDFORD AO AO HIKMA FARMACEUTICA AO MYLAN INSTITUTIONAL AO PADDOCK LLC AO SANDOZ AO AO WATSON LABS AO
3 - 397 (of 428)
A085635 A085635 A090387 A090387 A091244 A040652 A040530 A040615 A040615 A086030
002 003 001 002 001 001 001 001 002 001 Jul Jul May Dec Jan Aug Aug 15, 15, 01, 11, 31, 10, 10, 2010 2010 2012 2006 2005 2006 2006
TESTOSTERONE ENANTHATE
INJECTABLE; INJECTION DELATESTRYL + ENDO PHARM TESTOSTERONE ENANTHATE HIKMA FARMACEUTICA MYLAN INSTITUTIONAL PADDOCK LLC WATSON LABS
AO AO AO AO AO
N009165 A091120 A040647 A040575 A085598
003 001 001 001 001 Sep 18, 2012 Oct 05, 2009 Jun 14, 2006
TETRABENAZINE
TABLET; ORAL XENAZINE XX VALEANT BERMUDA XX +
12.5MG 25MG
N021894 N021894
001 002
Aug 15, 2008 Aug 15, 2008
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL TETRACYCLINE HYDROCHLORIDE IMPAX LABS AB 250MG AB 500MG IVAX SUB TEVA PHARMS 250MG AB AB + 500MG WATSON LABS AB 250MG AB 500MG TETRACYCLINE HYDROCHLORIDE
IMPAX LABS 100MG XX
A060469 A060469 A060704 A060704 A061837 A061837 A060469
001 003 001 002 001 002 002
TETRAHYDROZOLINE HYDROCHLORIDE
SOLUTION; NASAL
TYZINE
XX + FOUGERA PHARMS XX SPRAY; NASAL
TYZINE
XX + FOUGERA PHARMS
0.05% 0.1%
A086576 A086576
002
001
0.1%
A086576
003
THALIDOMIDE
CAPSULE; ORAL THALOMID CELGENE XX XX XX XX +
50MG 100MG 150MG 200MG
N020785 N020785 N020785 N020785
001 002 004 003
Jul Jan Jan Jan
16, 17, 10, 17,
1998 2003 2007 2003

THALLOUS CHLORIDE TL-201
INJECTABLE; INJECTION THALLOUS CHLORIDE TL 201 AP + GE HEALTHCARE 1mCi/ML AP + LANTHEUS MEDCL 1mCi/ML AP + MALLINCKRODT 1mCi/ML INJECTABLE; INTRAVENOUS THALLOUS CHLORIDE TL 201 AP + LANTHEUS MEDCL 2mCi/ML MALLINCKRODT AP 2mCi/ML
3 - 398 (of 428)
N018110 N017806 N018150
002 001 001
Feb 27, 1996
N017806 A077698
002 001
Oct 09, 1998 Nov 09, 2006
THEOPHYLLINE
CAPSULE, EXTENDED RELEASE; ORAL THEO-24 ACTIENT PHARMS 100MG 200MG 300MG + 400MG
XX XX XX XX
A087942 A087943 A087944 A081034
001 001 001 001
Aug Aug Aug Feb
22, 22, 22, 28,
1983 1983 1983 1992
ELIXIR; ORAL
ELIXOPHYLLIN
XX + CARACO
80MG/15ML
A085186
001
AA AA
XX XX
THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 40MG/100ML THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 80MG/100ML THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 160MG/100ML THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 320MG/100ML THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER 4MG/ML + HOSPIRA INC 40MG/100ML + 160MG/100ML + 320MG/100ML + SOLUTION; ORAL THEOPHYLLINE + SILARX 80MG/15ML TRIS PHARMA INC 80MG/15ML TABLET; ORAL THEOLAIR + MEDICIS 125MG + 250MG
N019826 N019826 N019826 N019826 N019211 N019211 N019211 N019211
001 002 003 006 007 001 003 006
Aug 14, 1992 Aug 14, 1992 Aug 14, 1992 Aug 14, 1992 Dec Dec Dec Jan 14, 14, 14, 20, 1984 1984 1984 1988
A091156 A091586
001 001
Apr 13, 2011 Jun 15, 2012
A086399 A086399
001 002
TABLET, EXTENDED RELEASE; ORAL THEOCHRON CARACO AB 100MG AB 200MG AB 300MG THEOPHYLLINE ALEMBIC LTD 300MG AB 450MG AB GLENMARK GENERICS 400MG AB 600MG AB NOSTRUM 400MG AB 600MG AB + 100MG AB + PLIVA 200MG AB + 300MG AB 450MG AB +
A088320 A088321 A087400 A090430 A090430 A090355 A090355 A040595 A040560 A089807 A089808 A089763 A081236
001 001 002 001 002 001 002 001 002 001 001 001 001
Feb 21, 1985 Feb 21, 1985 Jan 11, 1983 Oct Oct Jul Jul Apr Apr Apr Apr Apr Nov 27, 27, 13, 13, 21, 21, 30, 30, 30, 09, 2010 2010 2010 2010 2006 2006 1990 1990 1990 1992

THIAMINE HYDROCHLORIDE
INJECTABLE; INJECTION THIAMINE HYDROCHLORIDE + FRESENIUS KABI USA MYLAN INSTITUTIONAL WATSON LABS THIAMINE HYDROCHLORIDE + WATSON LABS
3 - 399 (of 428)
AP AP AP XX
A080556 A091623 A080571 A080571
001 001 001 002
Jun 25, 2012
THIOGUANINE
TABLET; ORAL
THIOGUANINE
40MG
N012429
001
THIORIDAZINE HYDROCHLORIDE
TABLET; ORAL THIORIDAZINE HYDROCHLORIDE MUTUAL PHARM 10MG 25MG 50MG 100MG MYLAN 10MG 25MG 50MG + 100MG
A089953 A089953 A089953 A089953 A088004 A088004 A088004 A088004
004 003 002 001 002 003 004 001
Aug Aug Aug Oct Mar Mar Mar Nov
01, 01, 01, 07, 15, 15, 15, 18,
1986 1986 1986 1988 1983 1983 1983 1983
THIOTEPA
INJECTABLE; INJECTION THIOTEPA XX BEDFORD
15MG/VIAL
A075547
001
Apr 02, 2001
THIOTHIXENE
CAPSULE; ORAL NAVANE PFIZER AB AB AB + AB THIOTHIXENE MYLAN AB AB AB AB SANDOZ AB AB AB AB WATSON LABS AB AB
N016584 N016584 N016584 N016584 A071093 A071093 A071093 A071093 A071610 A071570 A071529 A071530 A070601 A070602
001 002 003 004 002 003 004 001 001 001 001 001 001 001 Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun 23, 23, 23, 23, 24, 24, 24, 24, 05, 05, 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987
THYROTROPIN ALFA
THYROGEN
XX + GENZYME
1.1MG/VIAL
N020898
001
Nov 30, 1998
TIAGABINE HYDROCHLORIDE
TABLET; ORAL GABITRIL CEPHALON AB 2MG AB + 4MG TIAGABINE HYDROCHLORIDE SUN PHARM INDS AB 2MG
N020646 N020646 A077555
005 001 001
Apr 16, 1999 Sep 30, 1997 Nov 04, 2011

TABLET; ORAL TIAGABINE HYDROCHLORIDE SUN PHARM INDS AB 4MG GABITRIL CEPHALON 12MG XX 16MG XX
3 - 400 (of 428)
A077555 N020646 N020646
002 002 003
Nov 04, 2011 Sep 30, 1997 Sep 30, 1997
TICAGRELOR
TABLET; ORAL
BRILINTA
XX + ASTRAZENECA LP
90MG
N022433
001
Jul 20, 2011
TICLOPIDINE HYDROCHLORIDE
TABLET; ORAL TICLOPIDINE HYDROCHLORIDE APOTEX 250MG CARACO 250MG MYLAN 250MG + TEVA 250MG
AB AB AB AB
A075089 A075526 A075161 A075149
001 001 001 001
Jul Sep Sep Aug
01, 26, 13, 20,
1999 2002 1999 1999
TIGECYCLINE
TYGACIL
50MG/VIAL XX + WYETH PHARMS INC
N021821
001
Jun 15, 2005
TILUDRONATE DISODIUM
TABLET; ORAL
SKELID
EQ 200MG BASE
N020707
001
Mar 07, 1997
TIMOLOL
BETIMOL
XX + SANTEN OY EQ 0.25% BASE XX + EQ 0.5% BASE
N020439 N020439
001 002
Mar 31, 1995 Mar 31, 1995
TIMOLOL MALEATE
SOLUTION, GEL FORMING/DROPS; TIMOLOL MALEATE FALCON PHARMS EQ EQ TIMOPTIC-XE + ATON EQ + EQ SOLUTION/DROPS; OPHTHALMIC TIMOLOL MALEATE AKORN EQ EQ EQ APOTEX INC EQ EQ BAUSCH AND LOMB EQ EQ FALCON PHARMS EQ EQ FDC LTD EQ EQ HI TECH PHARMA EQ PACIFIC PHARMA EQ EQ WOCKHARDT EQ OPHTHALMIC 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE N020963 N020963 N020330 N020330 001 002 001 002 Oct 21, 1998 Oct 21, 1998 Nov 04, 1993 Nov 04, 1993
AB AB AB AB
AT AT AT AT AT AT AT AT AT AT AT AT AT AT AT
0.25% BASE 0.5% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.25% BASE
001 001 001 001 001 001 001 001 001 001 002 001 001 001 001
Mar Mar Mar Sep Sep Mar Mar Apr Apr Apr Apr Sep Mar Mar Sep
25, 25, 25, 08, 08, 25, 25, 28, 28, 30, 30, 10, 25, 25, 28,
1997 1997 1997 2000 2000 1997 1997 1995 1995 2008 2008 2002 1997 1997 2009

TIMOLOL MALEATE
SOLUTION/DROPS; OPHTHALMIC TIMOLOL MALEATE WOCKHARDT EQ 0.5% BASE TIMOPTIC + ATON EQ 0.25% BASE + EQ 0.5% BASE ISTALOL + ISTA PHARMS EQ 0.5% BASE TIMOPTIC IN OCUDOSE + ATON EQ 0.25% BASE + EQ 0.5% BASE TABLET; ORAL TIMOLOL MALEATE MYLAN 5MG 10MG + 20MG
3 - 401 (of 428)
AT AT AT BT XX XX
A078771 N018086 N018086 N021516 N019463 N019463
002 001 002 001 001 002
Sep 28, 2009
Jun 04, 2004 Nov 05, 1986 Nov 05, 1986
XX XX XX
A072668 A072668 A072668
002 003 001
Jun 08, 1990 Jun 08, 1990 Jun 08, 1990
TINIDAZOLE
TABLET; ORAL TINDAMAX MISSION PHARMA AB AB + TINIDAZOLE NOVEL LABS INC AB AB ROXANE AB AB
250MG 500MG 250MG 500MG 250MG 500MG
N021618 N021618 A202044 A202044 A201172 A201172
001 002 001 002 001 002
May 17, 2004 May 17, 2004 Apr Apr Apr Apr 30, 30, 30, 30, 2012 2012 2012 2012
TIOPRONIN
TABLET; ORAL
TIOPRONIN
XX + MISSION PHARMA
100MG
N019569
001
Aug 11, 1988
TIOTROPIUM BROMIDE MONOHYDRATE

POWDER; INHALATION
SPIRIVA
XX + BOEHRINGER INGELHEIM EQ 0.018MG BASE/INH
N021395
001
Jan 30, 2004
TIPRANAVIR
CAPSULE; ORAL
APTIVUS
XX + BOEHRINGER INGELHEIM 250MG SOLUTION; ORAL
APTIVUS
XX + BOEHRINGER INGELHEIM 100MG/ML
N021814
001
Jun 22, 2005
N022292
001
Jun 23, 2008
TIROFIBAN HYDROCHLORIDE
INJECTABLE; INJECTION AGGRASTAT MEDICURE XX XX +
EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML)
N020913 N020913
002 003
May 17, 2002 Apr 20, 2000
TIZANIDINE HYDROCHLORIDE
CAPSULE; ORAL TIZANIDINE HYDROCHLORIDE APOTEX INC EQ EQ EQ MYLAN LABS EQ EQ
AB AB AB AB AB
2MG 4MG 6MG 2MG 4MG
A078868 A078868 A078868 A091502 A091502
001 002 003 001 002
Feb Feb Feb Nov Nov
03, 03, 03, 09, 09,
2012 2012 2012 2012 2012

CAPSULE; ORAL TIZANIDINE HYDROCHLORIDE MYLAN LABS EQ ZANAFLEX ACORDA EQ EQ + EQ TABLET; ORAL TIZANIDINE HYDROCHLORIDE APOTEX EQ EQ CARACO EQ EQ COREPHARMA EQ EQ DR REDDYS LABS INC EQ EQ MYLAN EQ EQ MYLAN PHARMS INC EQ EQ PROSAM LABS EQ EQ SANDOZ INC EQ EQ TEVA EQ EQ UNICHEM LABS LTD EQ EQ ZANAFLEX + ACORDA EQ
3 - 402 (of 428)
AB AB AB AB
A091502 N021447 N021447 N021447
003 001 002 003
Nov 09, 2012 Aug 29, 2002 Aug 29, 2002 Aug 29, 2002
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A076533 A076533 A076416 A076416 A076347 A076347 A076286 A076286 A076354 A076354 A076282 A076282 A076281 A076281 A076280 A076280 A076284 A076284 A091283 A091283 N020397
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001
Jan Jan Sep Sep Oct Oct Jul Jul Mar Mar Dec Dec Oct Oct Nov Jun Jul Jul Nov Nov
16, 16, 29, 29, 11, 11, 03, 03, 28, 28, 16, 16, 20, 20, 26, 27, 03, 03, 28, 28,
2004 2004 2003 2003 2002 2002 2002 2002 2003 2003 2003 2003 2003 2003 2002 2002 2002 2002 2012 2012
4MG BASE
Nov 27, 1996
TOBRAMYCIN
TOBREX
XX + ALCON
0.3%
N050555
001
XX XX
AT AT AT AT AT AT
BETHKIS
CORNERSTONE THERAP 300MG/4ML TOBI + NOVARTIS PHARMS 300MG/5ML SOLUTION/DROPS; OPHTHALMIC AKTOB AKORN 0.3% TOBRAMYCIN BAUSCH AND LOMB 0.3% FERA PHARMS 0.3% NOVEX 0.3% TOBREX ALCON 0.3% + FALCON PHARMS 0.3%
N201820 N050753
001 001
Oct 12, 2012 Dec 22, 1997
A064096 A064052 A065026 A065087 A062535 N050541
001 001 001 001 001 001
Jan 31, 1996 Nov 29, 1993 Sep 11, 2001 Feb 25, 2002 Dec 13, 1984
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION TOBRAMYCIN SULFATE FRESENIUS KABI USA AP AP + AP HIKMA MAPLE AP AP + HOSPIRA
EQ EQ EQ EQ EQ
10MG BASE/ML 40MG BASE/ML 1.2GM BASE/VIAL 40MG BASE/ML 10MG BASE/ML
A065122 A065122 N050789 A063117 A063112
001 002 001 001 001
Nov Nov Jul Apr Apr
29, 29, 13, 26, 30,
2002 2002 2004 1991 1991

TOBRAMYCIN SULFATE
INJECTABLE; INJECTION TOBRAMYCIN SULFATE HOSPIRA EQ 40MG BASE/ML + EQ 40MG BASE/ML MARSAM PHARMS LLC EQ 10MG BASE/ML PFIZER EQ 40MG BASE/ML TEVA PARENTERAL EQ 40MG BASE/ML + X GEN PHARMS EQ 1.2GM BASE/VIAL TOBRAMYCIN SULFATE (PHARMACY BULK) FRESENIUS KABI USA EQ 40MG BASE/ML TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER + HOSPIRA EQ 1.2MG BASE/ML + EQ 1.6MG BASE/ML + EQ 80MG BASE/100ML
3 - 403 (of 428)
AP AP AP AP AP AP AP XX XX XX
A063111 A063116 A062945 A065407 A063100 A065013 A065120 A063081 A063081 A063081
001 001 001 001 001 001 001 003 006 001
Apr May Aug Mar Jan Aug
30, 18, 09, 11, 30, 17,
1991 1992 1989 2008 1992 2001
Nov 29, 2002 Jul 31, 1990 Jun 02, 1993 Jul 31, 1990
TOFACITINIB CITRATE
TABLET; ORAL
XELJANZ
XX + PFIZER
EQ 5MG BASE
N203214
001
Nov 06, 2012
TOLAZAMIDE
TABLET; ORAL TOLAZAMIDE MYLAN AB AB + WATSON LABS AB AB
250MG 500MG 250MG 500MG
A070259 A070259 A070514 A070515
001 003 001 001
Jan Mar Jan Jan
02, 17, 09, 09,
1986 1986 1986 1986
TOLBUTAMIDE
TABLET; ORAL
TOLBUTAMIDE
XX + MYLAN PHARMS INC
500MG
A086445
001
TOLCAPONE
TABLET; ORAL
TASMAR
XX + VALEANT PHARMS LLC
100MG
N020697
001
Jan 29, 1998
TOLMETIN SODIUM
CAPSULE; ORAL TOLMETIN SODIUM MYLAN AB AB + TEVA TABLET; ORAL TOLMETIN SODIUM MUTUAL PHARM AB AB + MYLAN
A073393 A073290
001 001
May 27, 1993 Nov 27, 1991
A073310 A074473
001 001
Nov 27, 1991 Aug 30, 1994
TOLTERODINE TARTRATE
CAPSULE, EXTENDED RELEASE; ORAL DETROL LA PHARMACIA AND UPJOHN 2MG + 4MG TABLET; ORAL DETROL PHARMACIA AND UPJOHN 1MG + 2MG TOLTERODINE TARTRATE APOTEX CORP 1MG 2MG MYLAN PHARMS INC 1MG
XX XX
N021228 N021228
001 002
Dec 22, 2000 Dec 22, 2000
AB AB AB AB AB
N020771 N020771 A200164 A200164 A202641
001 002 001 002 001
Mar 25, 1998 Mar 25, 1998 Sep 25, 2012 Sep 25, 2012 Nov 27, 2012

TOLTERODINE TARTRATE
TABLET; ORAL TOLTERODINE TARTRATE MYLAN PHARMS INC AB
3 - 404 (of 428)
2MG
A202641
002
Nov 27, 2012
TOLVAPTAN
TABLET; ORAL SAMSCA OTSUKA AMERICA PHARM XX XX +
15MG 30MG
N022275 N022275
001 002
May 19, 2009 May 19, 2009
TOPIRAMATE
CAPSULE; ORAL TOPAMAX JANSSEN PHARMS AB AB + TOPIRAMATE MYLAN AB AB SANDOZ AB AB TEVA AB AB WATSON LABS AB AB ZYDUS PHARMS USA INC AB AB TABLET; ORAL TOPAMAX AB + JANSSEN PHARMS AB AB AB TOPIRAMATE ACCORD HLTHCARE AB AB AB AB APOTEX INC AB AB AB AB AUROBINDO PHARMA AB AB AB AB CIPLA LTD AB AB AB AB GLENMARK GENERICS AB AB AB AB INVAGEN PHARMS AB AB AB AB MYLAN AB AB AB
N020844 N020844 A078418 A078418 A079206 A079206 A076575 A076575 A077868 A077868 A078877 A078877
001 002 001 002 001 002 001 002 001 002 001 002
Oct 26, 1998 Oct 26, 1998 Oct Oct Oct Oct Apr Apr Apr Apr Oct Oct 14, 14, 14, 14, 17, 17, 15, 15, 14, 14, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
N020505 N020505 N020505 N020505 A076311 A076311 A076311 A076311 A077733 A077733 A077733 A077733 A078462 A078462 A078462 A078462 A076343 A076343 A076343 A076343 A077627 A077627 A077627 A077627 A079162 A079162 A079162 A079162 A076314 A076314 A076314
004 005 001 002 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003
Dec Dec Dec Dec Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar
24, 24, 24, 24, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
1996 1996 1996 1996 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009

TOPIRAMATE
TABLET; ORAL TOPIRAMATE MYLAN AB RANBAXY AB AB AB SUN PHARM INDS LTD AB AB AB AB TEVA AB AB AB AB TORRENT PHARMS AB AB AB AB UNICHEM AB AB AB UPSHER SMITH AB AB AB AB WATSON LABS AB AB AB AB WOCKHARDT USA AB AB AB AB ZYDUS PHARMS USA INC AB AB AB AB
3 - 405 (of 428)
200MG 25MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG
A076314 A076327 A076327 A076327 A090278 A090278 A090278 A090278 A076317 A076317 A076317 A076317 A079153 A079153 A079153 A079153 A090162 A090162 A090162 A078499 A078499 A078499 A078499 A077643 A077643 A077643 A077643 A090353 A090353 A090353 A090353 A078235 A078235 A078235 A078235
004 001 002 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Jan Jan Jan Jan Mar Mar Mar Mar Sep Sep Sep Sep Mar Mar Mar Mar
27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 07, 07, 07, 07, 27, 27, 27, 27, 01, 01, 01, 01, 27, 27, 27, 27,
2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009
TOPOTECAN HYDROCHLORIDE
CAPSULE; ORAL HYCAMTIN SMITHKLINE BEECHAM XX XX + INJECTABLE; INJECTION HYCAMTIN + GLAXOSMITHKLINE TOPOTECAN HYDROCHLORIDE ACTAVIS TOTOWA DR REDDYS LABS LTD FRESENIUS KABI ONCOL FRESENIUS KABI USA MYLAN LLC ONCO THERAPIES LTD SAGENT PHARMS THREE RIVERS PHARMS
N020981 N020981
001 002
Oct 11, 2007 Oct 11, 2007
EQ 4MG BASE/VIAL EQ EQ EQ EQ EQ EQ EQ EQ 4MG 4MG 4MG 4MG 4MG 4MG 4MG 4MG BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
N020671 A090620 A201191 A091376 A091089 A201166 A091542 A091284 A091199
001 001 001 001 001 001 001 001 001
May 28, 1996 Dec Mar Nov Nov Aug Aug Jan Dec 02, 09, 29, 29, 08, 28, 26, 01, 2010 2011 2010 2010 2012 2012 2011 2010
SOLUTION; INTRAVENOUS TOPOTECAN AP + HOSPIRA INC TEVA PHARMS AP
EQ 4MG BASE/4ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (1MG/ML)
N200582 N022453
001 001
Feb 02, 2011 Dec 20, 2012

TOREMIFENE CITRATE
TABLET; ORAL
FARESTON
XX + GTX INC
3 - 406 (of 428)
EQ 60MG BASE
N020497
001
May 29, 1997
TORSEMIDE
INJECTABLE; INJECTION TORSEMIDE AP + BEDFORD LABS AP + LUITPOLD AP AP TABLET; ORAL DEMADEX MEDA PHARMS AB AB AB + AB TORSEMIDE APOTEX INC AB AB AB AB AUROBINDO PHARMA AB AB AB AB HETERO DRUGS AB AB AB AB PAR PHARM AB AB AB AB PLIVA PHARM IND AB AB AB AB ROXANE AB AB AB SUN PHARM INDS AB AB AB AB TEVA AB AB AB AB VINTAGE PHARMS AB AB AB AB
(10MG/ML) (10MG/ML) (10MG/ML) (10MG/ML)
A078007 A078007 A090656 A090656
001 002 002 001
Jun Jun Apr Apr
11, 11, 21, 21,
2008 2008 2010 2010
N020136 N020136 N020136 N020136 A076894 A076894 A076894 A076894 A078249 A078249 A078249 A078249 A079234 A079234 A079234 A079234 A076226 A076226 A076226 A076226 A076346 A076346 A076346 A076346 A076943 A076943 A076943 A078478 A078478 A078478 A078478 A076110 A076110 A076110 A076110 A090613 A090613 A090613 A090613
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 004 001 002 003 004
Aug Aug Aug Aug May May May May Oct Oct Oct Oct Jan Jan Jan Jan May May May May May May May Oct Mar Mar Mar Feb Feb Feb Feb May May May May Mar Mar Mar Mar
23, 23, 23, 23, 31, 31, 31, 31, 17, 17, 17, 17, 27, 27, 27, 27, 27, 27, 27, 27, 30, 30, 30, 19, 01, 01, 01, 26, 26, 26, 26, 14, 14, 14, 14, 22, 22, 22, 22,
1993 1993 1993 1993 2005 2005 2005 2005 2007 2007 2007 2007 2009 2009 2009 2009 2003 2003 2003 2003 2003 2003 2003 2004 2005 2005 2005 2008 2008 2008 2008 2002 2002 2002 2002 2011 2011 2011 2011
TRAMADOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL CONZIP 100MG XX + CIPHER PHARMS INC 150MG XX 200MG XX
N022370 N022370 N022370
001 004 002
May 07, 2010 Aug 01, 2011 May 07, 2010

CAPSULE, EXTENDED RELEASE; ORAL CONZIP XX CIPHER PHARMS INC 300MG TABLET; ORAL TRAMADOL HYDROCHLORIDE ALVOGEN AB 50MG AMNEAL PHARMS AB 50MG APOTEX AB 50MG CARACO AB 50MG IPCA LABS LTD AB 50MG MALLINCKRODT AB 50MG MUTUAL PHARM AB 50MG MYLAN AB 50MG MYLAN PHARMS INC AB 50MG NORTHSTAR HLTHCARE AB 50MG PLIVA AB 50MG TEVA AB 50MG WATSON LABS AB 50MG ZYDUS PHARMS USA INC 50MG AB ULTRAM AB + JANSSEN PHARMS 50MG TABLET, EXTENDED RELEASE; ORAL TRAMADOL HYDROCHLORIDE LUPIN LTD AB1 100MG AB1 200MG AB1 300MG PAR PHARM AB1 100MG AB1 200MG AB1 300MG SUN PHARMA GLOBAL AB1 100MG AB1 200MG AB1 300MG ULTRAM ER AB1 + VALEANT INTL 100MG AB1 200MG AB1 300MG RYZOLT AB2 + PURDUE PHARMA 100MG AB2 200MG AB2 300MG TRAMADOL HYDROCHLORIDE ACTAVIS AB2 100MG AB2 200MG AB2 300MG ANCHEN PHARMS AB2 100MG AB2 200MG AB2 300MG SUN PHARMA GLOBAL AB2 100MG AB2 200MG AB2 300MG TABLET, ORALLY DISINTEGRATING; ORAL
RYBIX ODT
50MG XX + SHIONOGI INC
3 - 407 (of 428)
N022370
003
May 07, 2010
A202075 A076003 A075981 A075964 A201973 A075983 A076100 A075986 A075980 A078935 A075982 A075977 A075962 A090404 N020281
001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Nov Jun Jul Jun Nov Jun Jun Jun Nov May Jul Jun Jun Jan
28, 20, 10, 19, 16, 25, 20, 21, 21, 26, 01, 19, 24, 31,
2011 2002 2002 2002 2012 2002 2002 2002 2002 2010 2002 2002 2002 2011
Mar 03, 1995
A200503 A200503 A200503 A078783 A078783 A078783 A201384 A201384 A201384 N021692 N021692 N021692 N021745 N021745 N021745 A091609 A091609 A091609 A200491 A200491 A200491 A091607 A091607 A091607
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Aug Aug Aug Nov Nov Sep Dec Dec Dec
29, 29, 29, 13, 13, 20, 07, 07, 07,
2011 2011 2011 2009 2009 2011 2011 2011 2011
Sep 08, 2005 Sep 08, 2005 Sep 08, 2005 Dec 30, 2008 Dec 30, 2008 Dec 30, 2008 Jun Jun Jun Jun Jun Jun Dec Dec Dec 27, 27, 27, 27, 27, 27, 30, 30, 30, 2012 2012 2012 2012 2012 2012 2011 2011 2011
N021693
001
May 05, 2005
TRANDOLAPRIL
TABLET; ORAL MAVIK ABBVIE AB AB AB +
1MG 2MG 4MG
N020528 N020528 N020528
001 002 003
Apr 26, 1996 Apr 26, 1996 Apr 26, 1996

TRANDOLAPRIL
TABLET; ORAL TRANDOLAPRIL AUROBINDO PHARMA AB AB AB CIPLA AB AB AB COREPHARMA AB AB AB DR REDDYS LABS LTD AB AB AB EPIC PHARMA AB AB AB INVAGEN PHARMS AB AB AB LUPIN AB AB AB MYLAN AB AB AB TEVA PHARMS AB AB AB WATSON LABS AB AB AB
3 - 408 (of 428)
001 002 003 002 001 003 001 002 003 001 002 003 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jun Jun Jun Jun Jun Jun Jun Jun Jun Aug Aug Aug Jun Jun Jun Jun Jun Jun Jun Jun Jun Apr Apr Apr Dec Dec Dec Jun Jun Jun
12, 12, 12, 12, 12, 12, 12, 12, 12, 25, 25, 25, 18, 18, 18, 12, 12, 12, 12, 12, 12, 28, 28, 28, 12, 12, 12, 12, 12, 12,
2007 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2008 2008 2008 2008 2007 2007 2007 2007 2007 2007 2008 2008 2008 2006 2006 2006 2007 2007 2007
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL TARKA ABBVIE AB 1MG;240MG AB 2MG;180MG AB 2MG;240MG AB + 4MG;240MG TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE GLENMARK GENERICS AB 1MG;240MG AB 2MG;180MG AB 2MG;240MG AB 4MG;240MG
N020591 N020591 N020591 N020591 A079135 A079135 A079135 A079135
003 001 004 002 004 001 002 003
Oct Oct Oct Oct Aug May May May
22, 22, 22, 22, 30, 26, 26, 05,
1996 1996 1996 1996 2010 2010 2010 2010
TRANEXAMIC ACID
INJECTABLE; INJECTION CYKLOKAPRON + PHARMACIA AND UPJOHN TRANEXAMIC ACID FRESENIUS KABI USA LUITPOLD MYLAN INSTITUTIONAL VERSAPHARM INC
AP AP AP AP AP
N019281 A091596 A201885 A091657 A202373
001 001 001 001 001
Dec 30, 1986 Mar Aug Nov Nov 02, 10, 03, 17, 2012 2011 2011 2011
TABLET; ORAL LYSTEDA AB + FERRING PHARMS AS TRANEXAMIC ACID WATSON LABS INC FL AB
650MG 650MG
N022430 A202093
001 001
Nov 13, 2009 Dec 27, 2012

TRANYLCYPROMINE SULFATE
TABLET; ORAL PARNATE AB + COVIS PHARMA EQ 10MG BASE TRANYLCYPROMINE SULFATE PAR PHARM AB EQ 10MG BASE
3 - 409 (of 428)
N012342 A040640
003 001
Aug 16, 1985 Jun 29, 2006
TRAVOPROST
TRAVATAN Z
XX + ALCON PHARMS LTD 0.004%
N021994
001
Sep 21, 2006
TRAZODONE HYDROCHLORIDE
TABLET; ORAL TRAZODONE HYDROCHLORIDE ALVOGEN AB 50MG AB 100MG APOTEX AB 50MG AB + APOTEX INC 100MG AB 150MG AB 300MG MUTUAL PHARM AB 50MG AB 100MG AB 150MG MYLAN PHARMS INC AB 50MG AB 100MG AB 150MG AB 300MG PLIVA AB 50MG AB 100MG AB 150MG VINTAGE AB 50MG AB 100MG WATSON LABS AB 50MG AB 100MG TABLET, EXTENDED RELEASE; ORAL
OLEPTRO
150MG XX + ANGELINI LLC 300MG XX
001 001 001 001 002 003 002 001 003 001 002 003 004 001 001 001 001 001 001 001
Apr Apr Mar Mar Apr Apr Mar Mar Dec Jun Jun Jun Jun Dec Dec Mar Feb Feb Oct Oct
18, 18, 25, 25, 26, 26, 24, 24, 22, 02, 02, 02, 02, 11, 11, 09, 02, 02, 10, 10,
1988 1988 1987 1987 1999 1999 1993 1993 1995 2009 2009 2009 2009 1987 1987 1988 1989 1989 1986 1986
N022411 N022411
001 002
Feb 02, 2010 Feb 02, 2010
TREPROSTINIL SODIUM
INJECTABLE; IV (INFUSION)-SC REMODULIN UNITED THERAP 1MG/ML 2.5MG/ML 5MG/ML + 10MG/ML
XX XX XX XX
N021272 N021272 N021272 N021272
001 002 003 004
May May May May
21, 21, 21, 21,
2002 2002 2002 2002
TYVASO
XX + UNITED THERAP
EQ 0.6MG BASE/ML
N022387
001
Jul 30, 2009
TRETINOIN
CAPSULE; ORAL TRETINOIN ANCHEN PHARMS AB AB + BARR LABS INC CREAM; TOPICAL AVITA MYLAN PHARMS INC AB RETIN-A AB + VALEANT INTL
10MG 10MG
A201687 A077684
001 001
Oct 24, 2012 Jun 22, 2007
0.025% 0.025%
N020404 N019049
003 001
Jan 14, 1997 Sep 16, 1988

TRETINOIN
CREAM; TOPICAL RETIN-A AB + VALEANT INTL TRETINOIN PRECISION DERMAT AB AB RETIN-A AB1 + VALEANT INTL TRETINOIN PRECISION DERMAT AB1 RENOVA AB2 + VALEANT INTL TRETINOIN SUNEVA MEDCL AB2 RENOVA XX + VALEANT INTL TRETINOIN XX + PRECISION DERMAT XX GEL; TOPICAL RETIN-A AB + VALEANT INTL AB + TRETINOIN PRECISION DERMAT AB AB AVITA BT MYLAN ATRALIN XX + DOW PHARM SCIENCES RETIN-A MICRO XX + VALEANT INTL XX + SOLUTION; TOPICAL RETIN-A AT + VALEANT INTL TRETINOIN WOCKHARDT AT
3 - 410 (of 428)
0.1% 0.025% 0.1% 0.05% 0.05% 0.05% 0.05% 0.02% 0.0375% 0.075%
N017340 A075264 A075213 N017522 A075265 N019963 A076498 N021108 A090098 A202209
001 001 001 001 001 001 001 001 001 001 Dec 24, 1998 Dec 29, 1995 Sep 15, 2005 Aug 31, 2000 Mar 22, 2010 Oct 11, 2012 Dec 24, 1998 Dec 24, 1998
0.01% 0.025% 0.01% 0.025% 0.025% 0.05% 0.04% 0.1%
N017955 N017579 A075589 A075529 N020400 N022070 N020475 N020475
001 002 001 001 001 001 002 001 Jun 11, 2002 Feb 22, 2000 Jan 29, 1998 Jul 26, 2007 May 10, 2002 Feb 07, 1997
0.05% 0.05%
N016921 A075260
001 001 Jan 25, 1999
TRIAMCINOLONE ACETONIDE
CREAM; TOPICAL KENALOG AT + APOTHECON AT + TRIACET TEVA AT AT TRIAMCINOLONE ACETONIDE FOUGERA PHARMS AT AT AT + G AND W LABS AT PERRIGO NEW YORK AT AT AT TARO AT AT AT AT VINTAGE AT AT
0.025% 0.1% 0.025% 0.5% 0.025% 0.1% 0.5% 0.025% 0.025% 0.1% 0.5% 0.025% 0.1% 0.1% 0.5% 0.025% 0.1%
N011601 N011601 A084908 A084908 A085692 A085692 A085692 A089797 A086415 A086414 A086413 A086277 A040039 A086276 A086275 A040671 A040671
003 006 001 003 001 003 002 001 001 001 001 001 001 001 001 001 002
May 31, 1991
Nov 26, 1997
Jun 09, 2006 Jun 09, 2006

CREAM; TOPICAL TRIDERM CROWN LABS INJECTABLE; INJECTION KENALOG-10 APOTHECON KENALOG-40 + APOTHECON TRIAMCINOLONE ACETONIDE SANDOZ
3 - 411 (of 428)
AT
0.1%
A088042
001
Mar 19, 1984
AB AB AB AB
10MG/ML 40MG/ML
N012041 N014901 A090166 A090164
001 001 001 001 May 27, 2009 May 27, 2009
10MG/ML 40MG/ML INJECTABLE; INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL

TRIVARIS
8MG/0.1ML (8MG/0.1ML) XX + ALLERGAN INJECTABLE; INTRAVITREAL
TRIESENCE
40MG/ML (40MG/ML) XX + ALCON LOTION; TOPICAL TRIAMCINOLONE ACETONIDE FOUGERA PHARMS AT 0.025% AT 0.1% AT + MORTON GROVE 0.025% TARO AT 0.1% VINTAGE AT 0.1% AT + WOCKHARDT 0.1% OINTMENT; TOPICAL KENALOG APOTHECON AT 0.025% AT 0.1% TRIAMCINOLONE ACETONIDE FOUGERA PHARMS AT 0.025% AT 0.1% AT 0.5% AT + PERRIGO NEW YORK 0.025% AT + 0.1% AT + 0.5% TARO AT 0.025% AT 0.025% AT 0.1% AT 0.1% AT 0.5% TRIAMCINOLONE ACETONIDE IN ABSORBASE 0.05% XX + CAROLINA MEDCL PASTE; DENTAL TRIAMCINOLONE ACETONIDE LYNE AT 0.1% AT + TARO 0.1% SPRAY; TOPICAL
KENALOG
0.147MG/GM XX + RANBAXY SPRAY, METERED; NASAL
NASACORT AQ AB + SANOFI AVENTIS US 0.055MG/SPRAY TRIAMCINOLONE ACETONIDE TEVA PHARMS AB 0.055MG/SPRAY
N022220
001
Jun 16, 2008
N022048
001
Nov 29, 2007
A040467 A040467 A088450 A089129 A040672 A088451
001 002 001 001 002 001
Apr Apr Apr Aug Dec Apr
21, 21, 01, 14, 13, 03,
2003 2003 1985 1986 2006 1985
N011600 N011600 A085691 A085691 A085691 A087356 A087357 A087385 A040040 A040374 A040037 A087902 A040386 A089595
003 001 001 003 002 001 001 001 001 001 001 001 001 001
Sep Jun Sep Dec Jun
30, 05, 30, 27, 05,
1994 2001 1994 1982 2001
Mar 23, 1995
A040771 A070730
001 001
Jul 01, 2010 Oct 01, 1986
N012104
001
N020468 A078104
001 001
May 20, 1996 Jul 30, 2009
TRIAMCINOLONE HEXACETONIDE
ARISTOSPAN
XX + SANDOZ XX +
5MG/ML 20MG/ML
N016466 N016466
001 002

TRIAMTERENE
CAPSULE; ORAL DYRENIUM XX WELLSPRING PHARM XX +
3 - 412 (of 428)
50MG 100MG
N013174 N013174
001 002
TRIAZOLAM
TABLET; ORAL HALCION PHARMACIA AND UPJOHN AB AB + TRIAZOLAM MYLAN PHARMS INC AB AB ROXANE AB AB WATSON LABS AB AB
0.125MG 0.25MG 0.125MG 0.25MG 0.125MG 0.25MG 0.125MG 0.25MG
N017892 N017892 A074031 A074031 A074224 A074224 A074445 A074445
003 001 001 002 001 002 001 002
Apr 26, 1985 Nov 15, 1982 Mar Mar Jun Jun Oct Oct 25, 25, 01, 01, 20, 20, 1994 1994 1994 1994 1995 1995
TRIENTINE HYDROCHLORIDE
CAPSULE; ORAL SYPRINE XX + ATON
250MG
N019194
001
Nov 08, 1985
TRIFLUOPERAZINE HYDROCHLORIDE
TABLET; ORAL TRIFLUOPERAZINE HYDROCHLORIDE MYLAN AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 5MG BASE AB + EQ 10MG BASE SANDOZ AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 5MG BASE AB EQ 10MG BASE
A040209 A040209 A040209 A040209 A085785 A085786 A085789 A085788
001 002 003 004 001 001 001 001
Jul Jul Jul Jul
07, 07, 07, 07,
1997 1997 1997 1997
TRIFLURIDINE
SOLUTION/DROPS; OPHTHALMIC TRIFLURIDINE ALCON PHARMS LTD AT 1% VIROPTIC AT + MONARCH PHARMS 1%
A074311 N018299
001 001
Oct 06, 1995
TRIHEXYPHENIDYL HYDROCHLORIDE
ELIXIR; ORAL TRIHEXYPHENIDYL HYDROCHLORIDE MIKART AA 2MG/5ML AA + PHARM ASSOC 2MG/5ML TABLET; ORAL TRIHEXYPHENIDYL HYDROCHLORIDE NATCO PHARMA LTD AA 2MG AA 5MG VINTAGE PHARMS AA 2MG AA 5MG WATSON LABS AA 2MG AA + 2MG AA 5MG AA + 5MG WEST WARD AA 2MG AA 5MG
A040251 A040177
001 001
Sep 27, 1999 Apr 17, 1997
A091630 A091630 A040254 A040254 A040184 A084363 A040184 A084364 A040337 A040337
001 002 001 002 001 001 002 001 002 001
Nov Nov Dec Dec Feb
17, 17, 24, 24, 06,
2010 2010 1998 1998 1998
Feb 06, 1998 Feb 16, 2000 Feb 16, 2000

TRIMETHADIONE
TABLET; ORAL TRIDIONE XX + ABBVIE
3 - 413 (of 428)
150MG
N005856
009
TRIMETHOBENZAMIDE HYDROCHLORIDE
CAPSULE; ORAL TIGAN + KING PHARMS 300MG TRIMETHOBENZAMIDE HYDROCHLORIDE GAVIS PHARMS 300MG MUTUAL PHARMA 300MG INJECTABLE; INJECTION TIGAN + JHP PHARMS 100MG/ML TRIMETHOBENZAMIDE HYDROCHLORIDE LUITPOLD 100MG/ML TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE LUITPOLD 100MG/ML
AB AB AB
N017531 A076546 A076570
006 001 001
Dec 13, 2001 Aug 20, 2003 Aug 28, 2003
AP AP AP
N017530 A091330 A091329
001 001 001 Mar 08, 2011 Mar 08, 2011
TRIMETHOPRIM
TABLET; ORAL TRIMETHOPRIM NOVEL LABS INC TEVA WATSON LABS TRIMETHOPRIM + TEVA
AB AB AB XX
100MG 100MG 100MG 200MG
A091437 N018679 A070049 A071259
001 001 001 001
Jun 15, 2011 Jul 30, 1982 Jun 06, 1985 Jun 18, 1987
TRIMETHOPRIM HYDROCHLORIDE
SOLUTION; ORAL
PRIMSOL
XX + FSC
EQ 50MG BASE/5ML
N074973
001
Jan 24, 2000
TRIMIPRAMINE MALEATE
CAPSULE; ORAL SURMONTIL ODYSSEY PHARMS AB AB AB + TRIMIPRAMINE MALEATE MIKAH PHARMA AB AB AB
N016792 N016792 N016792 A077361 A077361 A077361
001 002 003 001 002 003
Sep 15, 1982 Aug 02, 2006 Aug 02, 2006 Aug 02, 2006
TRIPTORELIN PAMOATE
TRELSTAR
XX + WATSON LABS EQ 3.75MG BASE/VIAL XX + EQ 11.25MG BASE/VIAL XX + EQ 22.5MG BASE/VIAL
N020715 N021288 N022437
001 001 001
Jun 15, 2000 Jun 29, 2001 Mar 10, 2010
TROMETHAMINE
THAM
XX + HOSPIRA
3.6GM/100ML
N013025
002
TROPICAMIDE
SOLUTION/DROPS; OPHTHALMIC MYDRIACYL AT + ALCON 0.5% AT + 1%
A084305 A084306
001 001

TROPICAMIDE
SOLUTION/DROPS; OPHTHALMIC TROPICACYL AKORN AT 0.5% AT 1% TROPICAMIDE BAUSCH AND LOMB AT 0.5% AT 1%
3 - 414 (of 428)
A040314 A040315 A040067 A040064
001 001 001 001
Sep 29, 2000 Sep 29, 2000 Jul 27, 1994 Jul 27, 1994
TROSPIUM CHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL SANCTURA XR + ALLERGAN 60MG TROSPIUM CHLORIDE WATSON LABS INC FL 60MG TABLET; ORAL SANCTURA + ALLERGAN 20MG TROSPIUM CHLORIDE APOTEX 20MG GLENMARK GENERICS 20MG PADDOCK LLC 20MG
AB AB
N022103 A091289
001 001
Aug 03, 2007 Oct 12, 2012
AB AB AB AB
N021595 A091513 A091575 A091573
001 001 001 001
May 28, 2004 Dec 06, 2011 Aug 13, 2010 Nov 17, 2010
TRYPAN BLUE
SOLUTION; OPHTHALMIC
MEMBRANEBLUE
XX + DORC VISIONBLUE XX + DORC
0.15% 0.06%
N022278 N021670
001 001
Feb 20, 2009 Dec 16, 2004
ULIPRISTAL ACETATE
TABLET; ORAL
ELLA
XX + LAB HRA PHARMA
30MG
N022474
001
Aug 13, 2010
UNOPROSTONE ISOPROPYL
SOLUTION/DROPS; OPHTHALMIC RESCULA XX SUCAMPO PHARMS 0.15%
N021214
001
Aug 03, 2000
UREA C-13
FOR SOLUTION; ORAL
BREATHTEK UBT FOR H-PYLORI
EQ 75MG /POUCH XX + OTSUKA AMERICA
N020586
002
May 10, 2001
UREA, C-14
CAPSULE; ORAL
PYTEST
XX + AVENT PYTEST KIT XX + AVENT
1uCi 1uCi
N020617 N020617
001 002
May 09, 1997 May 09, 1997
UROFOLLITROPIN
INJECTABLE; INTRAMUSCULAR, SUBCUTANEOUS
BRAVELLE
XX + FERRING 75 IU/VIAL
N021289
001
May 06, 2002
URSODIOL
CAPSULE; ORAL ACTIGALL AB + WATSON PHARMS
300MG
N019594
002
Dec 31, 1987

URSODIOL
CAPSULE; ORAL URSODIOL COREPHARMA EPIC PHARMA LANNETT MYLAN TEVA PHARMS
3 - 415 (of 428)
AB AB AB AB AB
300MG 300MG 300MG 300MG 300MG
A077895 A075517 A079082 A090530 A075592
001 001 001 001 001
Jul Mar Dec Feb May
27, 14, 15, 17, 25,
2006 2000 2008 2010 2000
TABLET; ORAL URSO 250 APTALIS PHARMA US AB URSO FORTE AB + APTALIS PHARMA US URSODIOL GLENMARK GENERICS AB AB TEVA PHARMS AB AB WATSON LABS INC AB AB
N020675 N020675 A090801 A090801 A079184 A079184 A200826 A200826
001 002 001 002 001 002 001 002
Dec 10, 1997 Jul 21, 2004 Jul Jul May May Dec Dec 12, 12, 13, 13, 23, 23, 2011 2011 2009 2009 2011 2011
VALACYCLOVIR HYDROCHLORIDE
TABLET; ORAL VALACYCLOVIR HYDROCHLORIDE ACTAVIS PHARMA EQ EQ AUROBINDO PHARMA EQ EQ DR REDDYS LABS LTD EQ EQ JUBILANT ORGANOSYS EQ EQ MYLAN EQ EQ MYLAN PHARMS INC EQ EQ RANBAXY EQ EQ ROXANE EQ EQ SANDOZ EQ EQ TEVA PHARMS EQ EQ WATSON LABS EQ EQ WOCKHARDT EQ EQ VALTREX GLAXOSMITHKLINE EQ + EQ
500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE
A090370 A090370 A090682 A090682 A079012 A079012 A201506 A201506 A078070 A078070 A078518 A078518 A076588 A076588 A078656 A078656 A077478 A077478 A077655 A077655 A077135 A077135 A090216 A090216 N020487 N020487
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Mar Mar May May May May Apr Apr May May May May Jan Jan May May May May May May May May May May
16, 16, 24, 24, 24, 24, 03, 03, 24, 24, 24, 24, 31, 31, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24,
2011 2011 2010 2010 2010 2010 2012 2012 2010 2010 2010 2010 2007 2007 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
Jun 23, 1995 Jun 23, 1995
VALGANCICLOVIR HYDROCHLORIDE
FOR SOLUTION; ORAL
VALCYTE
XX + HOFFMANN LA ROCHE TABLET; ORAL
VALCYTE
50MG/ML
N022257
001
Aug 28, 2009
EQ 450MG BASE
N021304
001
Mar 29, 2001

VALPROATE SODIUM
INJECTABLE; INJECTION DEPACON + ABBVIE VALPROATE SODIUM BEDFORD FRESENIUS KABI USA HIKMA FARMACEUTICA
3 - 416 (of 428)
AP AP AP AP
EQ 100MG BASE/ML EQ 100MG BASE/ML EQ 100MG BASE/ML EQ 100MG BASE/ML
N020593 A076295 A076539 A078523
001 001 001 001
Dec 30, 1996 Nov 14, 2002 Jun 26, 2003 Feb 17, 2010
VALPROIC ACID
CAPSULE; ORAL DEPAKENE AB + ABBVIE VALPROIC ACID BANNER PHARMACAPS AB CATALENT AB CAPSULE, DELAYED RELEASE; STAVZOR BANNER PHARMACAPS XX XX XX + SYRUP; ORAL DEPAKENE + ABBVIE VALPROIC ACID ALPHARMA HIGH TECH PHARMA PHARM ASSOC SUN PHARM INDS INC TEVA PHARMS VINTAGE WOCKHARDT
250MG 250MG 250MG ORAL 125MG 250MG 500MG
N018081 A073484 A073229
001 001 001 Jun 29, 1993 Oct 29, 1991
N022152 N022152 N022152
001 002 003
Jul 29, 2008 Jul 29, 2008 Jul 29, 2008
AA AA AA AA AA AA AA AA
N018082 A075782 A074060 A075379 A090517 A073178 A077960 A070868
001 001 001 001 001 001 001 001 Dec Jan Dec May Aug Oct Jul 22, 13, 15, 28, 25, 13, 01, 2000 1995 2000 2010 1992 2006 1986
VALRUBICIN
SOLUTION; INTRAVESICAL
VALSTAR PRESERVATIVE FREE
XX + ENDO PHARM 40MG/ML
N020892
001
Sep 25, 1998
VALSARTAN
TABLET; ORAL DIOVAN XX NOVARTIS XX XX XX +
40MG 80MG 160MG 320MG
N021283 N021283 N021283 N021283
004 001 002 003
Aug Jul Jul Jul
14, 18, 18, 18,
2002 2001 2001 2001
VANCOMYCIN HYDROCHLORIDE
CAPSULE; ORAL VANCOCIN HYDROCHLORIDE VIROPHARMA EQ + EQ VANCOMYCIN HYDROCHLORIDE AKORN EQ EQ FRESENIUS KABI USA EQ EQ STRIDES ARCOLAB LTD EQ EQ WATSON LABS EQ EQ
125MG BASE 250MG BASE 125MG 250MG 125MG 250MG 125MG 250MG 125MG 250MG BASE BASE BASE BASE BASE BASE BASE BASE
N050606 N050606 A065478 A065478 A065453 A065453 A065490 A065490 A065510 A065510
001 002 001 002 001 002 001 002 001 002
Apr 15, 1986 Apr 15, 1986 Apr Apr Jun Jun Apr Apr Apr Apr 09, 09, 18, 18, 09, 09, 09, 09, 2012 2012 2012 2012 2012 2012 2012 2012

INJECTABLE; INJECTION VANCOMYCIN HYDROCHLORIDE BIONICHE PHARMA USA EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL + FRESENIUS KABI USA EQ 500MG BASE/VIAL + EQ 1GM BASE/VIAL + EQ 5GM BASE/VIAL + EQ 10GM BASE/VIAL + HOSPIRA EQ 500MG BASE/VIAL + EQ 500MG BASE/VIAL EQ 750MG BASE/VIAL EQ 750MG BASE/VIAL + EQ 1GM BASE/VIAL + EQ 1GM BASE/VIAL + EQ 5GM BASE/VIAL HOSPIRA INC EQ 10GM BASE/VIAL PFIZER EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL SAGENT PHARMS EQ 5GM BASE/VIAL SANDOZ EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL SANDOZ INC EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL STRIDES ARCOLAB LTD EQ 10GM BASE/VIAL VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER + BAXTER HLTHCARE EQ 500MG BASE/100ML + EQ 750MG BASE/150ML
3 - 417 (of 428)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX
001 002 001 002 003 004 001 001 002 002 001 001 001 001 001 002 001 001 001 001 002 001 002 001 001 002
Jun Jun Mar Jul Jun Nov Aug Oct Jan May Aug Oct Dec Apr Dec Dec Dec Jul Aug Apr Apr Aug Aug Sep
30, 30, 17, 31, 03, 28, 04, 29, 07, 27, 04, 29, 21, 29, 30, 30, 30, 01, 10, 27, 27, 10, 10, 19,
2008 2008 1987 1987 1988 1997 1988 1992 2009 2009 1988 1992 1990 2009 2008 2008 2008 2011 2012 2010 2010 2012 2012 2011
Apr 29, 1993 Dec 20, 2010
VANDETANIB
TABLET; ORAL CAPRELSA XX IPR PHARMS INC XX +
100MG 300MG
N022405 N022405
001 002
Apr 06, 2011 Apr 06, 2011
VARDENAFIL HYDROCHLORIDE
TABLET; ORAL LEVITRA BAYER HLTHCARE AB 2.5MG AB 5MG AB 10MG AB + 20MG VARDENAFIL HYDROCHLORIDE TEVA PHARMS AB 2.5MG AB 5MG AB 10MG AB 20MG TABLET, ORALLY DISINTEGRATING; ORAL
STAXYN
10MG XX + BAYER HLTHCARE
N021400 N021400 N021400 N021400 A091347 A091347 A091347 A091347
003 001 002 004 001 002 003 004
Aug Aug Aug Aug May May May May
19, 19, 19, 19, 03, 03, 03, 03,
2003 2003 2003 2003 2012 2012 2012 2012
N200179
001
Jun 17, 2010
VARENICLINE TARTRATE
TABLET; ORAL CHANTIX XX PFIZER INC XX +
N021928 N021928
001 002
May 10, 2006 May 10, 2006

VECURONIUM BROMIDE
INJECTABLE; INJECTION VECURONIUM BROMIDE BEDFORD AP AP HOSPIRA AP AP MUSTAFA NEVZAT AP AP PFIZER AP AP AP + SUN PHARMA GLOBAL AP + TEVA PARENTERAL AP AP WATSON LABS AP AP
3 - 418 (of 428)
10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL
A075549 A075549 A075164 A075164 A078274 A078274 A090243 A090243 A079001 A079001 A074688 A074688 A074334 A074334
001 002 001 002 001 002 001 002 001 002 001 002 001 002
Jun Jun Oct Oct Dec Dec May May Jun Jun Aug Aug Aug Aug
13, 13, 21, 21, 29, 29, 11, 11, 17, 17, 25, 25, 31, 31,
2000 2000 1999 1999 2008 2008 2010 2010 2009 2009 1999 1999 1995 1995
VELAGLUCERASE ALFA
INJECTABLE; IV (INFUSION) VPRIV SHIRE HUMAN GENETIC 400 UNITS/VIAL XX
N022575
001
Feb 26, 2010
VEMURAFENIB
TABLET; ORAL
ZELBORAF
240MG
N202429
001
Aug 17, 2011
VENLAFAXINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL EFFEXOR XR WYETH PHARMS INC EQ 37.5MG BASE EQ 75MG BASE + EQ 150MG BASE VENLAFAXINE HYDROCHLORIDE ANCHEN PHARMS EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE AUROBINDO PHARMA LTD EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE DR REDDYS LABS LTD EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE MYLAN EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE ORCHID HLTHCARE EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE TEVA EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE TORRENT PHARMS LLC EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE VALEANT INTL EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE WOCKHARDT EQ 37.5MG BASE EQ 75MG BASE
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
N020699 N020699 N020699 A078087 A078087 A078087 A200834 A200834 A200834 A078421 A078421 A078421 A078789 A078789 A078789 A091123 A091123 A091123 A076565 A076565 A076565 A090899 A090899 A090899 A090071 A090071 A090071 A078865 A078865
001 002 004 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002
Oct 20, 1997 Oct 20, 1997 Oct 20, 1997 Mar Mar Mar Apr Apr Apr May May May Jun Jun Jun Jul Jul Jul Jun Jun Jun Jun Jun Jun Apr Apr Apr Apr Apr 16, 16, 16, 14, 14, 14, 06, 06, 06, 01, 01, 01, 11, 11, 11, 28, 28, 28, 01, 01, 01, 15, 15, 15, 14, 14, 2012 2012 2012 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2010 2010 2010 2011 2011 2011 2011 2011 2011 2011 2011

CAPSULE, EXTENDED RELEASE; ORAL VENLAFAXINE HYDROCHLORIDE WOCKHARDT EQ 150MG BASE ZYDUS PHARMS USA INC EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE TABLET; ORAL VENLAFAXINE HYDROCHLORIDE ALEMBIC PHARMS LTD EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE AMNEAL PHARMS EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE AUROBINDO PHARMA EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE CARACO EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE DR REDDYS LABS LTD EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE HERITAGE PHARMS INC EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE MYLAN EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE TEVA EQ 25MG BASE EQ 37.5MG BASE + EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE VINTAGE EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE ZYDUS PHARMS USA EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE
3 - 419 (of 428)
AB AB AB AB
A078865 A090174 A090174 A090174
003 001 002 003
Apr Apr Apr Apr
14, 14, 14, 14,
2011 2011 2011 2011
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005
Dec Dec Dec Dec Dec May May May May May Apr Apr Apr Apr Apr Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jan Jan Jan Jan Jan Jun Jun Jun Jun Jun Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Jun Jun Jun Jun Jun
14, 14, 14, 14, 14, 11, 11, 11, 11, 11, 07, 07, 07, 07, 07, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 09, 09, 09, 09, 09, 13, 13, 13, 13, 13, 03, 03, 03, 03, 03, 04, 04, 04, 04, 04, 13, 13, 13, 13, 13,
2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2009 2009 2009 2009 2009 2008 2008 2008 2008 2008 2006 2006 2006 2006 2006 2010 2010 2010 2010 2010 2008 2008 2008 2008 2008

TABLET, EXTENDED RELEASE; ORAL VENLAFAXINE HYDROCHLORIDE OSMOTICA PHARM EQ 37.5MG BASE EQ 75MG BASE + EQ 150MG BASE SUN PHARMA GLOBAL EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE VENLAFAXINE HYDROCHLORIDE OSMOTICA PHARM EQ 225MG BASE
3 - 420 (of 428)
N022104 N022104 N022104 A091272 A091272 A091272 N022104
001 002 003 001 002 003 004
May May May Aug Aug Aug
20, 20, 20, 18, 18, 18,
2008 2008 2008 2010 2010 2010
May 20, 2008
VERAPAMIL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL VERAPAMIL HYDROCHLORIDE MYLAN 100MG 120MG 180MG 200MG 240MG 300MG VERELAN ALKERMES GAINESVILLE 120MG 180MG 240MG VERELAN PM ELAN DRUG 100MG 200MG + 300MG VERELAN + ALKERMES GAINESVILLE 360MG
AB AB AB AB AB AB AB AB AB AB AB AB XX
A078306 A075138 A075138 A078306 A075138 A078306 N019614 N019614 N019614 N020943 N020943 N020943 N019614
001 001 002 002 003 003 001 003 002 001 002 003 004
Aug Apr Apr Aug Apr Aug
09, 20, 20, 09, 20, 09,
2007 1999 1999 2007 1999 2007
May 29, 1990 Jan 09, 1992 May 29, 1990 Nov 25, 1998 Nov 25, 1998 Nov 25, 1998 May 10, 1996
INJECTABLE; INJECTION VERAPAMIL HYDROCHLORIDE HOSPIRA AP AP AP INTL MEDICATION AP TABLET; ORAL CALAN GD SEARLE LLC AB AB AB + VERAPAMIL HYDROCHLORIDE MYLAN AB AB WATSON LABS AB AB AB AB AB AB AB AB TABLET, EXTENDED RELEASE; CALAN SR AB + PFIZER AB + AB + VERAPAMIL HYDROCHLORIDE APOTEX CORP AB AB
A070737 A070738 A075136 A070451
001 001 001 001
May May Oct Dec
06, 06, 20, 16,
1987 1987 1998 1985
40MG 80MG 120MG 80MG 120MG 40MG 40MG 80MG 80MG 80MG 120MG 120MG 120MG ORAL 120MG 180MG 240MG 120MG 180MG
N018817 N018817 N018817 A071482 A071483 A072923 A072924 A070855 A070995 A071366 A070856 A070994 A071367
003 001 002 001 001 001 001 001 001 001 001 001 001
Feb 23, 1988 Sep 10, 1984 Sep 10, 1984 Feb Feb Jun Jun Sep Oct Oct Sep Oct Oct 15, 15, 29, 29, 24, 01, 01, 24, 01, 01, 1989 1989 1993 1993 1986 1986 1986 1986 1986 1986
N019152 N019152 N019152 A200878 A200878
003 002 001 001 002
Mar 06, 1991 Dec 15, 1989 Dec 16, 1986 Apr 20, 2012 Apr 20, 2012

TABLET, EXTENDED RELEASE; ORAL VERAPAMIL HYDROCHLORIDE APOTEX CORP AB 240MG GLENMARK GENERICS AB 120MG AB 180MG AB 240MG IVAX SUB TEVA PHARMS 120MG AB AB 180MG AB 240MG MYLAN AB 120MG AB 180MG AB 240MG PAR PHARM AB 120MG AB 240MG SUN PHARM INDS INC AB 120MG AB 180MG AB 240MG COVERA-HS BC + GD SEARLE LLC 180MG BC + 240MG
3 - 421 (of 428)
003 001 002 001 002 001 001 002 003 001 001 003 001 002 003 001 002
Apr Aug Aug Sep Oct Jan Jul Feb Sep Mar May May Dec Dec Dec
20, 03, 03, 17, 10, 31, 31, 21, 09, 23, 25, 25, 30, 30, 30,
2012 2011 2011 2009 1997 1994 1992 1997 1997 1996 1999 1999 2011 2011 2011
Feb 26, 1996 Feb 26, 1996
VERTEPORFIN
VISUDYNE
XX + QLT
15MG/VIAL
N021119
001
Apr 12, 2000
VIGABATRIN
FOR SOLUTION; ORAL
SABRIL
XX + LUNDBECK LLC TABLET; ORAL
SABRIL
XX + LUNDBECK LLC
500MG/PACKET
N022006
001
Aug 21, 2009
500MG
N020427
001
Aug 21, 2009
VILAZODONE HYDROCHLORIDE
TABLET; ORAL
VIIBRYD
XX + FOREST LABS INC XX XX
10MG 20MG 40MG
N022567 N022567 N022567
001 002 003
Jan 21, 2011 Jan 21, 2011 Jan 21, 2011
VINBLASTINE SULFATE
VINBLASTINE SULFATE
XX + BEDFORD XX + FRESENIUS KABI USA
10MG/VIAL 1MG/ML
A089395 A089515
001 001
Apr 09, 1987 Apr 29, 1987
VINCRISTINE SULFATE
INJECTABLE; INJECTION VINCRISTINE SULFATE PFS AP + HOSPIRA 1MG/ML TEVA PARENTERAL AP 1MG/ML INJECTABLE, LIPOSOMAL; INTRAVENOUS
MARQIBO KIT
5MG/5ML (1MG/ML) XX + TALON THERAP
A071484 A075493
001 001
Apr 19, 1988 Sep 01, 1999
N202497
001
Aug 09, 2012
VINORELBINE
INJECTABLE; INJECTION VINORELBINE ONCO THERAPIES LTD AP
EQ 10MG BASE/ML
A200148
001
Aug 31, 2012

VINORELBINE TARTRATE
INJECTABLE; INJECTION NAVELBINE + PIERRE FABRE VINORELBINE TARTRATE ACTAVIS TOTOWA BEDFORD EBEWE PHARMA FRESENIUS KABI USA HIKMA MAPLE HOSPIRA JIANGSU HANSOH PHARM TEVA PARENTERAL
3 - 422 (of 428)
EQ 10MG BASE/ML EQ EQ EQ EQ EQ EQ EQ EQ 10MG 10MG 10MG 10MG 10MG 10MG 10MG 10MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
N020388 A078011 A076461 A078408 A076849 A075992 A076827 A091106 A076028
001 001 001 001 001 001 001 001 001
Dec 23, 1994 Jul Dec Feb Apr Jun Jun Sep Feb 22, 11, 13, 18, 10, 02, 26, 03, 2009 2003 2008 2005 2003 2005 2012 2003
VISMODEGIB
CAPSULE; ORAL ERIVEDGE XX + GENENTECH
150MG
N203388
001
Jan 30, 2012
VITAMIN A PALMITATE
INJECTABLE; INJECTION AQUASOL A XX + HOSPIRA
EQ 50,000 UNITS BASE/ML
N006823
001
VORICONAZOLE
FOR SUSPENSION; ORAL VFEND 200MG/5ML XX + PFIZER INJECTABLE; IV (INFUSION) VFEND 200MG/VIAL AP + PFIZER VORICONAZOLE SANDOZ INC 200MG/VIAL AP TABLET; ORAL VFEND PFIZER 50MG AB 200MG AB + VORICONAZOLE MYLAN PHARMS INC 50MG AB 200MG AB SANDOZ INC 50MG AB 200MG AB TEVA PHARMS 50MG AB 200MG AB
N021630
001
Dec 19, 2003
N021267 A090862
001 001
May 24, 2002 May 30, 2012
N021266 N021266 A090547 A090547 A200265 A200265 A091658 A091658
001 002 001 002 001 002 001 002
May 24, 2002 May 24, 2002 Apr Apr Dec Dec Apr Apr 22, 22, 12, 12, 06, 06, 2010 2010 2011 2011 2012 2012
VORINOSTAT
CAPSULE; ORAL ZOLINZA XX + MERCK
100MG
N021991
001
Oct 06, 2006
WARFARIN SODIUM
INJECTABLE; INJECTION COUMADIN XX + BRISTOL MYERS SQUIBB TABLET; ORAL COUMADIN BRISTOL MYERS SQUIBB AB AB AB AB AB AB
5MG/VIAL
N009218
024
Feb 07, 1995
1MG 2MG 2.5MG 3MG 4MG 5MG
N009218 N009218 N009218 N009218 N009218 N009218
022 013 018 025 023 007
Mar 01, 1990
Nov 18, 1996 Aug 24, 1993

WARFARIN SODIUM
TABLET; ORAL COUMADIN BRISTOL MYERS SQUIBB AB AB AB + JANTOVEN USL PHARMA AB AB AB AB AB AB AB AB AB WARFARIN SODIUM BARR AB AB AB AB AB AB AB AB AB INVAGEN PHARMS AB AB AB AB AB AB AB AB AB MYLAN AB AB AB AB AB AB AB AB AB PLIVA AB AB AB AB AB AB AB AB AB TARO AB AB AB AB AB AB AB AB
3 - 423 (of 428)
6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG
N009218 N009218 N009218 A040416 A040416 A040416 A040416 A040416 A040416 A040416 A040416 A040416 A040145 A040145 A040145 A040145 A040145 A040145 A040145 A040145 A040145 A090935 A090935 A090935 A090935 A090935 A090935 A090935 A090935 A090935 A040415 A040415 A040415 A040415 A040415 A040415 A040415 A040415 A040415 A040616 A040616 A040616 A040616 A040616 A040616 A040616 A040616 A040616 A040301 A040301 A040301 A040301 A040301 A040301 A040301 A040301
026 016 005 001 002 003 004 005 006 007 008 009 001 002 003 008 004 005 009 006 007 001 002 003 004 005 006 007 008 009 001 002 003 004 005 006 007 008 009 009 001 002 003 004 005 006 007 008 002 003 004 005 006 007 008 009
Nov 18, 1996
Oct Oct Oct Oct Oct Oct Oct Oct Oct Mar Mar Mar Nov Mar Mar Nov Mar Mar May May May May May May May May May Sep Sep Sep Sep Sep Sep Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
02, 02, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 05, 26, 26, 05, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 27, 27, 29, 27, 27, 27, 27, 27, 27, 05, 05, 05, 05, 05, 05, 05, 05, 05, 15, 15, 15, 15, 15, 15, 15, 15,
2003 2003 2003 2003 2003 2003 2003 2003 2003 1997 1997 1997 1998 1997 1997 1998 1997 1997 2011 2011 2011 2011 2011 2011 2011 2011 2011 2004 2004 2004 2004 2004 2004 2004 2004 2004 2006 2006 2006 2006 2006 2006 2006 2006 2006 1999 1999 1999 1999 1999 1999 1999 1999

WARFARIN SODIUM
TABLET; ORAL WARFARIN SODIUM TARO AB ZYDUS PHARMS USA AB AB AB AB AB AB AB AB AB
3 - 424 (of 428)
10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG
A040301 A040663 A040663 A040663 A040663 A040663 A040663 A040663 A040663 A040663
001 001 002 003 004 005 006 007 008 009
Jul May May May May May May May May May
15, 30, 30, 30, 30, 30, 30, 30, 30, 30,
1999 2006 2006 2006 2006 2006 2006 2006 2006 2006
XENON XE-133
GAS; INHALATION XENON XE 133 LANTHEUS MEDCL AA XENON XE 133 LANTHEUS MEDCL XX
20mCi/VIAL 10mCi/VIAL
N017284 N017284
002 001
ZAFIRLUKAST
TABLET; ORAL ACCOLATE ASTRAZENECA AB AB + ZAFIRLUKAST DR REDDYS LABS LTD AB AB
10MG 20MG 10MG 20MG
N020547 N020547 A090372 A090372
003 001 001 002
Sep 17, 1999 Sep 26, 1996 Nov 18, 2010 Nov 18, 2010
ZALEPLON
CAPSULE; ORAL SONATA KING PHARMS AB AB + ZALEPLON AUROBINDO PHARMA AB AB CIPLA LTD AB AB MYLAN AB AB ORCHID HLTHCARE AB AB ROXANE AB AB TEVA PHARMS AB AB UNICHEM AB AB UPSHER SMITH AB AB WEST WARD AB AB
N020859 N020859 A078829 A078829 A077505 A077505 A077238 A077238 A090374 A090374 A077237 A077237 A077239 A077239 A078989 A078989 A078706 A078706 A078147 A078147
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Aug 13, 1999 Aug 13, 1999 Jun Jun Jun Jun Jun Jun Sep Sep Jun Jun Jun Jun Jun Jun Jun Jun Nov Nov 06, 06, 20, 20, 06, 06, 17, 17, 06, 06, 06, 06, 06, 06, 06, 06, 25, 25, 2008 2008 2008 2008 2008 2008 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
ZANAMIVIR
POWDER; INHALATION RELENZA XX + GLAXOSMITHKLINE
5MG
N021036
001
Jul 26, 1999

ZICONOTIDE ACETATE
PRIALT
XX + JAZZ PHARMS INTL XX + XX +
3 - 425 (of 428)
100MCG/1ML (100MCG/ML) 500MCG/5ML (100MCG/ML) 500MCG/20ML (25MCG/ML)
N021060 N021060 N021060
002 004 001
Dec 28, 2004 Dec 28, 2004 Dec 28, 2004
ZIDOVUDINE
CAPSULE; ORAL RETROVIR AB + VIIV HLTHCARE ZIDOVUDINE AUROBINDO PHARMA LTD AB CIPLA LTD AB INJECTABLE; INJECTION RETROVIR AP + VIIV HLTHCARE ZIDOVUDINE LUITPOLD AP SYRUP; ORAL RETROVIR AA + VIIV HLTHCARE ZIDOVUDINE AUROBINDO AA CIPLA LTD AA TABLET; ORAL RETROVIR + VIIV HLTHCARE ZIDOVUDINE AUROBINDO CIPLA HEC PHARM USA INC HETERO DRUGS LTD MYLAN PHARMS INC ROXANE
100MG 100MG 100MG
N019655 A078128 A078349
001 001 001
Mar 19, 1987 Mar 27, 2006 May 23, 2007
10MG/ML 10MG/ML
N019951 A091457
001 001
Feb 02, 1990 May 06, 2010
N019910 A077268 A077981
001 001 001
Sep 28, 1989 Sep 19, 2005 Jun 26, 2008
300MG 300MG 300MG 300MG 300MG 300MG 300MG
N020518 A077267 A090561 A202058 A090092 A078922 A076844
002 001 001 001 001 001 001
Oct 04, 1996 Sep Oct Oct Apr Feb Sep 19, 27, 07, 25, 14, 19, 2005 2010 2011 2008 2008 2005
ZILEUTON
TABLET; ORAL
ZYFLO
XX + CORNERSTONE THERAP
600MG
N020471
003
Dec 09, 1996

ZYFLO CR
XX + CORNERSTONE THERAP 600MG
N022052
001
May 30, 2007
ZINC ACETATE
CAPSULE; ORAL GALZIN TEVA XX XX +
EQ 25MG ZINC EQ 50MG ZINC
N020458 N020458
001 002
Jan 28, 1997 Jan 28, 1997
ZINC CHLORIDE
ZINC CHLORIDE IN PLASTIC CONTAINER
XX + HOSPIRA EQ 1MG ZINC/ML
N018959
001
Jun 26, 1986
ZIPRASIDONE HYDROCHLORIDE
CAPSULE; ORAL GEODON AB + PFIZER AB AB AB
EQ EQ EQ EQ
20MG 40MG 60MG 80MG
BASE BASE BASE BASE
N020825 N020825 N020825 N020825
001 002 003 004
Feb Feb Feb Feb
05, 05, 05, 05,
2001 2001 2001 2001

CAPSULE; ORAL ZIPRASIDONE HYDROCHLORIDE APOTEX CORP EQ EQ EQ EQ DR REDDYS LABS INC EQ EQ EQ EQ LUPIN PHARMS EQ EQ EQ EQ SANDOZ INC EQ EQ EQ EQ WOCKHARDT LTD EQ EQ EQ EQ SUSPENSION; ORAL
GEODON
+ PFIZER INC EQ
3 - 426 (of 428)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Jun Jun Jun Jun Sep Sep Sep Sep
02, 02, 02, 02, 02, 02, 02, 02, 02, 02, 02, 02, 01, 01, 01, 01, 05, 05, 05, 05,
2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012
XX
10MG BASE/ML
N021483
001
Mar 29, 2006
ZIPRASIDONE MESYLATE
GEODON
XX + PFIZER EQ 20MG BASE/ML
N020919
001
Jun 21, 2002
ZOLEDRONIC ACID
RECLAST
XX + NOVARTIS EQ 5MG BASE/100ML ZOMETA XX + NOVARTIS EQ 4MG BASE/5ML XX + EQ 4MG BASE/100ML
N021817 N021223 N021223
001 002 003
Apr 16, 2007 Mar 07, 2003 Jun 17, 2011
ZOLMITRIPTAN
SPRAY; NASAL
ZOMIG
XX + ASTRAZENECA TABLET; ORAL ZOMIG XX IPR XX +
5MG/SPRAY
N021450
004
Sep 30, 2003
2.5MG 5MG
N020768 N020768
001 002
Nov 25, 1997 Nov 25, 1997
TABLET, ORALLY DISINTEGRATING; ORAL ZOMIG-ZMT XX ASTRAZENECA 2.5MG XX + 5MG
N021231 N021231
001 002
Feb 13, 2001 Sep 17, 2001
ZOLPIDEM TARTRATE
SPRAY, METERED; ORAL
ZOLPIMIST
XX + NOVADEL TABLET; ORAL AMBIEN SANOFI AVENTIS US AB AB +
5MG/SPRAY
N022196
001
Dec 19, 2008
5MG 10MG
N019908 N019908
001 002
Dec 16, 1992 Dec 16, 1992

ZOLPIDEM TARTRATE
TABLET; ORAL ZOLPIDEM TARTRATE APOTEX INC AB AB AUROBINDO PHARMA AB AB CARACO AB AB CARLSBAD AB AB CIPLA LTD AB AB DR REDDYS LABS LTD AB AB HIKMA AB AB INVAGEN PHARMS AB AB LEK PHARMS DD AB AB MYLAN AB AB RANBAXY AB AB ROXANE AB AB TEVA AB AB TORRENT PHARMS AB AB VINTAGE AB AB WATSON LABS AB AB WOCKHARDT AB AB TABLET; SUBLINGUAL EDLUAR MEDA PHARMS XX XX + INTERMEZZO PURDUE PHARMA XX XX + TABLET, EXTENDED RELEASE; AMBIEN CR SANOFI AVENTIS US AB AB + ZOLPIDEM TARTRATE ACTAVIS S ATLANTIC AB AB ANCHEN PHARMS AB AB SANDOZ AB AB SYNTHON PHARMS AB AB
3 - 427 (of 428)
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG
A077884 A077884 A078413 A078413 A077359 A077359 A077990 A077990 A077388 A077388 A077985 A077985 A078129 A078129 A078184 A078184 A077322 A077322 A076578 A076578 A078055 A078055 A077214 A077214 A076410 A076410 A077903 A077903 A078616 A078616 A077773 A077773 A078426 A078426
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Apr Apr May May Apr Apr Apr Apr Jul Jul Apr Apr Apr Apr Sep Sep Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Aug Aug Nov Nov Apr Apr May May
23, 23, 04, 04, 23, 23, 23, 23, 30, 30, 23, 23, 30, 30, 07, 07, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 17, 17, 21, 21, 23, 23, 15, 15,
2007 2007 2007 2007 2007 2007 2007 2007 2012 2012 2007 2007 2008 2008 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2007 2007 2007 2007
5MG 10MG 1.75MG 3.5MG ORAL 6.25MG 12.5MG 6.25MG 12.5MG 6.25MG 12.5MG 6.25MG 12.5MG 6.25MG 12.5MG
N021997 N021997 N022328 N022328
001 002 001 002
Mar 13, 2009 Mar 13, 2009 Nov 23, 2011 Nov 23, 2011
N021774 N021774 A078179 A078179 A078148 A078148 A090107 A090107 A078483 A078483
002 001 002 001 002 001 001 002 001 002
Sep 02, 2005 Sep 02, 2005 Oct Jun Apr Dec Jul Jul Apr Jun 13, 06, 14, 03, 01, 01, 12, 06, 2010 2011 2011 2010 2011 2011 2011 2011

ZONISAMIDE
CAPSULE; ORAL ZONEGRAN EISAI INC AB AB AB + ZONISAMIDE APOTEX INC AB AB AB BANNER PHARMACAPS AB AB AB BARR AB AB AB COREPHARMA AB AB AB DR REDDYS LABS LTD AB AB AB GLENMARK GENERICS AB AB AB INVAGEN PHARMS AB AB AB MYLAN AB AB AB MYLAN PHARMS INC AB AB AB SANDOZ AB AB AB SUN PHARM INDS (IN) AB AB AB WOCKHARDT AB AB AB ZYDUS PHARMS USA AB AB AB
3 - 428 (of 428)
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
N020789 N020789 N020789 A077642 A077642 A077642 A077813 A077813 A077813 A077639 A077639 A077639 A077876 A077876 A077876 A077645 A077645 A077645 A077651 A077651 A077651 A077869 A077869 A077869 A077637 A077637 A077637 A077647 A077647 A077647 A077644 A077644 A077644 A077634 A077634 A077634 A077636 A077636 A077636 A077625 A077625 A077625
003 002 001 001 002 003 001 002 003 001 002 003 001 002 003 002 003 001 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 003 002 001 001 002 003
Aug 22, 2003 Aug 22, 2003 Mar 27, 2000 Dec Dec Dec Aug Aug Aug Dec Dec Dec Feb Feb Feb Sep Sep Dec Jan Jan Jan May May May Dec Dec Dec Dec Dec Dec Dec Dec Dec Mar Mar Mar Jul Jul Dec Oct Oct Oct 22, 22, 22, 16, 16, 16, 22, 22, 22, 21, 21, 21, 29, 29, 22, 30, 30, 30, 31, 31, 31, 22, 22, 22, 22, 22, 22, 22, 22, 22, 17, 17, 17, 27, 27, 22, 16, 16, 16, 2005 2005 2005 2006 2006 2006 2005 2005 2005 2007 2007 2007 2006 2006 2005 2006 2006 2006 2006 2006 2006 2005 2005 2005 2005 2005 2005 2005 2005 2005 2006 2006 2006 2006 2006 2005 2006 2006 2006
OTC DRUG PRODUCT LIST

ACETAMINOPHEN
SUPPOSITORY; RECTAL ACEPHEN G AND W LABS
4 - 1 (of 20)
120MG 325MG 325MG 650MG 650MG 120MG 325MG 650MG 120MG 650MG 80MG 120MG ORAL 650MG 650MG 650MG 650MG 650MG
N018060 A072344 N018060 A072237 N018060 N018337 N018337 N018337 A070607 A070608
001 001 003 001 002 003 002 001 001 001
Mar 27, 1992 Dec 18, 1986 Mar 27, 1992
ACETAMINOPHEN ACTAVIS MID ATLANTIC + PERRIGO NEW YORK INFANTS' FEVERALL ACTAVIS MID ATLANTIC NEOPAP POLYMEDICA TABLET, EXTENDED RELEASE; ACETAMINOPHEN OHM LABS PERRIGO RANBAXY LABS LTD TYLENOL (CAPLET) + MCNEIL CONS TYLENOL (GELTAB) + MCNEIL CONS
Sep 12, 1983
Apr 06, 1987 Dec 01, 1986 Aug 26, 1992
N018337 004 N016401 001
A076200 001 A075077 001 A078569 001 N019872 001 N019872 002
Mar 19, 2002 Feb 25, 2000 Dec 14, 2011 Jun 08, 1994 Jan 11, 2001
ACETAMINOPHEN; ASPIRIN; CAFFEINE

TABLET; ORAL ACETAMINOPHEN, ASPIRIN AND CAFFEINE PERRIGO 250MG;250MG;65MG EXCEDRIN (MIGRAINE) + NOVARTIS 250MG;250MG;65MG
A075794 001 N020802 001
Nov 26, 2001 Jan 14, 1998
ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE

TABLET; ORAL
TAVIST ALLERGY/SINUS/HEADACHE
+ NOVARTIS 500MG;EQ 0.25MG BASE;30MG
N021082 001
Mar 01, 2001
ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE

DRIXORAL PLUS
+ SCHERING PLOUGH 500MG;3MG;60MG
N019453 001
May 22, 1987
ALCOHOL; CHLORHEXIDINE GLUCONATE

SOLUTION; TOPICAL
AVAGARD
+ 3M
61%;1%
N021074 001
Jun 07, 2001
ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE

TABLET, CHEWABLE; ORAL FOAMCOAT GUARDIAN DRUG GAVISCON SANOFI AVENTIS US +
80MG;20MG 80MG;20MG 160MG;40MG
A071793 001 N018685 001 N018685 002
Sep 04, 1987 Dec 09, 1983 Dec 09, 1983
AVOBENZONE; ECAMSULE; OCTOCRYLENE

CREAM; TOPICAL
ANTHELIOS SX
+ LOREAL USA CAPITAL SOLEIL 15 + LOREAL USA
2%;2%;10% 2%;3%;10%
N021502 001 N021501 001
Jul 21, 2006 Oct 02, 2006

AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
CREAM; TOPICAL
ANTHELIOS 20
+ LOREAL USA ANTHELIOS 40 + LOREAL USA +
4 - 2 (of 20)
2%;2%;10%;2% 2%;3%;10%;5% 2%;3%;10%;5%
N021471 001 N022009 001 N022009 002
Oct 05, 2006 Mar 31, 2008 Oct 29, 2009
AVOBENZONE; OCTINOXATE; OXYBENZONE

LOTION; TOPICAL
SHADE UVAGUARD
+ SCHERING PLOUGH
3%;7.5%;3%
N020045 001
Dec 07, 1992
BENTOQUATAM
LOTION; TOPICAL
IVY BLOCK
+ STAND HOMEOPATH
5%
N020532 001
Aug 26, 1996
BUTENAFINE HYDROCHLORIDE
CREAM; TOPICAL
LOTRIMIN ULTRA
+ SCHERING PLOUGH
1%
N021307 001
Dec 07, 2001
CREAM; VAGINAL
FEMSTAT 3
+ BAYER
2%
N020421 001
Dec 21, 1995
CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE

TABLET, CHEWABLE; ORAL CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE PERRIGO R AND D 800MG;10MG;165MG PEPCID COMPLETE + MCNEIL CONS 800MG;10MG;165MG
A077355 001 N020958 001
Feb 06, 2008 Oct 16, 2000
CAPSULE; ORAL CETIRIZINE HYDROCHLORIDE ALLERGY BANNER PHARMACAPS 5MG + 10MG CETIRIZINE HYDROCHLORIDE HIVES RELIEF BANNER PHARMACAPS 5MG + 10MG SYRUP; ORAL CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY AMNEAL PHARMS 5MG/5ML APOTEX 5MG/5ML AUROBINDO PHARMA 5MG/5ML CYPRESS PHARM 5MG/5ML DR REDDYS LABS LTD 5MG/5ML PERRIGO R AND D 5MG/5ML SILARX 5MG/5ML SUN PHARM INDS INC 5MG/5ML TARO 5MG/5ML 5MG/5ML TRIS PHARMA INC 5MG/5ML CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF AMNEAL PHARMS 5MG/5ML APOTEX 5MG/5ML AUROBINDO PHARMA 5MG/5ML CYPRESS PHARM 5MG/5ML DR REDDYS LABS LTD 5MG/5ML PERRIGO R AND D 5MG/5ML SILARX 5MG/5ML
N022429 001 N022429 004 N022429 003 N022429 002
Jul 23, 2009 Jul 23, 2009 Jul 23, 2009 Jul 23, 2009
002 002 002 001 002 002 001 001 002 001 001 001 001 001 002 001 001 002
Oct Apr Feb Oct Mar Apr Apr Oct Apr May Nov Oct Apr Feb Oct Mar Apr Apr
07, 22, 02, 10, 30, 09, 22, 17, 22, 20, 16, 07, 22, 02, 10, 30, 09, 22,
2009 2008 2010 2008 2009 2008 2011 2011 2008 2011 2012 2009 2008 2010 2008 2009 2008 2011

SYRUP; ORAL CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF SUN PHARM INDS INC 5MG/5ML TARO 5MG/5ML 5MG/5ML TRIS PHARMA INC 5MG/5ML CHILDREN'S ZYRTEC ALLERGY + MCNEIL CONSUMER 5MG/5ML CHILDREN'S ZYRTEC HIVES RELIEF + MCNEIL CONSUMER 5MG/5ML TABLET, CHEWABLE; ORAL CETIRIZINE HYDROCHLORIDE ALLERGY CARACO 5MG 10MG SANDOZ 5MG 10MG CETIRIZINE HYDROCHLORIDE HIVES RELIEF CARACO 5MG 10MG CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY SUN PHARMA GLOBAL 5MG 10MG CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF SUN PHARMA GLOBAL 5MG 10MG CHILDREN'S ZYRTEC ALLERGY MCNEIL CONS 5MG + 10MG CHILDREN'S ZYRTEC HIVES RELIEF MCNEIL CONS 5MG + 10MG TABLET, ORALLY DISINTEGRATING; ORAL ZYRTEC ALLERGY + MCNEIL CONSUMER 10MG TABLET; ORAL CETIRIZINE HYDROCHLORIDE ALLERGY AMNEAL PHARMS NY 5MG 10MG APOTEX INC 5MG 10MG CADISTA PHARMS 5MG 10MG CARACO 5MG 10MG CONTRACT PHARMA 5MG 10MG DR REDDYS LABS LTD 5MG 10MG MYLAN 5MG 10MG ORCHID HLTHCARE 5MG 10MG PERRIGO R AND D 5MG 10MG RANBAXY 5MG 10MG SANDOZ 5MG 10MG TARO 5MG 5MG TORRENT PHARMS LLC 5MG 10MG UNICHEM 5MG 10MG
4 - 3 (of 20)
A091327 A090182 A201546 A090572
002 001 002 002
Oct Apr May Nov
17, 22, 20, 16,
2011 2008 2011 2012
N022155 002 N022155 001
Nov 16, 2007 Nov 16, 2007
A077631 A077631 A078692 A078692
004 003 001 002
Jan Jan Feb Feb
11, 11, 14, 14,
2008 2008 2008 2008
A077631 001 A077631 002 A090142 001 A090142 002 A090142 003 A090142 004 N021621 003 N021621 004 N021621 005 N021621 006
Jan 11, 2008 Jan 11, 2008 Aug 30, 2011 Aug 30, 2011 Aug 30, 2011 Aug 30, 2011 Nov 16, 2007 Nov 16, 2007 Nov 16, 2007 Nov 16, 2007
N022578 001
Sep 03, 2010
001 004 001 002 001 002 001 002 001 002 004 003 001 002 001 002 001 002 001 002 001 002 001 003 001 004 003 004
Jan Jan Dec Dec Jun Jun Dec Dec Dec Dec Jan Jan Dec Dec Feb Feb Dec Dec Dec Dec Dec Dec Jul Jul Apr Apr Jun Jun
21, 21, 27, 27, 15, 15, 27, 27, 27, 27, 15, 15, 27, 27, 19, 19, 27, 27, 27, 27, 27, 27, 22, 22, 15, 15, 26, 26,
2010 2010 2007 2007 2010 2010 2007 2007 2007 2007 2008 2008 2007 2007 2009 2009 2007 2007 2007 2007 2007 2007 2009 2009 2010 2010 2009 2009

TABLET; ORAL CETIRIZINE HYDROCHLORIDE ALLERGY UNIQUE PHARM LABS 5MG 10MG WOCKHARDT 5MG 10MG CETIRIZINE HYDROCHLORIDE HIVES CADISTA PHARMS 5MG 10MG CARACO 5MG 10MG DR REDDYS LABS LTD 5MG 10MG MYLAN 5MG 10MG ORCHID HLTHCARE 5MG 10MG PERRIGO R AND D 5MG 10MG RANBAXY 5MG 10MG UNICHEM 5MG 10MG UNIQUE PHARM LABS 5MG 10MG CETIRIZINE HYDROCHLORIDE HIVES RELIEF AMNEAL PHARMS NY 5MG 10MG TARO 10MG 10MG TORRENT PHARMS LLC 5MG 10MG ZYRTEC ALLERGY MCNEIL CONSUMER 5MG + 10MG ZYRTEC HIVES RELIEF MCNEIL CONSUMER 5MG + 10MG
4 - 4 (of 20)
001 004 003 004 003 004 003 004 001 002 004 003 003 004 003 004 003 004 001 002 003 002 003 002 002 004 003 002
Aug Aug Dec Dec Jun Jun Dec Dec Jan Jan Dec Dec Feb Feb Dec Dec Dec Dec Jun Jun Aug Aug Jan Jan Jul Jul Apr Apr
26, 26, 28, 28, 15, 15, 27, 27, 15, 15, 27, 27, 19, 19, 27, 27, 27, 27, 26, 26, 26, 26, 21, 21, 22, 22, 15, 15,
2009 2009 2007 2007 2010 2010 2007 2007 2008 2008 2007 2007 2009 2009 2007 2007 2007 2007 2009 2009 2009 2009 2010 2010 2009 2009 2010 2010
N019835 003 N019835 004 N019835 005 N019835 006
Nov 16, 2007 Nov 16, 2007 Nov 16, 2007 Nov 16, 2007
CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE IVAX SUB TEVA PHARMS 5MG;120MG SANDOZ 5MG;120MG SUN PHARM INDS LTD 5MG;120MG ZYRTEC-D 12 HOUR + MCNEIL 5MG;120MG
A077170 001 A077991 001 A090922 001 N021150 002
Feb 25, 2008 Mar 05, 2008 Sep 28, 2012 Nov 09, 2007
AEROSOL, METERED; TOPICAL
EXIDINE
+ XTTRIUM CLOTH; TOPICAL CHLORHEXIDINE GLUCONATE + SAGE PRODS SOLUTION; TOPICAL BRIAN CARE SOAPCO CHG SCRUB ECOLAB CIDA-STAT ECOLAB
4%
N019127 001
Dec 24, 1984
2%
N021669 001
Apr 25, 2005
4% 4% 2%
A071419 001 N019258 002 N019258 001
Dec 17, 1987 Jul 22, 1986 Jul 22, 1986

SOLUTION; TOPICAL DYNA-HEX XTTRIUM EXIDINE + XTTRIUM HIBICLENS + MOLNLYCKE HLTH HIBISTAT
+ MOLNLYCKE HLTH SPONGE; TOPICAL BIOSCRUB GRIFFEN CHLORHEXIDINE GLUCONATE BECTON DICKINSON PHARMASEAL SCRUB CARE + CAREFUSION
4 - 5 (of 20)
0.75% 2% 4% 4% 0.5%
N020111 001 N019422 001 N019125 001 N017768 001

N018300 001
Sep 11, 1997 Dec 17, 1985 Dec 24, 1984
4% 4% 4%
N019822 001 A072525 001 N019793 001
Mar 31, 1989 Oct 24, 1989 Dec 02, 1988
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL

SPONGE; TOPICAL
CHLORAPREP ONE-STEP
+ CAREFUSION 2%;70% (3ML) + 2%;70% (10.5ML) + 2%;70% (26ML) CHLORAPREP ONE-STEP FREPP + CAREFUSION 2%;70% (1.5ML) CHLORAPREP WITH TINT + CAREFUSION 2%;70% (26ML) + 2%;70% (10.5ML) + 2%;70% (3ML) SWAB; TOPICAL
CHLORAPREP ONE-STEP SEPP
+ CAREFUSION 2%;70% (0.67ML) CHLORAPREP SINGLE SWABSTICK + CAREFUSION 2%;70% (1.75ML) CHLORAPREP TRIPLE SWABSTICK + CAREFUSION 2%;70% (5.25ML) CHLORASCRUB MAXI SWABSTICK + PROF DSPLS 3.15%;70% (5.1ML) CHLORASCRUB SWAB + PROF DSPLS 3.15%;70% (1ML) CHLORASCRUB SWABSTICK + PROF DSPLS 3.15%;70% (1.6ML)
N020832 001 N020832 004 N020832 006 N020832 003 N020832 002 N020832 005 N020832 007
Jul 14, 2000 Aug 20, 2003 Nov 21, 2006 Apr 26, 2002 May 03, 2005 Apr 03, 2006 Oct 10, 2006
N021555 001 N021555 002 N021555 003 N021524 003 N021524 001 N021524 002
Oct 07, 2002 May 10, 2005 Jun 10, 2009 Jun 03, 2005 Jun 03, 2005 Jun 03, 2005
CHLORPHENIRAMINE MALEATE
TABLET, EXTENDED RELEASE; ORAL CHLORPHENIRAMINE MALEATE AVANTHI INC 12MG CHLOR-TRIMETON + SCHERING PLOUGH 12MG
A040829 001 N007638 002
May 13, 2009
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE

TABLET; ORAL
ADVIL ALLERGY AND CONGESTION RELIEF
+ PFIZER 4MG;200MG;10MG
N022113 001
Dec 21, 2011
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

SUSPENSION; ORAL
CHILDREN'S ADVIL ALLERGY SINUS
+ PFIZER 1MG/5ML;100MG/5ML;15MG/5ML TABLET; ORAL
ADVIL ALLERGY SINUS
+ PFIZER 2MG;200MG;30MG
N021587 001
Feb 24, 2004
N021441 001
Dec 19, 2002

CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
CHLOR-TRIMETON
+ SCHERING PLOUGH 8MG;120MG
4 - 6 (of 20)
N018397 001
CIMETIDINE
TABLET; ORAL CIMETIDINE APOTEX CONTRACT PHARMACAL IVAX SUB TEVA PHARMS PERRIGO WATSON LABS TAGAMET HB + GLAXOSMITHKLINE
A074948 A074948 A074961 A074963 A075345 A075285 A075425
001 002 001 001 001 001 001
Jun Jul Jun Jun Jun Oct Jul
19, 26, 19, 19, 16, 29, 29,
1998 2002 1998 1998 1999 1998 1999
N020238 002
Aug 21, 1996
CLEMASTINE FUMARATE
TABLET; ORAL CLEMASTINE FUMARATE PERRIGO SANDOZ TAVIST-1 + NOVARTIS
1.34MG 1.34MG 1.34MG
A074512 001 A073458 001 N020925 001
Nov 22, 1995 Oct 31, 1993 Aug 21, 1992
CLOTRIMAZOLE
CREAM, TABLET; TOPICAL, VAGINAL
GYNE-LOTRIMIN 3 COMBINATION PACK
+ SCHERING PLOUGH 1%,200MG GYNE-LOTRIMIN COMBINATION PACK + SCHERING PLOUGH 1%,100MG MYCELEX-7 COMBINATION PACK BAYER PHARMS 1%,100MG CREAM; VAGINAL CLOTRIMAZOLE ACTAVIS MID ATLANTIC 1% TARO 1% GYNE-LOTRIMIN + SCHERING PLOUGH 1% GYNE-LOTRIMIN 3 + SCHERING PLOUGH 2% MYCELEX-7 BAYER PHARMS 1% TRIVAGIZOLE 3 TARO 2% TABLET; VAGINAL
GYNE-LOTRIMIN
+ SCHERING PLOUGH 100MG GYNE-LOTRIMIN 3 + SCHERING PLOUGH 200MG MYCELEX-7 BAYER PHARMS 100MG
N020526 002 N020289 002 N020389 002
Jul 29, 1996 Apr 26, 1993 Jun 23, 1994
A074165 001 A072641 001 N018052 002 N020574 001 N018230 002 N021143 001
Jul 16, 1993 Dec 04, 1995 Nov 30, 1990 Nov 24, 1998 Dec 26, 1991 Apr 12, 2000
N017717 002 N020525 001 N018182 002
Nov 30, 1990 Jul 29, 1996 Dec 26, 1991
CROMOLYN SODIUM
CROMOLYN SODIUM
+ BAUSCH AND LOMB PERRIGO
5.2MG/SPRAY 5.2MG/SPRAY
A075702 001 A075427 001
Jul 03, 2001 Dec 12, 2001
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE

TABLET, EXTENDED RELEASE; ORAL DISOPHROL SCHERING PLOUGH 6MG;120MG
N013483 004
Sep 13, 1982

TABLET, EXTENDED RELEASE; ORAL DRIXORAL + SCHERING PLOUGH 6MG;120MG
4 - 7 (of 20)
N013483 003
Sep 13, 1982
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN

TABLET, EXTENDED RELEASE; ORAL MUCINEX DM RECKITT BENCKISER 30MG;600MG + 60MG;1.2GM
N021620 002 N021620 001
Apr 29, 2004 Apr 29, 2004
DEXTROMETHORPHAN POLISTIREX
SUSPENSION, EXTENDED RELEASE; ORAL DELSYM + RECKITT BENCKISER EQ 30MG HBR/5ML DEXTROMETHORPHAN POLISTIREX TRIS PHARMA INC EQ 30MG HBR/5ML
N018658 001 A091135 001
Oct 08, 1982 May 25, 2012
DIPHENHYDRAMINE CITRATE; IBUPROFEN

TABLET; ORAL ADVIL PM + PFIZER 38MG;200MG IBUPROFEN AND DIPHENHYDRAMINE CITRATE DR REDDYS LABS LTD 38MG;200MG PERRIGO R AND D 38MG;200MG
N021394 001 A090619 001 A079113 001
Dec 21, 2005 Jul 08, 2009 Dec 22, 2008
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN

CAPSULE; ORAL ADVIL PM + PFIZER
25MG;EQ 200MG FREE ACID AND POTASSIUM SALT IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE BANNER PHARMACAPS 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT STRIDES ARCOLAB LTD 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT
N021393 001
Dec 21, 2005
A090397 001 A200888 001
Nov 22, 2010 Mar 05, 2012
DOCOSANOL
CREAM; TOPICAL ABREVA + GLAXOSMITHKLINE
10%
N020941 001
Jul 25, 2000
DOXYLAMINE SUCCINATE
TABLET; ORAL DOXYLAMINE SUCCINATE LNK PERRIGO UNISOM + CHATTEM
25MG 25MG 25MG
A040564 001 A040167 001 N018066 001
Aug 27, 2004 Sep 18, 1996
EPINEPHRINE
AEROSOL, METERED; INHALATION EPINEPHRINE ARMSTRONG PHARMS 0.2MG/INH
A087907 001
May 23, 1984
FAMOTIDINE
TABLET, CHEWABLE; ORAL FAMOTIDINE PERRIGO PEPCID AC + MCNEIL CONS TABLET; ORAL FAMOTIDINE DR REDDYS LABS LTD
10MG 20MG
A075715 001 N020801 002
Aug 22, 2003 Dec 17, 2007
10MG
A075758 001
Aug 17, 2001

FAMOTIDINE
TABLET; ORAL FAMOTIDINE DR REDDYS LABS LTD IVAX SUB TEVA PHARMS MYLAN PERRIGO RANBAXY TEVA WATSON LABS WOCKHARDT PEPCID AC MCNEIL CONS + PEPCID AC (GELTAB) MCNEIL CONS
4 - 8 (of 20)
A077367 A075512 A075674 A075400 A077351 A090283 A090283 A075312 A075404 A077146 A090837
001 001 001 001 001 001 002 001 001 001 001
Sep Jul Dec Mar Sep Nov Nov May Nov Mar Aug
25, 26, 21, 18, 25, 17, 17, 31, 28, 07, 04,
2006 2001 2001 2005 2006 2009 2009 2001 2001 2005 2010
N020325 001 N020325 002 N020902 001
Apr 28, 1995 Sep 23, 2003 Aug 05, 1999
SUSPENSION; ORAL
CHILDREN'S ALLEGRA ALLERGY
+ SANOFI AVENTIS US 30MG/5ML CHILDREN'S ALLEGRA HIVES + SANOFI AVENTIS US 30MG/5ML TABLET, ORALLY DISINTEGRATING; ORAL
CHILDREN'S ALLEGRA ALLERGY
+ SANOFI AVENTIS US 30MG CHILDREN'S ALLEGRA HIVES + SANOFI AVENTIS US 30MG TABLET; ORAL ALLEGRA ALLERGY SANOFI AVENTIS US 60MG + 180MG ALLEGRA HIVES SANOFI AVENTIS US 60MG + 180MG CHILDREN'S ALLEGRA ALLERGY SANOFI AVENTIS US 30MG CHILDREN'S ALLEGRA HIVES SANOFI AVENTIS US 30MG CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY DR REDDYS LABS LTD 30MG MYLAN 30MG SUN PHARM INDS 30MG TEVA 30MG WOCKHARDT LTD 30MG CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES DR REDDYS LABS LTD 30MG MYLAN 30MG SUN PHARM INDS 30MG TEVA 30MG WOCKHARDT LTD 30MG FEXOFENADINE HYDROCHLORIDE ALLERGY DR REDDYS LABS LTD 60MG 180MG MYLAN 60MG 180MG SUN PHARM INDS 60MG 180MG TEVA 60MG 180MG WOCKHARDT LTD 60MG
N201373 001 N201373 002
Jan 24, 2011 Jan 24, 2011
N021909 002 N021909 003
Jan 24, 2011 Jan 24, 2011
N020872 007 N020872 010 N020872 008 N020872 009 N020872 005 N020872 006 A076502 A077081 A091567 A076447 A079112 A076502 A077081 A091567 A076447 A079112 A076502 A076502 A077081 A077081 A091567 A091567 A076447 A076447 A079112 004 004 002 004 002 005 005 001 005 001 006 008 006 008 004 006 006 008 004
Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Apr Jul Feb Apr Feb Apr Jul Feb Apr Feb Apr Apr Jul Jul Feb Feb Apr Apr Feb 12, 21, 06, 13, 08, 12, 21, 06, 13, 08, 12, 12, 21, 21, 06, 06, 13, 13, 08, 2011 2011 2012 2011 2012 2011 2011 2012 2011 2012 2011 2011 2011 2011 2012 2012 2011 2011 2012

TABLET; ORAL FEXOFENADINE HYDROCHLORIDE ALLERGY WOCKHARDT LTD 180MG FEXOFENADINE HYDROCHLORIDE HIVES DR REDDYS LABS LTD 60MG 180MG MYLAN 60MG 180MG SUN PHARM INDS 60MG 180MG TEVA 60MG 180MG WOCKHARDT LTD 60MG 180MG
4 - 9 (of 20)
A079112 006 A076502 A076502 A077081 A077081 A091567 A091567 A076447 A076447 A079112 A079112 007 009 007 009 003 005 007 009 003 005
Feb 08, 2012 Apr Apr Jul Jul Feb Feb Apr Apr Feb Feb 12, 12, 21, 21, 06, 06, 13, 13, 08, 08, 2011 2011 2011 2011 2012 2012 2011 2011 2012 2012
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
+ SANOFI AVENTIS US 60MG;120MG ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION + SANOFI AVENTIS US 180MG;240MG FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE DR REDDYS LABS LTD 180MG;240MG
N020786 002 N021704 002 A079043 002
Jan 24, 2011 Jan 24, 2011 Jun 22, 2011
GUAIFENESIN
TABLET, EXTENDED RELEASE; GUAIFENESIN PERRIGO R AND D MUCINEX RECKITT BENCKISER + ORAL 600MG 600MG 1.2GM A078912 001 N021282 001 N021282 002 Nov 23, 2011 Jul 12, 2002 Dec 18, 2002
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL MUCINEX D RECKITT BENCKISER 600MG;60MG + 1.2GM;120MG
N021585 001 N021585 002
Jun 22, 2004 Jun 22, 2004
IBUPROFEN
CAPSULE; ORAL
ADVIL LIQUI-GELS
+ PFIZER EQ 200MG FREE ADVIL MIGRAINE LIQUI-GELS + PFIZER EQ 200MG FREE IBUPROFEN AMNEAL PHARMS EQ 200MG FREE BANNER PHARMACAPS EQ 200MG FREE + CONTRACT PHARMACAL 200MG MARKSANS PHARMA EQ 200MG FREE PLD ACQUISITIONS EQ 200MG FREE MIDOL LIQUID GELS + BANNER PHARMACAPS 200MG SUSPENSION/DROPS; ORAL
CHILDREN'S MOTRIN
+ MCNEIL CONS 40MG/ML IBUPROFEN PERRIGO 40MG/ML TRIS PHARMA INC 40MG/ML PEDIATRIC ADVIL + PFIZER 100MG/2.5ML SUSPENSION; ORAL CHILDREN'S ADVIL PFIZER 100MG/5ML
ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT
N020402 001 N020402 002 A202300 A078682 A074782 A079205 A077338 001 001 001 001 001
Apr 20, 1995 Mar 16, 2000 Dec Mar Jul Jun Jul 23, 24, 06, 26, 10, 2011 2009 1998 2009 2009
N021472 001
Oct 18, 2002
N020603 001 A075217 001 A079058 001 N020812 001
Jun 10, 1996 Dec 16, 1998 Aug 31, 2009 Jan 30, 1998
N020589 001
Jun 27, 1996

IBUPROFEN
SUSPENSION; ORAL CHILDREN'S ADVIL-FLAVORED PFIZER 100MG/5ML CHILDREN'S ELIXSURE ALTERNA TCHP LLC 100MG/5ML CHILDREN'S IBUPROFEN PERRIGO 100MG/5ML CHILDREN'S MOTRIN + MCNEIL 100MG/5ML IBUPROFEN ACTAVIS MID ATLANTIC 100MG/5ML AMNEAL PHARMS 100MG/5ML TABLET, CHEWABLE; ORAL CHILDREN'S ADVIL PFIZER 50MG CHILDREN'S MOTRIN MCNEIL CONS 50MG IBUPROFEN PERRIGO 50MG 100MG JUNIOR STRENGTH ADVIL PFIZER 100MG JUNIOR STRENGTH MOTRIN + MCNEIL CONS 100MG TABLET; ORAL ADVIL PFIZER 200MG IBUPROFEN AMNEAL PHARMS NY 200MG 200MG AVEMA PHARMA 200MG CONTRACT PHARMACAL 200MG 200MG 200MG 200MG DR REDDYS LA 200MG DR REDDYS LABS INC 100MG GRANULES INDIA 200MG LNK 100MG 200MG 200MG MARKSANS PHARMA 200MG 200MG MCNEIL 200MG MERRO PHARM 200MG OHM 200MG PAR PHARM 200MG PERRIGO 200MG 200MG PERRIGO R AND D 200MG SVADS HOLDINGS SA 200MG 200MG VINTAGE PHARMS 200MG 200MG WATSON LABS 200MG IBUPROHM OHM LABS 200MG IBU-TAB 200 ALRA 200MG JUNIOR STRENGTH ADVIL PFIZER 100MG JUNIOR STRENGTH IBUPROFEN PERRIGO 100MG
4 - 10 (of 20)
N020589 002 N021604 001 A074937 001 N020516 001 A074916 001 A200457 001
Nov 07, 1997 Jan 07, 2004 Dec 22, 1998 Jun 16, 1995 Apr 30, 1999 Aug 18, 2011
N020944 001 N020601 001 A076359 001 A076359 002 N020944 002 N020601 003
Dec 18, 1998 Nov 15, 1996 Jan 16, 2004 Jan 16, 2004 Dec 18, 1998 Nov 15, 1996
N018989 001 A071333 A072199 A076460 A071732 A071735 A072299 A074931 A075661 A076117 A079174 A076741 A075010 A075139 A091237 A091239 A073019 A070985 A071163 A070481 A072096 A075995 A077349 A079129 A091355 A071229 A071639 A070435 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
May 18, 1984 Feb May Nov Sep Sep Jul Jul Dec Nov Dec Jun Mar Mar Feb Feb Mar Oct Jul Sep Dec Mar Jun Mar Apr Apr Feb Mar 17, 23, 26, 10, 10, 01, 20, 12, 20, 10, 17, 01, 01, 08, 01, 30, 02, 15, 24, 08, 14, 21, 28, 04, 01, 02, 05, 1987 1988 2003 1987 1987 1988 1998 2001 2001 2010 2004 1999 1999 2011 2011 1994 1987 1986 1986 1987 2002 2005 2011 2011 1987 1988 1986
A071214 001 A071057 001 N020267 002 A075367 001
Dec 01, 1986 Aug 11, 1988 Dec 13, 1996 Apr 22, 1999

IBUPROFEN
TABLET; ORAL JUNIOR STRENGTH MOTRIN MCNEIL CONS MOTRIN IB + MCNEIL MOTRIN MIGRAINE PAIN + MCNEIL PROFEN CONTRACT PHARMACAL TAB-PROFEN PERRIGO
4 - 11 (of 20)
100MG 200MG 200MG 200MG 200MG
N020602 001 N019012 003 N019012 004 A071265 001 A072095 001
Jun 10, 1996 Dec 17, 1990 Feb 25, 2000 Oct 15, 1986 Dec 08, 1987
IBUPROFEN SODIUM
TABLET; ORAL
ADVIL
+ PFIZER CONS HLTHCARE EQ 200MG BASE
N201803 001
Jun 12, 2012
IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE

TABLET; ORAL
ADVIL CONGESTION RELIEF
+ PFIZER 200MG;10MG
N022565 001
May 27, 2010
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

CAPSULE; ORAL
ADVIL COLD AND SINUS
+ PFIZER
EQ 200MG FREE ACID AND POTASSIUM SALT;30MG
N021374 001
May 30, 2002
SUSPENSION; ORAL CHILDREN'S ADVIL COLD PFIZER 100MG/5ML;15MG/5ML CHILDREN'S MOTRIN COLD + MCNEIL CONS 100MG/5ML;15MG/5ML IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE PERRIGO 100MG/5ML;15MG/5ML TABLET; ORAL
ADVIL COLD AND SINUS
+ PFIZER 200MG;30MG IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE CONTRACT PHARMACAL 200MG;30MG DR REDDYS LABS LTD 200MG;30MG IBUPROHM COLD AND SINUS OHM LABS 200MG;30MG SINE-AID IB MCNEIL CONS 200MG;30MG
N021373 001 N021128 001 A076478 001
Apr 18, 2002 Aug 01, 2000 Nov 05, 2003
N019771 001 A075588 001 A077628 001 A074567 001 N019899 001
Sep 19, 1989 Apr 08, 2002 Aug 14, 2006 Apr 17, 2001 Dec 31, 1992

HUMULIN R
+ LILLY HUMULIN R PEN + LILLY NOVOLIN R + NOVO NORDISK INC
100 UNITS/ML 100 UNITS/ML 100 UNITS/ML
N018780 001 N018780 005 N019938 001
Oct 28, 1982 Aug 06, 1998 Jun 25, 1991
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

HUMULIN 70/30
+ LILLY HUMULIN 70/30 PEN + LILLY NOVOLIN 70/30 + NOVO NORDISK INC
30 UNITS/ML;70 UNITS/ML 30 UNITS/ML;70 UNITS/ML 30 UNITS/ML;70 UNITS/ML
N019717 001 N019717 002 N019991 001
Apr 25, 1989 Aug 06, 1998 Jun 25, 1991

INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
HUMULIN N
+ LILLY NOVOLIN N + NOVO NORDISK INC
4 - 12 (of 20)
N018781 001 N019959 001
Oct 28, 1982 Jul 01, 1991
IODINE POVACRYLEX; ISOPROPYL ALCOHOL

SPONGE; TOPICAL
DURAPREP
+ 3M +
EQ 0.7% IODINE;74% (6ML) EQ 0.7% IODINE;74% (26ML)
N021586 001 N021586 002
Sep 29, 2006 Sep 29, 2006
KETOCONAZOLE
SHAMPOO; TOPICAL
NIZORAL A-D
+ MCNEIL CONS
1%
N020310 001
Oct 10, 1997
KETOPROFEN
FILM; ORAL
NEXCEDE
+ NOVARTIS
12.5MG
N022470 001
Nov 25, 2009
KETOTIFEN FUMARATE
ALAWAY
+ BAUSCH AND LOMB EQ KETOTIFEN FUMARATE AKORN EQ ALCON PHARMS LTD EQ APOTEX INC EQ ZADITOR + ALCON PHARMA EQ
0.025% BASE 0.025% BASE 0.025% BASE 0.025% BASE 0.025% BASE
N021996 001 A077958 001 A077200 001 A077354 001 N021066 002
Dec 01, 2006 Jul 26, 2007 Sep 02, 2008 May 09, 2006 Oct 19, 2006
LANSOPRAZOLE
CAPSULE, DELAYED REL PELLETS; ORAL LANSOPRAZOLE DR REDDYS LABS LTD 15MG PERRIGO R AND D 15MG WOCKHARDT LTD 15MG PREVACID 24 HR + NOVARTIS 15MG
A202194 001 A202319 001 A202727 001 N022327 001
May 18, 2012 May 18, 2012 May 18, 2012 May 18, 2009
LEVONORGESTREL
TABLET; ORAL LEVONORGESTREL PERRIGO R AND D + WATSON LABS WATSON LABS INC PLAN B + TEVA BRANDED PHARM PLAN B ONE-STEP + DURAMED
0.75MG 0.75MG 1.5MG 0.75MG 1.5MG
A090740 001 A078665 001 A200670 001 N021045 002 N021998 001
Dec 30, 2010 Aug 28, 2009 Jul 12, 2012 Aug 24, 2006 Jul 10, 2009
CAPSULE; ORAL LOPERAMIDE HYDROCHLORIDE BANNER PHARMACAPS 1MG + 2MG SOLUTION; ORAL
IMODIUM A-D
+ MCNEIL CONS 1MG/5ML LOPERAMIDE HYDROCHLORIDE HI TECH PHARMA 1MG/5ML
N021855 001 N021855 002
Aug 04, 2005 Aug 04, 2005
N019487 001 A074352 001
Mar 01, 1988 Nov 17, 1995

SOLUTION; ORAL LOPERAMIDE HYDROCHLORIDE PERRIGO 1MG/5ML ROXANE 1MG/5ML WOCKHARDT 1MG/5ML SUSPENSION; ORAL IMODIUM A-D + MCNEIL CONS 1MG/7.5ML LOPERAMIDE HYDROCHLORIDE PERRIGO R AND D 1MG/7.5ML TABLET, CHEWABLE; ORAL
IMODIUM A-D EZ CHEWS
+ MCNEIL 2MG TABLET; ORAL
IMODIUM A-D
+ MCNEIL CONS 2MG LOPERAMIDE HYDROCHLORIDE CONTRACT PHARMACAL 2MG LNK 2MG OHM LABS 2MG PERRIGO 2MG
4 - 13 (of 20)
A073243 001 A073079 001 A074730 001
Jan 21, 1992 Apr 30, 1992 Aug 28, 1997
N019487 002 A091292 001
Jul 08, 2004 May 20, 2011
N020448 001
Jul 24, 1997
N019860 001 A073254 A076497 A074091 A075232 001 001 001 001
Nov 22, 1989 Jul Jun Dec Jan 30, 10, 10, 06, 1993 2003 1992 2000
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE

IMODIUM MULTI-SYMPTOM RELIEF
+ MCNEIL 2MG;125MG LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE PERRIGO 2MG;125MG TABLET; ORAL
IMODIUM MULTI-SYMPTOM RELIEF
+ MCNEIL CONS 2MG;125MG LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE RANBAXY 2MG;125MG
N020606 001 A076029 001
Jun 26, 1996 Aug 30, 2002
N021140 001 A077500 001
Nov 30, 2000 Sep 06, 2006
LORATADINE
CAPSULE; ORAL
CLARITIN
+ SCHERING PLOUGH 10MG SUSPENSION; ORAL
LORATADINE
+ TARO 1MG/ML SYRUP; ORAL
CLARITIN
+ SCHERING PLOUGH 1MG/ML LORATADINE APOTEX INC 1MG/ML PERRIGO 1MG/ML SILARX 1MG/ML TARO 1MG/ML TEVA 1MG/ML WOCKHARDT 1MG/ML TABLET, CHEWABLE; ORAL
CHILDREN'S CLARITIN
+ SCHERING PLOUGH 5MG TABLET, ORALLY DISINTEGRATING; ORAL ALAVERT PFIZER 10MG CLARITIN HIVES RELIEF REDITAB + SCHERING PLOUGH 10MG CLARITIN REDITABS + SCHERING PLOUGH 5MG + 10MG LORATADINE IMPAX LABS 10MG
N021952 001
Jun 16, 2008
N021734 001
Oct 04, 2005
N020641 002 A075565 A075728 A077421 A076805 A075505 A075815 001 001 001 001 001 001
Nov 27, 2002 Oct Aug Jun Aug Nov Aug 05, 20, 29, 20, 07, 20, 2004 2004 2006 2004 2003 2004
N021891 001
Aug 23, 2006
N021375 001 N020704 003 N021993 001 N020704 002 A076011 001
Dec 19, 2002 Nov 19, 2003 Dec 12, 2006 Nov 27, 2002 Sep 29, 2003

LORATADINE
TABLET, ORALLY DISINTEGRATING; ORAL LORATADINE PFIZER 10MG WATSON LABS FLORIDA 10MG LORATADINE REDIDOSE RANBAXY 10MG TABLET; ORAL CLARITIN + SCHERING PLOUGH 10MG CLARITIN HIVES RELIEF + SCHERING PLOUGH 10MG LORATADINE APOTEX INC 10MG MYLAN 10MG 10MG 10MG PERRIGO 10MG RANBAXY 10MG SANDOZ 10MG
4 - 14 (of 20)
A075822 001 A075990 001 A077153 001
Feb 10, 2003 Nov 03, 2003 Apr 11, 2007
N019658 002 N019658 003 A076471 A075790 A076154 A078447 A076301 A076134 A075209 001 001 001 001 001 001 001
Nov 27, 2002 Nov 19, 2003 Feb Nov Aug Aug Jun Aug Jan 14, 07, 20, 12, 25, 18, 21, 2006 2008 2003 2011 2004 2003 2003
LORATADINE; PSEUDOEPHEDRINE SULFATE

CLARITIN-D
+ SCHERING PLOUGH 5MG;120MG CLARITIN-D 24 HOUR + SCHERING PLOUGH 10MG;240MG LORATADINE AND PSEUDOEPHEDRINE SULFATE IMPAX LABS 5MG;120MG 10MG;240MG RANBAXY 10MG;240MG WATSON LABS FLORIDA 5MG;120MG 10MG;240MG
N019670 002 N020470 002 A076050 A075989 A076557 A076208 A075706 001 001 001 001 001
Nov 27, 2002 Nov 27, 2002 Jan Mar Sep Jan Feb 30, 04, 22, 28, 21, 2003 2004 2004 2004 2003
MENTHOL; METHYL SALICYLATE

PATCH; TOPICAL
SALONPAS
+ HISAMITSU PHARM CO
3%;10% 3%;10%
N022029 001 N022029 002
Feb 20, 2008 Nov 05, 2012
MICONAZOLE NITRATE
CREAM, SUPPOSITORY; TOPICAL, VAGINAL MICONAZOLE 7 COMBINATION PACK G AND W LABS 2%,100MG MICONAZOLE NITRATE PERRIGO R AND D 2%,1.2GM MICONAZOLE NITRATE COMBINATION PACK PERRIGO 2%,200MG MONISTAT 1 COMBINATION PACK + INSIGHT PHARMS 2%,1.2GM MONISTAT 7 COMBINATION PACK + INSIGHT PHARMS 2%,100MG MONISTAT-3 COMBINATION PACK + INSIGHT PHARMS 2%,200MG M-ZOLE 3 COMBINATION PACK ACTAVIS MID ATLANTIC 2%,200MG CREAM; TOPICAL, VAGINAL MICONAZOLE 3 COMBINATION PACK PERRIGO 2%,4% MONISTAT 3 COMBINATION PACK INSIGHT PHARMS 2%,4% MONISTAT 3 COMBINATION PACK (PREFILLED) + INSIGHT PHARMS 2%,4%
A076585 001 A079114 001 A075329 001 N021308 001 N020288 002 N020670 002 A074926 001
Mar 26, 2004 Jun 02, 2010 Apr 20, 1999 Jun 29, 2001 Apr 26, 1993 Apr 16, 1996 Apr 16, 1999
A076357 001 N021261 003 N021261 001
Mar 30, 2004 Jun 17, 2003 Feb 02, 2001

MICONAZOLE NITRATE
CREAM; VAGINAL MICONAZOLE 3 TARO MICONAZOLE 7 ACTAVIS MID ATLANTIC MICONAZOLE NITRATE G AND W LABS PERRIGO PERRIGO R AND D TARO MONISTAT 3 + INSIGHT PHARMS MONISTAT 7 + INSIGHT PHARMS SUPPOSITORY; VAGINAL MICONAZOLE NITRATE ACTAVIS MID ATLANTIC G AND W LABS + PERRIGO MONISTAT 7 + INSIGHT PHARMS
4 - 15 (of 20)
4% 2% 2% 2% 4% 2% 4% 2%
A076773 001 A074164 001 A074366 A074760 A091366 A074444 001 001 001 001
Mar 02, 2005 Mar 29, 1996 Feb May Jan Jan 22, 15, 15, 13, 1996 1997 2010 1997
N020827 001 N017450 002
Mar 30, 1998 Feb 15, 1991
100MG 100MG 100MG 100MG
A073507 001 A074414 001 A074395 001 N018520 002
Nov 19, 1993 Apr 30, 1997 Mar 20, 1997 Feb 15, 1991
MINOXIDIL
MEN'S ROGAINE
+ JOHNSON AND JOHNSON 5% MINOXIDIL PERRIGO ISRAEL 5% SOLUTION; TOPICAL MINOXIDIL (FOR MEN) ACTAVIS MID ATLANTIC 2% HI TECH PHARMA 2% NOVEX 2% PERRIGO 2% WOCKHARDT 2% MINOXIDIL (FOR WOMEN) HI TECH PHARMA 2% NOVEX 2% PERRIGO 2% MINOXIDIL EXTRA STRENGTH (FOR MEN) ACTAVIS MID ATLANTIC 5% AVACOR PRODS 5% NOVEX 5% PERRIGO 5% PERRIGO NEW YORK 5% WOCKHARDT 5% ROGAINE (FOR MEN) + JOHNSON AND JOHNSON 2% ROGAINE (FOR WOMEN) + JOHNSON AND JOHNSON 2% ROGAINE EXTRA STRENGTH (FOR MEN) + JOHNSON AND JOHNSON 5% THEROXIDIL EI INC 2% 5%
N021812 001 A091344 001
Jan 20, 2006 Apr 28, 2011
A074588 A074731 A074924 A075357 A074767
001 001 001 001 001
Apr Dec Apr Jul Feb
05, 24, 29, 30, 28,
1996 1996 1998 1999 1997
A074731 002 A074924 002 A075357 002 A075518 A075619 A075839 A075598 A075737 A075438 001 001 001 001 001 001
May 11, 2005 Apr 29, 1998 Jul 30, 1999 Nov Nov Oct Jun Mar Feb 17, 17, 01, 13, 15, 27, 2000 2000 2001 2001 2002 2003
N019501 002 N019501 003 N020834 001 A078176 001 A076239 001
Feb 09, 1996 Feb 09, 1996 Nov 14, 1997 Nov 09, 2007 Aug 24, 2004
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE

SOLUTION/DROPS; OPHTHALMIC NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE ALTAIRE PHARMS INC 0.02675%;0.315% NAPHCON-A + ALCON 0.025%;0.3%
A078208 001 N020226 001
Sep 27, 2010 Jun 08, 1994

NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
OPCON-A
+ BAUSCH AND LOMB 0.02675%;0.315% VISINE-A + JOHNSON AND JOHNSON 0.025%;0.3%
4 - 16 (of 20)
N020065 001 N020485 001
Jun 08, 1994 Jan 31, 1996
NAPROXEN SODIUM
CAPSULE; ORAL
NAPROXEN SODIUM
+ BANNER PHARMACAPS TABLET; ORAL ALEVE + BAYER NAPROXEN SODIUM AMNEAL PHARMS NY CONTRACT PHARMACAL DR REDDYS LABS INC GRANULES INDIA MARKSANS PHARMA PERRIGO RANBAXY LABS LTD
EQ 200MG BASE
N021920 001
Feb 17, 2006
EQ 200MG BASE EQ EQ EQ EQ EQ EQ EQ EQ 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG BASE BASE BASE BASE BASE BASE BASE BASE
N020204 002 A079096 A074635 A074789 A075168 A091353 A090545 A074661 A091183 001 001 001 001 001 001 001 001
Jan 11, 1994 Dec Jan Feb Jul Sep Mar Jan May 16, 13, 27, 28, 20, 16, 13, 20, 2008 1997 1997 1998 2011 2011 1997 2011
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE

ALEVE-D SINUS & COLD
+ BAYER 200MG;120MG NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE DR REDDYS LABS INC EQ 220MG BASE;120MG PERRIGO EQ 200MG BASE;120MG
N021076 001 A077381 001 A076518 001
Nov 29, 1999 Sep 27, 2006 Mar 17, 2004
NICOTINE
HABITROL
+ NOVARTIS 7MG/24HR + 14MG/24HR + 21MG/24HR NICODERM CQ + SANOFI AVENTIS US 7MG/24HR + 14MG/24HR + 21MG/24HR NICOTINE AVEVA 7MG/24HR 14MG/24HR 21MG/24HR
N020076 004 N020076 005 N020076 006 N020165 006 N020165 005 N020165 004 A074612 002 A074612 003 A074612 001
Nov 12, 1999 Nov 12, 1999 Nov 12, 1999 Aug 02, 1996 Aug 02, 1996 Aug 02, 1996 Jul 28, 2003 Oct 20, 1997 Oct 20, 1997
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL
NICORETTE
+ GLAXOSMITHKLINE + NICORETTE (MINT) GLAXOSMITHKLINE NICOTINE POLACRILEX IVAX SUB TEVA PHARMS PERRIGO
EQ EQ EQ EQ
2MG 2MG 4MG 4MG
BASE BASE BASE BASE
N018612 N018612 N020066 N020066
002 004 002 004
Feb Sep Feb Sep
09, 25, 09, 25,
1996 2000 1996 2000
EQ 2MG BASE EQ 4MG BASE EQ EQ EQ EQ EQ EQ 2MG 4MG 2MG 2MG 2MG 4MG BASE BASE BASE BASE BASE BASE
N018612 003 N020066 003 A076880 A077850 A076775 A076776 A076777 A076778 001 001 001 001 001 001
Dec 23, 1998 Dec 23, 1998 Feb Feb Sep Sep Sep Sep 18, 18, 16, 16, 16, 16, 2009 2009 2004 2004 2004 2004

NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL NICOTINE POLACRILEX PERRIGO PERRIGO R AND D
4 - 17 (of 20)
WATSON LABS
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001
Sep Sep Oct May Apr Jul Oct May Apr Jul Mar Jul Dec Jul Jul Mar Jul Dec Jul Jul
16, 16, 30, 24, 23, 20, 30, 24, 23, 20, 15, 29, 29, 08, 08, 19, 29, 29, 08, 08,
2004 2004 2006 2007 2008 2011 2006 2007 2008 2011 1999 2004 2008 2009 2009 1999 2004 2008 2009 2009
THRIVE NOVARTIS TROCHE/LOZENGE; ORAL COMMIT GLAXOSMITHKLINE CONS + NICORETTE GLAXOSMITHKLINE CONS + NICOTINE POLACRILEX PERRIGO R AND D
A077658 001 A077656 001
Jun 19, 2007 Jun 19, 2007
EQ 2MG BASE EQ 4MG BASE EQ 2MG BASE EQ 4MG BASE EQ EQ EQ EQ EQ EQ EQ EQ 2MG 2MG 2MG 2MG 4MG 4MG 4MG 4MG BASE BASE BASE BASE BASE BASE BASE BASE
N021330 001 N021330 002 N022360 001 N022360 002 A077007 A090711 A090821 A203690 A077007 A090711 A090821 A203690 001 001 001 001 002 002 002 002
Oct 31, 2002 Oct 31, 2002 May 18, 2009 May 18, 2009 Jan Jul Jul Oct Jan Jul Jul Oct 31, 10, 10, 09, 31, 10, 10, 09, 2006 2009 2009 2012 2006 2009 2009 2012
NIZATIDINE
TABLET; ORAL
AXID AR
+ PFIZER
75MG
N020555 001
May 09, 1996
NONOXYNOL-9
SPONGE; VAGINAL
TODAY
+ AZTIQ PHARMA
1GM
N018683 001
Apr 01, 1983
OMEPRAZOLE
OMEPRAZOLE
+ DEXCEL PHARMA 20MG
N022032 001
Dec 04, 2007
CAPSULE, DELAYED RELEASE; ORAL
+ DR REDDYS LABS LTD EQ 20MG BASE
A078878 001
Jun 05, 2009

PRILOSEC OTC
+ ASTRAZENECA EQ 20MG BASE
4 - 18 (of 20)
N021229 001
Jun 20, 2003
OMEPRAZOLE; SODIUM BICARBONATE

CAPSULE; ORAL
ZEGERID OTC
+ MSD CONSUMER
20MG;1.1GM
N022281 001
Dec 01, 2009
ORLISTAT
CAPSULE; ORAL
ALLI
+ GLAXOSMITHKLINE CONS
60MG
N021887 001
Feb 07, 2007
OXYMETAZOLINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC OCUCLEAR SCHERING PLOUGH 0.025% VISINE L.R. + JOHNSON AND JOHNSON 0.025%
N018471 001 N019407 001
May 30, 1986 Mar 31, 1989
PERMETHRIN
LOTION; TOPICAL
NIX
+ INSIGHT PHARMS PERMETHRIN ACTAVIS MID ATLANTIC PERRIGO NEW YORK
1% 1% 1%
N019918 001 A075014 001 A076090 001
May 02, 1990 Mar 28, 2000 Dec 20, 2001
PIPERONYL BUTOXIDE; PYRETHRINS

AEROSOL; TOPICAL
RID MOUSSE
+ BAYER HLTHCARE
4%;EQ 0.33% BASE
N021043 001
Mar 07, 2000

FOR SOLUTION; ORAL GLYCOLAX KREMERS URBAN PHARMS
17GM/PACKET 17GM/SCOOPFUL
A090600 001 A090600 002 N022015 001 A202071 A078915 A078915 A090812 A091077 A090685 A090685 001 001 002 001 001 001 002
Oct 06, 2009 Oct 06, 2009 Oct 06, 2006 Dec Oct Oct Oct Oct Oct Oct 28, 06, 06, 07, 06, 06, 06, 2012 2009 2009 2009 2009 2009 2009
MIRALAX + SCHERING PLOUGH 17GM/SCOOPFUL POLYETHYLENE GLYCOL 3350 EMCURE PHARMS USA 17GM/SCOOPFUL MYLAN 17GM/PACKET 17GM/SCOOPFUL NEXGEN PHARMA 17GM/SCOOPFUL NOVEL LABS INC 17GM/SCOOPFUL PERRIGO R AND D 17GM/PACKET 17GM/SCOOPFUL
POTASSIUM IODIDE
SOLUTION; ORAL
THYROSHIELD
+ ARCO PHARMS LLC TABLET; ORAL IOSAT ANBEX + THYROSAFE + RECIP
65MG/ML
A077218 001
Jan 12, 2005
65MG 130MG 65MG
N018664 002 N018664 001 A076350 001
May 12, 2011 Oct 14, 1982 Sep 10, 2002

POVIDONE-IODINE
SOLUTION; TOPICAL
POVIDONE IODINE
+ ALLEGIANCE HLTHCARE SPONGE; TOPICAL E-Z SCRUB 201 + BECTON DICKINSON E-Z SCRUB 241 + BECTON DICKINSON
4 - 19 (of 20)
1%
N019522 001
Mar 31, 1989
20% 10%
N019240 001 N019476 001
Nov 29, 1985 Jan 07, 1987
PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL PSEUDOEPHEDRINE HYDROCHLORIDE PERRIGO 120MG RANBAXY 120MG SUDAFED 12 HOUR + MCNEIL CONS 120MG SUDAFED 24 HOUR + MCNEIL CONS 240MG
A075153 001 A077442 001 A073585 001 N020021 002
Feb 26, 1999 Sep 28, 2005 Oct 31, 1991 Dec 15, 1992
PSEUDOEPHEDRINE SULFATE
AFRINOL
+ SCHERING PLOUGH 120MG
N018191 001
PURIFIED WATER
SOLUTION; OPHTHALMIC
PUR-WASH
+ NIAGARA PHARMS
98.3%
N022305 001
Sep 01, 2011
TABLET; ORAL RANITIDINE HYDROCHLORIDE APOTEX INC EQ CONTRACT PHARMACAL EQ DR REDDYS LABS LTD EQ EQ IVAX SUB TEVA PHARMS EQ MYLAN EQ PERRIGO EQ PERRIGO R AND D EQ EQ SHASUN CHEMS EQ SVADS HOLDINGS SA EQ TORPHARM EQ WATSON LABS EQ WOCKHARDT EQ EQ EQ ZANTAC 150 + BOEHRINGER INGELHEIM EQ EQ ZANTAC 75 BOEHRINGER INGELHEIM EQ
150MG BASE 75MG BASE 75MG BASE 150MG BASE 75MG BASE 75MG BASE 75MG BASE 150MG BASE 150MG BASE 75MG BASE 150MG BASE 75MG BASE 75MG BASE 75MG BASE 75MG BASE 150MG BASE 150MG BASE 150MG BASE 75MG BASE
001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001
May Jun Mar Aug Jan Jan Aug May May Feb Jun May Jan Feb Jul Nov
31, 21, 28, 31, 14, 14, 30, 11, 11, 29, 28, 04, 14, 24, 31, 26,
2012 1999 2000 2007 2000 2000 2002 2011 2011 2012 2011 2000 2000 2006 2008 2007
N021698 001 N021698 002 N020520 001
Aug 31, 2004 Mar 13, 2007 Dec 19, 1995
SODIUM CHLORIDE
BRONCHO SALINE
+ BLAIREX 0.9%
N019912 001
Sep 03, 1992
SODIUM FLUORIDE; TRICLOSAN

PASTE; DENTAL
COLGATE TOTAL
+ COLGATE PALMOLIVE
0.24%;0.3%
N020231 001
Jul 11, 1997

TERBINAFINE
GEL; TOPICAL
LAMISIL AT
+ NOVARTIS
4 - 20 (of 20)
1%
N021958 001
Jul 24, 2006
CREAM; TOPICAL
LAMISIL
+ NOVARTIS 1% TERBINAFINE HYDROCHLORIDE TARO 1% SOLUTION; TOPICAL
LAMISIL AT
+ NOVARTIS 1% SPRAY; TOPICAL
LAMISIL AT
+ NOVARTIS 1%
N020980 001 A077511 001
Mar 09, 1999 Jul 02, 2007
N021124 001
Mar 17, 2000
N021124 002
Mar 17, 2000
TIOCONAZOLE
OINTMENT; VAGINAL TIOCONAZOLE PERRIGO VAGISTAT-1 + NOVARTIS
6.5% 6.5%
A075915 001 N020676 001
Nov 21, 2001 Feb 11, 1997
33RD EDITION - 2013- APPROVED DRUG PRODUCT LIST
5 - 1 of 5
DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT

ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST
ANTICOAGULANT 4% SODIUM CITRATE SOLUTION USP

INJECTABLE; INJECTION NONE HAEMONETICS MANUFACTURING INC
N760305
Jun 30, 1978
ANTICOAGULANT CITRATE DEXTROSE SOLUTION (ACD)

INJECTABLE; INJECTION CITRA LABS LLC ACD-A SOLUTION GAMBRO BCT INC ADSOL WITH ACD-A FENWAL INC ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A HAEMONETICS CORP AS3 SOLUTION/ACD-A GAMBRO BCT INC N020037 A010228 N000922 A980728 N001214 ANDA ANDA Aug 26, 2003 Feb 25, 2002 Aug 29, 2002 Feb 06, 2002 May 29, 2002
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP

INJECTABLE; INJECTION NONE FENWAL INC FRESENIUS MEDICAL CARE NORTH AMERICA MEDSEP CORPORATION MILES INC
N100855 N160918 N110912 A710497 N100102 ANDA
Jun 03, 1959 Mar 17, 1978 Sep 02, 1959
Dec 14, 1961
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD-A)

INJECTABLE; INJECTION NONE ARTERIOCYTE MEDICAL SYSTEMS, INC
A110057
May 11, 2012
ANTICOAGULANT CITRATE PHOSPHATE 2X DEXTROSE SOLUTION (CP2D)

INJECTABLE; INJECTION CITRATE PHOSPHATE DOUBLE DEXTROSE/ADDITIVE SOLUTION 3 HAEMONETICS CORP
N000127
Jan 18, 2002
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION

INJECTABLE; INJECTION NONE FRESENIUS MEDICAL CARE NORTH AMERICA TERUMO MEDICAL CORP
N780519 N820528
Apr 23, 1980 Nov 03, 1982
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION (CPDA)

INJECTABLE; INJECTION CPDA-1 BLOOD-PACK UNIT (PL 146 PLASTIC) 250, 450, 500 ML BLOOD PACK UNITS FENWAL INC N770420
May 12, 1978
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION USP

INJECTABLE; INJECTION BLOOD PACK UNIT CPDA-1 IN PLASTIC CONTAINER FENWAL INC
N940404
Jul 28, 1994
5 - 2 of 5

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE-1 SOLUTION

INJECTABLE; INJECTION NONE HAEMONETICS MANUFACTURING INC
N800077
Nov 06, 1980
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION

INJECTABLE; INJECTION ADSOL IN PLASTIC CONTAINER FENWAL INC
N900223
Dec 27, 1991
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION (CPD)

INJECTABLE; INJECTION MACOPRODUCTIONS SAS CPD/AS-1: MACOPHARMA LEUCOFLEX MTL1 LEUKOREDUCTION SYSTEM FOR BLOOD COMPONENTS KNOWN AS MTL1-WB MACOPRODUCTIONS SAS N040083 Nov 21, 2005 NONE GAMBRO BCT INC A070025 Jan 06, 2008
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP

INJECTABLE; INJECTION NONE FENWAL INC FRESENIUS MEDICAL CARE NORTH AMERICA HAEMONETICS MANUFACTURING INC MILES INC TERUMO MEDICAL CORP
N170401 N811012 N160907 N800222 N160527 N781211
Dec 06, 1977 Jun 28, 1983 May 16, 1973 Aug 23, 1982 Jun 22, 1970 Jun 10, 1981
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-1: DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
INJECTABLE; INJECTION ADSOL RED BLOOD CELL PRESERVATIVE SOLUTION FENWAL INC
N811104
May 16, 1983
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-5: DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
INJECTABLE; INJECTION OPTISOL RED BLOOD CELL PRESERVATIVE SOLUTION TERUMO MEDICAL CORP
N880217
Oct 07, 1988
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION WITH:

AS-3: CITRIC ACID USP; MONOBASIC SODIUM PHOSPHATE USP; SODIUM CHLORIDE USP; ADENINE;
DEXTROSE USP; SODIUM CITRATE USP
INJECTABLE; INJECTION AS-3 NUTRICEL ADDITIVE SYSTEM HAEMONETICS 0.042GM/100ML;0.276GM/100ML; MANUFACTURING INC 0.410GM/100ML;0.30GM/100ML; 1.10GM/100ML;0.588GM/100ML
N820915
Oct 19, 1984
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION WITH:

AS-2: CITRIC ACID USP; DIBASIC SODIUM PHOSPHATE USP; SODIUM CHLORIDE USP; ADENINE;
DEXTROSE USP; SODIUM CITRATE USP
INJECTABLE; INJECTION AS-2 NUTRICEL ADDITIVE SYSTEM MEDSEP CORP 0.042GM/100ML;0.285GM/100ML; 0.718GM/100ML;0.017GM/100ML; 0.396GM/100ML;0.588GM/100ML
N820915
Sep 22, 1983
5 - 3 of 5

ANTICOAGULANT ETHYLENEDIAMINE TETRAACETIC ACID (EDTA)

INJECTABLE; INJECTION NONE FENWAL INC
N090480
Mar 07, 1955
ANTICOAGULANT HEPARIN SOLUTION USP

INJECTABLE; INJECTION NONE FRESENIUS MEDICAL CARE NORTH AMERICA
N770822
May 17, 1978
ANTICOAGULANT SODIUM CITRATE 4% SOLUTION

INJECTABLE; INJECTION NONE HAEMONETICS CORPORATION
N980123
Mar 03, 2000
ANTICOAGULANT SODIUM CITRATE SOLUTION

INJECTABLE; INJECTION TRICITRASOL CYTOSOL LABORATORIES INC
N010409
Jul 10, 2003
ANTICOAGULANT SODIUM CITRATE SOLUTION USP

INJECTABLE; INJECTION NONE FENWAL INC FRESENIUS MEDICAL CARE NORTH AMERICA TERUMO MEDICAL CORP
N770923 N160702 N781214
Jan 20, 1978 Dec 28, 1970 Feb 08, 1980
DEXTRAN 1 IN SODIUM CHLORIDE 0.6%

INJECTABLE; INJECTION PROMIT MEDA AB
N830715
Oct 30, 1984
DEXTRAN 40, 10% IN DEXTROSE 5%

INJECTABLE; INJECTION GENTRAN 40 BAXTER HLTHCARE CORP 10GM/100ML;5GM/100ML LMD IN PLASTIC CONTAINER HOSPIRA INC 10GM/100ML;5GM/100ML NONE B BRAUN MEDICAL INC 10GM/100ML;5GM/100ML HOSPIRA INC 10GM/100ML;5GM/100ML MILES INC 10GM/100ML;5GM/100ML PHARMACHEM CORP 10GM/100ML;5GM/100ML
N840619 A720563 N160767 N160375 N160653 N160836 ANDA
Feb 22, 1985 Oct 30, 1992 Apr Jul Sep Nov 06, 25, 23, 14, 1970 1967 1969 1972
DEXTRAN 40, 10% IN SODIUM CHLORIDE 0.9%

INJECTABLE; INJECTION GENTRAN 40 BAXTER HLTHCARE CORP 10GM/100ML;0.9GM/100ML LMD IN PLASTIC CONTAINER HOSPIRA INC 10GM/100ML;0.9GM/100ML NONE B BRAUN MEDICAL INC 10GM/100ML;0.9GM/100ML HOSPIRA INC 10GM/100ML;0.9GM/100ML MILES INC 10GM/100ML;0.9GM/100ML PHARMACHEM CORP 10GM/100ML;0.9GM/100ML
N840620 A720562 N160767 N160375 N160653 N160836 ANDA
Feb 22, 1985 Oct 30, 1992 Apr Jul Sep Nov 06, 25, 23, 14, 1970 1967 1969 1972
5 - 4 of 5


INJECTABLE; INJECTION GENTRAIN 70 BAXTER HLTHCARE CORP NONE B BRAUN MEDICAL INC MILES INC
N160607 6GM/100ML;0.9 GM/100ML 6GM/100ML;0.9 GM/100ML N090024 N080716
Jan 26, 1970 Aug 18, 1969 Mar 13, 1953

INJECTABLE; INJECTION NONE PHARMACHEM CORP
6GM/100ML;0.9GM/100ML 6GM/100ML;0.9GM/100ML
N080564 N160759
Sep 19, 1952 Aug 19, 1970
HETASTARCH 6% IN LACTATED ELECTROLYTE INJECTION

INJECTABLE; INJECTION HEXTEND BIOTIME INC
6GM/100ML
N200952
Mar 31, 1999
HETASTARCH 6% IN SODIUM CHLORIDE 0.9%

INJECTABLE; INJECTION 6% HETASTARCH IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA INC 6GM/100ML;0.9GM/100ML HESPAN B BRAUN MEDICAL INC 6GM/100ML;0.9GM/100ML HESPAN IN PLASTIC CONTAINER B BRAUN MEDICAL INC 6GM/100ML;0.9GM/100ML NONE B BRAUN MEDICAL INC 6GM/100ML;0.9GM/100ML TEVA PARENTERAL 6GM/100ML;0.9GM/100ML MEDICINES INC
A740193 N160889 N890105 A740283 A740592
ANDA
Jan 30, 1995 Jul 17, 1972 Apr 04, 1991
ANDA ANDA
Oct 21, 1998 Nov 12, 1998
HETASTARCH 6% IN SODIUM CHLORIDE 0.9% NACL 500 ML GLASS BOTTLES

INJECTABLE; INJECTION NONE HOSPIRA INC
6GM/100ML;0.9 GM/100ML
A720746
ANDA
Feb 07, 1996
HYDROXYETHYL STARCH 130/0.4 IN 6% SODIUM CHLORIDE 0.9%

INJECTABLE; INJECTION VOLUVEN FRESENIUS KABI DEUTSCHLAND GMBH
6GM/100ML;0.9GM/100ML
N070012
NDA
Dec 27, 2007
PENTASTARCH 10% IN SODIUM CHLORIDE 0.9%

INJECTABLE; PENTASPAN B BRAUN PENTASPAN B BRAUN INJECTION MEDICAL INC 10GM/100ML;0.9GM/100ML IN PLASTIC CONTAINER MEDICAL INC 10GM/100ML;0.9GM/100ML N841207 N890104 May 19, 1987 Apr 04, 1991
PERFLUORODECALIN; PERFLUOROTRI-N-PROPYLAMINE
INJECTABLE; INJECTION FLUOSOL ALPHA THERAPEUTIC CORP
17.5GM/100ML;7.5GM/100ML
N860909
Dec 26, 1989
5 - 5 of 5

RED BLOOD CELL PROCESSING SOLUTION

INJECTABLE; INJECTION REJUVESOL CITRA LABS LLC
N950522
Feb 26, 1997
SODIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, DIABASIC ANHYDROUS; SODIUM PHOSPHATE MONOBASIC, MONOHYDRATE
INJECTABLE; INJECTION INTERSOL SOLUTION FENWAL INC.
2.26G/500ML; 2.21G/500ML; 1.59G/500ML; 1.53G/500ML; 0.465G/500ML
N080041
NDA
Dec 09, 2009
DISCONTINUED DRUG PRODUCT LIST

ABARELIX
INJECTABLE; INTRAMUSCULAR PLENAXIS SPECIALITY EUROPEAN 100MG/VIAL
6 - 1 (of 360)
N021320
001
Nov 25, 2003
ACETAMINOPHEN
INJECTABLE; INJECTION INJECTAPAP ORTHO MCNEIL PHARM SUPPOSITORY; RECTAL ACEPHEN G AND W LABS ACETAMINOPHEN ABLE
100MG/ML
N017785
001
Mar 07, 1986
120MG 120MG 325MG 650MG 120MG 650MG
A072218 A073106 A073107 A073108 A071010 A071011 N017756 N017756
001 001 001 001 001 001 002 001
Mar 27, 1992 Feb Feb Feb May May 27, 27, 27, 12, 12, 1995 1995 1995 1987 1987
ROXANE TYLENOL MCNEIL CONS
120MG 650MG TABLET, EXTENDED RELEASE; ORAL ACETAMINOPHEN RANBAXY 650MG
A090205
001
Nov 18, 2009
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE

CAPSULE; ORAL ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE MIKART 150MG;180MG;15MG 150MG;180MG;30MG 150MG;180MG;60MG CODEINE, ASPIRIN, APAP FORMULA NO. 2 SCHERER LABS 150MG;180MG;15MG CODEINE, ASPIRIN, APAP FORMULA NO. 3 SCHERER LABS 150MG;180MG;30MG CODEINE, ASPIRIN, APAP FORMULA NO. 4 SCHERER LABS 150MG;180MG;60MG
A081095 A081096 A081097 A085640 A085639 A085638
001 001 001 001 001 001
Oct 26, 1990 Oct 26, 1990 Oct 26, 1990
ACETAMINOPHEN; BUTALBITAL
CAPSULE; ORAL BANCAP FOREST PHARMS 325MG;50MG BUCET MALLINCKRODT 650MG;50MG TENCON MALLINCKRODT 650MG;50MG TRIAPRIN DUNHALL 325MG;50MG TABLET; ORAL BUTALBITAL AND ACETAMINOPHEN HALSEY 325MG;50MG WATSON LABS 325MG;50MG PHRENILIN VALEANT 325MG;50MG SEDAPAP MAYRAND 650MG;50MG
A088889 A088991 A089405 A089268
001 001 001 001
Jan 16, 1986 Jun 28, 1985 May 15, 1990 Jul 02, 1987
A089568 A087550 A087811 A088944
001 001 001 001
Oct 05, 1988 Oct 19, 1984 Jun 19, 1985 Oct 17, 1985

CAPSULE; ORAL ANOQUAN SHIRE 325MG;50MG;40MG BUTALBITAL, ACETAMINOPHEN AND CAFFEINE GRAHAM DM 325MG;50MG;40MG
A087628 A088743
001 001
Oct 01, 1986 Jul 18, 1985

CAPSULE; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE GRAHAM DM 325MG;50MG;40MG 325MG;50MG;40MG MALLINCKRODT 325MG;50MG;40MG BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE GILBERT LABS 325MG;50MG;40MG FEMCET MALLINCKRODT 325MG;50MG;40MG MEDIGESIC PLUS US CHEM 325MG;50MG;40MG TRIAD MALLINCKRODT 325MG;50MG;40MG TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE ABLE 325MG;50MG;40MG 500MG;50MG;40MG GILBERT LABS 325MG;50MG;40MG MUTUAL PHARM 325MG;50MG;40MG WATSON LABS 325MG;50MG;40MG ESGIC FOREST PHARMS 325MG;50MG;40MG
6 - 2 (of 360)
A088765 A089067 A088758 A088825 A089102 A089115 A089023
001 001 001 001 001 001 001
Mar 27, 1985 Apr 19, 1985 Mar 27, 1985 Dec 05, 1984 Jun 19, 1985 Jan 14, 1986 Jun 19, 1985
A040390 A040394 A087629 A040601 A089536 A089660
001 001 001 001 001 001
Jul Jul Nov Jul Feb
23, 23, 13, 29, 16,
2001 2001 1984 2005 1988
Dec 23, 1988
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

CAPSULE; ORAL BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE ABLE 325MG;50MG;40MG;30MG
A076528
001
Aug 21, 2003
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE

CAPSULE; ORAL DHC PLUS PHARM RES ASSOC 356.4MG;30MG;16MG SYNALGOS-DC-A LEITNER PHARMS 356.4MG;30MG;16MG TABLET; ORAL ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE WEST-WARD PHARM CORP 712.8MG;60MG;32MG
A088584 A089166
001 001
Mar 04, 1986 May 14, 1986
A040637
001
Sep 22, 2006

CAPSULE; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE TEVA 300MG;15MG 300MG;30MG 300MG;60MG PHENAPHEN W/ CODEINE NO. 2 ROBINS AH 325MG;15MG PHENAPHEN W/ CODEINE NO. 3 ROBINS AH 325MG;30MG PHENAPHEN W/ CODEINE NO. 4 ROBINS AH 325MG;60MG PROVAL #3 SOLVAY 325MG;30MG TYLENOL W/ CODEINE NO. 3 ORTHO MCNEIL PHARM 300MG;30MG TYLENOL W/ CODEINE NO. 4 ORTHO MCNEIL PHARM 300MG;60MG SOLUTION; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE ACTAVIS MID ATLANTIC 120MG/5ML;12MG/5ML CLONMEL 120MG/5ML;12MG/5ML ROXANE 120MG/5ML;12MG/5ML
A088537 A088324 A088599 A084444 A084445 A084446 A085685 A087422 A087421
001 001 001 001 001 001 001 001 001
Jun 04, 1984 Dec 29, 1983 Jun 01, 1984
A085861 A040098 A086366
001 001 001
Sep 20, 1996

SOLUTION; ORAL TYLENOL W/ CODEINE ORTHO MCNEIL PHARM 120MG/5ML;12MG/5ML SUSPENSION; ORAL CAPITAL AND CODEINE ACTAVIS MID ATLANTIC 120MG/5ML;12MG/5ML TABLET; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE ABLE 300MG;30MG 300MG;60MG AM THERAP 300MG;15MG 300MG;15MG 300MG;30MG 300MG;30MG 300MG;60MG 300MG;60MG DURAMED PHARMS BARR 300MG;15MG 300MG;15MG 300MG;30MG 300MG;30MG 300MG;60MG 300MG;60MG EVERYLIFE 325MG;30MG HALSEY 300MG;15MG 300MG;30MG 300MG;60MG KV PHARM 300MG;30MG 300MG;60MG 325MG;15MG 325MG;45MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** LEDERLE 300MG;30MG MIKART 300MG;60MG MUTUAL PHARM 300MG;15MG 300MG;15MG 300MG;30MG 300MG;30MG 300MG;60MG 300MG;60MG PURACAP PHARM 300MG;30MG PUREPAC PHARM 300MG;30MG 300MG;30MG 300MG;60MG ROXANE 300MG;15MG 300MG;30MG 300MG;60MG 500MG;15MG 500MG;30MG 500MG;60MG SANDOZ 300MG;15MG 300MG;30MG 300MG;30MG 300MG;30MG 300MG;60MG 300MG;60MG 300MG;60MG SUPERPHARM 300MG;15MG 300MG;30MG 300MG;30MG 300MG;60MG 300MG;60MG
6 - 3 (of 360)
A085057
001
A085883
001
001 001 001 001 001 001 001 001 001 001 002 001 003 001 001 001
001
001
001
001
001
001
Aug Aug Mar Mar Mar Mar Mar Mar Nov Feb Nov Feb Nov Feb
01, 01, 03, 03, 03, 03, 03, 03, 18, 06, 18, 06, 18, 06,
2002 2002 1987 1987 1987 1987 1987 1987 1997 1984 1997 1984 1997 1984
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001
Feb 25, 1986 Feb 10, 1988 Feb Apr Feb Dec 10, 13, 10, 10, 1988 1982 1988 1982
Jul 17, 1986
Apr 25, 1989 Apr 25, 1989 Apr 25, 1989 Jul 16, 1992
Jul 16, 1992
Oct Oct May Oct May
18, 18, 19, 18, 19,
1985 1985 1986 1985 1986

TABLET; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE USL PHARMA 300MG;30MG 300MG;60MG VALEANT PHARM INTL 300MG;30MG VITARINE 300MG;30MG WARNER CHILCOTT 300MG;15MG 300MG;30MG 300MG;60MG WATSON LABS 300MG;15MG 300MG;15MG 300MG;30MG 300MG;30MG 300MG;60MG 300MG;60MG WATSON LABS FLORIDA 300MG;15MG 300MG;30MG 300MG;60MG WHITEWORTH TOWN PLSN 300MG;30MG 300MG;60MG CAPITAL AND CODEINE CARNRICK 325MG;30MG CODRIX WATSON LABS FLORIDA 500MG;15MG 500MG;30MG 500MG;60MG EMPRACET W/ CODEINE PHOSPHATE #3 GLAXOSMITHKLINE 300MG;30MG EMPRACET W/ CODEINE PHOSPHATE #4 GLAXOSMITHKLINE 300MG;60MG PAPA-DEINE #3 VANGARD 300MG;30MG PAPA-DEINE #4 VANGARD 300MG;60MG PHENAPHEN-650 W/ CODEINE ROBINS AH 650MG;30MG TYLENOL W/ CODEINE ORTHO MCNEIL PHARM 325MG;7.5MG 325MG;15MG 325MG;30MG 325MG;60MG TYLENOL W/ CODEINE NO. 1 JANSSEN PHARMS 300MG;7.5MG TYLENOL W/ CODEINE NO. 2 JANSSEN PHARMS 300MG;15MG
6 - 4 (of 360)
001 001 001 001 001 002 001 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 002 001 001 001 001 002 003 004 001 002
Jun 22, 1982 Jun 22, 1982
May Dec May Dec May Dec Jan Jan Jan
26, 28, 26, 28, 26, 28, 22, 22, 22,
1982 1994 1982 1994 1982 1994 2003 2003 2003
Feb 26, 2003 Mar 27, 2003 Mar 28, 2003
Mar 20, 1984 Mar 20, 1984

CAPSULE; ORAL ACETAMINOPHEN AND HYDROCODONE BITARTRATE CENT PHARMS 500MG;5MG ALLAY IVAX PHARMS 500MG;5MG BANCAP HC FOREST PHARMS 500MG;5MG CO-GESIC CENT PHARMS 500MG;5MG HYDROCODONE BITARTRATE AND ACETAMINOPHEN MALLINCKRODT 500MG;5MG 500MG;5MG MIKART 500MG;5MG 500MG;5MG 500MG;5MG
A088898 A089907 A087961 A089360 A088956 A089006 A081068 A081069 A081070
001 001 001 001 001 001 001 001 001
Mar 27, 1985 Jan 13, 1989 Mar 17, 1983 Mar 02, 1988 Jul Aug Nov Nov Nov 19, 09, 30, 30, 30, 1985 1985 1989 1989 1989

CAPSULE; ORAL LORCET-HD MALLINCKRODT 500MG;5MG SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN MALLINCKRODT INC 500MG/15ML;10MG/15ML MIKART 500MG/15ML;5MG/15ML 500MG/15ML;5MG/15ML NESHER PHARMS 500MG/15ML;7.5MG/15ML TABLET; ORAL DURADYNE DHC FOREST PHARMS 500MG;5MG HYDROCODONE BITARTRATE AND ACETAMINOPHEN ABLE 325MG;5MG 325MG;7.5MG 325MG;10MG 500MG;5MG 500MG;7.5MG 500MG;10MG 650MG;7.5MG 650MG;10MG 750MG;7.5MG BARR 500MG;2.5MG 500MG;5MG 500MG;5MG 500MG;7.5MG 500MG;10MG 650MG;7.5MG 650MG;10MG 750MG;7.5MG HALSEY 500MG;5MG IVAX PHARMS 500MG;5MG MIKART 500MG;5MG 500MG;5MG MUTUAL PHARM 500MG;5MG 650MG;7.5MG 650MG;10MG 750MG;7.5MG RANBAXY 500MG;5MG 500MG;10MG RANBAXY LABS LTD 325MG;10MG 750MG;7.5MG SANDOZ 500MG;5MG 750MG;7.5MG UCB INC 500MG;10MG 650MG;7.5MG USL PHARMA 500MG;5MG 500MG;5MG VINTAGE PHARMS 500MG;5MG VINTAGE PHARMS LLC 500MG;5MG 500MG;7.5MG 650MG;7.5MG 650MG;10MG 750MG;7.5MG WATSON LABS 325MG;7.5MG 325MG;10MG 500MG;2.5MG 500MG;5MG 500MG;7.5MG 650MG;7.5MG 650MG;10MG 750MG;7.5MG WATSON LABS FLORIDA 500MG;5MG
6 - 5 (of 360)
A087336
001
Jul 08, 1982
A040508 A081226 A089557 A040366
001 001 001 001
Aug Oct Apr Jan
29, 27, 29, 23,
2003 1992 1992 2002
A087809 A040478 A040464 A040464 A040477 A040490 A040473 A040474 A040476 A040469 A040307 A040308 A088577 A040307 A040309 A040307 A040307 A040308 A089554 A089696 A089271 A089697 A040236 A040240 A040240 A040236 A040825 A040824 A040826 A040822 A040149 A040149 A040210 A040134 A089290 A089291 A089831 A040281 A040280 A040280 A040280 A040281 A040248 A040248 A040123 A040122 A040123 A040123 A040123 A040122 A040493
001 001 001 002 001 001 001 001 001 001 001 001 001 002 001 003 004 002 001 001 001 001 001 002 001 002 001 001 001 001 001 002 001 001 001 001 001 001 001 002 003 002 001 002 003 001 004 001 002 002 001
Mar 17, 1983 Nov Oct Oct Nov May Nov Jan Oct Oct Jul Jul Dec Jul Jul Jul Jul Jul Jun Apr Jul Jan Sep Nov Nov Sep Aug Aug Aug Aug Jan Jan Aug Nov May May Sep Sep Sep Sep Sep Sep Apr Apr Mar Mar Mar Mar Mar Mar May 08, 23, 23, 06, 21, 06, 02, 23, 25, 26, 26, 21, 26, 26, 26, 26, 26, 12, 21, 16, 28, 25, 26, 26, 25, 16, 16, 16, 16, 27, 27, 13, 21, 29, 29, 07, 30, 30, 30, 30, 30, 28, 28, 04, 04, 04, 04, 04, 04, 28, 2002 2002 2002 2002 2003 2002 2003 2002 2002 2000 2000 1984 2000 2000 2000 2000 2000 1987 1988 1986 1992 1997 1997 1997 1997 2007 2007 2007 2007 1997 1997 1997 1996 1987 1987 1988 1998 1998 1998 1998 1998 2000 2000 1996 1996 1996 1996 1996 1996 2003

TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN WATSON LABS FLORIDA 750MG;7.5MG HY-PHEN ASCHER 500MG;5MG NORCET ABANA 500MG;5MG TYCOLET ORTHO MCNEIL PHARM 500MG;5MG VICODIN ABBOTT 500MG;5MG ABBVIE 500MG;5MG VICODIN ES ABBVIE 750MG;7.5MG VICODIN HP ABBVIE 660MG;10MG
6 - 6 (of 360)
A040494 A087677 A088871 A089385 A085667 A088058 A089736 A040117
001 001 001 001 001 001 001 001
May 28, 2003 May 03, 1982 May 15, 1986 Aug 27, 1986
Jan 07, 1983 Dec 09, 1988 Sep 23, 1996

CAPSULE; ORAL OXYCODONE AND ACETAMINOPHEN ACTAVIS TOTOWA 500MG;5MG BARR 500MG;5MG HALSEY 500MG;5MG MUTUAL PHARM 500MG;5MG VINTAGE PHARMS LLC 500MG;5MG TYLOX-325 ORTHO MCNEIL PHARM 325MG;5MG SOLUTION; ORAL OXYCODONE AND ACETAMINOPHEN MALLINCKRODT INC 325MG/5ML;5MG/5ML TABLET; ORAL OXYCODONE 2.5/APAP 500 BRISTOL MYERS SQUIBB 500MG;2.5MG OXYCODONE 5/APAP 500 BRISTOL MYERS SQUIBB 500MG;5MG OXYCODONE AND ACETAMINOPHEN ACTAVIS TOTOWA 325MG;5MG BARR 325MG;5MG DURAMED PHARMS BARR 325MG;5MG PERCOCET VINTAGE PHARMS LLC 325MG;5MG
A040199 A040304 A089994 A040219 A040303 A088246
001 001 001 001 001 001
Dec Oct May Jan Dec
30, 02, 04, 22, 30,
1998 2000 1989 1998 1999
Nov 08, 1984
A040680
001
Sep 29, 2006
A085910 A085911 A040203 A087406 A040272 A085106
001 001 001 001 001 002 Mar 15, 1999 Jun 30, 1998
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE

CAPSULE; ORAL TYLOX ORTHO MCNEIL PHARM
500MG;4.5MG;0.38MG
A085375
001
ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE

TABLET; ORAL TALACEN SANOFI AVENTIS US
650MG;EQ 25MG BASE
N018458
001
Sep 23, 1982
ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE

TABLET; ORAL DARVOCET AAIPHARMA LLC 325MG;32.5MG DOLENE AP-65 LEDERLE 650MG;65MG PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN MYLAN 325MG;32MG 650MG;65MG SANDOZ 650MG;65MG
N016844 A085100 A083689 A083978 A089959
001 001 001 001 001
Jul 18, 1989

ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
TABLET; ORAL PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN VINTAGE PHARMS 650MG;65MG WATSON LABS 650MG;65MG WYGESIC CARACO 650MG;65MG
6 - 7 (of 360)
A040507 A040139 A084999
001 001 001
Jul 30, 2003 Dec 16, 1996
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE

TABLET; ORAL DARVOCET A500 XANODYNE PHARM 500MG;100MG DARVOCET-N 100 XANODYNE PHARM 650MG;100MG DARVOCET-N 50 XANODYNE PHARM 325MG;50MG PROPACET 100 TEVA 650MG;100MG PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN ABLE 650MG;100MG ACTAVIS ELIZABETH 650MG;100MG CORNERSTONE 325MG;100MG 500MG;100MG HALSEY 325MG;50MG 650MG;100MG IVAX SUB TEVA PHARMS 650MG;100MG MALLINCKRODT 650MG;100MG MIRROR PHARMS 650MG;100MG MUTUAL PHARM 325MG;50MG 650MG;100MG 650MG;100MG 650MG;100MG 650MG;100MG MYLAN 650MG;100MG MYLAN PHARMS INC 650MG;100MG SANDOZ 650MG;100MG SUPERPHARM 650MG;100MG TEVA 650MG;100MG 650MG;100MG VINTAGE PHARMS 325MG;50MG 650MG;100MG WATSON LABS 325MG;50MG 650MG;100MG WATSON LABS FLORIDA 500MG;100MG 650MG;100MG WOCKHARDT LTD 325MG;50MG 650MG;100MG
A076429 N017122 N017122 A070107 A075838 A070910 A076743 A076750 A072105 A072106 A070146 A075738 A077821 A070115 A070116 A070615 A070771 A070775 A072195 A070145 A070443 A071319 A070732 A074119 A074843 A074843 A070398 A070399 A077196 A076609 A077677 A077677
001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 002
Sep 10, 2003
Jun 12, 1985 Jul Jan May Jun May May Aug Feb Feb Jun Jun Mar Mar Mar Feb Jun Jan Jan Jan Dec Feb Feb Dec Dec Jun Nov Mar Mar 11, 02, 07, 28, 13, 13, 02, 02, 11, 12, 12, 21, 21, 21, 16, 12, 23, 06, 03, 19, 15, 12, 18, 18, 28, 16, 16, 16, 2001 1987 2004 2004 1988 1988 1985 2001 2008 1985 1985 1986 1986 1986 1988 1985 1986 1987 1986 1994 2001 1997 1986 1986 2005 2004 2007 2007
ACETAZOLAMIDE
TABLET; ORAL ACETAZOLAMIDE ALRA ASCOT MUTUAL PHARM VANGARD WATSON LABS DIAMOX DURAMED PHARMS BARR
250MG 250MG 250MG 250MG 250MG 125MG 250MG
A083320 A087686 A089753 A087654 A084498 N008943 N008943
001 001 001 001 002 001 002
Oct 20, 1982 Jun 22, 1988 Feb 05, 1982

ACETAZOLAMIDE SODIUM
INJECTABLE; INJECTION ACETAZOLAMIDE SODIUM HOSPIRA DIAMOX TEVA WOMENS
6 - 8 (of 360)
A040108 N009388
001 001
Oct 30, 1995 Dec 05, 1990
ACETIC ACID, GLACIAL

SOLUTION/DROPS; OTIC ACETASOL ACTAVIS MID ATLANTIC ACETIC ACID KV PHARM ORLEX WARNER CHILCOTT
2% 2% 2%
A087146 A085493 A086845
001 001 001
ACETIC ACID, GLACIAL; ALUMINUM ACETATE

SOLUTION/DROPS; OTIC BOROFAIR PHARMAFAIR DOMEBORO BAYER PHARMS
2%;0.79% 2%;0.79%
A088606 A084476
001 001
Aug 21, 1985
ACETIC ACID, GLACIAL; DESONIDE

SOLUTION/DROPS; OTIC TRIDESILON BAYER PHARMS
2%;0.05%
N017914
001
ACETIC ACID, GLACIAL; HYDROCORTISONE

SOLUTION/DROPS; OTIC ACETIC ACID W/ HYDROCORTISONE KV PHARM 2%;1% HYDROCORTISONE AND ACETIC ACID BAUSCH AND LOMB 2%;1% WOCKHARDT 2%;1% ORLEX HC WARNER CHILCOTT 2%;1%
A085492 A040097 A040168 A086844
001 001 001 001 Oct 31, 1994 Aug 30, 1996
ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE

SUSPENSION/DROPS; OTIC NEO-CORT-DOME BAYER PHARMS
2%;1%;EQ 0.35% BASE
N050238
001
ACETOHEXAMIDE
TABLET; ORAL ACETOHEXAMIDE BARR USL PHARMA DYMELOR LILLY
250MG 500MG 250MG 500MG 250MG 500MG
A070869 A070870 A070753 A070754 N013378 N013378
001 001 001 001 002 001
Feb Feb Nov Nov
09, 09, 03, 03,
1987 1987 1986 1986
ACETOPHENAZINE MALEATE
TABLET; ORAL TINDAL SCHERING
20MG
N012254
002
ACETRIZOATE SODIUM
SOLUTION; INTRAUTERINE SALPIX ORTHO MCNEIL PHARM
53%
N009008
001

ACETYLCHOLINE CHLORIDE
MIOCHOL
NOVARTIS
6 - 9 (of 360)
20MG/VIAL
N016211
001
ACETYLCYSTEINE
SOLUTION; INHALATION, ORAL
ACETYLCYSTEINE
HOSPIRA 10% 20% ROXANE 10% 20% MUCOMYST APOTHECON 10% 20% MUCOSIL-10 DEY 10% MUCOSIL-20 DEY 20%
A071364 A071365 A072621 A072622 N013601 N013601 A070575 A070576
001 001 001 001 002 001 001 001
May May Sep Sep
01, 01, 30, 30,
1989 1989 1992 1992
Oct 14, 1986 Oct 14, 1986
ACETYLCYSTEINE; ISOPROTERENOL HYDROCHLORIDE

MUCOMYST W/ ISOPROTERENOL
MEAD JOHNSON 10%;0.05%
N017366
001
ACETYLDIGITOXIN
TABLET; ORAL
ACYLANID
NOVARTIS
0.1MG
N009436
001
ACRISORCIN
CREAM; TOPICAL
AKRINOL
SCHERING
2MG/GM
N012470
001
ACYCLOVIR
CAPSULE; ORAL ACYCLOVIR ACTAVIS ELIZABETH DAVA PHARMS INC HERITAGE PHARMS INC IVAX SUB TEVA PHARMS LEK PHARM ROXANE TEVA TEVA PHARMS TABLET; ORAL
ACYCLOVIR
ACTAVIS ELIZABETH DAVA PHARMS INC HERITAGE PHARMS INC IVAX SUB TEVA PHARMS LEK PHARM TEVA
A074906 A074872 A074889 A074674 A074750 A074570 A074828 A074914
001 001 001 001 001 002 001 001
Aug Apr Oct Apr Apr Apr Apr Nov
26, 22, 31, 22, 22, 22, 22, 26,
1997 1997 1997 1997 1997 1997 1997 1997
TEVA PHARMS
400MG 800MG 400MG 800MG 400MG 800MG 400MG 800MG 400MG 800MG 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 400MG 800MG
A074870 A074870 A074834 A074834 A074891 A074891 A074836 A074836 A074658 A074658 A074556
001 002 001 002 001 002 001 002 001 002 001
Jun Jun Apr Apr Oct Oct Apr Apr Apr Apr Apr
05, 05, 24, 24, 31, 31, 22, 22, 22, 22, 22,
1997 1997 1997 1997 1997 1997 1997 1997 1997 1997 1997
A075021 A075021
001 002
Mar 18, 1998 Mar 18, 1998

ACYCLOVIR SODIUM
INJECTABLE; INJECTION ACYCLOVIR ABBVIE ACYCLOVIR SODIUM APOTHECON HOSPIRA
6 - 10 (of 360)
EQ 50MG BASE/ML EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 500MG BASE/VIAL 1GM BASE/VIAL 25MG BASE/ML 50MG BASE/ML 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 50MG BASE/ML 500MG BASE/VIAL 1GM BASE/VIAL
001 001 002 001 001 001 001 002 002 001 001 002 003 001 002
Jul 26, 1999 Feb Feb Apr Feb Apr Apr Apr Apr Mar Aug Aug 27, 27, 22, 25, 22, 22, 22, 22, 28, 26, 26, 1998 1998 1997 1999 1997 1997 1997 1997 2001 1997 1997
TEVA PARENTERAL
ZOVIRAX GLAXOSMITHKLINE
Aug 30, 1983 Oct 22, 1982 Jun 29, 1989
ADAPALENE
SOLUTION; TOPICAL DIFFERIN GALDERMA LABS LP
0.1%
N020338
001
May 31, 1996
ADENOSINE
INJECTABLE; INJECTION ADENOSINE HIKMA MAPLE TEVA PARENTERAL
A076501 A076564 A078676
001 001 001
Jun 16, 2004 Jun 16, 2004 Jul 31, 2008
ALATROFLOXACIN MESYLATE
INJECTABLE; INJECTION TROVAN PRESERVATIVE FREE PFIZER EQ 200MG BASE/VIAL EQ 300MG BASE/VIAL
N020760 N020760
001 002
Dec 18, 1997 Dec 18, 1997
ALBUMIN CHROMATED CR-51 SERUM

INJECTABLE; INJECTION CHROMALBIN ISO TEX
100uCi/VIAL 250uCi/VIAL 500uCi/VIAL
N017835 N017835 N017835
001 002 003

INJECTABLE; INJECTION RADIO-IODINATED (I 125) SERUM ALBUMIN (HUMAN) BAYER PHARMS 2.5uCi/AMP RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125 MALLINCKRODT 6.67uCi/ML 10uCi/ML 100uCi/ML
N017846 N017844 N017844 N017844
001 003 001 002

INJECTABLE; INJECTION MEGATOPE ISO TEX
2mCi/VIAL 5uCi/AMP 20uCi/AMP
N017837 N017837 N017837
003 004 005

ALBUTEROL
AEROSOL, METERED; INHALATION ALBUTEROL ARMSTRONG PHARMS 0.09MG/INH GENPHARM 0.09MG/INH IVAX SUB TEVA PHARMS 0.09MG/INH PLIVA 0.09MG/INH PROVENTIL SCHERING 0.09MG/INH VENTOLIN GLAXOSMITHKLINE 0.09MG/INH
6 - 11 (of 360)
A072273 A073045 A073272 A074072 N017559 N018473
001 001 001 001 001 001
Aug Aug Dec Aug
14, 19, 28, 01,
1996 1997 1995 1996
ALBUTEROL SULFATE
CAPSULE; INHALATION VENTOLIN ROTACAPS GLAXOSMITHKLINE SOLUTION; INHALATION ALBUTEROL SULFATE ACTAVIS MID ATLANTIC BAUSCH AND LOMB COPLEY PHARM ROXANE PROVENTIL SCHERING VENTOLIN GLAXOSMITHKLINE SYRUP; ORAL ALBUTEROL SULFATE ACTAVIS MID ATLANTIC MOVA WATSON LABS PROVENTIL SCHERING VENTOLIN GLAXOSMITHKLINE TABLET; ORAL ALBUTEROL SULFATE AM THERAP COPLEY PHARM DAVA PHARMS INC PLIVA SANDOZ TEVA
EQ 0.2MG BASE
N019489
001
May 04, 1988
EQ EQ EQ EQ EQ
A073533 A075358 A073495 A073307 A075129 N019243 N019243 N019773 N019269
001 001 001 001 001 002 001 001 002
Sep Mar May Nov Feb
26, 29, 28, 27, 13,
1995 2000 1993 1991 2001
EQ 0.083% BASE EQ 0.5% BASE EQ 0.083% BASE EQ 0.5% BASE
Jan 14, 1987 Jan 14, 1987 Apr 23, 1992 Jan 16, 1987
EQ 2MG BASE/5ML EQ 2MG BASE/5ML EQ 2MG BASE/5ML EQ 2MG BASE/5ML EQ 2MG BASE/5ML
A075262 A074302 A073165 N018062 N019621
001 001 001 001 001
Mar 30, 1999 Sep 30, 1994 Apr 29, 1993 Jan 19, 1983 Jun 10, 1987
UCB INC WARNER CHILCOTT WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A072449 A072450 A072966 A072967 A072859 A072860 A072316 A072317 A072151 A072152 A072619 A072779 A072938 A072620 A072780 A072939 A073120 A073121 A072817 A072818 A072629 A072630 A072765
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Dec Dec Nov Nov Dec Dec Dec Dec Dec Dec Dec Jun Mar Dec Jun Mar Sep Sep Jan Jan Jan Jan Aug
05, 05, 22, 22, 20, 20, 05, 05, 05, 05, 05, 25, 30, 05, 25, 30, 29, 29, 09, 09, 31, 31, 28,
1989 1989 1991 1991 1989 1989 1989 1989 1989 1989 1989 1993 1990 1989 1993 1990 1992 1992 1990 1990 1991 1991 1991

ALBUTEROL SULFATE
TABLET; ORAL PROVENTIL SCHERING VENTOLIN GLAXOSMITHKLINE
6 - 12 (of 360)
N017853 N017853 N019112 N019112
001 002 001 002
May 07, 1982 May 07, 1982 Jul 10, 1986 Jul 10, 1986
EQ 2MG BASE EQ 4MG BASE TABLET, EXTENDED RELEASE; ORAL PROVENTIL SCHERING EQ 4MG BASE VOLMAX MURO EQ 4MG BASE EQ 8MG BASE
N019383 N019604 N019604
001 002 001
Jul 13, 1987 Dec 23, 1992 Dec 23, 1992

SOLUTION; INHALATION ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE SANDOZ INC EQ 0.083% BASE;0.017%
A076867
001
Dec 21, 2006
ALCOHOL
INJECTABLE; INJECTION ALCOHOL 5% IN DEXTROSE 5% MILES 5ML/100ML
A083483
001
ALCOHOL; DEXTROSE
INJECTABLE; INJECTION ALCOHOL 5% IN D5-W HOSPIRA 5ML/100ML;5GM/100ML ALCOHOL 5% IN DEXTROSE 5% IN WATER BAXTER HLTHCARE 5ML/100ML;5GM/100ML
A083263 A083256
001 001
ALENDRONATE SODIUM
TABLET; ORAL ALENDRONATE SODIUM SANDOZ
TEVA PHARMS
5MG BASE 10MG BASE 35MG BASE 40MG BASE 70MG BASE 35MG BASE 70MG BASE
A075871 A075871 A075871 A075871 A075871 A076184 A076184
001 002 004 003 005 002 001
Apr Apr Apr Apr Apr Aug Feb
22, 22, 22, 22, 22, 04, 06,
2009 2009 2009 2009 2009 2008 2008
ALGLUCERASE
INJECTABLE; INJECTION CEREDASE GENZYME
N020057 N020057
004 003
May 08, 1992 Apr 05, 1991
ALKAVERVIR
TABLET; ORAL VERILOID 3M
2MG 3MG
N007336 N007336
002 003
ALLOPURINOL
TABLET; ORAL ALLOPURINOL MUTUAL PHARM PURACAP PHARM PUREPAC PHARM
100MG 300MG 100MG 300MG 100MG
A070466 A070467 A070150 A070147 A070579
001 001 001 001 001
Dec Dec Dec Dec Apr
24, 24, 10, 10, 14,
1985 1985 1985 1985 1986

ALLOPURINOL
TABLET; ORAL ALLOPURINOL PUREPAC PHARM SANDOZ SUPERPHARM WATSON LABS
6 - 13 (of 360)
A070580 A070268 A070269 A070950 A070951 N018241 N018785 N018241 N018785 N018297 N018297
001 001 001 001 001 001 001 002 002 001 002
Apr Dec Dec Nov Nov Nov Sep Nov Sep
14, 31, 31, 30, 30, 16, 28, 16, 28,
1986 1985 1985 1988 1988 1984 1984 1984 1984
LOPURIN ABBOTT
ALPRAZOLAM
SOLUTION; ORAL ALPRAZOLAM ROXANE TABLET; ORAL ALPRAZOLAM IVAX SUB TEVA PHARMS
0.5MG/5ML
A074314
001
Oct 31, 1993
0.25MG 0.5MG 1MG 2MG ROXANE 0.25MG 0.5MG 1MG TEVA 0.25MG 0.5MG 1MG 2MG WATSON LABS 0.25MG 0.25MG 0.5MG 0.5MG 1MG 1MG TABLET, EXTENDED RELEASE; ORAL ALPRAZOLAM SANDOZ INC 0.5MG 1MG 2MG 3MG VINTAGE PHARMS 0.5MG 1MG 2MG 3MG
001 002 003 004 001 002 003 001 002 003 004 001 001 002 002 003 003
Jul Jul Jul Jul Oct Oct Oct Feb Feb Feb Feb Aug Jan Aug Jan Aug Jan
29, 29, 29, 29, 19, 19, 19, 16, 16, 16, 26, 31, 21, 31, 21, 31, 21,
1994 1994 1994 1994 1993 1993 1993 1994 1994 1994 1996 1995 1997 1995 1997 1995 1997
A077777 A077777 A077777 A077777 A078442 A078442 A078442 A078442
001 002 003 004 001 002 003 004
Jun Jun Jun Jun Oct Oct Oct Oct
30, 30, 30, 30, 15, 15, 15, 15,
2006 2006 2006 2006 2007 2007 2007 2007
ALPROSTADIL
INJECTABLE; INJECTION CAVERJECT PFIZER
0.005MG/ML 0.01MG/ML 0.02MG/ML 0.005MG/VIAL
N020755 N020755 N020755 N020649
001 002 003 001
Oct 31, 1997 Oct 01, 1997 Oct 01, 1997 Jun 12, 1997
EDEX ACTIENT PHARMS
ALSEROXYLON
TABLET; ORAL RAUTENSIN NOVARTIS
2MG
N009215
001

ALSEROXYLON
TABLET; ORAL RAUWILOID 3M
6 - 14 (of 360)
2MG
N008867
001
ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE

TABLET, CHEWABLE; ORAL ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE PENNEX 80MG;20MG FOAMICON NOVARTIS 80MG;20MG
A089449 A072687
001 001
Nov 27, 1987 Jun 28, 1989
CAPSULE; ORAL AMANTADINE HYDROCHLORIDE ACTAVIS TOTOWA 100MG WATSON LABS 100MG SYMADINE SOLVAY 100MG SYMMETREL ENDO PHARMS 100MG SYRUP; ORAL AMANTADINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 50MG/5ML TEVA PHARMS 50MG/5ML SYMMETREL ENDO PHARMS 50MG/5ML TABLET; ORAL SYMMETREL ENDO PHARMS 100MG
A077659 A071382 A071000 N016020
001 001 001 001
Feb 23, 2006 Jan 21, 1987 Sep 04, 1986
A072655 A073115 N016023
001 001 002
Oct 30, 1990 Aug 23, 1991
N018101
001
AMCINONIDE
CREAM; TOPICAL CYCLOCORT ASTELLAS LOTION; TOPICAL CYCLOCORT ASTELLAS OINTMENT; TOPICAL CYCLOCORT ASTELLAS
0.025% 0.1%
N018116 N018116
001 002
0.1%
N019729
001
Jun 13, 1988
0.1%
N018498
001
AMDINOCILLIN
INJECTABLE; INJECTION COACTIN ROCHE
250MG/VIAL 500MG/VIAL 1GM/VIAL
N050565 N050565 N050565
001 002 003
Dec 21, 1984 Dec 21, 1984 Dec 21, 1984
AMIFOSTINE
INJECTABLE; INJECTION ETHYOL MEDIMMUNE
375MG/VIAL
N020221
002
Sep 10, 1999
AMIKACIN SULFATE
INJECTABLE; INJECTION AMIKACIN SULFATE ABBOTT ASTRAZENECA HIKMA MAPLE
EQ EQ EQ EQ EQ
250MG BASE/ML 250MG BASE/ML 50MG BASE/ML 250MG BASE/ML 50MG BASE/ML
A063265 A063266 A063167 A063169 A063274
001 001 001 001 001
Nov Oct Dec Dec May
30, 31, 14, 14, 18,
1994 1994 1995 1995 1992

AMIKACIN SULFATE
INJECTABLE; INJECTION AMIKACIN SULFATE HIKMA MAPLE HOSPIRA
6 - 15 (of 360)
EQ 250MG BASE/ML EQ 50MG BASE/ML EQ 50MG BASE/ML EQ 62.5MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML TEVA PARENTERAL EQ 50MG BASE/ML AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA EQ 500MG BASE/100ML AMIKIN APOTHECON EQ 50MG BASE/ML EQ 50MG BASE/ML EQ 50MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER APOTHECON EQ 5MG BASE/ML EQ 10MG BASE/ML
A063275 A063263 A063350 A063283 A063350 A064098 A064099 A064045 A064146 A062311 A062562 N050495 A062311 A062562 N050495 N050618 N050618
001 001 001 001 002 001 001 001 001 001 001 001 002 002 002 002 001
May Nov Jul Oct Jul Jun Jun Sep
18, 30, 30, 31, 30, 26, 20, 28,
1992 1994 1993 1994 1993 1995 1995 1993
Apr 02, 1997
Sep 20, 1984
Sep 20, 1984
Nov 30, 1987 Nov 30, 1987
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

TABLET; ORAL AMILORIDE HYDROCHLORIDE SANDOZ TEVA WATSON LABS HYDRO-RIDE PAR PHARM MODURETIC 5-50 MERCK AND HYDROCHLOROTHIAZIDE EQ 5MG ANHYDROUS;50MG EQ 5MG ANHYDROUS;50MG EQ 5MG ANHYDROUS;50MG EQ 5MG ANHYDROUS;50MG EQ 5MG ANHYDROUS;50MG
A073357 A070795 A073334 A070347 N018201
001 001 001 001 001
Nov 27, 1991 Apr 17, 1988 Jul 19, 1991 Dec 25, 1990
AMINO ACIDS
INJECTABLE; INJECTION AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE HOSPIRA 5.2% (5.2GM/100ML) AMINOSYN 3.5% IN PLASTIC CONTAINER ABBOTT 3.5% (3.5GM/100ML) 3.5% (3.5GM/100ML) AMINOSYN II 3.5% HOSPIRA 3.5% (3.5GM/100ML) AMINOSYN II 3.5% IN PLASTIC CONTAINER ABBOTT 3.5% (3.5GM/100ML) AMINOSYN II 5% HOSPIRA 5% (5GM/100ML) AMINOSYN-HBC 7% IN PLASTIC CONTAINER ABBOTT 7% (7GM/100ML) BRANCHAMIN 4% BAXTER HLTHCARE 4% (4GM/100ML) FREAMINE 8.5% B BRAUN 8.5% (8.5GM/100ML) FREAMINE II 8.5% B BRAUN 8.5% (8.5GM/100ML) NEOPHAM 6.4% HOSPIRA 6.4% (6.4GM/100ML) NOVAMINE 11.4% HOSPIRA INC 11.4% (11.4GM/100ML) NOVAMINE 15% HOSPIRA INC 15% (75GM/500ML)
N018901 N018804 N018875 N019438 N019491 N019438 N019400 N018678 N016822 N016822 N018792 N017957 N017957
001 001 001 001 001 002 001 001 001 002 001 003 004
Apr 06, 1984 May 15, 1984 Aug 08, 1984 Apr 03, 1986 Oct 10, 1986 Apr 03, 1986 Jul 23, 1986 Sep 28, 1984
Jan 17, 1984 Aug 09, 1982 Nov 28, 1986

AMINO ACIDS
INJECTABLE; INJECTION NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER BAXTER HLTHCARE 15% (15GM/100ML) NOVAMINE 8.5% HOSPIRA INC 8.5% (8.5GM/100ML)
6 - 16 (of 360)
N020107 N017957
001 002
Feb 05, 1993 Aug 09, 1982
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML N019714 001 Sep ;22.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML N019683 001 Nov ;22.4MG/100ML;261MG/100ML;205MG/100ML AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 4.25%;36.8MG/100ML;20GM/100ML;51MG/100M N019714 002 Sep L;22.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 4.25%;36.8MG/100ML;20GM/100ML;51MG/100M N019683 002 Nov L;22.4MG/100ML;261MG/100ML;205MG/100ML AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 4.25%;36.8MG/100ML;25GM/100ML;51MG/100M N019714 004 Sep L;22.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 4.25%;36.8MG/100ML;25GM/100ML;51MG/100M N019683 003 Nov L;22.4MG/100ML;261MG/100ML;205MG/100ML AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2 N019714 003 Sep 2.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2 N019683 004 Nov 2.4MG/100ML;261MG/100ML;205MG/100ML
12, 1988 07, 1988
12, 1988 07, 1988
12, 1988 07, 1988
12, 1988 07, 1988

INJECTABLE; INJECTION AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 3.5%;25GM/100ML AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER ABBOTT 3.5%;5GM/100ML AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 4.25%;25GM/100ML AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 3.5%;25GM/100ML 3.5%;25GM/100ML HOSPIRA 3.5%;25GM/100ML AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER ABBOTT 3.5%;5GM/100ML 3.5%;5GM/100ML HOSPIRA 3.5%;5GM/100ML AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER ABBOTT 4.25%;10GM/100ML HOSPIRA 4.25%;10GM/100ML AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER ABBOTT 4.25%;20GM/100ML HOSPIRA 4.25%;20GM/100ML AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 4.25%;25GM/100ML 4.25%;25GM/100ML HOSPIRA 4.25%;25GM/100ML AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 5%;25GM/100ML 5%;25GM/100ML HOSPIRA 5%;25GM/100ML TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;10GM/100ML TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;15GM/100ML
N019118 N019120 N019119 N019505 N019713 N019681 N019506 N019713 N019681 N019713 N019681 N019713 N019681 N019504 N019713 N019681 N019565 N019713 N019681 N019520 N019520
001 001 001 002 006 001 001 002 002 001 004 004 005 002 005 003 001 003 006 002 003
Oct 11, 1984 Oct 11, 1984 Oct 11, 1984 Nov 07, 1986 Sep 09, 1988 Nov 01, 1988 Nov 07, 1986 Sep 09, 1988 Nov 01, 1988 Sep 09, 1988 Nov 01, 1988 Sep 09, 1988 Nov 01, 1988 Nov 07, 1986 Sep 09, 1988 Nov 01, 1988 Dec 17, 1986 Sep 09, 1988 Nov 01, 1988 Sep 23, 1988 Sep 23, 1988

INJECTABLE; INJECTION TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;20GM/100ML TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;25GM/100ML TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;5GM/100ML TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;10GM/100ML TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;15GM/100ML TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;20GM/100ML TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;25GM/100ML TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;5GM/100ML
6 - 17 (of 360)
N019520 N019520 N019520 N019520 N019520 N019520 N019520 N019520
004 005 001 007 008 009 010 006
Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER ABBOTT 4.25%;10GM/100ML;51MG/100ML;176.5MG/100 N019712 002 Sep 08, 1988 ML;22.4MG/100ML;104.5MG/100ML;205MG/100 ML HOSPIRA INC 4.25%;10GM/100ML;51MG/100ML;176.5MG/100 N019682 003 Nov 01, 1988 ML;22.4MG/100ML;104.5MG/100ML;205MG/100 ML
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 3.5%;25GM/100ML;51MG/100ML;22.4MG/100ML N019564 ;261MG/100ML;205MG/100ML AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 4.25%;25GM/100ML;51MG/100ML;22.4MG/100M N019564 L;261MG/100ML;205MG/100ML
002
Dec 16, 1986
004
Dec 16, 1986
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER ABBOTT 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 0MG/100ML;49.3MG/100ML 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 0MG/100ML;49.3MG/100ML HOSPIRA INC 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 0MG/100ML;49.3MG/100ML AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER ABBOTT 4.25%;10GM/100ML;30MG/100ML;97MG/100ML; 120MG/100ML;49.3MG/100ML HOSPIRA INC 4.25%;5GM/100ML;30MG/100ML;97MG/100ML;1 20MG/100ML;49.3MG/100ML
N019564 N019712 N019682
001 001 001
Dec 16, 1986 Sep 08, 1988 Nov 01, 1988
N019564 N019682
003 002
Dec 16, 1986 Nov 01, 1988
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;10GM/100ML;51MG/100ML;261MG/100ML N020147 002 Oct 23, 1995 ;216MG/100ML;112MG/100ML TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;15GM/100ML;51MG/100ML;261MG/100ML N020147 003 Oct 23, 1995 ;216MG/100ML;112MG/100ML
6 - 18 (of 360)
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;20GM/100ML;51MG/100ML;261MG/100ML N020147 004 Oct ;216MG/100ML;112MG/100ML TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;25GM/100ML;51MG/100ML;261MG/100ML N020147 005 Oct ;216MG/100ML;112MG/100ML TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;5GM/100ML;51MG/100ML;261MG/100ML; N020147 001 Oct 216MG/100ML;112MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;10GM/100ML;51MG/100ML;261MG/100ML N020147 007 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;15GM/100ML;51MG/100ML;261MG/100ML N020147 008 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;20GM/100ML;51MG/100ML;261MG/100ML N020147 009 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;25GM/100ML;51MG/100ML;261MG/100ML N020147 010 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;5GM/100ML;51MG/100ML;261MG/100ML; N020147 006 Oct 297MG/100ML;77MG/100ML
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN 3.5% M IN PLASTIC CONTAINER ABBOTT 3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N018804 234MG/100ML 3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N018875 234MG/100ML
002 002
May 15, 1984 Aug 08, 1984
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE

AMINOSYN 3.5% M
HOSPIRA
3.5%;21MG/100ML;128MG/100ML;234MG/100ML N017789
005
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION AMINOSYN II 3.5% M IN PLASTIC CONTAINER ABBOTT 3.5%;32MG/100ML;128MG/100ML;222MG/100ML N019493 ;49MG/100ML
001
Oct 16, 1986
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
INJECTABLE; INJECTION VEINAMINE 8% HOSPIRA INC
8%;61MG/100ML;211MG/100ML;56MG/100ML;38 N017957 8MG/100ML
001
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 7% W/ ELECTROLYTES HOSPIRA 7%;102MG/100ML;45MG/100ML;522MG/100ML;4 N019437 10MG/100ML
006
Apr 03, 1986
6 - 19 (of 360)
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION AMINOSYN II 3.5% M HOSPIRA
3.5%;30MG/100ML;97MG/100ML;120MG/100ML; N019437 49MG/100ML
007
Apr 03, 1986
AMINOCAPROIC ACID
AMICAR
CLOVER PHARMS AMINOCAPROIC ACID ABRAXIS PHARM BAXTER HLTHCARE HOSPIRA
N015229 A070522 N018590 A070888
002
001 001 001 Jun 17, 1986 Oct 29, 1982 Jun 16, 1988
AMINOGLUTETHIMIDE
TABLET; ORAL
CYTADREN
NOVARTIS
250MG
N018202
001
AMINOPHYLLINE
ENEMA; RECTAL SOMOPHYLLIN FISONS INJECTABLE; INJECTION AMINOPHYLLIN GD SEARLE LLC AMINOPHYLLINE ABRAXIS PHARM
300MG/5ML
N018232
001
Apr 02, 1982
25MG/ML 25MG/ML
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 003 004
May 24, 1982 May 24, 1982
25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML ELKINS SINN 25MG/ML HOSPIRA 25MG/ML INTL MEDICATION 25MG/ML 25MG/ML KING PHARMS 25MG/ML LUITPOLD 25MG/ML LYPHOMED 25MG/ML PHARMA SERVE NY 25MG/ML SMITH AND NEPHEW 25MG/ML 25MG/ML TEVA PARENTERAL 25MG/ML AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% HOSPIRA 100MG/100ML 200MG/100ML AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER HOSPIRA 100MG/100ML 200MG/100ML 400MG/100ML 500MG/100ML SOLUTION; ORAL AMINOPHYLLINE MORTON GROVE 105MG/5ML ROXANE 105MG/5ML AMINOPHYLLINE DYE FREE ACTAVIS MID ATLANTIC 105MG/5ML SOMOPHYLLIN FISONS 105MG/5ML SOMOPHYLLIN-DF FISONS 105MG/5ML
Jan 06, 1982 Aug 30, 1983 Jan 25, 1984 Jul 23, 1982 Nov 10, 1983 Nov 10, 1983
Jun May May Sep
03, 30, 30, 25,
1983 1985 1985 1991
May 03, 1983 May 03, 1983 Dec Dec Dec Dec 12, 12, 12, 12, 1984 1984 1984 1984
A088156 A088126 A087727 A086466 A087045
001 001 001 001 001
Dec 05, 1983 Aug 19, 1983 Apr 16, 1982

AMINOPHYLLINE
SUPPOSITORY; RECTAL TRUPHYLLINE G AND W LABS TABLET; ORAL AMINOPHYLLIN GD SEARLE LLC AMINOPHYLLINE ASCOT
6 - 20 (of 360)
250MG 500MG
A085498 A085498
001 002
Mar 23, 1983 Jan 03, 1983
100MG 200MG
N002386 N002386 A087522 A087523 A088297 A088298 A088182 A088183 A084674 A084574 A084576 A085284 A085289 A084588 A084588 A084533 A084552 A084552 A084699 A085333 A087500 A087501 A085261 A085262 A085261 A084563 A088314 A088319 A085409 A085410 A085567 A085564
002 003 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 002 001 001 001 001 003 002 002 001 001 001 001 001 001 001 Feb Feb Aug Aug Mar Mar 12, 12, 19, 19, 31, 31, 1982 1982 1983 1983 1983 1983
100MG 200MG BARR 100MG 200MG DURAMED PHARMS BARR 100MG 200MG HALSEY 100MG IMPAX LABS 100MG 200MG KV PHARM 100MG 200MG LANNETT 100MG 200MG PAL PAK 100MG PANRAY 100MG 200MG PUREPAC PHARM 100MG 200MG ROXANE 100MG 200MG SANDOZ 100MG 100MG 200MG VALEANT PHARM INTL 200MG VANGARD 100MG 200MG VINTAGE PHARMS 100MG 200MG WATSON LABS 100MG 200MG TABLET, DELAYED RELEASE; ORAL AMINOPHYLLINE IMPAX LABS 100MG 200MG TABLICAPS 100MG VALE 100MG 200MG TABLET, EXTENDED RELEASE; ORAL PHYLLOCONTIN PHARM RES ASSOC 225MG
Feb 09, 1982 Feb 09, 1982
Oct 03, 1983 Oct 03, 1983
A084577 A084575 A084632 A084531 A084530
001 001 002 001 001
A086760
001
AMINOSALICYLATE SODIUM
POWDER; ORAL P.A.S. SODIUM
CENTURY PHARMS 4GM/PACKET SODIUM AMINOSALICYLATE
HEXCEL 100% TABLET; ORAL
PARASAL SODIUM
PANRAY 500MG 1GM SODIUM P.A.S.
LANNETT 500MG
A080947 A080097
001
001
N006811 N006811 A080138
006
011
002

AMINOSALICYLATE SODIUM
TABLET; ORAL TEEBACIN CONSOLIDATED MIDLAND
6 - 21 (of 360)
500MG
N007320
002
AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID

TABLET; ORAL NEOPASALATE MEDPOINTE PHARM HLC
846MG;112MG
A080059
002
AMINOSALICYLIC ACID
TABLET; ORAL PARASAL PANRAY
500MG 1GM
N006811 N006811
001 002
AMINOSALICYLIC ACID RESIN COMPLEX

POWDER; ORAL REZIPAS BRISTOL MYERS SQUIBB
EQ 500MG BASE/GM
N009052
001
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION AMIODARONE HYDROCHLORIDE BEDFORD 50MG/ML BEDFORD LABS 50MG/ML BEN VENUE 50MG/ML HOSPIRA 50MG/ML INTL MEDICATION SYS 50MG/ML TEVA PARENTERAL 50MG/ML CORDARONE WYETH PHARMS INC 50MG/ML TABLET; ORAL AMIODARONE HYDROCHLORIDE TEVA 200MG
A076018 A076299 A076088 A076108 N021594 A076163 N020377
001 001 001 001 001 001 001
Oct Oct Oct Oct Feb Sep
15, 24, 15, 15, 04, 05,
2002 2002 2002 2002 2004 2003
Aug 03, 1995
A074895
001
Apr 16, 1999
CONCENTRATE; ORAL ENDEP ROCHE 40MG/ML INJECTABLE; INJECTION AMITRIPTYLINE HYDROCHLORIDE WATSON LABS 10MG/ML ELAVIL ASTRAZENECA 10MG/ML TABLET; ORAL AMITID BRISTOL MYERS SQUIBB 10MG 25MG 50MG 75MG 100MG AMITRIL WARNER CHILCOTT 10MG 25MG 50MG 75MG 100MG 150MG AMITRIPTYLINE HYDROCHLORIDE AM THERAP 25MG 50MG 75MG
A085749
001
A085594 N012704
001 001
A086454 A086454 A086454 A086454 A086454 A083939 A083937 A083938 A084957 A085093 A086295 A088672 A088673 A088674
001 002 003 004 005 001 001 002 001 001 001 001 001 001 Nov 20, 1984 Nov 20, 1984 Nov 20, 1984

TABLET; ORAL AMITRIPTYLINE HYDROCHLORIDE AM THERAP 100MG COPLEY PHARM 10MG 25MG 50MG 75MG 100MG 150MG HALSEY 10MG 25MG 50MG 50MG 75MG 100MG LEDERLE 10MG 10MG 25MG 25MG 50MG 50MG 75MG 75MG 100MG 100MG 150MG MUTUAL PHARM 10MG 25MG 50MG 75MG 100MG 150MG PAR PHARM 10MG 25MG 50MG 75MG 100MG 150MG PLIVA 10MG 25MG 50MG 75MG 100MG 150MG PUREPAC PHARM 10MG 10MG 25MG 25MG 50MG 50MG 75MG 75MG 100MG 100MG ROXANE 10MG 10MG 25MG 25MG 50MG 50MG 75MG 75MG
6 - 22 (of 360)
A088675 A088421 A088422 A088423 A088424 A088425 A088426 A085923 A085922 A085925 A087557 A085926 A085927 A086744 A087366 A086746 A087367 A086743 A087181 A086745 A087369 A086747 A087368 A087370 A085744 A085627 A085745 A085743 A085742 A089423 A088697 A088698 A088699 A088700 A088701 A088702 A088883 A088884 A088885 A088886 A088887 A088888 A088075 A088084 A088076 A088085 A088077 A088105 A088078 A088106 A088079 A088107 A086002 A086144 A085944 A086145 A085945 A086143 A086004 A086147
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Nov Apr Apr Apr Apr Apr Apr
20, 30, 30, 30, 30, 30, 30,
1984 1984 1984 1984 1984 1984 1984
Mar 05, 1982 May 20, 1983 May 20, 1983 Jan 04, 1982 May 03, 1982 Jan 04, 1982 Jan 04, 1982 May 03, 1982 Jan 04, 1982
May Feb Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Jul May Jul Sep Jul Sep Jul Sep Jul
11, 17, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 16, 18, 20, 18, 16, 18, 16, 18, 16, 18,
1982 1987 1984 1984 1984 1984 1984 1984 1984 1984 1984 1984 1984 1984 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983

TABLET; ORAL AMITRIPTYLINE HYDROCHLORIDE ROXANE 100MG 100MG 150MG 150MG SUPERPHARM 10MG 25MG 50MG 75MG 100MG TEVA 10MG 10MG 25MG 25MG 50MG 50MG 75MG 75MG 100MG 100MG 150MG UCB INC 10MG 25MG 50MG 75MG 100MG 150MG USL PHARMA 25MG VANGARD 10MG 50MG 75MG 100MG WATSON LABS 10MG 10MG 25MG 25MG 50MG 50MG 75MG 75MG 100MG 100MG 150MG 150MG WEST WARD 10MG 25MG ELAVIL ASTRAZENECA 10MG 25MG 50MG 75MG 100MG 150MG ENDEP ROCHE 10MG 25MG 50MG 75MG 100MG 150MG
6 - 23 (of 360)
A086003 A086146 A086090 A086148 A088853 A088854 A088855 A088856 A088857 A084910 A086610 A085031 A086859 A085032 A086857 A085030 A086860 A085836 A086854 A086853 A085864 A085935 A085936 A086337 A086336 A086335 A087775 A087632 A087616 A087617 A087639 A085816 A088620 A085817 A088621 A085815 A088622 A085819 A088633 A085820 A088634 A085821 A088635 A087647 A087278 N012703 N012703 N012703 N012703 N012703 N012703 A083639 A083639 A083639 A083639 A083639 A085303
001 001 001 001 001 001 001 001 001 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003 004 005 006 007 001 002 003 004 005 001
Nov Nov Nov Nov Nov
13, 13, 13, 13, 13,
1984 1984 1984 1984 1984
Feb Feb Feb Feb Feb
10, 01, 08, 05, 08,
1982 1982 1982 1982 1982
Mar 02, 1984 Mar 02, 1984 Mar 02, 1984 Mar 02, 1984 Mar 02, 1984 Mar 02, 1984 Mar 05, 1982

AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE
TABLET; ORAL CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE MUTUAL PHARM EQ 12.5MG BASE;5MG EQ 25MG BASE;10MG PAR PHARM EQ 12.5MG BASE;5MG EQ 25MG BASE;10MG USL PHARMA EQ 12.5MG BASE;5MG EQ 25MG BASE;10MG WATSON LABS EQ 12.5MG BASE;5MG EQ 25MG BASE;10MG LIMBITROL VALEANT PHARM INTL EQ 12.5MG BASE;5MG LIMBITROL DS VALEANT PHARM INTL EQ 25MG BASE;10MG
6 - 24 (of 360)
A070765 A070766 A072277 A072278 A070477 A070478 A072052 A072053 N016949 N016949
001 001 001 001 001 001 001 001 001 002
Dec Dec May May Jan Jan Dec Dec
10, 10, 09, 09, 12, 12, 16, 16,
1986 1986 1988 1988 1988 1988 1988 1988

TABLET; ORAL ETRAFON 2-10 SCHERING 10MG;2MG ETRAFON 2-25 SCHERING 25MG;2MG ETRAFON-A SCHERING 10MG;4MG ETRAFON-FORTE SCHERING 25MG;4MG PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE IVAX SUB TEVA PHARMS 10MG;2MG 10MG;4MG 25MG;2MG 25MG;4MG 50MG;4MG MUTUAL PHARM 10MG;2MG 10MG;4MG 25MG;2MG 25MG;4MG PAR PHARM 10MG;2MG 10MG;4MG 25MG;2MG 25MG;4MG 50MG;4MG SANDOZ 10MG;2MG 10MG;4MG 25MG;2MG 25MG;4MG 50MG;4MG WATSON LABS 10MG;2MG 10MG;2MG 10MG;2MG 10MG;4MG 10MG;4MG 10MG;4MG 25MG;2MG 25MG;2MG 25MG;2MG 25MG;4MG 25MG;4MG 25MG;4MG 50MG;4MG 50MG;4MG 50MG;4MG TRIAVIL 2-10 NEW RIVER 10MG;2MG
N014713 N014713 N014713 N014713 A070935 A070937 A070936 A070938 A070939 A071077 A071078 A070297 A071079 A070565 A070620 A070621 A070595 A070574 A071062 A071862 A071063 A071064 A071863 A070373 A072539 A073007 A070375 A072540 A073009 A070374 A072541 A073008 A070376 A072134 A073010 A070377 A071558 A072135 N014715
007 004 002 006 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 004 Sep Sep Sep Sep Sep Nov Nov Nov Nov Sep Sep Sep Sep Sep Nov Dec Nov Nov Dec Aug Feb Oct Aug Feb Oct Aug Feb Oct Aug Feb Oct Nov Mar Feb 11, 11, 11, 11, 12, 12, 12, 12, 12, 11, 11, 11, 11, 11, 27, 21, 27, 27, 21, 25, 15, 17, 25, 15, 17, 25, 15, 17, 25, 15, 17, 04, 02, 15, 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1987 1987 1987 1987 1987 1986 1989 1991 1986 1989 1991 1986 1989 1991 1986 1989 1991 1986 1987 1989

TABLET; ORAL TRIAVIL 2-25 NEW RIVER TRIAVIL 4-10 NEW RIVER TRIAVIL 4-25 NEW RIVER TRIAVIL 4-50 NEW RIVER
6 - 25 (of 360)
25MG;2MG 10MG;4MG 25MG;4MG 50MG;4MG
N014715 N014715 N014715 N014715
002 003 005 006
AMLEXANOX
PATCH; TOPICAL AMLEXANOX ULURU
2MG
N021727
001
Sep 29, 2004
AMLODIPINE BESYLATE
TABLET; ORAL AMLODIPINE BESYLATE GEDEON RICHTER USA
EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE GENPHARM EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE MUTUAL PHARMA EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE SANDOZ EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE SYNTHON PHARMS EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE TABLET, ORALLY DISINTEGRATING; ORAL AMLODIPINE BESYLATE SYNTHON PHARMS EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jul Jul Jul Jul Jul Jul Jan Jan Jan Sep Sep Sep Jun Jun Jun
17, 17, 17, 09, 09, 09, 31, 31, 31, 10, 10, 10, 27, 27, 27,
2007 2007 2007 2007 2007 2007 2008 2008 2008 2007 2007 2007 2007 2007 2007
N022026 N022026 N022026
001 002 003
Sep 27, 2007 Sep 27, 2007 Sep 27, 2007
AMLODIPINE MALEATE
TABLET; ORAL AMVAZ DR REDDYS LABS INC
2.5MG 5MG 10MG
N021435 N021435 N021435
001 002 003
Oct 31, 2003 Oct 31, 2003 Oct 31, 2003
AMMONIUM CHLORIDE
INJECTABLE; INJECTION AMMONIUM CHLORIDE ABBOTT 5MEQ/ML GD SEARLE LLC 3MEQ/ML AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE MCGAW 900MG/100ML AMMONIUM CHLORIDE 2.14% B BRAUN 40MEQ/100ML
A083130 A086205 N006580 A085734
001 001 001 001
AMODIAQUINE HYDROCHLORIDE
TABLET; ORAL CAMOQUIN HYDROCHLORIDE PARKE DAVIS
EQ 200MG BASE
N006441
001

AMOXAPINE
TABLET; ORAL AMOXAPINE SANDOZ
6 - 26 (of 360)
WATSON LABS
A072943 A072944 A072878 A072879 A072418 A072419 A072420 A072421 N018021 N018021 N018021 N018021
001 001 001 001 001 001 001 001 001 002 003 004
Jun Jun Jun Jun May May May May
28, 28, 28, 28, 11, 11, 11, 11,
1991 1991 1991 1991 1989 1989 1989 1989
ASENDIN LEDERLE
AMOXICILLIN
CAPSULE; ORAL AMOXICILLIN LABS ATRAL MYLAN TEVA
A062528 A062528 A062067 A062067 A062853 A063030 A062854 A063031 N050459 N050459 A061885 A062098 A062152 A063099 A061885 A062098 A062152 A063099 A062107 A062107 A062120 A062120
001 002 001 002 001 001 001 001 001 002 001 001 001 001 002 002 002 002 001 002 001 002
Aug 07, 1985 Aug 07, 1985
Dec Feb Dec Feb
22, 28, 22, 28,
1987 1989 1987 1989
AMOXIL GLAXOSMITHKLINE TRIMOX APOTHECON
Mar 20, 1992
Mar 20, 1992
UTIMOX PARKE DAVIS WYMOX WYETH AYERST FOR SUSPENSION; ORAL AMOXICILLIN AM ANTIBIOTICS MYLAN TEVA AMOXIL GLAXOSMITHKLINE
125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 50MG/ML 125MG/5ML 250MG/5ML 50MG/ML 125MG/5ML 125MG/5ML
A062059 A062059 A062090 A062090 A062946 A063001 N050460 N050460 N050460 N050460 A061851 A062323
001 002 001 002 001 001 005 001 002 006 001 001
Nov 01, 1988 Jan 06, 1989
LAROTID GLAXOSMITHKLINE POLYMOX APOTHECON

AMOXICILLIN
POLYMOX
APOTHECON TRIMOX
APOTHECON
6 - 27 (of 360)
250MG/5ML 250MG/5ML 50MG/ML 125MG/5ML 125MG/5ML 125MG/5ML 125MG/5ML 250MG/5ML 250MG/5ML 250MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML
002
002
001 002 001 001 001 003 002 002 002 001
002
001
002
Mar 08, 1988
Mar 08, 1988
UTIMOX
PARKE DAVIS WYMOX
WYETH AYERST TABLET, CHEWABLE; ORAL
AMOXICILLIN
APOTHECON
125MG 250MG TEVA 125MG 250MG TABLET, FOR SUSPENSION; ORAL

DISPERMOX
RANBAXY LABS LTD 200MG 400MG 600MG
A064131 A064131 A064031 A064031
001 002 001 002
May May Dec Dec
06, 06, 19, 19,
1996 1996 1996 1996
A065080 A065080 A065159
002 001 001
Aug 11, 2003 Aug 11, 2003 Dec 04, 2003
AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE

CAPSULE; ORAL DELCOBESE TEVA
1.25MG;1.25MG;1.25MG;1.25MG **Federal Register determination that product

was not discontinued or withdrawn for
safety or efficacy reasons**
5MG;5MG;5MG;5MG **Federal Register determination that product was not
discontinued or withdrawn for safety
or efficacy reasons**
A083564
001
A083564
002
A083564
003
A083564
004
TABLET; ORAL
DELCOBESE
TEVA

A083563
004
A083563
003
A083563
002

AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE
TABLET; ORAL DELCOBESE TEVA
6 - 28 (of 360)
5MG;5MG;5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
A083563
001
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

TABLET; ORAL ADDERALL 10 TEVA WOMENS 2.5MG;2.5MG;2.5MG;2.5MG N011522 ADDERALL 12.5 TEVA WOMENS 3.125MG;3.125MG;3.125MG;3.125MG N011522 ADDERALL 15 TEVA WOMENS 3.75MG;3.75MG;3.75MG;3.75MG N011522 ADDERALL 20 TEVA WOMENS 5MG;5MG;5MG;5MG N011522 ADDERALL 30 TEVA WOMENS 7.5MG;7.5MG;7.5MG;7.5MG N011522 ADDERALL 5 TEVA WOMENS 1.25MG;1.25MG;1.25MG;1.25MG N011522 ADDERALL 7.5 TEVA WOMENS 1.875MG;1.875MG;1.875MG;1.875MG N011522 DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE MALLINCKRODT INC 1.25MG;1.25MG;1.25MG;1.25MG A040440 1.875MG;1.875MG;1.875MG;1.875MG A040440 2.5MG;2.5MG;2.5MG;2.5MG A040440 3.125MG;3.125MG;3.125MG;3.125MG A040440 3.75MG;3.75MG;3.75MG;3.75MG A040440 5MG;5MG;5MG;5MG A040440 7.5MG;7.5MG;7.5MG;7.5MG A040440 MUTUAL PHARM 1.25MG;1.25MG;1.25MG;1.25MG A040480 1.875MG;1.875MG;1.875MG;1.875MG A040480 2.5MG;2.5MG;2.5MG;2.5MG A040480 3.125MG;3.125MG;3.125MG;3.125MG A040480 3.75MG;3.75MG;3.75MG;3.75MG A040480 5MG;5MG;5MG;5MG A040480 7.5MG;7.5MG;7.5MG;7.5MG A040480 WATSON LABS 1.25MG;1.25MG;1.25MG;1.25MG A040456 2.5MG;2.5MG;2.5MG;2.5MG A040456 5MG;5MG;5MG;5MG A040456 7.5MG;7.5MG;7.5MG;7.5MG A040456
007 012 013 008 010 009 011 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004
Feb 13, 1996 Aug 31, 2000 Aug 31, 2000 Feb 13, 1996 May 12, 1997 May 12, 1997 Aug 31, 2000 Oct Oct Oct Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Sep May May May May 07, 07, 07, 07, 07, 07, 07, 09, 09, 09, 09, 09, 09, 09, 06, 06, 06, 06, 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX

BIPHETAMINE 12.5
UCB INC EQ 6.25MG BASE;EQ 6.25MG BASE BIPHETAMINE 20
UCB INC EQ 10MG BASE;EQ 10MG BASE BIPHETAMINE 7.5
UCB INC EQ 3.75MG BASE;EQ 3.75MG BASE
N010093 N010093 N010093
007
003
009
AMPHETAMINE SULFATE
TABLET; ORAL AMPHETAMINE SULFATE LANNETT
5MG 10MG
A083901 A083901
001 002
Aug 31, 1984 Aug 31, 1984

AMPHOTERICIN B
CREAM; TOPICAL FUNGIZONE APOTHECON INJECTABLE; INJECTION AMPHOTERICIN B ABBOTT ABRAXIS PHARM TEVA PARENTERAL FUNGIZONE APOTHECON LOTION; TOPICAL FUNGIZONE APOTHECON OINTMENT; TOPICAL FUNGIZONE APOTHECON SUSPENSION; ORAL FUNGIZONE BRISTOL MYERS SQUIBB
6 - 29 (of 360)
3%
N050314
001
A064141 A062728 A064062 A060517
001 001 001 001
Dec 23, 1996 Apr 13, 1987 Mar 31, 1995
3%
A060570
001
3%
N050313
001
100MG/ML
N050341
003
AMPICILLIN SODIUM
INJECTABLE; INJECTION AMPICILLIN SODIUM APOTHECON
CONSOLIDATED PHARM
HANFORD GC
HIKMA MAPLE
INTL MEDICATION LILLY
MARSAM PHARMS LLC
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 125MG BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL
001 002 003 004 005 005 001 002 003 004 001 001 001 001 001 002 003 004 005 006 002 003 001 002 003 001 002 003 004 005 001 001 001 002 002 003 003 004 004
Feb Feb Feb Feb Feb
05, 05, 05, 05, 05,
1988 1988 1988 1988 1988
Apr Apr Apr Apr Jun Jun Jun Jun Jun Jun Jan Jan Apr Apr Jun Oct Oct Oct Oct Oct Sep
15, 15, 15, 15, 24, 24, 24, 24, 24, 24, 09, 09, 04, 04, 24, 24, 24, 24, 24, 24, 15,
1993 1993 1993 1993 1986 1986 1986 1986 1986 1986 1987 1987 1985 1985 1986 1988 1988 1988 1988 1988 1988
OMNIPEN-N WYETH AYERST
Dec 16, 1986 Dec 16, 1986 Dec 16, 1986 Dec 16, 1986

AMPICILLIN SODIUM
INJECTABLE; INJECTION OMNIPEN-N WYETH AYERST PENBRITIN-S WYETH AYERST
6 - 30 (of 360)
EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
A060626 A062718 N050072 N050072 N050072 N050072 N050072 N050072 N050309 N050309 N050309 N050309 N050309 A060677 A060677 A060677 A060677 A062727 A060677 A062727 A060677
005 005 001 002 003 004 005 006 001 002 003 004 005 001 002 003 004 001 005 002 006
Dec 16, 1986
POLYCILLIN-N BRISTOL
TOTACILLIN-N GLAXOSMITHKLINE
Dec 19, 1986 Dec 19, 1986

INJECTABLE; INJECTION UNASYN PFIZER
EQ 500MG BASE/VIAL;EQ 250MG BASE/VIAL
N050608
003
Dec 31, 1986
CAPSULE; ORAL AMCILL PARKE DAVIS AMPICILLIN TRIHYDRATE AM ANTIBIOTICS IVAX SUB TEVA PHARMS LEDERLE MYLAN PUREPAC PHARM TEVA VITARINE OMNIPEN (AMPICILLIN) WYETH AYERST PENBRITIN WYETH AYERST PFIZERPEN-A PFIZER
EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 003 001 002 001 002 001 002
250MG 500MG EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE

CAPSULE; ORAL POLYCILLIN BRISTOL PRINCIPEN APOTHECON BRISTOL MYERS SQUIBB PRINCIPEN '250' APOTHECON PRINCIPEN '500' APOTHECON TOTACILLIN GLAXOSMITHKLINE
6 - 31 (of 360)
EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ 250MG 500MG 250MG 500MG BASE BASE BASE BASE
N050310 N050310 A062888 A062888 A061392 A061392 A062157 N050056 A062157 N050056 A060060 A062212 A060060 A062212
001 002 001 002 001 002 002 001 001 002 001 001 002 002 Mar 04, 1988 Mar 04, 1988
EQ 250MG BASE EQ 250MG BASE EQ 500MG BASE EQ 500MG BASE EQ EQ EQ EQ 250MG 250MG 500MG 500MG BASE BASE BASE BASE
FOR SUSPENSION; ORAL AMCILL PARKE DAVIS AMPICILLIN TRIHYDRATE AM ANTIBIOTICS MYLAN PUREPAC PHARM TEVA OMNIPEN (AMPICILLIN) WYETH AYERST
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ EQ EQ EQ EQ 125MG 250MG 125MG 250MG 125MG 250MG 125MG 250MG BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062030 A062030 A061601 A061601 A061829 A061829 A061980 A061980 A061370 A061370 A060625 A060625 A060625 A060625 N050019 N050019 N050019 A062049 A062049 A062297 A062297 N050308 N050308 N050308 N050308 A061394 A061394 A061394 A060127 A062151 A060127 A062151
001 002 001 002 002 001 001 002 001 002 001 002 003 004 001 002 003 001 002 001 002 004 001 002 003 001 002 003 002 001 001 002
100MG/ML 125MG/5ML 250MG/5ML 500MG/5ML EQ 100MG BASE/ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ EQ EQ 125MG 250MG 100MG 125MG 250MG 500MG BASE/5ML BASE/5ML BASE/ML BASE/5ML BASE/5ML BASE/5ML
PENBRITIN WYETH AYERST
PFIZERPEN-A PFIZER POLYCILLIN APOTHECON BRISTOL
PRINCIPEN APOTHECON
EQ 100MG BASE/ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 250MG BASE/5ML
PRINCIPEN '125' APOTHECON PRINCIPEN '250' APOTHECON

TOTACILLIN
GLAXOSMITHKLINE
6 - 32 (of 360)
EQ EQ EQ EQ
125MG 125MG 250MG 250MG
A060666 A062223 A060666 A062223
001
001
002
002

POLYCILLIN
BRISTOL
EQ 125MG BASE
N050093
001
AMPICILLIN/AMPICILLIN TRIHYDRATE; PROBENECID

CAPSULE; ORAL
PRINCIPEN W/ PROBENECID
APOTHECON EQ EQ FOR SUSPENSION; ORAL
POLYCILLIN-PRB
APOTHECON EQ BRISTOL EQ PROBAMPACIN
TEVA EQ
389MG BASE;111MG 389MG BASE;111MG
A062150 N050488
001
001
3.5GM BASE/BOT;1GM/BOT 3.5GM BASE/BOT;1GM/BOT 3.5GM BASE/BOT;1GM/BOT
A061898 N050457 A061741
001
001
001
AMPRENAVIR
CAPSULE; ORAL AGENERASE GLAXOSMITHKLINE SOLUTION; ORAL AGENERASE GLAXOSMITHKLINE
50MG 150MG
N021007 N021007
001 002
Apr 15, 1999 Apr 15, 1999
15MG/ML **Federal Register notice determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N021039
001
Apr 15, 1999
ANAGRELIDE HYDROCHLORIDE
CAPSULE; ORAL AGRYLIN SHIRE LLC EQ ANAGRELIDE HYDROCHLORIDE ROXANE EQ EQ SANDOZ INC EQ EQ
1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE
N020333 A076489 A076489 A076683 A076683
002 001 002 001 002
Mar 14, 1997 Apr Apr Apr Apr 18, 18, 18, 18, 2005 2005 2005 2005
ANASTROZOLE
TABLET; ORAL ANASTROZOLE SYNTHON PHARMS
1MG
A078322
001
Jun 28, 2010
ANILERIDINE HYDROCHLORIDE
TABLET; ORAL
LERITINE
MERCK
EQ 25MG BASE
N010585
002
ANILERIDINE PHOSPHATE
LERITINE
MERCK
25MG/ML
N010520
003
ANISINDIONE
TABLET; ORAL
MIRADON
SCHERING
50MG
N010909
003

ANISOTROPINE METHYLBROMIDE
TABLET; ORAL ANISOTROPINE METHYLBROMIDE WATSON LABS 50MG VALPIN 50 ENDO PHARMS 50MG
6 - 33 (of 360)
A086046 N013428
001 001
ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE

SOLUTION/DROPS; OPHTHALMIC VASOCON-A NOVARTIS 0.5%;0.05%
N018746
002
Jul 11, 1994
APOMORPHINE HYDROCHLORIDE
INJECTABLE; SUBCUTANEOUS APOKYN US WORLDMEDS
20MG/2ML (10MG/ML)
N021264
001
Apr 20, 2004
APROTININ
INJECTABLE; INJECTION TRASYLOL BAYER HLTHCARE
10,000KIU/ML
N020304
001
Dec 29, 1993
ARBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION GENESA GENSIA AUTOMEDICS
0.05MG/ML
N020420
001
Sep 12, 1997
ARDEPARIN SODIUM
INJECTABLE; INJECTION NORMIFLO PHARMACIA AND UPJOHN
5,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 10,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020227
002
May 23, 1997
N020227
001
May 23, 1997
ARGATROBAN
SOLUTION; IV (INFUSION) ARGATROBAN IN DEXTROSE SANDOZ
N201743
001
May 09, 2011
ARIPIPRAZOLE
TABLET, ORALLY DISINTEGRATING; ORAL ABILIFY OTSUKA 20MG **Federal Register determination that the product was not discontinued or withdrawn for safety or efficacy reasons** 30MG **Federal Register determination that the product was not discontinued or withdrawn for safety or efficacy reasons**
N021729
004
Jun 07, 2006
N021729
005
Jun 07, 2006
ARMODAFINIL
TABLET; ORAL NUVIGIL CEPHALON
100MG 200MG
N021875 N021875
002 005
Mar 26, 2009 Mar 26, 2009
6 - 34 (of 360)
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN E
BEROCCA PN
ROCHE
50MG/ML;0.03MG/ML;0.0025MG/ML;7.5MG/ML; N006071 100 IU/ML;0.2MG/ML;20MG/ML;2MG/ML;1.8MG/ML; 1.5MG/ML;1,650 IU/ML;5 IU/ML
003
Oct 10, 1985
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
INJECTABLE; INJECTION M.V.C. 9+3 ABRAXIS PHARM
10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N018440 0 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ ML;0.3MG/ML;330 UNITS/ML;1 IU/ML 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N008809 0 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ ML;0.3MG/ML;330 UNITS/ML;1 IU/ML 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N018439 0 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ ML;0.3MG/ML;330 UNITS/ML;1 IU/ML
002
Aug 08, 1985
M.V.I.-12 HOSPIRA
004
Aug 08, 1985
MVC PLUS WATSON LABS
002
Aug 08, 1985
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
M.V.I.-12
HOSPIRA
20MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N008809 0 IU/ML;0.6MG/ML;4MG/ML;0.4MG/ML;0.36MG/M L;0.6MG/ML;330 UNITS/ML;1 IU/ML
005
Apr 22, 2004
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE; VITAMIN A; VITAMIN E
M.V.I.-12 LYOPHILIZED
ASTRAZENECA
100MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15M N018933 G/VIAL;5MCG/VIAL;0.4MG/VIAL;40MG/VIAL;4 MG/VIAL;3.6MG/VIAL;3MG/VIAL;1MG/VIAL;10 MG/VIAL
002
Aug 08, 1985
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E
VITAPED
HOSPIRA
N/A,80MG/VIAL;N/A,0.02MG/VIAL;N/A,0.001 N020176 MG/VIAL;400 IU/10ML,N/A;N/A,0.14MG/VIAL;N/A,17MG/VI AL;N/A,5MG/VIAL;0.2MG/10ML,N/A;N/A,1MG/ VIAL;N/A,1.4MG/VIAL;N/A,1.2MG/VIAL;EQ 2,300 UNITS BASE/10ML,N/A;7 IU/10ML,N/A
001
Dec 29, 1993
ASPIRIN
TABLET; ORAL BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN BAYER 500MG TABLET, EXTENDED RELEASE; ORAL 8-HOUR BAYER BAYER 650MG
N021317
001
Oct 18, 2001
N016030
001

ASPIRIN
TABLET, EXTENDED RELEASE; ORAL MEASURIN BAYER 650MG
6 - 35 (of 360)
N016030
002
ASPIRIN; BUTALBITAL
TABLET; ORAL AXOTAL SAVAGE LABS
650MG;50MG
A088305
001
Oct 13, 1983
ASPIRIN; BUTALBITAL; CAFFEINE

CAPSULE; ORAL BUTALBITAL, ASPIRIN AND CAFFEINE MUTUAL PHARM 325MG;50MG;40MG WATSON LABS 325MG;50MG;40MG TABLET; ORAL BUTALBITAL, ASPIRIN AND CAFFEINE ACTAVIS ELIZABETH 325MG;50MG;40MG HALSEY 325MG;50MG;40MG IVAX PHARMS 325MG;50MG;40MG PURACAP PHARM 325MG;50MG;40MG QUANTUM PHARMICS 325MG;50MG;40MG SANDOZ 325MG;50MG;40MG WATSON LABS 325MG;50MG;40MG FIORINAL WATSON LABS INC 325MG;50MG;40MG LANORINAL LANNETT 325MG;50MG;40MG
A078149 A086231
001 002
Jun 13, 2007 Feb 12, 1985
A086710 A089448 A085441 A087048 A088972 A086398 A086237 N017534 A086986
002 001 002 002 001 002 002 003 002
Aug Dec Oct Dec Jun Apr Mar
23, 01, 31, 09, 18, 06, 23,
1983 1986 1984 1983 1985 1984 1984
Apr 16, 1986 Oct 18, 1985
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

CAPSULE; ORAL BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE VINTAGE PHARMS LLC 325MG;50MG;40MG;30MG
A075351
001
Mar 05, 1999
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

TABLET; ORAL INVAGESIC SANDOZ INVAGESIC FORTE SANDOZ ORPHENGESIC SOLCO HLTHCARE ORPHENGESIC FORTE SOLCO HLTHCARE
385MG;30MG;25MG 770MG;60MG;50MG 385MG;30MG;25MG 770MG;60MG;50MG
A074817 A074817 A075141 A075141
001 002 001 002
Nov 27, 1996 Nov 27, 1996 May 29, 1998 May 29, 1998
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE

CAPSULE; ORAL COMPOUND 65 ALRA 389MG;32.4MG;65MG DARVON COMPOUND XANODYNE PHARM 389MG;32.4MG;32MG DARVON COMPOUND-65 XANODYNE PHARM 389MG;32.4MG;65MG PROPOXYPHENE COMPOUND 65 IVAX SUB TEVA PHARMS 389MG;32.4MG;65MG SANDOZ 389MG;32.4MG;65MG TEVA 389MG;32.4MG;65MG PROPOXYPHENE COMPOUND-65 SANDOZ 389MG;32.4MG;65MG PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE WATSON LABS 389MG;32.4MG;65MG
A084553 N010996 N010996 A083077 A080044 A089025 A083101 A085732
002 006 007 002 002 001 002 002
Aug 17, 1983 Mar 08, 1983 Mar 08, 1983 Dec 07, 1984 Sep 16, 1983 Mar 29, 1985 Jun 24, 1985 Sep 03, 1984

ASPIRIN; CARISOPRODOL
TABLET; ORAL CARISOPRODOL COMPOUND WATSON LABS
6 - 36 (of 360)
325MG;200MG
A088809
001
Oct 03, 1985
ASPIRIN; HYDROCODONE BITARTRATE

TABLET; ORAL
AZDONE
SCHWARZ PHARMA
500MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 500MG;5MG
A089420
001
Jan 25, 1988
VICOPRIN ABBOTT
A086333
001
Sep 14, 1983
ASPIRIN; MEPROBAMATE
TABLET; ORAL EQUAGESIC CARACO MEPRO-ASPIRIN SANDOZ MEPROBAMATE AND ASPIRIN PAR PHARM MICRAININ MEDPOINTE PHARM HLC Q-GESIC QUANTUM PHARMICS
325MG;200MG 325MG;200MG 325MG;200MG 325MG;200MG 325MG;200MG
N011702 A089127 A089126 A084978 A088740
003 001 001 001 001
Dec 29, 1983 Mar 02, 1987 Aug 19, 1986
Jun 01, 1984
ASPIRIN; METHOCARBAMOL
TABLET; ORAL METHOCARBAMOL AND ASPIRIN IVAX SUB TEVA PHARMS 325MG;400MG MCNEIL 325MG;400MG PAR PHARM 325MG;400MG ROBAXISAL
ROBINS AH 325MG;400MG
A087211 A089193 A089657 N012281
001 001 001 001
Dec 22, 1982 Feb 12, 1986 Nov 04, 1988
ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE

TABLET; ORAL CODOXY HALSEY OXYCODONE AND ASPIRIN MUTUAL PHARM
325MG;4.5MG;0.38MG
A087464 A040260 A087794 A087742 N007337 N007337 A087743
001 001 001 001 006 005 001
Jul 01, 1982 Jul 17, 1998 May 26, 1982 Jun 04, 1982
325MG;4.5MG;0.38MG 325MG;4.5MG;0.38MG OXYCODONE AND ASPIRIN (HALF-STRENGTH) ROXANE 325MG;2.25MG;0.19MG PERCODAN ENDO PHARMS 325MG;4.5MG;0.38MG PERCODAN-DEMI ENDO PHARMS 325MG;2.25MG;0.19MG ROXIPRIN ROXANE 325MG;4.5MG;0.38MG
Jun 04, 1982
ASPIRIN; PENTAZOCINE HYDROCHLORIDE

TABLET; ORAL
TALWIN COMPOUND
SANOFI AVENTIS US
325MG;EQ 12.5MG BASE
N016891
001
ASPIRIN; PRAVASTATIN SODIUM

TABLET, TABLET; ORAL PRAVIGARD PAC (COPACKAGED) BRISTOL MYERS SQUIBB 325MG,N/A;N/A,80MG
N021387
006
Jun 24, 2003

ASPIRIN; PRAVASTATIN SODIUM
TABLET, TABLET, TABLET; ORAL
PRAVIGARD PAC (COPACKAGED)
BRISTOL MYERS SQUIBB 81MG,N/A;N/A,20MG 81MG,N/A;N/A,40MG 81MG,N/A;N/A,80MG 325MG,N/A;N/A,20MG 325MG,N/A;N/A,40MG
6 - 37 (of 360)
N021387 N021387 N021387 N021387 N021387
001 002 003 004 005
Jun Jun Jun Jun Jun
24, 24, 24, 24, 24,
2003 2003 2003 2003 2003
ASPIRIN; PROPOXYPHENE HYDROCHLORIDE

CAPSULE; ORAL
DARVON W/ ASA
XANODYNE PHARM
325MG;65MG
N010996
005
ASPIRIN; PROPOXYPHENE NAPSYLATE

CAPSULE; ORAL
DARVON-N W/ AAIPHARMA TABLET; ORAL
DARVON-N W/ AAIPHARMA ASA
LLC ASA
LLC
325MG;100MG
N016829
001
325MG;100MG
N016863
001
ATENOLOL
TENORMIN
ASTRAZENECA
0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N019058
001
Sep 13, 1989
TABLET; ORAL
ATENOLOL
ABLE
APOTHECON NOSTRUM LABS PLIVA
SANDOZ
SCS TEVA TEVA PHARMS
25MG 50MG 100MG 50MG 100MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG
001 002 003 001 001 001 002 001 002 003 001 002 003 001 002 001 001 001 002
Jul Jul Jul Mar Mar Feb Feb Jul Jul Jul Feb Feb Feb Oct Oct May May Feb Feb
30, 30, 30, 20, 20, 21, 21, 17, 17, 17, 28, 28, 28, 30, 30, 28, 28, 24, 24,
2004 2004 2004 1992 1992 1995 1995 1997 1997 1997 1994 1994 1994 1992 1992 1993 1993 1995 1995
ATENOLOL; CHLORTHALIDONE
TABLET; ORAL
ATENOLOL AND CHLORTHALIDONE
NOSTRUM LABS 50MG;25MG 100MG;25MG PLIVA 50MG;25MG 100MG;25MG
A074404 A074404 A074107 A074107
001 002 001 002
May May Sep Sep
14, 14, 24, 24,
1998 1998 1997 1997
CAPSULE; ORAL ATOMOXETINE HYDROCHLORIDE ZYDUS PHARMS USA INC 18MG 25MG
A079017 A079017
001 002
Sep 17, 2010 Sep 17, 2010

CAPSULE; ORAL
ZYDUS PHARMS USA INC 40MG 60MG 80MG 100MG STRATTERA LILLY 5MG
6 - 38 (of 360)
A079017 A079017 A079017 A079017 N021411
003 004 005 006 001
Sep Sep Sep Sep
17, 17, 17, 17,
2010 2010 2010 2010
Nov 26, 2002
TABLET; ORAL
TEVA PHARMS
EQ EQ EQ EQ
10MG 20MG 40MG 80MG
BASE BASE BASE BASE
A078773 A078773 A078773 A078773
001 002 003 004
May May May May
29, 29, 29, 29,
2012 2012 2012 2012
ATOVAQUONE
TABLET; ORAL
MEPRON
GLAXOSMITHKLINE LLC
250MG **Federal Register determination that product was not discontinued or withdrawn for safety of efficacy reasons**
N020259
001
Nov 25, 1992
ATRACURIUM BESYLATE
INJECTABLE; INJECTION ATRACURIUM BESYLATE BAXTER HLTHCARE BAXTER HLTHCARE CORP HOSPIRA
10MG/ML 10MG/ML 10MG/ML 10MG/ML MARSAM PHARMS LLC 10MG/ML TEVA PARENTERAL 10MG/ML ATRACURIUM BESYLATE PRESERVATIVE FREE BAXTER HLTHCARE 10MG/ML BAXTER HLTHCARE CORP 10MG/ML HOSPIRA 10MG/ML 10MG/ML 10MG/ML MARSAM PHARMS LLC 10MG/ML TRACRIUM HOSPIRA 10MG/ML TRACRIUM PRESERVATIVE FREE HOSPIRA 10MG/ML
A074824 A074753 A074632 A074740 A074945 A074784 A074825 A074768 A074633 A074639 A074741 A074944 N018831 N018831
001 001 001 001 001 001 001 001 001 001 001 001 002 001
Sep Jan Dec Mar Jul Jun Sep Jan Dec Mar Mar Jul
30, 23, 23, 28, 28, 11, 30, 23, 23, 25, 28, 28,
1997 1997 1996 1997 1998 1997 1997 1997 1996 1997 1997 1998
Jun 20, 1985 Nov 23, 1983
ATROPINE
INJECTABLE; INJECTION ATROPINE ABBVIE
EQ 2MG SULFATE/0.7ML
A071295
001
Jan 30, 1987
ATROPINE SULFATE
AEROSOL, METERED; INHALATION ATROPINE SULFATE US ARMY EQ 0.36MG BASE/INH
N020056
001
Sep 19, 1990
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE

TABLET; ORAL
MOTOFEN HALF-STRENGTH
VALEANT
0.025MG;0.5MG
N017744
001

ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
CAPSULE; ORAL DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE SCHERER RP 0.025MG;2.5MG SOLUTION; ORAL COLONAID MEDPOINTE PHARM HLC 0.025MG/5ML;2.5MG/5ML LOMANATE ALPHARMA US PHARMS 0.025MG/5ML;2.5MG/5ML LOMOTIL GD SEARLE LLC 0.025MG/5ML;2.5MG/5ML TABLET; ORAL COLONAID MEDPOINTE PHARM HLC 0.025MG;2.5MG DI-ATRO MD PHARM 0.025MG;2.5MG DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE ABLE 0.025MG;2.5MG ASCOT 0.025MG;2.5MG HEATHER 0.025MG;2.5MG INWOOD LABS 0.025MG;2.5MG IVAX PHARMS 0.025MG;2.5MG KV PHARM 0.025MG;2.5MG LEDERLE 0.025MG;2.5MG MUTUAL PHARM 0.025MG;2.5MG PARKE DAVIS 0.025MG;2.5MG PVT FORM 0.025MG;2.5MG R AND S PHARMA 0.025MG;2.5MG ROXANE 0.025MG;2.5MG SANDOZ 0.025MG;2.5MG USL PHARMA 0.025MG;2.5MG VALEANT PHARM INTL 0.025MG;2.5MG WATSON LABS 0.025MG;2.5MG WEST WARD 0.025MG;2.5MG LOGEN SUPERPHARM 0.025MG;2.5MG LO-TROL VANGARD 0.025MG;2.5MG LOW-QUEL HALSEY 0.025MG;2.5MG
6 - 39 (of 360)
A086440
001
A085735 A085746 N012699
001 001 001
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Nov 27, 2000 Jul 19, 1983
Mar 29, 1982 Feb 16, 1982 Mar 15, 1982 May 10, 1985 Mar 25, 1983
ATROPINE SULFATE; EDROPHONIUM CHLORIDE

INJECTABLE; INJECTION ENLON-PLUS MYLAN INSTITUTIONAL
0.14MG/ML;10MG/ML
N019677
001
Nov 06, 1991
ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE

INJECTABLE; INJECTION ATROPINE AND DEMEROL ABBVIE
0.4MG/ML;50MG/ML 0.4MG/ML;75MG/ML 0.4MG/ML;100MG/ML MEPERIDINE AND ATROPINE SULFATE WYETH AYERST 0.4MG/ML;50MG/ML 0.4MG/ML;75MG/ML 0.4MG/ML;100MG/ML
A087853 A087847 A087848 A085121 A085121 A085121
001 001 001 001 002 003
Nov 26, 1982 Nov 26, 1982 Nov 26, 1982
ATROPINE; PRALIDOXIME CHLORIDE

INJECTABLE; INTRAMUSCULAR ATNAA US ARMY 2.1MG/0.7ML;600MG/0.7ML
N021175
001
Jan 17, 2002

AZATADINE MALEATE
TABLET; ORAL
OPTIMINE
SCHERING
6 - 40 (of 360)
1MG
N017601
001
AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE

TABLET, EXTENDED RELEASE; ORAL TRINALIN SCHERING 1MG;120MG
N018506
001
Mar 23, 1982
AZATHIOPRINE
TABLET; ORAL
IMURAN
PROMETHEUS LABS
25MG
N016324
002
AZATHIOPRINE SODIUM
IMURAN
PROMETHEUS LABS
EQ 100MG BASE/VIAL
N017391
001
AZELASTINE HYDROCHLORIDE
SPRAY, METERED; NASAL ASTEPRO MEDA PHARMS
EQ 0.125MG BASE/SPRAY
N022203
001
Oct 15, 2008
AZITHROMYCIN
CAPSULE; ORAL
ZITHROMAX
PFIZER
EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N050670
001
Nov 01, 1991
FOR SUSPENSION; ORAL AZITHROMYCIN SANDOZ INJECTABLE; INJECTION AZITHROMYCIN PLIVA HRVATSKA DOO TEVA PARENTERAL
A065297 A065297
001 002
Sep 18, 2006 Sep 18, 2006
EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 2.5GM BASE/VIAL
A065265 N050809 N050809
001 001 002
Jan 18, 2007 Dec 19, 2006 Dec 19, 2006
AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE

FOR SUSPENSION, TABLET; ORAL TROVAN/ZITHROMAX COMPLIANCE PAK PFIZER EQ 1GM BASE,N/A;N/A,EQ 100MG BASE
N050762
001
Dec 18, 1998
AZLOCILLIN SODIUM
AZLIN
BAYER PHARMS
2GM 2GM 2GM 3GM 3GM 3GM 4GM 4GM 4GM
BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
A062388 A062417 N050562 A062388 A062417 N050562 A062388 A062417 N050562
001 001 001 002 002 002 003 003 003
Sep Oct Sep Sep Oct Sep Sep Oct Sep
08, 12, 03, 08, 12, 03, 08, 12, 03,
1982 1982 1982 1982 1982 1982 1982 1982 1982
AZTREONAM
INJECTABLE; INJECTION AZACTAM BRISTOL MYERS SQUIBB
500MG/VIAL
N050580
001
Dec 31, 1986

AZTREONAM
INJECTABLE; INJECTION AZACTAM IN PLASTIC CONTAINER BRISTOL MYERS SQUIBB 10MG/ML
6 - 41 (of 360)
N050632
003
May 24, 1989
BACAMPICILLIN HYDROCHLORIDE
FOR SUSPENSION; ORAL SPECTROBID PFIZER TABLET; ORAL SPECTROBID PFIZER
125MG/5ML
N050556
001
Mar 23, 1982
400MG 800MG
N050520 N050520
001 002
Sep 12, 1983
BACITRACIN
INJECTABLE; INJECTION BACITRACIN PFIZER 50,000 UNITS/VIAL OINTMENT; OPHTHALMIC BACIGUENT PHARMACIA AND UPJOHN 500 UNITS/GM BACITRACIN LILLY 500 UNITS/GM PHARMADERM 500 UNITS/GM PHARMAFAIR 500 UNITS/GM OINTMENT; TOPICAL BACITRACIN COMBE 500 UNITS/GM NASKA 500 UNITS/GM POWDER; FOR RX COMPOUNDING BACITRACIN APOTHEKERNES 5,000,000 UNITS/BOT PADDOCK LLC 5,000,000 UNITS/BOT
A060282
001
A060734 A060687 A062158 A062453
001 001 001 001
Mar 28, 1984
A062799 A062857
001 001
May 14, 1987 Nov 13, 1987
A061699 A062456
001 001
Jul 27, 1983
BACITRACIN ZINC
ZIBA-RX
X GEN PHARMS 500,000 UNITS/BOT
A061737
001
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

CORTISPORIN
MONARCH PHARMS
400 UNITS/GM;1%;EQ 3.5MG N050416 BASE/GM;10,000 UNITS/GM

ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE
PHARMAFAIR 400 UNITS/GM;1%;EQ 3.5MG A062389 BASE/GM;10,000 UNITS/GM OINTMENT; TOPICAL NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE PHARMAFAIR 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 A062381 UNITS/GM
002
001
Jul 02, 1982
001
Sep 06, 1985
BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

OINTMENT; TOPICAL LANABIOTIC COMBE
400 UNITS/GM;40MG/GM;EQ 5MG BASE/GM;5,000 UNITS/GM
A062499
001
Jun 03, 1985

OINTMENT; OPHTHALMIC BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE PHARMAFAIR 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
A062386
001
Sep 09, 1982

OINTMENT; OPHTHALMIC BACITRACIN-NEOMYCIN-POLYMYXIN PHARMADERM 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM NEO-POLYCIN DOW PHARM 500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM NEOSPORIN MONARCH PHARMS 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM OINTMENT; TOPICAL BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE NASKA 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM
6 - 42 (of 360)
A062167
001
A060647
001
N050417
001
A062833
001
Nov 09, 1987
BACITRACIN ZINC; POLYMYXIN B SULFATE

AEROSOL; TOPICAL POLYSPORIN GLAXOSMITHKLINE 10,000 UNITS/GM;2,000,000 UNITS/GM OINTMENT; OPHTHALMIC OCUMYCIN PHARMAFAIR 500 UNITS/GM;10,000 UNITS/GM POLYSPORIN MONARCH PHARMS 500 UNITS/GM;10,000 UNITS/GM OINTMENT; TOPICAL BACITRACIN ZINC-POLYMYXIN B SULFATE NASKA 500 UNITS/GM;10,000 UNITS/GM
N050167
002
Mar 01, 1985
A062430 A061229
001 001
Apr 08, 1983
A062849
001
Nov 13, 1987
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
ALTANA 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
A060731
002
BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

MYCITRACIN
500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
A061048
001
BACITRACIN; POLYMYXIN B SULFATE

DISC; TOPICAL LANABIOTIC COMBE
500 UNITS/GM;5,000 UNITS/GM
N050598
001
Sep 22, 1986
BACLOFEN
TABLET; ORAL BACLOFEN TEVA USL PHARMA WATSON LABS
A073043 A073044 A071260 A071261 A073092 A074698 A073093 A074698 N017851 N017851
001 001 001 001 001 001 001 002 001 003
Feb Feb May May Jan Aug Jan Aug
27, 27, 06, 06, 28, 20, 28, 20,
1992 1992 1988 1988 1994 1996 1994 1996
10MG 20MG TABLET, ORALLY DISINTEGRATING; ORAL KEMSTRO UCB INC 10MG 20MG
LIORESAL NOVARTIS
Jan 20, 1982
N021589 N021589
001 002
Oct 30, 2003 Oct 30, 2003

AEROSOL, METERED; INHALATION BECLOVENT GLAXOSMITHKLINE 0.042MG/INH VANCERIL SCHERING 0.042MG/INH VANCERIL DOUBLE STRENGTH SCHERING 0.084MG/INH AEROSOL, METERED; NASAL BECONASE GLAXOSMITHKLINE 0.042MG/INH VANCENASE SCHERING 0.042MG/INH
6 - 43 (of 360)
N018153 N017573 N020486
001 001 001 Dec 24, 1996
N018584 N018521
001 001
BECLOMETHASONE DIPROPIONATE MONOHYDRATE

SPRAY, METERED; NASAL VANCENASE AQ SCHERING
EQ 0.042MG DIPROP/SPRAY EQ 0.084MG DIPROP/SPRAY
N019589 N020469
001 001
Dec 23, 1987 Jun 26, 1996
TABLET; ORAL BENAZEPRIL HYDROCHLORIDE GENPHARM 5MG 10MG 20MG 40MG
A076476 A076476 A076476 A076476
001 002 003 004
Feb Feb Feb Feb
11, 11, 11, 11,
2004 2004 2004 2004
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

TABLET; ORAL BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE MYLAN PHARMS INC 5MG;6.25MG 10MG;12.5MG 20MG;12.5MG 20MG;25MG
A076612 A076612 A076612 A076612
001 002 003 004
Feb Feb Feb Feb
11, 11, 11, 11,
2004 2004 2004 2004
BENDROFLUMETHIAZIDE
TABLET; ORAL NATURETIN-10 APOTHECON NATURETIN-2.5 APOTHECON NATURETIN-5 APOTHECON
10MG 2.5MG 5MG
N012164 N012164 N012164
003 001 002
BENOXINATE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC BENOXINATE HYDROCHLORIDE SOLA BARNES HIND 0.4%
A084149
001
BENTIROMIDE
SOLUTION; ORAL CHYMEX SAVAGE LABS
500MG/7.5ML
N018366
001
Dec 29, 1983
BENZONATATE
CAPSULE; ORAL BENZONATATE NESHER PHARMS
100MG 200MG
A040795 A040795
001 002
Oct 31, 2007 Oct 31, 2007

TABLET; ORAL DIDREX PHARMACIA AND UPJOHN
6 - 44 (of 360)
25MG
N012427
003
BENZQUINAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION EMETE-CON PFIZER SUPPOSITORY; RECTAL EMETE-CON ROERIG
EQ 50MG BASE/VIAL
N016820
001
EQ 100MG BASE
N016818
006
BENZTHIAZIDE
TABLET; ORAL AQUATAG SOLVAY BENZTHIAZIDE PVT FORM EXNA AH ROBINS INC FOVANE PFIZER URESE PFIZER
N016001 N016001 A083206 N012489 N012128 N012128
001 002 001 001 002 003
TABLET; ORAL BENZTROPINE MESYLATE LANNETT HOLDINGS INC
MUTUAL PHARM QUANTUM PHARMICS
USL PHARMA
0.5MG 1MG 2MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG
A088877 A088894 A088895 A081264 A081265 A088514 A088510 A088511 A089211 A089212 A089213 N009193 N009193 N009193
001 001 001 001 001 001 001 001 001 001 001 004 003 002
Apr Apr Apr Jan Jan Jan Jan Jan Jun Jun Jun
11, 11, 11, 23, 23, 31, 31, 31, 14, 14, 14,
1985 1985 1985 1992 1992 1984 1984 1984 1988 1988 1988
COGENTIN MERCK
BENZYL BENZOATE
EMULSION; TOPICAL BENZYL BENZOATE LANNETT
50%
A084535
001
BEPRIDIL HYDROCHLORIDE
TABLET; ORAL BEPADIN MEDPOINTE PHARM HLC
200MG 300MG 400MG 200MG 300MG 400MG
N019001 N019001 N019001 N019002 N019002 N019002
001 002 003 001 002 003
Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Dec 28, 1990
VASCOR JOHNSON AND JOHNSON

BETA CAROTENE
CAPSULE; ORAL SOLATENE ROCHE
6 - 45 (of 360)
30MG
N017589
001
BETAMETHASONE
CREAM; TOPICAL CELESTONE SCHERING SYRUP; ORAL CELESTONE SCHERING TABLET; ORAL CELESTONE SCHERING
0.2%
N014762
001
0.6MG/5ML
N014215
002
0.6MG
N012657
003
BETAMETHASONE BENZOATE
CREAM; TOPICAL UTICORT PARKE DAVIS GEL; TOPICAL UTICORT PARKE DAVIS LOTION; TOPICAL UTICORT PARKE DAVIS OINTMENT; TOPICAL UTICORT PARKE DAVIS
0.025%
N016998
002
0.025%
N017244
001
0.025%
N017528
001
0.025%
N018089
001
CREAM; TOPICAL ALPHATREX SAVAGE LABS EQ 0.05% BASE BETAMETHASONE DIPROPIONATE PERRIGO NEW YORK EQ 0.05% BASE EQ 0.05% BASE PHARMADERM EQ 0.05% BASE TARO EQ 0.05% BASE TEVA EQ 0.05% BASE DIPROSONE SCHERING EQ 0.05% BASE CREAM, AUGMENTED; TOPICAL DIPROLENE SCHERING EQ 0.05% BASE DISC; TOPICAL DIPROSONE SCHERING EQ 0.1% BASE GEL, AUGMENTED; TOPICAL DIPROLENE SCHERING EQ 0.05% BASE LOTION; TOPICAL ALPHATREX SAVAGE LABS EQ 0.05% BASE BETAMETHASONE DIPROPIONATE ALPHARMA US PHARMS EQ 0.05% BASE PHARMADERM EQ 0.05% BASE TARO EQ 0.05% BASE EQ 0.05% BASE TEVA PHARMS EQ 0.05% BASE DIPROSONE SCHERING EQ 0.05% BASE
N019138 A072536 A074579 N019136 A071143 A071476 N017536
001 001 001 001 001 001 001
Jun 26, 1984 Jan Nov Jun Jun Aug 31, 26, 26, 17, 10, 1990 1997 1984 1987 1987
N019408
001
Jan 31, 1986
N017829
001
N019408
002
Nov 22, 1991
A070273 A071085 A070274 A072276 A074272 A071882 N017781
001 001 001 001 001 001 001
Aug 12, 1985 Feb Aug Aug Sep Jun 03, 12, 24, 30, 06, 1987 1985 1988 1994 1988

OINTMENT; TOPICAL ALPHATREX SAVAGE LABS EQ BETAMETHASONE DIPROPIONATE PERRIGO NEW YORK EQ PHARMADERM EQ TEVA EQ DIPROSONE
SCHERING EQ
6 - 46 (of 360)
N019143 A072526 N019140 A071477 N017691
001 001 001 001 001
Sep 04, 1984 Jan 31, 1990 Sep 04, 1984 Aug 10, 1987
BETAMETHASONE SODIUM PHOSPHATE

BETAMETHASONE SODIUM PHOSPHATE
WATSON LABS EQ 3MG BASE/ML CELESTONE
SCHERING EQ 3MG BASE/ML **Federal Register determination that product was not
A085738 N017561
001
001
BETAMETHASONE VALERATE
CREAM; TOPICAL BETADERM ROACO BETAMETHASONE VALERATE PERRIGO NEW YORK PHARMADERM PHARMAFAIR TARO BETATREX SAVAGE LABS VALISONE SCHERING LOTION; TOPICAL BETAMETHASONE VALERATE PHARMADERM PHARMAFAIR TEVA PHARMS BETATREX SAVAGE LABS VALISONE SCHERING OINTMENT; TOPICAL BETAMETHASONE VALERATE PERRIGO NEW YORK PHARMADERM PHARMAFAIR BETATREX SAVAGE LABS BETA-VAL TEVA VALISONE SCHERING
EQ 0.1% BASE EQ EQ EQ EQ 0.1% 0.1% 0.1% 0.1% BASE BASE BASE BASE
N018839 A070053 N018860 A070485 A070062 N018862 N016322 N016322
001 001 002 001 001 001 002 001
Jun 30, 1983 Jun Aug May May 10, 31, 29, 14, 1986 1983 1987 1985
Aug 31, 1983
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE
N018870 A070484 A071883 N018867 N016932
001 001 001 001 001
Aug 31, 1983 May 29, 1987 Apr 22, 1988 Aug 31, 1983
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE
A071478 N018864 A070486 N018863 A070069 N016740
001 001 001 001 001 001
Dec 23, 1987 Aug 31, 1983 May 29, 1987 Aug 31, 1983 Dec 19, 1985
BETAXOLOL HYDROCHLORIDE
TABLET; ORAL KERLONE SANOFI AVENTIS US
10MG 20MG
N019507 N019507
001 002
Oct 27, 1989 Oct 27, 1989

BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE
TABLET; ORAL KERLEDEX SANOFI AVENTIS US
6 - 47 (of 360)
5MG;12.5MG 10MG;12.5MG
N019807 N019807
001 002
Oct 30, 1992 Oct 30, 1992
BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE

SUSPENSION/DROPS; OPHTHALMIC BETOPTIC PILO ALCON EQ 0.25% BASE;1.75%
N020619
001
Apr 17, 1997
BETAZOLE HYDROCHLORIDE
HISTALOG
LILLY
50MG/ML
N009344
001
URECHOLINE
ODYSSEY PHARMS
5MG/ML **Federal Register determination that product was not

N006536
001
TABLET; ORAL
ABLE
ACTAVIS TOTOWA
ASCOT IVAX SUB TEVA PHARMS LANNETT
SANDOZ
WATSON LABS
5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 10MG 25MG 25MG 5MG 10MG 25MG 5MG 10MG 10MG 25MG 25MG 5MG 5MG 5MG 10MG 10MG 10MG 25MG 25MG 25MG 50MG 50MG 5MG 10MG 25MG 5MG 10MG 25MG 50MG
A040492 A040483 A040485 A040509 A040552 A040553 A040554 A040551 A088288 A088289 A084689 A084702 A084712 A084074 A084353 A084378 A084379 A084383 A084384 A084402 A085230 A085841 A084408 A085228 A085842 A084441 A085229 A085839 A087397 A087444 A084188 A084188 A084188 N006536 N006536 N006536 N006536
001 001 001 001 001 001 001 001 001 001 001 001 001
001
001
001
001
001
001
001
002
001
001
001
001
001
001
001
001
001
001
003
004
003
002
004
005
Jul Jul Jul Jul Oct Oct Oct Oct Jun Jun
27, 27, 27, 27, 28, 28, 28, 28, 08, 08,
2004 2004 2004 2004 2004 2004 2004 2004 1983 1983
MYOTONACHOL GLENWOOD
URECHOLINE ODYSSEY PHARMS

BETHANIDINE SULFATE
TABLET; ORAL
TENATHAN
ROBINS AH
6 - 48 (of 360)
10MG 25MG
N017675 N017675
001
002
BIPERIDEN LACTATE
AKINETON
ABBVIE
5MG/ML
N012418
002
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
FOR SOLUTION, TABLET, DELAYED RELEASE; ORAL HALFLYTELY BRAINTREE 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM N021551 ;N/A,5.6GM
002
Sep 24, 2007
BISOPROLOL FUMARATE
TABLET; ORAL BISOPROLOL FUMARATE MUTUAL PHARM
5MG 10MG
A075474 A075474
001 002
Oct 25, 2002 Oct 25, 2002
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE

TABLET; ORAL
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
ACTAVIS ELIZABETH 2.5MG;6.25MG 5MG;6.25MG 10MG;6.25MG APOTHECON 2.5MG;6.25MG 5MG;6.25MG 10MG;6.25MG IVAX SUB TEVA PHARMS 2.5MG;6.25MG 5MG;6.25MG 10MG;6.25MG SANDOZ 2.5MG;6.25MG 5MG;6.25MG 10MG;6.25MG TEVA 2.5MG;6.25MG 5MG;6.25MG 10MG;6.25MG
001 002 003 002 001 003 001 002 003 001 003 002 001 002 003
Sep Sep Sep Dec Dec Dec Sep Sep Sep Sep Sep Sep Jan Jan Jan
25, 25, 25, 27, 27, 27, 27, 27, 27, 25, 25, 25, 19, 19, 19,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2001 2001 2001
BITOLTEROL MESYLATE
AEROSOL, METERED; INHALATION TORNALATE SANOFI AVENTIS US 0.37MG/INH SOLUTION; INHALATION TORNALATE SANOFI AVENTIS US 0.2%
N018770
001
Dec 28, 1984
N019548
001
Feb 19, 1992
BLEOMYCIN SULFATE
INJECTABLE; INJECTION BLENOXANE BRISTOL MYERS SQUIBB BLEOMYCIN SULFATE TEVA PARENTERAL
EQ 15 UNITS BASE/VIAL EQ 30 UNITS BASE/VIAL EQ 15 UNITS BASE/VIAL EQ 30 UNITS BASE/VIAL
N050443 N050443 A064084 A064084
001 002 001 002
Sep 07, 1995 Jun 01, 1996 Jun 01, 1996

BRETYLIUM TOSYLATE
INJECTABLE; INJECTION BRETYLIUM TOSYLATE ABRAXIS PHARM
6 - 49 (of 360)
50MG/ML 100MG/ML ASTRAZENECA 50MG/ML 50MG/ML 50MG/ML HIKMA MAPLE 50MG/ML 50MG/ML HOSPIRA 50MG/ML 50MG/ML INTL MEDICATION 50MG/ML LUITPOLD 50MG/ML BRETYLIUM TOSYLATE IN DEXTROSE 5% ABBOTT 200MG/100ML 400MG/100ML 800MG/100ML BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 200MG/100ML 400MG/100ML HOSPIRA INC 200MG/100ML 400MG/100ML 800MG/100ML BRETYLOL HOSPIRA 50MG/ML
A070134 A071298 A071151 A071152 A071153 A070545 A070546 N019030 N019033 A070119 A070891 N019005 N019005 N019005 N019837 N019837 N019008 N019008 N019008 N017954
001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 001 002 003 001 001
Apr Feb Aug Aug Aug May May Apr Apr Apr Jul
29, 13, 10, 10, 10, 14, 14, 29, 29, 29, 26,
1986 1987 1987 1987 1987 1986 1986 1986 1986 1986 1988
Apr 29, 1986 Apr 29, 1986 Apr 29, 1986 Apr Apr Apr Apr Apr 12, 12, 29, 29, 29, 1989 1989 1986 1986 1986
BRIMONIDINE TARTRATE
SOLUTION/DROPS; OPHTHALMIC ALPHAGAN ALLERGAN 0.2% 0.5% BRIMONIDINE TARTRATE TEVA PARENTERAL 0.2%
N020613 N020490 A076372
001 001 001
Sep 06, 1996 Mar 13, 1997 Sep 10, 2004
BROMFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC XIBROM ISTA PHARMS INC 0.09%
N021664
001
Mar 24, 2005
CAPSULE; ORAL BROMOCRIPTINE MESYLATE LEK PHARM
EQ 5MG BASE
A075100
001
Dec 10, 1998
BROMODIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE; ORAL AMBODRYL PARKE DAVIS
25MG
N007984
001
BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE

SYRUP; ORAL AMBENYL FOREST LABS 12.5MG/5ML;10MG/5ML BROMANYL ALPHARMA US PHARMS 12.5MG/5ML;10MG/5ML BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE WOCKHARDT 12.5MG/5ML;10MG/5ML
N009319 A088343 A088626
006 001 001
Jan 10, 1984 Aug 15, 1984 Oct 12, 1984
BROMPHENIRAMINE MALEATE
ELIXIR; ORAL BROMPHENIRAMINE MALEATE ALPHARMA US PHARMS 2MG/5ML
A086936
001

BROMPHENIRAMINE MALEATE
ELIXIR; ORAL BROMPHENIRAMINE MALEATE KV PHARM PHARM ASSOC USL PHARMA INJECTABLE; INJECTION BROMPHENIRAMINE MALEATE WATSON LABS DIMETANE-TEN WYETH AYERST TABLET; ORAL BROMPHENIRAMINE MALEATE BARR IVAX SUB TEVA PHARMS NEWTRON PHARMS NEXGEN PHARMA INC PAR PHARM PIONEER PHARMS SANDOZ VITARINE WATSON LABS
6 - 50 (of 360)
A085466 A087517 A087964
001 001 001
Jan 25, 1983
A083821 A083820 N011418
001 001 002
A084468 A084351 A086987 A086187 A087009 A088604 A083215 A085850 A083123 A085769 N010799
001 001 001 001 001 001 001 001 001 001 003
Jul 13, 1984
DIMETANE WYETH CONS 4MG TABLET, EXTENDED RELEASE; ORAL DIMETANE WYETH CONS 8MG 12MG
N010799 N010799
010 011
Jun 10, 1983 Jun 10, 1983
BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

SYRUP; ORAL BROMANATE DC ALPHARMA US PHARMS DIMETANE-DC ROBINS AH MYPHETANE DC WOCKHARDT
2MG/5ML;10MG/5ML;12.5MG/5ML 2MG/5ML;10MG/5ML;12.5MG/5ML 2MG/5ML;10MG/5ML;12.5MG/5ML
A088723 N011694 A088904
001 006 001
Feb 25, 1985 Mar 29, 1984 Feb 21, 1985
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

SYRUP; ORAL BROMANATE DM ALPHARMA US PHARMS BROMFED-DM WOCKHARDT DIMETANE-DX ROBINS AH
2MG/5ML;10MG/5ML;30MG/5ML 2MG/5ML;10MG/5ML;30MG/5ML 2MG/5ML;10MG/5ML;30MG/5ML
A088722 A089681 N019279
001 001 001
Mar 07, 1985 Dec 22, 1988 Aug 24, 1984
BROMPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

ELIXIR; ORAL BIPHETAP MORTON GROVE BROMANATE ALPHARMA US PHARMS DIMETAPP WYETH CONS TABLET, EXTENDED RELEASE; BROMATAPP COPLEY PHARM DIMETAPP WYETH CONS
4MG/5ML;25MG/5ML 4MG/5ML;25MG/5ML 2MG/5ML;12.5MG/5ML ORAL 12MG;75MG 12MG;75MG
A088687 A088688 N013087
001 001 003
Sep 26, 1984 Feb 06, 1985 Mar 29, 1984
A071099 N012436
001 003
Jul 02, 1987 May 14, 1985

BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE ALZA 16MG;240MG
6 - 51 (of 360)
N019672
001
Mar 29, 1996
BUCLIZINE HYDROCHLORIDE
TABLET; ORAL
BUCLADIN-S
STUART PHARMS
50MG
N010911
006
BUDESONIDE
AEROSOL, METERED; NASAL RHINOCORT ASTRAZENECA 0.032MG/INH POWDER, METERED; INHALATION PULMICORT ASTRAZENECA 0.16MG/INH 0.32MG/INH SPRAY, METERED; NASAL RHINOCORT ASTRAZENECA 0.064MG/INH
N020233
001
Feb 14, 1994
N020441 N020441
002 003
Jun 24, 1997 Jun 24, 1997
N020746
002
Oct 01, 1999
BUMETANIDE
INJECTABLE; INJECTION BUMETANIDE HOSPIRA TEVA PARENTERAL BUMEX VALIDUS PHARMS INC TABLET; ORAL BUMEX VALIDUS PHARMS INC
A074160 A074613 N018226
001 001 001
Oct 30, 1997 Nov 18, 1997 Feb 28, 1983
0.5MG 1MG 2MG
N018225 N018225 N018225
002 001 003
Feb 28, 1983 Feb 28, 1983 Jun 14, 1985
BUPIVACAINE
INJECTABLE, LIPOSOMAL; INJECTION EXPAREL PACIRA PHARMS INC 133MG/10ML (13.3MG/ML)
N022496
001
Oct 28, 2011
BUPIVACAINE HYDROCHLORIDE KIT
HOSPIRA 0.075% 0.114% 0.23%
N019978 N019978 N019978
001 002 003
Sep 03, 1992 Sep 03, 1992 Sep 03, 1992
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
HOSPIRA 0.25%;0.005MG/ML 0.5%;0.005MG/ML 0.75%;0.005MG/ML
A071166 A071169 A071171
001 001 001
Jun 16, 1988 Jun 16, 1988 Jun 16, 1988
BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE

INJECTABLE; INJECTION DUOCAINE AMPHASTAR PHARMS INC
EQ 0.375% (37.5MG/10ML);EQ 1% (100MG/10ML)
N021496
001
May 23, 2003

TABLET; SUBLINGUAL SUBUTEX RECKITT BENCKISER
6 - 52 (of 360)
N020732 N020732
002 003
Oct 08, 2002 Oct 08, 2002
TABLET; ORAL BUPROPION HYDROCHLORIDE SANDOZ 75MG 100MG WELLBUTRIN GLAXOSMITHKLINE 50MG TABLET, EXTENDED RELEASE; ORAL BUPROPION HYDROCHLORIDE SANDOZ 100MG 150MG 150MG WELLBUTRIN SR GLAXOSMITHKLINE 50MG ZYBAN GLAXOSMITHKLINE 100MG
A075613 A075613 N018644
002 001 001
Oct 10, 2000 Oct 10, 2000 Dec 30, 1985
A076845 A076834 A076845 N020358 N020711
001 001 002 001 002
Jul 14, 2005 Jul 14, 2005 Jul 14, 2005 Oct 04, 1996 May 14, 1997
BUSPIRONE HYDROCHLORIDE
CAPSULE; ORAL BUSPAR BRISTOL MYERS SQUIBB
5MG 7.5MG 10MG 15MG
N021190 N021190 N021190 N021190
001 002 003 004
Dec Dec Dec Dec
20, 20, 20, 20,
2000 2000 2000 2000
TABLET; ORAL BUSPAR BRISTOL MYERS SQUIBB
5MG 10MG 15MG 30MG
N018731 N018731 N018731 N018731 A075521 A075521 A075521 A075119 A075119 A075119 A075385 A075385 A075385 A075572 A075572 A075572 A075388 A075388 A075388 A075413 A075413 A075413
001 002 003 004 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Sep Sep Apr Apr Apr Apr Apr Mar Mar Jan Mar Mar Mar Feb Feb Feb May May May Mar Mar Mar
29, 29, 22, 22, 05, 05, 05, 14, 14, 23, 01, 01, 01, 27, 27, 27, 09, 09, 09, 19, 19, 19,
1986 1986 1996 1996 2002 2002 2002 2002 2002 2003 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002
BUSPIRONE HYDROCHLORIDE APOTEX 5MG 10MG 15MG EGIS 5MG 10MG 15MG IVAX SUB TEVA PHARMS 5MG 10MG 15MG NESHER PHARMS 5MG 10MG 15MG PROSAM LABS 5MG 10MG 15MG SANDOZ 5MG 10MG 15MG
BUTABARBITAL SODIUM
CAPSULE; ORAL BUTICAPS MEDPOINTE PHARM HLC
A085381 A085381 A085381 A085381
001 002 003 004

BUTABARBITAL SODIUM
ELIXIR; ORAL BUTABARB ALPHARMA US PHARMS BUTABARBITAL SODIUM WOCKHARDT BUTALAN LANNETT SARISOL HALSEY TABLET; ORAL BUTABARBITAL BUNDY BUTABARBITAL SODIUM SANDOZ
6 - 53 (of 360)
30MG/5ML 30MG/5ML 33.3MG/5ML 30MG/5ML
A085873 A085383 A085880 A084723
001 001 001 001
30MG 15MG 15MG 30MG 30MG 16.2MG 32.4MG 48.6MG 97.2MG 15MG 30MG 15MG 30MG 15MG 30MG 15MG 100MG 15MG 30MG 15MG 30MG 15MG 30MG 100MG 16.2MG 32.4MG 15MG 30MG
A085550 A084292 A085938 A084272 A085934 A083606 A083898 A083897 A083896 A088632 A088631 A085764 A085772 A083325 A083337 N000793 N000793 A084719 A084719 A083484 A084040 A085849 A085866 A085881 A083524 A083858 A085418 A085432
001 003 001 002 001 001 001 001 001 001 001 001 001 002 001 002 005 001 002 001 001 001 001 001 001 001 001 001 Feb 09, 1982
SOLVAY
TEVA WATSON LABS WHITEWORTH TOWN PLSN BUTISOL SODIUM MEDA PHARMS SARISOL NO. 1 HALSEY SARISOL NO. 2 HALSEY SODIUM BUTABARBITAL IVAX SUB TEVA PHARMS LANNETT
May 18, 1985 May 01, 1985
MARSHALL PHARMA WEST WARD
CREAM; VAGINAL FEMSTAT ROCHE PALO SUPPOSITORY; VAGINAL FEMSTAT ROCHE PALO
2%
N019215
001
Nov 25, 1985
100MG
N019359
001
Nov 25, 1985
INJECTABLE; INJECTION BUTORPHANOL TARTRATE HOSPIRA
1MG/ML 1MG/ML 2MG/ML 2MG/ML BUTORPHANOL TARTRATE PRESERVATIVE FREE HOSPIRA 1MG/ML
A075342 A075559 A075342 A075559 A074620
001 001 002 002 001
Nov Mar Nov Mar
04, 20, 04, 20,
1999 2000 1999 2000
Jan 22, 1997

INJECTABLE; INJECTION BUTORPHANOL TARTRATE PRESERVATIVE FREE HOSPIRA 1MG/ML 2MG/ML 2MG/ML SPRAY, METERED; NASAL STADOL BRISTOL MYERS SQUIBB 1MG/SPRAY
6 - 54 (of 360)
A075170 A074620 A075170
001 002 002
Sep 28, 1998 Jan 22, 1997 Sep 28, 1998
N019890
001
Dec 12, 1991
CABERGOLINE
TABLET; ORAL DOSTINEX PHARMACIA AND UPJOHN
0.5MG
N020664
001
Dec 23, 1996
CAFFEINE; ERGOTAMINE TARTRATE

SUPPOSITORY; RECTAL CAFERGOT NOVARTIS TABLET; ORAL CAFERGOT NOVARTIS WIGRAINE ORGANON USA INC
100MG;2MG
N009000
002
100MG;1MG 100MG;1MG
N006620 A086562
001 001
CALCIFEDIOL
CAPSULE; ORAL CALDEROL ORGANON USA INC
0.02MG 0.05MG
N018312 N018312
001 002
CALCIPOTRIENE
OINTMENT; TOPICAL DOVONEX LEO PHARM
0.005%
N020273
001
Dec 29, 1993
CALCITONIN HUMAN
INJECTABLE; INJECTION CIBACALCIN NOVARTIS
0.5MG/VIAL
N018470
001
Oct 31, 1986
CALCITONIN SALMON
INJECTABLE; INJECTION CALCIMAR SANOFI AVENTIS US CALCITONIN-SALMON ASTRAZENECA MIACALCIN NOVARTIS
200 IU/ML 400 IU/VIAL 200 IU/ML 100 IU/ML
N017769 N017497 A073690 N017808
001 001 001 001 Apr 14, 1995 Jul 03, 1986
CALCITRIOL
INJECTABLE; INJECTION CALCITRIOL HOSPIRA TEVA PARENTERAL
0.001MG/ML 0.002MG/ML 0.001MG/ML
A075816 A075816 A075823
001 002 001
Jan 16, 2004 Jan 16, 2004 Mar 31, 2003
CALCIUM ACETATE
CAPSULE; ORAL PHOSLO FRESENIUS MEDCL
EQ 84.5MG CALCIUM EQ 169MG CALCIUM
N021160 N021160
001 002
Apr 02, 2001 Apr 02, 2001

CALCIUM ACETATE
TABLET; ORAL CALCIUM ACETATE ROXANE PHOSLO FRESENIUS MEDCL
6 - 55 (of 360)
EQ 169MG CALCIUM EQ 169MG CALCIUM
A077693 N019976
001 001
Jan 30, 2008 Dec 10, 1990
CALCIUM CARBONATE; RISEDRONATE SODIUM

TABLET, TABLET; ORAL
ACTONEL WITH CALCIUM (COPACKAGED)
WARNER CHILCOTT EQ 500MG BASE,N/A;N/A,35MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N021823
001
Aug 12, 2005
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
INJECTABLE; INJECTION PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER GAMBRO RENAL PRODS 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; 3.05GM/1000ML;0.157GM/1000ML;2.21GM/100 0ML;7.07GM/1000ML PRISMASOL BGK 4/0 IN PLASTIC CONTAINER GAMBRO RENAL PRODS N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 5GM/1000ML;0.314GM/1000ML;3.09GM/1000ML ;6.46GM/1000ML PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER GAMBRO RENAL PRODS 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML; 2.03GM/1000ML;0.314GM/1000ML;3.09GM/100 0ML;6.46GM/1000ML PRISMASOL BK 0/0 IN PLASTIC CONTAINER GAMBRO RENAL PRODS N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05 GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46 GM/1000ML PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER GAMBRO RENAL PRODS 3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3 .05GM/1000ML;0.314GM/1000ML;3.09GM/1000 ML;6.46GM/1000ML
N021703
012
Oct 10, 2008
N021703
005
Oct 25, 2006
N021703
008
Oct 25, 2006
N021703
007
Oct 25, 2006
N021703
009
Oct 25, 2006
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 37MG/100ML;5GM/100ML;31MG/100ML;120MG/1 N018271 00ML;330MG/100ML;88MG/100ML
001
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
INJECTABLE; INJECTION ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 35MG/100ML;5GM/100ML;30MG/100ML;74MG/10 N018269 0ML;640MG/100ML;500MG/100ML;74MG/100ML
002
Jan 17, 1983
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

SOLUTION; INTRAPERITONEAL DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER B BRAUN 29MG/100ML;2.5GM/100ML;15MG/100ML;610MG N018460 /100ML;560MG/100ML DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER B BRAUN 29MG/100ML;1.5GM/100ML;15MG/100ML;610MG N018460 /100ML;560MG/100ML DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER B BRAUN 29MG/100ML;4.25GM/100ML;15MG/100ML;610M N018460 G/100ML;560MG/100ML
006
Jan 29, 1986
001
003
6 - 56 (of 360)

SOLUTION; INTRAPERITONEAL DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER B BRAUN 26MG/100ML;1.5GM/100ML;15MG/100ML;560MG N018460 /100ML;390MG/100ML DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER B BRAUN 26MG/100ML;5GM/100ML;5MG/100ML;530MG/10 N018460 0ML;450MG/100ML DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER B BRAUN 26MG/100ML;4.25GM/100ML;15MG/100ML;560M N018460 G/100ML;390MG/100ML
002
008
Jan 29, 1986
004
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER
B BRAUN 33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N018256 00ML
001

INJECTABLE; INJECTION DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER B BRAUN 4MG/100ML;4GM/100ML;6MG/100ML;120MG/100 N019634 002 Feb ML;62MG/100ML DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER B BRAUN 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 N017510 001 00ML;310MG/100ML MILES 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 N018499 001 00ML;310MG/100ML POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER HOSPIRA 20MG/100ML;5GM/100ML;104MG/100ML;600MG/ N019685 005 Oct 100ML;310MG/100ML 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ N019685 006 Oct 100ML;310MG/100ML POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER HOSPIRA 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ N019685 007 Oct 100ML;310MG/100ML POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER HOSPIRA 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ N019685 003 Oct 100ML;310MG/100ML POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER HOSPIRA 20MG/100ML;5GM/100ML;104MG/100ML;600MG/ N019685 001 Oct 100ML;310MG/100ML
24, 1988
17, 1988 17, 1988
17, 1988
17, 1988
17, 1988
CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE

SOLUTION; INTRAPERITONEAL INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;538MG/100ML;44 N019395 8MG/100ML INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;538MG/100ML;44 N019395 8MG/100ML INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;538MG/100ML;4 N019395 48MG/100ML
001
Mar 26, 1986
002
Mar 26, 1986
003
Mar 26, 1986
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TPN ELECTROLYTES IN PLASTIC CONTAINER ABBOTT 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML; N019399 16.1MG/ML
001
Jun 16, 1986
6 - 57 (of 360)
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
INJECTABLE; INJECTION ISOLYTE E IN PLASTIC CONTAINER B BRAUN 35MG/100ML;30MG/100ML;74MG/100ML;640MG/ N018899 100ML;500MG/100ML;74MG/100ML
001
Oct 31, 1983
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

INJECTABLE; INJECTION ACETATED RINGER'S IN PLASTIC CONTAINER B BRAUN 20MG/100ML;30MG/100ML;380MG/100ML;600MG N018725 /100ML
001
Nov 29, 1982

INJECTABLE; INJECTION RINGER'S IN PLASTIC CONTAINER B BRAUN 33MG/100ML;30MG/100ML;860MG/100ML SOLUTION; IRRIGATION RINGER'S IN PLASTIC CONTAINER ABBOTT 33MG/100ML;30MG/100ML;860MG/100ML
N018721
001
Nov 09, 1982
N018462
001
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

INJECTABLE; INJECTION LACTATED RINGER'S IN PLASTIC CONTAINER ABBOTT 20MG/100ML;30MG/100ML;600MG/100ML;310MG N019485 /100ML B BRAUN 20MG/100ML;30MG/100ML;600MG/100ML;310MG N018023 /100ML MILES 20MG/100ML;30MG/100ML;600MG/100ML;310MG N018417 /100ML
001 001 001
Oct 24, 1985
CALCIUM GLUCEPTATE
INJECTABLE; INJECTION CALCIUM GLUCEPTATE ABBOTT ABRAXIS PHARM LILLY
EQ EQ EQ EQ
90MG 90MG 90MG 90MG
CALCIUM/5ML CALCIUM/5ML CALCIUM/5ML CALCIUM/5ML
A080001 A083159 A089373 N006470
001 001 001 001
Apr 30, 1987
CALCIUM METRIZOATE; MEGLUMINE METRIZOATE; METRIZOATE MAGNESIUM; METRIZOATE SODIUM

ISOPAQUE 440
GE HEALTHCARE
0.78MG/ML;75.9MG/ML;0.15MG/ML;16.6MG/ML N016847
001
CALCIUM; MEGLUMINE; METRIZOIC ACID

ISOPAQUE 280
GE HEALTHCARE
0.35MG/ML;140.1MG/ML;461.8MG/ML
N017506
001
CANDICIDIN
OINTMENT; VAGINAL
VANOBID
SANOFI AVENTIS US TABLET; VAGINAL
VANOBID
SANOFI AVENTIS US
0.6MG/GM
A061596
001
3MG
A061613
001
CAPTOPRIL
TABLET; ORAL CAPOTEN PAR PHARM
37.5MG 75MG 150MG
N018343 N018343 N018343
006 007 004
Sep 17, 1986 Jun 13, 1995 Jun 13, 1995

CAPTOPRIL
TABLET; ORAL CAPTOPRIL APOTHECON
6 - 58 (of 360)
CLONMEL HLTHCARE
EGIS PHARMS
IVAX SUB TEVA PHARMS
PAR PHARM
PUREPAC PHARM
SANDOZ
TEVA
TEVA PHARMS
VINTAGE PHARMS LLC
WATSON LABS
12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 12.5MG 25MG 25MG 50MG 50MG 100MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG
A074472 A074472 A074472 A074472 A074423 A074423 A074423 A074423 A074748 A074748 A074748 A074748 A074590 A074590 A074590 A074590 A074493 A074493 A074493 A074493 A074640 A074640 A074640 A074640 A074481 A074519 A074481 A074519 A074481 A074519 A074481 A074519 A074433 A074433 A074433 A074433 A074462 A074462 A074462 A074462 A074418 A074418 A074418 A074418 A074576 A074576 A074576 A074576
001 002 003 004 001 002 003 004 004 002 001 003 004 002 001 003 001 002 003 004 001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar Feb Feb Feb Feb May May May May Aug Aug Aug Aug Feb Feb Feb Feb Mar Mar Mar Mar Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Apr Apr Apr Apr
31, 31, 31, 31, 13, 13, 13, 13, 29, 29, 29, 29, 30, 30, 30, 30, 13, 13, 13, 13, 31, 31, 31, 31, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 23, 23, 23, 23,
1995 1995 1995 1995 1996 1996 1996 1996 1997 1997 1997 1997 1996 1996 1996 1996 1996 1996 1996 1996 1997 1997 1997 1997 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996
TABLET; ORAL CAPTOPRIL AND HYDROCHLOROTHIAZIDE IVAX SUB TEVA PHARMS 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG VINTAGE PHARMS LLC 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG
A075055 A075055 A075055 A075055 A074788 A074788 A074788 A074788
001 002 004 003 001 002 004 003
Jun Jun Jun Jun Dec Dec Dec Dec
18, 18, 18, 18, 29, 29, 29, 29,
1998 1998 1998 1998 1997 1997 1997 1997

TABLET; ORAL CAPTOPRIL AND HYDROCHLOROTHIAZIDE WATSON LABS 50MG;25MG
6 - 59 (of 360)
A074832
001
Dec 29, 1997
CARBACHOL
SOLUTION; INTRAOCULAR CARBACHOL PHARMAFAIR CARBASTAT NOVARTIS
0.01% 0.01%
A070292 A073677
001 001
May 21, 1986 Apr 28, 1995
CARBAMAZEPINE
SUSPENSION; ORAL CARBAMAZEPINE TARO TABLET; ORAL CARBAMAZEPINE ACTAVIS ELIZABETH INWOOD LABS PLIVA USL PHARMA WARNER CHILCOTT TERIL TARO TABLET, CHEWABLE; ORAL CARBAMAZEPINE JUBILANT CADISTA
100MG/5ML
A075875
001
Dec 21, 2000
200MG 200MG 200MG 200MG 200MG 200MG
A071696 A070231 A071479 A070300 A070429 A076525
001 001 001 001 001 001
Nov Aug Jul May Jan
09, 14, 24, 15, 02,
1987 1986 1987 1986 1987
Sep 26, 2003
100MG
A071940
001
Feb 01, 1988
CARBENICILLIN DISODIUM
INJECTABLE; INJECTION GEOPEN ROERIG
1GM BASE/VIAL 2GM BASE/VIAL 5GM BASE/VIAL 10GM BASE/VIAL 30GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 5GM BASE/VIAL 10GM BASE/VIAL 20GM BASE/VIAL
N050306 N050306 N050306 N050306 N050306 N050298 N050298 N050298 N050298 N050298
001 004 002 006 007 001 002 003 006 007
PYOPEN GLAXOSMITHKLINE
CARBENICILLIN INDANYL SODIUM

TABLET; ORAL GEOCILLIN PFIZER
EQ 382MG BASE
N050435
001
CARBIDOPA; LEVODOPA
TABLET; ORAL CARBIDOPA AND LEVODOPA SANDOZ
SCS
WATSON LABS
10MG;100MG 25MG;100MG 25MG;250MG 10MG;100MG 25MG;100MG 25MG;250MG 10MG;100MG 25MG;100MG 25MG;250MG
A073586 A073587 A073620 A074080 A074080 A074080 A073381 A073382 A073383
001 001 001 001 002 003 001 001 001
Jun Jun Jun Mar Mar Mar Sep Sep Sep
29, 29, 29, 25, 25, 25, 28, 28, 28,
1995 1995 1995 1994 1994 1994 1993 1993 1993

CARBIDOPA; LEVODOPA
TABLET, EXTENDED RELEASE; ORAL CARBIDOPA AND LEVODOPA KV PHARM 50MG;200MG TABLET, FOR SUSPENSION; ORAL CARBILEV RANBAXY 10MG;100MG 25MG;100MG 25MG;250MG
6 - 60 (of 360)
A076663
001
Jun 24, 2004
A076643 A076643 A076643
001 002 003
Jun 10, 2005 Jun 10, 2005 Jun 10, 2005
ELIXIR; ORAL
CLISTIN
MCNEIL
4MG/5ML **Federal Register determination that product was not

N008955
001
TABLET; ORAL
CLISTIN
ORTHO MCNEIL PHARM
4MG
N008915
001
CARBOPLATIN
CARBOPLATIN
HOSPIRA
50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL
A076473 A076473 A076473 N019880 N019880 N019880
001 002 003 001 002 003
Oct 27, 2004 Oct 27, 2004 Oct 27, 2004 Mar 03, 1989 Mar 03, 1989 Mar 03, 1989
PARAPLATIN CORDEN PHARMA
INJECTABLE; IV (INFUSION) CARBOPLATIN FRESENIUS KABI USA 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) SAGENT PHARMS 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) TEVA PARENTERAL 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) PARAPLATIN BRISTOL MYERS SQUIBB 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) 600MG/60ML (10MG/ML)
A077247 A077247 A077096 A077096 A077096 A077389 A077389 A077389 N020452 N020452 N020452 N020452
001 002 001 002 003 001 002 003 001 002 003 004
Oct Oct Jun Jun Jun Mar Mar Mar Jul Jul Jul Jan
21, 21, 14, 14, 14, 30, 30, 30, 14, 14, 14, 15,
2004 2004 2005 2005 2005 2007 2007 2007 2003 2003 2003 2004
CARISOPRODOL
CAPSULE; ORAL
SOMA
MEDA PHARMS TABLET; ORAL
CARISOPRODOL ABLE PIONEER PHARMS SANDOZ WATSON LABS
250MG
N011792
003
A040421 A089390 A081025 A089566 A040152 A085433 A086179 N012155
001 001 001 001 001 001 001 001
Jun Oct Apr Aug Dec
21, 13, 13, 30, 03,
2001 1988 1989 1988 1996
RELA
SCHERING

CARPHENAZINE MALEATE
CONCENTRATE; ORAL PROKETAZINE WYETH AYERST TABLET; ORAL PROKETAZINE WYETH AYERST
6 - 61 (of 360)
50MG/ML
N014173
001
12.5MG 25MG 50MG
N012768 N012768 N012768
001 002 004
CARPROFEN
TABLET; ORAL RIMADYL ROCHE
100MG 150MG
N018550 N018550
002 003
Dec 31, 1987 Dec 31, 1987
CARTEOLOL HYDROCHLORIDE
TABLET; ORAL CARTROL ABBVIE
2.5MG 5MG 10MG
N019204 N019204 N019204
001 002 003
Dec 28, 1988 Dec 28, 1988 Dec 28, 1988
CEFACLOR
CAPSULE; ORAL CECLOR LILLY CEFACLOR CEPH INTL CLONMEL HLTHCARE IVAX SUB TEVA PHARMS MARSAM PHARMS LLC RANBAXY TEVA
EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 002 001 002 001 002 001 002 001 002 001 002 001 001 002 002
Apr Apr Apr Apr May May Aug Aug Sep Jun Sep Jun
27, 27, 27, 27, 23, 23, 28, 28, 16, 24, 16, 24,
1995 1995 1995 1995 1996 1996 1997 1997 1996 1996 1996 1996
FOR SUSPENSION; ORAL CECLOR LILLY CEFACLOR CLONMEL HLTHCARE
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 125MG 187MG 250MG 375MG 125MG 187MG 250MG 375MG 125MG 187MG 250MG 375MG 125MG 187MG 250MG BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
N050522 N050522 A064114 A064115 A064116 A064110 A062206 A062206 A062206 A062206 A064087 A064086 A064085 A064070 A064204 A064205 A064206
001 002 001 001 001 001 001 003 002 004 001 001 001 001 001 001 001 Apr Apr Apr Apr 28, 28, 28, 28, 1995 1995 1995 1995
FACTA FARMA
Apr 20, 1988 Apr Apr Apr Apr Apr Feb Feb Feb 20, 28, 28, 28, 28, 18, 18, 18, 1988 1995 1995 1995 1995 1998 1998 1998
MARSAM PHARMS LLC

CEFACLOR
FOR SUSPENSION; ORAL CEFACLOR MARSAM PHARMS LLC RANBAXY
6 - 62 (of 360)
EQ EQ EQ EQ EQ
375MG 125MG 187MG 250MG 375MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A064207 A064166 A064165 A064164 A064155
001 001 001 001 001
Feb Oct Oct Oct Oct
18, 02, 02, 02, 02,
1998 1997 1997 1997 1997
TABLET, CHEWABLE; ORAL RANICLOR RANBAXY LABS LTD
EQ 125MG EQ 187MG EQ 250MG EQ 375MG TABLET, EXTENDED RELEASE; ORAL CECLOR CD LILLY EQ 375MG EQ 500MG CEFACLOR WORLD GEN EQ 500MG
BASE BASE BASE BASE
A065092 A065092 A065092 A065092
001 002 003 004
Dec Dec Dec Dec
22, 22, 22, 22,
2003 2003 2003 2003
BASE BASE BASE
N050673 N050673 A065057
001 002 001
Jun 28, 1996 Jun 28, 1996 Jan 05, 2001
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL CEFADROXIL IVAX SUB TEVA PHARMS PUREPAC PHARM RANBAXY LABS LTD TEVA DURICEF WARNER CHILCOTT ULTRACEF BRISTOL FOR SUSPENSION; ORAL CEFADROXIL APOTHECON
EQ EQ EQ EQ
500MG 500MG 500MG 500MG
BASE BASE BASE BASE
A062766 A063017 A065015 A062695 N050512 N050512 A062378
001 001 001 001 002 001 001
Mar Jan Jun Feb
03, 05, 22, 10,
1987 1989 1999 1989
Mar 16, 1982
TEVA
EQ EQ EQ EQ EQ EQ
125MG 250MG 500MG 125MG 250MG 500MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062334 A062334 A062334 A062698 A062698 A062698 N050527 N050527 N050527 A062376 A062376 A062376
001 002 003 001 002 003 002 003 001 001 002 003
Mar 01, 1989 Mar 01, 1989 Mar 01, 1989
DURICEF WARNER CHILCOTT
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 500MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 500MG BASE/5ML
ULTRACEF BRISTOL
Mar 16, 1982 Mar 16, 1982 Mar 16, 1982
TABLET; ORAL CEFADROXIL RANBAXY DURICEF WARNER CHILCOTT ULTRACEF APOTHECON BRISTOL
EQ 1GM BASE EQ 1GM BASE EQ 1GM BASE EQ 1GM BASE
A065018 N050528 A062390 A062408
001 001 001 001
Apr 23, 1999
Jun 10, 1982 Aug 31, 1982
CEFAMANDOLE NAFATE
INJECTABLE; INJECTION MANDOL LILLY
EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL
N050504 A062560 N050504
001 001 002
Sep 10, 1985

CEFAMANDOLE NAFATE
INJECTABLE; INJECTION MANDOL LILLY
6 - 63 (of 360)
EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL
A062560 N050504 N050504
002 003 004
Sep 10, 1985
CEFAZOLIN SODIUM
INJECTABLE; INJECTION ANCEF GLAXOSMITHKLINE
EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** EQ 10GM BASE/VIAL ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 10MG BASE/ML EQ 20MG BASE/ML ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 10MG BASE/ML EQ 20MG BASE/ML CEFAZOLIN AND DEXTROSE B BRAUN EQ 500MG BASE/VIAL CEFAZOLIN SODIUM ABRAXIS PHARM EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL BEDFORD EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL CEPHAZONE PHARMA EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL FRESENIUS KABI USA EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL GLAXOSMITHKLINE EQ 1GM BASE/VIAL HIKMA MAPLE EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL MARSAM PHARMS LLC EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL TEVA PHARMS EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL
N050461
001
N050461 N050461 N050461
002 003 004
N050461 N050566 N050566 N050566 N050566 N050779 A062688 A062688 A062688 A062688 A062894 A062894 A062894 A062894 A062894 A065280 A065280 A065295 A065296 A064169 A064169 A064170 A064170 A064033 A062807 A062807 A062807 A062807 A062807 A062807 A062988 A062988 A062988 A062989 A062989 A062989 A063016 A063016 A063016 A063018
005 003 004 001 002 001 002 003 004 005 001 002 003 004 005 001 002 001 001 001 002 001 002 001 001 002 003 004 005 006 001 002 003 001 002 003 001 002 003 001 Jun 08, 1983 Jun 08, 1983 Jun 08, 1983 Jun 08, 1983 Jul 27, 2000 Nov Nov Nov Aug Jul Jul Jul Jul Jul Mar Mar Mar Mar Aug Aug Mar Mar Oct Jan Jan Jan Jan Jan Jan Dec Dec Dec Dec Dec Dec Mar Mar Mar Mar 17, 17, 17, 03, 21, 21, 21, 21, 21, 18, 18, 18, 18, 14, 14, 18, 18, 31, 12, 12, 12, 12, 12, 12, 29, 29, 29, 29, 29, 29, 14, 14, 14, 05, 1986 1986 1986 1987 1988 1988 1988 1988 1988 2009 2009 2009 2009 1998 1998 1998 1998 1993 1988 1988 1988 1988 1988 1988 1989 1989 1989 1989 1989 1989 1989 1989 1989 1990

CEFAZOLIN SODIUM
INJECTABLE; INJECTION CEFAZOLIN SODIUM TEVA PHARMS KEFZOL ACS DOBFAR LILLY
6 - 64 (of 360)
EQ 10GM BASE/VIAL EQ EQ EQ EQ 250MG BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A063018 A061773 A061773 A062557 A062557
002 001 005 001 002
Mar 05, 1990
Sep 08, 1987 Sep 10, 1985 Sep 10, 1985
CEFDINIR
CAPSULE; ORAL OMNICEF ABBVIE FOR SUSPENSION; ORAL OMNICEF ABBVIE
300MG
N050739
001
Dec 04, 1997
125MG/5ML 250MG/5ML
N050749 N050749
001 002
Dec 04, 1997 Jul 29, 2004
CEFIXIME
FOR SUSPENSION; ORAL SUPRAX LEDERLE TABLET; ORAL SUPRAX LEDERLE
100MG/5ML
N050622
001
Apr 28, 1989
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 400MG
N050621
001
Apr 28, 1989
N050621
002
Apr 28, 1989
CEFMENOXIME HYDROCHLORIDE
CEFMAX
TAP PHARM
N050571 N050571 N050571
001 002 003
Dec 30, 1987 Dec 30, 1987 Dec 30, 1987
CEFMETAZOLE SODIUM
INJECTABLE; INJECTION ZEFAZONE PHARMACIA AND UPJOHN
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL ZEFAZONE IN PLASTIC CONTAINER PHARMACIA AND UPJOHN EQ 20MG BASE/ML EQ 40MG BASE/ML
N050637 N050637 N050683 N050683
001 002 001 002
Dec 11, 1989 Dec 11, 1989 Dec 29, 1992 Dec 29, 1992
CEFONICID SODIUM
MONOCID
GLAXOSMITHKLINE
EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
N050579 A063295 N050579 N050579 N050579
001 001 002 003 004
May Jul May May May
23, 26, 23, 23, 23,
1984 1993 1984 1984 1984
CEFOPERAZONE SODIUM
CEFOBID
PFIZER
EQ EQ EQ EQ EQ
1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
A063333 N050551 A063333 N050551 N050551
001 001 002 002 003
Mar Nov Mar Nov Mar
31, 18, 31, 18, 05,
1995 1982 1995 1982 1990

CEFOPERAZONE SODIUM
INJECTABLE; INJECTION CEFOBID IN PLASTIC CONTAINER PFIZER EQ 20MG BASE/ML EQ 40MG BASE/ML
6 - 65 (of 360)
N050613 N050613
002 001
Jul 31, 1987 Jul 23, 1986
CEFORANIDE
INJECTABLE; INJECTION PRECEF APOTHECON
BRISTOL
500MG/VIAL 1GM/VIAL 2GM/VIAL 10GM/VIAL 20GM/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 10GM/VIAL 20GM/VIAL
A062579 A062579 A062579 A062579 A062579 N050554 N050554 N050554 N050554 N050554
001 002 003 004 005 001 002 003 004 005
Nov Nov Nov Nov Nov May May May May May
26, 26, 26, 26, 26, 24, 24, 24, 24, 24,
1984 1984 1984 1984 1984 1984 1984 1984 1984 1984
CEFOTAXIME SODIUM
INJECTABLE; INJECTION CEFOTAXIME FRESENIUS KABI USA
EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER B BRAUN EQ 2GM BASE CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER B BRAUN EQ 1GM BASE CEFOTAXIME SODIUM CEPHAZONE PHARMA EQ 10GM BASE/VIAL CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER SANOFI AVENTIS US EQ 20MG BASE/ML EQ 40MG BASE/ML
A064200 A064200 A064200 A064201 A064201 N050792 N050792 A065348 N050596 N050596
001 002 003 001 002 001 002 001 001 003
Mar Mar Mar Mar Mar
24, 24, 24, 24, 24,
2000 2000 2000 2000 2000
Jul 29, 2004 Jul 29, 2004 Jan 25, 2010 May 20, 1985 May 20, 1985
CEFOTETAN DISODIUM
INJECTABLE; INJECTION CEFOTAN ASTRAZENECA
EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL CEFOTAN IN PLASTIC CONTAINER ASTRAZENECA EQ 20MG BASE/ML EQ 40MG BASE/ML
A063293 N050588 A063293 N050588 N050588 N050694 N050694
001 001 002 002 003 002 001
Apr Dec Apr Dec Apr
29, 27, 29, 27, 25,
1993 1985 1993 1985 1988
Jul 30, 1993 Jul 30, 1993
CEFOTIAM HYDROCHLORIDE
INJECTABLE; INJECTION CERADON TAKEDA
EQ 1GM BASE/VIAL
N050601
001
Dec 30, 1988
CEFOXITIN SODIUM
INJECTABLE; INJECTION CEFOXITIN FRESENIUS KABI USA
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL EQ 1GM BASE/VIAL
A065012 A065012 A065011 A062757
001 002 001 001
Jul 03, 2000 Jul 03, 2000 Jul 03, 2000 Jan 08, 1987
MEFOXIN BIONICHE PHARMA

CEFOXITIN SODIUM
INJECTABLE; INJECTION MEFOXIN BIONICHE PHARMA MYLAN INSTITUTIONAL
6 - 66 (of 360)
EQ 2GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER MERCK EQ 20MG BASE/ML EQ 40MG BASE/ML MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER MERCK EQ 20MG BASE/ML EQ 40MG BASE/ML
A062757 N050517 N050517 N050517 N050581 N050581 N050581 N050581
002 001 002 003 003 004 002 001
Jan 08, 1987
Sep 20, 1984 Sep 20, 1984 Sep 20, 1984 Sep 20, 1984
CEFPIRAMIDE SODIUM
INJECTABLE; INJECTION CEFPIRAMIDE SODIUM WYETH AYERST
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL
N050633 N050633 N050633
002 003 005
Jan 31, 1989 Jan 31, 1989 Jan 31, 1989
FOR SUSPENSION; ORAL BANAN SANKYO VANTIN PHARMACIA AND UPJOHN TABLET; ORAL BANAN SANKYO VANTIN PHARMACIA AND UPJOHN
N050688 N050688 N050675 N050675
002 001 001 002
Aug 07, 1992 Aug 07, 1992 Aug 07, 1992 Aug 07, 1992
N050687 N050687 N050674 N050674
001 002 001 002
Aug 07, 1992 Aug 07, 1992 Aug 07, 1992 Aug 07, 1992
CEFPROZIL
FOR SUSPENSION; ORAL CEFPROZIL RANBAXY LABS LTD CEFZIL CORDEN PHARMA TABLET; ORAL CEFPROZIL RANBAXY LABS LTD CEFZIL CORDEN PHARMA
A065202 A065202 N050665 N050665
001 002 001 002
Jun 30, 2006 Jun 30, 2006 Dec 23, 1991 Dec 23, 1991
250MG 500MG 250MG 500MG
A065198 A065198 N050664 N050664
001 002 001 002
Dec 13, 2006 Dec 13, 2006 Dec 23, 1991 Dec 23, 1991
CEFTAZIDIME
INJECTABLE; INJECTION CEPTAZ GLAXOSMITHKLINE
500MG/VIAL 1GM/VIAL 2GM/VIAL 10GM/VIAL 1GM/VIAL 1GM/VIAL
N050646 N050646 N050646 N050646 A063322 A064006
001 002 003 004 001 001
Sep Sep Sep Sep
27, 27, 27, 27,
1990 1990 1990 1990
PENTACEF GLAXOSMITHKLINE
Nov 07, 1995 Mar 31, 1992

CEFTAZIDIME
INJECTABLE; INJECTION PENTACEF GLAXOSMITHKLINE
6 - 67 (of 360)
2GM/VIAL 2GM/VIAL 6GM/VIAL 10GM/VIAL
A063322 A064006 A064008 A064008 A062655 A062655 A062739 A062739
002 002 001 002 001 002 001 002
Nov Mar Mar Mar
07, 31, 31, 31,
1995 1992 1992 1992
TAZIDIME LILLY
1GM/VIAL 2GM/VIAL TAZIDIME IN PLASTIC CONTAINER LILLY 1GM/VIAL 2GM/VIAL
Nov 20, 1985 Nov 20, 1985 Jul 10, 1986 Jul 10, 1986
CEFTAZIDIME SODIUM
INJECTABLE; INJECTION CEFTAZIDIME SODIUM IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 10MG BASE/ML EQ 20MG BASE/ML EQ 40MG BASE/ML FORTAZ IN PLASTIC CONTAINER COVIS PHARMA EQ 10MG BASE/ML
A063221 A063221 A063221 N050634
001 002 003 001
Apr 29, 1993 Apr 29, 1993 Apr 29, 1993 Apr 28, 1989
CEFTIBUTEN DIHYDRATE
FOR SUSPENSION; ORAL CEDAX PERNIX THERAP
EQ 180MG BASE/5ML
N050686
002
Dec 20, 1995
CEFTIZOXIME SODIUM
INJECTABLE; INJECTION CEFIZOX ASTELLAS
CEFIZOX IN ASTELLAS CEFIZOX IN ASTELLAS
EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL DEXTROSE 5% IN PLASTIC CONTAINER EQ 20MG BASE/ML EQ 40MG BASE/ML PLASTIC CONTAINER EQ 20MG BASE/ML EQ 40MG BASE/ML
N050560 A063294 N050560 A063294 N050560 N050560 N050589 N050589 N050589 N050589
001 002 002 003 003 005 001 002 003 004
Sep Mar Sep Mar Sep Mar
15, 31, 15, 31, 15, 19,
1983 1994 1983 1994 1983 1993
Oct 03, 1984 Oct 03, 1984 Apr 13, 1995 Apr 13, 1995
CEFTRIAXONE SODIUM
INJECTABLE; IM-IV CEFTRIAXONE CEPHAZONE PHARMA
FRESENIUS KABI USA
250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL
A065294 A065294 A065294 A065294 A065245 A065245 A065245 N050585 N050585 N050585 N050585
001 002 003 004 002 003 004 001 002 003 004
Mar Mar Mar Mar Feb Feb Feb Dec Dec Dec Dec
26, 26, 26, 26, 15, 15, 15, 21, 21, 21, 21,
2007 2007 2007 2007 2006 2006 2006 1984 1984 1984 1984
ROCEPHIN HOFFMANN LA ROCHE
INJECTABLE; INJECTION CEFTRIAXONE FRESENIUS KABI USA
EQ 10GM BASE/VIAL
A065252
001
Feb 15, 2006

CEFTRIAXONE SODIUM
INJECTABLE; INJECTION ROCEPHIN HOFFMANN LA ROCHE
6 - 68 (of 360)
EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL ROCHE EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER HOFFMANN LA ROCHE EQ 10MG BASE/ML EQ 20MG BASE/ML EQ 40MG BASE/ML
A063239 A062654 A062654 A062654 N050585 A062510 A062510 A062510 N050624 N050624 N050624
001 001 002 003 005 001 002 003 001 002 003
Aug Apr Apr Apr Dec Mar Mar Mar
13, 30, 30, 30, 21, 12, 12, 12,
1993 1987 1987 1987 1984 1985 1985 1985
Feb 11, 1987 Feb 11, 1987 Feb 11, 1987
CEFTRIAXONE SODIUM; LIDOCAINE

INJECTABLE; INJECTION ROCEPHIN KIT HOFFMANN LA ROCHE
EQ 500MG BASE/VIAL,N/A;N/A,1% EQ 1GM BASE/VIAL,N/A;N/A,1%
N050585 N050585
007 006
May 08, 1996 May 08, 1996
CEFUROXIME AXETIL
TABLET; ORAL CEFUROXIME AXETIL RANBAXY LABS LTD
SANDOZ
EQ EQ EQ EQ EQ
125MG 250MG 500MG 250MG 500MG
A065043 A065043 A065043 A065126 A065126
003 002 001 001 002
Feb Feb Feb Oct Oct
15, 15, 15, 28, 28,
2002 2002 2002 2003 2003
CEFUROXIME SODIUM
INJECTABLE; IM-IV CEFUROXIME SODIUM FRESENIUS KABI USA MARSAM PHARMS LLC KEFUROX ACS DOBFAR INJECTABLE; INJECTION CEFUROXIME SODIUM FRESENIUS KABI USA MARSAM PHARMS LLC KEFUROX ACS DOBFAR
A065001 A064035 A062591
001 001 001
May 30, 2001 Feb 26, 1993 Jan 10, 1986
EQ EQ EQ EQ
1.5GM 7.5GM 1.5GM 7.5GM
BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
A065001 A065002 A064035 A064036 A062591 A062591 A062592 A062590
002 001 002 001 002 003 002 002
May Sep Feb Feb
30, 28, 26, 26,
2001 1998 1993 1993
EQ 1.5GM EQ 7.5GM LILLY EQ 1.5GM KEFUROX IN PLASTIC CONTAINER LILLY EQ 1.5GM INJECTABLE; INTRAVENOUS KEFUROX LILLY EQ 750MG KEFUROX IN PLASTIC CONTAINER LILLY EQ 750MG
Jan 10, 1986 Dec 17, 1987 Jan 10, 1986 Jan 10, 1986
BASE/VIAL BASE/VIAL
A062592 A062590
001 001
Jan 10, 1986 Jan 10, 1986
CELLULOSE SODIUM PHOSPHATE

POWDER; ORAL CALCIBIND MISSION PHARMA
2.5GM/PACKET 300GM/BOT
N018757 N018757
002 003
Dec 28, 1982 Oct 16, 1984

CEPHALEXIN
CAPSULE; ORAL CEPHALEXIN APOTHECON
6 - 69 (of 360)
BARR IVAX SUB TEVA PHARMS PUREPAC PHARM STEVENS J TEVA
YOSHITOMI KEFLEX SHIONOGI INC
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A062973 A063063 A063186 A062974 A063063 A063186 A062773 A062775 A061969 A061969 A062809 A062809 A062869 A062760 A062821 A062761 A062823 A062872 A062871 N050405
001 001 001 001 002 002 001 001 001 002 001 002 001 001 001 001 001 001 001 004
Nov Sep Dec Nov Sep Dec Jun Apr
08, 29, 30, 23, 29, 30, 26, 22,
1988 1989 1994 1988 1989 1994 1987 1987
Apr Apr Mar Apr Feb Apr Feb Jun Jul
22, 22, 17, 24, 05, 24, 05, 20, 05,
1987 1987 1988 1987 1988 1987 1988 1988 1988
EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
May 12, 2006
FOR SUSPENSION; ORAL CEPHALEXIN APOTHECON BARR FACTA FARMA TEVA
VITARINE KEFLEX SHIONOGI INC
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062986 A062987 A062778 A062777 A062117 A062767 A062873 A062768 A062867 A062779 A062781 N050406 N050406 N050406
001 001 001 001 001 001 001 001 001 001 001 003 001 002
Apr Jul Aug Aug Jun May Jun Apr Dec Dec
18, 25, 06, 06, 16, 23, 16, 15, 22, 22,
1991 1989 1987 1987 1987 1988 1987 1988 1987 1987
EQ 100MG BASE/ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML
TABLET; ORAL CEPHALEXIN BARR VITARINE
EQ EQ EQ EQ EQ
250MG BASE 500MG BASE 250MG BASE 500MG BASE 1GM BASE 250MG BASE 250MG BASE 500MG BASE 500MG BASE 1GM BASE
A062826 A062827 A062863 A062863 A062863 A062745 N050440 A062745 N050440 N050440
001 001 001 002 003 001 003 002 001 002
Aug Aug Aug Aug Aug
17, 17, 11, 11, 11,
1987 1987 1988 1988 1988
EQ EQ EQ EQ EQ TABLET, FOR SUSPENSION; ORAL PANIXINE DISPERDOSE RANBAXY LABS LTD EQ EQ
KEFLET LILLY
Dec 01, 1986 Feb 26, 1987 Dec 01, 1986
A065100 A065100
002 001
Sep 11, 2003 Sep 11, 2003

CEPHALEXIN HYDROCHLORIDE
TABLET; ORAL KEFTAB LILLY
6 - 70 (of 360)
N050614 N050614 N050614
001 003 002
Oct 29, 1987 May 16, 1988 Oct 29, 1987
CEPHALOGLYCIN
CAPSULE; ORAL KAFOCIN LILLY
250MG
N050219
001
CEPHALOTHIN SODIUM
INJECTABLE; INJECTION CEPHALOTHIN INTL MEDICATION
EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL
A062426 A062426 A062426 A062426 A062547 A062548 A062547 A062548 A062666 A062666 A062464 A062464 A062464 A062422 A062422 A062730 A062422 A062422 A062730 A062422 A062422 N050482 N050482 N050482 N050482 A062549 A062549 A062435 A062435 A062435
001 002 003 004 001 001 002 002 002 001 001 002 003 003 005 001 004 006 002 001 002 001 002 003 007 001 002 001 002 003
May May May May Sep Sep Sep Sep Jun Jun May May May Jan Jul Mar Jan Jul Mar
03, 03, 03, 03, 11, 11, 11, 11, 10, 10, 07, 07, 07, 31, 16, 05, 31, 16, 05,
1985 1985 1985 1985 1985 1985 1985 1985 1987 1987 1984 1984 1984 1984 1991 1987 1984 1991 1987
EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL ABRAXIS PHARM EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL BRISTOL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 4GM BASE/VIAL CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/ML EQ 20MG BASE/ML EQ 20MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/ML EQ 40MG BASE/ML KEFLIN LILLY EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 4GM BASE/VIAL EQ 20GM BASE/VIAL KEFLIN IN PLASTIC CONTAINER LILLY EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL SEFFIN GLAXOSMITHKLINE EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL
CEPHALOTHIN SODIUM ABBOTT
Jan 31, 1984 Jan 31, 1984
Sep 10, 1985 Sep 10, 1985 Nov 15, 1983 Nov 15, 1983 Nov 15, 1983
CEPHAPIRIN SODIUM
INJECTABLE; INJECTION CEFADYL APOTHECON
500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL
A062961 N050446 A061769 A062724 A062961 N050446 A061769 A062724
001 005 001 001 002 001 002 002
Sep 20, 1988
Dec 23, 1986 Sep 20, 1988
Dec 23, 1986

CEPHAPIRIN SODIUM
INJECTABLE; INJECTION CEFADYL APOTHECON
6 - 71 (of 360)
2GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 20GM BASE/VIAL
A062961 N050446 A061769 A062961 N050446 N050446 A062723 A062723 A062723 A062723 A062723 A062720 A062720 A062720 A062720
003 002 003 004 003 004 001 002 003 004 005 001 002 003 004
Sep 20, 1988
Sep 20, 1988
CEPHAPIRIN SODIUM ABRAXIS PHARM
HIKMA MAPLE
Nov Nov Nov Nov Nov Jul Jul Jul Jul
17, 17, 17, 17, 17, 02, 02, 02, 02,
1986 1986 1986 1986 1986 1987 1987 1987 1987
CEPHRADINE
CAPSULE; ORAL ANSPOR GLAXOSMITHKLINE CEPHRADINE BARR IVAX SUB TEVA PHARMS TEVA VITARINE VELOSEF APOTHECON VELOSEF '250' ERSANA VELOSEF '500' ERSANA FOR SUSPENSION; ORAL ANSPOR GLAXOSMITHKLINE CEPHRADINE BARR TEVA VELOSEF '125' APOTHECON VELOSEF '250' APOTHECON INJECTABLE; INJECTION VELOSEF APOTHECON
A061859 A061859 A062850 A062851 A062762 A062762 A062683 A062683 A062813 A062813 A061764 A061764 N050548 N050548
001 002 001 001 001 002 001 002 001 002 001 002 001 002 Apr Apr Mar Mar Jan Jan Feb Feb 22, 22, 06, 06, 09, 09, 25, 25, 1988 1988 1987 1987 1987 1987 1988 1988
A061866 A061866 A062858 A062859 A062693 A062693 A061763 A061763
001 002 001 001 001 002 001 002 May May Jan Jan 19, 19, 09, 09, 1988 1988 1987 1987
250MG/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 4GM/VIAL
A061976 A061976 A061976 A061976 A061976
001 002 004 003 005
TABLET; ORAL VELOSEF BRISTOL MYERS SQUIBB
1GM
N050530
001

CERIVASTATIN SODIUM
TABLET; ORAL BAYCOL BAYER PHARMS
6 - 72 (of 360)
0.05MG 0.1MG 0.2MG 0.3MG 0.4MG 0.8MG
N020740 N020740 N020740 N020740 N020740 N020740
001 002 003 004 005 006
Jun Jun Jun Jun May Jul
26, 26, 26, 26, 24, 24,
1997 1997 1997 1997 1999 2000
CERULETIDE DIETHYLAMINE
INJECTABLE; INJECTION TYMTRAN PHARMACIA AND UPJOHN
0.02MG/ML
N018296
001
SYRUP; ORAL CETIRIZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 5MG/5ML RANBAXY LABS LTD 5MG/5ML CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY ACTAVIS MID ATLANTIC 5MG/5ML RANBAXY LABS LTD 5MG/5ML CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF ACTAVIS MID ATLANTIC 5MG/5ML RANBAXY LABS LTD 5MG/5ML TABLET; ORAL CETIRIZINE HYDROCHLORIDE ALLERGY ACTAVIS ELIZABETH 5MG 10MG
A078617 A077472 A090378 A090183 A090378 A090183
001 001 002 002 001 001
Feb 02, 2010 Jun 18, 2008 May 09, 2008 Apr 24, 2008 May 09, 2008 Apr 24, 2008
A078615 A078615
003 004
Dec 28, 2007 Dec 28, 2007
CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL

FOR SUSPENSION; INTRATRACHEAL EXOSURF NEONATAL GLAXOSMITHKLINE 12MG/VIAL;108MG/VIAL;8MG/VIAL
N020044
001
Aug 02, 1990
CHENODIOL
TABLET; ORAL CHENIX SIGMA TAU
250MG
N018513
002
Jul 28, 1983
CHLOPHEDIANOL HYDROCHLORIDE
SYRUP; ORAL ULO 3M
25MG/5ML
N012126
001
CHLORAMPHENICOL
CAPSULE; ORAL AMPHICOL FERRANTE CHLOROMYCETIN PARKEDALE CREAM; TOPICAL CHLOROMYCETIN PARKE DAVIS FOR SOLUTION; OPHTHALMIC CHLOROMYCETIN PARKEDALE INJECTABLE; INJECTION CHLOROMYCETIN PARKE DAVIS
100MG 50MG 100MG
A060058 A060591 A060591
001 001 003
1%
N050183
001
25MG/VIAL
N050143
001
250MG/ML
N050153
001

CHLORAMPHENICOL
OINTMENT; OPHTHALMIC CHLORAMPHENICOL ALTANA 1% CHLOROFAIR PHARMAFAIR 1% CHLOROMYCETIN PARKEDALE 1% CHLOROPTIC S.O.P. ALLERGAN 1% ECONOCHLOR ALCON 1% SOLUTION/DROPS; OPHTHALMIC CHLORAMPHENICOL AKORN 0.5% ALCON 0.5% CHLOROFAIR PHARMAFAIR 0.5% CHLOROPTIC ALLERGAN 0.5% ECONOCHLOR ALCON 0.5% OPHTHOCHLOR PARKEDALE 0.5% OPTOMYCIN OPTOPICS 0.5% SOLUTION/DROPS; OTIC CHLOROMYCETIN PARKEDALE 0.5%
6 - 73 (of 360)
A060133 A062439 N050156 A061187 A061648
001 001 001 001 001 Apr 21, 1983
A062042 A062628 A062437 N050091 A061645 A061220 A062171
001 001 001 001 001 001 001
Sep 25, 1985 Apr 14, 1983
Mar 31, 1982
N050205
001
CHLORAMPHENICOL PALMITATE
SUSPENSION; ORAL CHLOROMYCETIN PALMITATE PARKE DAVIS EQ 150MG BASE/5ML EQ 150MG BASE/5ML
A062301 N050152
001 001

INJECTABLE; INJECTION CHLORAMPHENICOL ELKINS SINN EQ 1GM BASE/VIAL CHLORAMPHENICOL SODIUM SUCCINATE GRUPPO LEPETIT EQ 1GM BASE/VIAL CHLOROMYCETIN PARKEDALE EQ 1GM BASE/VIAL MYCHEL-S ANGUS EQ 1GM BASE/VIAL
A062406 A062278 N050155 A060132
001 001 001 001
Nov 09, 1982
CHLORAMPHENICOL; DESOXYRIBONUCLEASE; FIBRINOLYSIN

OINTMENT; TOPICAL ELASE-CHLOROMYCETIN PARKE DAVIS
10MG/GM;666 UNITS/GM;1 UNITS/GM
N050294
001
CHLORAMPHENICOL; HYDROCORTISONE ACETATE

FOR SUSPENSION; OPHTHALMIC CHLOROMYCETIN HYDROCORTISONE PARKEDALE 12.5MG/VIAL;25MG/VIAL
N050202
001
CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE

OINTMENT; OPHTHALMIC OPHTHOCORT PARKEDALE
10MG/GM;5MG/GM;10,000 UNITS/GM
N050201
002

CHLORAMPHENICOL; POLYMYXIN B SULFATE
OINTMENT; OPHTHALMIC CHLOROMYXIN PARKE DAVIS
6 - 74 (of 360)
1%;10,000 UNITS/GM
N050203
002
CHLORAMPHENICOL; PREDNISOLONE
OINTMENT; OPHTHALMIC CHLOROPTIC-P S.O.P. ALLERGAN
1%;0.5%
A061188
001
CHLORDIAZEPOXIDE
CAPSULE, EXTENDED RELEASE; ORAL LIBRELEASE VALEANT PHARM INTL 30MG TABLET; ORAL LIBRITABS VALEANT PHARM INTL 5MG 10MG 25MG
N017813
001
Sep 12, 1983
A085482 A085481 A085488
001 001 001
CAPSULE; ORAL A-POXIDE ABBOTT
001 001 002 001 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jan 07, 1982 Jan 07, 1982 Jan 07, 1982
5MG 10MG 25MG CHLORDIAZEPOXIDE HYDROCHLORIDE ASCOT 5MG 10MG 25MG FERRANTE 5MG 10MG 25MG HALSEY 5MG 10MG 25MG IMPAX LABS 5MG 10MG 25MG IVAX SUB TEVA PHARMS 5MG 10MG 25MG LEDERLE 5MG 5MG 10MG 10MG 25MG 25MG MAST MM 10MG MYLAN 5MG 10MG 25MG PARKE DAVIS 5MG 10MG 25MG PIONEER PHARMS 10MG
CHLORDIAZACHEL RACHELLE
Jul 15, 1988

CAPSULE; ORAL CHLORDIAZEPOXIDE HYDROCHLORIDE PIONEER PHARMS 25MG PUREPAC PHARM 5MG 10MG 25MG ROXANE 5MG 10MG 25MG SANDOZ 5MG 5MG 10MG 10MG 25MG 25MG SUPERPHARM 5MG 10MG 25MG TEVA 5MG 10MG 25MG 25MG USL PHARMA 5MG 25MG VANGARD 5MG 10MG 25MG WEST WARD 5MG 10MG 25MG LIBRIUM VALEANT PHARM INTL 5MG 10MG 25MG LYGEN ALRA 5MG 10MG 25MG INJECTABLE; INJECTION LIBRIUM VALEANT PHARM INTL 100MG/AMP
6 - 75 (of 360)
A089558 A085155 A084939 A085144 A084706 A084700 A084705 A084678 A084919 A084041 A084920 A084679 A084823 A088987 A088986 A088988 A088705 A088706 A086494 A088707 A084644 A084645 A088129 A088010 A088130 A085014 A085000 A085294 N012249 N012249 N012249 A085107 A085009 A085108
001 001 002 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 003 001 001 001
Jul 15, 1988
Apr Apr Apr Jan Jan
25, 25, 25, 18, 18,
1985 1985 1985 1985 1985
Jan 18, 1985
Mar 28, 1983 Mar 28, 1983 Mar 28, 1983
N012301
001
CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED

TABLET; ORAL MENRIUM 10-4 ROCHE MENRIUM 5-2 ROCHE MENRIUM 5-4 ROCHE
10MG;0.4MG 5MG;0.2MG 5MG;0.4MG
N014740 N014740 N014740
006 002 004
SOLUTION; TOPICAL EXIDINE XTTRIUM MICRODERM J AND J PREVACARE R J AND J STERI-STAT MATRIX MEDCL
2.5% 4% 0.5% 4%
N019421 A072255 A072292 A070104
001 001 001 001
Dec 17, 1985 Apr 15, 1991 Jan 28, 1992 Jul 24, 1986

SPONGE; TOPICAL CHLORHEXIDINE GLUCONATE KENDALL IL 4% E-Z SCRUB BECTON DICKINSON 4% HIBICLENS MOLNLYCKE HLTH 4% **Federal Register determination that product was not discontinued or
withdrawn for safety or efficacy
reasons**
MICRODERM J AND J 4%
6 - 76 (of 360)
N019490 A073416 N018423
001 001 001
Mar 27, 1987 Mar 14, 2000
A072295
001
Feb 28, 1991
CHLORMERODRIN HG-197
CHLORMERODRIN HG 197
BRACCO
0.6-1.4mCi/ML
N017269
001
CHLORMEZANONE
TABLET; ORAL
TRANCOPAL
SANOFI AVENTIS US
100MG 200MG
N011467 N011467
003
005
CHLOROPROCAINE HYDROCHLORIDE
NESACAINE-MPF
FRESENIUS KABI USA
2% 3%
N009435 N009435
003
004
CHLOROQUINE HYDROCHLORIDE
ARALEN HYDROCHLORIDE
SANOFI AVENTIS US
EQ 40MG BASE/ML
N006002
002
CHLOROQUINE PHOSPHATE
TABLET; ORAL CHLOROQUINE PHOSPHATE MD PHARM PUREPAC PHARM TEVA WATSON LABS
EQ EQ EQ EQ EQ
150MG 150MG 150MG 150MG 300MG
A087228 A080886 A087504 A087979 A088030
001 001 001 001 001
Jan 13, 1982 Dec 21, 1982 Dec 21, 1982
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE

TABLET; ORAL
ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE
SANOFI AVENTIS US EQ 300MG BASE;EQ 45MG BASE
N014860
002
CHLOROTHIAZIDE
TABLET; ORAL CHLOROTHIAZIDE
ABC HOLDING LEDERLE SANDOZ WATSON LABS
A085569 A086940 A086938 A085485 A085165 A085173 A086795 A084026 A086796
001
001
001
001
001
001 001 001 001
Aug 15, 1983 Sep 01, 1982 Aug 15, 1983

CHLOROTHIAZIDE
TABLET; ORAL DIURIL LUNDBECK INC OAK PHARMS AKORN
6 - 77 (of 360)
250MG 500MG
N011145 N011145
004 002
CHLOROTHIAZIDE; METHYLDOPA
TABLET; ORAL ALDOCLOR-150 MERCK 150MG;250MG ALDOCLOR-250 MERCK 250MG;250MG METHYLDOPA AND CHLOROTHIAZIDE PAR PHARM 150MG;250MG 250MG;250MG
N016016 N016016 A070783 A070654
001 002 001 001 Nov 06, 1987 Nov 06, 1987
CHLOROTHIAZIDE; RESERPINE
TABLET; ORAL CHLOROTHIAZIDE AND RESERPINE WEST WARD 250MG;0.125MG 500MG;0.125MG CHLOROTHIAZIDE W/ RESERPINE WATSON LABS 250MG;0.125MG 500MG;0.125MG CHLOROTHIAZIDE-RESERPINE MYLAN 250MG;0.125MG 500MG;0.125MG DIUPRES-250 MERCK 250MG;0.125MG DIUPRES-500 MERCK 500MG;0.125MG
A088557 A088365 A084853 A088151 A087744 A087745 N011635 N011635
001 001 001 001 001 001 003 006
Dec 22, 1983 Dec 22, 1983
Jun 09, 1983 May 06, 1982 May 06, 1982 Aug 26, 1987 Aug 26, 1987
CHLOROTRIANISENE
CAPSULE; ORAL CHLOROTRIANISENE BANNER PHARMACAPS TACE SANOFI AVENTIS US
12MG 12MG 25MG 72MG
A084652 N008102 N011444 N016235
001 004 001 001
CHLOROXINE
SHAMPOO; TOPICAL CAPITROL WESTWOOD SQUIBB
2%
N017594
001
CHLORPHENESIN CARBAMATE
TABLET; ORAL MAOLATE PHARMACIA AND UPJOHN
400MG
N014217
002
CAPSULE, EXTENDED RELEASE; ORAL CHLORPHENIRAMINE MALEATE SANDOZ 12MG TELDRIN GLAXOSMITHKLINE 8MG 12MG INJECTABLE; INJECTION CHLORPHENIRAMINE MALEATE BEL MAR 10MG/ML ELKINS SINN 10MG/ML WATSON LABS 10MG/ML
A070797 N017369 N017369
001 001 002
Aug 12, 1988
A080821 A080797 A083593
001 001 001

INJECTABLE; INJECTION CHLORPHENIRAMINE MALEATE WATSON LABS 10MG/ML 100MG/ML CHLOR-TRIMETON SCHERING PLOUGH 10MG/ML 100MG/ML PYRIDAMAL 100 BEL MAR 100MG/ML SYRUP; ORAL CHLORPHENIRAMINE MALEATE PHARM ASSOC 2MG/5ML CHLOR-TRIMETON SCHERING 2MG/5ML TABLET; ORAL ANTAGONATE BAYER PHARMS 4MG CHLORPHENIRAMINE MALEATE ANABOLIC 4MG BELL PHARMA 4MG ELKINS SINN 4MG IMPAX LABS 4MG IVAX SUB TEVA PHARMS 4MG KV PHARM 4MG LEDERLE 4MG MUTUAL PHARM 4MG NEWTRON PHARMS 4MG PANRAY 4MG PHARMAVITE 4MG PHARMERAL 4MG PIONEER PHARMS 4MG PUREPAC PHARM 4MG PVT FORM 4MG ROXANE 4MG SANDOZ 4MG VITARINE 4MG WATSON LABS 4MG 4MG 4MG WEST WARD 4MG CHLOR-TRIMETON SCHERING 4MG KLOROMIN HALSEY 4MG PHENETRON LANNETT 4MG TABLET, EXTENDED RELEASE; ORAL CHLOR-TRIMETON SCHERING PLOUGH 8MG EFIDAC 24 CHLORPHENIRAMINE MALEATE ALZA 16MG
6 - 78 (of 360)
A086096 A086095 N008826 N008794 A083733
001 001 001 001 001
A087520 N006921
001 006
Feb 10, 1982
A083381 A083078 A083062 A080938 A080809 A080779 A087164 A086941 A080700 A086519 A083243 A085104 A083753 A088556 A086306 A080786 A080626 A080961 A085837 A080696 A080791 A085139 A083787 N006921 A083629 A080846
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001
Jul 13, 1984
N007638 N019746
001 002 Nov 18, 1994
CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

CAPSULE, EXTENDED RELEASE; ORAL CHLOROHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE WATSON LABS 12MG;75MG CHLORPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE SANDOZ 12MG;75MG COLD CAPSULE IV GRAHAM DM 12MG;75MG COLD CAPSULE V GRAHAM DM 8MG;75MG
A088681 A088940 N018793 N018794
001 001 001 001
Sep 29, 1987 Jan 26, 1989 Apr 25, 1985 Apr 23, 1985

CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL CONTAC 12 HOUR GLAXOSMITHKLINE 8MG;75MG DRIZE ASCHER 12MG;75MG ORNADE GLAXOSMITHKLINE 12MG;75MG PHENYLPROPANOLAMINE HYDROCHLORIDE W/ CHLORPHENIRAMINE MALEATE CENT PHARMS 8MG;75MG TABLET, EXTENDED RELEASE; ORAL CONTAC NOVARTIS 12MG;75MG DEMAZIN SCHERING PLOUGH 4MG;25MG TRIAMINIC-12 NOVARTIS 12MG;75MG
6 - 79 (of 360)
N018099 A088359 N012152 N018809
001 001 004 001 May 07, 1984 Feb 13, 1986
N019613 N018556 N018115
001 001 001
Jun 13, 1986 May 14, 1984
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE

CAPSULE, EXTENDED RELEASE; ORAL CODIMAL-L.A. 12 SCHWARZ PHARMA 12MG;120MG ISOCLOR FISONS 8MG;120MG PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE CENT PHARMS 8MG;120MG GRAHAM DM 8MG;120MG 12MG;120MG KV PHARM 12MG;120MG
N018935 N018747 N019428 N018844 N018843 A071455
001 001 001 001 001 001
Apr 15, 1985 Mar 06, 1986 Aug Mar Mar Mar 02, 20, 18, 01, 1988 1985 1985 1989
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX

SUSPENSION, EXTENDED RELEASE; ORAL CODEPREX UCB INC EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML PENNTUSS FISONS EQ 4MG MALEATE/5ML;EQ 10MG BASE/5ML
N021369 N018928
001 001
Jun 21, 2004 Aug 14, 1985
CHLORPHENIRAMINE POLISTIREX; PHENYLPROPANOLAMINE POLISTIREX

SUSPENSION, EXTENDED RELEASE; ORAL CORSYM UCB INC EQ 4MG MALEATE/5ML;EQ 37.5MG HCL/5ML
N018050
001
Jan 04, 1984
CHLORPHENTERMINE HYDROCHLORIDE
TABLET; ORAL
PRE-SATE
PARKE DAVIS
EQ 65MG BASE
N014696
001
CHLORPROMAZINE
SUPPOSITORY; RECTAL
THORAZINE
GLAXOSMITHKLINE
25MG **Federal Register determination that product was not discontinued or

reasons**
100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N009149
024
N009149
033
CAPSULE, EXTENDED RELEASE; ORAL THORAZINE GLAXOSMITHKLINE 30MG 75MG
N011120 N011120
016 017

THORAZINE
GLAXOSMITHKLINE 150MG 200MG 300MG CONCENTRATE; ORAL CHLORPROMAZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 100MG/ML PHARM ASSOC 30MG/ML 100MG/ML WOCKHARDT 30MG/ML 100MG/ML CHLORPROMAZINE HYDROCHLORIDE INTENSOL ROXANE 30MG/ML 100MG/ML SONAZINE SANDOZ 30MG/ML 100MG/ML THORAZINE GLAXOSMITHKLINE 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** INJECTABLE; INJECTION CHLORPROMAZINE HYDROCHLORIDE ABRAXIS PHARM 25MG/ML MARSAM PHARMS LLC 25MG/ML WATSON LABS 25MG/ML 25MG/ML WYETH AYERST 25MG/ML THORAZINE
GLAXOSMITHKLINE 25MG/ML SYRUP; ORAL
ALPHARMA US PHARMS 10MG/5ML SONAZINE
SANDOZ 10MG/5ML THORAZINE
GLAXOSMITHKLINE 10MG/5ML **Federal Register determination that product was not
TABLET; ORAL
ABBOTT 10MG 25MG 50MG 100MG 200MG IVAX SUB TEVA PHARMS 10MG 25MG 50MG 100MG 200MG KV PHARM 10MG 25MG 50MG 100MG 200MG LEDERLE 10MG
6 - 80 (of 360)
N011120 N011120 N011120
018
019
020
A086863 A040231 A040224 A087032 A087053 A088157 A088158 A080983 A080983 N009149
001 001 001 001 001 001 001 004 005 032
Dec 30, 1999 Jan 26, 1999 Jul 08, 1982
Apr 27, 1983 Apr 27, 1983
N009149
043
A084911 A089563 A080365 A085591 A080370 N009149
001 001 001 001

001
011
Apr 15, 1988
A086712 A083040 N009149
001
001
022
001
001
001
001
001
001
002
003
001
001
002 001 001 001 002 001
Jan 04, 1982
Jan 04, 1982

TABLET; ORAL CHLORPROMAZINE HYDROCHLORIDE LEDERLE 25MG 50MG 100MG 200MG PUREPAC PHARM 10MG 25MG 50MG 100MG 200MG PVT FORM 25MG 50MG 200MG ROXANE 10MG 25MG 50MG 100MG 200MG VANGARD 10MG 25MG 50MG WATSON LABS 10MG 25MG 50MG 100MG 200MG WEST WARD 10MG 25MG 50MG 100MG 200MG PROMAPAR PARKE DAVIS 10MG 25MG 50MG 100MG 200MG THORAZINE GLAXOSMITHKLINE 10MG 25MG 50MG 100MG 200MG
6 - 81 (of 360)
A084801 A084800 A084789 A084802 A080403 A080403 A080403 A080403 A080403 A080340 A080340 A080340 A085331 A085331 A085331 A085331 A085331 A088038 A087645 A087646 A085959 A085956 A085960 A085957 A085958 A087783 A087865 A087878 A087884 A087880 A086886 A084423 A086887 A086888 A086885 N009149 N009149 N009149 N009149 N009149
001 001 001 001 004 001 002 003 005 001 002 003 001 002 003 004 005 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 007 013 018 020
Aug 16, 1982
Sep Sep Sep Sep Sep
16, 16, 15, 15, 16,
1982 1982 1982 1982 1982
CHLORPROPAMIDE
TABLET; ORAL CHLORPROPAMIDE BARR
CLONMEL HLTHCARE DURAMED PHARMS BARR HALSEY IVAX PHARMS PAR PHARM
A088812 A089446 A088813 A089447 A089561 A089562 A088918 A088919 A089321 A088662 A088840 A087353 A088175 A088176
001 001 001 001 001 001 001 001 001 001 001 001 001 001
Oct Nov Oct Nov Sep Sep Oct Oct Jan Jan Oct
19, 17, 19, 17, 04, 04, 16, 16, 16, 09, 25,
1984 1986 1984 1986 1987 1987 1984 1984 1986 1986 1984
Feb 27, 1984 Feb 27, 1984

CHLORPROPAMIDE
TABLET; ORAL CHLORPROPAMIDE SANDOZ
6 - 82 (of 360)
SUPERPHARM TEVA USL PHARMA WATSON LABS
A088725 A084669 A088726 A088694 A088695 A088768 A088708 A088709 A086865 A088608 A086866 A088568 A088641
001 001 001 001 001 001 001 001 001 001 001 001 001
Aug 31, 1984 Aug Sep Sep Oct Aug Aug Sep Apr 31, 17, 17, 11, 30, 30, 24, 12, 1984 1984 1984 1984 1984 1984 1984 1984
Apr 12, 1984 Oct 11, 1984
GLUCAMIDE TEVA
CHLORPROTHIXENE
CONCENTRATE; ORAL TARACTAN ROCHE INJECTABLE; INJECTION TARACTAN ROCHE TABLET; ORAL TARACTAN ROCHE
100MG/5ML
N016149
002
12.5MG/ML
N012487
001
N012486 N012486 N012486 N012486
005 004 003 001
CHLORTETRACYCLINE HYDROCHLORIDE
OINTMENT; OPHTHALMIC AUREOMYCIN LEDERLE
1%
N050404
001
CHLORTHALIDONE
TABLET; ORAL CHLORTHALIDONE ABBOTT ASCOT DAVA PHARMS INC IVAX PHARMS
KV PHARM MUTUAL PHARM
PIONEER PHARMS PUREPAC PHARM SANDOZ
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Oct 20, 1982 Oct 20, 1982
Jan 09, 1984 Feb 27, 1984
Jul 21, 1986 Sep 19, 1988 Jul Sep Jul Jul Aug 21, 19, 21, 16, 11, 1986 1988 1988 1986 1983

CHLORTHALIDONE
TABLET; ORAL CHLORTHALIDONE SANDOZ SUPERPHARM TEVA USL PHARMA VANGARD WARNER CHILCOTT WATSON LABS
6 - 83 (of 360)
A087381 A087473 A087247 A088651 A089051 A089052 A088012 A088073 A087515 A087516 A087050 A087100 A087296 A087706 A087029 A087082 A087521 A087689 N012283 N012283 A088051 N019574
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 004 003 001 002
Feb Feb May Jun Jun Jul Mar Jan Feb
09, 09, 30, 01, 01, 14, 25, 24, 09,
1983 1983 1985 1987 1987 1982 1983 1983 1983
HYGROTON SANOFI AVENTIS US THALITONE MONARCH PHARMS
Nov 12, 1982 Feb 12, 1992
CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE

TABLET; ORAL CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE PAR PHARM 15MG;0.1MG 15MG;0.2MG 15MG;0.3MG COMBIPRES BOEHRINGER INGELHEIM 15MG;0.1MG 15MG;0.2MG 15MG;0.3MG
A071179 A071178 A071142 N017503 N017503 N017503
001 001 001 001 002 003
Dec 16, 1987 Dec 16, 1987 Dec 16, 1987
Apr 10, 1984
CHLORTHALIDONE; METOPROLOL TARTRATE

CAPSULE; ORAL LOPRESSIDONE NOVARTIS
25MG;100MG 25MG;200MG
N019451 N019451
001 002
Dec 31, 1987 Dec 31, 1987
CHLORTHALIDONE; RESERPINE
TABLET; ORAL DEMI-REGROTON SANOFI AVENTIS US REGROTON SANOFI AVENTIS US
25MG;0.125MG 50MG;0.25MG
N015103 N015103
002 001
CHLORZOXAZONE
TABLET; ORAL CHLORZOXAZONE ACTAVIS TOTOWA MUTUAL PHARM OHM LABS PAR PHARM PIONEER PHARMS
A088928 A040113 A089970 A081298 A081299 A087981 A089592 A089948
001 001 001 001 001 001 001 001
May Sep Sep Dec Dec Sep Jan Jan
08, 29, 27, 29, 29, 20, 06, 06,
1987 1995 1990 1993 1993 1983 1989 1989

CHLORZOXAZONE
TABLET; ORAL CHLORZOXAZONE SANDOZ WATSON LABS
6 - 84 (of 360)
250MG 500MG 250MG 250MG 500MG 250MG 500MG
A089852 A089853 A086901 A086948 A081019 N011300 A081008
001 001 001 001 001 003 001
May 04, 1988 May 04, 1988 Aug 09, 1982 Jul 29, 1991
PARAFLEX ORTHO MCNEIL PHARM STRIFON FORTE DSC FERNDALE LABS
Dec 23, 1988
CHOLESTYRAMINE
BAR, CHEWABLE; ORAL CHOLYBAR PARKE DAVIS POWDER; ORAL CHOLESTYRAMINE IVAX SUB TEVA PHARMS TEVA TEVA PHARMS CHOLESTYRAMINE LIGHT TEVA TEVA PHARMS LOCHOLEST SANDOZ LOCHOLEST LIGHT SANDOZ QUESTRAN BRISTOL MYERS QUESTRAN LIGHT BRISTOL MYERS TABLET; ORAL QUESTRAN APOTHECON
EQ 4GM RESIN/BAR EQ 4GM RESIN/BAR
A071621 A071739
001 001
May 26, 1988 May 26, 1988
4GM 4GM 4GM 4GM 4GM 4GM 4GM 4GM 4GM 4GM
RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 003 001 003
Jul Jul May May Oct Oct May May Sep Sep
09, 09, 28, 28, 02, 02, 28, 28, 30, 30,
1997 1997 1998 1998 1996 1996 1998 1998 1998 1998
EQ 4GM RESIN/PACKET EQ 4GM RESIN/SCOOPFUL EQ 4GM RESIN/PACKET EQ 4GM RESIN/SCOOPFUL EQ 4GM RESIN/PACKET EQ 4GM RESIN/SCOOPFUL EQ 4GM RESIN/PACKET EQ 4GM RESIN/SCOOPFUL
Aug 15, 1996 Aug 15, 1996 Aug 15, 1996 Aug 15, 1996
Dec 05, 1988 Dec 05, 1988
EQ 800MG RESIN EQ 1GM RESIN
A073403 A073403
002 001
Dec 27, 1999 Apr 28, 1994
CHORIOGONADOTROPIN ALFA
INJECTABLE; INJECTION OVIDREL EMD SERONO
0.25MG/VIAL
N021149
001
Sep 20, 2000
CHROMIC CHLORIDE
INJECTABLE; INJECTION CHROMIC CHLORIDE ABRAXIS PHARM
EQ 0.004MG CHROMIUM/ML
N019271
001
May 05, 1987
CHROMIC PHOSPHATE P-32

INJECTABLE; INJECTION PHOSPHOCOL P32 MALLINCKRODT
5mCi/ML
N017084
001

CHYMOPAPAIN
CHYMODIACTIN
CHART MEDCL
6 - 85 (of 360)
4,000 UNITS/VIAL 10,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 12,500 UNITS/VIAL
N018663 N018663
002 001
Aug 21, 1984 Nov 10, 1982
DISCASE ABBOTT
N018625
001
Jan 18, 1984
CHYMOTRYPSIN
ALPHA CHYMAR
SOLA BARNES HIND CATARASE
CIBA NOVARTIS ZOLYSE
ALCON
750 UNITS/VIAL 300 UNITS/VIAL 150 UNITS/VIAL 750 UNITS/VIAL
N011837 N016938 N018121 N011903
001
001
001
001
CILASTATIN SODIUM; IMIPENEM

INJECTABLE; INJECTION PRIMAXIN MERCK
EQ 750MG BASE/VIAL;750MG/VIAL
N050630
002
Dec 14, 1990
CILOSTAZOL
TABLET; ORAL CILOSTAZOL ACTAVIS TOTOWA IVAX SUB TEVA PHARMS MUTUAL PHARM
100MG 100MG 50MG 100MG
A077028 A077020 A077208 A077208
002 002 002 001
Nov Mar Mar Mar
26, 01, 29, 29,
2004 2005 2006 2006
CIMETIDINE
SUSPENSION; ORAL TAGAMET HB 200 GLAXOSMITHKLINE 200MG/20ML TABLET; ORAL CIMETIDINE IVAX SUB TEVA PHARMS 200MG 300MG 400MG 800MG LEK PHARMS 100MG 200MG 200MG 300MG 400MG 800MG PERRIGO 100MG ROXANE 300MG 400MG 800MG SANDOZ 200MG 200MG 300MG 300MG 400MG 400MG 800MG 800MG TEVA 200MG 300MG
N020951
001
Jul 09, 1999
001 002 003 001 001 001 002 002 003 004 001 001 002 001 001 001 002 002 003 003 004 004 001 002
May May May May Jun Jun Jun Jun Jun Jun Jun Dec Dec Dec Jan Jan Jan Jan Jan Jan Jan Jan Feb Feb
30, 30, 30, 30, 19, 29, 19, 29, 29, 29, 19, 23, 23, 23, 31, 24, 31, 24, 31, 24, 31, 24, 28, 28,
1995 1995 1995 1995 1998 1995 1998 1995 1995 1995 1998 1994 1994 1994 1995 1996 1995 1996 1995 1996 1995 1996 1995 1995

CIMETIDINE
TABLET; ORAL CIMETIDINE TEVA VINTAGE PHARMS LLC
6 - 86 (of 360)
400MG 800MG 200MG 300MG 400MG 800MG 100MG
A074365 A074365 A074281 A074281 A074281 A074329 N020238
003 004 001 002 003 001 001
Feb Feb May May May May
28, 28, 17, 17, 17, 17,
1995 1995 1994 1994 1994 1994
TAGAMET HB GLAXOSMITHKLINE
Jun 19, 1995
CIMETIDINE HYDROCHLORIDE
INJECTABLE; INJECTION CIMETIDINE HYDROCHLORIDE HOSPIRA EQ 300MG BASE/2ML A074296 EQ 300MG BASE/2ML A074344 EQ 300MG BASE/2ML A074345 EQ 300MG BASE/2ML A074412 EQ 300MG BASE/2ML A074422 LUITPOLD EQ 300MG BASE/2ML A074353 TEVA PARENTERAL EQ 300MG BASE/2ML A074252 VINTAGE PHARMS LLC EQ 300MG BASE/2ML A074005 CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA EQ 6MG BASE/ML A074269 EQ 90MG BASE/100ML A074468 EQ 120MG BASE/100ML A074468 EQ 180MG BASE/100ML A074468 EQ 240MG BASE/100ML A074468 EQ 360MG BASE/100ML A074468 EQ 480MG BASE/100ML A074468 TAGAMET GLAXOSMITHKLINE EQ 300MG BASE/2ML N017939 TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER GLAXOSMITHKLINE EQ 6MG BASE/ML N019434 SOLUTION; ORAL CIMETIDINE HYDROCHLORIDE ACTAVIS MID ATLANTIC EQ 300MG BASE/5ML A074176 DURAMED PHARMS BARR EQ 300MG BASE/5ML A075110 ROXANE EQ 300MG BASE/5ML A074541 TEVA PHARMS EQ 300MG BASE/5ML A074859 VINTAGE PHARMS LLC EQ 300MG BASE/5ML A074251 TAGAMET GLAXOSMITHKLINE EQ 300MG BASE/5ML N017924
001 001 001 001 001 001 001 001 001 005 006 003 004 001 002 002 001
Mar Jan Jan Mar Jan Dec Nov Aug Dec Dec Dec Dec Dec Dec Dec
28, 31, 31, 28, 31, 20, 26, 31, 27, 29, 29, 29, 29, 29, 29,
1997 1995 1995 1997 1995 1994 1997 1994 1994 1994 1994 1994 1994 1994 1994
Oct 31, 1985
001 001 001 001 001 001
Jun Jun Aug Jul Dec
01, 18, 05, 09, 22,
1994 1998 1997 1998 1994
CINOXACIN
CAPSULE; ORAL CINOBAC LILLY CINOXACIN TEVA
250MG 500MG 250MG 500MG
N018067 N018067 A073005 A073006
001 002 001 001 Feb 28, 1992 Feb 28, 1992
CIPROFLOXACIN
INJECTABLE; INJECTION CIPRO BAYER HLTHCARE 1200MG/120ML (10MG/ML) CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAYER PHARMS 200MG/100ML CIPROFLOXACIN BEDFORD LABS 200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML)
N019847 N019858 A076992 A076992
003 001 001 002
Dec 26, 1990 Dec 26, 1990 Aug 28, 2006 Aug 28, 2006

CIPROFLOXACIN
INJECTABLE; INJECTION CIPROFLOXACIN BEDFORD LABS FRESENIUS KABI USA
6 - 87 (of 360)
1200MG/120ML (10MG/ML) 200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) TEVA PARENTERAL 200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) CIPROFLOXACIN IN DEXTROSE 5% HIKMA FARMACEUTICA 200MG/100ML CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 200MG/100ML 400MG/200ML BEDFORD 200MG/100ML 400MG/200ML TEVA PHARMS 200MG/100ML 400MG/200ML
A076993 A076484 A076484 A077782 A077782 A076757 A077888 A077888 A078114 A078114 A077138 A077138
001 001 002 001 002 001 001 002 001 002 001 002
Aug Aug Aug Aug Aug
28, 28, 28, 28, 28,
2006 2006 2006 2006 2006
Apr 21, 2008 Mar Mar Mar Mar Mar Mar 18, 18, 18, 18, 18, 18, 2008 2008 2008 2008 2008 2008
TABLET; ORAL CIPROFLOXACIN HYDROCHLORIDE BARR EQ 250MG EQ 500MG EQ 750MG NOSTRUM LABS EQ 250MG EQ 500MG EQ 750MG PLIVA EQ 100MG EQ 250MG EQ 500MG EQ 750MG SANDOZ EQ 100MG EQ 250MG EQ 250MG EQ 500MG EQ 500MG EQ 750MG EQ 750MG TEVA EQ 250MG EQ 500MG EQ 750MG TABLET, EXTENDED RELEASE; ORAL PROQUIN XR DEPOMED INC EQ 500MG
001 002 003 001 002 003 001 002 003 004 001 002 002 003 003 004 004 001 002 003
Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Mar Jun Jun Jun Jun Jun Jun Jun Jun Jun
09, 09, 09, 09, 09, 09, 15, 15, 15, 15, 03, 09, 09, 09, 09, 09, 09, 09, 09, 09,
2004 2004 2004 2004 2004 2004 2005 2005 2005 2005 2005 2004 2004 2004 2004 2004 2004 2004 2004 2004
BASE
N021744
001
May 19, 2005
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL CIPROFLOXACIN EXTENDED RELEASE SANDOZ 212.6MG;EQ 287.5MG BASE
A078712
001
Dec 11, 2007
CISAPRIDE MONOHYDRATE
SUSPENSION; ORAL PROPULSID JANSSEN PHARMS TABLET; ORAL PROPULSID JANSSEN PHARMS
EQ 1MG BASE/ML
N020398
001
Sep 15, 1995
EQ 10MG BASE EQ 20MG BASE TABLET, ORALLY DISINTEGRATING; ORAL PROPULSID QUICKSOLV JANSSEN PHARMA EQ 20MG BASE
N020210 N020210
001 002
Jul 29, 1993 Dec 23, 1993
N020767
001
Nov 07, 1997

CISPLATIN
INJECTABLE; INJECTION CISPLATIN BEDFORD TEVA PARENTERAL PLATINOL CORDEN PHARMA PLATINOL-AQ CORDEN PHARMA
6 - 88 (of 360)
10MG/VIAL 50MG/VIAL 1MG/ML 10MG/VIAL 50MG/VIAL 0.5MG/ML 1MG/ML
A074713 A074713 A074814 N018057 N018057 N018057 N018057
001 002 001 001 002 003 004
Nov 14, 2000 Nov 14, 2000 May 16, 2000
Jul 18, 1984 Nov 08, 1988
SOLUTION; ORAL CITALOPRAM HYDROBROMIDE APOTEX INC EQ 10MG BASE/5ML TABLET; ORAL CELEXA FOREST LABS EQ 60MG BASE CITALOPRAM HYDROBROMIDE ACTAVIS ELIZABETH EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE MUTUAL PHARM EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE ROXANE EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE SANDOZ EQ 10MG BASE EQ 10MG BASE EQ 20MG BASE EQ 20MG BASE EQ 40MG BASE EQ 40MG BASE TARO EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE TEVA PHARMS EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE TABLET, ORALLY DISINTEGRATING; ORAL CITALOPRAM HYDROBROMIDE BIOVAIL LABS INTL EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE
A077601
001
Nov 15, 2005
N020822 A077033 A077033 A077033 A077052 A077052 A077052 A077041 A077041 A077041 A077035 A077040 A077035 A077040 A077035 A077040 A077278 A077278 A077278 A077213 A077213 A077213
004 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003
Jul 17, 1998 Oct Oct Oct Jul Jul Jul Nov Nov Nov Oct Aug Oct Aug Oct Aug Mar Mar Mar Mar Mar Mar 28, 28, 28, 03, 03, 03, 23, 23, 23, 28, 17, 28, 17, 28, 17, 22, 22, 22, 31, 31, 31, 2004 2004 2004 2006 2006 2006 2004 2004 2004 2004 2005 2004 2005 2004 2005 2006 2006 2006 2006 2006 2006
N021763 N021763 N021763
001 002 003
Dec 20, 2005 Dec 20, 2005 Dec 20, 2005
CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE

SOLUTION; IRRIGATION IRRIGATING SOLUTION G IN PLASTIC CONTAINER BAXTER HLTHCARE 3.24GM/100ML;380MG/100ML;430MG/100ML UROLOGIC G IN PLASTIC CONTAINER HOSPIRA 3.24GM/100ML;380MG/100ML;430MG/100ML
N018519 N018904
001 001
Jun 22, 1982 May 27, 1983
CLARITHROMYCIN
FOR SUSPENSION; ORAL BIAXIN ABBVIE TABLET; ORAL CLARITHROMYCIN IVAX SUB TEVA PHARMS
187MG/5ML
N050698
003
Sep 30, 1998
250MG 500MG
A065137 A065137
001 002
May 31, 2005 May 31, 2005

CLARITHROMYCIN
TABLET, EXTENDED RELEASE; ORAL CLARITHROMYCIN RANBAXY 1GM SANDOZ 500MG
6 - 89 (of 360)
A065210 A065250
001 001
Jan 26, 2005 Aug 25, 2005
CLEMASTINE FUMARATE
SYRUP; ORAL CLEMASTINE FUMARATE ACTAVIS MID ATLANTIC TEVA PHARMS TAVIST NOVARTIS TABLET; ORAL CLEMASTINE FUMARATE TEVA TAVIST NOVARTIS TAVIST-1 NOVARTIS
A074075 A073095 N018675
001 001 001
Oct 31, 1993 Apr 21, 1992 Jun 28, 1985
1.34MG 1.34MG 2.68MG 1.34MG 1.34MG
A073282 A073282 N017661 N017661 N017661
001 002 001 002 003
Jan 31, 1992 Dec 03, 1992
Aug 21, 1992
CLEMASTINE FUMARATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

TABLET, EXTENDED RELEASE; ORAL TAVIST-D NOVARTIS EQ 1MG BASE;75MG 1.34MG;75MG 1.34MG;75MG
N018298 N018298 N020640
001 002 001
Dec 15, 1982 Aug 21, 1992 Aug 09, 1996
CLIDINIUM BROMIDE
CAPSULE; ORAL QUARZAN ROCHE
2.5MG 5MG
N010355 N010355
001 002
CLINDAMYCIN HYDROCHLORIDE
CAPSULE; ORAL CLEOCIN PHARMACIA AND UPJOHN
EQ EQ CLINDAMYCIN HYDROCHLORIDE TEVA EQ WATSON LABS EQ
A061809 A061809 A063027 A063082
001 002 001 001 Sep 20, 1989 Jul 31, 1991

FOR SOLUTION; ORAL CLEOCIN PHARMACIA AND UPJOHN
EQ 75MG BASE/5ML
A061827
001
CREAM; VAGINAL CLEOCIN PHARMACIA AND UPJOHN INJECTABLE; INJECTION CLEOCIN PHOSPHATE PHARMACIA AND UPJOHN CLINDAMYCIN PHOSPHATE ABRAXIS PHARM ASTRAZENECA BEDFORD BRISTOL MYERS SQUIBB HIKMA MAPLE
EQ 2% BASE
N050680
001
Aug 11, 1992
EQ 150MG BASE/ML EQ EQ EQ EQ EQ 150MG 150MG 150MG 150MG 150MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A061839 A062747 A062928 A063163 A062908 A062806
001 001 001 001 001 001 Jun Feb Jun Feb Oct 03, 13, 30, 01, 15, 1988 1989 1994 1989 1987

INJECTABLE; INJECTION CLINDAMYCIN PHOSPHATE HIKMA MAPLE
6 - 90 (of 360)
EQ 150MG BASE/ML EQ 150MG BASE/ML LOCH EQ 150MG BASE/ML MARSAM PHARMS LLC EQ 150MG BASE/ML SOLOPAK EQ 150MG BASE/ML EQ 150MG BASE/ML TEVA PARENTERAL EQ 150MG BASE/ML EQ 150MG BASE/ML WATSON LABS EQ 150MG BASE/ML EQ 150MG BASE/ML CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% ABRAXIS PHARM EQ 12MG BASE/ML CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER ABBVIE EQ 6MG BASE/ML EQ 12MG BASE/ML EQ 18MG BASE/ML BAXTER HLTHCARE EQ 6MG BASE/ML EQ 12MG BASE/ML EQ 900MG BASE/100ML SOLUTION; TOPICAL CLEOCIN T PHARMACIA AND UPJOHN EQ 1% BASE CLINDAMYCIN PHOSPHATE BOCA PHARMA EQ 1% BASE COPLEY PHARM EQ 1% BASE G AND W LABS INC EQ 1% BASE RENAISSANCE PHARMA EQ 1% BASE
A062953 A063068 A062905 A062913 A062819 A062852 A063041 A063282 A062900 A063079 N050636 A065027 A065027 A065027 N050648 N050648 N050648
001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 003
Apr Aug May Oct Mar Mar Dec May Jun Mar
21, 28, 09, 20, 15, 17, 29, 29, 08, 05,
1988 1989 1988 1988 1988 1988 1989 1992 1988 1990
Dec 22, 1989 Jun Jun Jun Dec Dec Dec 29, 29, 29, 29, 29, 29, 2001 2001 2001 1989 1989 1989
A062363 A062930 A062944 A062811 A064108
001 001 001 001 001
Feb 08, 1982 Jun Jan Sep Sep 28, 11, 01, 27, 1989 1989 1988 1996
CLIOQUINOL; NYSTATIN
OINTMENT; TOPICAL NYSTAFORM BAYER PHARMS
10MG/GM;100,000 UNITS/GM
N050235
001
CREAM; TOPICAL CLOBETASOL PROPIONATE G AND W LABS INC 0.05% RENAISSANCE PHARMA 0.05% CLOBETASOL PROPIONATE (EMOLLIENT) RENAISSANCE PHARMA 0.05% OINTMENT; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC 0.05% RENAISSANCE PHARMA 0.05% SOLUTION; TOPICAL CLOBETASOL PROPIONATE G AND W LABS INC 0.05%
A074139 A075338 A075733
001 001 001
Aug 03, 1994 Feb 09, 2001 Aug 22, 2001
A074128 A075057
001 001
Aug 03, 1994 Aug 12, 1998
A074331
001
Dec 15, 1995
CLOFAZIMINE
CAPSULE; ORAL LAMPRENE NOVARTIS
100MG
N019500
001
Dec 15, 1986
CLOFIBRATE
CAPSULE; ORAL ATROMID-S WYETH AYERST CLOFIBRATE BANNER PHARMACAPS SANDOZ
500MG 500MG 500MG
N016099 A073396 A072191
002 001 001 Mar 20, 1992 May 02, 1988

CLOFIBRATE
CAPSULE; ORAL CLOFIBRATE TEVA USL PHARMA WATSON LABS
6 - 91 (of 360)
500MG 500MG 500MG
A072600 A070531 A071603
001 001 001
Jul 25, 1991 Jun 16, 1986 Sep 18, 1987
CLOMIPHENE CITRATE
TABLET; ORAL MILOPHENE MILEX
50MG
A072196
001
Dec 20, 1988
CAPSULE; ORAL CLOMIPRAMINE HYDROCHLORIDE SANDOZ 25MG 50MG 75MG TEVA 25MG 50MG 75MG WATSON LABS 25MG 25MG 50MG 50MG 75MG 75MG
A074953 A074953 A074953 A074849 A074849 A074849 A074600 A074751 A074600 A074751 A074600 A074751
001 002 003 001 002 003 001 001 002 002 003 003
Jun Jun Jun Apr Apr Apr Nov Sep Nov Sep Nov Sep
25, 25, 25, 04, 04, 04, 27, 30, 27, 30, 27, 30,
1997 1997 1997 1997 1997 1997 1996 1998 1996 1998 1996 1998
CLONAZEPAM
TABLET; ORAL CLONAZEPAM SANDOZ
TEVA
A074925 A074925 A074925 A074920 A074920 A074920 N017533 N017533
001 002 003 001 002 003 005 006
Sep Sep Sep Aug Aug Aug
30, 30, 30, 04, 04, 04,
1997 1997 1997 1998 1998 1998
0.125MG 0.25MG TABLET, ORALLY DISINTEGRATING; ORAL KLONOPIN RAPIDLY DISINTEGRATING ROCHE 0.125MG 0.25MG 0.5MG 1MG 2MG
KLONOPIN ROCHE
Apr 09, 1997 Apr 09, 1997
N020813 N020813 N020813 N020813 N020813
001 002 003 004 005
Dec Dec Dec Dec Dec
23, 23, 23, 23, 23,
1997 1997 1997 1997 1997
CLONIDINE
SUSPENSION, EXTENDED RELEASE; ORAL CLONIDINE TRIS PHARMA INC EQ 0.09MG BASE/ML TABLET, EXTENDED RELEASE; ORAL CLONIDINE TRIS PHARMA INC EQ 0.17MG BASE EQ 0.26MG BASE
N022499
001
Dec 03, 2009
N022500 N022500
001 002
Dec 03, 2009 Dec 03, 2009
TABLET; ORAL CLONIDINE HYDROCHLORIDE AM THERAP 0.1MG 0.2MG 0.3MG
A070881 A070882 A070883
001 001 001
Jul 08, 1986 Jul 08, 1986 Jul 08, 1986

TABLET; ORAL CLONIDINE HYDROCHLORIDE DURAMED PHARMS BARR 0.1MG 0.2MG 0.3MG INTERPHARM 0.1MG 0.2MG 0.3MG PAR PHARM 0.1MG 0.2MG 0.3MG SANDOZ 0.1MG 0.2MG 0.3MG TEVA 0.1MG 0.2MG 0.3MG WARNER CHILCOTT 0.1MG 0.2MG 0.3MG WATSON LABS 0.1MG 0.1MG 0.2MG 0.2MG 0.3MG TABLET, EXTENDED RELEASE; ORAL JENLOGA SHIONOGI INC 0.1MG 0.2MG
6 - 92 (of 360)
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Aug Aug Aug Oct Oct Oct Jul Jul Jul Aug Aug Aug Jul Jul Jul Jun Jun Jun Mar Jul Mar Jul Mar
14, 14, 14, 01, 01, 01, 08, 08, 08, 31, 31, 31, 08, 08, 08, 13, 13, 13, 23, 08, 23, 08, 23,
1986 1986 1986 1986 1986 1986 1986 1986 1986 1988 1988 1988 1986 1986 1986 1988 1988 1988 1987 1986 1987 1986 1987
N022331 N022331
001 002
Sep 30, 2009 May 25, 2010
CAPSULE; ORAL CLORAZEPATE DIPOTASSIUM ABLE 3.75MG 7.5MG 15MG AM THERAP 3.75MG 7.5MG 15MG CLONMEL HLTHCARE 3.75MG 7.5MG 15MG GD SEARLE LLC 3.75MG 7.5MG 15MG MYLAN 3.75MG 7.5MG 15MG PUREPAC PHARM 3.75MG 7.5MG 15MG QUANTUM PHARMICS 3.75MG 7.5MG 15MG SANDOZ 3.75MG 7.5MG 15MG USL PHARMA 3.75MG 7.5MG 15MG WARNER CHILCOTT 3.75MG 7.5MG
A071777 A071778 A071779 A071429 A071430 A071431 A071742 A071743 A071744 A071727 A071728 A071729 A071509 A071510 A071511 A071924 A071925 A071926 A071549 A071550 A071522 A072219 A072220 A072112 A071242 A071243 A071244 A071774 A071775
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul Jul Jul Jun Jun Jun Dec Dec Dec Dec Dec Dec Oct Oct Oct Apr Apr Apr Sep Sep Sep Aug Aug Aug Jun Jun Jun Mar Mar
14, 14, 14, 23, 23, 23, 14, 14, 14, 18, 18, 18, 19, 19, 19, 25, 25, 25, 12, 12, 12, 26, 26, 26, 23, 23, 23, 01, 01,
1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1988 1988 1988 1988 1988 1988 1988 1988 1988 1987 1987 1987 1988 1988

CAPSULE; ORAL CLORAZEPATE DIPOTASSIUM WARNER CHILCOTT 15MG WATSON LABS 3.75MG 7.5MG 15MG TRANXENE LUNDBECK LLC 3.75MG 7.5MG 15MG TABLET; ORAL CLORAZEPATE DIPOTASSIUM ABLE 3.75MG 7.5MG 15MG AM THERAP 3.75MG 7.5MG 15MG LEDERLE 3.75MG 7.5MG 15MG PUREPAC PHARM 3.75MG 7.5MG 15MG QUANTUM PHARMICS 3.75MG 7.5MG 15MG SANDOZ 3.75MG 7.5MG 15MG WARNER CHILCOTT 3.75MG 7.5MG 15MG TRANXENE SD LUNDBECK LLC 11.25MG 22.5MG
6 - 93 (of 360)
A071776 A071878 A071879 A071860 N017105 N017105 N017105
001 001 001 001 001 002 003
Mar Mar Mar Mar
01, 15, 15, 15,
1988 1988 1988 1988
A071780 A071781 A071782 A071747 A071748 A071749 A072013 A072014 A072015 A072330 A072331 A072332 A071730 A071731 A071702 A072512 A072513 A072514 A071828 A071829 A071830 N017105 N017105
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 005 004
Jun Jun Jun Jun Jun Jun Dec Dec Dec Aug Aug Aug Oct Oct Oct May May May Mar Mar Mar
26, 26, 26, 23, 23, 23, 15, 15, 15, 08, 08, 08, 26, 26, 26, 11, 11, 11, 03, 03, 03,
1987 1987 1987 1987 1987 1987 1987 1987 1987 1988 1988 1988 1987 1987 1987 1990 1990 1990 1988 1988 1988
CLOTRIMAZOLE
CREAM; TOPICAL LOTRIMIN SCHERING PLOUGH MYCELEX BAYER PHARMS LOTION; TOPICAL LOTRIMIN SCHERING SOLUTION; TOPICAL LOTRIMIN SCHERING PLOUGH TABLET; VAGINAL GYNIX TEVA PHARMS MYCELEX-G BAYER PHARMS TROCHE/LOZENGE; ORAL MYCELEX BAYER HLTHCARE
1% 1%
N017619 N018183
001 001
1%
N018813
001
Feb 17, 1984
1%
N017613
001
100MG 500MG
A073249 N019069
001 001
Feb 13, 1998 Apr 19, 1985
10MG
N018713
001
Jun 17, 1983
CLOXACILLIN SODIUM
CAPSULE; ORAL CLOXACILLIN SODIUM APOTHECON
A061452 A061452
001 002

CLOXACILLIN SODIUM
CAPSULE; ORAL CLOXACILLIN SODIUM TEVA CLOXAPEN GLAXOSMITHKLINE
6 - 94 (of 360)
EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ 250MG 250MG 500MG 500MG BASE BASE BASE BASE
A062240 A062240 A061806 A062233 A061806 A062233
001 002 001 001 002 002
FOR SOLUTION; ORAL CLOXACILLIN SODIUM TEVA TEGOPEN APOTHECON
A062268 A062978 A061453 N050192
001 001 001 001
Apr 06, 1989
CLOZAPINE
TABLET; ORAL CLOZAPINE PAR PHARM
25MG 100MG SANDOZ 25MG 100MG TABLET, ORALLY DISINTEGRATING; ORAL FAZACLO ODT JAZZ PHARMS III 50MG
A075162 A075162 A074546 A074546
001 002 001 002
Apr Apr Aug Aug
26, 26, 30, 30,
2005 2005 1996 1996
N021590
003
Jun 03, 2005
COBALT CHLORIDE CO-57; CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR

N/A; N/A RUBRATOPE-57 KIT BRACCO
N/A;N/A;N/A;N/A
N016089
001
COBALT CHLORIDE CO-60; CYANOCOBALAMIN; CYANOCOBALAMIN CO-60; INTRINSIC FACTOR

N/A; N/A RUBRATOPE-60 KIT BRACCO
N/A;N/A;N/A;N/A
N016090
001
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE

SYRUP; ORAL PHENERGAN VC W/ CODEINE ANI PHARMS 10MG/5ML;5MG/5ML;6.25MG/5ML PHERAZINE VC W/ CODEINE HALSEY 10MG/5ML;5MG/5ML;6.25MG/5ML PROMETHAZINE VC W/ CODEINE CENCI 10MG/5ML;5MG/5ML;6.25MG/5ML WOCKHARDT 10MG/5ML;5MG/5ML;6.25MG/5ML
N008306 A088870 A088816 A088896
005 001 001 001
Apr 02, 1984 Mar 02, 1987 Nov 22, 1985 Jan 04, 1985
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE

SYRUP; ORAL PHENERGAN W/ CODEINE ANI PHARMS 10MG/5ML;6.25MG/5ML PHERAZINE W/ CODEINE HALSEY 10MG/5ML;6.25MG/5ML PROMETHAZINE W/ CODEINE CENCI 10MG/5ML;6.25MG/5ML
N008306 A088739 A088814
004 001 001
Apr 02, 1984 Dec 23, 1988 Nov 22, 1985

SYRUP; ORAL ACTIFED W/ CODEINE GLAXOSMITHKLINE
10MG/5ML;30MG/5ML;1.25MG/5ML
N012575
003
Apr 04, 1984
6 - 95 (of 360)

SYRUP; ORAL TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE CENCI 10MG/5ML;30MG/5ML;1.25MG/5ML TRIPROLIDINE HCL, PSEUDOEPHEDRINE HCL AND CODEINE PHOSPHATE WOCKHARDT 10MG/5ML;30MG/5ML;1.25MG/5ML
A089018 A088833
001 001
Jul 23, 1986 Nov 16, 1984
COLCHICINE; PROBENECID
TABLET; ORAL COLBENEMID MERCK 0.5MG;500MG PROBEN-C WATSON LABS 0.5MG;500MG PROBENECID AND COLCHICINE BEECHAM 0.5MG;500MG IMPAX LABS 0.5MG;500MG IVAX SUB TEVA PHARMS 0.5MG;500MG SANDOZ 0.5MG;500MG PROBENECID W/ COLCHICINE LEDERLE 0.5MG;500MG WATSON LABS 0.5MG;500MG
N012383 A085552 A084321 A083720 A083734 A086130 A086954 A083221
001 001 001 002 001 001 001 001
COLESEVELAM HYDROCHLORIDE
CAPSULE; ORAL WELCHOL DAIICHI SANKYO
375MG
N021141
001
May 26, 2000
COLISTIN SULFATE
SUSPENSION; ORAL COLY-MYCIN S PARKE DAVIS
EQ 25MG BASE/5ML
N050355
001
INJECTABLE; IV (INFUSION) VAPRISOL ASTELLAS 20MG/4ML (5MG/ML)
N021697
001
Dec 29, 2005
COPPER
INTRAUTERINE DEVICE; INTRAUTERINE CU-7 GD SEARLE LLC 89MG TATUM-T GD SEARLE LLC 120MG
N017408 N018205
001 001
CORTICOTROPIN
INJECTABLE; INJECTION ACTH PARKEDALE ACTHAR SANOFI AVENTIS US CORTICOTROPIN ORGANICS LAGRANGE
25 UNITS/VIAL 40 UNITS/VIAL 25 UNITS/VIAL 40 UNITS/VIAL 40 UNITS/ML 80 UNITS/ML 40 UNITS/VIAL
N008317 N008317 N007504 N007504 N010831 N010831 A088772 N008372 N008975 N008975
002 004 002 003 001 002 001 006

001
002
WATSON LABS H.P. ACTHAR GEL

QUESTCOR PHARMS 40 UNITS/ML PURIFIED CORTROPHIN GEL
ORGANON USA INC 40 UNITS/ML 80 UNITS/ML
Nov 21, 1984

CORTICOTROPIN-ZINC HYDROXIDE
INJECTABLE; INJECTION CORTROPHIN-ZINC ORGANON USA INC
6 - 96 (of 360)
40 UNITS/ML
N009854
001
CORTISONE ACETATE
INJECTABLE; INJECTION CORTISONE ACETATE PHARMACIA AND UPJOHN WATSON LABS
N008126 A083147 A085677 A083147 A085677 N007110 N007110
002 003 001 004 002 002 003
CORTONE MERCK TABLET; ORAL CORTISONE ACETATE BARR ELKINS SINN EVERYLIFE HEATHER IMPAX LABS INWOOD LABS IVAX SUB TEVA PHARMS LANNETT PANRAY PHARMACIA AND UPJOHN
PUREPAC PHARM VITARINE WATSON LABS WHITEWORTH TOWN PLSN CORTONE MERCK
A083471 A080836 A084246 A085736 N009458 A080731 A080630 A083536 A080694 N008284 N008284 N008126 N008126 N008126 A080493 A080333 A085884 A080341 N007750
001 001 001 001 001 001 001 001 001 002 001 003 004 001 001 001 001 001 003
CROMOLYN SODIUM
AEROSOL, METERED; INHALATION INTAL KING PFIZER 0.8MG/INH CAPSULE; INHALATION INTAL SANOFI AVENTIS US 20MG CAPSULE; ORAL GASTROCROM UCB INC 100MG CONCENTRATE; ORAL CROMOLYN SODIUM GENERA PHARMS 100MG/5ML SOLUTION; INHALATION CROMOLYN SODIUM ACTAVIS MID ATLANTIC 10MG/ML PHARMASCIENCE INC 10MG/ML ROXANE 10MG/ML INTAL KING PHARMS 10MG/ML SOLUTION/DROPS; OPHTHALMIC CROMOPTIC KING PHARMS 4%
N018887
001
Dec 05, 1985
N016990
001
N019188
001
Dec 22, 1989
A090954
001
Dec 18, 2009
A075067 A075437 A075175 N018596
001 001 001 001
Jul 19, 1999 Apr 21, 2000 Sep 30, 1999 May 28, 1982
A075088
001
Apr 27, 1999

CROMOLYN SODIUM
SPRAY, METERED; NASAL CROMOLYN SODIUM ACTAVIS MID ATLANTIC HH AND P NASALCROM BLACKSMITH BRANDS
6 - 97 (of 360)
5.2MG/SPRAY 5.2MG/SPRAY 5.2MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
A074800 A077976 N020463
001 001 001
Jul 26, 2001 Sep 07, 2007 Jan 03, 1997
CRYPTENAMINE ACETATES
UNITENSEN
MEDPOINTE PHARM HLC
260CSR UNIT/ML
N008814
001
CRYPTENAMINE TANNATES
TABLET; ORAL
UNITENSEN
MEDPOINTE PHARM HLC
260CSR UNIT
N009217
001
CUPRIC SULFATE
INJECTABLE; INJECTION CUPRIC SULFATE ABRAXIS PHARM
EQ 0.4MG COPPER/ML
N019350
001
May 05, 1987
CYANOCOBALAMIN
GEL, METERED; NASAL NASCOBAL PAR PHARM INJECTABLE; INJECTION BERUBIGEN PHARMACIA AND UPJOHN BETALIN 12 LILLY COBAVITE WATSON LABS CYANOCOBALAMIN ABRAXIS PHARM
0.5MG/INH
N019722
001
Nov 05, 1996
1MG/ML 0.1MG/ML 1MG/ML 0.1MG/ML 1MG/ML 0.03MG/ML 0.1MG/ML 1MG/ML 1MG/ML 1MG/ML 0.03MG/ML 0.1MG/ML 1MG/ML 0.1MG/ML 1MG/ML 0.03MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 0.1MG/ML 0.1MG/ML 1MG/ML 1MG/ML 0.1MG/ML 1MG/ML 1MG/ML
N006798 A080855 A080855 A083013 A083064 A080510 A080510 A080510 A087969 A040451 A080689 A080689 A080689 A080557 A080515 A080668 A083075 A080564 A087551 N007085 A080573 A083120 A080573 A083120 A080554 A080554 N006668
001 001 002 001 001 003 001 002 001 001 001 002 003 002 002 001 001 001 001 002 002 001 001 002 001 002 010
AKORN BIONICHE PHARMA DELL LABS
Nov 10, 1983 Sep 23, 2003
FRESENIUS KABI USA HIKMA MAPLE LUITPOLD LYPHOMED SANOFI AVENTIS US SOLOPAK WARNER CHILCOTT WATSON LABS
Feb 29, 1984
WYETH AYERST REDISOL MERCK

CYANOCOBALAMIN
INJECTABLE; INJECTION RUBIVITE BEL MAR
6 - 98 (of 360)
0.03MG/ML 0.05MG/ML 0.1MG/ML 0.12MG/ML 1MG/ML 0.1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML
N010791 N010791 N010791 N010791 N010791 N006799 N006799 N006799 A080570 N007012
004 001 002 005 003 002 004 010 002 002
RUBRAMIN PC BRISTOL MYERS SQUIBB
Apr 28, 1988
RUVITE SAVAGE LABS VI-TWEL BAYER HLTHCARE SPRAY, METERED; NASAL CALOMIST PAR PHARM TABLET; ORAL CYANOCOBALAMIN WEST WARD
25MCG/SPRAY
N022102
001
Jul 27, 2007
1MG
A084264
001
CYANOCOBALAMIN CO-57
CAPSULE; ORAL RUBRATOPE-57 BRACCO
0.5-1uCi
N016089
002
CYANOCOBALAMIN CO-60
CAPSULE; ORAL RUBRATOPE-60 BRACCO
0.5-1uCi
N016090
002
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58

N/A; N/A DICOPAC KIT GE HEALTHCARE
N/A;N/A;N/A
N017406
001
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR

N/A; N/A CYANOCOBALAMIN CO 57 SCHILLING TEST KIT MALLINCKRODT 0.1MG;0.5uCi;60MG
N016635
001
CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE

INJECTABLE; INJECTION DEPINAR ARMOUR PHARM
0.5MG/ML;2.3MG/ML;1MG/ML
N011208
001
CYCLACILLIN
FOR SUSPENSION; ORAL CYCLAPEN-W WYETH AYERST
N050508 N050508 N050508
001 002 003
TABLET; ORAL CYCLACILLIN TEVA CYCLAPEN-W WYETH AYERST
250MG 500MG 250MG 500MG
A062895 A062895 N050509 N050509
001 002 001 002
Aug 04, 1988 Aug 04, 1988

CYCLIZINE LACTATE
INJECTABLE; INJECTION MAREZINE GLAXOSMITHKLINE
6 - 99 (of 360)
50MG/ML
N009495
001
TABLET; ORAL CYCLOBENZAPRINE HYDROCHLORIDE SANDOZ 10MG WATSON LABS 10MG 10MG FLEXERIL JANSSEN RES AND DEV 5MG 10MG
A073683 A073143 A074436 N017821 N017821
001 001 001 001 002
Feb 26, 1993 Nov 27, 1991 Nov 30, 1994
CYCLOPENTOLATE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AK-PENTOLATE AKORN 1% CYCLOPENTOLATE HYDROCHLORIDE ALCON PHARMS LTD 1% SOLA BARNES HIND 1% 1% PENTOLAIR PHARMAFAIR 0.5% 1%
A085555 A089162 A084150 A084863 A088643 A088150
001 001 001 001 001 001 Jan 24, 1991
Feb 09, 1987 Feb 25, 1983
CYCLOPHOSPHAMIDE
INJECTABLE; INJECTION CYCLOPHOSPHAMIDE BAXTER HLTHCARE
100MG/VIAL 200MG/VIAL 500MG/VIAL 1GM/VIAL 100MG/VIAL 200MG/VIAL 100MG/VIAL 200MG/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 100MG/VIAL 100MG/VIAL 200MG/VIAL 200MG/VIAL 500MG/VIAL 500MG/VIAL 1GM/VIAL 1GM/VIAL 2GM/VIAL 2GM/VIAL
A088371 A088372 A088373 A088374 N012142 N012142 N012142 N012142 N012142 N012142 N012142 A040015 A087442 A040015 A087442 A040015 A087442 A040015 A087442 A040015 A087442
001 001 001 001 001 002 006 007 008 010 009 001 001 002 002 003 003 004 004 005 005
Jul Jul Jul Sep
03, 03, 03, 24,
1986 1986 1986 1986
CYTOXAN BAXTER HLTHCARE LYOPHILIZED CYTOXAN BAXTER HLTHCARE
Dec Dec Jan Sep Dec Apr Feb Apr Feb Apr Feb Apr Jul Apr Mar
05, 10, 04, 24, 10, 29, 16, 29, 16, 29, 16, 29, 08, 29, 30,
1985 1985 1984 1985 1985 1993 1982 1993 1982 1993 1982 1993 1983 1993 1989
NEOSAR TEVA PARENTERAL
TABLET; ORAL CYTOXAN BAXTER HLTHCARE
25MG 50MG
N012141 N012141
002 001
CYCLOSPORINE
CAPSULE; ORAL NEORAL NOVARTIS
50MG
N050715
003
Jul 14, 1995

CYCLOTHIAZIDE
TABLET; ORAL
ANHYDRON
LILLY FLUIDIL
6 - 100 (of 360)
2MG 2MG
N013157 N018173
002
001
CYCRIMINE HYDROCHLORIDE
TABLET; ORAL
PAGITANE
LILLY
1.25MG 2.5MG
N008951 N008951
001
002
SYRUP; ORAL CYPROHEPTADINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 2MG/5ML HALSEY 2MG/5ML MORTON GROVE 2MG/5ML NASKA 2MG/5ML PERIACTIN
MERCK 2MG/5ML TABLET; ORAL
CYPROHEPTADINE HYDROCHLORIDE AM THERAP 4MG ASCOT 4MG DURAMED PHARMS BARR 4MG HALSEY 4MG KV PHARM 4MG MD PHARM 4MG MYLAN 4MG PIONEER PHARMS 4MG PLIVA 4MG SANDOZ 4MG SUPERPHARM 4MG TG UNITED LABS 4MG VITARINE 4MG WATSON LABS 4MG 4MG 4MG PERIACTIN
MERCK 4MG
A086833 A089199 A087001 A089021 N013220
001 001 001 001 002
Jul 03, 1986 Nov 04, 1982 Dec 21, 1987
A088798 A087685 A088232 A089057 A086737 A087566 A086678 A087839 A088205 A086808 A087405 A088212 A087284 A085245 A086165 A086580 N012649
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
001
001
Feb Oct Oct Jul
15, 25, 25, 03,
1985 1982 1983 1986
Nov 10, 1982 Feb 08, 1984 Jul 26, 1983
May 26, 1983
CYSTEINE HYDROCHLORIDE
CYSTEINE HYDROCHLORIDE
HOSPIRA 7.25% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N019523
001
Oct 22, 1986
CYTARABINE
CYTARABINE
TEVA PARENTERAL
100MG/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL
N016793 N016793 N016793 N016793
001 002 003 004
Dec 21, 1987 Dec 21, 1987
DACARBAZINE
INJECTABLE; INJECTION DACARBAZINE ABRAXIS PHARM
A070962 A070990
001 001
Aug 28, 1986 Aug 28, 1986

DALFOPRISTIN; QUINUPRISTIN
INJECTABLE; IV (INFUSION) SYNERCID KING PHARMS 420MG/VIAL;180MG/VIAL
6 - 101 (of 360)
N050748
002
Aug 24, 2000
DALTEPARIN SODIUM
INJECTABLE; INJECTION FRAGMIN EISAI INC
7,500 IU/0.75ML
N020287
008
Apr 04, 2002
DANAPAROID SODIUM
INJECTABLE; INJECTION ORGARAN ORGANON USA INC
750 UNITS/0.6ML
N020430
001
Dec 24, 1996
DANAZOL
CAPSULE; ORAL DANAZOL AM THERAP DANOCRINE SANOFI AVENTIS US
200MG 50MG 100MG 200MG
A071569 N017557 N017557 N017557
001 003 004 002
Dec 30, 1987
DANTROLENE SODIUM
CAPSULE; ORAL DANTROLENE SODIUM MIKAH PHARMA
25MG 50MG 100MG
A076686 A076686 A076686
001 002 003
Oct 24, 2005 Oct 24, 2005 Oct 24, 2005
DAPIPRAZOLE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC DAPIPRAZOLE HYDROCHLORIDE FERA PHARMS 0.5%
N019849
001
Dec 31, 1990
DAPTOMYCIN
INJECTABLE; IV (INFUSION) CUBICIN CUBIST 250MG/VIAL
N021572
001
Sep 12, 2003
DARUNAVIR ETHANOLATE
TABLET; ORAL PREZISTA JANSSEN PRODS
EQ 300MG BASE
N021976
001
Jun 23, 2006
DAUNORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION CERUBIDINE SANOFI AVENTIS US EQ WYETH AYERST EQ DAUNORUBICIN HYDROCHLORIDE TEVA PARENTERAL EQ EQ
20MG BASE/VIAL 20MG BASE/VIAL 20MG BASE/VIAL 50MG BASE/VIAL
A061876 N050484 A064212 A064212
001 001 001 002 Jun 23, 1998 May 03, 1999
DECAMETHONIUM BROMIDE
INJECTABLE; INJECTION SYNCURINE GLAXOSMITHKLINE
1MG/ML
N006931
002

DEMECARIUM BROMIDE
SOLUTION/DROPS; OPHTHALMIC HUMORSOL MERCK 0.125% 0.25%
6 - 102 (of 360)
N011860 N011860
002 001
DEMECLOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL DECLOMYCIN LEDERLE SYRUP; ORAL DECLOMYCIN LEDERLE TABLET; ORAL DECLOMYCIN COREPHARMA
150MG
N050262
001
75MG/5ML
N050257
001
75MG 150MG 300MG
N050261 N050261 N050261
001 002 003
DESERPIDINE
TABLET; ORAL HARMONYL ABBVIE
0.1MG 0.25MG
N010796 N010796
001 002
DESERPIDINE; HYDROCHLOROTHIAZIDE
TABLET; ORAL ORETICYL 25 ABBVIE ORETICYL 50 ABBVIE ORETICYL FORTE ABBVIE
0.125MG;25MG 0.125MG;50MG 0.25MG;25MG
N012148 N012148 N012148
001 003 002
DESERPIDINE; METHYCLOTHIAZIDE
TABLET; ORAL ENDURONYL ABBOTT 0.25MG;5MG ENDURONYL FORTE ABBOTT 0.5MG;5MG METHYCLOTHIAZIDE AND DESERPIDINE WATSON LABS 0.25MG;5MG 0.5MG;5MG
N012775 N012775 A088486 A088452
001 002 001 001 Aug 10, 1984 Aug 10, 1984
CAPSULE; ORAL PERTOFRANE SANOFI AVENTIS US
25MG 50MG
N013621 N013621
001 002
TABLET; ORAL DESIPRAMINE HYDROCHLORIDE PLIVA 25MG 50MG 75MG 100MG 150MG USL PHARMA 25MG 50MG 75MG 100MG
A071800 A071801 A071802 A071803 A071804 A071864 A071865 A071866 A071867
001 001 001 001 001 001 001 001 001
Dec Dec Dec May May Sep Sep Sep Sep
08, 08, 08, 29, 29, 09, 09, 09, 09,
1987 1987 1987 1997 1997 1987 1987 1987 1987

DESLANOSIDE
INJECTABLE; INJECTION CEDILANID-D NOVARTIS
6 - 103 (of 360)
0.2MG/ML
N009282
002
INJECTABLE; INJECTION DDAVP SANOFI AVENTIS US 0.015MG/ML DESMOPRESSIN ACETATE BEDFORD 0.004MG/ML DESMOPRESSIN ACETATE PRESERVATIVE FREE BEDFORD 0.004MG/ML SOLUTION; NASAL CONCENTRAID FERRING 0.01% SPRAY, METERED; NASAL DDAVP SANOFI AVENTIS US 0.01MG/SPRAY STIMATE CSL BEHRING 0.15MG/SPRAY
N018938 A074575 A074574
002 001 001
Apr 25, 1995 Feb 18, 2000 Feb 18, 2000
N019776
001
Dec 26, 1990
N017922 N020355
002 001
Feb 06, 1989 Mar 07, 1994
DESOGESTREL; ETHINYL ESTRADIOL

TABLET; ORAL-21 DESOGEN ORGANON USA INC DESOGESTREL AND ETHINYL DURAMED PHARMS BARR ORTHO-CEPT JANSSEN PHARMS
0.15MG;0.03MG ESTRADIOL 0.15MG;0.03MG 0.15MG;0.03MG
N020071 A075256 N020301
001 001 001
Dec 10, 1992 Aug 12, 1999 Dec 14, 1992
DESONIDE
CREAM; TOPICAL DESONIDE TEVA PHARMS
0.05%
A074027
001
Sep 28, 1992
DESOXIMETASONE
CREAM; TOPICAL TOPICORT TARO PHARMS NORTH TOPICORT LP TARO PHARMS NORTH GEL; TOPICAL TOPICORT TARO PHARMS NORTH OINTMENT; TOPICAL DESOXIMETASONE ALTANA TOPICORT TARO PHARMS NORTH
0.25% 0.05%
N017856 N018309
001 001
0.05%
N018586
001
Mar 29, 1982
0.25% 0.25%
A073440 N018763
001 001
Apr 01, 1998 Sep 30, 1983
DESOXYCORTICOSTERONE ACETATE
INJECTABLE; INJECTION DOCA ORGANON USA INC PELLET; IMPLANTATION PERCORTEN NOVARTIS
5MG/ML
N001104
001
125MG
N005151
001
DESOXYCORTICOSTERONE PIVALATE
INJECTABLE; INJECTION PERCORTEN NOVARTIS
25MG/ML
N008822
001

DEXAMETHASONE
AEROSOL; TOPICAL
AEROSEB-DEX
ALLERGAN HERBERT
6 - 104 (of 360)
0.01% **Federal Register determination that product was not discontinued or

reasons**
0.04% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
A083296
002
DECASPRAY MERCK
N012731
002
ELIXIR; ORAL DECADRON MERCK 0.5MG/5ML DEXAMETHASONE ALPHARMA US PHARMS 0.5MG/5ML HEXADROL ORGANON USA INC 0.5MG/5ML GEL; TOPICAL DECADERM MERCK 0.1% SUSPENSION/DROPS; OPHTHALMIC DEXAMETHASONE WATSON LABS 0.1% TABLET; ORAL DECADRON MERCK 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 0.5MG 0.75MG 1.5MG 4MG 6MG DEXAMETHASONE
IMPAX LABS 0.75MG MUTUAL PHARM 0.25MG 0.25MG 0.5MG 0.5MG 0.75MG 0.75MG 1.5MG 1.5MG PAR PHARM 0.25MG PHOENIX LABS NY 0.75MG PVT FORM 0.75MG ROXANE 0.25MG SANDOZ 0.75MG UPSHER SMITH 0.75MG 1.5MG WATSON LABS 0.25MG 0.5MG 0.75MG 0.75MG 0.75MG 1.5MG 1.5MG WHITEWORTH TOWN PLSN 0.75MG DEXONE 0.5
SOLVAY 0.5MG DEXONE 0.75
SOLVAY 0.75MG
N012376 A088997 N012674
002 001 001 Oct 10, 1986
N013538
001
A089170
001
May 09, 1989
N011664
004
N011664 N011664 N011664 N011664 N011664 A085376 A084013 A084764 A084084 A084766 A084081 A084765 A084086 A084763 A088149 A083806 A083420 A084614 A080399 A087534 A087533 A085455 A085458 A080968 A084457 A085818 A085456 A085840 A084327 A084991 A084993
001 002 003 005 006 001

001
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
001
001
001
001
001
001
001
001
001
Jul 30, 1982
Apr 28, 1983

DEXAMETHASONE
TABLET; ORAL
DEXONE 1.5
SOLVAY DEXONE 4
SOLVAY HEXADROL
ORGANON USA INC
6 - 105 (of 360)
1.5MG 4MG 0.5MG 0.75MG 1.5MG 4MG
A084990 A084992 N012675 N012675 N012675 N012675
001
001
004
007
009
010
DEXAMETHASONE ACETATE
DECADRON-LA
MERCK
EQ 8MG BASE/ML **Federal Register determination that product was not

EQ 8MG BASE/ML EQ 16MG BASE/ML
N016675
001
DEXAMETHASONE ACETATE WATSON LABS
A084315 A087711
001 001
May 24, 1982

AEROSOL; NASAL
DEXACORT
UCB INC EQ 0.1MG PHOSPHATE/INH AEROSOL, METERED; INHALATION
DEXACORT
UCB INC EQ 0.1MG PHOSPHATE/INH CREAM; TOPICAL
DECADRON
MERCK EQ 0.1% PHOSPHATE INJECTABLE; INJECTION
DECADRON
MERCK EQ 4MG PHOSPHATE/ML EQ 24MG PHOSPHATE/ML **Federal Register determination that product
DEXACEN-4
CENT PHARMS EQ 4MG PHOSPHATE/ML DEXAMETHASONE ABRAXIS PHARM EQ 4MG PHOSPHATE/ML FRESENIUS KABI USA EQ 10MG PHOSPHATE/ML DEXAMETHASONE SODIUM PHOSPHATE AKORN EQ 4MG PHOSPHATE/ML BEL MAR EQ 4MG PHOSPHATE/ML DELL LABS EQ 4MG PHOSPHATE/ML HIKMA MAPLE EQ 4MG PHOSPHATE/ML INTL MEDICATION EQ 20MG PHOSPHATE/ML LYPHOMED EQ 4MG PHOSPHATE/ML TEVA PARENTERAL EQ 4MG PHOSPHATE/ML EQ 10MG PHOSPHATE/ML WATSON LABS EQ 4MG PHOSPHATE/ML EQ 4MG PHOSPHATE/ML EQ 4MG PHOSPHATE/ML EQ 10MG PHOSPHATE/ML EQ 24MG PHOSPHATE/ML WYETH AYERST EQ 4MG PHOSPHATE/ML HEXADROL
ORGANON USA INC EQ 4MG PHOSPHATE/ML EQ 10MG PHOSPHATE/ML EQ 20MG PHOSPHATE/ML
N014242
001
N013413
001
N011983
002
N012071 N012071
002
004
A084342 A088448 A088469 A084493 A084752 A083161 A084282 A088522 A087065 A081125 A081126 A083702 A084355 A089169 A087668 A085606 A085641 N014694 N014694 N014694
001
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
002 003 004 Jan 25, 1984 Jan 25, 1984
Feb 17, 1984 Aug 31, 1990 Aug 31, 1990
Apr 09, 1986 Jul 01, 1982

OINTMENT; OPHTHALMIC DECADRON MERCK EQ 0.05% PHOSPHATE DEXAIR PHARMAFAIR EQ 0.05% PHOSPHATE MAXIDEX ALCON EQ 0.05% PHOSPHATE SOLUTION/DROPS; OPHTHALMIC DEXAIR PHARMAFAIR EQ 0.1% PHOSPHATE DEXAMETHASONE SODIUM PHOSPHATE SOLA BARNES HIND EQ 0.1% PHOSPHATE EQ 0.1% PHOSPHATE SOLUTION/DROPS; OPHTHALMIC, OTIC DECADRON MERCK EQ 0.1% PHOSPHATE SOLUTION/DROPS; OTIC DEXAMETHASONE SODIUM PHOSPHATE AKORN EQ 0.1% PHOSPHATE
6 - 106 (of 360)
N011977 A088071 A083342
001 001 001 Dec 28, 1982
A088433 A084170 A084173
001 001 001
Dec 15, 1983
N011984
001
A084855
001
DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE

INJECTABLE; INJECTION DECADRON W/ XYLOCAINE MERCK
EQ 4MG PHOSPHATE/ML;10MG/ML
N013334
002
DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE

OINTMENT; OPHTHALMIC NEODECADRON MERCK EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM SOLUTION/DROPS; OPHTHALMIC NEODECADRON MERCK EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE BAUSCH AND LOMB EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE ALCON PHARMS LTD EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML PHARMAFAIR EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML
N050324
001
N050322 A064055 A062714 A062539
001 001 001 001 Oct 30, 1995 Jul 21, 1986 Jan 10, 1985

OINTMENT; OPHTHALMIC DEXACIDIN NOVARTIS 0.1%;EQ DEXASPORIN PHARMAFAIR 0.1%;EQ SUSPENSION/DROPS; OPHTHALMIC DEXACIDIN NOVARTIS 0.1%;EQ DEXASPORIN PHARMAFAIR 0.1%;EQ
3.5MG BASE/GM;10,000 UNITS/GM 3.5MG BASE/GM;10,000 UNITS/GM
A062566 A062411
001 001
Feb 22, 1985 May 16, 1983
3.5MG BASE/ML;10,000 UNITS/ML 3.5MG BASE/ML;10,000 UNITS/ML
A062544 A062428
001 001
Oct 29, 1984 May 18, 1983
DEXBROMPHENIRAMINE MALEATE
SYRUP; ORAL DISOMER SCHERING TABLET; ORAL DISOMER SCHERING
2MG/5ML
N011814
002
2MG
N011814
001

TABLET; ORAL DISOPHROL SCHERING
2MG;60MG
N012394
002

TABLET, EXTENDED RELEASE; BROMPHERIL COPLEY PHARM DISOBROM SANDOZ RESPORAL PIONEER PHARMS ORAL 6MG;120MG 6MG;120MG 6MG;120MG A089116 A070770 A089139
6 - 107 (of 360)
001 001 001
Jan 22, 1987 Sep 30, 1991 Jun 16, 1988
SYRUP; ORAL POLARAMINE SCHERING 2MG/5ML TABLET; ORAL DEXCHLORPHENIRAMINE MALEATE PLIVA 2MG POLARAMINE SCHERING 2MG
A086837
001
Jul 19, 1982
A088682 A086835
001 001
Jan 17, 1986
CAPSULE; ORAL
DEXAMPEX
TEVA 15MG CAPSULE, EXTENDED RELEASE; ORAL
ABLE 5MG 10MG 15MG ELIXIR; ORAL
DEXEDRINE
GLAXOSMITHKLINE 5MG/5ML **Federal Register determination that product was not
TABLET; ORAL
DEXAMPEX
TEVA 5MG 10MG DEXEDRINE
GLAXOSMITHKLINE 5MG DEXTROAMPHETAMINE SULFATE
HALSEY 10MG LANNETT 5MG 10MG 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** MAST MM 5MG NESHER PHARMS 5MG 10MG PUREPAC PHARM 5MG SANDOZ 5MG 10MG VINTAGE PHARMS LLC 5MG VITARINE 5MG 10MG DEXTROSTAT
SHIRE 5MG 10MG FERNDEX
FERNDALE LABS 5MG
A085355
001
A076814 A076814 A076814
001 002 003
Aug 25, 2004 Aug 25, 2004 Aug 25, 2004
A083902
001
A083735 A083735 A084935 A083930 A083903 A083903 A085652
001
002
001
001
001
003 001
A086521 A040365 A040367 A084125 A085370 A085371 A040299 A084986 A085892 A084051 A084051 A084001
001 001 001 001 001 001 001 001 001

001
002
001
Oct 31, 2002 Oct 31, 2002
May 13, 1999

DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL PHERAZINE DM HALSEY 15MG/5ML;6.25MG/5ML PROMETHAZINE HYDROCHLORIDE AND DESTROMETHORPHAN HYDROBROMIDE ANI PHARMS 15MG/5ML;6.25MG/5ML
6 - 108 (of 360)
A088913 N011265
001 002
Mar 02, 1987 Apr 02, 1984
DEXTROSE
INJECTABLE; INJECTION DEXTROSE 10% IN PLASTIC CONTAINER B BRAUN 10GM/100ML MILES 10GM/100ML DEXTROSE 2.5% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML 2.5GM/100ML DEXTROSE 38.5% IN PLASTIC CONTAINER ABBOTT 38.5GM/100ML DEXTROSE 5% IN PLASTIC CONTAINER DHL 5GM/100ML DEXTROSE 60% B BRAUN 60GM/100ML DEXTROSE 60% IN PLASTIC CONTAINER B BRAUN 60GM/100ML BAXTER HLTHCARE 60GM/100ML HOSPIRA 60GM/100ML DEXTROSE 7.7% IN PLASTIC CONTAINER B BRAUN 7.7GM/100ML
N018046 N018504 N018358 N019626 N018923 N019971 N017995 N017995 N020047 N019346 N019626
001 001 001 001 001 001 002 001 002 001 003
Feb 02, 1988 Sep 19, 1984 Sep 28, 1995 Sep 22, 1982
Jul 02, 1991 Jan 25, 1985 Feb 02, 1988
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
INJECTABLE; INJECTION ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML;26MG/1 N019025 00ML;320MG/100ML
001
Dec 27, 1984
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;30MG/100ML;97MG/100ML;220MG/1 N018273 00ML;140MG/100ML
001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;370MG/1 N018274 00ML;530MG/100ML;500MG/100ML
001

INJECTABLE; POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN POTASSIUM B BRAUN INJECTION CHLORIDE 0.037% IN DEXTROSE 5% IN PLASTIC CONTAINER 5GM/100ML;37MG/100ML CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER 5GM/100ML;75MG/100ML CHLORIDE 0.11% IN DEXTROSE 5% IN PLASTIC CONTAINER 5GM/100ML;110MG/100ML CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML
N019699 N019699 N019699 N019699
001 002 003 005
Sep 29, 1989 Sep 29, 1989 Sep 29, 1989 Sep 29, 1989
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE; INJECTION IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;111MG/100ML;256MG/100ML;146MG N019514 /100ML;207MG/100ML
001
May 08, 1986
6 - 109 (of 360)
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;150MG/100ML;130MG/100ML;280MG N018270 /100ML;91MG/100ML
001

INJECTABLE; INJECTION DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM B BRAUN DEXTROSE 5%, SODIUM BAXTER HLTHCARE DEXTROSE 5%, SODIUM BAXTER HLTHCARE DEXTROSE 5%, SODIUM BAXTER HLTHCARE CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075% 5GM/100ML;75MG/100ML;200MG/100ML N018268 009 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER 5GM/100ML;150MG/100ML;200MG/100ML N018268 004 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;200MG/100ML N018268 005 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;200MG/100ML N018268 006 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER 5GM/100ML;75MG/100ML;330MG/100ML N018268 011 Jan 18, 1986 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER 5GM/100ML;150MG/100ML;330MG/100ML N018268 012 Jan 18, 1986 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;330MG/100ML N018268 013 Jan 18, 1986 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;330MG/100ML N018268 014 Jan 18, 1986 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075% 5GM/100ML;75MG/100ML;450MG/100ML N018268 010 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER 5GM/100ML;150MG/100ML;450MG/100ML N018268 001 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;450MG/100ML N018268 002 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;450MG/100ML N018268 003 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER 5GM/100ML;224MG/100ML;450MG/100ML N018008 003 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;450MG/100ML N018008 001 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER 5GM/100ML;75MG/100ML;450MG/100ML N018008 002

INJECTABLE; INJECTION DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;200MG/100ML DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;450MG/100ML DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;900MG/100ML DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML;450MG/100ML HOSPIRA 2.5GM/100ML;450MG/100ML DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 2.5GM/100ML;900MG/100ML DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER ABBOTT 3.3GM/100ML;300MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;110MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;200MG/100ML MILES 5GM/100ML;200MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER ABBOTT 5GM/100ML;225MG/100ML DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER ABBOTT 5GM/100ML;300MG/100ML
N018386 N018229 N018047 N018030 N018096 N018376 N018055 N018030 N018030 N018399 N019482 N019486
001 001 001 001 001 001 001 005 004 001 001 001 Oct 04, 1985 Oct 04, 1985

INJECTABLE; INJECTION DEXTROSE 5% AND SODIUM MILES DEXTROSE 5% AND SODIUM B BRAUN DEXTROSE 5% AND SODIUM ABBOTT B BRAUN MILES DEXTROSE 5% AND SODIUM ABBOTT B BRAUN MILES CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML CHLORIDE 0.33% IN PLASTIC CONTAINER 5GM/100ML;330MG/100ML CHLORIDE 0.45% IN PLASTIC CONTAINER 5GM/100ML;450MG/100ML 5GM/100ML;450MG/100ML 5GM/100ML;450MG/100ML CHLORIDE 0.9% IN PLASTIC CONTAINER 5GM/100ML;900MG/100ML 5GM/100ML;900MG/100ML 5GM/100ML;900MG/100ML
6 - 110 (of 360)
N018501 N018030 N019484 N018030 N018400 N019483 N018026 N018500
001 003 001 002 001 001 001 001 Oct 04, 1985
Oct 04, 1985
DEXTROTHYROXINE SODIUM
TABLET; ORAL CHOLOXIN ABBVIE
1MG 2MG 4MG 6MG
N012302 N012302 N012302 N012302
005 002 004 006
DEZOCINE
INJECTABLE; INJECTION DALGAN ASTRAZENECA
N019082 N019082 N019082
001 002 003
Dec 29, 1989 Dec 29, 1989 Dec 29, 1989
DIATRIZOATE MEGLUMINE
INJECTABLE; INJECTION ANGIOVIST 282 BAYER HLTHCARE CARDIOGRAFIN BRACCO DIATRIZOATE MEGLUMINE BRACCO HYPAQUE GE HEALTHCARE
60% 85% 76% 30% 60%
A087726 N011620 N010040 N016403 N016403 N010040 N010040 A087739
001 002 017 002 001 016 012 001
Sep 23, 1982
RENO-60 BRACCO 60% RENO-DIP BRACCO 30% UROVIST MEGLUMINE DIU/CT BAYER HLTHCARE 30% SOLUTION; URETERAL RENO-30 BRACCO 30% UROVIST CYSTO BAYER HLTHCARE 30% UROVIST CYSTO PEDIATRIC BAYER HLTHCARE 30% SOLUTION; URETHRAL HYPAQUE-CYSTO GE HEALTHCARE 30%
Sep 23, 1982
N010040 A087729 A087731
021 001 001 Sep 23, 1982 Sep 23, 1982
N016403
003

INJECTABLE; INJECTION ANGIOVIST 292 BAYER HLTHCARE
52%;8%
A087724
001
Sep 23, 1982

INJECTABLE; INJECTION ANGIOVIST 370 BAYER HLTHCARE DIATRIZOATE-60 INTL MEDICATION HYPAQUE-76 GE HEALTHCARE HYPAQUE-M,75% GE HEALTHCARE HYPAQUE-M,90% GE HEALTHCARE MD-60 MALLINCKRODT MD-76 MALLINCKRODT RENOCAL-76 BRACCO RENOGRAFIN-60 BRACCO RENOVIST BRACCO RENOVIST II BRACCO SOLUTION; ORAL, RECTAL GASTROVIST BAYER HLTHCARE
6 - 111 (of 360)
66%;10% 52%;8% 66%;10% 50%;25% 60%;30% 52%;8% 66%;10% 66%;10% 52%;8% 34.3%;35% 28.5%;29.1%
A087723 A088166 A086505 N010220 N010220 A087074 A087073 A089347 N010040 N010040 N010040
001 001 001 003 002 001 001 001 006 020 019
Sep 23, 1982 Jun 17, 1983
Jun 01, 1988
66%;10%
A087728
001
Sep 23, 1982
DIATRIZOATE SODIUM
FOR SOLUTION; ORAL, RECTAL HYPAQUE GE HEALTHCARE 100% INJECTABLE; INJECTION HYPAQUE GE HEALTHCARE 25% 50% MD-50 MALLINCKRODT 50% UROVIST SODIUM 300 BAYER HLTHCARE 50% SOLUTION; ORAL, RECTAL HYPAQUE GE HEALTHCARE 40% SOLUTION; URETERAL HYPAQUE SODIUM 20% GE HEALTHCARE 20%
N011386
001
N009561 N009561 A087075 A087725
003 001 001 001 Sep 23, 1982
N011386
003
N009561
002
DIAZEPAM
CAPSULE, EXTENDED RELEASE; ORAL VALRELEASE ROCHE 15MG GEL; RECTAL DIASTAT VALEANT 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 10MG/2ML (5MG/ML) 15MG/3ML (5MG/ML) 20MG/4ML (5MG/ML) INJECTABLE; INJECTION DIAZEPAM ABRAXIS PHARM 5MG/ML HIKMA MAPLE 5MG/ML 5MG/ML
N018179
001
N020648
002
Jul 29, 1997
N020648 N020648 N020648
003 004 005
Jul 29, 1997 Jul 29, 1997 Jul 29, 1997
A070662 A070311 A070312
001 001 001
Jun 25, 1986 Dec 16, 1985 Dec 16, 1985

DIAZEPAM
INJECTABLE; INJECTION DIAZEPAM HIKMA MAPLE
6 - 112 (of 360)
HOSPIRA MARSAM PHARMS LLC
PARENTA PHARMS US ARMY WARNER CHILCOTT WATSON LABS
5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML
A070313 A071308 A071309 A071310 A071584 A072370 A072371 A072397 A076815 N020124 A071613 A071614 A070911 A070912 A070930 N019287 N016087
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Dec Jul Jul Jul Oct Jan Jan Jan Apr Dec Oct Oct Aug Aug Dec
16, 17, 17, 17, 13, 29, 29, 29, 15, 05, 22, 22, 28, 28, 01,
1985 1987 1987 1987 1987 1993 1993 1993 2004 1990 1987 1987 1986 1986 1986
DIZAC PHARMACIA AND UPJOHN VALIUM ROCHE TABLET; ORAL DIAZEPAM ACTAVIS ELIZABETH
Jun 18, 1993
DAVA PHARMS INC DURAMED PHARMS BARR
FERNDALE LABS
HALSEY
MARTEC USA LLC PAR PHARM
PIONEER PHARMS
ROXANE
SANDOZ
TEVA PHARMS WARNER CHILCOTT
WATSON LABS
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Mar Mar Mar Sep Sep Aug Aug Aug Apr Apr Apr Aug Aug Aug Sep Sep Sep Apr Feb Feb Feb Aug Aug Aug Jun Jun Jun Dec Dec Dec Nov Sep Sep Sep Nov Nov Nov
19, 19, 19, 26, 26, 27, 27, 27, 01, 01, 01, 15, 15, 15, 04, 04, 04, 25, 25, 25, 25, 02, 02, 02, 17, 17, 17, 20, 20, 20, 01, 04, 04, 04, 01, 01, 01,
1986 1986 1986 1985 1985 1986 1986 1986 1987 1987 1987 1986 1986 1986 1985 1985 1985 1989 1986 1986 1986 1988 1988 1988 1986 1986 1986 1985 1985 1985 1985 1985 1985 1985 1985 1985 1985
Q-PAM QUANTUM PHARMICS
Dec 12, 1985

DIAZEPAM
TABLET; ORAL
Q-PAM
QUANTUM PHARMICS
6 - 113 (of 360)
A072431 A070424 A072432 A070425 A072433
001 001 001 001 001
Apr Dec Apr Dec Apr
29, 12, 29, 12, 29,
1988 1985 1988 1985 1988
DIAZOXIDE
CAPSULE; ORAL PROGLYCEM TEVA BRANDED PHARM INJECTABLE; INJECTION DIAZOXIDE ABRAXIS PHARM HYPERSTAT SCHERING
50MG 100MG
N017425 N017425
001 002
15MG/ML 15MG/ML
A071519 N016996
001 001
Aug 26, 1987
DIBUCAINE HYDROCHLORIDE
HEAVY SOLUTION NUPERCAINE
NOVARTIS 2.5MG/ML
N006203
001
DICHLORPHENAMIDE
TABLET; ORAL
DARANIDE
TARO

withdrawn for safety of efficacy
reasons**
N011366
001
DICLOFENAC POTASSIUM
TABLET; ORAL
CATAFLAM
NOVARTIS
25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 50MG 50MG 50MG
N020142
001
Nov 24, 1993
DICLOFENAC POTASSIUM MUTUAL PHARM SANDOZ WATSON LABS
A075470 A075582 A075152
001 001 001
Feb 21, 2002 Feb 23, 2001 Nov 27, 1998
DICLOFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC DICLOFENAC SODIUM FALCON PHARMS 0.1% TABLET, DELAYED RELEASE; ORAL DICLOFENAC SODIUM NOSTRUM LABS 50MG 75MG PLIVA 50MG 75MG ROXANE 25MG 50MG 75MG TEVA 50MG 75MG TEVA PHARMS 25MG 50MG 75MG
N020809
001
May 04, 1998
A074986 A074986 A074432 A074432 A074391 A074391 A074391 A074723 A074390 A074459 A074459 A074459
001 002 002 003 001 002 003 001 001 001 002 003
Feb Feb Jul Jul Jun Jun Jun Mar Aug Jun Jun Jun
26, 26, 29, 29, 29, 29, 29, 30, 15, 25, 25, 25,
1999 1999 1999 1999 1995 1995 1995 1999 1996 1997 1997 1997

DICLOFENAC SODIUM
TABLET, DELAYED RELEASE; ORAL VOLTAREN NOVARTIS 25MG 50MG 75MG
6 - 114 (of 360)
N019201 N019201 N019201
001 002 003
Jul 28, 1988 Jul 28, 1988 Jul 28, 1988
DICLOXACILLIN SODIUM
CAPSULE; ORAL DYCILL GLAXOSMITHKLINE
EQ EQ EQ EQ
250MG 250MG 500MG 500MG
BASE BASE BASE BASE
A060254 A062238 A060254 A062238 N050011 N050011
002 001 003 002 002 003
PATHOCIL WYETH AYERST FOR SUSPENSION; ORAL DICLOXACILLIN SODIUM APOTHECON DYNAPEN APOTHECON PATHOCIL WYETH AYERST
Mar 28, 1983
A061455 N050337 N050092
001 002 001
DICUMAROL
CAPSULE; ORAL DICUMAROL LILLY TABLET; ORAL DICUMAROL ABBVIE
25MG 50MG
N005509 N005509
003 001
25MG 50MG 100MG
N005545 N005545 N005545
003 004 005
DICYCLOMINE HYDROCHLORIDE
CAPSULE; ORAL DICYCLOMINE HYDROCHLORIDE MUTUAL PHARM 10MG PIONEER PHARMS 10MG WATSON LABS 10MG INJECTABLE; INJECTION DICYCLOMINE HYDROCHLORIDE WATSON LABS 10MG/ML SYRUP; ORAL DICYCLOMINE HYDROCHLORIDE ALPHARMA US PHARMS 10MG/5ML TABLET; ORAL DICYCLOMINE HYDROCHLORIDE MUTUAL PHARM 20MG PIONEER PHARMS 20MG WATSON LABS 20MG
A084505 A089361 A083179
001 001 001
Oct 21, 1986 Jan 10, 1989 Feb 12, 1986
A080614
001
Feb 11, 1986
A084479
001
A084600 A088585 A084361
001 001 001
Jul 29, 1985 Aug 20, 1986 Feb 06, 1986
DIDANOSINE
FOR SOLUTION; ORAL VIDEX BRISTOL MYERS SQUIBB
100MG/PACKET 167MG/PACKET 250MG/PACKET 375MG/PACKET
N020155 N020155 N020155 N020155
003 004 005 006
Oct Oct Oct Oct
09, 09, 09, 09,
1991 1991 1991 1991
TABLET, CHEWABLE; ORAL VIDEX BRISTOL MYERS SQUIBB
25MG
N020154
002
Oct 09, 1991

DIDANOSINE
TABLET, CHEWABLE; ORAL VIDEX BRISTOL MYERS SQUIBB
6 - 115 (of 360)
50MG 100MG 150MG 200MG
N020154 N020154 N020154 N020154
003 004 005 006
Oct Oct Oct Oct
09, 09, 09, 28,
1991 1991 1991 1999
DIENESTROL
CREAM; VAGINAL DIENESTROL ORTHO MCNEIL PHARM DV SANOFI AVENTIS US ESTRAGUARD SOLVAY SUPPOSITORY; VAGINAL DV SANOFI AVENTIS US
0.01% 0.01% 0.01%
N006110 A083518 A084436
005 001 001
0.7MG
A083517
001
DIETHYLCARBAMAZINE CITRATE
TABLET; ORAL HETRAZAN LEDERLE
50MG
N006459
001
DIETHYLPROPION HYDROCHLORIDE
TABLET; ORAL DIETHYLPROPION HYDROCHLORIDE SANDOZ 25MG TEVA 25MG TG UNITED LABS 25MG 25MG UCB INC 25MG WATSON LABS 25MG TENUATE SANOFI AVENTIS US 25MG TEPANIL 3M 25MG TABLET, EXTENDED RELEASE; ORAL TENUATE SANOFI AVENTIS US 75MG TEPANIL TEN-TAB 3M 75MG
A085916 A088642 A088267 A088268 A085544 A085741 N017668 N011673
001 001 001 001 001 001 001 001
Sep 20, 1984 Aug 25, 1983 Aug 25, 1983
N017669 N017956
001 001
DIETHYLSTILBESTROL
INJECTABLE; INJECTION STILBESTROL BRISTOL MYERS SQUIBB
0.2MG/ML 0.5MG/ML 1MG/ML 5MG/ML
N004056 N004056 N004056 N004056
003 004 005 006
SUPPOSITORY; VAGINAL DIETHYLSTILBESTROL LILLY STILBESTROL BRISTOL MYERS SQUIBB TABLET; ORAL DIETHYLSTILBESTROL LILLY
0.1MG 0.5MG 0.1MG 0.5MG
N004040 N004040 N004056 N004056
001 002 001 002
0.1MG 0.5MG 1MG 5MG
N004041 N004041 N004041 N004041
002 003 004 005

DIETHYLSTILBESTROL
TABLET; ORAL STILBESTROL TABLICAPS
6 - 116 (of 360)
0.5MG 1MG 5MG
A083004 A083002 A083006 N004056 N004056 N004056 N004056 N004056
001 001 001 007 017 008 009 010
0.1MG 0.25MG 0.5MG 1MG 5MG TABLET, DELAYED RELEASE; ORAL DIETHYLSTILBESTROL LILLY 0.1MG 0.25MG 0.5MG 1MG 5MG STILBESTROL TABLICAPS 0.5MG 1MG 5MG STILBETIN BRISTOL MYERS SQUIBB 0.1MG 0.5MG 1MG 5MG
STILBETIN BRISTOL MYERS SQUIBB
N004039 N004039 N004039 N004039 N004039 A083003 A083005 A083007 N004056 N004056 N004056 N004056
002 005 003 004 006 001 001 001 011 012 013 014
DIETHYLSTILBESTROL DIPHOSPHATE
INJECTABLE; INJECTION STILPHOSTROL BAYER PHARMS TABLET; ORAL STILPHOSTROL BAYER PHARMS
250MG/5ML
N010010
001
50MG
N010010
002
DIFLORASONE DIACETATE
CREAM; TOPICAL FLORONE PHARMACIA AND FLORONE E PHARMACIA AND PSORCON TARO OINTMENT; TOPICAL PSORCON PHARMACIA AND PSORCON E PHARMACIA AND
UPJOHN UPJOHN
0.05% 0.05% 0.05%
N017741 N019259 N020205
001 001 001 Aug 28, 1985 Nov 20, 1992
UPJOHN UPJOHN
0.05% 0.05%
N019260 N017994
001 001
Aug 28, 1985
DIFLUNISAL
TABLET; ORAL DIFLUNISAL PUREPAC PHARM ROXANE SANDOZ TEVA WATSON LABS
A074285 A074285 A073562 A073563 A074604 A073679 A074400 A074400
001 002 001 001 001 001 001 002
May May Nov Nov Jun Jul Jul Jul
07, 07, 27, 27, 10, 31, 17, 17,
1996 1996 1992 1992 1996 1992 1997 1997

DIFLUNISAL
TABLET; ORAL
DOLOBID
MERCK
6 - 117 (of 360)
250MG **Federal Register determation that product was not discontinued or withdrawn for safety or efficacy reasons** 500MG
N018445
001
Apr 19, 1982
N018445
002
Apr 19, 1982
DIGITOXIN
CRYSTODIGIN
LILLY
0.2MG/ML
A084100
005
DIGOXIN
CAPSULE; ORAL
LANOXICAPS
GLAXOSMITHKLINE LLC
0.05MG 0.1MG 0.15MG 0.2MG
N018118 N018118 N018118 N018118
002 003 004 001
Jul Jul Sep Jul
26, 26, 24, 26,
1982 1982 1984 1982
INJECTABLE; INJECTION DIGOXIN ABRAXIS PHARM HOSPIRA WYETH AYERST DIGOXIN PEDIATRIC HOSPIRA TABLET; ORAL DIGOXIN MYLAN PHARMS INC LANOXIN COVIS PHARMA
0.25MG/ML 0.25MG/ML 0.25MG/ML 0.25MG/ML 0.1MG/ML
A083217 A040093 A040206 A084386 A040092
001 001 001 001 001
May 16, 1996 Aug 28, 1998
Apr 25, 1996
0.125MG 0.25MG 0.0625MG 0.1875MG 0.375MG 0.5MG
A040282 A040282 N020405 N020405 N020405 N020405
001 002 001 003 005 006
Dec 23, 1999 Dec 23, 1999 Sep Sep Sep Sep 30, 30, 30, 30, 1997 1997 1997 1997
DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE

EMBOLEX
NOVARTIS
0.5MG/0.5ML;2,500 UNITS/0.5ML;5.33MG/0.5ML 0.5MG/0.7ML;5,000 UNITS/0.7ML;7.46MG/0.7ML
N018885 N018885
001 002
Nov 30, 1984 Nov 30, 1984
CARDIZEM SR
BIOVAIL 60MG 90MG 120MG 180MG DILTIAZEM HYDROCHLORIDE BIOVAIL 60MG 90MG 120MG 120MG 180MG 240MG 300MG 360MG 420MG
N019471 N019471 N019471 N019471 A074845 A074845 A074845 N020939 N020939 N020939 N020939 N020939 N020939
001 002 003 004 001 002 003 001 002 003 004 005 006
Jan Jan Jan Jan Sep Sep Sep Jan Jan Jan Jan Sep Sep
23, 23, 23, 23, 15, 15, 15, 28, 28, 28, 28, 14, 14,
1989 1989 1989 1989 1999 1999 1999 2000 2000 2000 2000 2001 2001

TEVA 60MG 90MG 120MG INJECTABLE; INJECTION CARDIZEM BIOVAIL 100MG/VIAL BIOVAIL LABS INTL 5MG/ML 25MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** DILTIAZEM HYDROCHLORIDE HOSPIRA 5MG/ML 5MG/ML TEVA PARENTERAL 5MG/ML TABLET; ORAL
APOTHECON 30MG 60MG 90MG 120MG IVAX SUB TEVA PHARMS 30MG 60MG 90MG 120MG TEVA 30MG 60MG TEVA PHARMS 30MG 60MG 90MG 120MG
6 - 118 (of 360)
A074079 A074079 A074079
001 002 003
Nov 30, 1993 Nov 30, 1993 Nov 30, 1993
N020792 N020027 N020027
001 001 003
Sep 05, 1997 Oct 24, 1991 Aug 18, 1995
A075004 A075106 A074894
001 001 001
Feb 16, 2000 Apr 29, 1999 Aug 26, 1997
A074051 A074051 A074051 A074051 A074168 A074168 A074168 A074168 A074084 A074084 A074067 A074067 A074067 A074067
001 002 003 004 001 002 003 004 001 002 001 002 003 004
Mar Mar Mar Mar Mar Mar Mar Mar Feb Feb Nov Nov Nov Nov
31, 31, 31, 31, 03, 03, 03, 03, 25, 25, 05, 05, 05, 05,
1993 1993 1993 1993 1995 1995 1995 1995 1994 1994 1992 1992 1992 1992
DILTIAZEM MALATE
TIAMATE
MERCK EQ 120MG HCL EQ 180MG HCL EQ 240MG HCL
N020506 N020506 N020506
001 002 003
Oct 04, 1996 Oct 04, 1996 Oct 04, 1996
DILTIAZEM MALATE; ENALAPRIL MALEATE

TABLET, EXTENDED RELEASE; ORAL TECZEM BIOVAIL EQ 180MG HCL;5MG
N020507
001
Oct 04, 1996
DIMENHYDRINATE
INJECTABLE; INJECTION DIMENHYDRINATE
BAXTER HLTHCARE WATSON LABS WYETH AYERST LIQUID; ORAL
DIMENHYDRINATE
ALRA TABLET; ORAL
DIMENHYDRINATE
HEATHER NEXGEN PHARMA INC WATSON LABS
A084767 A083531 A084316
001
001
001
12.5MG/4ML
A080715
001
50MG 50MG 50MG
A080841 A085985 A085166
001
001
001

DIMYRISTOYL LECITHIN; PERFLEXANE
INJECTABLE; INTRAVENOUS IMAGENT IMCOR PHARMS CO
6 - 119 (of 360)
0.92MG/VIAL;0.092MG/VIAL
N021191
001
May 31, 2002
DINOPROST TROMETHAMINE
INJECTABLE; INJECTION PROSTIN F2 ALPHA PHARMACIA AND UPJOHN
EQ 5MG BASE/ML
N017434
001
DIPHEMANIL METHYLSULFATE
TABLET; ORAL PRANTAL SCHERING
100MG
N008114
004
CAPSULE; ORAL BENADRYL MCNEIL CONS
25MG 50MG DIPHENHYDRAMINE HYDROCHLORIDE ALRA 25MG 50MG ANABOLIC 50MG ELKINS SINN 25MG 50MG HALSEY 50MG HEATHER 25MG 50MG IMPAX LABS 25MG 50MG IVAX SUB TEVA PHARMS 25MG 50MG LANNETT 25MG 50MG LEDERLE 25MG 50MG LNK 25MG 50MG MK LABS 25MG 50MG MUTUAL PHARM 25MG 25MG 50MG NEWTRON PHARMS 25MG 50MG NEXGEN PHARMA INC 25MG PERRIGO 25MG 50MG PIONEER PHARMS 25MG 50MG PUREPAC PHARM 25MG 50MG PVT FORM 25MG 50MG ROXANE 50MG SANDOZ 25MG 25MG 50MG 50MG SUPERPHARM 25MG 50MG TEVA 25MG
N005845 N005845 A080519 A080519 A083275 A085701 A085701 A087914 A084524 A083953 A080807 A080807 A080762 A080762 A080868 A080868 A086874 A086875 A087977 A087978 A083087 A083087 A084506 A089488 A089489 A086543 A086544 A083634 A083061 A083061 A089101 A088880 A085156 A085150 A083027 A083027 A080635 A080832 A080845 A080832 A080845 A089040 A089041 A085874
007 001 004 003 001 001 002 001 001 001 001 002 001 002 001 002 001 001 001 001 001 002 001 001 001 001 001 001 001 002 001 001 001 001 001 002 001 001 002 002 001 001 001 001
Jun 04, 1984
Jan 27, 1983 Jan 27, 1983
Jan 02, 1987 Jan 02, 1987
Dec 20, 1985 Dec 20, 1985
May 15, 1985 May 15, 1985

CAPSULE; ORAL DIPHENHYDRAMINE HYDROCHLORIDE TEVA 50MG VALEANT PHARM INTL 25MG 50MG VANGARD 25MG 50MG WATSON LABS 25MG 25MG 25MG 50MG 50MG 50MG WEST WARD 50MG WHITEWORTH TOWN PLSN 25MG 50MG ELIXIR; ORAL BELIX HALSEY 12.5MG/5ML BENADRYL MCNEIL CONS 12.5MG/5ML DIBENIL CENCI 12.5MG/5ML DIPHEN USL PHARMA 12.5MG/5ML DIPHENHYDRAMINE HYDROCHLORIDE BUNDY 12.5MG/5ML CENCI 12.5MG/5ML KV PHARM 12.5MG/5ML LANNETT 12.5MG/5ML LEDERLE 12.5MG/5ML MK LABS 12.5MG/5ML NASKA 12.5MG/5ML PERRIGO 12.5MG/5ML PUREPAC PHARM 12.5MG/5ML PVT FORM 12.5MG/5ML ROXANE 12.5MG/5ML HYDRAMINE ALPHARMA US PHARMS 12.5MG/5ML INJECTABLE; INJECTION BENADRYL MCNEIL CONS 10MG/ML 50MG/ML BENADRYL PRESERVATIVE FREE MCNEIL CONS 50MG/ML DIPHENHYDRAMINE HYDROCHLORIDE BEL MAR 10MG/ML HIKMA MAPLE 50MG/ML LYPHOMED 10MG/ML WATSON LABS 10MG/ML WYETH AYERST 50MG/ML DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE ABRAXIS PHARM 50MG/ML SYRUP; ORAL ANTITUSSIVE PERRIGO 12.5MG/5ML BELDIN HALSEY 12.5MG/5ML BENYLIN PARKE DAVIS 12.5MG/5ML DIPHEN MORTON GROVE 12.5MG/5ML
6 - 120 (of 360)
A085874 A080596 A080592 A088034 A087630 A080728 A083797 A085138 A080727 A083797 A085083 A083567 A083441 A080800
002 001 001 001 001 001 001 001 001 002 001 001 001 001
Oct 27, 1982
A086586 N005845 A088304 A084640 A083674 A087941 A085621 A080939 A086937 A083088 A088680 A083063 A083237 A085287 A080643 A080763
001 004 001 001 001 001 001 002 001 002 001 001 001 001 001 002
Oct 03, 1983
Dec 16, 1983
Dec 17, 1982
May 31, 1985 Jan 25, 1982
N006146 N006146 N009486 A080822 A083183 A087066 A083533 A080577 A080586
001 002 001 001 001 001 001 001 002
A071292 A089179 N006514 A070118
001 001 004 001
Apr 10, 1987 Jun 05, 1986
Oct 01, 1985

SYRUP; ORAL DIPHENHYDRAMINE HYDROCHLORIDE ALPHARMA US PHARMS 12.5MG/5ML CUMBERLAND SWAN 12.5MG/5ML HI TECH PHARMA 12.5MG/5ML HYDRAMINE ALPHARMA US PHARMS 12.5MG/5ML SILPHEN SILARX 12.5MG/5ML VICKS FORMULA 44 WARNER CHILCOTT 12.5MG/5ML
6 - 121 (of 360)
A070497 A073611 A072416 A070205 A072646 A070524
001 001 001 001 001 001
Apr 25, 1989 Aug 20, 1992 Sep 28, 1990 Jan 28, 1986 Feb 27, 1992 Jan 14, 1987
DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

SOLUTION; ORAL BENYLIN PARKE DAVIS
12.5MG/5ML;30MG/5ML
N019014
001
Jun 11, 1985
DIPHENIDOL HYDROCHLORIDE
TABLET; ORAL VONTROL GLAXOSMITHKLINE
EQ 25MG BASE
N016033
001
DIPHENYLPYRALINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL HISPRIL GLAXOSMITHKLINE 5MG
N011945
001
DIPIVEFRIN HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC DIPIVEFRIN HYDROCHLORIDE BAUSCH AND LOMB 0.1%
A074188
001
May 19, 1995
DIPYRIDAMOLE
INJECTABLE; INJECTION DIPYRIDAMOLE HOSPIRA TEVA PARENTERAL IV PERSANTINE BOEHRINGER INGELHEIM TABLET; ORAL DIPYRIDAMOLE PUREPAC PHARM SANDOZ
A074601 A074952 N019817
001 001 001
Dec 19, 1997 Nov 26, 1997 Dec 13, 1990
A089426 A089427 A086944 A087562 A087561
001 001 002 001 001
Jul Jul Apr Feb Feb
12, 12, 16, 25, 25,
1990 1990 1991 1992 1992
DIRITHROMYCIN
TABLET, DELAYED RELEASE; ORAL DYNABAC LILLY RES LABS 250MG
N050678
001
Jun 19, 1995
CAPSULE; ORAL DISOPYRAMIDE PHOSPHATE INTERPHARM IVAX SUB TEVA PHARMS MUTUAL PHARM MYLAN
100MG 150MG 100MG 150MG 100MG 150MG 100MG
A071190 A071191 A070186 A070187 A070351 A070352 A070138
001 001 001 001 001 001 001
Jan Jan Nov Nov Dec Dec Jun
15, 15, 18, 18, 17, 17, 14,
1987 1987 1985 1985 1985 1985 1985

CAPSULE; ORAL DISOPYRAMIDE PHOSPHATE MYLAN SANDOZ
6 - 122 (of 360)
EQ 150MG EQ 100MG EQ 150MG SUPERPHARM EQ 100MG EQ 150MG WATSON LABS EQ 100MG EQ 150MG CAPSULE, EXTENDED RELEASE; ORAL DISOPYRAMIDE PHOSPHATE NESHER PHARMS EQ 150MG
A070139 A070470 A070471 A070940 A070941 A070240 A070241
001 001 001 001 001 001 001
Jun Dec Dec Feb Feb Feb Feb
14, 10, 10, 09, 09, 02, 02,
1985 1985 1985 1987 1987 1986 1986
BASE
A071200
001
Dec 15, 1987
DISULFIRAM
TABLET; ORAL ANTABUSE TEVA WOMENS DISULFIRAM PAR PHARM WATSON LABS
N007883 N007883 A088792 A088793 A086889 A087973 A086890 A087974
003 002 001 001 001 001 001 001 Aug 14, 1984 Aug 14, 1984 Aug 05, 1983 Aug 05, 1983
DIVALPROEX SODIUM
TABLET, DELAYED RELEASE; ORAL DEPAKOTE CP ABBOTT EQ 250MG BASE EQ 500MG BASE
N019794 N019794
001 002
Jul 11, 1990 Jul 11, 1990
DOBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION DOBUTAMINE HYDROCHLORIDE ASTRAZENECA EQ BAXTER HLTHCARE EQ HOSPIRA EQ LUITPOLD EQ MARSAM PHARMS LLC EQ EQ TEVA PARENTERAL EQ DOBUTREX LILLY EQ
12.5MG 12.5MG 1.25GM 12.5MG 12.5MG 12.5MG 12.5MG
BASE/ML BASE/ML BASE/100ML BASE/ML BASE/ML BASE/ML BASE/ML
A074098 A074381 A074634 A074545 A074279 A074995 A074206 N017820
001 001 001 001 001 001 001 002
Feb Sep Sep Jun Feb Mar Oct
21, 26, 27, 25, 18, 31, 19,
1995 1996 1996 1998 1998 1998 1993
12.5MG BASE/ML
DOCETAXEL
TAXOTERE
SANOFI AVENTIS US
40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020449
001
May 14, 1996
SOLUTION; ORAL
ARICEPT
EISAI INC 5MG/5ML TABLET, ORALLY DISINTEGRATING; ORAL DONEPEZIL HYDROCHLORIDE MUTUAL PHARM 5MG 10MG
N021719
001
Oct 18, 2004
A077975 A077975
002 001
Dec 11, 2009 Dec 11, 2009

DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION DOPAMINE HYDROCHLORIDE ABBOTT
6 - 123 (of 360)
40MG/ML 80MG/ML ABRAXIS PHARM 40MG/ML 40MG/ML 80MG/ML 80MG/ML 160MG/ML ASTRAZENECA 40MG/ML 40MG/ML 80MG/ML 80MG/ML 80MG/ML 160MG/ML 160MG/ML 160MG/ML BAXTER HLTHCARE 40MG/ML 80MG/ML HOSPIRA 40MG/ML INTL MEDICATION 40MG/ML LYPHOMED 40MG/ML SMITH AND NEPHEW 40MG/ML 40MG/ML 80MG/ML TEVA PARENTERAL 40MG/ML 80MG/ML WARNER CHILCOTT 40MG/ML 40MG/ML 80MG/ML DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% HOSPIRA 1.6MG/ML INTROPIN HOSPIRA 40MG/ML 80MG/ML 160MG/ML
A070656 A070657 A070012 A070058 A070013 A070059 A070364 A070087 N018656 A070089 A070090 A070091 A070092 A070093 A070094 N018398 N018398 A074403 N018014 N018549 A070011 A070046 A070047 A072999 A073000 A070558 N018138 A070559 N020542 N017395 N017395 N017395
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003
Jan Jan Jun Mar Jun Mar Dec Oct Jun Oct Oct Oct Oct Oct Oct
24, 24, 12, 20, 12, 20, 04, 23, 28, 23, 23, 23, 23, 23, 23,
1989 1989 1985 1985 1985 1985 1985 1985 1983 1985 1985 1985 1985 1985 1985
Mar 22, 1982 May 23, 1996 Mar Aug Aug Aug Oct Oct Sep 11, 29, 29, 29, 23, 23, 20, 1983 1985 1985 1985 1991 1991 1985
Sep 20, 1985 Aug 30, 1995
DOXACURIUM CHLORIDE
INJECTABLE; INJECTION NUROMAX ABBVIE
EQ 1MG BASE/ML
N019946
001
Mar 07, 1991
DOXAZOSIN MESYLATE
TABLET; ORAL DOXAZOSIN MESYLATE ACTAVIS ELIZABETH
GENPHARM
NESHER PHARMS
SANDOZ
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001
Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000

DOXAZOSIN MESYLATE
TABLET; ORAL DOXAZOSIN MESYLATE SANDOZ
6 - 124 (of 360)
TEVA
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075646 A075432 A075646 A075432 A075646 A075432 A075646 A075353 A075353 A075353 A075353
001 002 002 003 003 004 004 001 002 003 004
Oct Oct Oct Oct Oct Oct Oct Jan Jan Jan Jan
18, 18, 18, 18, 18, 18, 18, 12, 12, 12, 12,
2000 2000 2000 2000 2000 2000 2000 2001 2001 2001 2001
CAPSULE; ORAL DOXEPIN HYDROCHLORIDE DAVA PHARMS INC
MUTUAL PHARM
NEW RIVER
PUREPAC PHARM
QUANTUM PHARMICS
SANDOZ
WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 10MG BASE 25MG BASE 25MG BASE 50MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE
A071685 A071686 A071673 A071674 A071675 A071676 A071502 A071653 A071654 A071521 N016987 N016987 N016987 N016987 N016987 N016987 A073054 A072109 A073055 A072386 A072110 A072387 A070972 A070973 A070931 A070932 A072375 A072376 A071487 A070827 A070828 A070825 A071562 A070952 A072985 A070953 A072986 A070954 A072987 A071763 A070955 A071764 N016798 N016798
001 001 001 001 001 001 001 001 001 001 001 002 003 006 004 007 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003 001
Jan Jan Jan Jan Jan Jan Feb Feb Feb Feb
05, 05, 05, 05, 05, 05, 18, 18, 18, 18,
1988 1988 1988 1988 1988 1988 1988 1988 1988 1988
Apr Dec Dec Dec Sep Sep Sep Sep Sep Sep Sep Mar Mar Mar May May May Mar Mar Mar May Mar May Mar Feb May Feb
13, 28, 28, 28, 08, 08, 08, 29, 29, 29, 29, 15, 15, 02, 15, 15, 15, 02, 04, 29, 15, 29, 15, 29, 09, 15, 09,
1987 1990 1990 1990 1988 1988 1988 1987 1987 1987 1987 1989 1989 1987 1986 1986 1986 1987 1987 1991 1986 1991 1986 1991 1988 1986 1988
SINEQUAN PFIZER

CAPSULE; ORAL
SINEQUAN
PFIZER
6 - 125 (of 360)
EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE EQ 150MG BASE **Federal Register notice determination that product was
not discontinued or withdrawn for
N016798 N016798 N016798 N016798
002
006
005
007
CONCENTRATE; ORAL
SINEQUAN
PFIZER
EQ 10MG BASE/ML
N017516
001
ADRIAMYCIN PFS
PHARMACIA AND UPJOHN 2MG/ML 2MG/ML 200MG/100ML 200MG/100ML ADRIAMYCIN RDF PHARMACIA AND UPJOHN 10MG/VIAL 20MG/VIAL 50MG/VIAL 150MG/VIAL RUBEX BRISTOL MYERS SQUIBB 10MG/VIAL 50MG/VIAL 100MG/VIAL
A063165 N050629 A063165 N050629 N050467 N050467 N050467 N050467 A062926 A062926 A062926
001 001 002 002 001 003 002 004 001 002 003
Jan Dec Jan May
30, 23, 30, 03,
1991 1987 1991 1988
May 20, 1985 Jul 22, 1987 Apr 13, 1989 Apr 13, 1989 Apr 13, 1989
DOXYCYCLINE
CAPSULE; ORAL DOXYCYCLINE PAR PHARM SANDOZ INC FOR SUSPENSION; ORAL DOXYCHEL RACHELLE TABLET; ORAL DOXYCYCLINE MUTUAL PHARM
A065055 A065032 A065032
004 001 002
Apr 18, 2005 Jun 30, 2000 Jun 30, 2000
EQ 25MG BASE/5ML
A061720
001
SANDOZ INC
EQ EQ EQ EQ EQ EQ
A065471 A065471 A065471 A065353 A065353 A065353
001 002 003 001 002 003
Apr Apr Apr Nov Nov Nov
17, 17, 17, 27, 27, 27,
2009 2009 2009 2006 2006 2006
DOXYCYCLINE HYCLATE
CAPSULE; ORAL
DOXYCYCLINE HYCLATE
HALSEY HEATHER INTERPHARM MUTUAL PHARM MYLAN PAR PHARM
A062119 A062119 A062463 A062463 A062763 A062763 A062418 A062418 A062337 A062337 A062434 A062442
002 001 001 002 001 002 001 002 001 002 001 001
May May Dec Dec Sep Sep Jan Jan Mar Mar Oct Dec
24, 24, 07, 07, 02, 02, 28, 28, 29, 29, 19, 22,
1985 1985 1983 1983 1988 1988 1983 1983 1982 1982 1984 1983

DOXYCYCLINE HYCLATE
CAPSULE; ORAL DOXYCYCLINE HYCLATE PVT FORM RANBAXY SUPERPHARM WARNER CHILCOTT WATSON LABS
6 - 126 (of 360)
001 002 001 002 001 002 001 002 001 001 002 002 001 002 001
Jul Jul Dec Dec Oct Oct Dec Dec
24, 24, 23, 23, 31, 31, 05, 05,
1986 1986 1983 1983 1984 1984 1985 1985
DOXY-LEMMON TEVA
Aug 23, 1984 Jun 15, 1984 Sep 30, 1998
PERIOSTAT COLLAGENEX EQ 20MG BASE CAPSULE, COATED PELLETS; ORAL DOXYCYCLINE HYCLATE PLIVA EQ 100MG BASE CAPSULE, DELAYED RELEASE; ORAL DORYX MAYNE PHARMA INTL EQ 75MG BASE EQ 100MG BASE WARNER CHILCOTT EQ 100MG BASE INJECTABLE; INJECTION DOXYCHEL HYCLATE RACHELLE EQ 100MG BASE/VIAL DOXYCYCLINE BEDFORD EQ 200MG BASE/VIAL HIKMA MAPLE EQ 100MG BASE/VIAL EQ 200MG BASE/VIAL DOXYCYCLINE HYCLATE HIKMA MAPLE EQ 100MG BASE/VIAL EQ 200MG BASE/VIAL VIBRAMYCIN PFIZER EQ 100MG BASE/VIAL EQ 200MG BASE/VIAL TABLET; ORAL DOXYCYCLINE HYCLATE HEATHER EQ 100MG BASE INTERPHARM EQ 100MG BASE MUTUAL PHARM EQ 100MG BASE MYLAN EQ 100MG BASE SUPERPHARM EQ 100MG BASE TRUXTON INC EQ 50MG BASE EQ 100MG BASE WARNER CHILCOTT EQ 100MG BASE WATSON LABS EQ 50MG BASE EQ 100MG BASE DOXY-LEMMON TEVA EQ 100MG BASE VIBRA-TABS PFIZER EQ 100MG BASE
A063187
001
Jun 30, 1992
N050582 N050582 A062653
002 001 001
Aug 13, 2001 Jul 22, 1985 Oct 30, 1985
A061953 A062569 A062450 A062450 A062992 A062992 N050442 N050442
001 002 001 002 001 002 002 001 Mar 09, 1988 Oct 27, 1983 Oct 27, 1983 Feb 16, 1989 Feb 16, 1989
A062462 A062764 A062391 A062432 A062494 A062269 A062269 A062593 A062392 A062392 A062581 N050533
001 001 001 001 001 003 002 001 001 002 001 001
May Sep Sep Feb Feb Nov Aug Mar Mar
11, 02, 30, 15, 20, 08, 28, 31, 31,
1983 1988 1982 1983 1985 1982 1985 1983 1983
Mar 15, 1985
CAPSULE; ORAL UNISOM PFIZER
25MG
N019440
001
Feb 05, 1986

TABLET; ORAL
DECAPRYN
SANOFI AVENTIS US DOXYLAMINE SUCCINATE COPLEY PHARM QUANTUM PHARMICS DOXY-SLEEP-AID PAR PHARM
6 - 127 (of 360)
12.5MG 25MG 25MG 25MG 25MG
N006412 N006412 A088900 A088603 A070156
015
014
002 001 001 Feb 12, 1988 Aug 07, 1984 Jul 02, 1987
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

BENDECTIN
SANOFI AVENTIS US 10MG;10MG **Federal Register determination that product was not
N010598
002
DROMOSTANOLONE PROPIONATE
DROLBAN
LILLY
50MG/ML
N012936
001
DROPERIDOL
INJECTABLE; INJECTION DROPERIDOL ABRAXIS PHARM ASTRAZENECA
HOSPIRA LUITPOLD SMITH AND NEPHEW SOLOPAK WATSON LABS
2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Nov Nov Oct Oct Oct Oct Apr Aug Oct Sep Sep Sep Nov Nov Nov
17, 17, 20, 19, 19, 19, 07, 31, 24, 06, 06, 06, 27, 27, 27,
1986 1986 1988 1988 1988 1988 1988 1995 1988 1988 1988 1988 1991 1991 1991
DROPERIDOL; FENTANYL CITRATE

FENTANYL CITRATE AND DROPERIDOL
ASTRAZENECA 2.5MG/ML;EQ 2.5MG/ML;EQ 2.5MG/ML;EQ HOSPIRA 2.5MG/ML;EQ INNOVAR AKORN MFG 2.5MG/ML;EQ
0.05MG 0.05MG 0.05MG 0.05MG
A072026 A072027 A072028 A071982 N016049
001 001 001 001 001
Apr Apr Apr May
13, 13, 13, 04,
1989 1989 1989 1988
0.05MG BASE/ML
DYCLONINE HYDROCHLORIDE
SOLUTION; TOPICAL
DYCLONE
ASTRAZENECA

reasons**
1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N009925
002
N009925
001

DYDROGESTERONE
TABLET; ORAL
GYNOREST
SOLVAY
6 - 128 (of 360)
5MG 10MG
N017388 N017388
001
002
DYPHYLLINE
ELIXIR; ORAL
NEOTHYLLINE
TEVA INJECTABLE; INJECTION
NEOTHYLLINE
TEVA TABLET; ORAL
DILOR
SAVAGE LABS DILOR-400
SAVAGE LABS NEOTHYLLINE
TEVA
160MG/15ML
N007794
003
250MG/ML
N009088
001
200MG 400MG 200MG 400MG
A084514 A084751 N007794 N007794
001
001
001
002
ECHOTHIOPHATE IODIDE
PHOSPHOLINE IODIDE
WYETH PHARMS INC
0.03% 0.06% 0.25%
N011963 N011963 N011963
002
004
003
ECONAZOLE NITRATE
CREAM; TOPICAL SPECTAZOLE ORTHO JANSSEN
1%
N018751
001
Dec 23, 1982
EDETATE CALCIUM DISODIUM

TABLET; ORAL
CALCIUM DISODIUM VERSENATE
MEDICIS 500MG
N008922
002
EDROPHONIUM CHLORIDE
INJECTABLE; INJECTION EDROPHONIUM CHLORIDE HOSPIRA 10MG/ML WATSON LABS 10MG/ML EDROPHONIUM CHLORIDE PRESERVATIVE FREE WATSON LABS 10MG/ML REVERSOL ORGANON USA INC 10MG/ML
A040131 A040044 A040043 A089624
001 001 001 001
Feb 24, 1998 Mar 20, 1996 Mar 20, 1996 May 13, 1988
EFAVIRENZ
CAPSULE; ORAL
SUSTIVA
BRISTOL MYERS SQUIBB 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET; ORAL
SUSTIVA
BRISTOL MYERS SQUIBB 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020972
002
Sep 17, 1998
N021360
001
Feb 01, 2002

EFLORNITHINE HYDROCHLORIDE
INJECTABLE; INJECTION ORNIDYL SANOFI AVENTIS US
6 - 129 (of 360)
200MG/ML
N019879
002
Nov 28, 1990
ENALAPRIL MALEATE
TABLET; ORAL ENALAPRIL MALEATE APOTHECON
KRKA DD NOVO MESTO
RANBAXY
SANDOZ
SANDOZ INC
2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 2.5MG 5MG 5MG 10MG 10MG 20MG 20MG
001 002 003 004 001 002 003 004 001 002 001 002 001 002 003 004 001 002 003 004 001 001 002 002 001 003 002 004
Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug
22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000
ENALAPRIL MALEATE; FELODIPINE

TABLET, EXTENDED RELEASE; ORAL LEXXEL ASTRAZENECA 5MG;2.5MG 5MG;5MG
N020668 N020668
002 001
Oct 28, 1998 Dec 27, 1996

TABLET; ORAL ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE IVAX SUB TEVA PHARMS 5MG;12.5MG 10MG;25MG SANDOZ INC 5MG;12.5MG 10MG;25MG
A075736 A075736 A076116 A076116
001 002 001 002
Mar Mar Sep Sep
25, 25, 19, 19,
2003 2003 2001 2001
ENALAPRILAT
INJECTABLE; INJECTION ENALAPRILAT HOSPIRA VASOTEC BIOVAIL LABS INTL
A075456 A075571 N019309
001 001 001
Aug 22, 2000 Aug 22, 2000 Feb 09, 1988
ENFLURANE
LIQUID; INHALATION ENFLURANE ABBOTT
99.9%
A070803
001
Sep 08, 1987

ENOXACIN
TABLET; ORAL PENETREX SANOFI AVENTIS US
6 - 130 (of 360)
200MG 400MG
N019616 N019616
004 005
Dec 31, 1991 Dec 31, 1991
ENOXAPARIN SODIUM
LOVENOX (PRESERVATIVE FREE)
SANOFI AVENTIS US 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020164
006
Jun 02, 2000
EPINEPHRINE
AEROSOL, METERED; INHALATION BRONKAID MIST STERLING 0.25MG/INH PRIMATENE MIST WYETH CONS 0.2MG/INH INJECTABLE; INJECTION SUS-PHRINE SULFITE-FREE FOREST LABS 1.5MG/AMP 5MG/ML INJECTABLE; INTRAMUSCULAR EPI E Z PEN JR MERIDIAN MEDCL TECHN 0.15MG/DELIVERY EPIPEN E Z PEN MERIDIAN MEDCL TECHN 0.3MG/DELIVERY
N016803 N016126
001 001
N007942 N007942
003 001
Feb 05, 1999
N019430 N019430
004 003
Aug 03, 1995 Aug 03, 1995
EPINEPHRINE BITARTRATE
BRONITIN MIST
WYETH CONS 0.3MG/INH MEDIHALER-EPI
3M 0.3MG/INH
N016126 N010374
002
003
EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE

DURANEST
ASTRAZENECA DENTSPLY PHARM
0.005MG/ML;1% 0.005MG/ML;1.5% 0.005MG/ML;1.5%
N017751 N017751 N021384
006
007
001
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE

CITANEST FORTE
ASTRAZENECA
0.005MG/ML;4%
N014763
008
EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE

DURANEST
ASTRAZENECA
0.005MG/ML;0.5%
N017751
004

INJECTABLE; INJECTION ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE CARLISLE 0.01MG/ML;2% 0.02MG/ML;2% LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE GRAHAM CHEM 0.01MG/ML;2% 0.02MG/ML;2% HIKMA MAPLE 0.01MG/ML;1% 0.01MG/ML;2%
A084720 A084732 A080504 A080504 A080406 A080406
001 001 004 005 001 002 Oct 19, 1983 Oct 19, 1983

INJECTABLE; INJECTION LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE HOSPIRA 0.005MG/ML;1% 0.005MG/ML;1.5% LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE
ABBOTT 0.01MG/ML;1% BEL MAR 0.01MG/ML;1% 0.01MG/ML;2% DELL LABS 0.01MG/ML;1% 0.01MG/ML;2% INTL MEDICATION 0.01MG/ML;1% WATSON LABS 0.01MG/ML;1% 0.01MG/ML;1% 0.01MG/ML;2% LIDOCATON PHARMATON 0.01MG/ML;2% 0.02MG/ML;2% XYLOCAINE DENTAL WITH EPINEPHRINE DENTSPLY PHARM 0.01MG/ML;2% 0.02MG/ML;2% XYLOCAINE W/ EPINEPHRINE ASTRAZENECA 0.005MG/ML;1% 0.005MG/ML;1.5% 0.005MG/ML;2% FRESENIUS KABI USA 0.01MG/ML;2% PATCH; IONTOPHORESIS, TOPICAL LIDOSITE TOPICAL SYSTEM KIT VYTERIS 1.05MG/PATCH;100MG/PATCH SOLUTION; IONTOPHORESIS IONTOCAINE IOMED 0.01MG/ML;2% SOLUTION; IONTOPHORESIS, TOPICAL LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE EMPI 0.01MG/ML;2%
6 - 131 (of 360)
A089649 A089650 A083154 A080820 A080757 A083389 A083390 A086402 A080377 A085463 A080377 A084729 A084728 N021381 N021381 N010418 N010418 N010418 N006488
001 001 001

001
001
001
001
001
003
001 004 001 001 001 002 006
010
008
003
Jun 21, 1988 Jun 21, 1988
Aug 17, 1983 Aug 17, 1983
N021504
001
May 06, 2004
N020530
001
Dec 21, 1995
N021486
001
Oct 26, 2004
EPINEPHRINE; PROCAINE HYDROCHLORIDE

INJECTABLE; INJECTION PROCAINE HYDROCHLORIDE W/ EPINEPHRINE BEL MAR 0.02MG/ML;1% 0.02MG/ML;2%
A080758 A080759
001 001
INJECTABLE; IV (INFUSION) EPIRUBICIN HYDROCHLORIDE HOSPIRA 200MG/VIAL
N050807
002
Sep 15, 2006
EPLERENONE
TABLET; ORAL INSPRA GD SEARLE LLC
100MG
N021437
003
Sep 27, 2002
EPROSARTAN MESYLATE
TABLET; ORAL TEVETEN ABBVIE
EQ 300MG BASE
N020738
004
Dec 22, 1997
ERGOCALCIFEROL
CAPSULE; ORAL DELTALIN LILLY VITAMIN D CHASE CHEM
50,000 IU 50,000 IU
A080884 A080747
001 001

ERGOCALCIFEROL
CAPSULE; ORAL VITAMIN D EVERYLIFE IMPAX LABS LANNETT VITARINE WEST WARD
6 - 132 (of 360)
50,000 50,000 50,000 50,000 50,000
IU IU IU IU IU
A080956 A080951 A080825 A084053 A083102
001 001 001 001 001
ERGOLOID MESYLATES
CAPSULE; ORAL HYDERGINE LC NOVARTIS SOLUTION; ORAL HYDERGINE NOVARTIS TABLET; ORAL ERGOLOID MESYLATES MUTUAL PHARM WATSON LABS GERIMAL WATSON LABS HYDERGINE NOVARTIS TABLET; SUBLINGUAL ALKERGOT SANDOZ CIRCANOL 3M DEAPRIL-ST BRISTOL MYERS SQUIBB ERGOLOID MESYLATES KV PHARM
1MG
N018706
001
Jan 18, 1983
1MG/ML
N018418
001
1MG 1MG 1MG 1MG 0.5MG
A088891 A086433 A087244 A088207 N017993
001 001 001 001 003
Nov 01, 1985 May 27, 1982 Aug 16, 1982 Mar 22, 1984
0.5MG 1MG 0.5MG 1MG 1MG 0.5MG 0.5MG 1MG 1MG 0.5MG 1MG 0.5MG 1MG 0.5MG 1MG 0.5MG 1MG 0.5MG 1MG 1MG 0.5MG 1MG
A085153 A087417 A084868 A085809 A085020 A085899 A086265 A085900 A086264 A086984 A086985 A087407 A087552 A089233 A089234 A088013 A088014 A084930 A085177 A087183 A086189 A086188 N009087 N009087 A087186 A087185
001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001
LEDERLE MUTUAL PHARM SUPERPHARM VANGARD WATSON LABS
Sep Sep Sep Sep
23, 23, 20, 20,
1986 1986 1982 1982
GERIMAL WATSON LABS HYDERGINE NOVARTIS
0.5MG 1MG HYDROGENATED ERGOT ALKALOIDS IVAX PHARMS 0.5MG 1MG
ERGOTAMINE TARTRATE
AEROSOL, METERED; INHALATION MEDIHALER ERGOTAMINE 3M 0.36MG/INH
N012102
001

ERGOTAMINE TARTRATE
TABLET; SUBLINGUAL ERGOSTAT PARKE DAVIS WIGRETTES ORGANON USA INC
6 - 133 (of 360)
2MG 2MG
A088337 A086750
001 001
Jun 08, 1984 Jul 29, 1982
ERYTHROMYCIN
CAPSULE, DELAYED REL PELLETS; ORAL ERYC PARKE DAVIS 250MG 250MG ERYC 125 PARKE DAVIS 125MG ERYC SPRINKLES HOSPIRA 125MG ERYTHROMYCIN BARR 250MG GEL; TOPICAL E-GLADES RENAISSANCE PHARMA 2% EMGEL ALTANA 2% LOTION; TOPICAL E-SOLVE 2 SYOSSET 2% OINTMENT; OPHTHALMIC ERYTHROMYCIN PHARMADERM 5MG/GM PHARMAFAIR 5MG/GM ILOTYCIN DISTA 0.5% POWDER; FOR RX COMPOUNDING ERYTHROMYCIN PADDOCK LLC 100% SOLUTION; TOPICAL A/T/S TARO PHARMS NORTH 2% ERYDERM ARBOR PHARMS INC 2% ERYMAX MERZ PHARMS 2% ERYTHROMYCIN ALPHARMA US PHARMS 1.5% 2% 2% 2% 2% BAUSCH AND LOMB 2% LILLY 2% PHARMAFAIR 1.5% 2% RENAISSANCE PHARMA 2% SANSAC DOW PHARM SCIENCES 2% STATICIN WESTWOOD SQUIBB 1.5% T-STAT WESTWOOD SQUIBB 2% SWAB; TOPICAL C-SOLVE-2 IVAX SUB TEVA PHARMS 2% ERYCETTE JOHNSON AND JOHNSON 2%
A062546 A062618 A062648 N050593 A063098
001 001 001 001 001
Jul 25, 1985 Sep 25, 1985 Oct 24, 1985 Jul 22, 1985 May 04, 1989
A065009 A063107
001 001
Mar 18, 2002 Aug 23, 1991
A062467
001
Jul 03, 1985
A062446 A062481 N050368
001 001 001
Sep 26, 1983 Apr 05, 1984
N050610
001
Nov 07, 1986
A062405 A062290 A062508 A062328 A062326 A062327 A062342 A062957 A064039 N050532 A062485 A062616 A064127 A062522 N050526 A062436
001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001
Nov 18, 1982
Jul 11, 1985 Apr Apr Apr Feb Jul Jan 19, 19, 19, 25, 21, 27, 1982 1982 1982 1982 1988 1994
Jul 11, 1984 Jul 25, 1985 Feb 14, 1997 Jan 24, 1985
Mar 09, 1983
A062751 N050594
001 001
Jul 30, 1993 Feb 15, 1985

ERYTHROMYCIN
SWAB; TOPICAL ERYTHROMYCIN RENAISSANCE PHARMA 2% T-STAT WESTWOOD SQUIBB 2% TABLET, DELAYED RELEASE; ORAL E-BASE BARR 333MG 333MG 500MG E-MYCIN ARBOR PHARMS INC 250MG 333MG ILOTYCIN DISTA 250MG ROBIMYCIN ROBINS AH 250MG R-P MYCIN SOLVAY 250MG
6 - 134 (of 360)
A064128 A062748
001 001
Jul 03, 1996 Jul 23, 1987
A063028 A063086 A062999 A060272 A060272 A061910 A061633 A061659
001 001 001 001 002 001 001 001
May 15, 1990 May 15, 1990 Nov 25, 1988
ERYTHROMYCIN ESTOLATE
CAPSULE; ORAL ERYTHROMYCIN ESTOLATE BARR IVAX SUB TEVA PHARMS WATSON LABS ILOSONE LILLY FOR SUSPENSION; ORAL ILOSONE DISTA SUSPENSION; ORAL ERYTHROMYCIN ESTOLATE ALPHARMA US PHARMS BARR LIFE LABS ILOSONE LILLY
EQ EQ EQ EQ
125MG 250MG 250MG 250MG
BASE BASE BASE BASE
A062162 A062162 A062237 A062087 A061897 A061897
001 002 001 001 001 002
EQ 125MG BASE/5ML
A061893
001
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062353 A062409 A062169 A062169 A062362 A061894 N050010 A061894 N050010
001 001 001 002 001 001 001 002 002
Nov Dec Oct Oct Dec
18, 16, 17, 17, 17,
1982 1982 1990 1990 1982
SUSPENSION/DROPS; ORAL ILOSONE LILLY TABLET; ORAL ILOSONE LILLY TABLET, CHEWABLE; ORAL ILOSONE DISTA
EQ 100MG BASE/ML
A061894
003
EQ 500MG BASE
A061896
001
A061895 A061895
001 002
ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL

SUSPENSION; ORAL ILOSONE SULFA LILLY
EQ 125MG BASE/5ML;EQ 600MG BASE/5ML
N050599
001
Sep 29, 1989

ERYTHROMYCIN ETHYLSUCCINATE
GRANULE; ORAL ERYTHROMYCIN ETHYLSUCCINATE BARR EQ 200MG PEDIAMYCIN ROSS LABS EQ 200MG SUSPENSION; ORAL E-MYCIN E PHARMACIA AND UPJOHN EQ 200MG EQ 400MG ERYTHROMYCIN ETHYLSUCCINATE ALPHARMA US PHARMS EQ 200MG EQ 400MG DISTA EQ 200MG EQ 400MG NASKA EQ 400MG PARKE DAVIS EQ 200MG EQ 400MG PHARMAFAIR EQ 200MG EQ 400MG WYAMYCIN E WYETH AYERST EQ 200MG EQ 400MG SUSPENSION/DROPS; ORAL PEDIAMYCIN ROSS LABS EQ 100MG TABLET; ORAL E.E.S. 400
ARBOR PHARMS INC EQ 400MG ERYTHROMYCIN ETHYLSUCCINATE BARR EQ 400MG MYLAN EQ 400MG TABLET, CHEWABLE; ORAL E.E.S. ARBOR PHARMS INC EQ 200MG ERYPED ARBOR PHARMS INC EQ 200MG PEDIAMYCIN
ROSS LABS EQ 200MG
6 - 135 (of 360)
BASE/5ML BASE/5ML
A062055 A062305
001 001
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062198 A062198 A062200 A062200 A062177 A062177 A062674 A062231 A062231 A062559 A062558 A062123 A062123
001 002 001 002 001 002 001 001 002 001 001 002 001
Mar 10, 1987
Mar 15, 1985 Mar 15, 1985
BASE/2.5ML
A062305
002
BASE BASE BASE
A061905 A062256 A062847
001
001 001
Sep 14, 1988
BASE BASE BASE
N050297 N050297 A062306
002 003 001

Jul 05, 1988
ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

GRANULE; ORAL ERYZOLE ALRA PEDIAZOLE ROSS LABS
EQ 200MG BASE/5ML;EQ 600MG BASE/5ML EQ 200MG BASE/5ML;EQ 600MG BASE/5ML
A062758 N050529
001 001
Jun 15, 1988
ERYTHROMYCIN GLUCEPTATE
INJECTABLE; INJECTION ILOTYCIN GLUCEPTATE DISTA
N050370 N050370 N050370
001 002 003
INJECTABLE; INJECTION ERYTHROCIN ABBOTT HOSPIRA
EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL
A062586 A062586 N050182 N050182 N050609 A062563
001 002 002 003 002 001
Jan 04, 1988 Jan 04, 1988
Sep 24, 1986 Mar 28, 1985
ERYTHROMYCIN ELKINS SINN
EQ 500MG BASE/VIAL

INJECTABLE; INJECTION ERYTHROMYCIN ELKINS SINN EQ ERYTHROMYCIN LACTOBIONATE ABRAXIS PHARM EQ EQ BAXTER HLTHCARE EQ EQ TEVA PARENTERAL EQ EQ
6 - 136 (of 360)
1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A062563 A062604 A062604 A062993 A062993 A063253 A063253
002 001 002 001 002 001 002
Mar 28, 1985 Nov Nov May May Jul Jul 24, 24, 09, 09, 30, 30, 1986 1986 1989 1989 1993 1993
ERYTHROMYCIN STEARATE
TABLET; ORAL BRISTAMYCIN BRISTOL ERYPAR PARKE DAVIS WARNER CHILCOTT ERYTHROCIN STEARATE ARBOR PHARMS INC ERYTHROMYCIN STEARATE BARR IVAX SUB TEVA PHARMS LEDERLE MYLAN PUREPAC PHARM WATSON LABS ETHRIL 250 BRISTOL MYERS SQUIBB ETHRIL 500 BRISTOL MYERS SQUIBB PFIZER-E PFIZER WYAMYCIN S WYETH AYERST
EQ 250MG BASE EQ 250MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 125MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 001 001 002 001 002 003 001 001 001 002 001 002 001 002 001 002 001 001 002 001 002 001 002
May 15, 1990
CAPSULE; ORAL ESCITALOPRAM OXALATE MYLAN PHARMS INC
A077660 A077660 A077660
001 002 003
Jul 31, 2007 Jul 31, 2007 Jul 31, 2007
ESMOLOL HYDROCHLORIDE
INJECTABLE; INJECTION BREVIBLOC BAXTER HLTHCARE
10MG/ML 20MG/ML
N019386 N019386
003 007
Aug 15, 1988 May 28, 2003

ESTAZOLAM
TABLET; ORAL PROSOM ABBOTT
6 - 137 (of 360)
1MG 2MG
N019080 N019080
001 002
Dec 26, 1990 Dec 26, 1990
ESTRADIOL
FILM, EXTENDED RELEASE; TRANSDERMAL ESCLIM WOMEN FIRST HLTHCARE 0.025MG/24HR 0.0375MG/24HR 0.05MG/24HR 0.075MG/24HR 0.1MG/24HR ESTRADIOL ORTHO MCNEIL PHARM 0.05MG/24HR 0.075MG/24HR 0.1MG/24HR FEMPATCH PARKE DAVIS 0.025MG/24HR VIVELLE NOVARTIS 0.025MG/24HR 0.0375MG/24HR 0.075MG/24HR GEL; TOPICAL ESTROGEL ASCEND 0.06% TABLET; ORAL ESTRACE BRISTOL MYERS SQUIBB 0.5MG 1MG 2MG ESTRADIOL AAI PHARMA INC 0.5MG 1MG 2MG HERITAGE PHARMS INC 0.5MG 1MG 2MG GYNODIOL DURAMED PHARMS BARR 0.5MG 1MG 1.5MG 2MG INNOFEM NOVO NORDISK INC 0.5MG 1MG 2MG TABLET; VAGINAL VAGIFEM NOVO NORDISK INC 25MCG
N020847 N020847 N020847 N020847 N020847 N021048 N021048 N021048 N020417 N020323 N020323 N020323
001 002 003 004 005 001 002 003 001 005 001 003
Aug Aug Aug Aug Aug
04, 04, 04, 04, 04,
1998 1998 1998 1998 1998
Sep 20, 1999 Sep 20, 1999 Sep 20, 1999 Dec 03, 1996 Aug 16, 2000 Oct 28, 1994 Oct 28, 1994
N021166
001
Feb 09, 2004
001 001 001 001 002 003 001 002 003 001 002 003 004 001 002 003
Jun 30, 1993
Jan Jan Jan Dec Dec Dec Dec Dec Dec Dec
30, 30, 30, 29, 29, 29, 29, 29, 29, 29,
1998 1998 1998 1998 1998 1998 1997 1997 1997 1997
Nov 19, 1999 Nov 19, 1999 Nov 19, 1999
N020908
001
Mar 26, 1999
ESTRADIOL CYPIONATE
INJECTABLE; INJECTION DEPO-ESTRADIOL PHARMACIA AND UPJOHN
1MG/ML 3MG/ML
A085470 A085470
001 002
ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE

INJECTABLE; INTRAMUSCULAR LUNELLE PHARMACIA AND UPJOHN 5MG/0.5ML;25MG/0.5ML
N020874
001
Oct 05, 2000

ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
INJECTABLE; INJECTION DEPO-TESTADIOL PHARMACIA AND UPJOHN 2MG/ML;50MG/ML TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE WATSON LABS 2MG/ML;50MG/ML
6 - 138 (of 360)
N017968 A085603
001 001 Mar 13, 1986
ESTRADIOL VALERATE
INJECTABLE; INJECTION ESTRADIOL VALERATE WATSON LABS
10MG/ML
A083546
001
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE

INJECTABLE; INJECTION DITATE-DS SAVAGE LABS 8MG/ML;180MG/ML TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE WATSON LABS 4MG/ML;90MG/ML 8MG/ML;180MG/ML
A086423 A085865 A085860
001 001 001
ESTROGENS, CONJUGATED
TABLET; ORAL PREMARIN WYETH PHARMS INC
2.5MG
N004782
002
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE

TABLET; ORAL-28 PREMPHASE (PREMARIN;CYCRIN 14/14) WYETH PHARMS INC 0.625MG,0.625MG;N/A,5MG PREMPRO (PREMARIN;CYCRIN) WYETH PHARMS INC 0.625MG,0.625MG;2.5MG,2.5MG
N020303 N020303
002 001
Dec 30, 1994 Dec 30, 1994
ESTROGENS, CONJUGATED; MEPROBAMATE

TABLET; ORAL MILPREM-200 MEDPOINTE PHARM HLC MILPREM-400 MEDPOINTE PHARM HLC PMB 200 WYETH AYERST PMB 400 WYETH AYERST
0.45MG;200MG 0.45MG;400MG 0.45MG;200MG 0.45MG;400MG
N011045 N011045 N010971 N010971
002 001 005 003
TABLET; ORAL AMNESTROGEN BRISTOL MYERS SQUIBB
0.3MG 0.625MG 1.25MG 2.5MG 0.625MG 1.25MG 2.5MG 1.25MG 0.3MG 0.625MG 1.25MG 2.5MG 0.625MG 1.25MG
A083266 A083266 A083266 A083266 A083414 A083765 A085907 A085302 A086715 A083209 A083856 A083857 A084215 A083376
001 002 003 004 001 001 001 001 001 001 001 001 001 002
ESTERIFIED ESTROGENS PVT FORM
SANDOZ ESTRATAB SOLVAY
EVEX ROCHE PALO

TABLET; ORAL FEMOGEN PVT FORM
6 - 139 (of 360)
0.625MG 1.25MG 2.5MG
A085076 A085008 A085007
001 001 001
ESTRONE
INJECTABLE; INJECTION ESTROGENIC SUBSTANCE WYETH AYERST 2MG/ML ESTRONE WATSON LABS 2MG/ML NATURAL ESTROGENIC SUBSTANCE-ESTRONE WATSON LABS 2MG/ML THEELIN PARKEDALE 1MG/ML 2MG/ML 5MG/ML
A083488 A083397 A085237 N003977 N003977 N003977
001 001 001 001 002 003 Nov 23, 1982
ESTROPIPATE
CREAM; VAGINAL OGEN PHARMACIA AND UPJOHN TABLET; ORAL ESTROPIPATE DURAMED PHARMS BARR
1.5MG/GM
A084710
001
MYLAN
0.75MG 1.5MG 3MG 3MG
A040296 A040296 A040296 A040359
001 002 003 003
Nov Nov Nov Aug
01, 01, 01, 26,
1999 1999 1999 1999
ESZOPICLONE
TABLET; ORAL ESZOPICLONE LUPIN LTD
TEVA
WOCKHARDT LTD
A091124 A091124 A091124 A091169 A091169 A091169 A091165 A091165 A091165
001 002 003 001 002 003 001 002 003
Sep Sep Sep May May May Jul Jul Jul
13, 13, 13, 23, 23, 23, 14, 14, 14,
2011 2011 2011 2011 2011 2011 2011 2011 2011
ETHACRYNIC ACID
TABLET; ORAL EDECRIN ATON
50MG
N016092
002
ETHAMBUTOL HYDROCHLORIDE
TABLET; ORAL MYAMBUTOL STI PHARMA LLC
200MG 500MG
N016320 N016320
002 004
ETHCHLORVYNOL
CAPSULE; ORAL ETHCHLORVYNOL BANNER PHARMACAPS
100MG 200MG 500MG 750MG
A084463 A084463 A084463 A084463
001 002 003 004

ETHCHLORVYNOL
CAPSULE; ORAL
PLACIDYL
ABBVIE
6 - 140 (of 360)
100MG 200MG 500MG 750MG
N010021 N010021 N010021 N010021
004
007
002
010
ETHINAMATE
CAPSULE; ORAL
VALMID
DISTA
500MG
N009750
001
ETHINYL ESTRADIOL
TABLET; ORAL
ESTINYL
SCHERING
0.02MG 0.05MG 0.5MG 0.05MG 0.01MG 0.05MG
N005292 N005292 N005292 N016649 N005490 N005490
001
002
003
001
003
002
FEMINONE
PHARMACIA AND UPJOHN LYNORAL
ORGANON USA INC
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE

TABLET; ORAL-21
DEMULEN 1/35-21
GD SEARLE LLC
0.035MG;1MG **Federal Register determination that product was not

0.05MG;1MG 0.035MG;1MG 0.05MG;1MG
N018168
001
DEMULEN 1/50-21 GD SEARLE LLC ZOVIA 1/35E-21 WATSON LABS ZOVIA 1/50E-21 WATSON LABS TABLET; ORAL-28 DEMULEN 1/35-28 GD SEARLE LLC DEMULEN 1/50-28 GD SEARLE LLC
N016927 A072720 A072722
001 001 001 Dec 30, 1991 Dec 30, 1991
0.035MG;1MG 0.05MG;1MG
N018160 N016936
001 001
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE

TABLET; ORAL-28 NORQUEST FE GD SEARLE LLC
0.035MG;75MG;1MG
N018926
001
Jul 18, 1986
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE

TABLET; ORAL-28
NORLESTRIN FE 1/50
PARKE DAVIS NORLESTRIN FE 2.5/50
PARKE DAVIS
0.05MG;75MG;1MG 0.05MG;75MG;2.5MG
N016766 N016854
001
001

TABLET; ORAL LYBREL WYETH PHARMS INC 0.02MG;0.09MG PREVEN EMERGENCY CONTRACEPTIVE KIT TEVA BRANDED PHARM 0.05MG;0.25MG
N021864 N020946
001 001
May 22, 2007 Sep 01, 1998

TABLET; ORAL-21
ALESSE
WYETH PHARMS
6 - 141 (of 360)
0.02MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 0.02MG;0.1MG
N020683
001
Mar 27, 1997
AVIANE-21 DURAMED PHARMS BARR ENPRESSE-21 DURAMED PHARMS BARR
A075796
002 001
Apr 30, 2001 Jul 16, 2001
0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A075809 25MG A075803 N020860 A075862 A073592 N018668 A075866 N019192
LESSINA-21 BARR 0.02MG;0.1MG LEVLITE BAYER HLTHCARE 0.02MG;0.1MG LEVONORGESTREL AND ETHINYL ESTRADIOL BARR 0.02MG;0.1MG LEVORA 0.15/30-21 WATSON LABS 0.03MG;0.15MG NORDETTE-21 TEVA BRANDED PHARM 0.03MG;0.15MG PORTIA-21 BARR 0.03MG;0.15MG TRIPHASIL-21 WYETH PHARMS 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TRIVORA-21 WATSON LABS 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 25MG TABLET; ORAL-28 ALESSE WYETH PHARMS 0.02MG;0.1MG LEVLITE BAYER HLTHCARE 0.02MG;0.1MG LEVONORGESTREL AND ETHINYL ESTRADIOL BARR 0.02MG;0.1MG TRIPHASIL-28 WYETH PHARMS INC 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 25MG
001 001 001 001 001 001 001
Mar 20, 2002 Jul 13, 1998 Apr 29, 2003 Dec 13, 1993 May 10, 1982 May 23, 2002 Nov 01, 1984
A074538
001
Dec 18, 1997
N020683 N020860 A075862 N019190
002 002 002 001
Mar 27, 1997 Jul 13, 1998 Apr 29, 2003 Nov 01, 1984

TABLET; ORAL-21 BALZIVA-21 BARR 0.035MG;0.4MG BREVICON 21-DAY WATSON LABS 0.035MG;0.5MG GENCEPT 10/11-21 BARR 0.035MG,0.035MG;0.5MG,1MG MODICON 21 ORTHO MCNEIL PHARM 0.035MG;0.5MG N.E.E. 1/35 21 LPI 0.035MG;1MG NORCEPT-E 1/35 21 ORTHO MCNEIL PHARM 0.035MG;1MG NORETHINDRONE AND ETHINYL ESTRADIOL WATSON LABS 0.035MG;0.5MG NORTREL 0.5/35-21 BARR 0.035MG;0.5MG ORTHO-NOVUM 1/35-21
ORTHO MCNEIL PHARM 0.035MG;1MG
A076198 N017566 A072694 N017488 A071541 A071545 A070684 A072692 N017489
001 001 001 001 001 001 001 001 002
Apr 22, 2004
Feb 28, 1992
Dec 14, 1987 Feb 09, 1989 Jan 29, 1987 Feb 28, 1992

TABLET; ORAL-21 ORTHO-NOVUM 10/11-21 ORTHO MCNEIL JANSSEN ORTHO-NOVUM 7/14-21 ORTHO MCNEIL PHARM ORTHO-NOVUM 7/7/7-21 JANSSEN PHARMS OVCON-35 WARNER CHILCOTT OVCON-50 WARNER CHILCOTT TRI-NORINYL 21-DAY WATSON LABS TABLET; ORAL-28 GENCEPT 10/11-28 BARR N.E.E. 1/35 28 LPI NORCEPT-E 1/35 28 ORTHO MCNEIL PHARM ORTHO-NOVUM 10/11-28 ORTHO MCNEIL JANSSEN ORTHO-NOVUM 7/14-28 ORTHO MCNEIL PHARM
6 - 142 (of 360)
0.035MG,0.035MG;0.5MG,1MG 0.035MG,0.035MG;0.5MG,1MG
N018354 N019004
001 001 001
Jan 11, 1982 Apr 04, 1984 Apr 04, 1984
0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M N018985 G 0.035MG;0.4MG 0.05MG;1MG N018127 N018128
001 001 001 Apr 13, 1984
0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG N018977
0.035MG,0.035MG;0.5MG,1MG 0.035MG;1MG 0.035MG;1MG 0.035MG,0.035MG;0.5MG,1MG 0.035MG,0.035MG;0.5MG,1MG
A072697 A071542 A071546 N018354 N019004
001 001 001 002 002
Feb 28, 1992 Dec 14, 1987 Feb 09, 1989 Jan 11, 1982 Apr 04, 1984
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

TABLET; ORAL-21 ESTROSTEP 21 WARNER CHILCOTT LLC NORLESTRIN 21 1/50 PARKE DAVIS NORLESTRIN 21 2.5/50 PARKE DAVIS TABLET; ORAL-28 NORLESTRIN 28 1/50 PARKE DAVIS
0.02MG,0.03MG,0.035MG;1MG,1MG,1MG 0.05MG;1MG 0.05MG;2.5MG
N020130 N016749 N016852
001 001 001
Oct 09, 1996
0.05MG;1MG
N016723
001
ETHINYL ESTRADIOL; NORGESTIMATE

TABLET; ORAL-21 ORTHO CYCLEN-21 JANSSEN PHARMS ORTHO TRI-CYCLEN JANSSEN PHARMS
0.035MG;0.25MG
N019653
001 002
Dec 29, 1989 Jul 03, 1992
0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, N019697 0.25MG
ETHINYL ESTRADIOL; NORGESTREL

TABLET; ORAL-21 LO/OVRAL WYETH PHARMS INC OGESTREL 0.5/50-21 WATSON LABS OVRAL WYETH PHARMS TABLET; ORAL-28 OVRAL-28 WYETH PHARMS
0.03MG;0.3MG 0.05MG;0.5MG 0.05MG;0.5MG
N017612 A075406 N016672
001 001 001 Dec 15, 1999
0.05MG;0.5MG
N016806
001
ETHIODIZED OIL
OIL; INTRALYMPHATIC
ETHIODOL
GUERBET
99%
N009190
001

ETHOPROPAZINE HYDROCHLORIDE
TABLET; ORAL PARSIDOL PARKE DAVIS
6 - 143 (of 360)
10MG 50MG 100MG
N009078 N009078 N009078
003 006 008
ETHOTOIN
TABLET; ORAL PEGANONE LUNDBECK LLC
500MG
N010841
003
ETHOXZOLAMIDE
TABLET; ORAL CARDRASE PHARMACIA AND UPJOHN ETHAMIDE ALLERGAN
62.5MG 125MG 125MG
N011047 N011047 N016144
002 001 001
ETHYLESTRENOL
ELIXIR; ORAL MAXIBOLIN ORGANON USA INC TABLET; ORAL MAXIBOLIN ORGANON USA INC
2MG/5ML
N014006
002
2MG
N014005
002
ETHYNODIOL DIACETATE; MESTRANOL

TABLET; ORAL-20 OVULEN GD SEARLE LLC TABLET; ORAL-21 OVULEN-21 GD SEARLE LLC TABLET; ORAL-28 OVULEN-28 GD SEARLE LLC
1MG;0.1MG
N016029
002
1MG;0.1MG
N016029
003
1MG;0.1MG
N016705
001
ETIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION DURANEST ASTRAZENECA
0.5% 1%
N017751 N017751
003 005
ETIDRONATE DISODIUM
INJECTABLE; INJECTION DIDRONEL MGI PHARMA INC
50MG/ML
N019545
001
Apr 20, 1987
ETODOLAC
CAPSULE; ORAL ETODOLAC AAIPHARMA LLC IVAX SUB TEVA PHARMS MYLAN
SANDOZ
A074929 A074899 A074899 A074932 A075071 A074932 A075071 A074840 A074942 A074840
001 001 002 001 001 002 002 001 001 002
Jan Jul Jul May Sep May Sep Aug Sep Aug
30, 08, 08, 16, 30, 16, 30, 29, 30, 29,
1998 1997 1997 1997 1998 1997 1998 1997 1997 1997

ETODOLAC
CAPSULE; ORAL ETODOLAC SANDOZ TEVA VINTAGE PHARMS LLC WATSON LABS LODINE WYETH PHARMS INC TABLET; ORAL ETODOLAC AAIPHARMA LLC IVAX SUB TEVA PHARMS MYLAN RANBAXY LABS LTD SANDOZ TEVA VINTAGE PHARMS LLC WATSON LABS
6 - 144 (of 360)
A074942 A075126 A074842 A074842 A074844 A074844 N018922 N018922
002 001 001 002 001 002 002 003
Sep Sep Jul Jul Dec Dec
30, 16, 17, 17, 23, 23,
1997 1999 1997 1997 1997 1997
Jan 31, 1991 Jan 31, 1991
001 001 002 001 002 001 002 001 001 001 002 001 001 001 002 004 005
Oct Feb Nov Sep Sep Nov Nov Jul Feb Apr Apr Jun Apr Apr Oct
30, 28, 20, 30, 30, 24, 24, 11, 28, 23, 23, 27, 16, 16, 29,
1997 1997 1998 1998 1998 1998 1998 1997 1997 1999 1999 1997 1997 1998 1998
400MG 500MG TABLET, EXTENDED RELEASE; ORAL ETODOLAC ACTAVIS ELIZABETH 400MG SANDOZ 400MG 500MG 600MG WATSON LABS FLORIDA 400MG 500MG LODINE XL WYETH PHARMS INC 400MG 500MG 600MG
LODINE WYETH PHARMS INC
Jul 29, 1993 Jun 28, 1996
A075696 A075943 A075943 A075943 A075829 A075829 N020584 N020584 N020584
001 001 002 003 001 002 001 003 002
Jul Jul Jul Jul Nov Nov
31, 26, 26, 26, 30, 30,
2000 2002 2002 2002 2001 2001
Oct 25, 1996 Jan 20, 1998 Oct 25, 1996
ETOPOSIDE
CAPSULE; ORAL VEPESID CORDEN PHARMA INJECTABLE; INJECTION ETOPOSIDE HOSPIRA MARSAM PHARMS LLC PIERRE FABRE TEVA PARENTERAL WATSON LABS TOPOSAR TEVA PARENTERAL VEPESID CORDEN PHARMA
50MG 100MG
N019557 N019557
001 002
Dec 30, 1986 Dec 30, 1986
20MG/ML 20MG/ML 20MG/ML 20MG/ML 20MG/ML 20MG/ML 20MG/ML 20MG/ML
A074320 A074351 A074968 A074813 A074510 A074228 A074166 N018768
001 001 001 001 001 001 001 001
Aug Aug Jan Jul Jun Oct
30, 30, 09, 09, 29, 15,
1995 1995 1998 1997 1995 1996
Feb 27, 1995 Nov 10, 1983

ETOPOSIDE PHOSPHATE
INJECTABLE; INJECTION ETOPOPHOS PRESERVATIVE FREE BRISTOL MYERS SQUIBB EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
6 - 145 (of 360)
N020906 N020906
001 002
Feb 27, 1998 Feb 27, 1998
ETRETINATE
CAPSULE; ORAL TEGISON ROCHE
10MG 25MG
N019369 N019369
001 002
Sep 30, 1986 Sep 30, 1986
EVANS BLUE
EVANS BLUE
PARKE DAVIS

reasons**
N008041
001
FAMOTIDINE
INJECTABLE; INJECTION FAMOTIDINE APOTEX INC APOTHECON HOSPIRA
10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML FAMOTIDINE PRESERVATIVE FREE APOTHECON 10MG/ML HOSPIRA 10MG/ML FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER ABBVIE 0.4MG/ML PEPCID MERCK 10MG/ML PEPCID PRESERVATIVE FREE MERCK 10MG/ML PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER MERCK 0.4MG/ML TABLET; ORAL FAMOTIDINE ACTAVIS ELIZABETH 20MG 40MG APOTEX 10MG MUTUAL PHARM 20MG 40MG MYLAN PHARMS INC 20MG 40MG SANDOZ 10MG 20MG 20MG 20MG 40MG 40MG 40MG TABLET, CHEWABLE; ORAL PEPCID AC MCNEIL CONS 10MG TABLET, ORALLY DISINTEGRATING; ORAL FLUXID UCB INC 20MG 40MG PEPCID RPD MERCK 20MG
A075942 A075707 A075705 A075870 A075905 A075708 A075669 A075729 N019510 N019510 N020249
001 001 001 001 001 001 001 001 001 004 001
Aug Apr Apr Nov Nov
02, 16, 16, 23, 23,
2002 2001 2001 2001 2001
Apr 16, 2001 Apr 16, 2001 Dec 17, 2001 Nov 04, 1986 Nov 04, 1986 Feb 18, 1994
A075650 A075650 A075610 A075639 A075639 A075457 A075457 A076101 A075302 A075607 A075793 A075302 A075607 A075793
001 002 001 002 001 001 002 001 001 001 001 002 002 002
Sep Sep Mar Dec Dec Apr Apr Oct Apr May Apr Apr May Apr
14, 14, 12, 12, 12, 18, 18, 21, 16, 10, 16, 16, 10, 16,
2001 2001 2002 2001 2001 2001 2001 2002 2001 2001 2001 2001 2001 2001
N020801
001
Sep 24, 1998
N021712 N021712 N020752
001 002 001
Sep 24, 2004 Sep 24, 2004 May 28, 1998

FAMOTIDINE
TABLET, ORALLY DISINTEGRATING; ORAL PEPCID RPD MERCK 40MG
6 - 146 (of 360)
N020752
002
May 28, 1998
FENOFIBRATE
CAPSULE; ORAL ANTARA (MICRONIZED) LUPIN ATLANTIS LIPIDIL ABBVIE LIPOFEN CIPHER PHARMS INC TRICOR (MICRONIZED) ABBVIE
87MG 100MG 100MG 67MG 134MG 200MG
N021695 N019304 N021612 N019304 N019304 N019304
002 001 002 002 003 004
Nov 30, 2004 Dec 31, 1993 Jan 11, 2006 Feb 09, 1998 Jun 30, 1999 Jun 30, 1999
TABLET; ORAL FENOFIBRATE MYLAN TRICOR ABBOTT
107MG 54MG 160MG
A076520 N021203 N021203
002 001 003
Dec 29, 2005 Sep 04, 2001 Sep 04, 2001
FENOLDOPAM MESYLATE
INJECTABLE; INJECTION FENOLDOPAM MESYLATE LUITPOLD TEVA PARENTERAL
A076656 A077826
001 001
Dec 01, 2003 Mar 07, 2007
FENOPROFEN CALCIUM
CAPSULE; ORAL FENOPROFEN CALCIUM AM THERAP HALSEY PAR PHARM QUANTUM PHARMICS SANDOZ WARNER CHILCOTT WATSON LABS
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Aug Aug Aug Aug Aug Aug Aug Aug Oct Oct Apr Apr Aug Aug Aug Aug
22, 22, 17, 17, 22, 22, 17, 17, 17, 17, 30, 30, 17, 19, 17, 19,
1988 1988 1988 1988 1988 1988 1988 1988 1988 1988 1991 1991 1988 1991 1988 1991
NALFON XSPIRE TABLET; ORAL FENOPROFEN CALCIUM ACTAVIS ELIZABETH AM THERAP CLONMEL HLTHCARE HALSEY MUTUAL PHARM PAR PHARM QUANTUM PHARMICS SANDOZ USL PHARMA WATSON LABS
EQ 300MG BASE
A072274 A072309 A072326 A072357 A072902 A072429 A072194 A072396 A072362 A072165
001 001 001 001 001 001 001 001 001 001
May Aug Aug Aug Dec Aug Aug Oct Aug Aug
02, 17, 17, 17, 21, 17, 17, 17, 17, 17,
1988 1988 1988 1988 1990 1988 1988 1988 1988 1988

FENOPROFEN CALCIUM
TABLET; ORAL FENOPROFEN CALCIUM WATSON LABS NALFON DISTA
6 - 147 (of 360)
A072407 A072602 N017710
001 001 001
Aug 17, 1988 Oct 11, 1988
FENTANYL CITRATE
INJECTABLE; INJECTION FENTANYL CITRATE ABBOTT
EQ 0.05MG BASE/ML EQ 0.05MG BASE/ML WATSON LABS EQ 0.05MG BASE/ML FENTANYL CITRATE PRESERVATIVE FREE MARSAM PHARMS LLC EQ 0.05MG BASE/ML TABLET; BUCCAL FENTORA CEPHALON EQ 0.3MG BASE TROCHE/LOZENGE; ORAL FENTANYL CEPHALON EQ 0.1MG BASE EQ 0.2MG BASE EQ 0.3MG BASE EQ 0.4MG BASE
A070636 A070637 A073488 A074917
001 001 001 001
Apr 30, 1990 Apr 30, 1990 Jun 30, 1992 Feb 03, 1998
N021947
006
Mar 02, 2007
N020195 N020195 N020195 N020195
007 001 002 003
Oct Oct Oct Oct
30, 04, 04, 04,
1995 1993 1993 1993
FENTANYL HYDROCHLORIDE
SYSTEM; IONTOPHORESIS, TRANSDERMAL IONSYS INCLINE THERAP 10.8MCG
N021338
001
May 22, 2006
FERRIC AMMONIUM CITRATE

FOR SOLUTION; ORAL FERRISELTZ OTSUKA
600MG/PACKET
N020292
001
Oct 14, 1997
FERROUS CITRATE, FE-59

INJECTABLE; INJECTION FERROUS CITRATE FE 59 MALLINCKRODT
25uCi/ML
N016729
001
FERROUS SULFATE; FOLIC ACID

CAPSULE; ORAL FOLVRON LEDERLE
182MG;0.33MG
N006012
003
FERUMOXIDES
INJECTABLE; INJECTION FERIDEX I.V. AMAG PHARMS INC
EQ 11.2MG IRON/ML
N020416
001
Aug 30, 1996
CAPSULE; ORAL ALLEGRA SANOFI AVENTIS US 60MG FEXOFENADINE HYDROCHLORIDE BARR 60MG
N020625 A076169
001 001
Jul 25, 1996 Jul 13, 2005
FIBRINOGEN, I-125
INJECTABLE; INJECTION IBRIN GE HEALTHCARE
154uCi/VIAL
N017879
001

FIBRINOGEN, I-125
INJECTABLE; INJECTION RADIONUCLIDE-LABELED (125 I) FIBRINOGEN (HUMAN) SENSOR ABBOTT 140uCi/ML
6 - 148 (of 360)
N017787
001
FINASTERIDE
TABLET; ORAL FINASTERIDE IVAX SUB TEVA PHARMS
5MG
A076340
001
Jun 19, 2006
FLAVOXATE HYDROCHLORIDE
TABLET; ORAL URISPAS ORTHO MCNEIL JANSSEN
100MG
N016769
001
FLECAINIDE ACETATE
TABLET; ORAL FLECAINIDE ACETATE SANDOZ
50MG 100MG 150MG 200MG
A076030 A076030 A076030 N018830
001 002 003 002
Oct 28, 2002 Oct 28, 2002 Oct 28, 2002 Oct 31, 1985
TAMBOCOR MEDICIS
FLOXURIDINE
INJECTABLE; INJECTION FUDR HOSPIRA
500MG/VIAL
N016929
001
FLUCONAZOLE
INJECTABLE; INJECTION FLUCONAZOLE IN SODIUM CHLORIDE 0.9% AGILA SPECLTS 200MG/100ML 400MG/200ML HOSPIRA 200MG/100ML 400MG/200ML TABLET; ORAL FLUCONAZOLE GEDEON RICHTER USA 50MG 100MG 150MG 200MG MYLAN PHARMS INC 50MG 100MG 150MG 200MG PLIVA 50MG 100MG 150MG 200MG RANBAXY LABS LTD 50MG 100MG 150MG 200MG ROXANE 50MG 100MG 150MG 200MG SANDOZ 50MG 100MG 150MG 200MG IN PLASTIC CONTAINER (2MG/ML) (2MG/ML) (2MG/ML) (2MG/ML)
A076889 A076889 A076617 A076617
001 002 001 002
Mar Mar Jul Jul
25, 25, 29, 29,
2005 2005 2004 2004
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004

FLUDARABINE PHOSPHATE
INJECTABLE; INJECTION FLUDARA GENZYME CORP TABLET; ORAL OFORTA SANOFI AVENTIS US
6 - 149 (of 360)
50MG/VIAL
N020038
001
Apr 18, 1991
10MG
N022273
001
Dec 18, 2008
INJECTABLE; INJECTION FLUDEOXYGLUCOSE F 18 DOWNSTATE CLINCL
4-40mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 4-90mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020306
001
Aug 19, 1994
N020306
002
Sep 25, 2001
TABLET; ORAL
FLORINEF
KING PHARMS
0.1MG
N010060
001
FLUMAZENIL
INJECTABLE; INJECTION FLUMAZENIL TEVA PARENTERAL
0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML)
A076589 A076589
002 001
Oct 12, 2004 Oct 12, 2004
FLUMETHASONE PIVALATE
CREAM; TOPICAL
LOCORTEN
NOVARTIS
0.03%
N016379
001
FLUNISOLIDE
SPRAY, METERED; NASAL NASALIDE IVAX RES NASAREL TEVA BRANDED PHARM
0.025MG/SPRAY 0.029MG/SPRAY
N018148 N020409
001 001 Mar 08, 1995
CREAM; TOPICAL FLUOCET ALPHARMA US PHARMS FLUOCINOLONE ACETONIDE ALPHARMA US PHARMS PERRIGO NEW YORK PHARMADERM PHARMAFAIR TARO
0.025% 0.01% 0.01% 0.025% 0.01% 0.025% 0.01% 0.025% 0.01% 0.01% 0.025% 0.01% 0.025% 0.025% 0.01%
001 001 001 001 001 001 001 001 001 001 001 001 001 002 001
Jan 16, 1984 Jan Mar Mar Dec Dec Aug Aug Oct Apr Oct Feb Mar 16, 04, 04, 16, 16, 02, 02, 31, 27, 31, 11, 28, 1984 1982 1982 1982 1982 1984 1984 1994 1982 1994 1985 1985
USL PHARMA FLUONID ALLERGAN HERBERT FLUOTREX SAVAGE LABS
Sep 06, 1984 May 06, 1983

CREAM; TOPICAL FLUOTREX SAVAGE LABS SYNALAR-HP MEDIMETRIKS PHARMS GEL; TOPICAL FLUONID ALLERGAN HERBERT OINTMENT; TOPICAL FLUOCINOLONE ACETONIDE PHARMADERM PHARMAFAIR USL PHARMA FLUONID ALLERGAN HERBERT FLUOTREX SAVAGE LABS SOLUTION; TOPICAL FLUOCINOLONE ACETONIDE ALPHARMA US PHARMS BAUSCH AND LOMB MORTON GROVE PHARMADERM PHARMAFAIR FLUONID ALLERGAN HERBERT FLUOTREX SAVAGE LABS
6 - 150 (of 360)
0.025% 0.2%
A088173 N016161
001 002
Mar 09, 1983
0.025%
A087300
001
May 27, 1982
0.025% 0.025% 0.025% 0.025% 0.025%
A088046 A088507 A088742 A087157 A088172
001 001 001 001 001
Dec 16, 1982 Feb 27, 1984 Feb 08, 1985 Sep 06, 1984 Mar 09, 1983
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
A087159 A040059 A088312 A088048 A088449 A087158 A088171
001 001 001 001 001 001 001
Jun Dec Jan Dec Feb
16, 20, 27, 16, 08,
1982 1993 1984 1982 1984
Mar 17, 1983 Mar 09, 1983
FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE

CREAM; TOPICAL NEO-SYNALAR MEDIMETRIKS PHARMS
0.025%;EQ 3.5MG BASE/GM
A060700
001
FLUOCINONIDE
CREAM; TOPICAL FLUOCINONIDE PERRIGO NEW YORK TARO FLUOCINONIDE EMULSIFIED G AND W LABS INC LIDEX MEDICIS LIDEX-E MEDICIS SOLUTION; TOPICAL FLUOCINONIDE TARO TEVA PHARMS
0.05% 0.05% BASE 0.05% 0.05% 0.05%
A071790 A071500 A074204 N016908 N016908
001 001 001 002 003
Jul 13, 1988 Jun 10, 1987 Jun 13, 1995
0.05% 0.05%
A072857 A072522
001 001
Aug 02, 1989 Sep 28, 1990
FLUORESCEIN SODIUM
INJECTABLE; INJECTION FUNDUSCEIN-25 NOVARTIS
25%
N017869
001
FLUOROMETHOLONE
CREAM; TOPICAL OXYLONE PHARMACIA AND UPJOHN 0.025% SUSPENSION/DROPS; OPHTHALMIC FLUOR-OP NOVARTIS 0.1%
N011748
001
A070185
001
Feb 27, 1986

FLUOROMETHOLONE ACETATE; TOBRAMYCIN
SUSPENSION/DROPS; OPHTHALMIC TOBRASONE ALCON 0.1%;0.3%
6 - 151 (of 360)
N050628
001
Jul 21, 1989
FLUOROMETHOLONE; SULFACETAMIDE SODIUM

SUSPENSION/DROPS; OPHTHALMIC FML-S ALLERGAN 0.1%;10%
N019525
001
Sep 29, 1989
FLUOROURACIL
INJECTABLE; INJECTION ADRUCIL PHARMACIA AND UPJOHN TEVA PARENTERAL FLUOROURACIL ABIC ABRAXIS PHARM
50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 500MG/10ML (50MG/ML)
A081222 N017959 A040023 A081225 A088929 A089152 A089428 A089519 A089508 A040291 A040379 A087791 A088766 A088767 A089434 A087792 N012209
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jun 28, 1991 Oct 18, 1991 Aug 28, 1991 Mar Mar Jan Mar Jan Mar Nov Jan Dec Dec Mar Oct 04, 21, 12, 12, 26, 24, 15, 18, 28, 28, 26, 13, 1986 1986 1987 1987 1988 1999 2000 1983 1984 1984 1987 1982
BEDFORD FRESENIUS KABI USA MARCHAR SMITH AND NEPHEW
SPECTRUM PHARMS VALEANT SOLUTION; TOPICAL FLUOROPLEX ELORAC
1%
N016765
001
CAPSULE; ORAL FLUOXETINE MUTUAL PHARMA WATSON LABS
EQ EQ EQ EQ
BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075787 A075787 A075662 A075662 A076251 A076922 A076922 A075807 A075807 N018936
001 002 001 002 001 001 002 001 002 004
Jan Jan Jan Jan May Dec Dec Jan Jan
29, 29, 29, 29, 18, 16, 16, 29, 29,
2002 2002 2002 2002 2005 2004 2004 2002 2002
FLUOXETINE HYDROCHLORIDE BARR EQ PAR PHARM EQ EQ SANDOZ EQ EQ PROZAC ELI LILLY AND CO EQ SOLUTION; ORAL FLUOXETINE HYDROCHLORIDE ACTAVIS MID ATLANTIC EQ HI TECH PHARMA EQ PROZAC LILLY EQ TABLET; ORAL FLUOXETINE HYDROCHLORIDE BARR EQ IVAX SUB TEVA PHARMS EQ EQ SANDOZ EQ
60MG BASE
Jun 15, 1999
20MG BASE/5ML 20MG BASE/5ML 20MG BASE/5ML
A075690 A075525 N020101
001 001 001
Jan 31, 2002 Jun 27, 2002 Apr 24, 1991
10MG 10MG 40MG 10MG
BASE BASE BASE BASE
A075810 A075865 A075865 A076024
001 001 003 001
Feb Feb Aug Jan
01, 28, 30, 29,
2002 2002 2004 2002

TABLET; ORAL PROZAC LILLY
6 - 152 (of 360)
N020974 N020974
001 002
Mar 09, 1999 Mar 09, 1999
FLUOXYMESTERONE
TABLET; ORAL ANDROID-F VALEANT PHARM INTL FLUOXYMESTERONE VALEANT PHARM INTL WATSON LABS
A087196 A088221 A088260 A088265 A088309 N010611 N010611 N010611 N011359 N011359
001 001 001 001 001 002 006 010 001 002 May Dec Dec Dec 05, 06, 06, 06, 1983 1983 1983 1983
HALOTESTIN PHARMACIA AND UPJOHN
ORA-TESTRYL BRISTOL MYERS SQUIBB
FLUPHENAZINE DECANOATE
INJECTABLE; INJECTION FLUPHENAZINE DECANOATE HOSPIRA TEVA PARENTERAL PROLIXIN DECANOATE BRISTOL MYERS SQUIBB
A074966 A074795 N016727
001 001 001
Apr 16, 1998 Sep 10, 1996
FLUPHENAZINE ENANTHATE
INJECTABLE; INJECTION PROLIXIN ENANTHATE APOTHECON
25MG/ML
N016110
001
CONCENTRATE; ORAL FLUPHENAZINE HYDROCHLORIDE TEVA PHARMS 5MG/ML PERMITIL SCHERING 5MG/ML PROLIXIN APOTHECON 5MG/ML ELIXIR; ORAL FLUPHENAZINE HYDROCHLORIDE TEVA PHARMS 2.5MG/5ML PROLIXIN APOTHECON 2.5MG/5ML INJECTABLE; INJECTION PROLIXIN APOTHECON 2.5MG/ML TABLET; ORAL FLUPHENAZINE HYDROCHLORIDE WATSON LABS 1MG 2.5MG 5MG 10MG PERMITIL SCHERING 0.25MG 2.5MG 5MG 10MG
A073058 N016008 A070533
001 001 001
Aug 30, 1991
Nov 07, 1985
A081310 N012145
001 003
Apr 29, 1993
N011751
005
A088555 A088544 A088527 A088550 N012034 N012034 N012034 N012034
001 001 001 001 001 004 005 006
Dec Dec Dec Dec
18, 18, 18, 18,
1987 1987 1987 1987

TABLET; ORAL PROLIXIN APOTHECON
6 - 153 (of 360)
1MG 2.5MG 5MG 10MG TABLET, EXTENDED RELEASE; ORAL PERMITIL SCHERING 1MG
N011751 N011751 N011751 N011751
004 001 003 002
N012419
004
FLUPREDNISOLONE
TABLET; ORAL ALPHADROL PHARMACIA AND UPJOHN
1.5MG
N012259
002
FLURANDRENOLIDE
LOTION; TOPICAL FLURANDRENOLIDE ALPHARMA US PHARMS OINTMENT; TOPICAL CORDRAN AQUA PHARMS
0.05%
A087203
001
Apr 29, 1982
0.025% 0.05%
N012806 N012806
004 001
FLURANDRENOLIDE; NEOMYCIN SULFATE

CREAM; TOPICAL CORDRAN-N LILLY OINTMENT; TOPICAL CORDRAN-N LILLY
N050346
001
N050345
001
FLURAZEPAM HYDROCHLORIDE
CAPSULE; ORAL DALMANE VALEANT PHARM INTL
15MG 30MG
N016721 N016721 A071808 A071809 A070454 A070455 A070444 A070445 A071927 A071551 A071716 A071717 A071659 A071660 A070562 A070563 A071767 A071768 A072368
001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jan Jan Aug Aug Mar Mar Sep Sep Jul Jul Aug Aug Jul Jul Dec Dec Mar 07, 07, 04, 04, 20, 20, 09, 09, 31, 31, 04, 04, 09, 09, 04, 04, 30, 1988 1988 1986 1986 1986 1986 1987 1987 1991 1991 1988 1988 1987 1987 1987 1987 1989
FLURAZEPAM HYDROCHLORIDE HALSEY 15MG 30MG MUTUAL PHARM 15MG 30MG PAR PHARM 15MG 30MG PUREPAC PHARM 15MG 30MG SANDOZ 15MG 30MG SUPERPHARM 15MG 30MG USL PHARMA 15MG 30MG WARNER CHILCOTT 15MG 30MG WATSON LABS 15MG
FLURBIPROFEN
TABLET; ORAL FLURBIPROFEN IVAX SUB TEVA PHARMS PLIVA
50MG 100MG 50MG
A074411 A074411 A074647
001 002 001
May 31, 1995 May 31, 1995 Apr 01, 1997

FLURBIPROFEN
TABLET; ORAL FLURBIPROFEN PLIVA SANDOZ TEVA THERAGEN
6 - 154 (of 360)
100MG 50MG 100MG 50MG 100MG 100MG
A074647 A074448 A074448 A074405 A074405 A074560
002 001 002 002 001 002
Apr Jul Jul May May May
01, 28, 28, 24, 24, 16,
1997 1995 1995 1995 1995 1997
FLUTAMIDE
CAPSULE; ORAL EULEXIN SCHERING FLUTAMIDE SANDOZ
125MG 125MG
N018554 A075818
001 001
Jan 27, 1989 Sep 18, 2001
AEROSOL, METERED; INHALATION FLOVENT GLAXOSMITHKLINE 0.044MG/INH 0.11MG/INH 0.22MG/INH CREAM; TOPICAL FLUTICASONE PROPIONATE NESHER PHARMS 0.05% OINTMENT; TOPICAL FLUTICASONE PROPIONATE TARO PHARM INDS 0.005% POWDER; INHALATION FLOVENT GLAXOSMITHKLINE 0.044MG/INH 0.088MG/INH 0.22MG/INH
N020548 N020548 N020548
001 002 003
Mar 27, 1996 Mar 27, 1996 Mar 27, 1996
A076865
001
Sep 10, 2004
A077145
001
Jun 14, 2005
N020549 N020549 N020549
001 002 003
Nov 07, 1997 Nov 07, 1997 Nov 07, 1997
FLUVOXAMINE MALEATE
TABLET; ORAL FLUVOXAMINE MALEATE ACTAVIS ELIZABETH
MUTUAL PHARM
MYLAN SANDOZ
SYNTHON PHARMS
WATSON LABS
001 002 003 001 002 003 001 002 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 004
Dec Dec Dec Mar Mar Mar Apr Apr Apr Oct Oct Jan Jan Jan Jan Jan Jan Apr Apr Apr Dec Dec Dec Dec
28, 28, 28, 12, 12, 12, 29, 29, 29, 15, 15, 05, 05, 05, 17, 17, 17, 18, 18, 18, 05, 05, 05, 05,
2000 2000 2000 2001 2001 2001 2002 2002 2002 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 1994 1994 1994 1994
LUVOX SOLVAY

FOLIC ACID
INJECTABLE; INJECTION FOLIC ACID BEN VENUE FOLVITE HIKMA (MAPLE) TABLET; ORAL FOLIC ACID BARR EVERYLIFE HALSEY IMPAX LABS IVAX SUB TEVA PHARMS LANNETT LILLY MK LABS MUTUAL PHARM NEXGEN PHARMA INC PHARMERAL PIONEER PHARMS PUREPAC PHARM SANDOZ TABLICAPS UDL USL PHARMA VALEANT PHARM INTL VANGARD VINTAGE PHARMS WATSON LABS WHITEWORTH TOWN PLSN FOLICET MISSION PHARMA FOLVITE HIKMA (MAPLE)
6 - 155 (of 360)
5MG/ML 5MG/ML
A081066 N005897
001 008
Dec 29, 1993
A089177 A080755 A083598 A080686 A083000 A080816 N006135 A083526 A040582 A084915 A084158 A088949 A080784 A084472 A083133 A088199 A087828 A080903 A088730 A086296 A083141 A085141 A080691 A087438 N005897
001 001 001 001 001 001 003 001 001 001 001 001 001 001 002 001 001 001 001 001 001 002 002 001 004
Jan 08, 1986
Jul 18, 2005
Sep 13, 1985
Mar 29, 1983 May 13, 1982 Mar 23, 1984
FOLLITROPIN ALFA/BETA
INJECTABLE; IM-SC FOLLISTIM ORGANON USA INC INJECTABLE; SUBCUTANEOUS FOLLISTIM AQ ORGANON USA INC GONAL-F EMD SERONO
75 IU/VIAL 150 IU/VIAL
N020582 N020582
001 002
Sep 29, 1997 Sep 29, 1997
150 IU/0.18ML 37.5 IU/VIAL 37.5 IU/VIAL 75 IU/VIAL 150 IU/VIAL 150 IU/VIAL
N021211 N020378 N021765 N020378 N020378 N021765
003 003 001 001 002 003
Feb 11, 2004 May Mar Sep Sep Mar 25, 25, 29, 29, 25, 2000 2004 1997 1997 2004
FOMIVIRSEN SODIUM
INJECTABLE; INJECTION VITRAVENE PRESERVATIVE FREE NOVARTIS 6.6MG/ML
N020961
001
Aug 26, 1998
FORMOTEROL FUMARATE
POWDER; INHALATION FORADIL CERTIHALER NOVARTIS
0.0085MG/INH
N021592
001
Dec 15, 2006

FOSINOPRIL SODIUM
TABLET; ORAL FOSINOPRIL SODIUM RANBAXY LABS LTD
6 - 156 (of 360)
SANDOZ
A076580 A076580 A076580 A076188 A076188 A076188 N019915 N019915 N019915
001 002 003 001 002 003 002 003 004
Apr Apr Apr Oct Oct Oct
23, 23, 23, 08, 08, 08,
2004 2004 2004 2004 2004 2004
MONOPRIL BRISTOL MYERS SQUIBB
May 16, 1991 May 16, 1991 Mar 28, 1995
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE

TABLET; ORAL FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE TEVA 10MG;12.5MG 20MG;12.5MG WATSON LABS 10MG;12.5MG 20MG;12.5MG MONOPRIL-HCT BRISTOL MYERS SQUIBB 10MG;12.5MG 20MG;12.5MG
A076945 A076945 A077144 A077144 N020286 N020286
001 002 001 002 002 001
Jul Jul Aug Aug
05, 05, 16, 16,
2006 2006 2005 2005
Nov 30, 1994 Nov 30, 1994
FOSPHENYTOIN SODIUM
INJECTABLE; INJECTION CEREBYX PARKE DAVIS FOSPHENYTOIN SODIUM TEVA PARENTERAL
EQ 50MG PHENYTOIN NA/ML EQ 50MG PHENYTOIN NA/ML
N020450 A076886
001 001
Aug 05, 1996 Aug 06, 2007
FOSPROPOFOL DISODIUM
SOLUTION; INTRAVENOUS LUSEDRA EISAI INC
1050MG/30ML (35MG/ML)
N022244
001
Dec 12, 2008
FURAZOLIDONE
SUSPENSION; ORAL FUROXONE SHIRE TABLET; ORAL FUROXONE SHIRE
50MG/15ML
N011323
002
100MG
N011270
002
FUROSEMIDE
INJECTABLE; INJECTION FUROSEMIDE ABRAXIS PHARM ASTRAZENECA
HIKMA MAPLE HOSPIRA
MARSAM PHARMS LLC ORGANON USA INC SMITH AND NEPHEW WARNER CHILCOTT
10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML
N018507 N019036 A070014 A070095 A070096 A071439 N018267 A070578 A072080 A074337 A074017 A070017 A070023 A070078 N018420
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul Aug Sep Sep Sep Sep Jul Aug Oct Jun Dec Feb Feb Feb
30, 13, 09, 09, 09, 14, 08, 13, 31, 30, 15, 05, 05, 26,
1982 1984 1985 1985 1985 1990 1987 1991 1994 1994 1986 1986 1986 1982

FUROSEMIDE
INJECTABLE; INJECTION FUROSEMIDE WATSON LABS WYETH AYERST LASIX SANOFI AVENTIS US SOLUTION; ORAL LASIX SANOFI AVENTIS US TABLET; ORAL FUROSEMIDE INTL MEDICATION KALAPHARM MUTUAL PHARM
6 - 157 (of 360)
A070019 A070604 N018670 N016363
001 001 001 001
Sep 22, 1986 Jan 02, 1987 Jul 20, 1982
10MG/ML
N017688
001
SANDOZ SUPERPHARM WARNER CHILCOTT
WATSON LABS
N018753 N018753 N018868 N018868 A070043 N018790 A070100 N018750 N018370 N018370 N018419 N018419 N018419 N018369 A070413 N018369
001 002 001 002 001 001 001 002 002 001 001 002 003 001 001 002
Feb Feb Jun Jun Sep Nov Jan Jul Jun Feb Jan Jan Nov May Feb May
28, 28, 28, 28, 26, 29, 26, 30, 26, 10, 31, 31, 13, 14, 26, 14,
1984 1984 1983 1983 1985 1983 1988 1984 1984 1983 1983 1983 1984 1982 1986 1982
GABAPENTIN
CAPSULE; ORAL GABAPENTIN IVAX SUB TEVA PHARMS
MUTUAL PHARM
SANDOZ
A075477 A075477 A075477 A076537 A076537 A076537 A075428 A075539 A075428 A075539 A075428 A075539
001 002 003 001 002 003 001 001 002 002 003 003
Mar Mar Mar Jun Jun Jun Jan Apr Jan Apr Jan Apr
23, 23, 23, 30, 30, 30, 24, 06, 24, 06, 24, 06,
2005 2005 2005 2005 2005 2005 2006 2005 2006 2005 2006 2005
TABLET; ORAL GABAPENTIN RANBAXY SANDOZ
TEVA
A076605 A076605 A076120 A076877 A076120 A076877 A075827 A075827
001 002 001 001 002 002 001 002
Sep Sep Jan Jul Jan Jul Dec Dec
14, 14, 27, 06, 27, 06, 15, 15,
2005 2005 2006 2006 2006 2006 2004 2004
GADODIAMIDE
INJECTABLE; INJECTION OMNISCAN GE HEALTHCARE
14.35GM/50ML (287MG/ML)
N022066
001
Sep 05, 2007

TABLET; ORAL
ACTAVIS ELIZABETH EQ EQ EQ YABAO BIOPHARMS EQ EQ EQ
6 - 158 (of 360)
A077585 A077585 A077585 A077604 A077604 A077604
001 002 003 001 002 003
Sep Sep Sep Feb Feb Feb
15, 15, 15, 06, 06, 06,
2009 2009 2009 2009 2009 2009
GALLAMINE TRIETHIODIDE
FLAXEDIL
DAVIS AND GECK
20MG/ML 100MG/ML
N007842 N007842
001
002
GALLIUM CITRATE GA-67

GALLIUM CITRATE GA 67
GE HEALTHCARE NEOSCAN
GE HEALTHCARE
1mCi/ML 2mCi/ML
N017700 N017655
001
001
GANCICLOVIR
CAPSULE; ORAL
CYTOVENE
ROCHE PALO
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 250MG 500MG
N020460
001
Dec 22, 1994
N020460
002
Dec 12, 1997
GANCICLOVIR RANBAXY LABS LTD
A076457 A076457
001 002
Jun 27, 2003 Jun 27, 2003
GANCICLOVIR SODIUM
INJECTABLE; INJECTION GANCICLOVIR SODIUM BEDFORD
EQ 500MG BASE/VIAL
A076222
001
Jul 16, 2003
GEFITINIB
TABLET; ORAL IRESSA ASTRAZENECA
250MG
N021399
001
May 05, 2003
GEMFIBROZIL
CAPSULE; ORAL GEMFIBROZIL MYLAN PUREPAC PHARM LOPID PFIZER PHARMS TABLET; ORAL GEMFIBROZIL MYLAN PUREPAC PHARM SANDOZ WATSON LABS
300MG 300MG 200MG 300MG
A073466 A072929 N018422 N018422
001 001 001 002
Jan 25, 1993 Jan 29, 1993
600MG 600MG 600MG 600MG
A074452 A074360 A074615 A074156
001 001 001 001
Feb Aug Sep Oct
16, 31, 29, 24,
1995 1994 1995 1994

GEMTUZUMAB OZOGAMICIN
INJECTABLE; INJECTION MYLOTARG WYETH PHARMS INC
6 - 159 (of 360)
5MG/VIAL
N021174
001
May 17, 2000
GENTAMICIN SULFATE
CREAM; TOPICAL GARAMYCIN SCHERING GENTAFAIR PHARMAFAIR GENTAMICIN SULFATE ALPHARMA US PHARMS BAUSCH AND LOMB PHARMADERM INJECTABLE; INJECTION APOGEN KING PHARMS BRISTAGEN BRISTOL GARAMYCIN SCHERING
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 1MG BASE/GM
A060462 A062458 A062471 A064056 A062530
001 001 001 001 001 Sep 01, 1983 Sep 27, 1983 Apr 29, 1994 Jul 05, 1984
EQ 10MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML EQ 1MG BASE/ML EQ 10MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML EQ 1MG BASE/ML EQ 40MG BASE/ML EQ 100MG BASE/100ML
001 002 001 002 001 001 001 003 001 004 001 002 003 004 005 006 007 008 009 010 002 001 001 001 001 002 001 002 002 001 001 002 001 002 003 004 005 006 007 008 Aug 28, 1985 Jun 23, 1982 Jun 23, 1982 Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983
GENTAFAIR PHARMAFAIR GENTAMICIN INTL MEDICATION
EQ 1.2MG BASE/ML EQ 1.4MG BASE/ML EQ 1.6MG BASE/ML EQ 1.8MG BASE/ML EQ 2MG BASE/ML EQ 60MG BASE/100ML EQ 70MG BASE/100ML EQ 80MG BASE/100ML EQ 90MG BASE/100ML EQ 100MG BASE/100ML HIKMA MAPLE EQ 10MG BASE/ML EQ 40MG BASE/ML KALAPHARM EQ 40MG BASE/ML PHARM SPEC EQ 40MG BASE/ML SOLOPAK EQ 10MG BASE/ML EQ 40MG BASE/ML TEVA PARENTERAL EQ 10MG BASE/ML EQ 40MG BASE/ML WATSON LABS EQ 10MG BASE/ML EQ 40MG BASE/ML WYETH AYERST EQ 10MG BASE/ML EQ 40MG BASE/ML GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA EQ 1.2MG BASE/ML EQ 1.4MG BASE/ML EQ 1.6MG BASE/ML EQ 1.8MG BASE/ML EQ 2MG BASE/ML EQ 60MG BASE/100ML EQ 70MG BASE/100ML EQ 80MG BASE/100ML
GENTAMICIN SULFATE ABBOTT
Apr Mar Jun Jun Nov Nov
05, 28, 06, 06, 21, 21,
1982 1983 1985 1985 1991 1991
Jan Jan Jan Jan Jan Jan Jan Jan
06, 06, 06, 06, 06, 06, 06, 06,
1986 1986 1986 1986 1986 1986 1986 1986

GENTAMICIN SULFATE
INJECTABLE; INJECTION GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA EQ 90MG BASE/100ML EQ 100MG BASE/100ML U-GENCIN PHARMACIA AND UPJOHN EQ 10MG BASE/ML EQ 40MG BASE/ML INJECTABLE; INTRATHECAL GARAMYCIN SCHERING EQ 2MG BASE/ML OINTMENT; OPHTHALMIC GARAMYCIN SCHERING EQ 0.3% BASE GENTACIDIN NOVARTIS EQ 0.3% BASE GENTAFAIR PHARMAFAIR EQ 3MG BASE/GM OINTMENT; TOPICAL GARAMYCIN SCHERING EQ 0.1% BASE GENTAFAIR PHARMAFAIR EQ 0.1% BASE GENTAMICIN SULFATE ALPHARMA US PHARMS EQ 0.1% BASE BAUSCH AND LOMB EQ 0.1% BASE PHARMADERM EQ 0.1% BASE SOLUTION/DROPS; OPHTHALMIC GARAMYCIN SCHERING EQ 0.3% BASE GENTACIDIN NOVARTIS EQ 0.3% BASE GENTAFAIR PHARMAFAIR EQ 0.3% BASE GENTAMICIN SULFATE ALCON PHARMS LTD EQ 0.3% BASE PACO EQ 3MG BASE/ML
6 - 160 (of 360)
A062588 A062588 A062248 A062248
009 010 001 002
Jan 06, 1986 Jan 06, 1986
N050505
001
N050425 A062501 A062443
001 001 001 Jul 26, 1984 May 26, 1983
A060463 A062444 A062496 A064054 A062534
001 001 001 001 001 May 26, 1983 Mar 14, 1984 Apr 29, 1994 Oct 10, 1984
N050039 A062480 A062440 A062523 A062932
002 001 001 001 001 Mar 30, 1984 May 03, 1983 Nov 25, 1985 Nov 07, 1988
GENTIAN VIOLET
SUPPOSITORY; VAGINAL GVS SAVAGE LABS TAMPON; VAGINAL GENAPAX KEY PHARMS
0.4%
A083513
001
5MG
A085017
001
GLATIRAMER ACETATE
FOR SOLUTION; SUBCUTANEOUS COPAXONE TEVA 20MG/VIAL
N020622
001
Dec 20, 1996
GLIMEPIRIDE
TABLET; ORAL GLIMEPIRIDE RANBAXY RANBAXY LABS LTD
A077366 A077366 A076875 A076875 A076875 A076875
001 002 001 002 003 004
Oct Oct Oct Oct Oct Oct
06, 06, 06, 06, 06, 06,
2005 2005 2005 2005 2005 2005

GLIPIZIDE
TABLET; ORAL GLIPIZIDE PLIVA SANDOZ TEVA VINTAGE PHARMS LLC GLUCOTROL PFIZER
6 - 161 (of 360)
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 2.5MG
A074619 A074619 A074542 A074542 A074387 A074387 A074378 A074378 N017783
001 002 001 002 001 002 001 002 003
Apr Apr Jun Jun Mar Mar Nov Nov
04, 04, 20, 20, 04, 04, 28, 28,
1997 1997 1995 1995 1996 1996 1994 1994
May 11, 1993

TABLET; ORAL METAGLIP BRISTOL MYERS SQUIBB
2.5MG;250MG 2.5MG;500MG 5MG;500MG
N021460 N021460 N021460
001 002 003
Oct 21, 2002 Oct 21, 2002 Oct 21, 2002
GLUCAGON HYDROCHLORIDE
INJECTABLE; INJECTION GLUCAGON LILLY
N012122 N012122
001 002
GLUTETHIMIDE
CAPSULE; ORAL DORIDEN SANOFI AVENTIS US TABLET; ORAL DORIDEN SANOFI AVENTIS US GLUTETHIMIDE HALSEY LANNETT SANDOZ UCB INC VITARINE WATSON LABS
500MG
N009519
008
N009519 N009519 A089458 A089459 A083475 A085571 A083234 A085171 A087297 A084362 A085763
002 005 001 001 001 001 002 001 001 001 001 Oct 10, 1986 Oct 10, 1986
GLYBURIDE
TABLET; ORAL GLYBURIDE ACTAVIS TOTOWA
1.5MG 3MG 6MG 1.5MG 3MG 1.5MG 3MG 6MG 4.5MG 1.25MG 2.5MG
A075947 A075947 A075947 A075174 A075174 N020055 N020055 N020055 N020051 N017498 N017498
001 002 003 001 002 001 002 003 003 001 002
Nov 14, 2002 Nov 14, 2002 Nov 14, 2002 Jun Jun Apr Apr Mar 22, 22, 17, 17, 08, 1998 1998 1992 1992 2000
GLYBURIDE (MICRONIZED) SANDOZ SANOFI AVENTIS US
GLYNASE PHARMACIA AND UPJOHN MICRONASE PHARMACIA AND UPJOHN
Sep 24, 1993 May 01, 1984 May 01, 1984

GLYBURIDE
TABLET; ORAL MICRONASE PHARMACIA AND UPJOHN
6 - 162 (of 360)
5MG
N017498
003
May 01, 1984
GLYBURIDE; METFORMIN HYDROCHLORIDE

TABLET; ORAL GLYBURIDE AND METFORMIN HYDROCHLORIDE TEVA 1.25MG;250MG 2.5MG;500MG 5MG;500MG
A076821 A076821 A076821
001 002 003
Jan 27, 2005 Jan 27, 2005 Jan 27, 2005
GLYCINE
SOLUTION; IRRIGATION GLYCINE 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 1.5GM/100ML HOSPIRA 1.5GM/100ML
N018522 N017633
001 001
Feb 19, 1982
GLYCOPYRROLATE
INJECTABLE; INJECTION GLYCOPYRROLATE ABRAXIS PHARM HOSPIRA TEVA PARENTERAL WATSON LABS ROBINUL ROBINS AH TABLET; ORAL GLYCOPYRROLATE WATSON LABS
0.2MG/ML 0.2MG/ML 0.2MG/ML 0.2MG/ML 0.2MG/ML
A088475 A089393 A081169 A086947 N014764
001 001 001 001 001
Jun Jun Sep Jun
12, 15, 10, 24,
1984 1988 1991 1983
1MG 1MG 2MG 2MG 2MG
A085562 A086902 A085563 A086178 A086900
001 001 001 001 001
GONADORELIN ACETATE
INJECTABLE; INJECTION LUTREPULSE KIT FERRING
0.8MG/VIAL 3.2MG/VIAL
N019687 N019687
001 002
Oct 10, 1989 Oct 10, 1989
GONADORELIN HYDROCHLORIDE
INJECTABLE; INJECTION FACTREL HIKMA (MAPLE)
EQ 0.1MG BASE/VIAL EQ 0.2MG BASE/VIAL EQ 0.5MG BASE/VIAL
N018123 N018123 N018123
001 002 003
Sep 30, 1982 Sep 30, 1982 Sep 30, 1982
INJECTABLE; INJECTION A.P.L. FERRING
5,000 UNITS/VIAL 10,000 UNITS/VIAL 20,000 UNITS/VIAL
N017055 N017055 N017055 N017054 N017054 N017016 N017016 N017016 N017016 N017016 N017067
001
002
003
001
002
009 011 006 010 004 001
CHORIONIC GONADOTROPIN
BEL MAR 5,000 UNITS/VIAL 10,000 UNITS/VIAL FERRING 2,000 UNITS/VIAL 2,000 UNITS/VIAL 5,000 UNITS/VIAL 15,000 UNITS/VIAL 20,000 UNITS/VIAL FRESENIUS KABI USA 5,000 UNITS/VIAL
Dec 27, 1984 Feb 16, 1990 Feb 15, 1985

CHORIONIC GONADOTROPIN
FRESENIUS KABI USA 15,000 UNITS/VIAL 20,000 UNITS/VIAL FOLLUTEIN
BRISTOL MYERS SQUIBB 10,000 UNITS/VIAL
6 - 163 (of 360)
N017067 N017067 N017056
004
003
001
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

SOLUTION/DROPS; OPHTHALMIC NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN IPHARM 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML WATSON LABS 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN PHARMAFAIR 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML NEO-POLYCIN DOW PHARM 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
A062818 A062788
001 001
Oct 11, 1988 Jun 11, 1987
A062383
001
Aug 31, 1982
A060427
001
INJECTABLE; INJECTION GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE TEVA PARENTERAL EQ 1MG BASE/ML (EQ 1MG BASE/ML) KYTRIL ROCHE EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 3MG BASE/ML EQ 4MG BASE/4ML (EQ 1MG BASE/ML) SOLUTION; ORAL KYTRIL ROCHE EQ 2MG BASE/10ML TABLET; ORAL GRANISETRON HYDROCHLORIDE BARR EQ 1MG BASE KYTRIL ROCHE EQ 1MG BASE EQ 2MG BASE
A077165 N020239 N020239 N020239 N020239
001 003 004 001 002
Dec 31, 2007 Sep Mar Dec Mar 17, 11, 29, 11, 2004 1994 1993 1994
N021238
001
Jun 27, 2001
A078221 N020305 N020305
001 001 002
Dec 31, 2007 Mar 16, 1995 Jun 15, 1998
GREPAFLOXACIN HYDROCHLORIDE
TABLET; ORAL
RAXAR
OTSUKA
N020695 N020695 N020695
001 002 003
Nov 06, 1997 May 14, 1998 May 14, 1998
GRISEOFULVIN, MICROCRYSTALLINE
CAPSULE; ORAL
GRISACTIN
WYETH AYERST SUSPENSION; ORAL
GRIFULVIN V
JOHNSON AND JOHNSON TABLET; ORAL
FULVICIN-U/F
ELORAC GRIFULVIN V
J AND J
125MG 250MG
N050051 N050051
002
001
125MG/5ML
N050448
001
250MG 500MG 125MG 250MG 500MG
A060569 A060569 A060618 A060618 A060618
002
001
001
002
003

GRISEOFULVIN, MICROCRYSTALLINE
TABLET; ORAL
GRIFULVIN V
VALEANT LUXEMBOURG
6 - 164 (of 360)
125MG 250MG **Federal Register determination that product was not discontinued or
reasons**
500MG
A062279 A062279
001
002
GRISACTIN
WYETH AYERST
A060212
001
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
TABLET; ORAL FULVICIN P/G ELORAC FULVICIN P/G 165 ELORAC FULVICIN P/G 330 ELORAC GRISACTIN ULTRA WYETH AYERST
A061996 A061996 A061996 A061996 A062178 A062438 A062178 A062438 A062645 A062646
001 002 003 004 001 001 002 002 001 001 Apr 06, 1982 Apr 06, 1982
Nov 17, 1983 Nov 17, 1983 Jun 30, 1992 Jun 30, 1992
ULTRAGRIS-165 PLIVA ULTRAGRIS-330 PLIVA
GUANABENZ ACETATE
TABLET; ORAL
GUANABENZ ACETATE
SANDOZ TEVA PHARMS WATSON LABS WYTENSIN WYETH AYERST
EQ EQ EQ EQ EQ EQ
A074517 A074517 A074267 A074267 A074025 A074025 N018587 N018587 N018587
001 002 001 002 001 002 001 002 003
Sep Sep Jun Jun Feb Feb
30, 30, 01, 01, 28, 28,
1998 1998 1994 1994 1994 1994
Sep 07, 1982 Sep 07, 1982 Sep 07, 1982
GUANADREL SULFATE
TABLET; ORAL HYLOREL PHARMACIA AND UPJOHN
10MG 25MG
N018104 N018104
001 002
Dec 29, 1982 Dec 29, 1982
GUANETHIDINE MONOSULFATE
TABLET; ORAL GUANETHIDINE MONOSULFATE WATSON LABS EQ EQ ISMELIN NOVARTIS EQ EQ
10MG SULFATE 25MG SULFATE 10MG SULFATE 25MG SULFATE
A086113 A086114 N012329 N012329
001 001 001 002
Mar 26, 1985 Mar 26, 1985
GUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE

TABLET; ORAL ESIMIL NOVARTIS
10MG;25MG
N013553
001

GUANFACINE HYDROCHLORIDE
TABLET; ORAL GUANFACINE HYDROCHLORIDE WATSON LABS EQ 1MG BASE EQ 2MG BASE TENEX PROMIUS PHARMA EQ 3MG BASE
6 - 165 (of 360)
A074762 A074762 N019032
001 002 003
Jun 25, 1997 Jun 25, 1997 Nov 07, 1988
HALAZEPAM
TABLET; ORAL PAXIPAM SCHERING
20MG 40MG
N017736 N017736
003 004
HALCINONIDE
CREAM; TOPICAL HALOG WESTWOOD SQUIBB HALOG-E RANBAXY OINTMENT; TOPICAL HALOG BRISTOL MYERS SQUIBB SOLUTION; TOPICAL HALOG RANBAXY
0.025% 0.1%
N017818 N018234
001 001
0.025%
N018125
001
0.1%
N017823
001
OINTMENT; TOPICAL HALOBETASOL PROPIONATE VENUS PHARMS
0.05%
A077109
001
Jun 14, 2005
HALOFANTRINE HYDROCHLORIDE
TABLET; ORAL HALFAN GLAXOSMITHKLINE
250MG
N020250
001
Jul 24, 1992
HALOPERIDOL
TABLET; ORAL HALDOL ORTHO MCNEIL
0.5MG 1MG 2MG 5MG 10MG 20MG 1MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG
N015921 N015921 N015921 N015921 N015921 N015921 N017079 A071216 A071217 A071218 A071219 A071220 A071221 A072727 A072728 A072729 A072730 A072731 A072732 A071156 A071157
001 002 003 004 005 006 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Feb 02, 1982
HALDOL SOLUTAB ORTHO MCNEIL PHARM HALOPERIDOL DURAMED PHARMS BARR
LEDERLE
MUTUAL PHARM
Dec Dec Dec Dec Jul Jul Sep Sep Sep Sep Sep Sep Jan Jan
04, 04, 04, 04, 07, 07, 19, 19, 19, 19, 19, 19, 02, 02,
1986 1986 1986 1986 1987 1987 1989 1989 1989 1989 1989 1989 1987 1987

HALOPERIDOL
TABLET; ORAL HALOPERIDOL MUTUAL PHARM
6 - 166 (of 360)
PAR PHARM PUREPAC PHARM
QUANTUM PHARMICS
ROXANE
ROYCE LABS
SCS
VINTAGE
WATSON LABS
2MG 5MG 10MG 20MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 0.5MG 0.5MG 1MG 1MG 2MG 2MG 5MG 5MG 10MG 10MG 20MG 20MG
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jan Jan Jan Jan Jul Nov Nov Nov Nov Aug Aug Feb Feb Feb Feb Feb Feb Feb Feb May May Dec Dec Dec Dec Dec Dec Jun Jun Jun Jun Jun Sep Nov Nov Nov Nov Jul Mar Jun Mar Jun Mar Jun Mar Jun Jun Aug Jun Aug
02, 07, 07, 07, 20, 03, 03, 03, 03, 04, 04, 17, 17, 17, 17, 17, 17, 17, 17, 12, 12, 24, 24, 24, 24, 24, 24, 10, 10, 10, 10, 10, 24, 03, 03, 03, 03, 20, 06, 03, 06, 03, 06, 03, 06, 03, 03, 27, 03, 27,
1987 1988 1988 1988 1987 1986 1986 1986 1986 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1987 1987 1988 1987 1988 1987 1988 1987 1988 1988 1991 1988 1991
HALOPERIDOL DECANOATE
INJECTABLE; INJECTION HALOPERIDOL DECANOATE HOSPIRA SANDOZ
EQ EQ EQ EQ
A075176 A075176 A076463 A076463
001 002 001 002
Feb Feb Jun Jun
09, 09, 24, 24,
2000 2000 2005 2005

HALOPERIDOL LACTATE
CONCENTRATE; ORAL HALDOL ORTHO MCNEIL HALOPERIDOL ALPHARMA MORTON GROVE SCS TEVA HALOPERIDOL INTENSOL ROXANE INJECTABLE; INJECTION HALOPERIDOL ABRAXIS PHARM MARSAM PHARMS LLC SANDOZ SMITH AND NEPHEW SOLOPAK
6 - 167 (of 360)
N015922 A070318 A070710 A070726 A071015 A072045
001 001 001 001 001 001 Apr Mar Jun Aug 11, 07, 10, 25, 1986 1986 1986 1987
EQ 2MG BASE/ML
Apr 12, 1988
WATSON LABS
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A071187 A072516 A072517 A076464 A070802 A070800 A070801 A070864 A070713 A070714 A070744
001 001 001 001 001 001 001 001 001 001 001
Jan Feb Feb Sep Dec Dec Dec Dec May May May
20, 25, 25, 29, 14, 14, 14, 14, 17, 17, 17,
1987 1993 1993 2004 1987 1987 1987 1987 1988 1988 1988
SOLUTION; ORAL HALOPERIDOL LACTATE ACTAVIS MID ATLANTIC
EQ 1MG BASE/ML
A074536
001
Nov 02, 1995
HALOPROGIN
CREAM; TOPICAL HALOTEX WESTWOOD SQUIBB SOLUTION; TOPICAL HALOTEX WESTWOOD SQUIBB
1%
N016942
001
1%
N016943
001
HALOTHANE
LIQUID; INHALATION FLUOTHANE WYETH AYERST HALOTHANE BH HALOCARBON HOSPIRA
99.99% 99.99% 99.99% 99.99%
N011338 A084977 A080810 A083254
001 001 001 001
HEPARIN CALCIUM
INJECTABLE; INJECTION CALCIPARINE SANOFI AVENTIS US
25,000 UNITS/ML
N018237
001
HEPARIN SODIUM
INJECTABLE; INJECTION HEPARIN LOCK FLUSH HOSPIRA INTL MEDICATION LUITPOLD PARKE DAVIS SMITH AND NEPHEW
100 UNITS/ML 10 UNITS/ML 500 UNITS/ML 10 UNITS/ML 100 UNITS/ML 10 UNITS/ML 10 UNITS/ML 10 UNITS/ML 10 UNITS/ML 10 UNITS/ML
N005264 A086357 A086357 A089063 A089064 N017346 A087904 A087958 A088458 A088580
010 001 002 001 001 006 001 001 001 001
Oct 09, 1985 Oct 09, 1985 Apr Apr Jul Oct 20, 20, 26, 25, 1983 1983 1984 1984

HEPARIN SODIUM
INJECTABLE; INJECTION HEPARIN LOCK FLUSH SMITH AND NEPHEW
6 - 168 (of 360)
SOLOPAK
100 UNITS/ML 100 UNITS/ML 100 UNITS/ML 100 UNITS/ML 10 UNITS/ML 10 UNITS/ML 100 UNITS/ML 100 UNITS/ML 1,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 40,000 UNITS/ML 5,000 UNITS/0.5ML 1,000 UNITS/ML 2,500 UNITS/ML 5,000 UNITS/ML 5,000 UNITS/0.5ML 7,500 UNITS/ML 10,000 UNITS/ML 15,000 UNITS/ML 20,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 40,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 2,500 UNITS/ML 10,000 UNITS/ML 1,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 1,000 UNITS/ML 1,000 UNITS/ML 1,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 7,500 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML
A087906 A087959 A088460 A088581 A087903 A088457 A087905 A088459 N017033 N017979 N017979 N017979 N017486 N017486 N017486 N017486 N017486 N017037 N017007 N017007 N017007 N017007 N017007 N017007 N017007 N017007 N017130 N017130 N017130 N017130 N017540 N017540 N017540 N017540 N017540 N017651 N017029 N017651 N017651 A088099 A040095 N005521 N005521 N005521 A087452 A040007 A040008 N000552 N000552 N000552 N017346 N017346 N017346 N017346 N017346 N017780 N017780 N017780 N017780
001 001 001 001 001 001 001 001 001 001 003 002 001 002 003 004 005 013 001 007 002 010 003 004 005 006 001 002 003 004 001 002 003 004 005 005 002 003 008 001 001 001 002 004 001 001 001 008 009 010 001 002 003 004 005 001 002 003 004
Apr Apr Jul Oct Apr Oct Apr Jul
20, 20, 26, 25, 20, 25, 20, 26,
1983 1983 1984 1984 1983 1984 1983 1984
HEPARIN SODIUM ABRAXIS PHARM
AKORN
BAXTER HLTHCARE BAXTER HLTHCARE CORP
Apr 07, 1986
CHAMBERLIN PARENTERL
DELL LABS
FRESENIUS KABI USA
HOSPIRA LILLY
Apr 28, 1983 Jul 26, 1996
LUITPOLD MARSAM PHARMS LLC ORGANON USA INC
Oct 31, 1983 Jun 07, 1996 Oct 10, 1995
PARKE DAVIS
PHARM SPEC

HEPARIN SODIUM
INJECTABLE; INJECTION HEPARIN SODIUM PHARM SPEC PHARMACIA AND UPJOHN
6 - 169 (of 360)
40,000 UNITS/ML N017780 1,000 UNITS/ML N004570 5,000 UNITS/ML N004570 10,000 UNITS/ML N004570 SMITH AND NEPHEW 1,000 UNITS/ML A088239 SOLOPAK 1,000 UNITS/ML A087043 5,000 UNITS/ML A087077 5,000 UNITS/0.5ML A087395 10,000 UNITS/ML A087107 10,000 UNITS/0.5ML A087363 WATSON LABS 1,000 UNITS/ML N017064 2,500 UNITS/ML N017064 3,000 UNITS/ML N017064 4,000 UNITS/ML N017064 5,000 UNITS/ML N017064 6,000 UNITS/ML N017064 7,500 UNITS/ML N017064 10,000 UNITS/ML N017064 20,000 UNITS/ML N017064 40,000 UNITS/ML N017064 HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER MCGAW 200 UNITS/100ML N019130 HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 200 UNITS/100ML N019042 HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 2,000 UNITS/100ML N018814 HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% HOSPIRA 10,000 UNITS/100ML N018911 HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% HOSPIRA 10,000 UNITS/100ML N018911 10,000 UNITS/100ML N018916 HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% HOSPIRA 10,000 UNITS/100ML N018911 10,000 UNITS/100ML N018916 HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% HOSPIRA 5,000 UNITS/100ML N018911 HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 5,000 UNITS/100ML N019802 HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9% HOSPIRA 5,000 UNITS/100ML N018911 5,000 UNITS/100ML N018916 HEPARIN SODIUM 2,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER MCGAW 200 UNITS/100ML N019130 HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 200 UNITS/100ML N019042 HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 4,000 UNITS/100ML N018814 HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 5,000 UNITS/100ML N018814 10,000 UNITS/100ML N018814 HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% HOSPIRA 5,000 UNITS/100ML N018911 10,000 UNITS/100ML N018911 HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5,000 UNITS/100ML N019134 HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 5,000 UNITS/100ML N019802 10,000 UNITS/100ML N019802 HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% HOSPIRA 5,000 UNITS/100ML N018911
005 001 002 003 001 001 001 001 001 001 002 015 016 017 003 018 019 004 005 006 001 001 002 006 001 005 003 002 007 001 005 003 003 002 001 003 004 009 008 001 005 002 004
Jul 26, 1984
Dec 31, 1984 Mar 29, 1985 Jul 09, 1985 Jan 30, 1985 Jan 30, 1985 Jan 31, 1984 Jan 30, 1985 Jan 31, 1984 Jan 30, 1985 Jul 20, 1992 Jan 30, 1985 Jan 31, 1984 Dec 31, 1984 Mar 29, 1985 Oct 31, 1983 Jul 09, 1985 Jul 02, 1987 Jan 30, 1985 Jan 30, 1985 Mar 29, 1985 Jul 20, 1992 Jul 20, 1992 Jan 30, 1985

HEPARIN SODIUM
INJECTABLE; INJECTION HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 5,000 UNITS/100ML N019135 5,000 UNITS/100ML N019802 HOSPIRA 5,000 UNITS/100ML N018916 HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE 500 UNITS/100ML N018609 HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER MCGAW 1,000 UNITS/100ML N019130 HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% HOSPIRA 100 UNITS/ML N018911 100 UNITS/ML N018916 HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% HOSPIRA 1,000 UNITS/100ML N018916 HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 1,000 UNITS/100ML N019042 HEPARIN SODIUM PRESERVATIVE FREE HOSPIRA 2,000 UNITS/ML N005264 2,500 UNITS/ML N005264 MARSAM PHARMS LLC 1,000 UNITS/ML A089464 PHARMA SERVE NY 1,000 UNITS/ML A086129 LIPO-HEPIN 3M 1,000 UNITS/0.5ML N017027 1,000 UNITS/ML N017027 5,000 UNITS/0.5ML N017027 5,000 UNITS/ML N017027 7,500 UNITS/0.5ML N017027 10,000 UNITS/0.5ML N017027 10,000 UNITS/ML N017027 15,000 UNITS/0.5ML N017027 20,000 UNITS/0.5ML N017027 20,000 UNITS/ML N017027 40,000 UNITS/ML N017027 LIQUAEMIN LOCK FLUSH ORGANON USA INC 100 UNITS/ML N000552 LIQUAEMIN SODIUM ORGANON USA INC 1,000 UNITS/ML N000552 5,000 UNITS/ML N000552 10,000 UNITS/ML N000552 20,000 UNITS/ML N000552 40,000 UNITS/ML N000552 LIQUAEMIN SODIUM PRESERVATIVE FREE ORGANON USA INC 1,000 UNITS/ML N000552 5,000 UNITS/ML N000552 10,000 UNITS/ML N000552 PANHEPRIN HOSPIRA 1,000 UNITS/ML N005264 5,000 UNITS/ML N005264 10,000 UNITS/ML N005264 20,000 UNITS/ML N005264 40,000 UNITS/ML N005264 SODIUM HEPARIN ABRAXIS PHARM 5,000 UNITS/ML N017033 10,000 UNITS/ML N017033 20,000 UNITS/ML N017033 BAXTER HLTHCARE 1,000 UNITS/ML N017036
6 - 170 (of 360)
001 003 009 003 002 002 004 001 004 013 014 001 001 001 006 002 008 010 003 009 011 004 007 005 007 004 003 005 001 002 011 012 013 004 006 007 008 009 002 003 004 001
Mar 29, 1985 Jul 20, 1992 Jan 31, 1984 Apr 28, 1982 Dec 31, 1984 Jan 30, 1985 Jan 31, 1984 Jan 31, 1984 Mar 29, 1985 Apr 07, 1986 Apr 07, 1986 Jun 03, 1986
Apr 11, 1986 Apr 11, 1986 Apr 11, 1986
Mar 04, 1988
HETACILLIN
FOR SUSPENSION; ORAL VERSAPEN BRISTOL
EQ 112.5MG AMPICIL/ML EQ 112.5MG AMPICIL/5ML
A061398 N050060
001 001

HETACILLIN
FOR SUSPENSION; ORAL VERSAPEN BRISTOL
6 - 171 (of 360)
EQ 112.5MG AMPICIL/ML EQ 225MG AMPICIL/5ML
N050060 A061398
003 002
HETACILLIN POTASSIUM
CAPSULE; ORAL VERSAPEN-K BRISTOL
EQ 225MG AMPICIL EQ 450MG AMPICIL
A061396 A061396
001 002
HEXACHLOROPHENE
AEROSOL; TOPICAL SEPTISOL VESTAL LABS 0.23% TURGEX XTTRIUM 3% EMULSION; TOPICAL HEXA-GERM HUNTINGTON LABS 3% PHISOHEX SANOFI AVENTIS US 3% SOY-DOME BAYER PHARMS 3% TURGEX XTTRIUM 3% SOAP; TOPICAL GAMOPHEN ARBROOK 2% SOLUTION; TOPICAL DIAL DIAL 0.25% GERMA-MEDICA HUNTINGTON LABS 1% GERMA-MEDICA "MG" HUNTINGTON LABS 0.25% SEPTI-SOFT CALGON 0.25% SEPTISOL VESTAL LABS 0.25% SPONGE; TOPICAL E-Z SCRUB BECTON DICKINSON 450MG HEXASCRUB PROF DSPLS 3% PHISO-SCRUB SANOFI AVENTIS US 3% SCRUBTEAM SURGICAL SPONGEBRUSH 3M 330MG
N017424 N018375
001 001
N017411 N008402 N017405 N019055
001 001 001 001 Nov 30, 1984
N006270
003
N017421 N017412 N017412 N017460 N017423
002 001 002 001 001
N017452 N018363 N017446 N017413
001 001 001 001
HEXAFLUORENIUM BROMIDE
INJECTABLE; INJECTION MYLAXEN MEDPOINTE PHARM HLC
20MG/ML
N009789
003
HEXOCYCLIUM METHYLSULFATE
TABLET; ORAL TRAL ABBVIE
25MG
N010599
001

HEXYLCAINE HYDROCHLORIDE
SOLUTION; TOPICAL
CYCLAINE
MERCK
6 - 172 (of 360)
5%
N008472
001
HISTAMINE PHOSPHATE
HISTAMINE PHOSPHATE
LILLY
EQ 0.1MG BASE/ML EQ 0.2MG BASE/ML EQ 1MG BASE/ML
N000734 N000734 N000734
003
002
001
HISTRELIN ACETATE
SUPPRELIN
SHIRE
EQ 0.2MG BASE/ML EQ 0.5MG BASE/ML EQ 1MG BASE/ML
N019836 N019836 N019836
001 002 003
Dec 24, 1991 Dec 24, 1991 Dec 24, 1991
HOMATROPINE METHYLBROMIDE
TABLET; ORAL
HOMAPIN-10
MISSION PHARMA HOMAPIN-5
MISSION PHARMA TABLET, CHEWABLE; ORAL
EQUIPIN
MISSION PHARMA
10MG 5MG
A086308 A086309
001
001
3MG
A086310
001
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE

SYRUP; ORAL HYCODAN ENDO PHARMS 1.5MG/5ML;5MG/5ML HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE IVAX SUB TEVA PHARMS 1.5MG/5ML;5MG/5ML HYDROPANE HALSEY 1.5MG/5ML;5MG/5ML TABLET; ORAL HOMATROPRINE METHYLBROMIDE AND HYDROCODONE BITARTRATE ACTAVIS TOTOWA 1.5MG;5MG HYCODAN ENDO PHARMS 1.5MG;5MG
N005213 A040285 A088066
002 001 001
Jul 26, 1988 Jul 19, 1999 Jun 28, 1985
A040295 N005213
001 001
Dec 01, 2000 Jul 26, 1988
HYALURONIDASE
INJECTABLE; INJECTION HYDASE AKORN INC VITRASE ISTA PHARMS WYDASE BAXTER HLTHCARE
150 UNITS/ML 6,200 UNITS/VIAL 150 UNITS/ML 150 UNITS/VIAL **Federal Register determination that product was not
1,500 UNITS/VIAL **Federal Register determination that product was not
N021716 N021640 N006343 N006343
001 001 002

006
Oct 25, 2005 May 05, 2004
N006343
005
APRESOLINE
NOVARTIS
20MG/ML
N008303
003

INJECTABLE; INJECTION HYDRALAZINE HYDROCHLORIDE ABRAXIS PHARM 20MG/ML SMITH AND NEPHEW 20MG/ML SOLOPAK 20MG/ML TEVA PARENTERAL 20MG/ML TABLET; ORAL APRESOLINE NOVARTIS 10MG 25MG 50MG 100MG DRALZINE TEVA 25MG HYDRALAZINE HYDROCHLORIDE ACTAVIS TOTOWA 25MG 50MG ASCOT 25MG 50MG HALSEY 10MG 25MG 50MG 100MG IMPAX LABS 25MG 50MG IVAX SUB TEVA PHARMS 10MG 25MG 50MG 100MG MUTUAL PHARM 10MG 10MG 25MG 25MG 50MG 50MG 100MG PUREPAC PHARM 25MG 50MG QUANTUM PHARMICS 10MG 25MG 50MG 100MG SANDOZ 10MG 25MG 50MG 50MG SUPERPHARM 10MG 25MG 50MG TG UNITED LABS 10MG 25MG 50MG 100MG USL PHARMA 25MG 50MG VANGARD 25MG 50MG VITARINE 25MG WATSON LABS 25MG 50MG WEST WARD 25MG 50MG
6 - 173 (of 360)
A089532 A088518 A088517 A040373
001 001 001 001
Aug Apr Aug Feb
11, 20, 22, 23,
1987 1984 1985 2000
N008303 N008303 N008303 N008303 A084301 A088560 A088649 A088310 A088311 A089218 A089130 A089222 A089178 A084922 A084923 A084443 A084437 A084469 A084581 A088728 A089359 A084106 A089258 A084107 A089259 A088729 A088177 A088178 A088671 A088657 A088652 A088686 A083241 A083560 A083561 A085088 A088787 A088788 A088789 A088846 A088847 A088848 A088849 A087780 A087751 A087712 A087908 A086088 A085532 A085533 A088240 A088241
004 001 002 005 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 002 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 002 001 001 Oct Oct Dec Dec Jan Jan Jan Jan 04, 18, 19, 19, 22, 15, 22, 15, 1984 1984 1984 1984 1986 1986 1986 1986
Apr 11, 1985 Jul 25, 1986 May 05, 1986 May Apr Jul Aug May Jun May May 05, 11, 29, 15, 01, 15, 08, 01, 1986 1985 1983 1983 1984 1984 1984 1984
Aug Aug Aug Feb Feb Feb Feb Mar Mar
28, 28, 28, 26, 26, 26, 26, 29, 29,
1984 1984 1984 1985 1985 1985 1985 1982 1982
May 07, 1982 May May May May 24, 25, 27, 27, 1982 1982 1983 1983

HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
CAPSULE; ORAL APRESAZIDE NOVARTIS
6 - 174 (of 360)
25MG;25MG 50MG;50MG 100MG;50MG HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE SOLVAY 25MG;25MG 50MG;50MG 100MG;50MG SUPERPHARM 25MG;25MG 50MG;50MG WATSON LABS 25MG;25MG 50MG;50MG 100MG;50MG HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50 IVAX PHARMS 100MG;50MG HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 IVAX PHARMS 25MG;25MG HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 IVAX PHARMS 50MG;50MG HYDRA-ZIDE PAR PHARM 100MG;50MG TABLET; ORAL APRESOLINE-ESIDRIX NOVARTIS 25MG;15MG HYDRALAZINE AND HYDROCHLORTHIAZIDE WATSON LABS 25MG;15MG HYDROCHLOROTHIAZIDE W/ HYDRALAZINE WATSON LABS 25MG;15MG
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Feb Feb Feb Feb Feb Mar Mar Mar 08, 08, 08, 09, 09, 04, 04, 04, 1982 1982 1982 1987 1987 1982 1982 1982
Apr 10, 1984 Apr 10, 1984 Apr 10, 1984 Oct 21, 1985
N012026 A085827 A085373
002 001 001
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

TABLET; ORAL CAM-AP-ES TG UNITED LABS 25MG;15MG;0.1MG HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE IVAX SUB TEVA PHARMS 25MG;15MG;0.1MG HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE MYLAN 25MG;15MG;0.1MG HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE WATSON LABS 25MG;15MG;0.1MG HYDRAP-ES SANDOZ 25MG;15MG;0.1MG HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE WATSON LABS 25MG;15MG;0.1MG HYDROSERPINE PLUS (R-H-H) IVAX SUB TEVA PHARMS 25MG;15MG;0.1MG RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE MUTUAL PHARM 25MG;15MG;0.1MG SOLVAY 25MG;15MG;0.1MG WATSON LABS 25MG;15MG;0.1MG 25MG;15MG;0.1MG RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE LEDERLE 25MG;15MG;0.1MG SER-A-GEN SOLVAY 25MG;15MG;0.1MG SER-AP-ES NOVARTIS 25MG;15MG;0.1MG UNIPRES SOLVAY 25MG;15MG;0.1MG 25MG;15MG;0.1MG
A084897 A084291 A087085 A085771 A084876 A083770 A083877 A088570 A088376 A085549 A087556 A087709 A087210 N012193 A085893 A086298
001 001 001 001 001 001 001 001 001 001 001 001 001 005 001 001 Apr 10, 1984 Oct 28, 1983
May 13, 1982

HYDRALAZINE HYDROCHLORIDE; RESERPINE
TABLET; ORAL DRALSERP SANDOZ SERPASIL-APRESOLINE NOVARTIS
6 - 175 (of 360)
25MG;0.1MG 25MG;0.1MG 50MG;0.2MG
A084617 N009296 N009296
001 004 002
HYDROCHLOROTHIAZIDE
SOLUTION; ORAL HYDROCHLOROTHIAZIDE MORTON GROVE 50MG/5ML ROXANE 50MG/5ML HYDROCHLOROTHIAZIDE INTENSOL ROXANE 100MG/ML TABLET; ORAL ESIDRIX NOVARTIS 25MG 50MG 100MG HYDROCHLOROTHIAZIDE ABC HOLDING 50MG ACTAVIS ELIZABETH 25MG 50MG ALRA 25MG 50MG ASCOT 25MG 50MG BARR 50MG DAVA PHARMS INC 100MG ELKINS SINN 50MG HEATHER 50MG IMPAX LABS 25MG 50MG 100MG INWOOD LABS 25MG 25MG 50MG IVAX SUB TEVA PHARMS 50MG 100MG MAST MM 25MG 50MG MUTUAL PHARM 25MG 50MG 100MG MYLAN 25MG 50MG PVT FORM 50MG ROXANE 25MG 50MG 50MG SANDOZ 25MG 25MG 50MG 50MG SOLVAY 25MG SUPERPHARM 25MG 50MG 100MG TEVA 25MG 50MG TG UNITED LABS 25MG 50MG
A089661 A088587 A088588
001 001 001
Jun 20, 1988 Jul 02, 1984 Jul 02, 1984
N011793 N011793 N011793 A085672 A085054 A085208 A086369 A083554 A087539 A087540 A084771 A087060 A085152 A084135 A084029 A083607 A085098 A084776 A085067 A084776 A084658 A085022 A086192 A086192 A083972 A083972 A083972 A084880 A085112 A086597 A085004 A084536 A085005 A083899 A087565 A084912 A085219 A085323 A088827 A088828 A088829 A088924 A088923 A085683 A083965
005 008 009 001 002 001 001 001 001 001 001 001 002 001 001 002 001 001 001 002 001 001 001 002 001 002 003 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001
Feb 03, 1982 Feb 03, 1982
Mar 09, 1982
Dec Dec Dec Feb Feb
28, 28, 28, 07, 07,
1984 1984 1984 1985 1985

HYDROCHLOROTHIAZIDE
TABLET; ORAL HYDROCHLOROTHIAZIDE USL PHARMA
6 - 176 (of 360)
25MG 50MG VANGARD 25MG 50MG WARNER CHILCOTT 25MG 50MG WATSON LABS 25MG 25MG 50MG 50MG 50MG 50MG 50MG 100MG 100MG 100MG WEST WARD 25MG WHITEWORTH TOWN PLSN 25MG 50MG 100MG HYDRO-D
HALSEY 25MG 50MG HYDRODIURIL
MERCK 25MG 50MG 100MG ORETIC
ABBVIE 25MG ZIDE
SOLVAY 50MG
A087827 A087752 A087638 A087610 A087586 A087587 A083458 A085232 A083232 A083456 A085233 A086087 A086594 A081190 A085099 A087002 A084899 A083809 A083809 A085347 A086504 A083891 N011835 N011835 N011835 N011971 A083925
001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 002
001
001
001
002
003
006
007
001
001
Apr 19, 1982 Apr 19, 1982
May 03, 1982 May 03, 1982
Jan 24, 1992
TABLET; ORAL
AVALIDE
SANOFI AVENTIS US
12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** IRBESARTAN AND HYDROCHLOROTHIAZIDE TEVA 25MG;300MG
N020758
001
Sep 30, 1997
N020758
004
Mar 15, 2005
A077369
003
Mar 30, 2012
HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE

TABLET; ORAL
NORMOZIDE
SCHERING
25MG;100MG 25MG;200MG 25MG;300MG 25MG;400MG 25MG;100MG 25MG;200MG 25MG;300MG 25MG;400MG
N019046 N019046 N019046 N019046 N019174 N019174 N019174 N019174
001 002 003 004 001 002 003 004
Apr Apr Apr Apr Apr Apr Apr Apr
06, 06, 06, 06, 10, 10, 10, 10,
1987 1987 1987 1987 1987 1987 1987 1987
TRANDATE HCT GLAXOSMITHKLINE

TABLET; ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE SANDOZ 12.5MG;10MG 12.5MG;20MG 25MG;20MG TEVA 12.5MG;10MG 12.5MG;20MG 25MG;20MG PRINZIDE MERCK 25MG;20MG
6 - 177 (of 360)
A075926 A075926 A075926 A075869 A075869 A075869 N019778
001 002 003 001 002 003 002
Jul Jul Jul Jul Jul Jul
01, 01, 01, 01, 01, 01,
2002 2002 2002 2002 2002 2002
Feb 16, 1989
TABLET; ORAL ALDORIL 15 MERCK 15MG;250MG ALDORIL 25 MERCK 25MG;250MG ALDORIL D30 MERCK 30MG;500MG ALDORIL D50 MERCK 50MG;500MG METHYLDOPA AND HYDROCHLOROTHIAZIDE CLONMEL HLTHCARE 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG IVAX SUB TEVA PHARMS 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG PAR PHARM 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG PARKE DAVIS 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG PUREPAC PHARM 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG SANDOZ 15MG;250MG 15MG;250MG 25MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG TEVA 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG WATSON LABS 15MG;250MG 15MG;250MG 15MG;250MG 25MG;250MG 25MG;250MG 25MG;250MG 30MG;500MG 30MG;500MG 30MG;500MG 50MG;500MG
N013402 N013402 N013402 N013402 A072507 A072508 A072509 A072510 A071458 A071459 A071460 A071461 A070616 A070612 A070613 A070614 A071897 A071898 A071899 A071900 A070853 A070688 A070854 A070689 A070182 A070829 A070183 A070830 A070543 A070544 A071819 A071820 A071821 A071822 A070365 A070958 A071920 A070366 A070959 A071921 A070367 A071069 A071922 A070368
001 002 003 004 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jun Jun Jun Jun Mar Mar Mar Mar Feb Feb Feb Feb Nov Nov Nov Nov Oct Apr Oct Apr Jan Mar Jan Mar Jan Jan Apr Apr Apr Apr Mar Feb Aug Apr Jan Aug Mar Jan Aug Apr 02, 02, 02, 02, 08, 08, 08, 08, 02, 02, 02, 02, 23, 23, 23, 23, 08, 24, 08, 24, 15, 09, 15, 09, 15, 15, 08, 08, 08, 08, 19, 06, 29, 16, 19, 29, 19, 19, 29, 16, 1989 1989 1989 1989 1988 1988 1988 1988 1987 1987 1987 1987 1987 1987 1987 1987 1986 1986 1986 1986 1986 1987 1986 1987 1986 1986 1988 1988 1988 1988 1986 1989 1988 1986 1989 1988 1986 1989 1988 1986

TABLET; ORAL METHYLDOPA AND HYDROCHLOROTHIAZIDE WATSON LABS 50MG;500MG 50MG;500MG
6 - 178 (of 360)
A070960 A071923
001 001
Feb 06, 1989 Aug 29, 1988
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE

TABLET; ORAL LOPRESSOR HCT US PHARMS HOLDINGS I
50MG;100MG
N018303
003
Dec 31, 1984
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE

TABLET; ORAL MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE PADDOCK LLC 12.5MG;7.5MG 12.5MG;15MG 25MG;15MG
A090096 A090096 A090096
001 002 003
Sep 25, 2008 Sep 25, 2008 Sep 25, 2008
HYDROCHLOROTHIAZIDE; PINDOLOL
TABLET; ORAL VISKAZIDE NOVARTIS
25MG;5MG 25MG;10MG
N018872 N018872
001 002
Jul 22, 1987 Jul 22, 1987
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

CAPSULE, EXTENDED RELEASE; ORAL INDERIDE LA 120/50 WYETH AYERST 50MG;120MG INDERIDE LA 160/50 WYETH AYERST 50MG;160MG INDERIDE LA 80/50 WYETH AYERST 50MG;80MG TABLET; ORAL INDERIDE-80/25 AKRIMAX PHARMS 25MG;80MG PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE DURAMED PHARMS BARR 25MG;40MG 25MG;80MG PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE ACTAVIS ELIZABETH 25MG;40MG 25MG;80MG BARR 25MG;40MG 25MG;80MG IVAX SUB TEVA PHARMS 25MG;40MG 25MG;80MG SANDOZ 25MG;40MG 25MG;80MG WARNER CHILCOTT 25MG;40MG 25MG;80MG WATSON LABS 25MG;40MG 25MG;80MG
N019059 N019059 N019059
002 003 001
Jul 03, 1985 Jul 03, 1985 Jul 03, 1985
N018031 A071126 A071127 A070851 A070852 A070704 A070705 A071552 A071553 A071060 A071061 A071771 A071772 A071498 A071501
002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Mar 02, 1987 Mar 02, 1987 May May Oct Oct Dec Dec Aug Aug Jan Jan Dec Dec 15, 15, 01, 01, 01, 01, 26, 26, 26, 26, 18, 18, 1986 1986 1986 1986 1988 1988 1987 1987 1988 1988 1991 1991
HYDROCHLOROTHIAZIDE; RESERPINE
TABLET; ORAL H.R.-50 WHITEWORTH TOWN PLSN 50MG;0.125MG HYDROCHLOROTHIAZIDE W/ RESERPINE IVAX SUB TEVA PHARMS 25MG;0.1MG 25MG;0.125MG 50MG;0.1MG 50MG;0.125MG PHARMERAL 25MG;0.125MG 50MG;0.125MG
A085338 A083572 A083571 A083568 A083573 A085421 A085420
001 001 001 001 001 001 001

HYDROCHLOROTHIAZIDE; RESERPINE
TABLET; ORAL HYDROCHLOROTHIAZIDE W/ RESERPINE ROXANE 50MG;0.125MG WATSON LABS 25MG;0.125MG 25MG;0.125MG 25MG;0.125MG 50MG;0.125MG 50MG;0.125MG 50MG;0.125MG HYDROPRES 25 MERCK 25MG;0.125MG HYDROPRES 50 MERCK 50MG;0.125MG HYDRO-RESERP ABC HOLDING 50MG;0.125MG HYDRO-SERP "25" SANDOZ 25MG;0.125MG HYDRO-SERP "50" SANDOZ 50MG;0.125MG RESERPINE AND HYDROCHLOROTHIAZIDE BARR 25MG;0.125MG 50MG;0.125MG SANDOZ 50MG;0.125MG RESERPINE AND HYDROCHLOROTHIAZIDE-50 WEST WARD 50MG;0.125MG SERPASIL-ESIDRIX #1 NOVARTIS 25MG;0.1MG SERPASIL-ESIDRIX #2 NOVARTIS 50MG;0.1MG
6 - 179 (of 360)
A084603 A084466 A085317 A086330 A083666 A084467 A086331 N011958 N011958 A084714 A084827 A085213 A084580 A084579 A088200 A088189 N011878 N011878
001 001 001 002 001 001 001 002 003 002 001 001 001 001 001 001 003 005 Jun 29, 1982
Jan 31, 1984 May 10, 1984
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
TABLET; ORAL SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE ASCOT 25MG;25MG MUTUAL PHARM 25MG;25MG PUREPAC PHARM 25MG;25MG SANDOZ 25MG;25MG SUPERPHARM 25MG;25MG SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE IVAX PHARMS 25MG;25MG LEDERLE 25MG;25MG PARKE DAVIS 25MG;25MG PUREPAC PHARM 25MG;25MG UPSHER SMITH 25MG;25MG USL PHARMA 25MG;25MG VANGARD 25MG;25MG WATSON LABS 25MG;25MG 25MG;25MG
A088025 A087267 A087999 A086881 A089137 A087004 A087511 A087948 A088054 A087553 A087651 A087655 A085974 A086026
001 001 001 001 001 002 001 001 001 001 001 001 001 001
Nov 23, 1984 Nov 06, 1985 Aug 26, 1985 May 24, 1982 Feb 22, 1983 Aug 18, 1983
HYDROCHLOROTHIAZIDE; TIMOLOL MALEATE

TABLET; ORAL TIMOLIDE 10-25 MERCK
25MG;10MG
N018061
001
CAPSULE; ORAL DYAZIDE GLAXOSMITHKLINE LLC 25MG;50MG TRIAMTERENE AND HYDROCHLOROTHIAZIDE BARR 25MG;37.5MG NOVARTIS 25MG;37.5MG VITARINE 25MG;50MG
N016042 A074970 A074857 A071737
002 001 001 001 Jan 06, 1998 Sep 09, 1997 Feb 12, 1988

TABLET; ORAL TRIAMTERENE AND HYDROCHLOROTHIAZIDE AM THERAP 50MG;75MG QUANTUM PHARMICS 50MG;75MG
6 - 180 (of 360)
A072022 A071980
001 001
Apr 17, 1988 Apr 17, 1988
HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

SYRUP; ORAL CODAMINE ALPHARMA US PHARMS HYCOMINE ENDO PHARMS HYCOMINE PEDIATRIC ENDO PHARMS
5MG/5ML;25MG/5ML 5MG/5ML;25MG/5ML 2.5MG/5ML;12.5MG/5ML
A075103 N019410 N019411
001 001 001
Sep 29, 2000 Aug 17, 1990 Aug 17, 1990
HYDROCORTAMATE HYDROCHLORIDE
OINTMENT; TOPICAL MAGNACORT PFIZER
0.5%
N010554
001
HYDROCORTISONE
AEROSOL; TOPICAL AEROSEB-HC ALLERGAN HERBERT CREAM; TOPICAL CORT-DOME BAYER PHARMS DERMACORT MONARCH PHARMS ELDECORT VALEANT PHARM INTL FLEXICORT WESTWOOD SQUIBB
0.5%
A085805
001
0.5% 1% 1% 1% 2.5% 0.5% 1% 2.5% 0.5% 1% 0.5% 1% 0.5% 2.5% 2.5% 0.5% 1% 1% 2.5% 0.5% 1% 1% 0.5% 1% 1% 1% 0.5% 1%
N009585 N009585 A083011 A080459 A084055 A087136 A087136 A087136 A080438 A080438 A080482 A080482 A086823 A080483 A089754 A080848 A080848 A086080 A086271 A080452 A080452 A084059 A080456 A080456 A085733 A089706 A084970 A085026
003 001 002 001 001 003 002 001 001 002 003 004 001 001 001 002 003 001 001 001 002 001 002 003 001 001 002 001 Feb 01, 1989 Apr 08, 1982 Apr 08, 1982 Apr 08, 1982
HC #1 BAYER PHARMS HC #4 BAYER PHARMS HC (HYDROCORTISONE) C AND M PHARMA H-CORT PHARM ASSOC HI-COR C AND M PHARMA HYDROCORTISONE ALPHARMA US PHARMS ALTANA AMBIX EVERYLIFE G AND W LABS INGRAM PHARM IVAX PHARMS NASKA PERRIGO NEW YORK
Mar 10, 1988

HYDROCORTISONE
CREAM; TOPICAL HYDROCORTISONE PHARMADERM PHARMAFAIR STIEFEL SYOSSET TARO TEVA
6 - 181 (of 360)
TOPIDERM USL PHARMA WHITEWORTH TOWN PLSN HYTONE VALEANT INTL NOGENIC HC IVAX PHARMS NUTRACORT DOW PHARM PENECORT ALLERGAN HERBERT PROCTOCORT MONARCH PHARMS SYNACORT MEDICIS GEL; TOPICAL NUTRACORT HEALTHPOINT PENECORT ALLERGAN HERBERT INJECTABLE; INJECTION CORTEF PHARMACIA AND UPJOHN LOTION; TOPICAL ACTICORT BAKER NORTON BALNEOL-HC SOLVAY BETA-HC BETA DERMAC CETACORT DOW PHARM CORT-DOME BAYER PHARMS DERMACORT SOLVAY EPICORT BLULINE GLYCORT HERAN H-CORT PHARM ASSOC HYDROCORTISONE ALPHARMA US PHARMS
1% 2.5% 1% 1% 0.5% 0.5% 0.5% 1% 1% 2.5% 1% 1% 2.5% 1% 1% 2.5% 1% 0.5% 1% 1% 1% 0.5%
001 001 001 001 001 001 002 003 001 004 001 001 001 002 003 004 001 002 003 001 001 001
Feb 27, 1986 Dec 16, 1986 Jul 28, 1982
Feb 17, 1989 Sep 27, 1983 Sep 27, 1983
Apr 04, 1988
Jun 06, 1984
1% 1%
A084698 A088215
001 001 Jun 06, 1984
50MG/ML
N009864
001
1% 1% 1% 0.5% 1% 0.5% 1% 0.5% 1% 0.5% 1% 0.5% 0.5% 1%
A086535 A088041 A089495 A080426 A080426 N009895 N009895 A084573 A086462 A083219 A087489 A086824 A087317 A087315
001 001 001 002 001 003 001 002 001 002 001 001 001 001 Jun 07, 1982 Jun 07, 1982 Oct 03, 1983 Dec 03, 1982 Jan 25, 1988

HYDROCORTISONE
LOTION; TOPICAL HYDROCORTISONE MERICON NASKA PERRIGO NEW YORK TARO HYTONE VALEANT INTL NUTRACORT DOW PHARM OINTMENT; TOPICAL CORTRIL PFIZER GLOBAL HC (HYDROCORTISONE) C AND M PHARMA HYDROCORTISONE ALTANA AMBIX NASKA PERRIGO NEW YORK PHARMADERM TARO USL PHARMA HYTONE DERMIK LABS
6 - 182 (of 360)
0.5% 1% 1% 0.5% 1% 1% 1% 2.5% 0.5%
A085282 A085282 A089705 A085662 A085663 A089024 A080473 A080473 A080443
001 002 001 001 001 001 003 004 002
Feb 26, 1987 Apr 25, 1988
Feb 12, 1986
Nov 30, 1982
1% 2.5% 0.5% 1% 0.5% 1% 1% 2.5% 1% 0.5% 1% 1% 0.5% 1% 2.5% 1% 2.5%
001 002 001 002 002 003 001 001 001 003 001 001 001 001 001 003 004 001 Jun 06, 1984
Mar 10, 1988
Feb 09, 1987 Sep 27, 1983 Sep 27, 1983
PENECORT ALLERGAN HERBERT 2.5% POWDER; FOR RX COMPOUNDING H-CORT TORCH 100% HYDROCORTISONE PADDOCK LLC 100% SOLUTION; TOPICAL PENECORT ALLERGAN HERBERT 1% TEXACORT MISSION PHARMA 1% TABLET; ORAL CORTRIL PFIZER 10MG 20MG HYDROCORTISONE BARR 20MG ELKINS SINN 20MG FERRANTE 10MG 20MG IMPAX LABS 20MG INWOOD LABS 20MG LANNETT 20MG NEXGEN PHARMA INC 20MG PANRAY 10MG 20MG PARKE DAVIS 20MG
A087834 A088082
001 001
Mar 29, 1982 Apr 08, 1983
A088214 A080425
001 001
Jun 06, 1984
N009127 N009127 A083999 A080624 A080568 A080568 A080781 A080732 A085070 A083140 N009659 N009659 A084243
005 003 001 001 001 002 001 001 001 001 001 002 001

HYDROCORTISONE
TABLET; ORAL HYDROCORTISONE PUREPAC PHARM
6 - 183 (of 360)
ROXANE SANDOZ WATSON LABS WHITEWORTH TOWN PLSN HYDROCORTONE MERCK TABLET; VAGINAL CORTRIL PFIPHARMECS
A084247 A080395 A084247 A088539 A080642 A080355 A080344 A080344 N008506 N008506
003 001 002 001 002 001 001 002 007 011
Aug 31, 1982
Mar 21, 1984
10MG
N009796
001
CREAM; TOPICAL HEMSOL-HC ABLE HYDROCORTISONE ACETATE CENCI PARKE DAVIS PUREPAC PHARM INJECTABLE; INJECTION CORTEF ACETATE PHARMACIA AND UPJOHN CORTRIL PFIZER HYDROCORTISONE ACETATE AKORN BEL MAR WATSON LABS
1% 1% 1% 0.5% 1%
A081274 A080419 A089914 A086050 A086052
001 001 001 001 001
Jun 19, 1992 Jan 25, 1982 Jan 03, 1989
N009378 N009164 N009637 N009637 A083739 A083739 A083128 A083759 A083759 A085214 N008228 N008228
002 001 001 002 001 002 001 001 002 001 001 004
HYDROCORTONE MERCK
LOTION; TOPICAL DRICORT INGRAM PHARM 0.5% OINTMENT; OPHTHALMIC HYDROCORTISONE ACETATE FERA PHARMS 0.5% OINTMENT; OPHTHALMIC, OTIC HYDROCORTONE MERCK 1.5% OINTMENT; TOPICAL CORTEF ACETATE PHARMACIA AND UPJOHN 1% 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
A086207
001
A080828
001
N009018
003
N008917 N008917
002 001
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE

CREAM; TOPICAL NEO-CORTEF PHARMACIA AND UPJOHN
1%;EQ 3.5MG BASE/GM
A061049
001

HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
CREAM; TOPICAL NEO-CORTEF PHARMACIA AND UPJOHN OINTMENT; OPHTHALMIC NEO-CORTEF PHARMACIA AND UPJOHN OINTMENT; TOPICAL NEO-CORTEF PHARMACIA AND UPJOHN
6 - 184 (of 360)
A061049
002
0.5%;EQ 3.5MG BASE/GM 1.5%;EQ 3.5MG BASE/GM
A060610 A060610
001 002
0.5%;EQ 3.5MG BASE/GM 1%;EQ 3.5MG BASE/GM 2.5%;EQ 3.5MG BASE/GM SUSPENSION/DROPS; OPHTHALMIC COR-OTICIN AKORN 1.5%;EQ 3.5MG BASE/ML NEO-CORTEF PHARMACIA AND UPJOHN 0.5%;EQ 3.5MG BASE/ML 1.5%;EQ 3.5MG BASE/ML
A060751 A060751 A060751
001 002 003
A060188 A060612 A060612
001 002 001
HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE

SUSPENSION; OPHTHALMIC TERRA-CORTRIL PFIZER
1.5%;EQ 5MG BASE/ML
A061016
001
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE

AEROSOL, METERED; TOPICAL HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1% BOCA PHARMA 1%;1% LOTION; TOPICAL PRAMOSONE FERNDALE LABS 0.5%;1%
A089440
001
May 17, 1988
A083213
002
HYDROCORTISONE BUTYRATE
CREAM; TOPICAL LOCOID YAMANOUCHI OINTMENT; TOPICAL LOCOID YAMANOUCHI SOLUTION; TOPICAL LOCOID YAMANOUCHI
0.1%
N018795
001
Jan 07, 1983
0.1%
N019106
001
Jul 03, 1984
0.1%
N019819
001
Sep 15, 1988
HYDROCORTISONE CYPIONATE
SUSPENSION; ORAL CORTEF PHARMACIA AND UPJOHN
EQ 10MG BASE/5ML
N009900
001
HYDROCORTISONE SODIUM PHOSPHATE

INJECTABLE; INJECTION HYDROCORTONE MERCK
EQ 50MG BASE/ML
N012052
001

INJECTABLE; INJECTION A-HYDROCORT ABBOTT
HOSPIRA
100MG BASE/VIAL 100MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 100MG BASE/VIAL 250MG BASE/VIAL
A085928 A089577 A089578 A089579 A089580 A085929 A085930
001 001 001 001 001 001 001
Apr Apr Apr Apr
11, 11, 11, 11,
1989 1989 1989 1989

INJECTABLE; INJECTION A-HYDROCORT HOSPIRA
6 - 185 (of 360)
EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL HYDROCORTISONE SODIUM SUCCINATE ABRAXIS PHARM EQ 100MG BASE/VIAL EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL BAXTER HLTHCARE EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL INTL MEDICATION EQ 100MG BASE/VIAL WATSON LABS EQ 100MG BASE/VIAL EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 Jun Jun Jun Jun Jun 08, 08, 08, 08, 08, 1984 1984 1984 1984 1984
Mar 19, 1982
HYDROCORTISONE VALERATE
CREAM; TOPICAL HYDROCORTISONE VALERATE TEVA PHARMS 0.2% WESTCORT RANBAXY 0.2%
A074489 N017950
001 001
Aug 12, 1998
HYDROCORTISONE; NEOMYCIN SULFATE

CREAM; TOPICAL NEO-CORT-DOME BAYER PHARMS
0.5%;EQ 3.5MG BASE/GM 1%;EQ 3.5MG BASE/GM
N050237 N050237
006 005
Jun 05, 1984 Jun 05, 1984
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

SOLUTION/DROPS; OTIC NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML OTOCORT WATSON LABS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML SUSPENSION/DROPS; OPHTHALMIC CORTISPORIN MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML SUSPENSION/DROPS; OTIC NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML OTICAIR PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML OTOBIONE SCHERING 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML OTOCORT WATSON LABS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
A062394 A060730
001 002
Sep 29, 1982
N050169 A062623
001 001 Sep 24, 1985
A062617 A062399 A061816 A062521
001 001 001 001
Sep 18, 1985 Nov 18, 1982
Jul 11, 1985
HYDROCORTISONE; POLYMYXIN B SULFATE

SOLUTION/DROPS; OTIC OTOBIOTIC SCHERING PYOCIDIN FOREST LABS
5MG/ML;EQ 10,000 UNITS BASE/ML 5MG/ML;EQ 10,000 UNITS BASE/ML
A062302 A061606
001 001

HYDROCORTISONE; TETRACYCLINE HYDROCHLORIDE
OINTMENT; OPHTHALMIC ACHROMYCIN LEDERLE
6 - 186 (of 360)
1.5%;1%
N050272
001
HYDROCORTISONE; UREA
CREAM; TOPICAL ALPHADERM BIOGLAN CALMURID HC PHARMACIA AND UPJOHN
1%;10% 1%;10%
A086008 A083947
001 001
HYDROFLUMETHIAZIDE
TABLET; ORAL DIUCARDIN WYETH AYERST HYDROFLUMETHIAZIDE PAR PHARM WATSON LABS
50MG 50MG 50MG 50MG
A083383 A088850 A088031 A088528
001 001 001 001 May 31, 1985 Apr 06, 1983 Aug 15, 1984
HYDROFLUMETHIAZIDE; RESERPINE
TABLET; ORAL HYDROFLUMETHIAZIDE AND RESERPINE USL PHARMA 50MG;0.125MG WATSON LABS 25MG;0.125MG 50MG;0.125MG RESERPINE AND HYDROFLUMETHIAZIDE IVAX PHARMS 50MG;0.125MG PAR PHARM 50MG;0.125MG SALUTENSIN SHIRE 50MG;0.125MG SALUTENSIN-DEMI SHIRE 25MG;0.125MG
A088195 A088127 A088110 A088932 A088907 N012359 N012359
001 001 001 001 001 003 004
Oct 26, 1983 Mar 22, 1983 Mar 22, 1983 Jan 11, 1985 Sep 20, 1985
CAPSULE, EXTENDED RELEASE; ORAL PALLADONE PURDUE PHARMA LP 12MG 16MG 24MG 32MG INJECTABLE; INJECTION HYDROMORPHONE HYDROCHLORIDE WATSON LABS 10MG/ML TABLET; ORAL HYDROMORPHONE HYDROCHLORIDE NESHER PHARMS 2MG 4MG 8MG
N021044 N021044 N021044 N021044
001 002 003 004
Sep Sep Sep Sep
24, 24, 24, 24,
2004 2004 2004 2004
A074317
001
Aug 23, 1995
A077311 A077311 A077311
001 002 003
Nov 09, 2005 Nov 09, 2005 Nov 09, 2005
HYDROXOCOBALAMIN
INJECTABLE; INJECTION ALPHAREDISOL MERCK CYANOKIT MERCK SANTE SAS HYDROXOCOBALAMIN ABRAXIS PHARM WATSON LABS HYDROXOMIN BEL MAR
1MG/ML 2.5GM/VIAL (5GM/KIT) 1MG/ML 1MG/ML 1MG/ML
A080778 N022041 A084921 A085528 A084629
001 002 001 001 001 Dec 15, 2006

HYDROXYAMPHETAMINE HYDROBROMIDE
PAREDRINE
PHARMICS 1%
6 - 187 (of 360)
N000004
004
TABLET; ORAL HYDROXYCHLOROQUINE SULFATE SANDOZ 200MG
A040150
001
Jan 27, 1996
DELALUTIN
BRISTOL MYERS SQUIBB

discontinued or withdrawn for safety or efficacy reasons**
AKORN 125MG/ML WATSON LABS 125MG/ML 250MG/ML
N010347
N016911
N010347
N016911
004
001
002
002
N018004 N017439 N017439
001
001
002
HYDROXYSTILBAMIDINE ISETHIONATE
HYDROXYSTILBAMIDINE ISETHIONATE
SANOFI AVENTIS US 225MG/AMP
N009166
001
HYDROXYUREA
CAPSULE; ORAL HYDROXYUREA BARR DURAMED PHARMS BARR ROXANE TABLET; ORAL HYDROXYUREA BARR
250MG 250MG 500MG 500MG
A075143 A075020 A075020 A074476
002 002 001 001
Sep Jun Jul Aug
21, 26, 30, 18,
2000 2000 1998 1995
1GM
A075734
001
Aug 29, 2000
INJECTABLE; INJECTION HYDROXYZINE BAXTER HLTHCARE 50MG/ML HYDROXYZINE HYDROCHLORIDE ALTANA 25MG/ML 50MG/ML BAXTER HLTHCARE 25MG/ML FRESENIUS KABI USA 25MG/ML 50MG/ML HOSPIRA 25MG/ML 50MG/ML 50MG/ML PHARMAFAIR 25MG/ML 25MG/ML
A085551 A087273 A087273 A085551 A088184 A088185 A087416 A086821 A087546 A088862 A089106
002 001 002 001 001 001 001

001
001
001 001 Apr 20, 1982 Apr 20, 1982 Mar 31, 1983 Mar 31, 1983
Feb 14, 1986 Feb 14, 1986

INJECTABLE; INJECTION HYDROXYZINE HYDROCHLORIDE PHARMAFAIR 50MG/ML 50MG/ML SMITH AND NEPHEW 25MG/ML SOLOPAK 25MG/ML 25MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML WATSON LABS 25MG/ML 25MG/ML 50MG/ML 50MG/ML WYETH AYERST 25MG/ML 50MG/ML ORGATRAX ORGANON USA INC 25MG/ML 50MG/ML VISTARIL PFIZER 25MG/ML 50MG/ML SYRUP; ORAL ATARAX ROERIG 10MG/5ML HYDROXYZINE HYDROCHLORIDE ALPHARMA US PHARMS 10MG/5ML KV PHARM 10MG/5ML STI PHARMA LLC 10MG/5ML TABLET; ORAL ATARAX PFIZER 10MG 25MG 50MG 100MG HYDROXYZINE HYDROCHLORIDE ABLE 10MG 25MG 50MG ACTAVIS TOTOWA 10MG 25MG 50MG HALSEY 10MG 25MG 50MG IVAX PHARMS 10MG 25MG 50MG KV PHARM 10MG 25MG 50MG 100MG MIKAH PHARMA 10MG 25MG 50MG MUTUAL PHARM 10MG 25MG 50MG 100MG PLIVA 100MG PUREPAC PHARM 10MG 25MG
6 - 188 (of 360)
A088881 A089107 A087592 A086822 A087591 A087310 A087593 A087595 A087596 A085778 A087274 A085779 A087274 A086258 A086258 A087014 A087014 N011111 N011111
001 001 001 001 001 001 001 001 001 001 001 001 002 001 002 001 002 001 002
Feb 14, 1986 Feb 14, 1986
N010485 A088785 A087730 A086880
001 001 001 001 Feb 03, 1988 Jul 01, 1982
N010392 N010392 N010392 N010392 A040559 A040562 A040563 A089071 A089072 A089073 A089366 A089117 A089396 A087216 A087410 A087411 A087819 A087820 A087821 A087822 A040600 A040602 A040604 A088409 A087857 A087860 A087862 A081054 A088120 A088121
001 004 006 005 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jul Jul Jul Jul Jul Jul May May May 22, 22, 22, 22, 22, 22, 02, 02, 02, 2004 2004 2004 1986 1986 1986 1988 1988 1988
Jun Jun Jun Jun Dec Dec Dec Nov Apr Apr Apr Sep Sep Sep
23, 23, 23, 23, 28, 28, 28, 15, 18, 18, 18, 25, 25, 25,
1982 1982 1982 1982 2004 2004 2004 1983 1983 1983 1983 1995 1984 1984

TABLET; ORAL HYDROXYZINE HYDROCHLORIDE PUREPAC PHARM 50MG QUANTUM PHARMICS 10MG 25MG 50MG SANDOZ 10MG 10MG 25MG 25MG 50MG 50MG SUPERPHARM 10MG 25MG 50MG USL PHARMA 10MG 25MG 50MG VINTAGE 10MG 25MG 50MG WATSON LABS 10MG 25MG 50MG
6 - 189 (of 360)
001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Oct Oct Oct
25, 22, 22, 22,
1984 1985 1985 1985
Dec 20, 1982 Dec 20, 1982 Dec Dec Dec Dec Mar Mar Mar Jan Jan Jan 20, 05, 05, 05, 20, 20, 20, 22, 22, 22, 1982 1984 1984 1984 1986 1986 1986 1982 1982 1982
HYDROXYZINE PAMOATE
CAPSULE; ORAL HYDROXYZINE PAMOATE DURAMED PHARMS BARR
IVAX SUB TEVA PHARMS PAR PHARM
SANDOZ
SUPERPHARM
VANGARD WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
25MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 25MG HCL 25MG HCL 50MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 25MG HCL 25MG HCL 50MG HCL 50MG HCL 50MG HCL 100MG HCL 100MG HCL 100MG HCL
A088593 A088594 A088595 A087761 A087760 A087656 A089145 A087657 A089146 A087658 A081127 A081128 A081129 A089031 A089032 A089033 A088392 A088393 A086698 A086840 A086695 A086705 A087767 A086697 A086728 A087790 A088713 N011459
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 006
Feb Feb Feb Mar Mar Jun Mar Jun Mar Jun Jun Jun Jun Jan Jan Jan Sep Sep
29, 29, 29, 05, 05, 11, 17, 11, 17, 11, 28, 28, 28, 02, 02, 02, 19, 19,
1984 1984 1984 1982 1982 1982 1986 1982 1986 1982 1991 1991 1991 1987 1987 1987 1983 1983
Jul 01, 1982 Jul 01, 1982 Aug 16, 1982 Oct 05, 1982 Aug 16, 1982 Mar 04, 1985
HY-PAM "25" TEVA VISTARIL PFIZER SUSPENSION; ORAL VISTARIL PFIZER
EQ 25MG HCL EQ 100MG HCL
EQ 25MG HCL/5ML
N011795
001

IBANDRONATE SODIUM
TABLET; ORAL
BONIVA
HOFFMANN LA ROCHE
6 - 190 (of 360)
EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N021455
001
May 16, 2003
IBUPROFEN
CAPSULE; ORAL
MIDOL
BAYER
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
A070626
001
Sep 02, 1987
A071002
001
Sep 02, 1987
SUSPENSION; ORAL CHILDREN'S ADVIL WYETH CONS IBU ABBOTT MOTRIN MCNEIL CONSUMER SUSPENSION/DROPS; ORAL MOTRIN MCNEIL TABLET; ORAL ACHES-N-PAIN LEDERLE CAP-PROFEN PERRIGO IBU BASF
N019833 N019784 N019842
002 001 001
Sep 19, 1989 Dec 18, 1989 Sep 19, 1989
40MG/ML
N020476
001
May 25, 1995
A071065 A072097 A070083 N018197 A070088 A070099 A070745 A071773 A070556 A071264 A073691 A071027 A071028 A071029 A071030 A072137 A071144 A071154 A072040 A072901 A072903 A071145 A071146 A071769 A070629 A070630 A071266 A070081 A070476 A070493
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
May 28, 1987 Dec 08, 1987 Feb 22, 1985 Feb 08, 1985 Mar 29, 1985 Jul 23, 1986 Jul 16, 1987 Jun Jul Feb Sep Mar Mar Mar Feb Jan Oct Apr Dec Dec Sep Sep May Sep Sep Oct Jun Jun Dec 14, 25, 25, 29, 23, 23, 23, 05, 20, 27, 29, 19, 19, 23, 23, 08, 19, 19, 15, 16, 16, 24, 1985 1986 1994 1987 1987 1987 1987 1988 1987 1987 1988 1991 1991 1986 1986 1987 1986 1986 1986 1986 1986 1985
IBUPRIN PLIVA IBUPROFEN ABBOTT CONTRACT PHARMACAL HALSEY
LEDERLE LEINER MCNEIL MUTUAL PHARM

IBUPROFEN
TABLET; ORAL IBUPROFEN MUTUAL PHARM
6 - 191 (of 360)
MYLAN
NORTHSTAR HLTHCARE
OHM LABS PAR PHARM
PERRIGO PLIVA
PUREPAC PHARM
SANDOZ
SUPERPHARM TEVA
VINTAGE PHARMS WATSON LABS
200MG 200MG 400MG 600MG 800MG 200MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 200MG 300MG 400MG 600MG 800MG 200MG 400MG 600MG 800MG 200MG 200MG 300MG 400MG 600MG 800MG 200MG 200MG 200MG 200MG 300MG 400MG 400MG 600MG 600MG 800MG 800MG 600MG 200MG 400MG 600MG 800MG 200MG 200MG 200MG 300MG 400MG 600MG 800MG 800MG 400MG 800MG 200MG 200MG
A070908 A071462 A070079 A070080 A071448 A071870 A070045 A070057 A071999 A078132 A078132 A078132 A070818 A071575 A070328 A070329 A070330 A070986 A072098 A071666 A071667 A071668 A071122 A071664 A071123 A071124 A071125 A071964 A070733 A071807 A074525 A074533 A070734 A070735 A072064 A070736 A072065 A071938 A072169 A070709 A073141 A073343 A073344 A073345 A072249 A071765 A071905 A071338 A070038 A070041 A071547 A071911 A070469 A071965 A070475 A071215
001 001 001 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Oct Jul Jul Feb May Sep Sep Dec Sep Sep Sep Dec May Aug Aug Aug Jul Dec Jun Jun Jun Oct Feb Sep Sep Sep Feb Sep Feb Dec Dec Jun Jun Jan Jun Jan Jan Dec Apr May Jun Jun Jun Jan Sep Mar Dec Sep Sep Jul Oct
26, 02, 24, 24, 18, 05, 24, 24, 03, 10, 10, 10, 26, 08, 06, 06, 06, 25, 08, 18, 18, 18, 03, 03, 19, 19, 19, 01, 19, 25, 15, 15, 12, 12, 14, 12, 14, 14, 11, 25, 29, 30, 30, 30, 10, 04, 08, 01, 06, 06, 02, 13,
1986 1986 1985 1985 1987 1988 1985 1985 1987 2007 2007 2007 1985 1987 1985 1985 1985 1986 1987 1987 1987 1987 1986 1987 1986 1986 1986 1988 1986 1988 1995 1995 1986 1986 1988 1986 1988 1988 1987 1986 1992 1992 1992 1992 1989 1987 1988 1986 1985 1985 1987 1987
IBUPROHM OHM LABS IBU-TAB ALRA MEDIPREN MCNEIL
Aug 29, 1985 Aug 11, 1988 Feb 06, 1986 Jun 26, 1986

IBUPROFEN
TABLET; ORAL MIDOL BAYER MOTRIN MCNEIL CONSUMER
6 - 192 (of 360)
A070591 A071001 N017463 N017463 N017463 N017463 N020418 A072035 A072036 N019012 N019012 N018197
001 001 003 002 004 005 001 001 001 001 002 002
Sep 02, 1987 Sep 02, 1987
MCNEIL PED NUPRIN BRISTOL MYERS MCNEIL RUFEN BASF TABLET, CHEWABLE; ORAL MOTRIN MCNEIL PED
May 22, 1985 Nov 16, 1994 Feb Feb May Jul 16, 16, 18, 29, 1988 1988 1984 1987
Mar 05, 1984
50MG 100MG
N020135 N020135
001 002
Nov 16, 1994 Nov 16, 1994
IBUPROFEN; OXYCODONE HYDROCHLORIDE

TABLET; ORAL COMBUNOX FOREST LABS
400MG;5MG
N021378
001
Nov 26, 2004
IDARUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION IDAMYCIN PHARMACIA AND UPJOHN
5MG/VIAL 10MG/VIAL 20MG/VIAL
N050661 N050661 N050661 A065037 A065037 A065037
002 001 003 003 002 001
Sep 27, 1990 Sep 27, 1990 Apr 25, 1995 May 01, 2002 May 01, 2002 May 01, 2002
IDARUBICIN HYDROCHLORIDE TEVA PARENTERAL 5MG/VIAL 10MG/VIAL 20MG/VIAL
IDOXURIDINE
OINTMENT; OPHTHALMIC STOXIL GLAXOSMITHKLINE 0.5% SOLUTION/DROPS; OPHTHALMIC STOXIL GLAXOSMITHKLINE 0.1%
N015868
001
N013934
001
IFOSFAMIDE; MESNA
INJECTABLE; INJECTION IFEX/MESNEX KIT BAXTER HLTHCARE
1GM/VIAL;100MG/ML 3GM/VIAL;100MG/ML
N019763 N019763
003 004
Oct 10, 1992 Oct 10, 1992
ILOPROST
SOLUTION; INHALATION VENTAVIS ACTELION PHARMS LTD
20MCG/2ML (10MCG/ML)
N021779
001
Dec 29, 2004
IMATINIB MESYLATE
CAPSULE; ORAL GLEEVEC NOVARTIS
N021335 N021335
001 002
May 10, 2001 May 10, 2001

IMIPRAMINE HYDROCHLORIDE
CONCENTRATE; ORAL IMIPRAMINE HYDROCHLORIDE NOVARTIS 25MG/ML INJECTABLE; INJECTION TOFRANIL NOVARTIS 12.5MG/ML TABLET; ORAL IMIPRAMINE HYDROCHLORIDE LEDERLE 10MG 25MG 50MG PAR PHARM 25MG ROXANE 10MG 25MG 50MG SANDOZ 10MG 25MG 50MG TEVA 10MG 25MG 50MG USL PHARMA 25MG VANGARD 10MG 25MG 50MG WATSON LABS 10MG 10MG 25MG 25MG 50MG 50MG WEST WARD 25MG 50MG JANIMINE ABBOTT 10MG 25MG 50MG PRAMINE ALRA 10MG 25MG 50MG PRESAMINE SANOFI AVENTIS US 10MG 25MG 50MG
6 - 193 (of 360)
A086765
001
N011838
002
A086269 A086267 A086268 A089497 A083799 A083799 A083799 A085200 A084869 A085133 A083729 A083729 A083729 A087776 A088036 A087619 A087631 A085220 A085875 A084252 A085878 A085221 A085877 A088222 A088223 N017895 N017895 N017895 A083827 A083827 A083827 N011836 N011836 N011836
001 001 001 001 001 002 003 001 002 001 001 004 003 001 001 001 001 001 001 002 001 001 001 001 001 001 002 003 001 002 003 006 003 007
Jul 14, 1987
Feb Nov Feb Jan
10, 03, 09, 04,
1982 1982 1982 1982
May 26, 1983 May 26, 1983
INAMRINONE LACTATE
INJECTABLE; INJECTION AMRINONE LACTATE BAXTER HLTHCARE CORP HOSPIRA INOCOR SANOFI AVENTIS US
A075542 A074616 N018700
001 001 001
May 10, 2000 Aug 03, 1998 Jul 31, 1984
INDAPAMIDE
TABLET; ORAL INDAPAMIDE CADISTA PHARMS SANDOZ TEVA
1.25MG 2.5MG 1.25MG 2.5MG 1.25MG
A075201 A075201 A074594 A074594 A074498
001 002 001 002 002
Dec Dec May May Feb
04, 04, 23, 23, 12,
1998 1998 1996 1996 1998

INDAPAMIDE
TABLET; ORAL INDAPAMIDE TEVA
6 - 194 (of 360)
1.25MG 2.5MG 2.5MG 1.25MG 2.5MG
A074665 A074498 A074665 N018538 N018538
001 001 002 002 001
Apr 04, 1997 Oct 31, 1996 Apr 04, 1997 Apr 29, 1993 Jul 06, 1983
LOZOL SANOFI AVENTIS US
INDECAINIDE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL DECABID LILLY EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE
N019693 N019693 N019693
001 002 003
Dec 29, 1989 Dec 29, 1989 Dec 29, 1989
INDINAVIR SULFATE
CAPSULE; ORAL CRIXIVAN MERCK SHARP DOHME
EQ 333MG BASE
N020685
005
Dec 17, 1998
INDOCYANINE GREEN
INJECTABLE; INJECTION IC-GREEN AKORN
N011525 N011525 N011525
003 004 002
INDOMETHACIN
CAPSULE; ORAL INDOCIN IROKO PHARMS INDO-LEMMON TEVA INDOMETHACIN ABLE DURAMED PHARMS BARR HALSEY IVAX SUB TEVA PHARMS MUTUAL PHARM
25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 25MG 50MG 50MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG
N016059 N016059 A070266 A070267 A076666 A076666 A070326 A070327 A070782 A070635 N018730 N018730 A070067 A070899 A070068 A070900 N018858 N018806 N018806 A070813 A070592 A071148 A071149 A070353 A070354 A070487 A070488 A071342 A071343
001 002 001 001 001 002 001 001 001 001 001 002 001 001 001 001 002 001 002 001 001 001 001 001 001 001 001 001 001 Nov 07, 1985 Nov 07, 1985 Dec Dec Oct Oct Jun Jun May May Oct Feb Oct Feb Apr Nov Nov Aug Aug Mar Mar Jun Jun Oct Oct Apr Apr 17, 17, 18, 18, 03, 03, 04, 04, 03, 09, 03, 09, 20, 23, 23, 11, 11, 18, 18, 18, 18, 10, 10, 18, 18, 2003 2003 1985 1985 1987 1987 1984 1984 1986 1987 1986 1987 1984 1984 1984 1986 1986 1987 1987 1985 1985 1986 1986 1988 1988
MYLAN PARKE DAVIS PIONEER PHARMS PLIVA ROXANE SUPERPHARM TEVA

INDOMETHACIN
CAPSULE; ORAL
INDOMETHACIN
VINTAGE
6 - 195 (of 360)
25MG 50MG 50MG WATSON LABS 25MG 25MG 25MG 25MG 50MG 50MG 50MG 50MG 50MG CAPSULE, EXTENDED RELEASE; ORAL INDOCIN SR IROKO PHARMS 75MG INDOMETHACIN ABLE 75MG INWOOD LABS 75MG SUPPOSITORY; RECTAL INDOCIN IROKO PHARMS 50MG SUSPENSION; ORAL INDOMETHACIN ROXANE 25MG/5ML
N018829 A070651 N018829 A070529 A070784 A072996 N018690 A070530 A070785 A071635 A072997 N018690
002 001 001 001 001 001 001 001 001 001 001 002
Aug Mar Aug Oct Aug Jul Jul Oct Aug May Jul Jul
06, 05, 06, 18, 20, 31, 31, 18, 20, 18, 31, 31,
1984 1986 1984 1985 1986 1991 1984 1985 1986 1987 1991 1984
N018185 A076114 A072410
001 001 001
Feb 23, 1982 Feb 06, 2002 Mar 15, 1989
N017814
001
Aug 13, 1984
A071412
001
Mar 18, 1987
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

INJECTABLE; SUBCUTANEOUS NOVOLOG MIX 50/50 NOVO NORDISK INC 50 UNITS/ML;50 UNITS/ML NOVOLOG MIX 70/30 PENFILL NOVO NORDISK INC 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
N021810 N021172 N021172
001 002 003
Aug 26, 2008 Nov 01, 2001 Nov 01, 2001
INSULIN ASPART RECOMBINANT

INJECTABLE; SUBCUTANEOUS NOVOLOG INNOLET NOVO NORDISK INC
300 UNITS/3ML (100 UNITS/ML)
N020986
004
Apr 23, 2004
INSULIN DETEMIR RECOMBINANT

INJECTABLE; SUBCUTANEOUS LEVEMIR INNOLET NOVO NORDISK INC LEVEMIR PENFILL NOVO NORDISK INC
300 UNITS/3ML (100 UNITS/ML) 300 UNITS/3ML (100 UNITS/ML)
N021536 N021536
003 004
Jun 16, 2005 Jun 16, 2005
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

INJECTABLE; INJECTION HUMALOG MIX 50/50 PEN LILLY HUMALOG MIX 75/25 PEN LILLY
50 UNITS/ML;50 UNITS/ML 75 UNITS/ML;25 UNITS/ML
N021018 N021017
003 003
Dec 22, 1999 Dec 22, 1999
INSULIN LISPRO RECOMBINANT

INJECTABLE; INJECTION HUMALOG PEN LILLY
100 UNITS/ML
N020563
002
Aug 06, 1998

INSULIN PORK
ILETIN I
LILLY INSULIN
NOVO NORDISK INC REGULAR INSULIN
NOVO NORDISK INC
6 - 196 (of 360)
500 UNITS/ML 40 UNITS/ML 100 UNITS/ML
N017931 N017926 N017926
001
001
003
INSULIN PURIFIED BEEF

REGULAR ILETIN II
LILLY
100 UNITS/ML
N018478
001
INSULIN PURIFIED PORK

ILETIN II
LILLY 500 UNITS/ML REGULAR ILETIN II (PORK)
LILLY 100 UNITS/ML REGULAR PURIFIED PORK INSULIN
NOVO NORDISK INC 100 UNITS/ML VELOSULIN
NOVO NORDISK INC 100 UNITS/ML
N018344 N018344 N018381 N018193
002
001
001
001
INSULIN PURIFIED PORK; INSULIN SUSP ISOPHANE PURIFIED PORK

INSULIN NORDISK MIXTARD (PORK)
NOVO NORDISK INC 30 UNITS/ML;70 UNITS/ML
N018195
001

INJECTABLE; INJECTION HUMULIN BR LILLY VELOSULIN BR NOVO NORDISK INC POWDER; INHALATION EXUBERA PFIZER
N019529 N021028
001 001
Apr 28, 1986 Jul 19, 1999
1MG/INH 3MG/INH
N021868 N021868
001 002
Jan 27, 2006 Jan 27, 2006
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

INJECTABLE; INJECTION HUMULIN 50/50 LILLY
50 UNITS/ML;50 UNITS/ML
N020100
001
Apr 29, 1992
INSULIN RECOMBINANT PURIFIED HUMAN

INJECTABLE; INJECTION NOVOLIN R NOVO NORDISK INC VELOSULIN BR HUMAN NOVO NORDISK INC
N018778 N019450
001 001
Aug 30, 1983 May 30, 1986
INSULIN RECOMBINANT PURIFIED HUMAN; INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN
INJECTABLE; INJECTION MIXTARD HUMAN 70/30 BAYER PHARMS NOVOLIN 70/30 NOVO NORDISK INC
30 UNITS/ML;70 UNITS/ML 30 UNITS/ML;70 UNITS/ML
N019585 N019441
001 001
Mar 11, 1988 Jul 11, 1986

INSULIN SUSP ISOPHANE BEEF
INJECTABLE; INJECTION NPH INSULIN NOVO NORDISK INC
6 - 197 (of 360)
N017929 N017929
001 003
INSULIN SUSP ISOPHANE BEEF/PORK

INJECTABLE; INJECTION NPH ILETIN I (BEEF-PORK) LILLY 40 UNITS/ML 100 UNITS/ML
N017936 N017936
001 002
INSULIN SUSP ISOPHANE PURIFIED BEEF

INJECTABLE; INJECTION NPH ILETIN II LILLY
100 UNITS/ML
N018479
001
INSULIN SUSP ISOPHANE PURIFIED PORK

INJECTABLE; INJECTION INSULIN INSULATARD NPH NORDISK NOVO NORDISK INC 100 UNITS/ML NPH ILETIN II (PORK) LILLY 100 UNITS/ML NPH PURIFIED PORK ISOPHANE INSULIN NOVO NORDISK INC 100 UNITS/ML
N018194 N018345 N018623
001 001 001
INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN

INJECTABLE; INJECTION INSULATARD NPH HUMAN NOVO NORDISK INC NOVOLIN N NOVO NORDISK INC
N019449 N019065
001 001
May 30, 1986 Jan 23, 1985
INSULIN SUSP PROTAMINE ZINC BEEF/PORK

INJECTABLE; INJECTION PROTAMINE ZINC & ILETIN I (BEEF-PORK) LILLY 40 UNITS/ML 100 UNITS/ML
N017932 N017932
001 002
INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF

INJECTABLE; PROTAMINE LILLY PROTAMINE BRISTOL INJECTION ZINC AND ILETIN II 100 UNITS/ML ZINC INSULIN MYERS SQUIBB 40 UNITS/ML 100 UNITS/ML
N018476 N017928 N017928
001 001 003
INSULIN SUSP PROTAMINE ZINC PURIFIED PORK

INJECTABLE; INJECTION PROTAMINE ZINC AND ILETIN II (PORK) LILLY 100 UNITS/ML
N018346
001
INSULIN ZINC SUSP BEEF

INJECTABLE; INJECTION LENTE INSULIN NOVO NORDISK INC
N017998 N017998
001 003
INSULIN ZINC SUSP EXTENDED BEEF

INJECTABLE; INJECTION ULTRALENTE INSULIN NOVO NORDISK INC
100 UNITS/ML
N017997
003

INSULIN ZINC SUSP EXTENDED PURIFIED BEEF
INJECTABLE; INJECTION ULTRALENTE NOVO NORDISK INC
6 - 198 (of 360)
100 UNITS/ML
N018385
001
INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN

INJECTABLE; INJECTION HUMULIN U LILLY
N019571 N019571
001 002
Jun 10, 1987 Jun 10, 1987
INSULIN ZINC SUSP PROMPT BEEF

INJECTABLE; INJECTION SEMILENTE INSULIN NOVO NORDISK INC
100 UNITS/ML
N017996
003
INSULIN ZINC SUSP PROMPT PURIFIED PORK

INJECTABLE; INJECTION SEMILENTE NOVO NORDISK INC
100 UNITS/ML
N018382
001
INSULIN ZINC SUSP PURIFIED BEEF

INJECTABLE; INJECTION LENTE ILETIN II LILLY
100 UNITS/ML
N018477
001
INSULIN ZINC SUSP PURIFIED BEEF/PORK

INJECTABLE; INJECTION LENTARD NOVO NORDISK INC
100 UNITS/ML
N018384
001
INSULIN ZINC SUSP PURIFIED PORK

INJECTABLE; INJECTION LENTE NOVO NORDISK INC LENTE ILETIN II (PORK) LILLY
N018383 N018347
001 001
INSULIN ZINC SUSP RECOMBINANT HUMAN

INJECTABLE; INJECTION HUMULIN L LILLY NOVOLIN L NOVO NORDISK INC
N019377 N019965
002 001
Sep 30, 1985 Jun 25, 1991
INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN

INJECTABLE; INJECTION NOVOLIN L NOVO NORDISK INC
100 UNITS/ML
N018777
001
Aug 30, 1983
INULIN
INJECTABLE; INJECTION INULIN AND SODIUM CHLORIDE ISO TEX 100MG/ML
N002282
001
INVERT SUGAR
INJECTABLE; INJECTION TRAVERT 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 10GM/100ML
N016717
001

IOBENGUANE SULFATE I-131
INJECTABLE; INJECTION IOBENGUANE SULFATE I 131 PHARMALUCENCE 2.3mCi/ML
6 - 199 (of 360)
N020084
001
Mar 25, 1994
IOCETAMIC ACID
TABLET; ORAL CHOLEBRINE MALLINCKRODT
750MG
N017129
001
IODAMIDE MEGLUMINE
INJECTABLE; INJECTION RENOVUE-65 BRACCO RENOVUE-DIP BRACCO
65% 24%
N017902 N017903
001 001
IODIPAMIDE MEGLUMINE
INJECTABLE; INJECTION CHOLOGRAFIN MEGLUMINE BRACCO
10.3%
N009321
007
IODIPAMIDE SODIUM
INJECTABLE; INJECTION CHOLOGRAFIN SODIUM BRACCO
20%
N009321
001
IODOHIPPURATE SODIUM I-123

INJECTABLE; INJECTION NEPHROFLOW GE HEALTHCARE
1mCi/ML
N018289
001
Dec 28, 1984
IODOHIPPURATE SODIUM I-131

INJECTABLE; INJECTION HIPPURAN I 131 MALLINCKRODT 0.25mCi/ML HIPPUTOPE BRACCO 1-2mCi/VIAL IODOHIPPURATE SODIUM I 131 PHARMALUCENCE 0.2mCi/ML
N016666 N015419 N017313
001 002 001
IODOXAMATE MEGLUMINE
INJECTABLE; INJECTION CHOLOVUE BRACCO
9.9% 40.3%
N018077 N018076
001 001
IOFETAMINE HYDROCHLORIDE I-123

INJECTABLE; INJECTION SPECTAMINE IMP
1mCi/ML
N019432
001
Dec 24, 1987
IOHEXOL
INJECTABLE; INJECTION OMNIPAQUE 210 GE HEALTHCARE SOLUTION; URETHRAL OMNIPAQUE 70 GE HEALTHCARE
45.3%
N018956
006
Jun 30, 1989
15.1%
N018956
007
Jun 01, 1994

IOPAMIDOL
INJECTABLE; INJECTION IOPAMIDOL BAXTER HLTHCARE
6 - 200 (of 360)
HOSPIRA
41% 51% 61% 76% 61% 76%
A074629 A074629 A074629 A074629 A074734 A074734 A074881 A074898 A074636 A074881 A074898 A075005 A074636 A074638 A074881 A074898 A075005 A074636 A074637 A074881 A074898 A075005 A074636 N018735 N020327
001 004 002 003 001 002 001 001 001 002 002 001 002 001 003 003 002 003 001 004 004 003 004 005 001
Nov Mar Nov Nov Dec Dec
06, 31, 06, 06, 10, 10,
1996 1998 1996 1996 1996 1996
IOPAMIDOL-200 COOK IMAGING 41% HOSPIRA 41% IOPAMIDOL-200 IN PLASTIC CONTAINER HOSPIRA 41% IOPAMIDOL-250 COOK IMAGING 51% HOSPIRA 51% 51% IOPAMIDOL-250 IN PLASTIC CONTAINER HOSPIRA 51% IOPAMIDOL-300 ABBVIE 61% COOK IMAGING 61% HOSPIRA 61% 61% IOPAMIDOL-300 IN PLASTIC CONTAINER HOSPIRA 61% 61% IOPAMIDOL-370 COOK IMAGING 76% HOSPIRA 76% 76% IOPAMIDOL-370 IN PLASTIC CONTAINER HOSPIRA 76% ISOVUE-128 BRACCO 26% ISOVUE-200 BRACCO 41%
Jul 28, 2000 Dec 30, 1997 Dec 30, 1997 Jul 28, 2000 Dec 30, 1997 Feb 24, 1998 Dec 30, 1997 Apr Jul Dec Feb 30, 28, 30, 24, 1997 2000 1997 1998
Dec 30, 1997 Apr 03, 1997 Jul 28, 2000 Dec 30, 1997 Feb 24, 1998 Dec 30, 1997 Oct 21, 1986 Oct 12, 1994
IOPANOIC ACID
TABLET; ORAL TELEPAQUE GE HEALTHCARE
500MG
N008032
001
IOPHENDYLATE
INJECTABLE; INJECTION PANTOPAQUE ALCON
100%
N005319
001
IOTHALAMATE MEGLUMINE; IOTHALAMATE SODIUM

INJECTABLE; INJECTION VASCORAY MALLINCKRODT
52%;26%
N016783
001
IOTHALAMATE SODIUM
INJECTABLE; INJECTION ANGIO-CONRAY MALLINCKRODT CONRAY 325 MALLINCKRODT CONRAY 400 MALLINCKRODT
80% 54.3% 66.8%
N013319 N017685 N014295
001 001 001

IOTROLAN
INJECTABLE; INTRATHECAL OSMOVIST 190 BAYER HLTHCARE OSMOVIST 240 BAYER HLTHCARE
6 - 201 (of 360)
40.6% 51.3%
N019580 N019580
001 002
Dec 07, 1989 Dec 07, 1989
IOVERSOL
INJECTABLE; INJECTION OPTIRAY 160 MALLINCKRODT OPTIRAY 240 MALLINCKRODT OPTIRAY 320 MALLINCKRODT
34% 51% 68%
N019710 N020923 N020923
003 001 002
Dec 30, 1988 May 28, 1998 May 29, 1998
IPODATE CALCIUM
GRANULE; ORAL ORAGRAFIN CALCIUM BRACCO
3GM/PACKET
N012968
001
IPODATE SODIUM
CAPSULE; ORAL BILIVIST BAYER HLTHCARE ORAGRAFIN SODIUM BRACCO
500MG 500MG
A087768 N012967
001 001
Aug 11, 1982
IPRATROPIUM BROMIDE
AEROSOL, METERED; INHALATION ATROVENT BOEHRINGER INGELHEIM 0.018MG/INH SOLUTION; INHALATION ATROVENT BOEHRINGER INGELHEIM 0.02% IPRATROPIUM BROMIDE ACTAVIS MID ATLANTIC 0.02% PHARMASCIENCE INC 0.02% ROXANE 0.02%
N019085
001
Dec 29, 1986
N020228 A075111 A075507 A075867
001 001 001 001
Sep 29, 1993 Apr 22, 1999 Jan 19, 2001 Jul 22, 2002
INJECTABLE; INJECTION IRINOTECAN HYDROCHLORIDE SANDOZ 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML)
A077994 A077994
001 002
Feb 27, 2008 Feb 27, 2008
IRON DEXTRAN
INJECTABLE; INJECTION IRON DEXTRAN SANOFI AVENTIS US
EQ 50MG IRON/ML
N010787
002
IRON SUCROSE
INJECTABLE; INTRAVENOUS VENOFER LUITPOLD
EQ 75MG BASE/3.75ML (EQ 20MG BASE/ML)
N021135
003
Mar 29, 2005
ISOETHARINE HYDROCHLORIDE
SOLUTION; INHALATION BETA-2 NEPHRON BRONKOSOL SANOFI AVENTIS US
1% 0.25% 1%
A086711 N012339 N012339
001 009 008

ISOETHARINE HYDROCHLORIDE
SOLUTION; INHALATION ISOETHARINE HYDROCHLORIDE ALPHARMA US PHARMS 1% ASTRAZENECA 0.062% 0.062% 0.125% 0.125% 0.167% 0.167% 0.2% 0.2% 0.25% 0.25% BAXTER HLTHCARE 0.08% 0.14% 0.25% DEY 0.08% 0.1% 0.17% 0.25% 1% INTL MEDICATION 0.077% 0.08% 0.1% 0.143% 0.167% 0.2% 0.25% 1% PARKE DAVIS 0.5% 1% ROXANE 0.1% 0.125% 0.167% 0.2% 0.25% 1% ISOETHARINE HYDROCHLORIDE S/F DEY 0.08% 0.1% 0.17% 0.25% 1%
6 - 202 (of 360)
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 004 005 006 007 008 001 001 001 001 001 001 001 001 001 001 001 001 001
Nov Jun Nov Jun Mar Jun Mar Jun Mar Jun Jul Mar Aug Dec
15, 13, 15, 13, 14, 13, 14, 13, 14, 13, 29, 26, 01, 03,
1982 1991 1982 1991 1984 1991 1984 1991 1984 1991 1983 1984 1983 1982
Dec 03, 1982
Sep 16, 1983 Jun 03, 1983
Nov Nov Nov Nov Sep
22, 22, 22, 22, 15,
1988 1988 1988 1988 1986
ISOETHARINE MESYLATE
AEROSOL, METERED; INHALATION BRONKOMETER SANOFI AVENTIS US 0.34MG/INH ISOETHARINE MESYLATE ALPHARMA US PHARMS 0.34MG/INH
N012339 A087858
007 001 Aug 21, 1984
ISOFLURANE
LIQUID; INHALATION ISOFLURANE MARSAM PHARMS LLC
99.9%
A074393
001
May 12, 1995
ISOFLUROPHATE
OINTMENT; OPHTHALMIC FLOROPRYL MERCK
0.025%
N010656
001

ISONIAZID
INJECTABLE; INJECTION NYDRAZID SANDOZ RIMIFON ROCHE SYRUP; ORAL ISONIAZID MIKART LANIAZID LANNETT RIMIFON ROCHE TABLET; ORAL DOW-ISONIAZID DOW PHARM HYZYD MEDPOINTE PHARM HLC INH NOVARTIS ISONIAZID DURAMED PHARMS BARR HALSEY IMPAX LABS IVAX SUB TEVA PHARMS LILLY MK LABS MUTUAL PHARM NEXGEN PHARMA INC PANRAY
6 - 203 (of 360)
N008662 N008420 N008420
001 002 003
A081118 A089243 N008420
001 001 001
Jul 21, 1997 Feb 03, 1986
A080330 A080134 A080134 A080935 A088231 A088119 A083632 A080153 A080270 A083610 N008499 N008499 A080941 A080136 A083633 A084050 N008428 N008428 N008428 A083060 A085091 A080368 A080368 A080132 A080132 A080522 A080401 A080523 A085790 A083178 A085784 A080120 A080140 A080140 A089776 N008392 A080126 A080126
002 003 004 001 001 001 001 001 001 001 002 003 001 001 001 001 001 002 003 001 001 001 002 003 004 001 001 001 001 001 001 002 001 002 001 003 001 002 Mar 17, 1983 Mar 17, 1983
PERRIGO PHARMAVITE PHOENIX LABS NY PUREPAC PHARM WATSON LABS
Jul 14, 1982 Jul 14, 1982
WHITEWORTH TOWN PLSN LANIAZID LANNETT
Jun 13, 1988
NYDRAZID BRISTOL MYERS SQUIBB STANOZIDE EVERYLIFE

ISOPROPAMIDE IODIDE
TABLET; ORAL DARBID GLAXOSMITHKLINE
6 - 204 (of 360)
EQ 5MG BASE
N010744
001
ISOPROTERENOL HYDROCHLORIDE
AEROSOL, METERED; INHALATION ISOPROTERENOL HYDROCHLORIDE 3M 0.12MG/INH ALPHARMA US PHARMS 0.12MG/INH ISUPREL SANOFI AVENTIS US 0.103MG/INH DISC; INHALATION NORISODRINE AEROTROL ABBOTT 0.25% INJECTABLE; INJECTION ISOPROTERENOL HYDROCHLORIDE ABRAXIS PHARM 0.2MG/ML BAXTER HLTHCARE 0.2MG/ML HOSPIRA 0.02MG/ML 0.2MG/ML SOLUTION; INHALATION AEROLONE LILLY 0.25% ISOPROTERENOL HYDROCHLORIDE ARMOUR PHARM 0.031% 0.062% DEY 0.5% PARKE DAVIS 0.25% 0.5% ISUPREL SANOFI AVENTIS US 0.5% 1% VAPO-ISO FISONS 0.5% TABLET; RECTAL, SUBLINGUAL ISUPREL SANOFI AVENTIS US 10MG 15MG
N010375 A085904 N011178
004 001 001
N016814
001
A083431 A083486 A083283 A083346
001 001 001 001
N007245 A087935 A087936 A086764 A085994 A085540 N006327 N006327 N016813
001 001 001 001 001 001 002 003 001 Nov 18, 1982 Nov 18, 1982 Jan 04, 1982
N006328 N006328
001 002
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE

AEROSOL, METERED; INHALATION DUO-MEDIHALER 3M 0.16MG/INH;0.24MG/INH
N013296
001
ISOPROTERENOL SULFATE
AEROSOL, METERED; INHALATION MEDIHALER-ISO 3M 0.08MG/INH POWDER; INHALATION NORISODRINE ABBVIE 10% 25%
N010375
003
N006905 N006905
003 002
ISOSORBIDE
SOLUTION; ORAL ISMOTIC ALCON
100GM/220ML
N017063
001
CAPSULE, EXTENDED RELEASE; ORAL ISORDIL WYETH AYERST 40MG
N012882
002
Jul 29, 1988

TABLET; ORAL
MUTUAL PHARM
6 - 205 (of 360)
SUPERPHARM
A086166 A086169 A086167 A087564 A089190 A089191 A089192 N016192 N016192 A086405 A088124 A088125
002 001 001 001 001 001 001 001 002 002 001 001
Sep Sep Sep Sep Feb Feb Feb Apr Apr Aug Aug Aug
19, 19, 19, 18, 17, 17, 17, 01, 01, 21, 21, 21,
1986 1986 1986 1986 1987 1987 1987 1996 1996 1990 1990 1990
SORBITRATE ASTRAZENECA
TABLET; SUBLINGUAL
ISORDIL
BIOVAIL
2.5MG 5MG 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 2.5MG 5MG 10MG 2.5MG 5MG 2.5MG 5MG
N012940 N012940 N012940
004 003 005
Jul 29, 1988 Jul 29, 1988 Jul 29, 1988
ISOSORBIDE DINITRATE MUTUAL PHARM
SANDOZ SORBITRATE ASTRAZENECA TABLET, CHEWABLE; ORAL SORBITRATE ASTRAZENECA
A084204 A086168 A087545 A086225 A086222 N016191 N016191
001 001 001 001 001 002 001
Sep Sep Sep Feb Feb
18, 18, 18, 19, 19,
1986 1986 1986 1988 1988
Apr 01, 1996 Apr 01, 1996
5MG 10MG TABLET, EXTENDED RELEASE; ORAL ISORDIL WYETH AYERST 40MG
N016776 N016776
002 003
Apr 01, 1996 Apr 01, 1996
N012882
001
Jul 29, 1988
ISOSORBIDE MONONITRATE
TABLET; ORAL ISMO PROMIUS PHARMA 20MG TABLET, EXTENDED RELEASE; ORAL IMDUR SCHERING PLOUGH 30MG 60MG 120MG ISOSORBIDE MONONITRATE ALKERMES GAINESVILLE 60MG IVAX SUB TEVA PHARMS 30MG 60MG 120MG SKYEPHARMA AG 60MG
N019091
001
Dec 30, 1991
N020225 N020225 N020225 A075041 A075448 A075448 A075448 A075166
001 002 003 001 002 001 003 001
Aug 12, 1993 Aug 12, 1993 Mar 30, 1995 Sep Aug Jun Aug Oct 22, 07, 19, 07, 07, 1998 2001 2000 2001 1999
ISOTRETINOIN
CAPSULE; ORAL
ACCUTANE
HOFFMANN LA ROCHE
10MG 20MG 40MG
N018662 N018662 N018662
002 004 003
May 07, 1982 Mar 28, 1983 May 07, 1982

ISRADIPINE
CAPSULE; ORAL DYNACIRC SMITHKLINE BEECHAM
6 - 206 (of 360)
2.5MG 5MG
N019546 N019546
001 002
Dec 20, 1990 Dec 20, 1990
ITRACONAZOLE
INJECTABLE; INJECTION SPORANOX JANSSEN PHARMS
10MG/ML
N020966
001
Mar 30, 1999
IVERMECTIN
TABLET; ORAL STROMECTOL MERCK SHARP DOHME
6MG
N050742
001
Nov 22, 1996
KANAMYCIN SULFATE
CAPSULE; ORAL KANTREX APOTHECON
A060516 A061911 A062726
001 001 001
Mar 06, 1987
INJECTABLE; INJECTION KANAMYCIN HIKMA MAPLE
EQ 75MG BASE/2ML EQ 500MG BASE/2ML EQ 1GM BASE/3ML EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 500MG BASE/2ML 1GM BASE/3ML 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 1GM BASE/3ML 1GM BASE/3ML 75MG BASE/2ML 75MG BASE/2ML 75MG BASE/2ML 500MG BASE/2ML 500MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 1GM BASE/3ML 1GM BASE/3ML
A062324 A062324 A062324 A062504 A062504 A062504 A062466 A062466 A063021 A063022 A063025 A062668 A062672 A062669 A062605 A062605 A062605 A063092 A062520 A061655 A061901 A062564 A061655 A061901 A062564 A061655 A061901 A062564 A062170 A062170 A062170
001 002 003 001 002 003 001 002 001 001 001 001 001 001 003 001 002 001 003 003 003 001 001 001 002 002 002 003 001 002 003 Apr Apr Apr Sep Sep Jul Jul Jul May May May Feb Feb Feb Oct May 05, 05, 05, 30, 30, 31, 31, 31, 07, 07, 07, 26, 26, 26, 11, 09, 1984 1984 1984 1983 1983 1992 1992 1992 1987 1987 1987 1986 1986 1986 1989 1985
KANAMYCIN SULFATE ABRAXIS PHARM
INTL MEDICATION LOCH
PHARMAFAIR
SOLOPAK
WARNER CHILCOTT WATSON LABS KANTREX APOTHECON
Sep 21, 1984
Sep 21, 1984
Sep 21, 1984
KLEBCIL KING PHARMS
EQ 75MG BASE/2ML EQ 500MG BASE/2ML EQ 1GM BASE/3ML
KETOCONAZOLE
CREAM; TOPICAL NIZORAL JANSSEN PHARMA
2%
N019084
001
Dec 31, 1985

KETOCONAZOLE
SUSPENSION; ORAL NIZORAL JANSSEN PHARMA TABLET; ORAL KETOCONAZOLE AAIPHARMA LLC TEVA
6 - 207 (of 360)
100MG/5ML
A070767
001
Nov 07, 1986
200MG 200MG
A075341 A074971
001 001
Jul 27, 1999 Jun 15, 1999
KETOPROFEN
CAPSULE; ORAL
KETOPROFEN
SANDOZ TEVA ORUDIS WYETH AYERST
50MG 75MG 25MG
A074024 A074024 A073515 N018754 N018754 N018754
001 002 001 001 002 003
Dec 29, 1995 Dec 29, 1995 Dec 22, 1992 Jul 31, 1987 Jan 09, 1986 Jan 09, 1986
25MG 50MG 75MG CAPSULE, EXTENDED RELEASE; ORAL KETOPROFEN ALKERMES GAINESVILLE 200MG ORUVAIL WYETH PHARMS INC 100MG 150MG 200MG TABLET; ORAL ACTRON BAYER 12.5MG KETOPROFEN PERRIGO 12.5MG ORUDIS KT WYETH CONS 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
A074879 N019816 N019816 N019816
001 003 002 001
Dec 10, 1997 Feb 08, 1995 Feb 08, 1995 Sep 24, 1993
N020499 A075364 N020429
001 001 001
Oct 06, 1995 Feb 07, 2002 Oct 06, 1995
AMPHASTAR PHARM 15MG/ML 30MG/ML APOTEX INC 30MG/ML 30MG/ML APOTHECON 15MG/ML 30MG/ML BEDFORD 15MG/ML 30MG/ML GLAND PHARMA LTD 15MG/ML 30MG/ML HOSPIRA 15MG/ML 30MG/ML TORADOL ROCHE PALO 15MG/ML 30MG/ML TABLET; ORAL KETOROLAC TROMETHAMINE ROXANE 10MG WATSON LABS 10MG TORADOL ROCHE PALO 10MG
A076209 A076209 A075626 A077201 A075348 A075348 A075230 A075230 A076722 A076722 A074801 A074801 N019698 N019698
001 002 001 001 001 002 002 001 001 002 001 002 001 002
Jul Jul Jul Oct Nov Nov Oct Oct Jul Jul Jun Jun
21, 21, 24, 14, 28, 28, 25, 25, 27, 27, 05, 05,
2004 2004 2001 2005 2000 2000 1999 1999 2004 2004 1997 1997
Nov 30, 1989 Nov 30, 1989
A074790 A074955 N019645
001 001 001
Jun 26, 1997 Sep 19, 1997 Dec 20, 1991

KRYPTON, KR-81M
GAS; INHALATION MPI KRYPTON 81M GENERATOR GE HEALTHCARE N/A
6 - 208 (of 360)
N018088
001
LABETALOL HYDROCHLORIDE
INJECTABLE; INJECTION LABETALOL HYDROCHLORIDE APOTHECON HOSPIRA NORMODYNE SCHERING TRANDATE PROMETHEUS LABS TABLET; ORAL LABETALOL HYDROCHLORIDE APOTHECON
A075355 A075242 N018686 N019425
001 001 001 001
Nov 29, 1999 Sep 30, 1999 Aug 01, 1984 Dec 31, 1985
MUTUAL PHARM
TEVA
001 002 003 001 002 003 001 002 003 001 002 003 004 003 004
Nov Nov Nov Jul Jul Jul Sep Sep Sep Aug Aug Aug Aug
20, 20, 20, 29, 29, 29, 30, 30, 30, 31, 01, 01, 01,
1998 1998 1998 1999 1999 1999 1998 1998 1998 1987 1984 1984 1984
NORMODYNE SCHERING
TRANDATE PROMETHEUS LABS
Aug 01, 1984 Aug 01, 1984
LACTULOSE
SOLUTION; ORAL CHRONULAC SANOFI AVENTIS US DUPHALAC SOLVAY EVALOSE TEVA PHARMS LACTULOSE MORTON GROVE PACO LAXILOSE NOSTRUM LABS SOLUTION; ORAL, RECTAL ACILAC NOSTRUM LABS CEPHULAC SANOFI AVENTIS US GENERLAC MORTON GROVE HEPTALAC TEVA PHARMS LACTULOSE PACO ROXANE SOLVAY PORTALAC SOLVAY
10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML
N017884 A072372 A073497 A071841 A073160 A073686
001 001 001 001 001 001 Mar 22, 1989 May 28, 1993 Sep 22, 1988 Aug 25, 1992 May 28, 1993
10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML 10GM/15ML
A073685 N017657 A071842 A073504 A072029 A073590 N017906 A072374
001 001 001 001 001 001 001 001
May 28, 1993
Sep 27, 1988 May 28, 1993 Aug 25, 1992 May 29, 1992
Mar 22, 1989

LAMOTRIGINE
TABLET; ORAL LAMICTAL GLAXOSMITHKLINE LAMOTRIGINE MATRIX LABS LTD
6 - 209 (of 360)
006 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Dec 27, 1994 Dec 27, 1994 Feb Feb Feb Feb Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan 11, 11, 11, 11, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
MYLAN
ROXANE
WOCKHARDT
TABLET, CHEWABLE; ORAL LAMICTAL CD GLAXOSMITHKLINE LAMOTRIGINE SANDOZ
100MG 5MG 25MG
N020764 A078409 A078409
003 002 003
Aug 24, 1998 Jan 22, 2009 Jan 22, 2009
LANSOPRAZOLE
FOR SUSPENSION, DELAYED RELEASE; ORAL PREVACID TAKEDA PHARMS NA 15MG/PACKET 30MG/PACKET INJECTABLE; INTRAVENOUS PREVACID IV TAKEDA PHARMS NA 30MG/VIAL TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING; ORAL LANSOPRAZOLE TEVA PHARMS 15MG 30MG
N021281 N021281
001 002
May 03, 2001 May 03, 2001
N021566
001
May 27, 2004
A078730 A078730
001 002
Oct 15, 2010 Oct 15, 2010
LANSOPRAZOLE; NAPROXEN
CAPSULE, DELAYED REL PELLETS, TABLET; ORAL
PREVACID NAPRAPAC 250 (COPACKAGED)
TAKEDA PHARMS NA 15MG,N/A;N/A,250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** PREVACID NAPRAPAC 375 (COPACKAGED) TAKEDA PHARMS NA 15MG,N/A;N/A,375MG PREVACID NAPRAPAC 500 (COPACKAGED) TAKEDA PHARMS NA 15MG,N/A;N/A,500MG
N021507
002
Nov 14, 2003
N021507 N021507
003 004
Nov 14, 2003 Nov 14, 2003
LANTHANUM CARBONATE
TABLET, CHEWABLE; ORAL FOSRENOL SHIRE LLC
EQ 250MG BASE
N021468
001
Oct 26, 2004
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX

SOLUTION; TOPICAL
VIRAC REX
CHESEBROUGH PONDS
0.5%;1.8%
N011914
001

LEFLUNOMIDE
TABLET; ORAL LEFLUNOMIDE SANDOZ
6 - 210 (of 360)
10MG 20MG
A077085 A077085
001 002
Sep 13, 2005 Sep 13, 2005
LETROZOLE
TABLET; ORAL LETROZOLE SYNTHON PHARMS
2.5MG
A090196
001
Jun 03, 2011
LEUCOVORIN CALCIUM
FOR SOLUTION; ORAL LEUCOVORIN CALCIUM HOSPIRA INJECTABLE; INJECTION LEUCOVORIN CALCIUM ABIC
EQ 60MG BASE/VIAL
N008107
003
Jan 30, 1987
EQ 3MG BASE/ML EQ 50MG BASE/VIAL ABRAXIS PHARM EQ 50MG BASE/VIAL ELKINS SINN EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL HOSPIRA EQ 3MG BASE/ML EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL EQ 350MG BASE/VIAL PHARMACHEMIE EQ 350MG BASE/VIAL PHARMACHEMIE USA EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL TEVA PARENTERAL EQ 50MG BASE/VIAL LEUCOVORIN CALCIUM PRESERVATIVE FREE HOSPIRA EQ 10MG BASE/ML TEVA PARENTERAL EQ 10MG BASE/ML WELLCOVORIN GLAXOSMITHKLINE EQ 5MG BASE/ML EQ 25MG BASE/VIAL EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL TABLET; ORAL LEUCOVORIN CALCIUM COREPHARMA EQ 5MG BASE EQ 25MG BASE PAR PHARM EQ 5MG BASE EQ 25MG BASE PHARMACHEMIE EQ 5MG BASE EQ 25MG BASE SANDOZ EQ 15MG BASE XANODYNE PHARM EQ 5MG BASE EQ 10MG BASE EQ 15MG BASE WELLCOVORIN GLAXOSMITHKLINE EQ 5MG BASE EQ 25MG BASE
A089352 A089353 A088939 A070480 A081224 N008107 N008107 N008107 N008107 A040262 A089628 A089915 A081278 A040147 A040332 A087439 A089833 A089465 A089834
001 001 001 001 001 001 002 004 005 001 001 001 001 001 001 001 001 001 001
Jun Jun Dec Jan Jun
01, 01, 01, 02, 03,
1988 1988 1986 1987 1994
May Apr Dec Apr Apr Sep
23, 05, 15, 17, 17, 28,
1988 1989 1999 1997 1997 1993
Jun 25, 1997 Jun 28, 1999 Oct Jan Jan Jan 19, 23, 23, 23, 1982 1989 1989 1989
A074544 A074544 A071600 A071598 A073099 A073101 A075327 N018459 A071962 A071104 N018342 N018342
001 002 001 001 001 001 001 001 001 001 001 002
Aug Aug Oct Oct Mar Mar Mar Jan Nov Mar
28, 28, 14, 14, 28, 28, 24, 30, 19, 04,
1997 1997 1987 1987 1997 1997 1999 1986 1987 1987
Jul 08, 1983 Jul 08, 1983
LEUPROLIDE ACETATE
IMPLANT; IMPLANTATION VIADUR ORTHO MCNEIL JANSSEN INJECTABLE; INJECTION LEUPROLIDE ACETATE GENZYME LUPRON ABBOTT LABS
EQ 65MG BASE
N021088
001
Mar 03, 2000
1MG/0.2ML 1MG/0.2ML
A075721 N019010
001 001
Nov 29, 2001 Apr 09, 1985

LEUPROLIDE ACETATE
INJECTABLE; INJECTION LUPRON DEPOT-PED ABBOTT ENDOCRINE
6 - 211 (of 360)
3.75MG/VIAL,7.5MG/VIAL 7.5MG/VIAL,7.5MG/VIAL
N020263 N020263
003 004
Apr 16, 1993 Apr 16, 1993
LEVALLORPHAN TARTRATE
INJECTABLE; INJECTION LORFAN ROCHE
1MG/ML
N010423
001
LEVAMISOLE HYDROCHLORIDE
TABLET; ORAL ERGAMISOL JANSSEN PHARMA
EQ 50MG BASE
N020035
001
Jun 18, 1990
LEVETIRACETAM
TABLET; ORAL LEVETIRACETAM MYLAN
WATSON LABS FLORIDA
250MG 500MG 750MG 1GM 250MG 500MG 750MG
A078731 A078731 A078731 A078731 A077408 A077408 A077408
001 002 003 004 001 002 003
Feb Feb Feb Feb Mar Mar Mar
10, 10, 10, 10, 02, 02, 02,
2009 2009 2009 2009 2009 2009 2009
LEVOBETAXOLOL HYDROCHLORIDE
SUSPENSION/DROPS; OPHTHALMIC BETAXON ALCON PHARMS LTD EQ 0.5% BASE
N021114
001
Feb 23, 2000
LEVOBUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION CHIROCAINE PURDUE PHARMA LP
EQ 2.5MG BASE/ML EQ 5MG BASE/ML EQ 7.5MG BASE/ML
N020997 N020997 N020997
001 002 003
Aug 05, 1999 Aug 05, 1999 Aug 05, 1999
LEVOCABASTINE HYDROCHLORIDE
SUSPENSION/DROPS; OPHTHALMIC LIVOSTIN NOVARTIS EQ 0.05% BASE
N020219
001
Nov 10, 1993
LEVOCARNITINE
SOLUTION; ORAL CARNITOR SIGMA TAU
1GM/10ML
N018948
002
Apr 27, 1988
LEVODOPA
CAPSULE; ORAL BENDOPA VALEANT PHARM INTL
N016948 N016948 N016948 N016913 N016913 N016913 N016912 N016912 N016912
003 001 002 003 001 002 002 001 006
DOPAR SHIRE
LARODOPA ROCHE

LEVODOPA
TABLET; ORAL
DOPAR
SHIRE LARODOPA
ROCHE
6 - 212 (of 360)
250MG 500MG 100MG 250MG 500MG
N016913 N016913 N016912 N016912 N016912
004
005
005
003
004
LEVOLEUCOVORIN CALCIUM
SOLUTION; IV (INFUSION) FUSILEV SPECTRUM PHARMS
N020140
003
Apr 29, 2011
LEVOMEPROMAZINE
LEVOPROME
IMMUNEX
20MG/ML
N015865
001
LEVOMETHADYL ACETATE HYDROCHLORIDE

CONCENTRATE; ORAL
ORLAAM
ROXANE
10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020315
001
Jul 09, 1993

INJECTABLE; INJECTION ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN SOLVAY 0.05MG/ML;2% CARBOCAINE W/ NEO-COBEFRIN EASTMAN KODAK 0.05MG/ML;2% MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN GRAHAM CHEM 0.05MG/ML;2% POLOCAINE W/ LEVONORDEFRIN DENTSPLY PHARM 0.05MG/ML;2%
A085010 N012125 A084850 A089517
001 002 002 001 Oct 21, 1983 Apr 14, 1988
LEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE

RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN
EASTMAN KODAK 0.05MG/ML;2%;0.4%
N008592
007
LEVONORGESTREL
IMPLANT; IMPLANTATION LEVONORGESTREL WYETH PHARMS INC 75MG/IMPLANT NORPLANT POPULATION COUNCIL 36MG/IMPLANT NORPLANT II POPULATION COUNCIL 75MG/IMPLANT NORPLANT SYSTEM IN PLASTIC CONTAINER WYETH PHARMS INC 36MG/IMPLANT TABLET; ORAL PLAN B TEVA BRANDED PHARM 0.75MG
N020627 N019897 N020544 N020088
001 001 001 001
Aug 15, 1996 Dec 10, 1990 Nov 01, 1996 Dec 10, 1990
N021045
001
Jul 28, 1999
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS

CAPSULE; ORAL
NOVRAD
LILLY
N012928 N012928
006
004

LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
SUSPENSION; ORAL NOVRAD LILLY
6 - 213 (of 360)
EQ 50MG BASE/5ML
N012928
002
LEVORPHANOL TARTRATE
INJECTABLE; INJECTION LEVO-DROMORAN VALEANT PHARM INTL TABLET; ORAL LEVO-DROMORAN VALEANT PHARM INTL
2MG/ML
N008719
001
Dec 19, 1991
2MG
N008720
001
Dec 19, 1991
TABLET; ORAL LEVOLET VINTAGE
0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG --> 0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG 0.3MG
N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021301 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292
001 002 003 004 005 006 007 008 009 010 011 012 012 001 002 003 004 005 006 007 008 009 010 011 012
Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun
06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
-->
LEVOXYL KING PHARMS NOVOTHYROX MERCK KGAA
May 25, 2001 May May May May May May May May May May May May 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002
LIDOCAINE
AEROSOL; ORAL XYLOCAINE ASTRAZENECA 10% FILM, EXTENDED RELEASE; BUCCAL DENTIPATCH NOVEN 23MG/PATCH OINTMENT; TOPICAL ALPHACAINE CARLISLE 5% 5% 5% LIDOCAINE GRAHAM CHEM 5% XYLOCAINE ASTRAZENECA 5% PATCH; TOPICAL DENTIPATCH NOVEN 46.1MG/PATCH
N014394
001
N020575
001
May 21, 1996
A084944 A084946 A084947 A080210 N008048
001 001 001 001 001
N020575
002
May 21, 1996

LIDOCAINE
SOLUTION; TOPICAL XYLOCAINE ASTRAZENECA SUPPOSITORY; RECTAL XYLOCAINE ASTRAZENECA
6 - 214 (of 360)
5%
N014127
001
100MG
N013077
001
INJECTABLE; INJECTION ALPHACAINE HYDROCHLORIDE CARLISLE 2% A084721 LIDOCAINE HYDROCHLORIDE ABBOTT 10% A087980 20% A089362 ABRAXIS PHARM 1% A080420 1% A086761 1.5% A080420 2% A080420 2% A080420 2% A086761 2% N017508 4% N017508 20% N017508 AKORN 1% A085037 2% A085037 BEL MAR 1% A080710 2% A080760 DELL LABS 1% A083387 2% A083388 ELKINS SINN 0.5% A085131 4% A084626 GD SEARLE LLC 1% A083135 2% A083135 GRAHAM CHEM 2% A080504 HIKMA MAPLE 1% A080407 2% A080407 HOSPIRA 1% A040013 1.5% A088330 2% A088331 INTL MEDICATION 1% A083173 1% N017701 2% A083173 2% N017701 1GM/VIAL N018543 2GM/VIAL N018543 LYPHOMED 1% A080390 2% A080390 MILES 1% A080414 2% A080414 WATSON LABS 1% A080377 1% A083627 2% A080377 2% A083627 WYETH AYERST 1% A083083 2% A083083 LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 100MG/100ML N018461 LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 200MG/100ML N018967 LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% HOSPIRA 200MG/100ML A083158
001 001 001 001 001 005 002 004 002 001 002 004 001 002 001 001 001 001 001 001 001 002 001 001 002 001 001 001 001 002 002 001 001 002 001 002 001 002 001 001 002 002 001 002 001 001 005 Mar 30, 1984 Feb 02, 1983 May 25, 1988
Jun 23, 1995 May 17, 1984 May 17, 1984

INJECTION HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER 200MG/100ML N018954 200MG/100ML N018388 HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER 400MG/100ML N018967 HYDROCHLORIDE 0.4% IN DEXTROSE 5% 400MG/100ML A083158 HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER 800MG/100ML N018967 HYDROCHLORIDE IN PLASTIC CONTAINER 1.5% A088326 10% A088367 20% A088368 LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE HIKMA MAPLE 1% A084625 2% A084625 INTL MEDICATION 4% N017702 LIDOCATON PHARMATON 2% A084727 XYLOCAINE ASTRAZENECA 1% N010418 1.5% N010418 2% N010418 XYLOCAINE DENTAL DENTSPLY PHARM 2% N021380 INJECTABLE; SPINAL XYLOCAINE 1.5% W/ DEXTROSE 7.5% FRESENIUS KABI USA 1.5% N016297 XYLOCAINE 5% W/ GLUCOSE 7.5% ASTRAZENECA 5% N010496 SOLUTION; ORAL LIDOCAINE HYDROCHLORIDE VISCOUS ACTAVIS MID ATLANTIC 2% A086578 INTL MEDICATION 2% A086389 SOLUTION; TOPICAL LARYNGOTRACHEAL ANESTHESIA KIT KENDALL IL 4% A087931 LIDOCAINE HYDROCHLORIDE PACO 4% A089688 LTA II KIT HOSPIRA 4% A088542 PEDIATRIC LTA KIT ABBOTT 2% A088572 HOSPIRA 2% A085995 SYSTEM; INTRADERMAL ZINGO POWDER PHARMS 0.5MG N022114 INJECTABLE; LIDOCAINE ABBOTT HOSPIRA LIDOCAINE B BRAUN LIDOCAINE HOSPIRA LIDOCAINE B BRAUN LIDOCAINE HOSPIRA
6 - 215 (of 360)
001 001 002 006 003 001 001 001 001 002 002 001 005 009 007 001
Jul 09, 1985
Mar 30, 1984
Mar 30, 1984 Jul 31, 1984 Jul 31, 1984 Jul 31, 1984
Aug 17, 1983
001 002 Jul 07, 1982
001 001
Feb 02, 1982
001 001 001 001 001
Jun 10, 1983 Jun 30, 1989 Jul 31, 1984 Jul 31, 1984
001
Aug 16, 2007
LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE

INJECTABLE; INJECTION TERRAMYCIN PFIZER
2%;50MG/ML 2%;125MG/ML
A060567 A060567
001 002
LIDOCAINE; PRILOCAINE
DISC; TOPICAL EMLA ASTRAZENECA
2.5%;2.5%
N020962
001
Feb 04, 1998

LINCOMYCIN HYDROCHLORIDE
CAPSULE; ORAL LINCOCIN PHARMACIA AND UPJOHN
6 - 216 (of 360)
N050316 N050316
001 002
INJECTABLE; INJECTION LINCOMYCIN HYDROCHLORIDE WATSON LABS EQ 300MG BASE/ML
A063180
001
Apr 16, 1991
LINDANE
CREAM; TOPICAL KWELL REED AND CARNRICK LOTION; TOPICAL GAMENE SOLA BARNES HIND KWELL REED AND CARNRICK SCABENE STIEFEL SHAMPOO; TOPICAL GAMENE SOLA BARNES HIND KWELL REED AND CARNRICK SCABENE STIEFEL
1% 1%
A084218 N006309
001 001
1% 1% 1% 1%
A084989 A084218 N006309 A086769
001 002 003 001
1% 1% 1% 1%
A084988 A084219 N010718 A087940
001 001 001 001 Apr 08, 1983
LINEZOLID
TABLET; ORAL ZYVOX PHARMACIA AND UPJOHN
N021130
001
Apr 18, 2000
LIOTHYRONINE SODIUM
TABLET; ORAL LIOTHYRONINE SODIUM WATSON LABS
A085755 A085753
001 001
Jan 25, 1982 Feb 03, 1982
LIOTRIX (T4;T3)
TABLET; ORAL EUTHROID-0.5 PARKE DAVIS EUTHROID-1 PARKE DAVIS EUTHROID-2 PARKE DAVIS EUTHROID-3 PARKE DAVIS THYROLAR-5 FOREST LABS
N016680 N016680 N016680 N016680 N016807
001 002 003 004 006
LISINOPRIL
TABLET; ORAL LISINOPRIL LEK PHARMS
2.5MG 5MG 10MG
A075999 A075999 A075999
001 002 003
Jul 01, 2002 Jul 01, 2002 Jul 01, 2002

LISINOPRIL
TABLET; ORAL LISINOPRIL LEK PHARMS
6 - 217 (of 360)
TEVA
20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG
A075999 A075999 A075999 A075783 A075783 A075783 A075783 A075783 A075783 N019558
004 005 006 001 002 003 004 005 006 006
Jul Jul Jul Jul Jul Jul Jul Jul Jul
01, 01, 01, 01, 01, 01, 01, 01, 01,
2002 2002 2002 2002 2002 2002 2002 2002 2002
PRINIVIL MERCK
Jan 28, 1994
LITHIUM CARBONATE
CAPSULE; ORAL ESKALITH NOVEN THERAP LITHIUM CARBONATE ABLE
N016860 A076823 A076121 A076823 A076823 A072542 A070407 N016782
001 001 001 002 003 001 001 001 Jun Sep Jun Jun Feb Mar 29, 27, 29, 29, 01, 19, 2004 2001 2004 2004 1989 1987
USL PHARMA WATSON LABS LITHONATE SOLVAY TABLET; ORAL ESKALITH JDS PHARMS LITHANE BAYER PHARMS LITHIUM CARBONATE PFIZER LITHOTABS SOLVAY TABLET, EXTENDED RELEASE; ESKALITH CR JDS PHARMS LITHIUM CARBONATE ABLE BARR
300MG 300MG 300MG 300MG ORAL 450MG 300MG 300MG 450MG
N017971 N018833 N016834 N016980
001 001 001 001 Jul 18, 1985
N018152 A076382 A076170 A076366
001 001 001 001
Mar 29, 1982 Apr 21, 2003 Jun 10, 2002 Aug 21, 2003
LITHIUM CITRATE
SYRUP; ORAL LITHONATE SOLVAY
EQ 300MG CARBONATE/5ML
N017672
001
LOMEFLOXACIN HYDROCHLORIDE
TABLET; ORAL MAXAQUIN PHARMACIA
EQ 400MG BASE
N020013
001
Feb 21, 1992
CAPSULE; ORAL IMODIUM MCNEIL PED 2MG LOPERAMIDE HYDROCHLORIDE ROXANE 2MG SANDOZ 2MG TEVA 2MG
N017690 A073080 A072993 A073122
001 001 001 001 Nov 27, 1991 Aug 28, 1992 Aug 30, 1991

SOLUTION; ORAL IMODIUM JANSSEN PHARMA 1MG/5ML LOPERAMIDE HYDROCHLORIDE ALPHARMA US PHARMS 1MG/5ML DURAMED PHARMS BARR 1MG/5ML TEVA 1MG/5ML WATSON LABS 1MG/5ML TABLET; ORAL LOPERAMIDE HYDROCHLORIDE ABLE 2MG PERRIGO 2MG
6 - 218 (of 360)
N019037 A073187 A074991 A073478 A073062
001 001 001 001 001
Jul 31, 1984 Sep Dec Jun May 15, 29, 23, 28, 1992 1997 1995 1993
A073528 A074194
001 001
Nov 30, 1993 Oct 30, 1992
LORACARBEF
CAPSULE; ORAL LORABID KING PHARMS FOR SUSPENSION; ORAL LORABID KING PHARMS
200MG 400MG
N050668 N050668
001 002
Dec 31, 1991 Apr 05, 1996
100MG/5ML 200MG/5ML
N050667 N050667
001 002
Dec 31, 1991 Dec 31, 1991
LORATADINE
SYRUP; ORAL CLARITIN HIVES RELIEF SCHERING PLOUGH
1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 1MG/ML
N020641
003
Nov 19, 2003
LORATADINE RANBAXY LABS LTD TABLET; ORAL LORATADINE PERRIGO
A076529
001
Aug 20, 2004
10MG
N021512
001
Jun 24, 2004
LORAZEPAM
INJECTABLE; INJECTION LORAZEPAM AKORN BEDFORD DAVA PHARMS INC HIKMA MAPLE HOSPIRA
MARSAM PHARMS LLC
2MG/ML 2MG/ML 4MG/ML 2MG/ML 4MG/ML 2MG/ML 4MG/ML 2MG/ML 2MG/ML 4MG/ML 4MG/ML 1MG/0.5ML 2MG/ML 2MG/ML 4MG/ML 4MG/ML
001 001 002 001 002 001 002 001 001 002 003 003 001 001 002 002
Jul Jul Jul Mar Mar Sep Sep May Apr May Mar Sep Sep Sep Sep Sep
23, 13, 13, 16, 16, 28, 28, 27, 12, 27, 19, 12, 12, 12, 12, 12,
1998 2005 2005 2000 2000 1998 1998 1994 1994 1994 1997 1996 1996 1996 1996 1996
SOLUTION; ORAL LORAZEPAM ROXANE TABLET; ORAL LORAZ QUANTUM PHARMICS
0.5MG/5ML
A074648
001
Mar 18, 1997
0.5MG 1MG 2MG
A070200 A070201 A070202
001 001 001
Aug 09, 1985 Aug 09, 1985 Aug 09, 1985

LORAZEPAM
TABLET; ORAL LORAZEPAM AM THERAP
6 - 219 (of 360)
HALSEY
MUTUAL PHARM
PAR PHARM
SUPERPHARM
USL PHARMA WARNER CHILCOTT WATSON LABS
0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 0.5MG 1MG 1MG 2MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 1MG 2MG 1MG 2MG 0.5MG 0.5MG 1MG 2MG 2MG
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Mar Mar Mar Sep Sep Sep Dec Mar Dec Mar Dec Mar Dec Dec Dec Feb Feb Feb Dec Dec Jan Jan Mar Jul Mar Mar Jul
07, 07, 07, 01, 01, 01, 10, 29, 10, 29, 10, 29, 01, 01, 01, 09, 09, 09, 22, 22, 12, 12, 23, 24, 23, 23, 24,
1986 1986 1986 1987 1987 1987 1985 1991 1985 1991 1985 1991 1986 1986 1986 1987 1987 1987 1986 1986 1988 1988 1987 1986 1987 1987 1986
LOTEPREDNOL ETABONATE
SUSPENSION/DROPS; OPHTHALMIC LOTEMAX PHARMOS 0.5%
N020841
001
Mar 09, 1998
LOVASTATIN
TABLET; ORAL MEVACOR MERCK 10MG TABLET, EXTENDED RELEASE; ORAL ALTOPREV ANDRX LABS LLC 10MG
N019643
002
Mar 28, 1991
N021316
001
Jun 26, 2002
LOXAPINE HYDROCHLORIDE
CONCENTRATE; ORAL LOXITANE C WATSON LABS INJECTABLE; INJECTION LOXITANE IM WATSON LABS
EQ 25MG BASE/ML
N017658
001
EQ 50MG BASE/ML
N018039
001
LOXAPINE SUCCINATE
CAPSULE; ORAL LOXAPINE SUCCINATE MIKAH PHARMA
EQ EQ EQ EQ
A076868 A076868 A076868 A076868 N017525 N017525 N017525
001 002 003 004 001 002 003
Aug Aug Aug Aug
04, 04, 04, 04,
2005 2005 2005 2005
LOXITANE WATSON LABS

LOXAPINE SUCCINATE
CAPSULE; ORAL LOXITANE WATSON LABS TABLET; ORAL LOXITANE WATSON LABS
6 - 220 (of 360)
EQ 50MG BASE
N017525
004
N017525 N017525 N017525
006 007 008
LUTROPIN ALFA
INJECTABLE; SUBCUTANEOUS LUVERIS EMD SERONO
75 IU/VIAL
N021322
001
Oct 08, 2004
LYPRESSIN
SOLUTION; NASAL DIAPID NOVARTIS
0.185MG/ML
N016755
001
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION ISOLYTE S PH 7.4 IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;0.82MG/100ML;370M N019006 G/100ML;530MG/100ML;500MG/100ML;12MG/10 0ML
001
Apr 04, 1984
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION ISOLYTE S IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG /100ML;500MG/100ML SOLUTION; IRRIGATION PHYSIOSOL IN PLASTIC CONTAINER HOSPIRA INC 14MG/100ML;37MG/100ML;222MG/100ML;526MG /100ML;502MG/100ML PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER HOSPIRA INC 30MG/100ML;37MG/100ML;222MG/100ML;526MG /100ML;502MG/100ML SYNOVALYTE IN PLASTIC CONTAINER BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG /100ML;502MG/100ML
N018252
001
N018406
001
N018406
002
Jul 08, 1982
N019326
001
Jan 25, 1985
MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE

TABLET; ORAL MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE SANTARUS 343MG;20MG;750MG 343MG;40MG;750MG TABLET, CHEWABLE; ORAL ZEGERID SANTARUS 700MG;20MG;600MG 700MG;40MG;600MG
N022456 N022456
001 002
Dec 04, 2009 Dec 04, 2009
N021850 N021850
001 002
Mar 24, 2006 Mar 24, 2006
MANGAFODIPIR TRISODIUM
INJECTABLE; INJECTION TESLASCAN GE HEALTHCARE
37.9MG/ML
N020652
001
Nov 26, 1997
MANGANESE CHLORIDE TETRAHYDRATE

FOR SOLUTION; ORAL LUMENHANCE BRACCO
3.49MG/GM
N020686
001
Dec 19, 1997

MANGANESE SULFATE
INJECTABLE; INJECTION MANGANESE SULFATE ABRAXIS PHARM
6 - 221 (of 360)
EQ 0.1MG MANGANESE/ML
N019228
001
May 05, 1987
MANNITOL
INJECTABLE; INJECTION MANNITOL 10% HOSPIRA MILES MANNITOL 15% HOSPIRA MILES MANNITOL 20% HOSPIRA MILES MANNITOL 25% ABRAXIS PHARM ASTRAZENECA HOSPIRA MERCK WATSON LABS MANNITOL 5% HOSPIRA SOLUTION; IRRIGATION RESECTISOL B BRAUN
10GM/100ML 10GM/100ML 15GM/100ML 15GM/100ML 20GM/100ML 20GM/100ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 5GM/100ML
N016269 N016472 N016269 N016472 N016269 N016472 A086754 A089239 A089240 N016269 N005620 A087460 N016269
002 002 003 005 004 004 001 001 001 005 001 001 001
May 06, 1987 May 06, 1987
Jun 27, 1983
5GM/100ML
N016704
002
MANNITOL; SORBITOL
SOLUTION; IRRIGATION SORBITOL-MANNITOL HOSPIRA 540MG/100ML;2.7GM/100ML SORBITOL-MANNITOL IN PLASTIC CONTAINER HOSPIRA 540MG/100ML;2.7GM/100ML
A080224 N017636
001 001
MAPROTILINE HYDROCHLORIDE
TABLET; ORAL LUDIOMIL NOVARTIS
25MG 50MG 75MG MAPROTILINE HYDROCHLORIDE AM THERAP 25MG 50MG 75MG WATSON LABS 25MG 25MG 50MG 50MG 75MG 75MG
N017543 N017543 N017543 A072129 A072130 A072131 A071943 A072162 A071944 A072163 A071945 A072164
001 002 003 001 001 001 001 001 001 001 001 001
Sep 30, 1982 Jan Jan Jan Dec Jun Dec Jun Dec Jun 14, 14, 14, 30, 01, 30, 01, 30, 01, 1988 1988 1988 1987 1988 1987 1988 1987 1988
MASOPROCOL
CREAM; TOPICAL ACTINEX UNIV AZ CANCER CTR
10%
N019940
001
Sep 04, 1992
MAZINDOL
TABLET; ORAL MAZANOR WYETH AYERST
1MG 2MG
N017980 N017980
002 001

MAZINDOL
TABLET; ORAL
SANOREX
NOVARTIS
6 - 222 (of 360)

reasons**
reasons**
N017247
001
N017247
002
MEBENDAZOLE
VERMOX
JANSSEN PHARMS
100MG
N017481
001
MEBUTAMATE
TABLET; ORAL
DORMATE
MEDPOINTE PHARM HLC
600MG
N017374
001
MECAMYLAMINE HYDROCHLORIDE
TABLET; ORAL
INVERSINE
TARGACEPT
2.5MG **Federal Register notice determination that product was not

N010251
001
MECASERMIN RINFABATE RECOMBINANT

INJECTABLE; SUBCUTANEOUS IPLEX INSMED
36MG/0.6ML
N021884
001
Dec 12, 2005
TABLET; ORAL
ABC HOLDING 12.5MG 25MG ANABOLIC 25MG BUNDY 12.5MG 25MG IVAX SUB TEVA PHARMS 12.5MG 12.5MG 25MG KV PHARM 12.5MG 25MG PLIVA 12.5MG 25MG SUPERPHARM 12.5MG 25MG UDL 12.5MG 25MG VANGARD 12.5MG 25MG WATSON LABS 12.5MG 12.5MG TABLET, CHEWABLE; ORAL
ANTIVERT
PFIZER 25MG MECLIZINE HYDROCHLORIDE IVAX SUB TEVA PHARMS 25MG NEXGEN PHARMA INC 25MG PLIVA 25MG
001
001
001
001
001 001
001
001
001
001
001 001 001 001 001 001 001 001 001
001
Dec Dec Aug Aug Jun Jun Apr Jan
11, 11, 20, 20, 13, 13, 20, 04,
1985 1985 1985 1985 1983 1983 1982 1982
N010721 A084976 A086392 A088733
005
001 001 001
Dec 11, 1985

MECLOCYCLINE SULFOSALICYLATE
CREAM; TOPICAL
MECLAN
JOHNSON AND JOHNSON
6 - 223 (of 360)
1%
N050518
001
MECLOFENAMATE SODIUM
CAPSULE; ORAL MECLODIUM QUANTUM PHARMICS MECLOFENAMATE SODIUM AM THERAP BARR PAR PHARM SANDOZ USL PHARMA VITARINE WATSON LABS
EQ 50MG BASE EQ 100MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 50MG BASE 100MG BASE 100MG BASE
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
002
Jul 14, 1987 Jul 14, 1987 Feb Feb Mar Mar Mar Mar Nov Nov Mar Mar Jun Jun Nov Aug Nov Aug 10, 10, 20, 20, 10, 10, 29, 29, 25, 25, 15, 15, 25, 11, 25, 11, 1987 1987 1989 1989 1988 1988 1988 1988 1988 1988 1988 1988 1986 1987 1986 1987
MECLOMEN
PARKE DAVIS
DEPO-PROVERA
PHARMACIA AND UPJOHN 100MG/ML **Federal Register determination that product was not
MEDROXYPROGESTERONE ACETATE TEVA PARENTERAL 150MG/ML TABLET; ORAL AMEN AMARIN PHARMS 10MG CURRETAB SOLVAY 10MG CYCRIN ESI 2.5MG 5MG 10MG MEDROXYPROGESTERONE ACETATE DURAMED PHARMS BARR 2.5MG 5MG 10MG
N012541
002
A076552
001
Oct 27, 2004
A083242 A085686 A081239 A081240 A089386 A040311 A040311 A040311
001 001 001 001 001 001 002 003 Oct 30, 1992 Oct 30, 1992 Sep 09, 1987 Dec 01, 1999 Dec 01, 1999 Dec 01, 1999
MEDRYSONE
SUSPENSION; OPHTHALMIC
HMS
ALLERGAN
1%
N016624
003
TABLET; ORAL LARIAM ROCHE
250MG
N019591
001
May 02, 1989

TABLET; ORAL MEFLOQUINE HYDROCHLORIDE US ARMY WALTER REED 250MG
6 - 224 (of 360)
N019578
001
May 02, 1989
MEGESTROL ACETATE
TABLET; ORAL MEGACE BRISTOL MYERS SQUIBB MEGESTROL ACETATE TEVA USL PHARMA
N016979 N016979 A074745 A070646 A070647
001 002 001 001 001 Feb 27, 1998 Oct 02, 1987 Oct 02, 1987
MELOXICAM
TABLET; ORAL MELOXICAM MUTUAL PHARM ROXANE YABAO BIOPHARMS
7.5MG 15MG 7.5MG 15MG 7.5MG 15MG
A077935 A077935 A077925 A077925 A077933 A077933
001 002 001 002 001 002
Jul Jul Jul Jul Jul Jul
19, 19, 19, 19, 19, 19,
2006 2006 2006 2006 2006 2006
TABLET; ORAL MEMANTINE SUN PHARMA GLOBAL
5MG 10MG
A090058 A090058 A090048 A090048 A090044 A090044 A090052 A090052
001 002 001 002 001 002 001 002
May 05, 2010 May 05, 2010 Apr Apr Mar Mar Oct Oct 14, 14, 12, 12, 25, 25, 2010 2010 2012 2012 2011 2011
MEMANTINE HYDROCHLORIDE DR REDDYS LABS LTD 5MG 10MG ORCHID HLTHCARE 5MG 10MG TEVA PHARMS 5MG 10MG
MENADIOL SODIUM DIPHOSPHATE

INJECTABLE; INJECTION KAPPADIONE LILLY SYNKAYVITE ROCHE
10MG/ML 5MG/ML 10MG/ML 37.5MG/ML
N005725 N003718 N003718 N003718
001 004 006 008
TABLET; ORAL SYNKAYVITE ROCHE
5MG
N003718
010
MENADIONE
TABLET; ORAL MENADIONE LILLY
5MG
N002139
003
INJECTABLE; INJECTION HUMEGON ORGANON USA INC MENOTROPINS FERRING
75 IU/VIAL;75 IU/VIAL 150 IU/VIAL;150 IU/VIAL 75 IU/VIAL;75 IU/VIAL 150 IU/VIAL;150 IU/VIAL
N020328 N020328 A073598 A073599
001 002 001 001
Sep 01, 1994 Sep 01, 1994 Jan 30, 1997 Jan 30, 1997

INJECTABLE; INJECTION PERGONAL SERONO REPRONEX FERRING
6 - 225 (of 360)
75 IU/AMP;75 IU/AMP 150 IU/AMP;150 IU/AMP 150 IU/VIAL;150 IU/VIAL
N017646 N017646 N021047
001 002 002
May 20, 1985 Aug 27, 1999
MEPENZOLATE BROMIDE
SOLUTION; ORAL CANTIL SANOFI AVENTIS US
25MG/5ML
N010679
004
INJECTABLE; INJECTION DEMEROL SANOFI AVENTIS US
N005010 N005010 N005010 N005010 A080388 A080385 A080387 A080389 A080386 A089781 A089782 A089783 A089784 A089785 A089786 A089787 A089788 A088279 A088280 A088281 A088282 A086332 A080364 A080364 A080364 A040305 A040163
007 002 009 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 001 001
MEPERIDINE HYDROCHLORIDE ABBOTT 25MG/ML 50MG/ML 50MG/ML 75MG/ML 100MG/ML ASTRAZENECA 25MG/ML 50MG/ML 50MG/ML 50MG/ML 75MG/ML 100MG/ML 100MG/ML 100MG/ML BAXTER HLTHCARE 25MG/ML 50MG/ML 75MG/ML 100MG/ML INTL MEDICATION 10MG/ML PARKE DAVIS 50MG/ML 75MG/ML 100MG/ML MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE HOSPIRA 10MG/ML MALLINCKRODT 10MG/ML SYRUP; ORAL DEMEROL SANOFI AVENTIS US 50MG/5ML TABLET; ORAL MEPERIDINE HYDROCHLORIDE DURAMED PHARMS BARR 50MG 100MG MUTUAL PHARM 50MG 100MG WYETH AYERST 50MG
Mar Mar Mar Mar Mar Mar Mar Mar Jun Jun Jun Jun
31, 31, 31, 31, 31, 31, 31, 31, 15, 15, 15, 15,
1989 1989 1989 1989 1989 1989 1989 1989 1984 1984 1984 1984
Mar 10, 1999 May 12, 1997
N005010
005
A040318 A040318 A080448 A080448 A080454
001 002 001 002 001
Oct 05, 1999 Oct 05, 1999
MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE

INJECTABLE; INJECTION MEPERGAN BAXTER HLTHCARE CORP
25MG/ML;25MG/ML
N011730
001

MEPHENTERMINE SULFATE
WYAMINE SULFATE
BAXTER HLTHCARE CORP
6 - 226 (of 360)
N008248 N008248
002
001
MEPHENYTOIN
TABLET; ORAL
MESANTOIN
NOVARTIS
100MG **Federal Register determination that the product was not discontinued
or withdrawn for safety or efficacy
reasons**
N006008
001
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION ARESTOCAINE HYDROCHLORIDE SOLVAY 3% CARBOCAINE EASTMAN KODAK 3% MEPIVACAINE HYDROCHLORIDE GRAHAM CHEM 3% INTL MEDICATION 1% POLOCAINE DENTSPLY PHARM 3%
A084777 N012125 A083559 A087509 A088653
002 003 001 001 001
Apr 18, 1982
Oct 05, 1982 Aug 21, 1984
MEPREDNISONE
TABLET; ORAL
BETAPAR
SCHERING
4MG
N016053
002
MEPROBAMATE
CAPSULE; ORAL
EQUANIL
WYETH AYERST 400MG CAPSULE, EXTENDED RELEASE; ORAL
MEPROSPAN
MEDPOINTE PHARM HLC 200MG 400MG TABLET; ORAL
AMOSENE
FERNDALE LABS 400MG BAMATE
ALRA 200MG 400MG EQUANIL
WYETH AYERST 200MG 400MG MEPRIAM
TEVA 400MG MEPROBAMATE
BARR 600MG ELKINS SINN 200MG 400MG HEATHER 400MG 600MG IMPAX LABS 200MG 400MG IVAX SUB TEVA PHARMS 200MG 400MG 600MG IVC INDS 400MG LANNETT 200MG 400MG
N012455
002
N011284 N011284
001
002
A084030 A080380 A080380 N010028 N010028 N016069 A084230 N015426 N015426 N016928 A084329 N014322 N014322 N015438 N015438 A084181 A084153 N014882 N014882
001
001
002
005
004
001
001
002
001
003
001
002
001
001
002
001
001
002
001

MEPROBAMATE
TABLET; ORAL MEPROBAMATE LEDERLE LEE KM MALLARD MK LABS MUTUAL PHARM MYLAN NEXGEN PHARMA INC PARKE DAVIS PERRIGO PHARMAVITE PUREPAC PHARM PVT FORM ROXANE SANDOZ
6 - 227 (of 360)
SCHERER LABS SOLVAY STANLABS PHARM TABLICAPS USL PHARMA VALEANT PHARM INTL VANGARD WATSON LABS
WEST WARD WHITEWORTH TOWN PLSN MILTOWN MEDPOINTE PHARM HLC
400MG 400MG 400MG 200MG 400MG 200MG 400MG 400MG 200MG 400MG 200MG 400MG 200MG 400MG 400MG 200MG 400MG 400MG 600MG 200MG 400MG 400MG 400MG 200MG 200MG 400MG 400MG 200MG 400MG 200MG 400MG 400MG 200MG 400MG 600MG 600MG 200MG 400MG 200MG 400MG 200MG 400MG 600MG 200MG 400MG 400MG 400MG
A086299 A089538 N015072 N014368 N014368 A080699 A080699 A083618 A084220 A084589 A084744 A084744 A084546 A084547 A084438 A084804 A084804 N014601 A084332 N014547 A080655 N014547 A083343 A084435 N014474 N014474 A083494 A087825 A087826 N015139 N015139 A088011 A085720 A085721 A084274 A085719 N015417 N015417 A083830 A083442 N009698 N009698 A083919 N014359 N014359 A084369 N016249
001 001 002 004 002 001 002 001 001 001 001 002 001 001 001 001 002 001 001 002 001 001 001 001 002 004 001 001 001 006 005 001 001 001 001 001 003 002 001 001 004 002 001 002 001 001 001
Nov 25, 1987
Mar 18, 1982 Mar 18, 1982
Jul 14, 1982
NEURAMATE HALSEY TRANMEP SOLVAY
MEQUINOL; TRETINOIN
SOLUTION; TOPICAL SOLAGE AQUA PHARMS
2%;0.01%
N020922
001
Dec 10, 1999
MERSALYL SODIUM; THEOPHYLLINE

INJECTABLE; INJECTION MERSALYL-THEOPHYLLINE WATSON LABS
100MG/ML;50MG/ML
A084875
001

MESALAMINE
SUPPOSITORY; RECTAL CANASA APTALIS PHARMA US ROWASA MEDA PHARMS
6 - 228 (of 360)
500MG 500MG
N021252 N019919
001 001
Jan 05, 2001 Dec 18, 1990
MESORIDAZINE BESYLATE
CONCENTRATE; ORAL SERENTIL NOVARTIS INJECTABLE; INJECTION SERENTIL NOVARTIS TABLET; ORAL SERENTIL NOVARTIS
EQ 25MG BASE/ML
N016997
001
EQ 25MG BASE/ML
N016775
001
EQ EQ EQ EQ
N016774 N016774 N016774 N016774
001 002 003 004
MESTRANOL; NORETHINDRONE
TABLET; ORAL-20 NORINYL WATSON LABS 0.1MG;2MG TABLET; ORAL-21 NORETHIN 1/50M-21 WATSON LABS 0.05MG;1MG NORETHINDRONE AND MESTRANOL WATSON LABS 0.05MG;1MG NORINYL 1+50 21-DAY WATSON LABS 0.05MG;1MG NORINYL 1+80 21-DAY GD SEARLE LLC 0.08MG;1MG ORTHO-NOVUM 1/50 21 ORTHO MCNEIL PHARM 0.05MG;1MG ORTHO-NOVUM 1/80 21 ORTHO MCNEIL PHARM 0.08MG;1MG ORTHO-NOVUM 10-21 ORTHO MCNEIL PHARM 0.06MG;10MG ORTHO-NOVUM 2-21 ORTHO MCNEIL PHARM 0.1MG;2MG TABLET; ORAL-28 NORETHIN 1/50M-28 WATSON LABS 0.05MG;1MG NORETHINDRONE AND MESTRANOL WATSON LABS 0.05MG;1MG NORINYL 1+80 28-DAY GD SEARLE LLC 0.08MG;1MG ORTHO-NOVUM 1/50 28 ORTHO MCNEIL JANSSEN 0.05MG;1MG ORTHO-NOVUM 1/80 28 ORTHO MCNEIL PHARM 0.08MG;1MG
N013625
004
A071539 A070758 N013625 N016724 N012728 N016715 N012728 N012728
001 001 002 001 004 001 001 005
Apr 12, 1988 Jul 01, 1988
A071540 A070759 N016725 N016709 N016715
001 001 001 001 002
Apr 12, 1988 Jul 01, 1988
MESTRANOL; NORETHYNODREL
TABLET; ORAL ENOVID GD SEARLE LLC TABLET; ORAL-20 ENOVID GD SEARLE LLC ENOVID-E GD SEARLE LLC
0.075MG;5MG 0.15MG;9.85MG
N010976 N010976
008 005
0.075MG;5MG 0.1MG;2.5MG
N010976 N010976
004 006

MESTRANOL; NORETHYNODREL
TABLET; ORAL-21 ENOVID-E 21 GD SEARLE LLC
6 - 229 (of 360)
0.1MG;2.5MG
N010976
007
AEROSOL, METERED; INHALATION ALUPENT BOEHRINGER INGELHEIM 0.65MG/INH SOLUTION; INHALATION ALUPENT BOEHRINGER INGELHEIM 0.4% 0.6% 5% METAPROTERENOL SULFATE ASTRAZENECA 0.4% 0.6% DEY 0.33% 0.5% 5% NEPHRON 0.4% 0.6% WOCKHARDT 5% PROMETA MURO 5% SYRUP; ORAL ALUPENT BOEHRINGER INGELHEIM 10MG/5ML METAPROTERENOL SULFATE MORTON GROVE 10MG/5ML TEVA 10MG/5ML TEVA PHARMS 10MG/5ML WOCKHARDT 10MG/5ML PROMETA MURO 10MG/5ML TABLET; ORAL ALUPENT BOEHRINGER INGELHEIM 10MG 20MG METAPROTERENOL SULFATE AM THERAP 10MG 20MG TEVA 10MG 20MG USL PHARMA 10MG 20MG
N016402
001
N018761 N018761 N017659 A071275 A071018 A071806 A071805 A070805 A071855 A071726 A072190 A073340
002 001 001 001 001 001 001 001 001 001 001 001
Oct 10, 1986 Jun 30, 1983
Jul Jul Aug Aug Aug Jul Jul Jun
27, 27, 05, 05, 17, 14, 14, 07,
1988 1988 1988 1988 1987 1988 1988 1988
Mar 30, 1992
N017571 A071656 A072761 A073034 A074702 A072023
001 001 001 001 001 001 Oct Feb Aug Mar 13, 27, 30, 24, 1987 1992 1991 1997
Sep 15, 1988
N015874 N015874 A072054 A072055 A072519 A072520 A071013 A071014
002 001 001 001 001 001 001 001 Jun Jun Mar Mar Jan Jan 23, 23, 30, 30, 25, 25, 1988 1988 1990 1990 1988 1988
METARAMINOL BITARTRATE
INJECTABLE; INJECTION ARAMINE MERCK METARAMINOL BITARTRATE ABRAXIS PHARM ELKINS SINN GD SEARLE LLC
N009509 A080431 A083363 A086418 A086418
002 001 001 001 002
Dec 22, 1987
METAXALONE
TABLET; ORAL SKELAXIN KING PHARMS
400MG
N013217
001

TABLET; ORAL GLUCOPHAGE BRISTOL MYERS SQUIBB
6 - 230 (of 360)
625MG 750MG
003 004 001 002 003 001 002 003 001 004 005 002 003 001 002 003
Nov 05, 1998 Nov 05, 1998 Jan Jan Jan Aug Aug Aug Jan Jan Jan Jan Jan Dec Dec Dec 25, 25, 25, 06, 06, 06, 24, 24, 24, 24, 24, 16, 16, 16, 2002 2002 2002 2007 2007 2007 2002 2002 2002 2002 2002 2002 2002 2002
METFORMIN HYDROCHLORIDE BARR 500MG 850MG 1GM IPCA LABS LTD 500MG 850MG 1GM IVAX SUB TEVA PHARMS 500MG 625MG 750MG 850MG 1GM TEVA 500MG 850MG 1GM TABLET, EXTENDED RELEASE; ORAL METFORMIN HYDROCHLORIDE ACTAVIS ELIZABETH 500MG 750MG BARR 500MG IVAX SUB TEVA PHARMS 500MG MUTUAL PHARM 500MG RANBAXY LABS LTD 500MG 750MG SANDOZ 500MG
A076450 A076878 A076496 A076545 A077124 A076413 A077211 A076223
001 001 001 001 001 001 001 001
Oct Apr Nov Dec Dec Jun Jun Dec
01, 13, 25, 01, 21, 18, 29, 14,
2004 2005 2005 2003 2005 2004 2005 2004
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE

TABLET; ORAL AVANDAMET SB PHARMCO
500MG;EQ 1MG BASE
N021410
001
Oct 10, 2002
METHACYCLINE HYDROCHLORIDE
CAPSULE; ORAL RONDOMYCIN MEDPOINTE PHARM HLC SYRUP; ORAL RONDOMYCIN MEDPOINTE PHARM HLC
A060641 A060641
001 002
EQ 70MG BASE/5ML
A060641
003
SYRUP; ORAL DOLOPHINE HYDROCHLORIDE ROXANE 10MG/30ML TABLET; ORAL METHADONE HYDROCHLORIDE ROXANE 5MG 10MG 40MG SANDOZ 5MG TABLET, DISPERSIBLE; ORAL WESTADONE SANDOZ 2.5MG TABLET, EFFERVESCENT; ORAL WESTADONE SANDOZ 5MG 10MG 40MG
N006134
004
A088108 A088109 A074081 A040241
001 001 001 001
Mar Mar Apr May
08, 08, 28, 29,
1983 1983 1995 1998
N017108
001
N017108 N017108 N017108
002 003 004

METHAMPHETAMINE HYDROCHLORIDE
TABLET; ORAL METHAMPEX TEVA 10MG METHAMPHETAMINE HYDROCHLORIDE ABLE 5MG REXAR 5MG 10MG TEVA 5MG TABLET, EXTENDED RELEASE; ORAL DESOXYN LUNDBECK INC 5MG 10MG 15MG
6 - 231 (of 360)
A083889 A040529 A084931 A084931 A086359
001 001 001 002 001 Feb 25, 2004
N005378 N005378 N005378
004 003 005
METHANTHELINE BROMIDE
TABLET; ORAL BANTHINE SHIRE
50MG
N007390
001
METHARBITAL
TABLET; ORAL GEMONIL ABBVIE
100MG
N008322
001
METHAZOLAMIDE
TABLET; ORAL METHAZOLAMIDE APPLIED ANAL SANDOZ NEPTAZANE LEDERLE
A040011 A040011 A040102 A040102 N011721 N011721
001 002 001 002 002 001
Jul Jul Aug Aug
17, 17, 28, 28,
1997 1997 1996 1996
Nov 25, 1991
METHDILAZINE
TABLET, CHEWABLE; ORAL TACARYL WESTWOOD SQUIBB
3.6MG
N011950
009
METHDILAZINE HYDROCHLORIDE
SYRUP; ORAL METHDILAZINE HYDROCHLORIDE ALPHARMA US PHARMS 4MG/5ML TACARYL WESTWOOD SQUIBB 4MG/5ML TABLET; ORAL TACARYL WESTWOOD SQUIBB 8MG
A087122 N011950
001 007
N011950
006
METHICILLIN SODIUM
INJECTABLE; INJECTION STAPHCILLIN APOTHECON
EQ EQ EQ EQ EQ EQ
900MG 900MG 3.6GM 3.6GM 5.4GM 5.4GM
BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
A061449 N050117 A061449 N050117 A061449 N050117
001 001 002 002 003 003

METHIMAZOLE
TABLET; ORAL METHIMAZOLE CEDAR PHARMS MYLAN TAPAZOLE KING PHARMS
6 - 232 (of 360)
A040619 A040547 A040350 N007517 N007517
003 004 003 002 004
Jul 12, 2005 Feb 18, 2005 Jun 07, 2001
METHIXENE HYDROCHLORIDE
TABLET; ORAL TREST NOVARTIS
1MG
N013420
001
METHOCARBAMOL
INJECTABLE; INJECTION METHOCARBAMOL MARSAM PHARMS LLC TABLET; ORAL DELAXIN FERNDALE LABS FORBAXIN FOREST LABS METHOCARBAMOL ABLE AM THERAP ASCOT CLONMEL HLTHCARE HEATHER IMPAX LABS INWOOD LABS IVAX SUB TEVA PHARMS KV PHARM MUTUAL PHARM MYLAN NYLOS PIONEER PHARMS PURACAP PHARM PUREPAC PHARM ROXANE SANDOZ SOLVAY SUPERPHARM TABLICAPS UPSHER SMITH
100MG/ML
A089849
001
Dec 27, 1991
500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 500MG
001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 002 001 001 001 001 001 001 001 001 001 001 Mar Mar Feb Feb Oct Oct 17, 17, 11, 11, 27, 27, 2003 2003 1987 1987 1982 1982
Dec 13, 1985 Dec 13, 1985
Feb 29, 1984 Feb 29, 1984
Jan 22, 1982 Jan 22, 1982

METHOCARBAMOL
TABLET; ORAL METHOCARBAMOL
UPSHER SMITH WATSON LABS
6 - 233 (of 360)
750MG 500MG 750MG
A087454 A083605 A083605
001
001
002
METHOHEXITAL SODIUM
BREVITAL SODIUM
JHP PHARMS
5GM/VIAL
N011559
003
METHOTREXATE SODIUM
ABITREXATE
ABIC
EQ EQ EQ EQ
25MG BASE/ML 50MG BASE/VIAL 100MG BASE/VIAL 250MG BASE/VIAL
A089161 A089354 A089355 A089356 A087695 A087695 A087695 A088954 A081242 A089180 N011719 A040265 N011719 N011719
001 001 001 001 001 002 003 001 001 001 007 001 014 013
Mar Jul Jul Jul Apr Apr Apr Oct
10, 17, 17, 17, 08, 08, 08, 24,
1987 1987 1987 1987 1983 1983 1983 1985
FOLEX PHARMACIA AND UPJOHN EQ 25MG BASE/VIAL EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL FOLEX PFS PHARMACIA AND UPJOHN EQ 25MG BASE/ML EQ 25MG BASE/ML METHOTREXATE LPF HOSPIRA EQ 25MG BASE/ML METHOTREXATE PRESERVATIVE FREE FRESENIUS KABI USA EQ 25MG BASE/ML HOSPIRA EQ 20MG BASE/2ML (EQ 10MG BASE/ML) EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM ABRAXIS PHARM EQ 2.5MG BASE/ML EQ 20MG BASE/VIAL EQ 25MG BASE/ML EQ 25MG BASE/ML EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL HOSPIRA EQ 2.5MG BASE/ML EQ 20MG BASE/VIAL EQ 25MG BASE/ML EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL NORBROOK EQ 25MG BASE/ML PHARMACHEMIE USA EQ 25MG BASE/ML METHOTREXATE SODIUM PRESERVATIVE FREE HOSPIRA EQ 1GM BASE/VIAL MEXATE BRISTOL EQ 20MG BASE/VIAL EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL MEXATE-AQ BRISTOL MYERS EQ 25MG BASE/ML MEXATE-AQ PRESERVED BRISTOL MYERS SQUIBB EQ 25MG BASE/ML
Aug 23, 1991 Jan 03, 1986 Mar 31, 1982 Feb 26, 1999 Apr 13, 2005 Apr 13, 2005
N011719 A089323 A088935 A089263 A089322 A088936 A088937 N011719 N011719 N011719 N011719 N011719 A088648 A089158 N011719 A086358 A086358 A086358 A086358 A088760 A089887
011 001 001 001 001 001 001 004

001
005
003
006
001 001 009 001
002
003
004
001 001
Apr 13, 2005 Jun Oct Jun Jun Oct Oct 13, 11, 13, 13, 11, 11, 1986 1985 1986 1986 1985 1985
May 09, 1986 Jul 08, 1988 Apr 07, 1988
Feb 14, 1985 Apr 14, 1989

METHOTREXATE SODIUM
TABLET; ORAL METHOTREXATE SODIUM DURAMED PHARMS BARR
6 - 234 (of 360)
EQ 2.5MG BASE
A040233
001
Jun 17, 1999
METHOXAMINE HYDROCHLORIDE
VASOXYL
GLAXOSMITHKLINE
10MG/ML 20MG/ML
N006772 N006772
002
001
METHOXSALEN
CAPSULE; ORAL METHOXSALEN SANDOZ
10MG
A087781
001
Jun 08, 1982
TABLET; ORAL
PVT FORM 2.5MG
A080970
001
METHYCLOTHIAZIDE
TABLET; ORAL
AQUATENSEN
MEDPOINTE PHARM HLC ENDURON
ABBVIE
5MG 2.5MG **Federal Register determination that product was not discontinued or
reasons**
5MG 2.5MG 5MG 2.5MG 2.5MG 5MG 2.5MG 5MG 5MG 2.5MG 2.5MG 5MG
N017364 N012524
001
001
N012524 A087913 A087786 A087671 A089135 A089136 A089835 A089837 A088745 A085487 A088750 A085476
004
001 001 001 001 001 001 001 001 001 001 001 Jun May Aug Feb Feb Aug Aug Mar Mar Sep Mar 03, 18, 17, 12, 12, 18, 18, 21, 11, 06, 11, 1982 1982 1982 1986 1986 1988 1988 1985 1982 1984 1982
METHYCLOTHIAZIDE IVAX PHARMS MYLAN PAR PHARM SANDOZ USL PHARMA WATSON LABS
METHYCLOTHIAZIDE; PARGYLINE HYDROCHLORIDE

TABLET; ORAL
EUTRON
ABBOTT
5MG;25MG
N016047
001
METHYCLOTHIAZIDE; RESERPINE
TABLET; ORAL
DIUTENSEN-R
MEDPOINTE PHARM HLC
2.5MG;0.1MG
N012708
005
METHYLDOPA
SUSPENSION; ORAL
ALDOMET
MERCK TABLET; ORAL
ALDOMET
MERCK
250MG/5ML
N018389
001
125MG 250MG 500MG
N013400 N013400 N013400
003
001
002

METHYLDOPA
TABLET; ORAL METHYLDOPA ACCORD HLTH DURAMED PHARMS BARR HALSEY
6 - 235 (of 360)
MUTUAL PHARM
PAR PHARM
PARKE DAVIS
PLIVA
PUREPAC PHARM
ROXANE
SANDOZ
SUPERPHARM TEVA
WATSON LABS
A070070 A071006 A071009 A071751 A071752 A071753 A070073 A070060 A070074 A070535 A070536 A070537 A070331 A070332 A070333 A072126 A072127 A072128 A070749 A070750 A070452 A070192 A070193 A070194 A071700 N018934 N018934 A070669 A070670 A071105 A071106 A071067 A070245 A070260 A070246 A070261 A070703 A070247 A070262
003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001
Oct Dec Dec Mar Mar Mar Oct Oct Oct Jan Jan Jan Apr Apr Apr Jul Jul Jul Feb Feb Feb Apr Apr Apr Mar Jun Jun Jun Jun Dec Dec Dec Feb Jun Feb Jun Jun Feb Jun
15, 16, 16, 28, 28, 28, 09, 09, 09, 02, 02, 02, 15, 15, 15, 07, 07, 07, 07, 07, 07, 25, 25, 25, 02, 29, 29, 23, 23, 05, 05, 05, 25, 24, 25, 24, 06, 25, 24,
1985 1986 1986 1988 1988 1988 1986 1986 1986 1987 1987 1987 1986 1986 1986 1988 1988 1988 1986 1986 1986 1986 1986 1986 1988 1984 1984 1989 1989 1986 1986 1986 1986 1985 1986 1985 1986 1986 1985
METHYLDOPATE HYDROCHLORIDE
INJECTABLE; INJECTION ALDOMET MERCK 50MG/ML METHYLDOPATE HYDROCHLORIDE ABRAXIS PHARM 50MG/ML BAXTER HLTHCARE 50MG/ML HOSPIRA 50MG/ML 50MG/ML 50MG/ML 50MG/ML MARSAM PHARMS LLC 50MG/ML SMITH AND NEPHEW 50MG/ML TEVA PARENTERAL 50MG/ML
N013401 A070652 A070291 A070691 A070698 A070699 A070849 A071812 A070841 A072974
001 001 001 001 001 001 001 001 001 001 Jun Jul Jun Jun Jun Jun Dec Jan Nov 03, 01, 19, 15, 15, 19, 22, 02, 22, 1986 1986 1987 1987 1987 1987 1987 1987 1991
TABLET; ORAL METHYLPHENIDATE HYDROCHLORIDE ABLE 5MG 10MG
A040404 A040404
001 002
Mar 29, 2001 Mar 29, 2001

TABLET; ORAL METHYLPHENIDATE HYDROCHLORIDE ABLE 20MG ACTAVIS ELIZABETH 5MG 10MG 20MG TABLET, EXTENDED RELEASE; ORAL METADATE ER UCB INC 10MG METHYLPHENIDATE HYDROCHLORIDE ABLE 20MG ACTAVIS ELIZABETH 20MG
6 - 236 (of 360)
A040404 A040321 A040321 A040321
003 001 002 003
Mar Feb Feb Feb
29, 05, 05, 05,
2001 2002 2002 2002
A040306 A076032 A075450
001 001 001
Oct 20, 1999 May 09, 2001 Dec 21, 2001
METHYLPREDNISOLONE
TABLET; ORAL MEDROL PHARMACIA AND UPJOHN METHYLPREDNISOLONE HEATHER PAR PHARM
N011153 N011153 A085650 A089207 A089208 A089209 A087341 A086161 A086159
002 005 001 001 001 001 001 001 001
Apr 25, 1988 Apr 25, 1988 Apr 25, 1988 Feb 09, 1982 Feb 09, 1982
SANDOZ WATSON LABS
METHYLPREDNISOLONE ACETATE
ENEMA; RECTAL MEDROL PHARMACIA AND UPJOHN 40MG/BOT INJECTABLE; INJECTION METHYLPREDNISOLONE ACETATE AKORN 40MG/ML 80MG/ML WATSON LABS 20MG/ML 20MG/ML 40MG/ML 40MG/ML 80MG/ML 80MG/ML M-PREDROL BEL MAR 40MG/ML 80MG/ML OINTMENT; TOPICAL MEDROL ACETATE PHARMACIA AND UPJOHN 0.25% 1%
N018102
001
A086903 A086903 A085597 A087248 A085374 A085600 A085595 A086507 A086666 A087135
001 002 001 001 001 001 001 001 001 001
Oct 20, 1982 Oct 20, 1982
N012421 N012421
001 002
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE

CREAM; TOPICAL NEO-MEDROL ACETATE PHARMACIA AND UPJOHN
0.25%;EQ 3.5MG BASE/GM 1%;EQ 3.5MG BASE/GM
A060611 A060611
002 001

INJECTABLE; INJECTION A-METHAPRED ABBOTT
EQ EQ EQ EQ
40MG BASE/VIAL 125MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A089573 A089574 A089575 A089576
001 001 001 001
Feb Feb Feb Feb
22, 22, 22, 22,
1991 1991 1991 1991

INJECTABLE; INJECTION A-METHAPRED HOSPIRA
6 - 237 (of 360)
EQ EQ EQ EQ EQ EQ
40MG BASE/VIAL 125MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL
001 001 001 001 001 001 002 003 004 001 002 001 001 001 001 001 001 001 001 001 001 001 002 003 001 004 002 001 001 001 001 001 001 001 001 001 001 001 001
Aug 18, 1987 Aug 18, 1987
EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL ORGANON USA INC EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL METHYLPREDNISOLONE SODIUM SUCCINATE ABRAXIS PHARM EQ 40MG BASE/VIAL EQ 40MG BASE/VIAL EQ 125MG BASE/VIAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL BEDFORD LABS EQ 40MG BASE/VIAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL ELKINS SINN EQ 40MG BASE/VIAL INTL MEDICATION EQ 40MG BASE/VIAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL TEVA PARENTERAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL WATSON LABS EQ 40MG BASE/VIAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
METHYLPREDNISOLONE ELKINS SINN
Jun 25, 1982 Jun 25, 1982 Jun Mar Jun Mar Jun Mar Mar Jun Mar Mar Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Nov Nov Nov Jul Jul Jul Jul 08, 28, 08, 28, 08, 28, 28, 08, 28, 28, 21, 21, 21, 21, 21, 21, 09, 09, 09, 09, 30, 30, 30, 22, 22, 24, 24, 1984 1986 1984 1986 1984 1986 1986 1984 1986 1986 2007 2007 2007 2007 2007 2007 1983 1983 1983 1983 1992 1992 1992 1982 1982 1984 1984
METHYLPREDNISOLONE; NEOMYCIN SULFATE

OINTMENT; OPHTHALMIC NEO-MEDROL PHARMACIA AND UPJOHN
A060645
001
METHYLTESTOSTERONE
CAPSULE; ORAL METHYLTESTOSTERONE HEATHER VIRILON STAR PHARMS FL TABLET; BUCCAL ANDROID 5 VALEANT PHARM INTL ORETON SCHERING
10MG 10MG
A084967 A087750
001 001 Nov 24, 1982
5MG 10MG
A087222 A080281
001 001

METHYLTESTOSTERONE
TABLET; BUCCAL/SUBLINGUAL METANDREN NOVARTIS 5MG 10MG METHYLTESTOSTERONE IMPAX LABS 10MG LILLY 10MG PUREPAC PHARM 10MG 10MG PVT FORM 5MG TABLICAPS 10MG USL PHARMA 10MG TABLET; ORAL METANDREN NOVARTIS 10MG 25MG METHYLTESTOSTERONE INWOOD LABS 10MG 25MG KV PHARM 10MG LANNETT 10MG 25MG LILLY 25MG PARKE DAVIS 10MG 25MG PUREPAC PHARM 10MG 10MG 25MG 25MG PVT FORM 5MG 10MG 25MG TABLICAPS 10MG 25MG WATSON LABS 10MG 25MG WEST WARD 10MG 25MG 25MG ORETON METHYL SCHERING 10MG 25MG
6 - 238 (of 360)
N003240 N003240 A084287 A080256 A080308 A080475 A083836 A085125 A080271
004 005 001 001 001 001 001 001 001
N003240 N003240 A080839 A080973 A084312 A087092 A087111 A080256 A084244 A084241 A080309 A080475 A080310 A080475 A080214 A080214 A080214 A080313 A085270 A080933 A080931 A084331 A084331 A084642 N003158 N003158
001 003 001 001 001 001 001 002 001 001 001 002 001 003 001 002 003 001 001 001 001 001 002 001 001 002
Nov 05, 1982 Jan 27, 1983
METHYPRYLON
CAPSULE; ORAL NOLUDAR ROCHE ELIXIR; ORAL NOLUDAR ROCHE TABLET; ORAL NOLUDAR ROCHE
300MG
N009660
008
50MG/5ML
N009660
007
50MG 200MG
N009660 N009660
002 004
METHYSERGIDE MALEATE
TABLET; ORAL SANSERT NOVARTIS
2MG
N012516
001

CONCENTRATE; ORAL METOCLOPRAMIDE INTENSOL ROXANE EQ 10MG BASE/ML INJECTABLE; INJECTION METOCLOPRAMIDE HYDROCHLORIDE BEDFORD EQ 5MG BASE/ML EQ 5MG BASE/ML EQ 5MG BASE/ML HOSPIRA EQ 5MG BASE/ML EQ 5MG BASE/ML EQ 5MG BASE/ML EQ 5MG BASE/ML EQ 5MG BASE/ML EQ 5MG BASE/ML EQ 5MG BASE/ML LYPHOMED EQ 10MG BASE/2ML NORBROOK EQ 10MG BASE/2ML SMITH AND NEPHEW EQ 5MG BASE/ML EQ 10MG BASE/2ML REGLAN BAXTER HLTHCARE CORP EQ 10MG BASE/ML SOLUTION; ORAL METOCLOPRAMIDE HYDROCHLORIDE ACTAVIS MID ATLANTIC EQ 5MG BASE/5ML MORTON GROVE EQ 5MG BASE/5ML PACO EQ 5MG BASE/5ML ROXANE EQ 5MG BASE/5ML TEVA EQ 5MG BASE/5ML EQ 5MG BASE/5ML REGLAN ROBINS AH EQ 5MG BASE/5ML TABLET; ORAL CLOPRA QUANTUM PHARMICS EQ 5MG BASE EQ 10MG BASE CLOPRA-"YELLOW" QUANTUM PHARMICS EQ 10MG BASE MAXOLON KING PHARMS EQ 10MG BASE METOCLOPRAMIDE HYDROCHLORIDE CLONMEL HLTHCARE EQ 10MG BASE HALSEY EQ 10MG BASE INTERPHARM EQ 10MG BASE MUTUAL PHARM EQ 10MG BASE EQ 10MG BASE PAR PHARM EQ 10MG BASE SANDOZ EQ 5MG BASE EQ 5MG BASE EQ 10MG BASE EQ 10MG BASE EQ 10MG BASE SCHERING EQ 10MG BASE SUPERPHARM EQ 10MG BASE USL PHARMA EQ 10MG BASE WATSON LABS EQ 10MG BASE EQ 10MG BASE EQ 10MG BASE EQ 10MG BASE TABLET, ORALLY DISINTEGRATING; ORAL REGLAN ODT MEDA PHARMS EQ 5MG BASE EQ 10MG BASE
6 - 239 (of 360)
A072995
001
Jan 30, 1992
001 001 001 001 001 001 001 001 001 001 001 001 001 001 004
Mar Mar May Jun Jun Nov Mar Jan Jan Aug Jan Aug Mar Mar
30, 30, 18, 23, 22, 07, 03, 18, 17, 02, 24, 26, 02, 02,
1992 1992 1992 1989 1989 1988 1989 1989 1991 1996 1986 1988 1987 1987
May 28, 1987
A071340 A070949 A071665 A072038 A070819 A071315 N018821
001 001 001 001 001 001 001
Aug Mar Dec Dec Jul Jun
18, 06, 05, 05, 10, 30,
1988 1987 1988 1988 1987 1993
Mar 25, 1983
001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001
Jun 02, 1988 Jul 29, 1985 Oct 28, 1985 Mar 04, 1986 May Oct Sep Feb Apr Mar Jun Oct Feb Jan Oct Feb Jun Jul Mar Jun Jan May 09, 28, 24, 10, 28, 25, 22, 05, 03, 30, 05, 02, 26, 29, 02, 06, 22, 11, 1991 1986 1986 1987 1993 1986 1989 1995 1987 1990 1995 1987 1987 1985 1987 1986 1986 1987
N021793 N021793
001 002
Jun 10, 2005 Jun 10, 2005

METOCURINE IODIDE
INJECTABLE; INJECTION METUBINE IODIDE LILLY
6 - 240 (of 360)
2MG/ML
N006632
003
METOLAZONE
TABLET; ORAL DIULO GD SEARLE LLC
2.5MG 5MG 10MG 10MG 10MG 0.5MG
N018535 N018535 N018535 A076482 A076891 N019532
001 002 003 002 001 001 Apr 29, 2004 Jul 21, 2004 Oct 30, 1987
METOLAZONE ROXANE WATSON LABS MYKROX UCB INC
METOPROLOL FUMARATE
TABLET, EXTENDED RELEASE; ORAL LOPRESSOR NOVARTIS EQ 100MG EQ 200MG EQ 300MG EQ 400MG
TARTRATE TARTRATE TARTRATE TARTRATE
N019786 N019786 N019786 N019786
001 002 003 004
Dec Dec Dec Dec
27, 27, 27, 27,
1989 1989 1989 1989
TABLET, EXTENDED RELEASE; ORAL METOPROLOL SUCCINATE NESHER PHARMS EQ 100MG TARTRATE EQ 200MG TARTRATE SANDOZ EQ 25MG TARTRATE EQ 50MG TARTRATE EQ 100MG TARTRATE EQ 200MG TARTRATE
A076640 A076640 A076969 A076969 A076969 A076969
002 001 001 002 003 004
May May Jul May Mar Mar
18, 18, 31, 18, 20, 20,
2007 2007 2006 2007 2008 2008
METOPROLOL TARTRATE
TABLET; ORAL METOPROLOL TARTRATE APOTHECON MYLAN PUREPAC PHARM SOLCO HLTHCARE TEVA TEVA PHARMS
A074258 A074258 A073666 A073666 A074380 A074380 A074453 A074453 A074143 A074143 A074333 A074333
001 002 001 002 001 002 001 002 001 002 001 002
Jan Jan Dec Dec Jul Jul Apr Apr Sep Sep Jan Jan
27, 27, 21, 21, 29, 29, 27, 27, 30, 30, 27, 27,
1994 1994 1993 1993 1994 1994 1995 1995 1994 1994 1994 1994
METRIZAMIDE
INJECTABLE; INJECTION AMIPAQUE GE HEALTHCARE
2.5GM/VIAL 3.75GM/VIAL 6.75GM/VIAL 13.5GM/VIAL
N017982 N017982 N017982 N017982
003 001 002 004
Sep 12, 1983
Sep 12, 1983
METRONIDAZOLE
CAPSULE; ORAL METRONIDAZOLE ABLE
375MG
A076505
001
Nov 13, 2003

METRONIDAZOLE
INJECTABLE; INJECTION METRO I.V. B BRAUN METRONIDAZOLE ABBOTT ABRAXIS PHARM HIKMA MAPLE INTL MEDICATION WATSON LABS TABLET; ORAL METROMIDOL LABS AF METRONIDAZOLE ABLE HALSEY IVAX SUB TEVA PHARMS LNK MUTUAL PHARM PAR PHARM SANDOZ
6 - 241 (of 360)
500MG/100ML 500MG/100ML 500MG/100ML 500MG/100ML 500MG/100ML 500MG/100ML 500MG/100ML
N018674 N018889 A070071 N018907 A070004 A070042 A070170
001 001 001 001 001 001 001
Aug 31, 1982 Nov Dec Mar May Dec Apr 18, 03, 30, 08, 20, 01, 1983 1984 1984 1985 1984 1986
A074523 A074523 A076519 A076519 A070021 A070593 N018517 N018517 N019029 N018818 N018818 N018845 N018930 N018620 N018740 N018620 N018740 A070008 A070009 N018599 N018599 A070040 A070039 N018871 N018871 A070029 A070731
001 002 001 002 001 001 001 002 001 001 002 001 001 001 001 002 002 001 001 001 002 001 001 001 002 001 001
Oct 24, 1996 Oct 24, 1996 Jun Jun Apr Feb May Apr Feb Feb Aug Aug Mar Oct Jun Oct Dec Dec Sep Feb Jan Jan 27, 27, 02, 27, 05, 10, 16, 16, 18, 18, 04, 22, 02, 22, 11, 11, 17, 13, 29, 29, 2003 2003 1985 1986 1982 1984 1983 1983 1983 1983 1982 1982 1983 1982 1984 1984 1982 1984 1985 1985
SUPERPHARM WATSON LABS WORLD GEN PROTOSTAT ORTHO MCNEIL PHARM SATRIC SAVAGE LABS
Mar 02, 1983 Mar 02, 1983 Mar 19, 1985 Jun 08, 1987
250MG 500MG TABLET, EXTENDED RELEASE; ORAL METRONIDAZOLE ABLE 750MG
A076462
001
Jun 25, 2003
METRONIDAZOLE HYDROCHLORIDE
INJECTABLE; INJECTION FLAGYL I.V. PFIZER EQ 500MG BASE/VIAL METRONIDAZOLE HYDROCHLORIDE ABRAXIS PHARM EQ 500MG BASE/VIAL
N018353 A070295
001 001 Oct 15, 1985
METYRAPONE
TABLET; ORAL METOPIRONE HRA PHARMA
250MG
N012911
001
CAPSULE; ORAL MEXILETINE HYDROCHLORIDE SANDOZ 150MG
A074450
001
May 16, 1996

CAPSULE; ORAL MEXILETINE HYDROCHLORIDE SANDOZ 200MG 250MG MEXITIL BOEHRINGER INGELHEIM 150MG 200MG 250MG
6 - 242 (of 360)
A074450 A074450 N018873 N018873 N018873
002 003 002 003 004
May 16, 1996 May 16, 1996 Dec 30, 1985 Dec 30, 1985 Dec 30, 1985
MEZLOCILLIN SODIUM MONOHYDRATE

INJECTABLE; INJECTION MEZLIN BAYER PHARMS
1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 20GM BASE/VIAL 20GM BASE/VIAL
A062333 A062372 N050549 A062333 A062372 N050549 A062333 A062372 A062697 N050549 A062333 A062372 A062697 N050549 A062372 N050549
001 005 001 002 001 002 003 002 001 003 004 003 002 004 004 005
Jan 13, 1983
May 13, 1982
May 13, 1982 Jan 22, 1987
May 13, 1982 Jan 22, 1987 Mar 02, 1988 Mar 02, 1988
MICONAZOLE
INJECTABLE; INJECTION MONISTAT JANSSEN PHARMA
10MG/ML
N018040
001
MICONAZOLE NITRATE
CREAM; TOPICAL MONISTAT-DERM INSIGHT PHARMS 2% CREAM; VAGINAL MICONAZOLE NITRATE TEVA 2% TEVA PHARMS 2% CREAM, SUPPOSITORY; TOPICAL, VAGINAL M-ZOLE 7 DUAL PACK ACTAVIS MID ATLANTIC 2%,100MG LOTION; TOPICAL MONISTAT-DERM INSIGHT PHARMS 2% TAMPON; VAGINAL MONISTAT 5 PERSONAL PRODS 100MG
N017494
001
A074136 A074030
001 001
Jan 04, 1995 Oct 30, 1992
A074586
001
Jul 17, 1997
N017739
001
N018592
001
Oct 27, 1989
INJECTABLE; INJECTION MIDAZOLAM HYDROCHLORIDE APOTHECON EQ EQ EQ ASTRAZENECA EQ BEDFORD EQ BEN VENUE EQ HOSPIRA EQ EQ
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A075620 A075620 A075641 A075263 A075249 A075455 A075396 A075396
001 002 001 001 001 001 001 002
Nov Nov Oct Jun Jun Jun Jun Jun
01, 01, 19, 26, 23, 20, 20, 20,
2000 2000 2000 2000 2000 2000 2000 2000

INJECTABLE; INJECTION MIDAZOLAM HYDROCHLORIDE HOSPIRA EQ 5MG HOSPIRA INC EQ 1MG EQ 5MG VERSED HLR EQ 1MG EQ 5MG SYRUP; ORAL VERSED ROCHE EQ 2MG
6 - 243 (of 360)
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A075484 A075409 A075409 N018654 N018654
001 002 001 002 001
Jun 20, 2000 Jun 20, 2000 Jun 20, 2000 May 26, 1987 Dec 20, 1985
BASE/ML
N020942
001
Oct 15, 1998
MIDODRINE HYDROCHLORIDE
TABLET; ORAL PROAMATINE SHIRE LLC
2.5MG 5MG 10MG
N019815 N019815 N019815
001 002 003
Sep 06, 1996 Sep 06, 1996 Mar 20, 2002
MILRINONE LACTATE
INJECTABLE; INJECTION MILRINONE LACTATE BIONICHE PHARMA HIKMA MAPLE HOSPIRA
EQ 1MG BASE/ML EQ 1MG BASE/ML EQ 1MG BASE/ML EQ 1MG BASE/ML MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) HIKMA MAPLE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) PRIMACOR SANOFI AVENTIS US EQ 1MG BASE/ML PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER SANOFI AVENTIS US EQ 10MG BASE/100ML EQ 15MG BASE/100ML EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
A076428 A075852 A075830 A075884 A076259 A075510 N019436 N020343 N020343 N020343 N020343
001 001 001 001 001 001 001 001 002 003 004
Jun May May May
16, 28, 28, 28,
2003 2002 2002 2002
Aug 08, 2002 May 28, 2002 Dec 31, 1987 Aug Aug Aug Aug 09, 09, 09, 09, 1994 1994 1994 1994
CAPSULE; ORAL DYNACIN MEDICIS MINOCIN PRECISION DERMAT TRIAX PHARMS
A063066 N050649 N050315 N050315
001 003 002 001
Aug 14, 1990 Feb 12, 2001
INJECTABLE; INJECTION MINOCIN LEDERLE EQ 100MG BASE/VIAL SUSPENSION; ORAL MINOCIN PRECISION DERMAT EQ 50MG BASE/5ML TABLET; ORAL MINOCYCLINE HYDROCHLORIDE TRIAX PHARMS EQ 50MG BASE EQ 100MG BASE TABLET, EXTENDED RELEASE; ORAL MINOCYCLINE HYDROCHLORIDE LUPIN LTD EQ 55MG BASE
A062139
001
N050445
001
N050451 N050451
003 002
Aug 10, 1982 Aug 10, 1982
A091424
002
Nov 30, 2011
MINOXIDIL
SOLUTION; TOPICAL MINOXIDIL (FOR MEN) BAUSCH AND LOMB
2%
A074643
001
Apr 09, 1996

MINOXIDIL
SOLUTION; TOPICAL MINOXIDIL (FOR MEN) COPLEY PHARM SIGHT PHARMS TEVA MINOXIDIL (FOR WOMEN) SIGHT PHARMS TABLET; ORAL LONITEN PHARMACIA AND UPJOHN MINODYL QUANTUM PHARMICS MINOXIDIL ROYCE LABS USL PHARMA
6 - 244 (of 360)
2% 2% 2% 2%
A074500 A074743 A074589 A074743
001 002 001 001
May 23, 1996 Oct 18, 1996 Apr 05, 1996 Oct 18, 1996
2.5MG 10MG 2.5MG 10MG 2.5MG 10MG 2.5MG
N018154 N018154 A072153 A071534 A071799 A071796 A071537
001 003 001 001 001 001 001 Jul 13, 1988 Mar 19, 1987 Nov 10, 1987 Nov 10, 1987 Dec 16, 1988
MIRTAZAPINE
TABLET; ORAL MIRTAZAPINE ACTAVIS ELIZABETH
15MG 30MG 45MG ACTAVIS TOTOWA 15MG 30MG 45MG IVAX SUB TEVA PHARMS 15MG 30MG 45MG ROXANE 15MG 30MG 45MG SANDOZ 15MG 30MG 45MG TABLET, ORALLY DISINTEGRATING; ORAL MIRTAZAPINE ACTAVIS TOTOWA 15MG 30MG 45MG
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jun Jun Jun Jun Jun Jun Dec Dec Dec Jun Jun Jun Jun Jun Jun
20, 20, 20, 25, 25, 25, 22, 22, 22, 19, 19, 19, 19, 19, 19,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
A076689 A076689 A076689
001 002 003
Aug 31, 2005 Aug 31, 2005 Aug 31, 2005
MITOMYCIN
INJECTABLE; INJECTION MITOMYCIN HOSPIRA MITOZYTREX SUPERGEN MUTAMYCIN BRISTOL BRISTOL MYERS
A064106 N050763 N050450 N050450 A062336 A062336 A062336
001 001 001 002 001 002 003
Nov 29, 1995 Nov 14, 2002
Mar 10, 1988
INJECTABLE; INJECTION MITOXANTRONE HYDROCHLORIDE FRESENIUS KABI ONCOL EQ 20MG BASE/10ML (EQ 2MG BASE/ML) EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
A078606 A078606 A078606
001 002 003
May 14, 2008 May 14, 2008 May 14, 2008

INJECTABLE; INJECTION NOVANTRONE EMD SERONO
6 - 245 (of 360)
EQ 20MG BASE/10ML (EQ 2MG BASE/ML) EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
N019297 N019297 N019297
001 002 003
Dec 23, 1987 Dec 23, 1987 Dec 23, 1987
MIVACURIUM CHLORIDE
INJECTABLE; INJECTION MIVACRON ABBVIE EQ MIVACRON IN DEXTROSE 5% IN ABBVIE EQ EQ MIVACURIUM CHLORIDE STRIDES ARCOLAB LTD EQ
2MG BASE/ML PLASTIC CONTAINER 0.5MG BASE/ML 50MG BASE/100ML 2MG BASE/ML
N020098 N020098 N020098 A078562
001 002 003 001
Jan 22, 1992 Jan 22, 1992 Jan 22, 1992 Apr 30, 2009
MOLINDONE HYDROCHLORIDE
CAPSULE; ORAL MOBAN ENDO PHARMS
5MG 10MG 25MG
N017111 N017111 N017111
001 002 003
CONCENTRATE; ORAL MOBAN ENDO PHARMS TABLET; ORAL MOBAN ENDO PHARMS
20MG/ML
N017938
001
N017111 N017111 N017111 N017111 N017111
004 005 006 007 008
MONOBENZONE
CREAM; TOPICAL BENOQUIN VALEANT PHARM INTL
20%
N008173
003
MONOCTANOIN
LIQUID; PERFUSION, BILIARY MOCTANIN ETHITEK 100%
N019368
001
Oct 29, 1985
MORICIZINE HYDROCHLORIDE
TABLET; ORAL ETHMOZINE SHIRE
200MG 250MG 300MG
N019753 N019753 N019753
001 002 003
Jun 19, 1990 Jun 19, 1990 Jun 19, 1990
MORPHINE SULFATE
INJECTABLE; INJECTION MORPHINE SULFATE HOSPIRA MALLINCKRODT
0.5MG/ML 1MG/ML 2MG/ML INJECTABLE, LIPOSOMAL; EPIDURAL DEPODUR PACIRA PHARMS INC 10MG/ML (10MG/ML) 15MG/1.5ML (10MG/ML) 20MG/2ML (10MG/ML)
N019917 N020631 N020631
001 001 002
Oct 30, 1992 Jul 03, 1996 Jul 03, 1996
N021671 N021671 N021671
001 002 003
May 18, 2004 May 18, 2004 May 18, 2004

MORPHINE SULFATE
TABLET, EXTENDED RELEASE; ORAL MORPHINE SULFATE WATSON LABS 100MG ORAMORPH SR XANODYNE PHARMS INC 15MG 30MG 60MG 100MG
6 - 246 (of 360)
A075656 N019977 N019977 N019977 N019977
001 004 001 002 003
Jan 30, 2001 Nov Aug Aug Aug 23, 15, 15, 15, 1994 1991 1991 1991
MOXALACTAM DISODIUM
INJECTABLE; INJECTION MOXAM LILLY
EQ EQ EQ EQ EQ
250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
N050550 N050550 N050550 N050550 N050550
001 002 003 004 008
MYCOPHENOLATE MOFETIL
CAPSULE; ORAL MYCOPHENOLATE MOFETIL ZYDUS PHARMS USA INC TABLET; ORAL MYCOPHENOLATE MOFETIL DR REDDYS LABS LTD ZYDUS PHARMS USA INC
250MG
A065433
001
May 04, 2009
500MG 500MG
A090464 A065477
001 001
Sep 13, 2010 May 04, 2009
NABUMETONE
TABLET; ORAL NABUMETONE COPLEY PHARM SANDOZ RELAFEN SMITHKLINE BEECHAM
750MG 500MG 750MG 500MG 750MG
A075179 A075590 A075590 N019583 N019583
001 001 002 001 002
Jun 06, 2000 Feb 25, 2002 Feb 25, 2002 Dec 24, 1991 Dec 24, 1991
NADOLOL
TABLET; ORAL CORGARD KING PHARMS NADOLOL IVAX SUB TEVA PHARMS TEVA PHARMS
120MG 160MG 120MG 160MG 80MG 120MG 160MG
N018063 N018063 A074255 A074255 A074368 A074368 A074368
003 004 002 003 001 002 003 Jan Jan Aug Aug Aug 24, 24, 31, 31, 31, 1996 1996 1994 1994 1994
NAFCILLIN SODIUM
CAPSULE; ORAL UNIPEN WYETH AYERST FOR SOLUTION; ORAL UNIPEN WYETH AYERST INJECTABLE; INJECTION NAFCILLIN SODIUM APOTHECON
EQ 250MG BASE
N050111
001
EQ 250MG BASE/5ML
N050199
001
EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL
A061984 A061984 A061984 A061984
001 002 003 005

NAFCILLIN SODIUM
INJECTABLE; INJECTION NAFCILLIN SODIUM MARSAM PHARMS LLC
6 - 247 (of 360)
SANDOZ NALLPEN GLAXOSMITHKLINE
500MG BASE/VIAL 1GM BASE/VIAL 1.5GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
A062844 A062844 A062844 A062844 A062844 A063008 A062527 A061999 A061999 A062755 A061999 A062755 A061999 A062717 N050320 A062717 A062717 N050320 N050320 N050320 N050320 N050320
001 002 003 004 005 001 001 001 002 001 003 002 004 001 001 002 004 003 004 005 006 002
Oct Oct Oct Oct Oct Sep Aug
26, 26, 26, 26, 26, 29, 02,
1988 1988 1988 1988 1988 1988 1984
Dec 19, 1986 Dec 19, 1986
EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 4GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL UNIPEN IN PLASTIC CONTAINER WYETH AYERST EQ 1GM BASE/VIAL TABLET; ORAL UNIPEN WYETH AYERST EQ 500MG BASE
UNIPEN WYETH AYERST
Dec 16, 1986 Dec 16, 1986 Dec 16, 1986
N050462
001
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION NALBUPHINE ABRAXIS PHARM
10MG/ML 20MG/ML
A070751 A070752 A070917 N020200 A072070 A072071 A072072 A072073 A072074 A072075 A074471 A074471 N018024 N018024
001 001 001 001 001 001 001 001 001 001 001 002 001 002
Jul 02, 1986 Sep 24, 1986 Feb Mar Apr Apr Apr Apr Apr Apr Mar Mar 03, 12, 10, 10, 10, 10, 10, 10, 19, 19, 1989 1993 1989 1989 1989 1989 1989 1989 1998 1998
NALBUPHINE HYDROCHLORIDE ABBOTT 20MG/ML ABBVIE 1.5MG/ML ASTRAZENECA 10MG/ML 10MG/ML 10MG/ML 20MG/ML 20MG/ML 20MG/ML BARR 10MG/ML 20MG/ML NUBAIN ENDO PHARMS 10MG/ML 20MG/ML
May 27, 1982
NALIDIXIC ACID
SUSPENSION; ORAL NEGGRAM SANOFI AVENTIS US TABLET; ORAL NALIDIXIC ACID MUTUAL PHARM
250MG/5ML
N017430
001
WATSON LABS
250MG 500MG 1GM 250MG 500MG
A070270 A070271 A070272 A071936 A072061
001 001 001 001 001
Jun Jun Jun Jun Jun
29, 29, 29, 29, 29,
1988 1988 1988 1988 1988

NALIDIXIC ACID
TABLET; ORAL NALIDIXIC ACID WATSON LABS NEGGRAM SANOFI AVENTIS US
6 - 248 (of 360)
1GM 250MG 500MG 1GM
A071919 N014214 N014214 N014214
001 002 004 005
Jun 29, 1988
NALMEFENE HYDROCHLORIDE
INJECTABLE; INJECTION REVEX BAXTER HLTHCARE CORP
EQ 0.1MG BASE/ML EQ 1MG BASE/ML
N020459 N020459
001 002
Apr 17, 1995 Apr 17, 1995
INJECTABLE; INJECTION NALOXONE HIKMA MAPLE
WYETH AYERST
0.4MG/ML 0.4MG/ML 0.4MG/ML 0.02MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 0.02MG/ML 0.02MG/ML 0.4MG/ML 1MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 1MG/ML 1MG/ML 1MG/ML 0.02MG/ML 1MG/ML 1MG/ML 1MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 1MG/ML 0.4MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 1MG/ML
A070298 A070299 A070496 A070188 A070189 A070190 A070191 A070648 A070661 A070649 A071604 A072081 A072082 A072083 A072084 A072085 A072086 A072087 A072088 A072089 A072090 A072091 A072092 A072093 A071272 A071273 A071274 A071287 A070171 A070252 A070253 A070255 A070417 A072115 A071811 A071671 A071681 A071682 A071672 A071683 A071339 A071083 A071084
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Sep Sep Sep Sep Sep Sep Nov Nov Nov Dec Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr May May May May Sep Jan Jan Jan Sep Apr Jul Nov Nov Nov Nov Nov Nov
24, 24, 24, 24, 24, 24, 24, 17, 17, 17, 16, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 24, 24, 24, 24, 24, 16, 16, 07, 24, 27, 19, 17, 17, 17, 17, 17, 18,
1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1988 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1988 1988 1988 1988 1986 1987 1987 1987 1986 1988 1988 1987 1987 1987 1987 1987 1987
NALOXONE HYDROCHLORIDE ABRAXIS PHARM
ASTRAZENECA
HIKMA MAPLE
HOSPIRA
INTL MEDICATION MARSAM PHARMS LLC SMITH AND NEPHEW
SOLOPAK WATSON LABS NARCAN BRISTOL MYERS SQUIBB
Jul 28, 1988 Jul 28, 1988

INJECTABLE; INJECTION NARCAN BRISTOL MYERS SQUIBB ENDO PHARMS
6 - 249 (of 360)
1MG/ML 0.02MG/ML 0.4MG/ML 1MG/ML
A071311 N016636 N016636 N016636
001 002 001 003
Jul 28, 1988
Jun 14, 1982
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE

TABLET; ORAL TALWIN NX SANOFI AVENTIS US
EQ 0.5MG BASE;EQ 50MG BASE
N018733
001
Dec 16, 1982
INJECTABLE; INJECTION DECA-DURABOLIN ORGANON USA INC
N013132 N013132 N013132 A088290 A088317 A087519 A086385 A087598 A088554 A086598 A087599 A088128
001 002 003 001 001 001 001 001 001 001 001 001
Jun 12, 1986 Jun 12, 1986 Jun 12, 1986 Oct Oct Sep Jan Oct Feb Jan Oct Dec 03, 14, 28, 13, 06, 10, 13, 06, 05, 1983 1983 1983 1984 1983 1986 1984 1983 1983
NANDROLONE DECANOATE ABRAXIS PHARM AKORN WATSON LABS
NANDROLONE PHENPROPIONATE
INJECTABLE; INJECTION DURABOLIN ORGANON USA INC
25MG/ML 50MG/ML NANDROLONE PHENPROPIONATE WATSON LABS 25MG/ML 50MG/ML
N011891 N011891 A086386 A087488
001 002 001 001 Jun 17, 1983 Jun 17, 1983
SOLUTION/DROPS; OPHTHALMIC NAFAZAIR BAUSCH AND LOMB 0.1% PHARMAFAIR 0.1% NAPHCON FORTE ALCON 0.1% OPCON BAUSCH AND LOMB 0.1% VASOCON NOVARTIS 0.1%
A040073 A088101 A080229 A087506 A080235
001 001 001 001 002
May 25, 1994 Apr 15, 1983
Mar 24, 1983
NAPROXEN
TABLET; ORAL NAPROXEN DAVA PHARMS INC
HAMILTON PHARMS
A074105 A074105 A074105 A074110 A074110 A074110 A074111 A074111 A074111
001 002 003 001 002 003 001 002 003
Dec Dec Dec Oct Oct Oct Feb Feb Feb
21, 21, 21, 30, 30, 30, 28, 28, 28,
1993 1993 1993 1992 1992 1992 1995 1995 1995

NAPROXEN
TABLET; ORAL NAPROXEN PLIVA
6 - 250 (of 360)
250MG 375MG 500MG PUREPAC PHARM 250MG 375MG 500MG ROXANE 250MG 375MG 500MG TEVA 250MG 250MG 375MG 375MG 500MG 500MG TEVA PHARMS 250MG 375MG 500MG WATSON LABS 250MG 375MG 500MG TABLET, DELAYED RELEASE; ORAL NAPROXEN ACTAVIS ELIZABETH 375MG 500MG
001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003
Jun Jun Jun Dec Dec Dec Feb Feb Feb Dec Apr Dec Apr Dec Apr Dec Dec Dec Feb Feb Feb
27, 27, 27, 21, 21, 21, 28, 28, 28, 21, 11, 21, 11, 21, 11, 21, 21, 21, 10, 10, 10,
1996 1996 1996 1993 1993 1993 1994 1994 1994 1993 1996 1993 1996 1993 1996 1993 1993 1993 1995 1995 1995
A074936 A074936
001 002
Feb 24, 1998 Feb 24, 1998
NAPROXEN SODIUM
TABLET; ORAL NAPROXEN SODIUM ABLE
EQ 250MG EQ 500MG HAMILTON PHARMS EQ 250MG EQ 500MG IVAX SUB TEVA PHARMS EQ 250MG EQ 500MG MYLAN EQ 250MG EQ 500MG PLIVA EQ 250MG EQ 500MG PUREPAC PHARM EQ 250MG EQ 500MG ROXANE EQ 250MG EQ 500MG SANDOZ EQ 200MG EQ 250MG EQ 250MG EQ 500MG EQ 500MG TEVA EQ 250MG EQ 500MG TEVA PHARMS EQ 250MG EQ 500MG WATSON LABS EQ 250MG EQ 500MG TABLET, EXTENDED RELEASE; ORAL NAPROXEN SODIUM WATSON LABS FLORIDA EQ 375MG EQ 500MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001 001 002 002 001 002 001 002 001 002
Aug Aug Aug Aug Mar Mar Aug Aug Jun Jun Mar Mar Dec Dec Jan Dec Dec Dec Dec Dec Dec Jan Jan Dec Dec
22, 22, 31, 31, 14, 14, 31, 31, 20, 20, 20, 20, 21, 21, 13, 21, 05, 21, 05, 21, 21, 27, 27, 21, 21,
2003 2003 1993 1993 1995 1995 1994 1994 1996 1996 1995 1995 1993 1993 1997 1993 1994 1993 1994 1993 1993 1994 1994 1993 1993
BASE BASE
A075416 A075416
002 001
Apr 23, 2003 Aug 27, 2002

NATEGLINIDE
TABLET; ORAL NATEGLINIDE TEVA PHARMS
6 - 251 (of 360)
60MG 120MG
A077467 A077467
001 002
Sep 09, 2009 Sep 09, 2009
NEDOCROMIL SODIUM
AEROSOL, METERED; INHALATION TILADE KING PHARMS 1.75MG/INH SOLUTION; INHALATION TILADE SANOFI AVENTIS US 0.5%
N019660
001
Dec 30, 1992
N020750
001
Oct 01, 1997
NEFAZODONE HYDROCHLORIDE
TABLET; ORAL NEFAZODONE HYDROCHLORIDE IVAX SUB TEVA PHARMS 50MG 100MG 150MG 200MG 250MG MYLAN 100MG 150MG 200MG 250MG ROXANE 50MG 100MG 150MG 200MG 250MG SANDOZ 50MG 50MG 100MG 100MG 150MG 150MG 200MG 200MG 250MG 250MG WATSON LABS 100MG 150MG 200MG 250MG SERZONE BRISTOL MYERS SQUIBB 50MG 100MG 150MG 200MG 250MG 300MG
A075763 A075763 A075763 A075763 A075763 A076129 A076129 A076129 A076129 A076196 A076196 A076196 A076196 A076196 A076072 A076302 A076072 A076302 A076072 A076302 A076072 A076302 A076072 A076302 A076073 A076073 A076073 A076073 N020152 N020152 N020152 N020152 N020152 N020152
001 002 003 004 005 002 003 004 005 001 002 003 004 005 001 001 002 002 003 003 004 004 005 005 002 003 004 005 001 002 003 004 005 006
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Dec Dec Dec Dec Dec Dec
16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 22, 22, 22, 22, 22, 22,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 1994 1994 1994 1994 1994 1994
NEOMYCIN SULFATE
SOLUTION; ORAL MYCIFRADIN PHARMACIA AND UPJOHN TABLET; ORAL MYCIFRADIN PHARMACIA AND UPJOHN NEOBIOTIC PFIZER
EQ 87.5MG BASE/5ML
N050285
001
A060520 A060475
001 001

NEOMYCIN SULFATE
TABLET; ORAL NEOMYCIN SULFATE BRISTOL MYERS SQUIBB LANNETT LILLY ROXANE SANDOZ
6 - 252 (of 360)
500MG 500MG 500MG 500MG 500MG
A060365 A060607 A060385 A062173 A061586
001 001 001 001 001
NEOMYCIN SULFATE; POLYMYXIN B SULFATE

CREAM; TOPICAL NEOSPORIN GLAXOSMITHKLINE EQ OINTMENT; OPHTHALMIC STATROL ALCON EQ SOLUTION/DROPS; OPHTHALMIC STATROL ALCON EQ EQ
3.5MG BASE/GM;10,000 UNITS/GM
N050176
002
Jan 14, 1985
3.5MG BASE/GM;10,000 UNITS/GM
N050344
002
3.5MG BASE/ML;16,250 UNITS/ML 3.5MG BASE/ML;16,250 UNITS/ML
A062339 N050456
001 001
Nov 30, 1984
NEOMYCIN SULFATE; PREDNISOLONE ACETATE

OINTMENT; OPHTHALMIC NEO-DELTA-CORTEF PHARMACIA AND UPJOHN
EQ 3.5MG BASE/GM;0.25% EQ 3.5MG BASE/GM;0.5% SUSPENSION/DROPS; OPHTHALMIC NEO-DELTA-CORTEF PHARMACIA AND UPJOHN EQ 3.5MG BASE/ML;0.25%
A061039 A061039
002 001
A061037
001
NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE

OINTMENT; OPHTHALMIC NEO-HYDELTRASOL MERCK
EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE
N050378
001
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE

CREAM; TOPICAL MYTREX A SAVAGE LABS EQ 3.5MG BASE/GM;0.1% NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE FOUGERA EQ 3.5MG BASE/GM;0.1% PHARMADERM EQ 3.5MG BASE/GM;0.1% OINTMENT; TOPICAL MYTREX A SAVAGE LABS EQ 3.5MG BASE/GM;0.1% NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE FOUGERA EQ 3.5MG BASE/GM;0.1% PHARMADERM EQ 3.5MG BASE/GM;0.1%
A062598 A062600 A062595
001 001 001
Jul 21, 1986 Jul 21, 1986 Jul 21, 1986
A062609 A062608 A062607
001 001 001
May 23, 1986 May 23, 1986 May 23, 1986
NETILMICIN SULFATE
INJECTABLE; INJECTION NETROMYCIN SCHERING
N050544 N050544 N050544
001 002 003
Feb 28, 1983 Feb 28, 1983 Feb 28, 1983
NIACIN
CAPSULE; ORAL WAMPOCAP MEDPOINTE PHARM HLC TABLET; ORAL NIACIN EVERYLIFE HALSEY
500MG
N011073
003
500MG 500MG
A083203 A083453
001 001

NIACIN
TABLET; ORAL NIACIN IMPAX LABS IVAX SUB TEVA PHARMS MK LABS PUREPAC PHARM SANDOZ TABLICAPS WATSON LABS
6 - 253 (of 360)
WEST WARD NICOLAR SANOFI AVENTIS US 500MG TABLET, EXTENDED RELEASE; ORAL NIACIN BARR 500MG 750MG 1GM NIASPAN ABBVIE 375MG NIASPAN TITRATION STARTER PACK ABBVIE 375MG;500MG;750MG
A083115 A083180 A083525 A083271 A083306 A084237 A083136 A083305 A085172 A083718 A083823
001 001 001 001 001 001 001 001 001 001 001
A076378 A076378 A076250 N020381 N020381
001 002 001 001 005
Apr 26, 2005 Apr 26, 2005 Apr 14, 2005 Jul 28, 1997 Jul 28, 1997
NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; TYROSINE

SUSPENSION; ORAL TPN INTL MINERALS
15MG/5ML;3.75MG/5ML;600MG/5ML
N008378
003
CAPSULE, EXTENDED RELEASE; ORAL CARDENE SR EKR THERAP 45MG
N020005
002
Feb 21, 1992
NICLOSAMIDE
TABLET, CHEWABLE; ORAL NICLOCIDE BAYER PHARMS
500MG
N018669
001
May 14, 1982
NICOTINE
FILM, EXTENDED RELEASE; TRANSDERMAL NICOTROL MCNEIL CONS 15MG/16HR PROSTEP AVEVA 11MG/24HR 22MG/24HR
N020536 N019983 N019983
001 003 004
Jul 03, 1996 Dec 23, 1998 Dec 23, 1998
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL NICOTINE POLACRILEX WATSON LABS
A076568 A076569
001 002
Jul 29, 2004 Jul 29, 2004
NIFEDIPINE
CAPSULE; ORAL ADALAT BAYER PHARMS NIFEDIPINE CATALENT CHASE LABS NJ
N019478 N019478 A074045 A072409 A073421
001 002 001 001 001
Nov 27, 1985 Sep 17, 1986 Apr 30, 1992 Jul 04, 1990 Jun 19, 1991

NIFEDIPINE
CAPSULE; ORAL NIFEDIPINE TEVA PROCARDIA PFIZER TABLET, EXTENDED RELEASE; NIFEDIPINE MARTEC USA LLC MYLAN
6 - 254 (of 360)
10MG 20MG ORAL 90MG 30MG
A072651 N018482
001 002
Feb 19, 1992 Jul 24, 1986
A075414 A075108
003 001
Mar 23, 2004 Dec 17, 1999
NILUTAMIDE
TABLET; ORAL NILANDRON SANOFI AVENTIS US
50MG
N020169
001
Sep 19, 1996
NIMODIPINE
CAPSULE; ORAL NIMOTOP BAYER PHARMS
30MG
N018869
001
Dec 28, 1988
NISOLDIPINE
TABLET, EXTENDED RELEASE; ORAL SULAR SHIONOGI INC 10MG 20MG 30MG 40MG
N020356 N020356 N020356 N020356
001 002 003 004
Feb Feb Feb Feb
02, 02, 02, 02,
1995 1995 1995 1995
NITROFURANTOIN
CAPSULE; ORAL NITROFURANTOIN WATSON LABS TABLET; ORAL FURADANTIN PROCTER AND GAMBLE FURALAN LANNETT NITROFURANTOIN ELKINS SINN IVAX SUB TEVA PHARMS SANDOZ WATSON LABS
50MG 100MG
A084326 A084326
001 002
N008693 N008693 A080017 A080017 A080003 A080003 A080078 A080078 A080043 A080043 A080447 A085797 A080447 A085796 A084085
001 002 001 002 001 002 002 001 001 002 001 001 002 001 002
WHITEWORTH TOWN PLSN
NITROFURANTOIN SODIUM
INJECTABLE; INJECTION IVADANTIN PROCTER AND GAMBLE
EQ 180MG BASE/VIAL
N012402
001
CAPSULE; ORAL NITROFURANTOIN MYLAN
100MG
A074967
002
Jul 09, 1997

CAPSULE; ORAL NITROFURANTOIN SANDOZ
6 - 255 (of 360)
25MG 50MG 100MG NITROFURANTOIN MACROCRYSTALLINE WATSON LABS 50MG 100MG
A074336 A074336 A074336 A070248 A070249
001 002 003 001 001
Jan 25, 1995 Jan 25, 1995 Jan 25, 1995 Jun 24, 1988 Jun 24, 1988
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

CAPSULE; ORAL NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) RANBAXY LABS LTD 75MG;25MG
A076951
001
Mar 30, 2005
NITROFURAZONE
CREAM; TOPICAL FURACIN SHIRE DRESSING; TOPICAL ACTIN-N SHERWOOD MEDCL OINTMENT; TOPICAL FURACIN SHIRE NITROFURAZONE AMBIX LANNETT PERRIGO NEW YORK TARO WENDT POWDER; TOPICAL FURACIN SHIRE SOLUTION; TOPICAL NITROFURAZONE PERRIGO NEW YORK WENDT
0.2%
A083789
001
0.2%
N017343
001
0.2% 0.2% 0.2% 0.2% 0.2% 0.2%
N005795 A086077 A084393 A084968 A086156 A086766
001 001 001 001 001 001
0.2%
A083791
001
0.2% 0.2%
A085130 A087081
001 001
NITROGLYCERIN
AEROSOL; SUBLINGUAL NITROLINGUAL POHL BOSKAMP 0.4MG/SPRAY FILM, EXTENDED RELEASE; TRANSDERMAL NITROGLYCERIN MYLAN TECHNOLOGIES 0.1MG/HR 0.2MG/HR 0.4MG/HR 0.6MG/HR TRANSDERM-NITRO NOVARTIS 0.1MG/HR 0.2MG/HR 0.4MG/HR 0.6MG/HR 0.8MG/HR INJECTABLE; INJECTION NITRO IV POHL BOSKAMP 5MG/ML NITRO-BID SANOFI AVENTIS US 5MG/ML 10MG/ML NITROGLYCERIN ABRAXIS PHARM 5MG/ML 5MG/ML
N018705
001
Oct 31, 1985
A074992 A074992 A074992 A074992 N020144 N020144 N020144 N020144 N020144
004 003 002 001 001 002 003 004 005
Nov Nov Nov Nov Feb Feb Feb Feb Feb
12, 12, 12, 12, 27, 27, 27, 27, 27,
1999 1999 1999 1999 1996 1996 1996 1996 1996
N018672 N018621 A071159 A070077 A071203
002 001 001 001 001
Aug 30, 1983 Jan 05, 1982 Feb 28, 1990 Dec 13, 1985 May 08, 1987

NITROGLYCERIN
INJECTABLE; INJECTION NITROGLYCERIN INTL MEDICATION LUITPOLD SMITH AND NEPHEW
6 - 256 (of 360)
5MG/ML 5MG/ML 5MG/ML 5MG/ML NITROGLYCERIN IN DEXTROSE 5% HOSPIRA 0.1MG/ML NITROL RORER 0.8MG/ML NITRONAL POHL BOSKAMP 1MG/ML NITROSTAT PARKE DAVIS 0.8MG/ML 5MG/ML 5MG/ML 10MG/ML 10MG/ML TRIDIL HOSPIRA 0.5MG/ML 5MG/ML
A070026 A071492 A070633 A070634 A074083 N018774 N018672 N018588 A070863 N018588 A070871 A070872 N018537 N018537
001 001 001 001 001 001 001 001 001 002 001 001 002 001
Sep May Jun Jun
10, 24, 19, 19,
1985 1988 1986 1986
Oct 26, 1994 Jan 19, 1983 Aug 30, 1983
Jan Dec Jan Jan
08, 23, 08, 08,
1987 1983 1987 1987
Jun 16, 1983
NIZATIDINE
CAPSULE; ORAL AXID SMITHKLINE BEECHAM NIZATIDINE IVAX SUB TEVA PHARMS MYLAN PHARMS INC
150MG 300MG 150MG 300MG 150MG 300MG
N019508 N019508 A075461 A075461 A075934 A075934
001 002 001 002 001 002
Apr 12, 1988 Apr 12, 1988 Jul Jul Jul Jul 08, 08, 09, 09, 2002 2002 2002 2002
NONOXYNOL-9
AEROSOL; VAGINAL DELFEN PERSONAL PRODS
12.5%
N014349
002
NOREPINEPHRINE BITARTRATE
INJECTABLE; INJECTION NOREPINEPHRINE BITARTRATE METRICS PHARM EQ 1MG BASE/ML
A040522
001
Sep 30, 2004
NOREPINEPHRINE BITARTRATE; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE

INJECTABLE; INJECTION RAVOCAINE AND NOVOCAIN W/ LEVOPHED EASTMAN KODAK EQ 0.033MG BASE/ML;2%;0.4%
N008592
003
NORETHINDRONE
TABLET; ORAL NORLUTIN PARKE DAVIS
5MG
N010895
002
NORETHINDRONE ACETATE
TABLET; ORAL NORLUTATE PARKE DAVIS
5MG
N012184
002
NORFLOXACIN
SOLUTION/DROPS; OPHTHALMIC CHIBROXIN MERCK 0.3%
N019757
001
Jun 17, 1991

NORGESTREL
TABLET; ORAL OVRETTE WYETH PHARMS
6 - 257 (of 360)
0.075MG
N017031
001
NORTRIPTYLINE HYDROCHLORIDE
CAPSULE; ORAL AVENTYL HYDROCHLORIDE LILLY
EQ 10MG EQ 25MG NORTRIPTYLINE HYDROCHLORIDE SANDOZ EQ 10MG EQ 10MG EQ 25MG EQ 25MG EQ 50MG EQ 50MG EQ 75MG EQ 75MG TEVA EQ 10MG EQ 25MG EQ 50MG EQ 75MG SOLUTION; ORAL PAMELOR MALLINCKRODT INC EQ 10MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N014684 N014684 A074054 A074835 A074054 A074835 A074054 A074835 A074054 A074835 A073667 A073667 A073667 A073667
001 002 001 001 002 002 003 003 004 004 001 002 003 004 Dec Jun Dec Jun Dec Jun Dec Jun Apr Apr Apr Apr 31, 30, 31, 30, 31, 30, 31, 30, 11, 11, 11, 11, 1992 1997 1992 1997 1992 1997 1992 1997 1996 1996 1996 1996
BASE/5ML
N018012
001
NYSTATIN
CREAM; TOPICAL CANDEX BAYER PHARMS MYCOSTATIN BRISTOL MYERS SQUIBB MYKINAC ALPHARMA US PHARMS NILSTAT LEDERLE NYSTATIN TARO TEVA LOTION; TOPICAL CANDEX BAYER PHARMS OINTMENT; TOPICAL MYCOSTATIN WESTWOOD SQUIBB MYKINAC ALPHARMA US PHARMS NILSTAT LEDERLE PASTILLE; ORAL MYCOSTATIN BRISTOL MYERS SQUIBB POWDER; ORAL BARSTATIN 100 BARLAN NILSTAT DAVA PHARMS INC NYSTATIN PADDOCK LLC POWDER; TOPICAL MYCOSTATIN BRISTOL MYERS SQUIBB
100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM
A061810 A060575 A062387 A061445 A062457 A061966
001 001 001 001 001 001 Jul 28, 1983 Jul 29, 1982
100,000 UNITS/ML
N050233
001
100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM
A060571 A062731 A061444
001 001 001 Sep 22, 1986
200,000 UNITS
N050619
001
Apr 09, 1987
100% 100% 100%
A062489 N050576 A062613
001 001 001
Apr 27, 1988 Dec 22, 1983 Nov 26, 1985
100,000 UNITS/GM
A060578
001

NYSTATIN
POWDER; TOPICAL NYSTATIN NESHER PHARMS SUPPOSITORY; VAGINAL NYSERT WARNER CHILCOTT SUSPENSION; ORAL MYCOSTATIN APOTHECON NYSTATIN ALPHARMA US PHARMS MORTON GROVE PHARMADERM PHARMAFAIR ROXANE TEVA NYSTEX SAVAGE LABS TABLET; ORAL MYCOSTATIN BRISTOL MYERS SQUIBB NILSTAT LEDERLE NYSTATIN QUANTUM PHARMICS SANDOZ USL PHARMA WATSON LABS TABLET; VAGINAL KOROSTATIN HOLLAND RANTOS MYCOSTATIN BRISTOL MYERS SQUIBB NILSTAT LEDERLE NYSTATIN FOUGERA PHARMADERM QUANTUM PHARMICS SANDOZ TEVA WATSON LABS
6 - 258 (of 360)
100,000 UNITS/GM
A065321
001
Aug 18, 2006
100,000 UNITS
N050478
001
100,000 UNITS/ML 100,000 100,000 100,000 100,000 100,000 100,000 100,000 UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML
A061533 A062571 A062835 A062518 A062541 A062832 A062670 A062776 A062519
001 001 001 001 001 001 001 001 001 Oct Nov Jul Jan Dec Jun Dec 29, 19, 06, 16, 27, 18, 17, 1985 1987 1984 1985 1991 1987 1987
100,000 UNITS/ML
Jul 06, 1984
500,000 UNITS 500,000 UNITS 500,000 500,000 500,000 500,000 UNITS UNITS UNITS UNITS
A060574 A061151 A062525 A062065 A062524 A062402
001 001 001 001 001 001 Oct 29, 1984 Nov 26, 1985 Dec 16, 1982
100,000 UNITS 100,000 UNITS 100,000 UNITS 100,000 100,000 100,000 100,000 100,000 100,000 UNITS UNITS UNITS UNITS UNITS UNITS
A061718 A060577 A061325 A062459 A062460 A062509 A061965 A062502 A062176
001 001 001 001 001 001 001 001 001 Nov 09, 1983 Nov 09, 1983 Apr 03, 1984 Dec 23, 1983

CREAM; TOPICAL MYCOLOG-II APOTHECON
100,000 UNITS/GM;0.1% 100,000 UNITS/GM;0.1%
A060576 A062606 A061954 A062367 A062597 A063010 A062186 A062657 A062347 A062596
002 001 002 001 001 001 002 001 001 001
May 01, 1985 May 15, 1985 Sep 20, 1985 May 28, 1985 Oct 08, 1985 Dec Jun Jul Mar 20, 06, 30, 30, 1988 1985 1986 1987
MYCO-TRIACET II TEVA 100,000 UNITS/GM;0.1% MYKACET G AND W LABS INC 100,000 UNITS/GM;0.1% MYTREX F SAVAGE LABS 100,000 UNITS/GM;0.1% NYSTATIN AND TRIAMCINOLONE ACETONIDE ALPHARMA US PHARMS 100,000 UNITS/GM;0.1% PERRIGO NEW YORK 100,000 UNITS/GM;0.1% PHARMAFAIR 100,000 UNITS/GM;0.1% TARO 100,000 UNITS/GM;0.1% NYSTATIN-TRIAMCINOLONE ACETONIDE PHARMADERM 100,000 UNITS/GM;0.1%
Oct 08, 1985

OINTMENT; TOPICAL MYCOLOG-II APOTHECON 100,000 UNITS/GM;0.1% MYCO-TRIACET II TEVA 100,000 UNITS/GM;0.1% MYKACET G AND W LABS INC 100,000 UNITS/GM;0.1% MYTREX F SAVAGE LABS 100,000 UNITS/GM;0.1% NYSTATIN AND TRIAMCINOLONE ACETONIDE PERRIGO NEW YORK 100,000 UNITS/GM;0.1% PHARMAFAIR 100,000 UNITS/GM;0.1% NYSTATIN-TRIAMCINOLONE ACETONIDE PHARMADERM 100,000 UNITS/GM;0.1%
6 - 259 (of 360)
A060572 A062045 A062733 A062601 A062280 A062656 A062603
001 002 001 001 002 001 001
Jun 28, 1985 Nov 26, 1985 Mar 09, 1987 Oct 09, 1985 Oct 10, 1985 Jul 30, 1986 Oct 09, 1985
OFLOXACIN
INJECTABLE; INJECTION FLOXIN ORTHO MCNEIL PHARM
20MG/ML 40MG/ML
N020087 N020087 N020087 N020087 N020087 A075762
002 003 001 004 005 001
Mar 31, 1992 Mar 31, 1992 Mar 31, 1992 Mar 31, 1992 Mar 31, 1992 Jan 16, 2002
FLOXIN IN DEXTROSE 5% ORTHO MCNEIL PHARM 400MG/100ML FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER ORTHO MCNEIL PHARM 4MG/ML 400MG/100ML OFLOXACIN BEDFORD 40MG/ML SOLUTION/DROPS; OPHTHALMIC OFLOXACIN SANDOZ 0.3% TABLET; ORAL FLOXIN JANSSEN PHARMS 200MG 300MG 400MG OFLOXACIN LARKEN LABS 200MG 300MG 400MG RANBAXY LABS LTD 200MG 300MG 400MG
A076848
001
Nov 25, 2008
N019735 N019735 N019735 A076093 A076093 A076093 A076220 A076220 A076220
001 002 003 001 002 003 001 002 003
Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Sep Sep Sep Sep Sep Sep 02, 02, 02, 02, 02, 02, 2003 2003 2003 2003 2003 2003
ONDANSETRON
TABLET, ORALLY DISINTEGRATING; ORAL ONDANSETRON NESHER PHARMS 4MG 8MG PAR PHARM 4MG 8MG 16MG 24MG
A077717 A077717 A076506 A076506 A077406 A077406
001 002 001 002 001 002
Jun Jun Dec Dec Dec Dec
25, 25, 26, 26, 26, 26,
2007 2007 2006 2006 2006 2006
INJECTABLE; INJECTION ONDANSETRON HYDROCHLORIDE HOSPIRA EQ 2MG BASE/ML SAGENT PHARMS EQ 2MG BASE/ML ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER HOSPIRA EQ 0.64MG BASE/ML TEVA PHARMS EQ 0.64MG BASE/ML
A076695 A078180 A076978 A077480
001 001 001 001
Dec 26, 2006 Mar 26, 2007 Feb 26, 2007 Nov 22, 2006

INJECTABLE; INJECTION ONDANSETRON HYDROCHLORIDE AND SODIUM CHLORIDE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 0.64MG BASE/ML N021915 ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE HOSPIRA EQ 2MG BASE/ML A076696 ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER GLAXOSMITHKLINE EQ 0.64MG BASE/ML N020403 TABLET; ORAL ONDANSETRON HYDROCHLORIDE PAR PHARM EQ 4MG BASE A077303 EQ 8MG BASE A077303 EQ 24MG BASE A077303 WEST WARD PHARM CORP EQ 4MG BASE A077545 EQ 8MG BASE A077545 EQ 24MG BASE A077545
6 - 260 (of 360)
002 001 001
Dec 27, 2006 Dec 26, 2006 Jan 31, 1995
001 002 004 001 002 003
Jun Jun Jun Sep Sep Sep
25, 25, 25, 06, 06, 06,
2007 2007 2007 2007 2007 2007
ORPHENADRINE CITRATE
TABLET, EXTENDED RELEASE; NORFLEX MEDICIS ORPHENADRINE CITRATE ASCOT SANDOZ WATSON LABS ORAL 100MG 100MG 100MG 100MG N012157 A088067 A085046 A084303 001 001 001 001 Apr 06, 1983
ORPHENADRINE HYDROCHLORIDE
TABLET; ORAL DISIPAL 3M
50MG
N010653
001
OSELTAMIVIR PHOSPHATE
FOR SUSPENSION; ORAL TAMIFLU ROCHE
EQ 12MG BASE/ML
N021246
001
Dec 14, 2000
OXACILLIN SODIUM
CAPSULE; ORAL BACTOCILL GLAXOSMITHKLINE
A061336 A062241 A061336 A062241 A061450 A061450 A062222 A062222 N050118
001 001 002 002 002 001 001 002 002
OXACILLIN SODIUM APOTHECON TEVA PROSTAPHLIN APOTHECON FOR SOLUTION; ORAL BACTOCILL GLAXOSMITHKLINE OXACILLIN SODIUM APOTHECON TEVA PROSTAPHLIN APOTHECON INJECTABLE; INJECTION BACTOCILL GLAXOSMITHKLINE
EQ 500MG BASE
A062321 A061457 A062252 N050194
001 001 001 001
A061334 A061334 A062736
009 006 001
Mar 26, 1982 Mar 26, 1982 Dec 19, 1986

OXACILLIN SODIUM
INJECTABLE; INJECTION BACTOCILL GLAXOSMITHKLINE
6 - 261 (of 360)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
2GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 10GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 10GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL
A061334 A062736 A061334 A061334 N050195 N050195 N050195 N050195 N050195 A062711 A062711 A062711 A062711 A062711 A062711 A062798 A062798 A062798 A062798 A062798 A062984 A061490 A061490 A062856 A062856 A062856 A062856 A062856
007 002 008 010 001 002 003 004 005 001 002 003 004 005 006 003 004 005 001 002 001 001 002 001 002 003 004 005
Mar 26, 1982 Dec 19, 1986 Mar 26, 1982
OXACILLIN SODIUM APOTHECON
ELKINS SINN
IBI
MARSAM PHARMS LLC SANDOZ WATSON LABS
Feb Feb Feb Feb Feb Feb Dec Dec Dec Dec Dec Sep
03, 03, 03, 03, 03, 03, 11, 11, 11, 11, 11, 29,
1989 1989 1989 1989 1989 1989 1995 1995 1995 1995 1995 1988
Oct Oct Oct Oct Oct
26, 26, 26, 26, 26,
1988 1988 1988 1988 1988
OXALIPLATIN
INJECTABLE; IV (INFUSION) ELOXATIN SANOFI AVENTIS US 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 100MG/VIAL OXALIPLATIN SANDOZ 50MG/VIAL 100MG/VIAL
N021492
001
Aug 09, 2002
N021492 A090849 A090849
002 001 002
Aug 09, 2002 Apr 28, 2011 Apr 28, 2011
OXAMNIQUINE
CAPSULE; ORAL VANSIL PFIZER
250MG
N018069
001
OXANDROLONE
TABLET; ORAL OXANDROLONE ROXANE SANDOZ
2.5MG 10MG 2.5MG 10MG
A077249 A077249 A076897 A076897
001 002 001 002
Jul Jul Dec Dec
10, 10, 01, 01,
2007 2007 2006 2006
OXAPROZIN
TABLET; ORAL OXAPROZIN ACTAVIS ELIZABETH MYLAN MYLAN PHARMS INC
600MG 600MG 600MG
A075843 A075851 A075847
001 001 001
Oct 03, 2001 Aug 17, 2001 Feb 28, 2001

OXAPROZIN
TABLET; ORAL OXAPROZIN SANDOZ
6 - 262 (of 360)
600MG 600MG
A075842 A075850
001 001
Apr 12, 2001 Apr 27, 2001
OXAPROZIN POTASSIUM
TABLET; ORAL DAYPRO ALTA GD SEARLE
600MG
N020776
001
Oct 17, 2002
OXAZEPAM
CAPSULE; ORAL OXAZEPAM AM THERAP
MUTUAL PHARM
MYLAN
A071955 A071956 A071957 A071026 A071026 A071026 A071713 A071714 A071715 N015539 N015539 N015539 A070650 A070640 A070641
001 001 001 002 003 001 001 001 001 002 004 006 001 001 001
Mar Mar Mar Aug Aug Aug Oct Oct Oct
03, 03, 03, 10, 10, 10, 20, 20, 20,
1988 1988 1988 1987 1987 1987 1987 1987 1987
SERAX ALPHARMA US PHARMS
ZAXOPAM QUANTUM PHARMICS
Mar 01, 1988 Mar 01, 1988 Mar 01, 1988
TABLET; ORAL OXAZEPAM MUTUAL PHARM PARKE DAVIS WATSON LABS SERAX ALPHARMA US PHARMS
15MG 15MG 15MG 15MG
A070683 A071508 A071494 N015539
001 001 001 008
Jan 16, 1987 Feb 02, 1987 Apr 21, 1987
OXPRENOLOL HYDROCHLORIDE
CAPSULE; ORAL TRASICOR NOVARTIS
N018166 N018166 N018166 N018166
001 002 003 004
Dec Dec Dec Dec
28, 28, 28, 28,
1983 1983 1983 1983
OXTRIPHYLLINE
SOLUTION; ORAL CHOLEDYL PARKE DAVIS 100MG/5ML OXTRIPHYLLINE MORTON GROVE 100MG/5ML SYRUP; ORAL CHOLEDYL PARKE DAVIS 50MG/5ML OXTRIPHYLLINE PEDIATRIC MORTON GROVE 50MG/5ML TABLET, DELAYED RELEASE; ORAL CHOLEDYL PARKE DAVIS 100MG 200MG
N009268 A088243
012 001
Nov 27, 1984 Dec 05, 1983
N009268 A088242
011 001 Dec 05, 1983
N009268 N009268
003 007

OXTRIPHYLLINE
TABLET, DELAYED RELEASE; ORAL OXTRIPHYLLINE WATSON LABS 100MG 200MG
6 - 263 (of 360)
A087866 A087835
001 001
Aug 25, 1983 Aug 25, 1983
OXYBUTYNIN CHLORIDE
SYRUP; ORAL DITROPAN ORTHO MCNEIL JANSSEN TABLET; ORAL DITROPAN JANSSEN PHARMS OXYBUTYNIN CHLORIDE QUANTUM PHARMICS USL PHARMA WATSON LABS
5MG/5ML
N018211
001
5MG 5MG 5MG 5MG
N017577 A072296 A070746 A072485
001 001 001 001 Dec 08, 1988 Mar 10, 1988 Apr 19, 1989
TABLET, EXTENDED RELEASE; ORAL OXYCONTIN PURDUE PHARMA LP 10MG 15MG 20MG 30MG 40MG 60MG 80MG 160MG ROXICODONE ROXANE 10MG 30MG
N020553 N020553 N020553 N020553 N020553 N020553 N020553 N020553 N020932 N020932
001 006 002 007 003 008 004 005 001 002
Dec Sep Dec Sep Dec Sep Jan Mar
12, 18, 12, 18, 12, 18, 06, 15,
1995 2006 1995 2006 1995 2006 1997 2000
Oct 26, 1998 Oct 26, 1998
OXYMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION OPANA ENDO PHARMS SUPPOSITORY; RECTAL NUMORPHAN ENDO PHARMS TABLET, EXTENDED RELEASE; OPANA ER ENDO PHARMS
1.5MG/ML
N011707
001
5MG ORAL 5MG 7.5MG 10MG 15MG 20MG 30MG 40MG
N011738
004
N021610 N021610 N021610 N021610 N021610 N021610 N021610
001 005 002 006 003 007 004
Jun Feb Jun Feb Jun Feb Jun
22, 29, 22, 29, 22, 29, 22,
2006 2008 2006 2008 2006 2008 2006
OXYPHENBUTAZONE
TABLET; ORAL OXYPHENBUTAZONE WATSON LABS TANDEARIL NOVARTIS
100MG 100MG
A088399 N012542
001 004
Sep 17, 1984 Sep 03, 1982
OXYPHENCYCLIMINE HYDROCHLORIDE
TABLET; ORAL DARICON PFIZER
10MG
N011612
001

OXYPHENONIUM BROMIDE
TABLET; ORAL ANTRENYL NOVARTIS
6 - 264 (of 360)
5MG
N008492
002
OXYTETRACYCLINE
TABLET; ORAL TERRAMYCIN PFIZER
250MG
N050287
001
OXYTETRACYCLINE CALCIUM
SYRUP; ORAL TERRAMYCIN PFIZER
EQ 125MG BASE/5ML
A060595
001
OXYTETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL OXY-KESSO-TETRA FERRANTE EQ 250MG OXYTETRACYCLINE HYDROCHLORIDE IMPAX LABS EQ 250MG PROTER EQ 250MG PUREPAC PHARM EQ 250MG WEST WARD EQ 250MG TERRAMYCIN PFIZER EQ 125MG EQ 250MG INJECTABLE; INJECTION TERRAMYCIN PFIZER EQ 250MG EQ 500MG
A060179 A060760 A060869 A060634 A060770 N050286 N050286
001 001 001 001 001 001 002
BASE/VIAL BASE/VIAL
A060586 A060586
001 002
OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE

OINTMENT; OTIC TERRAMYCIN W/ POLYMYXIN PFIZER EQ 5MG BASE/GM;10,000 UNITS/GM TABLET; VAGINAL TERRAMYCIN-POLYMYXIN PFIZER EQ 100MG BASE;100,000 UNITS
A061841
001
A061009
001
OXYTOCIN
INJECTABLE; INJECTION OXYTOCIN TEVA PARENTERAL
10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML) OXYTOCIN 10 USP UNITS IN DEXTROSE 5% ABBOTT 1USP UNITS/100ML 2USP UNITS/100ML OXYTOCIN 20 USP UNITS IN DEXTROSE 5% ABBOTT 2USP UNITS/100ML OXYTOCIN 5 USP UNITS IN DEXTROSE 5% ABBOTT 1USP UNITS/100ML SYNTOCINON NOVARTIS 10USP UNITS/ML SOLUTION; NASAL SYNTOCINON NOVARTIS 40USP UNITS/ML
A077453 A077453 N019185 N019185 N019185 N019185 N018245
001 002 004 003 002 001 001
Jan 24, 2008 Jan 24, 2008 Mar 29, 1985 Mar 29, 1985 Mar 29, 1985 Mar 29, 1985
N012285
001
PACLITAXEL
INJECTABLE; INJECTION PACLITAXEL HOSPIRA PLIVA LACHEMA
6MG/ML 6MG/ML
A076233 A077413
001 001
Aug 01, 2002 Mar 12, 2008

PACLITAXEL
INJECTABLE; INJECTION PACLITAXEL TEVA PARENTERAL TAXOL CORDEN PHARMA
6 - 265 (of 360)
6MG/ML 6MG/ML
A075297 N020262
001 001
Jan 25, 2002 Dec 29, 1992
PALIPERIDONE
TABLET, EXTENDED RELEASE; ORAL INVEGA JANSSEN PHARMS 12MG
N021999
004
Dec 19, 2006
PALONOSETRON HYDROCHLORIDE
CAPSULE; ORAL
ALOXI
HELSINN HLTHCARE
EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N022233
001
Aug 22, 2008
AREDIA
NOVARTIS
30MG/VIAL 60MG/VIAL 90MG/VIAL 30MG/VIAL 90MG/VIAL
N020036 N020036 N020036 A075594 A075594
001 003 004 001 002
Oct 31, 1991 May 06, 1993 May 06, 1993 May 06, 2002 May 06, 2002
PAMIDRONATE DISODIUM AESGEN
CAPSULE; ORAL COTAZYM ORGANON USA INC
30,000USP UNITS;8,000USP UNITS;30,000USP UNITS
N020580
001
Dec 09, 1996
PANCURONIUM BROMIDE
PANCURONIUM BROMIDE
ASTRAZENECA
ELKINS SINN
HOSPIRA PAVULON ORGANON USA INC
A072210 A072211 A072212 A072213 A072058 A072059 A072060 A072321 N017015 N017015
001 001 001 001 001 001 001 001 002 001
Mar Mar Mar Mar Mar Mar Mar Jan
31, 31, 31, 31, 23, 23, 23, 19,
1988 1988 1988 1988 1988 1988 1988 1989
PARAMETHADIONE
CAPSULE; ORAL
PARADIONE
ABBVIE SOLUTION; ORAL
PARADIONE
ABBVIE
150MG 300MG
N006800 N006800
003
001
300MG/ML
N006800
002
PARAMETHASONE ACETATE
TABLET; ORAL
HALDRONE
LILLY
1MG
N012772
005

PARAMETHASONE ACETATE
TABLET; ORAL
HALDRONE
LILLY
6 - 266 (of 360)
2MG
N012772
006
PARGYLINE HYDROCHLORIDE
TABLET; ORAL
EUTONYL
ABBOTT
10MG 25MG 50MG
N013448 N013448 N013448
002
003
004
PAROMOMYCIN SULFATE
CAPSULE; ORAL HUMATIN
KING PFIZER PARKEDALE SYRUP; ORAL
HUMATIN
PARKE DAVIS
A062310 A060521
001
001
EQ 125MG BASE/5ML
A060522
001
CAPSULE; ORAL
PAXIL
GLAXOSMITHKLINE
EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020885
001
Oct 09, 1998
N020885
002
Oct 09, 1998
N020885
003
Oct 09, 1998
N020885
004
Oct 09, 1998
TABLET; ORAL
ROXANE EQ EQ EQ EQ SANDOZ EQ EQ EQ EQ TEVA PHARMS EQ EQ EQ EQ PAXIL GLAXOSMITHKLINE EQ
A078026 A078026 A078026 A078026 A075566 A075566 A075566 A075566 A077082 A077082 A077082 A077082 N020031
001 002 003 004 001 002 003 004 001 002 003 004 004
Jun Jun Jun Jun Mar Mar Mar Mar Jun Jun Jun Jun
29, 29, 29, 29, 08, 08, 08, 08, 29, 29, 29, 29,
2007 2007 2007 2007 2004 2004 2004 2004 2007 2007 2007 2007
50MG BASE
Dec 29, 1992
PEMOLINE
TABLET; ORAL
CYLERT
ABBOTT
18.75MG 37.5MG 75MG 18.75MG
N016832 N016832 N016832 A075595
001
002
003
001 Feb 28, 2000
PEMOLINE ACTAVIS TOTOWA

PEMOLINE
TABLET; ORAL PEMOLINE ACTAVIS TOTOWA MALLINCKRODT
6 - 267 (of 360)
SANDOZ
TEVA PHARMS
VINTAGE PHARMS
WATSON LABS
37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG
002 003 003 002 001 001 002 003 003 001 002 001 002 003 001 002 003
Feb Feb Mar Mar Mar Dec Jun Jun Feb Jan Jan Apr Apr Apr Jun Sep Sep
28, 28, 30, 30, 30, 27, 30, 30, 22, 29, 29, 19, 19, 19, 13, 18, 18,
2000 2000 2001 2001 2001 1999 1999 1999 2000 1999 1999 2000 2000 2000 2001 2000 2000
TABLET, CHEWABLE; ORAL CYLERT ABBOTT PEMOLINE ACTAVIS TOTOWA TEVA PHARMS
37.5MG 37.5MG 37.5MG
N017703 A075678 A075555
001 001 001 Jul 26, 2000 Feb 18, 2000
PENBUTOLOL SULFATE
TABLET; ORAL LEVATOL ACTIENT PHARMS
10MG
N018976
001
Dec 30, 1987
PENICILLAMINE
CAPSULE; ORAL CUPRIMINE ATON
125MG
N019853
002
PENICILLIN G BENZATHINE
INJECTABLE; INJECTION BICILLIN L-A WYETH AYERST SUSPENSION; ORAL BICILLIN WYETH AYERST TABLET; ORAL BICILLIN WYETH AYERST
300,000 UNITS/ML
N050131
001
300,000 UNITS/5ML
N050126
002
200,000 UNITS
N050128
001
FOR SOLUTION; ORAL PENICILLIN TEVA PENICILLIN G POTASSIUM MYLAN
200,000 UNITS/5ML 400,000 UNITS/5ML 200,000 250,000 400,000 250,000 400,000 UNITS/5ML UNITS/5ML UNITS/5ML UNITS/5ML UNITS/5ML
A060307 A060307 A060752 A060752 A060752 A061740 A061740 A060307 A062149
002 004 003 002 001 001 002 003 001
PUREPAC PHARM PENICILLIN-2 TEVA PENTIDS '200' APOTHECON
250,000 UNITS/5ML 200,000 UNITS/5ML

FOR SOLUTION; ORAL PENTIDS '400' APOTHECON PFIZERPEN G PFIZER INJECTABLE; INJECTION PENICILLIN G POTASSIUM APOTHECON
6 - 268 (of 360)
400,000 UNITS/5ML 400,000 UNITS/5ML
A062149 A060587
002 001
CONSOLIDATED PHARM
LILLY
MARSAM PHARMS LLC
PARKE DAVIS PFIZER SANDOZ PFIZERPEN PFIZER TABLET; ORAL PENICILLIN G POTASSIUM APOTHECON IVAX SUB TEVA PHARMS LILLY MYLAN
1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 10,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 500,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 10,000,000 UNITS/VIAL 200,000 UNITS/VIAL 500,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 10,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL
001 003 004 002 001 002 003 004 004 003 002 001 005 001 001 002 003 004 001 002 003 001 001
Sep Sep Sep Sep
13, 13, 13, 13,
1988 1988 1988 1988
Aug 30, 2002
PUREPAC PHARM
TEVA
WYETH AYERST
250,000 400,000 250,000 200,000 250,000 400,000 500,000 800,000 200,000 250,000 400,000 200,000 250,000 400,000 500,000 200,000 250,000 400,000
UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS
003 004 001 001 002 003 005 004 001 002 003 001 002 003 004 001 002 003 001 002 004 003 005 004 001
PENTIDS '200' APOTHECON PENTIDS '250' APOTHECON PENTIDS '400' APOTHECON PENTIDS '800' APOTHECON PFIZERPEN G PFIZER
200,000 UNITS 250,000 UNITS 400,000 UNITS 400,000 UNITS 800,000 UNITS 800,000 UNITS 50,000 UNITS

TABLET; ORAL PFIZERPEN G PFIZER
6 - 269 (of 360)
100,000 200,000 250,000 400,000 800,000
UNITS UNITS UNITS UNITS UNITS
A060075 A060075 A060075 A060075 A060075
002 003 004 005 006
INJECTABLE; INJECTION DURACILLIN A.S. LILLY PENICILLIN G PROCAINE CONSOLIDATED PHARM PARKE DAVIS PFIZER PFIZERPEN-AS PFIZER
300,000 UNITS/ML 300,000 UNITS/ML 600,000 UNITS/1.2ML 300,000 UNITS/ML 300,000 UNITS/VIAL 1,500,000 UNITS/VIAL 300,000 UNITS/ML 600,000 UNITS/ML
A060093 A060800 A060800 A062029 A060099 A060099 A060286 A060286
001 001 002 001 001 002 001 002
PENICILLIN G SODIUM
INJECTABLE; IM-IV PENICILLIN G SODIUM MARSAM PHARMS LLC INJECTABLE; INJECTION PENICILLIN G SODIUM BRISTOL MYERS SQUIBB COPANOS PHARMACIA AND UPJOHN
5,000,000 UNITS/VIAL
A063014
001
Sep 13, 1988
5,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL
A061935 A061051 A061046
001 001 001
PENICILLIN V
FOR SUSPENSION; ORAL V-CILLIN LILLY
125MG/0.6ML
A060002
001
FOR SOLUTION; ORAL BEEPEN-VK GLAXOSMITHKLINE BETAPEN-VK APOTHECON LEDERCILLIN VK LEDERLE PENAPAR-VK PARKE DAVIS PENICILLIN V POTASSIUM AM ANTIBIOTICS MYLAN PUREPAC PHARM PEN-VEE K WYETH AYERST
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ EQ EQ 125MG 250MG 125MG 250MG 125MG 250MG BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
001 002 001 002 001 002 001 002 001 002 002 001 001 002 001 002

FOR SOLUTION; ORAL PFIZERPEN VK PFIZER V-CILLIN K LILLY VEETIDS APOTHECON VEETIDS '125' APOTHECON VEETIDS '250' APOTHECON TABLET; ORAL BEEPEN-VK GLAXOSMITHKLINE BETAPEN-VK BRISTOL LEDERCILLIN VK LEDERLE PENAPAR-VK PARKE DAVIS PENICILLIN V POTASSIUM AM ANTIBIOTICS IVAX SUB TEVA PHARMS
6 - 270 (of 360)
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 250MG BASE/5ML
A061815 A061815 A060004 A060004 A061410 A061410 A061206 A062153 A061206 A062153
001 002 001 002 001 002 001 001 002 002
EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 125MG 250MG 500MG 250MG 500MG 125MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 002 001 002 001 002 001 002 001 002 001 002 003 001 002 001 002 003 001 002 003 001 002 001 002 001 002 003 001 002 001 002 002
MYLAN PUREPAC PHARM
PEN-VEE K WYETH AYERST
EQ 125MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 125MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 250MG BASE EQ 500MG BASE
PFIZERPEN VK PFIZER UTICILLIN VK PHARMACIA AND UPJOHN V-CILLIN K LILLY
VEETIDS APOTHECON VEETIDS '250' APOTHECON VEETIDS '500' APOTHECON

TABLET; ORAL
VEETIDS '500'
APOTHECON
6 - 271 (of 360)
EQ 500MG BASE
A062156
001
PENTAGASTRIN
PEPTAVLON
WYETH AYERST
0.25MG/ML **Federal Register determination that product was not

N017048
001
PENTAMIDINE ISETHIONATE
FOR SOLUTION; INHALATION NEBUPENT FRESENIUS KABI USA INJECTABLE; INJECTION PENTACARINAT ARMOUR PHARM PENTAMIDINE ISETHIONATE BAXTER HLTHCARE HOSPIRA
600MG/VIAL
N019887
002
Mar 22, 1996
A073447 A073617 A073479
001 001 001
Apr 28, 1994 Dec 18, 1995 Jun 30, 1992
PENTAZOCINE HYDROCHLORIDE
TABLET; ORAL
TALWIN 50
SANOFI AVENTIS US
EQ 50MG BASE
N016732
001
PENTETATE CALCIUM TRISODIUM

SOLUTION; INHALATION, INTRAVENOUS
PENTETATE CALCIUM TRISODIUM
HAMELN PHARMS EQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N021749
001
Aug 11, 2004
PENTETATE CALCIUM TRISODIUM YB-169

YTTERBIUM YB 169 DTPA
3M
2mCi/ML
N017518
001
PENTETATE ZINC TRISODIUM

SOLUTION; INHALATION, INTRAVENOUS
PENTETATE ZINC TRISODIUM
HAMELN PHARMS EQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N021751
001
Aug 11, 2004
PENTOBARBITAL
ELIXIR; ORAL
NEMBUTAL
OAK PHARMS
18.2MG/5ML
A083244
001
CAPSULE; ORAL
NEMBUTAL SODIUM
OAK PHARMS
A084095 A084093 A083245 A085937
001
001
001
001
LANNETT

CAPSULE; ORAL PENTOBARBITAL SODIUM LANNETT VITARINE WHITEWORTH TOWN PLSN SODIUM PENTOBARBITAL ANABOLIC ELKINS SINN EVERYLIFE HALSEY IVAX SUB TEVA PHARMS PARKE DAVIS PERRIGO PUREPAC PHARM VALEANT PHARM INTL WATSON LABS WYETH AYERST INJECTABLE; INJECTION PENTOBARBITAL SODIUM ELKINS SINN SODIUM PENTOBARBITAL WYETH AYERST SUPPOSITORY; RECTAL NEMBUTAL OAK PHARMS
6 - 272 (of 360)
001 001 001 001 001 001 001 001 002 001 001 001 001 001 001
50MG/ML 50MG/ML
A083270 A083261
001 001
30MG 60MG 120MG 200MG
A083247 A083247 A083247 A083247
001 002 003 004
Jan Jan Jan Jan
25, 25, 25, 25,
1982 1982 1982 1982
TABLET; ORAL PENTOBARBITAL SODIUM VITARINE SODIUM PENTOBARBITAL NEXGEN PHARMA INC
100MG 100MG
A083285 A084238
001 001
PENTOLINIUM TARTRATE
INJECTABLE; INJECTION ANSOLYSEN WYETH AYERST
10MG/ML
N009372
001
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE; PENTOXIFYLLINE ACTAVIS ELIZABETH HERITAGE PHARMS INC TEVA ORAL 400MG 400MG 400MG A074878 A074877 A075199 001 001 001 Jul 09, 1997 Jul 08, 1997 Sep 03, 1999
PERFLUBRON
LIQUID; ORAL IMAGENT ALLIANCE PHARM
100%
N020091
001
Aug 13, 1993
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE

PASTE; TOPICAL SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS US ARMY 50%;50%
N021084
001
Feb 17, 2000
PERGOLIDE MESYLATE
TABLET; ORAL PERGOLIDE MESYLATE IVAX SUB TEVA PHARMS
A076094 A076094
001 002
Sep 04, 2003 Sep 04, 2003

PERGOLIDE MESYLATE
TABLET; ORAL PERGOLIDE MESYLATE IVAX SUB TEVA PHARMS PAR PHARM
6 - 273 (of 360)
EQ EQ EQ EQ
1MG BASE 0.05MG BASE 0.25MG BASE 1MG BASE
A076094 A076061 A076061 A076061 N019385 N019385 N019385
003 001 002 003 001 002 003
Sep Nov Nov Nov
04, 27, 27, 27,
2003 2002 2002 2002
PERMAX VALEANT PHARM INTL
EQ 0.05MG BASE EQ 0.25MG BASE EQ 1MG BASE
Dec 30, 1988 Dec 30, 1988 Dec 30, 1988
PERMETHRIN
LOTION; TOPICAL NIX GLAXOSMITHKLINE
1%
N019435
001
Mar 31, 1986
PERPHENAZINE
CONCENTRATE; ORAL PERPHENAZINE PHARM ASSOC TRILAFON SCHERING INJECTABLE; INJECTION TRILAFON SCHERING SYRUP; ORAL TRILAFON SCHERING TABLET; ORAL PERPHENAZINE IVAX PHARMS
16MG/5ML 16MG/5ML
A040360 N011557
001 001
May 25, 2001
5MG/ML
N011213
002
2MG/5ML
N011294
002
2MG 4MG 8MG 16MG
A089707 A089708 A089456 A089457 N010775 N010775 N010775 N010775
001 001 001 001 001

002
003
004
Sep Sep Sep Sep
10, 10, 10, 10,
1987 1987 1987 1987
2MG 4MG 8MG 16MG TABLET, EXTENDED RELEASE; ORAL

TRILAFON
SCHERING 8MG
TRILAFON SCHERING
N011361
002
PHENACEMIDE
TABLET; ORAL
PHENURONE
ABBVIE

reasons**
N007707
001
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE

TABLET; ORAL AZO GANTANOL ROCHE
100MG;500MG
N013294
001
Sep 10, 1987
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM

TABLET; ORAL
SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PENAZOPYRIDINE HYDROCHLORIDE
ABLE 200MG,N/A,N/A;N/A,800MG,160MG N021105
001
Jun 26, 2001

PHENAZOPYRIDINE HYDROCHLORIDE; SULFISOXAZOLE
TABLET; ORAL AZO GANTRISIN ROCHE
6 - 274 (of 360)
50MG;500MG
N019358
001
Aug 31, 1990
CAPSULE; ORAL PHENAZINE MAST MM
35MG 35MG 35MG
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Sep 22, 1982
PHENDIMETRAZINE TARTRATE SANDOZ 35MG 35MG 35MG 35MG VITARINE 35MG 35MG 35MG 35MG 35MG 35MG 35MG SPRX-3 SOLVAY 35MG STATOBEX TEVA 35MG X-TROZINE SHIRE RICHWOOD 35MG CAPSULE, EXTENDED RELEASE; ORAL MELFIAT-105 NUMARK 105MG PHENDIMETRAZINE TARTRATE GRAHAM DM 105MG 105MG 105MG 105MG 105MG 105MG SANDOZ 105MG SPRX-105 NUMARK 105MG X-TROZINE L.A. SHIRE RICHWOOD 105MG TABLET; ORAL ADPHEN FERNDALE LABS 35MG ALPHAZINE SANDOZ 35MG CAM-METRAZINE ABC HOLDING 35MG CAMALL 35MG TG UNITED LABS 35MG 35MG 35MG 35MG DI-METREX PVT FORM 35MG MELFIAT NUMARK 35MG METRA FOREST PHARMS 35MG
A087487 A087214 A088020 A088028 A088062 A088063 A088111 A087378 A088024 A087371
001 001 001 001 001 001 001 001 001 001
Oct 13, 1982 May Aug Aug Sep Sep Oct 26, 16, 16, 13, 10, 18, 1982 1982 1982 1982 1982 1982
Dec 22, 1982 Aug 24, 1982
A083655 A085034 A085511 A085756 A083922 A085318 A085320 A085321 A085698 A083790 A083754
001 001 001 001 001 001 001 001 001 002 001

TABLET; ORAL PHENAZINE MAST MM 35MG PHENAZINE-35 ABC HOLDING 35MG PHENDIMETRAZINE TARTRATE BARR 35MG 35MG 35MG 35MG 35MG 35MG 35MG FERNDALE LABS 35MG INWOOD LABS 35MG 35MG 35MG 35MG IVAX PHARMS 35MG 35MG IVAX SUB TEVA PHARMS 35MG KV PHARM 35MG 35MG 35MG MFG CHEMISTS 35MG NEXGEN PHARMA INC 35MG NUMARK 35MG PVT FORM 35MG 35MG SANDOZ 35MG 35MG 35MG 35MG 35MG SOLVAY 35MG TG UNITED LABS 35MG 35MG USL PHARMA 35MG 35MG 35MG VITARINE 35MG 35MG 35MG WATSON LABS 35MG 35MG 35MG 35MG PLEGINE WYETH AYERST 35MG STATOBEX TEVA 35MG STATOBEX-G TEVA 35MG X-TROZINE SHIRE RICHWOOD 35MG 35MG 35MG 35MG 35MG
6 - 275 (of 360)
A087305 A085512 A083644 A083684 A083686 A083687 A084831 A084834 A084835 A086834 A084740 A084741 A084742 A084743 A085611 A085612 A083682 A084138 A084141 A085525 A085914 A086020 A083790 A085199 A085697 A085402 A085497 A085830 A086365 A086370 A083993 A085761 A085941 A083805 A084398 A084399 A085519 A086005 A086106 A085767 A085768 A085770 A085773 N012248 A086013 A085095 A086550 A086551 A086552 A086553 A086554
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep 15, 1983
Jun 27, 1983

PHENINDIONE
TABLET; ORAL HEDULIN SANOFI AVENTIS US
6 - 276 (of 360)
50MG
N008767
002
PHENMETRAZINE HYDROCHLORIDE
TABLET; ORAL PRELUDIN BOEHRINGER INGELHEIM 25MG TABLET, EXTENDED RELEASE; ORAL PRELUDIN BOEHRINGER INGELHEIM 50MG 75MG
N010460
005
N011752 N011752
004 003
PHENPROCOUMON
TABLET; ORAL LIQUAMAR ORGANON USA INC
3MG
N011228
001
PHENSUXIMIDE
CAPSULE; ORAL MILONTIN PARKE DAVIS
500MG
N008855
004
CAPSULE; ORAL FASTIN GLAXOSMITHKLINE OBESTIN-30 FERNDALE LABS OBY-TRIM SHIRE RICHWOOD ONA-MAST MAST MM
30MG 30MG 30MG
N017352 A087144 A087764 A086511 A086516 A085411 A040497 A040403 A040427 A086735 A087226 A088948 A086329 A040460 A040227 A040448 A040228 A040527 A087208 A087223 A088414 A086911 A087126 A087777 A088612 A088613 A088614 A040083 A088576 A085417 A086732 A087215
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 Mar 18, 1982
30MG 30MG PHENTERMINE HYDROCHLORIDE ABC HOLDING 30MG ABLE 15MG 30MG 30MG CAMALL 15MG 30MG DURAMED PHARMS BARR 30MG IVAX PHARMS 30MG MIKAH PHARMA 15MG 30MG 30MG 37.5MG MUTUAL PHARM 37.5MG SANDOZ 30MG 30MG 37.5MG TEVA 30MG 30MG 30MG 30MG 30MG 30MG TG UNITED INC 30MG TG UNITED LABS 18.75MG 30MG 30MG 30MG
Mar 13, 2003 Aug 30, 2001 Aug 30, 2001
Apr 25, 1986 Jan Jun Jan Jun Oct 14, 18, 22, 19, 23, 2003 1997 2003 1997 2003
Oct 19, 1983
Nov Apr Apr Apr Mar May
01, 04, 09, 09, 07, 23,
1985 1984 1984 1984 1997 1984

CAPSULE; ORAL
TG UNITED LABS 37.5MG 37.5MG 37.5MG 37.5MG 37.5MG 37.5MG USL PHARMA 30MG 30MG 30MG VITARINE 30MG 30MG WATSON LABS 30MG TABLET; ORAL ONA-MAST MAST MM 8MG PHENTERMINE HYDROCHLORIDE ABLE 37.5MG ACTAVIS ELIZABETH 37.5MG IVAX PHARMS 8MG MIKAH PHARMA 37.5MG SANDOZ 8MG 8MG SANDOZ INC 30MG TG UNITED LABS 8MG 8MG 37.5MG 37.5MG USL PHARMA 8MG 37.5MG 37.5MG VITARINE 8MG 8MG WATSON LABS 8MG TORA
SOLVAY 8MG WILPO
SANDOZ 8MG **Federal Register determination that product was not discontinued or
reasons**
6 - 277 (of 360)
A087915 A087918 A087930 A088610 A088611 A088625 A084487 A088430 A088797 A087202 A087235 A086740
001 001 001 001 001 001 001 001 001 001 001 001
Dec Dec Oct Jun Jun Aug Apr Mar Dec
22, 22, 14, 04, 04, 23, 09, 27, 10,
1983 1983 1983 1984 1984 1984 1982 1984 1984
Mar 21, 1985
A086260 A040402 A040276 A085553 A040190 A085671 A085689 A088605 A083923 A085319 A087805 A088596 A083804 A088910 A088917 A086453 A086456 A085739 A084035 N012737
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
001
001
001
001
Aug 30, 2001 Nov 25, 1998 May 30, 1997
Sep 28, 1987
Dec 06, 1982 Apr 04, 1984 Jul 17, 1985 Jul 17, 1985

CAPSULE, EXTENDED RELEASE; ORAL IONAMIN UCB INC EQ 15MG BASE EQ 30MG BASE PHENTERMINE RESIN 30 QUANTUM PHARMICS EQ 30MG BASE
N011613 N011613 A089120
004 002 001 Feb 04, 1988
PHENYL AMINOSALICYLATE
POWDER; ORAL
PHENY-PAS-TEBAMIN
PHARM RES ASSOC TABLET; ORAL
PHENY-PAS-TEBAMIN
PHARM RES ASSOC
50%
N011695
002
500MG
N011695
003
PHENYLBUTAZONE
CAPSULE; ORAL
AZOLID
SANOFI AVENTIS US
100MG
A087260
001

PHENYLBUTAZONE
CAPSULE; ORAL
BUTAZOLIDIN
NOVARTIS PHENYLBUTAZONE IVAX PHARMS MUTUAL PHARM SANDOZ WATSON LABS TABLET; ORAL
AZOLID
SANOFI AVENTIS US BUTAZOLIDIN
NOVARTIS PHENYLBUTAZONE MUTUAL PHARM SANDOZ WATSON LABS
6 - 278 (of 360)
100MG 100MG 100MG 100MG 100MG
N008319 A088218 A088994 A087774 A087756
009
001 001 001 001 Jun Dec Jun Dec 24, 04, 16, 17, 1983 1985 1982 1982
100MG 100MG 100MG 100MG 100MG 100MG
A087091 N008319 A088863 A084339 A086151 A087674
001
008
001 001 001 001 Dec 04, 1985
Apr 21, 1982

SYRUP; ORAL
PHENERGAN VC
ANI PHARMS
5MG/5ML;6.25MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 5MG/5ML;6.25MG/5ML 5MG/5ML;6.25MG/5ML 5MG/5ML;6.25MG/5ML
N008604
003
Apr 02, 1984
PHERAZINE VC HALSEY PROMETHAZINE VC PLAIN CENCI WOCKHARDT
A088868 A088815 A088897
001 001 001
Mar 02, 1987 Nov 22, 1985 Jan 04, 1985
PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE

PREFRIN-A
ALLERGAN 0.12%;0.1%
N007953
001
PHENYTOIN
SUSPENSION; ORAL DILANTIN-30 PARKE DAVIS PHENYTOIN ACTAVIS MID ATLANTIC
30MG/5ML 125MG/5ML
N008762 A089892
002 001 Sep 25, 1992
PHENYTOIN SODIUM
CAPSULE; ORAL
DIPHENYLAN SODIUM
LANNETT
30MG PROMPT 100MG PROMPT EXTENDED PHENYTOIN SODIUM BARR 100MG EXTENDED PLIVA 100MG EXTENDED PHENYTEX WATSON LABS 100MG EXTENDED PHENYTOIN SODIUM
PHARMERAL 100MG PROMPT WATSON LABS 100MG PROMPT PROMPT PHENYTOIN SODIUM
IVAX SUB TEVA PHARMS 100MG PROMPT WATSON LABS 100MG PROMPT INJECTABLE; INJECTION
DILANTIN
PARKE DAVIS 50MG/ML
A080857 A080857 A040435 A089441 A088711 A085435 A085894 A080259 A080905
001
002
001 001 001 001
001
001
001
Jun 20, 2003 Dec 18, 1986 Dec 21, 1984
N010151
001

PHENYTOIN SODIUM
INJECTABLE; INJECTION PHENYTOIN SODIUM FRESENIUS KABI USA MARSAM PHARMS LLC SMITH AND NEPHEW SOLOPAK WARNER CHILCOTT WATSON LABS
6 - 279 (of 360)
50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML
A089003 A089501 A089779 A088519 A088521 A088520 A089900 A085434
001 001 001 001 001 001 001 001
May Oct Nov Dec Dec Dec Mar
31, 13, 27, 19, 18, 17, 30,
1985 1987 1992 1984 1984 1984 1990
PHYTONADIONE
INJECTABLE; INJECTION AQUAMEPHYTON BIOVAIL TECHNOLOGIES KONAKION ROCHE PHYTONADIONE GLAXOSMITHKLINE VITAMIN K1 HOSPIRA
1MG/0.5ML 10MG/ML 1MG/0.5ML 10MG/ML 1MG/0.5ML 10MG/ML 10MG/ML
N012223 N012223 N011745 N011745 A084060 A084060 A087956
002 001 001 003 001 002 001 Jul 25, 1983
PILOCARPINE
INSERT, EXTENDED RELEASE; OPHTHALMIC OCUSERT PILO-20 AKORN 5MG OCUSERT PILO-40 AKORN 11MG
N017431 N017548
001 001
PINACIDIL
CAPSULE, EXTENDED RELEASE; ORAL PINDAC LEO PHARM 12.5MG 25MG
N019456 N019456
001 002
Dec 28, 1989 Dec 28, 1989
PINDOLOL
TABLET; ORAL PINDOLOL IVAX SUB TEVA PHARMS MUTUAL PHARM MYLAN PHARMS INC NOSTRUM LABS PUREPAC PHARM SANDOZ TEVA
001 002 001 002 001 001 001 002 001 002 001 001 001 001 002 002 001 002
Feb Feb Jan Jan Sep Sep Oct Oct Apr Apr Mar Mar Oct Apr Oct Apr
26, 26, 27, 27, 24, 24, 28, 28, 28, 28, 29, 29, 31, 17, 31, 17,
1993 1993 1994 1994 1992 1992 1996 1996 1993 1993 1993 1993 1993 1997 1993 1997
VISKEN NOVARTIS
Sep 03, 1982 Sep 03, 1982

PIPECURONIUM BROMIDE
INJECTABLE; INJECTION ARDUAN ORGANON USA INC
6 - 280 (of 360)
10MG/VIAL
N019638
001
Jun 26, 1990
PIPERACETAZINE
TABLET; ORAL QUIDE DOW PHARM
10MG 25MG
N013615 N013615
001 002
PIPERACILLIN SODIUM
INJECTABLE; INJECTION PIPRACIL WYETH PHARMS INC
2GM BASE/VIAL 2GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 40GM BASE/VIAL
A062750 N050545 A062750 N050545 A062750 N050545 N050545
001 002 002 003 003 004 006
Oct 13, 1987 Oct 13, 1987 Oct 13, 1987 Sep 30, 1985
PIPERAZINE CITRATE
SYRUP; ORAL ANTEPAR GLAXOSMITHKLINE BRYREL SANOFI AVENTIS US MULTIFUGE BLULINE PIPERAZINE CITRATE ALPHARMA US PHARMS LANNETT LUITPOLD VERMIDOL SOLVAY TABLET; ORAL ANTEPAR GLAXOSMITHKLINE PIPERAZINE CITRATE IMPAX LABS
EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML
N009102 N017796 N009452 A080774 A080963 A080671 A080992
001 001 001 001 001 001 001
N009102 A080874
003 001
PIPOBROMAN
TABLET; ORAL VERCYTE ABBOTT
10MG 25MG
N016245 N016245
001 002
PIRBUTEROL ACETATE
AEROSOL, METERED; INHALATION MAXAIR MEDICIS EQ 0.2MG BASE/INH
N019009
001
Dec 30, 1986
PIROXICAM
CAPSULE; ORAL PIROXICAM EGIS IVAX SUB TEVA PHARMS MUTUAL PHARM MYLAN
A074808 A074808 A074148 A074148 A073536 A074043 A074043
001 002 001 002 001 001 002
Jul Jul Jun Jun Mar Sep Sep
08, 08, 03, 03, 12, 22, 22,
1997 1997 1996 1996 1993 1992 1992

PIROXICAM
CAPSULE; ORAL
PIROXICAM
ROXANE SCS TEVA TEVA PHARMS
6 - 281 (of 360)
A073651 A073651 A074036 A074036 A073637 A073638 A074103 A074103
001 002 001 002 001 001 001 002
Feb Feb May May Jan Jan Aug Aug
26, 26, 29, 29, 28, 28, 28, 28,
1993 1993 1992 1992 1994 1994 1992 1992
PLICAMYCIN
MITHRACIN
PFIZER
2.5MG/VIAL
N050109
001
POLYESTRADIOL PHOSPHATE
ESTRADURIN
WYETH AYERST
40MG/AMP
N010753
001

FOR SOLUTION; ORAL POLYETHYLENE GLYCOL 3350 PADDOCK LLC 17GM/SCOOPFUL TEVA PHARMS 17GM/SCOOPFUL
A090567 A077445
001 001
Oct 15, 2009 May 04, 2006
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
FOR SOLUTION; ORAL CLENZ-LYTE PADDOCK LLC SOLUTION; ORAL OCL HOSPIRA
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A090769 BOT;22.74GM/BOT
001
Jun 07, 2010
6GM/100ML;75MG/100ML;168MG/100ML;146MG/ N019284 100ML;1.29GM/100ML
001
Apr 30, 1986
FOR SOLUTION; ORAL COLYTE MEDA PHARMS
120GM/PACKET;1.49GM/PACKET;3.36GM/PACKE T;2.92GM/PACKET;11.36GM/PACKET 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC KET;5.53GM/PACKET;21.5GM/PACKET 360GM/PACKET;4.47GM/PACKET;10.08GM/PACK ET;8.76GM/PACKET;34.08GM/PACKET POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES PADDOCK LLC 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ BOT;22.72GM/BOT FOR SUSPENSION; ORAL CO-LAV BOCA PHARMA 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ BOT;22.72GM/BOT COLOVAGE DYNAPHARM 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC KET;5.53GM/PACKET;21.5GM/PACKET E-Z-EM PREP LYTE E Z EM 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ BOT;22.74GM/BOT GLYCOPREP GOLDLINE 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ BOT;22.74GM/BOT
N018983 N018983 N018983
005 004 006
Oct 26, 1984 Oct 26, 1984 Oct 26, 1984
A090712
001
Feb 25, 2010
A073428
001
Jan 28, 1992
A071320
001
Apr 20, 1988
A071278
001
Nov 21, 1988
A072319
001
Dec 23, 1988
6 - 282 (of 360)
FOR SUSPENSION; ORAL GO-EVAC BOCA PHARMA PEG-LYTE SANDOZ
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A073433 BOT;22.74GM/BOT 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A073098 BOT;22.74GM/BOT
001
Apr 28, 1992
001
Aug 31, 1993
POLYMYXIN B SULFATE
INJECTABLE; INJECTION AEROSPORIN GLAXOSMITHKLINE EQ 500,000 U BASE/VIAL POWDER; FOR RX COMPOUNDING POLYMYXIN B SULFATE PADDOCK LLC 100,000,000 UNITS/BOT
A062036
001
A062455
001
Jul 27, 1983
POLYTHIAZIDE
TABLET; ORAL
RENESE
PFIZER
1MG 2MG 4MG
N012845 N012845 N012845
001
002
003
POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE

CAPSULE; ORAL
MINIZIDE
PFIZER
0.5MG;EQ 1MG BASE 0.5MG;EQ 2MG BASE 0.5MG;EQ 5MG BASE
N017986 N017986 N017986
001
002
003
POLYTHIAZIDE; RESERPINE
TABLET; ORAL
RENESE-R
PFIZER
2MG;0.25MG
N013636
001
POTASSIUM AMINOSALICYLATE
CAPSULE; ORAL
PASKALIUM
GLENWOOD 500MG POWDER; ORAL
POTASSIUM AMINOSALICYLATE
HEXCEL 100% TABLET; ORAL
PASKALIUM
GLENWOOD 1GM
N009395
004
A080098
001
N009395
003
POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL K-LEASE SAVAGE LABS 8MEQ 10MEQ POTASSIUM CHLORIDE NESHER PHARMS 10MEQ TEVA 8MEQ 10MEQ FOR SUSPENSION, EXTENDED RELEASE; ORAL MICRO-K LS KV PHARM 20MEQ/PACKET INJECTABLE; INJECTION POTASSIUM CHLORIDE ABRAXIS PHARM 2MEQ/ML 2MEQ/ML
A073398 A072427 A070980 A073531 A073532
001 001 001 001 001
Jan 28, 1992 Mar 28, 1990 Feb 17, 1987 Apr 26, 1996 Apr 26, 1996
N019561
003
Aug 26, 1988
A080204 A084290
001 001

POTASSIUM CHLORIDE
INJECTABLE; INJECTION POTASSIUM CHLORIDE ABRAXIS PHARM
6 - 283 (of 360)
2MEQ/ML 2MEQ/ML 2MEQ/ML 2MEQ/ML AKORN 2MEQ/ML BAXTER HLTHCARE 2MEQ/ML FRESENIUS KABI USA 2MEQ/ML GD SEARLE LLC 1MEQ/ML 2MEQ/ML 2MEQ/ML 3MEQ/ML 3MEQ/ML 4MEQ/ML HOSPIRA 1MEQ/ML 1MEQ/ML 1.5MEQ/ML 2MEQ/ML 2.4MEQ/ML 3.2MEQ/ML LILLY 2MEQ/ML LUITPOLD 2MEQ/ML 2MEQ/ML 2MEQ/ML 2MEQ/ML MILES 1MEQ/ML 2MEQ/ML 3MEQ/ML 4MEQ/ML PHARMA SERVE NY 2MEQ/ML 2MEQ/ML WATSON LABS 2MEQ/ML 2MEQ/ML 2MEQ/ML 3MEQ/ML TABLET, EXTENDED RELEASE; ORAL K+10 FUTURE PAK 10MEQ K+8 FUTURE PAK 8MEQ KAON CL SAVAGE LABS 6.7MEQ KAON CL-10 SAVAGE LABS 10MEQ KLOTRIX APOTHECON 10MEQ POTASSIUM CHLORIDE COPLEY PHARM 8MEQ NESHER PHARMS 20MEQ SCHERING 10MEQ 20MEQ SLOW-K NOVARTIS 8MEQ TEN-K NOVARTIS 10MEQ
A086713 A086714 A087787 A087885 A088286 A080203 A087817 A086219 A086219 A086220 A086219 A086220 A086219 A080205 A083345 A083345 A083345 A080205 A080205 N007865 A080221 A080736 A087584 A087585 A080195 A080195 A080195 A080195 A086297 A087362 A086208 A089163 A089421 A086210
001 001 001 001 001 001 001 001 002 002 003 001 004 003 003 001 002 004 005 002 001 001 001 001 002 001 003 004 001 001 001 001 001 001
Apr 20, 1982 Feb 03, 1983 Sep 05, 1985 Oct 20, 1982
Mar 08, 1983 Mar 10, 1988 Jan 02, 1987
A070999 A070998 N017046 N017046 N017850 A070618 A076044 N019439 N019439 N017476 N019381
001 001 001 002 001 001 001 002 001 002 001
Oct 22, 1987 Jan 25, 1993
Sep Apr Jun Jun
09, 05, 13, 13,
1987 2002 1986 1986
Apr 16, 1986

POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 37MG/100ML;900MG/100ML N019708
001
Sep 29, 1989

INJECTABLE; INJECTION POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 75MG/100ML;900MG/100ML N019708 POTASSIUM CHLORIDE 0.11% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 110MG/100ML;900MG/100ML N019708 POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 220MG/100ML;900MG/100ML N019708 POTASSIUM CHLORIDE 0.3% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 300MG/100ML;900MG/100ML N019708 SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER B BRAUN 75MG/100ML;900MG/100ML N018722 BAXTER HLTHCARE 75MG/100ML;900MG/100ML N017648 SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER B BRAUN 150MG/100ML;900MG/100ML N018722 SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER B BRAUN 220MG/100ML;900MG/100ML N018722 SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER B BRAUN 300MG/100ML;900MG/100ML N018722
6 - 284 (of 360)
002 003 005 006 001 004 002 003 004
Sep 29, 1989 Sep 29, 1989 Sep 29, 1989 Sep 29, 1989 Nov 09, 1982
Nov 09, 1982 Nov 09, 1982 Nov 09, 1982
POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE

INJECTABLE; INJECTION THAM-E HOSPIRA
370MG/VIAL;1.75GM/VIAL;36GM/VIAL
N013025
001
POTASSIUM CITRATE
FOR SOLUTION; ORAL POTASSIUM CITRATE NOVA K
10MEQ/PACKET 20MEQ/PACKET
N019647 N019647
002 001
Oct 13, 1988 Oct 13, 1988
POTASSIUM IODIDE
SOLUTION; ORAL POTASSIUM IODIDE ROXANE TABLET; ORAL THYRO-BLOCK MEDPOINTE PHARM HLC
1GM/ML
N018551
001
Feb 19, 1982
130MG
N018307
001
POTASSIUM PERCHLORATE
CAPSULE; ORAL PERCHLORACAP MALLINCKRODT
200MG
N017551
001
POVIDONE-IODINE
SOLUTION; TOPICAL E-Z PREP CLINIPAD SPONGE; TOPICAL E-Z PREP CLINIPAD E-Z PREP 220 CLINIPAD
10%
N019382
001
Jul 25, 1989
5% 5%
N019382 N019382
002 003
Jul 25, 1989 Jul 25, 1989
INJECTABLE; INJECTION PRALIDOXIME CHLORIDE BAXTER HLTHCARE CORP TABLET; ORAL PROTOPAM CHLORIDE WYETH AYERST
300MG/ML
N018799
001
Dec 13, 1982
500MG
N014122
002

TABLET; ORAL MIRAPEX BOEHRINGER INGELHEIM
6 - 285 (of 360)
1.25MG
N020667
004
Jul 01, 1997
PRAVASTATIN SODIUM
TABLET; ORAL PRAVASTATIN SODIUM PLIVA HRVATSKA DOO
RANBAXY LABS LTD
SANDOZ
A077730 A077730 A077730 A077730 A076445 A076445 A076445 A076445 A076397 A076397 A076397 A077491
001 002 003 005 001 002 003 004 003 002 001 001
Nov Nov Nov Nov Apr Apr Apr Apr Oct Oct Oct Feb
21, 21, 21, 21, 23, 23, 23, 23, 23, 23, 23, 11,
2006 2006 2006 2006 2007 2007 2007 2007 2006 2006 2006 2008
PRAZEPAM
CAPSULE; ORAL CENTRAX PARKE DAVIS
N018144 N018144 N018144 A070427 A070428
001 002 003 001 001
May 10, 1982 Nov 06, 1987 Nov 06, 1987
PRAZEPAM USL PHARMA TABLET; ORAL CENTRAX PARKE DAVIS
10MG
N017415
001
PRAZOSIN HYDROCHLORIDE
CAPSULE; ORAL PRAZOSIN HYDROCHLORIDE AM THERAP
EQ 1MG EQ 2MG EQ 5MG CLONMEL HLTHCARE EQ 1MG EQ 2MG EQ 5MG PUREPAC PHARM EQ 1MG EQ 2MG EQ 5MG SANDOZ EQ 1MG EQ 2MG EQ 5MG WATSON LABS EQ 1MG EQ 2MG EQ 5MG TABLET, EXTENDED RELEASE; ORAL MINIPRESS XL PFIZER 2.5MG 5MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
May May May May May May May May May May May May May May May
16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16,
1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989
N019775 N019775
001 002
Jan 29, 1992 Jan 29, 1992
PREDNISOLONE
CREAM; TOPICAL METI-DERM SCHERING
0.5%
N010209
002

PREDNISOLONE
SYRUP; ORAL PREDNISOLONE IVAX SUB TEVA PHARMS NESHER PHARMS TEVA PHARMS WE PHARMS PRELONE MURO TABLET; ORAL CORTALONE HALSEY
6 - 286 (of 360)
A040287 A040423 A040364 A040322 A040192 A089654
001 001 001 001 001 001
May Oct Apr Jan May
28, 22, 10, 19, 28,
1999 2001 2002 2000 1998
Jan 17, 1989
1MG 2.5MG 5MG 5MG 5MG 5MG 5MG 5MG 1MG 2.5MG 5MG 2.5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 1MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 1MG 2.5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG
A080304 A080304 A080304 N009987 A083941 A084426 A083675 A080625 A084439 A084439 A084439 A080562 A080562 A080326 A080780 A080748 A080378 A080531 A080307 A080351 A080351 A084542 A080322 A080325 A080211 A080327 A080339 A084773 A080358 A080358 A080358 A088892 A085170 A080398 A087987 A080236 A080534 A085085 A085415 A085416 A080324 A080342 N009996
003 002 001 004 001 002 001 001 001 002 003 001 002 001 001 001 001 002 001 001 002 001 001 001 001 002 001 001 001 002 003 001 001 001 001 001 001 002 001 001 001 001 001
DELTA-CORTEF PHARMACIA AND UPJOHN FERNISOLONE-P FERNDALE LABS PREDNISOLONE BARR BUNDY ELKINS SINN EVERYLIFE
FERRANTE HEATHER IMPAX LABS INWOOD LABS IVAX SUB TEVA PHARMS LANNETT MARSHALL PHARMA PANRAY PERRIGO PHOENIX LABS NY PUREPAC PHARM PVT FORM ROXANE SANDOZ SPERTI
SUPERPHARM TABLICAPS TEVA UDL VALEANT PHARM INTL VITARINE WATSON LABS
Feb 26, 1985
Jan 18, 1983
WEST WARD WHITEWORTH TOWN PLSN STERANE PFIZER

PREDNISOLONE ACETATE
INJECTABLE; INJECTION METICORTELONE SCHERING PREDNISOLONE ACETATE AKORN BEL MAR CENT PHARMS WATSON LABS
6 - 287 (of 360)
N010255 A083032 A084492 A083738 A083738 A084717 A084717 A083398 A083654 A083767 A083764 A085781 N011446
002 001 001 001 002 001 002 001 001 001 001 001 001
STERANE PFIZER 25MG/ML SUSPENSION; ORAL FLO-PRED TARO EQ 5MG BASE/5ML SUSPENSION/DROPS; OPHTHALMIC ECONOPRED ALCON 0.125%
N022067
001
Jan 17, 2008
N017468
001
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

OINTMENT; OPHTHALMIC CETAPRED ALCON 0.25%;10% METIMYD SCHERING 0.5%;10% PREDSULFAIR PHARMAFAIR 0.5%;10% VASOCIDIN NOVARTIS 0.5%;10% SUSPENSION; OPHTHALMIC ISOPTO CETAPRED ALCON 0.25%;10% SUSPENSION/DROPS; OPHTHALMIC METIMYD SCHERING 0.5%;10% PREDAMIDE AKORN 0.5%;10% PREDSULFAIR PHARMAFAIR 0.5%;10% PREDSULFAIR II PHARMAFAIR 0.2%;10% SULPHRIN BAUSCH AND LOMB 0.5%;10%
A087771 N010210 A088032 A088791
001 002 001 001
Aug 06, 1993 Sep 09, 1984 Apr 15, 1983 Oct 05, 1984
A087547
001
N010210 A088059 A088007 A088837 A088089
001 001 001 001 001 Jul 29, 1983 Apr 19, 1983 Dec 24, 1985 Dec 28, 1982

INJECTABLE; INJECTION HYDELTRASOL MERCK EQ 20MG PHOSPHATE/ML PREDNISOLONE SODIUM PHOSPHATE WATSON LABS EQ 20MG PHOSPHATE/ML OINTMENT; OPHTHALMIC, OTIC HYDELTRASOL MERCK EQ 0.25% PHOSPHATE SOLUTION; ORAL PREDNISOLONE SODIUM PHOSPHATE NESHER PHARMS EQ 5MG BASE/5ML VINTAGE PHARMS EQ 5MG BASE/5ML WE PHARMS EQ 5MG BASE/5ML
N011583 A080517
002 001
N011028
001
A076982 A078416 A075181
001 001 001
May 24, 2005 Oct 31, 2007 Dec 23, 2002

SOLUTION/DROPS; OPHTHALMIC INFLAMASE FORTE NOVARTIS EQ 0.9% PHOSPHATE INFLAMASE MILD NOVARTIS EQ 0.11% PHOSPHATE METRETON SCHERING EQ 0.5% PHOSPHATE PREDAIR PHARMAFAIR EQ 0.11% PHOSPHATE PREDAIR FORTE PHARMAFAIR EQ 0.9% PHOSPHATE PREDNISOLONE SODIUM PHOSPHATE AKORN EQ 0.11% PHOSPHATE EQ 0.9% PHOSPHATE ALCON PHARMS LTD EQ 0.11% PHOSPHATE EQ 0.9% PHOSPHATE BAUSCH AND LOMB EQ 0.11% PHOSPHATE SOLA BARNES HIND EQ 0.11% PHOSPHATE EQ 0.9% PHOSPHATE EQ 0.9% PHOSPHATE EQ 0.9% PHOSPHATE
6 - 288 (of 360)
A080751 A080751 A083834 A088415 A088165 A083358 A083358 A081043 A081044 A040065 A084171 A084168 A084169 A084172
002 001 001 001 001 001 002 001 001 001 001 001 001 001 Feb 29, 1984 Mar 28, 1983
Oct 24, 1991 Oct 24, 1991 Jul 29, 1994
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM

SOLUTION/DROPS; OPHTHALMIC SULSTER AKORN EQ 0.23% PHOSPHATE;10%
A074511
001
Jul 30, 1996
PREDNISOLONE TEBUTATE
INJECTABLE; INJECTION HYDELTRA-TBA MERCK PREDNISOLONE TEBUTATE WATSON LABS
20MG/ML 20MG/ML
N010562 A083362
001 001 Feb 17, 1984
PREDNISONE
SOLUTION; ORAL PREDNISONE WOCKHARDT SYRUP; ORAL LIQUID PRED MURO TABLET; ORAL CORTAN HALSEY DELTA-DOME BAYER PHARMS DELTASONE PHARMACIA AND UPJOHN
5MG/5ML
A089726
001
Aug 02, 1988
5MG/5ML
A087611
002
Sep 07, 1982
20MG 5MG 2.5MG 5MG 10MG 20MG 50MG 5MG 1MG 5MG 1MG 5MG 10MG 20MG
A087480 A080293 N009986 N009986 N009986 N009986 N009986 A083364 N009766 N009766 A083009 A083009 A083009 A083009
001 001 005 002 006 007 008 001 002 001 001 002 003 004
FERNISONE FERNDALE LABS METICORTEN SCHERING ORASONE SOLVAY

PREDNISONE
TABLET; ORAL ORASONE SOLVAY PARACORT PARKE DAVIS PREDNICEN-M SCHWARZ PHARMA PREDNISONE AM THERAP
6 - 289 (of 360)
50MG 5MG 5MG 5MG 10MG 20MG 5MG 10MG 20MG 5MG 5MG 10MG 20MG 5MG 20MG 1MG 2.5MG 5MG 2.5MG 5MG 5MG 5MG 10MG 20MG 20MG 50MG 5MG 1MG 2.5MG 5MG 5MG 10MG 20MG 5MG 5MG 20MG 5MG 5MG 5MG 10MG 20MG 50MG 5MG 1MG 2.5MG 5MG 5MG 5MG 5MG 20MG 5MG 10MG 20MG 20MG 5MG 20MG 25MG
A085999 N010962 A084655 A089387 A089388 A089389 A089597 A089598 A089599 A083676 A088394 A088395 A088396 A080491 A085811 A084440 A084440 A084440 A080563 A080563 A080300 A080320 A084341 A084417 A085543 A086946 A080782 A080328 A080306 A080279 A080283 A084133 A084134 A084236 A080514 A084275 A086968 A080301 A080701 A086595 A084634 A086596 A085115 A080350 A080350 A080350 A083059 A084662 A080321 A083807 A080353 A086062 A086061 A085151 A080232 N017109 A087833
001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 001 001 001 001 001 001 001 001 001 Nov Nov Nov Oct Oct Oct 06, 06, 06, 05, 05, 05, 1986 1986 1986 1987 1987 1987
AMNEAL PHARMS NY
BUNDY DURAMED PHARMS BARR
Oct 04, 1983 Oct 04, 1983 Oct 04, 1983
ELKINS SINN EVERYLIFE
FERRANTE HALSEY HEATHER
IMPAX LABS INWOOD LABS
KV PHARM LANNETT LEDERLE MARSHALL PHARMA MUTUAL PHARM
NYLOS PANRAY
PERRIGO PHARMAVITE PHOENIX LABS NY PUREPAC PHARM
PVT FORM REXALL ROXANE
May 04, 1982

PREDNISONE
TABLET; ORAL PREDNISONE SANDOZ
6 - 290 (of 360)
SCHERER LABS SPERTI
SUPERPHARM
TEVA UDL
UPSHER SMITH VALEANT PHARM INTL VANGARD VITARINE WATSON LABS
5MG 5MG 10MG 20MG 50MG 5MG 1MG 2.5MG 5MG 5MG 10MG 20MG 5MG 5MG 10MG 20MG 5MG 20MG 5MG 5MG 20MG 5MG 5MG 5MG 10MG 20MG 50MG 50MG 2.5MG 5MG 10MG 20MG 5MG
002 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 002 001
Jan 12, 1989 Jan 12, 1989
Oct 25, 1984 Oct 25, 1984 Oct 25, 1984 Jan 18, 1983 Jan 18, 1983 Jan 18, 1983
Jan 15, 1982 Jan 15, 1982
Jul 13, 1982
Jul 13, 1982
Jul 24, 1986
SERVISONE LEDERLE
INJECTABLE; INJECTION CITANEST ASTRAZENECA
1% 2% 3% 4% 4%
N014763 N014763 N014763 N014763 N021382
004 005 003 007 001
CITANEST PLAIN ASTRAZENECA CITANEST PLAIN DENTAL DENTSPLY PHARM
PRIMIDONE
SUSPENSION; ORAL MYSOLINE NURO PHARMA TABLET; ORAL PRIMIDONE WATSON LABS
250MG/5ML
N010401
001
250MG
A085052
001
PROBENECID
TABLET; ORAL BENEMID MERCK PROBENECID LEDERLE
500MG 500MG
N007898 A086917
004 001

PROBENECID
TABLET; ORAL PROBENECID WATSON LABS
6 - 291 (of 360)
500MG
A086150
002
Apr 23, 1982
PROBUCOL
TABLET; ORAL LORELCO SANOFI AVENTIS US
250MG 500MG
N017535 N017535
001 002
Jul 06, 1988
CAPSULE; ORAL PROCAINAMIDE HYDROCHLORIDE ASCOT 250MG 375MG 500MG IVAX SUB TEVA PHARMS 250MG 375MG 500MG LANNETT 250MG 500MG LEDERLE 250MG 375MG 500MG ROXANE 250MG 500MG SANDOZ 250MG 375MG 500MG VANGARD 250MG 500MG WATSON LABS 250MG 250MG 250MG 375MG 375MG 500MG 500MG 500MG PROCAN PARKE DAVIS 250MG 375MG 500MG PROCAPAN PANRAY 250MG PRONESTYL APOTHECON 250MG 375MG 500MG INJECTABLE; INJECTION PROCAINAMIDE HYDROCHLORIDE ABRAXIS PHARM 100MG/ML 500MG/ML HIKMA MAPLE 100MG/ML 500MG/ML HOSPIRA 500MG/ML PHARMAFAIR 100MG/ML 500MG/ML SMITH AND NEPHEW 100MG/ML 500MG/ML SOLOPAK 500MG/ML WARNER CHILCOTT 100MG/ML
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 004 003
Jan 08, 1982 Mar 01, 1983 Jan 08, 1982
Apr Apr Jul Jul Jul Jun Jun
26, 26, 01, 01, 01, 01, 01,
1985 1985 1986 1986 1986 1982 1982
A089415 A089416 A089029 A089030 A089537 A088824 A088830 A088530 A088531 A088532 A089528
001 001 001 001 001 001 001 001 001 001 001
Nov Nov Apr Apr Aug Nov Nov Mar Mar Mar May
17, 17, 17, 17, 25, 20, 20, 04, 04, 04, 03,
1986 1986 1986 1986 1987 1985 1985 1985 1985 1985 1988

INJECTABLE; INJECTION PROCAINAMIDE HYDROCHLORIDE WARNER CHILCOTT 500MG/ML WATSON LABS 100MG/ML 500MG/ML PRONESTYL APOTHECON 100MG/ML 500MG/ML TABLET; ORAL PRONESTYL APOTHECON 250MG 375MG 500MG TABLET, EXTENDED RELEASE; ORAL PROCAINAMIDE HYDROCHLORIDE COPLEY PHARM 500MG 750MG 1GM INWOOD LABS 500MG PLIVA 250MG 500MG SANDOZ 250MG 500MG 500MG 750MG WATSON LABS 250MG 250MG 500MG 500MG 750MG 750MG 1GM PROCAN SR PARKE DAVIS 250MG PARKEDALE 500MG 750MG 1GM PROCANBID KING PHARMS 500MG 1GM PRONESTYL-SR APOTHECON 500MG
6 - 292 (of 360)
A089529 A087079 A087080 N007335 N007335
001 001 001 002 005
May 03, 1988
N017371 N017371 N017371
001 002 003
A088974 A089438 A040111 A089840 A088958 A088959 A089369 A089284 A089370 A089371 A088533 A089026 A088534 A089027 A088535 A089042 A089520 A086468 A086065 A087510 A088489 N020545 N020545 A087361
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001
Jul Mar Dec Mar Dec Dec Aug Jun Jan Aug Dec Oct Dec Oct Nov Oct Jan
22, 23, 13, 06, 02, 02, 14, 23, 09, 14, 03, 22, 03, 22, 03, 22, 15,
1985 1987 1996 1989 1985 1985 1987 1986 1987 1987 1984 1985 1984 1985 1984 1985 1987
Apr 01, 1982 Jan 16, 1985 Jan 31, 1996 Jan 31, 1996
PROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION NOVOCAIN HOSPIRA
1% 2% 10% 1% 1% 2% 2% 1% 2% 1% 2% 1% 2% 1% 2%
003 004 001 002 001 003 002 001 001 001 002 001 002 001 002
PROCAINE HYDROCHLORIDE ABRAXIS PHARM
BEL MAR ELKINS SINN GD SEARLE LLC HOSPIRA

PROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION PROCAINE HYDROCHLORIDE MILES WATSON LABS
6 - 293 (of 360)
1% 2% 1% 1% 2% 2%
A080415 A080415 A080658 A083535 A080658 A083535
001 002 001 001 002 002
PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE

INJECTABLE; INJECTION ACHROMYCIN LEDERLE TETRACYN PFIZER
40MG/VIAL;100MG/VIAL 40MG/VIAL;250MG/VIAL 40MG/VIAL;100MG/VIAL 40MG/VIAL;250MG/VIAL
N050276 N050276 A060285 A060285
001 003 002 003
PROCAINE MERETHOXYLLINE; THEOPHYLLINE

INJECTABLE; INJECTION DICURIN PROCAINE LILLY
100MG/ML;50MG/ML
N008869
001
PROCHLORPERAZINE
SUPPOSITORY; RECTAL COMPAZINE GLAXOSMITHKLINE
N011127 N011127 N011127 A040407 A040407 A040407
003 001 002 001 002 003 Jul 11, 2001 Jul 11, 2001 Jul 11, 2001
PROCHLORPERAZINE ABLE
CONCENTRATE; ORAL COMPAZINE GLAXOSMITHKLINE EQ PROCHLORPERAZINE ALPHARMA US PHARMS EQ PROCHLORPERAZINE EDISYLATE MORTON GROVE EQ INJECTABLE; INJECTION COMPAZINE GLAXOSMITHKLINE EQ PROCHLORPERAZINE BAXTER HLTHCARE EQ PROCHLORPERAZINE EDISYLATE HIKMA MAPLE EQ HOSPIRA EQ MARSAM PHARMS LLC EQ SMITH AND NEPHEW EQ TEVA PARENTERAL EQ WATSON LABS EQ EQ EQ WYETH AYERST EQ SYRUP; ORAL COMPAZINE GLAXOSMITHKLINE EQ PROCHLORPERAZINE EDISYLATE ALPHARMA US PHARMS EQ
10MG BASE/ML 10MG BASE/ML 10MG BASE/ML
N011276 A087153 A088598
001 001 001 Jun 08, 1982 Oct 25, 1984
5MG BASE/ML 5MG BASE/ML 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
N010742 A087759 A089523 A089703 A089675 A089251 A040505 A089530 A089605 A089606 A086348
002 001 001 001 001 001 001 001 001 001 001 Oct 01, 1982 May Apr Dec Dec May Jul Jul Jul 03, 07, 05, 04, 30, 08, 08, 08, 1988 1988 1988 1986 2003 1987 1987 1987
5MG BASE/5ML 5MG BASE/5ML
N011188 A087154
001 001 Sep 01, 1982

SYRUP; ORAL PROCHLORPERAZINE EDISYLATE MORTON GROVE EQ 5MG BASE/5ML
6 - 294 (of 360)
A088597
001
Oct 25, 1984
PROCHLORPERAZINE MALEATE
CAPSULE, EXTENDED RELEASE; ORAL COMPAZINE GLAXOSMITHKLINE EQ 10MG BASE EQ 10MG BASE EQ 15MG BASE EQ 15MG BASE EQ 30MG BASE EQ 75MG BASE TABLET; ORAL COMPAZINE GLAXOSMITHKLINE EQ 5MG BASE EQ 10MG BASE EQ 25MG BASE PROCHLORPERAZINE WATSON LABS EQ 5MG BASE EQ 10MG BASE EQ 25MG BASE PROCHLORPERAZINE MALEATE DURAMED PHARMS BARR EQ 5MG BASE EQ 5MG BASE EQ 10MG BASE EQ 10MG BASE EQ 25MG BASE IVAX SUB TEVA PHARMS EQ 5MG BASE EQ 10MG BASE SANDOZ EQ 25MG BASE
N011000 N021019 N011000 N021019 N011000 N011000
001 001 002 002 003 004
Oct 06, 1999 Oct 06, 1999
N010571 N010571 N010571 A085580 A085178 A085579 A040207 A089484 A040207 A089485 A089486 A040162 A040162 A040101
001 002 003 001 001 001 001 001 002 001 001 001 002 003 May Jan May Jan Jan Jan Jan Jul 01, 20, 01, 20, 20, 20, 20, 19, 1997 1987 1997 1987 1987 1998 1998 1996
PROCYCLIDINE HYDROCHLORIDE
TABLET; ORAL KEMADRIN MONARCH PHARMS
2MG 5MG
N009818 N009818
005 003
PROGESTERONE
CAPSULE; ORAL PROMETRIUM ABBOTT LABS INJECTABLE; INJECTION PROGESTERONE LILLY
300MG
N019781
003
Oct 15, 1999
25MG/ML 50MG/ML INSERT, EXTENDED RELEASE; INTRAUTERINE PROGESTASERT ALZA 38MG
N009238 N009238
002 001
N017553
001
PROMAZINE HYDROCHLORIDE
CONCENTRATE; ORAL SPARINE WYETH AYERST
30MG/ML 100MG/ML
N010942 N010942
001 004
INJECTABLE; INJECTION PROMAZINE HYDROCHLORIDE WATSON LABS 25MG/ML 50MG/ML SPARINE BAXTER HLTHCARE CORP 25MG/ML 50MG/ML
A084510 A084517 N010349 N010349
001 001 008 006

PROMAZINE HYDROCHLORIDE
SYRUP; ORAL SPARINE WYETH AYERST TABLET; ORAL SPARINE WYETH AYERST
6 - 295 (of 360)
10MG/5ML
N010942
003
10MG 25MG 50MG 100MG 200MG
N010348 N010348 N010348 N010348 N010348
006 001 002 003 004
INJECTABLE; INJECTION PHENERGAN WYETH AYERST
25MG/ML 50MG/ML PROMETHAZINE HYDROCHLORIDE ABBOTT 25MG/ML 50MG/ML AKORN 25MG/ML 50MG/ML BEDFORD LABS 25MG/ML 50MG/ML BIONICHE PHARMA 25MG/ML HOSPIRA 50MG/ML 50MG/ML MARSAM PHARMS LLC 25MG/ML 50MG/ML SANDOZ 25MG/ML 50MG/ML WATSON LABS 25MG/ML 25MG/ML 50MG/ML 50MG/ML ZIPAN-25 ALTANA 25MG/ML ZIPAN-50 ALTANA 50MG/ML SUPPOSITORY; RECTAL PHENERGAN SHIONOGI INC 12.5MG 25MG 50MG PROMETHACON POLYMEDICA 25MG 50MG PROMETHAZINE HYDROCHLORIDE ABLE 12.5MG 25MG 50MG SYRUP; ORAL MYMETHAZINE FORTIS USL PHARMA 25MG/5ML PROMETH FORTIS ALPHARMA US PHARMS 25MG/5ML PROMETH PLAIN ACTAVIS MID ATLANTIC 6.25MG/5ML PROMETHAZINE CENCI 6.25MG/5ML PROMETHAZINE HYDROCHLORIDE KV PHARM 6.25MG/5ML 25MG/5ML PHARM ASSOC 6.25MG/5ML
N008857 N008857 A084223 A084222 A083955 A083955 A040524 A040524 A040471 A040372 A083838 A089463 A089477 A040593 A040593 A083532 A084591 A080629 A083532 A083997 A083997
002 003 001 001 002 001 001 002 001 002 002 001 001 001 002 001 001 002 002 001 002
Mar Mar Nov Jun May May Nov Nov
17, 17, 21, 08, 02, 02, 08, 08,
2004 2004 2002 2000 1988 1988 2006 2006
N010926 N010926 N011689 A084901 A084902 A040504 A040504 A040449
002 001 001 001 001 001 002 001 Apr 11, 2003 Apr 11, 2003 Feb 27, 2003
A087996 A084772 A085953 A089013 A085388 A085385 A087518
001 001 001 001 001 001 001
Jan 18, 1983
Sep 20, 1985

SYRUP; ORAL
WHITEWORTH TOWN PLSN 6.25MG/5ML PROMETHAZINE HYDROCHLORIDE PLAIN
ANI PHARMS 6.25MG/5ML 25MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET; ORAL
PHENERGAN
WYETH PHARMS INC 12.5MG 25MG 50MG PROMETHAZINE HYDROCHLORIDE ABBOTT 12.5MG 25MG 50MG ABLE 12.5MG 25MG 50MG IMPAX LABS 25MG IVAX SUB TEVA PHARMS 12.5MG 25MG 50MG LANNETT 12.5MG 25MG 50MG MUTUAL PHARM 12.5MG 25MG 50MG PVT FORM 12.5MG 25MG SANDOZ 12.5MG 12.5MG 25MG 50MG TABLICAPS 12.5MG 25MG TEVA 25MG WATSON LABS 12.5MG 12.5MG 12.5MG 25MG 25MG 50MG 50MG REMSED
BRISTOL MYERS SQUIBB 25MG 50MG
6 - 296 (of 360)
A086395 N008381 N008381
001
004 003 Apr 18, 1984
N007935 N007935 N007935 A084160 A084166 A084539 A040558 A040558 A040558 A084214 A083604 A083603 A083613 A080949 A080949 A080949 A084555 A084554 A084557 A083214 A083658 A084176 A084233 A085146 A085146 A084080 A084027 A089109 A083401 A083712 A085986 A083204 A085684 A083403 A085664 A083176 A083176
002
003
004
001
001
001
001 002 003 002 001
001
001
001
002
003
001
001
001
001
001
002 001 001 002 001 001 001 001 001 001 001 001 001 001 002
001
Jul Jul Jul Jul
01, 01, 01, 07,
2004 2004 2004 1982
May 22, 2009
Sep 10, 1985
TABLET; ORAL
NESHER PHARMS 150MG 225MG 300MG
A076193 A076193 A076193
001 002 003
Feb 07, 2002 Feb 07, 2002 Feb 07, 2002
PRO-BANTHINE
GD SEARLE LLC
30MG/VIAL
N008843
001

TABLET; ORAL
PRO-BANTHINE
SHIRE
6 - 297 (of 360)
7.5MG **Federal Register determination that product was not discontinued or

reasons**
15MG 15MG 15MG 15MG 15MG 15MG 15MG 7.5MG 15MG 15MG 15MG 15MG
N008732
003
N008732 A087663 A085780 A084541 A083706 A088377 A080977 A080927 A080928 A084428 A083029 A083151
002
001 001 002 001 001 001 001 001 001 002 001 Oct 25, 1982
PROPANTHELINE BROMIDE ASCOT HEATHER IMPAX LABS MYLAN PAR PHARM PVT FORM ROXANE SANDOZ TABLICAPS WATSON LABS
Dec 08, 1983
PROPARACAINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC KAINAIR PHARMAFAIR 0.5% PARACAINE OPTOPICS 0.5% PROPARACAINE HYDROCHLORIDE SOLA BARNES HIND 0.5% 0.5%
A088087 A087681 A084144 A084151
001 001 001 001
Jun 07, 1983 Aug 05, 1982
PROPIOLACTONE
BETAPRONE
FOREST LABS
N/A
N011657
001
PROPIOMAZINE HYDROCHLORIDE
LARGON
BAXTER HLTHCARE CORP
20MG/ML
N012382
002
PROPOFOL
INJECTABLE; INJECTION DIPRIVAN FRESENIUS KABI USA PROPOFOL BEDFORD TEVA PARENTERAL
N019627 A074848 A075392
001 001 001
Oct 02, 1989 Apr 19, 2005 Sep 19, 2000
PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL
DARVON
XANODYNE PHARM
32MG 65MG
N010997 N010997 A080530 A083544 A083538 A083184 A083317
001
003
001
001
002
001
001
DOLENE
HERITAGE PHARMS INC 65MG KESSO-GESIC
MK LABS 65MG PROPHENE 65
HALSEY 65MG PROPOXYPHENE HYDROCHLORIDE
ALRA 65MG IMPAX LABS 65MG

PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL PROPOXYPHENE HYDROCHLORIDE IVAX SUB TEVA PHARMS 32MG MUTUAL PHARM 65MG MYLAN 32MG 65MG 65MG NEXGEN PHARMA INC 65MG PAR PHARM 65MG PUREPAC PHARM 65MG PVT FORM 32MG 65MG ROXANE 32MG 65MG SANDOZ 32MG 65MG 65MG 65MG 65MG TEVA 65MG VALEANT PHARM INTL 65MG VINTAGE PHARMS 65MG WATSON LABS 65MG 65MG WEST WARD 65MG WHITEWORTH TOWN PLSN 65MG PROPOXYPHENE HYDROCHLORIDE 65 WARNER CHILCOTT 65MG
6 - 298 (of 360)
001 001 001 001 001 001 001 001 001 001 001 002 001 002 001 002 001 001 001 001 002 001 001 001 001
Dec 16, 2004
Oct 22, 1984 Jul 17, 2009
PROPOXYPHENE NAPSYLATE
SUSPENSION; ORAL DARVON-N AAIPHARMA LLC TABLET; ORAL DARVON-N XANODYNE PHARM
50MG/5ML
N016861
001
100MG
N016862
002
CAPSULE, EXTENDED RELEASE; ORAL PROPRANOLOL HYDROCHLORIDE INWOOD LABS 60MG 80MG 120MG 160MG CONCENTRATE; ORAL PROPRANOLOL HYDROCHLORIDE INTENSOL ROXANE 80MG/ML INJECTABLE; INJECTION PROPRANOLOL HYDROCHLORIDE SMITH AND NEPHEW 1MG/ML 1MG/ML SOLOPAK 1MG/ML SOLUTION; ORAL PROPRANOLOL HYDROCHLORIDE MORTON GROVE 20MG/5ML 40MG/5ML SUSPENSION; ORAL INDERAL WYETH AYERST 10MG/ML TABLET; ORAL INDERAL AKRIMAX PHARMS 10MG 20MG
A072499 A072500 A072501 A072502
001 001 001 001
Apr Apr Apr Apr
11, 11, 11, 11,
1989 1989 1989 1989
A071388
001
May 15, 1987
A070135 A070137 A070136
001 001 001
Apr 15, 1986 Apr 15, 1986 Apr 15, 1986
A071984 A071985
001 001
Mar 03, 1989 Mar 03, 1989
N019536
001
Dec 12, 1986
N016418 N016418
001 003

TABLET; ORAL INDERAL AKRIMAX PHARMS
6 - 299 (of 360)
90MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** PROPRANOLOL HYDROCHLORIDE CLONMEL HLTHCARE 10MG 20MG 40MG 60MG 80MG 90MG DURAMED PHARMS BARR 10MG 20MG 40MG 60MG 80MG 90MG INTERPHARM 10MG 20MG 40MG 80MG IVAX SUB TEVA PHARMS 10MG 20MG 40MG 60MG 80MG LEDERLE 10MG 20MG 40MG 80MG MUTUAL PHARM 10MG 20MG 40MG 60MG 80MG MYLAN 60MG PAR PHARM 90MG PLIVA 90MG PUREPAC PHARM 10MG 20MG 40MG 60MG 80MG ROXANE 10MG 20MG 40MG 60MG 80MG 90MG SANDOZ 10MG 10MG 20MG 20MG 40MG 40MG 60MG 60MG 80MG 80MG 90MG SCHERING 10MG
N016418
010
Oct 18, 1982
A070125 A070126 A070127 A071495 A070128 A071496 A070306 A070307 A070308 A070309 A070310 A071327 A071368 A071369 A071370 A071371 A072063 A072066 A072067 A072068 A072069 A072117 A072118 A072119 A072120 A070319 A070320 A070103 A070321 A070322 A072275 A071288 A071977 A070814 A070815 A070816 A070817 A070757 A070516 A070517 A070518 A070519 A070520 A070521 A070663 A071658 A070664 A071687 A070665 A071688 A070666 A072197 A070667 A071689 A072198 A070120
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul Jul Jul Dec Jul Dec Sep Sep Sep Oct Sep Oct May May May May Jul Jul Jul Jul Jul Jun Jun Jun Jun Oct Oct Oct Sep Aug Jun Oct Apr Nov Nov Nov Nov Nov Jul Jul Jul Sep Jul Sep Jun Jul Jun Jul Jun Jul Oct Jul Jun Jul Jul Aug
30, 30, 30, 31, 30, 31, 09, 09, 09, 01, 09, 01, 05, 05, 05, 05, 29, 29, 29, 29, 29, 23, 23, 23, 23, 22, 22, 22, 24, 04, 09, 22, 06, 03, 03, 03, 03, 03, 07, 07, 07, 24, 07, 24, 13, 05, 13, 05, 13, 05, 10, 05, 13, 05, 05, 06,
1985 1985 1985 1987 1985 1987 1985 1985 1985 1986 1985 1986 1987 1987 1987 1987 1988 1988 1988 1988 1988 1988 1988 1988 1988 1985 1985 1985 1986 1986 1989 1986 1988 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1988 1986 1988 1986 1988 1986 1988 1986 1988 1988 1985

TABLET; ORAL PROPRANOLOL HYDROCHLORIDE SCHERING 20MG 40MG 60MG 80MG SUPERPHARM 10MG 20MG 40MG 80MG TEVA 10MG 20MG 40MG WARNER CHILCOTT 10MG 20MG 40MG 60MG 80MG WATSON LABS 10MG 10MG 10MG 20MG 20MG 20MG 40MG 40MG 40MG 60MG 60MG 60MG 60MG 80MG 80MG 80MG 90MG 90MG
6 - 300 (of 360)
A070121 A070122 A070123 A070124 A071515 A071516 A071517 A071518 A070232 A070233 A070234 A070438 A070439 A070440 A070441 A070442 A070140 A070378 A070548 A070141 A070379 A070549 A070142 A070380 A070550 A070143 A070381 A071098 A071791 A070144 A070382 A070551 A071183 A071792
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Aug Aug Oct Aug Jun Jun Jun Jun Oct Jun Jun Sep Sep Sep Sep Sep Jul Mar Jul Jul Mar Apr Jul Mar Apr Jan Mar Oct Jul Jul Mar Jul Oct Jul
06, 06, 29, 06, 08, 08, 08, 08, 07, 23, 23, 15, 15, 15, 24, 15, 30, 19, 10, 30, 19, 11, 30, 19, 11, 15, 19, 06, 15, 30, 19, 10, 06, 15,
1985 1985 1986 1985 1988 1988 1988 1988 1987 1986 1986 1986 1986 1986 1986 1986 1985 1987 1986 1985 1987 1986 1985 1987 1986 1987 1987 1986 1987 1985 1987 1986 1986 1987
PROPYLIODONE
SUSPENSION; INTRATRACHEAL DIONOSIL AQUEOUS GLAXOSMITHKLINE 50% DIONOSIL OILY GLAXOSMITHKLINE 60%
N009309 N009309
001 002
PROPYLTHIOURACIL
TABLET; ORAL PROPYLTHIOURACIL ABBOTT ANABOLIC HALSEY IMPAX LABS IVAX SUB TEVA PHARMS LANNETT LILLY MUTUAL PHARM PERRIGO TABLICAPS WATSON LABS
A084075 A080285 A080015 A080159 A080215 A080016 N006213 A083982 A084543 A080840 A080932 A085201
001 001 001 001 001 001 001 001 001 001 001 001

PROTAMINE SULFATE
INJECTABLE; INJECTION PROTAMINE SULFATE HIKMA MAPLE LILLY PHARMACIA AND UPJOHN
6 - 301 (of 360)
10MG/ML 10MG/ML 10MG/ML 50MG/VIAL 250MG/VIAL
A089474 A089475 N006460 N007413 N007413
001 001 002 001 002
Nov 05, 1986 Nov 05, 1986
Aug 02, 1984
PROTEIN HYDROLYSATE
INJECTABLE; INJECTION AMINOSOL 5% ABBVIE HYPROTIGEN 5% B BRAUN
5% 5%
N005932 N006170
012 003
Jan 31, 1985 Jan 10, 1984
PROTIRELIN
THYPINONE
ABBOTT THYREL TRH
FERRING
0.5MG/ML 0.5MG/ML
N017638 N018087
001
001
PROTOKYLOL HYDROCHLORIDE
TABLET; ORAL
VENTAIRE
SANOFI AVENTIS US
2MG
A083459
001
PROTRIPTYLINE HYDROCHLORIDE
TABLET; ORAL
VIVACTIL
TEVA WOMENS R AND D
5MG 10MG
N016012 N016012
001
002
PSEUDOEPHEDRINE HYDROCHLORIDE
NOVAFED
SANOFI AVENTIS US 120MG SUDAFED 12 HOUR
GLAXOSMITHKLINE 120MG **Federal Register determination that product was not discontinued or
reasons**
N017603 N017941
001
002
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE

CAPSULE, EXTENDED RELEASE; ORAL ACTIFED GLAXOSMITHKLINE 120MG;5MG TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES KV PHARM 120MG;5MG SYRUP; ORAL ACTAHIST CENCI 30MG/5ML;1.25MG/5ML HISTAFED CENCI 30MG/5ML;1.25MG/5ML MYFED USL PHARMA 30MG/5ML;1.25MG/5ML TRILITRON NEWTRON PHARMS 30MG/5ML;1.25MG/5ML TABLET; ORAL ALLERFED PVT FORM 60MG;2.5MG CORPHED SANDOZ 60MG;2.5MG
N018996 A071798
001 001
Jun 17, 1985 Mar 16, 1989
A088344 A088283 A088116 A088474
001 001 001 001
Feb 09, 1984 Apr 20, 1984 Mar 04, 1983 Feb 12, 1985
A088860 A088602
001 001
Jan 31, 1985 Apr 11, 1985

PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
TABLET; ORAL PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE SANDOZ 60MG;2.5MG TRILITRON NEWTRON PHARMS 60MG;2.5MG TRIPHED TEVA 60MG;2.5MG TRIPROLIDINE AND PSEUDOEPHEDRINE WATSON LABS 60MG;2.5MG WEST WARD 60MG;2.5MG TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE IVAX SUB TEVA PHARMS 60MG;2.5MG SUPERPHARM 60MG;2.5MG TABLET, EXTENDED RELEASE; ORAL TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES KV PHARM 120MG;5MG
6 - 302 (of 360)
A088193 A088515 A088630 A088318 A088117 A085273 A088578
001 001 001 002 001 001 001
May 17, 1983 Jan 09, 1985 May 17, 1984 Jan 13, 1984 Apr 19, 1983 Dec 12, 1984 Feb 21, 1985
A072758
001
Nov 25, 1991
PSEUDOEPHEDRINE POLISTIREX
SUSPENSION, EXTENDED RELEASE; ORAL PSEUDO-12 UCB INC EQ 60MG HCL/5ML
N019401
001
Jun 19, 1987
PYRIDOSTIGMINE BROMIDE
TABLET; ORAL PYRIDOSTIGMINE BROMIDE BARR SOLVAY US ARMY
30MG 60MG 30MG 30MG
A040512 A040512 A089572 N020414
002 001 001 001
Jul Oct Nov Feb
20, 08, 27, 05,
2005 2003 1990 2003
PYRIDOXINE HYDROCHLORIDE
INJECTABLE; INJECTION HEXA-BETALIN LILLY 100MG/ML PYRIDOXINE HYDROCHLORIDE AKORN 100MG/ML BEL MAR 100MG/ML DELL LABS 50MG/ML 100MG/ML ELKINS SINN 100MG/ML LUITPOLD 100MG/ML WATSON LABS 100MG/ML 100MG/ML
A080854 A087967 A080761 A083771 A083772 A080581 A080669 A080572 A083760
001 001 001 001 001 001 001 001 001 Oct 01, 1982
PYRILAMINE MALEATE
TABLET; ORAL PYRILAMINE MALEATE IMPAX LABS WATSON LABS
25MG 25MG
A080808 A085231
001 001
PYRIMETHAMINE; SULFADOXINE
TABLET; ORAL FANSIDAR ROCHE
25MG;500MG
N018557
001
PYRITHIONE ZINC
LOTION; TOPICAL HEAD & SHOULDERS CONDITIONER WARNER CHILCOTT 0.3%
N019412
002
Mar 10, 1986

PYRVINIUM PAMOATE
SUSPENSION; ORAL POVAN PARKE DAVIS TABLET; ORAL POVAN PARKE DAVIS
6 - 303 (of 360)
EQ 50MG BASE/5ML
N011964
001
EQ 50MG BASE
N012485
002
QUAZEPAM
TABLET; ORAL DORAL QUESTCOR PHARMS
7.5MG
N018708
003
Feb 26, 1987
QUETIAPINE FUMARATE
TABLET; ORAL SEROQUEL ASTRAZENECA
EQ 150MG BASE
N020639
004
Dec 20, 1998
TABLET; ORAL QUINAPRIL HYDROCHLORIDE ACTAVIS TOTOWA EQ EQ EQ EQ SANDOZ EQ EQ EQ EQ
A076459 A076459 A076459 A076459 A076803 A076803 A076803 A076803
001 002 003 004 001 002 003 004
Dec Dec Dec Dec Mar Mar Mar Mar
22, 22, 22, 22, 02, 02, 02, 02,
2004 2004 2004 2004 2005 2005 2005 2005
QUINESTROL
TABLET; ORAL ESTROVIS PARKE DAVIS
0.1MG 0.2MG
N016768 N016768
002 003
QUINETHAZONE
TABLET; ORAL HYDROMOX LEDERLE
50MG
N013264
001
QUINETHAZONE; RESERPINE
TABLET; ORAL HYDROMOX R LEDERLE
50MG;0.125MG
N013927
001
QUINIDINE GLUCONATE
TABLET; ORAL QUINACT BAYER HLTHCARE
266MG 400MG TABLET, EXTENDED RELEASE; ORAL DURAQUIN WARNER CHILCOTT 330MG QUINAGLUTE BAYER HLTHCARE 324MG QUINALAN LANNETT 324MG QUINATIME WATSON LABS 324MG QUINIDINE GLUCONATE ASCOT 324MG HALSEY 324MG
A085978 A086099
001 001
N017917 N016647 A088081 A087448 A088582 A089476
001 001 001 001 001 001 Jun 17, 1985 Apr 10, 1987 Feb 10, 1986

QUINIDINE GLUCONATE
TABLET, EXTENDED RELEASE; QUINIDINE GLUCONATE ROXANE SANDOZ SUPERPHARM WATSON LABS ORAL 324MG 324MG 324MG 324MG A088431 A089894 A089164 A087785
6 - 304 (of 360)
001 001 001 001
Jan Dec Nov Jan
06, 15, 21, 24,
1984 1988 1985 1983
QUINIDINE POLYGALACTURONATE
TABLET; ORAL CARDIOQUIN PHARM RES ASSOC
275MG
N011642
002
QUINIDINE SULFATE
CAPSULE; ORAL CIN-QUIN SOLVAY QUINIDINE SULFATE LILLY TABLET; ORAL CIN-QUIN SOLVAY
200MG 300MG 200MG
A085296 A085297 A085103
001 001 001
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001
QUINIDINE SULFATE BARR CLONMEL HLTHCARE CONTRACT PHARMACAL ELKINS SINN EVERYLIFE HALSEY IMPAX LABS IVAX SUB TEVA PHARMS KING PHARMS KV PHARM LANNETT LEDERLE LILLY MUTUAL PHARM PERRIGO PHARMAVITE PUREPAC PHARM ROXANE SANDOZ
Apr 14, 1989
Sep 29, 1988 Apr 10, 1985 Apr 14, 1982 Jul 13, 1982
SCHERER LABS SUPERPHARM USL PHARMA VALEANT PHARM INTL VANGARD VINTAGE PHARMS WARNER CHILCOTT WATSON LABS WEST WARD WHITEWORTH TOWN PLSN QUINORA KEY PHARMS SCHERING

QUINIDINE SULFATE
QUINIDEX
WYETH PHARMS INC 300MG
6 - 305 (of 360)
N012796
002
RABEPRAZOLE SODIUM
ACIPHEX
EISAI INC 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N020973
001
May 29, 2002
RAMIPRIL
CAPSULE; ORAL
RAMIPRIL
ACTAVIS ELIZABETH
RANBAXY LABS LTD TABLET; ORAL ALTACE KING PFIZER
1.25MG 2.5MG 5MG 10MG 5MG 10MG
A077513 A077513 A077513 A077513 A078849 A078849
001 002 003 004 001 002
Jun Jun Jun Jun Mar Mar
18, 18, 18, 18, 06, 06,
2008 2008 2008 2008 2009 2009
1.25MG 2.5MG 5MG 10MG
N022021 N022021 N022021 N022021
001 002 003 004
Feb Feb Feb Feb
27, 27, 27, 27,
2007 2007 2007 2007
RANITIDINE BISMUTH CITRATE

TABLET; ORAL TRITEC GLAXOSMITHKLINE
400MG
N020559
001
Aug 08, 1996
CAPSULE; ORAL
MYLAN EQ 150MG BASE EQ 300MG BASE TEVA EQ 150MG BASE EQ 300MG BASE ZANTAC 150 GLAXOSMITHKLINE EQ 150MG BASE ZANTAC 300 GLAXOSMITHKLINE EQ 300MG BASE GRANULE, EFFERVESCENT; ORAL ZANTAC 150 GLAXOSMITHKLINE EQ 150MG BASE/PACKET INJECTABLE; INJECTION RANITIDINE HYDROCHLORIDE BEDFORD EQ 25MG BASE/ML ZANTAC IN PLASTIC CONTAINER COVIS PHARMA EQ 50MG BASE/100ML SYRUP; ORAL RANITIDINE HYDROCHLORIDE RANBAXY EQ 15MG BASE/ML TABLET; ORAL RANITIDINE HYDROCHLORIDE BOEHRINGER INGELHEIM EQ 150MG BASE EQ 300MG BASE MYLAN EQ 150MG BASE EQ 300MG BASE RANBAXY EQ 75MG BASE EQ 75MG BASE
A075564 A075564 A075557 A075557 N020095 N020095
001 002 001 002 001 002
Oct Oct Oct Oct
27, 27, 31, 31,
2000 2000 2003 2003
Mar 08, 1994 Mar 08, 1994
N020251
002
Mar 31, 1994
A074764 N019593
001 001
Nov 19, 2004 Dec 17, 1986
A078448
001
Dec 13, 2007
A074662 A074662 A074552 A074552 A075132 A075254
001 002 001 002 001 001
Aug Aug Jul Jul Jan Jan
29, 29, 30, 30, 14, 14,
1997 1997 1998 1998 2000 2000

TABLET; ORAL
RANBAXY EQ 150MG BASE EQ 150MG BASE EQ 300MG BASE EQ 300MG BASE SANDOZ EQ 75MG BASE TABLET, EFFERVESCENT; ORAL ZANTAC 150 GLAXOSMITHKLINE EQ 150MG BASE ZANTAC 75 BOEHRINGER INGELHEIM EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
6 - 306 (of 360)
A075000 A075439 A075000 A075439 A075519
001 001 002 002 001
Jan Apr Jan Apr Sep
30, 19, 30, 19, 26,
1998 2000 1998 2000 2002
N020251 N020745
001 001
Mar 31, 1994 Feb 26, 1998
RAPACURONIUM BROMIDE
INJECTABLE; INJECTION RAPLON ORGANON USA INC
N020984 N020984
001 002
Aug 18, 1999 Aug 18, 1999
RAUWOLFIA SERPENTINA ROOT

TABLET; ORAL
HIWOLFIA
BOWMAN PHARMS
50MG 50MG 100MG 50MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG
N009276 N009276 N009276 N010581 N009278 N009278 N008842 N008842 N009926 N009926 N009108 N009108 N009477 N009477 A080498 A080498 N009273 N009273 N011521 N011521 A080842 A080842 A080583 A080583 A080500 A080500 A083867 A083444 N009668 N009668 A080907 A080914
003
005
004
001
001
002
001
002
002
004
002
004
001
002
001
002
001
002
001
002
001
002
001
002
001
002
001
001
001
002
001
001
HYSERPIN
PHYS PRODS VA KOGLUCOID
PANRAY RAUDIXIN
APOTHECON RAUSERPIN
FERNDALE LABS RAUVAL
PAL PAK RAUWOLFIA SERPENTINA
BUNDY HALSEY IMPAX LABS IVAX SUB TEVA PHARMS PUREPAC PHARM PVT FORM SOLVAY TABLICAPS VALEANT PHARM INTL WATSON LABS

RAUWOLFIA SERPENTINA ROOT
TABLET; ORAL WOLFINA FOREST PHARMS
6 - 307 (of 360)
50MG 100MG
N009255 N009255
008 006
RESCINNAMINE
CAPSULE; ORAL CINNASIL PANRAY TABLET; ORAL MODERIL PFIZER
0.5MG
A084736
001
0.25MG 0.5MG
N010686 N010686
003 006
RESERPINE
ELIXIR; ORAL SERPASIL NOVARTIS INJECTABLE; INJECTION SANDRIL LILLY SERPASIL NOVARTIS TABLET; ORAL HISERPIA BOWMAN PHARMS RAU-SED BRISTOL MYERS SQUIBB
0.2MG/4ML
N009115
005
2.5MG/ML 2.5MG/ML
N010012 N009434
001 002
0.1MG 0.25MG 0.1MG 0.25MG 0.5MG 1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.5MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.25MG 1MG
N009631 N009631 N009357 N009357 N009357 N009357 A080721 A083058 A083058 N009663 N009663 A083145 A083145 N010441 N010441 N010441 N010441 A080457 A080457 A080457 N009627 N009627 N011185 N011185 A080492 A080492 A080525 A080525 A084974 A084663 A080753 A080753 A086117 A080582 A085775 A080582
002 004 001 004 006 008 002 001 002 001 003 001 002 001 002 003 004 002 001 003 001 002 001 002 001 002 002 001 001 001 002 001 001 001 001 002
RESERPINE BARR BELL PHARMA BUNDY ELKINS SINN EVERYLIFE
HALSEY
IMPAX LABS IVAX SUB TEVA PHARMS MARSHALL PHARMA MK LABS MYLAN PHARMAVITE PUREPAC PHARM PVT FORM

RESERPINE
TABLET; ORAL RESERPINE REXALL ROXANE SOLVAY TABLICAPS TEVA VALEANT PHARM INTL WATSON LABS
6 - 308 (of 360)
WEST WARD
0.25MG 0.1MG 0.25MG 0.25MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.25MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 0.25MG
A080637 N009859 N009859 A080446 A085207 A089020 A089019 N009667 N009667 A080679 A080393 A085401 A080749 A080975 A080975 A080975 A080723 A080723 A080723 N009376 N009376 N009391 N009391 N009391 N009115 N009115 N009115 N009453 N009453 N009645
001 001 002 001 001 001 001 001 002 001 001 001 001 001 002 003 001 002 003 004 001 001 002 004 001 003 004 001 002 002
Mar 07, 1985 Mar 07, 1985
SANDRIL LILLY SERPANRAY PANRAY
SERPASIL NOVARTIS
SERPATE VALE SERPIVITE VITARINE
RESERPINE; TRICHLORMETHIAZIDE
TABLET; ORAL METATENSIN #2 SANOFI AVENTIS US 0.1MG;2MG METATENSIN #4 SANOFI AVENTIS US 0.1MG;4MG NAQUIVAL SCHERING 0.1MG;4MG TRICHLORMETHIAZIDE W/ RESERPINE WATSON LABS 0.1MG;4MG
N012972 N012972 N012265 A085248
001 002 003 001
RIBAVIRIN
TABLET; ORAL COPEGUS ROCHE
400MG
N021511
002
Jun 21, 2005
RIMANTADINE HYDROCHLORIDE
SYRUP; ORAL FLUMADINE FOREST LABS 50MG/5ML TABLET; ORAL RIMANTADINE HYDROCHLORIDE ACTAVIS TOTOWA 100MG
N019650
001
Sep 17, 1993
A076375
001
Jan 14, 2003

RISEDRONATE SODIUM
TABLET; ORAL
ACTONEL
WARNER CHILCOTT LLC
6 - 309 (of 360)
N020835
004
Apr 16, 2007
RISPERIDONE
TABLET; ORAL RISPERDAL JANSSEN PHARMS RISPERIDONE CADISTA PHARMS
5MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG
005 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006
Dec 29, 1993 Mar Mar Mar Mar Mar Mar Jun Jun Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct 23, 23, 23, 23, 23, 23, 08, 08, 08, 08, 08, 08, 22, 22, 22, 22, 22, 22, 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009
RATIOPHARM
SYNTHON PHARMS
RITODRINE HYDROCHLORIDE
RITODRINE HYDROCHLORIDE
ABRAXIS PHARM 10MG/ML 15MG/ML HOSPIRA 10MG/ML 15MG/ML RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 30MG/100ML YUTOPAR ASTRAZENECA 10MG/ML 15MG/ML TABLET; ORAL YUTOPAR ASTRAZENECA 10MG
A071188 A071189 A071618 A071619 A071438 N018580 N018580
001 001 001 001 001 001 002
Jul Jul Feb Feb
23, 23, 28, 28,
1987 1987 1991 1991
Jan 22, 1991
N018555
001
RITONAVIR
CAPSULE; ORAL NORVIR ABBOTT
100MG
N020680
001
Mar 01, 1996
ROCURONIUM BROMIDE
INJECTABLE; INJECTION ZEMURON SCHERING
10MG/ML (10MG/ML)
N020214
002
Mar 17, 1994
ROFECOXIB
SUSPENSION; ORAL VIOXX MERCK
12.5MG/5ML 25MG/5ML
N021052 N021052
001 002
May 20, 1999 May 20, 1999

ROFECOXIB
TABLET; ORAL VIOXX MERCK
6 - 310 (of 360)
12.5MG 25MG 50MG
N021042 N021042 N021042
001 002 003
May 20, 1999 May 20, 1999 Feb 25, 2000
TABLET, EXTENDED RELEASE; ORAL REQUIP XL SMITHKLINE BEECHAM EQ 3MG BASE
N022008
002
Jun 13, 2008
ROSE BENGAL SODIUM I-131

INJECTABLE; INJECTION ROBENGATOPE BRACCO
0.5mCi/VIAL 1mCi/VIAL 2mCi/VIAL
N016224 N016224 N016224 N017318
001 002 003 001
SODIUM ROSE BENGAL I 131 SORIN 0.5mCi/ML
RUFINAMIDE
TABLET; ORAL BANZEL EISAI INC
100MG
N021911
001
Nov 14, 2008
SAFFLOWER OIL
INJECTABLE; INJECTION LIPOSYN 10% ABBOTT LIPOSYN 20% ABBOTT
10% (10GM/100ML) 20% (20GM/100ML)
N018203 N018614
001 001
SALMETEROL XINAFOATE
AEROSOL, METERED; INHALATION SEREVENT GLAXOSMITHKLINE EQ 0.021MG BASE/INH
N020236
001
Feb 04, 1994
SAQUINAVIR
CAPSULE; ORAL FORTOVASE HOFFMANN LA ROCHE
200MG
N020828
001
Nov 07, 1997
SARALASIN ACETATE
INJECTABLE; INJECTION SARENIN PROCTER AND GAMBLE
EQ 0.6MG BASE/ML
N018009
001
SECOBARBITAL SODIUM
CAPSULE; ORAL SECOBARBITAL SODIUM ANABOLIC BARR EVERYLIFE HALSEY IVAX PHARMS KV PHARM LANNETT PARKE DAVIS PERRIGO PUREPAC PHARM VALEANT PHARM INTL
A084422 A084225 A085895 A084676 A085869 A085285 A085909 A085903 A084762 A084561 A085867 A085477
001 001 001 001 001 001 001 001 001 001 001 001

SECOBARBITAL SODIUM
CAPSULE; ORAL SECOBARBITAL SODIUM VITARINE WATSON LABS WEST WARD WHITEWORTH TOWN PLSN WYETH AYERST INJECTABLE; INJECTION SECOBARBITAL SODIUM ELKINS SINN WYETH AYERST SECONAL SODIUM LILLY SUPPOSITORY; RECTAL SECONAL SODIUM LILLY
6 - 311 (of 360)
100MG 100MG 100MG 100MG 100MG 100MG
A085898 A086273 A085792 A084926 A085798 A086390
001 001 001 001 001 001
100MG/VIAL 50MG/ML 50MG/ML
A083281 A083262 N007392
001 001 002
30MG 60MG 120MG 200MG
A086530 A086530 A086530 A086530
001 002 003 004
SECRETIN
INJECTABLE; INJECTION SECRETIN-FERRING FERRING
75CU/VIAL
N018290
001
SECRETIN SYNTHETIC PORCINE

FOR SOLUTION; INTRAVENOUS SECREFLO CHIRHOCLIN 16MCG/VIAL
N021136
001
Apr 04, 2002
CAPSULE; ORAL SELEGILINE HYDROCHLORIDE AAIPHARMA LLC 5MG TABLET; ORAL SELEGILINE HYDROCHLORIDE IVAX SUB TEVA PHARMS 5MG SIEGFRIED 5MG SOMERSET 5MG TEVA 5MG 5MG VINTAGE PHARMS LLC 5MG
A075145
001
Sep 15, 2003
A074756 A074672 N019334 A074537 A074744 A074565
001 001 001 001 001 001
Nov Apr Jun Aug Jan Aug
25, 01, 05, 02, 27, 02,
1998 1997 1989 1996 1997 1996
SELENIUM SULFIDE
LOTION/SHAMPOO; TOPICAL EXSEL ALLERGAN HERBERT SELENIUM SULFIDE ACTAVIS MID ATLANTIC IVAX PHARMS TARO
2.5% 2.5% 2.5% 2.5%
A083892 A084394 A085777 A086209
001 001 001 001
SELENOMETHIONINE SE-75
INJECTABLE; INJECTION SELENOMETHIONINE SE 75 GE HEALTHCARE MALLINCKRODT PHARMALUCENCE SETHOTOPE BRACCO
250uCi/ML 100uCi/ML 500uCi/ML 85-550uCi/ML
N017257 N017098 N017322 N017047
001 001 001 001

SERACTIDE ACETATE
INJECTABLE; INJECTION ACTHAR GEL-SYNTHETIC ARMOUR PHARM
6 - 312 (of 360)
N017861 N017861
001 002
SERMORELIN ACETATE
INJECTABLE; INJECTION GEREF EMD SERONO
EQ 0.05MG BASE/AMP EQ 0.5MG BASE/VIAL EQ 1MG BASE/VIAL
N019863 N020443 N020443
001 001 002
Dec 28, 1990 Sep 26, 1997 Sep 26, 1997
CONCENTRATE; ORAL SERTRALINE HYDROCHLORIDE RANBAXY LABS LTD EQ ROXANE EQ TABLET; ORAL SERTRALINE HYDROCHLORIDE ACTAVIS ELIZABETH EQ EQ EQ IVAX SUB TEVA PHARMS EQ EQ EQ MUTUAL PHARM EQ EQ EQ MYLAN PHARMS INC EQ EQ EQ PLIVA HRVATSKA DOO EQ EQ EQ ROXANE EQ EQ EQ SANDOZ EQ EQ EQ WATSON LABS EQ EQ EQ ZOLOFT PFIZER EQ EQ
20MG BASE/ML 20MG BASE/ML
A078053 A076934
001 001
Feb 05, 2007 Jun 30, 2006
25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE
001 002 003 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 003 004
Feb Feb Feb Jun Jun Jun Feb Feb Feb Mar Mar Mar Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb
06, 06, 06, 30, 30, 30, 06, 06, 06, 20, 20, 20, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06,
2007 2007 2007 2006 2006 2006 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
Dec 30, 1991 Dec 30, 1991
SEVELAMER HYDROCHLORIDE
CAPSULE; ORAL RENAGEL GENZYME
403MG
N020926
001
Oct 30, 1998
SIBUTRAMINE HYDROCHLORIDE
CAPSULE; ORAL MERIDIA ABBOTT
5MG 10MG 15MG
N020632 N020632 N020632
001 002 003
Nov 22, 1997 Nov 22, 1997 Nov 22, 1997

SILVER SULFADIAZINE
DRESSING; TOPICAL SILDAFLO FRANKLIN PHARMS
6 - 313 (of 360)
1%
N019608
001
Nov 30, 1989
SIMETHICONE-CELLULOSE
SUSPENSION; ORAL SONORX BRACCO
7.5MG/ML
N020773
001
Oct 29, 1998
SIMVASTATIN
TABLET; ORAL
SIMVASTATIN
SANDOZ INC
5MG 10MG 20MG 40MG 80MG TABLET, ORALLY DISINTEGRATING; ORAL

SIMVASTATIN
SYNTHON PHARMS 10MG 20MG 40MG 80MG
A077766 A077766 A077766 A077766 A077766
001 002 003 004 005
Dec Dec Dec Dec Dec
20, 20, 20, 20, 20,
2006 2006 2006 2006 2006
N021961 N021961 N021961 N021961
001 002 003 004
Oct Oct Oct Oct
09, 09, 09, 09,
2007 2007 2007 2007
SIROLIMUS
TABLET; ORAL
RAPAMUNE
WYETH PHARMS INC
N021110
003
Feb 23, 2004
SODIUM BENZOATE; SODIUM PHENYLACETATE

SOLUTION; ORAL UCEPHAN B BRAUN
100MG/ML;100MG/ML
N019530
001
Dec 23, 1987
SODIUM BICARBONATE
INJECTABLE; INJECTION SODIUM BICARBONATE IN PLASTIC CONTAINER ABBOTT 0.9MEQ/ML 1MEQ/ML
N019443 N019443
001 002
Jun 03, 1986 Jun 03, 1986
SODIUM BICARBONATE; TARTARIC ACID

GRANULE, EFFERVESCENT; ORAL BAROS MALLINCKRODT INC 460MG/GM;420MG/GM
N018509
001
Aug 07, 1985
SODIUM CHLORIDE
INJECTABLE; INJECTION BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ABRAXIS PHARM 9MG/ML SODIUM CHLORIDE
ABBOTT 20GM/100ML B BRAUN 20GM/100ML SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 450MG/100ML MILES 450MG/100ML SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ABBOTT 9MG/ML MILES 900MG/100ML
A088909 N017013 N017038 N018184 N018503 N019218 N018502
001 001
001
001
001
001 001
Feb 07, 1985
Jul 13, 1984

SODIUM CHLORIDE
INJECTABLE; INJECTION SODIUM CHLORIDE 23.4% ABRAXIS PHARM SODIUM CHLORIDE 3% IN B BRAUN SODIUM CHLORIDE 5% IN B BRAUN SOLUTION; IRRIGATION SODIUM CHLORIDE 0.45% BAXTER HLTHCARE HOSPIRA IN PLASTIC CONTAINER 234MG/ML PLASTIC CONTAINER 3GM/100ML PLASTIC CONTAINER 5GM/100ML
6 - 314 (of 360)
N019329 N019635 N019635
001 003 004
Apr 22, 1987 Mar 09, 1988 Mar 09, 1988
IN PLASTIC CONTAINER 450MG/100ML 450MG/100ML 450MG/100ML SODIUM CHLORIDE IN PLASTIC CONTAINER

MILES 900MG/100ML
N018497 N017670 N018380 N018247
001 001 001

001
Feb 19, 1982
SODIUM CHROMATE CR-51

CHROMITOPE SODIUM
BRACCO SODIUM CHROMATE CR 51
MALLINCKRODT
2mCi/VIAL 200uCi/ML 100uCi/ML
N013993 N013993 N016708
002
001
001

FLUORINE F-18
GE HEALTHCARE
2mCi/ML **Federal Register determination that product was not

10-200mCi/ML
N017042
001
SODIUM FLUORIDE F 18 NIH NCI DCTD
N022494
001
Jan 26, 2011
SODIUM IODIDE I-123

CAPSULE; ORAL
SODIUM IODIDE I 123
GE HEALTHCARE SOLUTION; ORAL
SODIUM IODIDE I 123
GE HEALTHCARE
100uCi
N017630
001
2mCi/ML
N017630
002
SODIUM IODIDE I-131

CAPSULE; ORAL
IODOTOPE
BRACCO SODIUM IODIDE I 131
CIS MALLINCKRODT SODIUM IODIDE I-131 JUBILANT DRAXIMAGE SOLUTION; ORAL HICON JUBILANT DRAXIMAGE
1-130mCi 1-150mCi 50uCi 100uCi 0.8-100mCi 15-100uCi 2-200mCi
N010929 N010929 N017316 N017316 N016515 N016517 N021305
001
003
001
002
002
002
004 Nov 18, 2004
1-250mCi/0.25ML 1-500mCi/0.5ML 1-1000mCi/ML 7-106mCi/BOT 50mCi/ML
N021305 N021305 N021305 N010929 N017315
002 003 005 002

001
Jan 24, 2003 Jan 24, 2003 Apr 04, 2006
IODOTOPE
BRACCO SODIUM IODIDE I 131
CIS

SODIUM LACTATE
INJECTABLE; INJECTION SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
B BRAUN 1.87GM/100ML HOSPIRA 1.87GM/100ML
6 - 315 (of 360)
N018186 N018249
001
001
SODIUM MONOFLUOROPHOSPHATE
GEL; DENTAL EXTRA-STRENGTH AIM CHESEBROUGH PONDS PASTE; DENTAL EXTRA-STRENGTH AIM CHESEBROUGH PONDS
1.2%
N019518
002
Aug 06, 1986
1.2%
N019518
001
Jun 03, 1987
SODIUM NITROPRUSSIDE
NIPRIDE
ROCHE NITROPRESS ABBOTT ABBVIE HOSPIRA SODIUM NITROPRUSSIDE ABRAXIS PHARM BAXTER HLTHCARE TEVA PARENTERAL
50MG/VIAL 50MG/VIAL 50MG/VIAL 50MG/VIAL 50MG/VIAL 50MG/VIAL 25MG/ML
N017546 A071555 N018450 A070566 A070031 N018581 A073465
001
001 001 001 001 001 001 Nov 16, 1987 Jun 09, 1986 Jan 17, 1985 Jul 28, 1982 Mar 30, 1992
SODIUM PHOSPHATE P-32

PHOSPHOTOPE
BRACCO 1-8mCi/VIAL SODIUM PHOSPHATE P 32
MALLINCKRODT 0.67mCi/ML 1.5mCi/VIAL
N010927 N011777 N011777
001
001
002

POWDER; ORAL, RECTAL SODIUM POLYSTYRENE SULFONATE CITRUSPHRMA 454GM/BOT WOCKHARDT 453.6GM/BOT SUSPENSION; ORAL, RECTAL SODIUM POLYSTYRENE SULFONATE MORTON GROVE 15GM/60ML ROXANE 15GM/60ML
A040909 A088786
001 001
Dec 03, 2008 Sep 11, 1984
A088717 A088453
001 001
Sep 11, 1984 Nov 17, 1983
SODIUM SUCCINATE
SODIUM SUCCINATE
ELKINS SINN
30%
A080516
001
SODIUM TETRADECYL SULFATE

SOTRADECOL
ELKINS SINN
1% **Federal Register determination that product was not discontinued or

reasons**
3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N005970
004
N005970
005

SODIUM THIOSULFATE
INJECTABLE; INJECTION SODIUM THIOSULFATE US ARMY
6 - 316 (of 360)
250MG/ML
N020166
001
Feb 14, 1992
SOMATREM
INJECTABLE; INJECTION PROTROPIN GENENTECH
5MG/VIAL 10MG/VIAL
N019107 N019107
001 002
Oct 17, 1985 Oct 24, 1989
SOMATROPIN
INJECTABLE; INJECTION ASELLACRIN 10 SERONO ASELLACRIN 2 SERONO CRESCORMON GENENTECH
10 IU/VIAL 2 IU/VIAL 4 IU/VIAL
N017726 N017726 N017992
001 002 001 Jul 21, 1983
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION ACCRETROPIN CANGENE BIO-TROPIN FERRING HUMATROPE LILLY NORDITROPIN NOVO NORDISK INC
5MG/ML (5MG/ML) 4.8MG/VIAL 2MG/VIAL 4MG/VIAL 5MG/1.5ML 8MG/VIAL 10MG/1.5ML 15MG/1.5ML 5MG/1.5ML 10MG/1.5ML 15MG/1.5ML 13.5MG/VIAL 18MG/VIAL 22.5MG/VIAL 4MG/VIAL 6MG/VIAL 8.8MG/VIAL 4MG/VIAL 5MG/VIAL 6MG/VIAL
N021538 N019774 N019640 N019721 N021148 N019721 N021148 N021148 N021148 N021148 N021148 N021075 N021075 N021075 N019764 N019764 N020604 N021597 N021597 N021597
001 001 001 001 001 002 002 003 004 005 006 001 002 003 005 001 004 001 002 003
Jan 23, 2008 May 25, 1995 Jun 23, 1987 May Jun May Jun Jun 08, 20, 08, 20, 20, 1995 2000 1995 2000 2000
NORDITROPIN NORDIFLEX NOVO NORDISK INC
Oct 01, 2004 Oct 01, 2004 Oct 01, 2004 Dec 22, 1999 Dec 22, 1999 Dec 22, 1999 Jan 16, 2007 Oct 08, 1996 Sep 06, 2001 Dec 01, 2003 Dec 01, 2003 Dec 01, 2003
NUTROPIN DEPOT GENENTECH
SAIZEN EMD SERONO SEROSTIM EMD SERONO ZORBTIVE EMD SERONO
INJECTABLE; SUBCUTANEOUS SEROSTIM LQ EMD SERONO
6MG/0.5ML (6MG/0.5ML)
N020604
005
Feb 11, 2005
SORBITOL
SOLUTION; IRRIGATION SORBITOL 3% IN PLASTIC CONTAINER BAXTER HLTHCARE 3GM/100ML
N018512
001
May 27, 1982

TABLET; ORAL BETAPACE BAYER HLTHCARE BETAPACE AF BAYER HLTHCARE
6 - 317 (of 360)
N019865 N021151 N021151 N021151 A075515 A076576 A075515 A076576 A075515 A076576 A075515 A075238 A075238 A075238 A075238
004 006 007 005 001 001 004 002 002 003 003 001 002 003 004
Oct 30, 1992 Apr 02, 2003 Apr 02, 2003 Mar 14, 2003 Oct Apr Oct Apr Oct Apr Oct Jul Jul Jul Jul 15, 08, 15, 08, 15, 08, 15, 13, 13, 13, 13, 2001 2004 2001 2004 2001 2004 2001 2000 2000 2000 2000
SOTALOL HYDROCHLORIDE MUTUAL PHARM
WATSON LABS
SOYBEAN OIL
INJECTABLE; INJECTION SOYACAL 10% ALPHA THERA SOYACAL 20% ALPHA THERA TRAVAMULSION 10% BAXTER HLTHCARE TRAVAMULSION 20% BAXTER HLTHCARE
10% 20% 10% 20%
N018465 N018786 N018660 N018758
001 001 001 001
Jun 29, 1983 Jun 29, 1983 Feb 26, 1982 Feb 15, 1983
SPARFLOXACIN
TABLET; ORAL ZAGAM MYLAN
200MG
N020677
001
Dec 19, 1996
SPECTINOMYCIN HYDROCHLORIDE
INJECTABLE; INJECTION TROBICIN PFIZER
EQ 2GM BASE/VIAL EQ 4GM BASE/VIAL
N050347 N050347
001 002
SPIRAPRIL HYDROCHLORIDE
TABLET; ORAL RENORMAX SCHERING
3MG 6MG 12MG 24MG
N020240 N020240 N020240 N020240
001 002 003 004
Dec Dec Dec Dec
29, 29, 29, 29,
1994 1994 1994 1994
SPIRONOLACTONE
TABLET; ORAL SPIRONOLACTONE ASCOT IVAX PHARMS LEDERLE MUTUAL PHARM MYLAN PUREPAC PHARM SUPERPHARM UPSHER SMITH
A087687 A087108 A087634 A087265 A087086 A087998 A088053 A089364 A087554
001 001 001 001 001 001 001 001 001
Oct 20, 1982
Oct 14, 1983 Aug 25, 1983 Nov 07, 1986

SPIRONOLACTONE
TABLET; ORAL SPIRONOLACTONE VANGARD WARNER CHILCOTT WATSON LABS
6 - 318 (of 360)
25MG 25MG 25MG 25MG
A087648 A087952 A086898 A087078
001 001 002 001
Feb 01, 1982 Nov 18, 1982 Mar 02, 1982
STANOZOLOL
TABLET; ORAL WINSTROL LUNDBECK INC
2MG
N012885
001
May 14, 1984
STAVUDINE
CAPSULE; ORAL ZERIT BRISTOL MYERS SQUIBB 5MG CAPSULE, EXTENDED RELEASE; ORAL ZERIT XR BRISTOL MYERS SQUIBB 37.5MG 50MG 75MG 100MG
N020412
001
Jun 24, 1994
N021453 N021453 N021453 N021453
001 002 003 004
Dec Dec Dec Dec
31, 31, 31, 31,
2002 2002 2002 2002
STERILE WATER FOR INJECTION

LIQUID; N/A BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER ABRAXIS PHARM 100% 100% STERILE WATER FOR INJECTION IN PLASTIC CONTAINER B BRAUN 100%
A089099 A089100 N019077
001 001 001
Dec 29, 1987 Dec 29, 1987 Mar 02, 1984
STERILE WATER FOR IRRIGATION

LIQUID; IRRIGATION STERILE WATER IN PLASTIC CONTAINER MILES 100%
N018246
001
INJECTABLE; INJECTION STREPTOMYCIN SULFATE COPANOS LILLY
PFIZER
500MG BASE/ML 1GM BASE/VIAL 1GM BASE/2ML 5GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/2.5ML 5GM BASE/VIAL
A060684 A060107 A060404 A060107 A060076 A060111 A060076
001 001 001 002 001 001 002
SUCCINYLCHOLINE CHLORIDE
INJECTABLE; INJECTION ANECTINE SANDOZ
50MG/ML 500MG/VIAL 1GM/VIAL QUELICIN PRESERVATIVE FREE HOSPIRA 50MG/ML SUCCINYLCHOLINE CHLORIDE INTL MEDICATION 100MG/VIAL ORGANON USA INC 20MG/ML SUCOSTRIN APOTHECON 20MG/ML 100MG/ML
N008453 N008453 N008453 N008845 A085400 A080997 N008847 N008847
003 001 004 002 001 001 001 003 Feb 04, 1982

SUFENTANIL CITRATE
INJECTABLE; INJECTION SUFENTANIL CITRATE WATSON LABS
6 - 319 (of 360)
EQ 0.05MG BASE/ML
A074406
001
Dec 15, 1995
SULFACETAMIDE SODIUM
OINTMENT; OPHTHALMIC BLEPH-10 ALLERGAN 10% SODIUM SULAMYD SCHERING 10% SULFAIR 10 PHARMAFAIR 10% SOLUTION/DROPS; OPHTHALMIC BLEPH-30 ALLERGAN 30% ISOPTO CETAMIDE ALCON 15% OCUSULF-10 MIZA PHARMS USA 10% OCUSULF-30 MIZA PHARMS USA 30% SODIUM SULAMYD SCHERING 10% 30% SODIUM SULFACETAMIDE AKORN 10% 15% 30% SOLA BARNES HIND 10% 10% 30% 30% SULF-10 NOVARTIS 10% SULF-15 NOVARTIS 15% SULFACEL-15 OPTOPICS 15% SULFACETAMIDE SODIUM AKORN 10% 30% ALCON PHARMS LTD 30% PHARMAFAIR 10% SULFAIR 10 PHARMAFAIR 10% SULFAIR FORTE PHARMAFAIR 30% SULFAIR-15 PHARMAFAIR 15% SULTEN-10 BAUSCH AND LOMB 10%
A084015 N005963 A088000
001 002 001 Dec 22, 1982
A080028 A080020 A080660 A080660 N005963 N005963 A083021 A083021 A083021 A084143 A084145 A084146 A084147 A080025 A089047 A080024 A040215 A040216 A089068 A088947 A087949 A088385 A088186 A087818
002 002 001 002 001 003 001 002 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 May May May May 25, 25, 05, 17, 1999 1999 1987 1985 Oct 31, 1995
Dec 13, 1982 Oct 13, 1983 May 25, 1983 Feb 03, 1983
SULFACYTINE
TABLET; ORAL RENOQUID GLENWOOD
250MG
N017569
001
SULFADIAZINE
TABLET; ORAL SULFADIAZINE ABBVIE EVERYLIFE
300MG 500MG
N004125 A080088
005 001

SULFADIAZINE
TABLET; ORAL SULFADIAZINE IMPAX LABS LANNETT LEDERLE LILLY
6 - 320 (of 360)
500MG 500MG 500MG 500MG
A080081 A080084 N004054 N004122
001 001 001 002
SULFADIAZINE SODIUM
INJECTABLE; INJECTION SULFADIAZINE SODIUM LEDERLE
250MG/ML
N004054
002
SULFADIAZINE; SULFAMERAZINE
SUSPENSION; ORAL SULFONAMIDES DUPLEX LILLY
250MG/5ML;250MG/5ML
N006317
007
SULFAMETER
TABLET; ORAL SULLA BAYER HLTHCARE
500MG
N016000
002
SULFAMETHIZOLE
TABLET; ORAL MICROSUL FOREST PHARMS PROKLAR FOREST PHARMS THIOSULFIL WYETH AYERST
1GM 500MG 250MG 500MG
A086012 A080273 N008565 N008565
001 001 001 004
SULFAMETHOXAZOLE
SUSPENSION; ORAL GANTANOL ROCHE TABLET; ORAL GANTANOL ROCHE GANTANOL-DS ROCHE SULFAMETHOXAZOLE ASCOT BARR HEATHER SANDOZ WATSON LABS UROBAK SHIONOGI
500MG/5ML
N013664
002
500MG 1GM 500MG 500MG 500MG 500MG 500MG 1GM 500MG
N012715 N012715 A087662 A087189 A086163 A085844 A085053 A086000 A087307
002 003 001 001 001 001 001 001 001 Oct 20, 1982 Jul 25, 1983
INJECTABLE; INJECTION BACTRIM MUTUAL PHARM 80MG/ML;16MG/ML SEPTRA MONARCH PHARMS 80MG/ML;16MG/ML SULFAMETHOXAZOLE AND TRIMETHOPRIM ABRAXIS PHARM 80MG/ML;16MG/ML BEDFORD 80MG/ML;16MG/ML HIKMA MAPLE 80MG/ML;16MG/ML 80MG/ML;16MG/ML
N018374 N018452 A070223 A072383 A070627 A070628
001 001 001 001 001 001 Dec Apr Dec Dec 29, 29, 29, 29, 1987 1992 1987 1987

INJECTABLE; INJECTION SULFAMETHOXAZOLE AND TRIMETHOPRIM HOSPIRA 80MG/ML;16MG/ML WATSON LABS 80MG/ML;16MG/ML SUSPENSION; ORAL BACTRIM MUTUAL PHARM 200MG/5ML;40MG/5ML BACTRIM PEDIATRIC MUTUAL PHARM 200MG/5ML;40MG/5ML SEPTRA MONARCH PHARMS 200MG/5ML;40MG/5ML SEPTRA GRAPE MONARCH PHARMS 200MG/5ML;40MG/5ML SULFAMETHOXAZOLE AND TRIMETHOPRIM TEVA 200MG/5ML;40MG/5ML 200MG/5ML;40MG/5ML 200MG/5ML;40MG/5ML TEVA PHARMS 200MG/5ML;40MG/5ML SULFATRIM STI PHARMA LLC 200MG/5ML;40MG/5ML SULMEPRIM USL PHARMA 200MG/5ML;40MG/5ML SULMEPRIM PEDIATRIC USL PHARMA 200MG/5ML;40MG/5ML TRIMETH/SULFA ALPHARMA US PHARMS 200MG/5ML;40MG/5ML 200MG/5ML;40MG/5ML NASKA 200MG/5ML;40MG/5ML TABLET; ORAL COTRIM TEVA 400MG;80MG COTRIM D.S. TEVA 800MG;160MG SULFAMETHOXAZOLE AND TRIMETHOPRIM HEATHER 400MG;80MG 800MG;160MG INTERPHARM 400MG;80MG 800MG;160MG MARTEC USA LLC 400MG;80MG MUTUAL PHARM 400MG;80MG 400MG;80MG PLIVA 400MG;80MG 800MG;160MG ROXANE 400MG;80MG SANDOZ 400MG;80MG 400MG;80MG 800MG;160MG TEVA 400MG;80MG 800MG;160MG USL PHARMA 400MG;80MG 800MG;160MG WATSON LABS 400MG;80MG 400MG;80MG 800MG;160MG SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH MARTEC USA LLC 800MG;160MG MUTUAL PHARM 800MG;160MG ROXANE 800MG;160MG WATSON LABS 800MG;160MG SULFATRIM-DS SUPERPHARM 800MG;160MG SULFATRIM-SS SUPERPHARM 400MG;80MG
6 - 321 (of 360)
A073199 A071556
001 001
Sep 11, 1992 Dec 29, 1987
N017560 N017560 N017598 N017598 A070028 N018812 N018812 A077612 N018615 A070063 A070064 A072289 A072398 A072399
001 002 001 002 001 001 002 001 002 001 001 001 001 001 Feb 12, 1986 Jun Jan Jun Nov 02, 28, 10, 13, 1987 1983 1983 2006
Jan 07, 1983 Aug 01, 1986 Aug 01, 1986 May 23, 1988 May 23, 1988 May 23, 1988
A070034 A070048 N018946 N018946 A071299 A071300 A072408 A070006 A071016 A070215 A070216 A072768 A070889 N018598 A070890 N018242 N018242 A070203 A070204 A070002 N018852 A070000 A072417 A070007 A072769 N018854 A070066 A070065
001 001 001 002 001 001 001 001 001 001 001 001 001 003 001 001 002 001 001 001 001 001 001 001 001 001 001 002
May 16, 1985 Mar 18, 1985 Aug Aug Oct Oct Dec Nov Aug Sep Sep Aug Nov May Nov 10, 10, 27, 27, 07, 14, 25, 10, 10, 30, 13, 19, 13, 1984 1984 1987 1987 1988 1984 1986 1985 1985 1991 1986 1982 1986
Nov Nov Nov May Nov Dec Nov Aug May
08, 08, 07, 09, 07, 07, 14, 30, 09,
1985 1985 1984 1983 1984 1988 1984 1991 1983
Jun 24, 1985 Jun 24, 1985

TABLET; ORAL UROPLUS DS SHIONOGI UROPLUS SS SHIONOGI
6 - 322 (of 360)
800MG;160MG 400MG;80MG
A071816 A071815
001 001
Sep 28, 1987 Sep 28, 1987
SULFANILAMIDE
CREAM; VAGINAL SULFANILAMIDE TEVA SUPPOSITORY; VAGINAL AVC MEDA PHARMS
15%
A088718
001
Sep 19, 1985
1.05GM
N006530
004
Jan 27, 1987
SULFAPHENAZOLE
SUSPENSION; ORAL
SULFABID
PHARM RES ASSOC TABLET; ORAL
SULFABID
PURDUE FREDERICK
500MG/5ML
N013093
001
500MG
N013092
002
SULFAPYRIDINE
TABLET; ORAL
SULFAPYRIDINE
LILLY
500MG
N000159
001
SULFASALAZINE
SUSPENSION; ORAL AZULFIDINE PHARMACIA AND UPJOHN 250MG/5ML TABLET; ORAL S.A.S.-500 SOLVAY 500MG SULFASALAZINE HERITAGE PHARMS INC 500MG MUTUAL PHARM 500MG SANDOZ 500MG SUPERPHARM 500MG WATSON LABS 500MG TABLET, DELAYED RELEASE; ORAL SULFASALAZINE WATSON LABS 500MG
N018605
001
A083450 A080197 A089590 A086184 A089339 A084964
001 001 001 001 001 001
Oct 19, 1987 Oct 26, 1987
A088052
001
May 24, 1983
SULFINPYRAZONE
CAPSULE; ORAL ANTURANE NOVARTIS
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 200MG 200MG 200MG 200MG
N011556
004
SULFINPYRAZONE BARR IVAX PHARMS PAR PHARM VANGARD TABLET; ORAL ANTURANE NOVARTIS
A087666 A087770 A088934 A088666
001 001 001 001
Sep Nov Sep Feb
17, 19, 06, 17,
1982 1982 1985 1984
100MG *Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 100MG
N011556
003
SULFINPYRAZONE BARR
A087665
001
Sep 17, 1982

SULFINPYRAZONE
TABLET; ORAL SULFINPYRAZONE IVAX PHARMS PAR PHARM WATSON LABS
6 - 323 (of 360)
100MG 100MG 100MG
A087769 A088933 A087667
001 001 001
Jun 01, 1982 Sep 06, 1985 May 26, 1982
SULFISOXAZOLE
TABLET; ORAL GANTRISIN ROCHE SOSOL MK LABS SOXAZOLE ALRA SULFALAR PARKE DAVIS SULFISOXAZOLE BARR HEATHER IMPAX LABS IVAX SUB TEVA PHARMS LANNETT LEDERLE PHARMERAL PUREPAC PHARM ROXANE SANDOZ VALEANT PHARM INTL VITARINE WATSON LABS WEST WARD SULSOXIN SOLVAY
001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001
SULFISOXAZOLE ACETYL
EMULSION; ORAL LIPO GANTRISIN ROCHE SUSPENSION; ORAL GANTRISIN PEDIATRIC ROCHE SYRUP; ORAL GANTRISIN ROCHE
EQ 1GM BASE/5ML
N009182
009
EQ 500MG BASE/5ML
N009182
004
EQ 500MG BASE/5ML
N009182
002
SULFISOXAZOLE DIOLAMINE
INJECTABLE; INJECTION GANTRISIN ROCHE EQ OINTMENT; OPHTHALMIC GANTRISIN ROCHE EQ SOLUTION/DROPS; OPHTHALMIC GANTRISIN ROCHE EQ SULFISOXAZOLE DIOLAMINE SOLA BARNES HIND EQ
400MG BASE/ML
N006917
001
4% BASE
N008414
002
4% BASE 4% BASE
N007757 A084148
002 001
SULFOXONE SODIUM
TABLET, DELAYED RELEASE; ORAL DIASONE SODIUM ABBVIE 165MG
N006044
003

SULFUR
POWDER; TOPICAL
BENSULFOID
POYTHRESS
6 - 324 (of 360)
33.32%
N002918
001
SULINDAC
TABLET; ORAL
CLINORIL
MERCK SULINDAC
HERITAGE PHARMS INC SANDOZ TEVA
150MG 150MG 200MG 150MG 200MG 150MG 200MG
N017911 A073262 A073262 A072712 A072713 A072972 A072973
001
002 001 001 001 001 001 Sep Sep Aug Aug Feb Feb 06, 06, 30, 30, 28, 28, 1991 1991 1991 1991 1992 1992
SUMATRIPTAN
SPRAY; NASAL IMITREX GLAXOSMITHKLINE
10MG/SPRAY
N020626
002
Aug 26, 1997
INJECTABLE; SUBCUTANEOUS SUMATRIPTAN SUCCINATE TEVA PARENTERAL TABLET; ORAL SUMATRIPTAN SUCCINATE ROXANE
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
A078318 A078318
001 002
Feb 06, 2009 Feb 06, 2009
A078241 A078241 A078241
001 002 003
Aug 10, 2009 Aug 10, 2009 Aug 10, 2009
SUPROFEN
SOLUTION/DROPS; OPHTHALMIC PROFENAL ALCON 1%
N019387
001
Dec 23, 1988
SUTILAINS
OINTMENT; TOPICAL
TRAVASE
ABBOTT
82,000 UNITS/GM **Federal Register determination that product was not

N012828
001
TACRINE HYDROCHLORIDE
CAPSULE; ORAL
COGNEX
SHIONOGI INC
EQ EQ EQ EQ
10MG 20MG 30MG 40MG
BASE BASE BASE BASE
N020070 N020070 N020070 N020070
001 002 003 004
Sep Sep Sep Sep
09, 09, 09, 09,
1993 1993 1993 1993
TALBUTAL
TABLET; ORAL
LOTUSATE
SANOFI AVENTIS US
120MG
N009410
005
TAMOXIFEN CITRATE
TABLET; ORAL
NOLVADEX
ASTRAZENECA
EQ 10MG BASE
N017970
001

TAMOXIFEN CITRATE
TABLET; ORAL NOLVADEX ASTRAZENECA TAMOXIFEN CITRATE AEGIS PHARMS IVAX SUB TEVA PHARMS PHARMACHEMIE ROXANE TEVA
6 - 325 (of 360)
EQ 20MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ 10MG 20MG 10MG 20MG 10MG 10MG 20MG 10MG 20MG BASE BASE BASE BASE BASE BASE BASE BASE BASE
N017970 A076398 A076398 A075740 A075740 A074539 A076027 A076027 A074504 A074504
002 001 002 001 002 001 001 002 001 002
Mar 21, 1994 Mar Mar Feb Feb Mar Feb Feb Apr Apr 31, 31, 20, 20, 31, 20, 20, 28, 28, 2003 2003 2003 2003 2003 2003 2003 2003 2003
TECHNETIUM TC-99M ALBUMIN AGGREGATED

INJECTABLE; INJECTION TC 99M-LUNGAGGREGATE GE HEALTHCARE
5mCi/ML
N017848
001
TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT

INJECTABLE; INJECTION A-N STANNOUS AGGREGATED SYNCOR PHARMS AN-MAA PHARMALUCENCE LUNGAGGREGATE REAGENT GE HEALTHCARE MACROTEC BRACCO TECHNESCAN MAA MALLINCKRODT TECHNETIUM TC 99M MAA GE HEALTHCARE ALBUMIN N/A N/A N/A N/A N/A N/A
N017916 N017792 N017838 N017833 N017842 N017773
001 001 001 001 001 001
TECHNETIUM TC-99M ALBUMIN COLLOID KIT

INJECTABLE; INJECTION MICROLITE PHARMALUCENCE
N/A
N018263
001
Mar 25, 1983
TECHNETIUM TC-99M ALBUMIN KIT

INJECTABLE; INJECTION TECHNETIUM TC 99M HSA GE HEALTHCARE
N/A
N017775
001
TECHNETIUM TC-99M ALBUMIN MICROSPHERES KIT

INJECTABLE; INJECTION INSTANT MICROSPHERES 3M
N/A
N017832
001
TECHNETIUM TC-99M APCITIDE

INJECTABLE; INJECTION ACUTECT CIS BIO INTL SA
N/A
N020887
001
Sep 14, 1998
TECHNETIUM TC-99M DEPREOTIDE

INJECTABLE; INJECTION NEO TECT KIT CIS BIO INTL SA
N/A
N021012
001
Aug 03, 1999

TECHNETIUM TC-99M ETIDRONATE KIT
INJECTABLE; INJECTION CINTICHEM TECHNETIUM 99M HEDSPA GE HEALTHCARE N/A MPI STANNOUS DIPHOSPHONATE GE HEALTHCARE N/A OSTEOSCAN MALLINCKRODT N/A TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT GE HEALTHCARE N/A
6 - 326 (of 360)
N017653 N017667 N017454 N017562
001 001 001 001
TECHNETIUM TC-99M FERPENTETATE KIT

INJECTABLE; INJECTION RENOTEC BRACCO
N/A
N017045
001
TECHNETIUM TC-99M GLUCEPTATE KIT

INJECTABLE; INJECTION GLUCOSCAN BRISTOL MYERS SQUIBB TECHNESCAN GLUCEPTATE DRAXIMAGE
N/A N/A
N017907 N018272
001 001 Jan 27, 1982
TECHNETIUM TC-99M LIDOFENIN KIT

INJECTABLE; INJECTION TECHNESCAN HIDA DRAXIMAGE
N/A
N018489
001
Oct 31, 1986
TECHNETIUM TC-99M MEDRONATE

INJECTABLE; INJECTION DRAXIMAGE MDP-10 JUBILANT DRAXIMAGE
N/A
N018035
001
TECHNETIUM TC-99M MEDRONATE KIT

INJECTABLE; INJECTION AMERSCAN MDP KIT GE HEALTHCARE N/A OSTEOLITE PHARMALUCENCE N/A TECHNETIUM TC 99M MPI MDP GE HEALTHCARE N/A N/A
N018335 N017972 N018141 N018141
001 001 001 002
Aug 05, 1982
Jun 12, 1989
TECHNETIUM TC-99M PENTETATE KIT

INJECTABLE; INJECTION MPI DTPA KIT - CHELATE GE HEALTHCARE N/A TECHNETIUM TC-99M PENTETATE KIT GE HEALTHCARE N/A
N017255 N017264
001 002
TECHNETIUM TC-99M POLYPHOSPHATE KIT

INJECTABLE; INJECTION SODIUM POLYPHOSPHATE-TIN KIT GE HEALTHCARE N/A
N017664
001
TECHNETIUM TC-99M PYRO/TRIMETA PHOSPHATES KIT

INJECTABLE; INJECTION PYROLITE PHARMALUCENCE
N/A
N017684
001

TECHNETIUM TC-99M PYROPHOSPHATE KIT
INJECTABLE; INJECTION PHOSPHOTEC BRACCO
6 - 327 (of 360)
N/A
N017680
001
TECHNETIUM TC-99M RED BLOOD CELL KIT

INJECTABLE; INJECTION RBC-SCAN CADEMA
N/A
N020063
001
Jun 11, 1992

INJECTABLE; INJECTION MIRALUMA LANTHEUS MEDCL
N/A
N019785
003
May 23, 1997
TECHNETIUM TC-99M SODIUM PERTECHNETATE

SOLUTION; INJECTION, ORAL SODIUM PERTECHNETATE TC GE HEALTHCARE MALLINCKRODT PHARMALUCENCE 99M 2-100mCi/ML 10-60mCi/ML 12mCi/ML 24mCi/ML 48mCi/ML
N017471 N017725 N017321 N017321 N017321
001 001 001 002 003
TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

SOLUTION; INJECTION, ORAL MINITEC BRACCO 0.22-2.22 CI/GENERATOR TECHNETIUM TC 99M GENERATOR GE HEALTHCARE 830-16600mCi/GENERATOR
N017339 N017693
001 001
TECHNETIUM TC-99M SULFUR COLLOID

SOLUTION; INJECTION, ORAL TECHNETIUM TC 99M SULFUR COLLOID GE HEALTHCARE 4mCi/ML SOLUTION; ORAL TECHNETIUM TC 99M SULFUR COLLOID MALLINCKRODT 3mCi/ML
N017456
001
N017724
001
TECHNETIUM TC-99M SULFUR COLLOID KIT

SOLUTION; INJECTION, ORAL TECHNECOLL MALLINCKRODT N/A TECHNETIUM TC 99M TSC GE HEALTHCARE N/A TESULOID BRACCO N/A
N017059 N017784 N016923
001 001 001
TECHNETIUM TC-99M TEBOROXIME KIT

INJECTABLE; INJECTION CARDIOTEC BRACCO
N/A
N019928
001
Dec 19, 1990
TEGASEROD MALEATE
TABLET; ORAL ZELNORM NOVARTIS
N021200 N021200
001 002
Jul 24, 2002 Jul 24, 2002
TELBIVUDINE
SOLUTION; ORAL TYZEKA NOVARTIS
100MG/5ML
N022154
001
Apr 28, 2009

TEMAZEPAM
CAPSULE; ORAL TEMAZ QUANTUM PHARMICS TEMAZEPAM DURAMED PHARMS BARR MUTUAL PHARM USL PHARMA WATSON LABS
6 - 328 (of 360)
A070564 A070547 A071708 A071709 A071174 A071175 A070489 A070490 A070383 A070384
001 001 001 001 001 001 001 001 001 001
Oct 15, 1985 Oct 15, 1985 Sep Sep Jul Jul Jul Jul Mar Mar 29, 29, 10, 10, 07, 07, 23, 23, 1988 1988 1986 1986 1986 1986 1987 1987
CAPSULE; ORAL TERAZOSIN HYDROCHLORIDE MYLAN TECHNOLOGIES EQ EQ EQ EQ RANBAXY LABS LTD EQ EQ EQ EQ SANDOZ EQ EQ EQ EQ TABLET; ORAL TERAZOSIN HYDROCHLORIDE IVAX SUB TEVA PHARMS EQ EQ EQ EQ EQ SANDOZ EQ EQ EQ EQ EQ EQ EQ TEVA EQ EQ EQ EQ
A075384 A075384 A075384 A075384 A076021 A076021 A076021 A076021 A075667 A075667 A075667 A075667
001 002 003 004 001 002 003 004 001 002 003 004
Dec Dec Dec Dec Aug Aug Aug Aug Jul Jul Jul Jul
01, 01, 01, 01, 22, 22, 22, 22, 28, 28, 28, 28,
2000 2000 2000 2000 2002 2002 2002 2002 2000 2000 2000 2000
1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 1MG BASE 2MG BASE 2MG BASE 5MG BASE 5MG BASE 10MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE
001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004
Apr Apr Apr Apr Dec Apr Dec Apr Dec Apr Dec Apr May May May May
21, 21, 21, 21, 31, 28, 31, 28, 31, 28, 31, 28, 18, 18, 18, 18,
2000 2000 2000 2000 1998 2000 1998 2000 1998 2000 1998 2000 2000 2000 2000 2000
TERBINAFINE
GEL; TOPICAL LAMISIL NOVARTIS
1%
N020846
001
Apr 29, 1998
CREAM; TOPICAL LAMISIL NOVARTIS SOLUTION; TOPICAL LAMISIL NOVARTIS
1%
N020192
001
Dec 30, 1992
1%
N020749
001
Oct 17, 1997

TABLET; ORAL TERBINAFINE HYDROCHLORIDE GEDEON RICHTER USA EQ 250MG BASE ROXANE EQ 250MG BASE
6 - 329 (of 360)
A077065 A077223
001 001
Jul 02, 2007 Jul 02, 2007
TERBUTALINE SULFATE
AEROSOL, METERED; INHALATION BRETHAIRE NOVARTIS 0.2MG/INH BRICANYL SANOFI AVENTIS US 0.2MG/INH INJECTABLE; INJECTION BRETHINE AAIPHARMA LLC 1MG/ML BRICANYL SANOFI AVENTIS US 1MG/ML TERBUTALINE SULFATE TEVA PARENTERAL 1MG/ML TABLET; ORAL BRETHINE LEHIGH VALLEY 2.5MG 5MG BRICANYL SANOFI AVENTIS US 2.5MG 5MG
N018762 N018000
001 001
Aug 17, 1984 Mar 19, 1985
N018571 N017466 A076853
001 001 001 Jul 20, 2004
N017849 N017849 N017618 N017618
001 002 001 002
TERIPARATIDE ACETATE
INJECTABLE; INJECTION PARATHAR SANOFI AVENTIS US
200 UNITS/VIAL
N019498
001
Dec 23, 1987
TERIPARATIDE RECOMBINANT HUMAN

INJECTABLE; SUBCUTANEOUS FORTEO LILLY
0.75MG/3ML (0.25MG/ML)
N021318
001
Nov 26, 2002
TESAMORELIN ACETATE
POWDER; SUBCUTANEOUS EGRIFTA EMD SERONO
EQ 1MG BASE/VIAL
N022505
001
Nov 10, 2010
TESTOLACTONE
INJECTABLE; INJECTION TESLAC BRISTOL MYERS SQUIBB TABLET; ORAL TESLAC BRISTOL MYERS SQUIBB
100MG/ML
N016119
001
50MG 250MG
N016118 N016118
001 002
TESTOSTERONE
FILM, EXTENDED RELEASE; TRANSDERMAL ANDRODERM WATSON LABS 2.5MG/24HR 5MG/24HR TESTODERM ALZA 4MG/24HR 6MG/24HR TESTODERM TTS ALZA 5MG/24HR
N020489 N020489 N019762 N019762 N020791
001 002 001 002 001
Sep 29, 1995 May 02, 1997 Oct 12, 1993 Oct 12, 1993 Dec 18, 1997

TESTOSTERONE
GEL; TRANSDERMAL TESTOSTERONE PAR PHARM WATSON LABS INJECTABLE; INJECTION TESTOSTERONE WATSON LABS
6 - 330 (of 360)
1% 1% 1% 1%
(2.5GM/PACKET) (5GM/PACKET) (2.5GM/PACKET) (5GM/PACKET)
A076744 A076744 A076737 A076737
001 002 001 002
May May Jan Jan
23, 23, 27, 27,
2007 2007 2006 2006
A086420 A086419 A086417
001 001 001
May 10, 1983 Aug 23, 1983 Jul 07, 1983
TESTOSTERONE CYPIONATE
INJECTABLE; INJECTION DEPO-TESTOSTERONE PHARMACIA AND UPJOHN TESTOSTERONE CYPIONATE WATSON LABS
A085635 A084401 A086029 A084401
001 001 001 002
TESTOSTERONE ENANTHATE
INJECTABLE; INJECTION DELATESTRYL ENDO PHARM TESTOSTERONE ENANTHATE WATSON LABS
N009165 A083667 A085599 A083667
001 001 001 002
TESTOSTERONE PROPIONATE
INJECTABLE; INJECTION TESTOSTERONE PROPIONATE BEL MAR 25MG/ML 50MG/ML 100MG/ML ELKINS SINN 25MG/ML LILLY 50MG/ML WATSON LABS 25MG/ML 25MG/ML 50MG/ML 50MG/ML 100MG/ML 100MG/ML
A080741 A080742 A080743 A080276 A080254 A080188 A085490 A080188 A085490 A080188 A083595
001 001 001 001 002 001 001 002 002 003 003
CAPSULE; ORAL ACHROMYCIN V HERITAGE PHARMS INC BRISTACYCLINE BRISTOL
N050278 N050278 A061658 A061888 A061658 A061888 A061725 A062175 A062332 A061725 A062332
003 001 001 001 002 002 001 001 001 002 002
CYCLOPAR WARNER CHILCOTT

CAPSULE; ORAL PANMYCIN PHARMACIA AND UPJOHN RETET SOLVAY ROBITET WYETH AYERST SUMYCIN APOTHECON
6 - 331 (of 360)
A060347 A061443 A061443 A061734 A061734 A060429 A060429 A060429 A060429 A060343 A060343 A061802 A061802 A060059 A060173 A060173 A061148 A061148 A062752 A062752 A062085 A060736 A060736 A060783 A060783 A060290 A060290 A062686 A062686 A061214 A061471 A062540 A062540 A060471 A060471 A062300 A062300 A062103 A062343 A062103 A062343 A060768 A060768 A061685 A061685 A060082 A060082
001 001 002 001 002 002 004 001 003 001 003 001 002 001 001 002 001 002 001 002 001 001 002 001 002 001 002 001 002 002 001 001 002 001 002 001 002 001 001 002 002 001 002 001 002 003 004
250MG 500MG TETRACYCLINE HYDROCHLORIDE ABBOTT 250MG 500MG ELKINS SINN 250MG FERRANTE 125MG 250MG HEATHER 250MG 500MG LABS ATRAL 250MG 500MG MAST MM 250MG MUTUAL PHARM 250MG 500MG MYLAN 250MG 500MG PUREPAC PHARM 250MG 500MG PVT FORM 250MG 500MG ROXANE 500MG SANDOZ 250MG SUPERPHARM 250MG 500MG VALEANT PHARM INTL 250MG 500MG WARNER CHILCOTT 250MG 500MG WATSON LABS 250MG 250MG 500MG 500MG WEST WARD 250MG 500MG WYETH AYERST 250MG 500MG TETRACYN PFIPHARMECS 250MG 500MG FIBER, EXTENDED RELEASE; PERIODONTAL ACTISITE SCHIFF AND CO 12.7MG/FIBER FOR SOLUTION; TOPICAL TOPICYCLINE SHIRE 2.2MG/ML
TETRACHEL ANGUS
Aug 12, 1988 Aug 12, 1988
Jul 24, 1986 Jul 24, 1986
Mar 21, 1985 Mar 21, 1985
N050653
001
Mar 25, 1994
N050493
001

INJECTABLE; INJECTION ACHROMYCIN LEDERLE TETRACYN PFIZER
6 - 332 (of 360)
N050273 N050273 A060096 A060096
002 003 001 002
OINTMENT; OPHTHALMIC ACHROMYCIN STORZ 10MG/GM SUSPENSION; ORAL ACHROMYCIN V LEDERLE 125MG/5ML SUMYCIN PAR PHARM 125MG/5ML TETRACYCLINE HYDROCHLORIDE ALPHARMA US PHARMS 125MG/5ML FERRANTE 125MG/5ML PROTER 125MG/5ML PUREPAC PHARM 125MG/5ML TETRACYN PFIPHARMECS 125MG/5ML TETRAMED IVAX SUB TEVA PHARMS 125MG/5ML SUSPENSION/DROPS; OPHTHALMIC ACHROMYCIN STORZ 1% TABLET; ORAL PANMYCIN PHARMACIA AND UPJOHN 250MG 500MG SUMYCIN PAR PHARM 50MG 100MG 250MG 500MG
N050266
001
N050263 A060400 A060633 A060174 A060446 A060291 A060095 A061468
002 001 001 001 001 001 001 001
N050268
001
A061705 A061705 A061147 A061147 A061147 A061147
001 002 003 002 001 004
TETRACYCLINE PHOSPHATE COMPLEX

CAPSULE; ORAL TETREX BRISTOL
100MG 250MG 250MG 250MG 500MG 500MG 500MG
HCL HCL HCL HCL HCL HCL HCL
A061653 A061653 A061889 N050212 A061653 A061889 N050212
001 002 002 002 003 001 003
THALLOUS CHLORIDE TL-201

INJECTABLE; INJECTION THALLOUS CHLORIDE TL 201 BRACCO 1mCi/ML TRACE LIFE 1mCi/ML
N018548 A075569
001 001
Dec 30, 1982 Nov 21, 2001
THEOPHYLLINE
CAPSULE; ORAL BRONKODYL SANOFI AVENTIS US ELIXOPHYLLIN FOREST LABS
100MG 200MG 100MG 200MG
A085264 A085264 A085545 A083921
001 002 001 001 Jul 31, 1984 Jul 31, 1984

THEOPHYLLINE
CAPSULE; ORAL SOMOPHYLLIN-T FISONS
6 - 333 (of 360)
100MG 200MG 250MG
A087155 A087155 A087155 A085263 A085263 A084731 A084731 A084731
001 002 003 001 002 002 001 003
Feb 25, 1985 Feb 25, 1985 Feb 25, 1985
100MG 200MG SCHERER RP 100MG 200MG 250MG CAPSULE, EXTENDED RELEASE; ORAL AEROLATE III FLEMING PHARMS 65MG AEROLATE JR FLEMING PHARMS 130MG AEROLATE SR FLEMING PHARMS 260MG ELIXOPHYLLIN SR FOREST LABS 125MG 250MG SLO-BID SANOFI AVENTIS US 50MG 75MG 100MG 125MG 200MG 300MG SLO-PHYLLIN SANOFI AVENTIS US 60MG 125MG 250MG SOMOPHYLLIN-CRT GRAHAM DM 50MG 100MG 200MG 250MG 300MG THEOBID WHITBY 260MG THEOBID JR. WHITBY 130MG THEOCLEAR L.A.-130 SCHWARZ PHARMA 130MG THEOCLEAR L.A.-260 SCHWARZ PHARMA 260MG THEO-DUR SCHERING 50MG 75MG 125MG 200MG THEOPHYLLINE CENT PHARMS 125MG 250MG HOSPIRA 100MG 200MG 300MG INWOOD LABS 100MG 125MG 200MG 300MG SANDOZ 260MG
THEOPHYLLINE KV PHARM
Nov 07, 1986 Nov 07, 1986 Nov 07, 1986
A085075 A085075 A085075 A086826 A086826 A088269 A089539 A087892 A089540 A087893 A087894 A085206 A085203 A085205 A087763 A087194 A088382 A087193 A088383 A085983 A087854 A086569 A086569 A088022 A088015 A088016 A087995 A088654 A088689 A089976 A089977 A089932 A040052 A040052 A040052 A040052 A087462
003 002 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 002 003 004 001
Nov 24, 1986 Nov 24, 1986 Nov 24, 1986 Jan 29, 1985 Jan 29, 1985 Jan May Jan May Jan Jan 31, 10, 31, 10, 31, 31, 1985 1989 1985 1989 1985 1985
May 24, 1982 May 24, 1982 May 24, 1982 Feb 27, 1985 Feb 27, 1985 Feb 27, 1985 Mar 20, 1985 Mar 20, 1985 May 27, 1982 May 27, 1982 Sep Sep Sep Sep Feb Feb Jan Jan Jan Feb Feb Feb Feb May 10, 10, 10, 10, 12, 12, 04, 04, 04, 14, 14, 14, 14, 11, 1985 1985 1985 1985 1985 1985 1995 1995 1995 1994 1994 1994 1994 1982

THEOPHYLLINE
CAPSULE, EXTENDED RELEASE; ORAL THEOPHYLLINE-SR SCHERER RP 300MG THEOPHYL-SR ORTHO MCNEIL PHARM 125MG 250MG THEOVENT SCHERING 125MG 250MG ELIXIR; ORAL ELIXOMIN CENCI 80MG/15ML LANOPHYLLIN LANNETT 80MG/15ML THEOLIXIR PANRAY 80MG/15ML THEOPHYL-225 ORTHO MCNEIL PHARM 112.5MG/15ML THEOPHYLLINE ALPHARMA US PHARMS 80MG/15ML CENCI 80MG/15ML HALSEY 80MG/15ML PERRIGO 80MG/15ML PHARM ASSOC 80MG/15ML PRECISION DOSE 80MG/15ML ROXANE 80MG/15ML TARO 80MG/15ML WOCKHARDT 80MG/15ML INJECTABLE; INJECTION THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 40MG/100ML THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 80MG/100ML THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 160MG/100ML THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 200MG/100ML 200MG/100ML THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 4MG/ML 400MG/100ML 400MG/100ML THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 4MG/ML 40MG/100ML 80MG/100ML 160MG/100ML 200MG/100ML 320MG/100ML 400MG/100ML THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA INC 80MG/100ML 200MG/100ML 400MG/100ML SOLUTION; ORAL AEROLATE FLEMING PHARMS 150MG/15ML THEOLAIR 3M 80MG/15ML THEOPHYLLINE ROXANE 80MG/15ML
6 - 334 (of 360)
A088255 A086480 A086471 A087010 A087910
001 001 001 001 001
Jun 12, 1986 Feb 08, 1985 Feb 08, 1985 Jan 31, 1985 Jan 31, 1985
A088303 A084578 A084559 A086485 A089223 A087679 A085169 A085952 A086720 A085863 A084739 A089626 A086748
001 001 001 001 001 001 001 001 001 001 001 001 001
Jan 25, 1984
May 27, 1988 Apr 15, 1982
Oct 28, 1988
N019083 N019083 N019083 N019212 N019826 N019212 N019212 N019826 N018649 N018649 N018649 N018649 N018649 N018649 N018649 N019211 N019211 N019211
001 002 003 001 004 003 002 005 007 001 002 003 004 006 005 002 004 005
Nov 07, 1984 Nov 07, 1984 Nov 07, 1984 Nov 07, 1984 Aug 14, 1992 Nov 07, 1984 Nov 07, 1984 Aug 14, 1992 Jul Jul Jul Jul Jul Nov Jul 26, 26, 26, 26, 26, 13, 26, 1982 1982 1982 1982 1982 1985 1982
Dec 14, 1984 Dec 14, 1984 Dec 14, 1984
A089141 A086107 A087449
001 001 001
Dec 03, 1986
Sep 15, 1983

THEOPHYLLINE
SUSPENSION; ORAL ELIXICON FOREST LABS SYRUP; ORAL ACCURBRON SANOFI AVENTIS US AQUAPHYLLIN FERNDALE LABS SLO-PHYLLIN SANOFI AVENTIS US THEOCLEAR-80 CENT PHARMS THEOPHYLLINE ALPHARMA US PHARMS TABLET; ORAL QUIBRON-T MONARCH PHARMS SLO-PHYLLIN SANOFI AVENTIS US THEOCLEAR-100 CENT PHARMS THEOCLEAR-200 CENT PHARMS THEOPHYL-225 ORTHO MCNEIL PHARM TABLET, CHEWABLE; ORAL THEOPHYL ORTHO MCNEIL PHARM TABLET, EXTENDED RELEASE; DURAPHYL FOREST LABS
6 - 335 (of 360)
100MG/5ML
A085502
001
A088746 A087917 A085187 A087095 A086001 A086545
001 001 001 001 001 001
Nov 22, 1985 Jan 18, 1983
Mar 01, 1982
300MG 100MG 200MG 100MG 200MG 225MG
A088656 A085202 A085204 A085353 A085353 A084726
001 001 001 002 001 001
Aug 22, 1985
100MG ORAL 100MG 200MG 300MG 250MG 300MG 100MG 300MG 100MG 200MG 300MG 450MG 200MG 250MG 300MG 500MG 300MG 400MG 450MG 600MG 450MG 200MG 400MG 600MG
A086506
001
Sep 12, 1985
001 001 001 001 001 001 002 001 001 002 001 001 002 001 001 001 001 001 001 001 001 001 001
Apr 03, 1985 Apr 03, 1985 Apr 03, 1985
LABID WARNER CHILCOTT QUIBRON-T/SR MONARCH PHARMS SUSTAIRE ROERIG THEO-DUR SCHERING
Jun 21, 1983
Jun 25, 1986 Jul Jul Jul Jul Apr Apr Apr Apr Apr 16, 16, 16, 16, 30, 27, 30, 27, 28, 1987 1987 1987 1987 2004 2004 2004 2004 1995
THEOLAIR-SR 3M
THEOPHYLLINE ABLE
INWOOD LABS T-PHYL PHARM RES ASSOC UNI-DUR SCHERING
Aug 17, 1983 Jan 04, 1995 Jan 04, 1995

THEOPHYLLINE
TABLET, EXTENDED RELEASE; ORAL UNIPHYL RHODES PHARMS 400MG 600MG
6 - 336 (of 360)
A087571 A040086
001 001
Sep 01, 1982 Apr 15, 1996
THEOPHYLLINE SODIUM GLYCINATE

ELIXIR; ORAL SYNOPHYLATE CENT PHARMS TABLET; ORAL ASBRON NOVARTIS
EQ 165MG BASE/15ML
N006333
008
EQ 150MG BASE
A085148
001
THIABENDAZOLE
SUSPENSION; ORAL MINTEZOL MERCK TABLET, CHEWABLE; ORAL MINTEZOL MERCK
500MG/5ML
N016097
001
500MG
N016096
001
THIAMINE HYDROCHLORIDE
INJECTABLE; INJECTION BETALIN S LILLY THIAMINE HYDROCHLORIDE ABRAXIS PHARM AKORN BEL MAR DELL LABS HIKMA MAPLE HOSPIRA LUITPOLD PARKE DAVIS WATSON LABS WYETH AYERST
100MG/ML 100MG/ML 100MG/ML 100MG/ML 200MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 200MG/ML 100MG/ML
A080853 A080509 A087968 A080718 A080712 A083775 A080575 A040079 A080667 A080770 A083534 A083534 A080553
001 001 001 001 001 001 001 001 001 001 001 002 001
Oct 01, 1982
May 03, 1996
THIAMYLAL SODIUM
INJECTABLE; INJECTION SURITAL PARKEDALE
1GM/VIAL 5GM/VIAL 10GM/VIAL
N007600 N007600 N007600
003 005 009
THIETHYLPERAZINE MALATE
INJECTABLE; INJECTION TORECAN NOVARTIS
5MG/ML
N012754
002
THIETHYLPERAZINE MALEATE
SUPPOSITORY; RECTAL
TORECAN
NOVARTIS TABLET; ORAL
TORECAN
NOVARTIS
10MG
N013247
001
10MG
N012753
001

THIOPENTAL SODIUM
SUSPENSION; RECTAL PENTOTHAL ABBOTT
6 - 337 (of 360)
400MG/GM
N011679
001
THIORIDAZINE
SUSPENSION; ORAL MELLARIL-S NOVARTIS
EQ 25MG HCL/5ML EQ 100MG HCL/5ML
N017923 N017923
001 002
CONCENTRATE; ORAL MELLARIL NOVARTIS
30MG/ML 100MG/ML THIORIDAZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 100MG/ML ALPHARMA US PHARMS 30MG/ML HI TECH PHARMA 30MG/ML 100MG/ML PHARM ASSOC 30MG/ML 100MG/ML SANDOZ 30MG/ML 100MG/ML TEVA PHARMS 30MG/ML 100MG/ML WOCKHARDT 30MG/ML 100MG/ML THIORIDAZINE HYDROCHLORIDE INTENSOL ROXANE 30MG/ML 100MG/ML TABLET; ORAL MELLARIL NOVARTIS 10MG 15MG 25MG 50MG 100MG 150MG 200MG THIORIDAZINE HYDROCHLORIDE IVAX PHARMS 10MG 15MG 25MG 50MG 100MG MUTUAL PHARM 10MG 15MG 25MG 50MG 100MG 150MG 200MG MYLAN 10MG 25MG 50MG 100MG PAR PHARM 10MG 15MG 25MG 50MG 100MG
012 018 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Aug Apr Aug Aug Aug May Nov Nov Nov Nov Jul Jul 23, 26, 16, 16, 28, 29, 23, 23, 09, 09, 25, 05, 1983 1983 1996 1996 1997 1998 1983 1983 1987 1987 1983 1983
Dec 16, 1985 Dec 16, 1985
N011808 N011808 N011808 N011808 N011808 N011808 N011808 A088270 A088271 A088272 A088194 A088273 A088375 A088461 A087264 A088370 A088379 A088737 A088738 A088332 A088333 A088334 A088335 A088351 A088352 A088336 A088322 A088480
003 016 006 011 009 017 015 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Apr Apr Apr Apr Oct Nov Nov Nov Nov Nov Sep Oct Jun Jun Jun Nov Dec Dec Dec Dec Dec 14, 14, 14, 14, 03, 18, 18, 18, 18, 16, 26, 16, 27, 27, 27, 18, 05, 05, 05, 05, 29, 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1984 1984 1983 1983 1983 1983 1983 1983 1983 1983 1983

TABLET; ORAL THIORIDAZINE HYDROCHLORIDE PAR PHARM 150MG 200MG ROXANE 10MG 25MG 50MG 100MG SANDOZ 10MG 15MG 25MG 50MG 100MG 150MG 200MG SUPERPHARM 10MG 25MG 50MG TEVA 10MG 100MG WATSON LABS 10MG 10MG 10MG 15MG 15MG 15MG 25MG 25MG 25MG 25MG 50MG 50MG 50MG 100MG 100MG 100MG 150MG 150MG 200MG 200MG WEST WARD 10MG 15MG 25MG 50MG
6 - 338 (of 360)
A089764 A089765 A088663 A088664 A088665 A089048 A088131 A088132 A088133 A088134 A088135 A088136 A088137 A089103 A089104 A089105 A088493 A088456 A088412 A088476 A088561 A088345 A088477 A088562 A088296 A088478 A088567 A088755 A088323 A088479 A088563 A088284 A088564 A088736 A088410 A088869 A088381 A088872 A088658 A088659 A088660 A088661
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Feb Feb Mar Mar Mar Feb Aug Aug Aug Aug Nov Sep Sep Jul Jul Jul May May Sep Nov May Jul Nov May Jul Nov May Jul Jul Nov May Aug May Jul Mar Jun Mar Apr Mar Mar Mar Mar
09, 09, 15, 15, 15, 26, 30, 30, 30, 30, 20, 17, 17, 02, 02, 02, 17, 17, 12, 08, 11, 28, 08, 11, 28, 08, 11, 24, 28, 08, 11, 25, 11, 24, 05, 28, 14, 26, 26, 26, 26, 26,
1988 1988 1984 1984 1984 1985 1983 1983 1983 1983 1984 1986 1986 1985 1985 1985 1985 1985 1983 1983 1984 1983 1983 1984 1983 1983 1984 1984 1983 1983 1984 1983 1984 1984 1984 1985 1984 1985 1984 1984 1984 1984
THIOTEPA
INJECTABLE; INJECTION THIOPLEX IMMUNEX THIOTEPA FRESENIUS KABI USA IMMUNEX TEVA PARENTERAL
N020058 A075698 N011683 A075730 A075730
001 001 001 001 002
Dec 22, 1994 Sep 20, 2001 Apr 20, 2001 Apr 20, 2001
THIOTHIXENE
CAPSULE; ORAL NAVANE PFIZER THIOTHIXENE AM THERAP
20MG 1MG 2MG
N016584 A071884 A071885
005 001 001 Aug 12, 1987 Aug 12, 1987

THIOTHIXENE
CAPSULE; ORAL THIOTHIXENE AM THERAP
6 - 339 (of 360)
WATSON LABS
A071886 A071887 A072200 A070600 A071626 A071627 A070603 A071628
001 001 001 001 001 001 001 001
Aug Aug Dec Jun Jun Jun Jun Jun
12, 12, 17, 05, 25, 25, 05, 25,
1987 1987 1987 1987 1987 1987 1987 1987
THIOTHIXENE HYDROCHLORIDE
CONCENTRATE; ORAL NAVANE PFIZER EQ 5MG BASE/ML THIOTHIXENE HYDROCHLORIDE ALPHARMA US PHARMS EQ 5MG BASE/ML PACO EQ 1MG BASE/ML EQ 5MG BASE/ML TEVA EQ 5MG BASE/ML TEVA PHARMS EQ 5MG BASE/ML THIOTHIXENE HYDROCHLORIDE INTENSOL ROXANE EQ 5MG BASE/ML INJECTABLE; INJECTION NAVANE PFIZER EQ 2MG BASE/ML EQ 10MG BASE/VIAL
N016758 A070969 A071917 A071939 A071184 A071554 A073494
001 001 001 001 001 001 001 Oct Sep Dec Jun Oct 16, 20, 16, 22, 16, 1987 1989 1988 1987 1987
Jun 30, 1992
N016904 N016904
001 002
THYROGLOBULIN
TABLET; ORAL PROLOID PARKE DAVIS
16MG 32MG 65MG 100MG 130MG 200MG 325MG 64.8MG
N002245 N002245 N002245 N002245 N002245 N002245 N002245 A080151
009 005 002 008 010 007 004 001
THYROGLOBULIN IMPAX LABS
THYROTROPIN
INJECTABLE; INJECTION THYTROPAR SANOFI AVENTIS US
10 IU/VIAL
N008682
001
TABLET; ORAL GABITRIL CEPHALON
6MG 8MG 10MG 20MG
N020646 N020646 N020646 N020646
006 007 008 004
Nov Nov Nov Sep
29, 29, 29, 30,
2005 2005 2005 1997
TICARCILLIN DISODIUM
INJECTABLE; INJECTION TICAR GLAXOSMITHKLINE
EQ EQ EQ EQ EQ
1GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 6GM BASE/VIAL 20GM BASE/VIAL
N050497 A062690 N050497 N050497 N050497
001 001 002 003 004
Dec 19, 1986

TICARCILLIN DISODIUM
INJECTABLE; INJECTION TICAR GLAXOSMITHKLINE
6 - 340 (of 360)
EQ 30GM BASE/VIAL
N050497
005
Apr 04, 1984
TICLOPIDINE HYDROCHLORIDE
TABLET; ORAL TICLID ROCHE PALO
125MG 250MG TICLOPIDINE HYDROCHLORIDE ACTAVIS ELIZABETH 250MG MYLAN 250MG SANDOZ 250MG 250MG WATSON LABS 250MG
N019979 N019979 A075253 A075316 A075318 A075326 A075309
001 002 001 001 001 001 001
Mar 24, 1993 Oct 31, 1991 Aug Nov Aug Aug Apr 20, 02, 20, 20, 26, 1999 1999 1999 1999 2000
TIMOLOL MALEATE
SOLUTION/DROPS; OPHTHALMIC TIMOLOL MALEATE AKORN EQ 0.25% BASE FOUGERA EQ 0.25% BASE EQ 0.5% BASE TABLET; ORAL BLOCADREN MERCK 5MG 10MG 20MG TIMOLOL MALEATE QUANTUM PHARMICS 5MG 10MG 20MG SANDOZ 5MG 10MG 20MG TEVA 5MG 10MG 20MG USL PHARMA 5MG 10MG 20MG WATSON LABS 5MG 5MG 10MG 10MG 20MG 20MG
A074465 A074667 A074668
001 001 001
Mar 25, 1997 Mar 25, 1997 Mar 25, 1997
N018017 N018017 N018017 A072466 A072467 A072468 A072550 A072551 A072552 A072648 A072649 A072650 A072001 A072002 A072003 A072269 A072917 A072270 A072918 A072271 A072919
001 002 004 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 May May May Apr Apr Apr Jun Jun Jun Apr Apr Apr Apr Jul Apr Jul Apr Jul 19, 19, 19, 13, 13, 13, 16, 16, 16, 11, 11, 11, 11, 31, 11, 31, 11, 31, 1989 1989 1989 1989 1989 1989 1993 1993 1993 1989 1989 1989 1989 1991 1989 1991 1989 1991
TINZAPARIN SODIUM
INJECTABLE; INJECTION INNOHEP LEO PHARMA AS
20,000 IU/ML
N020484
001
Jul 14, 2000
TIOCONAZOLE
CREAM; TOPICAL TZ-3 PFIZER
1%
N018682
001
Feb 18, 1983
TIROFIBAN HYDROCHLORIDE
AGGRASTAT
MEDICURE
EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML) N020912 EQ 25MG BASE/500ML (EQ 0.05MG BASE/ML) N020913
001 001
May 14, 1998 May 14, 1998

TABLET; ORAL TIZANIDINE HYDROCHLORIDE ACTAVIS ELIZABETH EQ EQ EQ BARR EQ IVAX SUB TEVA PHARMS EQ EQ ZANAFLEX ACORDA EQ
6 - 341 (of 360)
A076283 A076283 A076371 A076371 A076321 A076321 N020397
001 002 001 002 001 002 002
Jul Jul Apr Apr Sep Sep
12, 12, 09, 09, 30, 30,
2002 2002 2003 2003 2004 2004
2MG BASE
Feb 04, 2000
TOBRAMYCIN
SOLUTION/DROPS; OPHTHALMIC TOBRAMYCIN ALCON PHARMS LTD 0.3%
A063176
001
May 25, 1994
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION NEBCIN LILLY
10MG BASE/ML 10MG BASE/ML 10MG BASE/ML 40MG BASE/ML 1.2GM BASE/VIAL 10MG 40MG 40MG 10MG 40MG 40MG 40MG 10MG 10MG 40MG 40MG 10MG 40MG 40MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A062008 A062707 N050477 A062008 N050519 A064021 A064021 A064026 A063119 A063120 A063121 A063122 A063113 A063128 A063118 A063127 A063080 A063161 A062945
004 001 005 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 002
Apr 29, 1987
TOBRAMYCIN SULFATE APOTHECON
ASTRAZENECA
HIKMA MAPLE
HOSPIRA MARSAM PHARMS LLC
May May May Oct Oct Oct Oct Apr Nov Jul Nov Apr May Aug
31, 31, 31, 31, 31, 31, 31, 26, 27, 29, 27, 30, 29, 09,
1994 1994 1994 1994 1994 1994 1994 1991 1991 1991 1991 1991 1991 1989
TOCAINIDE HYDROCHLORIDE
TABLET; ORAL TONOCARD ASTRAZENECA
400MG 600MG
N018257 N018257
001 002
Nov 09, 1984 Nov 09, 1984
TOLAZAMIDE
TABLET; ORAL TOLAZAMIDE BARR
DURAMED PHARMS BARR
INTERPHARM IVAX SUB TEVA PHARMS
MUTUAL PHARM
A070162 A070163 A070164 A070165 A070166 A070167 A071270 A071271 N018894 N018894 N018894 A071357 A071358
001 001 001 001 001 001 001 001 001 002 003 001 001
Jan Jan Jan Jan Jan Jan Sep Sep Nov Nov Nov Jul Jul
14, 14, 14, 10, 10, 10, 23, 23, 02, 02, 02, 16, 16,
1986 1986 1986 1986 1986 1986 1986 1986 1984 1984 1984 1987 1987

TOLAZAMIDE
TABLET; ORAL TOLAZAMIDE MUTUAL PHARM PAR PHARM
6 - 342 (of 360)
SANDOZ
SUPERPHARM USL PHARMA
WATSON LABS
500MG 100MG 250MG 500MG 100MG 250MG 500MG 250MG 500MG 100MG 250MG 500MG 100MG 100MG 250MG 500MG 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** 250MG 500MG
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Jul Jan Jan Jan Dec Mar Mar Jun Jun Jan Apr Apr Aug Jan Aug Aug
16, 06, 06, 06, 09, 13, 13, 16, 16, 11, 02, 02, 01, 09, 01, 01,
1987 1986 1986 1986 1987 1986 1986 1986 1986 1988 1986 1986 1986 1986 1986 1986
TOLINASE PHARMACIA AND UPJOHN
N015500 N015500
004 005
TOLAZOLINE HYDROCHLORIDE
INJECTABLE; INJECTION PRISCOLINE NOVARTIS
25MG/ML
N006403
005
Feb 22, 1985
TOLBUTAMIDE
TABLET; ORAL ORINASE PHARMACIA AND UPJOHN TOLBUTAMIDE ALRA ASCOT BARR CLONMEL HLTHCARE IVAX PHARMS PARKE DAVIS PUREPAC PHARM SANDOZ SUPERPHARM VANGARD WATSON LABS
N010670 N010670 A086141 A087541 A087121 A086926 A087093 A086047 A088950 A086574 N012678 A088893 A087876 A089110 A086109 A087318 A089111
002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Mar 01, 1983
Jun 17, 1985
Nov 19, 1984 Apr 20, 1982 May 29, 1987
May 29, 1987
TOLBUTAMIDE SODIUM
INJECTABLE; INJECTION ORINASE DIAGNOSTIC PHARMACIA AND UPJOHN
EQ 1GM BASE/VIAL
N012095
001
TOLCAPONE
TABLET; ORAL TASMAR VALEANT PHARMS LLC
200MG
N020697
002
Jan 29, 1998

TOLMETIN SODIUM
CAPSULE; ORAL TOLECTIN DS ORTHO MCNEIL JANSSEN TOLMETIN SODIUM ACTAVIS ELIZABETH IVAX SUB TEVA PHARMS MUTUAL PHARM SANDOZ TEVA TABLET; ORAL TOLECTIN ORTHO MCNEIL JANSSEN TOLECTIN 600 ORTHO MCNEIL JANSSEN TOLMETIN SODIUM ACTAVIS ELIZABETH IVAX SUB TEVA PHARMS SANDOZ TEVA
6 - 343 (of 360)
EQ 400MG BASE EQ EQ EQ EQ EQ 400MG 400MG 400MG 400MG 400MG BASE BASE BASE BASE BASE
N018084 A073308 A073392 A073311 A073462 A073519
001 001 001 001 001 001 Jan Jan Nov Apr May 24, 24, 27, 30, 29, 1992 1992 1991 1992 1992
EQ 200MG BASE EQ 600MG BASE EQ EQ EQ EQ EQ 600MG 600MG 200MG 600MG 600MG BASE BASE BASE BASE BASE
N017628 N017628 A073527 A074399 A073588 A074002 A074729
001 002 001 001 001 001 001 Mar 08, 1989 Jun Mar Jul Sep Feb 30, 28, 31, 27, 27, 1992 1996 1992 1993 1997
TOLVAPTAN
TABLET; ORAL SAMSCA OTSUKA AMERICA PHARM
60MG
N022275
003
May 19, 2009
TOPIRAMATE
CAPSULE; ORAL TOPAMAX SPRINKLE JANSSEN PHARMS TOPIRAMATE BARR TABLET; ORAL TOPAMAX JANSSEN PHARMS TOPIRAMATE BARR
50MG 15MG 25MG
N020844 A076448 A076448
003 001 002
Oct 26, 1998 Apr 15, 2009 Apr 15, 2009
N020505 N020505 A076315 A076315 A076315 A077905 A077905 A077905 A077905 A076306 A076306 A076306 A076306
003 006 001 002 003 001 002 003 004 001 002 003 004
Dec 24, 1996 Dec 24, 1996 Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar 27, 27, 27, 30, 30, 30, 30, 27, 27, 27, 27, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
PLIVA HRVATSKA DOO
ROXANE
TOPOTECAN HYDROCHLORIDE
SOLUTION; INTRAVENOUS TOPOTECAN SANDOZ INC
EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 3MG BASE/3ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
N200199 N200199 N200199
001 002 003
Feb 25, 2011 Feb 25, 2011 Feb 25, 2011
TORSEMIDE
INJECTABLE; INJECTION DEMADEX ROCHE
N020137 N020137
002 001
Aug 23, 1993 Aug 23, 1993

TABLET; ORAL TRAMADOL HYDROCHLORIDE ACTAVIS ELIZABETH ASTA IVAX SUB TEVA PHARMS SANDOZ ULTRAM JANSSEN PHARMS
6 - 344 (of 360)
A075960 A075974 A075963 A075968 N020281
001 001 001 001 001
Jun Jul Jul Jun
19, 12, 03, 25,
2002 2002 2002 2002
Mar 03, 1995
TRANEXAMIC ACID
TABLET; ORAL CYKLOKAPRON PHARMACIA AND UPJOHN
500MG
N019280
001
Dec 30, 1986
TRAVOPROST
SOLUTION/DROPS; OPHTHALMIC TRAVATAN ALCON PHARMS LTD 0.004%
N021257
001
Mar 16, 2001
TRAZODONE HYDROCHLORIDE
TABLET; ORAL DESYREL APOTHECON
50MG 100MG 150MG 300MG
001 002 003 004 001 001 001 001 001 001 001 001 001 001 001 001 001
Mar 25, 1985 Nov 07, 1988 Oct Oct Feb Feb Dec Apr Apr Apr Apr Apr Nov Nov 29, 29, 27, 27, 01, 30, 30, 30, 29, 29, 17, 17, 1986 1986 1991 1991 1986 1990 1990 1997 1987 1987 1986 1986
TRAZODONE HYDROCHLORIDE AM THERAP 50MG 100MG MYLAN 50MG 100MG QUANTUM PHARMICS 100MG SANDOZ 50MG 100MG 150MG TEVA 50MG USL PHARMA 100MG 50MG WATSON LABS 100MG TRIALODINE QUANTUM PHARMICS 50MG
Dec 01, 1986
TRETINOIN
CAPSULE; ORAL VESANOID ROCHE SOLUTION; TOPICAL TRETINOIN TEVA PHARMS SWAB; TOPICAL RETIN-A VALEANT INTL
10MG
N020438
001
Nov 22, 1995
0.05%
A074873
001
Jun 19, 1998
0.05%
N016921
002
TRIAMCINOLONE
TABLET; ORAL ARISTOCORT ASTELLAS
N011161 N011161 N011161 N011161 N011161
009 004 007 011 010

TRIAMCINOLONE
TABLET; ORAL KENACORT BRISTOL MYERS SQUIBB
6 - 345 (of 360)
N011283 N011283 N011283 N011283 A084286 A084318 A084267 A084319 A084268 A084320 A084340 A083750 A084406 A084020 A084020 A084708 A084709 A084707 A085601 A084775 A084270 A085834
003 008 006 010 001 001 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001
TRIAMCINOLONE BARR
IMPAX LABS IVAX SUB TEVA PHARMS MYLAN PUREPAC PHARM ROXANE
SANDOZ TEVA WATSON LABS
AEROSOL, METERED; INHALATION AZMACORT ABBVIE 0.1MG/INH AEROSOL, METERED; NASAL NASACORT SANOFI AVENTIS US 0.055MG/INH CREAM; TOPICAL ARISTOCORT ASTELLAS 0.025% 0.1% 0.5% ARISTOCORT A ASTELLAS 0.025% 0.025% 0.1% 0.1% 0.5% 0.5% FLUTEX IVAX PHARMS 0.025% 0.1% 0.5% KENALOG APOTHECON 0.5% KENALOG-H APOTHECON 0.1% TRIACET TEVA 0.1% TRIACORT SOLVAY 0.1% TRIAMCINOLONE ACETONIDE ACTAVIS MID ATLANTIC 0.1% ALPHARMA US PHARMS 0.025% AMBIX 0.025% G AND W LABS 0.1%
N018117
001
Apr 23, 1982
N019798
001
Jul 11, 1991
003 004 002 004 001 005 001 003 001 001 002 003 001 001 002 001 001 001 001 001 Jun Jun May May 04, 07, 09, 31, 1982 1982 1983 1991
Oct 16, 1984 Oct 16, 1984 Oct 16, 1984

CREAM; TOPICAL TRIAMCINOLONE ACETONIDE MORTON GROVE 0.025% 0.1% 0.5% PHARMADERM 0.025% 0.1% 0.5% PHARMAFAIR 0.025% 0.1% 0.5% TARO 0.025% TOPIDERM 0.025% 0.1% 0.5% TRIATEX IVAX PHARMS 0.025% 0.1% 0.5% TRYMEX SAVAGE LABS 0.025% 0.1% 0.5% GEL; TOPICAL ARISTOGEL ASTELLAS 0.1% INJECTABLE; INJECTION TRIAMCINOLONE ACETONIDE PARNELL 3MG/ML WATSON LABS 40MG/ML LOTION; TOPICAL KENALOG APOTHECON 0.025% 0.1% BRISTOL MYERS SQUIBB 0.025% 0.1% TRIAMCINOLONE ACETONIDE ALPHARMA US PHARMS 0.025% 0.1% OINTMENT; TOPICAL ARISTOCORT ASTELLAS 0.1% 0.5% ARISTOCORT A ASTELLAS 0.1% 0.1% 0.5% 0.5% FLUTEX IVAX PHARMS 0.025% 0.1% 0.5% KENALOG APOTHECON 0.5% TRIAMCINOLONE ACETONIDE ACTAVIS MID ATLANTIC 0.1% ALPHARMA US PHARMS 0.5% G AND W LABS 0.025% 0.1% MORTON GROVE 0.025% 0.1% 0.5% PHARMADERM 0.025%
6 - 346 (of 360)
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Sep Sep Jul Jul Jul Aug Aug Aug Oct Feb Feb Feb
01, 01, 01, 07, 07, 07, 10, 10, 10, 26, 21, 21, 21,
1983 1983 1983 1983 1983 1983 1982 1982 1982 1994 1989 1989 1989
Nov 01, 1988 Nov 01, 1988 Nov 01, 1988 Mar 25, 1983 Mar 25, 1983 Mar 25, 1983
A083380
001
N019503 A085825
001 001
Oct 16, 1987
A084343 A084343 N011602 N011602 A087191 A087192
001 002 003 001 001 001 Sep 08, 1982 Sep 08, 1982
004 002 003 001 003 001 001 001 001 001 001 001 001 001 001 001 001 001 Jun Dec Dec Dec Sep Sep Sep Aug 07, 23, 23, 23, 01, 01, 01, 02, 1982 1988 1988 1988 1983 1983 1983 1984
Oct 01, 1984 Oct 05, 1984 Nov 01, 1988 Nov 01, 1988 Nov 01, 1988

OINTMENT; TOPICAL TRIAMCINOLONE ACETONIDE PHARMADERM 0.1% TRYMEX SAVAGE LABS 0.025% 0.1% PASTE; DENTAL KENALOG IN ORABASE APOTHECON 0.1% ORALONE TARO 0.1% SPRAY, METERED; NASAL ALLERNAZE LUPIN ATLANTIS 0.05MG/SPRAY NASACORT HFA SANOFI AVENTIS US 0.055MG/SPRAY
6 - 347 (of 360)
A088690 A088693 A088691
001 001 001
Aug 02, 1984 Aug 02, 1984 Aug 02, 1984
N012097 A071383
001 001 Jul 06, 1987
N020120 N020784
001 001
Feb 04, 2000 Apr 07, 2004
TRIAMCINOLONE DIACETATE
INJECTABLE; INJECTION ARISTOCORT SANDOZ
25MG/ML 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
N011685 N012802
003 001
TRIAMCINOLONE DIACETATE AKORN 25MG/ML 40MG/ML WATSON LABS 40MG/ML 40MG/ML SYRUP; ORAL ARISTOCORT ASTELLAS 2MG/5ML KENACORT BRISTOL MYERS SQUIBB EQ 4MG BASE/5ML
A085122 A086394 A084072 A085529
001 001 001 001
N011960 N012515
004 001
TRIAZOLAM
TABLET; ORAL HALCION PHARMACIA AND UPJOHN
0.5MG
N017892
002
Nov 15, 1982
TRICHLORMETHIAZIDE
TABLET; ORAL METAHYDRIN SANOFI AVENTIS US NAQUA SCHERING TRICHLOREX LANNETT TRICHLORMAS MAST MM TRICHLORMETHIAZIDE IMPAX LABS PAR PHARM SANDOZ TG UNITED LABS WATSON LABS
N012594 N012594 N012265 N012265 A083436 A085630 A086259 A083967 A087007 A087005 A086171 A085568 A083847 A086458 A083462
001 002 001 002 001 001 001 001 001 001 001 001 001 001 001
Jun 16, 1988 Jun 16, 1988

TRICHLORMETHIAZIDE
TABLET; ORAL TRICHLORMETHIAZIDE WATSON LABS
6 - 348 (of 360)
4MG 4MG
A083855 A085962
001 001
TRICLOFOS SODIUM
SOLUTION; ORAL TRICLOS SANOFI AVENTIS US TABLET; ORAL TRICLOS SANOFI AVENTIS US
1.5GM/15ML
N016830
001
750MG
N016809
002
TRIDIHEXETHYL CHLORIDE
INJECTABLE; INJECTION PATHILON LEDERLE TABLET; ORAL PATHILON LEDERLE
10MG/ML
N009729
001
25MG
N009489
005
TRIFLUOPERAZINE HYDROCHLORIDE
CONCENTRATE; ORAL STELAZINE GLAXOSMITHKLINE EQ 10MG BASE/ML TRIFLUOPERAZINE HYDROCHLORIDE SANDOZ EQ 10MG BASE/ML WOCKHARDT EQ 10MG BASE/ML INJECTABLE; INJECTION STELAZINE GLAXOSMITHKLINE EQ 2MG BASE/ML TABLET; ORAL STELAZINE GLAXOSMITHKLINE EQ 1MG BASE EQ 2MG BASE EQ 5MG BASE EQ 10MG BASE TRIFLUOPERAZINE HYDROCHLORIDE DURAMED PHARMS BARR EQ 1MG BASE EQ 2MG BASE EQ 5MG BASE EQ 10MG BASE IVAX PHARMS EQ 1MG BASE EQ 2MG BASE EQ 5MG BASE EQ 10MG BASE SANDOZ EQ 1MG BASE EQ 2MG BASE EQ 5MG BASE EQ 10MG BASE WATSON LABS EQ 1MG BASE EQ 2MG BASE EQ 5MG BASE EQ 10MG BASE
N011552 A085787 A088143
006 001 001 Apr 15, 1982 Jul 26, 1983
N011552
005
001 002 003 004 001 001 001 001 001 001 001 001 001 002 003 004 001 001 001 001 Apr Apr Apr Apr Nov Nov Nov Nov Oct Oct Oct Oct Jun Jun Jun Jun 23, 23, 23, 23, 19, 19, 19, 19, 25, 25, 25, 25, 23, 23, 23, 23, 1985 1985 1985 1985 1982 1982 1982 1982 1996 1996 1996 1996 1988 1988 1988 1988
TRIFLUPROMAZINE
SUSPENSION; ORAL VESPRIN APOTHECON
EQ 50MG HCL/5ML
N011491
004

TRIFLUPROMAZINE HYDROCHLORIDE
INJECTABLE; INJECTION VESPRIN APOTHECON
6 - 349 (of 360)
N011325 N011325 N011325
005 004 001
TABLET; ORAL VESPRIN BRISTOL MYERS SQUIBB
10MG 25MG 50MG
N011123 N011123 N011123
001 002 003
TRIHEXYPHENIDYL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL ARTANE LEDERLE 5MG 5MG ELIXIR; ORAL ARTANE LEDERLE 2MG/5ML TRIHEXYPHENIDYL HYDROCHLORIDE PHARM VENTURES 2MG/5ML TABLET; ORAL ARTANE LEDERLE 2MG 5MG TREMIN SCHERING 2MG 5MG TRIHEXYPHENIDYL HYDROCHLORIDE NYLOS 5MG VANGARD 2MG WATSON LABS 2MG 5MG
N006773 N012947
010 001
N006773 A089514
009 001 Apr 07, 1989
N006773 N006773 A080381 A080381 A085622 A088035 A085117 A085105
005 003 001 003 001 001 001 001
Jul 30, 1982
TRILOSTANE
CAPSULE; ORAL MODRASTANE BIOENVISION
30MG 60MG
N018719 N018719
002 001
Dec 31, 1984 Dec 31, 1984
TRIMEPRAZINE TARTRATE
CAPSULE, EXTENDED RELEASE; ORAL TEMARIL ALLERGAN HERBERT EQ 5MG BASE SYRUP; ORAL TEMARIL ALLERGAN HERBERT EQ 2.5MG BASE/5ML TRIMEPRAZINE TARTRATE ALPHARMA US PHARMS EQ 2.5MG BASE/5ML MORTON GROVE EQ 2.5MG BASE/5ML TABLET; ORAL TEMARIL ALLERGAN HERBERT EQ 2.5MG BASE
N011316
004
N011316 A085015 A088285
003 001 001 Feb 18, 1982 Apr 11, 1985
N011316
001
TRIMETHADIONE
CAPSULE; ORAL TRIDIONE ABBVIE SOLUTION; ORAL TRIDIONE ABBVIE
300MG
N005856
005
200MG/5ML
N005856
002

TRIMETHAPHAN CAMSYLATE
INJECTABLE; INJECTION ARFONAD ROCHE
6 - 350 (of 360)
50MG/ML
N008983
001
TRIMETHOBENZAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION TRIMETHOBENZAMIDE HYDROCHLORIDE HOSPIRA 100MG/ML SMITH AND NEPHEW 100MG/ML 100MG/ML SOLOPAK 100MG/ML WATSON LABS 100MG/ML 100MG/ML
A088804 A088960 A089043 A089094 A086577 A087939
001 001 001 001 001 001
Apr Apr Apr Apr Oct Dec
03, 04, 04, 04, 19, 28,
1987 1986 1986 1986 1982 1982
TRIMETHOPRIM
TABLET; ORAL PROLOPRIM MONARCH PHARMS TRIMETHOPRIM MUTUAL PHARM TRIMPEX ROCHE TRIMPEX 200 ROCHE
100MG 200MG 100MG 200MG 100MG 200MG
N017943 N017943 A070494 A070495 N017952 N017952
001 003 001 001 001 002
Jul 14, 1982 Jan 22, 1986 Sep 24, 1986
Nov 09, 1982
TRIMETHOPRIM HYDROCHLORIDE
SOLUTION; ORAL PRIMSOL FSC
EQ 25MG BASE/5ML
A074374
001
Jun 23, 1995
TRIMETREXATE GLUCURONATE
INJECTABLE; INJECTION NEUTREXIN MEDIMMUNE ONCOLOGY
N020326 N020326
001 002
Dec 17, 1993 Jul 31, 1998
TRIMIPRAMINE MALEATE
CAPSULE; ORAL TRIMIPRAMINE MALEATE USL PHARMA
A071283 A071284 A071285
001 001 001
Dec 08, 1987 Dec 08, 1987 Dec 08, 1987
TRIOXSALEN
TABLET; ORAL TRISORALEN VALEANT PHARM INTL
5MG
N012697
001
TRIPELENNAMINE CITRATE
ELIXIR; ORAL PBZ NOVARTIS
EQ 25MG HCL/5ML
N005914
004
TRIPELENNAMINE HYDROCHLORIDE
TABLET; ORAL PBZ NOVARTIS
25MG 50MG TRIPELENNAMINE HYDROCHLORIDE ANABOLIC 50MG
A083149 N005914 A083037
001 002 001

TRIPELENNAMINE HYDROCHLORIDE
TABLET; ORAL TRIPELENNAMINE HYDROCHLORIDE BARR 50MG HEATHER 50MG IMPAX LABS 50MG LANNETT 50MG NYLOS 50MG PARKE DAVIS 25MG 50MG WATSON LABS 50MG 50MG 50MG TABLET, EXTENDED RELEASE; ORAL PBZ-SR NOVARTIS 50MG 100MG
6 - 351 (of 360)
A080744 A083989 A080785 A083557 A085412 A083625 A083626 A080713 A080790 A085188
001 001 001 001 001 001 001 001 001 001
N010533 N010533
002 001
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)

CREAM; VAGINAL GYNE-SULF G AND W LABS SULTRIN ORTHO MCNEIL PHARM TRIPLE SULFA ALPHARMA US PHARMS FOUGERA PERRIGO NEW YORK TRYSUL SAVAGE LABS VAGILIA TEVA TABLET; VAGINAL SULTRIN ORTHO MCNEIL PHARM TRIPLE SULFA FOUGERA PHARMADERM
3.7%;2.86%;3.42% 3.7%;2.86%;3.42% 3.7%;2.86%;3.42% 3.7%;2.86%;3.42% 3.7%;2.86%;3.42% 3.7%;2.86%;3.42% 3.7%;2.86%;3.42%
A088607 N005794 A087864 A086424 A087285 A087887 A088821
001 001 001 001 001 001 001
Jun 09, 1986
Sep 01, 1982 Nov 15, 1982 Jul 23, 1982 Nov 09, 1987
184MG;143.75MG;172.5MG 184MG;143.75MG;172.5MG 184MG;143.75MG;172.5MG
N005794 A088463 A088462
002 001 001 Jan 03, 1985 Jan 03, 1985
TRIPROLIDINE HYDROCHLORIDE
SYRUP; ORAL ACTIDIL GLAXOSMITHKLINE 1.25MG/5ML MYIDYL USL PHARMA 1.25MG/5ML TRIPROLIDINE HYDROCHLORIDE ALPHARMA US PHARMS 1.25MG/5ML HALSEY 1.25MG/5ML PHARM ASSOC 1.25MG/5ML TABLET; ORAL ACTIDIL GLAXOSMITHKLINE 2.5MG TRIPROLIDINE HYDROCHLORIDE VITARINE 2.5MG WATSON LABS 2.5MG
N011496 A087963 A085940 A088735 A087514
002 001 001 001 001
Jul 01, 1983 Jan 18, 1983
Jan 17, 1985 Feb 10, 1982
N011110 A085610 A085094
002 001 001
Jul 01, 1983
TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
SUSPENSION; ORAL LANTRISUL LANNETT NEOTRIZINE LILLY
167MG/5ML;167MG/5ML;167MG/5ML 167MG/5ML;167MG/5ML;167MG/5ML
A080123 N006317
002 012

TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
SUSPENSION; ORAL SULFALOID FOREST PHARMS SULFOSE WYETH AYERST TERFONYL BRISTOL MYERS SQUIBB TRIPLE SULFA ALPHARMA US PHARMS TRIPLE SULFAS LEDERLE TABLET; ORAL NEOTRIZINE LILLY SULFALOID FOREST PHARMS SULFA-TRIPLE #2 IMPAX LABS SULFOSE WYETH AYERST TERFONYL BRISTOL MYERS SQUIBB TRIPLE SULFA PUREPAC PHARM TRIPLE SULFAS LEDERLE TRIPLE SULFOID PAL PAK
6 - 352 (of 360)
167MG/5ML;167MG/5ML;167MG/5ML 167MG/5ML;167MG/5ML;167MG/5ML 167MG/5ML;167MG/5ML;167MG/5ML 167MG/5ML;167MG/5ML;167MG/5ML 167MG/5ML;167MG/5ML;167MG/5ML
A080100 A080013 N006904 A080280 N006920
001 002 002 001 003
167MG;167MG;167MG 167MG;167MG;167MG 167MG;167MG;167MG 167MG;167MG;167MG 167MG;167MG;167MG 167MG;167MG;167MG 167MG;167MG;167MG 167MG;167MG;167MG
N006317 A080099 A080079 A080013 N006904 A080086 N006920 A080094
011 001 001 001 001 001 002 001
TROGLITAZONE
TABLET; ORAL PRELAY SANKYO
200MG 300MG 400MG 200MG 300MG 400MG
N020719 N020719 N020719 N020720 N020720 N020720
001 003 002 001 003 002
Jan 29, 1997 Aug 04, 1997 Jan 29, 1997 Jan 29, 1997 Aug 04, 1997 Jan 29, 1997
REZULIN PFIZER PHARMS
TROLAMINE POLYPEPTIDE OLEATE CONDENSATE

SOLUTION/DROPS; OTIC CERUMENEX PHARM RES ASSOC
10%
N011340
002
TROLEANDOMYCIN
CAPSULE; ORAL TAO PFIZER SUSPENSION; ORAL TAO PFIZER
EQ 250MG BASE
N050336
002
EQ 125MG BASE/5ML
N050332
001
TROPICAMIDE
SOLUTION/DROPS; OPHTHALMIC MYDRIACYL ALCON 0.5% 1% MYDRIAFAIR PHARMAFAIR 0.5% 1%
N012111 N012111 A088274 A088230
002 004 001 001 Sep 16, 1983 Sep 16, 1983

TROPICAMIDE
SOLUTION/DROPS; OPHTHALMIC TROPICAMIDE AKORN 1% ALCON PHARMS LTD 1% MIZA PHARMS USA 0.5% 1% WATSON LABS 0.5%
6 - 353 (of 360)
A088447 A089172 A087636 A087637 A089171
001 001 001 001 001
Aug Dec Jul Aug Dec
28, 28, 30, 09, 28,
1985 1990 1982 1982 1990
TROVAFLOXACIN MESYLATE
TABLET; ORAL TROVAN PFIZER
N020759 N020759
001 002
Dec 18, 1997 Dec 18, 1997
TUBOCURARINE CHLORIDE
INJECTABLE; INJECTION TUBOCURARINE CHLORIDE BRISTOL MYERS SQUIBB HOSPIRA LILLY
N005657 N006095 N006325
001 001 001
TYROPANOATE SODIUM
CAPSULE; ORAL BILOPAQUE GE HEALTHCARE
750MG
N013731
001
URACIL MUSTARD
CAPSULE; ORAL URACIL MUSTARD SHIRE
1MG
N012892
001
UREA
INJECTABLE; INJECTION STERILE UREA HOSPIRA UREAPHIL HOSPIRA
40GM/VIAL 40GM/VIAL
N017698 N012154
001 001
UREA C-13
FOR SOLUTION; ORAL HELICOSOL METABOLIC SOLUTIONS 125MG/VIAL MERETEK UBT KIT (W/ PRANACTIN) OTSUKA AMERICA 125MG/VIAL PYLORI-CHEK BREATH TEST DXS DEVICES 100MG/VIAL
N021092 N020586 N020900
001 001 001
Dec 17, 1999 Sep 17, 1996 Feb 04, 1999
UROFOLLITROPIN
INJECTABLE; INTRAMUSCULAR METRODIN SERONO 75 IU/AMP 150 IU/AMP INJECTABLE; SUBCUTANEOUS FERTINEX SERONO 75 IU/AMP 150 IU/AMP
N019415 N019415
002 003
Sep 18, 1986 Sep 18, 1986
N019415 N019415
005 004
Aug 23, 1996 Aug 23, 1996
UROKINASE
INJECTABLE; INJECTION KINLYTIC MICROBIX BIOSYSTEMS
5,000 IU/VIAL 9,000 IU/VIAL
N021846 N021846
003 002

UROKINASE
INJECTABLE; INJECTION KINLYTIC MICROBIX BIOSYSTEMS
6 - 354 (of 360)
250,000 IU/VIAL
N021846
001
URSODIOL
CAPSULE; ORAL ACTIGALL WATSON PHARMS
150MG
N019594
001
Dec 31, 1987
VALDECOXIB
TABLET; ORAL BEXTRA GD SEARLE
10MG 20MG
N021341 N021341
002 003
Nov 16, 2001 Nov 16, 2001
VALPROIC ACID
CAPSULE; ORAL VALPROIC ACID PAR PHARM SCHERER RP USL PHARMA SYRUP; ORAL VALPROIC ACID APOTEX INC
250MG 250MG 250MG
A070431 A070195 A070631
001 001 001
Feb 28, 1986 Jul 02, 1987 Jun 11, 1987
250MG/5ML
A077105
001
Jul 29, 2005
VALSARTAN
CAPSULE; ORAL DIOVAN NOVARTIS
80MG 160MG
N020665 N020665
001 002
Dec 23, 1996 Dec 23, 1996
FOR SOLUTION; ORAL VANCOCIN HYDROCHLORIDE VIROPHARMA VANCOLED LEDERLE INJECTABLE; INJECTION VANCOCIN HYDROCHLORIDE VIROPHARMA
A061667 A061667 A063321 A063321
002 001 002 003
Jul 13, 1983
Oct 15, 1993 Oct 15, 1993
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
500MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 5GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
001 001 001 001 002 002 002 002 003 001 002 003 004 005 001 002 001 002
Mar Mar Nov Mar Mar Mar Nov Nov Jul Mar May May May
15, 13, 17, 21, 21, 13, 17, 17, 22, 30, 11, 11, 11,
1984 1987 1987 1986 1986 1987 1987 1987 1986 1988 1988 1988 1988
VANCOLED HIKMA MAPLE
VANCOMYCIN HYDROCHLORIDE HIKMA MAPLE EQ EQ VANCOR PHARMACIA AND UPJOHN EQ EQ
Aug 02, 1988 Aug 02, 1988 Aug 01, 1988 Aug 01, 1988

VASOPRESSIN TANNATE
INJECTABLE; INJECTION PITRESSIN TANNATE PARKE DAVIS
6 - 355 (of 360)
5PRESSOR UNITS/ML
N003402
001
VECURONIUM BROMIDE
INJECTABLE; INJECTION NORCURON ORGANON USA INC VECURONIUM BROMIDE HIKMA MAPLE HOSPIRA
N018776 N018776 A075218 A075218 A075558
002 003 001 002 001
Apr 30, 1984 Jan 03, 1992 Aug 23, 1999 Aug 23, 1999 Sep 11, 2001
VELAGLUCERASE ALFA
POWDER; IV (INFUSION) VPRIV SHIRE HUMAN GENETIC
200 UNITS/VIAL
N022575
002
Feb 26, 2010
CAPSULE, EXTENDED RELEASE; ORAL EFFEXOR XR WYETH PHARMS INC EQ 100MG BASE TABLET; ORAL EFFEXOR WYETH PHARMS INC EQ 12.5MG BASE EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE VENLAFAXINE HYDROCHLORIDE PLIVA HRVATSKA DOO EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE SANDOZ EQ 25MG BASE EQ 37.5MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE
N020699
003
Oct 20, 1997
N020151 N020151 N020151 N020151 N020151 N020151 A078517 A078517 A078517 A078517 A078517 A077515 A077515 A077515 A077515 A077515
001 002 006 003 004 005 001 002 003 004 005 001 002 003 004 005
Dec Dec Dec Dec Dec Dec Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun
28, 28, 28, 28, 28, 28, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13,
1993 1993 1993 1993 1993 1993 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
INJECTABLE; INJECTION CALAN GD SEARLE LLC
2.5MG/ML 2.5MG/ML
N018925 N019038 N018485 A070348 A072888 A070577 A070739 A070740 A070225 A070617 A072233 A073485 A070696 A070697
001 001 001 001 001 001 001 001 001 001 001 001 001 001
Mar 30, 1984 Mar 30, 1984
ISOPTIN FSC 2.5MG/ML VERAPAMIL HYDROCHLORIDE ABRAXIS PHARM 2.5MG/ML BEDFORD 2.5MG/ML HOSPIRA 2.5MG/ML 2.5MG/ML 2.5MG/ML LUITPOLD 2.5MG/ML 2.5MG/ML MARSAM PHARMS LLC 2.5MG/ML 2.5MG/ML SMITH AND NEPHEW 2.5MG/ML 2.5MG/ML
May Jul Feb May May Nov Nov Feb Sep Jul Jul
01, 28, 02, 06, 06, 12, 12, 26, 27, 31, 31,
1986 1995 1987 1987 1987 1985 1985 1993 1993 1987 1987

INJECTABLE; INJECTION VERAPAMIL HYDROCHLORIDE SOLOPAK 2.5MG/ML TABLET; ORAL CALAN GD SEARLE LLC 160MG ISOPTIN FSC 40MG 80MG 120MG VERAPAMIL HYDROCHLORIDE ACTAVIS ELIZABETH 80MG 120MG HERITAGE PHARMS INC 80MG 120MG MUTUAL PHARM 80MG 80MG 120MG 120MG PLIVA 40MG 80MG 120MG SANDOZ 40MG 80MG 120MG WARNER CHILCOTT 80MG 120MG WATSON LABS 40MG TABLET, EXTENDED RELEASE; ORAL VERAPAMIL HYDROCHLORIDE PLIVA 240MG
6 - 356 (of 360)
A070695
001
Jul 31, 1987
N018817 N018593 N018593 N018593 A071019 A070468 A071880 A071881 A070482 A071489 A070483 A071489 A072751 A072124 A072125 A073168 A071423 A071424 A070340 A070341 A072799
004 003 001 002 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001
Feb 23, 1988 Nov 23, 1987 Mar 08, 1982 Mar 08, 1982 Sep Sep Apr Apr Sep Jan Sep Jan Feb Jan Jan Jul May May Sep Sep Apr 24, 24, 05, 05, 24, 13, 24, 13, 23, 26, 26, 31, 24, 25, 24, 24, 28, 1986 1986 1988 1988 1986 1988 1986 1988 1996 1989 1989 1992 1988 1988 1986 1986 1989
A072922
001
Mar 01, 1996
VERATRUM VIRIDE ROOT

TABLET; ORAL VERTAVIS MEDPOINTE PHARM HLC
130CSR UNIT
N005691
002
VIDARABINE
INJECTABLE; INJECTION VIRA-A PARKEDALE OINTMENT; OPHTHALMIC VIRA-A PARKEDALE
EQ 187.4MG BASE/ML
N050523
001
3%
N050486
001
VINBLASTINE SULFATE
INJECTABLE; INJECTION VELBAN LILLY VINBLASTINE SULFATE ABRAXIS PHARM HOSPIRA
N012665 A089011 A089565
001 001 001 Nov 18, 1985 Aug 18, 1987
VINCRISTINE SULFATE
INJECTABLE; INJECTION ONCOVIN LILLY
1MG/VIAL 1MG/ML 5MG/VIAL 1MG/ML
N014103 N014103 N014103 A071426
001 003 002 001
Mar 07, 1984
VINCASAR PFS TEVA PARENTERAL
Jul 17, 1987

VINCRISTINE SULFATE
INJECTABLE; INJECTION VINCREX BRISTOL MYERS SQUIBB VINCRISTINE SULFATE ABIC ABRAXIS PHARM FRESENIUS KABI USA HOSPIRA
6 - 357 (of 360)
5MG/VIAL 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/VIAL 2MG/VIAL 5MG/VIAL
A070867 A070873 A070411 A076296 A076401 A071559 A071560 A071561
001 001 001 001 001 001 001 001
Jul 12, 1988 Feb Sep Dec Oct Apr Apr Apr 19, 10, 20, 28, 11, 11, 11, 1987 1986 2002 2003 1988 1988 1988
VIOMYCIN SULFATE
INJECTABLE; INJECTION VIOCIN SULFATE PFIZER
EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL
A061086 A061086
001 002
VITAMIN A
CAPSULE; ORAL AQUASOL A ASTRAZENECA VITAMIN A BANNER PHARMACAPS CHASE CHEM EVERYLIFE IMPAX LABS WEST WARD
25,000USP UNITS 50,000USP UNITS 50,000USP UNITS 50,000 IU 50,000 IU 50,000USP UNITS 50,000USP UNITS
A083080 A083080 A083973 A083351 A083134 A080952 A080985
002 001 001 001 001 001 001
VITAMIN A PALMITATE
CAPSULE; ORAL AFAXIN STERLING WINTHROP ALPHALIN LILLY DEL-VI-A DEL RAY LABS VI-DOM-A BAYER PHARMS VITAMIN A BANNER PHARMACAPS BRISTOL MYERS SQUIBB CHASE CHEM ELKINS SINN EVERYLIFE IMPAX LABS IVAX SUB TEVA PHARMS MK LABS WEST WARD WHARTON LABS VITAMIN A PALMITATE ARCUM BANNER PHARMACAPS
EQ 50,000 UNITS BASE EQ 50,000 UNITS BASE EQ 50,000 UNITS BASE EQ 50,000 UNITS BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 25,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001

VITAMIN A PALMITATE
CAPSULE; ORAL VITAMIN A SOLUBILIZED TEVA INJECTABLE; INJECTION VITAMIN A PALMITATE BEL MAR
6 - 358 (of 360)
EQ 50,000 UNITS BASE
A080921
001
EQ 50,000 UNITS BASE/ML
A080819
001
WARFARIN POTASSIUM
TABLET; ORAL ATHROMBIN-K PHARM RES ASSOC
2MG 5MG 10MG 25MG
N011771 N011771 N011771 N011771
007 004 005 006
WARFARIN SODIUM
INJECTABLE; INJECTION COUMADIN BRISTOL MYERS SQUIBB TABLET; ORAL ATHROMBIN PHARM RES ASSOC
50MG/VIAL 75MG/VIAL
N009218 N009218
020 012
5MG 10MG 25MG 2MG 2.5MG 5MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 2MG 2.5MG 5MG 2MG 2.5MG 5MG 7.5MG 10MG
N011771 N011771 N011771 N017020 N017020 N017020 N017020 N017020 A040196 A040196 A040196 A040196 A040196 A040196 A040196 A040196 A040196 A088719 A088720 A088721 A086123 A086120 A086119 A086118 A086122
003 002 001 001 002 003 004 005 001 002 003 008 004 005 009 006 007 001 001 001 001 001 001 001 001 Sep Sep Sep Jul Sep Sep Jul Sep Sep Jun Aug Jul Aug Aug Aug Aug Aug 30, 30, 30, 26, 30, 30, 26, 30, 30, 27, 06, 02, 17, 17, 17, 17, 17, 1997 1997 1997 2000 1997 1997 2000 1997 1997 1985 1985 1985 1982 1982 1982 1982 1982
PANWARFIN ABBOTT
WARFARIN SODIUM SANDOZ
USL PHARMA
WATSON LABS
XENON XE-127
GAS; INHALATION XENON XE 127 MALLINCKRODT
5mCi/VIAL 10mCi/VIAL
N018536 N018536
001 002
Oct 01, 1982 Oct 01, 1982
XENON XE-133
GAS; INHALATION XENON XE 133 GE HEALTHCARE
1 CI/AMP 10mCi/VIAL 20mCi/VIAL
N017256 N017687 N017687
002 002 003

XENON XE-133
GAS; INHALATION XENON XE 133 GEN ELECTRIC MALLINCKRODT
6 - 359 (of 360)
5-100 CI/CYLINDER 0.25-5 CI/AMP 10mCi/VIAL 20mCi/VIAL
N017550 N017550 N018327 N018327 N017687
001 003 001 002 001
Mar 09, 1982 Mar 09, 1982
XENON XE 133-V.S.S. GE HEALTHCARE 10mCi/VIAL INJECTABLE; INJECTION XENON XE 133 GE HEALTHCARE 1.3-1.7 CI/AMP LANTHEUS MEDCL 6.3mCi/ML SOLUTION; INHALATION, INJECTION XENEISOL MALLINCKRODT 18-25mCi/AMP
N017256 N017283
001 001
N017262
002
XYLOSE
POWDER; ORAL XYLO-PFAN SAVAGE LABS XYLOSE LYNE
25GM/BOT 25GM/BOT
N017605 N018856
001 001 Mar 26, 1987
ZALCITABINE
TABLET; ORAL HIVID ROCHE
0.375MG 0.75MG
N020199 N020199
001 002
Jun 19, 1992 Jun 19, 1992
ZALEPLON
CAPSULE; ORAL ZALEPLON SANDOZ
5MG 10MG
A078095 A078095
001 002
Jun 06, 2008 Jun 06, 2008
ZICONOTIDE
INJECTABLE; INTRATHECAL PRIALT JAZZ PHARMS INTL
200MCG/2ML (100MCG/ML)
N021060
003
Dec 28, 2004
ZIDOVUDINE
TABLET; ORAL RETROVIR VIIV HLTHCARE ZIDOVUDINE AUROBINDO PHARMA MATRIX LABS LTD RANBAXY LABS LTD
200MG 60MG 100MG 300MG
N020518 N022294 N200732 A077327
001 001 001 001
Dec 19, 1995 Jul 23, 2009 Feb 23, 2011 Sep 19, 2005
ZILEUTON
TABLET; ORAL ZYFLO CORNERSTONE THERAP
300MG
N020471
001
Dec 09, 1996
ZINC SULFATE
INJECTABLE; INJECTION ZINC SULFATE ABRAXIS PHARM
EQ 1MG ZINC/ML
N019229
002
May 05, 1987

ZOLEDRONIC ACID
ZOMETA
NOVARTIS EQ 4MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
6 - 360 (of 360)
N021223
001
Aug 20, 2001
ZOLPIDEM TARTRATE
TABLET; ORAL
ZOLPIDEM TARTRATE
MUTUAL PHARMA
5MG 10MG MYLAN PHARMS INC 5MG 10MG SYNTHON PHARMS 5MG 10MG WORLD GEN 5MG 10MG TABLET, ORALLY DISINTEGRATING; ORAL TOVALT ODT BIOVAIL LABS INTL 5MG 10MG
A077288 A077288 A078016 A078016 A077540 A077540 A076062 A076062
001 002 001 002 001 002 001 002
Apr Apr Apr Apr Apr Apr Apr Apr
23, 23, 23, 23, 23, 23, 23, 23,
2007 2007 2007 2007 2007 2007 2007 2007
N021412 N021412
001 002
Apr 25, 2007 Apr 25, 2007
ZONISAMIDE
CAPSULE; ORAL
ZONISAMIDE
MUTUAL PHARM
ROXANE
TEVA PHARMS
WATSON LABS
A077635 A077635 A077635 A077648 A077648 A077648 A077641 A077641 A077641 A077650 A077650 A077650
001 002 003 001 002 003 003 002 001 001 002 003
Dec Dec Dec Dec Dec Dec Dec Dec Dec Apr Apr Apr
22, 22, 22, 22, 22, 22, 22, 22, 22, 20, 20, 20,
2005 2005 2005 2005 2005 2005 2005 2005 2005 2006 2006 2006
7-1
ORPHAN PRODUCT DESIGNATIONS AND APPROVALS LIST

The list of List of Orphan Designations and Approvals is available at:
http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/default.htm
8-1
DRUG PRODUCTS WHICH MUST DEMONSTRATE IN VIVO BIOAVAILABILITY

ONLY IF PRODUCT FAILS TO ACHIEVE ADEQUATE DISSOLUTION
ACETAMINOPHEN;ASPIRIN;BUTALBITAL CAPSULE OR TABLET; ORAL 160-165MG;160-165MG;50MG 325MG;325MG;50MG ACETAMINOPHEN;ASPIRIN;BUTALBITAL; CAFFEINE CAPSULE OR TABLET; ORAL 160-165MG;160-165MG;50MG;40MG 325MG;325MG;50MG;40MG ACETAMINOPHEN;BUTALBITAL CAPSULE OR TABLET; ORAL 325MG;50MG ACETAMINOPHEN;BUTALBITAL;CAFFEINE CAPSULE OR TABLET; ORAL 325MG;50MG;40MG AMINOPHYLLINE TABLET; ORAL 100MG;200MG ASPIRIN;BUTALBITAL CAPSULE OR TABLET; ORAL 325MG;50MG 650MG;50MG ASPIRIN;BUTALBITAL;CAFFEINE CAPSULE OR TABLET; ORAL 325MG;50MG;40MG 650MG;50MG;40MG ASPIRIN;CAFFEINE;CARISOPRODOL TABLET; ORAL 160MG;32MG;200MG
ASPIRIN;CAFFEINE;CARISOPRODOL; CODEINE PHOSPHATE TABLET; ORAL 160MG;32MG;200MG;16MG ASPIRIN;CARISOPRODOL TABLET; ORAL 325MG;200MG ASPIRIN;CARISOPRODOL; CODEINE PHOSPHATE TABLET; ORAL 325MG;200MG;16MG ASPIRIN;MEPROBAMATE TABLET; ORAL 325MG;200MG ASPIRIN;METHOCARBAMOL TABLET; ORAL 325MG;400MG CHLOROTHIAZIDE TABLET; ORAL 250MG HYDROXYZINE HYDROCHLORIDE TABLET; ORAL 10MG;25MG; 50MG;100MG PREDNISONE TABLET; ORAL 1MG;2.5MG;5MG;10MG; 20MG;25MG;50MG
APPENDIX A
8-MOP, METHOXSALEN
**
PRODUCT NAME INDEX

8 **
A - 1
**
**
ABACAVIR SULFATE, ABACAVIR SULFATE ABELCET, AMPHOTERICIN B ABILIFY, ARIPIPRAZOLE ABLAVAR, GADOFOSVESET TRISODIUM ABRAXANE, PACLITAXEL ABREVA, DOCOSANOL (OTC) ABSORICA, ISOTRETINOIN ABSTRAL, FENTANYL CITRATE ACANYA, BENZOYL PEROXIDE ACARBOSE, ACARBOSE ACCOLATE, ZAFIRLUKAST ACCUNEB, ALBUTEROL SULFATE ACCUPRIL, QUINAPRIL HYDROCHLORIDE ACCURETIC, HYDROCHLOROTHIAZIDE ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE ACEON, PERINDOPRIL ERBUMINE ACEPHEN, ACETAMINOPHEN (OTC) ACETADOTE, ACETYLCYSTEINE ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN ACETASOL HC, ACETIC ACID, GLACIAL ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM ACETAZOLAMIDE, ACETAZOLAMIDE ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE, ACETIC ACID, GLACIAL ACETIC ACID, ACETIC ACID, GLACIAL ACETOHEXAMIDE, ACETOHEXAMIDE ACETYLCYSTEINE, ACETYLCYSTEINE ACIPHEX, RABEPRAZOLE SODIUM ACLOVATE, ALCLOMETASONE DIPROPIONATE ACOVA, ARGATROBAN ACTHREL, CORTICORELIN OVINE TRIFLUTATE ACTIGALL, URSODIOL ACTIQ, FENTANYL CITRATE ACTIVELLA, ESTRADIOL ACTONEL, RISEDRONATE SODIUM ACTOPLUS MET XR, METFORMIN HYDROCHLORIDE ACTOPLUS MET, METFORMIN HYDROCHLORIDE ACTOS, PIOGLITAZONE HYDROCHLORIDE ACULAR LS, KETOROLAC TROMETHAMINE ACULAR PRESERVATIVE FREE, KETOROLAC TROMETHAMINE ACULAR, KETOROLAC TROMETHAMINE ACUVAIL, KETOROLAC TROMETHAMINE ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE, ACYCLOVIR SODIUM ACYCLOVIR SODIUM, ACYCLOVIR SODIUM ACYCLOVIR, ACYCLOVIR ACZONE, DAPSONE ADAGEN, PEGADEMASE BOVINE ADALAT CC, NIFEDIPINE ADAPALENE, ADAPALENE ADASUVE, LOXAPINE ADCIRCA, TADALAFIL ADDERALL XR 10, AMPHETAMINE ASPARTATE ADDERALL XR 15, AMPHETAMINE ASPARTATE ADDERALL XR 20, AMPHETAMINE ASPARTATE ADDERALL XR 25, AMPHETAMINE ASPARTATE ADDERALL XR 30, AMPHETAMINE ASPARTATE
APPENDIX A
**
PRODUCT NAME INDEX

A **
A - 2
ADDERALL XR 5, AMPHETAMINE ASPARTATE ADENOCARD, ADENOSINE ADENOSCAN, ADENOSINE ADENOSINE, ADENOSINE ADIPEX-P, PHENTERMINE HYDROCHLORIDE ADRENACLICK, EPINEPHRINE ADRENALIN, EPINEPHRINE ADREVIEW, IOBENGUANE SULFATE I-123 ADVAIR DISKUS 100/50, FLUTICASONE PROPIONATE ADVAIR DISKUS 250/50, FLUTICASONE PROPIONATE ADVAIR DISKUS 500/50, FLUTICASONE PROPIONATE ADVAIR HFA, FLUTICASONE PROPIONATE ADVICOR, LOVASTATIN ADVIL ALLERGY AND CONGESTION RELIEF, CHLORPHENIRAMINE MALEATE ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC) ADVIL COLD AND SINUS, IBUPROFEN (OTC) ADVIL CONGESTION RELIEF, IBUPROFEN (OTC) ADVIL LIQUI-GELS, IBUPROFEN (OTC) ADVIL MIGRAINE LIQUI-GELS, IBUPROFEN (OTC) ADVIL PM, DIPHENHYDRAMINE CITRATE (OTC) ADVIL PM, DIPHENHYDRAMINE HYDROCHLORIDE (OTC) ADVIL, IBUPROFEN (OTC) ADVIL, IBUPROFEN SODIUM (OTC) AEROBID, FLUNISOLIDE AEROSPAN HFA, FLUNISOLIDE AFEDITAB CR, NIFEDIPINE AFINITOR DISPERZ, EVEROLIMUS AFINITOR, EVEROLIMUS AFRINOL, PSEUDOEPHEDRINE SULFATE (OTC) AGGRASTAT, TIROFIBAN HYDROCHLORIDE AGGRENOX, ASPIRIN AGRYLIN, ANAGRELIDE HYDROCHLORIDE A-HYDROCORT, HYDROCORTISONE SODIUM SUCCINATE AKBETA, LEVOBUNOLOL HYDROCHLORIDE AK-FLUOR 10%, FLUORESCEIN SODIUM AK-FLUOR 25%, FLUORESCEIN SODIUM AKINETON, BIPERIDEN HYDROCHLORIDE AKNE-MYCIN, ERYTHROMYCIN AKPENTOLATE, CYCLOPENTOLATE HYDROCHLORIDE AKPRO, DIPIVEFRIN HYDROCHLORIDE AKTEN, LIDOCAINE HYDROCHLORIDE AKTOB, TOBRAMYCIN ALA-CORT, HYDROCORTISONE ALAMAST, PEMIROLAST POTASSIUM ALA-SCALP, HYDROCORTISONE ALAVERT, LORATADINE (OTC) ALAWAY, KETOTIFEN FUMARATE (OTC) ALBALON, NAPHAZOLINE HYDROCHLORIDE ALBENZA, ALBENDAZOLE ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALCAINE, PROPARACAINE HYDROCHLORIDE ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE ALCOHOL 10% AND DEXTROSE 5%, ALCOHOL ALCOHOL 5% AND DEXTROSE 5%, ALCOHOL ALDACTAZIDE, HYDROCHLOROTHIAZIDE ALDACTONE, SPIRONOLACTONE ALDARA, IMIQUIMOD ALENDRONATE SODIUM, ALENDRONATE SODIUM ALEVE, NAPROXEN SODIUM (OTC) ALEVE-D SINUS & COLD, NAPROXEN SODIUM (OTC) ALFENTA, ALFENTANIL HYDROCHLORIDE ALFENTANIL, ALFENTANIL HYDROCHLORIDE ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE
(OTC)
APPENDIX A
**
PRODUCT NAME INDEX

A **
A - 3
ALIMTA, PEMETREXED DISODIUM ALINIA, NITAZOXANIDE ALKERAN, MELPHALAN ALKERAN, MELPHALAN HYDROCHLORIDE ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA, FEXOFENADINE HYDROCHLORIDE ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE (OTC) ALLI, ORLISTAT (OTC) ALLOPURINOL SODIUM, ALLOPURINOL SODIUM ALLOPURINOL, ALLOPURINOL ALOCRIL, NEDOCROMIL SODIUM ALOMIDE, LODOXAMIDE TROMETHAMINE ALOPRIM, ALLOPURINOL SODIUM ALORA, ESTRADIOL ALOXI, PALONOSETRON HYDROCHLORIDE ALPHAGAN P, BRIMONIDINE TARTRATE ALPRAZOLAM, ALPRAZOLAM ALPROSTADIL, ALPROSTADIL ALREX, LOTEPREDNOL ETABONATE ALSUMA, SUMATRIPTAN SUCCINATE ALTABAX, RETAPAMULIN ALTACE, RAMIPRIL ALTAVERA, ETHINYL ESTRADIOL ALTOPREV, LOVASTATIN ALVESCO, CICLESONIDE ALYACEN 1/35, ETHINYL ESTRADIOL ALYACEN 7/7/7, ETHINYL ESTRADIOL AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMARYL, GLIMEPIRIDE AMBIEN CR, ZOLPIDEM TARTRATE AMBIEN, ZOLPIDEM TARTRATE AMBISOME, AMPHOTERICIN B AMCINONIDE, AMCINONIDE AMERGE, NARATRIPTAN HYDROCHLORIDE A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE AMICAR, AMINOCAPROIC ACID AMIDATE, ETOMIDATE AMIFOSTINE, AMIFOSTINE AMIKACIN SULFATE, AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE AMINO ACIDS, AMINO ACIDS AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, GLYCINE AMINOCAPROIC ACID IN PLASTIC CONTAINER, AMINOCAPROIC ACID AMINOCAPROIC ACID, AMINOCAPROIC ACID AMINOCAPROIC, AMINOCAPROIC ACID AMINOHIPPURATE SODIUM, AMINOHIPPURATE SODIUM AMINOPHYLLINE, AMINOPHYLLINE AMINOSYN 10% (PH6), AMINO ACIDS AMINOSYN 10%, AMINO ACIDS AMINOSYN 3.5% M, AMINO ACIDS AMINOSYN 3.5%, AMINO ACIDS AMINOSYN 5%, AMINO ACIDS AMINOSYN 7% (PH6), AMINO ACIDS AMINOSYN 7% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN 7%, AMINO ACIDS AMINOSYN 8.5% (PH6), AMINO ACIDS AMINOSYN 8.5% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN 8.5%, AMINO ACIDS AMINOSYN II 10% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 10% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 10%, AMINO ACIDS
APPENDIX A
**
PRODUCT NAME INDEX

A **
A - 4
AMINOSYN II 15% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 7%, AMINO ACIDS AMINOSYN II 8.5% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 8.5%, AMINO ACIDS AMINOSYN-HBC 7%, AMINO ACIDS AMINOSYN-HF 8%, AMINO ACIDS AMINOSYN-PF 10%, AMINO ACIDS AMINOSYN-PF 7%, AMINO ACIDS AMINOSYN-RF 5.2%, AMINO ACIDS AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMITIZA, LUBIPROSTONE AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE AMMONIA N 13, AMMONIA N-13 AMMONIA N 13, AMMONIA, N-13 AMMONIUM CHLORIDE IN PLASTIC CONTAINER, AMMONIUM CHLORIDE AMMONIUM LACTATE, AMMONIUM LACTATE AMMONUL, SODIUM BENZOATE AMNESTEEM, ISOTRETINOIN AMOXAPINE, AMOXAPINE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN PEDIATRIC, AMOXICILLIN AMOXICILLIN, AMOXICILLIN AMOXIL, AMOXICILLIN AMPHADASE, HYALURONIDASE AMPHETAMINE SULFATE, AMPHETAMINE SULFATE AMPHOTEC, AMPHOTERICIN B AMPHOTERICIN B, AMPHOTERICIN B AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM AMPICILLIN SODIUM, AMPICILLIN SODIUM AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE AMPYRA, DALFAMPRIDINE AMRINONE LACTATE, INAMRINONE LACTATE AMRIX, CYCLOBENZAPRINE HYDROCHLORIDE AMTURNIDE, ALISKIREN HEMIFUMARATE AMYVID, FLORBETAPIR F-18 ANADROL-50, OXYMETHOLONE ANAFRANIL, CLOMIPRAMINE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ANAPROX DS, NAPROXEN SODIUM ANAPROX, NAPROXEN SODIUM ANASTROZOLE, ANASTROZOLE ANCEF IN PLASTIC CONTAINER, CEFAZOLIN SODIUM ANCOBON, FLUCYTOSINE ANDRODERM, TESTOSTERONE ANDROGEL, TESTOSTERONE ANDROID 10, METHYLTESTOSTERONE ANDROID 25, METHYLTESTOSTERONE AN-DTPA, TECHNETIUM TC-99M PENTETATE KIT ANECTINE, SUCCINYLCHOLINE CHLORIDE ANESTACON, LIDOCAINE HYDROCHLORIDE ANEXSIA 5/325, ACETAMINOPHEN ANEXSIA 7.5/325, ACETAMINOPHEN ANEXSIA 7.5/650, ACETAMINOPHEN ANEXSIA, ACETAMINOPHEN ANGELIQ, DROSPIRENONE ANGIOMAX, BIVALIRUDIN ANSAID, FLURBIPROFEN AN-SULFUR COLLOID, TECHNETIUM TC-99M SULFUR COLLOID KIT ANTABUSE, DISULFIRAM ANTARA (MICRONIZED), FENOFIBRATE ANTHELIOS 20, AVOBENZONE (OTC)
APPENDIX A
**
PRODUCT NAME INDEX

A **
A - 5
ANTHELIOS 40, AVOBENZONE (OTC) ANTHELIOS SX, AVOBENZONE (OTC) ANTIVERT, MECLIZINE HYDROCHLORIDE ANTIZOL, FOMEPIZOLE ANTUROL, OXYBUTYNIN ANUSOL HC, HYDROCORTISONE ANZEMET, DOLASETRON MESYLATE APHTHASOL, AMLEXANOX APIDRA SOLOSTAR, INSULIN GLULISINE RECOMBINANT APIDRA, INSULIN GLULISINE RECOMBINANT APLENZIN, BUPROPION HYDROBROMIDE APOKYN, APOMORPHINE HYDROCHLORIDE APRACLONIDINE HYDROCHLORIDE, APRACLONIDINE HYDROCHLORIDE APREPITANT, APREPITANT APRISO, MESALAMINE APTIVUS, TIPRANAVIR AQUASOL A, VITAMIN A PALMITATE ARALEN, CHLOROQUINE PHOSPHATE ARANELLE, ETHINYL ESTRADIOL ARAVA, LEFLUNOMIDE ARCAPTA NEOHALER, INDACATEROL MALEATE ARESTIN, MINOCYCLINE HYDROCHLORIDE ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN ARGATROBAN, ARGATROBAN ARICEPT ODT, DONEPEZIL HYDROCHLORIDE ARICEPT, DONEPEZIL HYDROCHLORIDE ARIDOL KIT, MANNITOL ARIMIDEX, ANASTROZOLE ARISTOSPAN, TRIAMCINOLONE HEXACETONIDE ARIXTRA, FONDAPARINUX SODIUM ARMODAFINIL, ARMODAFINIL AROMASIN, EXEMESTANE ARRANON, NELARABINE ARTHROTEC, DICLOFENAC SODIUM ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, ARTICAINE HYDROCHLORIDE ARTICAINE HYDROCHLORIDE WITH EPINEPHRINE, ARTICAINE HYDROCHLORIDE ASACOL HD, MESALAMINE ASACOL, MESALAMINE ASCLERA, POLIDOCANOL ASMANEX TWISTHALER, MOMETASONE FUROATE ASPIRIN AND DIPYRIDAMOLE, ASPIRIN ASPIRIN, ASPIRIN (OTC) ASTELIN, AZELASTINE HYDROCHLORIDE ASTEPRO, AZELASTINE HYDROCHLORIDE ASTRAMORPH PF, MORPHINE SULFATE ATACAND HCT, CANDESARTAN CILEXETIL ATACAND, CANDESARTAN CILEXETIL ATELVIA, RISEDRONATE SODIUM ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL ATIVAN, LORAZEPAM ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE ATRACURIUM BESYLATE, ATRACURIUM BESYLATE ATRALIN, TRETINOIN ATRIDOX, DOXYCYCLINE HYCLATE ATRIPLA, EFAVIRENZ ATROPEN, ATROPINE ATROPINE SULFATE ANSYR PLASTIC SYRINGE, ATROPINE SULFATE ATROVENT HFA, IPRATROPIUM BROMIDE ATROVENT, IPRATROPIUM BROMIDE AUBAGIO, TERIFLUNOMIDE AUGMENTIN '125', AMOXICILLIN
APPENDIX A
**
PRODUCT NAME INDEX

A **
A - 6
AUGMENTIN '200', AMOXICILLIN AUGMENTIN '250', AMOXICILLIN AUGMENTIN '400', AMOXICILLIN AUGMENTIN '500', AMOXICILLIN AUGMENTIN '875', AMOXICILLIN AUGMENTIN ES-600, AMOXICILLIN AUGMENTIN XR, AMOXICILLIN AUVI-Q, EPINEPHRINE AVAGARD, ALCOHOL (OTC) AVAGE, TAZAROTENE AVALIDE, HYDROCHLOROTHIAZIDE AVANDAMET, METFORMIN HYDROCHLORIDE AVANDARYL, GLIMEPIRIDE AVANDIA, ROSIGLITAZONE MALEATE AVAPRO, IRBESARTAN AVC, SULFANILAMIDE AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER, MOXIFLOXACIN HYDROCHLORIDE AVELOX, MOXIFLOXACIN HYDROCHLORIDE AVENTYL HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE AVIANE-28, ETHINYL ESTRADIOL AVINZA, MORPHINE SULFATE AVITA, TRETINOIN AVODART, DUTASTERIDE AXERT, ALMOTRIPTAN MALATE AXID AR, NIZATIDINE (OTC) AXID, NIZATIDINE AXIRON, TESTOSTERONE AYGESTIN, NORETHINDRONE ACETATE AZACTAM IN PLASTIC CONTAINER, AZTREONAM AZACTAM, AZTREONAM AZASAN, AZATHIOPRINE AZASITE, AZITHROMYCIN AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM AZATHIOPRINE, AZATHIOPRINE AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE AZELEX, AZELAIC ACID AZILECT, RASAGILINE MESYLATE AZITHROMYCIN, AZITHROMYCIN AZITHROMYCIN, AZITHROMYCIN, UNSPECIFIED FORM AZOPT, BRINZOLAMIDE AZOR, AMLODIPINE BESYLATE AZTREONAM, AZTREONAM AZULFIDINE EN-TABS, SULFASALAZINE AZULFIDINE, SULFASALAZINE
**
**
BACIIM, BACITRACIN BACI-RX, BACITRACIN BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BACITRACIN, BACITRACIN BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, BACITRACIN BACLOFEN, BACLOFEN BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION BACTOCILL IN PLASTIC CONTAINER, OXACILLIN SODIUM BACTRIM DS, SULFAMETHOXAZOLE BACTRIM, SULFAMETHOXAZOLE BACTROBAN, MUPIROCIN BACTROBAN, MUPIROCIN CALCIUM BAL, DIMERCAPROL BALANCED SALT, CALCIUM CHLORIDE BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM BALZIVA-28, ETHINYL ESTRADIOL
APPENDIX A
**
PRODUCT NAME INDEX

B **
A - 7
BANZEL, RUFINAMIDE BARACLUDE, ENTECAVIR BECONASE AQ, BECLOMETHASONE DIPROPIONATE MONOHYDRATE BELVIQ, LORCASERIN HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BENICAR HCT, HYDROCHLOROTHIAZIDE BENICAR, OLMESARTAN MEDOXOMIL BENTYL PRESERVATIVE FREE, DICYCLOMINE HYDROCHLORIDE BENTYL, DICYCLOMINE HYDROCHLORIDE BENZACLIN, BENZOYL PEROXIDE BENZAMYCIN PAK, BENZOYL PEROXIDE BENZAMYCIN, BENZOYL PEROXIDE BENZONATATE, BENZONATATE BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE BEPREVE, BEPOTASTINE BESILATE BESIVANCE, BESIFLOXACIN HYDROCHLORIDE BETADINE, POVIDONE-IODINE BETAGAN, LEVOBUNOLOL HYDROCHLORIDE BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE BETAMETHASONE VALERATE, BETAMETHASONE VALERATE BETAPACE AF, SOTALOL HYDROCHLORIDE BETAPACE, SOTALOL HYDROCHLORIDE BETA-VAL, BETAMETHASONE VALERATE BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE BETHKIS, TOBRAMYCIN BETIMOL, TIMOLOL BETOPTIC S, BETAXOLOL HYDROCHLORIDE BETOPTIC, BETAXOLOL HYDROCHLORIDE BEYAZ, DROSPIRENONE BIAXIN XL, CLARITHROMYCIN BIAXIN, CLARITHROMYCIN BICALUTAMIDE, BICALUTAMIDE BICILLIN C-R 900/300, PENICILLIN G BENZATHINE BICILLIN C-R, PENICILLIN G BENZATHINE BICILLIN L-A, PENICILLIN G BENZATHINE BICNU, CARMUSTINE BIDIL, HYDRALAZINE HYDROCHLORIDE BILTRICIDE, PRAZIQUANTEL BINOSTO, ALENDRONATE SODIUM BIOSCRUB, CHLORHEXIDINE GLUCONATE (OTC) BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE BLEOMYCIN SULFATE, BLEOMYCIN SULFATE BLEPH-10, SULFACETAMIDE SODIUM BLEPHAMIDE S.O.P., PREDNISOLONE ACETATE BLEPHAMIDE, PREDNISOLONE ACETATE BONIVA, IBANDRONATE SODIUM BONTRIL PDM, PHENDIMETRAZINE TARTRATE BONTRIL, PHENDIMETRAZINE TARTRATE BOSULIF, BOSUTINIB MONOHYDRATE BRANCHAMIN 4% IN PLASTIC CONTAINER, AMINO ACIDS BRAVELLE, UROFOLLITROPIN BREATHTEK UBT FOR H-PYLORI, UREA C-13 BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER, BRETYLIUM TOSYLATE BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC, ESMOLOL HYDROCHLORIDE BREVICON 28-DAY, ETHINYL ESTRADIOL BREVITAL SODIUM, METHOHEXITAL SODIUM BRIAN CARE, CHLORHEXIDINE GLUCONATE (OTC)
APPENDIX A
**
PRODUCT NAME INDEX

B **
A - 8
BRIELLYN, ETHINYL ESTRADIOL BRILINTA, TICAGRELOR BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE BROMDAY, BROMFENAC SODIUM BROMFED-DM, BROMPHENIRAMINE MALEATE BROMFENAC SODIUM, BROMFENAC SODIUM BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE BRONCHO SALINE, SODIUM CHLORIDE (OTC) BROVANA, ARFORMOTEROL TARTRATE BSS PLUS, CALCIUM CHLORIDE BSS, CALCIUM CHLORIDE BUDESONIDE, BUDESONIDE BUMETANIDE, BUMETANIDE BUPHENYL, SODIUM PHENYLBUTYRATE BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE BUPRENEX, BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE BUSULFEX, BUSULFAN BUTALBITAL AND ACETAMINOPHEN, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN BUTALBITAL, ASPIRIN AND CAFFEINE, ASPIRIN BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN BUTAPAP, ACETAMINOPHEN BUTISOL SODIUM, BUTABARBITAL SODIUM BUTOCONAZOLE NITRATE, BUTOCONAZOLE NITRATE BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE BUTRANS, BUPRENORPHINE BYDUREON, EXENATIDE SYNTHETIC BYETTA, EXENATIDE SYNTHETIC BYSTOLIC, NEBIVOLOL HYDROCHLORIDE
**
**
CABERGOLINE, CABERGOLINE CADUET, AMLODIPINE BESYLATE CAFCIT, CAFFEINE CITRATE CAFERGOT, CAFFEINE CAFFEINE CITRATE, CAFFEINE CITRATE CALAN SR, VERAPAMIL HYDROCHLORIDE CALAN, VERAPAMIL HYDROCHLORIDE CALCIJEX, CALCITRIOL CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CALCIPOTRIENE, CALCIPOTRIENE CALCITONIN-SALMON, CALCITONIN SALMON CALCITRIOL, CALCITRIOL CALCIUM ACETATE, CALCIUM ACETATE CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE, CALCIUM CARBONATE CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER, CALCIUM CHLORIDE CALCIUM DISODIUM VERSENATE, EDETATE CALCIUM DISODIUM CALDOLOR, IBUPROFEN CAMBIA, DICLOFENAC POTASSIUM CAMILA, NORETHINDRONE CAMPRAL, ACAMPROSATE CALCIUM CAMPTOSAR, IRINOTECAN HYDROCHLORIDE CANASA, MESALAMINE CANCIDAS, CASPOFUNGIN ACETATE CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL
(OTC)
APPENDIX A
**
PRODUCT NAME INDEX

C **
A - 9
CANTIL, MEPENZOLATE BROMIDE CAPASTAT SULFATE, CAPREOMYCIN SULFATE CAPEX, FLUOCINOLONE ACETONIDE CAPITAL AND CODEINE, ACETAMINOPHEN CAPITAL SOLEIL 15, AVOBENZONE (OTC) CAPOTEN, CAPTOPRIL CAPOZIDE 25/15, CAPTOPRIL CAPOZIDE 25/25, CAPTOPRIL CAPOZIDE 50/15, CAPTOPRIL CAPOZIDE 50/25, CAPTOPRIL CAPRELSA, VANDETANIB CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL CAPTOPRIL, CAPTOPRIL CARAC, FLUOROURACIL CARAFATE, SUCRALFATE CARBAGLU, CARGLUMIC ACID CARBAMAZEPINE, CARBAMAZEPINE CARBATROL, CARBAMAZEPINE CARBIDOPA AND LEVODOPA, CARBIDOPA CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE CARBOCAINE, MEPIVACAINE HYDROCHLORIDE CARBOPLATIN, CARBOPLATIN CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE SR, NICARDIPINE HYDROCHLORIDE CARDENE, NICARDIPINE HYDROCHLORIDE CARDIOGEN-82, RUBIDIUM CHLORIDE RB-82 CARDIOLITE, TECHNETIUM TC-99M SESTAMIBI KIT CARDIOPLEGIC IN PLASTIC CONTAINER, CALCIUM CHLORIDE CARDIZEM CD, DILTIAZEM HYDROCHLORIDE CARDIZEM LA, DILTIAZEM HYDROCHLORIDE CARDIZEM, DILTIAZEM HYDROCHLORIDE CARDURA XL, DOXAZOSIN MESYLATE CARDURA, DOXAZOSIN MESYLATE CARISOPRODOL AND ASPIRIN, ASPIRIN CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN CARISOPRODOL, CARISOPRODOL CARMOL HC, HYDROCORTISONE ACETATE CARNITOR SF, LEVOCARNITINE CARNITOR, LEVOCARNITINE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE CARTIA XT, DILTIAZEM HYDROCHLORIDE CARVEDILOL, CARVEDILOL CASODEX, BICALUTAMIDE CATAFLAM, DICLOFENAC POTASSIUM CATAPRES, CLONIDINE HYDROCHLORIDE CATAPRES-TTS-1, CLONIDINE CATAPRES-TTS-2, CLONIDINE CATAPRES-TTS-3, CLONIDINE CAVERJECT IMPULSE, ALPROSTADIL CAVERJECT, ALPROSTADIL CAYSTON, AZTREONAM CEDAX, CEFTIBUTEN DIHYDRATE CEENU, LOMUSTINE CEFACLOR, CEFACLOR CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFAZOLIN AND DEXTROSE, CEFAZOLIN SODIUM CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFDINIR, CEFDINIR CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER, CEFEPIME HYDROCHLORIDE CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

C **
A - 10
CEFEPIME IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFOTAXIME, CEFOTAXIME SODIUM CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER, CEFOTETAN DISODIUM CEFOTETAN, CEFOTETAN DISODIUM CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER, CEFOXITIN SODIUM CEFOXITIN, CEFOXITIN SODIUM CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFTAZIDIME IN DEXTROSE CONTAINER, CEFTAZIDIME CEFTAZIDIME, CEFTAZIDIME CEFTIN, CEFUROXIME AXETIL CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER, CEFTRIAXONE SODIUM CEFTRIAXONE IN PLASTIC CONTAINER, CEFTRIAXONE SODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER, CEFUROXIME SODIUM CEFUROXIME AXETIL, CEFUROXIME AXETIL CEFUROXIME SODIUM IN PLASTIC CONTAINER, CEFUROXIME SODIUM CEFUROXIME SODIUM, CEFUROXIME SODIUM CELEBREX, CELECOXIB CELESTONE SOLUSPAN, BETAMETHASONE ACETATE CELEXA, CITALOPRAM HYDROBROMIDE CELLCEPT, MYCOPHENOLATE MOFETIL CELLCEPT, MYCOPHENOLATE MOFETIL HYDROCHLORIDE CELONTIN, METHSUXIMIDE CENESTIN, ESTROGENS, CONJUGATED SYNTHETIC A CENTANY, MUPIROCIN CEPHALEXIN, CEPHALEXIN CERETEC, TECHNETIUM TC-99M EXAMETAZIME KIT CEREZYME, IMIGLUCERASE CERUBIDINE, DAUNORUBICIN HYDROCHLORIDE CERVIDIL, DINOPROSTONE CESAMET, NABILONE CETAMIDE, SULFACETAMIDE SODIUM CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CETRAXAL, CIPROFLOXACIN HYDROCHLORIDE CETROTIDE, CETRORELIX CEVIMELINE, CEVIMELINE HYDROCHLORIDE CHANTIX, VARENICLINE TARTRATE CHEMET, SUCCIMER CHENODIOL, CHENODIOL CHG SCRUB, CHLORHEXIDINE GLUCONATE (OTC) CHILDREN'S ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC) CHILDREN'S ADVIL COLD, IBUPROFEN (OTC) CHILDREN'S ADVIL, IBUPROFEN (OTC) CHILDREN'S ADVIL-FLAVORED, IBUPROFEN (OTC) CHILDREN'S ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CLARITIN, LORATADINE (OTC) CHILDREN'S ELIXSURE, IBUPROFEN (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S IBUPROFEN, IBUPROFEN (OTC) CHILDREN'S MOTRIN COLD, IBUPROFEN (OTC) CHILDREN'S MOTRIN, IBUPROFEN (OTC) CHILDREN'S ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHIRHOSTIM, SECRETIN SYNTHETIC HUMAN
(OTC)
APPENDIX A
**
PRODUCT NAME INDEX

C **
A - 11
CHLORAMPHENICOL SODIUM SUCCINATE, CHLORAMPHENICOL SODIUM SUCCINATE CHLORAPREP ONE-STEP FREPP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP ONE-STEP SEPP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP ONE-STEP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP SINGLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP TRIPLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP WITH TINT, CHLORHEXIDINE GLUCONATE (OTC) CHLORASCRUB MAXI SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORASCRUB SWAB, CHLORHEXIDINE GLUCONATE (OTC) CHLORASCRUB SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE (OTC) CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM CHLOROTHIAZIDE, CHLOROTHIAZIDE CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE (OTC) CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE CHLORPROPAMIDE, CHLORPROPAMIDE CHLORTHALIDONE, CHLORTHALIDONE CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE (OTC) CHLORZOXAZONE, CHLORZOXAZONE CHOLAC, LACTULOSE CHOLEDYL SA, OXTRIPHYLLINE CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE CHOLESTYRAMINE, CHOLESTYRAMINE CHOLETEC, TECHNETIUM TC-99M MEBROFENIN KIT CHOLINE C-11, CHOLINE C-11 CHOLOGRAFIN MEGLUMINE, IODIPAMIDE MEGLUMINE CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC CHROMIC CHLORIDE IN PLASTIC CONTAINER, CHROMIC CHLORIDE CIALIS, TADALAFIL CICLOPIROX, CICLOPIROX CIDA-STAT, CHLORHEXIDINE GLUCONATE (OTC) CIDOFOVIR, CIDOFOVIR CILOSTAZOL, CILOSTAZOL CILOXAN, CIPROFLOXACIN HYDROCHLORIDE CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CIMETIDINE, CIMETIDINE CIMETIDINE, CIMETIDINE (OTC) CIPRO HC, CIPROFLOXACIN HYDROCHLORIDE CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPRO XR, CIPROFLOXACIN CIPRO, CIPROFLOXACIN CIPRO, CIPROFLOXACIN HYDROCHLORIDE CIPRODEX, CIPROFLOXACIN CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN CISATRACURIUM BESYLATE PRESERVATIVE FREE, CISATRACURIUM BESYLATE CISATRACURIUM BESYLATE, CISATRACURIUM BESYLATE CIS-MDP, TECHNETIUM TC-99M MEDRONATE KIT CISPLATIN, CISPLATIN CIS-PYRO, TECHNETIUM TC-99M PYROPHOSPHATE KIT CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CITANEST FORTE DENTAL, EPINEPHRINE BITARTRATE CLADRIBINE, CLADRIBINE CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER, CEFOTAXIME SODIUM CLAFORAN, CEFOTAXIME SODIUM CLARAVIS, ISOTRETINOIN CLARINEX D 24 HOUR, DESLORATADINE
APPENDIX A
**
PRODUCT NAME INDEX

C **
A - 12
CLARINEX, DESLORATADINE CLARINEX-D 12 HOUR, DESLORATADINE CLARITHROMYCIN, CLARITHROMYCIN CLARITIN HIVES RELIEF REDITAB, LORATADINE (OTC) CLARITIN HIVES RELIEF, LORATADINE (OTC) CLARITIN REDITABS, LORATADINE (OTC) CLARITIN, LORATADINE (OTC) CLARITIN-D 24 HOUR, LORATADINE (OTC) CLARITIN-D, LORATADINE (OTC) CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE (OTC) CLEOCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLEOCIN T, CLINDAMYCIN PHOSPHATE CLEOCIN, CLINDAMYCIN PALMITATE HYDROCHLORIDE CLEOCIN, CLINDAMYCIN PHOSPHATE CLEVIPREX, CLEVIDIPINE BUTYRATE CLIMARA PRO, ESTRADIOL CLIMARA, ESTRADIOL CLINDA-DERM, CLINDAMYCIN PHOSPHATE CLINDAGEL, CLINDAMYCIN PHOSPHATE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLINDESSE, CLINDAMYCIN PHOSPHATE CLINDETS, CLINDAMYCIN PHOSPHATE CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS
APPENDIX A
**
PRODUCT NAME INDEX

C **
A - 13
CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS CLINORIL, SULINDAC CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOBEX, CLOBETASOL PROPIONATE CLODERM, CLOCORTOLONE PIVALATE CLOLAR, CLOFARABINE CLOMID, CLOMIPHENE CITRATE CLOMIPHENE CITRATE, CLOMIPHENE CITRATE CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CLONIDINE, CLONIDINE CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM CLORPRES, CHLORTHALIDONE CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE CLOTRIMAZOLE, CLOTRIMAZOLE (OTC) CLOZAPINE, CLOZAPINE CLOZARIL, CLOZAPINE COARTEM, ARTEMETHER CODEINE SULFATE, CODEINE SULFATE COGENTIN, BENZTROPINE MESYLATE CO-GESIC, ACETAMINOPHEN COLAZAL, BALSALAZIDE DISODIUM COLCRYS, COLCHICINE COLESTID, COLESTIPOL HYDROCHLORIDE COLESTIPOL HYDROCHLORIDE, COLESTIPOL HYDROCHLORIDE COLGATE TOTAL, SODIUM FLUORIDE (OTC) COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM COLOCORT, HYDROCORTISONE COL-PROBENECID, COLCHICINE COLY-MYCIN M, COLISTIMETHATE SODIUM COLY-MYCIN S, COLISTIN SULFATE COLYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350 COLYTE, POLYETHYLENE GLYCOL 3350 COLYTE-FLAVORED, POLYETHYLENE GLYCOL 3350 COMBIGAN, BRIMONIDINE TARTRATE COMBIPATCH, ESTRADIOL COMBIVENT RESPIMAT, ALBUTEROL SULFATE COMBIVENT, ALBUTEROL SULFATE COMBIVIR, LAMIVUDINE COMETRIQ, CABOZANTINIB S-MALATE COMMIT, NICOTINE POLACRILEX (OTC) COMPLERA, EMTRICITABINE COMPRO, PROCHLORPERAZINE COMTAN, ENTACAPONE CONCERTA, METHYLPHENIDATE HYDROCHLORIDE CONDYLOX, PODOFILOX CONRAY 30, IOTHALAMATE MEGLUMINE CONRAY 43, IOTHALAMATE MEGLUMINE CONRAY, IOTHALAMATE MEGLUMINE CONSTILAC, LACTULOSE CONSTULOSE, LACTULOSE CONZIP, TRAMADOL HYDROCHLORIDE COPAXONE, GLATIRAMER ACETATE COPEGUS, RIBAVIRIN CORDARONE, AMIODARONE HYDROCHLORIDE CORDRAN SP, FLURANDRENOLIDE CORDRAN, FLURANDRENOLIDE COREG CR, CARVEDILOL PHOSPHATE COREG, CARVEDILOL CORGARD, NADOLOL
APPENDIX A
**
PRODUCT NAME INDEX

C **
A - 14
CORLOPAM, FENOLDOPAM MESYLATE CORMAX, CLOBETASOL PROPIONATE CORTEF, HYDROCORTISONE CORTENEMA, HYDROCORTISONE CORTIFOAM, HYDROCORTISONE ACETATE CORTISONE ACETATE, CORTISONE ACETATE CORTISPORIN, BACITRACIN ZINC CORTISPORIN, HYDROCORTISONE CORTISPORIN, HYDROCORTISONE ACETATE CORTROSYN, COSYNTROPIN CORVERT, IBUTILIDE FUMARATE CORZIDE, BENDROFLUMETHIAZIDE COSMEGEN, DACTINOMYCIN COSOPT PF, DORZOLAMIDE HYDROCHLORIDE COSOPT, DORZOLAMIDE HYDROCHLORIDE COSYNTROPIN, COSYNTROPIN COUMADIN, WARFARIN SODIUM COVERA-HS, VERAPAMIL HYDROCHLORIDE COZAAR, LOSARTAN POTASSIUM CREON, LIPASE CRESTOR, ROSUVASTATIN CALCIUM CRINONE, PROGESTERONE CRIXIVAN, INDINAVIR SULFATE CROLOM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM (OTC) CROTAN, CROTAMITON CRYSELLE, ETHINYL ESTRADIOL C-SOLVE-2, ERYTHROMYCIN CUBICIN, DAPTOMYCIN CUPRIC CHLORIDE IN PLASTIC CONTAINER, CUPRIC CHLORIDE CUPRIMINE, PENICILLAMINE CUROSURF, PORACTANT ALFA CUTIVATE, FLUTICASONE PROPIONATE CUVPOSA, GLYCOPYRROLATE CYANOCOBALAMIN, CYANOCOBALAMIN CYANOKIT, HYDROXOCOBALAMIN CYCLAFEM 1/35, ETHINYL ESTRADIOL CYCLAFEM 7/7/7, ETHINYL ESTRADIOL CYCLESSA, DESOGESTREL CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYCLOGYL, CYCLOPENTOLATE HYDROCHLORIDE CYCLOMYDRIL, CYCLOPENTOLATE HYDROCHLORIDE CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE CYCLOSET, BROMOCRIPTINE MESYLATE CYCLOSPORINE, CYCLOSPORINE CYKLOKAPRON, TRANEXAMIC ACID CYMBALTA, DULOXETINE HYDROCHLORIDE CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE CYSTADANE, BETAINE HYDROCHLORIDE CYSTAGON, CYSTEAMINE BITARTRATE CYSTARAN, CYSTEAMINE HYDROCHLORIDE CYSTO-CONRAY II, IOTHALAMATE MEGLUMINE CYSTOGRAFIN DILUTE, DIATRIZOATE MEGLUMINE CYSTOGRAFIN, DIATRIZOATE MEGLUMINE CYSVIEW KIT, HEXAMINOLEVULINATE HYDROCHLORIDE CYTARABINE, CYTARABINE CYTOMEL, LIOTHYRONINE SODIUM CYTOSAR-U, CYTARABINE CYTOTEC, MISOPROSTOL CYTOVENE, GANCICLOVIR SODIUM CYTOXAN, CYCLOPHOSPHAMIDE
APPENDIX A
**
PRODUCT NAME INDEX

D **
A - 15
D.H.E. 45, DIHYDROERGOTAMINE MESYLATE DACARBAZINE, DACARBAZINE DACOGEN, DECITABINE DACTINOMYCIN, DACTINOMYCIN DALIRESP, ROFLUMILAST DANAZOL, DANAZOL DANTRIUM, DANTROLENE SODIUM DANTROLENE SODIUM, DANTROLENE SODIUM DAPSONE, DAPSONE DARAPRIM, PYRIMETHAMINE DASETTA 1/35, ETHINYL ESTRADIOL DASETTA 7/7/7, ETHINYL ESTRADIOL DATSCAN, IOFLUPANE I-123 DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DAUNOXOME, DAUNORUBICIN CITRATE DAYPRO, OXAPROZIN DAYTRANA, METHYLPHENIDATE DDAVP (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DDAVP, DESMOPRESSIN ACETATE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEFINITY, PERFLUTREN DELATESTRYL, TESTOSTERONE ENANTHATE DELESTROGEN, ESTRADIOL VALERATE DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELSYM, DEXTROMETHORPHAN POLISTIREX (OTC) DEMADEX, TORSEMIDE DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE DEMEROL, MEPERIDINE HYDROCHLORIDE DEMSER, METYROSINE DENAVIR, PENCICLOVIR SODIUM DENDRID, IDOXURIDINE DEPACON, VALPROATE SODIUM DEPAKENE, VALPROIC ACID DEPAKOTE ER, DIVALPROEX SODIUM DEPAKOTE, DIVALPROEX SODIUM DEPEN, PENICILLAMINE DEPOCYT, CYTARABINE DEPO-ESTRADIOL, ESTRADIOL CYPIONATE DEPO-MEDROL, METHYLPREDNISOLONE ACETATE DEPO-PROVERA, MEDROXYPROGESTERONE ACETATE DEPO-SUBQ PROVERA 104, MEDROXYPROGESTERONE ACETATE DEPO-TESTOSTERONE, TESTOSTERONE CYPIONATE DERMABET, BETAMETHASONE VALERATE DERMA-SMOOTHE/FS, FLUOCINOLONE ACETONIDE DERMATOP E EMOLLIENT, PREDNICARBATE DERMATOP, PREDNICARBATE DERMOTIC, FLUOCINOLONE ACETONIDE DESFERAL, DEFEROXAMINE MESYLATE DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR, DESLORATADINE DESLORATADINE, DESLORATADINE
APPENDIX A
**
PRODUCT NAME INDEX

D **
A - 16
DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DESOGEN, DESOGESTREL DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL DESONATE, DESONIDE DESONIDE, DESONIDE DESOWEN, DESONIDE DESOXIMETASONE, DESOXIMETASONE DESOXYN, METHAMPHETAMINE HYDROCHLORIDE DETROL LA, TOLTERODINE TARTRATE DETROL, TOLTERODINE TARTRATE DEXAMETHASONE INTENSOL, DEXAMETHASONE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DEXAMETHASONE, DEXAMETHASONE DEXASPORIN, DEXAMETHASONE DEXCHLORPHENIRAMINE MALEATE, DEXCHLORPHENIRAMINE MALEATE DEXEDRINE, DEXTROAMPHETAMINE SULFATE DEXFERRUM, IRON DEXTRAN DEXILANT, DEXLANSOPRAZOLE DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE ASPARTATE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE DEXTROMETHORPHAN POLISTIREX, DEXTROMETHORPHAN POLISTIREX (OTC) DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 25%, DEXTROSE DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE
APPENDIX A
**
PRODUCT NAME INDEX

D **
A - 17
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 60% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE DIABETA, GLYBURIDE DIABINESE, CHLORPROPAMIDE DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIAMOX, ACETAZOLAMIDE DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIASTAT ACUDIAL, DIAZEPAM DIASTAT, DIAZEPAM DIAZEPAM INTENSOL, DIAZEPAM DIAZEPAM, DIAZEPAM DIBENZYLINE, PHENOXYBENZAMINE HYDROCHLORIDE DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM DICLOFENAC SODIUM AND MISOPROSTOL, DICLOFENAC SODIUM DICLOFENAC SODIUM, DICLOFENAC SODIUM DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE), DICYCLOMINE HYDROCHLORIDE DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DIDANOSINE, DIDANOSINE DIDREX, BENZPHETAMINE HYDROCHLORIDE DIDRONEL, ETIDRONATE DISODIUM DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE DIFFERIN, ADAPALENE DIFICID, FIDAXOMICIN DIFLORASONE DIACETATE, DIFLORASONE DIACETATE DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE DIFLUCAN IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE DIFLUCAN, FLUCONAZOLE
APPENDIX A
**
PRODUCT NAME INDEX

D **
A - 18
DIFLUNISAL, DIFLUNISAL DIGOXIN, DIGOXIN DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE DILACOR XR, DILTIAZEM HYDROCHLORIDE DILANTIN, PHENYTOIN DILANTIN, PHENYTOIN SODIUM DILANTIN-125, PHENYTOIN DILATRATE-SR, ISOSORBIDE DINITRATE DILAUDID, HYDROMORPHONE HYDROCHLORIDE DILAUDID-HP, HYDROMORPHONE HYDROCHLORIDE DILT-CD, DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DILTZAC, DILTIAZEM HYDROCHLORIDE DIMENHYDRINATE, DIMENHYDRINATE DIMETHYL SULFOXIDE, DIMETHYL SULFOXIDE DIOVAN HCT, HYDROCHLOROTHIAZIDE DIOVAN, VALSARTAN DIPENTUM, OLSALAZINE SODIUM DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE DIPIVEFRIN HYDROCHLORIDE, DIPIVEFRIN HYDROCHLORIDE DIPRIVAN, PROPOFOL DIPROLENE AF, BETAMETHASONE DIPROPIONATE DIPROLENE, BETAMETHASONE DIPROPIONATE DIPYRIDAMOLE, DIPYRIDAMOLE DISOPHROL, DEXBROMPHENIRAMINE MALEATE (OTC) DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE DISULFIRAM, DISULFIRAM DITROPAN XL, OXYBUTYNIN CHLORIDE DIURIL, CHLOROTHIAZIDE DIURIL, CHLOROTHIAZIDE SODIUM DIVALPROEX SODIUM, DIVALPROEX SODIUM DIVIGEL, ESTRADIOL DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%, DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOCEFREZ, DOCETAXEL DOCETAXEL, DOCETAXEL DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE DOPRAM, DOXAPRAM HYDROCHLORIDE DORAL, QUAZEPAM DORIBAX, DORIPENEM DORYX, DOXYCYCLINE HYCLATE DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE DOVONEX, CALCIPOTRIENE DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE DOXERCALCIFEROL, DOXERCALCIFEROL DOXIL, DOXORUBICIN HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE DOXY 100, DOXYCYCLINE HYCLATE DOXY 200, DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE DOXYCYCLINE, DOXYCYCLINE HYCLATE DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE (OTC)
APPENDIX A
**
PRODUCT NAME INDEX

D **
A - 19
DRAXIMAGE MDP-25, TECHNETIUM TC-99M MEDRONATE DRISDOL, ERGOCALCIFEROL DRIXORAL PLUS, ACETAMINOPHEN (OTC) DRIXORAL, DEXBROMPHENIRAMINE MALEATE (OTC) DRONABINOL, DRONABINOL DROPERIDOL, DROPERIDOL DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE DROXIA, HYDROXYUREA DTIC-DOME, DACARBAZINE DTPA, TECHNETIUM TC-99M PENTETATE KIT DUAC, BENZOYL PEROXIDE DUETACT, GLIMEPIRIDE DUEXIS, FAMOTIDINE DULERA, FORMOTEROL FUMARATE DUODOTE, ATROPINE DUONEB, ALBUTEROL SULFATE DURACLON, CLONIDINE HYDROCHLORIDE DURAGESIC-100, FENTANYL DURAGESIC-12, FENTANYL DURAGESIC-25, FENTANYL DURAGESIC-50, FENTANYL DURAGESIC-75, FENTANYL DURAMORPH PF, MORPHINE SULFATE DURAPREP, IODINE POVACRYLEX (OTC) DUREZOL, DIFLUPREDNATE DUTASTERIDE, DUTASTERIDE DUTOPROL, HYDROCHLOROTHIAZIDE DUVOID, BETHANECHOL CHLORIDE DYAZIDE, HYDROCHLOROTHIAZIDE DYMISTA, AZELASTINE HYDROCHLORIDE DYNACIN, MINOCYCLINE HYDROCHLORIDE DYNACIRC CR, ISRADIPINE DYNA-HEX, CHLORHEXIDINE GLUCONATE (OTC) DYRENIUM, TRIAMTERENE
**
E.E.S. 200, ERYTHROMYCIN ETHYLSUCCINATE E.E.S. 400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE EDARBI, AZILSARTAN KAMEDOXOMIL EDARBYCLOR, AZILSARTAN KAMEDOXOMIL EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDEX, ALPROSTADIL EDLUAR, ZOLPIDEM TARTRATE EDURANT, RILPIVIRINE HYDROCHLORIDE EFFEXOR XR, VENLAFAXINE HYDROCHLORIDE EFFIENT, PRASUGREL HYDROCHLORIDE EFUDEX, FLUOROURACIL EGRIFTA, TESAMORELIN ACETATE ELDEPRYL, SELEGILINE HYDROCHLORIDE ELELYSO, TALIGLUCERASE ALFA ELESTAT, EPINASTINE HYDROCHLORIDE ELESTRIN, ESTRADIOL ELIDEL, PIMECROLIMUS ELIGARD, LEUPROLIDE ACETATE ELIMITE, PERMETHRIN ELINEST, ETHINYL ESTRADIOL ELIPHOS, CALCIUM ACETATE ELIQUIS, APIXABAN ELIXOPHYLLIN, THEOPHYLLINE
**
APPENDIX A
**
PRODUCT NAME INDEX

E **
A - 20
ELLA, ULIPRISTAL ACETATE ELLENCE, EPIRUBICIN HYDROCHLORIDE ELLIOTTS B SOLUTION, CALCIUM CHLORIDE ELMIRON, PENTOSAN POLYSULFATE SODIUM ELOCON, MOMETASONE FUROATE ELOXATIN, OXALIPLATIN EMADINE, EMEDASTINE DIFUMARATE EMBEDA, MORPHINE SULFATE EMBELINE E, CLOBETASOL PROPIONATE EMBELINE, CLOBETASOL PROPIONATE EMCYT, ESTRAMUSTINE PHOSPHATE SODIUM EMEND, APREPITANT EMEND, FOSAPREPITANT DIMEGLUMINE EMLA, LIDOCAINE EMOQUETTE, DESOGESTREL EMSAM, SELEGILINE EMTRIVA, EMTRICITABINE ENABLEX, DARIFENACIN HYDROBROMIDE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ENALAPRIL MALEATE, ENALAPRIL MALEATE ENALAPRILAT, ENALAPRILAT ENDOMETRIN, PROGESTERONE ENDOSOL EXTRA, CALCIUM CHLORIDE ENFLURANE, ENFLURANE ENJUVIA, ESTROGENS, CONJUGATED SYNTHETIC B ENLON, EDROPHONIUM CHLORIDE ENLON-PLUS, ATROPINE SULFATE ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM ENOXAPARIN SODIUM, ENOXAPARIN SODIUM ENPRESSE-28, ETHINYL ESTRADIOL ENTACAPONE, ENTACAPONE ENTEREG, ALVIMOPAN ENTOCORT EC, BUDESONIDE ENULOSE, LACTULOSE EOVIST, GADOXETATE DISODIUM EPIDUO, ADAPALENE EPIFOAM, HYDROCORTISONE ACETATE EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE EPINEPHRINE, EPINEPHRINE (OTC) EPIPEN JR., EPINEPHRINE EPIPEN, EPINEPHRINE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE EPITOL, CARBAMAZEPINE EPIVIR, LAMIVUDINE EPIVIR-HBV, LAMIVUDINE EPLERENONE, EPLERENONE EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM EPROSARTAN MESYLATE, EPROSARTAN MESYLATE EPZICOM, ABACAVIR SULFATE EQUETRO, CARBAMAZEPINE ERAXIS, ANIDULAFUNGIN ERGOCALCIFEROL, ERGOCALCIFEROL ERGOLOID MESYLATES, ERGOLOID MESYLATES ERGOMAR, ERGOTAMINE TARTRATE ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE ERIVEDGE, VISMODEGIB ERRIN, NORETHINDRONE ERTACZO, SERTACONAZOLE NITRATE ERYC, ERYTHROMYCIN ERYGEL, ERYTHROMYCIN ERYPED, ERYTHROMYCIN ETHYLSUCCINATE ERY-TAB, ERYTHROMYCIN ERYTHRA-DERM, ERYTHROMYCIN ERYTHROCIN STEARATE, ERYTHROMYCIN STEARATE
APPENDIX A
**
PRODUCT NAME INDEX

E **
A - 21
ERYTHROCIN, ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN AND BENZOYL PEROXIDE, BENZOYL PEROXIDE ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN, ERYTHROMYCIN ERYTHRO-STATIN, ERYTHROMYCIN ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE ESGIC-PLUS, ACETAMINOPHEN ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE ESTARYLLA, ETHINYL ESTRADIOL ESTAZOLAM, ESTAZOLAM ESTRACE, ESTRADIOL ESTRADERM, ESTRADIOL ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL ESTRADIOL AND NORGESTIMATE, ESTRADIOL ESTRADIOL CYPIONATE, ESTRADIOL CYPIONATE ESTRADIOL VALERATE, ESTRADIOL VALERATE ESTRADIOL, ESTRADIOL ESTRASORB, ESTRADIOL HEMIHYDRATE ESTRING, ESTRADIOL ESTROGEL, ESTRADIOL ESTRONE, ESTRONE ESTROPIPATE, ESTROPIPATE ESTROSTEP FE, ETHINYL ESTRADIOL ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE ETHAMOLIN, ETHANOLAMINE OLEATE ETHOSUXIMIDE, ETHOSUXIMIDE ETHRANE, ENFLURANE ETHYOL, AMIFOSTINE ETIDRONATE DISODIUM, ETIDRONATE DISODIUM ETODOLAC, ETODOLAC ETOMIDATE, ETOMIDATE ETOPOPHOS PRESERVATIVE FREE, ETOPOSIDE PHOSPHATE ETOPOSIDE, ETOPOSIDE EURAX, CROTAMITON EVAMIST, ESTRADIOL EVISTA, RALOXIFENE HYDROCHLORIDE EVOCLIN, CLINDAMYCIN PHOSPHATE EVOXAC, CEVIMELINE HYDROCHLORIDE EXALGO, HYDROMORPHONE HYDROCHLORIDE EXCEDRIN (MIGRAINE), ACETAMINOPHEN (OTC) EXELDERM, SULCONAZOLE NITRATE EXELON, RIVASTIGMINE EXELON, RIVASTIGMINE TARTRATE EXEMESTANE, EXEMESTANE EXFORGE HCT, AMLODIPINE BESYLATE EXFORGE, AMLODIPINE BESYLATE EXIDINE, CHLORHEXIDINE GLUCONATE (OTC) EXJADE, DEFERASIROX EXPAREL, BUPIVACAINE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM EXTINA, KETOCONAZOLE EXTRANEAL, ICODEXTRIN E-Z SCRUB 201, POVIDONE-IODINE (OTC) E-Z SCRUB 241, POVIDONE-IODINE (OTC)
**
**
FABIOR, TAZAROTENE FACTIVE, GEMIFLOXACIN MESYLATE FALMINA, ETHINYL ESTRADIOL FAMCICLOVIR, FAMCICLOVIR FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK), FAMOTIDINE FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER, FAMOTIDINE
APPENDIX A
**
PRODUCT NAME INDEX

F **
A - 22
FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FAMVIR, FAMCICLOVIR FANAPT, ILOPERIDONE FARESTON, TOREMIFENE CITRATE FASLODEX, FULVESTRANT FAZACLO ODT, CLOZAPINE FELBAMATE, FELBAMATE FELBATOL, FELBAMATE FELDENE, PIROXICAM FELODIPINE, FELODIPINE FEMARA, LETROZOLE FEMCON FE, ETHINYL ESTRADIOL FEMHRT, ETHINYL ESTRADIOL FEMRING, ESTRADIOL ACETATE FEMSTAT 3, BUTOCONAZOLE NITRATE (OTC) FEMTRACE, ESTRADIOL ACETATE FENOFIBRATE (MICRONIZED), FENOFIBRATE FENOFIBRATE, FENOFIBRATE FENOGLIDE, FENOFIBRATE FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE FENOPROFEN CALCIUM, FENOPROFEN CALCIUM FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE FENTANYL CITRATE, FENTANYL CITRATE FENTANYL-100, FENTANYL FENTANYL-12, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL FENTORA, FENTANYL CITRATE FERAHEME, FERUMOXYTOL FERRIPROX, DEFERIPRONE FERRLECIT, SODIUM FERRIC GLUCONATE COMPLEX FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FIBRICOR, FENOFIBRIC ACID FINACEA, AZELAIC ACID FINASTERIDE, FINASTERIDE FIORICET W/ CODEINE, ACETAMINOPHEN FIORICET, ACETAMINOPHEN FIORINAL W/CODEINE, ASPIRIN FIORINAL, ASPIRIN FIRAZYR, ICATIBANT ACETATE FIRMAGON, DEGARELIX ACETATE FLAGYL ER, METRONIDAZOLE FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLAGYL, METRONIDAZOLE FLAREX, FLUOROMETHOLONE ACETATE FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLECTOR, DICLOFENAC EPOLAMINE FLOLAN, EPOPROSTENOL SODIUM FLOMAX, TAMSULOSIN HYDROCHLORIDE FLONASE, FLUTICASONE PROPIONATE FLO-PRED, PREDNISOLONE ACETATE FLOVENT DISKUS 100, FLUTICASONE PROPIONATE FLOVENT DISKUS 250, FLUTICASONE PROPIONATE FLOVENT DISKUS 50, FLUTICASONE PROPIONATE FLOVENT HFA, FLUTICASONE PROPIONATE
(OTC)
APPENDIX A
**
PRODUCT NAME INDEX

F **
A - 23
FLOXIN OTIC, OFLOXACIN FLOXURIDINE, FLOXURIDINE FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUCONAZOLE, FLUCONAZOLE FLUCYTOSINE, FLUCYTOSINE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FLUDEOXYGLUCOSE F 18, FLUDEOXYGLUCOSE F-18 FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18 FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE FLUMADINE, RIMANTADINE HYDROCHLORIDE FLUMAZENIL, FLUMAZENIL FLUNISOLIDE, FLUNISOLIDE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUORESCITE, FLUORESCEIN SODIUM FLUOROPLEX, FLUOROURACIL FLUOROURACIL, FLUOROURACIL FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUOXYMESTERONE, FLUOXYMESTERONE FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE FLURBIPROFEN SODIUM, FLURBIPROFEN SODIUM FLURBIPROFEN, FLURBIPROFEN FLUTAMIDE, FLUTAMIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FLUVASTATIN SODIUM, FLUVASTATIN SODIUM FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE FML FORTE, FLUOROMETHOLONE FML, FLUOROMETHOLONE FOAMCOAT, ALUMINUM HYDROXIDE (OTC) FOCALIN XR, DEXMETHYLPHENIDATE HYDROCHLORIDE FOCALIN, DEXMETHYLPHENIDATE HYDROCHLORIDE FOLIC ACID, FOLIC ACID FOLLISTIM AQ, FOLLITROPIN ALFA/BETA FOLOTYN, PRALATREXATE FOMEPIZOLE, FOMEPIZOLE FONDAPARINUX SODIUM, FONDAPARINUX SODIUM FORADIL, FORMOTEROL FUMARATE FORANE, ISOFLURANE FORFIVO XL, BUPROPION HYDROCHLORIDE FORTAMET, METFORMIN HYDROCHLORIDE FORTAZ IN PLASTIC CONTAINER, CEFTAZIDIME SODIUM FORTAZ, CEFTAZIDIME FORTEO, TERIPARATIDE RECOMBINANT HUMAN FORTESTA, TESTOSTERONE FORTICAL, CALCITONIN SALMON RECOMBINANT FOSAMAX PLUS D, ALENDRONATE SODIUM FOSAMAX, ALENDRONATE SODIUM FOSCARNET SODIUM, FOSCARNET SODIUM FOSCAVIR, FOSCARNET SODIUM FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FOSRENOL, LANTHANUM CARBONATE FRAGMIN, DALTEPARIN SODIUM FREAMINE HBC 6.9%, AMINO ACIDS FREAMINE III 10%, AMINO ACIDS FREAMINE III 3% W/ ELECTROLYTES, AMINO ACIDS
APPENDIX A
**
PRODUCT NAME INDEX

F **
A - 24
FREAMINE III 8.5% W/ ELECTROLYTES, AMINO ACIDS FREAMINE III 8.5%, AMINO ACIDS FROVA, FROVATRIPTAN SUCCINATE FULCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FULYZAQ, CROFELEMER FURADANTIN, NITROFURANTOIN FUROSEMIDE, FUROSEMIDE FUSILEV, LEVOLEUCOVORIN CALCIUM FUZEON, ENFUVIRTIDE FYCOMPA, PERAMPANEL
**
**
GABAPENTIN, GABAPENTIN GABITRIL, TIAGABINE HYDROCHLORIDE GABLOFEN, BACLOFEN GADAVIST, GADOBUTROL GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67 GALZIN, ZINC ACETATE GANCICLOVIR, GANCICLOVIR SODIUM GANIRELIX ACETATE INJECTION, GANIRELIX ACETATE GANITE, GALLIUM NITRATE GASTROCROM, CROMOLYN SODIUM GASTROGRAFIN, DIATRIZOATE MEGLUMINE GASTROMARK, FERUMOXSIL GATIFLOXACIN, GATIFLOXACIN GATTEX KIT, TEDUGLUTIDE GAVISCON, ALUMINUM HYDROXIDE (OTC) GELNIQUE, OXYBUTYNIN CHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GEMFIBROZIL, GEMFIBROZIL GEMZAR, GEMCITABINE HYDROCHLORIDE GENERLAC, LACTULOSE GENGRAF, CYCLOSPORINE GENOPTIC, GENTAMICIN SULFATE GENOTROPIN PRESERVATIVE FREE, SOMATROPIN RECOMBINANT GENOTROPIN, SOMATROPIN RECOMBINANT GENTAK, GENTAMICIN SULFATE GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE GENTAMICIN SULFATE, GENTAMICIN SULFATE GEN-XENE, CLORAZEPATE DIPOTASSIUM GEODON, ZIPRASIDONE HYDROCHLORIDE GEODON, ZIPRASIDONE MESYLATE GIAZO, BALSALAZIDE DISODIUM GILDAGIA, ETHINYL ESTRADIOL GILDESS FE 1.5/30, ETHINYL ESTRADIOL GILDESS FE 1/20, ETHINYL ESTRADIOL GILENYA, FINGOLIMOD GLEEVEC, IMATINIB MESYLATE GLIADEL, CARMUSTINE GLIMEPIRIDE, GLIMEPIRIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLIPIZIDE, GLIPIZIDE GLOFIL-125, IOTHALAMATE SODIUM I-125 GLUCAGEN, GLUCAGON HYDROCHLORIDE RECOMBINANT GLUCAGON, GLUCAGON RECOMBINANT GLUCOPHAGE XR, METFORMIN HYDROCHLORIDE GLUCOPHAGE, METFORMIN HYDROCHLORIDE GLUCOTROL XL, GLIPIZIDE GLUCOTROL, GLIPIZIDE GLUCOVANCE, GLYBURIDE GLUMETZA, METFORMIN HYDROCHLORIDE GLYBURIDE (MICRONIZED), GLYBURIDE
APPENDIX A
**
PRODUCT NAME INDEX

G **
A - 25
GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GLYBURIDE, GLYBURIDE GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE GLYCOLAX, POLYETHYLENE GLYCOL 3350 GLYCOLAX, POLYETHYLENE GLYCOL 3350 (OTC) GLYCOPYRROLATE, GLYCOPYRROLATE GLYNASE, GLYBURIDE GLYSET, MIGLITOL GOLYTELY, POLYETHYLENE GLYCOL 3350 GONAL-F RFF PEN, FOLLITROPIN ALFA/BETA GONAL-F RFF, FOLLITROPIN ALFA/BETA GONAL-F, FOLLITROPIN ALFA/BETA GRALISE, GABAPENTIN GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE GRANISTERON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE GRIFULVIN V, GRISEOFULVIN, MICROSIZE GRISEOFULVIN, GRISEOFULVIN, MICROSIZE GRISEOFULVIN,ULTRAMICROSIZE, GRISEOFULVIN, ULTRAMICROSIZE GRIS-PEG, GRISEOFULVIN, ULTRAMICROSIZE GUAIFENESIN, GUAIFENESIN (OTC) GUANABENZ ACETATE, GUANABENZ ACETATE GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE GUANIDINE HYDROCHLORIDE, GUANIDINE HYDROCHLORIDE GYNAZOLE-1, BUTOCONAZOLE NITRATE GYNE-LOTRIMIN 3 COMBINATION PACK, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN 3, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN COMBINATION PACK, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN, CLOTRIMAZOLE (OTC)
**
**
H.P. ACTHAR GEL, CORTICOTROPIN HABITROL, NICOTINE (OTC) HALAVEN, ERIBULIN MESYLATE HALCION, TRIAZOLAM HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALFLYTELY, BISACODYL HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE HALOG, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL HALOPERIDOL, HALOPERIDOL LACTATE HEATHER, NORETHINDRONE HECTOROL, DOXERCALCIFEROL HELIDAC, BISMUTH SUBSALICYLATE HEMABATE, CARBOPROST TROMETHAMINE HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM HEPATAMINE 8%, AMINO ACIDS HEPATASOL 8%, AMINO ACIDS HEPATOLITE, TECHNETIUM TC-99M DISOFENIN KIT
APPENDIX A
**
PRODUCT NAME INDEX

H **
A - 26
HEPSERA, ADEFOVIR DIPIVOXIL HERPLEX, IDOXURIDINE HEXABRIX, IOXAGLATE MEGLUMINE HEXALEN, ALTRETAMINE HIBICLENS, CHLORHEXIDINE GLUCONATE (OTC) HIBISTAT, CHLORHEXIDINE GLUCONATE (OTC) HICON, SODIUM IODIDE I-131 HIPREX, METHENAMINE HIPPURATE HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, HOMATROPINE METHYLBROMIDE HORIZANT, GABAPENTIN ENACARBIL HUMALOG KWIKPEN, INSULIN LISPRO RECOMBINANT HUMALOG MIX 50/50 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 50/50, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG, INSULIN LISPRO RECOMBINANT HUMATROPE, SOMATROPIN RECOMBINANT HUMULIN 70/30 PEN, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) HUMULIN R PEN, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN R, INSULIN RECOMBINANT HUMAN HUMULIN R, INSULIN RECOMBINANT HUMAN (OTC) HYCAMTIN, TOPOTECAN HYDROCHLORIDE HYDERGINE, ERGOLOID MESYLATES HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDRA-ZIDE, HYDRALAZINE HYDROCHLORIDE HYDREA, HYDROXYUREA HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX, CHLORPHENIRAMINE POLISTIREX HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX, CHLORPHENIRAMINE POLISTIREX HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE HYDROCORTISONE IN ABSORBASE, HYDROCORTISONE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE HYDROCORTISONE, HYDROCORTISONE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE HYDRO-RX, HYDROCORTISONE HYDROXOCOBALAMIN, HYDROXOCOBALAMIN HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE HYDROXYUREA, HYDROXYUREA HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE HYLENEX RECOMBINANT, HYALURONIDASE RECOMBINANT HUMAN HYTRIN, TERAZOSIN HYDROCHLORIDE HYZAAR, HYDROCHLOROTHIAZIDE
**
**
IBANDRONATE SODIUM, IBANDRONATE SODIUM

IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE (OTC)
IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC)
IBUPROFEN, IBUPROFEN
IBUPROFEN, IBUPROFEN (OTC)
IBUPROHM COLD AND SINUS, IBUPROFEN (OTC)
IBUPROHM, IBUPROFEN (OTC)
IBU-TAB 200, IBUPROFEN (OTC)
IBU-TAB, IBUPROFEN
IBUTILIDE FUMARATE, IBUTILIDE FUMARATE
(OTC)
APPENDIX A
**
PRODUCT NAME INDEX

I **
A - 27
IC-GREEN, INDOCYANINE GREEN ICLUSIG, PONATINIB HYDROCHLORIDE IDAMYCIN PFS, IDARUBICIN HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE PFS, IDARUBICIN HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IDKIT:HP, UREA C-13 IFEX, IFOSFAMIDE IFOSFAMIDE, IFOSFAMIDE IFOSFAMIDE/MESNA KIT, IFOSFAMIDE IMIPENEM AND CILASTATIN, CILASTATIN SODIUM IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE IMIQUIMOD, IMIQUIMOD IMITREX STATDOSE, SUMATRIPTAN SUCCINATE IMITREX, SUMATRIPTAN IMITREX, SUMATRIPTAN SUCCINATE IMODIUM A-D EZ CHEWS, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM A-D, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM, LOPERAMIDE HYDROCHLORIDE IMPLANON, ETONOGESTREL IMURAN, AZATHIOPRINE INAPSINE, DROPERIDOL INCIVEK, TELAPREVIR INCRELEX, MECASERMIN RECOMBINANT INDAPAMIDE, INDAPAMIDE INDERAL LA, PROPRANOLOL HYDROCHLORIDE INDERAL, PROPRANOLOL HYDROCHLORIDE INDERIDE-40/25, HYDROCHLOROTHIAZIDE INDICLOR, INDIUM IN-111 CHLORIDE INDIUM IN 111 CHLORIDE, INDIUM IN-111 CHLORIDE INDIUM IN-111 OXYQUINOLINE, INDIUM IN-111 OXYQUINOLINE INDOCIN, INDOMETHACIN INDOCIN, INDOMETHACIN SODIUM INDOCYANINE GREEN, INDOCYANINE GREEN INDOMETHACIN SODIUM, INDOMETHACIN SODIUM INDOMETHACIN, INDOMETHACIN INFANTS' FEVERALL, ACETAMINOPHEN (OTC) INFASURF PRESERVATIVE FREE, CALFACTANT INFED, IRON DEXTRAN INFUMORPH, MORPHINE SULFATE INFUVITE ADULT, ALPHA-TOCOPHEROL ACETATE INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), ASCORBIC ACID INFUVITE PEDIATRIC, ASCORBIC ACID INLYTA, AXITINIB INNOPRAN XL, PROPRANOLOL HYDROCHLORIDE INOMAX, NITRIC OXIDE INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INSPRA, EPLERENONE INTEGRILIN, EPTIFIBATIDE INTELENCE, ETRAVIRINE INTERMEZZO, ZOLPIDEM TARTRATE INTRALIPID 10%, SOYBEAN OIL INTRALIPID 20%, SOYBEAN OIL INTRALIPID 30%, SOYBEAN OIL INTROVALE, ETHINYL ESTRADIOL INTUNIV, GUANFACINE HYDROCHLORIDE INVANZ, ERTAPENEM SODIUM INVEGA SUSTENNA, PALIPERIDONE PALMITATE INVEGA, PALIPERIDONE INVIRASE, SAQUINAVIR MESYLATE
APPENDIX A
**
PRODUCT NAME INDEX

I **
A - 28
IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IOPAMIDOL-250, IOPAMIDOL IOPAMIDOL-300, IOPAMIDOL IOPAMIDOL-370, IOPAMIDOL IOPIDINE, APRACLONIDINE HYDROCHLORIDE IOSAT, POTASSIUM IODIDE (OTC) IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE IPRIVASK, DESIRUDIN RECOMBINANT IQUIX, LEVOFLOXACIN IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE ISENTRESS, RALTEGRAVIR POTASSIUM ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN, LEVONORDEFRIN ISOCAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE ISOFLURANE, ISOFLURANE ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE E IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE S IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ISOLYTE S PH 7.4 IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ISONIAZID, ISONIAZID ISOPROTERENOL HYDROCHLORIDE, ISOPROTERENOL HYDROCHLORIDE ISOPTO CARPINE, PILOCARPINE HYDROCHLORIDE ISORDIL, ISOSORBIDE DINITRATE ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE ISOSULFAN BLUE, ISOSULFAN BLUE ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER, GENTAMICIN SULFATE ISOVUE-200, IOPAMIDOL ISOVUE-250, IOPAMIDOL ISOVUE-300, IOPAMIDOL ISOVUE-370, IOPAMIDOL ISOVUE-M 200, IOPAMIDOL ISOVUE-M 300, IOPAMIDOL ISRADIPINE, ISRADIPINE ISTALOL, TIMOLOL MALEATE ISTODAX, ROMIDEPSIN ISUPREL, ISOPROTERENOL HYDROCHLORIDE ITRACONAZOLE, ITRACONAZOLE IVY BLOCK, BENTOQUATAM (OTC) IXEMPRA KIT, IXABEPILONE
**
JAKAFI, RUXOLITINIB PHOSPHATE JALYN, DUTASTERIDE JANTOVEN, WARFARIN SODIUM JANUMET XR, METFORMIN HYDROCHLORIDE JANUMET, METFORMIN HYDROCHLORIDE JANUVIA, SITAGLIPTIN PHOSPHATE JEANATOPE, ALBUMIN IODINATED I-125 SERUM JENTADUETO, LINAGLIPTIN JEVTANA KIT, CABAZITAXEL JUNEL 1.5/30, ETHINYL ESTRADIOL JUNEL 1/20, ETHINYL ESTRADIOL JUNEL FE 1.5/30, ETHINYL ESTRADIOL JUNEL FE 1/20, ETHINYL ESTRADIOL JUNIOR STRENGTH ADVIL, IBUPROFEN (OTC)
**
APPENDIX A
**
PRODUCT NAME INDEX

J **
A - 29
JUNIOR STRENGTH IBUPROFEN, IBUPROFEN (OTC)

JUNIOR STRENGTH MOTRIN, IBUPROFEN (OTC)
JUVISYNC, SIMVASTATIN
JUXTAPID, LOMITAPIDE MESYLATE
**
KADIAN, MORPHINE SULFATE KALETRA, LOPINAVIR KALEXATE, SODIUM POLYSTYRENE SULFONATE KALYDECO, IVACAFTOR KANAMYCIN SULFATE, KANAMYCIN SULFATE KAPVAY, CLONIDINE HYDROCHLORIDE KARIVA, DESOGESTREL KAYEXALATE, SODIUM POLYSTYRENE SULFONATE KAZANO, ALOGLIPTIN BENZOATE KEFLEX, CEPHALEXIN KEFZOL, CEFAZOLIN SODIUM KELNOR, ETHINYL ESTRADIOL KENALOG, TRIAMCINOLONE ACETONIDE KENALOG-10, TRIAMCINOLONE ACETONIDE KENALOG-40, TRIAMCINOLONE ACETONIDE KEPPRA XR, LEVETIRACETAM KEPPRA, LEVETIRACETAM KETALAR, KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE KETEK, TELITHROMYCIN KETOCONAZOLE, KETOCONAZOLE KETOPROFEN, KETOPROFEN KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC) KETOZOLE, KETOCONAZOLE KINEVAC, SINCALIDE KIONEX, SODIUM POLYSTYRENE SULFONATE KLARON, SULFACETAMIDE SODIUM KLONOPIN, CLONAZEPAM KLOR-CON M10, POTASSIUM CHLORIDE KLOR-CON M15, POTASSIUM CHLORIDE KLOR-CON M20, POTASSIUM CHLORIDE KLOR-CON, POTASSIUM CHLORIDE KOMBIGLYZE XR, METFORMIN HYDROCHLORIDE KORLYM, MIFEPRISTONE K-TAB, POTASSIUM CHLORIDE KURVELO, ETHINYL ESTRADIOL KUVAN, SAPROPTERIN DIHYDROCHLORIDE KYPROLIS, CARFILZOMIB
**
**
**
LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LABETALOL HYDROCLORIDE, LABETALOL HYDROCHLORIDE LAC-HYDRIN, AMMONIUM LACTATE LACRISERT, HYDROXYPROPYL CELLULOSE LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE LACTULOSE, LACTULOSE LAMICTAL CD, LAMOTRIGINE LAMICTAL ODT, LAMOTRIGINE LAMICTAL XR, LAMOTRIGINE LAMICTAL, LAMOTRIGINE LAMISIL AT, TERBINAFINE (OTC) LAMISIL AT, TERBINAFINE HYDROCHLORIDE (OTC) LAMISIL, TERBINAFINE HYDROCHLORIDE LAMISIL, TERBINAFINE HYDROCHLORIDE (OTC) LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE
APPENDIX A
**
PRODUCT NAME INDEX

L **
A - 30
LAMIVUDINE, LAMIVUDINE LAMOTRIGINE, LAMOTRIGINE LAMPRENE, CLOFAZIMINE LANORINAL, ASPIRIN LANOXIN PEDIATRIC, DIGOXIN LANOXIN, DIGOXIN LANSOPRAZOLE, LANSOPRAZOLE LANSOPRAZOLE, LANSOPRAZOLE (OTC) LANTUS, INSULIN GLARGINE RECOMBINANT LAROTID, AMOXICILLIN LARYNG-O-JET KIT, LIDOCAINE HYDROCHLORIDE LASIX, FUROSEMIDE LASTACAFT, ALCAFTADINE LATANOPROST, LATANOPROST LATISSE, BIMATOPROST LATUDA, LURASIDONE HYDROCHLORIDE LAX-LYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350 LAZANDA, FENTANYL CITRATE LEFLUNOMIDE, LEFLUNOMIDE LESCOL XL, FLUVASTATIN SODIUM LESCOL, FLUVASTATIN SODIUM LESSINA-28, ETHINYL ESTRADIOL LETAIRIS, AMBRISENTAN LETROZOLE, LETROZOLE LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEUKERAN, CHLORAMBUCIL LEUPROLIDE ACETATE, LEUPROLIDE ACETATE LEUSTATIN, CLADRIBINE LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN LEVAQUIN, LEVOFLOXACIN LEVATOL, PENBUTOLOL SULFATE LEVEMIR FLEXPEN, INSULIN DETEMIR RECOMBINANT LEVEMIR, INSULIN DETEMIR RECOMBINANT LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM LEVETIRACETAM, LEVETIRACETAM LEVITRA, VARDENAFIL HYDROCHLORIDE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE LEVOCARNITINE, LEVOCARNITINE LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN LEVOFLOXACIN, LEVOFLOXACIN LEVONEST, ETHINYL ESTRADIOL LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) LEVOPHED, NOREPINEPHRINE BITARTRATE LEVORA 0.15/30-28, ETHINYL ESTRADIOL LEVORPHANOL TARTRATE, LEVORPHANOL TARTRATE LEVO-T, LEVOTHYROXINE SODIUM LEVOTHROID, LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM LEVOXYL, LEVOTHYROXINE SODIUM LEVULAN, AMINOLEVULINIC ACID HYDROCHLORIDE LEXAPRO, ESCITALOPRAM OXALATE LEXISCAN, REGADENOSON LEXIVA, FOSAMPRENAVIR CALCIUM LIALDA, MESALAMINE LIBRIUM, CHLORDIAZEPOXIDE HYDROCHLORIDE LIDOCAINE AND PRILOCAINE, LIDOCAINE LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

L **
A - 31
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EPINEPHRINE LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE VISCOUS, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LIDOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE LIDOCAINE, LIDOCAINE LIDODERM, LIDOCAINE LIDOPEN, LIDOCAINE HYDROCHLORIDE LIGNOSPAN FORTE, EPINEPHRINE BITARTRATE LIGNOSPAN STANDARD, EPINEPHRINE BITARTRATE LINCOCIN, LINCOMYCIN HYDROCHLORIDE LINDANE, LINDANE LINEZOLID, LINEZOLID LINZESS, LINACLOTIDE LIORESAL, BACLOFEN LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM LIPITOR, ATORVASTATIN CALCIUM LIPOFEN, FENOFIBRATE LIPOSYN II 10%, SAFFLOWER OIL LIPOSYN II 20%, SAFFLOWER OIL LIPOSYN III 10%, SOYBEAN OIL LIPOSYN III 20%, SOYBEAN OIL LIPOSYN III 30%, SOYBEAN OIL LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LITHIUM CARBONATE, LITHIUM CARBONATE LITHIUM CITRATE, LITHIUM CITRATE LITHOBID, LITHIUM CARBONATE LITHOSTAT, ACETOHYDROXAMIC ACID LIVALO, PITAVASTATIN CALCIUM LO LOESTRIN FE, ETHINYL ESTRADIOL LO/OVRAL-28, ETHINYL ESTRADIOL LOCOID LIPOCREAM, HYDROCORTISONE BUTYRATE LOCOID, HYDROCORTISONE BUTYRATE LODOSYN, CARBIDOPA LOESTRIN 21 1.5/30, ETHINYL ESTRADIOL LOESTRIN 21 1/20, ETHINYL ESTRADIOL LOESTRIN 24 FE, ETHINYL ESTRADIOL LOESTRIN FE 1.5/30, ETHINYL ESTRADIOL LOESTRIN FE 1/20, ETHINYL ESTRADIOL LOMOTIL, ATROPINE SULFATE LONOX, ATROPINE SULFATE LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) LOPID, GEMFIBROZIL LOPRESSOR HCT, HYDROCHLOROTHIAZIDE LOPRESSOR, METOPROLOL TARTRATE LOPROX, CICLOPIROX LOPURIN, ALLOPURINOL LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE REDIDOSE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) LORAZEPAM INTENSOL, LORAZEPAM LORAZEPAM PRESERVATIVE FREE, LORAZEPAM LORAZEPAM, LORAZEPAM LORTAB, ACETAMINOPHEN LORYNA, DROSPIRENONE
APPENDIX A
**
PRODUCT NAME INDEX

L **
A - 32
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOSEASONIQUE, ETHINYL ESTRADIOL LOTEMAX, LOTEPREDNOL ETABONATE LOTENSIN HCT, BENAZEPRIL HYDROCHLORIDE LOTENSIN, BENAZEPRIL HYDROCHLORIDE LOTREL, AMLODIPINE BESYLATE LOTRIMIN ULTRA, BUTENAFINE HYDROCHLORIDE (OTC) LOTRISONE, BETAMETHASONE DIPROPIONATE LOTRONEX, ALOSETRON HYDROCHLORIDE LOVASTATIN, LOVASTATIN LOVAZA, OMEGA-3-ACID ETHYL ESTERS LOVENOX (PRESERVATIVE FREE), ENOXAPARIN SODIUM LOVENOX, ENOXAPARIN SODIUM LOW-OGESTREL-21, ETHINYL ESTRADIOL LOW-OGESTREL-28, ETHINYL ESTRADIOL LOXAPINE SUCCINATE, LOXAPINE SUCCINATE LTA II KIT, LIDOCAINE HYDROCHLORIDE LUFYLLIN, DYPHYLLINE LUMIGAN, BIMATOPROST LUNESTA, ESZOPICLONE LUPANETA PACK, LEUPROLIDE ACETATE LUPRON DEPOT, LEUPROLIDE ACETATE LUPRON DEPOT-PED, LEUPROLIDE ACETATE LUVOX CR, FLUVOXAMINE MALEATE LUVOX, FLUVOXAMINE MALEATE LUXIQ, BETAMETHASONE VALERATE LYMPHAZURIN, ISOSULFAN BLUE LYRICA, PREGABALIN LYSODREN, MITOTANE LYSTEDA, TRANEXAMIC ACID
**
**
M.V.I. ADULT (PHARMACY BULK PACKAGE), ASCORBIC ACID M.V.I. ADULT, ASCORBIC ACID M.V.I. PEDIATRIC, ASCORBIC ACID M.V.I.-12 (WITHOUT VITAMIN K), ASCORBIC ACID MACROBID, NITROFURANTOIN MACRODANTIN, NITROFURANTOIN, MACROCRYSTALLINE MACUGEN, PEGAPTANIB SODIUM MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MAGNESIUM SULFATE MAGNESIUM SULFATE IN PLASTIC CONTAINER, MAGNESIUM SULFATE MAGNESIUM SULFATE, MAGNESIUM SULFATE MAGNEVIST, GADOPENTETATE DIMEGLUMINE MAKENA, HYDROXYPROGESTERONE CAPROATE MALARONE PEDIATRIC, ATOVAQUONE MALARONE, ATOVAQUONE MALATHION, MALATHION MANGANESE CHLORIDE IN PLASTIC CONTAINER, MANGANESE CHLORIDE MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER, MANNITOL MANNITOL 10%, MANNITOL MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%, MANNITOL MANNITOL 15%, MANNITOL MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL MANNITOL 20%, MANNITOL MANNITOL 25%, MANNITOL MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%, MANNITOL MANNITOL 5%, MANNITOL MAPROTILINE HYDROCHLORIDE, MAPROTILINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

M **
A - 33
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE W/ EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE MARCAINE, BUPIVACAINE HYDROCHLORIDE MARINOL, DRONABINOL MARLISSA, ETHINYL ESTRADIOL MARPLAN, ISOCARBOXAZID MARQIBO KIT, VINCRISTINE SULFATE MATULANE, PROCARBAZINE HYDROCHLORIDE MAVIK, TRANDOLAPRIL MAXAIR, PIRBUTEROL ACETATE MAXALT, RIZATRIPTAN BENZOATE MAXALT-MLT, RIZATRIPTAN BENZOATE MAXIDEX, DEXAMETHASONE MAXIPIME, CEFEPIME HYDROCHLORIDE MAXITROL, DEXAMETHASONE MAXZIDE, HYDROCHLOROTHIAZIDE MAXZIDE-25, HYDROCHLOROTHIAZIDE MD-76R, DIATRIZOATE MEGLUMINE MD-GASTROVIEW, DIATRIZOATE MEGLUMINE MDP-BRACCO, TECHNETIUM TC-99M MEDRONATE KIT MEBENDAZOLE, MEBENDAZOLE MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM MEDROL, METHYLPREDNISOLONE MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE MEFENAMIC ACID, MEFENAMIC ACID MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEFOXIN IN PLASTIC CONTAINER, CEFOXITIN SODIUM MEGACE ES, MEGESTROL ACETATE MEGACE, MEGESTROL ACETATE MEGATOPE, ALBUMIN IODINATED I-131 SERUM MEGESTROL ACETATE, MEGESTROL ACETATE MELOXICAM, MELOXICAM MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE MEMBRANEBLUE, TRYPAN BLUE MENEST, ESTROGENS, ESTERIFIED MENOPUR, LUTEINIZING HORMONE MENOSTAR, ESTRADIOL MEN'S ROGAINE, MINOXIDIL (OTC) MENTAX, BUTENAFINE HYDROCHLORIDE MENTAX-TC, BUTENAFINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MEPHYTON, PHYTONADIONE MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE MEPROBAMATE, MEPROBAMATE MEPRON, ATOVAQUONE MERCAPTOPURINE, MERCAPTOPURINE MEROPENEM, MEROPENEM MERREM, MEROPENEM MESALAMINE, MESALAMINE MESNA, MESNA MESNEX, MESNA MESTINON, PYRIDOSTIGMINE BROMIDE METADATE CD, METHYLPHENIDATE HYDROCHLORIDE METADATE ER, METHYLPHENIDATE HYDROCHLORIDE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METARAMINOL BITARTRATE, METARAMINOL BITARTRATE METASTRON, STRONTIUM CHLORIDE SR-89 METAXALONE, METAXALONE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHADONE HYDROCHLORIDE INTENSOL, METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

M **
A - 34
METHADOSE, METHADONE HYDROCHLORIDE METHAMPHETAMINE HYDROCHLORIDE, METHAMPHETAMINE HYDROCHLORIDE METHAZOLAMIDE, METHAZOLAMIDE METHENAMINE HIPPURATE, METHENAMINE HIPPURATE METHERGINE, METHYLERGONOVINE MALEATE METHIMAZOLE, METHIMAZOLE METHOCARBAMOL AND ASPIRIN, ASPIRIN METHOCARBAMOL, METHOCARBAMOL METHOTREXATE PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM, METHOTREXATE SODIUM METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE METHYCLOTHIAZIDE, METHYCLOTHIAZIDE METHYLDOPA AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METHYLDOPA, METHYLDOPA METHYLDOPATE HYDROCHLORIDE, METHYLDOPATE HYDROCHLORIDE METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE METHYLIN ER, METHYLPHENIDATE HYDROCHLORIDE METHYLIN, METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE METHYLPREDNISOLONE, METHYLPREDNISOLONE METHYLTESTOSTERONE, METHYLTESTOSTERONE METIPRANOLOL, METIPRANOLOL HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOLAZONE, METOLAZONE METOPIRONE, METYRAPONE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE METOZOLV ODT, METOCLOPRAMIDE HYDROCHLORIDE METRO I.V. IN PLASTIC CONTAINER, METRONIDAZOLE METROCREAM, METRONIDAZOLE METROGEL, METRONIDAZOLE METROGEL-VAGINAL, METRONIDAZOLE METROLOTION, METRONIDAZOLE METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE METRONIDAZOLE, METRONIDAZOLE METVIXIA, METHYL AMINOLEVULINATE HYDROCHLORIDE MEVACOR, LOVASTATIN MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE MIACALCIN, CALCITONIN SALMON MICARDIS HCT, HYDROCHLOROTHIAZIDE MICARDIS, TELMISARTAN MICONAZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE 3, MICONAZOLE NITRATE (OTC) MICONAZOLE 7 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE 7, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MICORT-HC, HYDROCORTISONE ACETATE MICROGESTIN 1.5/30, ETHINYL ESTRADIOL MICROGESTIN 1/20, ETHINYL ESTRADIOL MICROGESTIN FE 1.5/30, ETHINYL ESTRADIOL MICROGESTIN FE 1/20, ETHINYL ESTRADIOL MICRO-K 10, POTASSIUM CHLORIDE MICRO-K, POTASSIUM CHLORIDE MICRONOR, NORETHINDRONE MICROZIDE, HYDROCHLOROTHIAZIDE MIDAMOR, AMILORIDE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

M **
A - 35
MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MIDOL LIQUID GELS, IBUPROFEN (OTC) MIDOZALAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MIFEPREX, MIFEPRISTONE MIGERGOT, CAFFEINE MIGRANAL, DIHYDROERGOTAMINE MESYLATE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE IN DEXTROSE 5%, MILRINONE LACTATE MILRINONE LACTATE IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE, MILRINONE LACTATE MINIPRESS, PRAZOSIN HYDROCHLORIDE MINIRIN, DESMOPRESSIN ACETATE MINITRAN, NITROGLYCERIN MINIVELLE, ESTRADIOL MINOCIN, MINOCYCLINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) MINOXIDIL, MINOXIDIL MINOXIDIL, MINOXIDIL (OTC) MIOCHOL-E, ACETYLCHOLINE CHLORIDE MIOSTAT, CARBACHOL MIRALAX, POLYETHYLENE GLYCOL 3350 (OTC) MIRAPEX ER, PRAMIPEXOLE DIHYDROCHLORIDE MIRAPEX, PRAMIPEXOLE DIHYDROCHLORIDE MIRCETTE, DESOGESTREL MIRENA, LEVONORGESTREL MIRTAZAPINE, MIRTAZAPINE MISOPROSTOL, MISOPROSTOL MITOMYCIN, MITOMYCIN MITOSOL, MITOMYCIN MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE MOBIC, MELOXICAM MODAFINIL, MODAFINIL MODICON 28, ETHINYL ESTRADIOL MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MOMETASONE FUROATE, MOMETASONE FUROATE MONISTAT 1 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONISTAT 3 COMBINATION PACK (PREFILLED), MICONAZOLE NITRATE (OTC) MONISTAT 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONISTAT 3, MICONAZOLE NITRATE MONISTAT 3, MICONAZOLE NITRATE (OTC) MONISTAT 7 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONISTAT 7, MICONAZOLE NITRATE (OTC) MONISTAT-3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS MONODOX, DOXYCYCLINE MONOKET, ISOSORBIDE MONONITRATE MONO-LINYAH, ETHINYL ESTRADIOL MONTELUKAST SODIUM, MONTELUKAST SODIUM MONUROL, FOSFOMYCIN TROMETHAMINE MORPHINE SULFATE, MORPHINE SULFATE MOTOFEN, ATROPINE SULFATE MOTRIN IB, IBUPROFEN (OTC) MOTRIN MIGRAINE PAIN, IBUPROFEN (OTC) MOVIPREP, ASCORBIC ACID MOXATAG, AMOXICILLIN MOXEZA, MOXIFLOXACIN HYDROCHLORIDE MOZOBIL, PLERIXAFOR MPI DMSA KIDNEY REAGENT, TECHNETIUM TC-99M SUCCIMER KIT MPI INDIUM DTPA IN 111, INDIUM IN-111 PENTETATE DISODIUM
APPENDIX A
**
PRODUCT NAME INDEX

M **
A - 36
MS CONTIN, MORPHINE SULFATE MUCINEX D, GUAIFENESIN (OTC) MUCINEX DM, DEXTROMETHORPHAN HYDROBROMIDE (OTC) MUCINEX, GUAIFENESIN (OTC) MULTAQ, DRONEDARONE HYDROCHLORIDE MULTIHANCE MULTIPACK, GADOBENATE DIMEGLUMINE MULTIHANCE, GADOBENATE DIMEGLUMINE MUPIROCIN, MUPIROCIN MUPIROCIN, MUPIROCIN CALCIUM MUSE, ALPROSTADIL MUSTARGEN, MECHLORETHAMINE HYDROCHLORIDE MYAMBUTOL, ETHAMBUTOL HYDROCHLORIDE MYCAMINE, MICAFUNGIN SODIUM MYCELEX, CLOTRIMAZOLE MYCELEX-7 COMBINATION PACK, CLOTRIMAZOLE (OTC) MYCELEX-7, CLOTRIMAZOLE (OTC) MYCOBUTIN, RIFABUTIN MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL MYCOPHENOLIC ACID, MYCOPHENOLIC ACID MYDRIACYL, TROPICAMIDE MYFORTIC, MYCOPHENOLIC ACID MYLERAN, BUSULFAN MYORISAN, ISOTRETINOIN MYOVIEW 30ML, TECHNETIUM TC-99M TETROFOSMIN KIT MYOVIEW, TECHNETIUM TC-99M TETROFOSMIN KIT MYRBETRIQ, MIRABEGRON MYSOLINE, PRIMIDONE MYTELASE, AMBENONIUM CHLORIDE MYZILRA, ETHINYL ESTRADIOL M-ZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC)
**
**
NABUMETONE, NABUMETONE NADOLOL AND BENDROFLUMETHAZIDE, BENDROFLUMETHIAZIDE NADOLOL AND BENDROFLUMETHIAZIDE, BENDROFLUMETHIAZIDE NADOLOL, NADOLOL NAFCILLIN SODIUM, NAFCILLIN SODIUM NAFTIN, NAFTIFINE HYDROCHLORIDE NALBUPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE NALFON, FENOPROFEN CALCIUM NALLPEN IN PLASTIC CONTAINER, NAFCILLIN SODIUM NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE NAMENDA XR, MEMANTINE HYDROCHLORIDE NAMENDA, MEMANTINE HYDROCHLORIDE NANDROLONE DECANOATE, NANDROLONE DECANOATE NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, NAPHAZOLINE HYDROCHLORIDE NAPHAZOLINE HYDROCHLORIDE, NAPHAZOLINE HYDROCHLORIDE NAPHCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) NAPRELAN, NAPROXEN SODIUM NAPROSYN, NAPROXEN NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NAPROXEN, NAPROXEN NARATRIPTAN, NARATRIPTAN NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NARDIL, PHENELZINE SULFATE NAROPIN, ROPIVACAINE HYDROCHLORIDE NASACORT AQ, TRIAMCINOLONE ACETONIDE NASCOBAL, CYANOCOBALAMIN NASONEX, MOMETASONE FUROATE MONOHYDRATE NATACYN, NATAMYCIN
(OTC)
APPENDIX A
**
PRODUCT NAME INDEX

N **
A - 37
NATAZIA, ESTRADIOL VALERATE NATEGLINIDE, NATEGLINIDE NATRECOR, NESIRITIDE RECOMBINANT NATROBA, SPINOSAD NAVANE, THIOTHIXENE NAVELBINE, VINORELBINE TARTRATE NAVSTEL, CALCIUM CHLORIDE NEBUPENT, PENTAMIDINE ISETHIONATE NEDOCROMIL SODIUM, NEDOCROMIL SODIUM NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE NEMBUTAL SODIUM, PENTOBARBITAL SODIUM NEO-FRADIN, NEOMYCIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC NEOMYCIN SULFATE, NEOMYCIN SULFATE NEOPAP, ACETAMINOPHEN (OTC) NEOPROFEN, IBUPROFEN LYSINE NEORAL, CYCLOSPORINE NEO-RX, NEOMYCIN SULFATE NEOSPORIN G.U. IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, GRAMICIDIN NEPAFENAC, NEPAFENAC NEPHRAMINE 5.4%, AMINO ACIDS NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE HYDROCHLORIDE NESINA, ALOGLIPTIN NEUPRO, ROTIGOTINE NEUROLITE, TECHNETIUM TC-99M BICISATE KIT NEURONTIN, GABAPENTIN NEVANAC, NEPAFENAC NEVIRAPINE, NEVIRAPINE NEXAVAR, SORAFENIB TOSYLATE NEXCEDE, KETOPROFEN (OTC) NEXIUM IV, ESOMEPRAZOLE SODIUM NEXIUM, ESOMEPRAZOLE MAGNESIUM NEXPLANON, ETONOGESTREL NEXTERONE, AMIODARONE HYDROCHLORIDE NIACIN, NIACIN NIACOR, NIACIN NIASPAN, NIACIN NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NICODERM CQ, NICOTINE (OTC) NICORETTE (MINT), NICOTINE POLACRILEX (OTC) NICORETTE, NICOTINE POLACRILEX (OTC) NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) NICOTINE, NICOTINE (OTC) NICOTROL, NICOTINE NIFEDIPINE, NIFEDIPINE NILANDRON, NILUTAMIDE NILSTAT, NYSTATIN NIMBEX PRESERVATIVE FREE, CISATRACURIUM BESYLATE NIMBEX, CISATRACURIUM BESYLATE NIMODIPINE, NIMODIPINE NIPENT, PENTOSTATIN NIRAVAM, ALPRAZOLAM NISOLDIPINE, NISOLDIPINE NITHIODOTE, SODIUM NITRITE NITRO-DUR, NITROGLYCERIN NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN NITROFURANTOIN, NITROFURANTOIN
APPENDIX A
**
PRODUCT NAME INDEX

N **
A - 38
NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN NITROGLYCERIN, NITROGLYCERIN NITROLINGUAL PUMPSPRAY, NITROGLYCERIN NITROMIST, NITROGLYCERIN NITROPRESS, SODIUM NITROPRUSSIDE NITROSTAT, NITROGLYCERIN NIX, PERMETHRIN (OTC) NIZATIDINE, NIZATIDINE NIZORAL A-D, KETOCONAZOLE (OTC) NIZORAL, KETOCONAZOLE NORCO, ACETAMINOPHEN NORDETTE-28, ETHINYL ESTRADIOL NORDITROPIN FLEXPRO, SOMATROPIN RECOMBINANT NORDITROPIN NORDIFLEX, SOMATROPIN RECOMBINANT NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE NORETHIDRONE ACETATE, NORETHINDRONE ACETATE NORETHIDRONE, NORETHINDRONE NORETHIN 1/35E-21, ETHINYL ESTRADIOL NORETHIN 1/35E-28, ETHINYL ESTRADIOL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORETHINDRONE ACETATE, NORETHINDRONE ACETATE NORETHINDRONE AND ETHINYL ESTRADIOL (10/11), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (7/14), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORETHINDRONE, NORETHINDRONE NORFLEX, ORPHENADRINE CITRATE NORGESIC FORTE, ASPIRIN NORGESIC, ASPIRIN NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORINYL 1+35 21-DAY, ETHINYL ESTRADIOL NORINYL 1+35 28-DAY, ETHINYL ESTRADIOL NORINYL 1+50 28-DAY, MESTRANOL NORITATE, METRONIDAZOLE NORMOCARB HF 25, MAGNESIUM CHLORIDE NORMOCARB HF 35, MAGNESIUM CHLORIDE NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE NOROXIN, NORFLOXACIN NORPACE CR, DISOPYRAMIDE PHOSPHATE NORPACE, DISOPYRAMIDE PHOSPHATE NORPRAMIN, DESIPRAMINE HYDROCHLORIDE NOR-QD, NORETHINDRONE NORTREL 0.5/35-28, ETHINYL ESTRADIOL NORTREL 1/35-21, ETHINYL ESTRADIOL NORTREL 1/35-28, ETHINYL ESTRADIOL NORTREL 7/7/7, ETHINYL ESTRADIOL NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE NORVASC, AMLODIPINE BESYLATE NORVIR, RITONAVIR NOVOLIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) NOVOLIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) NOVOLIN R, INSULIN RECOMBINANT HUMAN (OTC) NOVOLOG FLEXPEN, INSULIN ASPART RECOMBINANT NOVOLOG MIX 70/30 FLEXPEN, INSULIN ASPART PROTAMINE RECOMBINANT NOVOLOG MIX 70/30, INSULIN ASPART PROTAMINE RECOMBINANT NOVOLOG PENFILL, INSULIN ASPART RECOMBINANT NOVOLOG, INSULIN ASPART RECOMBINANT NOXAFIL, POSACONAZOLE NUCYNTA ER, TAPENTADOL HYDROCHLORIDE NUCYNTA, TAPENTADOL HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

N **
A - 39
NUEDEXTA, DEXTROMETHORPHAN HYDROBROMIDE NULYTELY, POLYETHYLENE GLYCOL 3350 NULYTELY-FLAVORED, POLYETHYLENE GLYCOL 3350 NUTRACORT, HYDROCORTISONE NUTRESTORE, GLUTAMINE NUTRILIPID 10%, SOYBEAN OIL NUTRILIPID 20%, SOYBEAN OIL NUTROPIN AQ PEN, SOMATROPIN RECOMBINANT NUTROPIN AQ, SOMATROPIN RECOMBINANT NUTROPIN, SOMATROPIN RECOMBINANT NUVARING, ETHINYL ESTRADIOL NUVIGIL, ARMODAFINIL NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN NYSTATIN, NYSTATIN NYSTOP, NYSTATIN
**
**
OCTOCAINE, EPINEPHRINE OCTREOSCAN, INDIUM IN-111 PENTETREOTIDE KIT OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE OCUCLEAR, OXYMETAZOLINE HYDROCHLORIDE (OTC) OCUFEN, FLURBIPROFEN SODIUM OCUFLOX, OFLOXACIN OCUPRESS, CARTEOLOL HYDROCHLORIDE OFIRMEV, ACETAMINOPHEN OFLOXACIN, OFLOXACIN OGEN .625, ESTROPIPATE OGEN 1.25, ESTROPIPATE OGEN 2.5, ESTROPIPATE OGEN 5, ESTROPIPATE OGESTREL 0.5/50-28, ETHINYL ESTRADIOL OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE OLANZAPINE, OLANZAPINE OLEPTRO, TRAZODONE HYDROCHLORIDE OLUX E, CLOBETASOL PROPIONATE OLUX, CLOBETASOL PROPIONATE OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN, AMOXICILLIN OMEPRAZOLE AND SODIUM BICARBONATE, OMEPRAZOLE OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM (OTC) OMEPRAZOLE, OMEPRAZOLE OMEPRAZOLE, OMEPRAZOLE (OTC) OMNARIS, CICLESONIDE OMNIPAQUE 140, IOHEXOL OMNIPAQUE 180, IOHEXOL OMNIPAQUE 240, IOHEXOL OMNIPAQUE 300, IOHEXOL OMNIPAQUE 350, IOHEXOL OMNIPRED, PREDNISOLONE ACETATE OMNISCAN, GADODIAMIDE OMNITROPE, SOMATROPIN RECOMBINANT OMONTYS PRESERVATIVE FREE, PEGINESATIDE ACETATE OMONTYS, PEGINESATIDE ACETATE ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON ONFI, CLOBAZAM ONGLYZA, SAXAGLIPTIN HYDROCHLORIDE ONMEL, ITRACONAZOLE ONSOLIS, FENTANYL CITRATE OPANA ER, OXYMORPHONE HYDROCHLORIDE OPANA, OXYMORPHONE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

O **
A - 40
OPCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) OPHTHAINE, PROPARACAINE HYDROCHLORIDE OPHTHETIC, PROPARACAINE HYDROCHLORIDE OPTICROM, CROMOLYN SODIUM OPTIMARK IN PLASTIC CONTAINER, GADOVERSETAMIDE OPTIMARK, GADOVERSETAMIDE OPTIPRANOLOL, METIPRANOLOL HYDROCHLORIDE OPTIRAY 240, IOVERSOL OPTIRAY 300, IOVERSOL OPTIRAY 320, IOVERSOL OPTIRAY 350, IOVERSOL OPTISON, ALBUMIN HUMAN OPTIVAR, AZELASTINE HYDROCHLORIDE ORABASE HCA, HYDROCORTISONE ACETATE ORACEA, DOXYCYCLINE ORAP, PIMOZIDE ORAPRED ODT, PREDNISOLONE SODIUM PHOSPHATE ORAPRED, PREDNISOLONE SODIUM PHOSPHATE ORAQIX, LIDOCAINE ORAVERSE, PHENTOLAMINE MESYLATE ORAVIG, MICONAZOLE ORETIC, HYDROCHLOROTHIAZIDE ORFADIN, NITISINONE ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN ORPHENADRINE CITRATE, ORPHENADRINE CITRATE ORSYTHIA, ETHINYL ESTRADIOL ORTHO CYCLEN-28, ETHINYL ESTRADIOL ORTHO EVRA, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN LO, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN, ETHINYL ESTRADIOL ORTHO-CEPT, DESOGESTREL ORTHO-EST, ESTROPIPATE ORTHO-NOVUM 1/35-28, ETHINYL ESTRADIOL ORTHO-NOVUM 7/7/7-28, ETHINYL ESTRADIOL ORVATEN, MIDODRINE HYDROCHLORIDE OSENI, ALOGLIPTIN OSMITROL 10% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 10% IN WATER, MANNITOL OSMITROL 15% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 15% IN WATER, MANNITOL OSMITROL 20% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 20% IN WATER, MANNITOL OSMITROL 5% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 5% IN WATER, MANNITOL OSMOPREP, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS OTICAIR, HYDROCORTISONE OVCON-35, ETHINYL ESTRADIOL OVCON-50, ETHINYL ESTRADIOL OVIDE, MALATHION OVIDREL, CHORIOGONADOTROPIN ALFA OXACILLIN SODIUM, OXACILLIN SODIUM OXALIPLATIN, OXALIPLATIN OXANDRIN, OXANDROLONE OXANDROLONE, OXANDROLONE OXAPROZIN, OXAPROZIN OXAZEPAM, OXAZEPAM OXCARBAZEPINE, OXCARBAZEPINE OXECTA, OXYCODONE HYDROCHLORIDE OXILAN-300, IOXILAN OXILAN-350, IOXILAN OXISTAT, OXICONAZOLE NITRATE OXSORALEN, METHOXSALEN OXSORALEN-ULTRA, METHOXSALEN OXTELLAR XR, OXCARBAZEPINE
APPENDIX A
**
PRODUCT NAME INDEX

O **
A - 41
OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE OXYCET, ACETAMINOPHEN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE AND ASPIRIN, ASPIRIN OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE OXYCONTIN, OXYCODONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE OXYTOCIN, OXYTOCIN OXYTROL FOR WOMEN, OXYBUTYNIN (OTC) OXYTROL, OXYBUTYNIN OZURDEX, DEXAMETHASONE
**
**
PACERONE, AMIODARONE HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAMELOR, NORTRIPTYLINE HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PAMINE FORTE, METHSCOPOLAMINE BROMIDE PAMINE, METHSCOPOLAMINE BROMIDE PANCREAZE, LIPASE PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PANDEL, HYDROCORTISONE PROBUTATE PANRETIN, ALITRETINOIN PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PARAFON FORTE DSC, CHLORZOXAZONE PARAGARD T 380A, COPPER PARCOPA, CARBIDOPA PAREMYD, HYDROXYAMPHETAMINE HYDROBROMIDE PARICALCITOL, PARICALCITOL PARLODEL, BROMOCRIPTINE MESYLATE PARNATE, TRANYLCYPROMINE SULFATE PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PASER, AMINOSALICYLIC ACID PATADAY, OLOPATADINE HYDROCHLORIDE PATANASE, OLOPATADINE HYDROCHLORIDE PATANOL, OLOPATADINE HYDROCHLORIDE PAXIL CR, PAROXETINE HYDROCHLORIDE PAXIL, PAROXETINE HYDROCHLORIDE PCE, ERYTHROMYCIN PEDIAMYCIN 400, ERYTHROMYCIN ETHYLSUCCINATE PEDIAMYCIN, ERYTHROMYCIN ETHYLSUCCINATE PEDIAPRED, PREDNISOLONE SODIUM PHOSPHATE PEDIATRIC ADVIL, IBUPROFEN (OTC) PEDIOTIC, HYDROCORTISONE PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL 3350 PEGANONE, ETHOTOIN PENICILLIN G POTASSIUM IN PLASTIC CONTAINER, PENICILLIN G POTASSIUM PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM PENICILLIN G PROCAINE, PENICILLIN G PROCAINE PENICILLIN G SODIUM, PENICILLIN G SODIUM PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PENICILLIN-VK, PENICILLIN V POTASSIUM PENLAC, CICLOPIROX PENNSAID, DICLOFENAC SODIUM PENTAM, PENTAMIDINE ISETHIONATE PENTAMIDINE ISETHIONATE, PENTAMIDINE ISETHIONATE PENTASA, MESALAMINE PENTAZOCINE AND NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE PENTAZOCINE AND NALOXONE HYDROCHLORIDES, NALOXONE HYDROCHLORIDE PENTOLAIR, CYCLOPENTOLATE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

P **
A - 42
PENTOSTATIN, PENTOSTATIN PENTOXIFYLLINE, PENTOXIFYLLINE PENTOXIL, PENTOXIFYLLINE PEPCID AC (GELTAB), FAMOTIDINE (OTC) PEPCID AC, FAMOTIDINE (OTC) PEPCID COMPLETE, CALCIUM CARBONATE (OTC) PEPCID, FAMOTIDINE PERCOCET, ACETAMINOPHEN PERCODAN, ASPIRIN PERFOROMIST, FORMOTEROL FUMARATE PERIDEX, CHLORHEXIDINE GLUCONATE PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE PERIOCHIP, CHLORHEXIDINE GLUCONATE PERIOGARD, CHLORHEXIDINE GLUCONATE PERIOSTAT, DOXYCYCLINE HYCLATE PERMAPEN, PENICILLIN G BENZATHINE PERMETHRIN, PERMETHRIN PERMETHRIN, PERMETHRIN (OTC) PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE PERPHENAZINE, PERPHENAZINE PERSANTINE, DIPYRIDAMOLE PERTZYE, PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) PEXEVA, PAROXETINE MESYLATE PFIZERPEN, PENICILLIN G POTASSIUM PHARMASEAL SCRUB CARE, CHLORHEXIDINE GLUCONATE (OTC) PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENELZINE SULFATE, PHENELZINE SULFATE PHENOXYBENZAMINE HYDROCHLORIDE, PHENOXYBENZAMINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PHENTERMINE RESIN COMPLEX, PHENTERMINE RESIN COMPLEX PHENTOLAMINE MESYLATE, PHENTOLAMINE MESYLATE PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PHENYTEK, PHENYTOIN SODIUM PHENYTOIN SODIUM, PHENYTOIN SODIUM PHENYTOIN, PHENYTOIN PHILITH, ETHINYL ESTRADIOL PHISOHEX, HEXACHLOROPHENE PHOSLO GELCAPS, CALCIUM ACETATE PHOSLYRA, CALCIUM ACETATE PHOSPHOLINE IODIDE, ECHOTHIOPHATE IODIDE PHOTOFRIN, PORFIMER SODIUM PHRENILIN FORTE, ACETAMINOPHEN PHRENILIN WITH CAFFEINE AND CODEINE, ACETAMINOPHEN PHYSIOLYTE IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PHYSIOSOL IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PHYTONADIONE, PHYTONADIONE PICATO, INGENOL MEBUTATE PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE PILOPINE HS, PILOCARPINE HYDROCHLORIDE PINDOLOL, PINDOLOL PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE, GLIMEPIRIDE PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM PIPERACILLIN, PIPERACILLIN SODIUM PIROXICAM, PIROXICAM PITOCIN, OXYTOCIN PLAN B ONE-STEP, LEVONORGESTREL PLAN B ONE-STEP, LEVONORGESTREL (OTC) PLAN B, LEVONORGESTREL PLAN B, LEVONORGESTREL (OTC) PLAQUENIL, HYDROXYCHLOROQUINE SULFATE PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE
APPENDIX A
**
PRODUCT NAME INDEX

P **
A - 43
PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASMA-LYTE 56 IN PLASTIC CONTAINER, MAGNESIUM ACETATE TETRAHYDRATE PLASMA-LYTE A IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLASMA-LYTE R IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLAVIX, CLOPIDOGREL BISULFATE PLEGISOL IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLENDIL, FELODIPINE PLETAL, CILOSTAZOL PLIAGLIS, LIDOCAINE PODOFILOX, PODOFILOX POLOCAINE, MEPIVACAINE HYDROCHLORIDE POLOCAINE-MPF, MEPIVACAINE HYDROCHLORIDE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) POLYMYCIN B SULFATE, POLYMYXIN B SULFATE POLYMYXIN B SULFATE, POLYMYXIN B SULFATE POLY-PRED, NEOMYCIN SULFATE POLY-RX, POLYMYXIN B SULFATE POLYTRIM, POLYMYXIN B SULFATE PONSTEL, MEFENAMIC ACID PORTIA-28, ETHINYL ESTRADIOL POTASSIUM ACETATE IN PLASTIC CONTAINER, POTASSIUM ACETATE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE
APPENDIX A
POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM CHLORIDE POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM CHLORIDE POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM CHLORIDE POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM CHLORIDE POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM CHLORIDE POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE
**
PRODUCT NAME INDEX

P **
A - 44
0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.224% IN SODIUM CHLORIDE 0.9%, POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM 10MEQ 10MEQ 10MEQ 10MEQ 10MEQ 15MEQ 15MEQ 15MEQ 15MEQ 15MEQ 20MEQ 20MEQ 20MEQ 20MEQ 20MEQ 20MEQ 20MEQ 20MEQ 20MEQ 30MEQ 30MEQ 30MEQ 30MEQ 30MEQ 30MEQ 30MEQ 40MEQ 40MEQ 40MEQ 40MEQ 40MEQ 40MEQ 40MEQ 40MEQ IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE PLASTIC CONTAINER, POTASSIUM CHLORIDE DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM DEXTROSE DEXTROSE DEXTROSE DEXTROSE DEXTROSE 5% 5% 5% 5% 5% AND AND AND AND AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE PLASTIC CONTAINER, POTASSIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASTIC CONTAINER, POTASSIUM CHLORIDE DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASTIC CONTAINER, POTASSIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

P **
A - 45
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE POTASSIUM CITRATE, POTASSIUM CITRATE POTIGA, EZOGABINE POVIDONE IODINE, POVIDONE-IODINE (OTC) PRADAXA, DABIGATRAN ETEXILATE MESYLATE PRALIDOXIME CHLORIDE, PRALIDOXIME CHLORIDE PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAMOSONE, HYDROCORTISONE ACETATE PRANDIMET, METFORMIN HYDROCHLORIDE PRANDIN, REPAGLINIDE PRAVACHOL, PRAVASTATIN SODIUM PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE PRECEDEX, DEXMEDETOMIDINE HYDROCHLORIDE PRECOSE, ACARBOSE PRED FORTE, PREDNISOLONE ACETATE PRED MILD, PREDNISOLONE ACETATE PRED-G, GENTAMICIN SULFATE PREDNICARBATE, PREDNICARBATE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE, PREDNISOLONE PREDNISONE INTENSOL, PREDNISONE PREDNISONE, PREDNISONE PREFEST, ESTRADIOL PREGABALIN, PREGABALIN PREGNYL, GONADOTROPIN, CHORIONIC PRELONE, PREDNISOLONE PREMARIN, ESTROGENS, CONJUGATED PREMASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS PREMASOL 6% IN PLASTIC CONTAINER, AMINO ACIDS PREMPHASE 14/14, ESTROGENS, CONJUGATED PREMPRO, ESTROGENS, CONJUGATED PRE-OP II, HEXACHLOROPHENE PRE-OP, HEXACHLOROPHENE PRE-PEN, BENZYLPENICILLOYL POLYLYSINE PREPIDIL, DINOPROSTONE PREPOPIK, CITRIC ACID PREVACID 24 HR, LANSOPRAZOLE (OTC) PREVACID, LANSOPRAZOLE PREVALITE, CHOLESTYRAMINE PREVIFEM, ETHINYL ESTRADIOL PREVPAC, AMOXICILLIN PREZISTA, DARUNAVIR ETHANOLATE PRIALT, ZICONOTIDE ACETATE PRIFTIN, RIFAPENTINE PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, EPINEPHRINE BITARTRATE PRILOCAINE HYDROCHLORIDE, PRILOCAINE HYDROCHLORIDE PRILOSEC OTC, OMEPRAZOLE MAGNESIUM (OTC) PRILOSEC, OMEPRAZOLE PRILOSEC, OMEPRAZOLE MAGNESIUM PRIMAQUINE, PRIMAQUINE PHOSPHATE PRIMAXIN, CILASTATIN SODIUM PRIMIDONE, PRIMIDONE PRIMSOL, TRIMETHOPRIM HYDROCHLORIDE PRINIVIL, LISINOPRIL PRINZIDE, HYDROCHLOROTHIAZIDE PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

P **
A - 46
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISTIQ, DESVENLAFAXINE SUCCINATE PROAIR HFA, ALBUTEROL SULFATE PROBALAN, PROBENECID PROBENECID AND COLCHICINE, COLCHICINE PROBENECID, PROBENECID PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE PROCALAMINE, AMINO ACIDS PROCARDIA XL, NIFEDIPINE PROCARDIA, NIFEDIPINE PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE PROCHLORPERAZINE, PROCHLORPERAZINE PROCOMP, PROCHLORPERAZINE MALEATE PROCTOFOAM HC, HYDROCORTISONE ACETATE PROFEN, IBUPROFEN (OTC) PROFERDEX, IRON DEXTRAN PROGESTERONE, PROGESTERONE PROGLYCEM, DIAZOXIDE PROGRAF, TACROLIMUS PROHANCE MULTIPACK, GADOTERIDOL PROHANCE, GADOTERIDOL PROMACTA, ELTROMBOPAG OLAMINE PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETH VC PLAIN, PHENYLEPHRINE HYDROCHLORIDE PROMETH VC W/ CODEINE, CODEINE PHOSPHATE PROMETH W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE DM, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROMETHAZINE PLAIN, PROMETHAZINE HYDROCHLORIDE PROMETHAZINE W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE WITH CODEINE, CODEINE PHOSPHATE PROMETHEGAN, PROMETHAZINE HYDROCHLORIDE PROMETRIUM, PROGESTERONE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE PROPANTHELINE BROMIDE, PROPANTHELINE BROMIDE PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE PROPECIA, FINASTERIDE PROPINE, DIPIVEFRIN HYDROCHLORIDE PROPOFOL, PROPOFOL PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PROPYLTHIOURACIL, PROPYLTHIOURACIL PROSCAR, FINASTERIDE PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS PROSTIN E2, DINOPROSTONE PROSTIN VR PEDIATRIC, ALPROSTADIL PROTAMINE SULFATE, PROTAMINE SULFATE PROTONIX IV, PANTOPRAZOLE SODIUM PROTONIX, PANTOPRAZOLE SODIUM PROTOPAM CHLORIDE, PRALIDOXIME CHLORIDE PROTOPIC, TACROLIMUS PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

P **
A - 47
PROVENTIL-HFA, ALBUTEROL SULFATE PROVERA, MEDROXYPROGESTERONE ACETATE PROVIGIL, MODAFINIL PROVOCHOLINE, METHACHOLINE CHLORIDE PROZAC WEEKLY, FLUOXETINE HYDROCHLORIDE PROZAC, FLUOXETINE HYDROCHLORIDE PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE PULMICORT FLEXHALER, BUDESONIDE PULMICORT RESPULES, BUDESONIDE PULMOLITE, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT PURINETHOL, MERCAPTOPURINE PUR-WASH, PURIFIED WATER (OTC) PYLERA, BISMUTH SUBCITRATE POTASSIUM PYRAZINAMIDE, PYRAZINAMIDE PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE PYTEST KIT, UREA, C-14 PYTEST, UREA, C-14
(OTC)
**
**
QNASL, BECLOMETHASONE DIPROPIONATE QSYMIA, PHENTERMINE HYDROCHLORIDE QUADRAMET, SAMARIUM SM-153 LEXIDRONAM PENTASODIUM QUALAQUIN, QUININE SULFATE QUASENSE, ETHINYL ESTRADIOL QUELICIN PRESERVATIVE FREE, SUCCINYLCHOLINE CHLORIDE QUELICIN, SUCCINYLCHOLINE CHLORIDE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE QUILLIVANT XR, METHYLPHENIDATE HYDROCHLORIDE QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE QUINARETIC, HYDROCHLOROTHIAZIDE QUINIDINE GLUCONATE, QUINIDINE GLUCONATE QUINIDINE SULFATE, QUINIDINE SULFATE QUININE SULFATE, QUININE SULFATE QUIXIN, LEVOFLOXACIN QUTENZA, CAPSAICIN QVAR 40, BECLOMETHASONE DIPROPIONATE QVAR 80, BECLOMETHASONE DIPROPIONATE
**
**
RADIOGARDASE (PRUSSIAN BLUE), FERRIC HEXACYANOFERRATE(II) RAMIPRIL, RAMIPRIL RANEXA, RANOLAZINE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RAPAFLO, SILODOSIN RAPAMUNE, SIROLIMUS RAYOS, PREDNISONE RAZADYNE ER, GALANTAMINE HYDROBROMIDE RAZADYNE, GALANTAMINE HYDROBROMIDE REBETOL, RIBAVIRIN RECLAST, ZOLEDRONIC ACID RECTIV, NITROGLYCERIN REFLUDAN, LEPIRUDIN RECOMBINANT REGITINE, PHENTOLAMINE MESYLATE REGLAN, METOCLOPRAMIDE HYDROCHLORIDE REGONOL, PYRIDOSTIGMINE BROMIDE RELENZA, ZANAMIVIR RELISTOR, METHYLNALTREXONE BROMIDE RELPAX, ELETRIPTAN HYDROBROMIDE REMERON SOLTAB, MIRTAZAPINE REMERON, MIRTAZAPINE
APPENDIX A
**
PRODUCT NAME INDEX

R **
A - 48
REMODULIN, TREPROSTINIL SODIUM RENACIDIN, CITRIC ACID RENAGEL, SEVELAMER HYDROCHLORIDE RENAMIN W/O ELECTROLYTES, AMINO ACIDS RENOGRAFIN-76, DIATRIZOATE MEGLUMINE RENOVA, TRETINOIN RENVELA, SEVELAMER CARBONATE REPREXAIN, HYDROCODONE BITARTRATE REPRONEX, LUTEINIZING HORMONE REQUIP XL, ROPINIROLE HYDROCHLORIDE REQUIP, ROPINIROLE HYDROCHLORIDE RESCRIPTOR, DELAVIRDINE MESYLATE RESCULA, UNOPROSTONE ISOPROPYL RESECTISOL IN PLASTIC CONTAINER, MANNITOL RESERPINE, RESERPINE RESTASIS, CYCLOSPORINE RESTORIL, TEMAZEPAM RETIN-A MICRO, TRETINOIN RETIN-A, TRETINOIN RETISERT, FLUOCINOLONE ACETONIDE RETROVIR, ZIDOVUDINE REVATIO, SILDENAFIL CITRATE REVIA, NALTREXONE HYDROCHLORIDE REVLIMID, LENALIDOMIDE REYATAZ, ATAZANAVIR SULFATE REZIRA, HYDROCODONE BITARTRATE R-GENE 10, ARGININE HYDROCHLORIDE RHINOCORT, BUDESONIDE RIBASPHERE, RIBAVIRIN RIBAVARIN, RIBAVIRIN RIBAVIRIN, RIBAVIRIN RID MOUSSE, PIPERONYL BUTOXIDE (OTC) RIDAURA, AURANOFIN RIFADIN, RIFAMPIN RIFAMATE, ISONIAZID RIFAMPIN AND ISONIAZID, ISONIAZID RIFAMPIN, RIFAMPIN RIFATER, ISONIAZID RILUTEK, RILUZOLE RILUZOLE, RILUZOLE RIMACTANE, RIFAMPIN RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE RIMSO-50, DIMETHYL SULFOXIDE RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE RIOMET, METFORMIN HYDROCHLORIDE RISEDRONATE SODIUM, RISEDRONATE SODIUM RISPERDAL CONSTA, RISPERIDONE RISPERDAL, RISPERIDONE RISPERIDONE, RISPERIDONE RITALIN LA, METHYLPHENIDATE HYDROCHLORIDE RITALIN, METHYLPHENIDATE HYDROCHLORIDE RITALIN-SR, METHYLPHENIDATE HYDROCHLORIDE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE ROBAXIN, METHOCARBAMOL ROBAXIN-750, METHOCARBAMOL ROBINUL FORTE, GLYCOPYRROLATE ROBINUL, GLYCOPYRROLATE ROCALTROL, CALCITRIOL ROCEPHIN, CEFTRIAXONE SODIUM ROCURONIUM BROMIDE, ROCURONIUM BROMIDE ROGAINE (FOR MEN), MINOXIDIL (OTC) ROGAINE (FOR WOMEN), MINOXIDIL (OTC) ROGAINE EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC)
APPENDIX A
**
PRODUCT NAME INDEX

R **
A - 49
ROMAZICON, FLUMAZENIL ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE ROSIGLITAZONE MALEATE, ROSIGLITAZONE MALEATE ROWASA, MESALAMINE ROXICET 5/500, ACETAMINOPHEN ROXICET, ACETAMINOPHEN ROXICODONE, OXYCODONE HYDROCHLORIDE ROXILOX, ACETAMINOPHEN ROZEREM, RAMELTEON RYBIX ODT, TRAMADOL HYDROCHLORIDE RYTHMOL SR, PROPAFENONE HYDROCHLORIDE RYTHMOL, PROPAFENONE HYDROCHLORIDE
**
**
SABRIL, VIGABATRIN SAFYRAL, DROSPIRENONE SAIZEN, SOMATROPIN RECOMBINANT SALAGEN, PILOCARPINE HYDROCHLORIDE SALONPAS, MENTHOL (OTC) SALURON, HYDROFLUMETHIAZIDE SAMSCA, TOLVAPTAN SANCTURA XR, TROSPIUM CHLORIDE SANCTURA, TROSPIUM CHLORIDE SANCUSO, GRANISETRON SANDIMMUNE, CYCLOSPORINE SANDOSTATIN LAR, OCTREOTIDE ACETATE SANDOSTATIN, OCTREOTIDE ACETATE SAPHRIS, ASENAPINE MALEATE SARAFEM, FLUOXETINE HYDROCHLORIDE SAVELLA, MILNACIPRAN HYDROCHLORIDE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCANLUX-300, IOPAMIDOL SCANLUX-370, IOPAMIDOL SCLEROSOL, TALC SEASONALE, ETHINYL ESTRADIOL SEASONIQUE, ETHINYL ESTRADIOL SECONAL SODIUM, SECOBARBITAL SODIUM SECTRAL, ACEBUTOLOL HYDROCHLORIDE SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE SELENIUM SULFIDE, SELENIUM SULFIDE SELSUN, SELENIUM SULFIDE SELZENTRY, MARAVIROC SEMPREX-D, ACRIVASTINE SENSIPAR, CINACALCET HYDROCHLORIDE SENSORCAINE, BUPIVACAINE HYDROCHLORIDE SEPTOCAINE, ARTICAINE HYDROCHLORIDE SEPTRA DS, SULFAMETHOXAZOLE SEPTRA, SULFAMETHOXAZOLE SEREVENT, SALMETEROL XINAFOATE SEROMYCIN, CYCLOSERINE SEROPHENE, CLOMIPHENE CITRATE SEROQUEL XR, QUETIAPINE FUMARATE SEROQUEL, QUETIAPINE FUMARATE SEROSTIM, SOMATROPIN RECOMBINANT SERPALAN, RESERPINE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SEVOFLURANE, SEVOFLURANE SFROWASA, MESALAMINE SHADE UVAGUARD, AVOBENZONE (OTC) SIGNIFOR, PASIREOTIDE DIASPARTATE SILDENAFIL CITRATE, SILDENAFIL CITRATE SILENOR, DOXEPIN HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

S **
A - 50
SILVADENE, SILVER SULFADIAZINE SIMCOR, NIACIN SIMVASTATIN, SIMVASTATIN SINE-AID IB, IBUPROFEN (OTC) SINEMET CR, CARBIDOPA SINEMET, CARBIDOPA SINGULAIR, MONTELUKAST SODIUM SINOGRAFIN, DIATRIZOATE MEGLUMINE SIRTURO, BEDAQUILINE FUMARATE SKELAXIN, METAXALONE SKELID, TILUDRONATE DISODIUM SKLICE, IVERMECTIN SKYLA, LEVONORGESTREL SODIUM ACETATE IN PLASTIC CONTAINER, SODIUM ACETATE ANHYDROUS SODIUM BICARBONATE, SODIUM BICARBONATE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9%, SODIUM CHLORIDE SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, SODIUM FERRIC GLUCONATE COMPLEX SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18 SODIUM IODIDE I 123, SODIUM IODIDE I-123 SODIUM IODIDE I 131, SODIUM IODIDE I-131 SODIUM IODIDE I-131, SODIUM IODIDE I-131 SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM LACTATE IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM NITRITE, SODIUM NITRITE SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE SODIUM PHOSPHATES IN PLASTIC CONTAINER, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE SODIUM THIOSULFATE, SODIUM THIOSULFATE SOJOURN, SEVOFLURANE SOLARAZE, DICLOFENAC SODIUM SOLODYN, MINOCYCLINE HYDROCHLORIDE SOLTAMOX, TAMOXIFEN CITRATE SOLU-CORTEF, HYDROCORTISONE SODIUM SUCCINATE SOLU-MEDROL, METHYLPREDNISOLONE SODIUM SUCCINATE SOMA COMPOUND W/ CODEINE, ASPIRIN SOMA COMPOUND, ASPIRIN SOMA, CARISOPRODOL SOMATULINE DEPOT, LANREOTIDE ACETATE SOMAVERT, PEGVISOMANT SONATA, ZALEPLON SORBITOL 3% IN PLASTIC CONTAINER, SORBITOL SORBITOL 3.3% IN PLASTIC CONTAINER, SORBITOL SORBITOL-MANNITOL IN PLASTIC CONTAINER, MANNITOL SORIATANE, ACITRETIN SORILUX, CALCIPOTRIENE SORINE, SOTALOL HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SOTRADECOL, SODIUM TETRADECYL SULFATE SOTRET, ISOTRETINOIN SPECTRACEF, CEFDITOREN PIVOXIL SPIRIVA, TIOTROPIUM BROMIDE MONOHYDRATE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SPIRONOLACTONE, SPIRONOLACTONE SPORANOX, ITRACONAZOLE SPRINTEC, ETHINYL ESTRADIOL SPRIX, KETOROLAC TROMETHAMINE SPRYCEL, DASATINIB
APPENDIX A
**
PRODUCT NAME INDEX

S **
A - 51
SPS, SODIUM POLYSTYRENE SULFONATE SSD AF, SILVER SULFADIAZINE SSD, SILVER SULFADIAZINE STADOL PRESERVATIVE FREE, BUTORPHANOL TARTRATE STADOL, BUTORPHANOL TARTRATE STALEVO 100, CARBIDOPA STALEVO 125, CARBIDOPA STALEVO 150, CARBIDOPA STALEVO 200, CARBIDOPA STALEVO 50, CARBIDOPA STALEVO 75, CARBIDOPA STARLIX, NATEGLINIDE STAVUDINE, STAVUDINE STAVZOR, VALPROIC ACID STAXYN, VARDENAFIL HYDROCHLORIDE STENDRA, AVANAFIL STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION STERILE WATER, STERILE WATER FOR IRRIGATION STIE-CORT, HYDROCORTISONE STIMATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE STIVARGA, REGORAFENIB STRATTERA, ATOMOXETINE HYDROCHLORIDE STREPTOMYCIN SULFATE, STREPTOMYCIN SULFATE STRIANT, TESTOSTERONE STRIBILD, COBICISTAT STROMECTOL, IVERMECTIN STRONTIUM CHLORIDE SR-89, STRONTIUM CHLORIDE SR-89 SUBLIMAZE PRESERVATIVE FREE, FENTANYL CITRATE SUBOXONE, BUPRENORPHINE HYDROCHLORIDE SUBSYS, FENTANYL SUCRAID, SACROSIDASE SUCRALFATE, SUCRALFATE SUDAFED 12 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) SUDAFED 24 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) SUFENTA PRESERVATIVE FREE, SUFENTANIL CITRATE SUFENTANIL CITRATE, SUFENTANIL CITRATE SULAR, NISOLDIPINE SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM SULFADIAZINE, SULFADIAZINE SULFAMETHOPRIM, SULFAMETHOXAZOLE SULFAMETHOPRIM-DS, SULFAMETHOXAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH, SULFAMETHOXAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SULFAMYLON, MAFENIDE ACETATE SULFASALAZINE, SULFASALAZINE SULFATRIM PEDIATRIC, SULFAMETHOXAZOLE SULINDAC, SULINDAC SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE SUMAVEL DOSEPRO, SUMATRIPTAN SUCCINATE SUPPRELIN LA, HISTRELIN ACETATE SUPRANE, DESFLURANE SUPRAX, CEFIXIME SUPRENZA, PHENTERMINE HYDROCHLORIDE SUPREP BOWEL PREP KIT, MAGNESIUM SULFATE ANHYDROUS SURFAXIN, LUCINACTANT SURMONTIL, TRIMIPRAMINE MALEATE SURVANTA, BERACTANT SUSTIVA, EFAVIRENZ SUTENT, SUNITINIB MALATE SYEDA, DROSPIRENONE SYMBICORT, BUDESONIDE
APPENDIX A
**
PRODUCT NAME INDEX

S **
A - 52
SYMBYAX, FLUOXETINE HYDROCHLORIDE SYMLIN, PRAMLINTIDE ACETATE SYNACORT, HYDROCORTISONE SYNALAR, FLUOCINOLONE ACETONIDE SYNALGOS-DC, ASPIRIN SYNAREL, NAFARELIN ACETATE SYNERA, LIDOCAINE SYNERCID, DALFOPRISTIN SYNRIBO, OMACETAXINE MEPESUCCINATE SYNTHETIC CONJUGATED ESTROGENS A, ESTROGENS, CONJUGATED SYNTHETIC A SYNTHROID, LEVOTHYROXINE SODIUM SYPRINE, TRIENTINE HYDROCHLORIDE
**
**
TAB-PROFEN, IBUPROFEN (OTC) TACLONEX, BETAMETHASONE DIPROPIONATE TACROLIMUS, TACROLIMUS TAGAMET HB, CIMETIDINE (OTC) TAGAMET, CIMETIDINE TALC, TALC TALWIN, PENTAZOCINE LACTATE TAMBOCOR, FLECAINIDE ACETATE TAMIFLU, OSELTAMIVIR PHOSPHATE TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TAPAZOLE, METHIMAZOLE TARCEVA, ERLOTINIB HYDROCHLORIDE TARGRETIN, BEXAROTENE TARKA, TRANDOLAPRIL TASIGNA, NILOTINIB HYDROCHLORIDE MONOHYDRATE TASMAR, TOLCAPONE TAVIST ALLERGY/SINUS/HEADACHE, ACETAMINOPHEN (OTC) TAVIST-1, CLEMASTINE FUMARATE (OTC) TAXOTERE, DOCETAXEL TAZICEF, CEFTAZIDIME TAZORAC, TAZAROTENE TAZTIA XT, DILTIAZEM HYDROCHLORIDE TECHNELITE, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR TECHNESCAN MAG3, TECHNETIUM TC-99M MERTIATIDE KIT TECHNESCAN PYP KIT, TECHNETIUM TC-99M PYROPHOSPHATE KIT TECHNESCAN, TECHNETIUM TC-99M OXIDRONATE KIT TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT TECHNETIUM TC-99 SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT TECHNETIUM TC-99M MEBROFENIN, TECHNETIUM TC-99M MEBROFENIN KIT TEFLARO, CEFTAROLINE FOSAMIL TEGRETOL, CARBAMAZEPINE TEGRETOL-XR, CARBAMAZEPINE TEKAMLO, ALISKIREN HEMIFUMARATE TEKTURNA HCT, ALISKIREN HEMIFUMARATE TEKTURNA, ALISKIREN HEMIFUMARATE TEMAZEPAM, TEMAZEPAM TEMODAR, TEMOZOLOMIDE TEMOVATE E, CLOBETASOL PROPIONATE TEMOVATE, CLOBETASOL PROPIONATE TEMOZOLOMIDE, TEMOZOLOMIDE TENEX, GUANFACINE HYDROCHLORIDE TENORETIC 100, ATENOLOL TENORETIC 50, ATENOLOL TENORMIN, ATENOLOL TENSILON PRESERVATIVE FREE, EDROPHONIUM CHLORIDE TENSILON, EDROPHONIUM CHLORIDE TENUATE DOSPAN, DIETHYLPROPION HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

T **
A - 53
TENUATE, DIETHYLPROPION HYDROCHLORIDE TERAZOL 3, TERCONAZOLE TERAZOL 7, TERCONAZOLE TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE (OTC) TERBUTALINE SULFATE, TERBUTALINE SULFATE TERCONAZOLE, TERCONAZOLE TERIL, CARBAMAZEPINE TERRAMYCIN W/ POLYMYXIN B SULFATE, OXYTETRACYCLINE HYDROCHLORIDE TESSALON, BENZONATATE TESTIM, TESTOSTERONE TESTOPEL, TESTOSTERONE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE TESTOSTERONE, TESTOSTERONE TESTRED, METHYLTESTOSTERONE TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE TEVETEN HCT, EPROSARTAN MESYLATE TEVETEN, EPROSARTAN MESYLATE TEV-TROPIN, SOMATROPIN RECOMBINANT TEXACORT, HYDROCORTISONE THALITONE, CHLORTHALIDONE THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201 THALOMID, THALIDOMIDE THAM, TROMETHAMINE THEO-24, THEOPHYLLINE THEOCHRON, THEOPHYLLINE THEOLAIR, THEOPHYLLINE THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE, THEOPHYLLINE THERMAZENE, SILVER SULFADIAZINE THEROXIDIL, MINOXIDIL (OTC) THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE THIOGUANINE, THIOGUANINE THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE THIOTEPA, THIOTEPA THIOTHIXENE, THIOTHIXENE THRIVE, NICOTINE POLACRILEX (OTC) THYROGEN, THYROTROPIN ALFA THYROLAR-0.25, LIOTHYRONINE SODIUM THYROLAR-0.5, LIOTHYRONINE SODIUM THYROLAR-1, LIOTHYRONINE SODIUM THYROLAR-2, LIOTHYRONINE SODIUM THYROLAR-3, LIOTHYRONINE SODIUM THYROSAFE, POTASSIUM IODIDE (OTC) THYROSHIELD, POTASSIUM IODIDE (OTC) TIAGABINE HYDROCHLORIDE, TIAGABINE HYDROCHLORIDE TIAZAC, DILTIAZEM HYDROCHLORIDE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE TIKOSYN, DOFETILIDE TIMENTIN IN PLASTIC CONTAINER, CLAVULANATE POTASSIUM TIMENTIN, CLAVULANATE POTASSIUM TIMOLOL MALEATE, TIMOLOL MALEATE TIMOPTIC IN OCUDOSE, TIMOLOL MALEATE TIMOPTIC, TIMOLOL MALEATE TIMOPTIC-XE, TIMOLOL MALEATE TINDAMAX, TINIDAZOLE TINIDAZOLE, TINIDAZOLE
APPENDIX A
**
PRODUCT NAME INDEX

T **
A - 54
TIOCONAZOLE, TIOCONAZOLE (OTC) TIOPRONIN, TIOPRONIN TIROSINT, LEVOTHYROXINE SODIUM TIS-U-SOL IN PLASTIC CONTAINER, MAGNESIUM SULFATE TIS-U-SOL, MAGNESIUM SULFATE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOBI, TOBRAMYCIN TOBRADEX ST, DEXAMETHASONE TOBRADEX, DEXAMETHASONE TOBRAMYCIN AND DEXAMETHASONE, DEXAMETHASONE TOBRAMYCIN SULFATE (PHARMACY BULK), TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE TOBRAMYCIN, TOBRAMYCIN TOBREX, TOBRAMYCIN TODAY, NONOXYNOL-9 (OTC) TOFRANIL, IMIPRAMINE HYDROCHLORIDE TOFRANIL-PM, IMIPRAMINE PAMOATE TOLAZAMIDE, TOLAZAMIDE TOLBUTAMIDE, TOLBUTAMIDE TOLMETIN SODIUM, TOLMETIN SODIUM TOLTERODINE TARTRATE, TOLTERODINE TARTRATE TOPAMAX, TOPIRAMATE TOPICORT, DESOXIMETASONE TOPIRAMATE, TOPIRAMATE TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE TOPOTECAN, TOPOTECAN HYDROCHLORIDE TOPROL-XL, METOPROLOL SUCCINATE TORISEL, TEMSIROLIMUS TORSEMIDE, TORSEMIDE TOTECT, DEXRAZOXANE HYDROCHLORIDE TOVIAZ, FESOTERODINE FUMARATE TPN ELECTROLYTES IN PLASTIC CONTAINER, CALCIUM CHLORIDE TRACLEER, BOSENTAN TRADJENTA, LINAGLIPTIN TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE, TRANDOLAPRIL TRANDOLAPRIL, TRANDOLAPRIL TRANEXAMIC ACID, TRANEXAMIC ACID TRANSDERM SCOP, SCOPOLAMINE TRANXENE, CLORAZEPATE DIPOTASSIUM TRANYLCYPROMINE SULFATE, TRANYLCYPROMINE SULFATE TRAVASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 10% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, TRAVASOL 3.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, TRAVASOL 5.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, TRAVASOL 8.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% W/O ELECTROLYTES, AMINO ACIDS TRAVATAN Z, TRAVOPROST TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TREANDA, BENDAMUSTINE HYDROCHLORIDE TRECATOR, ETHIONAMIDE TRELSTAR, TRIPTORELIN PAMOATE TRENTAL, PENTOXIFYLLINE TRETINOIN, TRETINOIN TREXALL, METHOTREXATE SODIUM TREXIMET, NAPROXEN SODIUM
TOBRAMYCIN SULFATE
AMINO ACIDS
AMINO ACIDS
AMINO ACIDS
APPENDIX A
**
PRODUCT NAME INDEX

T **
A - 55
TRI LO SPRINTEC, ETHINYL ESTRADIOL TRIACET, TRIAMCINOLONE ACETONIDE TRIACIN-C, CODEINE PHOSPHATE TRIAMCINOLONE ACETONIDE IN ABSORBASE, TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRIAZOLAM, TRIAZOLAM TRIBENZOR, AMLODIPINE BESYLATE TRICOR, FENOFIBRATE TRIDERM, TRIAMCINOLONE ACETONIDE TRIDIONE, TRIMETHADIONE TRIESENCE, TRIAMCINOLONE ACETONIDE TRI-ESTARYLLA, ETHINYL ESTRADIOL TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE TRIFLURIDINE, TRIFLURIDINE TRIGLIDE, FENOFIBRATE TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE TRI-LEGEST 21, ETHINYL ESTRADIOL TRI-LEGEST FE, ETHINYL ESTRADIOL TRILEPTAL, OXCARBAZEPINE TRI-LINYAH, ETHINYL ESTRADIOL TRILIPIX, CHOLINE FENOFIBRATE TRI-LUMA, FLUOCINOLONE ACETONIDE TRILYTE, POLYETHYLENE GLYCOL 3350 TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE, TRIMETHOBENZAMIDE HYDROCHLORIDE TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE TRIMETHOPRIM, TRIMETHOPRIM TRIMIPRAMINE MALEATE, TRIMIPRAMINE MALEATE TRI-NORINYL 28-DAY, ETHINYL ESTRADIOL TRIOSTAT, LIOTHYRONINE SODIUM TRI-PREVIFEM, ETHINYL ESTRADIOL TRISENOX, ARSENIC TRIOXIDE TRI-SPRINTEC, ETHINYL ESTRADIOL TRIVAGIZOLE 3, CLOTRIMAZOLE (OTC) TRIVARIS, TRIAMCINOLONE ACETONIDE TRIVORA-28, ETHINYL ESTRADIOL TRIZIVIR, ABACAVIR SULFATE TROPHAMINE 10%, AMINO ACIDS TROPHAMINE, AMINO ACIDS TROPICACYL, TROPICAMIDE TROPICAMIDE, TROPICAMIDE TROSPIUM CHLORIDE, TROSPIUM CHLORIDE TRUSOPT, DORZOLAMIDE HYDROCHLORIDE TRUVADA, EMTRICITABINE TUDORZA PRESSAIR, ACLIDINIUM BROMIDE TUSSICAPS, CHLORPHENIRAMINE POLISTIREX TUSSIGON, HOMATROPINE METHYLBROMIDE TUSSIONEX PENNKINETIC, CHLORPHENIRAMINE POLISTIREX TWINJECT 0.15, EPINEPHRINE TWINJECT 0.3, EPINEPHRINE TWYNSTA, AMLODIPINE BESYLATE TYGACIL, TIGECYCLINE TYKERB, LAPATINIB DITOSYLATE TYLENOL (CAPLET), ACETAMINOPHEN (OTC) TYLENOL (GELTAB), ACETAMINOPHEN (OTC) TYLENOL W/ CODEINE NO. 3, ACETAMINOPHEN TYLENOL W/ CODEINE NO. 4, ACETAMINOPHEN TYLOX, ACETAMINOPHEN TYVASO, TREPROSTINIL SODIUM TYZEKA, TELBIVUDINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

U **
A - 56
UCERIS, BUDESONIDE U-CORT, HYDROCORTISONE ACETATE ULESFIA, BENZYL ALCOHOL ULORIC, FEBUXOSTAT ULTANE, SEVOFLURANE ULTIVA, REMIFENTANIL HYDROCHLORIDE ULTRACET, ACETAMINOPHEN ULTRAM ER, TRAMADOL HYDROCHLORIDE ULTRAM, TRAMADOL HYDROCHLORIDE ULTRATAG, TECHNETIUM TC-99M RED BLOOD CELL KIT ULTRA-TECHNEKOW FM, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR ULTRAVATE, HALOBETASOL PROPIONATE ULTRAVIST (PHARMACY BULK), IOPROMIDE ULTRAVIST 150, IOPROMIDE ULTRAVIST 240, IOPROMIDE ULTRAVIST 300 IN PLASTIC CONTAINER, IOPROMIDE ULTRAVIST 300, IOPROMIDE ULTRAVIST 370, IOPROMIDE ULTRESA, LIPASE UNASYN, AMPICILLIN SODIUM UNIRETIC, HYDROCHLOROTHIAZIDE UNISOM, DOXYLAMINE SUCCINATE (OTC) UNITHROID, LEVOTHYROXINE SODIUM UNIVASC, MOEXIPRIL HYDROCHLORIDE URECHOLINE, BETHANECHOL CHLORIDE UREX, METHENAMINE HIPPURATE UROCIT-K, POTASSIUM CITRATE UROXATRAL, ALFUZOSIN HYDROCHLORIDE URSO 250, URSODIOL URSO FORTE, URSODIOL URSODIOL, URSODIOL UVADEX, METHOXSALEN
**
**
VAGIFEM, ESTRADIOL VAGISTAT-1, TIOCONAZOLE (OTC) VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VALCYTE, VALGANCICLOVIR HYDROCHLORIDE VALIUM, DIAZEPAM VALNAC, BETAMETHASONE VALERATE VALPROATE SODIUM, VALPROATE SODIUM VALPROIC ACID, VALPROIC ACID VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE VALSTAR PRESERVATIVE FREE, VALRUBICIN VALTREX, VALACYCLOVIR HYDROCHLORIDE VALTROPIN, SOMATROPIN RECOMBINANT VALTURNA, ALISKIREN HEMIFUMARATE VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER, VANCOMYCIN HYDROCHLORIDE VANCOCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VANDAZOLE, METRONIDAZOLE VANIQA, EFLORNITHINE HYDROCHLORIDE VANOS, FLUOCINONIDE VANTAS, HISTRELIN ACETATE VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER, CONIVAPTAN HYDROCHLORIDE VARDENAFIL HYDROCHLORIDE, VARDENAFIL HYDROCHLORIDE VASCEPA, ICOSAPENT ETHYL VASERETIC, ENALAPRIL MALEATE VASOCIDIN, PREDNISOLONE SODIUM PHOSPHATE VASOTEC, ENALAPRIL MALEATE VECTICAL, CALCITRIOL VECURONIUM BROMIDE, VECURONIUM BROMIDE VELCADE, BORTEZOMIB
APPENDIX A
**
PRODUCT NAME INDEX

V **
A - 57
VELETRI, EPOPROSTENOL SODIUM VELIVET, DESOGESTREL VELTIN, CLINDAMYCIN PHOSPHATE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE VENOFER, IRON SUCROSE VENTAVIS, ILOPROST VENTOLIN HFA, ALBUTEROL SULFATE VERAMYST, FLUTICASONE FUROATE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE VERDESO, DESONIDE VEREGEN, SINECATECHINS VERELAN PM, VERAPAMIL HYDROCHLORIDE VERELAN, VERAPAMIL HYDROCHLORIDE VESICARE, SOLIFENACIN SUCCINATE VEXOL, RIMEXOLONE VFEND, VORICONAZOLE VIAGRA, SILDENAFIL CITRATE VIBATIV, TELAVANCIN HYDROCHLORIDE VIBISONE, CYANOCOBALAMIN VIBRAMYCIN, DOXYCYCLINE VIBRAMYCIN, DOXYCYCLINE CALCIUM VIBRAMYCIN, DOXYCYCLINE HYCLATE VICOPROFEN, HYDROCODONE BITARTRATE VICTOZA, LIRAGLUTIDE RECOMBINANT VICTRELIS, BOCEPREVIR VIDAZA, AZACITIDINE VIDEX EC, DIDANOSINE VIDEX, DIDANOSINE VIGAMOX, MOXIFLOXACIN HYDROCHLORIDE VIIBRYD, VILAZODONE HYDROCHLORIDE VIMOVO, ESOMEPRAZOLE MAGNESIUM VIMPAT, LACOSAMIDE VINBLASTINE SULFATE, VINBLASTINE SULFATE VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE VINORELBINE TARTRATE, VINORELBINE TARTRATE VINORELBINE, VINORELBINE VIOKACE, LIPASE VIORELE, DESOGESTREL VIRACEPT, NELFINAVIR MESYLATE VIRAMUNE XR, NEVIRAPINE VIRAMUNE, NEVIRAPINE VIRAZOLE, RIBAVIRIN VIREAD, TENOFOVIR DISOPROXIL FUMARATE VIROPTIC, TRIFLURIDINE VISICOL, SODIUM PHOSPHATE, DIBASIC ANHYDROUS VISINE L.R., OXYMETAZOLINE HYDROCHLORIDE (OTC) VISINE-A, NAPHAZOLINE HYDROCHLORIDE (OTC) VISIONBLUE, TRYPAN BLUE VISIPAQUE 270, IODIXANOL VISIPAQUE 320, IODIXANOL VISTARIL, HYDROXYZINE PAMOATE VISTIDE, CIDOFOVIR VISUDYNE, VERTEPORFIN VITAMIN D, ERGOCALCIFEROL VITAMIN K1, PHYTONADIONE VITRASE, HYALURONIDASE VITRASERT, GANCICLOVIR VIVACTIL, PROTRIPTYLINE HYDROCHLORIDE VIVELLE, ESTRADIOL VIVELLE-DOT, ESTRADIOL VIVITROL, NALTREXONE VOLTAREN, DICLOFENAC SODIUM VOLTAREN-XR, DICLOFENAC SODIUM VORICONAZOLE, VORICONAZOLE
APPENDIX A
VOSOL HC, ACETIC ACID, GLACIAL VOSOL, ACETIC ACID, GLACIAL VOSPIRE ER, ALBUTEROL SULFATE VOTRIENT, PAZOPANIB HYDROCHLORIDE VPRIV, VELAGLUCERASE ALFA VUMON, TENIPOSIDE VUSION, MICONAZOLE NITRATE VYTORIN, EZETIMIBE VYVANSE, LISDEXAMFETAMINE DIMESYLATE
**
PRODUCT NAME INDEX

V **
A - 58
**
WARFARIN SODIUM, WARFARIN SODIUM WELCHOL, COLESEVELAM HYDROCHLORIDE WELLBUTRIN SR, BUPROPION HYDROCHLORIDE WELLBUTRIN XL, BUPROPION HYDROCHLORIDE WELLBUTRIN, BUPROPION HYDROCHLORIDE WERA, ETHINYL ESTRADIOL WESTCORT, HYDROCORTISONE VALERATE
**
**
**
XALATAN, LATANOPROST XALKORI, CRIZOTINIB XANAX XR, ALPRAZOLAM XANAX, ALPRAZOLAM XARELTO, RIVAROXABAN XELJANZ, TOFACITINIB CITRATE XELODA, CAPECITABINE XENAZINE, TETRABENAZINE XENICAL, ORLISTAT XENON XE 133, XENON XE-133 XERESE, ACYCLOVIR XIFAXAN, RIFAXIMIN XIMINO, MINOCYCLINE HYDROCHLORIDE XOLEGEL, KETOCONAZOLE XOPENEX HFA, LEVALBUTEROL TARTRATE XOPENEX, LEVALBUTEROL HYDROCHLORIDE XTANDI, ENZALUTAMIDE XYLOCAINE 4% PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE XYLOCAINE W/ EPINEPHRINE, EPINEPHRINE XYLOCAINE, LIDOCAINE HYDROCHLORIDE XYREM, SODIUM OXYBATE XYZAL, LEVOCETIRIZINE DIHYDROCHLORIDE
**
YASMIN, DROSPIRENONE YAZ, DROSPIRENONE
**
**
**
ZADITOR, KETOTIFEN FUMARATE (OTC) ZAFIRLUKAST, ZAFIRLUKAST ZALEPLON, ZALEPLON ZANAFLEX, TIZANIDINE HYDROCHLORIDE ZANOSAR, STREPTOZOCIN ZANTAC 150, RANITIDINE HYDROCHLORIDE ZANTAC 150, RANITIDINE HYDROCHLORIDE (OTC) ZANTAC 25, RANITIDINE HYDROCHLORIDE ZANTAC 300, RANITIDINE HYDROCHLORIDE ZANTAC 75, RANITIDINE HYDROCHLORIDE (OTC) ZANTAC IN PLASTIC CONTAINER, RANITIDINE HYDROCHLORIDE ZANTAC, RANITIDINE HYDROCHLORIDE
APPENDIX A
**
PRODUCT NAME INDEX

Z **
A - 59
ZARONTIN, ETHOSUXIMIDE ZAROXOLYN, METOLAZONE ZAVESCA, MIGLUSTAT ZEBETA, BISOPROLOL FUMARATE ZECUITY, SUMATRIPTAN SUCCINATE ZEGERID OTC, OMEPRAZOLE (OTC) ZEGERID, OMEPRAZOLE ZELAPAR, SELEGILINE HYDROCHLORIDE ZELBORAF, VEMURAFENIB ZEMPLAR, PARICALCITOL ZEMURON, ROCURONIUM BROMIDE ZENPEP, LIPASE ZERIT, STAVUDINE ZESTORETIC, HYDROCHLOROTHIAZIDE ZESTRIL, LISINOPRIL ZETIA, EZETIMIBE ZETONNA, CICLESONIDE ZIAC, BISOPROLOL FUMARATE ZIAGEN, ABACAVIR SULFATE ZIANA, CLINDAMYCIN PHOSPHATE ZIDOVUDINE, ZIDOVUDINE ZINACEF IN PLASTIC CONTAINER, CEFUROXIME SODIUM ZINACEF, CEFUROXIME SODIUM ZINC CHLORIDE IN PLASTIC CONTAINER, ZINC CHLORIDE ZINECARD, DEXRAZOXANE HYDROCHLORIDE ZIOPTAN, TAFLUPROST ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE ZIPSOR, DICLOFENAC POTASSIUM ZIRGAN, GANCICLOVIR ZITHROMAX, AZITHROMYCIN ZMAX, AZITHROMYCIN ZOCOR, SIMVASTATIN ZOFRAN ODT, ONDANSETRON ZOFRAN PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ZOFRAN, ONDANSETRON HYDROCHLORIDE ZOLADEX, GOSERELIN ACETATE ZOLINZA, VORINOSTAT ZOLOFT, SERTRALINE HYDROCHLORIDE ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE ZOLPIMIST, ZOLPIDEM TARTRATE ZOMETA, ZOLEDRONIC ACID ZOMIG, ZOLMITRIPTAN ZOMIG-ZMT, ZOLMITRIPTAN ZONALON, DOXEPIN HYDROCHLORIDE ZONEGRAN, ZONISAMIDE ZONISAMIDE, ZONISAMIDE ZORBTIVE, SOMATROPIN RECOMBINANT ZORTRESS, EVEROLIMUS ZOSYN IN PLASTIC CONTAINER, PIPERACILLIN SODIUM ZOSYN, PIPERACILLIN SODIUM ZOVIA 1/35E-28, ETHINYL ESTRADIOL ZOVIA 1/50E-28, ETHINYL ESTRADIOL ZOVIRAX, ACYCLOVIR ZUPLENZ, ONDANSETRON ZUTRIPRO, CHLORPHENIRAMINE MALEATE ZYBAN, BUPROPION HYDROCHLORIDE ZYCLARA, IMIQUIMOD ZYDONE, ACETAMINOPHEN ZYFLO CR, ZILEUTON ZYFLO, ZILEUTON ZYLET, LOTEPREDNOL ETABONATE ZYLOPRIM, ALLOPURINOL ZYMAR, GATIFLOXACIN ZYMAXID, GATIFLOXACIN
APPENDIX A
**
PRODUCT NAME INDEX

Z **
A - 60
ZYPREXA RELPREVV, OLANZAPINE PAMOATE ZYPREXA ZYDIS, OLANZAPINE ZYPREXA, OLANZAPINE ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC, CETIRIZINE HYDROCHLORIDE ZYRTEC-D 12 HOUR, CETIRIZINE HYDROCHLORIDE (OTC) ZYTIGA, ABIRATERONE ACETATE ZYVOX, LINEZOLID
B - 1
APPENDIX B
PRODUCT NAME SORTED BY APPLICANT

** 3 **
3M * 3M CO PERIDEX, CHLORHEXIDINE GLUCONATE * 3M HEALTH CARE INC AVAGARD, ALCOHOL (OTC)

DURAPREP, IODINE POVACRYLEX (OTC)
* 3M PHARMACEUTICALS INC PROVENTIL-HFA, ALBUTEROL SULFATE AAIPHARMA LLC * AAIPHARMA LLC AZASAN, AZATHIOPRINE ABBOTT * ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV HYTRIN, TERAZOSIN HYDROCHLORIDE ABBOTT ENDOCRINE * ABBOTT ENDOCRINE INC LUPRON DEPOT, LEUPROLIDE ACETATE
LUPRON DEPOT-PED, LEUPROLIDE ACETATE
ABBOTT LABS * ABBOTT LABORATORIES PROMETRIUM, PROGESTERONE ABBVIE * ABBVIE INC ADVICOR, LOVASTATIN AKINETON, BIPERIDEN HYDROCHLORIDE ANDROGEL, TESTOSTERONE BIAXIN XL, CLARITHROMYCIN BIAXIN, CLARITHROMYCIN CALCIJEX, CALCITRIOL CREON, LIPASE CYCLOSPORINE, CYCLOSPORINE DEPACON, VALPROATE SODIUM DEPAKENE, VALPROIC ACID DEPAKOTE ER, DIVALPROEX SODIUM DEPAKOTE, DIVALPROEX SODIUM GENGRAF, CYCLOSPORINE KALETRA, LOPINAVIR K-TAB, POTASSIUM CHLORIDE MARINOL, DRONABINOL MAVIK, TRANDOLAPRIL NIASPAN, NIACIN NIMBEX PRESERVATIVE FREE, CISATRACURIUM BESYLATE NIMBEX, CISATRACURIUM BESYLATE NORVIR, RITONAVIR ORETIC, HYDROCHLOROTHIAZIDE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE SIMCOR, NIACIN SURVANTA, BERACTANT SYNTHROID, LEVOTHYROXINE SODIUM TARKA, TRANDOLAPRIL TEVETEN HCT, EPROSARTAN MESYLATE TEVETEN, EPROSARTAN MESYLATE TRICOR, FENOFIBRATE TRIDIONE, TRIMETHADIONE TRILIPIX, CHOLINE FENOFIBRATE ULTANE, SEVOFLURANE VICOPROFEN, HYDROCODONE BITARTRATE
ZEMPLAR, PARICALCITOL
ABBVIE ENDOCRINE * ABBVIE ENDOCRINE INC LUPANETA PACK, LEUPROLIDE ACETATE
B - 2
APPENDIX B
ABRAXIS BIOSCIENCE * ABRAXIS BIOSCIENCE LLC ABRAXANE, PACLITAXEL
** A **
ABRAXIS PHARM * ABRAXIS PHARMACEUTICAL PRODUCTS CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%,
ACADEMIC PHARMS * ACADEMIC PHARMACEUTICALS INC SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE ACCORD HLTH * ACCORD HEALTH CARE INC METHYLDOPA, METHYLDOPA ACCORD HLTHCARE * ACCORD HEALTHCARE INC DOCETAXEL, DOCETAXEL DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GLIMEPIRIDE, GLIMEPIRIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM MITOMYCIN, MITOMYCIN MONTELUKAST SODIUM, MONTELUKAST SODIUM MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN TACROLIMUS, TACROLIMUS TOPIRAMATE, TOPIRAMATE ACCORD HLTHCARE INC * ACCORD HEALTHCARE INC USA ANASTROZOLE, ANASTROZOLE BICALUTAMIDE, BICALUTAMIDE CLONAZEPAM, CLONAZEPAM ETOPOSIDE, ETOPOSIDE FINASTERIDE, FINASTERIDE GLIPIZIDE, GLIPIZIDE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL PACLITAXEL, PACLITAXEL QUETIAPINE FUMARATE, QUETIAPINE FUMARATE ACELLA PHARMS LLC * ACELLA PHARMACEUTICALS LLC GABAPENTIN, GABAPENTIN ACORDA * ACORDA THERAPEUTICS INC AMPYRA, DALFAMPRIDINE ZANAFLEX, TIZANIDINE HYDROCHLORIDE ACS DOBFAR * ACS DOBFAR SPA AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE CEFOXITIN, CEFOXITIN SODIUM CEFTAZIDIME, CEFTAZIDIME CEFTRIAXONE, CEFTRIAXONE SODIUM IMIPENEM AND CILASTATIN, CILASTATIN SODIUM KEFZOL, CEFAZOLIN SODIUM MEROPENEM, MEROPENEM
B - 3
APPENDIX B

** A **
ACS DOBFAR INFO SA * ACS DOBFAR INFO SA CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN
ACTAVIS * ACTAVIS SOUTH ATLANTIC LLC METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
* ACTAVIS SOUTHATLANTIC LLC BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE
OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE
ACTAVIS ELIZABETH * ACTAVIS ELIZABETH LLC ALPRAZOLAM, ALPRAZOLAM CARBIDOPA AND LEVODOPA, CARBIDOPA CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, ASPARTATE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE
DICLOFENAC SODIUM, DICLOFENAC SODIUM
DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE
DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
GABAPENTIN, GABAPENTIN
GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE
GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE
HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
INDAPAMIDE, INDAPAMIDE
ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE
KADIAN, MORPHINE SULFATE
LEVETIRACETAM, LEVETIRACETAM
LOVASTATIN, LOVASTATIN
MIRTAZAPINE, MIRTAZAPINE
MORPHINE SULFATE, MORPHINE SULFATE
NIFEDIPINE, NIFEDIPINE
OXAZEPAM, OXAZEPAM
OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
PROPYLTHIOURACIL, PROPYLTHIOURACIL
SPIRONOLACTONE, SPIRONOLACTONE
TEMAZEPAM, TEMAZEPAM
ACTAVIS INC * ACTAVIS INC DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE
LOSARTAN POTASSIUM, LOSARTAN POTASSIUM
ACTAVIS MID ATLANTIC * ACTAVIS MID ATLANTIC LLC ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETASOL HC, ACETIC ACID, GLACIAL ACYCLOVIR, ACYCLOVIR ALBUTEROL SULFATE, ALBUTEROL SULFATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE BETAMETHASONE VALERATE, BETAMETHASONE VALERATE CICLOPIROX, CICLOPIROX CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE (OTC) CONSTULOSE, LACTULOSE ENULOSE, LACTULOSE FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE
GRISEOFULVIN, GRISEOFULVIN, MICROSIZE
AMPHETAMINE
B - 4
APPENDIX B

** A **
* ACTAVIS MID ATLANTIC LLC HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROCORTISONE, HYDROCORTISONE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) INFANTS' FEVERALL, ACETAMINOPHEN (OTC) LEVETIRACETAM, LEVETIRACETAM MICONAZOLE 7, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) M-ZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) NYSTATIN, NYSTATIN PERMETHRIN, PERMETHRIN PERMETHRIN, PERMETHRIN (OTC) PROMETH VC PLAIN, PHENYLEPHRINE HYDROCHLORIDE PROMETH VC W/ CODEINE, CODEINE PHOSPHATE PROMETH W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
VALNAC, BETAMETHASONE VALERATE
ACTAVIS PHARMA * ACTAVIS PHARMA MANUFACTURING PRIVATE LTD DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
ACTAVIS S ATLANTIC * ACTAVIS SOUTH ATLANTIC LLC ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE ACTAVIS TOTOWA * ACTAVIS TOTOWA LLC BICALUTAMIDE, BICALUTAMIDE CARBOPLATIN, CARBOPLATIN DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE FINASTERIDE, FINASTERIDE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE LETROZOLE, LETROZOLE OXALIPLATIN, OXALIPLATIN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE PACLITAXEL, PACLITAXEL PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE
VINORELBINE TARTRATE, VINORELBINE TARTRATE
ACTELION PHARMS LTD * ACTELION PHARMACEUTICALS LTD TRACLEER, BOSENTAN VELETRI, EPOPROSTENOL SODIUM VENTAVIS, ILOPROST
ZAVESCA, MIGLUSTAT
ACTIENT PHARMS * ACTIENT PHARMACEUTICALS LLC EDEX, ALPROSTADIL LEVATOL, PENBUTOLOL SULFATE ROBAXIN, METHOCARBAMOL ROBAXIN-750, METHOCARBAMOL STRIANT, TESTOSTERONE
TESTOPEL, TESTOSTERONE
B - 5
APPENDIX B
* ACTIENT PHARMACEUTICALS LLC THEO-24, THEOPHYLLINE ACTON PHARMS * ACTON PHARMACEUTICALS INC AEROSPAN HFA, FLUNISOLIDE

** A **
ADVENT PHARMS * ADVENT PHARMACEUTICALS INC CARISOPRODOL, CARISOPRODOL AEGERION * AEGERION PHARMACEUTICALS INC JUXTAPID, LOMITAPIDE MESYLATE AFFYMAX * AFFYMAX INC OMONTYS PRESERVATIVE FREE, PEGINESATIDE ACETATE
OMONTYS, PEGINESATIDE ACETATE
AGILA SPECLTS * AGILA SPECIALTIES PRIVATE LTD DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE
AGOURON * AGOURON PHARMACEUTICALS INC VIRACEPT, NELFINAVIR MESYLATE AJANTA PHARMA * AJANTA PHARMA LTD LEVETIRACETAM, LEVETIRACETAM AJANTA PHARMA LTD * AJANTA PHARMA LTD RISPERIDONE, RISPERIDONE AKORN * AKORN INC ADENOSINE, ADENOSINE AKBETA, LEVOBUNOLOL HYDROCHLORIDE AK-FLUOR 10%, FLUORESCEIN SODIUM AK-FLUOR 25%, FLUORESCEIN SODIUM AKPENTOLATE, CYCLOPENTOLATE HYDROCHLORIDE AKPRO, DIPIVEFRIN HYDROCHLORIDE AKTEN, LIDOCAINE HYDROCHLORIDE AKTOB, TOBRAMYCIN ALFENTA, ALFENTANIL HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BAL, DIMERCAPROL BALANCED SALT, CALCIUM CHLORIDE BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE CALCITRIOL, CALCITRIOL CAPASTAT SULFATE, CAPREOMYCIN SULFATE CARBOPLATIN, CARBOPLATIN CROMOLYN SODIUM, CROMOLYN SODIUM DICLOFENAC SODIUM, DICLOFENAC SODIUM ENDOSOL EXTRA, CALCIUM CHLORIDE ERYTHROMYCIN, ERYTHROMYCIN GENTAK, GENTAMICIN SULFATE GENTAMICIN SULFATE, GENTAMICIN SULFATE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IC-GREEN, INDOCYANINE GREEN IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC)
LATANOPROST, LATANOPROST
B - 6
APPENDIX B

** A **
* AKORN INC LEVOFLOXACIN, LEVOFLOXACIN LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE NEDOCROMIL SODIUM, NEDOCROMIL SODIUM NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC OFLOXACIN, OFLOXACIN ORPHENADRINE CITRATE, ORPHENADRINE CITRATE PAREMYD, HYDROXYAMPHETAMINE HYDROBROMIDE SUBLIMAZE PRESERVATIVE FREE, FENTANYL CITRATE SUFENTA PRESERVATIVE FREE, SUFENTANIL CITRATE TERBUTALINE SULFATE, TERBUTALINE SULFATE TIMOLOL MALEATE, TIMOLOL MALEATE TROPICACYL, TROPICAMIDE
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE
AKORN INC * AKORN INC APRACLONIDINE HYDROCHLORIDE, APRACLONIDINE HYDROCHLORIDE CEFTRIAXONE, CEFTRIAXONE SODIUM CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE INAPSINE, DROPERIDOL NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, NAPHAZOLINE HYDROCHLORIDE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM AKRIMAX PHARMS * AKRIMAX PHARMACEUTICALS LLC INDERAL LA, PROPRANOLOL HYDROCHLORIDE INDERAL, PROPRANOLOL HYDROCHLORIDE
INDERIDE-40/25, HYDROCHLOROTHIAZIDE
ALARA PHARM * ALARA PHARMACEUTICAL CORPORATION LEVO-T, LEVOTHYROXINE SODIUM ALCON * ALCON INC TRIESENCE, TRIAMCINOLONE ACETONIDE * ALCON LABORATORIES INC ALCAINE, PROPARACAINE HYDROCHLORIDE ALOMIDE, LODOXAMIDE TROMETHAMINE BETOPTIC S, BETAXOLOL HYDROCHLORIDE BETOPTIC, BETAXOLOL HYDROCHLORIDE BSS PLUS, CALCIUM CHLORIDE BSS, CALCIUM CHLORIDE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE CETAMIDE, SULFACETAMIDE SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOGYL, CYCLOPENTOLATE HYDROCHLORIDE CYCLOMYDRIL, CYCLOPENTOLATE HYDROCHLORIDE DENDRID, IDOXURIDINE EMADINE, EMEDASTINE DIFUMARATE FLAREX, FLUOROMETHOLONE ACETATE IOPIDINE, APRACLONIDINE HYDROCHLORIDE MAXIDEX, DEXAMETHASONE MAXITROL, DEXAMETHASONE MIOSTAT, CARBACHOL MYDRIACYL, TROPICAMIDE NAPHCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) NATACYN, NATAMYCIN OMNIPRED, PREDNISOLONE ACETATE PATANOL, OLOPATADINE HYDROCHLORIDE PILOPINE HS, PILOCARPINE HYDROCHLORIDE TOBRADEX, DEXAMETHASONE
TOBREX, TOBRAMYCIN
(OTC)
B - 7
APPENDIX B
* ALCON LABORATORIES INC VEXOL, RIMEXOLONE
** A **
ALCON PHARMA * ALCON RESEARCH LTD AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE ZADITOR, KETOTIFEN FUMARATE (OTC) ALCON PHARMS LTD * ALCON PHARMACEUTICALS LTD AZOPT, BRINZOLAMIDE BETADINE, POVIDONE-IODINE BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE CILOXAN, CIPROFLOXACIN HYDROCHLORIDE CIPRO HC, CIPROFLOXACIN HYDROCHLORIDE CIPRODEX, CIPROFLOXACIN DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DICLOFENAC SODIUM, DICLOFENAC SODIUM DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE DUREZOL, DIFLUPREDNATE FLUORESCITE, FLUORESCEIN SODIUM KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC) MOXEZA, MOXIFLOXACIN HYDROCHLORIDE NAVSTEL, CALCIUM CHLORIDE NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE NEVANAC, NEPAFENAC OFLOXACIN, OFLOXACIN PATADAY, OLOPATADINE HYDROCHLORIDE PATANASE, OLOPATADINE HYDROCHLORIDE SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM TOBRADEX ST, DEXAMETHASONE TRAVATAN Z, TRAVOPROST TRIFLURIDINE, TRIFLURIDINE VIGAMOX, MOXIFLOXACIN HYDROCHLORIDE ALCON RES * ALCON RESEARCH LTD DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, ISOPTO CARPINE, PILOCARPINE HYDROCHLORIDE LATANOPROST, LATANOPROST ALCON RES LTD * ALCON RESEARCH LTD NEPAFENAC, NEPAFENAC ALEMBIC LTD * ALEMBIC LTD IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LITHIUM CARBONATE, LITHIUM CARBONATE METRONIDAZOLE, METRONIDAZOLE MODAFINIL, MODAFINIL PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE THEOPHYLLINE, THEOPHYLLINE ALEMBIC PHARMS LTD * ALEMBIC PHARMACEUTICALS LTD CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE FAMOTIDINE, FAMOTIDINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN LAMOTRIGINE, LAMOTRIGINE LEFLUNOMIDE, LEFLUNOMIDE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM
DORZOLAMIDE HYDROCHLORIDE
B - 8
APPENDIX B

** A **
* ALEMBIC PHARMACEUTICALS LTD MEPROBAMATE, MEPROBAMATE METRONIDAZOLE, METRONIDAZOLE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
ALEXZA PHARMS * ALEXZA PHARMACEUTICALS INC ADASUVE, LOXAPINE ALKEM * ALKEM LABORATORIES LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CEPHALEXIN, CEPHALEXIN GABAPENTIN, GABAPENTIN
METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
ALKEM LABS LTD * ALKEM LABORATORIES LTD CEFUROXIME AXETIL, CEFUROXIME AXETIL HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL
ALKERMES * ALKERMES INC VIVITROL, NALTREXONE ALKERMES GAINESVILLE * ALKERMES GAINESVILLE LLC VERELAN, VERAPAMIL HYDROCHLORIDE ALKOPHARMA USA * ALKOPHARMA USA INC AMPHOTEC, AMPHOTERICIN B ALLEGIANCE HLTHCARE * ALLEGIANCE HEALTHCARE CORP POVIDONE IODINE, POVIDONE-IODINE
(OTC)
ALLERGAN * ALLERGAN ACULAR LS, KETOROLAC TROMETHAMINE ALPHAGAN P, BRIMONIDINE TARTRATE BLEPH-10, SULFACETAMIDE SODIUM GENOPTIC, GENTAMICIN SULFATE
ZYMAXID, GATIFLOXACIN
* ALLERGAN INC ACULAR PRESERVATIVE FREE, KETOROLAC TROMETHAMINE ACULAR, KETOROLAC TROMETHAMINE ACUVAIL, KETOROLAC TROMETHAMINE ACZONE, DAPSONE ALBALON, NAPHAZOLINE HYDROCHLORIDE ALOCRIL, NEDOCROMIL SODIUM ALPHAGAN P, BRIMONIDINE TARTRATE AVAGE, TAZAROTENE AZELEX, AZELAIC ACID COMBIGAN, BRIMONIDINE TARTRATE ELESTAT, EPINASTINE HYDROCHLORIDE LASTACAFT, ALCAFTADINE LATISSE, BIMATOPROST LUMIGAN, BIMATOPROST OCUFLOX, OFLOXACIN OPTICROM, CROMOLYN SODIUM OZURDEX, DEXAMETHASONE POLYTRIM, POLYMYXIN B SULFATE RESTASIS, CYCLOSPORINE SANCTURA XR, TROSPIUM CHLORIDE SANCTURA, TROSPIUM CHLORIDE TAZORAC, TAZAROTENE
TRIVARIS, TRIAMCINOLONE ACETONIDE
B - 9
APPENDIX B

** A **
* ALLERGAN INC ZYMAR, GATIFLOXACIN * ALLERGAN PHARMACEUTICAL BETAGAN, LEVOBUNOLOL HYDROCHLORIDE BLEPHAMIDE S.O.P., PREDNISOLONE ACETATE BLEPHAMIDE, PREDNISOLONE ACETATE FML FORTE, FLUOROMETHOLONE FML, FLUOROMETHOLONE HERPLEX, IDOXURIDINE OCUFEN, FLURBIPROFEN SODIUM OPHTHETIC, PROPARACAINE HYDROCHLORIDE POLY-PRED, NEOMYCIN SULFATE PRED FORTE, PREDNISOLONE ACETATE PRED MILD, PREDNISOLONE ACETATE PRED-G, GENTAMICIN SULFATE
PROPINE, DIPIVEFRIN HYDROCHLORIDE
ALLERQUEST * ALLERQUEST LLC PRE-PEN, BENZYLPENICILLOYL POLYLYSINE ALLOS * ALLOS THERAPEUTICS INC FOLOTYN, PRALATREXATE ALMATICA * ALMATICA PHARMA INC MACROBID, NITROFURANTOIN
MACRODANTIN, NITROFURANTOIN, MACROCRYSTALLINE
ALPHARMA * ALPHARMA USPD INC PREDNISOLONE, PREDNISOLONE
VALPROIC ACID, VALPROIC ACID
ALPHARMA KING * ALPHARMA PHARMACEUTICALS LLC KING PHARMACEUTICALS EMBEDA, MORPHINE SULFATE ALRA * ALRA LABORATORIES INC CHOLAC, LACTULOSE CONSTILAC, LACTULOSE GEN-XENE, CLORAZEPATE DIPOTASSIUM IBU-TAB 200, IBUPROFEN (OTC)
IBU-TAB, IBUPROFEN
ALTAIRE PHARMS INC * ALTAIRE PHARMACEUTICALS INC NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, ALTERNA TCHP LLC * ALTERNA TCHP LLC CHILDREN'S ELIXSURE,
(OTC)
IBUPROFEN
(OTC)
ALVOGEN * ALVOGEN INC METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
ALVOGEN INC * ALVOGEN INC DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN
AM ANTIBIOTICS * AMERICAN ANTIBIOTICS INC AMOXICILLIN, AMOXICILLIN
B - 10
APPENDIX B
AMAG PHARMS INC * AMAG PHARMACEUTICALS INC FERAHEME, FERUMOXYTOL
GASTROMARK, FERUMOXSIL
AMARIN PHARMA INC * AMARIN PHARMA INC VASCEPA, ICOSAPENT ETHYL

** A **
AMEDRA PHARMS * AMEDRA PHARMACEUTICALS LLC ADRENACLICK, EPINEPHRINE DEXEDRINE, DEXTROAMPHETAMINE SULFATE HYDROCORTISONE, HYDROCORTISONE TWINJECT 0.15, EPINEPHRINE
TWINJECT 0.3, EPINEPHRINE
AMGEN * AMGEN INC SENSIPAR,
AMNEAL PHARM * AMNEAL PHARMACEUTICAL ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FOLIC ACID, FOLIC ACID GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE
PRIMIDONE, PRIMIDONE
AMNEAL PHARMS * AMNEAL PHARMACEUTICALS ALBUTEROL SULFATE, ALBUTEROL SULFATE CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FELBAMATE, FELBAMATE GABAPENTIN, GABAPENTIN IBUPROFEN, IBUPROFEN (OTC) INDOMETHACIN, INDOMETHACIN LEVETIRACETAM, LEVETIRACETAM LORAZEPAM, LORAZEPAM MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE NITROFURANTOIN, NITROFURANTOIN NIZATIDINE, NIZATIDINE NORETHIDRONE ACETATE, NORETHINDRONE ACETATE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXCARBAZEPINE, OXCARBAZEPINE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SPIRONOLACTONE, SPIRONOLACTONE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE * AMNEAL PHARMACEUTICALS LLC TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE AMNEAL PHARMS NY * AMNEAL PHARMACEUTICALS NY LLC ACETAMINOPHEN AND CODEINE PHOSPHATE, ALPRAZOLAM, ALPRAZOLAM
ACETAMINOPHEN
B - 11
APPENDIX B

** A **
* AMNEAL PHARMACEUTICALS NY LLC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM GABAPENTIN, GABAPENTIN HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NAPROXEN, NAPROXEN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE REPREXAIN, HYDROCODONE BITARTRATE
SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE
AMPHASTAR PHARM * AMPHASTAR PHARMACEUTICAL INC AMPHADASE, HYALURONIDASE
ENOXAPARIN SODIUM (PRESERVATIVE FREE), AMPHASTAR PHARMS INC * AMPHASTAR PHARMACEUTICALS INC CORTROSYN, COSYNTROPIN AMPOLGEN * AMPOLGEN PHARMACEUTICALS LLC SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE AMYLIN * AMYLIN PHARMACEUTICALS INC BYDUREON, EXENATIDE SYNTHETIC BYETTA, EXENATIDE SYNTHETIC
SYMLIN, PRAMLINTIDE ACETATE
ANBEX * ANBEX INC IOSAT, POTASSIUM IODIDE
ENOXAPARIN SODIUM
(OTC)
ANCHEN PHARMS * ANCHEN PHARMACEUTICALS INC BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRETINOIN, TRETINOIN
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
* ANCHEN PHARMACEUTICALS TAIWAN INC DIVALPROEX SODIUM, DIVALPROEX SODIUM * ANCHEN PHARMACEUTICALS, INC ALPRAZOLAM, ALPRAZOLAM CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN
ANDRX LABS LLC * ANDRX LABS LLC ALTOPREV, LOVASTATIN
FORTAMET, METFORMIN HYDROCHLORIDE
ANGELINI LLC * ANGELINI LABOPHARM LLC OLEPTRO, TRAZODONE HYDROCHLORIDE
B - 12
APPENDIX B

** A **
ANI PHARMS * ANI PHARMACEUTICALS INC CORTENEMA, HYDROCORTISONE LACTULOSE, LACTULOSE LUVOX, FLUVOXAMINE MALEATE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE
REGLAN, METOCLOPRAMIDE HYDROCHLORIDE
ANTIBIOTICE * ANTIBIOTICE SA AMPICILLIN SODIUM, AMPICILLIN SODIUM
NAFCILLIN SODIUM, NAFCILLIN SODIUM
ANTIBIOTICOS BRASIL * ANTIBIOTICOS DO BRASIL LTDA CEFOXITIN, CEFOXITIN SODIUM APGDI * ASTELLAS PHARMA GLOBAL DEVELOPMENT INC MYRBETRIQ, MIRABEGRON APHENA PHARMA MD * APHENA PHARMA SOLUTIONS MARYLAND LLC MICONAZOLE NITRATE, MICONAZOLE NITRATE APOPHARMA INC * APOPHARMA INC FERRIPROX, DEFERIPRONE APOTEX * APOTEX CORP LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM
TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
* APOTEX INC ALENDRONATE SODIUM, ALENDRONATE SODIUM AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN BUDESONIDE, BUDESONIDE CAPTOPRIL, CAPTOPRIL CARBIDOPA AND LEVODOPA, CARBIDOPA CEFUROXIME AXETIL, CEFUROXIME AXETIL CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CIMETIDINE, CIMETIDINE CIMETIDINE, CIMETIDINE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CYCLOSPORINE, CYCLOSPORINE DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM DILT-CD, DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE ENALAPRIL MALEATE, ENALAPRIL MALEATE EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE EPLERENONE, EPLERENONE ETODOLAC, ETODOLAC FAMCICLOVIR, FAMCICLOVIR FAMOTIDINE, FAMOTIDINE FLUCONAZOLE, FLUCONAZOLE FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE GEMFIBROZIL, GEMFIBROZIL GLIPIZIDE, GLIPIZIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE KETOCONAZOLE, KETOCONAZOLE LAMIVUDINE, LAMIVUDINE
LATANOPROST, LATANOPROST
(OTC)
B - 13
APPENDIX B

** A **
* APOTEX INC LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NIZATIDINE, NIZATIDINE OMEPRAZOLE, OMEPRAZOLE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PENTOXIFYLLINE, PENTOXIFYLLINE PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RAMIPRIL, RAMIPRIL RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
TROSPIUM CHLORIDE, TROSPIUM CHLORIDE
APOTEX CORP * APOTEX CORP ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AZITHROMYCIN, AZITHROMYCIN CICLOPIROX, CICLOPIROX CLARITHROMYCIN, CLARITHROMYCIN GATIFLOXACIN, GATIFLOXACIN LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MONTELUKAST SODIUM, MONTELUKAST SODIUM MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NARATRIPTAN, NARATRIPTAN SILDENAFIL CITRATE, SILDENAFIL CITRATE TOLTERODINE TARTRATE, TOLTERODINE TARTRATE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE
APOTEX INC * APOTEX INC ABACAVIR SULFATE, ABACAVIR SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALPRAZOLAM, ALPRAZOLAM ANASTROZOLE, ANASTROZOLE ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE CALCITONIN-SALMON, CALCITONIN SALMON CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL CARBAMAZEPINE, CARBAMAZEPINE CARBIDOPA AND LEVODOPA, CARBIDOPA CEFPROZIL, CEFPROZIL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CEVIMELINE, CEVIMELINE HYDROCHLORIDE CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE DOCETAXEL, DOCETAXEL DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FLECAINIDE ACETATE, FLECAINIDE ACETATE
GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE
B - 14
APPENDIX B

** A **
* APOTEX INC IBANDRONATE SODIUM, IBANDRONATE SODIUM IMIQUIMOD, IMIQUIMOD IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN LAMOTRIGINE, LAMOTRIGINE LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LOVASTATIN, LOVASTATIN MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MONTELUKAST SODIUM, MONTELUKAST SODIUM MYCOPHENOLIC ACID, MYCOPHENOLIC ACID NABUMETONE, NABUMETONE NEVIRAPINE, NEVIRAPINE OFLOXACIN, OFLOXACIN OLANZAPINE, OLANZAPINE OXCARBAZEPINE, OXCARBAZEPINE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RISPERIDONE, RISPERIDONE RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TIMOLOL MALEATE, TIMOLOL MALEATE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
* APOTEX INC ETOBICOKE SITE ACYCLOVIR, ACYCLOVIR ALLOPURINOL, ALLOPURINOL AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CARBAMAZEPINE, CARBAMAZEPINE CARVEDILOL, CARVEDILOL CILOSTAZOL, CILOSTAZOL CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DILTZAC, DILTIAZEM HYDROCHLORIDE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ETODOLAC, ETODOLAC FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GABAPENTIN, GABAPENTIN KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC) LEFLUNOMIDE, LEFLUNOMIDE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LITHIUM CARBONATE, LITHIUM CARBONATE LORATADINE, LORATADINE (OTC) MELOXICAM, MELOXICAM MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE OXAPROZIN, OXAPROZIN SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TORSEMIDE, TORSEMIDE
ZONISAMIDE, ZONISAMIDE
B - 15
APPENDIX B

** A **
* APOTEX INC RICHMOND HILL ALBUTEROL SULFATE, ALBUTEROL SULFATE AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DICLOFENAC SODIUM, DICLOFENAC SODIUM FLUNISOLIDE, FLUNISOLIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LORATADINE, LORATADINE (OTC) MEGESTROL ACETATE, MEGESTROL ACETATE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE PREDNISOLONE, PREDNISOLONE
RISPERIDONE, RISPERIDONE
* APOTEX INC. GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE APOTHECON * APOTHECON INC DIV BRISTOL MYERS SQUIBB CAPOZIDE 25/15, CAPTOPRIL CAPOZIDE 25/25, CAPTOPRIL CAPOZIDE 50/15, CAPTOPRIL CAPOZIDE 50/25, CAPTOPRIL KENALOG, TRIAMCINOLONE ACETONIDE KENALOG-10, TRIAMCINOLONE ACETONIDE KENALOG-40, TRIAMCINOLONE ACETONIDE OPHTHAINE, PROPARACAINE HYDROCHLORIDE STADOL PRESERVATIVE FREE, BUTORPHANOL TARTRATE
STADOL, BUTORPHANOL TARTRATE
APP PHARMS * APP PHARMACEUTICALS LLC DIPHENHYDRAMINE HYDROCHLORIDE,
APRICUS PHARMS * APRICUS PHARMACEUTICALS USA INC TOTECT, DEXRAZOXANE HYDROCHLORIDE APTALIS PHARMA * APTALIS PHARMA LTD RECTIV, NITROGLYCERIN APTALIS PHARMA US * APTALIS PHARMA US INC BENTYL PRESERVATIVE FREE, DICYCLOMINE HYDROCHLORIDE BENTYL, DICYCLOMINE HYDROCHLORIDE CANASA, MESALAMINE CARAFATE, SUCRALFATE PYLERA, BISMUTH SUBCITRATE POTASSIUM ULTRESA, LIPASE URSO 250, URSODIOL URSO FORTE, URSODIOL VIOKACE, LIPASE
ZENPEP, LIPASE
APTALIS PHARMATECH * APTALIS PHARMATECH INC PROPRANOLOL HYDROCHLORIDE, AQUA PHARMS * AQUA PHARMACEUTICALS CORDRAN SP, FLURANDRENOLIDE CORDRAN, FLURANDRENOLIDE
MONODOX, DOXYCYCLINE
* AQUA PHARMACEUTICALS LLC FLUOROPLEX, FLUOROURACIL
XOLEGEL, KETOCONAZOLE
B - 16
APPENDIX B
AR HOLDING CO INC * AR HOLDING CO INC FIBRICOR, FENOFIBRIC ACID

** A **
ARBOR PHARMS INC * ARBOR PHARMACEUTICALS INC AMPHETAMINE SULFATE, AMPHETAMINE SULFATE
BIDIL, HYDRALAZINE HYDROCHLORIDE
E.E.S. 200, ERYTHROMYCIN ETHYLSUCCINATE E.E.S. 400, ERYTHROMYCIN ETHYLSUCCINATE
E.E.S., ERYTHROMYCIN ETHYLSUCCINATE
ERYPED, ERYTHROMYCIN ETHYLSUCCINATE
ERY-TAB, ERYTHROMYCIN
ERYTHROCIN STEARATE, ERYTHROMYCIN STEARATE
ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN, ERYTHROMYCIN
GLIADEL, CARMUSTINE
PCE, ERYTHROMYCIN
PEDIAMYCIN 400, ERYTHROMYCIN ETHYLSUCCINATE
PEDIAMYCIN, ERYTHROMYCIN ETHYLSUCCINATE
ARCHIMEDES * ARCHIMEDES DEVELOPMENT LTD LAZANDA, FENTANYL CITRATE ARCO PHARMS LLC * ARCO PHARMACEUTICALS LLC THYROSHIELD, POTASSIUM IODIDE
(OTC)
AREVA PHARMS * AREVA PHARMACEUTICALS INC PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM ARIAD * ARIAD PHARMACEUTICALS INC ICLUSIG, PONATINIB HYDROCHLORIDE ARMSTRONG PHARMS * ARMSTRONG PHARMACEUTICALS INC EPINEPHRINE, EPINEPHRINE (OTC) ASCEND * ASCEND THERAPEUTICS INC ESTROGEL, ESTRADIOL ASPEN GLOBAL * ASPEN GLOBAL INC MYLERAN, BUSULFAN ASPEN GLOBAL INC * ASPEN GLOBAL INC LEUKERAN, CHLORAMBUCIL ASTELLAS * ASTELLAS PHARMA US INC ADENOCARD, ADENOSINE ADENOSCAN, ADENOSINE AMBISOME, AMPHOTERICIN B LEXISCAN, REGADENOSON MYCAMINE, MICAFUNGIN SODIUM PROGRAF, TACROLIMUS PROTOPIC, TACROLIMUS VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER, VESICARE, SOLIFENACIN SUCCINATE
XTANDI, ENZALUTAMIDE
ASTRAZENECA * ASTRAZENECA LP DUTOPROL, HYDROCHLOROTHIAZIDE ENTOCORT EC, BUDESONIDE
NEXIUM IV, ESOMEPRAZOLE SODIUM
B - 17
APPENDIX B

** A **
* ASTRAZENECA LP NEXIUM, ESOMEPRAZOLE MAGNESIUM PRILOSEC OTC, OMEPRAZOLE MAGNESIUM PRILOSEC, OMEPRAZOLE PRILOSEC, OMEPRAZOLE MAGNESIUM PULMICORT FLEXHALER, BUDESONIDE PULMICORT RESPULES, BUDESONIDE RHINOCORT, BUDESONIDE SEROQUEL, QUETIAPINE FUMARATE SYMBICORT, BUDESONIDE TENORMIN, ATENOLOL
TOPROL-XL, METOPROLOL SUCCINATE
* ASTRAZENECA PHARMACEUTICALS LP ATACAND HCT, CANDESARTAN CILEXETIL ATACAND, CANDESARTAN CILEXETIL FASLODEX, FULVESTRANT PLENDIL, FELODIPINE SEROQUEL XR, QUETIAPINE FUMARATE TENORETIC 100, ATENOLOL TENORETIC 50, ATENOLOL ZOMIG, ZOLMITRIPTAN
ZOMIG-ZMT, ZOLMITRIPTAN
* ASTRAZENECA UK LTD ACCOLATE, ZAFIRLUKAST ARIMIDEX, ANASTROZOLE CASODEX, BICALUTAMIDE MERREM, MEROPENEM ZESTORETIC, HYDROCHLOROTHIAZIDE ZESTRIL, LISINOPRIL
ZOLADEX, GOSERELIN ACETATE
ASTRAZENECA LP * ASTRAZENECA LP BRILINTA, TICAGRELOR
VIMOVO, ESOMEPRAZOLE MAGNESIUM
(OTC)
ATON * ATON PHARMA INC CUPRIMINE, PENICILLAMINE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID LACRISERT, HYDROXYPROPYL CELLULOSE LODOSYN, CARBIDOPA SYPRINE, TRIENTINE HYDROCHLORIDE TIMOPTIC IN OCUDOSE, TIMOLOL MALEATE
TIMOPTIC, TIMOLOL MALEATE
AUROBINDO * AUROBINDO PHARMA LTD AMOXICILLIN, AMOXICILLIN CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLARITHROMYCIN, CLARITHROMYCIN DIDANOSINE, DIDANOSINE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE NEVIRAPINE, NEVIRAPINE
ZIDOVUDINE, ZIDOVUDINE
AUROBINDO PHARM * AUROBINDO PHARMA USA INC FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE GABAPENTIN, GABAPENTIN
B - 18
APPENDIX B
* AUROBINDO PHARMA USA INC RANITIDINE HYDROCHLORIDE,

** A **
AUROBINDO PHARMA * AUROBINDO PHARMA AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM * AUROBINDO PHARMA LTD ALENDRONATE SODIUM, ALENDRONATE SODIUM AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMPICILLIN SODIUM, AMPICILLIN SODIUM ATENOLOL, ATENOLOL BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE CARISOPRODOL, CARISOPRODOL CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFDINIR, CEFDINIR CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFTAZIDIME, CEFTAZIDIME CEFTRIAXONE, CEFTRIAXONE SODIUM CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DIDANOSINE, DIDANOSINE FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GLYBURIDE, GLYBURIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MELOXICAM, MELOXICAM METOPROLOL TARTRATE, METOPROLOL TARTRATE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE RIBAVARIN, RIBAVIRIN RIBAVIRIN, RIBAVIRIN RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN STAVUDINE, STAVUDINE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TORSEMIDE, TORSEMIDE TRANDOLAPRIL, TRANDOLAPRIL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
ZALEPLON, ZALEPLON
B - 19
APPENDIX B
* AUROBINDO PHARMA LTD ZOLPIDEM TARTRATE,

** A **
ZOLPIDEM TARTRATE
AUROBINDO PHARMA LTD * AUROBINDO PHARMA LIMITED DIVALPROEX SODIUM, DIVALPROEX SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE LEVOFLOXACIN, LEVOFLOXACIN
* AUROBINDO PHARMA LTD ABACAVIR SULFATE, ABACAVIR SULFATE ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FAMCICLOVIR, FAMCICLOVIR FELODIPINE, FELODIPINE GABAPENTIN, GABAPENTIN GLIMEPIRIDE, GLIMEPIRIDE IRBESARTAN, IRBESARTAN LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE LAMIVUDINE, LAMIVUDINE LEVOFLOXACIN, LEVOFLOXACIN METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MODAFINIL, MODAFINIL MONTELUKAST SODIUM, MONTELUKAST SODIUM NAFCILLIN SODIUM, NAFCILLIN SODIUM NAPROXEN SODIUM, NAPROXEN SODIUM OLANZAPINE, OLANZAPINE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXACILLIN SODIUM, OXACILLIN SODIUM PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE RAMIPRIL, RAMIPRIL
RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE
* AUROBINDO PHARMA LTD INC CEFPROZIL, CEFPROZIL CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE MIRTAZAPINE, MIRTAZAPINE
AUROBINDO PHARMA USA * AUROBINDO PHARMA USA INC ALPRAZOLAM, ALPRAZOLAM
NAPROXEN, NAPROXEN
AUROLIFE PHARMA LLC * AUROLIFE PHARMA LLC HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
AUSTARPHARMA LLC * AUSTARPHARMA LLC ALENDRONATE SODIUM, ALENDRONATE SODIUM METHOCARBAMOL, METHOCARBAMOL
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE
B - 20
APPENDIX B
AUXILIUM PHARMS * AUXILIUM PHARMACEUTICALS INC TESTIM, TESTOSTERONE
** A **
AVACOR PRODS * AVACOR PRODUCTS LLC MINOXIDIL EXTRA STRENGTH (FOR MEN),
MINOXIDIL
(OTC)
AVANIR PHARMS * AVANIR PHARMACEUTICALS INC NUEDEXTA, DEXTROMETHORPHAN HYDROBROMIDE AVANTHI INC * AVANTHI INC CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE (OTC) DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE INDOMETHACIN, INDOMETHACIN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE AVEMA PHARMA * AVEMA PHARMA SOLUTIONS IBUPROFEN, IBUPROFEN AVENT * AVENT INC PYTEST KIT, UREA, C-14 PYTEST, UREA, C-14 AVEVA * AVEVA DRUG DELIVERY SYSTEMS INC CLONIDINE, CLONIDINE FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL NICOTINE, NICOTINE (OTC) AVID RADIOPHARMS INC * AVID RADIOPHARMACEUTICALS INC AMYVID, FLORBETAPIR F-18 AZTIQ PHARMA * AZTIQ PHARMA INC TODAY, NONOXYNOL-9
(OTC)
(OTC)
B BRAUN * B BRAUN MEDICAL INC ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL ALCOHOL 10% AND DEXTROSE 5%, ALCOHOL ALCOHOL 5% AND DEXTROSE 5%, ALCOHOL AMINO ACIDS, AMINO ACIDS BALANCED SALT, CALCIUM CHLORIDE BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER, BRETYLIUM TOSYLATE CEFAZOLIN AND DEXTROSE, CEFAZOLIN SODIUM CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER, CEFEPIME HYDROCHLORIDE CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER, CEFOTETAN DISODIUM CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER, CEFOXITIN SODIUM CEFTAZIDIME IN DEXTROSE CONTAINER, CEFTAZIDIME CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER, CEFTRIAXONE SODIUM CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER, CEFUROXIME SODIUM DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE
B - 21
APPENDIX B

** B **
* B BRAUN MEDICAL INC DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%, DOPAMINE HYDROCHLORIDE FREAMINE HBC 6.9%, AMINO ACIDS FREAMINE III 10%, AMINO ACIDS FREAMINE III 3% W/ ELECTROLYTES, AMINO ACIDS FREAMINE III 8.5% W/ ELECTROLYTES, AMINO ACIDS FREAMINE III 8.5%, AMINO ACIDS GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPATAMINE 8%, AMINO ACIDS ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE E IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE S IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ISOLYTE S PH 7.4 IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE
HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE
HYDROCHLORIDE
MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER, MANNITOL
MANNITOL 10%, MANNITOL
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%, MANNITOL
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%, MANNITOL
METRO I.V. IN PLASTIC CONTAINER, METRONIDAZOLE
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE
NEPHRAMINE 5.4%, AMINO ACIDS
NUTRILIPID 10%, SOYBEAN OIL
NUTRILIPID 20%, SOYBEAN OIL
PHYSIOLYTE IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE
B - 22
APPENDIX B

** B **
* B BRAUN MEDICAL INC POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC
CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC
CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC
CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,
DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE
B - 23
APPENDIX B

** B **
* B BRAUN MEDICAL INC POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
DEXTROSE
DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PROCALAMINE, AMINO ACIDS RESECTISOL IN PLASTIC CONTAINER, MANNITOL RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SORBITOL 3.3% IN PLASTIC CONTAINER, SORBITOL STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE TROPHAMINE 10%, AMINO ACIDS TROPHAMINE, AMINO ACIDS BANNER PHARMACAPS * BANNER PHARMACAPS INC AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE BENZONATATE, BENZONATATE CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ETHOSUXIMIDE, ETHOSUXIMIDE IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE IBUPROFEN, IBUPROFEN (OTC)
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC)
(OTC)
B - 24
APPENDIX B
*
** B **
BANNER PHARMACAPS INC MIDOL LIQUID GELS, IBUPROFEN (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NIMODIPINE, NIMODIPINE STAVZOR, VALPROIC ACID VALPROIC ACID, VALPROIC ACID VITAMIN D, ERGOCALCIFEROL ZONISAMIDE, ZONISAMIDE
BARR * BARR LABORATORIES INC ALPRAZOLAM, ALPRAZOLAM AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ARANELLE, ETHINYL ESTRADIOL ASPIRIN AND DIPYRIDAMOLE, ASPIRIN BALZIVA-28, ETHINYL ESTRADIOL BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE CAMILA, NORETHINDRONE CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORZOXAZONE, CHLORZOXAZONE CLARAVIS, ISOTRETINOIN CLONAZEPAM, CLONAZEPAM CLONIDINE, CLONIDINE DANAZOL, DANAZOL DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE ASPARTATE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE DIAZEPAM, DIAZEPAM DIDANOSINE, DIDANOSINE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE DUTASTERIDE, DUTASTERIDE ERRIN, NORETHINDRONE ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, ERYTHROMYCIN ETHYLSUCCINATE ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL ESTRADIOL AND NORGESTIMATE, ESTRADIOL ESTROPIPATE, ESTROPIPATE ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE HYDROXYUREA, HYDROXYUREA HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE ISONIAZID, ISONIAZID JUNEL 1.5/30, ETHINYL ESTRADIOL JUNEL 1/20, ETHINYL ESTRADIOL JUNEL FE 1.5/30, ETHINYL ESTRADIOL JUNEL FE 1/20, ETHINYL ESTRADIOL KARIVA, DESOGESTREL KELNOR, ETHINYL ESTRADIOL LEFLUNOMIDE, LEFLUNOMIDE LESSINA-28, ETHINYL ESTRADIOL MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEGESTROL ACETATE, MEGESTROL ACETATE
B - 25
APPENDIX B

** B **
* BARR LABORATORIES INC MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHOTREXATE SODIUM, METHOTREXATE SODIUM NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORETHINDRONE ACETATE, NORETHINDRONE ACETATE NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORTREL 0.5/35-28, ETHINYL ESTRADIOL NORTREL 1/35-21, ETHINYL ESTRADIOL NORTREL 1/35-28, ETHINYL ESTRADIOL NORTREL 7/7/7, ETHINYL ESTRADIOL ONDANSETRON, ONDANSETRON PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PORTIA-28, ETHINYL ESTRADIOL PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE SPRINTEC, ETHINYL ESTRADIOL TEMOZOLOMIDE, TEMOZOLOMIDE TREXALL, METHOTREXATE SODIUM TRI LO SPRINTEC, ETHINYL ESTRADIOL TRI-LEGEST 21, ETHINYL ESTRADIOL TRI-LEGEST FE, ETHINYL ESTRADIOL TRI-SPRINTEC, ETHINYL ESTRADIOL WARFARIN SODIUM, WARFARIN SODIUM
* BARR PHARMACEUTICALS LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM BARR LABS INC * BARR LABORATORIES INC ESTRADIOL, ESTRADIOL METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NIMODIPINE, NIMODIPINE OLANZAPINE, OLANZAPINE OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN
TRETINOIN, TRETINOIN
BAUSCH AND LOMB * BAUSCH AND LOMB INC ALAWAY, KETOTIFEN FUMARATE (OTC) ALBUTEROL SULFATE, ALBUTEROL SULFATE ALREX, LOTEPREDNOL ETABONATE BESIVANCE, BESIFLOXACIN HYDROCHLORIDE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE FLURBIPROFEN SODIUM, FLURBIPROFEN SODIUM IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LATANOPROST, LATANOPROST LOTEMAX, LOTEPREDNOL ETABONATE MIOCHOL-E, ACETYLCHOLINE CHLORIDE OFLOXACIN, OFLOXACIN OPCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) RETISERT, FLUOCINOLONE ACETONIDE TIMOLOL MALEATE, TIMOLOL MALEATE VITRASERT, GANCICLOVIR ZIRGAN, GANCICLOVIR
ZYLET, LOTEPREDNOL ETABONATE
* BAUSCH AND LOMB PHARMACEUTICALS INC ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE, ACETIC ACID, GLACIAL BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE
BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE
B - 26
APPENDIX B

** B **
* BAUSCH AND LOMB PHARMACEUTICALS INC CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CROLOM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM (OTC) DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DEXASPORIN, DEXAMETHASONE ERYTHROMYCIN, ERYTHROMYCIN FLUNISOLIDE, FLUNISOLIDE GENTAMICIN SULFATE, GENTAMICIN SULFATE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC OFLOXACIN, OFLOXACIN OPTIPRANOLOL, METIPRANOLOL HYDROCHLORIDE OTICAIR, HYDROCORTISONE PENTOLAIR, CYCLOPENTOLATE HYDROCHLORIDE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM TIMOLOL MALEATE, TIMOLOL MALEATE TOBRAMYCIN AND DEXAMETHASONE, DEXAMETHASONE TOBRAMYCIN, TOBRAMYCIN TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE
TROPICAMIDE, TROPICAMIDE
BAXTER HLTHCARE * BAXTER HEALTHCARE CORP ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, GLYCINE ANCEF IN PLASTIC CONTAINER, CEFAZOLIN SODIUM BACTOCILL IN PLASTIC CONTAINER, OXACILLIN SODIUM BRANCHAMIN 4% IN PLASTIC CONTAINER, AMINO ACIDS BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC, ESMOLOL HYDROCHLORIDE CARDIOPLEGIC IN PLASTIC CONTAINER, CALCIUM CHLORIDE CEFEPIME IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE CEFTRIAXONE IN PLASTIC CONTAINER, CEFTRIAXONE SODIUM CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS
B - 27
APPENDIX B

** B **
* BAXTER HEALTHCARE CORP CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE CYTOXAN, CYCLOPHOSPHAMIDE DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE
DEXTROSE 60% IN PLASTIC CONTAINER, DEXTROSE
DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE
DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
B - 28
APPENDIX B
*

** B **
BAXTER HEALTHCARE CORP DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE ETHRANE, ENFLURANE EXTRANEAL, ICODEXTRIN FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER, FAMOTIDINE FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FORANE, ISOFLURANE HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPATASOL 8%, AMINO ACIDS IFEX, IFOSFAMIDE ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER, GENTAMICIN SULFATE LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE MESNEX, MESNA MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE NALLPEN IN PLASTIC CONTAINER, NAFCILLIN SODIUM NEXTERONE, AMIODARONE HYDROCHLORIDE NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN OSMITROL 10% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 10% IN WATER, MANNITOL OSMITROL 15% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 15% IN WATER, MANNITOL OSMITROL 20% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 20% IN WATER, MANNITOL OSMITROL 5% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 5% IN WATER, MANNITOL PENICILLIN G POTASSIUM IN PLASTIC CONTAINER, PENICILLIN G POTASSIUM PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASMA-LYTE 56 IN PLASTIC CONTAINER, MAGNESIUM ACETATE TETRAHYDRATE PLASMA-LYTE A IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLASMA-LYTE R IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
B - 29
APPENDIX B

** B **
* BAXTER HEALTHCARE CORP POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,
CALCIUM CHLORIDE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,
CALCIUM CHLORIDE
CALCIUM CHLORIDE
CALCIUM CHLORIDE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,
DEXTROSE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PREMASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS PREMASOL 6% IN PLASTIC CONTAINER, AMINO ACIDS RENAMIN W/O ELECTROLYTES, AMINO ACIDS RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE SEVOFLURANE, SEVOFLURANE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SORBITOL 3% IN PLASTIC CONTAINER, SORBITOL STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION STERILE WATER, STERILE WATER FOR IRRIGATION SUPRANE, DESFLURANE TIS-U-SOL IN PLASTIC CONTAINER, MAGNESIUM SULFATE TIS-U-SOL, MAGNESIUM SULFATE TRAVASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 10% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 3.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 5.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 8.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% W/O ELECTROLYTES, AMINO ACIDS VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER, VANCOMYCIN HYDROCHLORIDE * BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE DOPRAM, DOXAPRAM HYDROCHLORIDE FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE HEPARIN SODIUM, HEPARIN SODIUM
ROBINUL, GLYCOPYRROLATE
B - 30
APPENDIX B

** B **
* BAXTER HEALTHCARE INTERNATI0NAL SPECIALTY THERAPIES DIV PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS BAXTER HLTHCARE CORP * BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE PROTOPAM CHLORIDE, PRALIDOXIME CHLORIDE * BAXTER HEALTHCARE CORP ANESTHESIA CRITICAL CARE ATIVAN, LORAZEPAM OXYTOCIN, OXYTOCIN PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE REGLAN, METOCLOPRAMIDE HYDROCHLORIDE
ROBAXIN, METHOCARBAMOL
BAYER * BAYER HEALTHCARE LLC ALEVE, NAPROXEN SODIUM (OTC) ALEVE-D SINUS & COLD, NAPROXEN SODIUM (OTC)
FEMSTAT 3, BUTOCONAZOLE NITRATE (OTC)
BAYER HLTHCARE * BAYER HEALTHCARE CONSUMER CARE RID MOUSSE, PIPERONYL BUTOXIDE (OTC) * BAYER HEALTHCARE PHARMACEUTICALS INC ADALAT CC, NIFEDIPINE ANGELIQ, DROSPIRENONE AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER, MOXIFLOXACIN HYDROCHLORIDE AVELOX, MOXIFLOXACIN HYDROCHLORIDE BETAPACE AF, SOTALOL HYDROCHLORIDE BETAPACE, SOTALOL HYDROCHLORIDE BEYAZ, DROSPIRENONE CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPRO XR, CIPROFLOXACIN CIPRO, CIPROFLOXACIN CIPRO, CIPROFLOXACIN HYDROCHLORIDE CLIMARA PRO, ESTRADIOL CLIMARA, ESTRADIOL DTIC-DOME, DACARBAZINE EOVIST, GADOXETATE DISODIUM GADAVIST, GADOBUTROL LEVITRA, VARDENAFIL HYDROCHLORIDE MAGNEVIST, GADOPENTETATE DIMEGLUMINE MENOSTAR, ESTRADIOL MIRENA, LEVONORGESTREL MYCELEX, CLOTRIMAZOLE NATAZIA, ESTRADIOL VALERATE NEXAVAR, SORAFENIB TOSYLATE PRECOSE, ACARBOSE REFLUDAN, LEPIRUDIN RECOMBINANT SAFYRAL, DROSPIRENONE SKYLA, LEVONORGESTREL STAXYN, VARDENAFIL HYDROCHLORIDE STIVARGA, REGORAFENIB ULTRAVIST (PHARMACY BULK), IOPROMIDE ULTRAVIST 150, IOPROMIDE ULTRAVIST 240, IOPROMIDE ULTRAVIST 300 IN PLASTIC CONTAINER, IOPROMIDE ULTRAVIST 300, IOPROMIDE ULTRAVIST 370, IOPROMIDE YASMIN, DROSPIRENONE
YAZ, DROSPIRENONE
BAYER PHARMA AG * BAYER PHARMA AG BILTRICIDE, PRAZIQUANTEL BAYER PHARMS * BAYER PHARMACEUTICALS CORP MYCELEX-7 COMBINATION PACK,
CLOTRIMAZOLE
(OTC)
B - 31
APPENDIX B
* BAYER PHARMACEUTICALS CORP MYCELEX-7, CLOTRIMAZOLE

** B **
(OTC)
BAYSHORE PHARMS LLC * BAYSHORE PHARMACEUTICALS LLC METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE BECTON DICKINSON * BECTON DICKINSON AND CO CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE E-Z SCRUB 201, POVIDONE-IODINE (OTC)
E-Z SCRUB 241, POVIDONE-IODINE (OTC)
(OTC)
BEDFORD * BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM ACETYLCYSTEINE, ACETYLCYSTEINE ACYCLOVIR SODIUM, ACYCLOVIR SODIUM ADENOSINE, ADENOSINE ALPROSTADIL, ALPROSTADIL AMIKACIN SULFATE, AMIKACIN SULFATE AMRINONE LACTATE, INAMRINONE LACTATE ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE ATRACURIUM BESYLATE, ATRACURIUM BESYLATE AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM AZTREONAM, AZTREONAM BLEOMYCIN SULFATE, BLEOMYCIN SULFATE BUMETANIDE, BUMETANIDE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CARBOPLATIN, CARBOPLATIN CEFTRIAXONE, CEFTRIAXONE SODIUM CERUBIDINE, DAUNORUBICIN HYDROCHLORIDE CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE CISPLATIN, CISPLATIN CLADRIBINE, CLADRIBINE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CYCLOSPORINE, CYCLOSPORINE CYTARABINE, CYTARABINE DACARBAZINE, DACARBAZINE DACTINOMYCIN, DACTINOMYCIN DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE), DICYCLOMINE HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE DOXYCYCLINE, DOXYCYCLINE HYCLATE ENALAPRILAT, ENALAPRILAT EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE ETOMIDATE, ETOMIDATE ETOPOSIDE, ETOPOSIDE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLOXURIDINE, FLOXURIDINE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE INDOMETHACIN SODIUM, INDOMETHACIN SODIUM
KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE
B - 32
APPENDIX B

** B **
* BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEVOCARNITINE, LEVOCARNITINE MESNA, MESNA METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM, METHOTREXATE SODIUM MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE, MILRINONE LACTATE MITOMYCIN, MITOMYCIN MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PHENTOLAMINE MESYLATE, PHENTOLAMINE MESYLATE POLYMYXIN B SULFATE, POLYMYXIN B SULFATE PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RIFAMPIN, RIFAMPIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBUTALINE SULFATE, TERBUTALINE SULFATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE THIOTEPA, THIOTEPA VALPROATE SODIUM, VALPROATE SODIUM VECURONIUM BROMIDE, VECURONIUM BROMIDE VINBLASTINE SULFATE, VINBLASTINE SULFATE
BEDFORD LABS * BEDFORD LABORATORIES ALLOPURINOL SODIUM, ALLOPURINOL SODIUM CAFCIT, CAFFEINE CITRATE CARBOPLATIN, CARBOPLATIN DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUMAZENIL, FLUMAZENIL GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IFOSFAMIDE, IFOSFAMIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LORAZEPAM PRESERVATIVE FREE, LORAZEPAM MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ORPHENADRINE CITRATE, ORPHENADRINE CITRATE PENTOSTATIN, PENTOSTATIN
TORSEMIDE, TORSEMIDE
BEIJING DOUBLE CRANE * BEIJING DOUBLE CRANE PHARMACEUTICAL CO LTD FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE
MELOXICAM, MELOXICAM
B - 33
APPENDIX B
** B **
BELCHER PHARMS * BELCHER PHARMACEUTICALS LLC CEPHALEXIN, CEPHALEXIN DESLORATADINE, DESLORATADINE BEN VENUE * BEN VENUE LABORATORIES INC FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE BEXIMCO USA * BEXIMCO PHARMACEUTICALS USA INC CARVEDILOL, CARVEDILOL BHP DERMATOLOGY * BAYER HEALTHCARE PHARMACEUTICALS INC DERMATOLOGY DESONATE, DESONIDE FINACEA, AZELAIC ACID BIO NUCLEONICS * BIO NUCLEONICS INC STRONTIUM CHLORIDE SR-89, BIOKEY * BIOKEY INC BENAZEPRIL HYDROCHLORIDE, CILOSTAZOL, CILOSTAZOL
STRONTIUM CHLORIDE SR-89
BIOMARIN PHARM * BIOMARIN PHARMACEUTICAL INC KUVAN, SAPROPTERIN DIHYDROCHLORIDE BIONICHE PHARMA * BIONICHE PHARMA USA LLC AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM COSYNTROPIN, COSYNTROPIN DIMETHYL SULFOXIDE, DIMETHYL SULFOXIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE ENLON, EDROPHONIUM CHLORIDE ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE FLUOROURACIL, FLUOROURACIL IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE MEFOXIN IN PLASTIC CONTAINER, CEFOXITIN SODIUM RIMSO-50, DIMETHYL SULFOXIDE SOTRADECOL, SODIUM TETRADECYL SULFATE BIONICHE PHARMA USA * BIONICHE PHARMA USA LLC CARBOPLATIN, CARBOPLATIN EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FOMEPIZOLE, FOMEPIZOLE IBUTILIDE FUMARATE, IBUTILIDE FUMARATE MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE BIOVAIL TECHNOLOGIES * BIOVAIL TECHNOLOGIES LTD DEMSER, METYROSINE BLAIREX * BLAIREX LABORATORIES INC BRONCHO SALINE, SODIUM CHLORIDE
(OTC)
B - 34
APPENDIX B
BLU CARIBE * BLU CARIBE INC GEMFIBROZIL, SIMVASTATIN,

** B **
GEMFIBROZIL
SIMVASTATIN
BOCA PHARMA * BOCA PHARMACAL INC ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN ALPRAZOLAM, ALPRAZOLAM CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE GLYCOPYRROLATE, GLYCOPYRROLATE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN LEVETIRACETAM, LEVETIRACETAM METHIMAZOLE, METHIMAZOLE
METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE
BOEHRINGER INGELHEIM * BOEHRINGER INGELHEIM CATAPRES, CLONIDINE HYDROCHLORIDE CATAPRES-TTS-1, CLONIDINE CATAPRES-TTS-2, CLONIDINE CATAPRES-TTS-3, CLONIDINE MICARDIS HCT, HYDROCHLOROTHIAZIDE MICARDIS, TELMISARTAN MIRAPEX, PRAMIPEXOLE DIHYDROCHLORIDE ZANTAC 150, RANITIDINE HYDROCHLORIDE (OTC)
ZANTAC 75, RANITIDINE HYDROCHLORIDE (OTC)
* BOEHRINGER INGELHEIM PHARMACEUTICALS INC AGGRENOX, ASPIRIN APTIVUS, TIPRANAVIR ATROVENT HFA, IPRATROPIUM BROMIDE ATROVENT, IPRATROPIUM BROMIDE COMBIVENT RESPIMAT, ALBUTEROL SULFATE COMBIVENT, ALBUTEROL SULFATE FLOMAX, TAMSULOSIN HYDROCHLORIDE JENTADUETO, LINAGLIPTIN MIRAPEX ER, PRAMIPEXOLE DIHYDROCHLORIDE MOBIC, MELOXICAM PERSANTINE, DIPYRIDAMOLE PRADAXA, DABIGATRAN ETEXILATE MESYLATE SPIRIVA, TIOTROPIUM BROMIDE MONOHYDRATE TRADJENTA, LINAGLIPTIN TWYNSTA, AMLODIPINE BESYLATE VIRAMUNE XR, NEVIRAPINE
VIRAMUNE, NEVIRAPINE
BRACCO * BRACCO DIAGNOSTICS INC CARDIOGEN-82, RUBIDIUM CHLORIDE RB-82 CHOLETEC, TECHNETIUM TC-99M MEBROFENIN KIT CHOLOGRAFIN MEGLUMINE, IODIPAMIDE MEGLUMINE CYSTOGRAFIN DILUTE, DIATRIZOATE MEGLUMINE CYSTOGRAFIN, DIATRIZOATE MEGLUMINE GASTROGRAFIN, DIATRIZOATE MEGLUMINE ISOVUE-200, IOPAMIDOL ISOVUE-250, IOPAMIDOL ISOVUE-300, IOPAMIDOL ISOVUE-370, IOPAMIDOL ISOVUE-M 200, IOPAMIDOL ISOVUE-M 300, IOPAMIDOL KINEVAC, SINCALIDE MDP-BRACCO, TECHNETIUM TC-99M MEDRONATE KIT MULTIHANCE MULTIPACK, GADOBENATE DIMEGLUMINE MULTIHANCE, GADOBENATE DIMEGLUMINE PROHANCE MULTIPACK, GADOTERIDOL
PROHANCE, GADOTERIDOL
B - 35
APPENDIX B
*

** B **
BRACCO DIAGNOSTICS INC RENOGRAFIN-76, DIATRIZOATE MEGLUMINE

SINOGRAFIN, DIATRIZOATE MEGLUMINE
BRAINTREE * BRAINTREE LABORATORIES INC AXID, NIZATIDINE GOLYTELY, POLYETHYLENE GLYCOL 3350 HALFLYTELY, BISACODYL NULYTELY, POLYETHYLENE GLYCOL 3350
NULYTELY-FLAVORED, POLYETHYLENE GLYCOL 3350
BRAINTREE LABS * BRAINTREE LABORATORIES INC SUPREP BOWEL PREP KIT, MAGNESIUM SULFATE ANHYDROUS BRECKENRIDGE PHARM * BRECKENRIDGE PHARMACEUTICAL INC CILOSTAZOL, CILOSTAZOL ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL LEVETIRACETAM, LEVETIRACETAM MELOXICAM, MELOXICAM METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE OXCARBAZEPINE, OXCARBAZEPINE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE
TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
BRISTOL MYERS SQUIBB * BRISTOL MYERS SQUIBB AZACTAM, AZTREONAM BARACLUDE, ENTECAVIR GLUCOVANCE, GLYBURIDE KOMBIGLYZE XR, METFORMIN HYDROCHLORIDE LYSODREN, MITOTANE MEGACE, MEGESTROL ACETATE
PRAVACHOL, PRAVASTATIN SODIUM
* BRISTOL MYERS SQUIBB CO AZACTAM IN PLASTIC CONTAINER, AZTREONAM CEENU, LOMUSTINE DROXIA, HYDROXYUREA GLUCOPHAGE XR, METFORMIN HYDROCHLORIDE HYDREA, HYDROXYUREA IXEMPRA KIT, IXABEPILONE ONGLYZA, SAXAGLIPTIN HYDROCHLORIDE REYATAZ, ATAZANAVIR SULFATE SPRYCEL, DASATINIB SUSTIVA, EFAVIRENZ
VIDEX EC, DIDANOSINE
* BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE ELIQUIS, APIXABAN ETOPOPHOS PRESERVATIVE FREE, ETOPOSIDE PHOSPHATE GLUCOPHAGE, METFORMIN HYDROCHLORIDE VIDEX, DIDANOSINE VUMON, TENIPOSIDE
ZERIT, STAVUDINE
* BRISTOL MYERS SQUIBB PHARMA CO COUMADIN, WARFARIN SODIUM
SUSTIVA, EFAVIRENZ
BRYAN * BRYAN CORP SCLEROSOL, TALC
TALC, TALC
CADENCE PHARMS * CADENCE PHARMACEUTICALS INC OFIRMEV, ACETAMINOPHEN
B - 36
APPENDIX B
** C **
CADISTA PHARMS * CADISTA PHARMACEUTICALS INC ALENDRONATE SODIUM, ALENDRONATE SODIUM CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) LAMOTRIGINE, LAMOTRIGINE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM
OXCARBAZEPINE, OXCARBAZEPINE
CANYON * CANYON PHARMACEUTICALS INC IPRIVASK, DESIRUDIN RECOMBINANT CARACO * CARACO PHARMACEUTICAL LABORATORIES LTD ALLOPURINOL, ALLOPURINOL AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ATENOLOL, ATENOLOL BACLOFEN, BACLOFEN CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLONAZEPAM, CLONAZEPAM CLOZAPINE, CLOZAPINE DIGOXIN, DIGOXIN ELIXOPHYLLIN, THEOPHYLLINE FLUMADINE, RIMANTADINE HYDROCHLORIDE FLURBIPROFEN, FLURBIPROFEN FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLIPIZIDE, GLIPIZIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE MELOXICAM, MELOXICAM MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHIMAZOLE, METHIMAZOLE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIRTAZAPINE, MIRTAZAPINE PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE SYNALGOS-DC, ASPIRIN THEOCHRON, THEOPHYLLINE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
CARDINAL HEALTH 414 * CARDINAL HEALTH 414 LLC TECHNETIUM TC 99M SESTAMIBI, CARDINAL HLTH 414 * CARDINAL HEALTH 414 SODIUM IODIDE I 123,
SODIUM IODIDE I-123
CAREFUSION * CAREFUSION 213 LLC CHLORAPREP ONE-STEP FREPP, CHLORHEXIDINE GLUCONATE (OTC)
CHLORAPREP ONE-STEP SEPP, CHLORHEXIDINE GLUCONATE (OTC)
B - 37
APPENDIX B
** C **
* CAREFUSION 213 LLC CHLORAPREP ONE-STEP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP SINGLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP TRIPLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP WITH TINT, CHLORHEXIDINE GLUCONATE (OTC) PHARMASEAL SCRUB CARE, CHLORHEXIDINE GLUCONATE (OTC) CARLSBAD * CARLSBAD TECHNOLOGY INC ACYCLOVIR, ACYCLOVIR CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM FAMOTIDINE, FAMOTIDINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE GLIMEPIRIDE, GLIMEPIRIDE LOVASTATIN, LOVASTATIN MELOXICAM, MELOXICAM MODAFINIL, MODAFINIL
CAROLINA MEDCL * CAROLINA MEDICAL PRODUCTS CO AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE HYDROCORTISONE IN ABSORBASE, HYDROCORTISONE ISONIAZID, ISONIAZID SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE SPS, SODIUM POLYSTYRENE SULFONATE TRIAMCINOLONE ACETONIDE IN ABSORBASE, TRIAMCINOLONE ACETONIDE CATALENT * CATALENT PHARMA SOLUTIONS LLC NIFEDIPINE, NIFEDIPINE
CEDAR PHARMS * CEDAR PHARMACEUTICALS LLC METHIMAZOLE, METHIMAZOLE SODIUM POLYSTYRENE SULFONATE, CELGENE * CELGENE CORP ISTODAX, ROMIDEPSIN REVLIMID, LENALIDOMIDE THALOMID, THALIDOMIDE
VIDAZA, AZACITIDINE
CEPHALON * CEPHALON INC ACTIQ, FENTANYL CITRATE FENTORA, FENTANYL CITRATE GABITRIL, TIAGABINE HYDROCHLORIDE NUVIGIL, ARMODAFINIL PROVIGIL, MODAFINIL TREANDA, BENDAMUSTINE HYDROCHLORIDE
TRISENOX, ARSENIC TRIOXIDE
CEREXA * CEREXA INC TEFLARO,
CEFTAROLINE FOSAMIL
CHATTEM * CHATTEM INC SELSUN, SELENIUM SULFIDE

UNISOM, DOXYLAMINE SUCCINATE
(OTC)
CHEMISCH FBRK KRSSLR * CHEMISCHE FABRIK KREUSSLER & CO. GMBH ASCLERA, POLIDOCANOL
B - 38
APPENDIX B

** C **
CHIRHOCLIN * CHIRHOCLIN INC CHIRHOSTIM, SECRETIN SYNTHETIC HUMAN CIPHER * CIPHER PHARMACEUTICALS LTD ABSORICA, ISOTRETINOIN CIPHER PHARMS INC * CIPHER PHARMACEUTICALS INC CONZIP, TRAMADOL HYDROCHLORIDE
LIPOFEN, FENOFIBRATE
CIPLA * CIPLA LTD NEVIRAPINE, NEVIRAPINE RAMIPRIL, RAMIPRIL RISPERIDONE, RISPERIDONE TRANDOLAPRIL, TRANDOLAPRIL
CIPLA LTD * CIPLA LTD CARBOPLATIN, CARBOPLATIN DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IRBESARTAN, IRBESARTAN IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LEVOFLOXACIN, LEVOFLOXACIN STAVUDINE, STAVUDINE TOPIRAMATE, TOPIRAMATE ZALEPLON, ZALEPLON ZIDOVUDINE, ZIDOVUDINE
CITIUS PHARMS * CITIUS PHARMACEUTICALS LLC SUPRENZA, PHENTERMINE HYDROCHLORIDE CLARIS LIFESCIENCES * CLARIS LIFESCIENCES LTD AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN DIPYRIDAMOLE, DIPYRIDAMOLE FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK), FAMOTIDINE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUMAZENIL, FLUMAZENIL FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE FULCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE IN DEXTROSE 5%, MILRINONE LACTATE MILRINONE LACTATE, MILRINONE LACTATE
NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE
B - 39
APPENDIX B

** C **
CLINIGEN HLTHCARE * CLINIGEN HEALTHCARE LTD FOSCAVIR, FOSCARNET SODIUM CLONMEL HLTHCARE * CLONMEL HEALTHCARE LTD MORPHINE SULFATE, MORPHINE SULFATE CLOVER PHARMS * CLOVER PHARMACEUTICALS CORP AMICAR, AMINOCAPROIC ACID CNS THERAPS INC * CNS THERAPEUTICS INC GABLOFEN, BACLOFEN CNTY LINE PHARMS * COUNTY LINE PHARMACEUTICALS LLC ORPHENADRINE CITRATE, ORPHENADRINE CITRATE
UREX, METHENAMINE HIPPURATE
COASTAL PHARMS * COASTAL PHARMACEUTICALS BROMFENAC SODIUM, BROMFENAC SODIUM LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM METHAMPHETAMINE HYDROCHLORIDE, METHAMPHETAMINE HYDROCHLORIDE NYSTATIN, NYSTATIN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE AND ASPIRIN, ASPIRIN
COLGATE * COLGATE ORAL PHARMACEUTICALS INC ORABASE HCA, HYDROCORTISONE ACETATE
PERIOGARD, CHLORHEXIDINE GLUCONATE
COLGATE PALMOLIVE * COLGATE PALMOLIVE COLGATE TOTAL, SODIUM FLUORIDE CONTRACT PHARMA * CONTRACT PHARMACAL CORP CETIRIZINE HYDROCHLORIDE ALLERGY,
(OTC)
(OTC)
CONTRACT PHARMACAL * CONTRACT PHARMACAL CORP CIMETIDINE, CIMETIDINE (OTC) FOLIC ACID, FOLIC ACID IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) PREDNISONE, PREDNISONE PROFEN, IBUPROFEN (OTC)
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC)
CORCEPT THERAP * CORCEPT THERAPEUTICS INC KORLYM, MIFEPRISTONE COREPHARMA * COREPHARMA LLC ALBENZA, ALBENDAZOLE ALPRAZOLAM, ALPRAZOLAM BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CARISOPRODOL, CARISOPRODOL CILOSTAZOL, CILOSTAZOL CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE
CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE
B - 40
APPENDIX B

** C **
* COREPHARMA LLC CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE DARAPRIM, PYRIMETHAMINE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, ASPARTATE DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE
DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
GLIMEPIRIDE, GLIMEPIRIDE
GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE
GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE
GLYBURIDE, GLYBURIDE
GLYCOPYRROLATE, GLYCOPYRROLATE
ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE
LEVOCARNITINE, LEVOCARNITINE
METHENAMINE HIPPURATE, METHENAMINE HIPPURATE
PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE
POTASSIUM CITRATE, POTASSIUM CITRATE
PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE
RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE
ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE
TRANDOLAPRIL, TRANDOLAPRIL
URSODIOL, URSODIOL
CORNERSTONE THERAP * CORNERSTONE THERAPEUTICS INC BETHKIS, TOBRAMYCIN CUROSURF, PORACTANT ALFA FACTIVE, GEMIFLOXACIN MESYLATE HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX, ZYFLO CR, ZILEUTON
ZYFLO, ZILEUTON
COVIDIEN * COVIDIEN LYMPHAZURIN,
AMPHETAMINE
CHLORPHENIRAMINE POLISTIREX
ISOSULFAN BLUE
COVIS PHARMA * COVIS PHARMA SARL FORTAZ IN PLASTIC CONTAINER, CEFTAZIDIME SODIUM FORTAZ, CEFTAZIDIME LANOXIN PEDIATRIC, DIGOXIN LANOXIN, DIGOXIN PARNATE, TRANYLCYPROMINE SULFATE ZANTAC IN PLASTIC CONTAINER, RANITIDINE HYDROCHLORIDE ZANTAC, RANITIDINE HYDROCHLORIDE ZINACEF IN PLASTIC CONTAINER, CEFUROXIME SODIUM
ZINACEF, CEFUROXIME SODIUM
CPPI CV * CP PHARMACEUTICALS INTERNATIONAL CV SUTENT, SUNITINIB MALATE CROWN LABS * CROWN LABORATORIES INC ALA-CORT, HYDROCORTISONE ALA-SCALP, HYDROCORTISONE
TRIDERM, TRIAMCINOLONE ACETONIDE
CSL BEHRING * CSL BEHRING LLC STIMATE (NEEDS NO REFRIGERATION),
B - 41
APPENDIX B
CUBIST * CUBIST PHARMACEUTICALS INC CUBICIN, DAPTOMYCIN CUBIST PHARMS * CUBIST PHARMACEUTICALS INC ENTEREG, ALVIMOPAN

** C **
CUMBERLAND PHARMS * CUMBERLAND PHARMACEUTICALS INC ACETADOTE, ACETYLCYSTEINE CALDOLOR, IBUPROFEN

LACTULOSE, LACTULOSE
CYPRESS BIOSCIENCE * CYPRESS BIOSCIENCE INC SAVELLA, MILNACIPRAN HYDROCHLORIDE CYPRESS PHARM * CYPRESS PHARMACEUTICAL INC CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ELIPHOS, CALCIUM ACETATE EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE REZIRA, HYDROCODONE BITARTRATE
ZUTRIPRO, CHLORPHENIRAMINE MALEATE
DAIICHI * DAIICHI PHARMACEUTICAL CORP FLOXIN OTIC, OFLOXACIN DAIICHI SANKYO * DAIICHI SANKYO INC AZOR, AMLODIPINE BESYLATE BENICAR HCT, HYDROCHLOROTHIAZIDE BENICAR, OLMESARTAN MEDOXOMIL TRIBENZOR, AMLODIPINE BESYLATE
WELCHOL, COLESEVELAM HYDROCHLORIDE
DAIICHI SANKYO CO * DAIICHI SANKYO CO LTD EVOXAC, CEVIMELINE HYDROCHLORIDE DANCO LABS LLC * DANCO LABORATORIES LLC MIFEPREX, MIFEPRISTONE DARA BIOSCIENCES * DARA BIOSCIENCES INC SOLTAMOX, TAMOXIFEN CITRATE DAVA INTL INC * DAVA INTERNATIONAL INC ALPRAZOLAM, ALPRAZOLAM DAVA PHARMS INC * DAVA PHARMACEUTICALS INC ACYCLOVIR, ACYCLOVIR AMOXICILLIN, AMOXICILLIN AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE ATENOLOL, ATENOLOL CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CIMETIDINE, CIMETIDINE CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE DIAZEPAM, DIAZEPAM DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE
FUROSEMIDE, FUROSEMIDE
B - 42
APPENDIX B

** D **
* DAVA PHARMACEUTICALS INC GEMFIBROZIL, GEMFIBROZIL GLYBURIDE (MICRONIZED), GLYBURIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METHOTREXATE SODIUM, METHOTREXATE SODIUM NAPROXEN, NAPROXEN PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PROPYLTHIOURACIL, PROPYLTHIOURACIL PYRAZINAMIDE, PYRAZINAMIDE SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE
VOSPIRE ER, ALBUTEROL SULFATE
DAVIS AND GECK * DAVIS AND GECK DIV AMERICAN CYANAMID CO PRE-OP II, HEXACHLOROPHENE
PRE-OP, HEXACHLOROPHENE
DENCO ASSET * DENCO ASSET LLC DENAVIR, PENCICLOVIR SODIUM DENTSPLY PHARM * DENTSPLY PHARMACEUTICAL INC CITANEST FORTE DENTAL, EPINEPHRINE BITARTRATE
ORAQIX, LIDOCAINE
DEPOMED INC * DEPOMED INC GRALISE, GABAPENTIN
ZIPSOR, DICLOFENAC POTASSIUM
DEPROCO * DEPROCO INC LIGNOSPAN FORTE, EPINEPHRINE BITARTRATE LIGNOSPAN STANDARD, EPINEPHRINE BITARTRATE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE
SEPTOCAINE, ARTICAINE HYDROCHLORIDE
DEXCEL LTD * DEXCEL LTD DICLOFENAC SODIUM, DICLOFENAC SODIUM
ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE
DEXCEL PHARMA * DEXCEL PHARMA TECHNOLOGIES LTD OMEPRAZOLE, OMEPRAZOLE (OTC)
PERIOCHIP, CHLORHEXIDINE GLUCONATE
DEY * DEY LP ACCUNEB, ALBUTEROL SULFATE CROMOLYN SODIUM, CROMOLYN SODIUM DUONEB, ALBUTEROL SULFATE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE
METAPROTERENOL SULFATE, METAPROTERENOL SULFATE
DIALYSIS SUPS * DIALYSIS SUPPLIES INC NORMOCARB HF 25, MAGNESIUM CHLORIDE
NORMOCARB HF 35, MAGNESIUM CHLORIDE
DIGESTIVE CARE INC * DIGESTIVE CARE INC PERTZYE, PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) DISCOVERY LABS * DISCOVERY LABORATORIES INC SURFAXIN, LUCINACTANT
B - 43
APPENDIX B
DORADO PHARMA * DORADO PHARMA LLC KETOPROFEN, KETOPROFEN

** D **
DORC * DORC INTERNATIONAL BV MEMBRANEBLUE, TRYPAN BLUE

VISIONBLUE, TRYPAN BLUE
DOUGLAS PHARMS * DOUGLAS PHARMACEUTICALS AMERICA LTD MYORISAN, ISOTRETINOIN DOW PHARM * DOW PHARMACEUTICAL SCIENCES NUTRACORT, HYDROCORTISONE DOW PHARM SCI * DOW PHARMACEUTICAL SCIENCES ACANYA, BENZOYL PEROXIDE DOW PHARM SCIENCES * DOW PHARMACEUTICAL SCIENCES INC AKNE-MYCIN, ERYTHROMYCIN
ATRALIN, TRETINOIN
DR REDDYS LA * DR REDDYS LABORATORIES LOUISIANA LLC IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) LOPURIN, ALLOPURINOL SSD AF, SILVER SULFADIAZINE
SSD, SILVER SULFADIAZINE
DR REDDYS LABS INC * DR REDDYS LABORATORIES INC AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMOXIL, AMOXICILLIN AUGMENTIN '125', AMOXICILLIN AUGMENTIN '200', AMOXICILLIN AUGMENTIN '250', AMOXICILLIN AUGMENTIN '400', AMOXICILLIN AUGMENTIN '500', AMOXICILLIN AUGMENTIN '875', AMOXICILLIN AUGMENTIN ES-600, AMOXICILLIN AUGMENTIN XR, AMOXICILLIN CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) LAROTID, AMOXICILLIN LEVOFLOXACIN, LEVOFLOXACIN MELOXICAM, MELOXICAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE SIMVASTATIN, SIMVASTATIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
B - 44
APPENDIX B
* DR REDDYS LABORATORIES INC ZIPRASIDONE HYDROCHLORIDE,

** D **
DR REDDYS LABS LTD * DR REDDYS LABORATORIES LIMITED LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE * DR REDDYS LABORATORIES LTD ALENDRONATE SODIUM, ALENDRONATE SODIUM AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ANASTROZOLE, ANASTROZOLE ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR, DESLORATADINE DESLORATADINE, DESLORATADINE DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC)
FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE
FINASTERIDE, FINASTERIDE
FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE
FONDAPARINUX SODIUM, FONDAPARINUX SODIUM
GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE
GLIMEPIRIDE, GLIMEPIRIDE
GLYCOPYRROLATE, GLYCOPYRROLATE
IBANDRONATE SODIUM, IBANDRONATE SODIUM
IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE (OTC)
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC)
IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
IRBESARTAN, IRBESARTAN
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE
LAMOTRIGINE, LAMOTRIGINE
LANSOPRAZOLE, LANSOPRAZOLE
LANSOPRAZOLE, LANSOPRAZOLE (OTC)
LETROZOLE, LETROZOLE
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE
MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE
MONTELUKAST SODIUM, MONTELUKAST SODIUM
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL
NABUMETONE, NABUMETONE
NAPROXEN SODIUM, NAPROXEN SODIUM
NATEGLINIDE, NATEGLINIDE
NIZATIDINE, NIZATIDINE
OFLOXACIN, OFLOXACIN
OLANZAPINE, OLANZAPINE
OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM (OTC)
B - 45
APPENDIX B

** D **
* DR REDDYS LABORATORIES LTD OMEPRAZOLE, OMEPRAZOLE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXAPROZIN, OXAPROZIN PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PRIMIDONE, PRIMIDONE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE RAMIPRIL, RAMIPRIL RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SILDENAFIL CITRATE, SILDENAFIL CITRATE TACROLIMUS, TACROLIMUS TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE TRANDOLAPRIL, TRANDOLAPRIL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE ZAFIRLUKAST, ZAFIRLUKAST ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
DR REDDYS LABS SA * DR REDDYS LABORATORIES SA FENOFIBRATE (MICRONIZED),
FENOFIBRATE
DRAXIMAGE * DRAXIMAGE INC DTPA, TECHNETIUM TC-99M PENTETATE KIT TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT DURAMED * DURAMED PHARMACEUTICALS INC PLAN B ONE-STEP, LEVONORGESTREL PLAN B ONE-STEP, LEVONORGESTREL (OTC)
REVIA, NALTREXONE HYDROCHLORIDE
DURAMED PHARMS BARR * DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC AVIANE-28, ETHINYL ESTRADIOL CRYSELLE, ETHINYL ESTRADIOL DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL DIAMOX, ACETAZOLAMIDE ENPRESSE-28, ETHINYL ESTRADIOL METHYLPREDNISOLONE, METHYLPREDNISOLONE OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
VELIVET, DESOGESTREL
DURAMED RES * DURAMED RESEARCH INC AYGESTIN, NORETHINDRONE ACETATE DUSA * DUSA PHARMACEUTICALS INC LEVULAN, AMINOLEVULINIC ACID HYDROCHLORIDE EAGLE PHARMS * EAGLE PHARMACEUTICALS INC ARGATROBAN IN SODIUM CHLORIDE,
ARGATROBAN
EASTMAN KODAK * EASTMAN KODAK CO LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EBEWE PHARMA * EBEWE PHARMA GRANISETRON HYDROCHLORIDE,
EPINEPHRINE
B - 46
APPENDIX B

** E **
* EBEWE PHARMA GES MBH NFG KG CARBOPLATIN, CARBOPLATIN EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE FLUOROURACIL, FLUOROURACIL IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM OXALIPLATIN, OXALIPLATIN PACLITAXEL, PACLITAXEL
ECOLAB * ECOLAB INC CHG SCRUB, CIDA-STAT,
CHLORHEXIDINE GLUCONATE CHLORHEXIDINE GLUCONATE
(OTC)
(OTC)
ECR * ECR PHARMACEUTICALS DEXAMETHASONE, DEXAMETHASONE EDGEMONT PHARMS LLC * EDGEMONT PHARMACEUTICALS LLC FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE
FORFIVO XL, BUPROPION HYDROCHLORIDE
EI INC * EI INC THEROXIDIL,
MINOXIDIL
(OTC)
EISAI INC * EISAI INC ACIPHEX, RABEPRAZOLE SODIUM ARICEPT ODT, DONEPEZIL HYDROCHLORIDE ARICEPT, DONEPEZIL HYDROCHLORIDE BANZEL, RUFINAMIDE BELVIQ, LORCASERIN HYDROCHLORIDE DACOGEN, DECITABINE FRAGMIN, DALTEPARIN SODIUM FYCOMPA, PERAMPANEL HALAVEN, ERIBULIN MESYLATE HEXALEN, ALTRETAMINE PANRETIN, ALITRETINOIN SALAGEN, PILOCARPINE HYDROCHLORIDE TARGRETIN, BEXAROTENE
ZONEGRAN, ZONISAMIDE
EKR THERAP * EKR THERAPEUTICS INC CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE SR, NICARDIPINE HYDROCHLORIDE
CARDENE, NICARDIPINE HYDROCHLORIDE
ELAN DRUG * ELAN DRUG DELIVERY INC VERELAN PM, VERAPAMIL HYDROCHLORIDE ELI LILLY AND CO * ELI LILLY AND CO AXIRON, TESTOSTERONE EFFIENT, PRASUGREL HYDROCHLORIDE PROZAC, FLUOXETINE HYDROCHLORIDE
SARAFEM, FLUOXETINE HYDROCHLORIDE
ELI LILLY CO * ELI LILLY CO ADCIRCA, TADALAFIL
ZYPREXA RELPREVV, OLANZAPINE PAMOATE
B - 47
APPENDIX B
** E **
ELITE LABS * ELITE LABORATORIES INC HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE EMCURE PHARMS * EMCURE PHARMACEUTICALS LTD ONDANSETRON HYDROCHLORIDE,
EMCURE PHARMS INDIA * EMCURE PHARMACEUTICALS LTD INDIA FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE,
FOSINOPRIL
EMCURE PHARMS LTD * EMCURE PHARMACEUTICALS LTD ACARBOSE, ACARBOSE BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BICNU, CARMUSTINE CIDOFOVIR, CIDOFOVIR COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LEVOFLOXACIN, LEVOFLOXACIN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE EMCURE PHARMS USA * EMCURE PHARMACEUTICALS USA INC DIFLUNISAL, DIFLUNISAL METHIMAZOLE, METHIMAZOLE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE EMCURE USA * EMCURE PHARMACEUTICALS USA INC BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE EMD SERONO * EMD SERONO INC CETROTIDE, CETRORELIX EGRIFTA, TESAMORELIN ACETATE GONAL-F RFF PEN, FOLLITROPIN ALFA/BETA GONAL-F RFF, FOLLITROPIN ALFA/BETA GONAL-F, FOLLITROPIN ALFA/BETA OVIDREL, CHORIOGONADOTROPIN ALFA SAIZEN, SOMATROPIN RECOMBINANT SEROPHENE, CLOMIPHENE CITRATE SEROSTIM, SOMATROPIN RECOMBINANT ZORBTIVE, SOMATROPIN RECOMBINANT EMMAUS MEDCL * EMMAUS MEDICAL INC NUTRESTORE, GLUTAMINE ENDO PHARM * ENDO PHARMACEUTICAL SOLUTIONS INC SUPPRELIN LA, HISTRELIN ACETATE VALSTAR PRESERVATIVE FREE, VALRUBICIN VANTAS, HISTRELIN ACETATE ENDO PHARMS * ENDO PHARMACEUTICALS INC DELATESTRYL, TESTOSTERONE ENANTHATE FORTESTA, TESTOSTERONE FROVA, FROVATRIPTAN SUCCINATE OPANA ER, OXYMORPHONE HYDROCHLORIDE OPANA, OXYMORPHONE HYDROCHLORIDE PERCODAN, ASPIRIN
B - 48
APPENDIX B

** E **
EPIC PHARMA * EPIC PHARMA INC GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE
NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE
* EPIC PHARMA LLC BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE SULINDAC, SULINDAC TRANDOLAPRIL, TRANDOLAPRIL
URSODIOL, URSODIOL
EPIC PHARMA INC * EPIC PHARMA INC SOTALOL HYDROCHLORIDE,
EPIC PHARMA LLC * EPIC PHARMA LLC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE
PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE
ERGOJECT * ERGOJECT LLC METHYLERGONOVINE MALEATE,
METHYLERGONOVINE MALEATE
ETHYPHARM * ETHYPHARM BUPRENORPHINE HYDROCHLORIDE, EURAND * EURAND AMERICA INC POTASSIUM CHLORIDE, EXALENZ BIOSCIENCE * EXALENZ BIOSCIENCE LTD IDKIT:HP, UREA C-13
POTASSIUM CHLORIDE
EXCELLIUM * EXCELLIUM PHARMACEUTICAL INC BENZTROPINE MESYLATE, BENZTROPINE MESYLATE FOLIC ACID, FOLIC ACID FUROSEMIDE, FUROSEMIDE GLYCOPYRROLATE, GLYCOPYRROLATE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE
LORAZEPAM, LORAZEPAM
EXELA PHARMA SCIENCE * EXELA PHARMA SCIENCES NICARDIPINE HYDROCHLORIDE,
EXELIXIS * EXELIXIS INC COMETRIQ, CABOZANTINIB S-MALATE FACTA FARMA * FACTA FARMACEUTICI SPA CEPHALEXIN, CEPHALEXIN FALCON PHARMS * FALCON PHARMACEUTICALS INC TIMOLOL MALEATE, TIMOLOL MALEATE * FALCON PHARMACEUTICALS LTD DIPIVEFRIN HYDROCHLORIDE, DIPIVEFRIN HYDROCHLORIDE GENTAMICIN SULFATE, GENTAMICIN SULFATE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE MAXITROL, DEXAMETHASONE METIPRANOLOL, METIPRANOLOL HYDROCHLORIDE
TIMOLOL MALEATE, TIMOLOL MALEATE
B - 49
APPENDIX B
*

** F **
POLYMYXIN B SULFATE
FALCON PHARMACEUTICALS LTD TOBREX, TOBRAMYCIN

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE,
FAMY CARE LTD * FAMY CARE LTD LEVONORGESTREL AND ETHINYL ESTRADIOL,
ETHINYL ESTRADIOL
FDC LTD * FDC LTD CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE OFLOXACIN, OFLOXACIN
FEINSTEIN * FEINSTEIN INSTITUTE MEDICAL RESEARCH AMMONIA N 13, AMMONIA, N-13
FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18
FERA PHARMS * FERA PHARMACEUTICALS LLC BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BACITRACIN, BACITRACIN BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, BACITRACIN ERYTHROMYCIN, ERYTHROMYCIN GENTAMICIN SULFATE, GENTAMICIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE OFLOXACIN, OFLOXACIN SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM
TOBRAMYCIN, TOBRAMYCIN
FERNDALE LABS * FERNDALE LABORATORIES INC HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE MICORT-HC, HYDROCORTISONE ACETATE
PRAMOSONE, HYDROCORTISONE ACETATE
FERRING * FERRING PHARMACEUTICALS INC ACTHREL, CORTICORELIN OVINE TRIFLUTATE BRAVELLE, UROFOLLITROPIN CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE ENDOMETRIN, PROGESTERONE FIRMAGON, DEGARELIX ACETATE MENOPUR, LUTEINIZING HORMONE MINIRIN, DESMOPRESSIN ACETATE REPRONEX, LUTEINIZING HORMONE
TEV-TROPIN, SOMATROPIN RECOMBINANT
FERRING CONTROLLED * FERRING CONTROLLED THERAPEUTICS LTD CERVIDIL, DINOPROSTONE FERRING PHARMS AS * FERRING PHARMACEUTICALS AS LYSTEDA, TRANEXAMIC ACID
PREPOPIK, CITRIC ACID
FOREST LABS * FOREST LABORATORIES INC BYSTOLIC, NEBIVOLOL HYDROCHLORIDE CAMPRAL, ACAMPROSATE CALCIUM CELEXA, CITALOPRAM HYDROBROMIDE LEXAPRO, ESCITALOPRAM OXALATE NAMENDA XR, MEMANTINE HYDROCHLORIDE NAMENDA, MEMANTINE HYDROCHLORIDE THYROLAR-0.25, LIOTHYRONINE SODIUM
THYROLAR-0.5, LIOTHYRONINE SODIUM
B - 50
APPENDIX B

** F **
* FOREST LABORATORIES INC THYROLAR-1, LIOTHYRONINE SODIUM THYROLAR-2, LIOTHYRONINE SODIUM

THYROLAR-3, LIOTHYRONINE SODIUM
FOREST LABS INC * FOREST LABORATORIES INC LINZESS, LINACLOTIDE TUDORZA PRESSAIR, ACLIDINIUM BROMIDE
VIIBRYD, VILAZODONE HYDROCHLORIDE
FOREST RES INST INC * FOREST RESEARCH INSTITUTE INC DALIRESP, ROFLUMILAST FOUGERA * E FOUGERA DIV ALTANA INC BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE BETAMETHASONE VALERATE, BETAMETHASONE VALERATE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE, FLUOCINONIDE GENTAMICIN SULFATE, GENTAMICIN SULFATE HYDROCORTISONE, HYDROCORTISONE LIDOCAINE, LIDOCAINE NITROGLYCERIN, NITROGLYCERIN NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN
NYSTATIN, NYSTATIN
FOUGERA PHARMS * FOUGERA PHARMACEUTICALS INC ACLOVATE, ALCLOMETASONE DIPROPIONATE ADAPALENE, ADAPALENE ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE AMCINONIDE, AMCINONIDE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CALCIPOTRIENE, CALCIPOTRIENE CARMOL HC, HYDROCORTISONE ACETATE CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE C-SOLVE-2, ERYTHROMYCIN CUTIVATE, FLUTICASONE PROPIONATE DESONIDE, DESONIDE DESOXIMETASONE, DESOXIMETASONE DIFLORASONE DIACETATE, DIFLORASONE DIACETATE ECONAZOLE NITRATE, ECONAZOLE NITRATE ERYTHROMYCIN, ERYTHROMYCIN FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE HYDROCORTISONE, HYDROCORTISONE IMIQUIMOD, IMIQUIMOD KETOCONAZOLE, KETOCONAZOLE LIDOCAINE AND PRILOCAINE, LIDOCAINE METRONIDAZOLE, METRONIDAZOLE MOMETASONE FUROATE, MOMETASONE FUROATE MUPIROCIN, MUPIROCIN NYSTATIN, NYSTATIN OXISTAT, OXICONAZOLE NITRATE
PAMINE FORTE, METHSCOPOLAMINE BROMIDE
B - 51
APPENDIX B

** F **
* FOUGERA PHARMACEUTICALS INC PAMINE, METHSCOPOLAMINE BROMIDE PANDEL, HYDROCORTISONE PROBUTATE PREDNICARBATE, PREDNICARBATE SOLARAZE, DICLOFENAC SODIUM SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM TEMOVATE E, CLOBETASOL PROPIONATE TEMOVATE, CLOBETASOL PROPIONATE TERCONAZOLE, TERCONAZOLE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE
ZONALON, DOXEPIN HYDROCHLORIDE
FRESENIUS * FRESENIUS KABI DEUTSCHLAND GMBH INTRALIPID 10%, SOYBEAN OIL INTRALIPID 20%, SOYBEAN OIL
INTRALIPID 30%, SOYBEAN OIL
* FRESENIUS USA INC INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
FRESENIUS KABI * FRESENIUS KABI AUSTRIA GMBH LACTULOSE, LACTULOSE FRESENIUS KABI ONCOL * FRESENIUS KABI ONCOLOGY PLC ANASTROZOLE, ANASTROZOLE BICALUTAMIDE, BICALUTAMIDE CARBOPLATIN, CARBOPLATIN EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LETROZOLE, LETROZOLE OXALIPLATIN, OXALIPLATIN PACLITAXEL, PACLITAXEL
TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE
FRESENIUS KABI USA * FRESENIUS KABI USA LLC ACYCLOVIR SODIUM, ACYCLOVIR SODIUM ADENOSINE, ADENOSINE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE ASTRAMORPH PF, MORPHINE SULFATE AZITHROMYCIN, AZITHROMYCIN, UNSPECIFIED FORM AZTREONAM, AZTREONAM BACITRACIN, BACITRACIN BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE BLEOMYCIN SULFATE, BLEOMYCIN SULFATE CAFFEINE CITRATE, CAFFEINE CITRATE CALCITRIOL, CALCITRIOL CARBOPLATIN, CARBOPLATIN CEFOTETAN, CEFOTETAN DISODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CHLORAMPHENICOL SODIUM SUCCINATE, CHLORAMPHENICOL SODIUM SUCCINATE CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC CISPLATIN, CISPLATIN CLADRIBINE, CLADRIBINE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM
CYTARABINE, CYTARABINE
B - 52
APPENDIX B

** F **
* FRESENIUS KABI USA LLC DACARBAZINE, DACARBAZINE DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DIMENHYDRINATE, DIMENHYDRINATE DIPRIVAN, PROPOFOL DIPYRIDAMOLE, DIPYRIDAMOLE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE DOXY 100, DOXYCYCLINE HYCLATE DOXY 200, DOXYCYCLINE HYCLATE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE ETOPOSIDE, ETOPOSIDE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLOXURIDINE, FLOXURIDINE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FLUMAZENIL, FLUMAZENIL FLUOROURACIL, FLUOROURACIL FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE FOLIC ACID, FOLIC ACID FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FUROSEMIDE, FUROSEMIDE GANCICLOVIR, GANCICLOVIR SODIUM GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GENTAMICIN SULFATE, GENTAMICIN SULFATE GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IFOSFAMIDE, IFOSFAMIDE INDOMETHACIN, INDOMETHACIN IOPAMIDOL-250, IOPAMIDOL IOPAMIDOL-300, IOPAMIDOL IOPAMIDOL-370, IOPAMIDOL IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE KANAMYCIN SULFATE, KANAMYCIN SULFATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEVETIRACETAM, LEVETIRACETAM LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE MAGNESIUM SULFATE, MAGNESIUM SULFATE MANNITOL 25%, MANNITOL MESNA, MESNA METARAMINOL BITARTRATE, METARAMINOL BITARTRATE METHOTREXATE PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM, METHOTREXATE SODIUM METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE, MILRINONE LACTATE MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NAROPIN, ROPIVACAINE HYDROCHLORIDE
NEBUPENT, PENTAMIDINE ISETHIONATE
B - 53
APPENDIX B

** F **
* FRESENIUS KABI USA LLC NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE HYDROCHLORIDE OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXALIPLATIN, OXALIPLATIN OXYTOCIN, OXYTOCIN PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PENTAM, PENTAMIDINE ISETHIONATE POLOCAINE, MEPIVACAINE HYDROCHLORIDE POLOCAINE-MPF, MEPIVACAINE HYDROCHLORIDE POLYMYXIN B SULFATE, POLYMYXIN B SULFATE POTASSIUM CHLORIDE IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PROGESTERONE, PROGESTERONE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PROTAMINE SULFATE, PROTAMINE SULFATE PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SENSORCAINE, BUPIVACAINE HYDROCHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBUTALINE SULFATE, TERBUTALINE SULFATE THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE TOBRAMYCIN SULFATE (PHARMACY BULK), TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE TRANEXAMIC ACID, TRANEXAMIC ACID VALPROATE SODIUM, VALPROATE SODIUM VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VIBISONE, CYANOCOBALAMIN VINBLASTINE SULFATE, VINBLASTINE SULFATE VINORELBINE TARTRATE, VINORELBINE TARTRATE XYLOCAINE 4% PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE XYLOCAINE W/ EPINEPHRINE, EPINEPHRINE
XYLOCAINE, LIDOCAINE HYDROCHLORIDE
FRESENIUS MEDCL * FRESENIUS MEDICAL CARE NORTH AMERICA CALCITRIOL, CALCITRIOL DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
PHOSLO GELCAPS, CALCIUM ACETATE
PHOSLYRA, CALCIUM ACETATE
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE
B - 54
APPENDIX B

** F **
FSC * FSC LABORATORIES INC PRIMSOL, TRIMETHOPRIM HYDROCHLORIDE G AND W LABS * G AND W LABORATORIES INC ACEPHEN, ACETAMINOPHEN (OTC) CICLOPIROX, CICLOPIROX FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE INDOMETHACIN, INDOMETHACIN METRONIDAZOLE, METRONIDAZOLE MICONAZOLE 7 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MIGERGOT, CAFFEINE MOMETASONE FUROATE, MOMETASONE FUROATE PROCHLORPERAZINE, PROCHLORPERAZINE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROMETHEGAN, PROMETHAZINE HYDROCHLORIDE
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
G AND W LABS INC * G AND W LABORATORIES INC CALCIPOTRIENE, CALCIPOTRIENE CICLOPIROX, CICLOPIROX FLUOCINONIDE, FLUOCINONIDE
METRONIDAZOLE, METRONIDAZOLE
GALDERMA LABS * GALDERMA LABORATORIES INC CLOBEX, CLOBETASOL PROPIONATE GALDERMA LABS LP * GALDERMA LABORATORIES L P CLOBEX, CLOBETASOL PROPIONATE * GALDERMA LABORATORIES LP CAPEX, FLUOCINOLONE ACETONIDE CLINDAGEL, CLINDAMYCIN PHOSPHATE CLOBEX, CLOBETASOL PROPIONATE DESOWEN, DESONIDE DIFFERIN, ADAPALENE EPIDUO, ADAPALENE METROCREAM, METRONIDAZOLE METROGEL, METRONIDAZOLE METROLOTION, METRONIDAZOLE METVIXIA, METHYL AMINOLEVULINATE HYDROCHLORIDE ORACEA, DOXYCYCLINE PERIOSTAT, DOXYCYCLINE HYCLATE PLIAGLIS, LIDOCAINE TRI-LUMA, FLUOCINOLONE ACETONIDE
VECTICAL, CALCITRIOL
GALEN (UK) * GALEN LTD DAUNOXOME,
DAUNORUBICIN CITRATE
GAMBRO RENAL PRODS * GAMBRO RENAL PRODUCTS PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE
PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE
B - 55
APPENDIX B

** G **
CALCIUM CHLORIDE
* GAMBRO RENAL PRODUCTS PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER,
GASTROENTERO * GASTROENTERO LOGIC LLC OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN, GATE PHARMS * GATE PHARMACEUTICALS CLOPIDOGREL BISULFATE,
AMOXICILLIN
CLOPIDOGREL BISULFATE
GAVIS PHARMS * GAVIS PHARMACEUTICALS LLC ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE, ACETAMINOPHEN NYSTATIN, NYSTATIN ORPHENADRINE CITRATE, ORPHENADRINE CITRATE PENTAZOCINE AND NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE QUINARETIC, HYDROCHLOROTHIAZIDE
TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE
GD SEARLE * GD SEARLE LLC CELEBREX, CELECOXIB
DAYPRO, OXAPROZIN
GD SEARLE LLC * GD SEARLE LLC ALDACTAZIDE, HYDROCHLOROTHIAZIDE ALDACTONE, SPIRONOLACTONE ARTHROTEC, DICLOFENAC SODIUM CALAN, VERAPAMIL HYDROCHLORIDE COVERA-HS, VERAPAMIL HYDROCHLORIDE CYTOTEC, MISOPROSTOL FLAGYL ER, METRONIDAZOLE FLAGYL, METRONIDAZOLE INSPRA, EPLERENONE LOMOTIL, ATROPINE SULFATE NORPACE CR, DISOPYRAMIDE PHOSPHATE NORPACE, DISOPYRAMIDE PHOSPHATE
SYNAREL, NAFARELIN ACETATE
GE HEALTHCARE * GE HEALTHCARE ADREVIEW, IOBENGUANE SULFATE I-123 CERETEC, TECHNETIUM TC-99M EXAMETAZIME KIT INDICLOR, INDIUM IN-111 CHLORIDE INDIUM IN-111 OXYQUINOLINE, INDIUM IN-111 OXYQUINOLINE METASTRON, STRONTIUM CHLORIDE SR-89 MPI DMSA KIDNEY REAGENT, TECHNETIUM TC-99M SUCCIMER KIT MPI INDIUM DTPA IN 111, INDIUM IN-111 PENTETATE DISODIUM MYOVIEW 30ML, TECHNETIUM TC-99M TETROFOSMIN KIT MYOVIEW, TECHNETIUM TC-99M TETROFOSMIN KIT OMNIPAQUE 140, IOHEXOL OMNIPAQUE 180, IOHEXOL OMNIPAQUE 240, IOHEXOL OMNIPAQUE 300, IOHEXOL OMNIPAQUE 350, IOHEXOL OMNISCAN, GADODIAMIDE OPTISON, ALBUMIN HUMAN THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201 VISIPAQUE 270, IODIXANOL
VISIPAQUE 320, IODIXANOL
GE HLTHCARE INC * GE HEALTHCARE INC DATSCAN, IOFLUPANE I-123
B - 56
APPENDIX B
GEDEON RICHTER USA * GEDEON RICHTER USA INC FINASTERIDE, FINASTERIDE

** G **
GENENTECH * GENENTECH INC ERIVEDGE, VISMODEGIB NUTROPIN AQ PEN, SOMATROPIN RECOMBINANT NUTROPIN AQ, SOMATROPIN RECOMBINANT
NUTROPIN, SOMATROPIN RECOMBINANT
GENTA * GENTA INC GANITE,
GALLIUM NITRATE
GENZYME * GENZYME CORP CEREZYME, IMIGLUCERASE CLOLAR, CLOFARABINE MOZOBIL, PLERIXAFOR RENAGEL, SEVELAMER HYDROCHLORIDE RENVELA, SEVELAMER CARBONATE
THYROGEN, THYROTROPIN ALFA
GENZYME CORP * GENZYME CORP HECTOROL, DOXERCALCIFEROL * GENZYME CORPORATION HECTOROL, DOXERCALCIFEROL GILEAD * GILEAD SCIENCES INC ATRIPLA, EFAVIRENZ CAYSTON, AZTREONAM EMTRIVA, EMTRICITABINE HEPSERA, ADEFOVIR DIPIVOXIL LETAIRIS, AMBRISENTAN RANEXA, RANOLAZINE
TRUVADA, EMTRICITABINE
GILEAD SCIENCES INC * GILEAD SCIENCES INC COMPLERA, EMTRICITABINE STRIBILD, COBICISTAT VIREAD, TENOFOVIR DISOPROXIL FUMARATE
VISTIDE, CIDOFOVIR
GLAND PHARMA LTD * GLAND PHARMA LTD ADENOSINE, ADENOSINE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AZITHROMYCIN, AZITHROMYCIN HALOPERIDOL, HALOPERIDOL LACTATE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE, MILRINONE LACTATE
ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
GLAXO GRP LTD * GLAXO GROUP LTD HORIZANT, GABAPENTIN ENACARBIL * GLAXO GROUP LTD DBA GLAXOSMITHKLINE ALTABAX, RETAPAMULIN FLOVENT HFA, FLUTICASONE PROPIONATE
SEREVENT, SALMETEROL XINAFOATE
GLAXOSMITHKLINE * GLAXOSMITHKLINE ABREVA, DOCOSANOL (OTC)
ADVAIR DISKUS 100/50, FLUTICASONE PROPIONATE
B - 57
APPENDIX B

** G **
* GLAXOSMITHKLINE ADVAIR DISKUS 250/50, FLUTICASONE PROPIONATE ADVAIR DISKUS 500/50, FLUTICASONE PROPIONATE ADVAIR HFA, FLUTICASONE PROPIONATE ALKERAN, MELPHALAN ALKERAN, MELPHALAN HYDROCHLORIDE AMERGE, NARATRIPTAN HYDROCHLORIDE ARIXTRA, FONDAPARINUX SODIUM AVODART, DUTASTERIDE BACTROBAN, MUPIROCIN BACTROBAN, MUPIROCIN CALCIUM BECONASE AQ, BECLOMETHASONE DIPROPIONATE MONOHYDRATE CEFTIN, CEFUROXIME AXETIL EPIVIR-HBV, LAMIVUDINE FLONASE, FLUTICASONE PROPIONATE FLOVENT DISKUS 100, FLUTICASONE PROPIONATE FLOVENT DISKUS 250, FLUTICASONE PROPIONATE FLOVENT DISKUS 50, FLUTICASONE PROPIONATE HYCAMTIN, TOPOTECAN HYDROCHLORIDE IMITREX STATDOSE, SUMATRIPTAN SUCCINATE IMITREX, SUMATRIPTAN IMITREX, SUMATRIPTAN SUCCINATE JALYN, DUTASTERIDE LAMICTAL CD, LAMOTRIGINE LAMICTAL, LAMOTRIGINE MALARONE PEDIATRIC, ATOVAQUONE MALARONE, ATOVAQUONE NICORETTE (MINT), NICOTINE POLACRILEX (OTC) NICORETTE, NICOTINE POLACRILEX (OTC) PAXIL CR, PAROXETINE HYDROCHLORIDE PAXIL, PAROXETINE HYDROCHLORIDE POTIGA, EZOGABINE PROMACTA, ELTROMBOPAG OLAMINE RELENZA, ZANAMIVIR REQUIP, ROPINIROLE HYDROCHLORIDE TAGAMET HB, CIMETIDINE (OTC) TAGAMET, CIMETIDINE THIOGUANINE, THIOGUANINE TIMENTIN IN PLASTIC CONTAINER, CLAVULANATE POTASSIUM TIMENTIN, CLAVULANATE POTASSIUM VALTREX, VALACYCLOVIR HYDROCHLORIDE VENTOLIN HFA, ALBUTEROL SULFATE VERAMYST, FLUTICASONE FUROATE VOTRIENT, PAZOPANIB HYDROCHLORIDE WELLBUTRIN SR, BUPROPION HYDROCHLORIDE WELLBUTRIN, BUPROPION HYDROCHLORIDE ZANTAC 150, RANITIDINE HYDROCHLORIDE ZANTAC 25, RANITIDINE HYDROCHLORIDE ZANTAC 300, RANITIDINE HYDROCHLORIDE ZANTAC, RANITIDINE HYDROCHLORIDE ZOFRAN ODT, ONDANSETRON ZOFRAN PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ZOFRAN, ONDANSETRON HYDROCHLORIDE ZOVIRAX, ACYCLOVIR
ZYBAN, BUPROPION HYDROCHLORIDE
GLAXOSMITHKLINE CONS * GLAXOSMITHKLINE CONSUMER HEALTHCARE ALLI, ORLISTAT (OTC) COMMIT, NICOTINE POLACRILEX (OTC)
NICORETTE, NICOTINE POLACRILEX (OTC)
GLAXOSMITHKLINE LLC * GLAXOSMITHKLINE LLC DYAZIDE, HYDROCHLOROTHIAZIDE
DYNACIRC CR, ISRADIPINE
B - 58
APPENDIX B

** G **
* GLAXOSMITHKLINE LLC FLOLAN, EPOPROSTENOL SODIUM INNOPRAN XL, PROPRANOLOL HYDROCHLORIDE MEPRON, ATOVAQUONE RYTHMOL SR, PROPAFENONE HYDROCHLORIDE
RYTHMOL, PROPAFENONE HYDROCHLORIDE
GLENMARK GENERICS * GLENMARK GENERICS INC USA ADAPALENE, ADAPALENE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CALCIPOTRIENE, CALCIPOTRIENE DIPYRIDAMOLE, DIPYRIDAMOLE IMIQUIMOD, IMIQUIMOD MOMETASONE FUROATE, MOMETASONE FUROATE MUPIROCIN, MUPIROCIN CALCIUM NILSTAT, NYSTATIN NIZATIDINE, NIZATIDINE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
* GLENMARK GENERICS LIMITED BRIELLYN, ETHINYL ESTRADIOL FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE
LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE
* GLENMARK GENERICS LTD ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE ALYACEN 1/35, ETHINYL ESTRADIOL ALYACEN 7/7/7, ETHINYL ESTRADIOL ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE CARVEDILOL, CARVEDILOL CICLOPIROX, CICLOPIROX CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE FELODIPINE, FELODIPINE FLUCONAZOLE, FLUCONAZOLE GABAPENTIN, GABAPENTIN HEATHER, NORETHINDRONE LAMOTRIGINE, LAMOTRIGINE LEVOFLOXACIN, LEVOFLOXACIN LITHIUM CARBONATE, LITHIUM CARBONATE MARLISSA, ETHINYL ESTRADIOL MELOXICAM, MELOXICAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MOMETASONE FUROATE, MOMETASONE FUROATE MONTELUKAST SODIUM, MONTELUKAST SODIUM NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN, NAPROXEN NORETHIDRONE, NORETHINDRONE NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON OXCARBAZEPINE, OXCARBAZEPINE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE THEOPHYLLINE, THEOPHYLLINE TOPIRAMATE, TOPIRAMATE TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE, TRANDOLAPRIL TROSPIUM CHLORIDE, TROSPIUM CHLORIDE URSODIOL, URSODIOL VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
VIORELE, DESOGESTREL
* GLENMARK GENERICS LTD INDIA INDOMETHACIN, INDOMETHACIN
B - 59
APPENDIX B

** G **
* GLENMARK GENERICS LTD INDIA LITHIUM CARBONATE, LITHIUM CARBONATE NORETHINDRONE ACETATE, NORETHINDRONE ACETATE
PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE
GLENMARK PHARMS * GLENMARK PHARMACEUTICALS INC USA CICLOPIROX, CICLOPIROX CLOTRIMAZOLE, CLOTRIMAZOLE
MUPIROCIN, MUPIROCIN
* GLENMARK PHARMACEUTICALS LTD MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, GLENMARK PHARMS LTD * GLENMARK PHARMACEUTICALS LTD HYDRALAZINE HYDROCHLORIDE,
HYDROCHLOROTHIAZIDE
GRANULES INDIA * GRANULES INDIA LTD IBUPROFEN, IBUPROFEN (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
NAPROXEN SODIUM, NAPROXEN SODIUM (OTC)
GRIFFEN * KW GRIFFEN CO BIOSCRUB, CHLORHEXIDINE GLUCONATE GTX INC * GTX INC FARESTON,
(OTC)
TOREMIFENE CITRATE
GUARDIAN DRUG * GUARDIAN DRUG CO INC FOAMCOAT, ALUMINUM HYDROXIDE GUERBET * GUERBET LLC HEXABRIX, IOXAGLATE MEGLUMINE OXILAN-300, IOXILAN
OXILAN-350, IOXILAN
(OTC)
HAEMONETICS * HAEMONETICS CORP SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HALOCARBON PRODS * HALOCARBON PRODUCTS CORP ISOFLURANE, ISOFLURANE
SEVOFLURANE, SEVOFLURANE
SODIUM CHLORIDE
HALOZYME THERAP * HALOZYME THERAPEUTICS INC HYLENEX RECOMBINANT, HYALURONIDASE RECOMBINANT HUMAN HAMELN RDS GMBH * HAMELN RDS GMBH GEMCITABINE HYDROCHLORIDE,
HANFORD GC * GC HANFORD MANUFACTURING CO AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM AMPICILLIN SODIUM, AMPICILLIN SODIUM
PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM
HARRIS PHARM * HARRIS PHARMACEUTICAL INC FLUCONAZOLE, FLUCONAZOLE
TERBINAFINE HYDROCHLORIDE, HEC PHARM USA INC * HEC PHARM USA INC ZIDOVUDINE, ZIDOVUDINE
B - 60
APPENDIX B

** H **
HELSINN HLTHCARE * HELSINN HEALTHCARE SA ALOXI, PALONOSETRON HYDROCHLORIDE HERCON PHARM * HERCON PHARMACEUTICAL LLC NITROGLYCERIN, NITROGLYCERIN HERITAGE PHARMS INC * HERITAGE PHARMACEUTICALS INC ACETAZOLAMIDE, ACETAZOLAMIDE CARISOPRODOL AND ASPIRIN, ASPIRIN DOXYCYCLINE, DOXYCYCLINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GLYBURIDE, GLYBURIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE INDOMETHACIN, INDOMETHACIN LEFLUNOMIDE, LEFLUNOMIDE NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NYSTATIN, NYSTATIN PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE
HETERO DRUGS * HETERO DRUGS LTD METHOCARBAMOL, METHOCARBAMOL STAVUDINE, STAVUDINE
TORSEMIDE, TORSEMIDE
HETERO DRUGS LTD * HETERO DRUGS LTD UNIT III FINASTERIDE, FINASTERIDE LEVETIRACETAM, LEVETIRACETAM LITHIUM CARBONATE, LITHIUM CARBONATE
HETERO LABS LTD III * HETERO LABS LTD UNIT III ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE INDOMETHACIN, INDOMETHACIN LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE
NEVIRAPINE, NEVIRAPINE
HETERO LABS LTD V * HETERO LABS LTD UNIT V IRBESARTAN, IRBESARTAN HETERO LABS UNIT III * HETERO LABS LTD UNIT III HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE
INDOMETHACIN, INDOMETHACIN
HEYL CHEMISCH * HEYL CHEMISCH PHARMAZEUTISHE FABRIK RADIOGARDASE (PRUSSIAN BLUE), FERRIC HEXACYANOFERRATE(II) HI TECH PHARMA * HI TECH PHARMACAL CO INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACYCLOVIR, ACYCLOVIR ALBUTEROL SULFATE, ALBUTEROL SULFATE AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE CALCIPOTRIENE, CALCIPOTRIENE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE
CICLOPIROX, CICLOPIROX
B - 61
APPENDIX B
*

** H **
HI TECH PHARMACAL CO INC CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CORMAX, CLOBETASOL PROPIONATE DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE EMBELINE E, CLOBETASOL PROPIONATE EMBELINE, CLOBETASOL PROPIONATE ERYTHRO-STATIN, ERYTHROMYCIN FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE GABAPENTIN, GABAPENTIN HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LACTULOSE, LACTULOSE LEVOCARNITINE, LEVOCARNITINE LEVOFLOXACIN, LEVOFLOXACIN LIDOCAINE AND PRILOCAINE, LIDOCAINE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) NYSTATIN, NYSTATIN OFLOXACIN, OFLOXACIN PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE
VOSOL HC, ACETIC ACID, GLACIAL
VOSOL, ACETIC ACID, GLACIAL
HI TECH PHARMA CO * HI TECH PHARMACAL CO INC FLUNISOLIDE, FLUNISOLIDE PREDNISOLONE, PREDNISOLONE

TUSSICAPS, CHLORPHENIRAMINE POLISTIREX
HIGH TECH PHARMA * HIGH TECHNOLOGY PHARMACAL CO INC VALPROIC ACID, VALPROIC ACID HIKMA * HIKMA FARMACEUTICA LDA CEFOTAXIME, CEFOTAXIME SODIUM * HIKMA PHARMACEUTICALS AMOXICILLIN, AMOXICILLIN CARVEDILOL, CARVEDILOL CEFACLOR, CEFACLOR CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEPHALEXIN, CEPHALEXIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE GABAPENTIN, GABAPENTIN GLYBURIDE (MICRONIZED), GLYBURIDE NAPROXEN SODIUM, NAPROXEN SODIUM
HIKMA (MAPLE) * HIKMA (MAPLE) LTD SODIUM CHLORIDE 0.9%,
SODIUM CHLORIDE
HIKMA FARMACEUTICA * HIKMA FARMACEUTICA (PORTUGAL) SA AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE
BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE
B - 62
APPENDIX B

** H **
* HIKMA FARMACEUTICA (PORTUGAL) SA CEFOXITIN, CEFOXITIN SODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE ENALAPRILAT, ENALAPRILAT FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUMAZENIL, FLUMAZENIL FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GLYCOPYRROLATE, GLYCOPYRROLATE GRANISTERON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN METOPROLOL TARTRATE, METOPROLOL TARTRATE MILRINONE LACTATE IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE, MILRINONE LACTATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PROGESTERONE, PROGESTERONE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE TERBUTALINE SULFATE, TERBUTALINE SULFATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE
VALPROATE SODIUM, VALPROATE SODIUM
* HIKMA FARMACEUTICA PORTUGAL LDA CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFUROXIME SODIUM, CEFUROXIME SODIUM
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE
* HIKMA FARMACEUTICA PORTUGAL SA DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE
TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE
* HIKMA FARMACEUTICA SA BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE HIKMA MAPLE * HIKMA MAPLE LTD ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE, ACYCLOVIR SODIUM ACYCLOVIR SODIUM, ACYCLOVIR SODIUM ADENOSINE, ADENOSINE AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM BUMETANIDE, BUMETANIDE CEFOXITIN, CEFOXITIN SODIUM CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DIGOXIN, DIGOXIN DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DURAMORPH PF, MORPHINE SULFATE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLUMAZENIL, FLUMAZENIL FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE INFUMORPH, MORPHINE SULFATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE, MILRINONE LACTATE MITOMYCIN, MITOMYCIN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
B - 63
APPENDIX B

** H **
* HIKMA MAPLE LTD PHENYTOIN SODIUM, PHENYTOIN SODIUM PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE SUFENTANIL CITRATE, SUFENTANIL CITRATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE
HIKMA PHARM CO LTD * HIKMA PHARM CO LTD ARGATROBAN, ARGATROBAN HIKMA PHARMS * HIKMA PHARMACEUTICALS AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEPHALEXIN, CEPHALEXIN DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE GABAPENTIN, GABAPENTIN GEMFIBROZIL, GEMFIBROZIL LAMOTRIGINE, LAMOTRIGINE MODAFINIL, MODAFINIL
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE
* HIKMA PHARMACEUTICALS LLC SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, SODIUM FERRIC GLUCONATE COMPLEX HILL DERMAC * HILL DERMACEUTICALS INC DERMA-SMOOTHE/FS, FLUOCINOLONE ACETONIDE
DERMOTIC, FLUOCINOLONE ACETONIDE
HISAMITSU PHARM CO * HISAMITSU PHARMACEUTICAL CO INC SALONPAS, MENTHOL (OTC) HISUN PHARM HANGZHOU * HISUN PHARMACEUTICAL (HANGZHOU) CO LTD EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE
HITECH PHARMA * HITECH PHARMACAL CORP CIPROFLOXACIN HYDROCHLORIDE, HI-TECH PHARMA CO * HI-TECH PHARMACAL CO INC LORAZEPAM, LORAZEPAM HI-TECH PHARMACAL * HI-TECH PHARMACAL CO INC LEVETIRACETAM, LEVETIRACETAM HOFFMANN LA ROCHE * HOFFMANN LA ROCHE INC ANAPROX DS, NAPROXEN SODIUM ANAPROX, NAPROXEN SODIUM BONIVA, IBANDRONATE SODIUM INVIRASE, SAQUINAVIR MESYLATE ROCEPHIN, CEFTRIAXONE SODIUM ROMAZICON, FLUMAZENIL VALCYTE, VALGANCICLOVIR HYDROCHLORIDE XELODA, CAPECITABINE XENICAL, ORLISTAT
ZELBORAF, VEMURAFENIB
HOPE PHARMS * HOPE PHARMACEUTICALS NITHIODOTE, SODIUM NITRITE
B - 64
APPENDIX B
*

** H **
HOPE PHARMACEUTICALS SODIUM NITRITE, SODIUM NITRITE

SODIUM THIOSULFATE, SODIUM THIOSULFATE
HORIZON PHARMA * HORIZON PHARMA INC DUEXIS, FAMOTIDINE

RAYOS, PREDNISONE
HOSPIRA * HOSPIRA INC ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL ACETYLCYSTEINE, ACETYLCYSTEINE A-HYDROCORT, HYDROCORTISONE SODIUM SUCCINATE ALFENTANIL, ALFENTANIL HYDROCHLORIDE A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE AMIDATE, ETOMIDATE AMIKACIN SULFATE, AMIKACIN SULFATE AMINOCAPROIC ACID IN PLASTIC CONTAINER, AMINOCAPROIC ACID AMINOPHYLLINE, AMINOPHYLLINE AMINOSYN 10% (PH6), AMINO ACIDS AMINOSYN 10%, AMINO ACIDS AMINOSYN 3.5% M, AMINO ACIDS AMINOSYN 3.5%, AMINO ACIDS AMINOSYN 5%, AMINO ACIDS AMINOSYN 7% (PH6), AMINO ACIDS AMINOSYN 7% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN 7%, AMINO ACIDS AMINOSYN 8.5% (PH6), AMINO ACIDS AMINOSYN 8.5% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN 8.5%, AMINO ACIDS AMINOSYN II 10% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 10% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 10%, AMINO ACIDS AMINOSYN II 15% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 7%, AMINO ACIDS AMINOSYN II 8.5% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 8.5%, AMINO ACIDS AMINOSYN-HBC 7%, AMINO ACIDS AMINOSYN-HF 8%, AMINO ACIDS AMINOSYN-PF 10%, AMINO ACIDS AMINOSYN-PF 7%, AMINO ACIDS AMINOSYN-RF 5.2%, AMINO ACIDS AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMMONIUM CHLORIDE IN PLASTIC CONTAINER, AMMONIUM CHLORIDE AQUASOL A, VITAMIN A PALMITATE ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, ARTICAINE HYDROCHLORIDE ATROPINE SULFATE ANSYR PLASTIC SYRINGE, ATROPINE SULFATE AZITHROMYCIN, AZITHROMYCIN BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION BLEOMYCIN SULFATE, BLEOMYCIN SULFATE BUMETANIDE, BUMETANIDE BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER, CALCIUM CHLORIDE CARBOCAINE, MEPIVACAINE HYDROCHLORIDE CARBOPLATIN, CARBOPLATIN CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE CHROMIC CHLORIDE IN PLASTIC CONTAINER, CHROMIC CHLORIDE CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE
B - 65
APPENDIX B

** H **
* HOSPIRA INC CORLOPAM, FENOLDOPAM MESYLATE CUPRIC CHLORIDE IN PLASTIC CONTAINER, CUPRIC CHLORIDE CYTARABINE, CYTARABINE DACARBAZINE, DACARBAZINE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEMEROL, MEPERIDINE HYDROCHLORIDE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 25%, DEXTROSE DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE DIAZEPAM, DIAZEPAM DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%, DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE DROPERIDOL, DROPERIDOL ENALAPRILAT, ENALAPRILAT EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE ERYC, ERYTHROMYCIN ERYTHROCIN, ERYTHROMYCIN LACTOBIONATE FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE FENTANYL CITRATE, FENTANYL CITRATE FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FOSCARNET SODIUM, FOSCARNET SODIUM FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FUROSEMIDE, FUROSEMIDE GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE GENTAMICIN SULFATE, GENTAMICIN SULFATE GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE ISOFLURANE, ISOFLURANE ISUPREL, ISOPROTERENOL HYDROCHLORIDE KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE
LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE
B - 66
APPENDIX B

** H **
* HOSPIRA INC LEVOPHED, NOREPINEPHRINE BITARTRATE LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EPINEPHRINE LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LIPOSYN II 10%, SAFFLOWER OIL LIPOSYN II 20%, SAFFLOWER OIL LIPOSYN III 10%, SOYBEAN OIL LIPOSYN III 20%, SOYBEAN OIL LIPOSYN III 30%, SOYBEAN OIL LORAZEPAM, LORAZEPAM
LTA II KIT, LIDOCAINE HYDROCHLORIDE
M.V.I. ADULT (PHARMACY BULK PACKAGE), ASCORBIC ACID M.V.I. ADULT, ASCORBIC ACID M.V.I. PEDIATRIC, ASCORBIC ACID M.V.I.-12 (WITHOUT VITAMIN K), ASCORBIC ACID MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MAGNESIUM SULFATE MAGNESIUM SULFATE IN PLASTIC CONTAINER, MAGNESIUM SULFATE MAGNESIUM SULFATE, MAGNESIUM SULFATE MANGANESE CHLORIDE IN PLASTIC CONTAINER, MANGANESE CHLORIDE MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL MANNITOL 25%, MANNITOL MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE W/ EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE MARCAINE, BUPIVACAINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM, METHOTREXATE SODIUM METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE MORPHINE SULFATE, MORPHINE SULFATE NALBUPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN NITROGLYCERIN, NITROGLYCERIN NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PHENYTOIN SODIUM, PHENYTOIN SODIUM PHYSIOSOL IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLEGISOL IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM ACETATE IN PLASTIC CONTAINER, POTASSIUM ACETATE POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE
B - 67
APPENDIX B

** H **
* HOSPIRA INC POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
CALCIUM CHLORIDE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
CALCIUM CHLORIDE
DEXTROSE
DEXTROSE
DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
DEXTROSE
DEXTROSE
DEXTROSE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PRECEDEX, DEXMEDETOMIDINE HYDROCHLORIDE PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPOFOL, PROPOFOL QUELICIN PRESERVATIVE FREE, SUCCINYLCHOLINE CHLORIDE QUELICIN, SUCCINYLCHOLINE CHLORIDE
B - 68
APPENDIX B

** H **
* HOSPIRA INC RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SODIUM ACETATE IN PLASTIC CONTAINER, SODIUM ACETATE ANHYDROUS SODIUM BICARBONATE, SODIUM BICARBONATE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM LACTATE IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM PHOSPHATES IN PLASTIC CONTAINER, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE SORBITOL-MANNITOL IN PLASTIC CONTAINER, MANNITOL STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION SUFENTANIL CITRATE, SUFENTANIL CITRATE TALWIN, PENTAZOCINE LACTATE TAZICEF, CEFTAZIDIME THAM, TROMETHAMINE TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE TPN ELECTROLYTES IN PLASTIC CONTAINER, CALCIUM CHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VECURONIUM BROMIDE, VECURONIUM BROMIDE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE VINORELBINE TARTRATE, VINORELBINE TARTRATE VITAMIN K1, PHYTONADIONE
ZINC CHLORIDE IN PLASTIC CONTAINER, ZINC CHLORIDE
* HOSPIRA WORLDWIDE, INC DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NITROPRESS, SODIUM NITROPRUSSIDE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE
VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE
HOSPIRA INC * HOSPIRA INC A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE ATRACURIUM BESYLATE, ATRACURIUM BESYLATE CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFOXITIN, CEFOXITIN SODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME SODIUM, CEFUROXIME SODIUM DOCETAXEL, DOCETAXEL GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE HEPARIN SODIUM, HEPARIN SODIUM HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IMIPENEM AND CILASTATIN, CILASTATIN SODIUM LEVETIRACETAM, LEVETIRACETAM MAXIPIME, CEFEPIME HYDROCHLORIDE MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE MEROPENEM, MEROPENEM MORPHINE SULFATE, MORPHINE SULFATE NIPENT, PENTOSTATIN OXALIPLATIN, OXALIPLATIN PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE TOPOTECAN, TOPOTECAN HYDROCHLORIDE
B - 69
APPENDIX B
HOSPIRA WORLDWIDE * HOSPIRA WORLDWIDE PTY OXALIPLATIN, OXALIPLATIN

** H **
HOUSTON CYCLOTRON * HOUSTON CYCLOTRON PARTNERS LP AMMONIA N 13, AMMONIA N-13

SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18
HQ SPECIALITY PHARMA * HQ SPECIALITY PHARMA LLC LEVETIRACETAM IN SODIUM CHLORIDE, HRA PHARMA * HRA PHARMA LLC METOPIRONE, METYRAPONE IBI * ISTITUTO BIOCHIMICO ITALIANO SPA AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM AMPICILLIN SODIUM, AMPICILLIN SODIUM NAFCILLIN SODIUM, NAFCILLIN SODIUM PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM
PIPERACILLIN, PIPERACILLIN SODIUM
IDENTI PHARMS INC * IDENTI PHARMACEUTICALS INC FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE IMPAX LABS * IMPAX LABORATORIES INC ACARBOSE, ACARBOSE ALPRAZOLAM, ALPRAZOLAM ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE BACLOFEN, BACLOFEN BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CARBIDOPA AND LEVODOPA, CARBIDOPA CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE COLESTIPOL HYDROCHLORIDE, COLESTIPOL HYDROCHLORIDE DANTROLENE SODIUM, DANTROLENE SODIUM DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE DIGOXIN, DIGOXIN DIPYRIDAMOLE, DIPYRIDAMOLE DIVALPROEX SODIUM, DIVALPROEX SODIUM FENOFIBRATE (MICRONIZED), FENOFIBRATE FENOFIBRATE, FENOFIBRATE FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE LETROZOLE, LETROZOLE LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHYLTESTOSTERONE, METHYLTESTOSTERONE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NADOLOL AND BENDROFLUMETHIAZIDE, BENDROFLUMETHIAZIDE OMEPRAZOLE, OMEPRAZOLE OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE PENTOXIFYLLINE, PENTOXIFYLLINE PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE PRIMIDONE, PRIMIDONE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE RILUZOLE, RILUZOLE
RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE
LEVETIRACETAM
B - 70
APPENDIX B

** I **
* IMPAX LABORATORIES INC TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TERBUTALINE SULFATE, TERBUTALINE SULFATE
TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE
IMPAX LABS INC * IMPAX LABORATORIES INC ANASTROZOLE, ANASTROZOLE CABERGOLINE, CABERGOLINE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE
MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE
IMPAX PHARMS * IMPAX PHARMACEUTICALS FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE GEMFIBROZIL, GEMFIBROZIL MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE ORPHENADRINE CITRATE, ORPHENADRINE CITRATE OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE
INCYTE CORP * INCYTE CORP JAKAFI, RUXOLITINIB PHOSPHATE INDICUS PHARMA * INDICUS PHARMA LLC DONEPEZIL HYDROCHLORIDE, LETROZOLE, LETROZOLE
METFORMIN HYDROCHLORIDE, INJECTALIA * INJECTALIA SRL SUMATRIPTAN SUCCINATE, INNOPHARMA INC * INNOPHARMA INC ACETYLCYSTEINE,
DONEPEZIL HYDROCHLORIDE METFORMIN HYDROCHLORIDE
ACETYLCYSTEINE
INO * INO THERAPEUTICS INC INOMAX, NITRIC OXIDE INSIGHT PHARMS * INSIGHT PHARMACEUTICALS CORP MONISTAT 1 COMBINATION PACK, MICONAZOLE MONISTAT 3 COMBINATION PACK (PREFILLED), MONISTAT 3 COMBINATION PACK, MICONAZOLE MONISTAT 3, MICONAZOLE NITRATE MONISTAT 3, MICONAZOLE NITRATE (OTC) MONISTAT 7 COMBINATION PACK, MICONAZOLE MONISTAT 7, MICONAZOLE NITRATE (OTC) MONISTAT-3 COMBINATION PACK, MICONAZOLE NIX, PERMETHRIN (OTC)
INSPIRE * INSPIRE PHARMACEUTICALS INC AZASITE, AZITHROMYCIN INST BIOCHEM * INSTITUT BIOCHEMIQUE SA FLECTOR, DICLOFENAC EPOLAMINE INST BIOCHIMIQUE * INSTITUTE BIOCHIMIQUE SA (IBSA) TIROSINT, LEVOTHYROXINE SODIUM INSTITUT BIOCHIMIQUE * INSTITUT BIOCHIMIQUE SA IBSA TIROSINT, LEVOTHYROXINE SODIUM
NITRATE (OTC) MICONAZOLE NITRATE NITRATE (OTC)
(OTC)
NITRATE NITRATE
(OTC) (OTC)
B - 71
APPENDIX B
INSYS THERAP * INSYS THERAPEUTICS INC DRONABINOL, DRONABINOL
SUBSYS, FENTANYL
INTERGEL PHARM * INTERGEL PHARMACEUTICAL INC NIFEDIPINE, NIFEDIPINE

** I **
INTL MEDICATED * INTERNATIONAL MEDICATED SYSTEMS LTD BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
MILRINONE LACTATE, MILRINONE LACTATE
INTL MEDICATION * INTERNATIONAL MEDICATION SYSTEM AMINOPHYLLINE, AMINOPHYLLINE DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE ISOPROTERENOL HYDROCHLORIDE, ISOPROTERENOL HYDROCHLORIDE LARYNG-O-JET KIT, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE MANNITOL 25%, MANNITOL MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE PHYTONADIONE, PHYTONADIONE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
* INTERNATIONAL MEDICATION SYSTEMS LTD DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE
MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
INTL MEDICATION SYS * INTERNATIONAL MEDICATION SYSTEMS LTD LORAZEPAM, LORAZEPAM INVAGEN PHARMS * INVAGEN PHARMACEUTICALS INC ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FOLIC ACID, FOLIC ACID FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GABAPENTIN, GABAPENTIN GEMFIBROZIL, GEMFIBROZIL GLIMEPIRIDE, GLIMEPIRIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM MEPROBAMATE, MEPROBAMATE NABUMETONE, NABUMETONE NAPROXEN, NAPROXEN ORPHENADRINE CITRATE, ORPHENADRINE CITRATE QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RAMIPRIL, RAMIPRIL SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE
B - 72
APPENDIX B

** I **
* INVAGEN PHARMACEUTICALS INC WARFARIN SODIUM, WARFARIN SODIUM ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
INVENTIA HLTHCARE * INVENTIA HEALTHCARE PRIVATE LTD METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE IPCA LABS LTD * IPCA LABORATORIES LTD ALLOPURINOL, ALLOPURINOL ATENOLOL, ATENOLOL CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE FUROSEMIDE, FUROSEMIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
IPR * IPR PHARMACEUTICALS INC ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL CRESTOR, ROSUVASTATIN CALCIUM
ZOMIG, ZOLMITRIPTAN
IPR PHARMS INC * IPR PHARMACEUTICALS INC CAPRELSA, VANDETANIB IPSEN INC * IPSEN BIOPHARMACEUTICALS INC INCRELEX, MECASERMIN RECOMBINANT IPSEN PHARMA * IPSEN PHARMA BIOTECH SAS SOMATULINE DEPOT, LANREOTIDE ACETATE IROKO PHARMS * IROKO PHARMACEUTICALS LLC INDOCIN, INDOMETHACIN ISO TEX * ISO TEX DIAGNOSTICS INC JEANATOPE, ALBUMIN IODINATED I-125 SERUM
MEGATOPE, ALBUMIN IODINATED I-131 SERUM
ISOTEX * ISOTEX DIAGNOSTICS GLOFIL-125, IOTHALAMATE SODIUM I-125 ISTA PHARMS * ISTA PHARMACEUTICALS BEPREVE, BEPOTASTINE BESILATE ISTALOL, TIMOLOL MALEATE
VITRASE, HYALURONIDASE
ISTA PHARMS INC * ISTA PHARMACEUTICALS INC BROMDAY, BROMFENAC SODIUM IVAX INTL * IVAX INTERNATIONAL GMBH AMRIX, CYCLOBENZAPRINE HYDROCHLORIDE
SYNRIBO, OMACETAXINE MEPESUCCINATE
IVAX PHARMS * IVAX PHARMACEUTICALS INC PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE
B - 73
APPENDIX B

** I **
IVAX SUB TEVA PHARMS * IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE BACLOFEN, BACLOFEN BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BUMETANIDE, BUMETANIDE CABERGOLINE, CABERGOLINE CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE (OTC) CIMETIDINE, CIMETIDINE CIMETIDINE, CIMETIDINE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CLOZAPINE, CLOZAPINE CYCLOSPORINE, CYCLOSPORINE CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE DIAZEPAM, DIAZEPAM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FENOPROFEN CALCIUM, FENOPROFEN CALCIUM FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUTAMIDE, FLUTAMIDE FUROSEMIDE, FUROSEMIDE GABAPENTIN, GABAPENTIN GLIPIZIDE, GLIPIZIDE GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GRISEOFULVIN, GRISEOFULVIN, MICROSIZE GUANABENZ ACETATE, GUANABENZ ACETATE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE INDAPAMIDE, INDAPAMIDE INDOMETHACIN, INDOMETHACIN LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LORAZEPAM, LORAZEPAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHYLDOPA, METHYLDOPA MISOPROSTOL, MISOPROSTOL NADOLOL, NADOLOL NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE OXAPROZIN, OXAPROZIN OXAZEPAM, OXAZEPAM PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE PROBENECID, PROBENECID RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) SIMVASTATIN, SIMVASTATIN TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE JACOBUS * JACOBUS PHARMACEUTICAL CO DAPSONE, DAPSONE PASER, AMINOSALICYLIC ACID JANSSEN BIOTECH * JANSSEN BIOTECH INC ZYTIGA, ABIRATERONE ACETATE
B - 74
APPENDIX B

** J **
JANSSEN PHARMS * JANSSEN PHARMACEUTICALS INC AXERT, ALMOTRIPTAN MALATE CONCERTA, METHYLPHENIDATE HYDROCHLORIDE DITROPAN XL, OXYBUTYNIN CHLORIDE DORIBAX, DORIPENEM DURAGESIC-100, FENTANYL DURAGESIC-12, FENTANYL DURAGESIC-25, FENTANYL DURAGESIC-50, FENTANYL DURAGESIC-75, FENTANYL ELMIRON, PENTOSAN POLYSULFATE SODIUM HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE INVEGA SUSTENNA, PALIPERIDONE PALMITATE INVEGA, PALIPERIDONE LEUSTATIN, CLADRIBINE LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVAQUIN, LEVOFLOXACIN MICRONOR, NORETHINDRONE MODICON 28, ETHINYL ESTRADIOL NIZORAL, KETOCONAZOLE NUCYNTA ER, TAPENTADOL HYDROCHLORIDE NUCYNTA, TAPENTADOL HYDROCHLORIDE ORTHO CYCLEN-28, ETHINYL ESTRADIOL ORTHO EVRA, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN LO, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN, ETHINYL ESTRADIOL ORTHO-CEPT, DESOGESTREL ORTHO-NOVUM 1/35-28, ETHINYL ESTRADIOL ORTHO-NOVUM 7/7/7-28, ETHINYL ESTRADIOL PANCREAZE, LIPASE RAZADYNE ER, GALANTAMINE HYDROBROMIDE RAZADYNE, GALANTAMINE HYDROBROMIDE RISPERDAL CONSTA, RISPERIDONE RISPERDAL, RISPERIDONE SPORANOX, ITRACONAZOLE TERAZOL 3, TERCONAZOLE TERAZOL 7, TERCONAZOLE TOPAMAX, TOPIRAMATE TYLENOL W/ CODEINE NO. 3, ACETAMINOPHEN TYLENOL W/ CODEINE NO. 4, ACETAMINOPHEN TYLOX, ACETAMINOPHEN ULTRACET, ACETAMINOPHEN ULTRAM, TRAMADOL HYDROCHLORIDE
XARELTO, RIVAROXABAN
JANSSEN PRODS * JANSSEN PRODUCTS LP EDURANT, RILPIVIRINE HYDROCHLORIDE
PREZISTA, DARUNAVIR ETHANOLATE
JANSSEN R AND D * JANSSEN RESEARCH AND DEVELOPMENT LLC INTELENCE, ETRAVIRINE
PARAFON FORTE DSC, CHLORZOXAZONE
JANSSEN RES AND DEV * JANSSEN RESEARCH AND DEVELOPMENT LLC DOXIL, DOXORUBICIN HYDROCHLORIDE JANSSEN THERAP * JANSSEN THERAPEUTICS DIV JANSSEN PRODUCTS LP SIRTURO, BEDAQUILINE FUMARATE
LEVOFLOXACIN
B - 75
APPENDIX B

** J **
JAZZ EUSA PHARMA * JAZZ PHARMACEUTICALS EUSA PHARMA USA INC QUADRAMET, SAMARIUM SM-153 LEXIDRONAM PENTASODIUM JAZZ PHARMS * JAZZ PHARMACEUTICALS INC LUVOX CR, FLUVOXAMINE MALEATE
XYREM, SODIUM OXYBATE
JAZZ PHARMS III * JAZZ PHARMACEUTICALS III INTERNATIONAL LTD FAZACLO ODT, CLOZAPINE JAZZ PHARMS INTL * JAZZ PHARMACEUTICALS INTERNATIONAL LTD PRIALT, ZICONOTIDE ACETATE JHP PHARMS * JHP PHARMACEUTICALS LLC ADRENALIN, EPINEPHRINE BREVITAL SODIUM, METHOHEXITAL SODIUM COLY-MYCIN M, COLISTIMETHATE SODIUM COLY-MYCIN S, COLISTIN SULFATE DANTRIUM, DANTROLENE SODIUM DELESTROGEN, ESTRADIOL VALERATE KETALAR, KETAMINE HYDROCHLORIDE PITOCIN, OXYTOCIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE
TRIOSTAT, LIOTHYRONINE SODIUM
JIANGSU HANSOH PHARM * JIANGSU HANSOH PHARMACEUTICAL CO LTD VINORELBINE TARTRATE, VINORELBINE TARTRATE JIANGSU HENGRUI MED * JIANGSU HENGRUI MEDICINE CO LTD IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE JOHN O BUTLER CO * JOHN O BUTLER CO CHLORHEXIDINE GLUCONATE,
JOHNSON AND JOHNSON * JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES MEN'S ROGAINE, MINOXIDIL (OTC) ROGAINE (FOR MEN), MINOXIDIL (OTC) ROGAINE (FOR WOMEN), MINOXIDIL (OTC) ROGAINE EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) VISINE L.R., OXYMETAZOLINE HYDROCHLORIDE (OTC)
VISINE-A, NAPHAZOLINE HYDROCHLORIDE (OTC)
JUBILANT CADISTA * JUBILANT CADISTA PHARMACEUTICALS INC CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE FOLIC ACID, FOLIC ACID HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE METHYLPREDNISOLONE, METHYLPREDNISOLONE PREDNISONE, PREDNISONE PROCOMP, PROCHLORPERAZINE MALEATE
TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE
JUBILANT DRAXIMAGE * JUBILANT DRAXIMAGE INC DRAXIMAGE MDP-25, TECHNETIUM TC-99M MEDRONATE HICON, SODIUM IODIDE I-131
SODIUM IODIDE I-131, SODIUM IODIDE I-131
B - 76
APPENDIX B

** J **
JUBILANT LIFE * JUBILANT LIFE SCIENCES LTD DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
JUBILANT ORGANOSYS * JUBILANT ORGANOSYS LTD ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE OLANZAPINE, OLANZAPINE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM RISPERIDONE, RISPERIDONE
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
KEY PHARMS * KEY PHARMACEUTICALS INC SUB SCHERING PLOUGH CORP NITRO-DUR, NITROGLYCERIN KING PFIZER * KING PHARMACEUTICALS INC SUB PFIZER INC AVINZA, MORPHINE SULFATE KING PHARMS * KING PHARMACEUTICALS INC ALTACE, RAMIPRIL BICILLIN C-R 900/300, PENICILLIN G BENZATHINE BICILLIN C-R, PENICILLIN G BENZATHINE BICILLIN L-A, PENICILLIN G BENZATHINE CORGARD, NADOLOL CORZIDE, BENDROFLUMETHIAZIDE CYTOMEL, LIOTHYRONINE SODIUM LEVOXYL, LEVOTHYROXINE SODIUM PENICILLIN G PROCAINE, PENICILLIN G PROCAINE SILVADENE, SILVER SULFADIAZINE SKELAXIN, METAXALONE SYNERCID, DALFOPRISTIN
TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE
* KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC SUB KING PHARMACEUTICALS INC SONATA, ZALEPLON TAPAZOLE, METHIMAZOLE
TUSSIGON, HOMATROPINE METHYLBROMIDE
KING PHARMS R AND D * KING PHARMACEUTICALS RESEARCH DEVELOPMENT INC OXECTA, OXYCODONE HYDROCHLORIDE KOWA CO * KOWA CO LTD LIVALO, PITAVASTATIN CALCIUM KREMERS URBAN PHARMS * KREMERS URBAN PHARMACEUTICALS INC GLYCOLAX, POLYETHYLENE GLYCOL 3350 GLYCOLAX, POLYETHYLENE GLYCOL 3350 (OTC) ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE MONOKET, ISOSORBIDE MONONITRATE NITROGLYCERIN, NITROGLYCERIN
OMEPRAZOLE, OMEPRAZOLE
KUDCO IRELAND * KUDCO IRELAND LTD ANASTROZOLE, ANASTROZOLE BICALUTAMIDE, BICALUTAMIDE LETROZOLE, LETROZOLE MONTELUKAST SODIUM, MONTELUKAST SODIUM
PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
KV PHARM * KV PHARMACEUTICAL CO CLINDESSE, CLINDAMYCIN PHOSPHATE
EVAMIST, ESTRADIOL
B - 77
APPENDIX B
*

** K **
KV PHARMACEUTICAL CO GYNAZOLE-1, BUTOCONAZOLE NITRATE

MAKENA, HYDROXYPROGESTERONE CAPROATE
KVK TECH * KVK TECH INC BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE KALEXATE, SODIUM POLYSTYRENE SULFONATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE
PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
LAB HRA PHARMA * LABORATOIRE HRA PHARMA ELLA, ULIPRISTAL ACETATE LANDELA PHARM * LANDELA PHARMACEUTICAL ALBUTEROL SULFATE, ALBUTEROL SULFATE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE
IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE
LANNETT * LANNETT CO INC ACETAZOLAMIDE, ACETAZOLAMIDE DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE LANORINAL, ASPIRIN PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PRIMIDONE, PRIMIDONE PROBALAN, PROBENECID
SERPALAN, RESERPINE
* LANNETT HOLDINGS INC BACLOFEN, BACLOFEN BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE DANAZOL, DANAZOL DIPYRIDAMOLE, DIPYRIDAMOLE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE RIFAMPIN, RIFAMPIN TERBUTALINE SULFATE, TERBUTALINE SULFATE
URSODIOL, URSODIOL
LANNETT HOLDINGS INC * LANNETT HOLDINGS INC BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOXAPINE SUCCINATE, LOXAPINE SUCCINATE METHOCARBAMOL, METHOCARBAMOL MORPHINE SULFATE, MORPHINE SULFATE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PHENTERMINE RESIN COMPLEX, PHENTERMINE RESIN COMPLEX
TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
B - 78
APPENDIX B

** L **
LANTHEUS MEDCL * LANTHEUS MEDICAL IMAGING INC ABLAVAR, GADOFOSVESET TRISODIUM CARDIOLITE, TECHNETIUM TC-99M SESTAMIBI KIT DEFINITY, PERFLUTREN GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67 NEUROLITE, TECHNETIUM TC-99M BICISATE KIT TECHNELITE, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201
XENON XE 133, XENON XE-133
LARKEN LABS * LARKEN LABORATORIES INC DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE LAVIPHARM LABS * LAVIPHARM LABORATORIES INC FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL
FENTANYL-75, FENTANYL
LEHIGH VALLEY * LEHIGH VALLEY TECHNOLOGIES INC OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE LEK PHARMS * LEK PHARMACEUTICALS D D BROMOCRIPTINE MESYLATE,
LEK PHARMS DD * LEK PHARMACEUTICALS DD ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE LEO PHARM * LEO PHARMACEUTICAL PRODUCTS LTD DOVONEX, CALCIPOTRIENE
TACLONEX, BETAMETHASONE DIPROPIONATE
LEO PHARMA AS * LEO PHARMA AS DOVONEX, CALCIPOTRIENE PICATO, INGENOL MEBUTATE
TACLONEX, BETAMETHASONE DIPROPIONATE
LG LIFE * LG LIFE SCIENCES LTD VALTROPIN, SOMATROPIN RECOMBINANT LILLY * ELI LILLY AND CO ALIMTA, PEMETREXED DISODIUM CIALIS, TADALAFIL CYMBALTA, DULOXETINE HYDROCHLORIDE EVISTA, RALOXIFENE HYDROCHLORIDE FORTEO, TERIPARATIDE RECOMBINANT HUMAN GEMZAR, GEMCITABINE HYDROCHLORIDE GLUCAGON, GLUCAGON RECOMBINANT HUMALOG KWIKPEN, INSULIN LISPRO RECOMBINANT HUMALOG MIX 50/50 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 50/50, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG, INSULIN LISPRO RECOMBINANT HUMATROPE, SOMATROPIN RECOMBINANT HUMULIN 70/30 PEN, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) HUMULIN R PEN, INSULIN RECOMBINANT HUMAN (OTC)
HUMULIN R, INSULIN RECOMBINANT HUMAN
B - 79
APPENDIX B

** L **
* ELI LILLY AND CO HUMULIN R, INSULIN RECOMBINANT HUMAN (OTC) PROZAC WEEKLY, FLUOXETINE HYDROCHLORIDE QUINIDINE GLUCONATE, QUINIDINE GLUCONATE STRATTERA, ATOMOXETINE HYDROCHLORIDE SYMBYAX, FLUOXETINE HYDROCHLORIDE ZYPREXA ZYDIS, OLANZAPINE
ZYPREXA, OLANZAPINE
LLOYD * LLOYD INC LEVOTHROID,
LEVOTHYROXINE SODIUM
LNK * LNK INTERNATIONAL INC DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE (OTC) IBUPROFEN, IBUPROFEN (OTC)
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LOREAL USA * LOREAL USA PRODUCTS INC ANTHELIOS 20, AVOBENZONE (OTC) ANTHELIOS 40, AVOBENZONE (OTC) ANTHELIOS SX, AVOBENZONE (OTC)
CAPITAL SOLEIL 15, AVOBENZONE (OTC)
LOTUS PHARM CO LTD * LOTUS PHARMACEUTICAL CO LTD LEVETIRACETAM, LEVETIRACETAM
(OTC)
LUITPOLD * LUITPOLD PHARMACEUTICALS INC ACETYLCYSTEINE, ACETYLCYSTEINE ADENOSINE, ADENOSINE AMINOCAPROIC ACID, AMINOCAPROIC ACID AMINOPHYLLINE, AMINOPHYLLINE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE CAFFEINE CITRATE, CAFFEINE CITRATE CALCITRIOL, CALCITRIOL CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CYANOCOBALAMIN, CYANOCOBALAMIN CYCLOSPORINE, CYCLOSPORINE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DEXFERRUM, IRON DEXTRAN DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE DROPERIDOL, DROPERIDOL EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE ESTRADIOL VALERATE, ESTRADIOL VALERATE ETOMIDATE, ETOMIDATE FOMEPIZOLE, FOMEPIZOLE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FUROSEMIDE, FUROSEMIDE GLYCOPYRROLATE, GLYCOPYRROLATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IBUTILIDE FUMARATE, IBUTILIDE FUMARATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LATANOPROST, LATANOPROST LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEVETIRACETAM, LEVETIRACETAM LEVOCARNITINE, LEVOCARNITINE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE MANNITOL 25%, MANNITOL
METHYLDOPATE HYDROCHLORIDE, METHYLDOPATE HYDROCHLORIDE
B - 80
APPENDIX B

** L **
* LUITPOLD PHARMACEUTICALS INC METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE METOPROLOL TARTRATE, METOPROLOL TARTRATE NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE NITROGLYCERIN, NITROGLYCERIN OLANZAPINE, OLANZAPINE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PHENYTOIN SODIUM, PHENYTOIN SODIUM PROGESTERONE, PROGESTERONE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE SPRIX, KETOROLAC TROMETHAMINE TORSEMIDE, TORSEMIDE TRANEXAMIC ACID, TRANEXAMIC ACID TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE, TRIMETHOBENZAMIDE HYDROCHLORIDE TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE VENOFER, IRON SUCROSE
LUNDBECK INC * LUNDBECK INC DESOXYN, METHAMPHETAMINE HYDROCHLORIDE
MUSTARGEN, MECHLORETHAMINE HYDROCHLORIDE
LUNDBECK LLC * LUNDBECK LLC CHEMET, SUCCIMER COSMEGEN, DACTINOMYCIN INDOCIN, INDOMETHACIN SODIUM NEOPROFEN, IBUPROFEN LYSINE ONFI, CLOBAZAM PEGANONE, ETHOTOIN SABRIL, VIGABATRIN
TRANXENE, CLORAZEPATE DIPOTASSIUM
LUPIN * LUPIN LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFDINIR, CEFDINIR CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFPROZIL, CEFPROZIL CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN DIVALPROEX SODIUM, DIVALPROEX SODIUM ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOVASTATIN, LOVASTATIN QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RAMIPRIL, RAMIPRIL SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN
LUPIN ATLANTIS * LUPIN ATLANTIS HOLDINGS SA ANTARA (MICRONIZED), FENOFIBRATE LUPIN LTD * LUPIN LIMITED LEVETIRACETAM,
LEVETIRACETAM
B - 81
APPENDIX B

** L **
* LUPIN LIMITED LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL * LUPIN LTD DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FAMOTIDINE, FAMOTIDINE FENOFIBRATE, FENOFIBRATE IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE IRBESARTAN, IRBESARTAN KURVELO, ETHINYL ESTRADIOL LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MEFENAMIC ACID, MEFENAMIC ACID METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NABUMETONE, NABUMETONE NORETHINDRONE, NORETHINDRONE PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE PREGABALIN, PREGABALIN QUETIAPINE FUMARATE, QUETIAPINE FUMARATE SUPRAX, CEFIXIME
LUPIN PHARMS * LUPIN PHARMACEUTICALS INC AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE DESLORATADINE, DESLORATADINE MELOXICAM, MELOXICAM NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL PRAVASTATIN SODIUM, PRAVASTATIN SODIUM SUPRAX, CEFIXIME
LYNE * LYNE LABORATORIES INC CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE DEXAMETHASONE, DEXAMETHASONE HYDROCORTISONE, HYDROCORTISONE LEVOCARNITINE, LEVOCARNITINE
LYNROSE LABS * LYNROSE LABS LLC CARBINOXAMINE MALEATE,
MACLEODS PHARMS LTD * MACLEODS PHARMACEUTICALS LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FAMCICLOVIR, FAMCICLOVIR IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN LEVOFLOXACIN, LEVOFLOXACIN LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
B - 82
APPENDIX B

** M **
MALLINCKRODT * MALLINCKRODT CHEMICAL INC ANEXSIA 7.5/650, ACETAMINOPHEN ANEXSIA, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHADOSE, METHADONE HYDROCHLORIDE
OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN
* MALLINCKRODT INC ANEXSIA 5/325, ACETAMINOPHEN ANEXSIA 7.5/325, ACETAMINOPHEN ANEXSIA, ACETAMINOPHEN DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE FENTANYL CITRATE, FENTANYL CITRATE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHYLIN ER, METHYLPHENIDATE HYDROCHLORIDE METHYLIN, METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE OPTIMARK IN PLASTIC CONTAINER, GADOVERSETAMIDE OPTIMARK, GADOVERSETAMIDE OXYCET, ACETAMINOPHEN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN PENNSAID, DICLOFENAC SODIUM SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE TECHNETIUM TC-99 SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201
* MALLINCKRODT MEDICAL INC CONRAY 30, IOTHALAMATE MEGLUMINE CONRAY 43, IOTHALAMATE MEGLUMINE CONRAY, IOTHALAMATE MEGLUMINE CYSTO-CONRAY II, IOTHALAMATE MEGLUMINE GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67 INDIUM IN 111 CHLORIDE, INDIUM IN-111 CHLORIDE MD-76R, DIATRIZOATE MEGLUMINE MD-GASTROVIEW, DIATRIZOATE MEGLUMINE OCTREOSCAN, INDIUM IN-111 PENTETREOTIDE KIT OPTIRAY 240, IOVERSOL OPTIRAY 300, IOVERSOL OPTIRAY 320, IOVERSOL OPTIRAY 350, IOVERSOL SODIUM IODIDE I 123, SODIUM IODIDE I-123 SODIUM IODIDE I 131, SODIUM IODIDE I-131 TECHNESCAN MAG3, TECHNETIUM TC-99M MERTIATIDE KIT TECHNESCAN PYP KIT, TECHNETIUM TC-99M PYROPHOSPHATE KIT TECHNESCAN, TECHNETIUM TC-99M OXIDRONATE KIT THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201 ULTRATAG, TECHNETIUM TC-99M RED BLOOD CELL KIT
ULTRA-TECHNEKOW FM, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR
MALLINCKRODT INC * MALLINCKRODT INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE EXALGO, HYDROMORPHONE HYDROCHLORIDE FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL
FENTANYL-50, FENTANYL
B - 83
APPENDIX B

** M **
* MALLINCKRODT INC FENTANYL-75, FENTANYL HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE RESTORIL, TEMAZEPAM ROXICODONE, OXYCODONE HYDROCHLORIDE TOFRANIL, IMIPRAMINE HYDROCHLORIDE
TOFRANIL-PM, IMIPRAMINE PAMOATE
MALLINCKRODT LLC * MALLINCKRODT LLC ANAFRANIL, CLOMIPRAMINE HYDROCHLORIDE
PAMELOR, NORTRIPTYLINE HYDROCHLORIDE
MARATHON PHARMS * MARATHON PHARMACEUTICALS LLC PEPCID, FAMOTIDINE
SECONAL SODIUM, SECOBARBITAL SODIUM
MARKSANS PHARMA * MARKSANS PHARMA LTD GABAPENTIN, GABAPENTIN IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NAPROXEN SODIUM, NAPROXEN SODIUM (OTC)
NAPROXEN, NAPROXEN
MARSAM PHARMS LLC * MARSAM PHARMACEUTICALS LLC TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE MATRIX LABS LTD * MATRIX LABORATORIES LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE NIFEDIPINE, NIFEDIPINE
STAVUDINE, STAVUDINE
MAYNE PHARMA * MAYNE PHARMA INTERNATIONAL PTY LTD DORYX, DOXYCYCLINE HYCLATE MCNEIL * MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC CHILDREN'S MOTRIN, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN (OTC) IMODIUM A-D EZ CHEWS, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE MOTRIN IB, IBUPROFEN (OTC) MOTRIN MIGRAINE PAIN, IBUPROFEN (OTC)
ZYRTEC-D 12 HOUR, CETIRIZINE HYDROCHLORIDE (OTC)
(OTC)
MCNEIL CONS * MCNEIL CONSUMER HEALTHCARE CHILDREN'S MOTRIN COLD, IBUPROFEN (OTC) CHILDREN'S MOTRIN, IBUPROFEN (OTC) CHILDREN'S ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) IMODIUM A-D, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM, LOPERAMIDE HYDROCHLORIDE JUNIOR STRENGTH MOTRIN, IBUPROFEN (OTC) NIZORAL A-D, KETOCONAZOLE (OTC) PEPCID AC (GELTAB), FAMOTIDINE (OTC) PEPCID AC, FAMOTIDINE (OTC) PEPCID COMPLETE, CALCIUM CARBONATE (OTC)
SINE-AID IB, IBUPROFEN (OTC)
B - 84
APPENDIX B
** M **
(OTC) (OTC) HYDROCHLORIDE HYDROCHLORIDE (OTC)
(OTC)
* MCNEIL CONSUMER HEALTHCARE SUDAFED 12 HOUR, PSEUDOEPHEDRINE SUDAFED 24 HOUR, PSEUDOEPHEDRINE TYLENOL (CAPLET), ACETAMINOPHEN TYLENOL (GELTAB), ACETAMINOPHEN
MCNEIL CONSUMER * MCNEIL CONSUMER HEALTHCARE DIV MCNEIL PPC INC CHILDREN'S ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC)
ZYRTEC, CETIRIZINE HYDROCHLORIDE
MCPRF * MAYO CLINIC PET RADIOCHEMISTRY FACILITY CHOLINE C-11, CHOLINE C-11 MEDA PHARMS * MEDA PHARMACEUTICALS DYMISTA, AZELASTINE HYDROCHLORIDE
EDLUAR, ZOLPIDEM TARTRATE
* MEDA PHARMACEUTICALS INC ANADROL-50, OXYMETHOLONE ASTELIN, AZELASTINE HYDROCHLORIDE ASTEPRO, AZELASTINE HYDROCHLORIDE AVC, SULFANILAMIDE BUTISOL SODIUM, BUTABARBITAL SODIUM CESAMET, NABILONE COLYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350 COLYTE, POLYETHYLENE GLYCOL 3350 COLYTE-FLAVORED, POLYETHYLENE GLYCOL 3350 CORTIFOAM, HYDROCORTISONE ACETATE DEMADEX, TORSEMIDE DEPEN, PENICILLAMINE DIPENTUM, OLSALAZINE SODIUM ELESTRIN, ESTRADIOL EPIFOAM, HYDROCORTISONE ACETATE FELBATOL, FELBAMATE GASTROCROM, CROMOLYN SODIUM LUFYLLIN, DYPHYLLINE MUSE, ALPROSTADIL ONSOLIS, FENTANYL CITRATE OPTIVAR, AZELASTINE HYDROCHLORIDE PROCTOFOAM HC, HYDROCORTISONE ACETATE ROWASA, MESALAMINE SFROWASA, MESALAMINE
TRILYTE, POLYETHYLENE GLYCOL 3350
* MEDA PHARMACEUTICALS MEDA PHARMACEUTICALS INC SOMA COMPOUND W/ CODEINE, ASPIRIN SOMA COMPOUND, ASPIRIN
SOMA, CARISOPRODOL
MEDEFIL * MEDEFIL INC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, MEDICINES CO * THE MEDICINES CO ANGIOMAX, BIVALIRUDIN
CLEVIPREX, CLEVIDIPINE BUTYRATE
MEDICIS * MEDICIS PHARMACEUTICAL CORP ALDARA, IMIQUIMOD BUPHENYL, SODIUM PHENYLBUTYRATE CALCIUM DISODIUM VERSENATE, EDETATE CALCIUM DISODIUM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
DYNACIN, MINOCYCLINE HYDROCHLORIDE
SODIUM CHLORIDE
B - 85
APPENDIX B
** M **
* MEDICIS PHARMACEUTICAL CORP ESTRASORB, ESTRADIOL HEMIHYDRATE LOPROX, CICLOPIROX MAXAIR, PIRBUTEROL ACETATE METROGEL-VAGINAL, METRONIDAZOLE MINITRAN, NITROGLYCERIN NORFLEX, ORPHENADRINE CITRATE NORGESIC FORTE, ASPIRIN NORGESIC, ASPIRIN SOLODYN, MINOCYCLINE HYDROCHLORIDE SYNACORT, HYDROCORTISONE TAMBOCOR, FLECAINIDE ACETATE THEOLAIR, THEOPHYLLINE VANOS, FLUOCINONIDE ZIANA, CLINDAMYCIN PHOSPHATE
ZYCLARA, IMIQUIMOD
MEDICURE * MEDICURE INTERNATIONAL INC AGGRASTAT, TIROFIBAN HYDROCHLORIDE MEDIGENE AG * MEDIGENE AG VEREGEN, SINECATECHINS MEDIMETRIKS PHARMS * MEDIMETRIKS PHARMACEUTICALS INC SYNALAR, FLUOCINOLONE ACETONIDE MEDIMMUNE * MEDIMMUNE ETHYOL,
AMIFOSTINE
MEDTRONIC * MEDTRONIC INC LIORESAL, BACLOFEN MERCK * MERCK AND CO INC AMINOHIPPURATE SODIUM, AMINOHIPPURATE SODIUM CANCIDAS, CASPOFUNGIN ACETATE EMEND, APREPITANT FOSAMAX PLUS D, ALENDRONATE SODIUM FOSAMAX, ALENDRONATE SODIUM HYZAAR, HYDROCHLOROTHIAZIDE INVANZ, ERTAPENEM SODIUM MAXALT, RIZATRIPTAN BENZOATE MAXALT-MLT, RIZATRIPTAN BENZOATE PRIMAXIN, CILASTATIN SODIUM PROSCAR, FINASTERIDE SINGULAIR, MONTELUKAST SODIUM
ZOLINZA, VORINOSTAT
* MERCK RESEARCH LABORATORIES DIV MERCK CO INC CLINORIL, SULINDAC COSOPT, DORZOLAMIDE HYDROCHLORIDE COZAAR, LOSARTAN POTASSIUM MEVACOR, LOVASTATIN NOROXIN, NORFLOXACIN PRINIVIL, LISINOPRIL PRINZIDE, HYDROCHLOROTHIAZIDE PROPECIA, FINASTERIDE SINGULAIR, MONTELUKAST SODIUM TRUSOPT, DORZOLAMIDE HYDROCHLORIDE
ZOCOR, SIMVASTATIN
MERCK AND CO INC * MERCK AND CO INC EMEND, FOSAPREPITANT DIMEGLUMINE
FOSAMAX, ALENDRONATE SODIUM
B - 86
APPENDIX B
MERCK KGAA * MERCK KGAA LEVOTHYROXINE SODIUM,

** M **
LEVOTHYROXINE SODIUM
MERCK SANTE SAS * MERCK SANTE SAS CYANOKIT, HYDROXOCOBALAMIN MERCK SHARP DOHME * MERCK SHARP AND DOHME CORP CLARINEX D 24 HOUR, DESLORATADINE CLARINEX, DESLORATADINE CLARINEX-D 12 HOUR, DESLORATADINE COSOPT PF, DORZOLAMIDE HYDROCHLORIDE CRIXIVAN, INDINAVIR SULFATE DIPROLENE AF, BETAMETHASONE DIPROPIONATE DIPROLENE, BETAMETHASONE DIPROPIONATE DULERA, FORMOTEROL FUMARATE ELOCON, MOMETASONE FUROATE GUANIDINE HYDROCHLORIDE, GUANIDINE HYDROCHLORIDE ISENTRESS, RALTEGRAVIR POTASSIUM JANUMET XR, METFORMIN HYDROCHLORIDE JANUMET, METFORMIN HYDROCHLORIDE JANUVIA, SITAGLIPTIN PHOSPHATE JUVISYNC, SIMVASTATIN LOTRISONE, BETAMETHASONE DIPROPIONATE REBETOL, RIBAVIRIN SINEMET CR, CARBIDOPA SINEMET, CARBIDOPA STROMECTOL, IVERMECTIN TEMODAR, TEMOZOLOMIDE VICTRELIS, BOCEPREVIR
ZIOPTAN, TAFLUPROST
MERIDIAN MEDCL * MERIDIAN MEDICAL TECHNOLOGIES INC DUODOTE, ATROPINE * MERIDIAN MEDICAL TECHNOLOGIES INC SUB KING PHARMACEUTICALS INC ALSUMA, SUMATRIPTAN SUCCINATE MERIDIAN MEDCL TECHN * MERIDIAN MEDICAL TECHNOLOGIES INC ATROPEN, ATROPINE EPIPEN JR., EPINEPHRINE EPIPEN, EPINEPHRINE LIDOPEN, LIDOCAINE HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE
PRALIDOXIME CHLORIDE, PRALIDOXIME CHLORIDE
MERRO PHARM * MERRO PHARMACEUTICAL CO LTD IBUPROFEN, IBUPROFEN (OTC) MERZ PHARMS * MERZ PHARMACEUTICALS LLC CUVPOSA, GLYCOPYRROLATE ERYGEL, ERYTHROMYCIN NAFTIN, NAFTIFINE HYDROCHLORIDE
ONMEL, ITRACONAZOLE
METHAPHARM * METHAPHARM INC LEVETIRACETAM, LEVETIRACETAM
PROVOCHOLINE, METHACHOLINE CHLORIDE
MICRO LABS LTD * MICRO LABS LTD MEFENAMIC ACID, MEFENAMIC ACID
NEVIRAPINE, NEVIRAPINE
B - 87
APPENDIX B
* MICRO LABS LTD SIMVASTATIN, SIMVASTATIN

** M **
MICRO LABS LTD INDIA * MICRO LABS LTD INDIA LOSARTAN POTASSIUM, LOSARTAN POTASSIUM
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, MICRO LABS USA * MICRO LABS USA INC GLIMEPIRIDE, GLIMEPIRIDE
ACETAMINOPHEN
MIKAH PHARMA * MIKAH PHARMA LLC ISRADIPINE, ISRADIPINE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE
TRIMIPRAMINE MALEATE, TRIMIPRAMINE MALEATE
MIKART * MIKART INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMINOCAPROIC ACID, AMINOCAPROIC ACID AMINOCAPROIC, AMINOCAPROIC ACID BENZONATATE, BENZONATATE BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTAPAP, ACETAMINOPHEN CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE CHLORZOXAZONE, CHLORZOXAZONE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE ESGIC-PLUS, ACETAMINOPHEN ETHOSUXIMIDE, ETHOSUXIMIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN ISONIAZID, ISONIAZID MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METHAZOLAMIDE, METHAZOLAMIDE OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PYRAZINAMIDE, PYRAZINAMIDE
TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE
MILLENNIUM PHARMS * MILLENNIUM PHARMACEUTICALS INC VELCADE, BORTEZOMIB MIRROR PHARMS * MIRROR PHARMACEUTICALS LLC BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN CARISOPRODOL AND ASPIRIN, ASPIRIN CARISOPRODOL, CARISOPRODOL CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE
PROBENECID AND COLCHICINE, COLCHICINE
MISSION PHARMA * MISSION PHARMACAL CO BINOSTO, ALENDRONATE SODIUM LITHOSTAT, ACETOHYDROXAMIC ACID PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE TEXACORT, HYDROCORTISONE TINDAMAX, TINIDAZOLE TIOPRONIN, TIOPRONIN
UROCIT-K, POTASSIUM CITRATE
B - 88
APPENDIX B
MN PHARMS * MN PHARMACEUTICALS PAMIDRONATE DISODIUM, MOBIUS THERAP * MOBIUS THERAPEUTICS LLC MITOSOL, MITOMYCIN

** M **
MOLNLYCKE HLTH * MOLNLYCKE HEALTH CARE HIBICLENS, CHLORHEXIDINE GLUCONATE (OTC)

HIBISTAT, CHLORHEXIDINE GLUCONATE (OTC)
MONARCH PHARMS * MONARCH PHARMACEUTICALS INC CORTISPORIN, BACITRACIN ZINC CORTISPORIN, HYDROCORTISONE CORTISPORIN, HYDROCORTISONE ACETATE MENEST, ESTROGENS, ESTERIFIED NEOSPORIN G.U. IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, GRAMICIDIN PEDIOTIC, HYDROCORTISONE SEPTRA DS, SULFAMETHOXAZOLE SEPTRA, SULFAMETHOXAZOLE THALITONE, CHLORTHALIDONE
VIROPTIC, TRIFLURIDINE
MORTON GROVE * MORTON GROVE PHARMACEUTICALS INC LACTULOSE, LACTULOSE
MORTON GROVE PHARMS * MORTON GROVE PHARMACEUTICALS INC GENERLAC, LACTULOSE MSD CONSUMER * MSD CONSUMER CARE INC OXYTROL FOR WOMEN, OXYBUTYNIN (OTC)
ZEGERID OTC, OMEPRAZOLE (OTC)
MSD INTL * MSD INTERNATIONAL GMBH VYTORIN, EZETIMIBE MSD INTL GMBH * MSD INTERNATIONAL GMBH ZETIA, EZETIMIBE MURTY PHARMS * MURTY PHARMACEUTICALS INC AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE
DIPYRIDAMOLE, DIPYRIDAMOLE
MUSTAFA NEVSAT * MUSTAFA NEVSAT ILAC SANAYII AS EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE MUSTAFA NEVZAT * MUSTAFA NEVZAT ILAC SANAYII AS PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM
VECURONIUM BROMIDE, VECURONIUM BROMIDE
MUTUAL PHARM * MUTUAL PHARMACEUTICAL CO INC ACETAZOLAMIDE, ACETAZOLAMIDE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALLOPURINOL, ALLOPURINOL AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE
ATENOLOL AND CHLORTHALIDONE, ATENOLOL
B - 89
APPENDIX B

** M **
* MUTUAL PHARMACEUTICAL CO INC ATENOLOL, ATENOLOL BACTRIM DS, SULFAMETHOXAZOLE BACTRIM, SULFAMETHOXAZOLE CARISOPRODOL, CARISOPRODOL CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE ERGOLOID MESYLATES, ERGOLOID MESYLATES FELODIPINE, FELODIPINE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE LOVASTATIN, LOVASTATIN METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE METRONIDAZOLE, METRONIDAZOLE MINOXIDIL, MINOXIDIL NYSTATIN, NYSTATIN PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PIROXICAM, PIROXICAM PREDNISONE, PREDNISONE PRIMIDONE, PRIMIDONE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE QUINIDINE GLUCONATE, QUINIDINE GLUCONATE QUINIDINE SULFATE, QUINIDINE SULFATE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SPIRONOLACTONE, SPIRONOLACTONE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SULINDAC, SULINDAC TEMAZEPAM, TEMAZEPAM THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE TOLMETIN SODIUM, TOLMETIN SODIUM TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
MUTUAL PHARM CO INC * MUTUAL PHARMACEUTICAL CO INC IBANDRONATE SODIUM, IBANDRONATE SODIUM LEVETIRACETAM, LEVETIRACETAM
QUALAQUIN, QUININE SULFATE
MUTUAL PHARMA * MUTUAL PHARMACAL CO DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE KETOCONAZOLE, KETOCONAZOLE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE
MYLAN * MYLAN LABORATORIES INC ACYCLOVIR, ACYCLOVIR AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE CAPTOPRIL, CAPTOPRIL ETODOLAC, ETODOLAC OLANZAPINE, OLANZAPINE
TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE
* MYLAN PHARMACEUTICALS METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE * MYLAN PHARMACEUTICALS INC ACARBOSE, ACARBOSE ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE ACYCLOVIR, ACYCLOVIR ALBUTEROL SULFATE, ALBUTEROL SULFATE ALENDRONATE SODIUM, ALENDRONATE SODIUM ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE
ALLOPURINOL, ALLOPURINOL
B - 90
APPENDIX B

** M **
* MYLAN PHARMACEUTICALS INC ALPRAZOLAM, ALPRAZOLAM AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMNESTEEM, ISOTRETINOIN ANASTROZOLE, ANASTROZOLE ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL AVITA, TRETINOIN AZATHIOPRINE, AZATHIOPRINE AZITHROMYCIN, AZITHROMYCIN BACLOFEN, BACLOFEN BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BICALUTAMIDE, BICALUTAMIDE BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE BUDESONIDE, BUDESONIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL CARBIDOPA AND LEVODOPA, CARBIDOPA CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CHLOROTHIAZIDE, CHLOROTHIAZIDE CHLORPROPAMIDE, CHLORPROPAMIDE CHLORTHALIDONE, CHLORTHALIDONE CILOSTAZOL, CILOSTAZOL CIMETIDINE, CIMETIDINE CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLARITHROMYCIN, CLARITHROMYCIN CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM CLORPRES, CHLORTHALIDONE CLOZAPINE, CLOZAPINE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYSTAGON, CYSTEAMINE BITARTRATE DIAZEPAM, DIAZEPAM DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM DICLOFENAC SODIUM, DICLOFENAC SODIUM DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE DIVALPROEX SODIUM, DIVALPROEX SODIUM DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ENALAPRIL MALEATE, ENALAPRIL MALEATE ESTRADIOL, ESTRADIOL ESTROPIPATE, ESTROPIPATE
ETIDRONATE DISODIUM, ETIDRONATE DISODIUM
B - 91
APPENDIX B

** M **
* MYLAN PHARMACEUTICALS INC ETOPOSIDE, ETOPOSIDE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM FAMCICLOVIR, FAMCICLOVIR FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FELODIPINE, FELODIPINE FENOFIBRATE, FENOFIBRATE FENOPROFEN CALCIUM, FENOPROFEN CALCIUM FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE FLURBIPROFEN, FLURBIPROFEN FLUTAMIDE, FLUTAMIDE FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FUROSEMIDE, FUROSEMIDE GABAPENTIN, GABAPENTIN GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GLIMEPIRIDE, GLIMEPIRIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLIPIZIDE, GLIPIZIDE GLYBURIDE (MICRONIZED), GLYBURIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE INDAPAMIDE, INDAPAMIDE INDOMETHACIN, INDOMETHACIN KETOCONAZOLE, KETOCONAZOLE KETOPROFEN, KETOPROFEN KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LAMOTRIGINE, LAMOTRIGINE LATANOPROST, LATANOPROST LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LORATADINE, LORATADINE (OTC) LORAZEPAM, LORAZEPAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOVASTATIN, LOVASTATIN LOXAPINE SUCCINATE, LOXAPINE SUCCINATE MAPROTILINE HYDROCHLORIDE, MAPROTILINE HYDROCHLORIDE MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM MELOXICAM, MELOXICAM MENTAX, BUTENAFINE HYDROCHLORIDE MENTAX-TC, BUTENAFINE HYDROCHLORIDE MERCAPTOPURINE, MERCAPTOPURINE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHIMAZOLE, METHIMAZOLE METHOTREXATE SODIUM, METHOTREXATE SODIUM
METHYLDOPA AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
B - 92
APPENDIX B

** M **
* MYLAN PHARMACEUTICALS INC METHYLDOPA, METHYLDOPA METOLAZONE, METOLAZONE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIRTAZAPINE, MIRTAZAPINE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NADOLOL AND BENDROFLUMETHAZIDE, BENDROFLUMETHIAZIDE NADOLOL, NADOLOL NAPROXEN, NAPROXEN NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NIFEDIPINE, NIFEDIPINE NISOLDIPINE, NISOLDIPINE NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE OMEPRAZOLE, OMEPRAZOLE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE PACLITAXEL, PACLITAXEL PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL 3350 PENTOXIFYLLINE, PENTOXIFYLLINE PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE PHENYTEK, PHENYTOIN SODIUM PINDOLOL, PINDOLOL PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE PIROXICAM, PIROXICAM POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE PROBENECID, PROBENECID PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SPIRONOLACTONE, SPIRONOLACTONE STAVUDINE, STAVUDINE SULINDAC, SULINDAC SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TACROLIMUS, TACROLIMUS TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TEMAZEPAM, TEMAZEPAM TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE THIOTHIXENE, THIOTHIXENE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIMOLOL MALEATE, TIMOLOL MALEATE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOLAZAMIDE, TOLAZAMIDE TOLMETIN SODIUM, TOLMETIN SODIUM
TOPIRAMATE, TOPIRAMATE
B - 93
APPENDIX B

** M **
* MYLAN PHARMACEUTICALS INC TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRANDOLAPRIL, TRANDOLAPRIL TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE URSODIOL, URSODIOL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE WARFARIN SODIUM, WARFARIN SODIUM ZALEPLON, ZALEPLON ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
MYLAN BERTEK * MYLAN BERTEK PHARMACEUTICALS INC MAXZIDE, HYDROCHLOROTHIAZIDE
MAXZIDE-25, HYDROCHLOROTHIAZIDE
MYLAN INSTITUTIONAL * MYLAN INSTITUTIONAL LLC ALOPRIM, ALLOPURINOL SODIUM DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE DURACLON, CLONIDINE HYDROCHLORIDE ENLON-PLUS, ATROPINE SULFATE ETOMIDATE, ETOMIDATE ISOSULFAN BLUE, ISOSULFAN BLUE MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE MESNA, MESNA METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE TRANEXAMIC ACID, TRANEXAMIC ACID
ULTIVA, REMIFENTANIL HYDROCHLORIDE
MYLAN LABS * MYLAN LABORATORIES LTD CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL NEVIRAPINE, NEVIRAPINE
MYLAN LLC * MYLAN INSTITUTIONAL LLC CIDOFOVIR, CIDOFOVIR FOMEPIZOLE, FOMEPIZOLE SULFAMYLON, MAFENIDE ACETATE
MYLAN PHARMS INC * MYLAN PHARMACEUTICALS INC ABACAVIR SULFATE, ABACAVIR SULFATE ALPRAZOLAM, ALPRAZOLAM ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ARMODAFINIL, ARMODAFINIL ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM AVITA, TRETINOIN BACLOFEN, BACLOFEN CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE CICLOPIROX, CICLOPIROX CILOSTAZOL, CILOSTAZOL CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, BENZOYL PEROXIDE
B - 94
APPENDIX B

** M **
* MYLAN PHARMACEUTICALS INC CLONAZEPAM, CLONAZEPAM CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DESLORATADINE, DESLORATADINE DICLOFENAC SODIUM, DICLOFENAC SODIUM DIDANOSINE, DIDANOSINE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE EPROSARTAN MESYLATE, EPROSARTAN MESYLATE FENOFIBRATE (MICRONIZED), FENOFIBRATE FENOFIBRATE, FENOFIBRATE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE GABAPENTIN, GABAPENTIN HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IBANDRONATE SODIUM, IBANDRONATE SODIUM INDAPAMIDE, INDAPAMIDE IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN ITRACONAZOLE, ITRACONAZOLE LANSOPRAZOLE, LANSOPRAZOLE LEVETIRACETAM, LEVETIRACETAM LITHIUM CARBONATE, LITHIUM CARBONATE MALATHION, MALATHION MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHYCLOTHIAZIDE, METHYCLOTHIAZIDE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE MODAFINIL, MODAFINIL MONTELUKAST SODIUM, MONTELUKAST SODIUM MORPHINE SULFATE, MORPHINE SULFATE NABUMETONE, NABUMETONE NAPROXEN, NAPROXEN NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NEVIRAPINE, NEVIRAPINE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PHENYTOIN, PHENYTOIN PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM QUETIAPINE FUMARATE, QUETIAPINE FUMARATE QUININE SULFATE, QUININE SULFATE RAMIPRIL, RAMIPRIL RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SILDENAFIL CITRATE, SILDENAFIL CITRATE SIMVASTATIN, SIMVASTATIN TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOLBUTAMIDE, TOLBUTAMIDE TOLTERODINE TARTRATE, TOLTERODINE TARTRATE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRIAZOLAM, TRIAZOLAM VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE VORICONAZOLE, VORICONAZOLE ZIDOVUDINE, ZIDOVUDINE
B - 95
APPENDIX B

** M **
* MYLAN PHARMACEUTICALS INC. FLUVASTATIN SODIUM, FLUVASTATIN SODIUM NIZATIDINE, NIZATIDINE

OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
MYLAN SPECLT * MYLAN SPECIALTY LP ALBUTEROL SULFATE, ALBUTEROL SULFATE
PERFOROMIST, FORMOTEROL FUMARATE
MYLAN TECHNOLOGIES * MYLAN TECHNOLOGIES INC CLONIDINE, CLONIDINE ESTRADIOL, ESTRADIOL FENTANYL-100, FENTANYL FENTANYL-12, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL
NITROGLYCERIN, NITROGLYCERIN
NATCO PHARMA * NATCO PHARMA LTD GRANISETRON HYDROCHLORIDE,
NATCO PHARMA LTD * NATCO PHARMA LIMITED CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE * NATCO PHARMA LTD ANASTROZOLE, ANASTROZOLE CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE LANSOPRAZOLE, LANSOPRAZOLE LETROZOLE, LETROZOLE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE
NAUTILUS NEUROSCIENC * NAUTILUS NEUROSCIENCES INC CAMBIA, DICLOFENAC POTASSIUM NAVINTA LLC * NAVINTA LLC FAMOTIDINE, FAMOTIDINE FOMEPIZOLE, FOMEPIZOLE
NICARDIPINE HYDROCHLORIDE,
NEPHRON * NEPHRON CORP ALBUTEROL SULFATE, ALBUTEROL SULFATE

* NEPHRON PHARMACEUTICALS CORP ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE
ALBUTEROL SULFATE
NESHER PHARMS * NESHER PHARMACEUTICALS USA LLC DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE MICRO-K 10, POTASSIUM CHLORIDE MICRO-K, POTASSIUM CHLORIDE MORPHINE SULFATE, MORPHINE SULFATE OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE
NEUROGESX * NEUROGESX INC QUTENZA, CAPSAICIN
B - 96
APPENDIX B
** N **
NEW RIVER * NEW RIVER PHARMACEUTICALS INC PROFERDEX, IRON DEXTRAN NEXGEN PHARMA * NEXGEN PHARMA INC BUTALBITAL AND ACETAMINOPHEN, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN CHENODIOL, CHENODIOL GLYCOPYRROLATE, GLYCOPYRROLATE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) NEXGEN PHARMA INC * NEXGEN PHARMA INC BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 NEXTWAVE PHARMS * NEXTWAVE PHARMACEUTICALS INC QUILLIVANT XR, METHYLPHENIDATE HYDROCHLORIDE NEXUS PHARMS * NEXUS PHARMACEUTICALS INC CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM LEVOFLOXACIN, LEVOFLOXACIN NIAGARA PHARMS * NIAGARA PHARMACEUTICALS INC PUR-WASH, PURIFIED WATER
(OTC)
NORTHSTAR HLTHCARE * NORTHSTAR HEALTHCARE HOLDINGS LTD ALLOPURINOL, ALLOPURINOL ATENOLOL, ATENOLOL BACLOFEN, BACLOFEN GEMFIBROZIL, GEMFIBROZIL HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE NOSTRUM * NOSTRUM PHARMACEUTICALS INC CARBAMAZEPINE, CARBAMAZEPINE THEOPHYLLINE, THEOPHYLLINE NOSTRUM LABS * NOSTRUM LABORATORIES INC PIROXICAM, PIROXICAM SUCRALFATE, SUCRALFATE NOSTRUM PHARMS LLC * NOSTRUM PHARMACEUTICALS LLC METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NOVADEL * NOVADEL PHARMA INC NITROMIST, NITROGLYCERIN ZOLPIMIST, ZOLPIDEM TARTRATE NOVARTIS * NOVARTIS CONSUMER HEALTH INC EXCEDRIN (MIGRAINE), ACETAMINOPHEN (OTC) HABITROL, NICOTINE (OTC) LAMISIL AT, TERBINAFINE (OTC) LAMISIL AT, TERBINAFINE HYDROCHLORIDE (OTC) LAMISIL, TERBINAFINE HYDROCHLORIDE (OTC) NEXCEDE, KETOPROFEN (OTC) PREVACID 24 HR, LANSOPRAZOLE (OTC)
B - 97
APPENDIX B
** N **
(OTC)
* NOVARTIS CONSUMER HEALTH INC TAVIST ALLERGY/SINUS/HEADACHE, ACETAMINOPHEN THRIVE, NICOTINE POLACRILEX (OTC) TRANSDERM SCOP, SCOPOLAMINE VAGISTAT-1, TIOCONAZOLE (OTC)
VOLTAREN, DICLOFENAC SODIUM
* NOVARTIS PHARMACEUTICALS CORP AFINITOR, EVEROLIMUS AMTURNIDE, ALISKIREN HEMIFUMARATE ARCAPTA NEOHALER, INDACATEROL MALEATE CATAFLAM, DICLOFENAC POTASSIUM CLOZARIL, CLOZAPINE COARTEM, ARTEMETHER COMBIPATCH, ESTRADIOL DESFERAL, DEFEROXAMINE MESYLATE DIOVAN HCT, HYDROCHLOROTHIAZIDE DIOVAN, VALSARTAN ESTRADERM, ESTRADIOL EXELON, RIVASTIGMINE EXELON, RIVASTIGMINE TARTRATE EXFORGE HCT, AMLODIPINE BESYLATE EXFORGE, AMLODIPINE BESYLATE EXJADE, DEFERASIROX FAMVIR, FAMCICLOVIR FANAPT, ILOPERIDONE FOCALIN XR, DEXMETHYLPHENIDATE HYDROCHLORIDE FOCALIN, DEXMETHYLPHENIDATE HYDROCHLORIDE FORADIL, FORMOTEROL FUMARATE GILENYA, FINGOLIMOD GLEEVEC, IMATINIB MESYLATE HYDERGINE, ERGOLOID MESYLATES LAMISIL, TERBINAFINE HYDROCHLORIDE LAMPRENE, CLOFAZIMINE LESCOL XL, FLUVASTATIN SODIUM LESCOL, FLUVASTATIN SODIUM LOPRESSOR, METOPROLOL TARTRATE LOTREL, AMLODIPINE BESYLATE MIACALCIN, CALCITONIN SALMON MYFORTIC, MYCOPHENOLIC ACID NEORAL, CYCLOSPORINE OCUPRESS, CARTEOLOL HYDROCHLORIDE RECLAST, ZOLEDRONIC ACID REGITINE, PHENTOLAMINE MESYLATE RITALIN LA, METHYLPHENIDATE HYDROCHLORIDE RITALIN, METHYLPHENIDATE HYDROCHLORIDE RITALIN-SR, METHYLPHENIDATE HYDROCHLORIDE SANDIMMUNE, CYCLOSPORINE SANDOSTATIN LAR, OCTREOTIDE ACETATE SANDOSTATIN, OCTREOTIDE ACETATE SIGNIFOR, PASIREOTIDE DIASPARTATE STARLIX, NATEGLINIDE TASIGNA, NILOTINIB HYDROCHLORIDE MONOHYDRATE TAVIST-1, CLEMASTINE FUMARATE (OTC) TEGRETOL, CARBAMAZEPINE TEGRETOL-XR, CARBAMAZEPINE TEKAMLO, ALISKIREN HEMIFUMARATE TEKTURNA HCT, ALISKIREN HEMIFUMARATE TEKTURNA, ALISKIREN HEMIFUMARATE TRILEPTAL, OXCARBAZEPINE TYZEKA, TELBIVUDINE VALTURNA, ALISKIREN HEMIFUMARATE VASOCIDIN, PREDNISOLONE SODIUM PHOSPHATE VIVELLE, ESTRADIOL VIVELLE-DOT, ESTRADIOL
VOLTAREN, DICLOFENAC SODIUM
B - 98
APPENDIX B

** N **
* NOVARTIS PHARMACEUTICALS CORP VOLTAREN-XR, DICLOFENAC SODIUM ZOMETA, ZOLEDRONIC ACID

ZORTRESS, EVEROLIMUS
NOVARTIS PHARM * NOVARTIS PHARMACEUTICAL CORP AFINITOR DISPERZ, EVEROLIMUS NOVARTIS PHARMS * NOVARTIS PHARMACEUTICALS CORP FEMARA, LETROZOLE
TOBI, TOBRAMYCIN
NOVAST LABS LTD * NOVAST LABORATORIES LTD DASETTA 1/35, ETHINYL ESTRADIOL DASETTA 7/7/7, ETHINYL ESTRADIOL ELINEST, ETHINYL ESTRADIOL FALMINA, ETHINYL ESTRADIOL LEVONEST, ETHINYL ESTRADIOL MONO-LINYAH, ETHINYL ESTRADIOL PHILITH, ETHINYL ESTRADIOL TRI-LINYAH, ETHINYL ESTRADIOL
WERA, ETHINYL ESTRADIOL
NOVEL LABS INC * NOVEL LABORATORIES INC FAMOTIDINE, FAMOTIDINE HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, HOMATROPINE METHYLBROMIDE METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE MISOPROSTOL, MISOPROSTOL MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS MOVIPREP, ASCORBIC ACID PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL 3350 PHENELZINE SULFATE, PHENELZINE SULFATE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) SULFAMETHOPRIM, SULFAMETHOXAZOLE SULFAMETHOPRIM-DS, SULFAMETHOXAZOLE TEMAZEPAM, TEMAZEPAM TINIDAZOLE, TINIDAZOLE TRIMETHOPRIM, TRIMETHOPRIM NOVEN * NOVEN PHARMACEUTICALS INC FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL
MINIVELLE, ESTRADIOL
NOVEN PHARMS INC * NOVEN PHARMACEUTICALS INC DAYTRANA, METHYLPHENIDATE NOVEN THERAP * NOVEN THERAPEUTICS LLC LITHOBID, LITHIUM CARBONATE
PEXEVA, PAROXETINE MESYLATE
NOVEX * NOVEX PHARMA ALBUTEROL SULFATE, ALBUTEROL SULFATE BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE
CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE
B - 99
APPENDIX B

** N **
* NOVEX PHARMA CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOSPORINE, CYCLOSPORINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LACTULOSE, LACTULOSE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) OFLOXACIN, OFLOXACIN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
TOBRAMYCIN, TOBRAMYCIN
NOVO NORDISK * NOVO NORDISK PHARMACEUTICALS INC GLUCAGEN, GLUCAGON HYDROCHLORIDE RECOMBINANT NOVO NORDISK INC * NOVO NORDISK INC ACTIVELLA, ESTRADIOL LEVEMIR FLEXPEN, INSULIN DETEMIR RECOMBINANT LEVEMIR, INSULIN DETEMIR RECOMBINANT NORDITROPIN FLEXPRO, SOMATROPIN RECOMBINANT NORDITROPIN NORDIFLEX, SOMATROPIN RECOMBINANT NOVOLIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) NOVOLIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) NOVOLIN R, INSULIN RECOMBINANT HUMAN (OTC) NOVOLOG FLEXPEN, INSULIN ASPART RECOMBINANT NOVOLOG MIX 70/30 FLEXPEN, INSULIN ASPART PROTAMINE RECOMBINANT NOVOLOG MIX 70/30, INSULIN ASPART PROTAMINE RECOMBINANT NOVOLOG PENFILL, INSULIN ASPART RECOMBINANT NOVOLOG, INSULIN ASPART RECOMBINANT PRANDIMET, METFORMIN HYDROCHLORIDE PRANDIN, REPAGLINIDE VAGIFEM, ESTRADIOL
VICTOZA, LIRAGLUTIDE RECOMBINANT
NOVOCOL * NOVOCOL PHARMACEUTICAL INC ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN, LEVONORDEFRIN
ISOCAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE
NOVOCOL INC * NOVOCOL INC LIDOCAINE,
LIDOCAINE
NPS PHARMS INC * NPS PHARMACEUTICALS INC GATTEX KIT, TEDUGLUTIDE NU PHARM * NU PHARM INC DIVALPROEX SODIUM,
DIVALPROEX SODIUM
NUPATHE * NUPATHE INC ZECUITY, SUMATRIPTAN SUCCINATE NYCOMED US * NYCOMED US INC TERCONAZOLE,
TERCONAZOLE
OAK PHARMS * OAK PHARMACEUTICALS INC EMLA, LIDOCAINE NEMBUTAL SODIUM, PENTOBARBITAL SODIUM
XYLOCAINE, LIDOCAINE HYDROCHLORIDE
B - 100
APPENDIX B

** O **
OAK PHARMS AKORN * OAK PHARMACEUTICALS INC SUB AKORN INC COGENTIN, BENZTROPINE MESYLATE
DIURIL, CHLOROTHIAZIDE SODIUM
ODYSSEY PHARMS * ODYSSEY PHARMACEUTICALS INC ANTABUSE, DISULFIRAM NYSTATIN, NYSTATIN SURMONTIL, TRIMIPRAMINE MALEATE URECHOLINE, BETHANECHOL CHLORIDE
VIVACTIL, PROTRIPTYLINE HYDROCHLORIDE
OHM * OHM CORP IBUPROFEN,
IBUPROFEN
(OTC)
OHM LABS * OHM LABORATORIES INC ACETAMINOPHEN, ACETAMINOPHEN (OTC) IBUPROHM COLD AND SINUS, IBUPROFEN (OTC) IBUPROHM, IBUPROFEN (OTC)
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE OLTA PHARMS * OLTA PHARMACEUTICALS CORP LINDANE, LINDANE OMAN PHARM PRODUCTS * OMAN PHARMACEUTICAL PRODUCTS CO LLC NEOMYCIN SULFATE, NEOMYCIN SULFATE
(OTC)
ONCO THERAPIES LTD * ONCO THERAPIES LTD CARBOPLATIN, CARBOPLATIN CISPLATIN, CISPLATIN CLADRIBINE, CLADRIBINE CYTARABINE, CYTARABINE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FLUOROURACIL, FLUOROURACIL GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IFOSFAMIDE, IFOSFAMIDE METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE OXALIPLATIN, OXALIPLATIN PACLITAXEL, PACLITAXEL TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE
VINORELBINE, VINORELBINE
ONY * ONY INC INFASURF PRESERVATIVE FREE, ONYX PHARMS * ONYX PHARMACEUTICALS INC KYPROLIS, CARFILZOMIB OPTIMER PHARMS * OPTIMER PHARMACEUTICALS INC DIFICID, FIDAXOMICIN ORAPHARMA * ORAPHARMA INC ARESTIN, MINOCYCLINE HYDROCHLORIDE ORCHID HLTHCARE * ORCHID HEALTHCARE AMLODIPINE BESYLATE,
CALFACTANT
AMLODIPINE BESYLATE
B - 101
APPENDIX B

** O **
* ORCHID HEALTHCARE CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFDINIR, CEFDINIR CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) DESLORATADINE, DESLORATADINE DIVALPROEX SODIUM, DIVALPROEX SODIUM GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IBANDRONATE SODIUM, IBANDRONATE SODIUM LEVETIRACETAM, LEVETIRACETAM MODAFINIL, MODAFINIL NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE OLANZAPINE, OLANZAPINE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
* ORCHID HEALTHCARE DIV ORCHID CHEMICALS AND PHARMACEUTICALS LTD LEVOFLOXACIN, LEVOFLOXACIN
ZALEPLON, ZALEPLON
ORGANON SUB MERCK * ORGANON USA INC SUB MERCK AND CO INC SAPHRIS, ASENAPINE MALEATE ORGANON USA INC * ORGANON USA INC CYCLESSA, DESOGESTREL DESOGEN, DESOGESTREL FOLLISTIM AQ, FOLLITROPIN ALFA/BETA GANIRELIX ACETATE INJECTION, GANIRELIX ACETATE IMPLANON, ETONOGESTREL NEXPLANON, ETONOGESTREL NUVARING, ETHINYL ESTRADIOL PREGNYL, GONADOTROPIN, CHORIONIC REMERON SOLTAB, MIRTAZAPINE
REMERON, MIRTAZAPINE
ORION PHARMA * ORION PHARMA COMTAN, ENTACAPONE STALEVO 100, CARBIDOPA STALEVO 125, CARBIDOPA STALEVO 150, CARBIDOPA STALEVO 200, CARBIDOPA STALEVO 50, CARBIDOPA
STALEVO 75, CARBIDOPA
ORIT LABS LLC * ORIT LABORATORIES LLC BENZONATATE, BENZONATATE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE
ERGOCALCIFEROL, ERGOCALCIFEROL
ORPHAN EUROPE * ORPHAN EUROPE CARBAGLU, CARGLUMIC ACID ORTHO MCNEIL JANSSEN * ORTHO MCNEIL JANSSEN PHARMACEUTICALS INC NIZORAL, KETOCONAZOLE OSI PHARMS * OSI PHARMACEUTICALS INC TARCEVA, ERLOTINIB HYDROCHLORIDE
B - 102
APPENDIX B

** O **
OSMOTICA PHARM * OSMOTICA PHARMACEUTICAL CORP NIFEDIPINE, NIFEDIPINE OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
OTSUKA * OTSUKA PHARMACEUTICAL CO LTD ABILIFY, ARIPIPRAZOLE
PLETAL, CILOSTAZOL
* OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC ABILIFY, ARIPIPRAZOLE OTSUKA AMERICA * OTSUKA AMERICA PHARMACEUTICALS INC BREATHTEK UBT FOR H-PYLORI, UREA C-13 OTSUKA AMERICA PHARM * OTSUKA AMERICA PHARMACEUTICAL INC SAMSCA, TOLVAPTAN OTSUKA PHARM * OTSUKA PHARMACEUTICAL CO LTD BUSULFEX, BUSULFAN OUTLOOK PHARMS * OUTLOOK PHARMACEUTICALS INC DEXTROAMPHETAMINE SULFATE, PACIFIC PHARMA * PACIFIC PHARMA TIMOLOL MALEATE, * PACIFIC PHARMA INC TIMOLOL MALEATE,
TIMOLOL MALEATE TIMOLOL MALEATE
PACIRA PHARMS INC * PACIRA PHARMACEUTICALS INC DEPOCYT, CYTARABINE

EXPAREL, BUPIVACAINE
PACK PHARMS LLC * PACK PHARMACEUTICALS LLC CROMOLYN SODIUM, CROMOLYN SODIUM PADDOCK * PADDOCK LABORATORIES INC BENZPHETAMINE HYDROCHLORIDE,
PADDOCK LABS * PADDOCK LABORATORIES INC CLINDAMYCIN PALMITATE HYDROCHLORIDE,
PADDOCK LLC * PADDOCK LABORATORIES LLC BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE CAFFEINE CITRATE, CAFFEINE CITRATE CALCIUM ACETATE, CALCIUM ACETATE CICLOPIROX, CICLOPIROX CLINDA-DERM, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM COLOCORT, HYDROCORTISONE COMPRO, PROCHLORPERAZINE DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE ERYTHRA-DERM, ERYTHROMYCIN FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE INDOMETHACIN, INDOMETHACIN KIONEX, SODIUM POLYSTYRENE SULFONATE LAX-LYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350
LORAZEPAM, LORAZEPAM
B - 103
APPENDIX B

** P **
* PADDOCK LABORATORIES LLC MIDAMOR, AMILORIDE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NYSTOP, NYSTATIN PODOFILOX, PODOFILOX POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE
PALADIN LABS * PALADIN LABS USA INC ANTIZOL, FOMEPIZOLE PANACEA BIOTEC LTD * PANACEA BIOTEC LTD TACROLIMUS, TACROLIMUS PAR FORM * PAR FORMULATIONS PRIVATE LTD LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE PAR PHARM * PAR PHARMACEUTICAL NABUMETONE, NABUMETONE OMEPRAZOLE AND SODIUM BICARBONATE, OMEPRAZOLE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
* PAR PHARMACEUTICAL INC ALPRAZOLAM, ALPRAZOLAM AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE CABERGOLINE, CABERGOLINE CALCITONIN-SALMON, CALCITONIN SALMON CAPOTEN, CAPTOPRIL CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE CHOLESTYRAMINE, CHOLESTYRAMINE CLOMIPHENE CITRATE, CLOMIPHENE CITRATE CLONAZEPAM, CLONAZEPAM CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE DEXAMETHASONE, DEXAMETHASONE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE DOXYCYCLINE, DOXYCYCLINE ESTAZOLAM, ESTAZOLAM FENTANYL CITRATE, FENTANYL CITRATE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUTAMIDE, FLUTAMIDE GLYCOPYRROLATE, GLYCOPYRROLATE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDRA-ZIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYUREA, HYDROXYUREA IBUPROFEN, IBUPROFEN (OTC) IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE
MEGACE ES, MEGESTROL ACETATE
B - 104
APPENDIX B

** P **
* PAR PHARMACEUTICAL INC MEGESTROL ACETATE, MEGESTROL ACETATE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METRONIDAZOLE, METRONIDAZOLE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MINOXIDIL, MINOXIDIL NASCOBAL, CYANOCOBALAMIN NATEGLINIDE, NATEGLINIDE NIFEDIPINE, NIFEDIPINE OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE OLANZAPINE, OLANZAPINE OXANDROLONE, OXANDROLONE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TORSEMIDE, TORSEMIDE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRANYLCYPROMINE SULFATE, TRANYLCYPROMINE SULFATE
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
PAR PHARM INC * PAR PHARMACEUTICAL INC FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE
MORPHINE SULFATE, MORPHINE SULFATE
PARAPRO LLC * PARAPRO LLC NATROBA, SPINOSAD PARKE DAVIS * PARKE DAVIS DIV WARNER LAMBERT CO CELONTIN, METHSUXIMIDE DILANTIN, PHENYTOIN SODIUM DILANTIN-125, PHENYTOIN NARDIL, PHENELZINE SULFATE NEURONTIN, GABAPENTIN
ZARONTIN, ETHOSUXIMIDE
* PARKE DAVIS PHARMACEUTICAL RESEARCH DIV WARNER LAMBERT CO ZARONTIN, ETHOSUXIMIDE PEDIATRX * PEDIATRX INC GRANISETRON HYDROCHLORIDE,
PEDINOL * PEDINOL PHARMACAL INC GRIS-PEG, GRISEOFULVIN, ULTRAMICROSIZE PERNIX THERAP * PERNIX THERAPEUTICS LLC CEDAX, CEFTIBUTEN DIHYDRATE PERRIGO * L PERRIGO CO ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) CHILDREN'S IBUPROFEN, IBUPROFEN (OTC) CROMOLYN SODIUM, CROMOLYN SODIUM (OTC) DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE (OTC) FAMOTIDINE, FAMOTIDINE (OTC) IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN (OTC) LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC)
(OTC)
B - 105
APPENDIX B

** P **
* L PERRIGO CO LORATADINE, LORATADINE (OTC) MICONAZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) TAB-PROFEN, IBUPROFEN (OTC)
TIOCONAZOLE, TIOCONAZOLE (OTC)
* PERRIGO CO BETAMETHASONE VALERATE, BETAMETHASONE VALERATE CICLOPIROX, CICLOPIROX CIMETIDINE, CIMETIDINE (OTC) CLEMASTINE FUMARATE, CLEMASTINE FUMARATE (OTC) CLINDETS, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE ERYTHROMYCIN, ERYTHROMYCIN FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE IBUPROFEN, IBUPROFEN (OTC) JUNIOR STRENGTH IBUPROFEN, IBUPROFEN (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) MICONAZOLE NITRATE COMBINATION PACK, MICONAZOLE NITRATE (OTC) MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) MOMETASONE FUROATE, MOMETASONE FUROATE NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) STIE-CORT, HYDROCORTISONE PERRIGO CO TENNESSEE * PERRIGO CO TENNESSEE INC GRISEOFULVIN, GRISEOFULVIN, MICROSIZE
SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM
PERRIGO ISRAEL * PERRIGO ISRAEL PHARMACEUTICALS LTD BUTOCONAZOLE NITRATE, BUTOCONAZOLE NITRATE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, BENZOYL PEROXIDE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE IMIQUIMOD, IMIQUIMOD KETOCONAZOLE, KETOCONAZOLE MESALAMINE, MESALAMINE MINOXIDIL, MINOXIDIL (OTC)
TESTOSTERONE, TESTOSTERONE
PERRIGO NEW YORK * PERRIGO NEW YORK INC ACETAMINOPHEN, ACETAMINOPHEN (OTC) AMMONIUM LACTATE, AMMONIUM LACTATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CENTANY, MUPIROCIN CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE DESONIDE, DESONIDE DESOXIMETASONE, DESOXIMETASONE ECONAZOLE NITRATE, ECONAZOLE NITRATE ERYTHROMYCIN, ERYTHROMYCIN FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE GENTAMICIN SULFATE, GENTAMICIN SULFATE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE HYDROCORTISONE, HYDROCORTISONE KETOCONAZOLE, KETOCONAZOLE
MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC)
B - 106
APPENDIX B

** P **
* PERRIGO NEW YORK INC MOMETASONE FUROATE, MOMETASONE FUROATE MUPIROCIN, MUPIROCIN NYSTATIN, NYSTATIN PERMETHRIN, PERMETHRIN PERMETHRIN, PERMETHRIN (OTC) PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE SELENIUM SULFIDE, SELENIUM SULFIDE TERCONAZOLE, TERCONAZOLE
PERRIGO R AND D * PERRIGO R AND D CO CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE, CALCIUM CARBONATE (OTC) CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) DESLORATADINE, DESLORATADINE GUAIFENESIN, GUAIFENESIN (OTC) IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE (OTC) IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) LANSOPRAZOLE, LANSOPRAZOLE (OTC) LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) NAPROXEN, NAPROXEN NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC)
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC)
PERRIGO UK FINCO * PERRIGO UK FINCO LTD PARTNERSHIP CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE PETNET * PETNET SOLUTIONS INC FLUDEOXYGLUCOSE F18, PF PRISM * PF PRISM CV LYRICA, PREGABALIN PFIZER * PFIZER CENTRAL RESEARCH DIFLUCAN, FLUCONAZOLE
ZITHROMAX, AZITHROMYCIN
* PFIZER CHEMICALS DIV PFIZER INC DIFLUCAN, FLUCONAZOLE
* PFIZER INC ACOVA, ARGATROBAN ADVIL ALLERGY AND CONGESTION RELIEF, CHLORPHENIRAMINE MALEATE ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC) ADVIL COLD AND SINUS, IBUPROFEN (OTC) ADVIL CONGESTION RELIEF, IBUPROFEN (OTC) ADVIL LIQUI-GELS, IBUPROFEN (OTC) ADVIL MIGRAINE LIQUI-GELS, IBUPROFEN (OTC) ADVIL PM, DIPHENHYDRAMINE CITRATE (OTC) ADVIL PM, DIPHENHYDRAMINE HYDROCHLORIDE (OTC) ADVIL, IBUPROFEN (OTC) ALAVERT, LORATADINE (OTC) ANTIVERT, MECLIZINE HYDROCHLORIDE AXID AR, NIZATIDINE (OTC)
CADUET, AMLODIPINE BESYLATE
(OTC)
B - 107
APPENDIX B
** P **
* PFIZER INC CALAN SR, VERAPAMIL HYDROCHLORIDE CARDURA XL, DOXAZOSIN MESYLATE CHILDREN'S ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC) CHILDREN'S ADVIL COLD, IBUPROFEN (OTC) CHILDREN'S ADVIL, IBUPROFEN (OTC) CHILDREN'S ADVIL-FLAVORED, IBUPROFEN (OTC) DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE DIFLUCAN IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE DOXYCYCLINE, DOXYCYCLINE HYCLATE ELELYSO, TALIGLUCERASE ALFA FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLUMAZENIL, FLUMAZENIL FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GEODON, ZIPRASIDONE HYDROCHLORIDE GEODON, ZIPRASIDONE MESYLATE GLUCOTROL XL, GLIPIZIDE GLUCOTROL, GLIPIZIDE HALOPERIDOL, HALOPERIDOL LACTATE HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM INLYTA, AXITINIB JUNIOR STRENGTH ADVIL, IBUPROFEN (OTC) KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LIPITOR, ATORVASTATIN CALCIUM LORATADINE, LORATADINE (OTC) NAVANE, THIOTHIXENE NORVASC, AMLODIPINE BESYLATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PEDIATRIC ADVIL, IBUPROFEN (OTC) PROCARDIA, NIFEDIPINE REVATIO, SILDENAFIL CITRATE RIFAMPIN, RIFAMPIN TESSALON, BENZONATATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE TOVIAZ, FESOTERODINE FUMARATE UNASYN, AMPICILLIN SODIUM VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VECURONIUM BROMIDE, VECURONIUM BROMIDE VFEND, VORICONAZOLE XALKORI, CRIZOTINIB XELJANZ, TOFACITINIB CITRATE
* PFIZER LABORATORIES DIV PFIZER INC CARDURA, DOXAZOSIN MESYLATE DIABINESE, CHLORPROPAMIDE FELDENE, PIROXICAM MINIPRESS, PRAZOSIN HYDROCHLORIDE PERMAPEN, PENICILLIN G BENZATHINE PFIZERPEN, PENICILLIN G POTASSIUM PROCARDIA XL, NIFEDIPINE TERRAMYCIN W/ POLYMYXIN B SULFATE, OXYTETRACYCLINE HYDROCHLORIDE UNASYN, AMPICILLIN SODIUM VIBRAMYCIN, DOXYCYCLINE VIBRAMYCIN, DOXYCYCLINE CALCIUM VIBRAMYCIN, DOXYCYCLINE HYCLATE
VISTARIL, HYDROXYZINE PAMOATE
B - 108
APPENDIX B

** P **
* PFIZER PHARMACEUTICALS INC ZOLOFT, SERTRALINE HYDROCHLORIDE * PFIZER PHARMACEUTICALS PRODUCTION CORP LTD TIKOSYN, DOFETILIDE PFIZER CONS HLTHCARE * PFIZER CONSUMER HEALTHCARE ADVIL, IBUPROFEN SODIUM
(OTC)
PFIZER GLOBAL * PFIZER GLOBAL RESEARCH DEVELOPMENT ZMAX, AZITHROMYCIN PFIZER INC * PFIZER INC CAMPTOSAR, IRINOTECAN HYDROCHLORIDE CHANTIX, VARENICLINE TARTRATE ELLENCE, EPIRUBICIN HYDROCHLORIDE GEODON, ZIPRASIDONE HYDROCHLORIDE
NICOTROL, NICOTINE
PFIZER IRELAND * PFIZER IRELAND PHARMACEUTICALS RELPAX, ELETRIPTAN HYDROBROMIDE
VIAGRA, SILDENAFIL CITRATE
PFIZER PHARMS * PFIZER PHARMACEUTICALS LTD ACCUPRIL, QUINAPRIL HYDROCHLORIDE ACCURETIC, HYDROCHLOROTHIAZIDE DILANTIN, PHENYTOIN LOPID, GEMFIBROZIL NEURONTIN, GABAPENTIN
NITROSTAT, NITROGLYCERIN
PHARM ASSOC * PHARMACEUTICAL ASSOC INC DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN LORAZEPAM, LORAZEPAM NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE
PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE
* PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE ETHOSUXIMIDE, ETHOSUXIMIDE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL LACTATE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN LACTULOSE, LACTULOSE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE PREDNISOLONE, PREDNISOLONE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE
* PHARMACEUTICAL ASSOCIATES INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN PHARMA SERVE NY * PHARMA SERVE INC SUB TORIGIAN LABORATORIES AMINOPHYLLINE, AMINOPHYLLINE PHARMACHEMIE * PHARMACHEMIE BV CARBOPLATIN, CARBOPLATIN
CISPLATIN, CISPLATIN
B - 109
APPENDIX B
* PHARMACHEMIE BV DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, ETOPOSIDE

** P **
PHARMACHEMIE BV * PHARMACHEMIE BV BLEOMYCIN SULFATE, BLEOMYCIN SULFATE CARBOPLATIN, CARBOPLATIN METHOTREXATE PRESERVATIVE FREE, METHOTREXATE SODIUM
METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM
PHARMACIA AND UPJOHN * PHARMACIA AND UPJOHN XANAX XR, ALPRAZOLAM * PHARMACIA AND UPJOHN CO ANSAID, FLURBIPROFEN AROMASIN, EXEMESTANE AZULFIDINE EN-TABS, SULFASALAZINE AZULFIDINE, SULFASALAZINE BACITRACIN, BACITRACIN CAVERJECT IMPULSE, ALPROSTADIL CAVERJECT, ALPROSTADIL CLEOCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLEOCIN T, CLINDAMYCIN PHOSPHATE CLEOCIN, CLINDAMYCIN PALMITATE HYDROCHLORIDE CLEOCIN, CLINDAMYCIN PHOSPHATE COLESTID, COLESTIPOL HYDROCHLORIDE CORTEF, HYDROCORTISONE CORVERT, IBUTILIDE FUMARATE CYKLOKAPRON, TRANEXAMIC ACID DEPO-ESTRADIOL, ESTRADIOL CYPIONATE DEPO-MEDROL, METHYLPREDNISOLONE ACETATE DEPO-PROVERA, MEDROXYPROGESTERONE ACETATE DEPO-TESTOSTERONE, TESTOSTERONE CYPIONATE DETROL LA, TOLTERODINE TARTRATE DETROL, TOLTERODINE TARTRATE DIDREX, BENZPHETAMINE HYDROCHLORIDE EMCYT, ESTRAMUSTINE PHOSPHATE SODIUM ESTRING, ESTRADIOL FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE GENOTROPIN PRESERVATIVE FREE, SOMATROPIN RECOMBINANT GENOTROPIN, SOMATROPIN RECOMBINANT GLYNASE, GLYBURIDE GLYSET, MIGLITOL HALCION, TRIAZOLAM HEMABATE, CARBOPROST TROMETHAMINE IDAMYCIN PFS, IDARUBICIN HYDROCHLORIDE LINCOCIN, LINCOMYCIN HYDROCHLORIDE MEDROL, METHYLPREDNISOLONE MYCOBUTIN, RIFABUTIN NICOTROL, NICOTINE OGEN .625, ESTROPIPATE OGEN 1.25, ESTROPIPATE OGEN 2.5, ESTROPIPATE OGEN 5, ESTROPIPATE PREPIDIL, DINOPROSTONE PROSTIN E2, DINOPROSTONE PROSTIN VR PEDIATRIC, ALPROSTADIL PROVERA, MEDROXYPROGESTERONE ACETATE R-GENE 10, ARGININE HYDROCHLORIDE SOLU-CORTEF, HYDROCORTISONE SODIUM SUCCINATE SOLU-MEDROL, METHYLPREDNISOLONE SODIUM SUCCINATE SOMAVERT, PEGVISOMANT
XALATAN, LATANOPROST
B - 110
APPENDIX B

** P **
* PHARMACIA AND UPJOHN CO XANAX, ALPRAZOLAM ZINECARD, DEXRAZOXANE HYDROCHLORIDE

ZYVOX, LINEZOLID
* PHARMACIA AND UPJOHN SUB PFIZER INC DEPO-SUBQ PROVERA 104, MEDROXYPROGESTERONE ACETATE PHARMAFORCE * PHARMAFORCE INC BROMFENAC SODIUM, BROMFENAC SODIUM CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE NANDROLONE DECANOATE, NANDROLONE DECANOATE
NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE
PHARMALUCENCE * PHARMALUCENCE INC AN-DTPA, TECHNETIUM TC-99M PENTETATE KIT AN-SULFUR COLLOID, TECHNETIUM TC-99M SULFUR COLLOID KIT CIS-MDP, TECHNETIUM TC-99M MEDRONATE KIT CIS-PYRO, TECHNETIUM TC-99M PYROPHOSPHATE KIT HEPATOLITE, TECHNETIUM TC-99M DISOFENIN KIT PULMOLITE, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT
TECHNETIUM TC-99M MEBROFENIN, TECHNETIUM TC-99M MEBROFENIN KIT
PHARMAX * PHARMAX GROUP INC BETHANECHOL CHLORIDE, PHARMAXIS LTD * PHARMAXIS LTD ARIDOL KIT, PHOTOCURE ASA * PHOTOCURE ASA CYSVIEW KIT,
MANNITOL
HEXAMINOLEVULINATE HYDROCHLORIDE
PIERRE FABRE * PIERRE FABRE MEDICAMENT NAVELBINE, VINORELBINE TARTRATE PIERREL * PIERREL S.P.A. ARTICAINE HYDROCHLORIDE WITH EPINEPHRINE, PINNACLE BIOLGS * PINNACLE BIOLOGICS INC PHOTOFRIN, PORFIMER SODIUM PIRAMAL CRITICAL * PIRAMAL CRITICAL CARE INC ENFLURANE, ENFLURANE ISOFLURANE, ISOFLURANE
SOJOURN, SEVOFLURANE
PLD ACQUISITIONS * PLD ACQUISITIONS LLC IBUPROFEN, IBUPROFEN
ARTICAINE HYDROCHLORIDE
(OTC)
PLIVA * PLIVA INC AZITHROMYCIN, AZITHROMYCIN BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CARBOPLATIN, CARBOPLATIN CHLORPROPAMIDE, CHLORPROPAMIDE CHLORTHALIDONE, CHLORTHALIDONE CIMETIDINE, CIMETIDINE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE
B - 111
APPENDIX B

** P **
* PLIVA INC HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE KETOCONAZOLE, KETOCONAZOLE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE METRONIDAZOLE, METRONIDAZOLE NAPROXEN, NAPROXEN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE PENTOXIFYLLINE, PENTOXIFYLLINE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE THEOPHYLLINE, THEOPHYLLINE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
WARFARIN SODIUM, WARFARIN SODIUM
PLIVA HRVATSKA DOO * PLIVA HRVATSKA DOO ADAPALENE, ADAPALENE CARVEDILOL, CARVEDILOL CILOSTAZOL, CILOSTAZOL DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
PLIVA LACHEMA * PLIVA LACHEMA AS CARBOPLATIN, CARBOPLATIN IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE
PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM
PLIVA PHARM IND * PLIVA PHARMACEUTICAL INDUSTRY INC TORSEMIDE, TORSEMIDE PLX PHARMA * PLX PHARMA INC ASPIRIN, ASPIRIN
(OTC)
POHL BOSKAMP * POHL BOSKAMP NITROLINGUAL PUMPSPRAY,
NITROGLYCERIN
POLYMEDICA * POLYMEDICA INDUSTRIES INC ANESTACON, LIDOCAINE HYDROCHLORIDE

NEOPAP, ACETAMINOPHEN (OTC)
PRASCO * PRASCO LLC DBA PRASCO LABORATORIES ECONAZOLE NITRATE, ECONAZOLE NITRATE PRECISION DERMAT * PRECISION DERMATOLOGY INC LOCOID LIPOCREAM, HYDROCORTISONE BUTYRATE LOCOID, HYDROCORTISONE BUTYRATE MINOCIN, MINOCYCLINE HYDROCHLORIDE PODOFILOX, PODOFILOX
TRETINOIN, TRETINOIN
PRECISION DOSE * PRECISION DOSE INC RISPERIDONE, RISPERIDONE PRINSTON INC * PRINSTON PHARMACEUTICAL INC BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE CAPTOPRIL, CAPTOPRIL
DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
B - 112
APPENDIX B

** P **
* PRINSTON PHARMACEUTICAL INC IRBESARTAN, IRBESARTAN LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOSARTAN POTASSIUM, LOSARTAN POTASSIUM NEVIRAPINE, NEVIRAPINE RISPERIDONE, RISPERIDONE
ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
PROCTER AND GAMBLE * PROCTER AND GAMBLE PHARMACEUTICALS INC SUB PROCTER AND GAMBLE CO DIDRONEL, ETIDRONATE DISODIUM PROF DSPLS * PROFESSIONAL DISPOSABLES INC CHLORASCRUB MAXI SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORASCRUB SWAB, CHLORHEXIDINE GLUCONATE (OTC)
CHLORASCRUB SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC)
PROMETHEUS LABS * PROMETHEUS LABORATORIES INC HELIDAC, BISMUTH SUBSALICYLATE IMURAN, AZATHIOPRINE LOTRONEX, ALOSETRON HYDROCHLORIDE MERCAPTOPURINE, MERCAPTOPURINE RIDAURA, AURANOFIN
ZYLOPRIM, ALLOPURINOL
PROMIUS PHARMA * PROMIUS PHARMA LLC SECTRAL, ACEBUTOLOL HYDROCHLORIDE
TENEX, GUANFACINE HYDROCHLORIDE
PROMIUS PHARMA LLC * PROMIUS PHARMA LLC CLODERM, CLOCORTOLONE PIVALATE PROSAM LABS * PROSAM LABS LLC BACLOFEN, BACLOFEN BENZTROPINE MESYLATE, BENZTROPINE MESYLATE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE CARISOPRODOL AND ASPIRIN, ASPIRIN CARISOPRODOL, CARISOPRODOL CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE ETODOLAC, ETODOLAC IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE NABUMETONE, NABUMETONE PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE RIMACTANE, RIFAMPIN RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN
PROSTRAKAN INC * PROSTRAKAN INC ABSTRAL, FENTANYL CITRATE
SANCUSO, GRANISETRON
PROVIDENT PHARM * PROVIDENT PHARMACEUTICAL INC METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE PULSION MEDCL * PULSION MEDICAL SYSTEMS AG INDOCYANINE GREEN, INDOCYANINE GREEN
B - 113
APPENDIX B

** P **
PURACAP PHARM * PURACAP PHARMACEUTICAL LLC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

PURDUE GMP * PURDUE GMP CENTER LLC DBA THE CHAO CENTER INDUSTRIAL PHARMACY SEROMYCIN, CYCLOSERINE PURDUE PHARM PRODS * PURDUE PHARMACEUTICAL PRODUCTS LP DILAUDID, HYDROMORPHONE HYDROCHLORIDE
DILAUDID-HP, HYDROMORPHONE HYDROCHLORIDE
PURDUE PHARMA * PURDUE PHARMA PRODUCTS LP INTERMEZZO, ZOLPIDEM TARTRATE PURDUE PHARMA LP * PURDUE PHARMA LP BUTRANS, BUPRENORPHINE MS CONTIN, MORPHINE SULFATE
OXYCONTIN, OXYCODONE HYDROCHLORIDE
PUREPAC PHARM * PUREPAC PHARMACEUTICAL CO DIPYRIDAMOLE, DIPYRIDAMOLE QOL MEDCL * QOL MEDICAL LLC ELLIOTTS B SOLUTION, CALCIUM CHLORIDE ETHAMOLIN, ETHANOLAMINE OLEATE
SUCRAID, SACROSIDASE
QUESTCOR PHARMS * QUESTCOR PHARMACEUTICALS INC DORAL, QUAZEPAM H.P. ACTHAR GEL, CORTICOTROPIN RANBAXY * RANBAXY INC GLYCOPYRROLATE, GLYCOPYRROLATE * RANBAXY LABORATORIES INC EURAX, CROTAMITON EXELDERM, SULCONAZOLE NITRATE FAMOTIDINE, FAMOTIDINE (OTC) HALOG, HALCINONIDE KENALOG, TRIAMCINOLONE ACETONIDE LAC-HYDRIN, AMMONIUM LACTATE RISPERIDONE, RISPERIDONE ULTRAVATE, HALOBETASOL PROPIONATE
WESTCORT, HYDROCORTISONE VALERATE
* RANBAXY LABORATORIES LTD ACYCLOVIR, ACYCLOVIR AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CLARITHROMYCIN, CLARITHROMYCIN CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE
CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM
B - 114
APPENDIX B

** R **
* RANBAXY LABORATORIES LTD CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXYCYCLINE, DOXYCYCLINE FENOFIBRATE, FENOFIBRATE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM GABAPENTIN, GABAPENTIN LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE REDIDOSE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) LORAZEPAM, LORAZEPAM MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE ONDANSETRON, ONDANSETRON OXCARBAZEPINE, OXCARBAZEPINE PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN SOTRET, ISOTRETINOIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TOPIRAMATE, TOPIRAMATE VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
* RANBAXY PHARMACEUTICALS INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN AVENTYL HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE (OTC) PENTAZOCINE AND NALOXONE HYDROCHLORIDES, NALOXONE HYDROCHLORIDE RIOMET, METFORMIN HYDROCHLORIDE
SOTRET, ISOTRETINOIN
RANBAXY LABS LTD * RANBAXY LABORATORIES LIMITED NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) * RANBAXY LABORATORIES LTD ACETAMINOPHEN, ACETAMINOPHEN (OTC) ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM MORPHINE SULFATE, MORPHINE SULFATE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
XIMINO, MINOCYCLINE HYDROCHLORIDE
RARE DIS * RARE DISEASE THERAPEUTICS INC ORFADIN, NITISINONE RARE DIS THERAP * RARE DISEASE THERAPEUTICS INC CYSTADANE, BETAINE HYDROCHLORIDE RECIP * RECIP AB THYROSAFE,
POTASSIUM IODIDE
(OTC)
RECKITT BENCKISER * RECKITT BENCKISER LLC DELSYM, DEXTROMETHORPHAN POLISTIREX
(OTC)
B - 115
APPENDIX B
** R **
* RECKITT BENCKISER LLC MUCINEX D, GUAIFENESIN (OTC) MUCINEX DM, DEXTROMETHORPHAN HYDROBROMIDE MUCINEX, GUAIFENESIN (OTC)
* RECKITT BENCKISER PHARMACEUTICALS INC BUPRENEX, BUPRENORPHINE HYDROCHLORIDE
SUBOXONE, BUPRENORPHINE HYDROCHLORIDE
REDDYS * DOCTOR REDDYS LABORATORIES LTD DESLORATADINE, DESLORATADINE DIVALPROEX SODIUM, DIVALPROEX SODIUM
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE
REMPEX PHARMS INC * REMPEX PHARMACEUTICALS INC MINOCIN, MINOCYCLINE HYDROCHLORIDE RENAISSANCE PHARMA * RENAISSANCE PHARMA US HOLDINGS INC ELIMITE, PERMETHRIN
(OTC)
RHODES PHARMS * RHODES PHARMACEUTICALS LP MORPHINE SULFATE, MORPHINE SULFATE

RHODIA * RHODIA LTD ISOFLURANE,
ISOFLURANE
RITEDOSE CORP * THE RITEDOSE CORP ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE
ROCHE * HOFFMANN LA ROCHE INC BONIVA, IBANDRONATE SODIUM COPEGUS, RIBAVIRIN FUZEON, ENFUVIRTIDE INVIRASE, SAQUINAVIR MESYLATE KLONOPIN, CLONAZEPAM TAMIFLU, OSELTAMIVIR PHOSPHATE
VALIUM, DIAZEPAM
ALBUTEROL SULFATE
ROCHE PALO * ROCHE PALO ALTO LLC AEROBID, FLUNISOLIDE CELLCEPT, MYCOPHENOLATE MOFETIL CELLCEPT, MYCOPHENOLATE MOFETIL HYDROCHLORIDE CYTOVENE, GANCICLOVIR SODIUM EC-NAPROSYN, NAPROXEN
NAPROSYN, NAPROXEN
ROCKWELL MEDCL * ROCKWELL MEDICAL TECHNOLOGIES INC CALCITRIOL, CALCITRIOL ROMARK * ROMARK LABORATORIES ALINIA, NITAZOXANIDE ROSEDALE THERAPEUTIC * ROSEDALE THERAPEUTICS ERGOMAR, ERGOTAMINE TARTRATE ROUSES POINT PHARMS * ROUSES POINT PHARMACEUTICALS LLC LEVETIRACETAM, LEVETIRACETAM
B - 116
APPENDIX B

** R **
ROXANE * ROXANE LABORATORIES INC ACARBOSE, ACARBOSE ALPRAZOLAM, ALPRAZOLAM AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ANASTROZOLE, ANASTROZOLE AZATHIOPRINE, AZATHIOPRINE BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM BICALUTAMIDE, BICALUTAMIDE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CALCITRIOL, CALCITRIOL CALCIUM ACETATE, CALCIUM ACETATE CILOSTAZOL, CILOSTAZOL CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLARITHROMYCIN, CLARITHROMYCIN CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE CLOTRIMAZOLE, CLOTRIMAZOLE CODEINE SULFATE, CODEINE SULFATE CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE DEXAMETHASONE INTENSOL, DEXAMETHASONE DEXAMETHASONE, DEXAMETHASONE DIAZEPAM INTENSOL, DIAZEPAM DIAZEPAM, DIAZEPAM DIGOXIN, DIGOXIN DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXERCALCIFEROL, DOXERCALCIFEROL EXEMESTANE, EXEMESTANE FAMCICLOVIR, FAMCICLOVIR FLECAINIDE ACETATE, FLECAINIDE ACETATE FLUCONAZOLE, FLUCONAZOLE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FUROSEMIDE, FUROSEMIDE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN LACTULOSE, LACTULOSE LETROZOLE, LETROZOLE LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEVETIRACETAM, LEVETIRACETAM LEVORPHANOL TARTRATE, LEVORPHANOL TARTRATE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LIDOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE LITHIUM CARBONATE, LITHIUM CARBONATE LITHIUM CITRATE, LITHIUM CITRATE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) LORAZEPAM INTENSOL, LORAZEPAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEGESTROL ACETATE, MEGESTROL ACETATE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MERCAPTOPURINE, MERCAPTOPURINE METHADONE HYDROCHLORIDE INTENSOL, METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHOTREXATE SODIUM, METHOTREXATE SODIUM MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
MONTELUKAST SODIUM, MONTELUKAST SODIUM
B - 117
APPENDIX B

** R **
* ROXANE LABORATORIES INC MORPHINE SULFATE, MORPHINE SULFATE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NAPROXEN, NAPROXEN NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXCARBAZEPINE, OXCARBAZEPINE OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE PHENOXYBENZAMINE HYDROCHLORIDE, PHENOXYBENZAMINE HYDROCHLORIDE PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE PREDNISONE INTENSOL, PREDNISONE PREDNISONE, PREDNISONE PROPANTHELINE BROMIDE, PROPANTHELINE BROMIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE RAMIPRIL, RAMIPRIL RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE ROXICET 5/500, ACETAMINOPHEN ROXICET, ACETAMINOPHEN ROXILOX, ACETAMINOPHEN SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE TINIDAZOLE, TINIDAZOLE TORSEMIDE, TORSEMIDE TRIAZOLAM, TRIAZOLAM VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE ZALEPLON, ZALEPLON ZIDOVUDINE, ZIDOVUDINE
SAGE PRODS * SAGE PRODUCTS INC CHLORHEXIDINE GLUCONATE,
(OTC)
SAGENT AGILA * SAGENT AGILA LLC ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE
MESNA, MESNA
SAGENT PHARMS * SAGENT PHARMACEUTICALS INC ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE ATRACURIUM BESYLATE, ATRACURIUM BESYLATE CAFFEINE CITRATE, CAFFEINE CITRATE CALCITRIOL, CALCITRIOL FLUMAZENIL, FLUMAZENIL HALOPERIDOL, HALOPERIDOL LACTATE HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEVOFLOXACIN, LEVOFLOXACIN NAFCILLIN SODIUM, NAFCILLIN SODIUM ORPHENADRINE CITRATE, ORPHENADRINE CITRATE OXACILLIN SODIUM, OXACILLIN SODIUM TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE
SAGENT STRIDES * SAGENT STRIDES LLC AZITHROMYCIN, AZITHROMYCIN BACITRACIN, BACITRACIN
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE
B - 118
APPENDIX B

** S **
* SAGENT STRIDES LLC GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE LABETALOL HYDROCLORIDE, LABETALOL HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE MIDOZALAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE POLYMYCIN B SULFATE, POLYMYXIN B SULFATE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE
SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
SALIX PHARMS * SALIX PHARMACEUTICALS INC ANUSOL HC, HYDROCORTISONE APRISO, MESALAMINE COLAZAL, BALSALAZIDE DISODIUM DIURIL, CHLOROTHIAZIDE FULYZAQ, CROFELEMER GIAZO, BALSALAZIDE DISODIUM METOZOLV ODT, METOCLOPRAMIDE HYDROCHLORIDE MOVIPREP, ASCORBIC ACID OSMOPREP, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS PEPCID, FAMOTIDINE RELISTOR, METHYLNALTREXONE BROMIDE VISICOL, SODIUM PHOSPHATE, DIBASIC ANHYDROUS
XIFAXAN, RIFAXIMIN
SAMSON MEDCL * SAMSON MEDICAL TECHNOLOGIES LLC CEFAZOLIN SODIUM, CEFAZOLIN SODIUM
CEFUROXIME SODIUM IN PLASTIC CONTAINER,
CEFUROXIME SODIUM
SANDOZ * SANDOZ DOCETAXEL, DOCETAXEL * SANDOZ CANADA INC ANECTINE, SUCCINYLCHOLINE CHLORIDE ARISTOSPAN, TRIAMCINOLONE HEXACETONIDE BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE COSYNTROPIN, COSYNTROPIN DIGOXIN, DIGOXIN DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE ESTRADIOL VALERATE, ESTRADIOL VALERATE FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE FLUMAZENIL, FLUMAZENIL GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE INFUVITE ADULT, ALPHA-TOCOPHEROL ACETATE INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), ASCORBIC ACID INFUVITE PEDIATRIC, ASCORBIC ACID ISONIAZID, ISONIAZID KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE METOPROLOL TARTRATE, METOPROLOL TARTRATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE REGONOL, PYRIDOSTIGMINE BROMIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE
* SANDOZ INC ALPRAZOLAM, ALPRAZOLAM ALTAVERA, ETHINYL ESTRADIOL AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE
AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE
B - 119
APPENDIX B

** S **
* SANDOZ INC AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM AMPICILLIN SODIUM, AMPICILLIN SODIUM AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE ANASTROZOLE, ANASTROZOLE APREPITANT, APREPITANT ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN ATENOLOL, ATENOLOL AZITHROMYCIN, AZITHROMYCIN BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BICALUTAMIDE, BICALUTAMIDE BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE BUMETANIDE, BUMETANIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CAFERGOT, CAFFEINE CAPTOPRIL, CAPTOPRIL CARBOPLATIN, CARBOPLATIN CARISOPRODOL AND ASPIRIN, ASPIRIN CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFDINIR, CEFDINIR CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFTRIAXONE, CEFTRIAXONE SODIUM CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE (OTC) CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE CHOLESTYRAMINE, CHOLESTYRAMINE CILOSTAZOL, CILOSTAZOL CLARITHROMYCIN, CLARITHROMYCIN CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE (OTC) CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM COSYNTROPIN, COSYNTROPIN CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYCLOSPORINE, CYCLOSPORINE DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE DESLORATADINE, DESLORATADINE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE ASPARTATE
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM
DICLOFENAC SODIUM, DICLOFENAC SODIUM
DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM
DIVALPROEX SODIUM, DIVALPROEX SODIUM
DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE
ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM
EPLERENONE, EPLERENONE
ESTARYLLA, ETHINYL ESTRADIOL
ETODOLAC, ETODOLAC
FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE
FLUOROURACIL, FLUOROURACIL
FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE
FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE
B - 120
APPENDIX B

** S **
* SANDOZ INC FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM FUROSEMIDE, FUROSEMIDE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GLIPIZIDE, GLIPIZIDE HALOPERIDOL, HALOPERIDOL HEPARIN SODIUM, HEPARIN SODIUM HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE INDOMETHACIN, INDOMETHACIN INTROVALE, ETHINYL ESTRADIOL IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN ISONIAZID, ISONIAZID ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE ITRACONAZOLE, ITRACONAZOLE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE LANSOPRAZOLE, LANSOPRAZOLE LEFLUNOMIDE, LEFLUNOMIDE LEUPROLIDE ACETATE, LEUPROLIDE ACETATE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LONOX, ATROPINE SULFATE LORATADINE, LORATADINE (OTC) LORAZEPAM, LORAZEPAM LORYNA, DROSPIRENONE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOVASTATIN, LOVASTATIN MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEROPENEM, MEROPENEM METAXALONE, METAXALONE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHAZOLAMIDE, METHAZOLAMIDE METHIMAZOLE, METHIMAZOLE METHOCARBAMOL, METHOCARBAMOL METHYLPREDNISOLONE, METHYLPREDNISOLONE METOLAZONE, METOLAZONE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NABUMETONE, NABUMETONE NADOLOL, NADOLOL NAFCILLIN SODIUM, NAFCILLIN SODIUM NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE NAPROXEN, NAPROXEN NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN NIZATIDINE, NIZATIDINE OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE OMEPRAZOLE, OMEPRAZOLE OMNITROPE, SOMATROPIN RECOMBINANT ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON
ORPHENADRINE CITRATE, ORPHENADRINE CITRATE
B - 121
APPENDIX B

** S **
* SANDOZ INC ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN OXACILLIN SODIUM, OXACILLIN SODIUM OXALIPLATIN, OXALIPLATIN OXAPROZIN, OXAPROZIN OXAZEPAM, OXAZEPAM PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM PENICILLIN G SODIUM, PENICILLIN G SODIUM PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PERPHENAZINE, PERPHENAZINE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE, GLIMEPIRIDE PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE QUINIDINE SULFATE, QUINIDINE SULFATE RAMIPRIL, RAMIPRIL RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RESERPINE, RESERPINE RIBAVIRIN, RIBAVIRIN RIFAMPIN, RIFAMPIN RISPERIDONE, RISPERIDONE RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SPIRONOLACTONE, SPIRONOLACTONE SULFADIAZINE, SULFADIAZINE SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE SYEDA, DROSPIRENONE TACROLIMUS, TACROLIMUS TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TEMAZEPAM, TEMAZEPAM TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE THIOTHIXENE, THIOTHIXENE TOPIRAMATE, TOPIRAMATE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRI-ESTARYLLA, ETHINYL ESTRADIOL TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
SANDOZ CANADA INC * SANDOZ CANADA INC PARICALCITOL, PARICALCITOL SANDOZ INC * SANDOZ INC AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CISATRACURIUM BESYLATE PRESERVATIVE FREE, CISATRACURIUM BESYLATE CISATRACURIUM BESYLATE, CISATRACURIUM BESYLATE CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE ENOXAPARIN SODIUM, ENOXAPARIN SODIUM MONTELUKAST SODIUM, MONTELUKAST SODIUM OLANZAPINE, OLANZAPINE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE
VORICONAZOLE, VORICONAZOLE
B - 122
APPENDIX B
* SANDOZ INC ZIPRASIDONE HYDROCHLORIDE, SANOCHEMIA CORP USA * SANOCHEMIA CORP USA SCANLUX-300, IOPAMIDOL
SCANLUX-370, IOPAMIDOL

** S **
SANOFI AVENTIS US * SANOFI AVENTIS US INC JEVTANA KIT, CABAZITAXEL * SANOFI AVENTIS US LLC ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA, FEXOFENADINE HYDROCHLORIDE ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE AMARYL, GLIMEPIRIDE AMBIEN CR, ZOLPIDEM TARTRATE AMBIEN, ZOLPIDEM TARTRATE ANZEMET, DOLASETRON MESYLATE APIDRA SOLOSTAR, INSULIN GLULISINE RECOMBINANT APIDRA, INSULIN GLULISINE RECOMBINANT ARALEN, CHLOROQUINE PHOSPHATE ARAVA, LEFLUNOMIDE AUBAGIO, TERIFLUNOMIDE AUVI-Q, EPINEPHRINE AVALIDE, HYDROCHLOROTHIAZIDE AVAPRO, IRBESARTAN CANTIL, MEPENZOLATE BROMIDE CHILDREN'S ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER, CEFOTAXIME SODIUM CLAFORAN, CEFOTAXIME SODIUM CLOMID, CLOMIPHENE CITRATE DDAVP (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DDAVP, DESMOPRESSIN ACETATE DEMEROL, MEPERIDINE HYDROCHLORIDE DIABETA, GLYBURIDE DRISDOL, ERGOCALCIFEROL ELOXATIN, OXALIPLATIN FERRLECIT, SODIUM FERRIC GLUCONATE COMPLEX GAVISCON, ALUMINUM HYDROXIDE (OTC) HIPREX, METHENAMINE HIPPURATE KAYEXALATE, SODIUM POLYSTYRENE SULFONATE KETEK, TELITHROMYCIN KLARON, SULFACETAMIDE SODIUM LANTUS, INSULIN GLARGINE RECOMBINANT LASIX, FUROSEMIDE LOVENOX (PRESERVATIVE FREE), ENOXAPARIN SODIUM LOVENOX, ENOXAPARIN SODIUM MULTAQ, DRONEDARONE HYDROCHLORIDE MYTELASE, AMBENONIUM CHLORIDE NASACORT AQ, TRIAMCINOLONE ACETONIDE NICODERM CQ, NICOTINE (OTC) NILANDRON, NILUTAMIDE NORPRAMIN, DESIPRAMINE HYDROCHLORIDE PENLAC, CICLOPIROX PHISOHEX, HEXACHLOROPHENE PLAQUENIL, HYDROXYCHLOROQUINE SULFATE PLAVIX, CLOPIDOGREL BISULFATE PRIFTIN, RIFAPENTINE PRIMAQUINE, PRIMAQUINE PHOSPHATE RIFADIN, RIFAMPIN RIFAMATE, ISONIAZID
RIFATER, ISONIAZID
(OTC) (OTC)
B - 123
APPENDIX B

** S **
* SANOFI AVENTIS US LLC RILUTEK, RILUZOLE SKELID, TILUDRONATE DISODIUM TAXOTERE, DOCETAXEL TRENTAL, PENTOXIFYLLINE
UROXATRAL, ALFUZOSIN HYDROCHLORIDE
SANOFI PASTEUR INC * SANOFI PASTEUR INC SKLICE, IVERMECTIN SANTARUS * SANTARUS INC FENOGLIDE, FENOFIBRATE GLUMETZA, METFORMIN HYDROCHLORIDE UCERIS, BUDESONIDE
ZEGERID, OMEPRAZOLE
SANTEN * SANTEN INC ALAMAST, PEMIROLAST POTASSIUM IQUIX, LEVOFLOXACIN
QUIXIN, LEVOFLOXACIN
SANTEN OY * SANTEN OY BETIMOL,
TIMOLOL
SANTOS BIOTECH * SANTOS BIOTECH INDUSTRIES INC ANASTROZOLE, ANASTROZOLE SAVIENT PHARMS * SAVIENT PHARMACEUTICALS INC OXANDRIN, OXANDROLONE SB PHARMCO * SB PHARMCO PUERTO RICO INC AVANDAMET, METFORMIN HYDROCHLORIDE AVANDARYL, GLIMEPIRIDE AVANDIA, ROSIGLITAZONE MALEATE
COREG CR, CARVEDILOL PHOSPHATE
SCHERING * SCHERING CORP ASMANEX TWISTHALER, MOMETASONE FUROATE INTEGRILIN, EPTIFIBATIDE NOXAFIL, POSACONAZOLE REBETOL, RIBAVIRIN
ZEMURON, ROCURONIUM BROMIDE
* SCHERING CORP SUB SCHERING PLOUGH CORP CELESTONE SOLUSPAN, BETAMETHASONE ACETATE SCHERING CORP * SCHERING CORP LOTRISONE, BETAMETHASONE DIPROPIONATE SCHERING PLOUGH * SCHERING PLOUGH HEALTHCARE PRODUCTS INC AFRINOL, PSEUDOEPHEDRINE SULFATE (OTC) CHILDREN'S CLARITIN, LORATADINE (OTC) CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE (OTC) CLARITIN HIVES RELIEF REDITAB, LORATADINE (OTC) CLARITIN HIVES RELIEF, LORATADINE (OTC) CLARITIN REDITABS, LORATADINE (OTC) CLARITIN, LORATADINE (OTC) CLARITIN-D 24 HOUR, LORATADINE (OTC) CLARITIN-D, LORATADINE (OTC) DISOPHROL, DEXBROMPHENIRAMINE MALEATE (OTC) DRIXORAL PLUS, ACETAMINOPHEN (OTC)
DRIXORAL, DEXBROMPHENIRAMINE MALEATE (OTC)
B - 124
APPENDIX B

** S **
* SCHERING PLOUGH HEALTHCARE PRODUCTS INC GYNE-LOTRIMIN 3 COMBINATION PACK, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN 3, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN COMBINATION PACK, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN, CLOTRIMAZOLE (OTC) LOTRIMIN ULTRA, BUTENAFINE HYDROCHLORIDE (OTC) MIRALAX, POLYETHYLENE GLYCOL 3350 (OTC) NASONEX, MOMETASONE FUROATE MONOHYDRATE OCUCLEAR, OXYMETAZOLINE HYDROCHLORIDE (OTC)
SHADE UVAGUARD, AVOBENZONE (OTC)
SCHWARZ PHARMA * SCHWARZ PHARMA INC DILATRATE-SR, ISOSORBIDE DINITRATE SCIEGEN PHARMS INC * SCIEGEN PHARMACEUTICALS INC NEVIRAPINE, NEVIRAPINE SCIOS * SCIOS INC NATRECOR,
NESIRITIDE RECOMBINANT
SECAN PHARMS * SECAN PHARMACEUTICALS INC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE SEPTODONT * SEPTODONT INC BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, OCTOCAINE, EPINEPHRINE SEPTODONT HOLDING * SEPTODONT HOLDING SAS ORAVERSE, PHENTOLAMINE MESYLATE SEPTODONT INC * SEPTODONT INC PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, PRILOCAINE HYDROCHLORIDE, PRILOCAINE HYDROCHLORIDE SETON PHARM * SETON PHARMACEUTICAL LLC PEDIAPRED, PREDNISOLONE SODIUM PHOSPHATE SHASUN CHEMS * SHASUN CHEMICALS AND DRUGS LTD RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE SHASUN USA * SHASUN USA INC IBUPROFEN, IBUPROFEN SHIONOGI INC * SHIONOGI INC FURADANTIN, NITROFURANTOIN KAPVAY, CLONIDINE HYDROCHLORIDE KEFLEX, CEPHALEXIN MOXATAG, AMOXICILLIN ORAPRED ODT, PREDNISOLONE SODIUM PHOSPHATE ORAPRED, PREDNISOLONE SODIUM PHOSPHATE PONSTEL, MEFENAMIC ACID ROBINUL FORTE, GLYCOPYRROLATE ROBINUL, GLYCOPYRROLATE RYBIX ODT, TRAMADOL HYDROCHLORIDE SULAR, NISOLDIPINE
ULESFIA, BENZYL ALCOHOL
SHIRE * SHIRE DEVELOPMENT INC ADDERALL XR 10, AMPHETAMINE ASPARTATE
ADDERALL XR 15, AMPHETAMINE ASPARTATE
EPINEPHRINE BITARTRATE
(OTC)
B - 125
APPENDIX B

** S **
* SHIRE DEVELOPMENT INC ADDERALL XR 20, AMPHETAMINE ASPARTATE ADDERALL XR 25, AMPHETAMINE ASPARTATE ADDERALL XR 30, AMPHETAMINE ASPARTATE ADDERALL XR 5, AMPHETAMINE ASPARTATE CARBATROL, CARBAMAZEPINE INTUNIV, GUANFACINE HYDROCHLORIDE LIALDA, MESALAMINE
PENTASA, MESALAMINE
SHIRE DEVELOPMENT * SHIRE DEVELOPMENT INC VYVANSE, LISDEXAMFETAMINE DIMESYLATE SHIRE HUMAN GENETIC * SHIRE HUMAN GENETIC THERAPIES INC VPRIV, VELAGLUCERASE ALFA SHIRE LLC * SHIRE DEVELOPMENT LLC AGRYLIN, ANAGRELIDE HYDROCHLORIDE FOSRENOL, LANTHANUM CARBONATE
SALURON, HYDROFLUMETHIAZIDE
SHIRE ORPHAN THERAP * SHIRE ORPHAN THERAPIES INC FIRAZYR, ICATIBANT ACETATE SIGMA TAU * SIGMA TAU PHARMACEUTICALS INC ABELCET, AMPHOTERICIN B ADAGEN, PEGADEMASE BOVINE CARNITOR SF, LEVOCARNITINE CARNITOR, LEVOCARNITINE CYSTARAN, CYSTEAMINE HYDROCHLORIDE
MATULANE, PROCARBAZINE HYDROCHLORIDE
SIGMAPHARM LABS LLC * SIGMAPHARM LABORATORIES LLC AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE DISULFIRAM, DISULFIRAM ERGOCALCIFEROL, ERGOCALCIFEROL FLUCYTOSINE, FLUCYTOSINE GRISEOFULVIN, GRISEOFULVIN, MICROSIZE GRISEOFULVIN,ULTRAMICROSIZE, GRISEOFULVIN, ULTRAMICROSIZE LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM
PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE
SILARX * SILARX PHARMACEUTICALS INC AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL LACTATE LEVETIRACETAM, LEVETIRACETAM LORATADINE, LORATADINE (OTC) METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
THEOPHYLLINE, THEOPHYLLINE
B - 126
APPENDIX B

** S **
SKINMEDICA * SKINMEDICA INC VANIQA, EFLORNITHINE HYDROCHLORIDE SKYEPHARMA AG * SKYEPHARMA AG TRIGLIDE, FENOFIBRATE SMITHKLINE BEECHAM * SMITHKLINE BEECHAM LOVAZA, OMEGA-3-ACID ETHYL ESTERS * SMITHKLINE BEECHAM CORP LAMICTAL XR, LAMOTRIGINE * SMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINE ARRANON, NELARABINE COREG, CARVEDILOL HYCAMTIN, TOPOTECAN HYDROCHLORIDE LAMICTAL ODT, LAMOTRIGINE REQUIP XL, ROPINIROLE HYDROCHLORIDE TREXIMET, NAPROXEN SODIUM
TYKERB, LAPATINIB DITOSYLATE
SOAPCO * SOAPCO INC BRIAN CARE,
(OTC)
SOFGEN PHARMS * SOFGEN PHARMACEUTICALS LLC PROGESTERONE, PROGESTERONE SOLCO HLTHCARE * SOLCO HEALTHCARE US LLC LEVETIRACETAM, LEVETIRACETAM
METHOCARBAMOL, METHOCARBAMOL
SOMAXON * SOMAXON PHARMACEUTICALS INC SILENOR, DOXEPIN HYDROCHLORIDE SOMERSET * SOMERSET PHARMACEUTICALS INC ELDEPRYL, SELEGILINE HYDROCHLORIDE
EMSAM, SELEGILINE
SPEAR PHARMS * SPEAR PHARMACEUTICALS INC FLUOROURACIL, FLUOROURACIL SPECTRUM PHARMS * SPECTRUM PHARMACEUTICALS INC FUSILEV, LEVOLEUCOVORIN CALCIUM STAND HOMEOPATH * STANDARD HOMEOPATHIC CO IVY BLOCK, BENTOQUATAM STASON * STASON INDUSTRIAL CORP ACYCLOVIR, ACYCLOVIR CAPTOPRIL, CAPTOPRIL
SELEGILINE HYDROCHLORIDE,
(OTC)
STASON PHARMS * STASON PHARMACEUTICALS INC CYPROHEPTADINE HYDROCHLORIDE, STAT TRADE * STAT TRADE INC NAPRELAN, NAPROXEN SODIUM STERI PHARMA * STERI PHARMA LLC CEFAZOLIN SODIUM,
CEFAZOLIN SODIUM
B - 127
APPENDIX B
*

** S **
STERI PHARMA LLC CEFTRIAXONE, CEFTRIAXONE SODIUM

CEFUROXIME SODIUM, CEFUROXIME SODIUM
STEVENS J * JEROME STEVENS PHARMACEUTICALS INC BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN CEPHALEXIN, CEPHALEXIN DIGOXIN, DIGOXIN METHOCARBAMOL AND ASPIRIN, ASPIRIN ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN
UNITHROID, LEVOTHYROXINE SODIUM
STI PHARMA LLC * STI PHARMA LLC BETAMETHASONE VALERATE, BETAMETHASONE VALERATE DEXAMETHASONE, DEXAMETHASONE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE MYAMBUTOL, ETHAMBUTOL HYDROCHLORIDE SULFATRIM PEDIATRIC, SULFAMETHOXAZOLE
TRIACIN-C, CODEINE PHOSPHATE
STIEFEL * STIEFEL LABORATORIES INC DUAC, BENZOYL PEROXIDE
LUXIQ, BETAMETHASONE VALERATE
STIEFEL GSK * STIEFEL A GSK CO VELTIN, CLINDAMYCIN PHOSPHATE STIEFEL LABS INC * STIEFEL LABORATORIES INC EVOCLIN, CLINDAMYCIN PHOSPHATE EXTINA, KETOCONAZOLE FABIOR, TAZAROTENE OLUX E, CLOBETASOL PROPIONATE OLUX, CLOBETASOL PROPIONATE SORIATANE, ACITRETIN SORILUX, CALCIPOTRIENE VERDESO, DESONIDE
VUSION, MICONAZOLE NITRATE
STRIDES * STRIDES INC NEVIRAPINE,
NEVIRAPINE
STRIDES ARCOLAB * STRIDES ARCOLAB LIMITED FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM STRIDES ARCOLAB LTD * STRIDES ARCOLAB LTD ACARBOSE, ACARBOSE ADENOSINE, ADENOSINE CEFTRIAXONE, CEFTRIAXONE SODIUM ERGOCALCIFEROL, ERGOCALCIFEROL ETOMIDATE, ETOMIDATE IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE MELOXICAM, MELOXICAM MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL
SUCAMPO PHARMS * SUCAMPO PHARMACEUTICALS INC AMITIZA, LUBIPROSTONE
RESCULA, UNOPROSTONE ISOPROPYL
SUMMERS * SUMMERS LABORATORIES INC CROTAN, CROTAMITON
(OTC)
B - 128
APPENDIX B
** S **
SUN PHARM INDS * SUN PHARMACEUTICAL INDUSTRIES LTD CARBIDOPA AND LEVODOPA, CARBIDOPA CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) DESLORATADINE, DESLORATADINE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE OLANZAPINE, OLANZAPINE ONDANSETRON, ONDANSETRON OXCARBAZEPINE, OXCARBAZEPINE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TIAGABINE HYDROCHLORIDE, TIAGABINE HYDROCHLORIDE TORSEMIDE, TORSEMIDE SUN PHARM INDS (IN) * SUN PHARMACEUTICAL INDUSTRIES LTD CEPHALEXIN, CEPHALEXIN EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ORTHO-EST, ESTROPIPATE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE ZONISAMIDE, ZONISAMIDE SUN PHARM INDS INC * SUN PHARMACEUTICAL INDUSTRIES INC BENZONATATE, BENZONATATE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ERGOCALCIFEROL, ERGOCALCIFEROL GEMFIBROZIL, GEMFIBROZIL HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LITHIUM CARBONATE, LITHIUM CARBONATE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE NIMODIPINE, NIMODIPINE OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE VALPROIC ACID, VALPROIC ACID VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE SUN PHARM INDS LTD * SUN PHARMACEUTICAL INDUSTRIES LTD CARISOPRODOL, CARISOPRODOL CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE (OTC) DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE GABAPENTIN, GABAPENTIN LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM NARATRIPTAN, NARATRIPTAN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE
B - 129
APPENDIX B

** S **
* SUN PHARMACEUTICAL INDUSTRIES LTD QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE
* SUN PHARMACEUTICAL INDUSTRIES LTD. ANASTROZOLE, ANASTROZOLE SUN PHARMA GLOBAL * SUN PHARMA GLOBAL FZE AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CAFFEINE CITRATE, CAFFEINE CITRATE CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DOCEFREZ, DOCETAXEL DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE ENTACAPONE, ENTACAPONE FINASTERIDE, FINASTERIDE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE OXALIPLATIN, OXALIPLATIN QUETIAPINE FUMARATE, QUETIAPINE FUMARATE RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
* SUN PHARMA GLOBAL INC ALENDRONATE SODIUM, ALENDRONATE SODIUM ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALPRAZOLAM, ALPRAZOLAM AMIFOSTINE, AMIFOSTINE AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE BICALUTAMIDE, BICALUTAMIDE CARBOPLATIN, CARBOPLATIN FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LEUPROLIDE ACETATE, LEUPROLIDE ACETATE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
VECURONIUM BROMIDE, VECURONIUM BROMIDE
SUNEVA MEDCL * SUNEVA MEDICAL INC TRETINOIN, TRETINOIN SUNOVION * SUNOVION PHARMACEUTICALS INC BROVANA, ARFORMOTEROL TARTRATE XOPENEX HFA, LEVALBUTEROL TARTRATE
XOPENEX, LEVALBUTEROL HYDROCHLORIDE
SUNOVION PHARMS INC * SUNOVION PHARMACEUTICALS INC LATUDA, LURASIDONE HYDROCHLORIDE
LUNESTA, ESZOPICLONE
SUPERNUS PHARMS * SUPERNUS PHARMACEUTICALS INC OXTELLAR XR, OXCARBAZEPINE
B - 130
APPENDIX B
SUVEN LIFE * SUVEN LIFE SCIENCES LTD MALATHION, MALATHION

** S **
SVADS HOLDINGS SA * SVADS HOLDINGS SA IBUPROFEN, IBUPROFEN (OTC)

RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE SVC PHARMA * SVC PHARMA LP DRONABINOL,
(OTC)
DRONABINOL
SYNTHON PHARMS * SYNTHON PHARMACEUTICALS INC BICALUTAMIDE, BICALUTAMIDE LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE
TAKEDA GLOBAL * TAKEDA GLOBAL RESEARCH DEVELOPMENT CENTER INC KAZANO, ALOGLIPTIN BENZOATE NESINA, ALOGLIPTIN
OSENI, ALOGLIPTIN
TAKEDA GMBH * TAKEDA GMBH ALVESCO, CICLESONIDE OMNARIS, CICLESONIDE
ZETONNA, CICLESONIDE
TAKEDA PHARMS * TAKEDA PHARMACEUTICALS NORTH AMERICA INC DEXILANT, DEXLANSOPRAZOLE TAKEDA PHARMS USA * TAKEDA PHARMACEUTICALS USA INC ACTOPLUS MET XR, METFORMIN HYDROCHLORIDE ACTOPLUS MET, METFORMIN HYDROCHLORIDE ACTOS, PIOGLITAZONE HYDROCHLORIDE COLCRYS, COLCHICINE DUETACT, GLIMEPIRIDE EDARBI, AZILSARTAN KAMEDOXOMIL EDARBYCLOR, AZILSARTAN KAMEDOXOMIL PREVACID, LANSOPRAZOLE PREVPAC, AMOXICILLIN ROZEREM, RAMELTEON
ULORIC, FEBUXOSTAT
TALON THERAP * TALON THERAPEUTICS INC MARQIBO KIT, VINCRISTINE SULFATE TAMARANG * TAMARANG SA ROCURONIUM BROMIDE,
ROCURONIUM BROMIDE
TARO * TARO PHARMACEUTICAL INDUSTRIES LTD ACETAZOLAMIDE, ACETAZOLAMIDE CARBAMAZEPINE, CARBAMAZEPINE CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE
ENALAPRIL MALEATE, ENALAPRIL MALEATE
B - 131
APPENDIX B

** T **
* TARO PHARMACEUTICAL INDUSTRIES LTD ETODOLAC, ETODOLAC EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM FLUCONAZOLE, FLUCONAZOLE FLUOROURACIL, FLUOROURACIL HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE IMIQUIMOD, IMIQUIMOD KETOCONAZOLE, KETOCONAZOLE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LORATADINE, LORATADINE (OTC) MELOXICAM, MELOXICAM MEPROBAMATE, MEPROBAMATE METRONIDAZOLE, METRONIDAZOLE NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXCARBAZEPINE, OXCARBAZEPINE
PHENYTOIN, PHENYTOIN
* TARO PHARMACEUTICALS INC BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE CLOTRIMAZOLE, CLOTRIMAZOLE (OTC) DIFLORASONE DIACETATE, DIFLORASONE DIACETATE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE, FLUOCINONIDE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE TOPICORT, DESOXIMETASONE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
WARFARIN SODIUM, WARFARIN SODIUM
* TARO PHARMACEUTICALS USA INC ACETIC ACID, ACETIC ACID, GLACIAL ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMMONIUM LACTATE, AMMONIUM LACTATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CICLOPIROX, CICLOPIROX CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE DERMABET, BETAMETHASONE VALERATE DESONIDE, DESONIDE DIFLORASONE DIACETATE, DIFLORASONE DIACETATE ECONAZOLE NITRATE, ECONAZOLE NITRATE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FLO-PRED, PREDNISOLONE ACETATE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUOROURACIL, FLUOROURACIL GENTAMICIN SULFATE, GENTAMICIN SULFATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL HYDROCORTISONE, HYDROCORTISONE KETOZOLE, KETOCONAZOLE LIDOCAINE, LIDOCAINE LORATADINE, LORATADINE (OTC) MICONAZOLE 3, MICONAZOLE NITRATE (OTC)
MOMETASONE FUROATE, MOMETASONE FUROATE
B - 132
APPENDIX B

** T **
* TARO PHARMACEUTICALS USA INC MUPIROCIN, MUPIROCIN NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN NYSTATIN, NYSTATIN PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE (OTC) TERCONAZOLE, TERCONAZOLE TERIL, CARBAMAZEPINE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE TRIVAGIZOLE 3, CLOTRIMAZOLE (OTC)
U-CORT, HYDROCORTISONE ACETATE
* TARO PHARMACEUTICALS, INC. HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE
TOPICORT, DESOXIMETASONE
TARO PHARM INDS * TARO PHARMACEUTICAL INDUSTRIES LTD AMCINONIDE, AMCINONIDE CARBAMAZEPINE, CARBAMAZEPINE CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ETODOLAC, ETODOLAC FLUCONAZOLE, FLUCONAZOLE HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE
TARO PHARMS IRELAND * TARO PHARMACEUTICALS IRELAND LTD ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION TARO PHARMS NORTH * TARO PHARMACEUTICALS NORTH AMERICA INC OVIDE, MALATHION
TOPICORT, DESOXIMETASONE
TAYLOR * TAYLOR PHARMACEUTICALS LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LORAZEPAM, LORAZEPAM MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
NAPHAZOLINE HYDROCHLORIDE, NAPHAZOLINE HYDROCHLORIDE
TAYLOR PHARMA * TAYLOR PHARMACAL CO DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE
TEDOR PHARM * TEDOR PHARMA INC BENZPHETAMINE HYDROCHLORIDE, TEIKOKU PHARMA USA * TEIKOKU PHARMA USA INC LIDODERM, LIDOCAINE TEVA * TEVA NEUROSCIENCE INC AZILECT, RASAGILINE MESYLATE
COPAXONE, GLATIRAMER ACETATE
* TEVA PHARMACEUTICALS USA INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACYCLOVIR, ACYCLOVIR
ADIPEX-P, PHENTERMINE HYDROCHLORIDE
B - 133
APPENDIX B

** T **
* TEVA PHARMACEUTICALS USA INC ALBUTEROL SULFATE, ALBUTEROL SULFATE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN PEDIATRIC, AMOXICILLIN AMOXICILLIN, AMOXICILLIN ATENOLOL, ATENOLOL AZITHROMYCIN, AZITHROMYCIN BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE BETA-VAL, BETAMETHASONE VALERATE BICALUTAMIDE, BICALUTAMIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE CALCITRIOL, CALCITRIOL CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL CAPTOPRIL, CAPTOPRIL CARBIDOPA AND LEVODOPA, CARBIDOPA CARVEDILOL, CARVEDILOL CEFACLOR, CEFACLOR CEFPROZIL, CEFPROZIL CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CILOSTAZOL, CILOSTAZOL CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CIMETIDINE, CIMETIDINE CLARITHROMYCIN, CLARITHROMYCIN CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE CLOTRIMAZOLE, CLOTRIMAZOLE DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM DIFLUNISAL, DIFLUNISAL DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ENALAPRIL MALEATE, ENALAPRIL MALEATE EPITOL, CARBAMAZEPINE ESTAZOLAM, ESTAZOLAM ETODOLAC, ETODOLAC FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FENOFIBRATE (MICRONIZED), FENOFIBRATE FENOFIBRATE, FENOFIBRATE FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLURBIPROFEN, FLURBIPROFEN FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE
FOSINOPRIL SODIUM, FOSINOPRIL SODIUM
B - 134
APPENDIX B

** T **
* TEVA PHARMACEUTICALS USA INC GALZIN, ZINC ACETATE GEMFIBROZIL, GEMFIBROZIL GLIMEPIRIDE, GLIMEPIRIDE GLYBURIDE (MICRONIZED), GLYBURIDE GLYBURIDE, GLYBURIDE HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE KETOCONAZOLE, KETOCONAZOLE KETOPROFEN, KETOPROFEN KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LAMOTRIGINE, LAMOTRIGINE LEVOFLOXACIN, LEVOFLOXACIN LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LORATADINE, LORATADINE (OTC) LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOVASTATIN, LOVASTATIN MESALAMINE, MESALAMINE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOLAZONE, METOLAZONE METOPROLOL TARTRATE, METOPROLOL TARTRATE METRONIDAZOLE, METRONIDAZOLE MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MUPIROCIN, MUPIROCIN NABUMETONE, NABUMETONE NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN, NAPROXEN NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE NEOMYCIN SULFATE, NEOMYCIN SULFATE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NIZATIDINE, NIZATIDINE NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE NYSTATIN, NYSTATIN OFLOXACIN, OFLOXACIN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON ORAP, PIMOZIDE OXAPROZIN, OXAPROZIN OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PENICILLIN-VK, PENICILLIN V POTASSIUM PIROXICAM, PIROXICAM PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PRELONE, PREDNISOLONE PURINETHOL, MERCAPTOPURINE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RIBAVIRIN, RIBAVIRIN RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE ROSIGLITAZONE MALEATE, ROSIGLITAZONE MALEATE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SUCRALFATE, SUCRALFATE SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
TAMOXIFEN CITRATE, TAMOXIFEN CITRATE
B - 135
APPENDIX B

** T **
* TEVA PHARMACEUTICALS USA INC TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOLMETIN SODIUM, TOLMETIN SODIUM TOPIRAMATE, TOPIRAMATE TORSEMIDE, TORSEMIDE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRIACET, TRIAMCINOLONE ACETONIDE TRIMETHOPRIM, TRIMETHOPRIM VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
TEVA BRANDED PHARM * TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC CENESTIN, ESTROGENS, CONJUGATED SYNTHETIC A LOSEASONIQUE, ETHINYL ESTRADIOL MIRCETTE, DESOGESTREL NORDETTE-28, ETHINYL ESTRADIOL PLAN B, LEVONORGESTREL PLAN B, LEVONORGESTREL (OTC) QNASL, BECLOMETHASONE DIPROPIONATE QVAR 40, BECLOMETHASONE DIPROPIONATE QVAR 80, BECLOMETHASONE DIPROPIONATE SEASONALE, ETHINYL ESTRADIOL
SEASONIQUE, ETHINYL ESTRADIOL
TEVA GLOBAL * TEVA GLOBAL RESPIRATORY RESEARCH LLC PROAIR HFA, ALBUTEROL SULFATE
PROGLYCEM, DIAZOXIDE
TEVA PARENTERAL * TEVA PARENTERAL MEDICINES INC ALPROSTADIL, ALPROSTADIL AMIKACIN SULFATE, AMIKACIN SULFATE BLEOMYCIN SULFATE, BLEOMYCIN SULFATE CALCITRIOL, CALCITRIOL CARBOPLATIN, CARBOPLATIN CYTOSAR-U, CYTARABINE DACARBAZINE, DACARBAZINE DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE ENALAPRILAT, ENALAPRILAT EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM ETOPOSIDE, ETOPOSIDE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FLUOROURACIL, FLUOROURACIL GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE IDARUBICIN HYDROCHLORIDE PFS, IDARUBICIN HYDROCHLORIDE IFOSFAMIDE, IFOSFAMIDE IFOSFAMIDE/MESNA KIT, IFOSFAMIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEUPROLIDE ACETATE, LEUPROLIDE ACETATE LEVOCARNITINE, LEVOCARNITINE MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE MESNA, MESNA METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE
METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE
B - 136
APPENDIX B

** T **
* TEVA PARENTERAL MEDICINES INC MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPOFOL, PROPOFOL SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE VECURONIUM BROMIDE, VECURONIUM BROMIDE VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE VINORELBINE TARTRATE, VINORELBINE TARTRATE
ZANOSAR, STREPTOZOCIN
TEVA PHARMS * TEVA PHARMACEUTICALS USA ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALENDRONATE SODIUM, ALENDRONATE SODIUM ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALPRAZOLAM, ALPRAZOLAM AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE ANASTROZOLE, ANASTROZOLE AZITHROMYCIN, AZITHROMYCIN BISOPROLOL FUMARATE, BISOPROLOL FUMARATE BUDESONIDE, BUDESONIDE CARBAMAZEPINE, CARBAMAZEPINE CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFDINIR, CEFDINIR CEFPROZIL, CEFPROZIL CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME SODIUM, CEFUROXIME SODIUM CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE CROMOLYN SODIUM, CROMOLYN SODIUM DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE DIVALPROEX SODIUM, DIVALPROEX SODIUM DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE ETHOSUXIMIDE, ETHOSUXIMIDE FAMCICLOVIR, FAMCICLOVIR FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUVASTATIN SODIUM, FLUVASTATIN SODIUM GABAPENTIN, GABAPENTIN GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL LACTATE HYDROCORTISONE, HYDROCORTISONE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE IRBESARTAN, IRBESARTAN LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE LANSOPRAZOLE, LANSOPRAZOLE LEFLUNOMIDE, LEFLUNOMIDE
LETROZOLE, LETROZOLE
B - 137
APPENDIX B

** T **
* TEVA PHARMACEUTICALS USA LEVETIRACETAM, LEVETIRACETAM LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LINEZOLID, LINEZOLID LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MEBENDAZOLE, MEBENDAZOLE MEGESTROL ACETATE, MEGESTROL ACETATE MELOXICAM, MELOXICAM METHAZOLAMIDE, METHAZOLAMIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE MONTELUKAST SODIUM, MONTELUKAST SODIUM MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE OLANZAPINE, OLANZAPINE OXALIPLATIN, OXALIPLATIN OXCARBAZEPINE, OXCARBAZEPINE PACLITAXEL, PACLITAXEL PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE PREGABALIN, PREGABALIN PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE PROGESTERONE, PROGESTERONE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE QUINIDINE SULFATE, QUINIDINE SULFATE QUININE SULFATE, QUININE SULFATE RAMIPRIL, RAMIPRIL RISEDRONATE SODIUM, RISEDRONATE SODIUM RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SILDENAFIL CITRATE, SILDENAFIL CITRATE SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH, SULFAMETHOXAZOLE TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TESTOSTERONE, TESTOSTERONE TOPOTECAN, TOPOTECAN HYDROCHLORIDE TRANDOLAPRIL, TRANDOLAPRIL TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE URSODIOL, URSODIOL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VALPROIC ACID, VALPROIC ACID VANDAZOLE, METRONIDAZOLE VARDENAFIL HYDROCHLORIDE, VARDENAFIL HYDROCHLORIDE VORICONAZOLE, VORICONAZOLE
ZALEPLON, ZALEPLON
TEVA PHARMS USA * TEVA PHARMACEUTICALS USA INC ESTRADIOL AND NORETHINDRONE ACETATE, IMIQUIMOD, IMIQUIMOD
ESTRADIOL
TEVA WOMENS * TEVA WOMENS HEALTH INC ENJUVIA, ESTROGENS, CONJUGATED SYNTHETIC B PARAGARD T 380A, COPPER PREFEST, ESTRADIOL SYNTHETIC CONJUGATED ESTROGENS A, ESTROGENS, CONJUGATED SYNTHETIC A ZEBETA, BISOPROLOL FUMARATE
ZIAC, BISOPROLOL FUMARATE
THE PHARMA NETWORK * THE PHARMA NETWORK LLC BENZONATATE, BENZONATATE
B - 138
APPENDIX B
THE PHARMANETWORK * THE PHARMANETWORK LLC METHADONE HYDROCHLORIDE,

** T **
THEPHARMANETWORK LLC * THEPHARMANETWORK LLC THERMAZENE, SILVER SULFADIAZINE THERAKOS * THERAKOS INC UVADEX, METHOXSALEN THERAVANCE INC * THERAVANCE INC VIBATIV, TELAVANCIN HYDROCHLORIDE THREE RIVERS PHARMS * THREE RIVERS PHARMACEUTICALS LLC ANASTROZOLE, ANASTROZOLE RIBASPHERE, RIBAVIRIN RIBAVIRIN, RIBAVIRIN
TOLMAR * TOLMAR INC ADAPALENE, ADAPALENE ATRIDOX, DOXYCYCLINE HYCLATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CALCIPOTRIENE, CALCIPOTRIENE CICLOPIROX, CICLOPIROX CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE ERYTHROMYCIN AND BENZOYL PEROXIDE, BENZOYL PEROXIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE IMIQUIMOD, IMIQUIMOD KETOCONAZOLE, KETOCONAZOLE LEVETIRACETAM, LEVETIRACETAM LIDOCAINE AND PRILOCAINE, LIDOCAINE METRONIDAZOLE, METRONIDAZOLE MOMETASONE FUROATE, MOMETASONE FUROATE
TOLMAR THERAP * TOLMAR THERAPEUTICS INC ELIGARD, LEUPROLIDE ACETATE TORPHARM * TORPHARM INC RANITIDINE HYDROCHLORIDE, TORRENT PHARM * TORRENT PHARMA INC METFORMIN HYDROCHLORIDE,
(OTC)
TORRENT PHARMS * TORRENT PHARMACEUTICALS LIMITED LEVOFLOXACIN, LEVOFLOXACIN * TORRENT PHARMACEUTICALS LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CARBAMAZEPINE, CARBAMAZEPINE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
B - 139
APPENDIX B

** T **
* TORRENT PHARMACEUTICALS LTD RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE
* TORRENT PHARMACEUTICALS LTD. ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE TORRENT PHARMS LLC * TORRENT PHARMACEUTICALS LLC CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) OLANZAPINE, OLANZAPINE
TORRENT PHARMS LTD * TORRENT PHARMACEUTICALS LTD CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE FELODIPINE, FELODIPINE LEVETIRACETAM, LEVETIRACETAM MONTELUKAST SODIUM, MONTELUKAST SODIUM OLANZAPINE, OLANZAPINE QUETIAPINE FUMARATE, QUETIAPINE FUMARATE
SILDENAFIL CITRATE, SILDENAFIL CITRATE
TRIS PHARMA INC * TRIS PHARMA INC CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) DEXTROMETHORPHAN POLISTIREX, DEXTROMETHORPHAN POLISTIREX (OTC) HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX, CHLORPHENIRAMINE POLISTIREX IBUPROFEN, IBUPROFEN (OTC) LEVETIRACETAM, LEVETIRACETAM METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
THEOPHYLLINE, THEOPHYLLINE
TWI PHARMS INC * TWI PHARMACEUTICALS INC CYCLOBENZAPRINE HYDROCHLORIDE,
UCB INC * UCB INC CO-GESIC, ACETAMINOPHEN KEPPRA XR, LEVETIRACETAM KEPPRA, LEVETIRACETAM LORTAB, ACETAMINOPHEN METADATE CD, METHYLPHENIDATE HYDROCHLORIDE METADATE ER, METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE NEUPRO, ROTIGOTINE NIRAVAM, ALPRAZOLAM PARCOPA, CARBIDOPA SEMPREX-D, ACRIVASTINE TUSSIONEX PENNKINETIC, CHLORPHENIRAMINE POLISTIREX UNIRETIC, HYDROCHLOROTHIAZIDE UNIVASC, MOEXIPRIL HYDROCHLORIDE VIMPAT, LACOSAMIDE XYZAL, LEVOCETIRIZINE DIHYDROCHLORIDE
ZAROXOLYN, METOLAZONE
UCYCLYD * UCYCLYD PHARMA INC AMMONUL, SODIUM BENZOATE
B - 140
APPENDIX B
ULURU * ULURU INC APHTHASOL,

** U **
AMLEXANOX
UNICHEM * UNICHEM LABORATORIES LTD BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MELOXICAM, MELOXICAM TOPIRAMATE, TOPIRAMATE
ZALEPLON, ZALEPLON
UNICHEM LABS LTD * UNICHEM LABORATORIES LIMITED DIVALPROEX SODIUM, DIVALPROEX SODIUM * UNICHEM LABORATORIES LTD LAMOTRIGINE, LAMOTRIGINE
UNICHEM PHARMS (USA) * UNICHEM PHARMACEUTICALS (USA) INC BISOPROLOL FUMARATE, BISOPROLOL FUMARATE UNIQUE PHARM LABS * UNIQUE PHARMACEUTICAL LABORATORIES ATENOLOL, ATENOLOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM
FLUCONAZOLE, FLUCONAZOLE
UNITED GUARDIAN * UNITED GUARDIAN INC RENACIDIN, CITRIC ACID UNITED THERAP * UNITED THERAPEUTICS CORP REMODULIN, TREPROSTINIL SODIUM
TYVASO, TREPROSTINIL SODIUM
UPSHER SMITH * UPSHER SMITH LABORATORIES INC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE DIVALPROEX SODIUM, DIVALPROEX SODIUM DIVIGEL, ESTRADIOL FORTICAL, CALCITONIN SALMON RECOMBINANT LAMOTRIGINE, LAMOTRIGINE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM NIACOR, NIACIN NYSTATIN, NYSTATIN ORVATEN, MIDODRINE HYDROCHLORIDE OXANDROLONE, OXANDROLONE PACERONE, AMIODARONE HYDROCHLORIDE PENTOXIL, PENTOXIFYLLINE PREVALITE, CHOLESTYRAMINE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE SORINE, SOTALOL HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE
ZALEPLON, ZALEPLON
UPSHER SMITH LABS * UPSHER SMITH LABORATORIES INC KLOR-CON M10, POTASSIUM CHLORIDE
KLOR-CON M15, POTASSIUM CHLORIDE
B - 141
APPENDIX B

** U **
* UPSHER SMITH LABORATORIES INC KLOR-CON M20, POTASSIUM CHLORIDE UPSHER-SMITH LABS * UPSHER-SMITH LABORATORIES INC KLOR-CON, POTASSIUM CHLORIDE US PHARMS HOLDINGS I * US PHARMACEUTICALS HOLDINGS I LLC LOPRESSOR HCT, HYDROCHLOROTHIAZIDE LOPRESSOR, METOPROLOL TARTRATE LOTENSIN HCT, BENAZEPRIL HYDROCHLORIDE LOTENSIN, BENAZEPRIL HYDROCHLORIDE METHERGINE, METHYLERGONOVINE MALEATE
PARLODEL, BROMOCRIPTINE MESYLATE
US WORLDMEDS * US WORLDMEDS LLC APOKYN, APOMORPHINE HYDROCHLORIDE
DANTROLENE SODIUM, DANTROLENE SODIUM
USL PHARMA * USL PHARMA INC AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE BACLOFEN, BACLOFEN BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE ESTRADIOL, ESTRADIOL FLUOXYMESTERONE, FLUOXYMESTERONE JANTOVEN, WARFARIN SODIUM MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE
OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
VALEANT * VALEANT PHARMACEUTICALS INTERNATIONAL ANCOBON, FLUCYTOSINE BONTRIL PDM, PHENDIMETRAZINE TARTRATE
BONTRIL, PHENDIMETRAZINE TARTRATE
D.H.E. 45, DIHYDROERGOTAMINE MESYLATE
DIASTAT ACUDIAL, DIAZEPAM
DIASTAT, DIAZEPAM
MIGRANAL, DIHYDROERGOTAMINE MESYLATE
MOTOFEN, ATROPINE SULFATE
MYSOLINE, PRIMIDONE
PHRENILIN FORTE, ACETAMINOPHEN
PHRENILIN WITH CAFFEINE AND CODEINE, ACETAMINOPHEN
VALEANT BERMUDA * VALEANT INTERNATIONAL BERMUDA CARAC, FLUOROURACIL DERMATOP E EMOLLIENT, PREDNICARBATE DERMATOP, PREDNICARBATE ELIDEL, PIMECROLIMUS NORITATE, METRONIDAZOLE
XENAZINE, TETRABENAZINE
VALEANT INTL * VALEANT INTERNATIONAL BARBADOS SRL ATIVAN, LORAZEPAM BENZAMYCIN PAK, BENZOYL PEROXIDE CARDIZEM CD, DILTIAZEM HYDROCHLORIDE CARDIZEM LA, DILTIAZEM HYDROCHLORIDE CARDIZEM, DILTIAZEM HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE ERTACZO, SERTACONAZOLE NITRATE FENOFIBRATE, FENOFIBRATE
ISORDIL, ISOSORBIDE DINITRATE
B - 142
APPENDIX B

** V **
* VALEANT INTERNATIONAL BARBADOS SRL NIFEDIPINE, NIFEDIPINE PENTOXIFYLLINE, PENTOXIFYLLINE RENOVA, TRETINOIN RETIN-A MICRO, TRETINOIN RETIN-A, TRETINOIN TIAZAC, DILTIAZEM HYDROCHLORIDE ULTRAM ER, TRAMADOL HYDROCHLORIDE VASERETIC, ENALAPRIL MALEATE VASOTEC, ENALAPRIL MALEATE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE WELLBUTRIN XL, BUPROPION HYDROCHLORIDE XERESE, ACYCLOVIR
ZOVIRAX, ACYCLOVIR
* VALEANT INTERNATIONAL SRL APLENZIN, BUPROPION HYDROBROMIDE BENZACLIN, BENZOYL PEROXIDE
BENZAMYCIN, BENZOYL PEROXIDE
VALEANT LUXEMBOURG * VALEANT PHARMACEUTICALS LUXEMBOURG SARL GRIFULVIN V, GRISEOFULVIN, MICROSIZE VALEANT PHARM INTL * VALEANT PHARMACEUTICALS INTERNATIONAL 8-MOP, METHOXSALEN ANDROID 10, METHYLTESTOSTERONE ANDROID 25, METHYLTESTOSTERONE EFUDEX, FLUOROURACIL LIBRIUM, CHLORDIAZEPOXIDE HYDROCHLORIDE MESTINON, PYRIDOSTIGMINE BROMIDE OXSORALEN, METHOXSALEN OXSORALEN-ULTRA, METHOXSALEN TENSILON PRESERVATIVE FREE, EDROPHONIUM CHLORIDE TENSILON, EDROPHONIUM CHLORIDE TESTRED, METHYLTESTOSTERONE VIRAZOLE, RIBAVIRIN
ZELAPAR, SELEGILINE HYDROCHLORIDE
VALEANT PHARM NORTH * VALEANT PHARMACEUTICAL NORTH AMERICA LLC GRIFULVIN V, GRISEOFULVIN, MICROSIZE VALEANT PHARMS * VALEANT PHARMACEUTICALS NORTH AMERICA MEPHYTON, PHYTONADIONE VALEANT PHARMS INC * VALEANT PHARMACEUTICALS INTERNATIONAL INC VISUDYNE, VERTEPORFIN VALEANT PHARMS LLC * VALEANT PHARMACEUTICALS NORTH AMERICA LLC CAPITAL AND CODEINE, ACETAMINOPHEN MACUGEN, PEGAPTANIB SODIUM MESTINON, PYRIDOSTIGMINE BROMIDE TASMAR, TOLCAPONE
TIMOPTIC-XE, TIMOLOL MALEATE
VALIDUS PHARMS * VALIDUS PHARMACEUTICALS LLC ROCALTROL, CALCITRIOL VALIDUS PHARMS INC * VALIDUS PHARMACEUTICALS INC EQUETRO, CARBAMAZEPINE
MARPLAN, ISOCARBOXAZID
B - 143
APPENDIX B
VANSEN PHARMA * VANSEN PHARMA SPECTRACEF,

** V **
CEFDITOREN PIVOXIL
VEROSCIENCE * VEROSCIENCE LLC CYCLOSET, BROMOCRIPTINE MESYLATE VERSAPHARM * VERSAPHARM INC CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE DESOXIMETASONE, DESOXIMETASONE ERYTHROMYCIN, ERYTHROMYCIN ETHOSUXIMIDE, ETHOSUXIMIDE
RIFAMPIN, RIFAMPIN
VERSAPHARM INC * VERSAPHARM INC RIFAMPIN, RIFAMPIN * VERSAPHARM INCORPORATED TRANEXAMIC ACID, TRANEXAMIC ACID VERTEX PHARMS * VERTEX PHARMACEUTICALS INC INCIVEK, TELAPREVIR
KALYDECO, IVACAFTOR
VESTIQ PHARMS * VESTIQ PHARMACEUTICALS INC ORAVIG, MICONAZOLE
ZUPLENZ, ONDANSETRON
VICURON * VICURON PHARMACEUTICALS INC ERAXIS, ANIDULAFUNGIN VIIV HLTHCARE * VIIV HEALTHCARE CO COMBIVIR, LAMIVUDINE EPIVIR, LAMIVUDINE EPZICOM, ABACAVIR SULFATE LEXIVA, FOSAMPRENAVIR CALCIUM RESCRIPTOR, DELAVIRDINE MESYLATE RETROVIR, ZIDOVUDINE SELZENTRY, MARAVIROC TRIZIVIR, ABACAVIR SULFATE
ZIAGEN, ABACAVIR SULFATE
VINTAGE * VINTAGE PHARMACEUTICALS LLC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETIC ACID, ACETIC ACID, GLACIAL ALBUTEROL SULFATE, ALBUTEROL SULFATE ALPRAZOLAM, ALPRAZOLAM AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE DIVALPROEX SODIUM, DIVALPROEX SODIUM FOLIC ACID, FOLIC ACID GLIMEPIRIDE, GLIMEPIRIDE GLYCOPYRROLATE, GLYCOPYRROLATE HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL HYDROCORTISONE, HYDROCORTISONE LIDOCAINE HYDROCHLORIDE VISCOUS, LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE
B - 144
APPENDIX B

** V **
* VINTAGE PHARMACEUTICALS LLC LISINOPRIL, LISINOPRIL NYSTATIN, NYSTATIN PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE, PREDNISOLONE PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE DM, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROMETHAZINE WITH CODEINE, CODEINE PHOSPHATE RISPERIDONE, RISPERIDONE SPIRONOLACTONE, SPIRONOLACTONE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE VALPROIC ACID, VALPROIC ACID VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
VINTAGE PHARMS * VINTAGE PHARMACEUTICALS DISULFIRAM, DISULFIRAM GILDAGIA, ETHINYL ESTRADIOL GRISEOFULVIN, GRISEOFULVIN, MICROSIZE LEVETIRACETAM, LEVETIRACETAM
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
* VINTAGE PHARMACEUTICALS INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ALLOPURINOL, ALLOPURINOL AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE BACLOFEN, BACLOFEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN CARISOPRODOL, CARISOPRODOL CLONAZEPAM, CLONAZEPAM CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DEXAMETHASONE, DEXAMETHASONE DIAZEPAM, DIAZEPAM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE FUROSEMIDE, FUROSEMIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE HYDROCORTISONE, HYDROCORTISONE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE LACTULOSE, LACTULOSE LEVETIRACETAM, LEVETIRACETAM LORAZEPAM, LORAZEPAM MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METHOCARBAMOL, METHOCARBAMOL METHYLPREDNISOLONE, METHYLPREDNISOLONE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE NYSTATIN, NYSTATIN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE PERPHENAZINE, PERPHENAZINE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PREDNISONE, PREDNISONE PRIMIDONE, PRIMIDONE
B - 145
APPENDIX B

** V **
* VINTAGE PHARMACEUTICALS INC PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SULFASALAZINE, SULFASALAZINE TORSEMIDE, TORSEMIDE
VINTAGE PHARMS LLC * VINTAGE PHARMACEUTICALS LLC CYCLAFEM 1/35, ETHINYL ESTRADIOL CYCLAFEM 7/7/7, ETHINYL ESTRADIOL EMOQUETTE, DESOGESTREL FELODIPINE, FELODIPINE GILDESS FE 1.5/30, ETHINYL ESTRADIOL GILDESS FE 1/20, ETHINYL ESTRADIOL LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM MONTELUKAST SODIUM, MONTELUKAST SODIUM MORPHINE SULFATE, MORPHINE SULFATE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL MYZILRA, ETHINYL ESTRADIOL ORSYTHIA, ETHINYL ESTRADIOL PERCOCET, ACETAMINOPHEN PREVIFEM, ETHINYL ESTRADIOL TRI-PREVIFEM, ETHINYL ESTRADIOL
ZYDONE, ACETAMINOPHEN
VIROPHARMA * VIROPHARMA INC VANCOCIN HYDROCHLORIDE,
VISTA PHARMS * VISTA PHARMACEUTICALS INC SULFAMETHOXAZOLE AND TRIMETHOPRIM,
SULFAMETHOXAZOLE
VISTAPHARM * VISTAPHARM INC ALBUTEROL SULFATE, ALBUTEROL SULFATE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN LACTULOSE, LACTULOSE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE NYSTATIN, NYSTATIN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
PHENYTOIN, PHENYTOIN
VIVUS * VIVUS INC QSYMIA, PHENTERMINE HYDROCHLORIDE
STENDRA, AVANAFIL
WARNER CHILCOTT * WARNER CHILCOTT INC LOESTRIN 24 FE, ETHINYL ESTRADIOL
LOESTRIN FE 1/20, ETHINYL ESTRADIOL
WARNER CHILCOTT LLC * WARNER CHILCOTT CO LLC ACTONEL, RISEDRONATE SODIUM ASACOL HD, MESALAMINE ASACOL, MESALAMINE ATELVIA, RISEDRONATE SODIUM CHOLEDYL SA, OXTRIPHYLLINE ENABLEX, DARIFENACIN HYDROBROMIDE ERYC, ERYTHROMYCIN ESTROSTEP FE, ETHINYL ESTRADIOL
FEMCON FE, ETHINYL ESTRADIOL
B - 146
APPENDIX B

** W **
* WARNER CHILCOTT CO LLC FEMHRT, ETHINYL ESTRADIOL FEMTRACE, ESTRADIOL ACETATE LO LOESTRIN FE, ETHINYL ESTRADIOL LOESTRIN 21 1.5/30, ETHINYL ESTRADIOL LOESTRIN 21 1/20, ETHINYL ESTRADIOL LOESTRIN FE 1.5/30, ETHINYL ESTRADIOL OVCON-35, ETHINYL ESTRADIOL OVCON-50, ETHINYL ESTRADIOL
SARAFEM, FLUOXETINE HYDROCHLORIDE
WARNER CHILCOTT US * WARNER CHILCOTT US LLC ESTRACE, ESTRADIOL WARNER IRELAND * WARNER CHILCOTT IRELAND LTD FEMRING, ESTRADIOL ACETATE WATSON LABS * WATSON LABORATORIES ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE, ACETAMINOPHEN ALENDRONATE SODIUM, ALENDRONATE SODIUM ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ANASTROZOLE, ANASTROZOLE CARVEDILOL, CARVEDILOL FOLIC ACID, FOLIC ACID LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MICROGESTIN 1.5/30, ETHINYL ESTRADIOL MICROGESTIN 1/20, ETHINYL ESTRADIOL MICROGESTIN FE 1.5/30, ETHINYL ESTRADIOL MICROGESTIN FE 1/20, ETHINYL ESTRADIOL NORCO, ACETAMINOPHEN NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL OXAPROZIN, OXAPROZIN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE
* WATSON LABORATORIES INC ACARBOSE, ACARBOSE ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE ACETOHEXAMIDE, ACETOHEXAMIDE ACYCLOVIR, ACYCLOVIR AFEDITAB CR, NIFEDIPINE ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALENDRONATE SODIUM, ALENDRONATE SODIUM ALLOPURINOL, ALLOPURINOL ALORA, ESTRADIOL AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXAPINE, AMOXAPINE ANDRODERM, TESTOSTERONE ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL BACLOFEN, BACLOFEN BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BREVICON 28-DAY, ETHINYL ESTRADIOL BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN CABERGOLINE, CABERGOLINE CAPTOPRIL, CAPTOPRIL
CARBOPLATIN, CARBOPLATIN
B - 147
APPENDIX B

** W **
* WATSON LABORATORIES INC CARISOPRODOL, CARISOPRODOL CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORZOXAZONE, CHLORZOXAZONE CICLOPIROX, CICLOPIROX CIMETIDINE, CIMETIDINE CIMETIDINE, CIMETIDINE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM COL-PROBENECID, COLCHICINE CRINONE, PROGESTERONE CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYCLOSPORINE, CYCLOSPORINE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL DIAZEPAM, DIAZEPAM DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DILACOR XR, DILTIAZEM HYDROCHLORIDE DIMENHYDRINATE, DIMENHYDRINATE DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE DOXYCYCLINE, DOXYCYCLINE DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE ENALAPRIL MALEATE, ENALAPRIL MALEATE ERGOLOID MESYLATES, ERGOLOID MESYLATES ESTAZOLAM, ESTAZOLAM ESTRADIOL CYPIONATE, ESTRADIOL CYPIONATE ESTRADIOL VALERATE, ESTRADIOL VALERATE ESTRADIOL, ESTRADIOL ESTRONE, ESTRONE ESTROPIPATE, ESTROPIPATE FAMCICLOVIR, FAMCICLOVIR FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FENTANYL CITRATE, FENTANYL CITRATE FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE FOSINOPRIL SODIUM, FOSINOPRIL SODIUM FUROSEMIDE, FUROSEMIDE GABAPENTIN, GABAPENTIN GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GELNIQUE, OXYBUTYNIN CHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GEMFIBROZIL, GEMFIBROZIL GLIMEPIRIDE, GLIMEPIRIDE GLIPIZIDE, GLIPIZIDE GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN
HYDROXOCOBALAMIN, HYDROXOCOBALAMIN
B - 148
APPENDIX B

** W **
* WATSON LABORATORIES INC HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) INDAPAMIDE, INDAPAMIDE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ISONIAZID, ISONIAZID ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE ISRADIPINE, ISRADIPINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) LEVORA 0.15/30-28, ETHINYL ESTRADIOL LISINOPRIL, LISINOPRIL LORAZEPAM, LORAZEPAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOW-OGESTREL-21, ETHINYL ESTRADIOL LOW-OGESTREL-28, ETHINYL ESTRADIOL LOXAPINE SUCCINATE, LOXAPINE SUCCINATE MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM MELOXICAM, MELOXICAM MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE MEPROBAMATE, MEPROBAMATE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METHOCARBAMOL, METHOCARBAMOL METHYLDOPA, METHYLDOPA METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE METHYLPREDNISOLONE, METHYLPREDNISOLONE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE METRONIDAZOLE, METRONIDAZOLE MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE MICROZIDE, HYDROCHLOROTHIAZIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MINOXIDIL, MINOXIDIL MIRTAZAPINE, MIRTAZAPINE MORPHINE SULFATE, MORPHINE SULFATE NABUMETONE, NABUMETONE NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN, NAPROXEN NATEGLINIDE, NATEGLINIDE NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE NIZATIDINE, NIZATIDINE NORCO, ACETAMINOPHEN NORETHIN 1/35E-21, ETHINYL ESTRADIOL NORETHIN 1/35E-28, ETHINYL ESTRADIOL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (10/11), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (7/14), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL
NORINYL 1+35 21-DAY, ETHINYL ESTRADIOL
B - 149
APPENDIX B

** W **
* WATSON LABORATORIES INC NORINYL 1+35 28-DAY, ETHINYL ESTRADIOL NORINYL 1+50 28-DAY, MESTRANOL NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE OGESTREL 0.5/50-28, ETHINYL ESTRADIOL ORPHENADRINE CITRATE, ORPHENADRINE CITRATE OXAZEPAM, OXAZEPAM OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE AND ASPIRIN, ASPIRIN OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN PENTAMIDINE ISETHIONATE, PENTAMIDINE ISETHIONATE PENTAZOCINE AND NALOXONE HYDROCHLORIDES, NALOXONE HYDROCHLORIDE PENTOXIFYLLINE, PENTOXIFYLLINE PINDOLOL, PINDOLOL PIROXICAM, PIROXICAM PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PREDNISOLONE, PREDNISOLONE PREDNISONE, PREDNISONE PRIMIDONE, PRIMIDONE PROBENECID, PROBENECID PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE QUASENSE, ETHINYL ESTRADIOL QUINIDINE GLUCONATE, QUINIDINE GLUCONATE QUINIDINE SULFATE, QUINIDINE SULFATE RAMIPRIL, RAMIPRIL RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RAPAFLO, SILODOSIN RISPERIDONE, RISPERIDONE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SULFASALAZINE, SULFASALAZINE SULINDAC, SULINDAC SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TACROLIMUS, TACROLIMUS TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TEMAZEPAM, TEMAZEPAM TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE THIOTHIXENE, THIOTHIXENE TOLAZAMIDE, TOLAZAMIDE TOPIRAMATE, TOPIRAMATE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRANDOLAPRIL, TRANDOLAPRIL TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRELSTAR, TRIPTORELIN PAMOATE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRIAZOLAM, TRIAZOLAM TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE TRIMETHOPRIM, TRIMETHOPRIM TRI-NORINYL 28-DAY, ETHINYL ESTRADIOL TRIVORA-28, ETHINYL ESTRADIOL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VECURONIUM BROMIDE, VECURONIUM BROMIDE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
B - 150
APPENDIX B
*
** W **
WATSON LABORATORIES INC ZOVIA 1/35E-28, ETHINYL ESTRADIOL

ZOVIA 1/50E-28, ETHINYL ESTRADIOL
* WATSON LABS INC LISINOPRIL AND HYDROCHLOROTHIAZIDE, WATSON LABS (UTAH) * WATSON LABORATORIES INC INFED, IRON DEXTRAN NOR-QD, NORETHINDRONE OXYTROL, OXYBUTYNIN
PROGESTERONE, PROGESTERONE
HYDROCHLOROTHIAZIDE
WATSON LABS FLORIDA * WATSON LABORATORIES INC FLORIDA ALPRAZOLAM, ALPRAZOLAM BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CARTIA XT, DILTIAZEM HYDROCHLORIDE CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CLARITHROMYCIN, CLARITHROMYCIN DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIVALPROEX SODIUM, DIVALPROEX SODIUM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GLIMEPIRIDE, GLIMEPIRIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE KETOPROFEN, KETOPROFEN LEVETIRACETAM, LEVETIRACETAM LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE MIRTAZAPINE, MIRTAZAPINE OMEPRAZOLE, OMEPRAZOLE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RISPERIDONE, RISPERIDONE TAMOXIFEN CITRATE, TAMOXIFEN CITRATE
TAZTIA XT, DILTIAZEM HYDROCHLORIDE
WATSON LABS INC * WATSON LABORATORIES INC ALBUTEROL SULFATE, ALBUTEROL SULFATE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMMONIUM LACTATE, AMMONIUM LACTATE ANTUROL, OXYBUTYNIN ARMODAFINIL, ARMODAFINIL BUDESONIDE, BUDESONIDE CICLOPIROX, CICLOPIROX CYCLOSPORINE, CYCLOSPORINE DICLOFENAC SODIUM AND MISOPROSTOL, DICLOFENAC SODIUM FIORICET W/ CODEINE, ACETAMINOPHEN FIORINAL W/CODEINE, ASPIRIN FIORINAL, ASPIRIN IBANDRONATE SODIUM, IBANDRONATE SODIUM IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE IRBESARTAN, IRBESARTAN LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) LIDOCAINE, LIDOCAINE
METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
B - 151
APPENDIX B

** W **
ETHINYL ESTRADIOL
* WATSON LABORATORIES INC NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, PREGABALIN, PREGABALIN PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SILDENAFIL CITRATE, SILDENAFIL CITRATE
URSODIOL, URSODIOL
WATSON LABS INC FL * WATSON LABORATORIES INC FLORIDA DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE FLUTAMIDE, FLUTAMIDE TRANEXAMIC ACID, TRANEXAMIC ACID
WATSON PHARMS * WATSON PHARMACEUTICALS TENUATE DOSPAN, DIETHYLPROPION HYDROCHLORIDE
TENUATE, DIETHYLPROPION HYDROCHLORIDE
* WATSON PHARMACEUTICALS INC ACTIGALL, URSODIOL CONDYLOX, PODOFILOX CORDRAN, FLURANDRENOLIDE
FIORICET, ACETAMINOPHEN
WE PHARMS * WE PHARMACEUTICALS INC PREDNISOLONE SODIUM PHOSPHATE,
WEILL MEDCL COLL * WEILL MEDICAL COLLEGE CORNELL UNIV FLUDEOXYGLUCOSE F 18, FLUDEOXYGLUCOSE F-18 WELLSPRING PHARM * WELLSPRING PHARMACEUTICAL CORP DIBENZYLINE, PHENOXYBENZAMINE HYDROCHLORIDE DUVOID, BETHANECHOL CHLORIDE
DYRENIUM, TRIAMTERENE
WEST WARD * WEST WARD INC ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE
ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE
* WEST WARD PHARMACEUTICAL CORP AMINOPHYLLINE, AMINOPHYLLINE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, BUTALBITAL, ASPIRIN AND CAFFEINE, ASPIRIN CAPTOPRIL, CAPTOPRIL CARISOPRODOL, CARISOPRODOL CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CHLOROTHIAZIDE, CHLOROTHIAZIDE CORTISONE ACETATE, CORTISONE ACETATE DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DIGOXIN, DIGOXIN DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE FOLIC ACID, FOLIC ACID GLYCOPYRROLATE, GLYCOPYRROLATE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCORTISONE, HYDROCORTISONE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE ISONIAZID, ISONIAZID ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL
LITHIUM CARBONATE, LITHIUM CARBONATE
ACETAMINOPHEN
B - 152
APPENDIX B

** W **
* WEST WARD PHARMACEUTICAL CORP MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE METHOCARBAMOL, METHOCARBAMOL PREDNISONE, PREDNISONE PRIMIDONE, PRIMIDONE PROPYLTHIOURACIL, PROPYLTHIOURACIL TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE
ZALEPLON, ZALEPLON
WEST WARD PHARM CORP * WEST WARD PHARMACEUTICAL CORP PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE
WEST WARD PHARMS * WEST WARD PHARMACEUTICALS CORP RISPERIDONE, RISPERIDONE WESTWARD * WESTWARD PHARMACEUTICAL CORP NAPROXEN, NAPROXEN
RIFAMPIN AND ISONIAZID, ISONIAZID
WEST-WARD PHARM CORP * WEST-WARD PHARMACEUTICAL CORP CEFOTETAN, CEFOTETAN DISODIUM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE
WOCKHARDT * WOCKHARDT AMERICAS INC CAPTOPRIL, CAPTOPRIL FAMOTIDINE, FAMOTIDINE
* WOCKHARDT EU OPERATIONS (SWISS) AG ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETIC ACID, ACETIC ACID, GLACIAL ALBUTEROL SULFATE, ALBUTEROL SULFATE AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN BROMFED-DM, BROMPHENIRAMINE MALEATE CARBAMAZEPINE, CARBAMAZEPINE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOSPORINE, CYCLOSPORINE DEXAMETHASONE, DEXAMETHASONE DEXCHLORPHENIRAMINE MALEATE, DEXCHLORPHENIRAMINE MALEATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE ERYTHROMYCIN, ERYTHROMYCIN FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FUROSEMIDE, FUROSEMIDE HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LINDANE, LINDANE LITHIUM CITRATE, LITHIUM CITRATE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) LORATADINE, LORATADINE (OTC) MEGESTROL ACETATE, MEGESTROL ACETATE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE
METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE
B - 153
APPENDIX B

** W **
* WOCKHARDT EU OPERATIONS (SWISS) AG MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) NYSTATIN, NYSTATIN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE PHENYTOIN, PHENYTOIN PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE, PREDNISOLONE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE PLAIN, PROMETHAZINE HYDROCHLORIDE PROMETHAZINE W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE SELENIUM SULFIDE, SELENIUM SULFIDE TRETINOIN, TRETINOIN TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
* WOCKHARDT LTD ADENOSINE, ADENOSINE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AZITHROMYCIN, AZITHROMYCIN BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE CARVEDILOL, CARVEDILOL CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFOTAXIME, CEFOTAXIME SODIUM CEFPROZIL, CEFPROZIL CEFTAZIDIME, CEFTAZIDIME CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME AXETIL, CEFUROXIME AXETIL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CLARITHROMYCIN, CLARITHROMYCIN DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM FAMOTIDINE, FAMOTIDINE (OTC) FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FUROSEMIDE, FUROSEMIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LISINOPRIL, LISINOPRIL METOPROLOL SUCCINATE, METOPROLOL SUCCINATE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE NIACIN, NIACIN NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TIMOLOL MALEATE, TIMOLOL MALEATE VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
B - 154
APPENDIX B

** W **
WOCKHARDT LTD * WOCKHARDT LTD ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE ENTACAPONE, ENTACAPONE FELODIPINE, FELODIPINE FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) LAMOTRIGINE, LAMOTRIGINE LANSOPRAZOLE, LANSOPRAZOLE (OTC) ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
WOCKHARDT USA * WOCKHARDT USA INC EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE
* WOCKHARDT USA LLC ENALAPRIL MALEATE, ENALAPRIL MALEATE LANSOPRAZOLE, LANSOPRAZOLE
WORLD GEN * WORLD GEN LLC AMLODIPINE BESYLATE,
AMLODIPINE BESYLATE
WRASER PHARMS * WRASER PHARMACEUTICALS LLC CETRAXAL, CIPROFLOXACIN HYDROCHLORIDE WRASER PHARMS LLC * WRASER PHARMACEUTICALS LLC ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, WYETH PHARMS * WYETH PHARMACEUTICALS INC SUB PFIZER INC LO/OVRAL-28, ETHINYL ESTRADIOL WYETH PHARMS INC * WYETH PHARMACEUTICALS INC BOSULIF, BOSUTINIB MONOHYDRATE CORDARONE, AMIODARONE HYDROCHLORIDE EFFEXOR XR, VENLAFAXINE HYDROCHLORIDE PHOSPHOLINE IODIDE, ECHOTHIOPHATE IODIDE PREMARIN, ESTROGENS, CONJUGATED PREMPHASE 14/14, ESTROGENS, CONJUGATED PREMPRO, ESTROGENS, CONJUGATED PRISTIQ, DESVENLAFAXINE SUCCINATE PROTONIX IV, PANTOPRAZOLE SODIUM PROTONIX, PANTOPRAZOLE SODIUM RAPAMUNE, SIROLIMUS TORISEL, TEMSIROLIMUS TRECATOR, ETHIONAMIDE TYGACIL, TIGECYCLINE ZOSYN IN PLASTIC CONTAINER, PIPERACILLIN SODIUM
ZOSYN, PIPERACILLIN SODIUM
X GEN PHARMS * X GEN PHARMACEUTICALS INC ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM AMPHOTERICIN B, AMPHOTERICIN B
BACIIM, BACITRACIN
ACETAMINOPHEN
B - 155
APPENDIX B

** X **
* X GEN PHARMACEUTICALS INC BACI-RX, BACITRACIN COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE HYDRO-RX, HYDROCORTISONE LEVETIRACETAM, LEVETIRACETAM LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM NEO-FRADIN, NEOMYCIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE NEOMYCIN SULFATE, NEOMYCIN SULFATE NEO-RX, NEOMYCIN SULFATE NYSTATIN, NYSTATIN POLYMYXIN B SULFATE, POLYMYXIN B SULFATE POLY-RX, POLYMYXIN B SULFATE STREPTOMYCIN SULFATE, STREPTOMYCIN SULFATE
TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE
X-GEN PHARMS * X-GEN PHARMACEUTICALS INC PHENYTOIN SODIUM, PHENYTOIN SODIUM
XOMA * XOMA (US) LLC ACEON, PERINDOPRIL ERBUMINE XSPIRE * XSPIRE LLC NALFON, FENOPROFEN CALCIUM XTTRIUM * XTTRIUM LABORATORIES INC CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE DYNA-HEX, CHLORHEXIDINE GLUCONATE (OTC)
EXIDINE, CHLORHEXIDINE GLUCONATE (OTC)
YUNG SHIN PHARM * YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD CEFACLOR, CEFACLOR
CEPHALEXIN, CEPHALEXIN
ZAMBON SPA * ZAMBON SPA ITALY MONUROL, FOSFOMYCIN TROMETHAMINE ZARS PHARM * ZARS PHARMA INC SYNERA, LIDOCAINE ZOGENIX INC * ZOGENIX INC SUMAVEL DOSEPRO,
ZYDUS PHARMS USA * ZYDUS PHARMACEUTICALS USA INC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ATENOLOL, ATENOLOL AZATHIOPRINE, AZATHIOPRINE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BENZONATATE, BENZONATATE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE MELOXICAM, MELOXICAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NAPROXEN, NAPROXEN PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM
B - 156
APPENDIX B

** Z **
* ZYDUS PHARMACEUTICALS USA INC RAMIPRIL, RAMIPRIL RIBAVIRIN, RIBAVIRIN RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE WARFARIN SODIUM, WARFARIN SODIUM
ZYDUS PHARMS USA INC * ZYDUS PHARMACEUTICALS USA INC ACETAZOLAMIDE, ACETAZOLAMIDE ALPRAZOLAM, ALPRAZOLAM AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE ANASTROZOLE, ANASTROZOLE BICALUTAMIDE, BICALUTAMIDE BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE CARVEDILOL, CARVEDILOL CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE DIPYRIDAMOLE, DIPYRIDAMOLE DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE ETHOSUXIMIDE, ETHOSUXIMIDE FINASTERIDE, FINASTERIDE GABAPENTIN, GABAPENTIN GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE INDOMETHACIN, INDOMETHACIN IRBESARTAN, IRBESARTAN LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM OMEPRAZOLE, OMEPRAZOLE PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE RAMIPRIL, RAMIPRIL RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
C-1
APPENDIX C
UNIFORM TERMS
DOSAGE FORMS
AEROSOL AEROSOL, FOAM AEROSOL, METERED CAPSULE CAPSULE, DELAYED REL PELLETS CAPSULE, DELAYED RELEASE CAPSULE, EXTENDED RELEASE CLOTH CONCENTRATE CREAM CREAM, AUGMENTED ELIXIR EMULSION ENEMA FILM FILM, EXTENDED RELEASE FOR SOLUTION FOR SUSPENSION FOR SUSPENSION, DELAYED RELEASE FOR SUSPENSION, EXTENDED RELEASE GAS GEL GEL, AUGMENTED GEL, METERED GRANULE GRANULE, DELAYED RELEASE GUM, CHEWING IMPLANT INHALANT INJECTABLE INJECTABLE, LIPID COMPLEX INJECTABLE, LIPOSOMAL INJECTABLE, TABLET INSERT INSERT, EXTENDED RELEASE INTRAUTERINE DEVICE JELLY LIQUID LOTION LOTION, AUGMENTED Note: Terms comprise currently marketed products LOTION/SHAMPOO OIL OIL/DROPS OINTMENT OINTMENT, AUGMENTED PASTE PATCH PELLET POWDER POWDER, EXTENDED RELEASE POWDER, METERED RING SHAMPOO SOLUTION SOLUTION FOR SLUSH SOLUTION, GEL FORMING/DROPS SOLUTION, METERED SOLUTION/DROPS SPONGE SPRAY SPRAY, METERED SUPPOSITORY SUSPENSION SUSPENSION, EXTENDED RELEASE SUSPENSION/DROPS SWAB SYRUP SYSTEM, EXTENDED RELEASE TABLET TABLET, CHEWABLE TABLET, COATED PARTICLES TABLET, DELAYED RELEASE TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING TABLET, EFFERVESCENT TABLET, EXTENDED RELEASE TABLET, FOR SUSPENSION TABLET, ORALLY DISINTEGRATING TAPE TROCHE/LOZENGE
C-2
APPENDIX C UNIFORM TERMS ROUTES OF ADMINISTRATION

BUCCAL DENTAL ENDOCERVICAL FOR RX COMPOUNDING IMPLANTATION INHALATION INJECTION INTRA-ANAL INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL INTRACRANIAL INTRAMUSCULAR INTRAOCULAR INTRAPERITONEAL INTRAPLEURAL INTRATHECAL INTRATRACHEAL INTRAUTERINE INTRAVENOUS INTRAVESICAL INTRAVITREAL Note: Terms comprise currently marketed products IRRIGATION IV (INFUSION) N/A NASAL OPHTHALMIC ORAL ORAL-21 ORAL-28 OTIC PERFUSION, CARDIAC PERIODONTAL RECTAL SPINAL SUBCUTANEOUS SUBLINGUAL TOPICAL TRANSDERMAL TRANSMUCOSAL URETHRAL VAGINAL
C-3
APPENDIX C
UNIFORM TERMS
ABBREVIATIONS
AMP AMPICIL APPROX BOT CI CSR CU DIPROP ELECT EQ ER GM HBR HCL HR IM INH IU IV KIU MCG MCI MEQ MG ML N/A PPM REL SC SQ CM U UCI UMOLAR USP
AMPULE AMPICILLIN APPROXIMATELY BOTTLE CURIE CAROTID SINUS REFLEX CLINICAL UNITS DIPROPIONATE ELECTROLYTE EQUIVALENT TO EXTENDED RELEASE GRAM HYDROBROMIDE HYDROCHLORIDE HOUR INTRAMUSCULAR INHALATION INTERNATIONAL UNITS INTRAVENOUS KALLIKREIN INHIBITOR UNITS MICROGRAM MILLICURIE MILLIEQUIVALENT MILLIGRAM MILLILITER NOT APPLICABLE PARTS PER MILLION RELEASE SUBCUTANEOUS SQUARE CENTIMETER UNITS MICROCURIE MICROMOLAR UNITED STATES PHARMACOPEIA
PATENT AND EXCLUSIVITY INFORMATION ADDENDUM
This Addendum identifies drugs that qualify under the Drug Price Competition and Patent Term Restoration Act (1984 Amendments) for periods of exclusivity, during which abbreviated new drug applications (ANDAs) and applications described in Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (the Act) for those drug products may, in some instances, not be submitted or made effective as described below, and provides patent information concerning the listed drug products. Those drugs that have qualified for Orphan Drug Exclusivity pursuant to Section 527 of the Act and those drugs that have qualified for Pediatric Exclusivity pursuant to Section 505A are also included in this Addendum. This section is arranged in alphabetical order by active ingredient name followed the trade name. Active ingredient headings for multiple ingredient (combination) drug products are arranged alphabetically. For an explanation of the codes used in the Addendum, see the Patent and Exclusivity Terms Section. Exclusivity prevents the submission or effective approval of ANDAs or applications described in Section 505(b)(2) of the Act. It does not prevent the submission or approval of a second 505(b)(1) application except in the case of Orphan Drug exclusivity. Applications qualifying for periods of exclusivity are:
(1) A new drug application approved after September 24, 1984, for a drug product all active ingredients (including any ester or salt of the active ingredient) of which had never been approved in any other new drug application under Section 505 (b) of the Act. No subsequent ANDA or application described in Section 505(b)(2) of the Act for the same drug may be submitted for a period of five years from the date of approval of the original application, except that such an application may be submitted after four years if it contains a certification that a patent claiming the drug is invalid or will not be infringed by the product for which approval is sought.
(2) A new drug application approved after September 24, 1984, for a drug product containing an active ingredient (including any ester or salt of that active ingredient) that has been approved in an earlier new drug application and that includes reports of new clinical investigations (other than bioavailability studies). Such investigations must have been conducted or sponsored by the applicant and must have been essential to approval of the application. If these requirements are met, the approval of a subsequent ANDA or an application described in Section 505(b)(2) of the Act may not be made effective for the same drug or use, if for a new indication, before the expiration of three years from the date of approval of the original application. If an applicant has exclusivity for a new application or 505(b)(2) application for the drug product with indications or use, this does not preclude the approval of an ANDA or 505(b)(2) application not covered by the exclusivity.
(3) A supplement to a new drug application for a drug containing a previously approved active ingredient including (any ester or salt of the active ingredient) approved after September 24, 1984, that contains reports of new clinical investigations (other than bioavailability studies) essential to the approval of the supplement and conducted or sponsored by the applicant. The approval of a subsequent ANDA or 505(b)(2) application for a change approved in the supplement may not be
AD 1
made effective for three years from the date of approval of the original supplement.
The Act requires that patent information be filed with all newly submitted Section 505(b) drug applications. No NDA may be approved after September 24, 1984, without the submission of patent information to the Agency. Effective August 18, 2003, this information must be filed using FDA Form 3524a Patent Information Submitted with the Filing of an NDA, Amendment or Supplement.
Effective August 18, 2003, upon approval of an application, patent information for purposes of listing in the Orange Book must be submitted to the agency within 30 days of approval on FDA Form 3542 Patent Information Submitted Upon and After Approval of an NDA or Supplement. Patent information on unapproved applications or on patents beyond the scope of the Act (i.e., process or manufacturing patents) will not be published. FDA form 3542 will be the only form used for the purposes of this publication.
The patents that FDA regards as covered by the statutory provisions for submission of patent information are: patents that claim the active ingredient(s); drug product patents which include formulation/composition patents; use patents for a particular approved indication or method of using the product; and certain other patents as detailed on FDA Form 3542. This information, as provided by the sponsor on FDA form 3542, will be published as described above.
A requirement for submission of patent information to FDA for certain old antibiotics became effective October 7, 2008 under section 4(b)(1) of the Q1 Act. A guidance for industry on this subject is available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Gu idances/UCM080576.pdf
Upon approval, patent numbers and expiration dates, in addition to certain other information on appropriate patents claiming drug products that are the subject of approved applications, will be published daily in the Electronic Orange Book Query. The Addendum lists patent and exclusivity information up to January of the Edition year. The monthly Cumulative Supplements to the annual edition list patent and exclusivity information changes since the Annual Edition Addendum. Since all parts of this publication are subject to changes, additions, or deletions, the Electronic Orange Book, updated daily, should be consulted for the most recent patent and exclusivity information.
AD 2
ADA 1 of 227
PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST

See report footnote for information regarding report content PATENT EXPIRATION DATE PATENT DELIST REQUESTED EXCLUSIVITY EXPIRATION DATE
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PC
ABACAVIR SULFATE - ABACAVIR SULFATE A091294 001 ABACAVIR SULFATE - ZIAGEN N020977 001 6294540 6294540*PED ABACAVIR SULFATE - ZIAGEN N020978 001 6294540 6294540*PED 6641843 6641843*PED
Dec
16, 2012
May Nov
14, 2018 14, 2018
DS
DP
U-65 U-65
May Nov Feb Aug
14, 14, 04, 04,
2018 2018 2019 2019
DS
DP DP
U-65 U-65
ABACAVIR SULFATE; LAMIVUDINE - EPZICOM May 18, N021652 001 5905082 Nov 18, 5905082*PED May 14, 6294540 Nov 14, 6294540*PED Mar 28, 6417191
2016 2016 2018 2018 2016
DS DS
DP DP DP U-257 U-257
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE - TRIZIVIR N021205 001 5905082 May 18, 2016 DS DP Nov 18, 2016 5905082*PED DS DP May 14, 2018 6294540 Nov 14, 2018 6294540*PED DP Mar 28, 2016 6417191 ABARELIX - PLENAXIS N021320 001 5843901 5968895 6180608 6423686 6455499 6699833 ABIRATERONE ACETATE - ZYTIGA N202379 001 5604213 5604213 ACETAMINOPHEN - OFIRMEV N022450 001 6028222 6992218
U-248 U-65 U-65 U-248
Dec Dec Dec Jun Jun Dec
01, 11, 11, 07, 07, 11,
2015 2016 2016 2015 2015 2016
DS
DP DP DP
U-549 U-549
DS DP
Feb Feb
18, 2014 18, 2014
DS DS
DP DP
U-1126 U-1314
I-663 NCE
Dec Apr
10, 2015 28, 2016
Aug Jun
05, 2017 06, 2021
DP DP
NP
Nov
02, 2013
ACETAMINOPHEN; ASPIRIN; CAFFEINE - EXCEDRIN (MIGRAINE) U-296 N020802 001 5972916 Jul 14, 2017 ACETYLCHOLINE CHLORIDE - MIOCHOL-E Apr N020213 001 6261546 ACETYLCYSTEINE - ACETADOTE N021539 001 8148356 ACETYLCYSTEINE - ACETYLCYSTEINE A200644 001 ACLIDINIUM BROMIDE - TUDORZA PRESSAIR Jun 21, N202450 001 5840279 Jun 21, 6071498 Aug 07, 6681768 Sep 05, 6750226 Jul 16, 7078412 Apr 22, 8051851 ACYCLOVIR; HYDROCORTISONE - XERESE N022436 001 6514980 Jan 7223387 Feb RE39264 Feb
29, 2019
U-506
May
21, 2026
DP
PC 2016 2016 2022 2020 2020 2027 DP DP DP DP DP DP
May
29, 2013
NCE
Jul
23, 2017
DS DS
U-1264 U-1263
24, 2017 28, 2021 02, 2016
DP DP DP
U-1006 U-1006 U-1006
NC
Jul
31, 2012
ADA 2 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-818 DP U-1078 DP U-1078
EXCLUSIVITY CODE(S)
ADAPALENE - DIFFERIN N021753 001 7579377 7737181 7834060 7838558 7868044 ADAPALENE - DIFFERIN N022502 001 7998467
Feb Aug Mar Mar Mar
23, 29, 12, 12, 12,
2025 2024 2023 2023 2023
May
31, 2028
DP
U-1078
NDF
Mar
17, 2013
ADAPALENE; BENZOYL PEROXIDE - EPIDUO Nov 23, 2025 N022320 001 7820186 Sep 01, 2024 7964202 Jul 18, 2027 8071644 Jul 18, 2027 8080537 Dec 23, 2022 8105618 Jul 18, 2027 8129362 Dec 23, 2022 8241649 ADEFOVIR DIPIVOXIL - HEPSERA N021449 001 5663159 6451340 ADENOSINE - ADENOSCAN N020059 001 5731296
DP DP DP
U-1078 U-1078 U-1078 U-1078 U-1078
DP
Sep Jul
02, 2014 23, 2018
DS DS
DP DP
U-470
Mar
24, 2015
U-221
ALATROFLOXACIN MESYLATE - TROVAN PRESERVATIVE FREE N020760 001 5763454 Jun 15, 2015 6080756 Jul 05, 2016 6194429 Jul 23, 2018 ALATROFLOXACIN MESYLATE - TROVAN PRESERVATIVE FREE N020760 002 5763454 Jun 15, 2015 6080756 Jul 05, 2016 6194429 Jul 23, 2018 ALBUMIN HUMAN - OPTISON N020899 001 5529766 6723303 ALBUTEROL SULFATE - ACCUNEB N020949 001 6702997 ALBUTEROL SULFATE - ACCUNEB N020949 002 6702997
U-282
U-282
Jun Apr
25, 2013 20, 2021
U-505 DP
M-120
Aug
17, 2015
Dec
28, 2021
U-558
Dec
28, 2021
U-558
ALBUTEROL SULFATE - PROAIR HFA N021457 001 5605674 Feb 6446627 Dec 7105152 Sep Jun 7566445 Sep 8132712 ALBUTEROL SULFATE - PROVENTIL-HFA N020503 001 5605674 Feb 5766573 Jun
25, 18, 12, 04, 07,
2014 2017 2023 2017 2028
DP DP DP DP DP
25, 2014 16, 2015
ADA 3 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP U-716 DP DP DP DP DP DP DP DP U-716
EXCLUSIVITY CODE(S)
ALBUTEROL SULFATE - VENTOLIN HFA N020983 001 6161724 Jan 6161724*PED Jul 6170717 Dec 6170717*PED Jun 6315173 Dec 6315173*PED Jun 6431168 Jun 6431168*PED Dec 6435372 Jan 6435372*PED Jul 6510969 Dec 6510969*PED Jun 6558651 Dec 6558651*PED Jun 6596260 Aug 6596260*PED Feb 6743413 Jun 6743413*PED Dec 6938796 Jan 6938796*PED Jul 6966467 Dec 6966467*PED Jun 6997349 Jan 6997349*PED Jul 7107986 Jun 7107986*PED Dec 7143908 Jan 7143908*PED Jul 7350676 Aug 7350676*PED Feb 7500444 Jan 7500444*PED Jul 7832351 Jun 7832351*PED Dec
16, 16, 23, 23, 23, 23, 08, 08, 16, 16, 23, 23, 19, 19, 10, 10, 01, 01, 16, 16, 23, 23, 16, 16, 08, 06, 16, 16, 24, 24, 04, 04, 19, 19,
2018 2018 2017 2018 2017 2018 2018 2018 2018 2018 2017 2018 2016 2017 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2018 2018 2018 2018 2019 2025 2025 2023 2023
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - COMBIVENT N020291 001 5603918 Jun 09, 2015 ALBUTEROL SULFATE; IPRATROPIUM N021747 001 5472143 5497944 5662271 5911851 5964416 6007676 6149054 6176442 6453795 6503362 6726124 6846413 6977042 6988496 7104470 7246615 7284474 7396341 7802568 7837235 7896264 7988001 BROMIDE - COMBIVENT RESPIMAT DP Sep 29, 2013 DP Mar 12, 2013 DP Sep 02, 2014 Sep 29, 2013 DP DP Oct 04, 2016 DP Sep 29, 2013 DP Dec 19, 2016 Oct 04, 2016 DP DP Dec 05, 2016 DP Sep 29, 2013 DP Oct 04, 2016 DP Aug 28, 2018 Aug 28, 2018 DP DP Feb 23, 2020 DP Oct 04, 2016 DP May 31, 2016 DP Aug 26, 2024 Oct 10, 2026 DP DP Feb 26, 2019 DP Mar 13, 2028 DP May 26, 2025 Aug 04, 2021 DP
NP
Oct
07, 2014
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - DUONEB N020950 001 6632842 Dec 28, 2021 ALCAFTADINE - LASTACAFT N022134 001 5468743
U-532
Nov
21, 2013
DS
DP
NCE
Jul
28, 2015
ADA 4 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ALCOHOL; CHLORHEXIDINE GLUCONATE - AVAGARD N021074 001 5897031 Jun 21, 2016 6090395 Jun 22, 2015 6534069 Jun 22, 2015 6623744 Jun 23, 2015 7081246 Aug 03, 2016 7566460 Jun 22, 2015 ALENDRONATE SODIUM - BINOSTO N202344 001 7488496 7964212 ALENDRONATE SODIUM - FOSAMAX N020560 001 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED 6194004 6194004*PED ALENDRONATE SODIUM - FOSAMAX N020560 002 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N020560 003 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N020560 004 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N020560 005 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N021575 001 5462932 5462932*PED 5994329 5994329*PED 6015801 6015801*PED 6225294 6225294*PED
DP DP U-1008 DP DP U-1008
Aug Mar
11, 2023 06, 2023
DS DS
DP DP
Dec Jun Dec Jun Dec Jun Dec Jun
02, 02, 02, 02, 02, 02, 02, 02,
2012 2013 2012 2013 2012 2013 2012 2013
Dec Jun Dec Jun Dec Jun
02, 02, 02, 02, 02, 02,
2012 2013 2012 2013 2012 2013
02, 02, 02, 02, 02, 02,
2012 2013 2012 2013 2012 2013
02, 02, 02, 02, 02, 02,
2012 2013 2012 2013 2012 2013
02, 02, 02, 02, 02, 02,
2012 2013 2012 2013 2012 2013
May Nov Jul Jan Jul Jan Jul Jan
17, 17, 17, 17, 17, 17, 17, 17,
2014 2014 2018 2019 2018 2019 2018 2019
Y Y Y
ADA 5 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ALENDRONATE SODIUM; CHOLECALCIFEROL N021762 001 5358941 Dec 5358941*PED Jun 5681590 Dec 5681590*PED Jun 5994329 Jul 5994329*PED Jan 6090410 Dec 6090410*PED Jun ALENDRONATE SODIUM; CHOLECALCIFEROL N021762 002 5358941 Dec 5358941*PED Jun 5681590 Dec 5681590*PED Jun 6090410 Dec 6090410*PED Jun
- FOSAMAX PLUS D 02, 2012 DP 02, 2013 DP 02, 2012 02, 2013 17, 2018 17, 2019 DP 02, 2012 DP 02, 2013 - FOSAMAX PLUS D 02, 2012 DP 02, 2013 DP 02, 2012 02, 2013 DP 02, 2012 DP 02, 2013
U-647
ALFUZOSIN HYDROCHLORIDE - UROXATRAL N021287 001 6149940 Aug 22, 2017 6149940*PED Feb 22, 2018 ALISKIREN HEMIFUMARATE - TEKTURNA N021985 001 5559111 Jul ALISKIREN HEMIFUMARATE - TEKTURNA N021985 002 5559111 Jul
M-97 PED DS DP U-3
Dec Jun
15, 2013 15, 2014
21, 2018
21, 2018
DS
DP
U-3
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 001 5559111 Jul 21, 2018 DS DP ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 002 5559111 Jul 21, 2018 DS DP ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 003 5559111 Jul 21, 2018 DS DP ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 004 5559111 Jul 21, 2018 DS DP
U-3
NC
Aug
26, 2013
U-3
NC
Aug
26, 2013
U-3
NC
Aug
26, 2013
U-3
NC
Aug
26, 2013
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 001 5559111 Jul 21, 2018 DS DP U-3 DP 8183295 May 16, 2023 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 002 5559111 Jul 21, 2018 DS DP U-3 DP 8183295 May 16, 2023 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 003 5559111 Jul 21, 2018 DS DP U-3 DP 8183295 May 16, 2023 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 004 5559111 Jul 21, 2018 DS DP U-3 DP 8183295 May 16, 2023 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 005 5559111 Jul 21, 2018 DS DP U-3 DP 8183295 May 16, 2023 ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT N022107 001 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT N022107 002 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT N022107 003 5559111 Jul 21, 2018 DS DP U-3
NC
Dec
21, 2013
NC
Dec
21, 2013
NC
Dec
21, 2013
NC
Dec
21, 2013
NC
Dec
21, 2013
I-600
Jul
16, 2012
I-600
Jul
16, 2012
I-600
Jul
16, 2012
ADA 6 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-600
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT DS DP U-3 N022107 004 5559111 Jul 21, 2018 ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA N022217 001 5559111 Jul 21, 2018 8168616 Jul 05, 2025 ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA N022217 002 5559111 Jul 21, 2018 8168616 Jul 05, 2025 ALITRETINOIN - PANRETIN N020886 001 5932622 ALMOTRIPTAN MALATE - AXERT N021001 001 5565447 5565447*PED ALMOTRIPTAN MALATE - AXERT N021001 002 5565447 5565447*PED
Jul
16, 2012
DS
DP DP
U-3
NC
Sep
16, 2012
DS
DP DP
U-3
NC
Sep
16, 2012
Aug
03, 2016
U-562
May Nov
07, 2015 07, 2015
DS
DP
U-969
May Nov
07, 2015 07, 2015
DS
DP
U-969
ALOSETRON HYDROCHLORIDE - LOTRONEX N021107 001 5360800 Jan 6284770 Oct ALOSETRON HYDROCHLORIDE - LOTRONEX N021107 002 5360800 Jan 6284770 Oct ALPRAZOLAM - NIRAVAM N021726 001 6024981 6221392 ALPRAZOLAM - NIRAVAM N021726 002 6024981 6221392 ALPRAZOLAM - NIRAVAM N021726 003 6024981 6221392 ALPRAZOLAM - NIRAVAM N021726 004 6024981 6221392 ALPROSTADIL - CAVERJECT N020379 001 5741523 ALPROSTADIL - CAVERJECT N020379 002 5741523 ALPROSTADIL - CAVERJECT N020379 003 5741523 ALPROSTADIL - CAVERJECT N020379 004 5741523
13, 2013 05, 2018
DS
DP
U-405 U-405
13, 2013 05, 2018
DS
DP
U-405 U-405
Apr Apr
09, 2018 09, 2018
DP DP
Apr Apr
09, 2018 09, 2018
DP DP
Apr Apr
09, 2018 09, 2018
DP DP
Apr Apr
09, 2018 09, 2018
DP DP
Apr
21, 2015
Apr
21, 2015
Apr
21, 2015
Apr
21, 2015
ALPROSTADIL - CAVERJECT IMPULSE Apr N021212 001 5501673 Feb 5716338 ALPROSTADIL - CAVERJECT IMPULSE Apr N021212 002 5501673 Feb 5716338 ALPROSTADIL - MUSE N020700 001 5474535 5886039
16, 2013 10, 2015
DP DP
16, 2013 10, 2015
DP DP
Dec Mar
12, 2012 23, 2016
DP
U-155 U-155
ADA 7 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-155 U-155
EXCLUSIVITY CODE(S)
ALPROSTADIL - MUSE N020700 002 5474535 5886039 ALPROSTADIL - MUSE N020700 003 5474535 5886039 ALPROSTADIL - MUSE N020700 004 5474535 5886039 ALVIMOPAN - ENTEREG N021775 001 5250542 5434171 6469030 8112290 AMBRISENTAN - LETAIRIS N022081 001 5703017 5840722 5840722 7109205 7601730 RE42462 AMBRISENTAN - LETAIRIS N022081 002 5703017 5840722 5840722 7109205 7601730 RE42462 AMIFOSTINE - ETHYOL N020221 001 5424471 5591731 5994409 AMIFOSTINE - ETHYOL N020221 002 5424471 5591731 5994409
Dec Mar
12, 2012 23, 2016
DP
Dec Mar
12, 2012 23, 2016
DP
U-155 U-155
Dec Mar
12, 2012 23, 2016
DP
U-155 U-155
Mar Dec Nov Jul
29, 08, 29, 31,
2016 2013 2020 2030
DS DS
DP DP
U-878 U-878 U-879 U-1225
NCE
May
20, 2013
Dec Nov Nov Oct Oct Jul
30, 24, 24, 07, 07, 29,
2014 2015 2015 2015 2015 2018
DS U-1297 U-821 DS DS DP U-1080
ODE
Jun
15, 2014
Dec Nov Nov Oct Oct Jul
30, 24, 24, 07, 07, 29,
2014 2015 2015 2015 2015 2018
DS U-1297 U-821 DS DS DP U-1080
ODE
Jun
15, 2014
Jul Jul Dec
31, 2012 31, 2012 08, 2017
U-305
Jul Jul Dec
31, 2012 31, 2012 08, 2017 LEVULAN 30, 2013 31, 2017 01, 2018 17, 2019 01, 2018
U-305
AMINOLEVULINIC ACID HYDROCHLORIDE Sep N020965 001 5079262 Oct 5954703 May 6709446 Jun 7723910 May 8216289
U-289 U-289 U-289 U-289 U-289
M-82
Mar
12, 2013
AMIODARONE HYDROCHLORIDE - NEXTERONE May 04, 2022 N022325 001 6869939 Mar 13, 2029 7635773 AMIODARONE HYDROCHLORIDE - NEXTERONE May 04, 2022 N022325 002 6869939 Mar 13, 2029 7635773 AMIODARONE HYDROCHLORIDE - NEXTERONE May 04, 2022 N022325 003 6869939 Mar 13, 2029 7635773 AMLODIPINE BESYLATE - AMLODIPINE BESYLATE N022026 001 6828339 Nov 20, 2022 AMLODIPINE BESYLATE - AMLODIPINE BESYLATE N022026 002 6828339 Nov 20, 2022 AMLODIPINE BESYLATE - AMLODIPINE BESYLATE N022026 003 6828339 Nov 20, 2022
DP DP
DP DP
DP DP
DS
DS
DS
ADA 8 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP U-213
EXCLUSIVITY CODE(S)
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET Nov 11, 2014 N021540 001 5686104 May 11, 2015 5686104*PED Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 002 5686104 Nov 11, 2014 5686104*PED May 11, 2015 Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 003 5686104 Nov 11, 2014 5686104*PED May 11, 2015 Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 004 5686104 Nov 11, 2014 5686104*PED May 11, 2015 Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET Nov 11, 2014 N021540 005 5686104 May 11, 2015 5686104*PED Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET Nov 11, 2014 N021540 006 5686104 May 11, 2015 5686104*PED Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 007 5686104 Nov 11, 2014 5686104*PED May 11, 2015 Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
ADA 9 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP U-213
EXCLUSIVITY CODE(S)
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET Nov 11, 2014 N021540 008 5686104 May 11, 2015 5686104*PED Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 009 5686104 Nov 11, 2014 5686104*PED May 11, 2015 Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 010 5686104 Nov 11, 2014 5686104*PED May 11, 2015 Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 011 5686104 Nov 11, 2014 5686104*PED May 11, 2015 Jul 08, 2016 DS 5969156 Jan 08, 2017 5969156*PED Jan 19, 2013 6126971 Jul 19, 2013 6126971*PED Aug 11, 2018 6455574
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL U-367 N020364 002 6162802 Dec 19, 2017 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL U-367 N020364 003 6162802 Dec 19, 2017 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL U-367 N020364 004 6162802 Dec 19, 2017 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL U-367 N020364 005 6162802 Dec 19, 2017 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL DS DP U-185 N020364 006 6162802 Dec 19, 2017 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL DS DP U-185 N020364 007 6162802 Dec 19, 2017 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR Apr 25, 2016 DS DP U-3 N200175 001 5616599 Oct 25, 2016 5616599*PED AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR Apr 25, 2016 DS DP U-3 N200175 002 5616599 Oct 25, 2016 5616599*PED AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR Apr 25, 2016 DS DP U-3 N200175 003 5616599 Oct 25, 2016 5616599*PED AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR Apr 25, 2016 DS DP U-3 N200175 004 5616599 Oct 25, 2016 5616599*PED
NC
Jul
23, 2013
NC
Jul
23, 2013
NC
Jul
23, 2013
NC
Jul
23, 2013
ADA 10 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NC
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR Apr 25, 2016 DS DP U-3 N200175 005 5616599 Oct 25, 2016 5616599*PED AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 001 5399578*PED Sep 21, 2012 6294197 Jun 18, 2017 DP U-3 6294197*PED Dec 18, 2017 DP 8101599 May 16, 2023 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT Sep 21, 2012 N022314 002 5399578*PED Jun 18, 2017 DP U-3 6294197 Dec 18, 2017 6294197*PED DP May 16, 2023 8101599 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 003 5399578*PED Sep 21, 2012 Jun 18, 2017 DP U-3 6294197 Dec 18, 2017 6294197*PED DP May 16, 2023 8101599 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT Sep 21, 2012 N022314 004 5399578*PED Jun 18, 2017 DP U-3 6294197 Dec 18, 2017 6294197*PED DP May 16, 2023 8101599 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 005 5399578*PED Sep 21, 2012 Jun 18, 2017 DP U-3 6294197 Dec 18, 2017 6294197*PED DP May 16, 2023 8101599 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR N022100 001 5616599 Apr 25, 2016 DS 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR Apr 25, 2016 DS N022100 002 5616599 Oct 25, 2016 5616599*PED AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR N022100 003 5616599 Apr 25, 2016 DS 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR Apr 25, 2016 DS N022100 004 5616599 Oct 25, 2016 5616599*PED AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 001 5591762 Jan 07, 2014 AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 002 5591762 Jan 07, 2014 AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 003 5591762 Jan 07, 2014 AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 004 5591762 Jan 07, 2014 AMLODIPINE BESYLATE; VALSARTAN N021990 002 5399578*PED 6294197 6294197*PED 6395728 - EXFORGE Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019
Jul
23, 2013
DP
U-3
DP
U-3
DP
U-3
DP
U-3
DS
DP
U-3
NC
Oct
16, 2012
DS
DP
U-3
NC
Oct
16, 2012
DS
DP
U-3
NC
Oct
16, 2012
DS
DP
U-3
NC
Oct
16, 2012
DP DP
U-3
ADA 11 of 227

See report footnote for information regarding report content PATENT EXPIRATION DATE
- EXFORGE Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019 - EXFORGE Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019 - EXFORGE Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019
APPL/PROD NO
PATENT NO
PATENT CODES
PATENT DELIST REQUESTED
EXCLUSIVITY CODE(S)
EXCLUSIVITY EXPIRATION DATE
AMLODIPINE BESYLATE; VALSARTAN N021990 003 5399578*PED 6294197 6294197*PED 6395728 AMLODIPINE BESYLATE; VALSARTAN N021990 004 5399578*PED 6294197 6294197*PED 6395728 AMLODIPINE BESYLATE; VALSARTAN N021990 005 5399578*PED 6294197 6294197*PED 6395728 AMMONIA, N-13 - AMMONIA N 13 N022119 001 AMOXICILLIN - MOXATAG N050813 001 6544555 6669948 6723341 8299052
DP DP
U-3
DP DP
U-3
DP DP
U-3
NCE W Oct Oct Oct May 13, 13, 13, 07, 2020 2020 2020 2027 DS DS DS DP DP DP U-897 U-897 U-897 U-1304
Aug Aug
23, 2012 23, 2012
AMOXICILLIN; CLAVULANATE POTASSIUM - AUGMENTIN XR N050785 001 6746692 Apr 04, 2020 6783773 Apr 04, 2020 6878386 Apr 04, 2020 7217430 Apr 04, 2020 7250176 Apr 04, 2020
DP DP DP U-926 U-926 U-926
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 10 N011522 007 6384020 Jul 06, 2020
6384020*PED Jan 06, 2021
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 12.5 N011522 012 6384020 Jul 06, 2020
6384020*PED Jan 06, 2021
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 15 N011522 013 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 20 N011522 008 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 30 N011522 010 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 5 N011522 009 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 7.5 N011522 011 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021
ADA 12 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 10 N021303 001 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 15 N021303 006 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 RE42096 Oct 21, 2018 DP RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 20 N021303 002 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 25 N021303 004 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 30 N021303 003 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 RE42096 Oct 21, 2018 DP RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 5 N021303 005 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019 AMPHOTERICIN B - ABELCET N050724 001 5616334 6406713
Apr Jun
01, 2014 18, 2019
DS DS
ADA 13 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-922 U-922
EXCLUSIVITY CODE(S)
AMPHOTERICIN B - AMBISOME N050740 001 5874104 5965156 AMPRENAVIR - AGENERASE N021007 001 5585397 5646180 5723490 6730679 AMPRENAVIR - AGENERASE N021007 002 5585397 5646180 5723490 6730679 AMPRENAVIR - AGENERASE N021039 001 5585397 5646180 5723490 ANIDULAFUNGIN - ERAXIS N021632 001 5965525 6960564 7709444 ANIDULAFUNGIN - ERAXIS N021632 002 5965525 6960564 7709444 APIXABAN - ELIQUIS N202155 001 APIXABAN - ELIQUIS N202155 002 APREPITANT - EMEND N021549 001 5538982 5719147 6096742 7214692 8258132 8258132 APREPITANT - EMEND N021549 002 5538982 5719147 6096742 7214692 8258132 8258132 APREPITANT - EMEND N021549 003 5538982 5719147 6096742 7214692 8258132 8258132
Feb Oct
23, 2016 12, 2016
Dec Jul Mar Nov
17, 08, 03, 11,
2013 2014 2015 2017
U-257 U-257 DP
Dec Jul Mar Nov
17, 08, 03, 11,
2013 2014 2015 2017
U-257 U-257 DP
Dec Jul Mar
17, 2013 08, 2014 03, 2015
U-257 U-257
Feb Apr Apr
17, 2020 12, 2021 12, 2021
DS
DP DP DP
U-540 U-540 U-540
Feb Apr Apr
17, 2020 12, 2021 12, 2021
DS
DP DP DP
U-540 U-540 U-540
NCE
Dec
28, 2017
NCE Jul Apr Jul Sep Sep Sep 23, 17, 01, 18, 26, 26, 2013 2015 2018 2012 2027 2027 U-745 U-853 U-745 U-853 U-1282 U-901
Dec
28, 2017
M-82
Mar
19, 2013
DS DS
DP DP DP DP
Jul Apr Jul Sep Sep Sep
23, 17, 01, 18, 26, 26,
2013 2015 2018 2012 2027 2027
DS DS
DP DP DP DP
U-745 U-853 U-745 U-853 U-1282 U-901
M-82
Mar
19, 2013
Jul Apr Jul Sep Sep Sep
23, 17, 01, 18, 26, 26,
2013 2015 2018 2012 2027 2027
DS DS
DP DP DP DP
U-745 U-853 U-745 U-853 U-1282 U-901
M-82
Mar
19, 2013
ARFORMOTEROL TARTRATE - BROVANA N021912 001 6040344 Nov 6472563 Nov 6589508 Apr Jun 6667344 Nov 6720453 Jun 6814953 Nov 7145036 Nov 8110706
12, 09, 03, 22, 09, 22, 09, 09,
2016 2021 2013 2021 2021 2021 2021 2021
DS DS U-793 DP DS U-793 DS DP
ADA 14 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ARGATROBAN - ACOVA N020883 001 5214052
Jun
30, 2014
ARGATROBAN - ARGATROBAN IN SODIUM CHLORIDE Sep 26, 2027 N022434 001 7589106 Sep 26, 2027 7687516 ARIPIPRAZOLE - ABILIFY N021436 001 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021436 002 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021436 003 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021436 004 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021436 005 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021436 006 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021713 001 5006528 5006528*PED 6977257 6977257*PED ARIPIPRAZOLE - ABILIFY N021729 002 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021729 003 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021729 004 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021729 005 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021866 001 5006528 5006528*PED 7115587 7115587*PED 7550445 7550445*PED ARMODAFINIL - NUVIGIL N021875 001 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED
DP DP
U-1163 U-1164
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633 I-616
Feb Nov
16, 2014 19, 2012
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633 I-616
Feb Nov
16, 2014 19, 2012
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633 I-616
Feb Nov
16, 2014 19, 2012
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633 I-616
Feb Nov
16, 2014 19, 2012
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633 I-616
Feb Nov
16, 2014 19, 2012
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633 I-616
Feb Nov
16, 2014 19, 2012
Oct Apr Apr Oct
20, 20, 24, 24,
2014 2015 2022 2022
DS DS
DP DP
U-761
I-633
Feb
16, 2014
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633
Feb
16, 2014
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
I-633
Feb
16, 2014
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
Oct Apr
20, 2014 20, 2015
DS
DP
U-761
Oct Apr Jul Jan Jul Jan
20, 20, 21, 21, 21, 21,
2014 2015 2024 2025 2024 2025
DS DS
DP DP DP
U-763 U-764
I-633
Feb
16, 2014
Dec Jun Nov May Oct Apr
18, 18, 29, 29, 06, 06,
2023 2024 2023 2024 2014 2015
DS
DP DP DP U-820
ADA 15 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP U-820
EXCLUSIVITY CODE(S)
ARMODAFINIL - NUVIGIL N021875 002 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARMODAFINIL - NUVIGIL N021875 003 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARMODAFINIL - NUVIGIL N021875 004 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARMODAFINIL - NUVIGIL N021875 005 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARSENIC TRIOXIDE - TRISENOX N021248 001 6723351 6855339 6861076 6884439 6982096 8273379
18, 18, 29, 29, 06, 06,
2023 2024 2023 2024 2014 2015
18, 18, 29, 29, 06, 06,
2023 2024 2023 2024 2014 2015
DS
DP DP DP U-820
18, 18, 29, 29, 06, 06,
2023 2024 2023 2024 2014 2015
DS
DP DP DP U-820
18, 18, 29, 29, 06, 06,
2023 2024 2023 2024 2014 2015
DS
DP DP DP U-820
10, 10, 10, 10, 10, 10,
2018 2018 2018 2018 2018 2018
U-573 U-617 U-617 U-651 U-651 U-1291
ARTEMETHER; LUMEFANTRINE - COARTEM N022268 001 5677331 Oct
14, 2014
DP
U-977
NCE ODE
Apr Apr
07, 2014 07, 2016
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE - MOVIPREP N021881 001 7169381 Sep 01, 2024 DS DP
7658914 Sep 01, 2024 DS DP
ASENAPINE MALEATE - SAPHRIS N022117 001 5763476 7741358
Jun Apr
09, 2015 06, 2026
DS
DP DP
U-326 U-1064
I-629 I-628 NCE
Sep Sep Aug
03, 2013 03, 2013 13, 2014
ASENAPINE MALEATE - SAPHRIS N022117 002 5763476 7741358
Jun Apr
09, 2015 06, 2026
DS
DP DP
U-326 U-1064
I-629 I-628 NCE
Sep Sep Aug
03, 2013 03, 2013 13, 2014
ASPIRIN; DIPYRIDAMOLE - AGGRENOX N020884 001 6015577 Jan
18, 2017
U-302
ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 001 5622985 Apr 22, 2014 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) N021387 002 5622985 Apr 22, 2014 U-335 U-335 5622985*PED Oct 22, 2014
ADA 16 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 003 5622985 Apr 22, 2014 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) N021387 004 5622985 Apr 22, 2014 U-335 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 005 5622985 Apr 22, 2014 5622985*PED Oct 22, 2014 U-335 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) N021387 006 5622985 Apr 22, 2014 U-335 U-335 5622985*PED Oct 22, 2014 ATAZANAVIR SULFATE - REYATAZ N021567 001 5849911 6087383 ATAZANAVIR SULFATE - REYATAZ N021567 002 5849911 6087383 ATAZANAVIR SULFATE - REYATAZ N021567 003 5849911 6087383 ATAZANAVIR SULFATE - REYATAZ N021567 004 5849911 6087383
Jun Dec
20, 2017 21, 2018
DS DS
DP DP
U-167
D-130
Feb
04, 2014
Jun Dec
20, 2017 21, 2018
DS DS
DP DP
U-167
D-130
Feb
04, 2014
Jun Dec
20, 2017 21, 2018
DS DS
DP DP
U-167
D-130
Feb
04, 2014
Jun Dec
20, 2017 21, 2018
DS DS
DP DP
U-167
D-130
Feb
04, 2014
ATOMOXETINE HYDROCHLORIDE - STRATTERA N021411 001 5658590 Nov 26, 2016 5658590*PED May 26, 2017 ATOMOXETINE HYDROCHLORIDE - STRATTERA N021411 002 5658590 Nov 26, 2016 5658590*PED May 26, 2017 ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 003 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 004 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA N021411 005 5658590 Nov 26, 2016 5658590*PED May 26, 2017 ATOMOXETINE HYDROCHLORIDE - STRATTERA N021411 006 5658590 Nov 26, 2016 5658590*PED May 26, 2017 ATOMOXETINE HYDROCHLORIDE - STRATTERA N021411 007 5658590 Nov 26, 2016 5658590*PED May 26, 2017 ATOMOXETINE HYDROCHLORIDE - STRATTERA N021411 008 5658590 Nov 26, 2016 5658590*PED May 26, 2017 ATORVASTATIN CALCIUM - LIPITOR N020702 001 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED
U-494 U-494
U-494 U-494
U-494 U-494
U-494 U-494
U-494 U-494
U-494 U-494
U-494 U-494
U-494 U-494
Nov May Jul Jan Jan Jul
11, 11, 08, 08, 19, 19,
2014 2015 2016 2017 2013 2013
DP DS DP
U-213 U-213
ADA 17 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DS DP U-213 U-213
EXCLUSIVITY CODE(S)
ATORVASTATIN CALCIUM - LIPITOR N020702 002 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED ATORVASTATIN CALCIUM - LIPITOR N020702 003 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED ATORVASTATIN CALCIUM - LIPITOR N020702 004 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED ATOVAQUONE - MEPRON N020500 001 6649659 6649659*PED
11, 11, 08, 08, 19, 19,
2014 2015 2016 2017 2013 2013
11, 11, 08, 08, 19, 19,
2014 2015 2016 2017 2013 2013
DP DS DP
U-213 U-213
11, 11, 08, 08, 19, 19,
2014 2015 2016 2017 2013 2013
DP DS DP
U-213 U-213
Jul Jan
10, 2016 10, 2017 - MALARONE 25, 2013 25, 2014 25, 2013 25, 2014 25, 2013 25, 2014
DS
DP
U-69
ATOVAQUONE; PROGUANIL HYDROCHLORIDE N021078 001 5998449 Nov 5998449*PED May Nov 6166046 May 6166046*PED Nov 6291488 May 6291488*PED ATOVAQUONE; PROGUANIL HYDROCHLORIDE Nov N021078 002 5998449 May 5998449*PED Nov 6166046 May 6166046*PED Nov 6291488 May 6291488*PED AVANAFIL - STENDRA N202276 001 6656935 7501409 AVANAFIL - STENDRA N202276 002 6656935 7501409 AVANAFIL - STENDRA N202276 003 6656935 7501409
U-990 U-406 U-406
- MALARONE PEDIATRIC 25, 2013 U-990 25, 2014 25, 2013 25, 2014 U-406 25, 2013 25, 2014
Sep May
13, 2020 05, 2023
DS
DP DP
U-155
NCE
Apr
27, 2017
Sep May
13, 2020 05, 2023
DS
DP DP
U-155
NCE
Apr
27, 2017
Sep May
13, 2020 05, 2023
DS
DP DP
U-155
NCE
Apr
27, 2017
AVOBENZONE; ECAMSULE; OCTOCRYLENE - ANTHELIOS SX N021502 001 5587150 Dec 24, 2013
DP
U-752
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE - ANTHELIOS 40 N022009 002 AXITINIB - INLYTA N202324 001 6534524 7141581 AXITINIB - INLYTA N202324 002 6534524 7141581
NP
Oct
29, 2012
Jun Jun
30, 2020 30, 2020
DS
DP U-1220
NCE
Jan
27, 2017
Jun Jun
30, 2020 30, 2020
DS
DP U-1220
NCE
Jan
27, 2017
ADA 18 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
AZELAIC ACID - FINACEA N021470 001 6534070
Nov
18, 2018
AZELASTINE HYDROCHLORIDE - ASTEPRO N022203 001 8071073 Jun AZELASTINE HYDROCHLORIDE - ASTEPRO N022371 001 8071073 Jun
04, 2028
DP
04, 2028
DP
NP
Aug
31, 2012
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE - DYMISTA Aug 29, 2023 U-707 N202236 001 8163723 Aug 29, 2023 U-77 8163723 Aug 29, 2023 U-644 8163723 Aug 29, 2023 U-81 8163723 Feb 24, 2026 DP 8168620 AZILSARTAN KAMEDOXOMIL - EDARBI Dec N200796 001 5583141 Jun 5958961 May 7157584 Jan 7572920 AZILSARTAN KAMEDOXOMIL - EDARBI Dec N200796 002 5583141 Jun 5958961 May 7157584 Jan 7572920
NC
May
01, 2015
10, 06, 22, 07,
2013 2014 2025 2025
DS DS
DP DP DP
U-3 U-3 U-3
NCE
Feb
25, 2016
10, 06, 22, 07,
2013 2014 2025 2025
DS DS
DP DP DP
U-3 U-3 U-3
NCE
Feb
25, 2016
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE - EDARBYCLOR Dec 10, 2013 DS DP N202331 001 5583141 DS May 22, 2025 7157584 Jan 07, 2025 DP 7572920 AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE - EDARBYCLOR N202331 002 5583141 Dec 10, 2013 DS DP DS 7157584 May 22, 2025 Jan 07, 2025 DP 7572920 AZITHROMYCIN - AZASITE N050810 001 6159458 6239113 6569443 6861411 7056893 AZITHROMYCIN - ZITHROMAX N050693 001 6268489 AZITHROMYCIN - ZITHROMAX N050710 001 6268489 AZITHROMYCIN - ZITHROMAX N050710 002 6268489 AZITHROMYCIN - ZITHROMAX N050711 001 6268489 AZITHROMYCIN - ZITHROMAX N050730 001 6268489 AZITHROMYCIN - ZITHROMAX N050733 001 6268489 AZITHROMYCIN - ZITHROMAX N050784 001 6268489 AZITHROMYCIN - ZMAX N050797 001 6068859 6268489 6984403 7887844
U-3 U-3
NCE NC
Feb Dec
25, 2016 20, 2014
U-3 U-3
Nov Mar Mar Nov Mar
04, 31, 31, 25, 31,
2017 2019 2019 2018 2019
DP DP DP
U-709 U-709 U-709 U-709 U-709
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
May Jul Feb Feb
30, 31, 14, 14,
2017 2018 2024 2024
DP DS DP DP U-282
ADA 19 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP U-1031 U-1031
EXCLUSIVITY CODE(S)
ODE
AZTREONAM - CAYSTON N050814 001 7208141 7214364 7427633 BACLOFEN - KEMSTRO N021589 001 6024981 6221392 BACLOFEN - KEMSTRO N021589 002 6024981 6221392 BALSALAZIDE DISODIUM - COLAZAL N020610 001 7452872 7452872*PED 7625884 7625884*PED BALSALAZIDE DISODIUM - GIAZO N022205 001 6197341 7452872 7625884
Dec Dec Dec
20, 2021 20, 2021 20, 2021
Feb
22, 2017
Apr Apr
09, 2018 09, 2018
DP DP
Apr Apr
09, 2018 09, 2018
DP DP
Aug Feb Aug Feb
24, 24, 24, 24,
2026 2027 2026 2027
U-141 U-141
ODE PED
Dec Jun
20, 2013 20, 2014
Mar Aug Aug
13, 2018 24, 2026 24, 2026
DP
U-1229 U-1229 U-1229
NDF
Feb
03, 2015
BECLOMETHASONE DIPROPIONATE - QNASL N202813 001 5605674 Feb 25, 2014 5683677 Nov 04, 2014 5776432 Jul 07, 2015 7780038 Jan 24, 2027 BECLOMETHASONE DIPROPIONATE - QVAR 40 N020911 002 5605674 Feb 25, 2014 5683677 Nov 04, 2014 5776432 Jul 07, 2015 BECLOMETHASONE DIPROPIONATE - QVAR 80 N020911 001 5605674 Feb 25, 2014 5683677 Nov 04, 2014 5776432 Jul 07, 2015 BEDAQUILINE FUMARATE - SIRTURO N204384 001 BENDAMUSTINE HYDROCHLORIDE - TREANDA N022249 001
DP DP DP DP
NP
Mar
23, 2015
NCE
Dec
28, 2017
NCE ODE PED PED
Mar Mar Sep Sep
20, 20, 20, 20,
2013 2015 2013 2015
BENDAMUSTINE HYDROCHLORIDE - TREANDA N022249 002
NCE ODE PED PED DP DP U-124 U-124
Mar Mar Sep Sep
20, 20, 20, 20,
2013 2015 2013 2015
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE - ACANYA Mar 31, 2015 N050819 001 5733886 Aug 05, 2029 8288434 BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE - DUAC N050741 001 5466446 Feb 16, 2014 BENZYL ALCOHOL - ULESFIA N022129 001 5858383 6139859 6793931 7294342
DS
DP
Aug Aug Jul May
11, 11, 11, 19,
2017 2017 2022 2024
DP
U-970 U-970 U-970 U-970
NCE
Apr
09, 2014
ADA 20 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP
EXCLUSIVITY CODE(S)
NCE
BEPOTASTINE BESILATE - BEPREVE N022288 001 6780877 Dec
25, 2017
Sep
08, 2014
BESIFLOXACIN HYDROCHLORIDE - BESIVANCE N022308 001 5447926 Apr 13, 2016 6685958 Jun 29, 2021 6699492 Mar 31, 2019
DS
DP DP DP
U-80 U-80 U-80
NCE
May
28, 2014
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE N021852 001 5763426 Jun 09, 2015 DS 6753013 Jan 27, 2020 6753013 Jan 27, 2020 DS RE39706 Jun 09, 2015 BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE N022185 001 6753013 Jan 27, 2020 6753013 Jan 27, 2020 6787529 Jan 27, 2020 6787529 Jan 27, 2020 RE39706 Jun 09, 2015 DS BETAMETHASONE VALERATE - LUXIQ N020934 001 6126920 Mar 7078058 May
TACLONEX DP DP U-193 DP U-88 DP TACLONEX DP U-88 DP U-193 DP U-193 DP U-88 DP
I-659
Oct
17, 2015
01, 2016 24, 2017
U-484 DP
BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE - BETOPTIC PILO N020619 001 5635172 Jun 03, 2014 U-191 BEXAROTENE - TARGRETIN N021055 001 5780676 5962731 BEXAROTENE - TARGRETIN N021056 001 5780676 5962731 BIMATOPROST - LATISSE N022369 001 6403649 7351404 7388029 8017655 8038988 8101161 8101161 8263054 BIMATOPROST - LUMIGAN N021275 001 5688819 6403649 8017655 BIMATOPROST - LUMIGAN N022184 001 5688819 6403649 7851504 8017655 8278353 8299118 8309605 8309605 8338479 BISACODYL - HALFLYTELY N021551 003 7291324
Jul Oct
14, 2015 05, 2016
U-509 U-475
Jul Oct
14, 2015 05, 2016
U-510
Sep May Jan Nov Aug May May Aug
21, 25, 21, 27, 25, 25, 25, 25,
2012 2024 2022 2012 2023 2024 2024 2023
DS U-939 U-938 DS DS DP DP U-1208 U-1218 U-1217 U-1277
Aug Sep Nov
19, 2014 21, 2012 27, 2012
DS DS
DP DP
U-446 U-446
Aug Sep Jun Nov Mar Mar Mar Mar Mar
19, 21, 13, 27, 16, 16, 16, 16, 16,
2014 2012 2027 2012 2025 2025 2025 2025 2025
DS DS DS
U-1081 U-1081 DP DP DP U-1295 U-1293 U-1294 U-1295
NP
Aug
31, 2013
DP
Oct
22, 2022
U-837
NP
Jul
16, 2013
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - HALFLYTELY N021551 002 7291324 Oct 22, 2022 U-837
ADA 21 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE - PYLERA U-932 N050786 001 6350468 Dec 14, 2018 U-956 6350468 Dec 14, 2018 BIVALIRUDIN - ANGIOMAX N020873 001 5196404 5196404 5196404*PED 7582727 7582727*PED 7598343 7598343*PED BOCEPREVIR - VICTRELIS N202258 001 7772178 8119602 RE43298 BORTEZOMIB - VELCADE N021602 001 5780454 6083903 6297217 6297217 6297217 6617317 6713446 6747150 6958319 7119080 BOSENTAN - TRACLEER N021290 001 5292740 BOSENTAN - TRACLEER N021290 002 5292740
Dec Dec Jun Jul Jan Jul Jan
15, 15, 15, 27, 27, 27, 27,
2014 2014 2015 2028 2029 2028 2029
DS DS
DP DP DP DP
U-1040 U-1232
Nov Mar Feb
11, 2027 17, 2027 22, 2022
DP DS DP
U-1128 U-1233 U-1128
NCE
May
13, 2016
May Oct Oct Oct Oct Oct Jan Oct Jan Oct
03, 28, 28, 28, 28, 28, 25, 28, 25, 28,
2017 2014 2014 2014 2014 2014 2022 2014 2022 2014
DP DP
NR U-515 U-885 U-884 U-515
Jan
23, 2015
DS
DP DP DP DP DP
Nov
20, 2015
I-607
Aug
07, 2012
Nov
20, 2015
I-607
Aug
07, 2012
BOSUTINIB MONOHYDRATE - BOSULIF N203341 001 6002008 Mar 7417148 Jan 7767678 Nov 7919625 Dec RE42376 Sep BOSUTINIB MONOHYDRATE - BOSULIF N203341 002 6002008 Mar 7417148 Jan 7767678 Nov 7919625 Dec RE42376 Sep BRIMONIDINE TARTRATE - ALPHAGAN P N021262 001 5424078*PED Dec 6562873 Jul 6562873*PED Jan 6627210 Jul 6627210*PED Jan 6641834 Jul 6641834*PED Jan 6673337 Jul 6673337*PED Jan
27, 23, 23, 11, 24,
2018 2026 2026 2025 2019
DS DS DS
DP DP DP
U-1284 U-1283
NCE ODE
Sep Sep
04, 2017 04, 2019
27, 23, 23, 11, 24,
2018 2026 2026 2025 2019
DS DS DS
DP DP DP
U-1284 U-1283
NCE ODE
Sep Sep
04, 2017 04, 2019
13, 10, 10, 18, 18, 28, 28, 26, 26,
2012 2021 2022 2021 2022 2021 2022 2021 2022
DP DP DP
ADA 22 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
BRIMONIDINE TARTRATE - ALPHAGAN P N021770 001 5424078*PED Dec 6562873 Jul 6562873*PED Jan 6627210 Jul 6627210*PED Jan 6641834 Jul 6641834*PED Jan 6673337 Jul 6673337*PED Jan
13, 10, 10, 18, 18, 28, 28, 26, 26,
2012 2021 2022 2021 2022 2021 2022 2021 2022
DP DP DP DP
BRIMONIDINE TARTRATE - BRIMONIDINE TARTRATE Aug 19, 2025 N021764 001 7265117 BRIMONIDINE TARTRATE; TIMOLOL MALEATE N021398 001 7030149 Apr 19, 7320976 Apr 19, Jan 19, 7323463 Apr 19, 7642258 Apr 19, 8133890 BRINZOLAMIDE - AZOPT N020816 001 5378703*PED 5461081 5461081*PED BROMFENAC SODIUM - BROMDAY N021664 002 BROMOCRIPTINE MESYLATE - CYCLOSET N020866 001 5468755 Nov 5679685 Oct 5716957 Feb 5756513 Nov 5866584 Nov 7888310 Jul BUDESONIDE - ENTOCORT EC N021324 001 5643602 5643602*PED COMBIGAN 2022 2022 2023 DS 2022 2022
DP
U-849 U-849 DP DP U-1024 U-1235
Oct Oct Apr
01, 2012 24, 2012 24, 2013
DP
U-225
NP 21, 21, 10, 21, 21, 25, 2012 2014 2015 2012 2012 2023 U-976 DP U-976 U-976 U-976 U-976
Oct
16, 2013
Jul Jan
01, 2014 01, 2015
U-655 DP
BUDESONIDE - PULMICORT FLEXHALER N021949 001 6027714 Jan 6142145 May Jan 6287540 Mar 7143764 BUDESONIDE - PULMICORT FLEXHALER N021949 002 6027714 Jan 6142145 May Jan 6287540 Mar 7143764 BUDESONIDE - PULMICORT RESPULES Dec N020929 001 6598603 Jun 6598603*PED Dec 6899099 Jun 6899099*PED Nov 7524834 May 7524834*PED BUDESONIDE - PULMICORT RESPULES Dec N020929 002 6598603 Jun 6598603*PED Dec 6899099 Jun 6899099*PED Nov 7524834 May 7524834*PED
09, 08, 09, 13,
2018 2018 2018 2018
DP DP DP DP
U-787
09, 08, 09, 13,
2018 2018 2018 2018
DP DP DP DP
U-787
23, 23, 23, 23, 11, 11,
2018 2019 2018 2019 2018 2019
U-529 U-529 DP U-966
23, 23, 23, 23, 11, 11,
2018 2019 2018 2019 2018 2019
U-529 U-529 DP U-966
ADA 23 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-529 U-529 DP U-966
EXCLUSIVITY CODE(S)
BUDESONIDE - PULMICORT RESPULES Dec N020929 003 6598603 Jun 6598603*PED Dec 6899099 Jun 6899099*PED Nov 7524834 May 7524834*PED BUDESONIDE - RHINOCORT N020746 001 6291445 6291445*PED 6686346 6686346*PED 6986904 6986904*PED BUDESONIDE - RHINOCORT N020746 002 6291445 6291445*PED 6686346 6686346*PED 6986904 6986904*PED
23, 23, 23, 23, 11, 11,
2018 2019 2018 2019 2018 2019
Apr Oct Apr Oct Apr Oct
29, 29, 29, 29, 29, 29,
2017 2017 2017 2017 2017 2017
Y DP DP U-557 U-699 Y Y
Apr Oct Apr Oct Apr Oct
29, 29, 29, 29, 29, 29,
2017 2017 2017 2017 2017 2017
DP DP
U-557 U-699
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT N021929 001 5674860 Oct 07, 2014 DP DP 5972919 Dec 17, 2012 DP 6123924 Sep 26, 2017 Sep 23, 2012 DP 6641800 Nov 11, 2018 DP 7367333 DP Apr 10, 2026 7587988 DP Jan 29, 2023 7759328 DP Aug 11, 2021 7967011 Jan 29, 2023 DP 8143239 BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT Oct 07, 2014 DP N021929 002 5674860 DP Dec 17, 2012 5972919 DP Sep 26, 2017 6123924 Sep 23, 2012 DP 6641800 Nov 11, 2018 DP 7367333 DP Apr 10, 2026 7587988 DP Jan 29, 2023 7759328 Sep 09, 2018 7897646 Aug 11, 2021 DP 7967011 Jan 29, 2023 DP 8143239 BUPIVACAINE - EXPAREL N022496 001 6132766 8182835 BUPIVACAINE - EXPAREL N022496 002 6132766 8182835 BUPRENORPHINE - BUTRANS N021306 001 6264980 6344211 RE41408 RE41489 RE41571 BUPRENORPHINE - BUTRANS N021306 002 6264980 6344211 RE41408 RE41489 RE41571
U-1075 U-1075
U-1073 U-1073
U-1075 U-1075
U-1073 U-1118 U-1073
Nov Sep
16, 2013 18, 2018
DP DP
NP U-1246
Oct
28, 2014
Nov Sep
16, 2013 18, 2018
DP DP
NP U-1246
Oct
28, 2014
Dec Dec Sep Sep Sep
18, 18, 29, 29, 29,
2015 2015 2017 2017 2017
DP U-1072 U-1072 U-1072 U-1072
NDF
Jun
30, 2013
Dec Dec Sep Sep Sep
18, 18, 29, 29, 29,
2015 2015 2017 2017 2017
DP U-1072 U-1072 U-1072 U-1072
NDF
Jun
30, 2013
ADA 24 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP U-1072 U-1072 U-1072 U-1072
EXCLUSIVITY CODE(S)
NDF
BUPRENORPHINE - BUTRANS N021306 003 6264980 6344211 RE41408 RE41489 RE41571
Dec Dec Sep Sep Sep
18, 18, 29, 29, 29,
2015 2015 2017 2017 2017
Jun
30, 2013
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - SUBOXONE N022410 001 8017150 Feb 13, 2023 DP BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - SUBOXONE N022410 002 8017150 Feb 13, 2023 DP BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - SUBOXONE N022410 003 8017150 Feb 13, 2023 DP BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - SUBOXONE N022410 004 8017150 Feb 13, 2023 DP BUPROPION HYDROBROMIDE - APLENZIN N022108 001 7241805 Jun 7569610 Jun 7572935 Jun 7585897 Jun 7645802 Jun 7649019 Jun 7662407 Jun 7671094 Jun BUPROPION HYDROBROMIDE - APLENZIN N022108 002 7241805 Jun 7569610 Jun 7572935 Jun 7585897 Jun 7645802 Jun 7649019 Jun 7662407 Jun 7671094 Jun BUPROPION HYDROBROMIDE - APLENZIN N022108 003 7241805 Jun 7569610 Jun 7572935 Jun 7585897 Jun 7645802 Jun 7649019 Jun 7662407 Jun 7671094 Jun
NDF
Aug
30, 2013
NDF
Aug
30, 2013
NDF
Aug
30, 2013
NDF
Aug
30, 2013
27, 27, 27, 27, 27, 27, 27, 27,
2026 2026 2026 2026 2026 2026 2026 2026
DP U-997 DP DP DP DP DP DP
27, 27, 27, 27, 27, 27, 27, 27,
2026 2026 2026 2026 2026 2026 2026 2026
27, 27, 27, 27, 27, 27, 27, 27,
2026 2026 2026 2026 2026 2026 2026 2026
BUPROPION HYDROCHLORIDE - FORFIVO XL N022497 001 7674479 Jun 25, 2027 BUPROPION HYDROCHLORIDE - WELLBUTRIN SR N020358 001 5358970 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 Aug 12, 2013 BUPROPION HYDROCHLORIDE - WELLBUTRIN SR N020358 002 5358970 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 Aug 12, 2013 BUPROPION HYDROCHLORIDE - WELLBUTRIN SR N020358 003 5358970 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 Aug 12, 2013
DP
ADA 25 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
BUPROPION HYDROCHLORIDE - WELLBUTRIN SR Aug 12, 2013 N020358 004 5358970 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 BUPROPION HYDROCHLORIDE - WELLBUTRIN XL N021515 001 6096341 Oct 30, 2018 BUPROPION HYDROCHLORIDE - WELLBUTRIN XL N021515 002 6096341 Oct 30, 2018 BUPROPION HYDROCHLORIDE - ZYBAN Aug N020711 002 5358970 Aug 5427798 Aug 5731000 Aug 5763493 BUPROPION HYDROCHLORIDE - ZYBAN Aug N020711 003 5358970 Aug 5427798 Aug 5731000 Aug 5763493 BUSULFAN - BUSULFEX N020954 001 5430057 5430057*PED 5559148 5559148*PED
12, 12, 12, 12,
2013 2013 2013 2013
12, 12, 12, 12,
2013 2013 2013 2013
Sep Mar Sep Mar
30, 30, 30, 30,
2013 2014 2013 2014
U-263 U-263 U-264 U-264
BUTOCONAZOLE NITRATE - BUTOCONAZOLE NITRATE A200923 001 BUTOCONAZOLE NITRATE - GYNAZOLE-1 N019881 001 5993856 Nov CABAZITAXEL - JEVTANA KIT N201023 001 5438072 5698582 5847170 6331635 6372780 6387946 7241907
PC DP U-457
May
14, 2013
17, 2017
Nov Jul Mar Mar Mar Mar Dec
22, 03, 26, 26, 26, 26, 10,
2013 2012 2016 2016 2016 2016 2025
DS DS
DP DP DP DP U-1067 U-1067
NCE
Jun
17, 2015
DS
CABOZANTINIB S-MALATE - COMETRIQ N203756 001 7579473 Sep CABOZANTINIB S-MALATE - COMETRIQ N203756 002 7579473 Sep CALCIPOTRIENE - DOVONEX N020554 001 5763426 RE39706 CALCIPOTRIENE - DOVONEX N020611 001 5763426 RE39706 CALCIPOTRIENE - SORILUX N022563 001 8263580 CALCITONIN SALMON - MIACALCIN N020313 002 5733569 5759565
24, 2024
DS
DP
NCE
Nov
29, 2017
24, 2024
DS
DP
NCE
Nov
29, 2017
Jun Jun
09, 2015 09, 2015
DS DS
DP DP
Jun Jun
09, 2015 09, 2015
DS DS
DP DP
May
26, 2026
DP
U-1280
I-657 NDF
Sep Oct
27, 2015 06, 2013
Mar Mar
31, 2015 31, 2015
U-227
CALCITONIN SALMON RECOMBINANT - FORTICAL N021406 001 6440392 Feb 02, 2021 RE40812 Feb 02, 2021
DP DP
U-227
ADA 26 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CALCITRIOL - CALCIJEX N018874 001 6051567 6051567*PED 6265392 6265392*PED 6274169 6274169*PED CALCITRIOL - CALCIJEX N018874 002 6051567 6051567*PED 6265392 6265392*PED 6274169 6274169*PED CALCIUM ACETATE - PHOSLO N021160 002 6576665
Aug Feb Aug Feb Aug Feb
02, 02, 02, 02, 02, 02,
2019 2020 2019 2020 2019 2020
Aug Feb Aug Feb Aug Feb
02, 02, 02, 02, 02, 02,
2019 2020 2019 2020 2019 2020
Apr
03, 2021
CALCIUM ACETATE - PHOSLO GELCAPS N021160 003 6576665 Apr CALCIUM CARBONATE; FAMOTIDINE; N020958 001 5229137*PED 5989588 5989588*PED 6814978 6814978*PED CALCIUM CARBONATE; RISEDRONATE N021823 001 5583122 5583122*PED 5994329 5994329*PED 6015801 6015801*PED 6165513 6165513*PED 6432932 6432932*PED 6465443 6465443*PED
03, 2021
MAGNESIUM HYDROXIDE - PEPCID COMPLETE Nov 16, 2012 Sep 30, 2015 U-349 U-349 Mar 30, 2016 DP Aug 26, 2021 Feb 26, 2022 SODIUM Dec 10, Jun 10, Jul 17, Jan 17, Jul 17, Jan 17, Jun 10, Dec 10, Jul 17, Jan 17, Aug 14, Feb 14, ACTONEL WITH CALCIUM (COPACKAGED) DS DP U-353 2013 2014 U-353 2018 2019 U-353 2018 2019 DP 2018 2018 U-595 2018 2019 2018 DP 2019
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE - NAVSTEL N022193 001 7084130 Nov 29, 2021 DP U-891 CANDESARTAN CILEXETIL - ATACAND N020838 001 5196444*PED Dec 5534534 Jul 5534534*PED Jan CANDESARTAN CILEXETIL - ATACAND N020838 002 5196444*PED Dec 5534534 Jul 5534534*PED Jan CANDESARTAN CILEXETIL - ATACAND N020838 003 5196444*PED Dec 5534534 Jul 5534534*PED Jan CANDESARTAN CILEXETIL - ATACAND N020838 004 5196444*PED Dec 5534534 Jul 5534534*PED Jan
04, 2012 09, 2013 09, 2014
DP
04, 2012 09, 2013 09, 2014
DP
04, 2012 09, 2013 09, 2014
DP
04, 2012 09, 2013 09, 2014
DP
ADA 27 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT N021093 001 5196444*PED Dec 04, 2012 DP 5534534 Jul 09, 2013 5534534*PED Jan 09, 2014 DP U-3 5721263 Feb 24, 2015 DP U-3 5958961 Jun 06, 2014 CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT N021093 002 5196444*PED Dec 04, 2012 DP 5534534 Jul 09, 2013 5534534*PED Jan 09, 2014 DP U-3 5721263 Feb 24, 2015 DP U-3 5958961 Jun 06, 2014 CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT N021093 003 5196444*PED Dec 04, 2012 DP 5534534 Jul 09, 2013 5534534*PED Jan 09, 2014 DP U-3 5721263 Feb 24, 2015 DP U-3 5958961 Jun 06, 2014 CAPECITABINE - XELODA N020896 001 5472949 CAPECITABINE - XELODA N020896 002 5472949 CAPSAICIN - QUTENZA N022395 001 6239180 CARBAMAZEPINE - CARBATROL N020712 001 5912013 CARBAMAZEPINE - CARBATROL N020712 002 5912013 CARBAMAZEPINE - CARBATROL N020712 003 5912013 CARBAMAZEPINE - EQUETRO N021710 001 5912013 6977253 CARBAMAZEPINE - EQUETRO N021710 002 5912013 6977253 CARBAMAZEPINE - EQUETRO N021710 003 5912013 6977253
Dec
14, 2013
U-271
Dec
14, 2013
U-271
Nov
06, 2016
DP
NCE ODE U-277
Nov Nov
16, 2014 16, 2016
Jun
15, 2016
Jun
15, 2016
U-277
Jun
15, 2016
U-277
Jun May
15, 2016 19, 2024
DP U-693
Jun May
15, 2016 19, 2024
DP U-693
Jun May
15, 2016 19, 2024
DP U-693
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 100 N021485 002 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 125 N021485 006 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 150 N021485 003 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020
DS DP DP U-219
DS DP DP U-219
DS DP DP U-219
ADA 28 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP U-219
EXCLUSIVITY CODE(S)
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 200 N021485 004 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 50 N021485 001 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 75 N021485 005 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARFILZOMIB - KYPROLIS N202714 001 7232818 7417042 7491704 7737112 8129346 8207125 8207126 8207127 8207297 CARGLUMIC ACID - CARBAGLU N022562 001 CARVEDILOL - COREG N020297 001 RE40000 RE40000*PED CARVEDILOL - COREG N020297 002 RE40000 RE40000*PED CARVEDILOL - COREG N020297 003 RE40000 RE40000*PED CARVEDILOL - COREG N020297 004 RE40000 RE40000*PED
DS DP DP U-219
DS DP DP U-219
Apr Jun Apr Dec Dec Apr Apr Apr Apr
14, 07, 14, 07, 25, 14, 14, 14, 14,
2025 2026 2025 2027 2026 2025 2025 2025 2025
DS DS
DP DP U-1260 DP U-1260
NCE ODE
Jul Jul
20, 2017 20, 2019
DS
DP DP U-1260 DP
DS
NCE ODE Jun Dec 07, 2015 07, 2015 U-233
Mar Mar
18, 2015 18, 2017
Jun Dec
07, 2015 07, 2015
U-233
Jun Dec
07, 2015 07, 2015
U-233
Jun Dec
07, 2015 07, 2015
U-233
CARVEDILOL PHOSPHATE - COREG CR N022012 001 6022562 Oct 6022562*PED Apr Jun 7268156 Jun 7268156 Dec 7268156*PED Sep 8101209 Mar 8101209*PED Jun RE40000 Dec RE40000*PED CARVEDILOL PHOSPHATE - COREG CR N022012 002 6022562 Oct 6022562*PED Apr Jun 7268156 Jun 7268156 Dec 7268156*PED Sep 8101209 Mar 8101209*PED Jun RE40000 Dec RE40000*PED
17, 17, 27, 27, 27, 11, 11, 07, 07,
2015 2016 2023 2023 2023 2025 2026 2015 2015
DP DS DS DP DP DP U-777 U-313 U-3
17, 17, 27, 27, 27, 11, 11, 07, 07,
2015 2016 2023 2023 2023 2025 2026 2015 2015
ADA 29 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CARVEDILOL PHOSPHATE - COREG CR Oct N022012 003 6022562 Apr 6022562*PED Jun 7268156 Jun 7268156 Dec 7268156*PED Sep 8101209 Mar 8101209*PED Jun RE40000 Dec RE40000*PED CARVEDILOL PHOSPHATE - COREG CR Oct N022012 004 6022562 Apr 6022562*PED Jun 7268156 Jun 7268156 Dec 7268156*PED Sep 8101209 Mar 8101209*PED Jun RE40000 Dec RE40000*PED CASPOFUNGIN ACETATE - CANCIDAS N021227 001 5378804 5378804*PED 5514650 5514650*PED 5792746 5792746*PED 5952300 5952300*PED 6136783 6136783*PED CASPOFUNGIN ACETATE - CANCIDAS N021227 002 5378804 5378804*PED 5514650 5514650*PED 5792746 5792746*PED 5952300 5952300*PED 6136783 6136783*PED
17, 17, 27, 27, 27, 11, 11, 07, 07,
2015 2016 2023 2023 2023 2025 2026 2015 2015
17, 17, 27, 27, 27, 11, 11, 07, 07,
2015 2016 2023 2023 2023 2025 2026 2015 2015
Mar Sep Jan Jul Mar Sep Mar Sep Mar Sep
16, 16, 26, 26, 16, 16, 28, 28, 28, 28,
2013 2013 2015 2015 2013 2013 2017 2017 2017 2017
DS DP DS DP DP U-607 U-607 U-607
Mar Sep Jan Jul Mar Sep Mar Sep Mar Sep
16, 16, 26, 26, 16, 16, 28, 28, 28, 28,
2013 2013 2015 2015 2013 2013 2017 2017 2017 2017
DS DP DS DP DP U-607 U-607 U-607
CEFDITOREN PIVOXIL - SPECTRACEF N021222 001 5958915 Oct CEFDITOREN PIVOXIL - SPECTRACEF N021222 002 5958915 Oct CEFTAROLINE FOSAMIL - TEFLARO N200327 001 6417175 6906055 7419973 8247400 CEFTAROLINE FOSAMIL - TEFLARO N200327 002 6417175 6906055 7419973 8247400 CEFTIBUTEN DIHYDRATE - CEDAX N050685 002 5599557 CEFTIBUTEN DIHYDRATE - CEDAX N050686 001 5599557 5599557
14, 2016
14, 2016
DP
Dec Dec Dec Feb
17, 15, 15, 10,
2018 2021 2021 2031
DS DS
DP DP DP DP
U-282
NCE
Oct
29, 2015
U-282
Dec Dec Dec Feb
17, 15, 15, 10,
2018 2021 2021 2031
DS DS
DP DP DP DP
U-282
NCE
Oct
29, 2015
U-282
Apr
30, 2013
DP
Feb Feb
04, 2014 04, 2014
DP DP
U-282 U-578
ADA 30 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-578 U-282
EXCLUSIVITY CODE(S)
CEFTIBUTEN DIHYDRATE - CEDAX N050686 002 5599557 5599557 CELECOXIB - CELEBREX N020998 001 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED CELECOXIB - CELEBREX N020998 002 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED CELECOXIB - CELEBREX N020998 003 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED CELECOXIB - CELEBREX N020998 004 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED
Feb Feb
04, 2014 04, 2014
Nov May Nov May Jun Dec
30, 30, 30, 30, 02, 02,
2013 2014 2013 2014 2015 2015
DS DP U-672
30, 30, 30, 30, 02, 02,
2013 2014 2013 2014 2015 2015
DS DP U-672
30, 30, 30, 30, 02, 02,
2013 2014 2013 2014 2015 2015
DS DP U-672
30, 30, 30, 30, 02, 02,
2013 2014 2013 2014 2015 2015
DS DP U-672
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC ALLERGY DP N021621 003 6455533 Jul 02, 2018 CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC ALLERGY N021621 004 6455533 Jul 02, 2018 DP
U-295
U-295
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC HIVES RELIEF N021621 005 6455533 Jul 02, 2018 DP U-295 CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC HIVES RELIEF DP U-295 N021621 006 6455533 Jul 02, 2018 CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ZYRTEC-D 12 HOUR N021150 002 6469009 Jul 13, 2019 DP U-295 DP 6489329 Apr 08, 2016 DP Jun 10, 2022 7014867 U-295 Jun 10, 2022 7226614 CETRORELIX - CETROTIDE N021197 001 6319192 6863891 7605121 CETRORELIX - CETROTIDE N021197 002 6319192 6863891 7605121
Apr Feb Feb
23, 2019 22, 2014 22, 2014
U-426 U-426 DP
Apr Feb Feb
23, 2019 22, 2014 22, 2014
U-426 U-426 DP
CEVIMELINE HYDROCHLORIDE - CEVIMELINE A091260 001 CEVIMELINE HYDROCHLORIDE - EVOXAC N020989 002 5340821 Jul
PC U-309
Apr
06, 2013
07, 2013
ADA 31 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-737 DP DP DP DP U-1022 U-1022 U-1022
EXCLUSIVITY CODE(S)
CHLORHEXIDINE GLUCONATE - CHLORHEXIDINE GLUCONATE N021669 001 7066916 Feb 17, 2024 7427574 Apr 25, 2026 7595021 May 12, 2023 7717889 Feb 27, 2025 7935093 Oct 02, 2027
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP N020832 001 5690958 Sep 30, 2016 DP DP 6536975 Nov 10, 2020 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP N020832 004 5690958 Sep 30, 2016 DP DP 6536975 Nov 10, 2020 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP N020832 006 5690958 Sep 30, 2016 DP DP 6991394 Jan 31, 2024 DP 7182536 Dec 30, 2023 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP FREPP N020832 003 5538353 Aug 25, 2015 DP DP 5690958 Sep 30, 2016 DP 5752363 Apr 22, 2017 5772346 Apr 22, 2017 DP DP D396911 Aug 11, 2012 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP SEPP N021555 001 5690958 Sep 30, 2016 DP CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT N020832 002 5690958 Sep 30, 2016 DP DP 6729786 Mar 14, 2023 6991393 Mar 14, 2023 DP DP 6991394 Jan 31, 2024 DP 7182536 Dec 30, 2023 DP 7241065 Mar 14, 2023 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT N020832 005 5690958 Sep 30, 2016 DP DP 6536975 Nov 10, 2020 DP 6729786 Mar 14, 2023 DP 6991393 Jan 31, 2024 7241065 Mar 14, 2023 DP CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT N020832 007 5690958 Sep 30, 2016 DP 6536975 Nov 10, 2020 DP DP 6729786 Mar 14, 2023 DP 6991393 Mar 14, 2023 DP 7241065 Mar 14, 2023 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORASCRUB MAXI SWABSTICK N021524 003 D468424 Jan 07, 2017 CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE - ADVIL ALLERGY SINUS N021441 001 7863287 Feb 28, 2027 DP CHOLINE C-11 - CHOLINE C-11 N203155 001 CHOLINE FENOFIBRATE - TRILIPIX N022224 001 7259186 Jan CHOLINE FENOFIBRATE - TRILIPIX N022224 002 7259186 Jan CHORIOGONADOTROPIN ALFA - OVIDREL N021149 001 5767251 Jun
NCE W 07, 2025 DS
Sep Sep
12, 2017 12, 2017
07, 2025
DS
16, 2015
ADA 32 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP
EXCLUSIVITY CODE(S)
CHORIOGONADOTROPIN ALFA - OVIDREL N021149 002 5767251 Jun 6706681 Mar CICLESONIDE - ALVESCO N021658 002 5482934 5605674 5683677 5775321 6006745 6036942 6120752 6264923 CICLESONIDE - ALVESCO N021658 003 5482934 5605674 5683677 5775321 6006745 6036942 6120752 6264923 CICLESONIDE - OMNARIS N022004 001 5482934 6767901 6939559 7235247 CICLESONIDE - ZETONNA N202129 001 5482934 5605674 5683677 5775321 6006745 6036942 6120752 6264923 CICLOPIROX - LOPROX N020519 001 7018656 7026337 CICLOPIROX - LOPROX N021159 001 7981909 8227490
16, 2015 16, 2021
Oct Feb Nov Jul Dec Apr May May
24, 25, 04, 07, 28, 30, 13, 13,
2017 2014 2014 2015 2016 2013 2018 2018
DS
DP DP DP DP DP DP DP DP
U-1002
24, 25, 04, 07, 28, 30, 13, 13,
2017 2014 2014 2015 2016 2013 2018 2018
DS
U-1002
Oct Oct Apr Apr
24, 21, 21, 21,
2017 2020 2019 2019
DS
DP DP DP DP
U-557
24, 25, 04, 07, 28, 30, 13, 13,
2017 2014 2014 2015 2016 2013 2018 2018
DS
U-1002
NP
Jan
20, 2015
Sep Nov
05, 2018 21, 2016
DP U-714
Sep Sep
16, 2017 16, 2017
U-1162 U-1256
CINACALCET HYDROCHLORIDE - SENSIPAR N021688 001 6011068 Mar 08, 2018 6031003 Dec 14, 2016 6211244 Oct 23, 2015 6313146 Dec 14, 2016 7829595 Sep 22, 2026 CINACALCET HYDROCHLORIDE - SENSIPAR N021688 002 6011068 Mar 08, 2018 6031003 Dec 14, 2016 6211244 Oct 23, 2015 6313146 Dec 14, 2016 7829595 Sep 22, 2026 CINACALCET HYDROCHLORIDE - SENSIPAR N021688 003 6011068 Mar 08, 2018 6031003 Dec 14, 2016 6211244 Oct 23, 2015 6313146 Dec 14, 2016 7829595 Sep 22, 2026
DS DS DS
DP DP DP DP U-559 U-560 U-1098
I-634 M-101 ODE
Feb Feb Feb
25, 2014 25, 2014 25, 2018
DS DS DS
I-634 M-101 ODE
Feb Feb Feb
25, 2014 25, 2014 25, 2018
DS DS DS
DP DP DP DP U-559 U-560 U-1098
I-634 M-101 ODE
Feb Feb Feb
25, 2014 25, 2014 25, 2018
ADA 33 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CIPROFLOXACIN - CIPRO N020780 001 5695784 5695784*PED 6136347 6136347*PED CIPROFLOXACIN - CIPRO N020780 002 5695784 5695784*PED 6136347 6136347*PED
Dec Jun Jan Jul
09, 09, 06, 06,
2014 2015 2013 2013
U-362
Dec Jun Jan Jul
09, 09, 06, 06,
2014 2015 2013 2013
U-362
CIPROFLOXACIN HYDROCHLORIDE - PROQUIN XR Sep 19, 2016 N021744 001 5972389 Sep 19, 2016 6340475 Jun 20, 2020 6488962 Sep 19, 2016 6635280
DP DP DP DP
U-663 U-663 U-663
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE - CIPRO HC U-646 N020805 001 5843930 Jun 06, 2015 DP 5965549 Jun 06, 2015 CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE - CIPRO XR DP N021473 001 7709022 Jun 23, 2021 7709022*PED Dec 23, 2021 CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE - CIPRO XR DP N021473 002 7709022 Jun 23, 2021 7709022*PED Dec 23, 2021 CIPROFLOXACIN; DEXAMETHASONE - CIPRODEX N021537 001 6284804 Aug 10, 2020 Aug 10, 2020 6359016 CISAPRIDE MONOHYDRATE - PROPULSID QUICKSOLV N020767 001 5648093 Jul 15, 2014 CISATRACURIUM BESYLATE - NIMBEX Sep N020551 001 5453510
26, 2012
U-127
CISATRACURIUM BESYLATE - NIMBEX PRESERVATIVE FREE N020551 002 5453510 Sep 26, 2012 CISATRACURIUM BESYLATE - NIMBEX PRESERVATIVE FREE Sep 26, 2012 N020551 003 5453510
U-127
U-127
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE - PREPOPIK N202535 001 CLARITHROMYCIN - BIAXIN XL N050775 001 6010718 6551616
NP
Jul
16, 2015
Apr Jul
11, 2017 15, 2017
DP
U-924 U-924
CLEVIDIPINE BUTYRATE - CLEVIPREX N022156 001 5739152 Apr 5856346 Jan CLEVIDIPINE BUTYRATE - CLEVIPREX Apr N022156 002 5739152 Jan 5856346 CLINDAMYCIN PHOSPHATE - CLEOCIN N050767 001 6495157 Jul CLINDAMYCIN PHOSPHATE - CLINDAGEL N050782 001 6387383 Aug CLINDAMYCIN PHOSPHATE - CLINDESSE Nov N050793 001 5993856 Apr 6899890
14, 2015 05, 2021
DS
DP DP
U-893 U-893
NCE
Aug
01, 2013
14, 2015 05, 2021
DS
DP DP
U-893 U-893
NCE
Aug
01, 2013
20, 2020
DP
03, 2020
DP
U-818
17, 2017 27, 2023
DP DP
U-137 U-137
ADA 34 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP
EXCLUSIVITY CODE(S)
CLINDAMYCIN PHOSPHATE - EVOCLIN N050801 001 7141237 Jan 7374747 Aug
23, 2024 09, 2026
U-921
CLINDAMYCIN PHOSPHATE; TRETINOIN - VELTIN N050803 001 5690923 Nov 25, 2014 CLINDAMYCIN PHOSPHATE; TRETINOIN - ZIANA Aug 03, 2020 N050802 001 6387383 Feb 24, 2015 RE41134 CLOBAZAM - ONFI N202067 001 CLOBAZAM - ONFI N202067 002 CLOBAZAM - ONFI N202067 003 CLOBAZAM - ONFI N203993 001 CLOBETASOL PROPIONATE - CLOBEX Sep N021535 001 6106848 CLOBETASOL PROPIONATE - CLOBEX N021644 001 7316810 Jun 7700081 Jan 8066975 Jun 8066976 Jun CLOBETASOL PROPIONATE - CLOBEX N021835 001 5972920 Feb 5990100 Mar CLOBETASOL PROPIONATE - OLUX N021142 001 6126920
DP
DP DP
U-916 U-1033
NCE ODE
Oct Oct
21, 2016 21, 2018
NCE ODE
Oct Oct
21, 2016 21, 2018
NCE ODE
Oct Oct
21, 2016 21, 2018
NCE 22, 2017
Oct
21, 2016
17, 03, 17, 17,
2019 2022 2019 2019
DP U-1044 DP DP
12, 2018 24, 2018
DP DP
U-742
Mar
01, 2016
U-484
CLOBETASOL PROPIONATE - OLUX E N022013 001 6730288 Sep Sep 7029659 CLOFARABINE - CLOLAR N021673 001 5661136 5661136*PED
08, 2019 08, 2019
DP DP
Jan Jul
14, 2018 14, 2018
U-626
CLONIDINE HYDROCHLORIDE - JENLOGA N022331 001 5869100 Oct CLONIDINE HYDROCHLORIDE - JENLOGA N022331 002 5869100 Oct CLONIDINE HYDROCHLORIDE - KAPVAY N022331 003 5869100 Oct CLONIDINE HYDROCHLORIDE - KAPVAY N022331 004 5869100 Oct
13, 2013
DP
NP
Sep
29, 2012
13, 2013
DP
13, 2013
DP
NP
Sep
28, 2013
13, 2013
DP
NP
Sep
28, 2013
CLOPIDOGREL BISULFATE - CLOPIDOGREL BISULFATE A077665 002 CLOPIDOGREL BISULFATE - CLOPIDOGREL BISULFATE A091023 001
PC
Nov
13, 2012
PC
Nov
13, 2012
ADA 35 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP
EXCLUSIVITY CODE(S)
M-61 PED
CLOPIDOGREL BISULFATE - PLAVIX N020839 001 6429210 6429210*PED 6504030 6504030*PED CLOPIDOGREL BISULFATE - PLAVIX N020839 002 6429210 6429210*PED 6504030 6504030*PED CLOZAPINE - FAZACLO ODT N021590 001 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 002 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 003 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 004 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 005 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 006 6024981 6106861 6221392
Jun Dec Jun Dec
10, 10, 10, 10,
2019 2019 2019 2019
May Nov
06, 2014 06, 2014
Jun Dec Jun Dec
10, 10, 10, 10,
2019 2019 2019 2019
DS DS
DP
M-61 PED
May Nov
06, 2014 06, 2014
Apr Dec Apr
09, 2018 05, 2017 09, 2018
DP DP DP
Apr Dec Apr
09, 2018 05, 2017 09, 2018
DP DP DP
Apr Dec Apr
09, 2018 05, 2017 09, 2018
DP DP DP
Apr Dec Apr
09, 2018 05, 2017 09, 2018
DP DP DP
Apr Dec Apr
09, 2018 05, 2017 09, 2018
DP DP DP
Apr Dec Apr
09, 2018 05, 2017 09, 2018
DP DP DP
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - STRIBILD N203100 001 5814639 Sep 29, 2015 DS DP Jul 02, 2017 DS 5914331 DS U-257 Jul 25, 2017 5922695 DS DP U-257 Jul 25, 2017 5935946 DS DP U-257 Jul 25, 2017 5977089 U-257 Jul 25, 2017 6043230 U-257 Nov 04, 2020 6642245 DS DP Mar 09, 2021 6703396 DS DP U-257 Nov 20, 2023 7176220 DS DP U-257 Jan 12, 2026 7635704 DS DP U-1279 Sep 03, 2029 8148374 COLCHICINE - COLCRYS N022352 001 7601758 7619004 7820681 7906519 7915269 7935731 7964647 7964648 7981938 8093296 8093297 8093298 8097655
Feb Dec Feb Feb Feb Dec Oct Oct Oct Oct Oct Oct Oct
10, 03, 17, 17, 17, 03, 06, 06, 06, 06, 06, 06, 06,
2029 2028 2029 2029 2029 2028 2028 2028 2028 2028 2028 2028 2028
U-1007 U-1020 U-1020 U-1116 U-1007 U-1116 U-1007 U-1161 U-1166 U-1007 U-1161 U-1116 U-1020
I-603 ODE
Jul Jul
30, 2012 29, 2016
ADA 36 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-323 U-323
EXCLUSIVITY CODE(S)
COLESEVELAM HYDROCHLORIDE - WELCHOL N021141 001 5607669 Jun 10, 2014 5607669*PED Dec 10, 2014 5679717 Apr 29, 2014 5679717*PED Oct 29, 2014 5693675 Dec 02, 2014 5693675*PED Jun 02, 2015 5917007 Apr 29, 2014 5917007*PED Oct 29, 2014 5919832 Jun 10, 2014 5919832*PED Dec 10, 2014 6066678 Jun 10, 2014 6066678*PED Dec 10, 2014 6433026 Jun 10, 2014 6433026*PED Dec 10, 2014 COLESEVELAM HYDROCHLORIDE - WELCHOL N021176 001 5607669 Jun 10, 2014 5607669*PED Dec 10, 2014 5679717 Apr 29, 2014 5679717*PED Oct 29, 2014 5693675 Dec 02, 2014 5693675*PED Jun 02, 2015 5917007 Apr 29, 2014 5917007*PED Oct 29, 2014 5919832 Apr 29, 2014 5919832*PED Oct 29, 2014 6066678 Apr 29, 2014 6066678*PED Oct 29, 2014 6433026 Apr 29, 2014 6433026*PED Oct 29, 2014 6784254 Apr 29, 2014 6784254*PED Oct 29, 2014 7101960 Apr 29, 2014 7101960*PED Oct 29, 2014 7229613 Apr 17, 2022 7229613*PED Oct 17, 2022 COLESEVELAM HYDROCHLORIDE - WELCHOL Jun 10, 2014 N022362 001 5607669 Dec 10, 2014 5607669*PED Apr 29, 2014 5679717 Oct 29, 2014 5679717*PED Dec 02, 2014 5693675 Jun 02, 2015 5693675*PED Apr 29, 2014 5917007 Oct 29, 2014 5917007*PED Apr 29, 2014 5919832 Oct 29, 2014 5919832*PED Apr 29, 2014 6066678 Oct 29, 2014 6066678*PED Apr 29, 2014 6433026 Oct 29, 2014 6433026*PED Apr 29, 2014 6784254 Oct 29, 2014 6784254*PED Apr 29, 2014 7101960 Oct 29, 2014 7101960*PED Apr 17, 2022 7229613 Oct 17, 2022 7229613*PED
U-323
U-323
U-323 U-323 DS DS DS DS DS DS DS DP DP U-757 U-851 U-323 U-323
I-608 PED
Oct Apr
02, 2012 02, 2013
I-608 PED
Oct Apr
02, 2012 02, 2013
ADA 37 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-608 PED
COLESEVELAM HYDROCHLORIDE - WELCHOL Jun 10, 2014 N022362 002 5607669 Dec 10, 2014 5607669*PED Apr 29, 2014 5679717 Oct 29, 2014 5679717*PED Dec 02, 2014 5693675 Jun 02, 2015 5693675*PED Apr 29, 2014 5917007 Oct 29, 2014 5917007*PED Apr 29, 2014 5919832 Oct 29, 2014 5919832*PED Apr 29, 2014 6066678 Oct 29, 2014 6066678*PED Apr 29, 2014 6433026 Oct 29, 2014 6433026*PED Apr 29, 2014 6784254 Oct 29, 2014 6784254*PED Apr 29, 2014 7101960 Oct 29, 2014 7101960*PED Apr 17, 2022 7229613 Oct 17, 2022 7229613*PED COLESTIPOL HYDROCHLORIDE - COLESTID N020222 001 5490987 Feb 13, 2013 CONIVAPTAN HYDROCHLORIDE - VAPRISOL N021697 001 5723606 Dec 15, 2019 5723606 Dec 15, 2019
Oct Apr
02, 2012 02, 2013
DP
DS DS
DP DP
U-868 U-698
CONIVAPTAN HYDROCHLORIDE - VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER N021697 002 5723606 Dec 15, 2019 DS DP U-698 DS DP U-868 5723606 Dec 15, 2019 CORTICOTROPIN - H.P. ACTHAR GEL N008372 008 CRIZOTINIB - XALKORI N202570 001 7230098 7825137 7858643 8217057 CRIZOTINIB - XALKORI N202570 002 7230098 7825137 7858643 8217057 CROFELEMER - FULYZAQ N202292 001 7323195 7341744 CYANOCOBALAMIN - NASCOBAL N021642 001 7229636 7404489 7879349
ODE Mar May Oct Nov 01, 12, 08, 06, 2025 2027 2029 2029 DS U-1179 DS DS DP DP
Oct
15, 2017
NCE ODE
Aug Aug
26, 2016 26, 2018
Mar May Oct Nov
01, 12, 08, 06,
2025 2027 2029 2029
DS U-1179 DS DS DP DP
NCE ODE
Aug Aug
26, 2016 26, 2018
Jun Jun
07, 2018 16, 2018
DP U-1319
NCE
Dec
31, 2017
Jun Mar Jun
11, 2024 12, 2024 01, 2024
DP DP DP
U-817 U-1152
CYCLOBENZAPRINE HYDROCHLORIDE - AMRIX N021777 001 7387793 Feb 26, 7544372 Nov 14, 7790199 Nov 14, 7820203 Nov 14, 7829121 Nov 14, CYCLOBENZAPRINE HYDROCHLORIDE - AMRIX N021777 002 7387793 Feb 26, 7544372 Nov 14, 7790199 Nov 14, 7820203 Nov 14, 7829121 Nov 14,
2025 2023 2023 2023 2023
DP U-979 DP DP U-1088
2025 2023 2023 2023 2023
DP U-979 DP DP U-1088
ADA 38 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
CYCLOSPORINE - NEORAL N050715 001 5985321 CYCLOSPORINE - NEORAL N050715 002 5985321 CYCLOSPORINE - NEORAL N050715 003 5985321 CYCLOSPORINE - NEORAL N050716 001 5985321 CYCLOSPORINE - RESTASIS N050790 001 5474979
Sep
26, 2014
Sep
26, 2014
DP
Sep
26, 2014
DP
Sep
26, 2014
DP
May
17, 2014
DP
CYSTEAMINE HYDROCHLORIDE - CYSTARAN N200740 001 CYTARABINE - DEPOCYT N021041 001 5455044 5723147
NP ODE 14, 2013 03, 2015 U-806 U-806
Oct Oct
02, 2015 02, 2019
May Mar
DP
DABIGATRAN ETEXILATE MESYLATE - PRADAXA Feb 18, 2018 N022512 001 6087380 Aug 31, 2027 7866474 Sep 07, 2025 7932273 DABIGATRAN ETEXILATE MESYLATE - PRADAXA N022512 002 6087380 Feb 18, 2018 7866474 Aug 31, 2027 Sep 07, 2025 7932273 DALFAMPRIDINE - AMPYRA N022250 001 5540938 8007826 DAPSONE - ACZONE N021794 001 5863560 6060085 6620435 DAPTOMYCIN - CUBICIN N021572 001 6468967 6852689 8058238 DAPTOMYCIN - CUBICIN N021572 002 6468967 6852689 8003673 8058238 8129342 RE39071
DS DS
DP DP DP
U-1089
NCE
Oct
19, 2015
DS DS
DP DP DP
U-1089
NCE
Oct
19, 2015
Jul May
30, 2013 26, 2027
U-1030 U-1030
NCE ODE
Jan Jan
22, 2015 22, 2017
Sep Sep Sep
11, 2016 11, 2016 11, 2016
DP U-124 DP
Sep Sep Nov
24, 2019 24, 2019 28, 2020
U-282 U-282 DS DP
Sep Sep Sep Nov Nov Jun
24, 24, 04, 28, 28, 15,
2019 2019 2028 2020 2020 2016
U-282 U-282 U-1180 DS DS DS DP DP DP
U-728
DARIFENACIN HYDROBROMIDE - ENABLEX Mar N021513 001 5096890 Aug 6106864 DARIFENACIN HYDROBROMIDE - ENABLEX Mar N021513 002 5096890 Aug 6106864
13, 2015 21, 2016
DS
DP DP
U-631 U-630
13, 2015 21, 2016
DS
DP DP
U-631 U-630
ADA 39 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP U-903 U-1209 U-935 U-744 U-1305 U-935 U-1305 U-1209 DS DS DS DS DS DS DP DP DP DP DP U-1305 U-744 U-1305 U-935 U-1209 U-903 U-1209 U-935 U-1305 U-1305 U-1209 U-935 DS DP DP DS DP U-1305
EXCLUSIVITY CODE(S)
D-129 NPP PED PED
DARUNAVIR ETHANOLATE - PREZISTA Dec N021976 001 5843946 Dec 5843946 Dec 5843946 Dec 5843946 Dec 5843946 Jun 5843946*PED Jun 6037157 Jun 6037157 Jun 6037157 Dec 6037157*PED Aug 6248775 Feb 6248775*PED Aug 6335460 Aug 6335460 Aug 6335460 Aug 6335460 Aug 6335460 Feb 6335460*PED Jun 6703403 Jun 6703403 Jun 6703403 Dec 6703403*PED Jun 7470506 Jun 7470506 Jun 7470506 Dec 7470506*PED Dec 7700645 Jun 7700645*PED Oct RE42889 Apr RE42889*PED May RE43596 Nov RE43596*PED Oct RE43802 Apr RE43802*PED
01, 01, 01, 01, 01, 01, 26, 26, 26, 26, 13, 13, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 23, 23, 23, 23, 26, 26, 19, 19, 09, 09, 19, 19,
2015 2015 2015 2015 2015 2016 2016 2016 2016 2016 2014 2015 2012 2012 2012 2012 2012 2013 2016 2016 2016 2016 2019 2019 2019 2019 2026 2027 2016 2017 2017 2017 2016 2017
Dec Dec Jun Jun
13, 16, 16, 13,
2013 2014 2015 2014
ADA 40 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP U-1209 U-935 U-903 U-1305 U-744 U-1209 U-1305 U-935 DS DS DS DS DS DS DP DP DP DP DP U-744 U-903 U-935 U-1305 U-1209 U-935 U-1305 U-1209 U-1305 U-1209 U-935 DS DP DP DS DP U-1305
EXCLUSIVITY CODE(S)
D-129 NPP PED PED
01, 01, 01, 01, 01, 01, 26, 26, 26, 26, 13, 13, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 23, 23, 23, 23, 26, 26, 19, 19, 09, 09, 19, 19,
2015 2015 2015 2015 2015 2016 2016 2016 2016 2016 2014 2015 2012 2012 2012 2012 2012 2013 2016 2016 2016 2016 2019 2019 2019 2019 2026 2027 2016 2017 2017 2017 2016 2017
Dec Dec Jun Jun
13, 16, 16, 13,
2013 2014 2015 2014
ADA 41 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
D-129 NPP PED PED
01, 01, 01, 01, 01, 01, 26, 26, 26, 26, 13, 13, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 23, 23, 23, 23, 26, 26, 19, 19, 09, 09, 19, 19,
2015 2015 2015 2015 2015 2016 2016 2016 2016 2016 2014 2015 2012 2012 2012 2012 2012 2013 2016 2016 2016 2016 2019 2019 2019 2019 2026 2027 2016 2017 2017 2017 2016 2017
Dec Dec Jun Jun
13, 16, 16, 13,
2013 2014 2015 2014
ADA 42 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
D-129 NPP PED PED
01, 01, 01, 01, 01, 01, 26, 26, 26, 26, 13, 13, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 23, 23, 23, 23, 26, 26, 19, 19, 09, 09, 19, 19,
2015 2015 2015 2015 2015 2016 2016 2016 2016 2016 2014 2015 2012 2012 2012 2012 2012 2013 2016 2016 2016 2016 2019 2019 2019 2019 2026 2027 2016 2017 2017 2017 2016 2017
Dec Dec Jun Jun
13, 16, 16, 13,
2013 2014 2015 2014
ADA 43 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
D-129 NPP PED PED
01, 01, 01, 01, 01, 01, 26, 26, 26, 26, 13, 13, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 23, 23, 23, 23, 26, 26, 19, 19, 09, 09, 19, 19,
2015 2015 2015 2015 2015 2016 2016 2016 2016 2016 2014 2015 2012 2012 2012 2012 2012 2013 2016 2016 2016 2016 2019 2019 2019 2019 2026 2027 2016 2017 2017 2017 2016 2017
Dec Dec Jun Jun
13, 16, 16, 13,
2013 2014 2015 2014
ADA 44 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP U-744 U-1209 U-935 U-1305 U-903 U-1209 U-1305 U-935 DS DS DS DS DS DS DP DP DP DP DP U-1305 U-935 U-1209 U-1305 U-744 U-903 U-935 U-1209 U-1305 U-935 U-1305 U-1209 DS DP DP DS DP U-1305
EXCLUSIVITY CODE(S)
D-129 NPP PED PED
DARUNAVIR ETHANOLATE - PREZISTA Dec N021976 006 5843946 Dec 5843946 Dec 5843946 Dec 5843946 Dec 5843946 Jun 5843946*PED Jun 6037157 Jun 6037157 Jun 6037157 Dec 6037157*PED Aug 6248775 Feb 6248775*PED Aug 6335460 Aug 6335460 Aug 6335460 Aug 6335460 Aug 6335460 Feb 6335460*PED Jun 6703403 Jun 6703403 Jun 6703403 Dec 6703403*PED Jun 7470506 Jun 7470506 Jun 7470506 Dec 7470506*PED Dec 7700645 Jun 7700645*PED Oct RE42889 Apr RE42889*PED May RE43596 Nov RE43596*PED Oct RE43802 Apr RE43802*PED DARUNAVIR ETHANOLATE - PREZISTA Dec N202895 001 5843946 Dec 5843946 Jun 5843946*PED Jun 6037157 Jun 6037157 Dec 6037157*PED Aug 6248775 Feb 6248775*PED Aug 6335460 Aug 6335460 Feb 6335460*PED Jun 6703403 Jun 6703403 Dec 6703403*PED Jun 7470506 Dec 7470506*PED Dec 7700645 Jun 7700645*PED Oct RE42889 Apr RE42889*PED May RE43596 Nov RE43596*PED Oct RE43802 Apr RE43802*PED DASATINIB - SPRYCEL N021986 001 6596746 6596746 7125875 7125875 7153856 7491725
01, 01, 01, 01, 01, 01, 26, 26, 26, 26, 13, 13, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 23, 23, 23, 23, 26, 26, 19, 19, 09, 09, 19, 19,
2015 2015 2015 2015 2015 2016 2016 2016 2016 2016 2014 2015 2012 2012 2012 2012 2012 2013 2016 2016 2016 2016 2019 2019 2019 2019 2026 2027 2016 2017 2017 2017 2016 2017
Dec Dec Jun Jun
13, 16, 16, 13,
2013 2014 2015 2014
01, 01, 01, 26, 26, 26, 13, 13, 25, 25, 25, 26, 26, 26, 23, 23, 26, 26, 19, 19, 09, 09, 19, 19,
2015 2015 2016 2016 2016 2016 2014 2015 2012 2012 2013 2016 2016 2016 2019 2019 2026 2027 2016 2017 2017 2017 2016 2017
DP DP
U-1209 U-1305 U-1305 U-1209
NDF PED
Dec Jun
16, 2014 16, 2015
DS DS DS DP DP U-1209 U-1305 U-1305 U-1209 U-1209 DS DP DP DS DP U-1305 U-1305
Jun Jun Apr Apr Apr Mar
28, 28, 13, 13, 28, 28,
2020 2020 2020 2020 2020 2026
DS DS
DP DP
U-780 U-748 U-780 U-779 U-780
M-94 ODE ODE
Oct Jun Jun
28, 2013 28, 2013 28, 2013
DS
DP
ADA 45 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-780 U-748 U-779 U-780 U-780
EXCLUSIVITY CODE(S)
M-94 ODE ODE
DASATINIB - SPRYCEL N021986 002 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 003 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 004 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 005 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 006 6596746 6596746 7125875 7125875 7153856 7491725 DECITABINE - DACOGEN N021790 001 DEFERASIROX - EXJADE N021882 001 6465504 6596750 DEFERASIROX - EXJADE N021882 002 6465504 6596750 DEFERASIROX - EXJADE N021882 003 6465504 6596750 DEFERIPRONE - FERRIPROX N021825 001 DEGARELIX ACETATE - FIRMAGON N022201 001 5925730 DEGARELIX ACETATE - FIRMAGON N022201 002 5925730
28, 28, 13, 13, 28, 28,
2020 2020 2020 2020 2020 2026
Oct Jun Jun
28, 2013 28, 2013 28, 2013
DS
DP
28, 28, 13, 13, 28, 28,
2020 2020 2020 2020 2020 2026
DS DS
DP DP
U-780 U-748 U-779 U-780 U-780
M-94 ODE ODE
Oct Jun Jun
28, 2013 28, 2013 28, 2013
DS
DP
28, 28, 13, 13, 28, 28,
2020 2020 2020 2020 2020 2026
DS DS
DP DP
U-780 U-748 U-780 U-779 U-780
M-94 ODE ODE
Oct Jun Jun
28, 2013 28, 2013 28, 2013
DS
DP
28, 28, 13, 13, 28, 28,
2020 2020 2020 2020 2020 2026
DS DS
DP DP
U-780 U-748 U-780 U-779 U-780
M-94 ODE ODE
Oct Jun Jun
28, 2013 28, 2013 28, 2013
DS
DP
28, 28, 13, 13, 28, 28,
2020 2020 2020 2020 2020 2026
DS DS
DP DP
U-748 U-780 U-779 U-780 U-780
M-94 ODE ODE
Oct Jun Jun
28, 2013 28, 2013 28, 2013
DS
DP
D-123 ODE Apr Jun 05, 2019 24, 2017 DS DS DP U-735
Mar May
11, 2013 02, 2013
ODE
Nov
02, 2012
Apr Jun
05, 2019 24, 2017
DS DS
DP U-735
ODE
Nov
02, 2012
Apr Jun
05, 2019 24, 2017
DS DS
DP U-735
ODE
Nov
02, 2012
NCE ODE May 18, 2021 DS DP U-943
Oct Oct
14, 2016 14, 2018
NCE
Dec
24, 2013
May
18, 2021
DS
DP
U-943
NCE
Dec
24, 2013
DELAVIRDINE MESYLATE - RESCRIPTOR N020705 001 5563142 Oct
08, 2013
ADA 46 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
DELAVIRDINE MESYLATE - RESCRIPTOR N020705 002 5563142 Oct 6177101 Jun DESFLURANE - SUPRANE N020118 001 5617906 5617906*PED
08, 2013 07, 2019
Apr Oct
08, 2014 08, 2014
DP
DESIRUDIN RECOMBINANT - IPRIVASK N021271 001 5733874 Mar DESLORATADINE - CLARINEX N021165 001 6100274 6100274*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED 7405223 7405223*PED DESLORATADINE - CLARINEX N021300 001 6514520 6514520*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED DESLORATADINE - CLARINEX N021312 001 5607697 5607697*PED 6100274 6100274*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED 7618649 7618649*PED DESLORATADINE - CLARINEX N021312 002 5607697 5607697*PED 6100274 6100274*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED 7618649 7618649*PED
31, 2015
Jul Jan Dec Jun Dec Jun Dec Jun Jul Jan
07, 07, 30, 30, 30, 30, 30, 30, 07, 07,
2019 2020 2014 2015 2014 2015 2014 2015 2019 2020
U-809 DP U-138 U-886
Jun Dec Dec Jun Dec Jun Dec Jun
01, 01, 30, 30, 30, 30, 30, 30,
2018 2018 2014 2015 2014 2015 2014 2015
DP U-809 DP U-138
Jun Dec Jul Jan Dec Jun Dec Jun Dec Jun Dec Jun
07, 07, 07, 07, 30, 30, 30, 30, 30, 30, 19, 19,
2015 2015 2019 2020 2014 2015 2014 2015 2014 2015 2020 2021
DP DP U-809 DP U-138 DP U-1017
Jun Dec Jul Jan Dec Jun Dec Jun Dec Jun Dec Jun
07, 07, 07, 07, 30, 30, 30, 30, 30, 30, 19, 19,
2015 2015 2019 2020 2014 2015 2014 2015 2014 2015 2020 2021
DP DP U-809 DP U-138 DP U-1017
ADA 47 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
DESLORATADINE; PSEUDOEPHEDRINE SULFATE - CLARINEX D 24 HOUR N021605 001 6100274 Jul 07, 2019 DP 6100274*PED Jan 07, 2020 DP 6979463 Mar 28, 2022 DP 7214683 Dec 30, 2014 7214683*PED Jun 30, 2015 U-138 7214684 Dec 30, 2014 7214684*PED Jun 30, 2015 DP U-1017 7618649 Dec 19, 2020 7618649*PED Jun 19, 2021 DP 7820199 Mar 28, 2022 7820199*PED Sep 28, 2022 DESLORATADINE; PSEUDOEPHEDRINE SULFATE - CLARINEX-D N021313 001 6100274 Jul 07, 2019 6100274*PED Jan 07, 2020 6709676 Feb 18, 2021 7214683 Dec 30, 2014 7214683*PED Jun 30, 2015 7214684 Dec 30, 2014 7214684*PED Jun 30, 2015 7618649 Dec 19, 2020 7618649*PED Jun 19, 2021 8187630 Dec 19, 2020 DESMOPRESSIN ACETATE - DDAVP N017922 001 5500413 5674850 5763407 DESMOPRESSIN ACETATE - DDAVP N017922 002 5500413 5674850 5763407 DESMOPRESSIN ACETATE - DDAVP N018938 001 5500413 5763407 DESMOPRESSIN ACETATE - DDAVP N018938 002 5500413 5763407 DESMOPRESSIN ACETATE - DDAVP N019955 001 5500413 5674850 5763407 7022340 DESMOPRESSIN ACETATE - DDAVP N019955 002 5500413 5674850 5763407 7022340 12 HOUR DP DP DP U-707
U-138 DP DP U-1017 U-1017
Jun Dec Jun
29, 2013 23, 2013 29, 2013
Jun Dec Jun
29, 2013 23, 2013 29, 2013
Jun Jun
29, 2013 29, 2013
Jun Jun
29, 2013 29, 2013
Jun Dec Jun Apr
29, 23, 29, 30,
2013 2013 2013 2023
DP
Jun Dec Jun Apr
29, 23, 29, 30,
2013 2013 2013 2023
DP
DESMOPRESSIN ACETATE - DDAVP (NEEDS NO REFRIGERATION) N017922 003 5482931 Jun 29, 2013 5500413 Jun 29, 2013 5674850 Dec 23, 2013 5763407 Jun 29, 2013 DESMOPRESSIN ACETATE - DESMOPRESSIN ACETATE N021795 001 7022340 Apr 30, 2023 DESMOPRESSIN ACETATE - DESMOPRESSIN ACETATE N021795 002 7022340 Apr 30, 2023 DESONIDE - DESONATE N021844 001 6387383
DP
DP
Aug
03, 2020
DS
DP
U-783
ADA 48 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
DESONIDE - VERDESO N021978 001 6730288 7029659
Sep Sep
08, 2019 08, 2019
DESVENLAFAXINE SUCCINATE - PRISTIQ N021992 001 6673838 Feb 8269040 Jul DESVENLAFAXINE SUCCINATE - PRISTIQ N021992 002 6673838 Feb 8269040 Jul DEXAMETHASONE - OZURDEX N022315 001 6726918 6726918 6899717 7033605 7767223 8034366 8034366 8034370 8043628 8063031 8088407
11, 2022 05, 2027
DS DS
DP
U-860
NCE
Mar
01, 2013
11, 2022 05, 2027
DS DS
DP
U-860
NCE
Mar
01, 2013
Oct Oct Nov Oct Nov Jan Jan Jan Oct Oct Oct
20, 20, 01, 20, 28, 09, 09, 09, 20, 20, 20,
2020 2020 2023 2020 2021 2023 2023 2023 2020 2020 2020
DP DP DP DP DP DP DP DP DP DP
U-1204 U-1205 U-1206
ODE
Sep
24, 2017
U-1204 U-1205 U-1205 U-1205
DEXAMETHASONE; TOBRAMYCIN - TOBRADEX ST N050818 001 7795316 Aug 03, 2028 8101582 Dec 19, 2027 DEXLANSOPRAZOLE - DEXILANT N022287 001 6462058 6462058 6462058 6462058*PED 6664276 6664276 6664276 6664276*PED 6939971 6939971 6939971 6939971*PED 7285668 7285668*PED 7790755 7790755*PED 8105626 8105626*PED 8173158 8173158 8173158 8173158*PED
DP DP
U-1082 U-1082
Jun Jun Jun Dec Jun Jun Jun Dec Jun Jun Jun Dec Jun Dec Aug Feb Sep Mar Mar Mar Mar Sep
15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 02, 02, 27, 27, 17, 17, 17, 17,
2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2026 2027 2026 2027 2030 2030 2030 2030
DS DS DS DS DS DS
DP DP DP DP DP DP
U-949 U-950 U-951 U-951 U-949 U-950 U-950 U-949 U-951
PED
Jul
30, 2012
DS DP DP U-950 U-951 U-949
ADA 49 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DS DP DP DP DP DP DP U-950 U-949 U-951 U-951 U-950 U-949 U-951 U-949 U-950 DS DP DP U-950 U-951 U-949
EXCLUSIVITY CODE(S)
PED
DEXLANSOPRAZOLE - DEXILANT N022287 002 6462058 6462058 6462058 6462058*PED 6664276 6664276 6664276 6664276*PED 6939971 6939971 6939971 6939971*PED 7285668 7285668*PED 7790755 7790755*PED 8105626 8105626*PED 8173158 8173158 8173158 8173158*PED
Jun Jun Jun Dec Jun Jun Jun Dec Jun Jun Jun Dec Jun Dec Aug Feb Sep Mar Mar Mar Mar Sep
15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 02, 02, 27, 27, 17, 17, 17, 17,
2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2026 2027 2026 2027 2030 2030 2030 2030
Jul
30, 2012
DEXMEDETOMIDINE HYDROCHLORIDE - PRECEDEX N021038 001 4910214 Jul 15, 2013 6716867 Mar 31, 2019 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN N021278 001 5908850 Dec 04, 2015 6355656 Dec 04, 2015 6528530 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN N021278 002 5908850 Dec 04, 2015 6355656 Dec 04, 2015 6528530 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN N021278 003 5908850 Dec 04, 2015 6355656 Dec 04, 2015 6528530 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 001 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 002 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015
DS
DP
U-421 U-572
U-422 DS DP
U-422 DS DP
U-422 DS DP
DP DP DP DP DP DP DP U-678 U-676
D-121
Oct
23, 2012
U-677 U-676
D-121
Oct
23, 2012
U-677 U-676
ADA 50 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
D-121
DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 003 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 004 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 005 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 006 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 007 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 008 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXRAZOXANE HYDROCHLORIDE - TOTECT N022025 001 6727253 Mar DEXTROMETHORPHAN HYDROBROMIDE; N021620 001 6372252 6955821 7838032
Oct
23, 2012
U-677 U-676
D-121
Oct
23, 2012
U-677 U-676
D-121 U-678 U-676
Oct
23, 2012
U-677 U-676
U-677 U-678 U-676
D-121
Oct
23, 2012
U-677 U-676
D-121 U-678 U-676
Oct
23, 2012
U-677 U-676
D-121 U-678 U-676
Oct
23, 2012
U-677 U-676
13, 2020
U-829
ODE
Sep
06, 2014
GUAIFENESIN - MUCINEX DM Apr 28, 2020 DP DP U-685 Apr 28, 2020 Apr 28, 2020 DP
ADA 51 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
DEXTROMETHORPHAN HYDROBROMIDE; N021620 002 6372252 6955821 7838032 DEXTROMETHORPHAN HYDROBROMIDE; N021879 001 7659282 8227484 RE38115
GUAIFENESIN - MUCINEX DM Apr 28, 2020 DP DP U-685 Apr 28, 2020 DP Apr 28, 2020 QUINIDINE SULFATE - NUEDEXTA Aug 13, 2026 U-1093 Jul 17, 2023 U-1093 DP Jan 26, 2016
NC
Oct
29, 2013
DEXTROMETHORPHAN POLISTIREX - DELSYM N018658 001 5980882 Apr 16, 2017 DIAZEPAM - DIASTAT N020648 001 5462740 DIAZEPAM - DIASTAT N020648 002 5462740 DIAZEPAM - DIASTAT N020648 003 5462740 DIAZEPAM - DIASTAT N020648 004 5462740 DIAZEPAM - DIASTAT N020648 005 5462740 DIAZEPAM - DIASTAT ACUDIAL N020648 006 5462740 DIAZEPAM - DIASTAT ACUDIAL N020648 007 5462740
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
DICLOFENAC EPOLAMINE - FLECTOR Apr N021234 001 5607690 DICLOFENAC POTASSIUM - CAMBIA N022165 001 6974595 7482377 7759394 8097651 DICLOFENAC POTASSIUM - ZIPSOR N022202 001 6365180 7662858 7884095 7939518 8110606
13, 2014
DP
May May Jun Jun
15, 15, 16, 16,
2017 2017 2026 2026
DS DS DS
DP DP DP
U-436 U-436 U-436 U-436
Jul Feb Feb Feb Feb
15, 24, 24, 24, 24,
2019 2029 2029 2029 2029
DP
U-980 U-1035 U-1111 U-980 U-980
DICLOFENAC SODIUM - DICLOFENAC SODIUM N020809 001 5603929 Nov 16, 2014 5653972 Nov 16, 2014 DICLOFENAC SODIUM - PENNSAID N020947 001 8217078 DICLOFENAC SODIUM - SOLARAZE N021005 001 5639738 5792753 5852002 5914322 5929048 5985850
U-239 U-239
Jul
10, 2029
U-1248
NDF
Nov
04, 2012
Jun Aug Jun Aug Jun Aug
17, 11, 17, 11, 17, 11,
2014 2015 2014 2015 2014 2015
U-402 U-402 U-402 DP
DICLOFENAC SODIUM; MISOPROSTOL - ARTHROTEC N020607 001 5601843 Feb 11, 2014 DICLOFENAC SODIUM; MISOPROSTOL - ARTHROTEC N020607 002 5601843 Feb 11, 2014
ADA 52 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP U-112 U-828 U-1 U-1 U-1240
EXCLUSIVITY CODE(S)
I-648 NP
DIENOGEST; ESTRADIOL VALERATE - NATAZIA N022252 001 6133251 Oct 25, 6133251 Oct 25, 6133251 Oct 25, 6884793 Oct 25, 8071577 May 13, 8153616 Jan 30, DIFLUPREDNATE - DUREZOL N022212 001 6114319
2016 2016 2016 2016 2026 2028
Y Y Y Y
Mar May
14, 2015 06, 2013
May
18, 2019
DP
I-653 NCE ODE U-107
Jun Jun Jun
13, 2015 23, 2013 13, 2019
DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 001 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 002 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 003 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 004 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 005 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 001 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 002 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 003 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 004 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 005 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 006 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 001 5529791 Jun 25, 2013 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 002 5529791 Jun 25, 2013 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 003 5529791 Jun 25, 2013 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 004 5529791 Jun 25, 2013
U-107
U-107
U-107
DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
ADA 53 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 001 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 002 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 003 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 004 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 005 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 006 5529791 Jun
25, 2013
25, 2013
25, 2013
25, 2013
25, 2013
25, 2013
DIMYRISTOYL LECITHIN; PERFLEXANE - IMAGENT N021191 001 5605673 Feb 25, 2014 5626833 May 16, 2014 5639443 Jun 17, 2014 5695741 Dec 09, 2014 5720938 Feb 24, 2015 5798091 Aug 25, 2015 6280704 Jul 30, 2013 6280705 Jul 30, 2013 6287539 Jul 30, 2013 DINOPROSTONE - CERVIDIL N020411 001 5269321
U-458 U-458 U-458
Jul
14, 2012
DP
U-110
DIPHENHYDRAMINE CITRATE; IBUPROFEN - ADVIL PM N021394 001 8263647 May 30, 2022 DIVALPROEX SODIUM - DEPAKOTE ER N021168 001 6419953 Dec 6419953*PED Jun 6511678 Dec 6511678*PED Jun 6528090 Dec 6528090*PED Jun 6528091 Dec 6528091*PED Jun 6713086 Dec 6713086*PED Jun 6720004 Dec 6720004*PED Jun DIVALPROEX SODIUM - DEPAKOTE ER N021168 002 6511678 Dec 6511678*PED Jun 6528090 Dec 6528090*PED Jun 6713086 Dec 6713086*PED Jun 6720004 Dec 6720004*PED Jun DOCETAXEL - TAXOTERE N020449 001 5438072 5438072*PED 5698582 5698582*PED 5714512 5714512*PED 5750561 5750561*PED
DP
18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18,
2018 2019 2018 2019 2018 2019 2018 2019 2018 2019 2018 2019
DP U-106 DP DP U-579
18, 18, 18, 18, 18, 18, 18, 18,
2018 2019 2018 2019 2018 2019 2018 2019
DP DP DP U-579
Nov May Jul Jan Jul Jan Jul Jan
22, 22, 03, 03, 03, 03, 03, 03,
2013 2014 2012 2013 2012 2013 2012 2013
DP DP DP DP
M-61 PED
May Nov
13, 2013 13, 2013
ADA 54 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
M-61 PED
DOCETAXEL - TAXOTERE N020449 003 5698582 5698582*PED 5714512 5714512*PED 5750561 5750561*PED DOCETAXEL - TAXOTERE N020449 004 5698582 5698582*PED 5714512 5714512*PED 5750561 5750561*PED DOCOSANOL - ABREVA N020941 001 4874794 5534554 DOFETILIDE - TIKOSYN N020931 001 4959366 6124363 DOFETILIDE - TIKOSYN N020931 002 4959366 6124363 DOFETILIDE - TIKOSYN N020931 003 4959366 6124363
Jul Jan Jul Jan Jul Jan
03, 03, 03, 03, 03, 03,
2012 2013 2012 2013 2012 2013
May Nov
13, 2013 13, 2013
Jul Jan Jul Jan Jul Jan
03, 03, 03, 03, 03, 03,
2012 2013 2012 2013 2012 2013
DP DP DP
M-61 PED
May Nov
13, 2013 13, 2013
Apr Dec
28, 2014 13, 2013
DP
U-815 U-815
Sep Oct
25, 2012 09, 2018
DS
DP
U-652
Sep Oct
25, 2012 09, 2018
DS
DP
U-652
Sep Oct
25, 2012 09, 2018
DS
DP
U-652
DONEPEZIL HYDROCHLORIDE - ARICEPT N020690 001 5985864 Dec 6140321 Dec 6245911 Dec DONEPEZIL HYDROCHLORIDE - ARICEPT N020690 002 5985864 Dec 6140321 Dec 6245911 Dec DONEPEZIL HYDROCHLORIDE - ARICEPT N022568 001
30, 2016 30, 2016 01, 2018
30, 2016 30, 2016 01, 2018
NP DP DP U-1062
Jul
23, 2013
DONEPEZIL HYDROCHLORIDE - ARICEPT ODT N021720 001 7727548 Jun 23, 2022 7727552 Mar 26, 2018 DONEPEZIL HYDROCHLORIDE - ARICEPT ODT N021720 002 7727548 Jun 23, 2022 7727552 Mar 26, 2018 DORIPENEM - DORIBAX N022106 001 5317016 8247402 DORIPENEM - DORIBAX N022106 002 5317016 8247402
DP DP
U-1062
Jun Mar
05, 2015 30, 2021
DS DS
DP DP
U-282
NCE
Oct
12, 2012
Jun Mar
05, 2015 30, 2021
DS DS
DP DP
U-282
NCE
Oct
12, 2012
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE - COSOPT PF N202667 001
NP
Feb
01, 2015
ADA 55 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-620 DP DP DP DP DP U-620 DP U-620
EXCLUSIVITY CODE(S)
NP
DOXEPIN HYDROCHLORIDE - SILENOR Mar N022036 001 5502047 Jan 5585115 Jan 5725884 Jan 5866166 Jan 5948438 Jan 6103219 Feb 6211229 Jan 6217909 Aug 7915307 DOXEPIN HYDROCHLORIDE - SILENOR Mar N022036 002 5502047 Jan 5585115 Jan 5725884 Jan 5866166 Jan 5948438 Jan 6103219 Feb 6211229 Jan 6217909 Aug 7915307 DOXERCALCIFEROL - HECTOROL N020862 001 5602116 5602116 6903083 DOXERCALCIFEROL - HECTOROL N020862 002 5602116 5602116 6903083 DOXERCALCIFEROL - HECTOROL N020862 003 5602116 DOXERCALCIFEROL - HECTOROL N021027 001 5602116 6903083 7148211 DOXERCALCIFEROL - HECTOROL N021027 002 5602116 7148211
26, 09, 09, 09, 09, 09, 17, 09, 24,
2013 2015 2015 2015 2015 2015 2020 2015 2027
Mar
17, 2013
26, 09, 09, 09, 09, 09, 17, 09, 24,
2013 2015 2015 2015 2015 2015 2020 2015 2027
U-620 DP DP DP DP DP U-620 DP U-620
NP
Mar
17, 2013
Feb Feb Jul
11, 2014 11, 2014 18, 2021
U-278 U-987 DS DP Y
Feb Feb Jul
11, 2014 11, 2014 18, 2021
U-987 U-278 DS DP Y
Feb
11, 2014
U-987
Feb Jul Sep
11, 2014 18, 2021 14, 2023
U-321 DS DP DP Y Y
Feb Sep
11, 2014 14, 2023
U-321 DP Y
DOXORUBICIN HYDROCHLORIDE - DOXIL N050718 001 DOXORUBICIN HYDROCHLORIDE - DOXIL N050718 002 DOXYCYCLINE - ORACEA N050805 001 5789395 5919775 7211267 7232572 7749532 8206740 DOXYCYCLINE HYCLATE - DORYX N050795 001 6958161 DOXYCYCLINE HYCLATE - DORYX N050795 002 6958161 DOXYCYCLINE HYCLATE - DORYX N050795 003 6958161
ODE
May
17, 2014
ODE 30, 30, 05, 05, 19, 24, 2016 2016 2022 2022 2027 2025 U-925 U-925 U-925 U-925 U-1063 U-925
May
17, 2014
Aug Aug Apr Apr Dec Dec
DP DP
Dec
15, 2022
DP
U-918
Dec
15, 2022
DP
U-918
Dec
15, 2022
DP
U-918
ADA 56 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP DP DP U-1261 U-992
EXCLUSIVITY CODE(S)
NCE
DRONEDARONE HYDROCHLORIDE - MULTAQ N022425 001 5223510 Jul 5223510 Jul 7323493 Jun 8318800 Jun DROSPIRENONE; ESTRADIOL - ANGELIQ N021355 001 DROSPIRENONE; ESTRADIOL - ANGELIQ Aug N021355 002 6933395
26, 26, 19, 19,
2013 2013 2018 2018
Jul
01, 2014
NS 11, 2017 DS
Mar
01, 2015
DROSPIRENONE; ETHINYL ESTRADIOL - YASMIN Oct 29, 2013 N021098 001 5569652 Aug 31, 2020 6787531 Aug 11, 2017 6933395 DROSPIRENONE; ETHINYL ESTRADIOL - YAZ N021676 001 5569652 Oct 29, 5798338 Jul 10, 6787531 Aug 31, Aug 11, 6933395 Dec 20, 6958326 Dec 22, 6987101 Dec 20, 7163931 Jun 30, RE37564 Jun 30, RE37838 Jun 30, RE38253
U-1 DP DS
2013 2015 2020 2017 2021 2017 2021 2014 2014 2014
U-1 DP DP DP DP U-758 U-1 DP DP DP
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM - BEYAZ Jul 10, 2015 DP N022532 001 5798338 DS Apr 17, 2020 6441168 DP Dec 30, 2021 6958326 U-1 Mar 03, 2022 7163931 DP Jun 30, 2014 RE37564 DP Jun 30, 2014 RE37838 DP Jun 30, 2014 RE38253 DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM - SAFYRAL N022574 001 5798338 Jul 10, 2015 DP DS 6441168 Apr 17, 2020 DP Dec 20, 2021 6958326 U-1 Mar 03, 2022 7163931 DULOXETINE HYDROCHLORIDE - CYMBALTA N021427 001 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269*PED Dec 11, 2013 5508276 Jul 18, 2014 5508276*PED Jan 18, 2015 6596756 Sep 10, 2019 Mar 10, 2020 6596756*PED
NC NP
Sep Sep
24, 2013 24, 2013
NP
Dec
16, 2013
DS DS DS DS DS DS DS DS DS
U-882 U-799 U-839 U-398 U-1094 U-605 U-797 U-796 U-795
I-632 I-617 PED PED
Nov Nov May May
04, 19, 19, 04,
2013 2012 2013 2014
U-882
ADA 57 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP DP DP U-882 U-398 U-797 U-799 U-796 U-795 U-1094 U-839 U-882 U-605
EXCLUSIVITY CODE(S)
I-632 I-617 PED PED
DULOXETINE HYDROCHLORIDE - CYMBALTA Jun 11, 2013 N021427 002 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Dec 11, 2013 5023269*PED Jul 18, 2014 5508276 Jan 18, 2015 5508276*PED Sep 10, 2019 6596756 Mar 10, 2020 6596756*PED DULOXETINE HYDROCHLORIDE - CYMBALTA N021427 004 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269*PED Dec 11, 2013 5508276 Jul 18, 2014 5508276*PED Jan 18, 2015 6596756 Sep 10, 2019 Mar 10, 2020 6596756*PED DUTASTERIDE - AVODART N021319 001 5565467 5846976 5998427
Nov Nov May May
04, 19, 19, 04,
2013 2012 2013 2014
DS DS DS DS DS DS DS DS DS
U-795 U-605 U-882 U-398 U-1094 U-797 U-799 U-839 U-796
I-632 I-617 PED PED
Nov Nov May May
04, 19, 19, 04,
2013 2012 2013 2014
U-882
Nov Sep Sep
20, 2015 17, 2013 17, 2013 JALYN 2015 2013 2013
DS DS
DP DP U-476 U-477
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE Nov 20, N022460 001 5565467 Sep 17, 5846976 Sep 17, 5998427 EFAVIRENZ - SUSTIVA N020972 001 5519021 5663169 5811423 6238695 6555133 6639071 6939964 EFAVIRENZ - SUSTIVA N020972 002 5519021 5663169 5811423 6238695 6555133 6639071 6939964 EFAVIRENZ - SUSTIVA N020972 003 5519021 5663169 5811423 6238695 6555133 6639071 6939964
DS DS
DP DP U-1065 U-1066
May Sep Aug Apr Apr Feb Jan
21, 02, 07, 06, 06, 14, 20,
2013 2014 2012 2019 2019 2018 2018
DS DS
DP DP DP U-257 U-256 U-248
DS DS
21, 02, 07, 06, 06, 14, 20,
2013 2014 2012 2019 2019 2018 2018
DS DS
DP DP DP U-257 U-256 U-248
DS DS
21, 02, 07, 06, 06, 14, 20,
2013 2014 2012 2019 2019 2018 2018
DS DS
DP DP DP U-257 U-256 U-248
DS DS
ADA 58 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
EFAVIRENZ - SUSTIVA N021360 001 5519021 5663169 5811423 6639071 6939964 EFAVIRENZ - SUSTIVA N021360 002 5519021 5663169 5811423 6639071 6939964
May Sep Aug Feb Jan
21, 02, 07, 14, 20,
2013 2014 2012 2018 2018
U-256 DS DS
May Sep Aug Feb Jan
21, 02, 07, 14, 20,
2013 2014 2012 2018 2018
DS
DP U-248 U-256
DS DS
EFAVIRENZ; EMTRICITABINE; TENOFOVIR N021937 001 5519021 May 5663169 Sep 5663169 Sep 5811423 Aug 5811423 Aug 5814639 Sep 5814639*PED Mar 5914331 Jul 5914331*PED Jan 5922695 Jul 5922695 Jul 5922695*PED Jan 5935946 Jul 5935946 Jul 5935946*PED Jan 5977089 Jul 5977089 Jul 5977089*PED Jan 6043230 Jul 6043230 Jul 6043230*PED Jan 6639071 Feb 6642245 Nov 6642245 Nov 6642245*PED May 6703396 Mar 6703396*PED Sep 6939964 Jan
DISOPROXIL FUMARATE - ATRIPLA 21, 2013 DS DP 02, 2014 U-750 02, 2014 U-1170 07, 2012 U-750 07, 2012 U-1170 29, 2015 DS DP 29, 2016 DS 02, 2017 02, 2018 DS U-1170 25, 2017 DS U-750 25, 2017 25, 2018 DS DP U-750 25, 2017 DS DP U-1170 25, 2017 25, 2018 DS DP U-1170 25, 2017 DS DP U-750 25, 2017 25, 2018 U-750 25, 2017 U-1170 25, 2017 25, 2018 DS 14, 2018 U-1170 04, 2020 04, 2020 U-750 04, 2021 DS DP 09, 2021 09, 2021 DS 20, 2018
EFLORNITHINE HYDROCHLORIDE - VANIQA N021145 001 5648394 Jul 15, 2014 ELETRIPTAN HYDROBROMIDE - RELPAX N021016 001 5545644 Dec 6110940 Aug ELETRIPTAN HYDROBROMIDE - RELPAX N021016 002 5545644 Dec 6110940 Aug
U-334
26, 2016 29, 2017
DS
DP
U-876
26, 2016 29, 2017
DS
DP
U-876
ADA 59 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DP DP DP DP U-1306 U-930 U-1306 U-930 U-1306 U-930 U-1306 U-930 U-1306 U-930 U-930 U-1306 U-1306 U-930 U-1306 U-930
EXCLUSIVITY CODE(S)
I-664 NCE ODE
ELTROMBOPAG OLAMINE - PROMACTA N022291 001 6280959 6280959 7160870 7160870 7332481 7332481 7452874 7473686 7473686 7547719 7547719 7790704 7790704 7795293 7795293 8052993 8052993 ELTROMBOPAG OLAMINE - PROMACTA N022291 002 6280959 6280959 7160870 7160870 7332481 7332481 7452874 7473686 7473686 7547719 7547719 7790704 7790704 7795293 7795293 8052994 8052994 ELTROMBOPAG OLAMINE - PROMACTA N022291 003 6280959 6280959 7160870 7160870 7332481 7332481 7452874 7473686 7473686 7547719 7547719 7790704 7790704 7795293 7795293 8062665 8062665
Oct Oct Nov Nov May May May May May Jul Jul May May May May Aug Aug
30, 30, 20, 20, 24, 24, 24, 24, 24, 13, 13, 24, 24, 21, 21, 01, 01,
2018 2018 2022 2022 2021 2021 2021 2021 2021 2025 2025 2021 2021 2023 2023 2027 2027
Nov Nov Nov
16, 2015 20, 2013 20, 2015
DS DS DS DS DS
DP DP DP DP DP
DP DP
30, 30, 20, 20, 24, 24, 24, 24, 24, 13, 13, 24, 24, 21, 21, 01, 01,
2018 2018 2022 2022 2021 2021 2021 2021 2021 2025 2025 2021 2021 2023 2023 2027 2027
DS DS DS DS
DP DP DP DP
U-1306 U-930 U-1306 U-930 U-1306 U-930 U-930 U-1306 U-1306 U-930 U-1306 U-930 U-1306 U-930 U-930 U-1306
I-664 NCE ODE
Nov Nov Nov
16, 2015 20, 2013 20, 2015
DS DS DS DS DS
DP DP DP DP DP
DP DP
30, 30, 20, 20, 24, 24, 24, 24, 24, 13, 13, 24, 24, 21, 21, 01, 01,
2018 2018 2022 2022 2021 2021 2021 2021 2021 2025 2025 2021 2021 2023 2023 2027 2027
DS DS DS DS
DP DP DP DP
I-664 NCE ODE
Nov Nov Nov
16, 2015 20, 2013 20, 2015
DS DS DS DS DS
DP DP DP DP DP
DP DP
ADA 60 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DP DP DP DP U-930 U-1306 U-930 U-1306 U-930 U-1306 U-930 U-1306 U-1306 U-930 U-1306 U-930 U-1306 U-930 U-1306 U-930
EXCLUSIVITY CODE(S)
I-664 NCE ODE
ELTROMBOPAG OLAMINE - PROMACTA N022291 004 6280959 6280959 7160870 7160870 7332481 7332481 7452874 7473686 7473686 7547719 7547719 7790704 7790704 7795293 7795293 8071129 8071129 ELTROMBOPAG OLAMINE - PROMACTA N022291 005 6280959 6280959 7160870 7160870 7332481 7332481 7452874 7473686 7473686 7547719 7547719 7790704 7790704 7795293 7795293 8052995
30, 30, 20, 20, 24, 24, 24, 24, 24, 13, 13, 24, 24, 21, 21, 01, 01,
2018 2018 2022 2022 2021 2021 2021 2021 2021 2025 2025 2021 2021 2023 2023 2027 2027
Nov Nov Nov
16, 2015 20, 2013 20, 2015
DS DS DS DS DS
DP DP DP DP DP
DP DP
Oct Oct Nov Nov May May May May May Jul Jul May May May May Aug
30, 30, 20, 20, 24, 24, 24, 24, 24, 13, 13, 24, 24, 21, 21, 01,
2018 2018 2022 2022 2021 2021 2021 2021 2021 2025 2025 2021 2021 2023 2023 2027
DS DS DS DS
DP DP DP DP
U-930 U-1306 U-930 U-1306 U-1306 U-930 U-930 U-1306 U-930 U-1306 U-1306 U-930 U-930 U-1306 U-1306
I-664 NCE ODE
Nov Nov Nov
16, 2015 20, 2013 20, 2015
DS DS DS DS DS
DP DP DP DP DP
DP
EMEDASTINE DIFUMARATE - EMADINE N020706 001 5441958 Dec EMTRICITABINE - EMTRIVA N021500 001 5814639 5814639*PED 5914331 5914331*PED 6642245 6642245 6642245*PED 6703396 6703396*PED EMTRICITABINE - EMTRIVA N021896 001 5814639 5814639*PED 5914331 5914331*PED 6642245 6642245*PED 6703396 6703396*PED
08, 2013
U-404
Sep Mar Jul Jan Nov Nov May Mar Sep
29, 29, 02, 02, 04, 04, 04, 09, 09,
2015 2016 2017 2018 2020 2020 2021 2021 2021
DS DS
DP
U-257 U-541 DS DP
Sep Mar Jul Jan Nov May Mar Sep
29, 29, 02, 02, 04, 04, 09, 09,
2015 2016 2017 2018 2020 2021 2021 2021
DS DS
DP
U-257 DS DP
ADA 61 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DS N202123 001 5814639 Sep 29, 2015 5814639*PED Mar 29, 2016 DS 5914331 Jul 02, 2017 5914331*PED Jan 02, 2018 5922695 Jul 25, 2017 DS 5922695*PED Jan 25, 2018 DS 5935946 Jul 25, 2017 5935946*PED Jan 25, 2018 DS 5977089 Jul 25, 2017 5977089*PED Jan 25, 2018 6043230 Jul 25, 2017 6043230*PED Jan 25, 2018 6642245 Nov 04, 2020 6642245*PED May 04, 2021 6703396 Mar 09, 2021 DS 6703396*PED Sep 09, 2021 DS 6838464 Feb 26, 2021 DS 7067522 Dec 20, 2019 7125879 Apr 14, 2023 DS DS 8080551 Apr 11, 2023 8101629 Aug 09, 2022 EMTRICITABINE; TENOFOVIR DISOPROXIL N021752 001 5814639 Sep 5814639*PED Mar 5914331 Jul 5914331*PED Jan 5922695 Jul 5922695 Jul 5922695 Jul 5922695 Jul 5922695*PED Jan 5935946 Jul 5935946 Jul 5935946 Jul 5935946 Jul 5935946*PED Jan 5977089 Jul 5977089 Jul 5977089 Jul 5977089 Jul 5977089*PED Jan 6043230 Jul 6043230 Jul 6043230 Jul 6043230 Jul 6043230*PED Jan 6642245 Nov 6642245 Nov 6642245 Nov 6642245*PED May 6703396 Mar 6703396*PED Sep ENFUVIRTIDE - FUZEON N021481 001 5464933 6133418 6475491 ENTACAPONE - COMTAN N020796 001 5446194 6599530 ENTECAVIR - BARACLUDE N021797 001 5206244
DISOPROXIL FUMARATE - COMPLERA DP NCE
May
20, 2016
U-257 U-257 DP DP U-257 U-257 U-257 U-257 DP DP DP DP DP DP
U-257
FUMARATE - TRUVADA 29, 2015 DS DP 29, 2016 DS DP U-248 02, 2017 DS 02, 2018 DS U-248 25, 2017 25, 2017 DS U-1259 DS U-1170 25, 2017 DS U-541 25, 2017 25, 2018 DS DP U-248 25, 2017 DS DP U-541 25, 2017 DS DP U-1170 25, 2017 DS DP U-1259 25, 2017 25, 2018 DS DP U-541 25, 2017 DS DP U-1259 25, 2017 DS DP U-248 25, 2017 DS DP U-1170 25, 2017 25, 2018 DP U-541 25, 2017 DP U-1170 25, 2017 DP U-248 25, 2017 DP U-1259 25, 2017 25, 2018 U-248 04, 2020 U-541 04, 2020 U-1170 04, 2020 04, 2021 09, 2021 DS DP 09, 2021
Jun Nov Jun
07, 2013 17, 2014 07, 2015
DS
DP U-248
Oct Sep
19, 2013 14, 2018
DS DP U-219
Feb
21, 2015
DS
D-127 NPP NPP
Oct Oct Oct
15, 2013 12, 2015 12, 2015
ADA 62 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS
EXCLUSIVITY CODE(S)
D-127 NPP NPP
ENTECAVIR - BARACLUDE N021797 002 5206244
Feb
21, 2015
Oct Oct Oct
15, 2013 12, 2015 12, 2015
ENTECAVIR - BARACLUDE N021798 001 5206244
Feb
21, 2015
DS
D-127 NPP NPP DP U-1281
Oct Oct Oct
15, 2013 12, 2015 12, 2015
ENZALUTAMIDE - XTANDI N203415 001 7709517 8183274 EPINEPHRINE - ADRENACLICK N020800 003 5665071 EPINEPHRINE - ADRENACLICK N020800 004 5665071 EPINEPHRINE - AUVI-Q N201739 001 8226610 8231573 8313466 EPINEPHRINE - AUVI-Q N201739 002 8226610 8231573 8313466 EPINEPHRINE - EPIPEN N019430 001 7449012 7794432 8048035 EPINEPHRINE - EPIPEN JR. N019430 002 7449012 7794432 8048035 EPINEPHRINE - TWINJECT 0.15 N020800 002 7297136 7621891 EPINEPHRINE - TWINJECT 0.3 N020800 001 7297136 7621891
Aug May
13, 2027 15, 2026
DS
NCE
Aug
31, 2017
May
27, 2013
DP
May
27, 2013
DP
Apr Nov Nov
10, 2029 25, 2028 23, 2024
DP DP DP
Apr Nov Nov
10, 2029 25, 2028 23, 2024
DP DP DP
Sep Sep Sep
11, 2025 11, 2025 11, 2025
DP DP DP
Sep Sep Sep
11, 2025 11, 2025 11, 2025
DP DP DP
Jan Feb
18, 2025 04, 2025
DP DP
Jan Feb
18, 2025 04, 2025
DP DP TOPICAL SYSTEM KIT DS DP DS DP DS DP DS DP DS DP DS DP DP
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE - LIDOSITE Sep 30, 2013 N021504 001 5246418 Sep 30, 2013 5873850 Sep 30, 2013 6377847 Sep 30, 2013 6385488 Jun 30, 2020 6629968 Jun 29, 2021 6635045 Sep 30, 2013 6862473
ADA 63 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-3 U-537 U-467 U-537 U-3 U-537 U-3 DP U-537 U-587 DP DP U-664 U-664
EXCLUSIVITY CODE(S)
EPLERENONE - INSPRA N021437 001 6410054 6410054 6410054*PED 6410524 6410524*PED 6495165 6495165 6495165*PED 6534093 6534093 6534093*PED 6558707 6558707*PED 6747020 6747020*PED 6863902 6863902*PED 7157101 7157101*PED EPLERENONE - INSPRA N021437 002 6410054 6410054 6410054*PED 6410524 6410524*PED 6495165 6495165 6495165*PED 6534093 6534093 6534093*PED 6558707 6558707*PED 6747020 6747020*PED 6863902 6863902*PED 7157101 7157101*PED EPLERENONE - INSPRA N021437 003 6410054 6410054 6410054*PED 6410524 6410524*PED 6495165 6495165 6495165*PED 6534093 6534093 6534093*PED 6558707 6558707*PED 6747020 6747020*PED 6863902 6863902*PED 7157101 7157101*PED EPOPROSTENOL SODIUM - VELETRI N022260 001 8318802 EPOPROSTENOL SODIUM - VELETRI N022260 002 8318802
Dec Dec Jun Nov May Dec Dec Jun Dec Dec Jun Dec Jun Nov May Apr Oct Dec Jun
08, 08, 08, 05, 05, 08, 08, 08, 08, 08, 08, 08, 08, 05, 05, 10, 10, 08, 08,
2019 2019 2020 2019 2020 2019 2019 2020 2019 2019 2020 2019 2020 2019 2020 2020 2020 2019 2020
08, 08, 08, 05, 05, 08, 08, 08, 08, 08, 08, 08, 08, 05, 05, 10, 10, 08, 08,
2019 2019 2020 2019 2020 2019 2019 2020 2019 2019 2020 2019 2020 2019 2020 2020 2020 2019 2020
08, 08, 08, 05, 05, 08, 08, 08, 08, 08, 08, 08, 08, 05, 05, 10, 10, 08, 08,
2019 2019 2020 2019 2020 2019 2019 2020 2019 2019 2020 2019 2020 2019 2020 2020 2020 2019 2020
Feb
09, 2027
DP
Feb
09, 2027
DP
ADA 64 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-3
EXCLUSIVITY CODE(S)
EPROSARTAN MESYLATE - TEVETEN N020738 004 5656650 EPROSARTAN MESYLATE - TEVETEN N020738 005 5656650 EPROSARTAN MESYLATE - TEVETEN N020738 006 5656650
Aug
12, 2014
Aug
12, 2014
U-3
Aug
12, 2014
U-3
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE - TEVETEN HCT Aug 12, 2014 U-3 N021268 001 5656650 EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE - TEVETEN HCT Aug 12, 2014 U-3 N021268 002 5656650 EPTIFIBATIDE - INTEGRILIN N020718 001 5686570 5747447 5756451 5807825 5968902 EPTIFIBATIDE - INTEGRILIN N020718 002 5686570 5747447 5756451 5807825 5968902 ERIBULIN MESYLATE - HALAVEN N201532 001 6214865 6469182 7470720 8097648
Nov May Nov Sep Jun
11, 05, 11, 15, 02,
2014 2015 2014 2015 2015
U-244 U-453
Nov May Nov Sep Jun
11, 05, 11, 15, 02,
2014 2015 2014 2015 2015
U-244 U-453
Jun Jun Jun Jan
16, 16, 16, 22,
2019 2019 2019 2021
DS U-1096 DP U-1096
NCE
Nov
15, 2015
ERLOTINIB HYDROCHLORIDE - TARCEVA N021743 001 5747498 Nov 6900221 Nov 6900221 Nov 6900221 Nov 7087613 Nov 7087613 Nov RE41065 Nov ERLOTINIB HYDROCHLORIDE - TARCEVA N021743 002 5747498 Nov 6900221 Nov 6900221 Nov 6900221 Nov 7087613 Nov 7087613 Nov RE41065 Nov ERLOTINIB HYDROCHLORIDE - TARCEVA N021743 003 5747498 Nov 6900221 Nov 6900221 Nov 6900221 Nov 7087613 Nov 7087613 Nov RE41065 Nov
08, 09, 09, 09, 09, 09, 08,
2018 2020 2020 2020 2020 2020 2018
DS DS DS DS
DP DP DP DP
U-659 U-875 U-659 U-1046 U-1045 U-659
I-624
Apr
16, 2013
DS
DP
08, 09, 09, 09, 09, 09, 08,
2018 2020 2020 2020 2020 2020 2018
DS DS DS DS
DP DP DP DP
U-659 U-875 U-1046 U-659 U-659 U-1045
I-624
Apr
16, 2013
DS
DP
08, 09, 09, 09, 09, 09, 08,
2018 2020 2020 2020 2020 2020 2018
DS DS DS DS
DP DP DP DP
U-659 U-1046 U-659 U-875 U-1045 U-659
I-624
Apr
16, 2013
DS
DP
ADA 65 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP DP DP U-160 U-160
EXCLUSIVITY CODE(S)
ERTAPENEM SODIUM - INVANZ N021337 001 5478820 5478820*PED 5652233 5652233*PED 5952323 5952323*PED 7342005 7342005*PED
Nov May Feb Aug May Nov Feb Aug
21, 21, 02, 02, 15, 15, 02, 02,
2015 2016 2013 2013 2017 2017 2013 2013
ESCITALOPRAM OXALATE - ESCITALOPRAM OXALATE A076765 001 ESCITALOPRAM OXALATE - ESCITALOPRAM OXALATE A076765 002 ESCITALOPRAM OXALATE - ESCITALOPRAM OXALATE A076765 003 ESCITALOPRAM OXALATE - LEXAPRO N021323 001 6916941 6916941*PED 7420069 7420069*PED ESCITALOPRAM OXALATE - LEXAPRO N021323 002 6916941 6916941*PED 7420069 7420069*PED ESCITALOPRAM OXALATE - LEXAPRO N021323 003 6916941 6916941*PED 7420069 7420069*PED
PC
Sep
10, 2012
PC
Sep
10, 2012
PC DS DS DP DP DP
Sep
10, 2012
Aug Feb Aug Feb
12, 12, 12, 12,
2022 2023 2022 2023
Aug Feb Aug Feb
12, 12, 12, 12,
2022 2023 2022 2023
DS DS
DP DP DP
Aug Feb Aug Feb
12, 12, 12, 12,
2022 2023 2022 2023
DS DS
DP DP DP
ESMOLOL HYDROCHLORIDE - BREVIBLOC N019386 006 6310094 Jan 6310094*PED Jul 6528540 Jan 6528540*PED Jul ESMOLOL HYDROCHLORIDE - BREVIBLOC N019386 007 6310094 Jan 6310094*PED Jul 6528540 Jan 6528540*PED Jul
12, 12, 12, 12,
2021 2021 2021 2021
12, 12, 12, 12,
2021 2021 2021 2021
ESMOLOL HYDROCHLORIDE - BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER N019386 005 6310094 Jan 12, 2021 6310094*PED Jul 12, 2021 6528540 Jan 12, 2021 6528540*PED Jul 12, 2021 ESMOLOL HYDROCHLORIDE - BREVIBLOC IN PLASTIC CONTAINER N019386 004 6310094 Jan 12, 2021 6310094*PED Jul 12, 2021 6528540 Jan 12, 2021 6528540*PED Jul 12, 2021
ADA 66 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP DP DS DS DS U-770 U-373 U-729 U-373 U-770 U-373 U-729 U-373 U-770 U-729 U-373 U-373 U-729 U-373 U-770 U-373
EXCLUSIVITY CODE(S)
ESOMEPRAZOLE MAGNESIUM - NEXIUM Nov N021153 001 5690960 Nov 5690960 Nov 5690960 May 5690960*PED Feb 5714504 Feb 5714504 Feb 5714504 Aug 5714504*PED May 5877192 May 5877192 May 5877192 Nov 5877192*PED May 5900424 May 5900424 May 5900424 Nov 5900424*PED Oct 6147103 Apr 6147103*PED Oct 6166213 Apr 6166213*PED Oct 6191148 Apr 6191148*PED May 6369085 May 6369085 Nov 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED ESOMEPRAZOLE MAGNESIUM - NEXIUM Nov N021153 002 5690960 Nov 5690960 Nov 5690960 May 5690960*PED Feb 5714504 Feb 5714504 Feb 5714504 Aug 5714504*PED May 5877192 May 5877192 May 5877192 Nov 5877192*PED May 5900424 May 5900424 May 5900424 Nov 5900424*PED Oct 6147103 Apr 6147103*PED Oct 6166213 Apr 6166213*PED Oct 6191148 Apr 6191148*PED May 6369085 May 6369085 Nov 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 27, 04, 04, 04, 04, 09, 09, 09, 09, 09, 09, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2014 2016 2016 2016 2016 2018 2019 2018 2019 2018 2019 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
DS DS
DP DP DP DP DP
U-770 U-729 U-469 U-729 U-770 U-469
DS DS
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 27, 04, 04, 04, 04, 09, 09, 09, 09, 09, 09, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2014 2016 2016 2016 2016 2018 2019 2018 2019 2018 2019 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
DP DP DP DP DP DP DP DP DP DS DS DS
DS DS
DP DP DP DP DP
U-729 U-770 U-770 U-729 U-469 U-469
DS DS
ADA 67 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP U-773 U-729 U-1207 U-729 U-773 U-1207 U-1207 U-729 U-773 DS DS DS DS DS DS DP DP DP DP DP DP DS DS U-1207 U-729 U-773 U-1207 U-729 U-773 U-1207 U-773 U-729
EXCLUSIVITY CODE(S)
PED
ESOMEPRAZOLE MAGNESIUM - NEXIUM N021957 001 5690960 Nov 5690960 Nov 5690960 Nov 5690960*PED May 5714504 Feb 5714504 Feb 5714504 Feb 5714504*PED Aug 5877192 May 5877192 May 5877192 May 5877192*PED Nov 5900424 May 5900424 May 5900424 May 5900424*PED Nov 6369085 May 6369085 May 6369085 May 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 Nov 6428810*PED May 6875872 May 6875872*PED Nov 7411070 May 7411070*PED Nov ESOMEPRAZOLE MAGNESIUM - NEXIUM N021957 002 5690960 Nov 5690960 Nov 5690960 Nov 5690960*PED May Feb 5714504 Feb 5714504 Feb 5714504 Aug 5714504*PED May 5877192 May 5877192 May 5877192 Nov 5877192*PED May 5900424 May 5900424 May 5900424 Nov 5900424*PED May 6369085 May 6369085 May 6369085 Nov 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 27, 04, 04, 04, 04, 25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2014 2016 2016 2016 2016 2018 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
Dec
18, 2012
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 27, 04, 04, 04, 04, 25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2014 2016 2016 2016 2016 2018 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
DP DP DP DP DP DP
U-773 U-729 U-1207 U-773 U-729 U-1207 U-1207 U-729 U-773
PED
Dec
18, 2012
DS DS DS DS DS DS DP DP DP DP DP DP DS DS
U-1207 U-773 U-729 U-773 U-1207 U-729 U-729 U-773 U-1207
ADA 68 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-1207 U-1207 U-1207 DS DS DP DP DS DS U-1207 U-1207 U-1207
EXCLUSIVITY CODE(S)
ESOMEPRAZOLE MAGNESIUM - NEXIUM N021957 003 5690960 Nov 5690960*PED May 5714504 Feb 5714504*PED Aug 5877192 May 5877192*PED Nov 5900424 May 5900424*PED Nov 6369085 May 6369085*PED Nov 6428810 Nov 6428810*PED May 6875872 May 6875872*PED Nov 7411070 May 7411070*PED Nov ESOMEPRAZOLE MAGNESIUM - NEXIUM N021957 004 5690960 Nov 5690960*PED May 5714504 Feb 5714504*PED Aug 5877192 May 5877192*PED Nov 5900424 May 5900424*PED Nov 6369085 May 6369085*PED Nov 6428810 Nov 6428810*PED May 6875872 May 6875872*PED Nov 7411070 May 7411070*PED Nov ESOMEPRAZOLE MAGNESIUM - NEXIUM N022101 001 5690960 Nov 5690960*PED May 5714504 Feb 5714504*PED Aug 5877192 May 5877192*PED Nov 5900424 May 5900424*PED Nov 6369085 May 6369085*PED Nov 6428810 Nov 6428810*PED May 6875872 May 6875872*PED Nov 7411070 May 7411070*PED Nov
25, 25, 03, 03, 27, 27, 04, 04, 25, 25, 03, 03, 27, 27, 25, 25,
2014 2015 2015 2015 2014 2014 2016 2016 2018 2018 2019 2020 2014 2014 2018 2018
25, 25, 03, 03, 27, 27, 04, 04, 25, 25, 03, 03, 27, 27, 25, 25,
2014 2015 2015 2015 2014 2014 2016 2016 2018 2018 2019 2020 2014 2014 2018 2018
DP DP
U-1207 U-1207 U-1207
DS DS DP DP DS DS
U-1207 U-1207 U-1207
25, 25, 03, 03, 27, 27, 04, 04, 25, 25, 03, 03, 27, 27, 25, 25,
2014 2015 2015 2015 2014 2014 2016 2016 2018 2018 2019 2020 2014 2014 2018 2018
DP DP
U-858 U-858 U-858
PED
Dec
18, 2012
DS DS DP DP DS DS
U-858 U-858 U-858
ESOMEPRAZOLE MAGNESIUM; NAPROXEN - VIMOVO N022511 001 5714504 Feb 03, 2015 5714504*PED Aug 03, 2015 5900424 May 04, 2016 5900424*PED Nov 04, 2016 6369085 May 25, 2018 6369085*PED Nov 25, 2018 6875872 May 27, 2014 6875872*PED Nov 27, 2014 6926907 Feb 28, 2023 7411070 May 25, 2018 7411070*PED Nov 25, 2018 7745466 Oct 13, 2018
DP DS DS DS DP DS DP DP
U-1053 U-1053 U-1053
NC
Apr
30, 2013
U-1052 U-1053 U-1053
ADA 69 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DS DS DS DP DS DP U-1052 U-1053 U-1053 DP U-1053 U-1053 U-1053
EXCLUSIVITY CODE(S)
NC
ESOMEPRAZOLE MAGNESIUM; NAPROXEN - VIMOVO Feb 03, 2015 N022511 002 5714504 Aug 03, 2015 5714504*PED May 04, 2016 5900424 Nov 04, 2016 5900424*PED May 25, 2018 6369085 Nov 25, 2018 6369085*PED May 27, 2014 6875872 Nov 27, 2014 6875872*PED Feb 28, 2023 6926907 May 25, 2018 7411070 Nov 25, 2018 7411070*PED Oct 13, 2018 7745466 ESOMEPRAZOLE SODIUM - NEXIUM IV May N021689 001 5877192 Nov 5877192*PED May 6143771 ESOMEPRAZOLE SODIUM - NEXIUM IV N021689 002 5877192 May Nov 5877192*PED May 6143771 ESTRADIOL - ELESTRIN N021813 001 7198801 7470433 ESTRADIOL - EVAMIST N022014 001 6299900 6299900 6818226 6818226 6923983 6923983 6978945 ESTRADIOL - MENOSTAR N021674 001 5891868 6692763 ESTRADIOL - MINIVELLE N203752 001 6841716 ESTRADIOL - MINIVELLE N203752 002 6841716 ESTRADIOL - MINIVELLE N203752 003 6841716 ESTRADIOL - MINIVELLE N203752 004 6841716 ESTRADIOL - VAGIFEM N020908 002 5860946 7018992 ESTRADIOL - VIVELLE-DOT N020538 005 5474783 5656286 5958446 6024976 ESTRADIOL - VIVELLE-DOT N020538 006 5474783 5656286 5958446 6024976
Apr
30, 2013
27, 2014 27, 2014 27, 2014
U-643 DP U-643
27, 2014 27, 2014 27, 2014
U-643 DP U-643
Jun Aug
25, 2022 03, 2021
DP DP
Feb Feb Feb Feb Feb Feb Nov
19, 19, 19, 19, 19, 19, 30,
2017 2017 2017 2017 2017 2017 2021
DP DP DP DP DP DP DP
U-889 U-888 U-888 U-889 U-889 U-888
Nov Nov
21, 2017 21, 2017
DP DP
U-594 U-594
Apr
27, 2020
DP
Apr
27, 2020
DP
Apr
27, 2020
DP
Apr
27, 2020
DP
Jul Sep
01, 2017 17, 2022
DP U-1023
D-122
Nov
25, 2012
Dec Aug Dec Jan
12, 12, 12, 07,
2012 2014 2012 2014
Dec Aug Dec Jan
12, 12, 12, 07,
2012 2014 2012 2014
ADA 70 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ESTRADIOL - VIVELLE-DOT N020538 007 5474783 5656286 5958446 6024976 ESTRADIOL - VIVELLE-DOT N020538 008 5474783 5656286 5958446 6024976 ESTRADIOL - VIVELLE-DOT N020538 009 5474783 5656286 5958446 6024976 ESTRADIOL ACETATE - FEMRING N021367 001 5855906 ESTRADIOL ACETATE - FEMRING N021367 002 5855906 ESTRADIOL ACETATE - FEMTRACE N021633 001 6962908 7572779 7799771 ESTRADIOL ACETATE - FEMTRACE N021633 002 6962908 7572779 7799771 ESTRADIOL ACETATE - FEMTRACE N021633 003 6962908 7572779 7799771
Dec Aug Dec Jan
12, 12, 12, 07,
2012 2014 2012 2014
Dec Aug Dec Jan
12, 12, 12, 07,
2012 2014 2012 2014
Dec Aug Dec Jan
12, 12, 12, 07,
2012 2014 2012 2014
DP DP DP DP
Dec
19, 2015
U-508
Dec
19, 2015
U-508
Dec Oct Dec
21, 2021 02, 2025 21, 2021
DP U-904 DP
Dec Oct Dec
21, 2021 02, 2025 21, 2021
DP U-904 DP
Dec Oct Dec
21, 2021 02, 2025 21, 2021
DP U-904 DP
ESTRADIOL HEMIHYDRATE - ESTRASORB N021371 001 5629021 Jan
31, 2015
DP
ESTRADIOL; LEVONORGESTREL - CLIMARA PRO N021258 001 5676968 Oct 14, 2014 ESTRADIOL; NORETHINDRONE ACETATE - COMBIPATCH Dec 12, 2012 N020870 001 5474783 Aug 12, 2014 5656286 Dec 12, 2012 5958446 Jan 07, 2014 6024976 ESTRADIOL; NORETHINDRONE ACETATE - COMBIPATCH Dec 12, 2012 N020870 002 5474783 Aug 12, 2014 5656286 Dec 12, 2012 5958446 Jan 07, 2014 6024976 ESTRADIOL; NORGESTIMATE - PREFEST N021040 001 6747019 Mar 7320970 Mar
DP
20, 2020 30, 2020
DP
U-311 U-844
ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 001 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 002 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 003 5908638 Jul 26, 2015
DP
ADA 71 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 004 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 005 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC B N021443 001 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 002 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 003 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 004 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 005 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021
DS DS DS DS
DP DP DP DP
U-905 U-904 U-904 U-905
DS DS DS DS
DP DP DP DP
U-905 U-904 U-905 U-904
DS DS DS DS
DP DP DP DP
U-905 U-904 U-904 U-905
DS DS DS DS
DP DP DP DP
U-905 U-904 U-905 U-904
DS DS DS DS
DP DP DP DP
U-905 U-904 U-904 U-905
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPHASE 14/14 N020527 002 5547948 Jan 17, 2015 ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 001 5547948 Jan 17, 2015 ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 003 5547948 Jan 17, 2015 ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 004 5547948 Jan 17, 2015 ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 005 5547948 Jan 17, 2015 ESZOPICLONE - LUNESTA N021476 001 6319926*PED 6444673 6444673*PED 6864257 6864257*PED 7381724*PED ESZOPICLONE - LUNESTA N021476 002 6319926*PED 6444673 6444673*PED 6864257 6864257*PED 7381724*PED
Jul Feb Aug Aug Mar Jul
16, 14, 14, 30, 02, 16,
2012 2014 2014 2012 2013 2012
DS
DP U-629
16, 14, 14, 30, 02, 16,
2012 2014 2014 2012 2013 2012
DS
DP U-629
ADA 72 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ESZOPICLONE - LUNESTA N021476 003 6319926*PED 6444673 6444673*PED 6864257 6864257*PED 7381724*PED
16, 14, 14, 30, 02, 16,
2012 2014 2014 2012 2013 2012
DS
DP U-629
ETHINYL ESTRADIOL; ETONOGESTREL - NUVARING N021187 001 5989581 Apr 08, 2018 ETHINYL ESTRADIOL; LEVONORGESTREL N022262 001 7615545 Jun 7855190 Dec 7858605 Jun LOSEASONIQUE 15, 2023 05, 2028 23, 2023
U-1 U-1 DP
ETHINYL ESTRADIOL; LEVONORGESTREL - LYBREL N021864 001 6500814 Sep 03, 2018
U-1
ETHINYL ESTRADIOL; LEVONORGESTREL - PREVEN EMERGENCY CONTRACEPTIVE KIT N020946 001 6156742 Dec 05, 2020 U-374 ETHINYL ESTRADIOL; LEVONORGESTREL - SEASONALE N021544 001 5898032 Jun 23, 2017 RE39861 Jun 23, 2017 ETHINYL ESTRADIOL; LEVONORGESTREL N021840 001 7320969 Jan 7615545 Jun 7855190 Dec 7858605 Jun SEASONIQUE 30, 2024 15, 2023 05, 2028 23, 2023
U-1 U-828
U-828 U-1 U-1 DP
ETHINYL ESTRADIOL; NORELGESTROMIN - ORTHO EVRA N021180 001 5876746 Nov 20, 2015 5972377 Jun 07, 2015 ETHINYL ESTRADIOL; NORETHINDRONE - FEMCON FE N021490 001 6667050 Apr 06, 2019
DP
U-514 U-514
DP
U-1
ETHINYL ESTRADIOL; NORETHINDRONE - NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE N022573 001 5552394 Jul 22, 2014 U-828 NP Dec DP U-828 6667050 Apr 06, 2019 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - LO LOESTRIN FE N022501 001 5552394 Jul 22, 2014 U-1090 U-1090 7704984 Feb 02, 2029 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - LOESTRIN 24 FE N021871 001 5552394 Jul 22, 2014 U-1 ETHINYL ESTRADIOL; NORGESTIMATE - ORTHO TRI-CYCLEN LO N021241 001 6214815 Jun 09, 2019 6214815*PED Dec 09, 2019 ETONOGESTREL - NEXPLANON N021529 002 ETRAVIRINE - INTELENCE N022187 001 6878717 6878717 6878717 7037917 7037917 7037917 7887845 8003789
22, 2013
NP
Oct
21, 2013
U-112
NP Nov Nov Nov Dec Dec Dec Mar Nov 05, 05, 05, 13, 13, 13, 25, 01, 2019 2019 2019 2020 2020 2020 2019 2019 U-1237 U-1016 U-256 U-1237 U-256 U-1016
May
31, 2014
NPP NCE
Mar Jan
26, 2015 18, 2013
DS DS DS DS
DP DP DP DP DP
ADA 73 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1237 U-1016 U-256 U-1237 U-1016 U-256
EXCLUSIVITY CODE(S)
NPP NCE
ETRAVIRINE - INTELENCE N022187 002 6878717 6878717 6878717 7037917 7037917 7037917 7887845 8003789 ETRAVIRINE - INTELENCE N022187 003 6878717 6878717 6878717 7037917 7887845 8003789 EVEROLIMUS - AFINITOR N022334 001 5665772 5665772*PED 6004973 6004973*PED 7297703 7297703*PED
Nov Nov Nov Dec Dec Dec Mar Nov
05, 05, 05, 13, 13, 13, 25, 01,
2019 2019 2019 2020 2020 2020 2019 2019
Mar Jan
26, 2015 18, 2013
DS DS DS DS
DP DP DP DP DP
Nov Nov Nov Dec Mar Nov
05, 05, 05, 13, 25, 01,
2019 2019 2019 2020 2019 2019
DS DS
DP DP DP
U-1016 U-1237 U-256 U-1237
NCE NPP
Jan Mar
18, 2013 26, 2015
Sep Mar Jul Jan Dec Jun
09, 09, 12, 12, 06, 06,
2019 2020 2016 2017 2019 2020
DS
DP DP DP
I-655 I-650 I-638 I-630 NCE ODE ODE ODE PED PED PED PED PED PED PED
Jul Apr May Oct Mar Apr May Oct Apr Sep Nov Oct Apr Nov Oct
20, 26, 05, 29, 30, 26, 05, 29, 29, 30, 05, 26, 29, 05, 26,
2015 2015 2014 2013 2014 2019 2018 2017 2014 2014 2014 2015 2018 2018 2019
EVEROLIMUS - AFINITOR N022334 002 5665772 5665772*PED 6004973 6004973*PED 7297703 7297703*PED
09, 09, 12, 12, 06, 06,
2019 2020 2016 2017 2019 2020
DS
DP DP DP
20, 26, 05, 29, 30, 26, 05, 29, 29, 30, 05, 26, 29, 05, 26,
2015 2015 2014 2013 2014 2019 2018 2017 2014 2014 2014 2015 2018 2018 2019
ADA 74 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP
EXCLUSIVITY CODE(S)
09, 09, 12, 12, 06, 06,
2019 2020 2016 2017 2019 2020
20, 26, 05, 29, 30, 26, 05, 29, 29, 30, 05, 26, 29, 05, 26,
2015 2015 2014 2013 2014 2019 2018 2017 2014 2014 2014 2015 2018 2018 2019
09, 09, 12, 12, 06, 06,
2019 2020 2016 2017 2019 2020
DS
DP DP DP
Jul May Oct Apr Mar Apr May Oct Apr Sep Nov Oct Apr Nov Oct
20, 05, 29, 26, 30, 26, 05, 29, 29, 30, 05, 26, 29, 05, 26,
2015 2014 2013 2015 2014 2019 2018 2017 2014 2014 2014 2015 2018 2018 2019
EVEROLIMUS - AFINITOR DISPERZ N203985 001 5665772 5665772*PED 6004973 6004973*PED 7297703 7297703*PED EVEROLIMUS - AFINITOR DISPERZ N203985 002 5665772 5665772*PED 6004973 6004973*PED 7297703 7297703*PED EVEROLIMUS - AFINITOR DISPERZ N203985 003 5665772 5665772*PED 6004973 6004973*PED 7297703 7297703*PED
09, 09, 12, 12, 06, 06,
2019 2020 2016 2017 2019 2020
DS
DP DP DP
I-630 NCE ODE PED PED PED
Oct Mar Oct Apr Apr Sep
29, 30, 29, 29, 29, 30,
2013 2014 2017 2018 2014 2014
09, 09, 12, 12, 06, 06,
2019 2020 2016 2017 2019 2020
DS
DP DP DP
29, 30, 29, 29, 29, 30,
2013 2014 2017 2018 2014 2014
09, 09, 12, 12, 06, 06,
2019 2020 2016 2017 2019 2020
DS
DP DP DP
29, 30, 29, 29, 29, 30,
2013 2014 2017 2018 2014 2014
ADA 75 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP U-1049 U-1049 U-1049 DP U-1049 U-1049
EXCLUSIVITY CODE(S)
NP NCE PED PED
EVEROLIMUS - ZORTRESS N021560 001 5665772 5665772*PED 6004973 6004973*PED 6239124 6239124*PED 6440990 6440990*PED 6455518 6455518*PED EVEROLIMUS - ZORTRESS N021560 002 5665772 5665772*PED 6004973 6004973*PED 6239124 6239124*PED 6440990 6440990*PED 6455518 6455518*PED EVEROLIMUS - ZORTRESS N021560 003 5665772 5665772*PED 6004973 6004973*PED 6239124 6239124*PED 6440990 6440990*PED 6455518 6455518*PED EXENATIDE SYNTHETIC - BYDUREON N022200 001 5424286 6479065 6495164 6667061 6824822 6858576 6872700 6956026 7223440 7456254 7563871 7612176 7741269 8329648 EXENATIDE SYNTHETIC - BYETTA N021773 001 5424286 5424286 6858576 6872700 6902744 6956026 7297761 7521423 7741269
Sep Mar Jul Jan Aug Feb Sep Mar Jul Jan
09, 09, 12, 12, 11, 11, 24, 24, 29, 29,
2019 2020 2016 2017 2017 2018 2013 2014 2017 2018
Apr Mar Oct Sep
20, 30, 20, 30,
2013 2014 2013 2014
09, 09, 12, 12, 11, 11, 24, 24, 29, 29,
2019 2020 2016 2017 2017 2018 2013 2014 2017 2018
DS
DP DP
U-1049 U-1049 U-1049
NP NCE PED PED
Apr Mar Oct Sep
20, 30, 20, 30,
2013 2014 2013 2014
DP
U-1049 U-1049
09, 09, 12, 12, 11, 11, 24, 24, 29, 29,
2019 2020 2016 2017 2017 2018 2013 2014 2017 2018
DS
DP DP
U-1049 U-1049 U-1049
NP NCE PED PED
Apr Mar Oct Sep
20, 30, 20, 30,
2013 2014 2013 2014
DP
U-1049 U-1049
Dec Aug May May Oct Jan Jan Jan Aug Jun Apr Apr Jan Aug
01, 10, 25, 25, 09, 06, 14, 07, 31, 30, 15, 13, 07, 18,
2016 2020 2020 2020 2022 2017 2020 2018 2021 2025 2024 2025 2018 2026
U-1108 DP DP DP DP U-656 U-654 U-687 DP DP DP DP U-1223 U-1223 U-1224 U-1313
NP
Jan
27, 2015
Dec Dec Jan Jan Jan Jan Oct Oct Jan
01, 01, 06, 14, 14, 07, 15, 15, 07,
2016 2016 2017 2020 2020 2018 2017 2017 2018
U-653 U-1108 U-656 U-654 DP U-687 DP DP U-1074
M-113 M-111
Oct Oct
19, 2014 19, 2014
ADA 76 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1108 U-653 U-656 U-654 DP U-687 DP DP U-1074
EXCLUSIVITY CODE(S)
M-113 M-111
EXENATIDE SYNTHETIC - BYETTA N021773 002 5424286 5424286 6858576 6872700 6902744 6956026 7297761 7521423 7741269 EZETIMIBE - ZETIA N021445 001 5846966 5846966 5846966 5846966*PED 7030106 7030106*PED 7612058 7612058 7612058*PED RE37721 RE37721*PED RE42461 RE42461 RE42461*PED
Dec Dec Jan Jan Jan Jan Oct Oct Jan
01, 01, 06, 14, 14, 07, 15, 15, 07,
2016 2016 2017 2020 2020 2018 2017 2017 2018
Oct Oct
19, 2014 19, 2014
Sep Sep Sep Mar Jan Jul Jan Jan Jul Oct Apr Oct Oct Apr
21, 21, 21, 21, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25,
2013 2013 2013 2014 2022 2022 2022 2022 2022 2016 2017 2016 2016 2017
U-474 U-1172 U-473 DP U-1173 U-1027 DS DS DS DP DP DP U-473 U-1173 U-473
M-109
Jan
24, 2015
EZETIMIBE; SIMVASTATIN - VYTORIN Sep N021687 001 5846966 Sep 5846966 Mar 5846966*PED Oct RE37721 Apr RE37721*PED Oct RE42461 Apr RE42461*PED EZETIMIBE; SIMVASTATIN - VYTORIN N021687 002 5846966 Sep 5846966 Sep 5846966*PED Mar RE37721 Oct RE37721*PED Apr Oct RE42461 Apr RE42461*PED EZETIMIBE; SIMVASTATIN - VYTORIN N021687 003 5846966 Sep 5846966 Sep Mar 5846966*PED Oct RE37721 Apr RE37721*PED Oct RE42461 Apr RE42461*PED EZETIMIBE; SIMVASTATIN - VYTORIN N021687 004 5846966 Sep Sep 5846966 Mar 5846966*PED Oct RE37721 Apr RE37721*PED Oct RE42461 Apr RE42461*PED EZOGABINE - POTIGA N022345 001 EZOGABINE - POTIGA N022345 002 EZOGABINE - POTIGA N022345 003
21, 21, 21, 25, 25, 25, 25,
2013 2013 2014 2016 2017 2016 2017
DP DP DS DS DP DP
U-593 U-473 U-473 U-473
M-109
Jan
24, 2015
21, 21, 21, 25, 25, 25, 25,
2013 2013 2014 2016 2017 2016 2017
DP DP DS DS DP DP
U-593 U-473 U-473 U-473
M-109
Jan
24, 2015
21, 21, 21, 25, 25, 25, 25,
2013 2013 2014 2016 2017 2016 2017
DP DP DS DS DP DP
U-593 U-473 U-473 U-473
M-109
Jan
24, 2015
21, 21, 21, 25, 25, 25, 25,
2013 2013 2014 2016 2017 2016 2017
DP DP DS DS DP DP
U-473 U-593 U-473 U-473
M-109
Jan
24, 2015
NCE
Jun
10, 2016
NCE
Jun
10, 2016
NCE
Jun
10, 2016
ADA 77 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NCE
EZOGABINE - POTIGA N022345 004 FAMCICLOVIR - FAMVIR N020363 001 5840763 5840763*PED 5866581 5866581*PED 5916893 5916893*PED 6124304 6124304*PED FAMCICLOVIR - FAMVIR N020363 002 5840763 5840763*PED 5866581 5866581*PED 5916893 5916893*PED 6124304 6124304*PED FAMCICLOVIR - FAMVIR N020363 003 5840763 5840763*PED 5866581 5866581*PED 5916893 5916893*PED 6124304 6124304*PED FAMOTIDINE - FLUXID N021712 001 6024981 6221392 FAMOTIDINE - FLUXID N021712 002 6024981 6221392 FAMOTIDINE - PEPCID AC N020325 001 5854267 5854267*PED FAMOTIDINE - PEPCID AC N020801 001 5667794 5667794*PED 5854267 5854267*PED FAMOTIDINE - PEPCID AC N020801 002 6814978 6814978*PED Sep Mar Oct Apr Sep Mar Oct Apr 01, 01, 04, 04, 01, 01, 04, 04, 2015 2016 2014 2015 2015 2016
2014 2015
U-96 U-96 U-96
U-96
Jun
10, 2016
M-112 M-98 M-54 PED
Feb Jan Dec Jun
09, 31, 24, 24,
2015 2014 2012 2013
Sep Mar Oct Apr Sep Mar Oct Apr
01, 01, 04, 04, 01, 01, 04, 04,
2015 2016 2014 2015 2015 2016

2014 2015
U-96 U-96 U-96

U-96
M-112 M-98 M-54 PED
Feb Jan Dec Jun
09, 31, 24, 24,
2015 2014 2012 2013
Sep Mar Oct Apr Sep Mar Oct Apr
01, 01, 04, 04, 01, 01, 04, 04,
2015 2016 2014 2015 2015 2016

2014 2015
DP DP
U-96 U-96 U-96

U-96
M-112 M-98 M-54 PED
Feb Jan Dec Jun
09, 31, 24, 24,
2015 2014 2012 2013
Apr Apr
09, 2018 09, 2018
Apr Apr
09, 2018 09, 2018
DP DP
Dec Jun
29, 2015 29, 2016
U-267 U-267
May Nov Dec Jun
02, 02, 29, 29,
2015 2015 2015 2016
Y U-267
Aug Feb
26, 2021 26, 2022
DP
FAMOTIDINE - PEPCID AC (GELTAB) N020902 001 5854267 Dec 5854267*PED Jun FAMOTIDINE; IBUPROFEN - DUEXIS N022519 001 8067033 Jul 8067451 Jul 8309127 Jul 8318202 Jul FEBUXOSTAT - ULORIC N021856 001 5614520 6225474 7361676
29, 2015 29, 2016
U-368
U-368
18, 18, 18, 18,
2026 2026 2026 2026
DP DP DP DP
NC U-1196
Apr
23, 2014
Mar Jun Mar
25, 2014 18, 2019 08, 2024
DS DS
DP DP
U-954
NCE
Feb
13, 2014
ADA 78 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-954
EXCLUSIVITY CODE(S)
NCE
FEBUXOSTAT - ULORIC N021856 002 5614520 6225474 7361676
Mar Jun Mar
25, 2014 18, 2019 08, 2024
Feb
13, 2014
FENOFIBRATE - ANTARA (MICRONIZED) N021695 001 7101574 Aug 7863331 Aug 7863331 Aug FENOFIBRATE - ANTARA (MICRONIZED) N021695 003 7101574 Aug 7863331 Aug 7863331 Aug FENOFIBRATE - FENOGLIDE N022118 001 7658944 8124125 FENOFIBRATE - FENOGLIDE N022118 002 7658944 8124125 FENOFIBRATE - LIPOFEN N021612 001 5545628 FENOFIBRATE - LIPOFEN N021612 002 5545628 FENOFIBRATE - LIPOFEN N021612 003 5545628 FENOFIBRATE - TRICOR N021203 001 6074670 6277405 6589552 6652881 7037529 7041319 FENOFIBRATE - TRICOR N021203 003 6074670 6277405 6589552 6652881 7037529 7041319 FENOFIBRATE - TRICOR N021656 001 6277405 6375986 6652881 7037529 7041319 7276249 7320802 FENOFIBRATE - TRICOR N021656 002 6277405 6375986 6652881 7037529 7041319 7276249 7320802 FENOFIBRATE - TRIGLIDE N021350 001 6696084
20, 2020 08, 2020 08, 2020
DS
DP U-1107 U-1106
20, 2020 08, 2020 08, 2020
DS
DP U-1106 U-1107
Dec Oct
09, 2024 01, 2024
DP DP
U-1234
Dec Oct
09, 2024 01, 2024
DP DP
U-1234
Jan
10, 2015
DP
U-701
Jan
10, 2015
DP
U-701
Jan
10, 2015
DP
U-701
09, 09, 09, 09, 09, 09,
2018 2018 2018 2018 2018 2018
DP DP DP
09, 09, 09, 09, 09, 09,
2018 2018 2018 2018 2018 2018
DP DP DP
Jan Sep Jan Jan Jan Feb Feb
09, 21, 09, 09, 09, 21, 21,
2018 2020 2018 2018 2018 2023 2023
DS DP DS DP DP DP U-847 U-615
Jan Sep Jan Jan Jan Feb Feb
09, 21, 09, 09, 09, 21, 21,
2018 2020 2018 2018 2018 2023 2023
DS DP DS DP DP DP U-847 U-615
Sep
11, 2021
DS
DP
U-680
ADA 79 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-680
EXCLUSIVITY CODE(S)
FENOFIBRATE - TRIGLIDE N021350 002 6696084 FENOFIBRIC ACID - FIBRICOR N022418 001 7569612 7741373 7741374 7741374 7915247 7915247 7915247 FENOFIBRIC ACID - FIBRICOR N022418 002 7569612 7741373 7741374 7741374 7915247 7915247 7915247 FENTANYL - SUBSYS N202788 001 FENTANYL - SUBSYS N202788 002 FENTANYL - SUBSYS N202788 003 FENTANYL - SUBSYS N202788 004 FENTANYL - SUBSYS N202788 005 FENTANYL CITRATE - ABSTRAL N022510 001 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 002 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 003 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 004 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 005 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 006 6759059 6761910 7910132
Sep
11, 2021
Aug Aug Aug Aug Aug Aug Aug
20, 20, 20, 20, 20, 20, 20,
2027 2027 2027 2027 2027 2027 2027
U-1000 U-1059 U-1060 U-1061 U-1000 U-1061 U-1059
Aug Aug Aug Aug Aug Aug Aug
20, 20, 20, 20, 20, 20, 20,
2027 2027 2027 2027 2027 2027 2027
U-1000 U-1059 U-1061 U-1060 U-1059 U-1000 U-1061
NP
Jan
04, 2015
NP
Jan
04, 2015
NP
Jan
04, 2015
NP
Jan
04, 2015
NP Sep Sep Sep 24, 2019 24, 2019 24, 2019 DP DP DP U-767 U-767 U-767
Jan
04, 2015
Sep Sep Sep
24, 2019 24, 2019 24, 2019
DP DP DP
U-767 U-767 U-767
Sep Sep Sep
24, 2019 24, 2019 24, 2019
DP DP DP
U-767 U-767 U-767
Sep Sep Sep
24, 2019 24, 2019 24, 2019
DP DP DP
U-767 U-767 U-767
Sep Sep Sep
24, 2019 24, 2019 24, 2019
DP DP DP
U-767 U-767 U-767
Sep Sep Sep
24, 2019 24, 2019 24, 2019
DP DP DP
U-767 U-767 U-767
ADA 80 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-767 U-767 DP DP DP
EXCLUSIVITY CODE(S)
FENTANYL CITRATE - FENTORA N021947 001 6200604 6974590 7862832 7862833 8092832 FENTANYL CITRATE - FENTORA N021947 002 6200604 6974590 7862832 7862833 8092832 8119158 FENTANYL CITRATE - FENTORA N021947 003 6200604 6974590 7862832 7862833 8092832 8119158 FENTANYL CITRATE - FENTORA N021947 004 6200604 6974590 7862832 7862833 8092832 8119158 FENTANYL CITRATE - FENTORA N021947 005 6200604 6974590 7862832 7862833 8092832 8119158 FENTANYL CITRATE - FENTORA N021947 006 6200604 6974590 FENTANYL CITRATE - LAZANDA N022569 001 6432440 8216604 FENTANYL CITRATE - LAZANDA N022569 002 6432440 8216604 FENTANYL CITRATE - ONSOLIS N022266 001 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 002 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 003 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 004 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 005 6159498 7579019
Mar Mar Jun Jun Dec
26, 26, 15, 15, 30,
2019 2019 2028 2028 2024
Mar Mar Jun Jun Dec Dec
26, 26, 15, 15, 30, 30,
2019 2019 2028 2028 2024 2024
U-767 U-767 DP DP DP DP
26, 26, 15, 15, 30, 30,
2019 2019 2028 2028 2024 2024
26, 26, 15, 15, 30, 30,
2019 2019 2028 2028 2024 2024
26, 26, 15, 15, 30, 30,
2019 2019 2028 2028 2024 2024
Mar Mar
26, 2019 26, 2019
U-767 U-767
Apr Oct
20, 2018 03, 2024
DP
U-1169 U-767
NDF
Jun
30, 2014
Apr Oct
20, 2018 03, 2024
DP
U-1169 U-767
NDF
Jun
30, 2014
Oct Jan
18, 2016 22, 2020
DP U-767
NP
Jul
16, 2012
Oct Jan
18, 2016 22, 2020
DP U-767
NP
Jul
16, 2012
Oct Jan
18, 2016 22, 2020
DP U-767
NP
Jul
16, 2012
Oct Jan
18, 2016 22, 2020
DP U-767
NP
Jul
16, 2012
Oct Jan
18, 2016 22, 2020
DP U-767
NP
Jul
16, 2012
ADA 81 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP U-736 DP DP DP DP U-736 DP U-736 DP DP U-736 U-736
EXCLUSIVITY CODE(S)
FENTANYL HYDROCHLORIDE - IONSYS Dec N021338 001 5697896 Dec 5843014 Jan 6169920 Jun 6171294 Nov 6181963 Jan 6195582 Jun 6216033 Jun 6425892 Jun 6842640 Apr 6881208 Apr 6975902 Jun 7018370 Sep 7027859 Jun 7302293 FERUMOXYTOL - FERAHEME N022180 001 6599498 7553479 7871597
16, 01, 02, 05, 02, 28, 05, 05, 02, 19, 01, 05, 26, 05,
2014 2015 2018 2015 2019 2019 2015 2015 2015 2022 2024 2015 2014 2015
Mar Mar Mar
08, 2020 08, 2020 08, 2020
DS DS DS
DP DP DP
FESOTERODINE FUMARATE - TOVIAZ Jul N022030 001 6858650 May 7384980 Jun 7807715 May 7855230 May 7985772 Jun 8088398 FESOTERODINE FUMARATE - TOVIAZ Jul N022030 002 6858650 May 7384980 Jun 7807715 May 7855230 May 7985772 Jun 8088398
03, 11, 07, 11, 11, 07,
2022 2019 2027 2019 2019 2027
DS DS
DP DP DP DP
DS
U-913 U-913 U-913 U-913 U-913 U-913
NCE
Oct
31, 2013
03, 11, 07, 11, 11, 07,
2022 2019 2027 2019 2019 2027
DS DS
DP DP DP DP
DS
U-913 U-913 U-913 U-913 U-913 U-913
NCE
Oct
31, 2013
FEXOFENADINE HYDROCHLORIDE - ALLEGRA N020625 001 5578610 Nov 26, 2013 5578610*PED May 26, 2014 Feb 28, 2015 5738872 Aug 28, 2015 5738872*PED Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED Nov 11, 2012 6187791*PED Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - ALLEGRA Nov 26, 2013 N021963 001 5578610 Mar 14, 2017 6037353 May 18, 2014 7138524 Nov 18, 2014 7138524*PED
U-192 U-192
U-138 U-138
U-138 U-468 DS DS
DS DS
DP
U-772 U-772
ADA 82 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP U-1160 DP U-1160
EXCLUSIVITY CODE(S)
FEXOFENADINE HYDROCHLORIDE - ALLEGRA ALLERGY Nov 26, 2013 N020872 007 5578610 May 26, 2014 5578610*PED Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED Nov 11, 2012 6187791*PED Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - ALLEGRA ALLERGY N020872 010 5578610 Nov 26, 2013 5578610*PED May 26, 2014 Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED Nov 11, 2012 6187791*PED Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - ALLEGRA HIVES Nov 26, 2013 N020872 008 5578610 May 26, 2014 5578610*PED Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED Nov 11, 2012 6187791*PED Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED
DS DS
U-1160
DS
DP DP DP
U-1160
U-1160 DP
DS DS
U-1160
DS
DP DP DP
U-1160
U-1160 DP
DS DS
U-1160
ADA 83 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP U-1160 DP U-1160
EXCLUSIVITY CODE(S)
FEXOFENADINE HYDROCHLORIDE - ALLEGRA HIVES N020872 009 5578610 Nov 26, 2013 5578610*PED May 26, 2014 5855912 Feb 28, 2015 5855912*PED Aug 28, 2015 5932247 Feb 28, 2015 5932247*PED Aug 28, 2015 6037353 Mar 14, 2017 6037353*PED Sep 14, 2017 6113942 Feb 28, 2015 6113942*PED Aug 28, 2015 6187791*PED Nov 11, 2012 6399632*PED Nov 11, 2012 7135571 May 18, 2014 7135571*PED Nov 18, 2014 7138524 May 18, 2014 7138524*PED Nov 18, 2014 FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA N020872 005 5578610 Nov 26, 2013 5578610*PED May 26, 2014 5855912 Feb 28, 2015 5855912*PED Aug 28, 2015 5932247 Feb 28, 2015 5932247*PED Aug 28, 2015 6037353 Mar 14, 2017 6037353*PED Sep 14, 2017 6113942 Feb 28, 2015 6113942*PED Aug 28, 2015 6187791*PED Nov 11, 2012 6399632*PED Nov 11, 2012 7135571 May 18, 2014 7135571*PED Nov 18, 2014 7138524 May 18, 2014 7138524*PED Nov 18, 2014
DS DS
U-1160
ALLERGY DS DP U-1160 DP DP U-1160 DP
DS DS
U-1160
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA ALLERGY N021909 002 5578610 Nov 26, 2013 DS DP U-1158 5738872 Feb 28, 2015 DP U-1158 6037353 Mar 14, 2017 DS 7138524 May 18, 2014 FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA ALLERGY N201373 001 5578610 Nov 26, 2013 DS DP U-1157 5578610*PED May 26, 2014 U-1157 6037353 Mar 14, 2017 6037353*PED Sep 14, 2017 6187791*PED Nov 11, 2012 6399632*PED Nov 11, 2012 DS 7138524 May 18, 2014 7138524*PED Nov 18, 2014 FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA N020872 006 5578610 Nov 26, 2013 5578610*PED May 26, 2014 5855912 Feb 28, 2015 5855912*PED Aug 28, 2015 5932247 Feb 28, 2015 5932247*PED Aug 28, 2015 6037353 Mar 14, 2017 6037353*PED Sep 14, 2017 6113942 Feb 28, 2015 6113942*PED Aug 28, 2015 6187791*PED Nov 11, 2012 6399632*PED Nov 11, 2012 7135571 May 18, 2014 7135571*PED Nov 18, 2014 7138524 May 18, 2014 7138524*PED Nov 18, 2014 HIVES DS DP DP DP U-1160 DP
U-1160
DS DS
U-1160
ADA 84 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1158 U-1158
EXCLUSIVITY CODE(S)
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA HIVES N021909 003 5578610 Nov 26, 2013 DS DP DP 5738872 Feb 28, 2015 6037353 Mar 14, 2017 DS 7138524 May 18, 2014 FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA HIVES N201373 002 5578610 Nov 26, 2013 DS DP 5578610*PED May 26, 2014 6037353 Mar 14, 2017 6037353*PED Sep 14, 2017 6187791*PED Nov 11, 2012 6399632*PED Nov 11, 2012 DS 7138524 May 18, 2014 7138524*PED Nov 18, 2014
U-1157 U-1157
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION N020786 002 5578610 Nov 26, 2013 DS DP U-1159 5578610*PED May 26, 2014 5855912 Feb 28, 2015 DP 5855912*PED Aug 28, 2015 U-1159 6037353 Mar 14, 2017 U-138 6037353*PED Sep 14, 2017 DP 6039974 Jul 31, 2018 6113942 Feb 28, 2015 DP 6113942*PED Aug 28, 2015 U-138 6187791*PED Nov 11, 2012 U-468 6399632*PED Nov 11, 2012 DS U-1159 7135571 May 18, 2014 7135571*PED Nov 18, 2014 DS 7138524 May 18, 2014 7138524*PED Nov 18, 2014 FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION Nov 26, 2013 DS DP U-1159 N021704 002 5578610 May 26, 2014 5578610*PED Mar 14, 2017 U-1159 6037353 Sep 14, 2017 6037353*PED Nov 11, 2012 6187791*PED Nov 11, 2012 6399632*PED DP U-1159 Dec 25, 2020 6613357 DS May 18, 2014 7138524 Nov 18, 2014 7138524*PED May 29, 2018 DP RE39069 FIDAXOMICIN - DIFICID N201699 001 7378508 7863249 7906489 FINASTERIDE - FINASTERIDE A076436 001 FINASTERIDE - PROPECIA N020788 001 5547957 5571817 5886184 FINASTERIDE - PROSCAR N020180 001 5886184 5942519 FINGOLIMOD - GILENYA N022527 001 5604229 6004565 8324283 FLORBETAPIR F-18 - AMYVID N202008 001 7687052
Jul Jul Mar
31, 2027 31, 2027 04, 2027
DS DS
DP DP U-319
NCE
May
27, 2016
PC Oct Nov Nov 15, 2013 05, 2013 19, 2012 U-236 U-259
Jul
01, 2013
Nov Oct
19, 2012 23, 2018
DS U-280
Feb Sep Mar
18, 2014 23, 2017 29, 2026
DS
U-1086 U-1086
M-106 NCE
Jul Sep
20, 2014 21, 2015
Apr
30, 2027
DS
DP
NCE
Apr
06, 2017
ADA 85 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP
EXCLUSIVITY CODE(S)
NCE
FLORBETAPIR F-18 - AMYVID N202008 002 7687052 FLORBETAPIR F-18 - AMYVID N202008 003 7687052
Apr
30, 2027
Apr
06, 2017
Apr
30, 2027
DS
DP
NCE
Apr
06, 2017
FLUDARABINE PHOSPHATE - OFORTA N022273 001 7148207 Dec 7547776 Dec FLUNISOLIDE - AEROSPAN HFA N021247 001 5776433 5980867
20, 2022 10, 2018
DP DS
U-944
ODE
Dec
18, 2015
Jul Jul
07, 2015 06, 2018
DP DP
FLUOCINOLONE ACETONIDE - RETISERT N021737 001 6217895 Mar 6548078 Mar
22, 2019 22, 2019
DP DP
U-708 U-708
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN - TRI-LUMA N021112 001 7915243 Mar 22, 2026 DP DP 7939516 May 04, 2025 Oct 22, 2022 DP 8247395 FLUOCINONIDE - VANOS N021758 001 6765001 7220424 7794738 8232264 FLUOROURACIL - CARAC N020985 001 6670335
Dec Jan Sep Mar
21, 07, 11, 09,
2021 2023 2022 2023
DP U-861 U-1084 DP
Jun
02, 2021
DP
U-68
FLUOXETINE HYDROCHLORIDE - PROZAC N018936 001 6960577 Nov FLUOXETINE HYDROCHLORIDE - PROZAC N018936 003 6960577 Nov FLUOXETINE HYDROCHLORIDE - PROZAC N018936 006 6960577 Nov
01, 2017
U-963
01, 2017
U-963
01, 2017
U-963
FLUOXETINE HYDROCHLORIDE - PROZAC WEEKLY May 29, 2017 N021235 001 5910319 May 29, 2017 5985322 May 29, 2017 RE39030 May 29, 2017 RE39030 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 001 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 002 5945416 Mar 24, 2017 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 003 5945416 Mar 24, 2017 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 004 5945416 Mar 24, 2017 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 005 5945416 Mar 24, 2017 6960577 Nov 01, 2017
DP DP
U-396 U-397 U-396 U-397
U-962
DS
DP U-962
DS
DP U-962
DS
DP U-962
DS
DP U-962
ADA 86 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP U-808 U-808 U-988
EXCLUSIVITY CODE(S)
FLUTICASONE FUROATE - VERAMYST N022051 001 6858596 7101866 7541350 8062264 8147461
Aug Aug Aug Apr Mar
03, 03, 03, 05, 10,
2021 2021 2021 2026 2025
DS
FLUTICASONE PROPIONATE - CUTIVATE N021152 001 7300669 Oct
20, 2019
DP
U-835
FLUTICASONE PROPIONATE - FLOVENT DISKUS 100 Feb 23, 2016 N020833 002 5873360 Aug 23, 2016 5873360*PED FLUTICASONE PROPIONATE - FLOVENT DISKUS 250 Feb 23, 2016 N020833 003 5873360 Aug 23, 2016 5873360*PED FLUTICASONE PROPIONATE - FLOVENT DISKUS 50 N020833 001 5873360 Feb 23, 2016 5873360*PED Aug 23, 2016 FLUTICASONE PROPIONATE - FLOVENT HFA Aug 19, N021433 001 5658549 Feb 19, 5658549*PED Oct 07, 5674472 Apr 07, 5674472*PED Jan 16, 6161724 Jul 16, 6161724*PED Dec 23, 6170717 Jun 23, 6170717*PED Dec 04, 6251368 Jun 04, 6251368*PED Dec 23, 6315173 Jun 23, 6315173*PED Jun 08, 6431168 Dec 08, 6431168*PED Jan 16, 6435372 Jul 16, 6435372*PED Dec 23, 6510969 Jun 23, 6510969*PED Aug 10, 6596260 Feb 10, 6596260*PED Jun 01, 6743413 Dec 01, 6743413*PED Jan 16, 6938796 Jul 16, 6938796*PED Dec 23, 6966467 Jun 23, 6966467*PED Jan 16, 6997349 Jul 16, 6997349*PED Jun 08, 7107986 Dec 08, 7107986*PED Jan 16, 7143908 Jul 16, 7143908*PED Aug 24, 7350676 Feb 24, 7350676*PED Jan 04, 7500444 Jul 04, 7500444*PED Jun 19, 7832351 Dec 19, 7832351*PED
DP
DP
DP
2014 2015 2014 2015 2018 2018 2017 2018 2012 2013 2017 2018 2018 2018 2018 2018 2017 2018 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2019 2018 2018 2018 2019 2025 2025 2023 2023
U-710
U-581 DP DP DP DP DP DP DP DP
ADA 87 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP DP DP U-581 DP DP DP DP DP DP DP DP U-710
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE - FLOVENT HFA N021433 002 5658549 Aug 19, 5658549*PED Feb 19, 5674472 Oct 07, 5674472*PED Apr 07, 6161724 Jan 16, 6161724*PED Jul 16, 6170717 Dec 23, 6170717*PED Jun 23, 6251368 Dec 04, 6251368*PED Jun 04, 6315173 Dec 23, 6315173*PED Jun 23, 6431168 Jun 08, 6431168*PED Dec 08, 6435372 Jan 16, 6435372*PED Jul 16, 6510969 Dec 23, 6510969*PED Jun 23, 6596260 Aug 10, 6596260*PED Feb 10, 6743413 Jun 01, 6743413*PED Dec 01, 6938796 Jan 16, 6938796*PED Jul 16, 6966467 Dec 23, 6966467*PED Jun 23, 6997349 Jan 16, 6997349*PED Jul 16, 7107986 Jun 08, 7107986*PED Dec 08, 7143908 Jan 16, 7143908*PED Jul 16, 7350676 Aug 24, 7350676*PED Feb 24, 7500444 Jan 04, 7500444*PED Jul 04, 7832351 Jun 19, 7832351*PED Dec 19,
2014 2015 2014 2015 2018 2018 2017 2018 2012 2013 2017 2018 2018 2018 2018 2018 2017 2018 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2019 2018 2018 2018 2019 2025 2025 2023 2023
ADA 88 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP DP DP DP DP U-581 U-581 DP DP DP DP DP DP DP DP U-710 U-710
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE - FLOVENT HFA N021433 003 5658549 Aug 19, 5658549*PED Feb 19, 5674472 Oct 07, 5674472*PED Apr 07, 6161724 Jan 16, 6161724*PED Jul 16, 6170717 Dec 23, 6170717*PED Jun 23, 6251368 Dec 04, 6251368*PED Jun 04, 6315173 Dec 23, 6315173*PED Jun 23, 6431168 Jun 08, 6431168*PED Dec 08, 6435372 Jan 16, 6435372*PED Jul 16, 6510969 Dec 23, 6510969*PED Jun 23, 6596260 Aug 10, 6596260*PED Feb 10, 6743413 Jun 01, 6743413*PED Dec 01, 6938796 Jan 16, 6938796*PED Jul 16, 6966467 Dec 23, 6966467*PED Jun 23, 6997349 Jan 16, 6997349*PED Jul 16, 7107986 Jun 08, 7107986*PED Dec 08, 7143908 Jan 16, 7143908*PED Jul 16, 7350676 Aug 24, 7350676*PED Feb 24, 7500444 Jan 04, 7500444*PED Jul 04, 7832351 Jun 19, 7832351*PED Dec 19,
2014 2015 2014 2015 2018 2018 2017 2018 2012 2013 2017 2018 2018 2018 2018 2018 2017 2018 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2019 2018 2018 2018 2019 2025 2025 2023 2023
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 100/50 DP N021077 001 5873360 Feb 23, 2016 5873360*PED Aug 23, 2016 FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 250/50 DP N021077 002 5873360 Feb 23, 2016 5873360*PED Aug 23, 2016 FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 500/50 N021077 003 5873360 Feb 23, 2016 DP 5873360*PED Aug 23, 2016
ADA 89 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA Aug 19, 2014 DP U-738 N021254 001 5658549 Feb 19, 2015 U-738 5658549*PED DP Oct 07, 2014 5674472 Apr 07, 2015 5674472*PED Jan 16, 2018 DP 6161724 Jul 16, 2018 6161724*PED DP Dec 23, 2017 6170717 Jun 23, 2018 6170717*PED DP Dec 04, 2012 6251368 Jun 04, 2013 6251368*PED DP Dec 23, 2017 6315173 Jun 23, 2018 6315173*PED DP Jun 08, 2018 6431168 Dec 08, 2018 6431168*PED DP Jan 16, 2018 6435372 Jul 16, 2018 6435372*PED Dec 23, 2017 6510969 Jun 23, 2018 6510969*PED DP Aug 10, 2014 6596260 Feb 10, 2015 6596260*PED U-841 Jun 01, 2021 6743413 U-841 Dec 01, 2021 6743413*PED DP Jan 16, 2018 6938796 Jul 16, 2018 6938796*PED DP Dec 23, 2017 6966467 Jun 23, 2018 6966467*PED DP Jan 16, 2018 6997349 Jul 16, 2018 6997349*PED DP Jun 08, 2018 7107986 Dec 08, 2018 7107986*PED DP Jan 16, 2018 7143908 Jul 16, 2018 7143908*PED DP Aug 24, 2018 7350676 Feb 24, 2019 7350676*PED DP Jan 04, 2025 7500444 Jul 04, 2025 7500444*PED DP Jun 19, 2023 7832351 Dec 19, 2023 7832351*PED
ADA 90 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA Aug 19, 2014 DP U-738 N021254 002 5658549 Feb 19, 2015 DP U-738 5658549*PED DP Oct 07, 2014 5674472 DP Apr 07, 2015 5674472*PED Jan 16, 2018 DP 6161724 Jul 16, 2018 6161724*PED DP Dec 23, 2017 6170717 Jun 23, 2018 6170717*PED DP Dec 04, 2012 6251368 DP Jun 04, 2013 6251368*PED DP Dec 23, 2017 6315173 DP Jun 23, 2018 6315173*PED DP Jun 08, 2018 6431168 Dec 08, 2018 6431168*PED DP Jan 16, 2018 6435372 Jul 16, 2018 6435372*PED DP Dec 23, 2017 6510969 DP Jun 23, 2018 6510969*PED DP Aug 10, 2014 6596260 Feb 10, 2015 6596260*PED U-841 Jun 01, 2021 6743413 U-841 Dec 01, 2021 6743413*PED DP Jan 16, 2018 6938796 Jul 16, 2018 6938796*PED DP Dec 23, 2017 6966467 Jun 23, 2018 6966467*PED DP Jan 16, 2018 6997349 Jul 16, 2018 6997349*PED DP Jun 08, 2018 7107986 Dec 08, 2018 7107986*PED DP Jan 16, 2018 7143908 Jul 16, 2018 7143908*PED DP Aug 24, 2018 7350676 Feb 24, 2019 7350676*PED DP Jan 04, 2025 7500444 Jul 04, 2025 7500444*PED DP Jun 19, 2023 7832351 Dec 19, 2023 7832351*PED
ADA 91 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA DP U-738 N021254 003 5658549 Aug 19, 2014 DP U-738 5658549*PED Feb 19, 2015 DP 5674472 Oct 07, 2014 DP 5674472*PED Apr 07, 2015 6161724 Jan 16, 2018 DP 6161724*PED Jul 16, 2018 DP 6170717 Dec 23, 2017 6170717*PED Jun 23, 2018 DP 6251368 Dec 04, 2012 6251368*PED Jun 04, 2013 DP DP 6315173 Dec 23, 2017 DP 6315173*PED Jun 23, 2018 DP 6431168 Jun 08, 2018 6431168*PED Dec 08, 2018 DP 6435372 Jan 16, 2018 6435372*PED Jul 16, 2018 DP 6510969 Dec 23, 2017 DP 6510969*PED Jun 23, 2018 6596260 Aug 10, 2014 DP 6596260*PED Feb 10, 2015 U-841 6743413 Jun 01, 2021 U-841 6743413*PED Dec 01, 2021 DP 6938796 Jan 16, 2018 6938796*PED Jul 16, 2018 DP 6966467 Dec 23, 2017 6966467*PED Jun 23, 2018 DP 6997349 Jan 16, 2018 6997349*PED Jul 16, 2018 DP 7107986 Jun 08, 2018 7107986*PED Dec 08, 2018 DP 7143908 Jan 16, 2018 7143908*PED Jul 16, 2018 DP 7350676 Aug 24, 2018 7350676*PED Feb 24, 2019 DP 7500444 Jan 04, 2025 7500444*PED Jul 04, 2025 DP 7832351 Jun 19, 2023 7832351*PED Dec 19, 2023 FLUVASTATIN SODIUM - LESCOL XL N021192 001 6242003 Apr 6242003*PED Oct FLUVOXAMINE MALEATE - LUVOX CR N022033 001 7465462 May FLUVOXAMINE MALEATE - LUVOX CR N022033 002 7465462 May FOLLITROPIN ALFA/BETA - FOLLISTIM N020582 001 5767251 Jun FOLLITROPIN ALFA/BETA - FOLLISTIM N020582 002 5767251 Jun
13, 2020 13, 2020
10, 2020
DP
U-929
10, 2020
DP
U-929
16, 2015
16, 2015
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 001 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23, FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 002 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23,
2015 2018 2019 2019 2019
DS DP DP U-567 U-1183 U-993
D-133 I-306
Aug Jun
22, 2014 28, 2013
2015 2018 2019 2019 2019
DS DP DP U-567 U-993 U-1183
D-133 I-306
Aug Jun
22, 2014 28, 2013
ADA 92 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP U-567 U-993 U-1183
EXCLUSIVITY CODE(S)
D-133
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 003 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23, FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 004 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23, FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021273 001 FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021273 002 FOLLITROPIN ALFA/BETA - GONAL-F N020378 001 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N020378 002 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N020378 003 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N020378 004 5767067 Jun 5767251 Jun 7563763 Aug FOLLITROPIN ALFA/BETA - GONAL-F N020378 005 5767067 Jun 5767251 Jun 7563763 Aug FOLLITROPIN ALFA/BETA - GONAL-F N021765 001 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N021765 003 5767251 Jun
2015 2018 2019 2019 2019
Aug
22, 2014
2015 2018 2019 2019 2019
DS DP DP U-567 U-1183 U-993
D-133 I-306
Aug Jun
22, 2014 28, 2013
I-306
Jun
28, 2013
I-306 16, 2015 DS
Jun
28, 2013
16, 2015
DS
16, 2015
DS
16, 2015 16, 2015 23, 2019
DS DS DP
16, 2015 16, 2015 23, 2019
DS DS DP
16, 2015
DS
16, 2015
DS
FOLLITROPIN ALFA/BETA - GONAL-F RFF N021765 002 5767067 Jun 16, 2015 5767251 Jun 16, 2015 FOLLITROPIN ALFA/BETA - GONAL-F RFF N021684 001 5767067 Jun 5767251 Jun 7446090 Aug 7741268 Apr FOLLITROPIN ALFA/BETA - GONAL-F RFF N021684 002 5767067 Jun 5767251 Jun 7446090 Aug 7741268 Apr FOLLITROPIN ALFA/BETA - GONAL-F RFF N021684 003 5767067 Jun 5767251 Jun 7446090 Aug 7741268 Apr FOMEPIZOLE - ANTIZOL N020696 001 7553863 PEN 16, 16, 23, 02, PEN 16, 16, 23, 02, PEN 16, 16, 23, 02,
DS DS
2015 2015 2019 2024
DS DS DP DP
2015 2015 2019 2024
DS DS DP DP
2015 2015 2019 2024
DS DS DP DP
Jun
30, 2027
DS
DP
ADA 93 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FOMIVIRSEN SODIUM - VITRAVENE PRESERVATIVE FREE Aug 15, 2012 N020961 001 5442049 Aug 15, 2012 5595978 FORMOTEROL FUMARATE - FORADIL N020831 001 6488027 6887459
U-522
Mar Nov
08, 2019 28, 2020
U-762
FORMOTEROL FUMARATE - PERFOROMIST N022007 001 6667344 Jun 6814953 Jun 7348362 Jun 7462645 Jun
22, 22, 22, 22,
2021 2021 2021 2021 - DULERA 2014 2014 2014 2014 2017 2014 2020 2020 - DULERA 2014 2014 2014 2014 2017 2014 2020 2020
DP DP DP DP
U-813 U-813
FORMOTEROL FUMARATE; MOMETASONE FUROATE N022518 001 5889015 Jan 27, 5889015*PED Jul 27, 6057307 Jan 27, 6057307*PED Jul 27, 6068832 Aug 27, 6677323 Jan 27, 7067502 May 21, 7566705 May 08, FORMOTEROL FUMARATE; MOMETASONE FUROATE N022518 002 5889015 Jan 27, 5889015*PED Jul 27, 6057307 Jan 27, 6057307*PED Jul 27, 6068832 Aug 27, 6677323 Jan 27, 7067502 May 21, 7566705 May 08, FOSAMPRENAVIR CALCIUM - LEXIVA N021548 001 6436989 6436989*PED 6514953 6514953*PED
U-1068 DP DP DP DP U-1068 U-1068 U-1068 U-1068 U-1068
NC
Jun
22, 2013
U-1068 DP DP DP DP U-1068 U-1068 U-1068 U-1068 U-1068
NC
Jun
22, 2013
Dec Jun Jul Jan
24, 24, 15, 15,
2017 2018 2019 2020
DS DS
DP DP
U-257 U-257
NPP PED
Apr Oct
27, 2015 27, 2015
FOSAMPRENAVIR CALCIUM - LEXIVA N022116 001 6436989 Dec 6436989*PED Jun FOSAPREPITANT DIMEGLUMINE - EMEND N022023 001 5512570 Mar 5538982 Jul 5691336 Mar 5716942 Feb 7214692 Sep FOSAPREPITANT DIMEGLUMINE - EMEND N022023 002 5512570 Mar 5538982 Jul 5691336 Mar 5716942 Feb 7214692 Sep FOSPROPOFOL DISODIUM - LUSEDRA N022244 001 6204257 Jul 6872838 Aug FROVATRIPTAN SUCCINATE - FROVA Nov N021006 001 5464864 Apr 5616603 Jun 5637611 Oct 5827871 Dec 5962501
24, 2017 24, 2018
DS
DP
U-257
NPP PED
Apr Oct
27, 2015 27, 2015
04, 23, 04, 10, 18,
2014 2013 2019 2015 2012
U-850 U-850 DS DP U-850 U-850
NCE
Jan
25, 2013
04, 23, 04, 10, 18,
2014 2013 2019 2015 2012
U-850 U-850 DS DP U-850 U-850
D-128 NCE
Nov Jan
12, 2013 25, 2013
01, 2022 07, 2018
DS DS
DP
U-945
NCE
Dec
12, 2013
07, 01, 10, 27, 16,
2015 2014 2014 2015 2013
U-436 U-436 U-436 U-436 U-436
ADA 94 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-596 U-596 U-596
EXCLUSIVITY CODE(S)
D-126 M-123 M-103 PED PED
FULVESTRANT - FASLODEX N021344 001 6774122 6774122*PED 7456160 7456160*PED 8329680 8329680*PED GABAPENTIN - GRALISE N022544 001 6340475 6488962 6635280 6723340 7438927 7731989 8192756 8252332 GABAPENTIN - GRALISE N022544 002 6340475 6488962 6635280 6723340 7438927 7731989 8192756 8252332 GABAPENTIN - NEURONTIN N020235 001 6054482 6054482*PED GABAPENTIN - NEURONTIN N020235 002 6054482 6054482*PED GABAPENTIN - NEURONTIN N020235 003 6054482 6054482*PED GABAPENTIN - NEURONTIN N020882 001 6054482 6054482*PED GABAPENTIN - NEURONTIN N020882 002 6054482 6054482*PED GABAPENTIN - NEURONTIN N021129 001 6054482 6054482*PED 7256216 7256216*PED
Jan Jul Jan Jul Jan Jul
09, 09, 09, 09, 09, 09,
2021 2021 2021 2021 2021 2021
Sep Nov May Nov Mar
09, 09, 17, 17, 09,
2013 2015 2014 2014 2014
Sep Jun Sep Oct Feb Oct Oct Oct
19, 20, 19, 25, 26, 25, 25, 25,
2016 2020 2016 2021 2024 2022 2022 2022
DP DP DP DP U-1114 DP DP DP U-1114 U-1114
NP
Jan
28, 2014
Sep Jun Sep Oct Feb Oct Oct Oct
19, 20, 19, 25, 26, 25, 25, 25,
2016 2020 2016 2021 2024 2022 2022 2022
DP DP DP DP U-1114 DP DP DP U-1114 U-1114
NP
Jan
28, 2014
Apr Oct
25, 2017 25, 2017
Apr Oct
25, 2017 25, 2017
Apr Oct
25, 2017 25, 2017
Apr Oct
25, 2017 25, 2017
Apr Oct
25, 2017 25, 2017
Apr Oct May Nov
25, 25, 28, 28,
2017 2017 2022 2022
DP
GABAPENTIN ENACARBIL - HORIZANT N022399 001 6818787 Nov 8026279 Nov 8048917 Nov 8114909 Apr GABAPENTIN ENACARBIL - HORIZANT N022399 002 6818787 Nov 8026279 Nov 8048917 Nov 8114909 Apr GADOBENATE DIMEGLUMINE - MULTIHANCE N021357 001
06, 10, 06, 11,
2022 2026 2022 2026
DS DS DS
DP DP DP
I-652 NCE U-1247 U-1231
Jun Apr
06, 2015 06, 2016
06, 10, 06, 11,
2022 2026 2022 2026
DS DS DS
DP DP DP
I-652 NCE U-1247 U-1231
Jun Apr
06, 2015 06, 2016
I-654 NPP
Jul Mar
06, 2015 17, 2013
ADA 95 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-654 NPP
GADOBENATE DIMEGLUMINE - MULTIHANCE N021357 002 GADOBENATE DIMEGLUMINE - MULTIHANCE N021357 003 GADOBENATE DIMEGLUMINE - MULTIHANCE N021357 004 GADOBENATE DIMEGLUMINE - MULTIHANCE MULTIPACK N021358 001 GADOBENATE DIMEGLUMINE - MULTIHANCE MULTIPACK N021358 002 GADOBUTROL - GADAVIST N201277 001 5980864 GADOBUTROL - GADAVIST N201277 002 5980864 GADOBUTROL - GADAVIST N201277 003 5980864 GADOBUTROL - GADAVIST N201277 004 5980864 GADOBUTROL - GADAVIST N201277 005 5980864 GADODIAMIDE - OMNISCAN N020123 001 5560903 GADODIAMIDE - OMNISCAN N022066 001 5560903 GADODIAMIDE - OMNISCAN N022066 002 5560903
Jul Mar
06, 2015 17, 2013
I-654 NPP
Jul Mar
06, 2015 17, 2013
I-654 NPP
Jul Mar
06, 2015 17, 2013
I-654
Jul
06, 2015
I-654 DS DP U-1119
Jul
06, 2015
Nov
09, 2016
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Oct
01, 2013
DP
Oct
01, 2013
DP
Oct
01, 2013
DP
GADOFOSVESET TRISODIUM - ABLAVAR May N021711 001 6676929 Feb 7011815 May 7060250 May 7229606 May 8017105 GADOFOSVESET TRISODIUM - ABLAVAR May N021711 002 6676929 Feb 7011815 May 7060250 May 7229606 May 8017105 GADOTERIDOL - PROHANCE N020131 001 5474756 5846519 6143274
04, 01, 26, 26, 26,
2020 2015 2015 2015 2015
DP U-1112 DS U-1112 DS
NCE
Dec
22, 2013
04, 01, 26, 26, 26,
2020 2015 2015 2015 2015
DP U-1112 DS U-1112 DS
NCE
Dec
22, 2013
Dec Dec Dec
12, 2012 08, 2015 12, 2012
U-480 U-480
GADOTERIDOL - PROHANCE MULTIPACK N021489 001 5474756 Dec 5846519 Dec 6143274 Dec GADOXETATE DISODIUM - EOVIST N022090 001 5798092 6039931
12, 2012 08, 2015 12, 2012
U-536 U-536
Aug Nov
25, 2015 13, 2021
DS
DP U-1239
NCE
Jul
03, 2013
ADA 96 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
GALANTAMINE HYDROBROMIDE - RAZADYNE N021169 001 6099863 Jun 06, 2017 6358527 Jun 06, 2017 GALANTAMINE HYDROBROMIDE - RAZADYNE N021169 002 6099863 Jun 06, 2017 6358527 Jun 06, 2017 GALANTAMINE HYDROBROMIDE - RAZADYNE N021169 003 6099863 Jun 06, 2017 6358527 Jun 06, 2017 GALANTAMINE HYDROBROMIDE - RAZADYNE ER N021615 001 7160559 Dec 20, 2019 GALANTAMINE HYDROBROMIDE - RAZADYNE ER N021615 002 7160559 Dec 20, 2019 GALANTAMINE HYDROBROMIDE - RAZADYNE ER N021615 003 7160559 Dec 20, 2019 GANCICLOVIR - ZIRGAN N022211 001 GANIRELIX ACETATE - GANIRELIX ACETATE INJECTION N021057 001 5767082 Jun 16, 2015 GATIFLOXACIN - ZYMAR N021493 001 5880283 5880283*PED 6333045 6333045*PED GATIFLOXACIN - ZYMAXID N022548 001 5880283 5880283*PED 6333045 6333045*PED GEFITINIB - IRESSA N021399 001 5457105 5616582 5770599
DP
U-322
DP
U-322
DP
U-322
DP
DP
DP
NDF ODE
Sep Sep
15, 2012 15, 2016
Dec Jun Aug Feb
05, 05, 20, 20,
2015 2016 2019 2020
DP
Dec Jun Aug Feb
05, 05, 20, 20,
2015 2016 2019 2020
DS DS DP
NP
May
18, 2013
Jan Jan May
19, 2013 19, 2013 05, 2017
DS
DP
U-881
GEMCITABINE HYDROCHLORIDE - GEMZAR N020509 001 5464826 Nov 5464826*PED May GEMCITABINE HYDROCHLORIDE - GEMZAR N020509 002 5464826 Nov 5464826*PED May GEMIFLOXACIN MESYLATE - FACTIVE N021158 001 5633262 Jun 5776944 Apr Jun 5962468 Sep 6262071 Sep 6331550 Sep 6340689 Sep 6455540 Mar 6723734 Sep 6803376 Sep 6803376
07, 2012 07, 2013
U-146
07, 2012 07, 2013
U-146
15, 04, 15, 21, 21, 14, 21, 20, 21, 21,
2015 2017 2015 2019 2019 2019 2019 2018 2019 2019
DS
DP U-282 U-513 U-511 U-512 U-511
DS DS DS
DP DP DP
U-609 U-608
ADA 97 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
GEMTUZUMAB OZOGAMICIN - MYLOTARG Dec N021174 001 5585089 Feb 5606040 Dec 5693762 Apr 5739116 Jun 5767285 Jun 5773001 GLATIRAMER ACETATE - COPAXONE N020622 001 5981589 6054430 6342476 6362161 6620847 6939539 7199098 GLATIRAMER ACETATE - COPAXONE N020622 002 5981589 6054430 6342476 6362161 6620847 6939539 7199098
17, 25, 02, 14, 16, 30,
2013 2014 2014 2015 2015 2015
U-320
24, 24, 24, 24, 24, 24, 24,
2014 2014 2014 2014 2014 2014 2014
U-441 U-441 DS DS DS
24, 24, 24, 24, 24, 24, 24,
2014 2014 2014 2014 2014 2014 2014
U-441 U-441 DS DS DS
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE - DUETACT N021925 001 6150383 Jun 19, 2016 6211205 Jun 19, 2016 6303640 Aug 09, 2016 Jun 19, 2016 6329404 Jun 19, 2016 7538125 Jan 30, 2027 7700128 Jun 08, 2028 8071130 GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE - DUETACT Jun 19, 2016 N021925 002 6150383 Jun 19, 2016 6211205 Aug 09, 2016 6303640 Jun 19, 2016 6329404 Jun 19, 2016 7538125 Jan 30, 2027 7700128 Jun 08, 2028 8071130 GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL Apr 21, 2015 N021700 001 5741803 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL Apr 21, 2015 N021700 002 5741803 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL Apr 21, 2015 N021700 003 5741803 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL N021700 004 7358366 Apr 19, 2020 7358366*PED Oct 19, 2020
DP DP DP DP
U-753 U-753 U-753 U-753
DP DP DP DP
U-753 U-753 U-753 U-753
DS DS DS
DP DP
U-781 U-690
DS DS DS
DP DP
U-690 U-781
DS DS DS
DP DP
U-690 U-781
DS
ADA 98 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS
EXCLUSIVITY CODE(S)
GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL Apr 19, 2020 N021700 005 7358366 Oct 19, 2020 7358366*PED GLIPIZIDE - GLUCOTROL XL N020329 001 5591454 GLIPIZIDE - GLUCOTROL XL N020329 002 5591454 GLIPIZIDE - GLUCOTROL XL N020329 003 5591454
Jan
07, 2014
U-150
Jan
07, 2014
U-150
Jan
07, 2014
U-111
GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE N021178 001 6303146 Jul 14, 2019 6303146*PED Jan 14, 2020 GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE N021178 002 6303146 Jul 14, 2019 6303146*PED Jan 14, 2020 GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE N021178 003 6303146 Jul 14, 2019 6303146*PED Jan 14, 2020 GLYCOPYRROLATE - CUVPOSA N022571 001 7638552 7816396 GLYCOPYRROLATE - ROBINUL N012827 001 7091236
U-412 U-412
U-412 U-412
U-412 U-412
Aug Aug
20, 2023 20, 2023
U-1076 U-1076
NP ODE
Jul Jul
28, 2013 28, 2017
Apr
24, 2024
U-877
GLYCOPYRROLATE - ROBINUL FORTE N012827 002 7091236 Apr GOSERELIN ACETATE - ZOLADEX N019726 001 7118552 7220247 7500964 GOSERELIN ACETATE - ZOLADEX N020578 001 7118552 7220247 7500964 GRANISETRON - SANCUSO N022198 001 7608282
24, 2024
U-877
Apr Apr Feb
13, 2022 09, 2022 26, 2021
DP DP DP
Apr Apr Feb
13, 2022 09, 2022 26, 2021
DP DP DP
Oct
22, 2024
DP
U-1011
GRANISETRON HYDROCHLORIDE - KYTRIL N020239 001 5952340 Sep GRANISETRON HYDROCHLORIDE - KYTRIL Sep N020239 002 5952340 GRANISETRON HYDROCHLORIDE - KYTRIL N020239 003 GRANISETRON HYDROCHLORIDE - KYTRIL Sep N020239 004 5952340
14, 2016
U-519
M-102
Apr
29, 2014
14, 2016
U-519
M-102
Apr
29, 2014
M-102 14, 2016 U-519
Apr
29, 2014
M-102
Apr
29, 2014
GREPAFLOXACIN HYDROCHLORIDE - RAXAR N020695 001 5563138 Oct 08, 2013 GUAIFENESIN - MUCINEX N021282 001 6372252 6955821 7838032
Apr Apr Apr
28, 2020 28, 2020 28, 2020
DP DP
U-489 U-489
ADA 99 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-489 U-489
EXCLUSIVITY CODE(S)
GUAIFENESIN - MUCINEX N021282 002 6372252 6955821 7838032
Apr Apr Apr
28, 2020 28, 2020 28, 2020
DP DP
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE - MUCINEX D N021585 001 6372252 Apr 28, 2020 DP DP U-686 6955821 Apr 28, 2020 DP 7838032 Apr 28, 2020 GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE - MUCINEX D N021585 002 6372252 Apr 28, 2020 DP DP U-686 6955821 Apr 28, 2020 DP 7838032 Apr 28, 2020 GUANFACINE HYDROCHLORIDE - INTUNIV N022037 001 5854290 Sep 6287599 Dec 6811794 Jul GUANFACINE HYDROCHLORIDE - INTUNIV N022037 002 5854290 Sep 6287599 Dec 6811794 Jul GUANFACINE HYDROCHLORIDE - INTUNIV N022037 003 5854290 Sep 6287599 Dec 6811794 Jul GUANFACINE HYDROCHLORIDE - INTUNIV N022037 004 5854290 Sep 6287599 Dec 6811794 Jul
21, 2015 20, 2020 04, 2022
U-494 DP DP U-494
I-635 NP
Feb Sep
25, 2014 02, 2012
21, 2015 20, 2020 04, 2022
U-494 DP DP U-494
I-635 NP
Feb Sep
25, 2014 02, 2012
21, 2015 20, 2020 04, 2022
U-494 DP DP U-494
I-635 NP
Feb Sep
25, 2014 02, 2012
21, 2015 20, 2020 04, 2022
U-494 DP DP U-494
I-635 NP
Feb Sep
25, 2014 02, 2012
HEXAMINOLEVULINATE HYDROCHLORIDE - CYSVIEW KIT N022555 001 6034267 Mar 08, 2016 7247655 Mar 08, 2016 7348361 Apr 22, 2019 7530461 Jan 11, 2017 HISTRELIN ACETATE - SUPPRELIN LA N022058 001 8062652 Jun
DP DP DP
U-1087 U-1087 U-1087 U-1087
NP
May
28, 2013
16, 2026
U-1197
ODE
May
03, 2014
HYALURONIDASE RECOMBINANT HUMAN - HYLENEX RECOMBINANT N021859 001 7767429 Sep 23, 2027 DS DP HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE - BIDIL N020727 001 6465463 Sep 08, 2020 U-71 U-71 6784177 Sep 08, 2020 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 001 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 002 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 003 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 004 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015
DP
HYDROCHLOROTHIAZIDE; IRBESARTAN - IRBESARTAN AND HYDROCHLOROTHIAZIDE A077369 001
PC
Sep
26, 2012
ADA 100 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PC
HYDROCHLOROTHIAZIDE; IRBESARTAN - IRBESARTAN AND HYDROCHLOROTHIAZIDE A077369 002 HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT Apr 25, 2016 DS DP U-500 N021532 002 5616599 Oct 25, 2016 5616599*PED U-3 Nov 19, 2021 6878703 May 19, 2022 6878703*PED HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT N021532 003 5616599 Apr 25, 2016 DS DP U-500 5616599*PED Oct 25, 2016 U-3 6878703 Nov 19, 2021 6878703*PED May 19, 2022 HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT Apr 25, 2016 DS DP U-500 N021532 005 5616599 Oct 25, 2016 5616599*PED U-3 Nov 19, 2021 6878703 May 19, 2022 6878703*PED HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT N021162 001 5591762 Jan 07, 2014 DS 6358986 Jan 10, 2020 HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT DS N021162 002 5591762 Jan 07, 2014 6358986 Jan 10, 2020 HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT DS N021162 003 5591762 Jan 07, 2014 HYDROCHLOROTHIAZIDE; VALSARTAN N020818 001 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 002 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 003 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 004 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 005 5399578*PED 6294197 6294197*PED - DIOVAN Sep 21, Jun 18, Dec 18, - DIOVAN Sep 21, Jun 18, Dec 18, - DIOVAN Sep 21, Jun 18, Dec 18, - DIOVAN Sep 21, Jun 18, Dec 18, - DIOVAN Sep 21, Jun 18, Dec 18, HCT 2012 2017 2017 HCT 2012 2017 2017 HCT 2012 2017 2017 HCT 2012 2017 2017 HCT 2012 2017 2017
Sep
26, 2012
DP
U-3
DP
U-3
DP
U-3
U-3
U-3
U-3
U-3
U-3
HYDROCHLOROTHIAZIDE; VALSARTAN - VALSARTAN AND HYDROCHLOROTHIAZIDE A078020 001 HYDROCHLOROTHIAZIDE; VALSARTAN - VALSARTAN AND HYDROCHLOROTHIAZIDE A078020 002 HYDROCHLOROTHIAZIDE; VALSARTAN - VALSARTAN AND HYDROCHLOROTHIAZIDE A078020 003 HYDROCHLOROTHIAZIDE; VALSARTAN - VALSARTAN AND HYDROCHLOROTHIAZIDE A078020 004 HYDROCHLOROTHIAZIDE; VALSARTAN - VALSARTAN AND HYDROCHLOROTHIAZIDE A078020 005
PC
Mar
20, 2013
PC
Mar
20, 2013
PC
Mar
20, 2013
PC
Mar
20, 2013
PC
Mar
20, 2013
ADA 101 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
HYDROCODONE BITARTRATE; IBUPROFEN - VICOPROFEN N020716 001 6348216 Jun 10, 2017 6599531 Jun 10, 2017 HYDROCORTISONE BUTYRATE - LOCOID N022076 001 7378405 Dec 7981877 Jan
19, 2026 23, 2025
DP DP
HYDROCORTISONE BUTYRATE - LOCOID LIPOCREAM N020769 001 5635497 Jun 03, 2014 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019034 003 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019034 004 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019034 005 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019891 001 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019892 001 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019892 002 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019892 003 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID-HP N019034 001 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID-HP N019034 002 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - EXALGO N021217 001 5702725 Jul 07, 2014 5914131 Jul 07, 2014 HYDROMORPHONE HYDROCHLORIDE - EXALGO N021217 002 5702725 Jul 07, 2014 5914131 Jul 07, 2014 HYDROMORPHONE HYDROCHLORIDE - EXALGO N021217 003 5702725 Jul 07, 2014 5914131 Jul 07, 2014 HYDROMORPHONE HYDROCHLORIDE - EXALGO N021217 004 5702725 Jul 07, 2014 5914131 Jul 07, 2014 HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 001 5958452 Nov 04, 2014 5965161 Nov 04, 2014 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014 HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 002 5958452 Nov 04, 2014 5965161 Nov 04, 2014 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014
I-613
Oct
19, 2012
DS
DP
DS
DP
DS
DP
DS
DP
DS
DP
DS
DP
DS
DP
DP
DP
DP DP
U-1043 U-1043
NDF
Mar
01, 2013
DP DP
U-1043 U-1043
NDF
Mar
01, 2013
DP DP
U-1043 U-1043
NDF
Mar
01, 2013
DP DP
U-1043 U-1043
NDF
Mar
01, 2013
DP DP DP DP DP DP
U-616 U-616 U-616
DP DP DP DP DP DP
U-616 U-616 U-616
ADA 102 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP
EXCLUSIVITY CODE(S)
HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 003 5958452 Nov 04, 2014 5965161 Nov 04, 2014 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014 HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 004 5958452 Nov 04, 2014 5965161 Nov 04, 2014 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014 HYDROXOCOBALAMIN - CYANOKIT N022041 001 5834448 HYDROXOCOBALAMIN - CYANOKIT N022041 002 5834448
U-616 U-616 U-616
DP DP DP DP DP DP
U-616 U-616 U-616
Nov
14, 2016
DP
ODE
Dec
15, 2013
Nov
14, 2016
DP
U-789
ODE
Dec
15, 2013
HYDROXYPROGESTERONE CAPROATE - MAKENA N021945 001 IBANDRONATE SODIUM - BONIVA N021455 001 6143326 6294196 IBANDRONATE SODIUM - BONIVA N021455 002 6294196 7192938 7410957 7718634 IBANDRONATE SODIUM - BONIVA N021858 001 5662918 IBUPROFEN - CALDOLOR N022348 001 6727286 IBUPROFEN - CALDOLOR N022348 002 6727286 IBUPROFEN - MIDOL LIQUID GELS N021472 001 6251426 IBUPROFEN LYSINE - NEOPROFEN N021903 001 6342530 6342530 6344479
ODE U-642 DP
Feb
03, 2018
Apr Oct
21, 2017 07, 2019
Oct May May May
07, 06, 06, 06,
2019 2023 2023 2023
DP U-798 U-887 U-642
Sep
02, 2014
DP
Nov
27, 2021
DP
U-981
Nov
27, 2021
DP
U-981
Jun
25, 2018
Nov Nov Mar
14, 2020 14, 2020 20, 2021
DS
DP DP DP
U-1127 U-794 U-794
ODE Y
Apr
13, 2013
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE - CHILDREN'S MOTRIN COLD N021128 001 6211246 Jun 10, 2019 ICATIBANT ACETATE - FIRAZYR N022150 001 5648333 ICODEXTRIN - EXTRANEAL N021321 001 6077836 6248726 ICOSAPENT ETHYL - VASCEPA N202057 001 8188146 8293727 8293728 8298554 8314086 8318715
Jul
15, 2014
DS
DP
U-1187
NCE ODE
Aug Aug
25, 2016 25, 2018
Jun Jun
20, 2017 19, 2018
U-495 U-495
Jan Feb Feb Apr Feb Feb
27, 09, 09, 29, 09, 09,
2020 2030 2030 2030 2030 2030
DS
DP U-1287 U-1287 DP U-1287 U-1287
ADA 103 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-971
EXCLUSIVITY CODE(S)
NCE
ILOPERIDONE - FANAPT N022192 001 RE39198 ILOPERIDONE - FANAPT N022192 002 RE39198 ILOPERIDONE - FANAPT N022192 003 RE39198 ILOPERIDONE - FANAPT N022192 004 RE39198 ILOPERIDONE - FANAPT N022192 005 RE39198 ILOPERIDONE - FANAPT N022192 006 RE39198 ILOPERIDONE - FANAPT N022192 007 RE39198 IMATINIB MESYLATE - GLEEVEC N021335 001 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED IMATINIB MESYLATE - GLEEVEC N021335 002 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED IMATINIB MESYLATE - GLEEVEC N021588 001 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED 7544799 7544799*PED IMATINIB MESYLATE - GLEEVEC N021588 002 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED 7544799 7544799*PED IMIGLUCERASE - CEREZYME N020367 001 5549892 IMIGLUCERASE - CEREZYME N020367 002 5549892 IMIQUIMOD - ALDARA N020723 001 7696159 7696159 7696159*PED
Nov
15, 2016
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Jan Jul May Nov Dec Jun
04, 04, 23, 23, 19, 19,
2015 2015 2019 2019 2021 2022
DS DS
DP DP U-649 U-791
Jan Jul May Nov Dec Jun
04, 04, 23, 23, 19, 19,
2015 2015 2019 2019 2021 2022
DS DS
DP DP
U-649 U-649 U-791
Jan Jul May Nov Dec Jun Jan Jul
04, 04, 23, 23, 19, 19, 16, 16,
2015 2015 2019 2019 2021 2022 2019 2019
DS DS
DP DP U-649 U-791
DS
DP
ODE ODE ODE ODE ODE ODE
Dec Oct Oct Oct Oct Oct
19, 19, 19, 19, 19, 19,
2015 2013 2013 2013 2013 2013
Jan Jul May Nov Dec Jun Jan Jul
04, 04, 23, 23, 19, 19, 16, 16,
2015 2015 2019 2019 2021 2022 2019 2019
DS
DP
U-649 U-791
DS
DP
ODE ODE ODE ODE ODE ODE
Dec Oct Oct Oct Oct Oct
19, 19, 19, 19, 19, 19,
2015 2013 2013 2013 2013 2013
Aug
27, 2013
U-252
Aug
27, 2013
U-252
Apr Apr Oct
01, 2024 01, 2024 01, 2024
DS DS
U-1047 U-1048
ADA 104 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-68 U-68
EXCLUSIVITY CODE(S)
I-636 NP
IMIQUIMOD - ZYCLARA N022483 001 8236816 8299109 IMIQUIMOD - ZYCLARA N022483 002 8222270
Dec Dec
11, 2029 11, 2029
Mar Mar
24, 2014 25, 2013
Dec
11, 2029
U-68
NS
Jul
15, 2014
INDACATEROL MALEATE - ARCAPTA NEOHALER N022383 001 6878721 Oct 10, 2020 INDINAVIR SULFATE - CRIXIVAN N020685 001 6645961 6689761 INDINAVIR SULFATE - CRIXIVAN N020685 003 6645961 6689761 INDINAVIR SULFATE - CRIXIVAN N020685 005 6645961 6689761 INDINAVIR SULFATE - CRIXIVAN N020685 006 6645961 6689761
DS
DP
U-1168
NCE
Jul
01, 2016
Mar Feb
04, 2018 10, 2021
DP U-554
Mar Feb
04, 2018 10, 2021
DP U-554
Mar Feb
04, 2018 10, 2021
DP U-554
Mar Feb
04, 2018 10, 2021
DP U-554
INDIUM IN-111 PENTETREOTIDE KIT - OCTREOSCAN N020314 001 5753627 May 19, 2015 Jul 07, 2015 5776894 INGENOL MEBUTATE - PICATO N202833 001 6432452 6844013 7410656 8278292 INGENOL MEBUTATE - PICATO N202833 002 6432452 6844013 7410656 8278292
U-1125 DS DP
Aug Aug Aug Feb
19, 19, 19, 20,
2018 2018 2018 2027
DS DS DS DS
DP DP
U-68 U-1221 U-1222
NCE
Jan
23, 2017
Aug Aug Aug Feb
19, 19, 19, 20,
2018 2018 2018 2027
DS DS DS DS
DP DP
U-68 U-1221 U-1222
NCE
Jan
23, 2017
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 50/50 DS DP N021810 001 5547930 Sep 28, 2013 DS DP 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 DP U-471 5834422 Sep 28, 2013 5840680 Sep 28, 2013 DS DP U-471 DP 5866538 Jun 20, 2017 5866538*PED Dec 20, 2017 INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 N021172 001 5547930 Sep 28, 2013 DS DP DS DP 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 DP U-471 5834422 Sep 28, 2013 DS DP U-471 5840680 Sep 28, 2013 5866538 Jun 19, 2017 DP 5866538*PED Dec 19, 2017
ADA 105 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 FLEXPEN DS DP N021172 004 5547930 Sep 28, 2013 DS DP 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 DP U-471 5834422 Sep 28, 2013 5840680 Sep 28, 2013 DS DP U-471 DP 5866538 Jun 19, 2017 5866538*PED Dec 19, 2017 DP 6004297 Jan 28, 2019 DP RE41956 Jan 21, 2021 RE43834 Jan 28, 2019 DP INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 PENFILL DS DP N021172 002 5547930 Sep 28, 2013 DS DP 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 DP U-471 5834422 Sep 28, 2013 DS DP U-471 5840680 Sep 28, 2013 DP 5866538 Jun 19, 2017 5866538*PED Dec 19, 2017 INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 PENFILL Sep 28, 2013 DS DP N021172 003 5547930 Jun 07, 2014 DS DP 5618913 Dec 07, 2014 5618913*PED DP U-471 Sep 28, 2013 5834422 Sep 28, 2013 DS DP U-471 5840680 Jun 19, 2017 DP 5866538 Dec 19, 2017 5866538*PED INSULIN ASPART RECOMBINANT - NOVOLOG N020986 001 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 5866538 Jun 20, 2017 5866538*PED Dec 20, 2017 INSULIN ASPART RECOMBINANT - NOVOLOG FLEXPEN N020986 003 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 5866538 Jun 20, 2017 5866538*PED Dec 20, 2017 6004297 Jan 28, 2019 6004297*PED Jul 28, 2019 RE41956 Jan 21, 2021 RE41956*PED Jul 21, 2021 RE43834 Jan 28, 2019 INSULIN ASPART RECOMBINANT - NOVOLOG INNOLET N020986 004 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 5866538 Jun 20, 2017 5866538*PED Dec 20, 2017 RE41956 Jan 21, 2021 RE41956*PED Jul 21, 2021 INSULIN ASPART RECOMBINANT - NOVOLOG PENFILL N020986 002 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 5626566 May 06, 2014 Nov 06, 2014 5626566*PED Dec 02, 2014 5693027 Jun 02, 2015 5693027*PED Jun 20, 2017 5866538 Dec 20, 2017 5866538*PED INSULIN DETEMIR RECOMBINANT - LEVEMIR N021536 001 5750497 Jun 16, 5866538 Jun 20, 6011007 Feb 02, 6869930 Feb 02,
DS
DP DP
DS
DP DP DP DP DP
DS
DP DP DP
DS
DP DP DP DP
2019 2017 2014 2014
DS DS DS DS
DP DP DP DP
U-668 U-668 U-668
M-117 M-115
May Apr
18, 2015 06, 2015
ADA 106 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DP DP DP DP DP DP DP U-668
EXCLUSIVITY CODE(S)
INSULIN DETEMIR RECOMBINANT - LEVEMIR FLEXPEN N021536 002 5750497 Jun 16, 2019 5866538 Jun 20, 2017 6004297 Jan 28, 2019 6011007 Feb 02, 2014 6869930 Feb 02, 2014 RE41956 Jan 21, 2021 RE43834 Jan 28, 2019 INSULIN DETEMIR RECOMBINANT - LEVEMIR INNOLET N021536 003 5750497 Jun 16, 2019 5866538 Jun 20, 2017 6011007 Feb 02, 2014 6869930 Feb 02, 2014 INSULIN DETEMIR RECOMBINANT - LEVEMIR PENFILL N021536 004 5750497 Jun 16, 2019 5866538 Jun 20, 2017 6011007 Feb 02, 2014 6869930 Feb 02, 2014 INSULIN GLARGINE RECOMBINANT - LANTUS N021081 001 5656722 Aug 12, 5656722*PED Feb 12, 7476652 Jul 23, 7476652*PED Jan 23, 7713930 Jun 13, 7713930*PED Dec 13, 7918833 Sep 23, 7918833*PED Mar 23, INSULIN GLULISINE RECOMBINANT - APIDRA N021629 001 6221633 Jun 18, 6960561 Jan 25, 7452860 Mar 22, 7696162 Mar 22, INSULIN GLULISINE RECOMBINANT - APIDRA N021629 002 6221633 Jun 18, 6960561 Jan 25, 7452860 Mar 22, 7696162 Mar 22,
U-668 U-668
DS DS DS DS
DP DP DP DP
U-668 U-668 U-668
DS DS DS DS
DP DP DP DP
U-668 U-668 U-668
2014 2015 2023 2024 2023 2023 2027 2028
DS
DP DP DP DP
U-948
2018 2023 2022 2022
DS
DP DP DP DP
U-471 U-471 U-471
2018 2023 2022 2022
DS
DP DP DP DP
U-471 U-471 U-471
INSULIN GLULISINE RECOMBINANT - APIDRA SOLOSTAR N021629 003 6221633 Jun 18, 2018 DS 6960561 Jan 25, 2023 7452860 Mar 22, 2022 7696162 Mar 22, 2022 7918833 Sep 23, 2027
DP DP DP DP DP
U-471 U-471 U-471
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 50/50 DP U-948 N021018 001 5461031 Jun 16, 2014 5474978 Jun 16, 2014 DS DP U-948 DS DP U-1312 5514646 May 07, 2013 DP 5747642 Jun 16, 2014 INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 50/50 KWIKPEN N021018 002 5461031 Jun 16, 2014 DP U-948 DS DP U-948 5474978 Jun 16, 2014 DS DP U-1312 5514646 May 07, 2013 DP 5747642 Jun 16, 2014 INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 75/25 N021017 001 5461031 Jun 16, 2014 DP U-948 DS DP U-948 5474978 Jun 16, 2014 DS DP U-1312 5514646 May 07, 2013 5747642 Jun 16, 2014 DP
ADA 107 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 75/25 KWIKPEN Jun 16, 2014 DP U-948 N021017 002 5461031 DS DP U-948 Jun 16, 2014 5474978 DS DP U-1312 May 07, 2013 5514646 Jun 16, 2014 DP 5747642 INSULIN LISPRO RECOMBINANT - HUMALOG Jun 16, 2014 N020563 001 5474978 Jun 16, 2014 5474978 May 07, 2013 5514646 May 07, 2013 5514646 INSULIN LISPRO RECOMBINANT - HUMALOG KWIKPEN Jun 16, 2014 N020563 003 5474978 May 07, 2013 5514646 INSULIN LISPRO RECOMBINANT - HUMALOG PEN N020563 002 5474978 Jun 16, 2014 5514646 May 07, 2013 INSULIN RECOMBINANT HUMAN - EXUBERA Apr 21, 2015 N021868 001 5740794 Mar 07, 2014 5997848 Mar 07, 2014 6051256 May 14, 2019 6257233 Mar 07, 2014 6423344 Sep 21, 2014 6543448 May 14, 2019 6546929 Jun 24, 2020 6582728 Mar 07, 2014 6592904 Sep 11, 2018 6685967 Mar 07, 2014 6737045 INSULIN RECOMBINANT HUMAN - EXUBERA N021868 002 5740794 Apr 21, 2015 5997848 Mar 07, 2014 6051256 Mar 07, 2014 6257233 May 14, 2019 Mar 07, 2014 6423344 Sep 21, 2014 6543448 May 14, 2019 6546929 Jun 24, 2020 6582728 Mar 07, 2014 6592904 Sep 11, 2018 6685967 Mar 07, 2014 6737045 INSULIN RECOMBINANT HUMAN - HUMULIN R N018780 001 INSULIN RECOMBINANT HUMAN - HUMULIN R PEN N018780 005 IOBENGUANE SULFATE I-123 - ADREVIEW N022290 001 IOFLUPANE I-123 - DATSCAN N022454 001 5310912
DS DS DS DS
DP DP DP DP
U-948 U-534 U-1312 U-534
NR
Oct
12, 2015
DS DS
DP DP
U-948 U-1312
U-534 U-534
NR
Oct
12, 2015
DP U-704 DP U-704 DP DP U-704 DP DP DP U-704
DP U-704 DP U-704 DP DP U-704 DP DP DP U-704
NR
Mar
25, 2014
NR
Mar
25, 2014
NCE ODE 25, 2013 DS
Sep Sep
19, 2013 19, 2015
Feb
NCE
Jan
14, 2016
IOPROMIDE - ULTRAVIST (PHARMACY BULK) N021425 002 IOPROMIDE - ULTRAVIST 370 N020220 001 IPRATROPIUM BROMIDE - ATROVENT N021527 001 5676930 5683677 6739333 6983743 HFA Oct Nov May May
I-619
Dec
30, 2012
I-619 14, 04, 26, 26, 2014 2014 2020 2020 DP DP DP DP
Dec
30, 2012
ADA 108 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
IRBESARTAN - AVAPRO N020757 001 6342247 6342247*PED IRBESARTAN - AVAPRO N020757 002 6342247 6342247*PED IRBESARTAN - AVAPRO N020757 003 6342247 6342247*PED IRBESARTAN - IRBESARTAN A077159 001 IRBESARTAN - IRBESARTAN A077159 002 IRBESARTAN - IRBESARTAN A077159 003
Jun Dec
07, 2015 07, 2015
Jun Dec
07, 2015 07, 2015
Jun Dec
07, 2015 07, 2015
PC
Sep
26, 2012
PC
Sep
26, 2012
PC U-449 U-606
Sep
26, 2012
IRINOTECAN HYDROCHLORIDE - CAMPTOSAR Apr 28, 2020 N020571 001 6403569 Oct 28, 2020 6403569*PED May 01, 2020 6794370 Nov 01, 2020 6794370*PED IRINOTECAN HYDROCHLORIDE - CAMPTOSAR N020571 002 6403569 Apr 28, 2020 6403569*PED Oct 28, 2020 6794370 May 01, 2020 Nov 01, 2020 6794370*PED IRON DEXTRAN - DEXFERRUM A040024 001 5624668 IRON SUCROSE - VENOFER N021135 001 IRON SUCROSE - VENOFER N021135 002 IRON SUCROSE - VENOFER N021135 004 ISOTRETINOIN - ABSORICA N021951 001 7435427 ISOTRETINOIN - ABSORICA N021951 002 7435427 ISOTRETINOIN - ABSORICA N021951 003 7435427 ISOTRETINOIN - ABSORICA N021951 004 7435427 ITRACONAZOLE - ONMEL N022484 001 6509038 7081255 ITRACONAZOLE - SPORANOX N020083 001 5633015 ITRACONAZOLE - SPORANOX N020657 001 5707975 6407079 ITRACONAZOLE - SPORANOX N020966 001 6407079
U-449 U-606
Sep
29, 2015
NPP
Sep
21, 2015
NPP
Sep
21, 2015
NPP Sep 21, 2021 DP
Sep
21, 2015
NP
May
25, 2015
Sep
21, 2021
DP
NP
May
25, 2015
Sep
21, 2021
DP
NP
May
25, 2015
Sep
21, 2021
DP
NP
May
25, 2015
May May
12, 2017 12, 2017
DP DP
U-1054 U-1054
NP
Apr
29, 2013
May
27, 2014
Jan Jun
13, 2015 18, 2019
Jun
18, 2019
ADA 109 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-1311
EXCLUSIVITY CODE(S)
NCE ODE
IVACAFTOR - KALYDECO N203188 001 7495103 8324242 IVERMECTIN - SKLICE N202736 001 6103248 IXABEPILONE - IXEMPRA KIT N022065 001 6670384 6670384 6670384*PED 7022330 7022330*PED 7125899 7125899*PED 7312237 7312237*PED RE41393 RE41393*PED RE41911 RE41911*PED IXABEPILONE - IXEMPRA KIT N022065 002 6670384 6670384 6670384*PED 7022330 7022330*PED 7125899 7125899*PED 7312237 7312237*PED RE41393 RE41393*PED RE41911 RE41911*PED KETOCONAZOLE - EXTINA N021738 001 7553835 8026238 KETOCONAZOLE - NIZORAL A-D N020310 001 5456851 KETOCONAZOLE - XOLEGEL N021946 001 7179475 8232276
May Apr
20, 2027 18, 2027
Jan Jan
31, 2017 31, 2019
May
22, 2018
DP
NP
Feb
07, 2015
Jan Jan Jul Jan Jul May Nov Aug Feb Feb Aug Sep Mar
23, 23, 23, 23, 23, 26, 26, 21, 21, 08, 08, 28, 28,
2022 2022 2022 2022 2022 2018 2018 2024 2025 2022 2022 2020 2021
DP DP DP DS DP
U-959 U-960 U-958 U-957 U-965 U-961
M-61 NCE PED PED
Oct Oct Apr Apr
18, 16, 18, 16,
2014 2012 2015 2013
DS
DP
U-961
Jan Jan Jul Jan Jul May Nov Aug Feb Feb Aug Sep Mar
23, 23, 23, 23, 23, 26, 26, 21, 21, 08, 08, 28, 28,
2022 2022 2022 2022 2022 2018 2018 2024 2025 2022 2022 2020 2021
DP DP DP DS DP
U-960 U-959 U-958 U-957 U-965 U-961
M-61 NCE PED PED
Oct Oct Apr Apr
18, 16, 18, 16,
2014 2012 2015 2013
DS
DP
U-961
Oct Oct
19, 2018 19, 2018
DP DP
U-245 U-1213
Apr
07, 2014
Dec Nov
04, 2018 24, 2020
DP DP
U-792
KETOROLAC TROMETHAMINE - ACULAR LS N021528 001 8008338 May 8008338*PED Nov 8207215 May 8207215*PED Nov KETOROLAC TROMETHAMINE - ACUVAIL N022427 001 7842714 Aug KETOROLAC TROMETHAMINE - SPRIX N022382 001 6333044 Dec 7476689 Oct LACOSAMIDE - VIMPAT N022253 001 5654301 RE38551 LACOSAMIDE - VIMPAT N022253 002 5654301 RE38551
24, 24, 28, 28,
2027 2027 2024 2024
DS
DP
U-1181 U-1251
15, 2029
DS
DP
NP
Jul
22, 2012
25, 2018 11, 2012
DP DP
U-1057 U-1056
NDF
May
14, 2013
Aug Mar
05, 2014 17, 2022
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
Aug Mar
05, 2014 17, 2022
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
ADA 110 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-914 U-914
EXCLUSIVITY CODE(S)
NCE
LACOSAMIDE - VIMPAT N022253 003 5654301 RE38551 LACOSAMIDE - VIMPAT N022253 004 5654301 RE38551 LACOSAMIDE - VIMPAT N022254 001 5654301 RE38551 LACOSAMIDE - VIMPAT N022255 001 5654301 RE38551 LAMIVUDINE - EPIVIR N020564 001 5905082 5905082*PED LAMIVUDINE - EPIVIR N020564 003 5905082 5905082*PED LAMIVUDINE - EPIVIR N020596 001 6004968 6004968*PED LAMIVUDINE - EPIVIR-HBV N021003 001 5905082 5905082*PED RE39155 RE39155*PED LAMIVUDINE - EPIVIR-HBV N021004 001 6004968 6004968*PED RE39155 RE39155*PED
Aug Mar
05, 2014 17, 2022
Oct
28, 2013
Aug Mar
05, 2014 17, 2022
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
Aug Mar
05, 2014 17, 2022
DS DS
DP DP
U-911 U-911
NCE
Oct
28, 2013
Aug Mar
05, 2014 17, 2022
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
May Nov
18, 2016 18, 2016
DS
DP
U-248
May Nov
18, 2016 18, 2016
Mar Sep
20, 2018 20, 2018
May Nov Jul Jan
18, 18, 02, 02,
2016 2016 2013 2014
U-250
Mar Sep Jul Jan
20, 20, 02, 02,
2018 2018 2013 2014
U-250
LAMIVUDINE; ZIDOVUDINE - COMBIVIR N020857 001 5905082 May Nov 5905082*PED LAMOTRIGINE - LAMICTAL CD N020764 001 5698226*PED LAMOTRIGINE - LAMICTAL CD N020764 002 5698226*PED LAMOTRIGINE - LAMICTAL CD N020764 003 5698226*PED LAMOTRIGINE - LAMICTAL CD N020764 004 5698226*PED LAMOTRIGINE - LAMICTAL ODT N022251 001 7919115 LAMOTRIGINE - LAMICTAL ODT N022251 002 7919115 LAMOTRIGINE - LAMICTAL ODT N022251 003 7919115 LAMOTRIGINE - LAMICTAL ODT N022251 004 7919115
18, 2016 18, 2016
DS
DP
U-248 U-248
Jul
29, 2012
Jul
29, 2012
Jul
29, 2012
Jul
29, 2012
Jan
04, 2029
DS
DP
Jan
04, 2029
DS
DP
Jan
04, 2029
DS
DP
Jan
04, 2029
DS
DP
ADA 111 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-644 I-622 PED
LAMOTRIGINE - LAMICTAL XR N022115 001
Apr Jan Nov
25, 2014 29, 2013 29, 2012
I-644 I-622 PED
Apr Jan Nov
15, 2014 29, 2013 29, 2012
I-644 I-622 PED
Apr Jan Nov
25, 2014 29, 2013 29, 2012
I-644 I-622 PED
Apr Jan Nov
25, 2014 29, 2013 29, 2012
I-644 I-622 PED
Apr Jan Nov
25, 2014 29, 2013 29, 2012
I-622 I-644 PED DP U-831
Jan Apr Nov
29, 2013 25, 2014 29, 2012
LANREOTIDE ACETATE - SOMATULINE DEPOT N022074 001 5595760 Mar 08, 2020
D-131 NCE ODE
Mar Aug Aug
04, 2014 30, 2012 30, 2014
DP
U-831
D-131 NCE ODE
Mar Aug Aug
04, 2014 30, 2012 30, 2014
DP
U-831
D-131 NCE ODE
Mar Aug Aug
04, 2014 30, 2012 30, 2014
LANSOPRAZOLE - PREVACID N021428 001 5464632 5464632*PED 6328994 6328994*PED 7399485 7399485*PED 7431942 7431942*PED 7875292 7875292*PED
Nov May May Nov May Nov May Nov May Nov
07, 07, 17, 17, 26, 26, 17, 17, 17, 17,
2012 2013 2019 2019 2018 2018 2019 2019 2019 2019
DP DP DP
ADA 112 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
LANSOPRAZOLE - PREVACID N021428 002 5464632 5464632*PED 6328994 6328994*PED 7399485 7399485*PED 7431942 7431942*PED 7875292 7875292*PED LANSOPRAZOLE - PREVACID IV N021566 001 7396841 7396841*PED
Nov May May Nov May Nov May Nov May Nov
07, 07, 17, 17, 26, 26, 17, 17, 17, 17,
2012 2013 2019 2019 2018 2018 2019 2019 2019 2019
DP DP DP
Aug Feb
17, 2021 17, 2022
DP
U-947
LANTHANUM CARBONATE - FOSRENOL N021468 001 5968976 Oct 7381428 Aug Aug 7465465 LANTHANUM CARBONATE - FOSRENOL N021468 002 5968976 Oct 7381428 Aug Aug 7465465 LANTHANUM CARBONATE - FOSRENOL N021468 003 5968976 Oct 7381428 Aug Aug 7465465 LANTHANUM CARBONATE - FOSRENOL N021468 004 5968976 Oct 7381428 Aug Aug 7465465 LAPATINIB DITOSYLATE - TYKERB N022059 001 6391874 6713485 6727256 6828320 7157466 LENALIDOMIDE - REVLIMID N021880 001 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 8204763 8288415 8315886
26, 2018 26, 2024 26, 2024
DP DP
U-613 U-890
26, 2018 26, 2024 26, 2024
DP DP
U-613 U-890
26, 2018 26, 2024 26, 2024
DP DP
U-613 U-890
26, 2018 26, 2024 26, 2024
DP DP
U-613 U-890
Jul Sep Jan Jul Nov
11, 29, 08, 11, 19,
2017 2020 2019 2017 2021
DS DS DS DS
DP DP DP DP
U-800 U-800 U-800 U-800
I-620
Jan
29, 2013
Oct Aug Jul Oct Jul Aug Oct Oct Aug Jul Apr Apr Nov Oct Aug Jul Oct
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 27, 24, 07, 28, 24, 23,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2027 2024 2023 2018 2016 2020
DS
DP
U-1211 U-1210 U-1212 U-1210 U-1211 U-1210 U-1210 U-1210 U-1210 U-1215
ODE ODE
Jun Dec
29, 2013 27, 2012
DP DS DS DP DP U-1216 U-1249 DS DP U-1249
ADA 113 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS U-1211 U-1210 U-1212 U-1210 U-1211 U-1210 U-1210 U-1210 U-1210 U-1215 DS DS DP DP U-1216 U-1249 DS DP U-1249
EXCLUSIVITY CODE(S)
ODE ODE
LENALIDOMIDE - REVLIMID N021880 002 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 8204763 8288415 8315886 LENALIDOMIDE - REVLIMID N021880 003 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 8204763 8288415 8315886 LENALIDOMIDE - REVLIMID N021880 004 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 8204763 8288415 8315886
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 27, 24, 07, 28, 24, 23,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2027 2024 2023 2018 2016 2020
Jun Dec
29, 2013 27, 2012
DP
DP
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 27, 24, 07, 28, 24, 23,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2027 2024 2023 2018 2016 2020
DS
DP
U-1211 U-1210 U-1212 U-1210 U-1211 U-1210 U-1210 U-1210 U-1210 U-1215
ODE
Jun
29, 2013
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 27, 24, 07, 28, 24, 23,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2027 2024 2023 2018 2016 2020
DS
DP
U-1211 U-1210 U-1212 U-1210 U-1211 U-1210 U-1210 U-1210 U-1210 U-1215
ODE
Jun
29, 2013
ADA 114 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS U-1211 U-1210 U-1212 U-1210 U-1211 U-1210 U-1210 U-1210 U-1210 U-1215 DS DS DP DP U-1216 U-1249 DS DP U-1249
EXCLUSIVITY CODE(S)
ODE ODE
LENALIDOMIDE - REVLIMID N021880 005 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 8204763 8288415 8315886 LEUPROLIDE ACETATE - ELIGARD N021343 001 5599552 6395293 6565874 6626870 6773714 LEUPROLIDE ACETATE - ELIGARD N021379 001 5599552 6395293 6565874 6626870 6773714 LEUPROLIDE ACETATE - ELIGARD N021488 001 5599552 6395293 6565874 6626870 6773714 LEUPROLIDE ACETATE - ELIGARD N021731 001 5599552 6395293 6565874 6626870 6773714
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 27, 24, 07, 28, 24, 23,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2027 2024 2023 2018 2016 2020
Dec Jun
27, 2012 29, 2013
DP
DP
Feb Sep Oct Mar Oct
04, 28, 28, 27, 28,
2014 2013 2018 2020 2018
DP DP DP DP
U-801 U-801 U-801
Feb Sep Oct Mar Oct
04, 28, 28, 27, 28,
2014 2013 2018 2020 2018
DP DP DP DP
U-801 U-801
Feb Sep Oct Mar Oct
04, 28, 28, 27, 28,
2014 2013 2018 2020 2018
DP DP DP DP
U-801 U-801
Feb Sep Oct Mar Oct
04, 28, 28, 27, 28,
2014 2013 2018 2020 2018
DP DP DP DP
U-621 U-621 U-621
LEUPROLIDE ACETATE - LUPRON DEPOT N019732 001 5575987 Sep May 5631020 Sep 5716640 Dec 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT Sep N020011 001 5575987 May 5631021 Sep 5716640 LEUPROLIDE ACETATE - LUPRON DEPOT Jan N020517 001 5480656 Sep 5575987 May 5631020 Jan 5643607 Sep 5716640 Dec 6036976
02, 20, 02, 13,
2013 2014 2013 2016
02, 2013 20, 2014 02, 2013
02, 02, 20, 02, 02, 13,
2013 2013 2014 2013 2013 2016
ADA 115 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
LEUPROLIDE ACETATE - LUPRON DEPOT Jan N020517 002 5480656 Sep 5575987 May 5631020 Jan 5643607 Sep 5716640 Dec 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT N020517 003 6036976 Dec 7429559 Dec LEUPROLIDE ACETATE - LUPRON DEPOT Jan N020708 001 5480656 Sep 5575987 May 5631020 Jan 5643607 Sep 5716640 Dec 6036976
02, 02, 20, 02, 02, 13,
2013 2013 2014 2013 2013 2016
13, 2016 13, 2016
DP DP
D-132 NS
Jun Jun
17, 2014 17, 2014
02, 02, 20, 02, 02, 13,
2013 2013 2014 2013 2013 2016
LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 002 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 003 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 004 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 005 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 006 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 007 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED N020263 008 5480656 Jan 02, 5575987 Sep 02, May 20, 5631020 Jan 02, 5643607 Sep 02, 5716640 Dec 13, 6036976
2013 2014 2013 2016
M-107
Oct
08, 2014
2013 2014 2013 2013
2013 2014 2013 2013
2013 2014 2013 2016
M-107
Oct
08, 2014
2013 2014 2013 2016
M-107
Oct
08, 2014
2013 2014 2013 2016
DP DP DP DP
NP
Aug
15, 2014
2013 2013 2014 2013 2013 2016
DP DP DP DP DP DP
NP
Aug
15, 2014
ADA 116 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-316
EXCLUSIVITY CODE(S)
LEUPROLIDE ACETATE - VIADUR N021088 001 5728396 5932547 5985305 6113938 6124261 6132420 6156331 6235712 6375978 6395292
Jan Jun Jan Jul Jun Jan Jan Jun Dec Jan
30, 13, 30, 24, 13, 30, 30, 13, 17, 30,
2017 2017 2017 2018 2017 2017 2017 2017 2018 2017
LEVALBUTEROL HYDROCHLORIDE - XOPENEX Mar 25, 2013 N020837 001 5362755 Aug 20, 2013 5547994 Mar 21, 2021 6451289 LEVALBUTEROL HYDROCHLORIDE - XOPENEX Mar 25, 2013 N020837 002 5362755 Aug 20, 2013 5547994 Mar 21, 2021 6451289 LEVALBUTEROL HYDROCHLORIDE - XOPENEX N020837 003 5362755 Mar 25, 2013 5547994 Aug 20, 2013 Mar 21, 2021 6451289 LEVALBUTEROL HYDROCHLORIDE - XOPENEX Mar 25, 2013 N020837 004 5362755 Aug 20, 2013 5547994 Mar 21, 2021 6451289 LEVALBUTEROL TARTRATE - XOPENEX HFA N021730 001 5362755 Mar 5547994 Aug Feb 5605674 Nov 5836299 Oct 7256310 LEVETIRACETAM - KEPPRA N021035 001 LEVETIRACETAM - KEPPRA N021035 002 LEVETIRACETAM - KEPPRA N021035 003 LEVETIRACETAM - KEPPRA N021035 004 LEVETIRACETAM - KEPPRA N021505 001 LEVETIRACETAM - KEPPRA XR N022285 001 7858122 LEVETIRACETAM - KEPPRA XR N022285 002 7858122
U-332 U-332
U-332 U-332
U-332 U-332
U-332 U-332 DP
25, 20, 25, 17, 08,
2013 2013 2014 2015 2024
U-636 U-636 DP DP DP
DS
U-636
NPP PED
Dec Jun
16, 2014 16, 2015
NPP PED
Dec Jun
16, 2014 16, 2015
NPP PED
Dec Jun
16, 2014 16, 2015
NPP PED
Dec Jun
16, 2014 16, 2015
NPP PED Sep 17, 2028 DP
Dec Jun
16, 2014 16, 2015
Sep
17, 2028
DP
LEVOBETAXOLOL HYDROCHLORIDE - BETAXON N021114 001 5540918 Jul 30, 2013 5540918*PED Jan 30, 2014
DP
ADA 117 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-276
EXCLUSIVITY CODE(S)
LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE N020997 001 5708011 Oct 13, 2014 LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE N020997 002 5708011 Oct 13, 2014 LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE N020997 003 5708011 Oct 13, 2014 LEVOCARNITINE - CARNITOR N020182 001 6335369 6429230 6696493
U-276
U-276
Jan Jan Jan
18, 2021 18, 2021 18, 2021
U-433 U-433 U-433
LEVOCETIRIZINE DIHYDROCHLORIDE - XYZAL N022064 001 5698558 Jul 26, 2013 5698558*PED Jan 26, 2014 LEVOCETIRIZINE DIHYDROCHLORIDE - XYZAL N022157 001 5698558 Jul 26, 2013 5698558*PED Jan 26, 2014 LEVOFLOXACIN - LEVAQUIN N021721 001 6806256 6806256*PED
U-812
NPP PED
Aug Feb
21, 2012 21, 2013
U-852
NPP PED
Aug Feb
21, 2012 21, 2013
Feb Aug
26, 2022 26, 2022
DP
LEVOLEUCOVORIN CALCIUM - FUSILEV N020140 001 6500829 Dec
31, 2019
DS
DP
I-637 ODE ODE
Apr Apr Mar
29, 2014 29, 2018 07, 2015
31, 2019
DS
DP
I-637 ODE ODE
Apr Apr Mar
29, 2014 29, 2018 07, 2015
31, 2019
DS
DP
I-637 ODE ODE
Apr Apr Mar
29, 2014 29, 2018 07, 2015
LEVONORGESTREL - MIRENA N021225 001 5785053
Dec
05, 2015
DP
I-610
Oct
01, 2012
LEVONORGESTREL - PLAN B ONE-STEP N021998 001 LEVOTHYROXINE SODIUM - LEVO-T N021342 001 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 002 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 003 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 004 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 005 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 006 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 007 6399101
NP 30, 2020
Jul
10, 2012
Mar
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
ADA 118 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
LEVOTHYROXINE SODIUM - LEVO-T N021342 008 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 009 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 010 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 011 6399101
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 001 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 002 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 003 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 004 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 005 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 006 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 007 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL N021301 008 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL N021301 009 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 010 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 011 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 012 6555581 Feb 7067148 Feb 7101569 Aug
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
15, 2022 15, 2022 14, 2022
DP U-759
ADA 119 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
LEVOTHYROXINE SODIUM - TIROSINT N021924 002 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 003 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 004 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 005 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 006 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 007 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 008 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 009 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 010 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N022121 001 7723390 Mar LIDOCAINE - LIDODERM N020612 001 5741510 5827529
14, 2024
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
Mar Oct
30, 2014 27, 2015
DP U-486
LIDOCAINE HYDROCHLORIDE - ZINGO May N022114 001 5630796 May 5899880 Mar 6004286 Jun 6881200 LIDOCAINE; PRILOCAINE - ORAQIX N021451 001 6031007 Apr LIDOCAINE; TETRACAINE - PLIAGLIS Jul N021717 001 5919479 Sep 6528086 LIDOCAINE; TETRACAINE - SYNERA N021623 001 5658583 Jul 5919479 Jul 6306431 Jul 6465006 Jul 6465709 Jul 6546281 Jul 6780426 Jul LINACLOTIDE - LINZESS N202811 001 7304036 7371727 7704947 7745409 8080526 8110553 LINACLOTIDE - LINZESS N202811 002 7304036 7371727 7704947 7745409 8080526 8110553
20, 04, 17, 11,
2014 2016 2017 2016
DP DP DP
01, 2017
DP
U-553
28, 2015 28, 2019
DP DP
28, 28, 28, 28, 07, 28, 28,
2015 2015 2015 2015 2020 2015 2015
28, 28, 28, 28, 28, 28,
2024 2024 2024 2024 2024 2024
DS DS DS DS DS
DP DP DP DP
U-1278
NCE
Aug
30, 2017
U-1278
28, 28, 28, 28, 28, 28,
2024 2024 2024 2024 2024 2024
DS DS DS DS DS
DP DP DP DP
U-1278
NCE
Aug
30, 2017
U-1278
ADA 120 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1270 U-774 U-1270 U-493 U-493 U-1270 DS DP U-1270 U-493 U-774 U-1270 U-1245 U-775 U-1244 U-1270
EXCLUSIVITY CODE(S)
M-121 M-118 NCE
LINAGLIPTIN - TRADJENTA N201280 001 6303661 6303661 6890898 6890898 7078381 7078381 7407955 7459428 7459428 8119648 8119648 8178541 8178541 8178541 8178541
Apr Apr Feb Feb Feb Feb Aug Feb Feb Aug Aug Aug Aug Aug Aug
24, 24, 02, 02, 02, 02, 12, 02, 02, 12, 12, 12, 12, 12, 12,
2017 2017 2019 2019 2019 2019 2023 2019 2019 2023 2023 2023 2023 2023 2023
Aug Aug May
13, 2015 13, 2015 02, 2016
LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO Apr 24, 2017 N201281 001 6303661 Feb 02, 2019 6890898 Feb 02, 2019 7078381 DS Aug 12, 2023 7407955 Feb 02, 2019 7459428 Aug 12, 2023 8119648 Aug 12, 2023 8178541 LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO N201281 002 6303661 Apr 24, 2017 6890898 Feb 02, 2019 7078381 Feb 02, 2019 DS 7407955 Aug 12, 2023 Feb 02, 2019 7459428 Aug 12, 2023 8119648 Aug 12, 2023 8178541 LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO N201281 003 6303661 Apr 24, 2017 6890898 Feb 02, 2019 7078381 Feb 02, 2019 DS 7407955 Aug 12, 2023 Feb 02, 2019 7459428 Aug 12, 2023 8119648 Aug 12, 2023 8178541 LINEZOLID - ZYVOX N021130 001 5688792 5688792*PED 6514529 6514529*PED 6559305 6559305*PED LINEZOLID - ZYVOX N021130 002 5688792 5688792*PED 6514529 6514529*PED 6559305 6559305*PED LINEZOLID - ZYVOX N021131 001 5688792 5688792*PED 6559305 6559305*PED
U-802 U-1039 U-1039 DP U-1039 U-802 U-775
NCE NC
May Jan
02, 2016 30, 2015
DP
U-802 U-1039 U-1039 DP U-1039 U-802 U-775
NCE NC
May Jan
02, 2016 30, 2015
DP
U-802 U-1039 U-1039 DP U-1039 U-802 U-775
NCE NC
May Jan
02, 2016 30, 2015
DP
Nov May Mar Sep Jan Jul
18, 18, 15, 15, 29, 29,
2014 2015 2021 2021 2021 2021
DS DP DS
U-319
Nov May Mar Sep Jan Jul
18, 18, 15, 15, 29, 29,
2014 2015 2021 2021 2021 2021
DS DP DS
U-319
Nov May Jan Jul
18, 18, 29, 29,
2014 2015 2021 2021
U-319 DS
ADA 121 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS U-319
EXCLUSIVITY CODE(S)
LINEZOLID - ZYVOX N021132 001 5688792 5688792*PED 6559305 6559305*PED
Nov May Jan Jul
18, 18, 29, 29,
2014 2015 2021 2021
LIRAGLUTIDE RECOMBINANT - VICTOZA Jan N022341 001 6004297 Aug 6268343 Aug 6458924 Aug 7235627 Aug 8114833 Jan RE41956 Jan RE43834
28, 22, 22, 22, 13, 21, 28,
2019 2017 2017 2017 2025 2021 2019
DS DS DS
U-968 U-968
M-115 NCE
Apr Jan
06, 2015 25, 2015
LISDEXAMFETAMINE DIMESYLATE - VYVANSE N021977 001 7105486 Jun 29, 7223735 Jun 29, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7662788 Feb 24, 7671030 Feb 24, 7671031 Feb 28, 7674774 Mar 18, 7678770 Mar 25, 7678771 Mar 25, 7687466 Feb 24, 7687467 Apr 08, Jun 29, 7700561 Feb 24, 7713936 Feb 24, 7718619 Feb 24, 7723305 LISDEXAMFETAMINE DIMESYLATE - VYVANSE N021977 002 7105486 Jun 29, 7223735 Jun 29, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7662788 Feb 24, 7671030 Feb 24, 7671031 Feb 28, 7674774 Mar 18, 7678770 Mar 25, 7678771 Mar 25, 7687466 Feb 24, 7687467 Apr 08, Jun 29, 7700561 Feb 24, 7713936 Feb 24, 7718619 Feb 24, 7723305
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
U-727 DP DS DS DS DP DP DP DP DP DP DP DP U-727 U-727 U-727 U-842 U-842 U-842 U-842 U-727 U-842 U-842 DP U-727 U-1034
I-645 M-82 NPP
Jan Apr Nov
31, 2015 05, 2013 10, 2013
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
I-645 M-82 NPP
Jan Apr Nov
31, 2015 05, 2013 10, 2013
ADA 122 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-645 M-82 NPP
LISDEXAMFETAMINE DIMESYLATE - VYVANSE Jun 29, N021977 003 7105486 Jun 29, 7223735 Feb 24, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7662788 Feb 24, 7671030 Feb 28, 7671031 Mar 18, 7674774 Mar 25, 7678770 Mar 25, 7678771 Feb 24, 7687466 Apr 08, 7687467 Jun 29, 7700561 Feb 24, 7713936 Feb 24, 7718619 Feb 24, 7723305 LISDEXAMFETAMINE DIMESYLATE - VYVANSE Jun 29, N021977 004 7105486 Jun 29, 7223735 Feb 24, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7662788 Feb 24, 7671030 Feb 28, 7671031 Mar 18, 7674774 Mar 25, 7678770 Mar 25, 7678771 Feb 24, 7687466 Apr 08, 7687467 Jun 29, 7700561 Feb 24, 7713936 Feb 24, 7718619 Feb 24, 7723305 LISDEXAMFETAMINE DIMESYLATE - VYVANSE Jun 29, N021977 005 7105486 Jun 29, 7223735 Feb 24, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7662788 Feb 24, 7671030 Feb 28, 7671031 Mar 18, 7674774 Mar 25, 7678770 Mar 25, 7678771 Feb 24, 7687466 Apr 08, 7687467 Jun 29, 7700561 Feb 24, 7713936 Feb 24, 7718619 Feb 24, 7723305
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
Jan Apr Nov
31, 2015 05, 2013 10, 2013
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
I-645 M-82 NPP
Jan Apr Nov
31, 2015 05, 2013 10, 2013
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
I-645 M-82 NPP
Jan Apr Nov
31, 2015 05, 2013 10, 2013
ADA 123 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-645 M-82 NPP
LISDEXAMFETAMINE DIMESYLATE - VYVANSE N021977 006 7105486 Jun 29, 7223735 Jun 29, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7662788 Feb 24, 7671030 Feb 24, 7671031 Feb 28, 7674774 Mar 18, 7678770 Mar 25, 7678771 Mar 25, 7687466 Feb 24, 7687467 Apr 08, 7700561 Jun 29, 7713936 Feb 24, 7718619 Feb 24, 7723305 Feb 24, LODOXAMIDE TROMETHAMINE - ALOMIDE N020191 001 5457126 Oct LOMITAPIDE MESYLATE - JUXTAPID N203858 001 5712279 5739135 6492365 7932268 LOMITAPIDE MESYLATE - JUXTAPID N203858 002 5712279 5739135 6492365 7932268 LOMITAPIDE MESYLATE - JUXTAPID N203858 003 5712279 5739135 6492365 7932268
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
Jan Apr Nov
31, 2015 05, 2013 10, 2013
10, 2012
U-117
Feb Apr Dec Aug
21, 14, 10, 19,
2015 2015 2019 2027
DS DS
U-1316 U-1317 U-1318 U-1317
NCE
Dec
21, 2017
Feb Apr Dec Aug
21, 14, 10, 19,
2015 2015 2019 2027
DS DS
U-1316 U-1317 U-1318 U-1317
NCE
Dec
21, 2017
Feb Apr Dec Aug
21, 14, 10, 19,
2015 2015 2019 2027
DS DS
U-1316 U-1317 U-1318 U-1317
NCE
Dec
21, 2017
LOPERAMIDE HYDROCHLORIDE - IMODIUM A-D EZ CHEWS N020448 001 5489436 Feb 06, 2013 6814978 Aug 26, 2021
DP DP
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE - IMODIUM MULTI-SYMPTOM RELIEF N020606 001 5489436 Feb 06, 2013 Y 5679376 Oct 21, 2014 LOPERAMIDE HYDROCHLORIDE; SIMETHICONE - IMODIUM MULTI-SYMPTOM RELIEF DP N021140 001 6103260 Jul 17, 2017
ADA 124 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS U-348
EXCLUSIVITY CODE(S)
LOPINAVIR; RITONAVIR - KALETRA N021226 001 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332*PED 5948436 5948436*PED 6037157 6037157*PED 6232333 6232333*PED 6284767 6284767 6284767*PED 6458818 6458818*PED 6521651 6521651*PED 6703403 6703403*PED 7141593 7141593*PED 7432294 7432294*PED LOPINAVIR; RITONAVIR - KALETRA N021251 001 5484801 5484801*PED 5541206 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332 5914332*PED 5948436 5948436*PED 6037157 6037157 6037157*PED 6284767 6284767 6284767*PED 6703403 6703403 6703403*PED 6911214 6911214*PED
Jul Jan Jul Jan Nov May Dec Jun Sep Mar Jun Dec Nov May Feb Feb Aug Nov May Nov May Jun Dec May Nov May Nov
30, 30, 15, 15, 19, 19, 13, 13, 13, 13, 26, 26, 07, 07, 15, 15, 15, 07, 07, 07, 07, 26, 26, 22, 22, 22, 22,
2013 2014 2014 2015 2013 2014 2015 2016 2013 2014 2016 2016 2017 2018 2016 2016 2016 2017 2018 2017 2018 2016 2016 2020 2020 2020 2020
DS
DP U-351 DP U-346
DP DP
U-688 U-401
DP U-257 DP DP
Jan Jul Jul Jul Jan Jul Jan Nov May Dec Dec Jun Sep Mar Jun Jun Dec Feb Feb Aug Jun Jun Dec Nov May
28, 28, 30, 30, 30, 15, 15, 19, 19, 13, 13, 13, 13, 13, 26, 26, 26, 15, 15, 15, 26, 26, 26, 28, 28,
2014 2014 2013 2013 2014 2014 2015 2013 2014 2015 2015 2016 2013 2014 2016 2016 2016 2016 2016 2016 2016 2016 2016 2021 2022
DP DS DS DS DS DS DS DP DP DP DP U-895 U-346 DP DP U-895 U-401 U-257 U-895 DP U-895 U-895 U-351 U-895 DP DP U-348 U-895
D-124
Apr
27, 2013
ADA 125 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DP DP DP DP U-895 U-688 U-688 DP U-688 U-688 DP DP DP DP U-688 U-688 U-688
EXCLUSIVITY CODE(S)
D-124
LOPINAVIR; RITONAVIR - KALETRA N021906 001 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332*PED 6037157 6037157*PED 6284767 6284767*PED 6703403 6703403*PED 7148359 7148359*PED 7364752 7364752*PED 8025899 8025899*PED 8268349 8268349*PED 8309613 8309613*PED LOPINAVIR; RITONAVIR - KALETRA N021906 002 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332*PED 6037157 6037157*PED 6284767 6284767*PED 6703403 6703403*PED 7148359 7148359*PED 7364752 7364752*PED 8025899 8025899*PED 8268349 8268349*PED 8309613 8309613*PED LORATADINE - CLARITIN N020641 002 6132758
Jul Jan Jul Jan Nov May Dec Jun Jun Dec Feb Aug Jun Dec Jul Jan Nov May Sep Mar Aug Feb Dec Jun
30, 30, 15, 15, 19, 19, 13, 13, 26, 26, 15, 15, 26, 26, 19, 19, 10, 10, 26, 26, 25, 25, 24, 24,
2013 2014 2014 2015 2013 2014 2015 2016 2016 2016 2016 2016 2016 2016 2019 2020 2020 2021 2027 2028 2024 2025 2024 2025
Apr
27, 2013
Jul Jan Jul Jan Nov May Dec Jun Jun Dec Feb Aug Jun Dec Jul Jan Nov May Sep Mar Aug Feb Dec Jun
30, 30, 15, 15, 19, 19, 13, 13, 26, 26, 15, 15, 26, 26, 19, 19, 10, 10, 26, 26, 25, 25, 24, 24,
2013 2014 2014 2015 2013 2014 2015 2016 2016 2016 2016 2016 2016 2016 2019 2020 2020 2021 2027 2028 2024 2025 2024 2025
DS DS DS DS
DP DP DP DP
U-688
D-124
Apr
27, 2013
U-895 U-688 U-688
DP
U-688 U-688
Jun
01, 2018
LORATADINE; PSEUDOEPHEDRINE SULFATE - CLARITIN-D 24 HOUR N020470 002 5314697 Oct 23, 2012
ADA 126 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DP DP DP DP U-1254 U-1255 U-1252 U-1253 U-1255 U-1254 U-1252 U-1253 U-1252 U-1255 U-1253 U-1254 U-1254 U-1253 U-1252 U-1255 U-1254 U-1255
EXCLUSIVITY CODE(S)
NCE
LORCASERIN HYDROCHLORIDE - BELVIQ N022529 001 6953787 Apr 6953787 Apr 6953787 Apr 6953787 Apr 7514422 Apr 7514422 Apr 7514422 Apr 7514422 Apr 7977329 Apr 7977329 Apr 7977329 Apr 7977329 Apr 8168624 Apr 8207158 Apr 8207158 Apr 8207158 Apr 8207158 Apr 8273734 Apr 8273734 Apr LOTEPREDNOL ETABONATE - ALREX N020803 001 4996335*PED 5540930 5540930*PED 5747061 5747061*PED
10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 18, 10, 10, 10, 10, 10, 10,
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2029 2023 2023 2023 2023 2023 2023
Jun
27, 2017
DS DS DS DS DS
DP DP DP DP DP
Sep Oct Apr Oct Apr
09, 25, 25, 25, 25,
2012 2013 2014 2013 2014
DP
U-576
LOTEPREDNOL ETABONATE - LOTEMAX N020583 001 4996335*PED Sep 5540930 Oct 5540930*PED Apr 5747061 Oct 5747061*PED Apr LOTEPREDNOL ETABONATE - LOTEMAX N020841 001 5540930 Oct LOTEPREDNOL ETABONATE - LOTEMAX N200738 001 LOTEPREDNOL ETABONATE - LOTEMAX N202872 001 LOTEPREDNOL ETABONATE; TOBRAMYCIN N050804 001 4996335*PED Sep 5540930 Oct 5540930*PED Apr 5747061 Oct 5747061*PED Apr LOVASTATIN - ALTOPREV N021316 001 5916595 6080778 6485748 LOVASTATIN - ALTOPREV N021316 002 5916595 6080778 6485748 LOVASTATIN - ALTOPREV N021316 003 5916595 6080778 6485748
09, 25, 25, 25, 25,
2012 2013 2014 2013 2014
DP
U-575
25, 2013
NDF PED
Apr Oct
15, 2014 15, 2014
NDF ZYLET 09, 2012 25, 2013 25, 2014 25, 2013 25, 2014
Sep
28, 2015
DP DP U-920
Dec Mar Dec
12, 2017 23, 2018 12, 2017
U-456 DP
Dec Mar Dec
12, 2017 23, 2018 12, 2017
U-456 DP
Dec Mar Dec
12, 2017 23, 2018 12, 2017
U-456 DP
ADA 127 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
LOVASTATIN - ALTOPREV N021316 004 5916595 6080778 6485748 LOVASTATIN; NIACIN - ADVICOR N021249 001 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506 LOVASTATIN; NIACIN - ADVICOR N021249 002 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506
Dec Mar Dec
12, 2017 23, 2018 12, 2017
U-456 DP
May May May May Sep Sep Sep Sep Sep Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
DP DP
U-447 U-1134 U-1133 U-1132 U-448 U-1133 U-1132 U-1134 U-450 U-1131 U-1129 U-1130 U-768 U-548 U-1132 U-1134 U-1133 U-586 U-712 U-1137 U-1135 U-1136 U-1137 U-1135 U-1136
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
DP DP
ADA 128 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
LOVASTATIN; NIACIN - ADVICOR N021249 003 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506 LOVASTATIN; NIACIN - ADVICOR N021249 004 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506 LOXAPINE - ADASUVE N022549 001
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
DP DP
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
U-1134 U-1132 U-447 U-1133 U-448 U-1133 U-1134 U-1132 U-1129 U-768 U-1131 U-1130 U-548 U-1132 U-1134 U-1133 U-586 U-1136 U-1135 U-1137 U-712 U-1137 U-1136 U-1135
DP DP
NDF
Dec
21, 2015
ADA 129 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS U-717 DP U-739 DP DP U-1203 DS DP U-1214 DP DP
EXCLUSIVITY CODE(S)
LUBIPROSTONE - AMITIZA N021908 001 5284858 6414016 6583174 7064148 7417067 8026393 8071613 8088934 8097649 8097653 8114890 8338639 LUBIPROSTONE - AMITIZA N021908 002 5284858 6414016 6583174 7064148 7064148 7417067 7795312 8026393 8071613 8088934 8097649 8114890 8338639 LUCINACTANT - SURFAXIN N021746 001 5407914
Jul Sep Oct Aug Oct Oct Sep May Oct Nov Sep Jan
14, 05, 16, 30, 16, 25, 05, 18, 16, 14, 05, 23,
2014 2020 2020 2022 2020 2027 2020 2021 2020 2022 2020 2027
Jul Sep Oct Aug Aug Oct Sep Oct Sep May Oct Sep Jan
14, 05, 16, 30, 30, 16, 17, 25, 05, 18, 16, 05, 23,
2014 2020 2020 2022 2022 2020 2024 2027 2020 2021 2020 2020 2027
DS U-874 DP U-739 U-873 DP U-1085 DP U-1202 DS DP DP DP
Nov
17, 2013
DS
DP
U-1242
LURASIDONE HYDROCHLORIDE - LATUDA N200603 001 5532372 Jul LURASIDONE HYDROCHLORIDE - LATUDA N200603 002 5532372 Jul LURASIDONE HYDROCHLORIDE - LATUDA N200603 003 5532372 Jul LURASIDONE HYDROCHLORIDE - LATUDA N200603 004 5532372 Jul LUTROPIN ALFA - LUVERIS N021322 001 5767251
02, 2013
DS
D-134 NCE
Apr Oct
26, 2015 28, 2015
02, 2013
DS
D-134 NCE
Apr Oct
26, 2015 28, 2015
02, 2013
DS
D-134 NCE
Apr Oct
26, 2015 28, 2015
02, 2013
DS
D-134 NCE
Apr Oct
26, 2015 28, 2015
Jun
16, 2015
DS
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - NORMOCARB HF 25 N021910 001 5945449 Oct 31, 2017 DP U-785 DP U-785 7300674 Mar 04, 2023 MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - NORMOCARB HF 35 N021910 002 5945449 Oct 31, 2017 DP U-785 MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE N022456 001 6489346 Jul 16, 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 6699885 Jul 16, 7399772 Jul 16, 7399772 Jul 16,
ODE
Jul
26, 2013
ODE
Jul
26, 2013
BICARBONATE - MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM 2016 2016 2016 2016 2016 2016 2016 DP DP DP
DP DP DP DP U-588
U-1021
U-1021
U-588
U-588
U-1021
ADA 130 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE N022456 002 6489346 Jul 16, 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 6699885 Jul 16, 7399772 Jul 16, 7399772 Jul 16, MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM N021850 001 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 7399772 Jul 16, MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM N021850 002 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 7399772 Jul 16,
BICARBONATE - MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM 2016 2016 2016 2016 2016 2016 2016 DP DP DP DP DP DP DP U-1021 U-588 U-588 U-1021 U-1021 U-588
BICARBONATE - ZEGERID 2016 DS DP U-588 DS DP U-588 2016 U-588 2016 U-588 2016 BICARBONATE - ZEGERID 2016 DS DP U-623 DS DP U-623 2016 2016 U-623 U-623 2016
MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE - SUPREP BOWEL PREP KIT N022372 001 6946149 Mar 07, 2023 DP U-837 NC MALATHION - OVIDE N018613 001 7560445 7977324 MANNITOL - ARIDOL KIT N022368 001 5817028 MARAVIROC - SELZENTRY N022128 001 6586430 6667314 7368460 7576097 MARAVIROC - SELZENTRY N022128 002 6586430 6667314 7368460 7576097
Aug
05, 2013
Feb Aug
01, 2027 14, 2026
DS
DP DP
U-986
Feb
23, 2015
U-1091
NP
Oct
05, 2013
Dec Aug Nov May
01, 06, 25, 25,
2019 2021 2022 2021
DS DS DS
DP DP
U-824 U-824 U-824
NPP NCE
May Aug
28, 2013 06, 2012
Dec Aug Nov May
01, 06, 25, 25,
2019 2021 2022 2021
DS DS DS
DP DP
U-824 U-824 U-824
NPP NCE
May Aug
28, 2013 06, 2012
MECASERMIN RECOMBINANT - INCRELEX Sep N021839 001 5681814 Jul 5824642 Apr 6207640
18, 2017 08, 2014 07, 2014
DP U-681 U-681
ODE
Aug
30, 2012
MECASERMIN RINFABATE RECOMBINANT - IPLEX N021884 001 5681818 Oct 28, 2014 MEDROXYPROGESTERONE ACETATE - DEPO-SUBQ PROVERA 104 May 15, 2020 DP N021583 001 6495534 MEGESTROL ACETATE - MEGACE ES N021778 001 6592903 7101576 MELOXICAM - MOBIC N020938 001 MELOXICAM - MOBIC N020938 002 MELOXICAM - MOBIC N021530 001 6184220 6184220*PED
U-697
ODE
Dec
12, 2012
Sep Apr
21, 2020 22, 2024
DP U-755
ODE PED
Aug Feb
11, 2012 11, 2013
ODE PED Mar Sep 25, 2019 25, 2019 DP
Aug Feb
11, 2012 11, 2013
ODE PED
Aug Feb
11, 2012 11, 2013
ADA 131 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-539
EXCLUSIVITY CODE(S)
MEMANTINE HYDROCHLORIDE - NAMENDA N021487 001 5061703 Apr MEMANTINE HYDROCHLORIDE - NAMENDA N021487 002 5061703 Apr MEMANTINE HYDROCHLORIDE - NAMENDA N021627 001 5061703 Apr
11, 2015
11, 2015
U-539
11, 2015
U-539
MEMANTINE HYDROCHLORIDE - NAMENDA XR N022525 001 5061703 Apr 11, 2015 8039009 Mar 24, 2029 MEMANTINE HYDROCHLORIDE - NAMENDA XR N022525 002 5061703 Apr 11, 2015 8039009 Mar 24, 2029 MEMANTINE HYDROCHLORIDE - NAMENDA XR N022525 003 5061703 Apr 11, 2015 8039009 Mar 24, 2029 MEMANTINE HYDROCHLORIDE - NAMENDA XR Apr 11, 2015 N022525 004 5061703 Mar 24, 2029 8039009 MEQUINOL; TRETINOIN - SOLAGE N020922 001 5194247 6353029 MESALAMINE - APRISO N022301 001 6551620 8337886 MESALAMINE - ASACOL N019651 001 5541170 5541171 MESALAMINE - ASACOL HD N021830 001 5541170 5541171 6893662 MESALAMINE - LIALDA N022000 001 6773720 MESALAMINE - SFROWASA N019618 002 7645801 METAXALONE - SKELAXIN N013217 003 7122566 7714006
U-539 U-539
NDF
Jun
21, 2013
U-539 U-539
NDF
Jun
21, 2013
U-539 U-539
NDF
Jun
21, 2013
U-539 U-539
NDF
Jun
21, 2013
Dec Aug
10, 2013 24, 2020
DP
U-294
Apr Apr
20, 2018 20, 2018
DS
DP DP
U-907 U-1310
Jul Jul
30, 2013 30, 2013
U-141 U-141
Jul Jul Nov
30, 2013 30, 2013 15, 2021
DP DP DP
U-141 U-141 U-141
Jun
08, 2020
DP
I-640
Jul
14, 2014
Jul
24, 2027
DS
DP
Feb Dec
06, 2026 03, 2021
U-915 U-1050
METFORMIN HYDROCHLORIDE - FORTAMET N021574 001 6099859 Mar 6495162 Mar 6790459 Mar 6866866 Mar 7919116 Mar METFORMIN HYDROCHLORIDE - FORTAMET N021574 002 6099859 Mar 6495162 Mar 6790459 Mar 6866866 Mar 7919116 Mar
20, 20, 17, 17, 20,
2018 2018 2021 2021 2018
DP DP U-604 DP DP
20, 20, 17, 17, 20,
2018 2018 2021 2021 2018
DP DP U-604 DP DP
METFORMIN HYDROCHLORIDE - GLUCOPHAGE XR N021202 001 6475521 Mar 19, 2018 6660300 Mar 19, 2018
U-542
ADA 132 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
METFORMIN HYDROCHLORIDE - GLUCOPHAGE XR N021202 004 6475521 Mar 19, 2018 6660300 Mar 19, 2018 METFORMIN HYDROCHLORIDE - GLUMETZA N021748 001 6340475 Sep 6488962 Jun 6635280 Sep 6723340 Oct METFORMIN HYDROCHLORIDE - GLUMETZA N021748 002 6488962 Jun 7780987 Mar 8323692 Mar METFORMIN HYDROCHLORIDE - RIOMET N021591 001 6890957 Sep
U-542
19, 20, 19, 25,
2016 2020 2016 2021
DS DS DS DS
DP DP DP DP
U-669
20, 2020 23, 2025 23, 2025
DS DS
DP DP DP
14, 2023
DP
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - ACTOPLUS MET N021842 001 5965584 Jun 19, 2016 DP U-1055 U-679 6166042 Jun 19, 2016 U-679 6166043 Jun 19, 2016 U-679 6172090 Jun 19, 2016 METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - ACTOPLUS MET N021842 002 5965584 Jun 19, 2016 DP U-1055 U-679 6166042 Jun 19, 2016 U-679 6166043 Jun 19, 2016 U-679 6172090 Jun 19, 2016 METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE N022024 001 5965584 Jun 19, 2016 6099859 Mar 20, 2018 6166042 Jun 19, 2016 6166043 Jun 19, 2016 6172090 Jun 19, 2016 6495162 Mar 20, 2018 6790459 Mar 17, 2021 6866866 Mar 17, 2021 7785627 Jul 31, 2026 7919116 Mar 20, 2018 7919116 Mar 20, 2018 7959946 Jul 31, 2026 METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE N022024 002 5965584 Jun 19, 2016 6099859 Mar 20, 2018 6166042 Jun 19, 2016 6166043 Jun 19, 2016 6172090 Jun 19, 2016 6495162 Mar 20, 2018 6790459 Mar 17, 2021 6866866 Mar 17, 2021 7785627 Jul 31, 2026 7919116 Mar 20, 2018 7919116 Mar 20, 2018 7959946 Jul 31, 2026 - ACTOPLUS MET XR DP U-973 DP U-973 U-973 U-973 DP U-974 DP DP U-973 U-1120 DP - ACTOPLUS MET XR DP U-973 DP U-973 U-973 U-973 DP U-974 DP DP U-973 U-1120 DP
M-116
May
17, 2015
M-116
May
17, 2015
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE A090406 001 PC Feb 13, 2013 METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE A090406 002 PC Feb 13, 2013 METFORMIN HYDROCHLORIDE; REPAGLINIDE - PRANDIMET N022386 001 6677358 Jun 12, 2018 METFORMIN HYDROCHLORIDE; REPAGLINIDE - PRANDIMET N022386 002 6677358 Jun 12, 2018 DP U-546
DP
U-546
ADA 133 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET Apr 21, 2015 DS DP U-493 N021410 001 5741803 DS DP U-734 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED U-493 Jun 19, 2016 5965584 U-493 Jun 19, 2016 6166042 U-493 Feb 11, 2017 6288095 Aug 11, 2017 6288095*PED Apr 19, 2020 DS 7358366 Oct 19, 2020 7358366*PED DP Oct 07, 2022 8236345 METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET Apr 21, 2015 DS DP U-493 N021410 002 5741803 DS DP U-734 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED U-493 Jun 19, 2016 5965584 U-493 Jun 19, 2016 6166042 U-493 Feb 11, 2017 6288095 Aug 11, 2017 6288095*PED Apr 19, 2020 DS 7358366 Oct 19, 2020 7358366*PED DP Oct 07, 2022 8236345 METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET Apr 21, 2015 DS DP U-493 N021410 003 5741803 DS DP U-734 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED U-493 Jun 19, 2016 5965584 U-493 Jun 19, 2016 6166042 U-493 Feb 11, 2017 6288095 Aug 11, 2017 6288095*PED Apr 19, 2020 DS 7358366 Oct 19, 2020 7358366*PED DP Oct 07, 2022 8236345 METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET N021410 004 5741803 Apr 21, 2015 DS DP U-734 5741803 Apr 21, 2015 DS DP U-493 5741803*PED Oct 21, 2015 DS 7358366 Apr 19, 2020 Oct 19, 2020 7358366*PED DP Oct 07, 2022 8236345 METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET Apr 21, 2015 DS DP U-734 N021410 005 5741803 DS DP U-493 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED DS Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED DP Oct 07, 2022 8236345 METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - KOMBIGLYZE XR DS DP U-1097 N200678 001 6395767 Feb 16, 2021 METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - KOMBIGLYZE XR DS DP U-1097 N200678 002 6395767 Feb 16, 2021 METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - KOMBIGLYZE XR DS DP U-1097 N200678 003 6395767 Feb 16, 2021
Y Y Y Y Y
Y Y Y Y Y
Y Y Y Y Y
Y Y
Y Y
NCE
Jul
31, 2014
NCE
Jul
31, 2014
NCE
Jul
31, 2014
ADA 134 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET N022044 001 6303661 Apr 24, 2017 U-802 DS DP U-802 6699871 Jul 26, 2022 U-1036 6890898 Feb 02, 2019 U-1038 6890898 Feb 02, 2019 6890898 Feb 02, 2019 U-803 U-1036 7078381 Feb 02, 2019 U-1038 7078381 Feb 02, 2019 U-803 7078381 Feb 02, 2019 DP U-803 7125873 Jul 26, 2022 7125873 Jul 26, 2022 DP U-1038 DP U-1036 7125873 Jul 26, 2022 DS DP U-802 7326708 Apr 11, 2026 METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET N022044 002 6303661 Apr 24, 2017 U-802 DS DP U-802 6699871 Jul 26, 2022 U-1038 6890898 Feb 02, 2019 U-1036 6890898 Feb 02, 2019 6890898 Feb 02, 2019 U-803 U-803 7078381 Feb 02, 2019 U-1038 7078381 Feb 02, 2019 U-1036 7078381 Feb 02, 2019 DP U-1036 7125873 Jul 26, 2022 7125873 Jul 26, 2022 DP U-1038 DP U-803 7125873 Jul 26, 2022 DS DP U-802 7326708 Apr 11, 2026 METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR N202270 001 6303661 Apr 24, 2017 U-1227 DP 6340475 Sep 19, 2016 DP 6635280 Sep 19, 2016 DS DP U-1227 6699871 Jul 26, 2022 6890898 Feb 02, 2019 U-1228 U-1227 7078381 Feb 02, 2019 DP U-1227 7125873 Jul 26, 2022 DS DP U-1227 7326708 Apr 11, 2026 U-1227 7459428 Feb 02, 2019 METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR N202270 002 6303661 Apr 24, 2017 U-1227 DP 6340475 Sep 19, 2016 DP 6635280 Sep 19, 2016 6699871 Jul 26, 2022 DS DP U-1227 U-1228 6890898 Feb 02, 2019 U-1227 7078381 Feb 02, 2019 DP U-1227 7125873 Jul 26, 2022 7326708 Apr 11, 2026 DS DP U-1227 U-1227 7459428 Feb 02, 2019 METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR N202270 003 6303661 Apr 24, 2017 U-1227 6340475 Sep 19, 2016 DP DP 6635280 Sep 19, 2016 DS DP U-1227 6699871 Jul 26, 2022 U-1228 6890898 Feb 02, 2019 U-1227 7078381 Feb 02, 2019 7125873 Jul 26, 2022 DP U-1227 DS DP U-1227 7326708 Apr 11, 2026 U-1227 7459428 Feb 02, 2019 METHYL AMINOLEVULINATE HYDROCHLORIDE - METVIXIA N021415 001 6034267 Mar 08, 2016 METHYLNALTREXONE BROMIDE - RELISTOR N021964 001 6559158 Nov 03, 2017 8247425 Dec 31, 2030
U-804
U-1185 U-1185
NCE
Apr
24, 2013
ADA 135 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1185 U-1185
EXCLUSIVITY CODE(S)
NCE
METHYLNALTREXONE BROMIDE - RELISTOR N021964 002 6559158 Nov 03, 2017 8247425 Dec 31, 2030 METHYLNALTREXONE BROMIDE - RELISTOR N021964 003 8247425 Dec 31, 2030 METHYLPHENIDATE - DAYTRANA N021514 001 5958446 6210705 6348211 METHYLPHENIDATE - DAYTRANA N021514 002 5958446 6210705 6348211 METHYLPHENIDATE - DAYTRANA N021514 003 5958446 6210705 6348211 METHYLPHENIDATE - DAYTRANA N021514 004 5958446 6210705 6348211
Apr
24, 2013
U-1185
Dec Sep Sep
12, 2012 30, 2018 30, 2018
DP DP DP
NPP U-727 U-727
Jun
29, 2013
Dec Sep Sep
12, 2012 30, 2018 30, 2018
DP DP DP
NPP U-727 U-727
Jun
29, 2013
Dec Sep Sep
12, 2012 30, 2018 30, 2018
DP DP DP
NPP U-727 U-727
Jun
29, 2013
Dec Sep Sep
12, 2012 30, 2018 30, 2018
DP DP DP
NPP U-727 U-727
Jun
29, 2013
METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 001 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 8163798 Jul 31, 2017 8163798*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 002 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 8163798 Jul 31, 2017 8163798*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 003 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 8163798 Jul 31, 2017 8163798*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 004 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 8163798 Jul 31, 2017 8163798*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 001 6344215 Oct 27, 2020 METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 002 6344215 Oct 27, 2020 METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 003 6344215 Oct 27, 2020 METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 004 6344215 Oct 27, 2020
U-666 U-666 DP
M-88
Nov
04, 2012
U-666 U-666 DP
M-88
Nov
04, 2012
U-666 U-666 DP
M-88
Nov
04, 2012
U-666 U-666 DP
M-88
Nov
04, 2012
DP
DP
DP
DP
ADA 136 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
METHYLPHENIDATE HYDROCHLORIDE - METHYLIN N021419 001 7691880 Oct 07, 2024 METHYLPHENIDATE HYDROCHLORIDE - METHYLIN N021419 002 7691880 Oct 07, 2024
DP
METHYLPHENIDATE HYDROCHLORIDE - METHYLPHENIDATE HYDROCHLORIDE A078458 001 METHYLPHENIDATE HYDROCHLORIDE - METHYLPHENIDATE HYDROCHLORIDE A078458 002 METHYLPHENIDATE HYDROCHLORIDE - METHYLPHENIDATE HYDROCHLORIDE A078458 003 METHYLPHENIDATE HYDROCHLORIDE - QUILLIVANT XR N202100 001 METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 001 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 002 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 003 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 004 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, LA 2015 2019 2015 2015 LA 2015 2019 2015 2015 LA 2015 2019 2015 2015 LA 2015 2019 2015 2015
PC
Jul
01, 2012
PC
Jul
01, 2012
PC
Jul
01, 2012
NDF DP DP DP DP
Sep
27, 2015
U-472 U-591
DP DP DP DP
U-472 U-591
DP DP DP DP
U-472 U-591
DP DP DP DP
U-472 U-591
METOCLOPRAMIDE HYDROCHLORIDE - METOZOLV ODT N022246 001 6413549 Jul 11, 2017 METOCLOPRAMIDE HYDROCHLORIDE - METOZOLV ODT N022246 002 6413549 Jul 11, 2017 METOCLOPRAMIDE HYDROCHLORIDE - REGLAN ODT N021793 001 6024981 Apr 09, 2018 6221392 Apr 09, 2018 METOCLOPRAMIDE HYDROCHLORIDE - REGLAN ODT N021793 002 6024981 Apr 09, 2018 6221392 Apr 09, 2018 METRONIDAZOLE - FLAGYL ER N020868 001 6103262 METRONIDAZOLE - METROGEL N021789 001 6881726 7348317
DP
DP
DP DP
DP DP
Aug
15, 2017
DP
U-137
Feb Feb
21, 2022 21, 2022
DP DP
U-743 U-743
METRONIDAZOLE - METROGEL-VAGINAL N020208 001 5536743 Jul METRONIDAZOLE - VANDAZOLE N021806 001 7456207
16, 2013
U-137
Sep
22, 2024
DP
ADA 137 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DP DP DP DP DP DP U-650 U-845 U-650 U-845 U-650 U-845
EXCLUSIVITY CODE(S)
MICAFUNGIN SODIUM - MYCAMINE N021506 002 6107458 6107458 6265536 6265536 6774104 6774104 MICAFUNGIN SODIUM - MYCAMINE N021506 003 6107458 6107458 6265536 6265536 6774104 6774104 MICONAZOLE - ORAVIG N022404 001 6916485 7651698
Mar Mar Sep Sep Jan Jan
16, 16, 29, 29, 08, 08,
2019 2019 2015 2015 2021 2021
Mar Mar Sep Sep Jan Jan
16, 16, 29, 29, 08, 08,
2019 2019 2015 2015 2021 2021
DS DS DS DS
DP DP DP DP DP DP
U-650 U-845 U-650 U-845 U-650 U-845
Sep Sep
11, 2022 11, 2022
DP
U-1051 U-1051
NDF
Apr
16, 2013
MICONAZOLE NITRATE - MONISTAT 1 COMBINATION PACK N021308 001 5514698 Mar 21, 2014 6153635 Nov 28, 2020 MIFEPRISTONE - KORLYM N202107 001 MIGLUSTAT - ZAVESCA N021348 001 5472969 5525616
Y Y
NP ODE May Jun 13, 2013 11, 2013
Feb Feb
17, 2015 17, 2019
MILNACIPRAN HYDROCHLORIDE - SAVELLA N022256 001 6602911 Jan 14, 2023 6992110 Nov 05, 2021 7888342 Nov 05, 2021 7994220 Sep 19, 2029 MILNACIPRAN HYDROCHLORIDE - SAVELLA N022256 002 6602911 Jan 14, 2023 6992110 Nov 05, 2021 7888342 Nov 05, 2021 7994220 Sep 19, 2029 MILNACIPRAN HYDROCHLORIDE - SAVELLA Jan 14, 2023 N022256 003 6602911 Nov 05, 2021 6992110 Nov 05, 2021 7888342 Sep 19, 2029 7994220 MILNACIPRAN HYDROCHLORIDE - SAVELLA Jan 14, 2023 N022256 004 6602911 Nov 05, 2021 6992110 Nov 05, 2021 7888342 Sep 19, 2029 7994220 MINOCYCLINE HYDROCHLORIDE - ARESTIN N050781 001 6682348 Mar 29, 2022 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 001 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 8252776 Jun 24, 2025 8268804 Jun 24, 2025
U-882 U-882 U-882 U-819
NCE
Jan
14, 2014
U-882 U-882 U-882 U-819
NCE
Jan
14, 2014
U-882 U-882 U-882 U-819
NCE
Jan
14, 2014
U-882 U-882 U-882 U-819
NCE
Jan
14, 2014
DP
U-917 U-1078 U-1078 U-124 U-1078
ADA 138 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-917 U-917 DP U-1078 U-1078 U-124 U-1078
EXCLUSIVITY CODE(S)
MINOCYCLINE HYDROCHLORIDE - SOLODYN Feb 19, 2018 N050808 002 5908838 Apr 02, 2027 7541347 Apr 02, 2027 7544373 Jun 24, 2025 7790705 Mar 07, 2027 7919483 Jun 24, 2025 8252776 Jun 24, 2025 8268804 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 003 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 8252776 Jun 24, 2025 8268804 Jun 24, 2025 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 004 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 8252776 Jun 24, 2025 8268804 Jun 24, 2025 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 005 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 8252776 Jun 24, 2025 8268804 Jun 24, 2025 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 006 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 8252776 Jun 24, 2025 8268804 Jun 24, 2025 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 007 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 8252776 Jun 24, 2025 8268804 Jun 24, 2025 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 008 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 8252776 Jun 24, 2025 8268804 Jun 24, 2025 MINOXIDIL - MEN'S ROGAINE N021812 001 6946120 MIRABEGRON - MYRBETRIQ N202611 001 6346532 6562375 6699503 7342117 7750029 7982049 MIRABEGRON - MYRBETRIQ N202611 002 6346532 6562375 6699503 7342117 7750029 7982049
U-917 U-1078 U-1078 U-124 U-1078
U-917 U-1078 U-1078 U-124 U-1078
U-917 U-1078 U-1078 U-124 U-1078
U-917 U-1078 U-1078 U-124 U-1078
U-917 U-1078 U-1078 U-124 U-1078
U-917 U-1078 U-1078 U-124 U-1078
Apr
20, 2019
DP
U-702
Oct Aug Sep Nov Dec Nov
15, 01, 10, 04, 18, 04,
2018 2020 2013 2023 2023 2023
DS
DP DP DP U-913 DP
NCE
Jun
28, 2017
DS
Oct Aug Sep Nov Dec Nov
15, 01, 10, 04, 18, 04,
2018 2020 2013 2023 2023 2023
DS
DP DP DP U-913 DP
NCE
Jun
28, 2017
DS
ADA 139 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
ODE
MITOMYCIN - MITOSOL N022572 001 7806265 8186511 MODAFINIL - PROVIGIL N020717 001 7297346 7297346*PED RE37516 RE37516*PED MODAFINIL - PROVIGIL N020717 002 7297346 7297346*PED RE37516 RE37516*PED
Feb Jul
01, 2029 19, 2026
Feb
07, 2019
Nov May Oct Apr
29, 29, 06, 06,
2023 2024 2014 2015
DP U-255
Nov May Oct Apr
29, 29, 06, 06,
2023 2024 2014 2015
DP U-255
MOMETASONE FUROATE - ASMANEX TWISTHALER N021067 001 5394868*PED Dec 25, 2012 5687710 Nov 18, 2014 5687710*PED May 18, 2015 5829434 Nov 03, 2015 5829434*PED May 03, 2016 5889015 Jan 27, 2014 5889015*PED Jul 27, 2014 6057307 Jan 27, 2014 6057307*PED Jul 27, 2014 6240918 Feb 20, 2017 6240918*PED Aug 20, 2017 6365581 Jan 27, 2014 6365581*PED Jul 27, 2014 6503537 Mar 17, 2018 6503537*PED Sep 17, 2018 6677322 Jan 27, 2014 6677322*PED Jul 27, 2014 6949532 Jan 27, 2014 6949532*PED Jul 27, 2014 8173172 Mar 17, 2018 8173172*PED Sep 17, 2018 MOMETASONE FUROATE - ASMANEX TWISTHALER N021067 002 5394868*PED Dec 25, 2012 5687710 Nov 18, 2014 5687710*PED May 18, 2015 5829434 Nov 03, 2015 5829434*PED May 03, 2016 5889015 Jan 27, 2014 5889015*PED Jul 27, 2014 6057307 Jan 27, 2014 6057307*PED Jul 27, 2014 6240918 Feb 20, 2017 6240918*PED Aug 20, 2017 6365581 Jan 27, 2014 6365581*PED Jul 27, 2014 6503537 Mar 17, 2018 6503537*PED Sep 17, 2018 6677322 Jan 27, 2014 6677322*PED Jul 27, 2014 6949532 Jan 27, 2014 6949532*PED Jul 27, 2014 8173172 Mar 17, 2018 8173172*PED Sep 17, 2018 MOMETASONE FUROATE MONOHYDRATE N020762 001 5837699 5837699*PED 6127353 6127353*PED 6723713 6723713*PED - NASONEX Jan 27, 2014 Jul 27, 2014 Oct 03, 2017 Apr 03, 2018 Jan 27, 2014 Jul 27, 2014
DP DP U-645 DP DP U-645 DP U-645 U-645 DP U-645
DP DP U-645 DP DP U-645 DP U-645 U-645 DP U-645
DP DS DP
U-625
I-626 M-99
May Jan
26, 2013 19, 2014
U-625
ADA 140 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-228
EXCLUSIVITY CODE(S)
NPP
MONTELUKAST SODIUM - SINGULAIR N020829 002 5565473*PED Aug MONTELUKAST SODIUM - SINGULAIR N020830 001 5565473*PED Aug MONTELUKAST SODIUM - SINGULAIR N020830 002 5565473*PED Aug MONTELUKAST SODIUM - SINGULAIR N021409 001 5565473*PED Aug 8007830 Oct MORPHINE SULFATE - AVINZA N021260 001 6066339 MORPHINE SULFATE - AVINZA N021260 002 6066339 MORPHINE SULFATE - AVINZA N021260 003 6066339 MORPHINE SULFATE - AVINZA N021260 004 6066339 MORPHINE SULFATE - AVINZA N021260 005 6066339 MORPHINE SULFATE - AVINZA N021260 006 6066339 MORPHINE SULFATE - DEPODUR N021671 001 5723147 5807572 5891467 5931809 5962016 5997899 6171613 6193998 6241999 MORPHINE SULFATE - DEPODUR N021671 002 5723147 5807572 5891467 5931809 5962016 5997899 6171613 6193998 6241999 MORPHINE SULFATE - DEPODUR N021671 003 5723147 5807572 5891467 5931809 5962016 5997899 6171613 6193998 6241999
03, 2012
Mar
26, 2015
03, 2012
U-228
NPP
Mar
26, 2015
03, 2012
U-228
NPP
Mar
26, 2015
03, 2012 24, 2022
NPP DP
Mar
26, 2015
Nov
25, 2017
Nov
25, 2017
Nov
25, 2017
Nov
25, 2017
Nov
25, 2017
DP
Nov
25, 2017
DP
Mar Sep Jan Jul Jan Sep Oct Sep Sep
03, 15, 31, 14, 31, 01, 01, 01, 01,
2015 2015 2017 2015 2017 2016 2016 2016 2016
U-584
U-584 U-584
03, 15, 31, 14, 31, 01, 01, 01, 01,
2015 2015 2017 2015 2017 2016 2016 2016 2016
U-584
U-584 U-584
03, 15, 31, 14, 31, 01, 01, 01, 01,
2015 2015 2017 2015 2017 2016 2016 2016 2016
U-584
U-584 U-584
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 001 7682633 Jun 19, 2027 7682634 Jun 19, 2027 DP DP 7815934 Dec 12, 2027 8158156 Jun 19, 2027
U-1241
NC
Aug
13, 2012
U-1241
ADA 141 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1241
EXCLUSIVITY CODE(S)
NC
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 002 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027 8158156 Jun 19, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 003 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027 8158156 Jun 19, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 004 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 7815934 Dec 12, 2027 DP 8158156 Jun 19, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 005 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027 8158156 Jun 19, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 006 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027 8158156 Jun 19, 2027 MOXIFLOXACIN HYDROCHLORIDE - AVELOX N021085 001 5607942 Mar 04, 2014 5849752 Dec 05, 2016 6610327 Oct 29, 2019
Aug
13, 2012
U-1241
U-1241
NC
Aug
13, 2012
U-1241
U-1241
NC
Aug
13, 2012
U-1241
U-1241
NC
Aug
13, 2012
U-1241
U-1241
NC
Aug
13, 2012
U-1241
DP
U-298 U-298 U-298
MOXIFLOXACIN HYDROCHLORIDE - AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER N021277 001 5607942 Mar 04, 2014 U-298 U-298 5849752 Dec 05, 2016 DP U-298 6548079 Jul 25, 2020 MOXIFLOXACIN HYDROCHLORIDE - MOXEZA N022428 001 5607942 Mar 04, 2014 5607942*PED Sep 04, 2014 6716830 Sep 29, 2019 6716830*PED Mar 29, 2020 7671070 Sep 29, 2019 7671070*PED Mar 29, 2020 MOXIFLOXACIN HYDROCHLORIDE - VIGAMOX N021598 001 5607942 Mar 04, 2014 5607942*PED Sep 04, 2014 Sep 29, 2019 6716830 Mar 29, 2020 6716830*PED Sep 29, 2019 7671070 Mar 29, 2020 7671070*PED MUPIROCIN - CENTANY N050788 001 6013657 MUPIROCIN CALCIUM - BACTROBAN N050746 001 6025389
DS
DP DP DP
U-709
NP PED
Nov May
19, 2013 19, 2014
U-709
DS
DP DP
U-709
U-709
Jul
08, 2018
DP
Oct
20, 2014
DP
U-1122
MYCOPHENOLATE MOFETIL - CELLCEPT N050759 001 5688529 Nov
18, 2014
DP
MYCOPHENOLATE MOFETIL HYDROCHLORIDE - CELLCEPT N050758 001 5543408 Sep 15, 2013
DP
ADA 142 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
MYCOPHENOLIC ACID - MYFORTIC N050791 001 6025391 6172107 6306900 MYCOPHENOLIC ACID - MYFORTIC N050791 002 6025391 6172107 6306900
Apr Apr Apr
10, 2017 10, 2017 10, 2017
Apr Apr Apr
10, 2017 10, 2017 10, 2017
DP DP DP
U-908 U-908
NAFTIFINE HYDROCHLORIDE - NAFTIN N019599 002 NALTREXONE - VIVITROL N021897 001 5792477 5916598 6194006 6264987 6331317 6379703 6379704 6395304 6403114 6495164 6495166 6534092 6537586 6596316 6667061 6713090 6939033 7799345 7919499 7919499 NAPROXEN SODIUM - NAPRELAN N020353 001 5637320 NAPROXEN SODIUM - NAPRELAN N020353 002 5637320 NAPROXEN SODIUM - NAPRELAN N020353 003 5637320
NS 02, 02, 30, 19, 12, 30, 19, 12, 02, 25, 12, 19, 12, 30, 25, 12, 12, 25, 15, 15, 2017 2017 2018 2020 2019 2018 2020 2019 2017 2020 2019 2020 2019 2018 2020 2019 2019 2020 2029 2029 DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP U-1123 U-1124
Jan
13, 2015
May May Dec May Nov Dec May Nov May May Nov May Nov Dec May Nov Nov May Oct Oct
I-631
Oct
12, 2013
Jun
10, 2014
Jun
10, 2014
Jun
10, 2014
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE - TREXIMET Aug 14, 2017 N021926 001 6060499 Aug 14, 2017 6586458 Oct 02, 2025 7332183 Aug 14, 2017 8022095 NATEGLINIDE - STARLIX N021204 001 5463116 5488150 6559188 6641841 6844008 6878749 NATEGLINIDE - STARLIX N021204 002 5463116 5488150 6559188 6641841 6844008 6878749
DP DP DP DP
U-867 U-867 U-867 U-867
Oct Jan Sep Nov Nov Sep
21, 30, 15, 14, 14, 15,
2012 2013 2020 2017 2017 2020
DP DP DP DP
U-827 U-214 U-214
Oct Jan Sep Nov Nov Sep
21, 30, 15, 14, 14, 15,
2012 2013 2020 2017 2017 2020
DP DP DP DP
U-827 U-214 U-214
NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 002 5759580 Jun 6545040 Dec
02, 2015 17, 2021
DP DP
NCE U-3
Dec
17, 2012
ADA 143 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
NCE
NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 003 5759580 Jun 6545040 Dec NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 004 5759580 Jun 6545040 Dec NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 005 5759580 Jun 6545040 Dec NEDOCROMIL SODIUM - ALOCRIL N021009 001 RE38628 NELARABINE - ARRANON N021877 001 5424295 5492897 5747472 5747472 5747472 5821236 NELFINAVIR MESYLATE - VIRACEPT N020778 001 5484926 5484926*PED 5952343 5952343*PED 6162812 6162812*PED NELFINAVIR MESYLATE - VIRACEPT N020779 001 5484926 5484926*PED 5952343 5952343*PED 6162812 6162812*PED NELFINAVIR MESYLATE - VIRACEPT N021503 001 5484926 5484926*PED 5952343 5952343*PED 6162812 6162812*PED NEPAFENAC - NEPAFENAC N203491 001 NEPAFENAC - NEVANAC N021862 001 5475034 7834059 8071648 8324281
02, 2015 17, 2021
Dec
17, 2012
U-3
02, 2015 17, 2021
DP DP
NCE U-3
Dec
17, 2012
02, 2015 17, 2021
DP DP
NCE U-3
Dec
17, 2012
Aug
22, 2012
U-304
Jun Feb Feb Feb Feb Feb
13, 20, 20, 20, 20, 20,
2017 2013 2013 2013 2013 2013
DS
DP U-689 U-689 U-696 U-695 U-695
ODE
Oct
28, 2012
Oct Apr Oct Apr Oct Apr
07, 07, 07, 07, 07, 07,
2013 2014 2013 2014 2013 2014
U-257 U-257 U-248 U-248
07, 07, 07, 07, 07, 07,
2013 2014 2013 2014 2013 2014
U-257 U-257 U-248 U-248
07, 07, 07, 07, 07, 07,
2013 2014 2013 2014 2013 2014
U-257 U-257 U-248 U-248
NP Jun Jan Dec Dec 06, 31, 02, 02, 2014 2027 2025 2025 U-100 U-1095 DP DP
Oct
16, 2015
NESIRITIDE RECOMBINANT - NATRECOR May N020920 001 5114923 NEVIRAPINE - VIRAMUNE XR N201152 001 NEVIRAPINE - VIRAMUNE XR N201152 002
19, 2014
DS
DP
U-855
NPP NDF
Nov Mar
08, 2015 25, 2014
NPP NDF
Nov Mar
08, 2015 25, 2014
ADA 144 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-331 U-354 U-450 U-586 DP U-712
EXCLUSIVITY CODE(S)
NIACIN - NIASPAN N020381 001 6080428 6129930 6406715 6746691 6818229 7011848 NIACIN - NIASPAN N020381 002 6080428 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7011848 7998506 7998506 7998506 7998506
May Sep Sep Sep Feb Sep
27, 20, 20, 20, 15, 20,
2017 2013 2013 2013 2014 2013
May May May May May Sep Sep Sep Sep Sep Sep Mar Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 15, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2017 2013 2013 2013 2013 2013 2013 2018 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP DP
DP DP
U-1138 U-331 U-1141 U-1140 U-1139 U-1141 U-1138 U-1140 U-1139 U-354 U-450 U-1144 U-1142 U-1145 U-768 U-1143 U-1146 U-1139 U-548 U-1140 U-1138 U-586 U-712 U-1140 U-1141 U-1147 U-1148 U-1140 U-1138 U-1141 U-1139
ADA 145 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-331 U-1139 U-1140 U-1138 U-1141 U-1141 U-1139 U-1138 U-1140 U-354 U-450 U-1142 U-768 U-1145 U-1144 U-1143 U-1138 U-1139 U-1140 U-1146 U-1141 U-548 U-586 U-1141 U-1140 U-1148 U-1147 U-712 U-1140 U-1138 U-1141 U-1139
EXCLUSIVITY CODE(S)
NIACIN - NIASPAN N020381 003 6080428 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7011848 7998506 7998506 7998506 7998506 NIACIN - NIASPAN N020381 004 6080428 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7011848 7998506 7998506 7998506 7998506
May May May May May Sep Sep Sep Sep Sep Sep Mar Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 15, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2017 2013 2013 2013 2013 2013 2013 2018 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP DP
DP DP
May May May May May Sep Sep Sep Sep Sep Sep Mar Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 15, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2017 2013 2013 2013 2013 2013 2013 2018 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP DP
DP DP
ADA 146 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-331 U-354 U-450 U-586 U-712
EXCLUSIVITY CODE(S)
NIACIN - NIASPAN TITRATION STARTER PACK N020381 005 6080428 May 27, 2017 6129930 Sep 20, 2013 6406715 Sep 20, 2013 6746691 Sep 20, 2013 7011848 Sep 20, 2013 NIACIN; SIMVASTATIN - SIMCOR N022078 001 6080428 6080428 6080428 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506 NIACIN; SIMVASTATIN - SIMCOR N022078 002 6080428 6080428 6080428 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506
May May May Sep Sep Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP
U-1132 U-862 U-1134 U-1132 U-1134 U-862 U-1129 U-1149 U-863 U-1132 U-1134 U-862
DP DP U-862 U-1151 U-1150 U-1151 U-1150
27, 27, 27, 20, 20, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP
U-862 U-1132 U-1134 U-1132 U-1134 U-862 U-1149 U-863 U-1129 U-1134 U-862 U-1132
DP DP U-1151 U-862 U-1150 U-1150 U-1151
ADA 147 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1134 U-1132 U-862 U-1132 U-862 U-1134 U-863 U-1129 U-1149 U-1132 U-1134 U-862 DP DP U-1151 U-862 U-1150 U-1151 U-1150
EXCLUSIVITY CODE(S)
NIACIN; SIMVASTATIN - SIMCOR N022078 003 6080428 6080428 6080428 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506 NIACIN; SIMVASTATIN - SIMCOR N022078 004 6080428 6080428 6080428 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506 NIACIN; SIMVASTATIN - SIMCOR N022078 005 6080428 6080428 6080428 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506
27, 27, 27, 20, 20, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP
May May May Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP
U-1132 U-1134 U-862 U-862 U-1149 U-863 U-1129 U-1134 U-1132 U-862
DP DP U-1150 U-1151 U-862 U-1151 U-1150
May May May Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP
U-1134 U-862 U-1132 U-862 U-1129 U-863 U-1149 U-862 U-1134 U-1132
DP DP U-1150 U-862 U-1151 U-1151 U-1150
NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER N019734 004 7612102 Dec 26, 2027 DP U-1029 7659291 Apr 18, 2027 NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER N019734 003 7612102 Dec 26, 2027 DP U-1029 7659291 Apr 18, 2027
ADA 148 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NICARDIPINE HYDROCHLORIDE - CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER N019734 002 7612102 Dec 26, 2027 DP U-1029 7659291 Apr 18, 2027 NICARDIPINE HYDROCHLORIDE - CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER N019734 005 7612102
DP Dec 26, 2027 Apr 18, 2027 U-1029 7659291
NICOTINE - NICODERM CQ N020165 004 5508038 8075911 NICOTINE - NICODERM CQ N020165 005 5508038 8075911 NICOTINE - NICODERM CQ N020165 006 5508038 8075911 NICOTINE - NICOTROL N020385 001 5656255
Apr May
16, 2013 22, 2021
DP
Apr May
16, 2013 22, 2021
DP
Apr May
16, 2013 22, 2021
DP
Aug
12, 2014
NICOTINE POLACRILEX - NICORETTE Apr N018612 002 8323683 NICOTINE POLACRILEX - NICORETTE Apr N020066 002 8323683
30, 2028
30, 2028
DP
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA N022068 001 7169791 Jul 04, 2023 8163904 Aug 23, 2028
DS DS
DP DP
U-836
I-627 NCE ODE
Jun Oct Oct
17, 2013 29, 2012 29, 2014
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA Jul 04, 2023 N022068 002 7169791 Aug 23, 2028 8163904
DS DS
DP DP
U-836
I-627 NCE ODE
Jun Oct Oct
17, 2014 29, 2012 29, 2014
NISOLDIPINE - SULAR N020356 005 5626874 NISOLDIPINE - SULAR N020356 006 5626874 NISOLDIPINE - SULAR N020356 007 5626874 NISOLDIPINE - SULAR N020356 008 5626874 NITAZOXANIDE - ALINIA N021497 001 5578621 5968961 6020353 NITAZOXANIDE - ALINIA N021498 001 5578621 5965590 5968961 6020353 6117894 NITISINONE - ORFADIN N021232 001 5550165 NITISINONE - ORFADIN N021232 002 5550165
Nov
30, 2014
DP
Nov
30, 2014
DP
Nov
30, 2014
DP
Nov
30, 2014
DP
Nov May Sep
26, 2013 07, 2017 18, 2014
DS
DP DP DP
U-525
Sep Jul May Sep May
08, 03, 07, 08, 07,
2014 2017 2017 2014 2017
U-525 U-523
Aug
27, 2013
Aug
27, 2013
ADA 149 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NITISINONE - ORFADIN N021232 003 5550165 NITRIC OXIDE - INOMAX N020845 002 5485827 5485827*PED 5558083 5558083*PED 5732693 5732693*PED 5752504 5752504*PED 5873359 5873359*PED 8282966 8282966*PED 8291904 8291904*PED 8293284 8293284*PED NITRIC OXIDE - INOMAX N020845 003 5485827 5485827*PED 5558083 5558083*PED 5732693 5732693*PED 5752504 5752504*PED 5873359 5873359*PED 8282966 8282966*PED 8291904 8291904*PED 8293284 8293284*PED
Aug
27, 2013
Jan Jul Nov May Dec Jun Dec Jun Jan Jul Jun Dec Jan Jul Jun Dec
23, 23, 22, 22, 13, 13, 13, 13, 23, 23, 30, 30, 06, 06, 30, 30,
2013 2013 2013 2014 2016 2017 2016 2017 2013 2013 2029 2029 2031 2031 2029 2029
U-297 DP DP DP U-1226 U-1230 U-1230 U-297 U-1286 DP U-1226 U-1286
Jan Jul Nov May Dec Jun Dec Jun Jan Jul Jun Dec Jan Jul Jun Dec
23, 23, 22, 22, 13, 13, 13, 13, 23, 23, 30, 30, 06, 06, 30, 30,
2013 2013 2013 2014 2016 2017 2016 2017 2013 2013 2029 2029 2031 2031 2029 2029
U-297 DP DP DP U-1226 U-1230 U-1230 U-297 U-1286 DP U-1226 U-1286
NITROGLYCERIN - NITROLINGUAL PUMPSPRAY N018705 002 7872049 Mar 14, 2028 NITROGLYCERIN - NITROMIST N021780 001 5869082 NITROGLYCERIN - NITROSTAT N021134 001 6500456 NITROGLYCERIN - NITROSTAT N021134 002 6500456 NITROGLYCERIN - NITROSTAT N021134 003 6500456 NITROGLYCERIN - RECTIV N021359 001 7189761 NIZATIDINE - AXID N021494 001 6930119
DP
U-39
Apr
16, 2016
DP
Sep
16, 2018
Sep
16, 2018
Sep
16, 2018
May
27, 2014
DP
U-1198
NP
Jun
21, 2014
Jul
17, 2022
DP
OCTREOTIDE ACETATE - SANDOSTATIN N019667 001 5753618 May 5753618*PED Nov OCTREOTIDE ACETATE - SANDOSTATIN N019667 002 5753618 May 5753618*PED Nov
19, 2015 19, 2015
19, 2015 19, 2015
ADA 150 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
OCTREOTIDE ACETATE - SANDOSTATIN N019667 003 5753618 May 5753618*PED Nov OCTREOTIDE ACETATE - SANDOSTATIN N019667 004 5753618 May 5753618*PED Nov OCTREOTIDE ACETATE - SANDOSTATIN N019667 005 5753618 May 5753618*PED Nov
19, 2015 19, 2015
19, 2015 19, 2015
19, 2015 19, 2015
OCTREOTIDE ACETATE - SANDOSTATIN LAR N021008 001 5538739 Jul 23, 5538739*PED Jan 23, 5639480 Jun 17, 5639480*PED Dec 17, 5688530 Nov 18, 5688530*PED May 18, 5922338 Jul 13, 5922338*PED Jan 13, 5922682 Jul 13, 5922682*PED Jan 13, OCTREOTIDE ACETATE - SANDOSTATIN LAR N021008 002 5538739 Jul 23, 5538739*PED Jan 23, 5639480 Jun 17, 5639480*PED Dec 17, 5688530 Nov 18, 5688530*PED May 18, 5922338 Jul 13, 5922338*PED Jan 13, 5922682 Jul 13, 5922682*PED Jan 13, OCTREOTIDE ACETATE - SANDOSTATIN LAR N021008 003 5538739 Jul 23, 5538739*PED Jan 23, 5639480 Jun 17, 5639480*PED Dec 17, 5688530 Nov 18, 5688530*PED May 18, Jul 13, 5922338 Jan 13, 5922338*PED Jul 13, 5922682 Jan 13, 5922682*PED OLANZAPINE - ZYPREXA N020592 001 6960577
2013 2014 2014 2014 2014 2015 2016 2017 2016 2017
DP DP U-268 DP DP
2013 2014 2014 2014 2014 2015 2016 2017 2016 2017
DP U-268 DP DP
2013 2014 2014 2014 2014 2015 2016 2017 2016 2017
DP U-268 DP DP
Nov
01, 2017
U-963
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
OLANZAPINE - ZYPREXA N020592 002 6960577
Nov
01, 2017
U-963
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
Nov
01, 2017
U-963
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
ADA 151 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-963
EXCLUSIVITY CODE(S)
NPP NPP PED PED
Nov
01, 2017
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
Nov
01, 2017
U-963
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
Nov
01, 2017
U-963
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
OLANZAPINE - ZYPREXA ZYDIS N021086 001 6960577
Nov
01, 2017
U-964
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
Nov
01, 2017
U-964
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
Nov
01, 2017
U-964
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
Nov
01, 2017
U-964
NPP NPP PED PED
Dec Dec Jun Jun
04, 04, 04, 04,
2012 2012 2013 2013
OLANZAPINE PAMOATE - ZYPREXA RELPREVV N022173 001 6169084 Sep 30, 2018 OLANZAPINE PAMOATE - ZYPREXA RELPREVV N022173 002 6169084 Sep 30, 2018 OLANZAPINE PAMOATE - ZYPREXA RELPREVV N022173 003 6169084 Sep 30, 2018 OLMESARTAN MEDOXOMIL - BENICAR N021286 001 5616599 5616599*PED 6878703 6878703*PED OLMESARTAN MEDOXOMIL - BENICAR N021286 003 5616599 5616599*PED 6878703 6878703*PED
DS
DP
U-1026
NP
Dec
11, 2012
DS
DP
U-1026
NP
Dec
11, 2012
DS
DP
U-1026
NP
Dec
11, 2012
Apr Oct Nov May
25, 25, 19, 19,
2016 2016 2021 2022
DS
DP
U-500 U-3 Y
NPP PED
Feb Aug
04, 2013 04, 2013
Apr Oct Nov May
25, 25, 19, 19,
2016 2016 2021 2022
DS
DP
U-500 U-3 Y
NPP PED
Feb Aug
04, 2013 04, 2013
ADA 152 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-500 U-3
EXCLUSIVITY CODE(S)
NPP PED
OLMESARTAN MEDOXOMIL - BENICAR N021286 004 5616599 5616599*PED 6878703 6878703*PED
Apr Oct Nov May
25, 25, 19, 19,
2016 2016 2021 2022
Feb Aug
04, 2013 04, 2013
OLOPATADINE HYDROCHLORIDE - PATADAY N021545 001 5641805 Jun 06, 2015 5641805*PED Dec 06, 2015 6995186 Nov 12, 2023 6995186*PED May 12, 2024 7402609 Jun 19, 2022 7402609*PED Dec 19, 2022 OLOPATADINE HYDROCHLORIDE - PATANASE N021861 001 7977376 Feb 02, 2023 7977376*PED Aug 02, 2023 OLOPATADINE HYDROCHLORIDE - PATANOL N020688 001 5641805 Jun 06, 2015 5641805*PED Dec 06, 2015 OMACETAXINE MEPESUCCINATE - SYNRIBO N203585 001 6987103 Jun 28, 2023 7842687 Mar 16, 2019 OMEGA-3-ACID ETHYL ESTERS - LOVAZA N021654 001 5502077 Mar 5656667 Apr 7732488 Jan OMEPRAZOLE - PRILOSEC N019810 001 6147103 6147103*PED 6150380 6150380*PED 6166213 6166213*PED 6191148 6191148*PED OMEPRAZOLE - PRILOSEC N019810 002 6147103 6147103*PED 6150380 6150380*PED 6166213 6166213*PED 6191148 6191148*PED OMEPRAZOLE - PRILOSEC N019810 003 6147103 6147103*PED 6150380 6150380*PED 6166213 6166213*PED 6191148 6191148*PED
U-765 DP DP U-765
DP DP
NPP PED U-184
Dec Jun
01, 2012 01, 2013
DS
DP
U-1300 U-1299
NCE ODE
Oct Oct
26, 2017 26, 2019
26, 2013 10, 2017 30, 2025
DS DS DS
DP DP
U-822 U-822
M-87
Sep
16, 2012
Oct Apr Nov May Oct Apr Oct Apr
09, 09, 10, 10, 09, 09, 09, 09,
2018 2019 2018 2019 2018 2019 2018 2019
09, 09, 10, 10, 09, 09, 09, 09,
2018 2019 2018 2019 2018 2019 2018 2019
09, 09, 10, 10, 09, 09, 09, 09,
2018 2019 2018 2019 2018 2019 2018 2019
OMEPRAZOLE MAGNESIUM - PRILOSEC N022056 001 5690960 Nov 5900424 May 6428810 Nov OMEPRAZOLE MAGNESIUM - PRILOSEC N022056 002 5690960 Nov 5900424 May Nov 6428810
25, 2014 04, 2016 03, 2019
DP DS DP
U-864 U-864 U-864
25, 2014 04, 2016 03, 2019
DP DS DP
U-864 U-864 U-864
ADA 153 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
OMEPRAZOLE MAGNESIUM - PRILOSEC OTC Nov N021229 001 5690960 Jun 5753265 Oct 5817338 May 5900424 Nov 6403616 Nov 6428810 OMEPRAZOLE; SODIUM BICARBONATE N021636 001 5840737 6489346 6645988 6699885 6780882 7399772 OMEPRAZOLE; SODIUM BICARBONATE N021636 002 5840737 5840737 6489346 6489346 6645988 6699885 6699885 6780882 7399772 7399772 OMEPRAZOLE; SODIUM BICARBONATE N021849 001 6489346 6645988 6699885 7399772 OMEPRAZOLE; SODIUM BICARBONATE N021849 002 6489346 6645988 6699885 7399772 OMEPRAZOLE; SODIUM BICARBONATE N022281 001 6489346 6645988 6699885 7399772 ONDANSETRON - ZOFRAN ODT N020781 001 5955488 5955488*PED 6063802 6063802*PED ONDANSETRON - ZOFRAN ODT N020781 002 5955488 5955488*PED 6063802 6063802*PED
25, 07, 06, 04, 15, 03,
2014 2015 2015 2016 2019 2019
- ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID OTC Jul 15, 2016 Jul 15, 2016 Jul 15, 2016 Jul 15, 2016
DS DS DS
DP DP DP
U-588 U-588 U-588 U-588
DS DS DS
DP DP DP
U-623 U-624 U-624 U-623 U-623 U-624
DS
DP U-624 U-623
DS DS
DP DP
U-588 U-588 U-588
DS DS
DP DP
U-623 U-623 U-623
DP DP DP
U-1025
U-1025
Nov May Nov May
14, 14, 14, 14,
2015 2016 2015 2016
Nov May Nov May
14, 14, 14, 14,
2015 2016 2015 2016
ONDANSETRON HYDROCHLORIDE - ZOFRAN Nov N020605 001 5854270 May 5854270*PED ORLISTAT - ALLI N021887 001 6004996 ORLISTAT - XENICAL N020766 001 6004996 6004996*PED
20, 2015 20, 2016
DP
U-44
Jan
06, 2018
DP
Jan Jul
06, 2018 06, 2018
ADA 154 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP DP U-1113
EXCLUSIVITY CODE(S)
M-90
OSELTAMIVIR PHOSPHATE - TAMIFLU Dec N021087 001 5763483 Jun 5763483*PED Feb 5866601 Aug 5866601*PED Feb 5952375 Aug 5952375*PED OSELTAMIVIR PHOSPHATE - TAMIFLU Dec N021087 002 5763483 Jun 5763483*PED Feb 5866601 Aug 5866601*PED Feb 5952375 Aug 5952375*PED OSELTAMIVIR PHOSPHATE - TAMIFLU Dec N021087 003 5763483 Jun 5763483*PED Feb 5866601 Aug 5866601*PED Feb 5952375 Aug 5952375*PED OSELTAMIVIR PHOSPHATE - TAMIFLU N021246 001 5763483 Dec 5763483 Dec 5763483*PED Jun 5866601 Feb 5866601*PED Aug Feb 5952375 Aug 5952375*PED OSELTAMIVIR PHOSPHATE - TAMIFLU N021246 002 5763483 Dec 5763483*PED Jun 5866601 Feb 5866601*PED Aug Feb 5952375 Aug 5952375*PED OXALIPLATIN - ELOXATIN N021492 001 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED OXALIPLATIN - ELOXATIN N021492 002 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED OXALIPLATIN - ELOXATIN N021759 001 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED 5716988 5716988*PED
27, 27, 02, 02, 27, 27,
2016 2017 2016 2016 2015 2015
Feb
22, 2013
27, 27, 02, 02, 27, 27,
2016 2017 2016 2016 2015 2015
DS DS DS DP DP
U-1113
M-90
Feb
22, 2013
27, 27, 02, 02, 27, 27,
2016 2017 2016 2016 2015 2015
DS DS DS DP DP
U-1113
27, 27, 27, 02, 02, 27, 27,
2016 2016 2017 2016 2016 2015 2015
DS DS DS DS DP DP
U-376 U-1113
M-90
Feb
22, 2013
27, 27, 02, 02, 27, 27,
2016 2017 2016 2016 2015 2015
DS DS DS
DP DP DP
U-1113
Jan Jul Apr Oct Aug Feb
12, 12, 07, 07, 09, 09,
2013 2013 2013 2013 2016 2017
DS DS DS
Jan Jul Apr Oct Aug Feb
12, 12, 07, 07, 09, 09,
2013 2013 2013 2013 2016 2017
DS DS DS
Jan Jul Apr Oct Aug Feb Aug Feb
12, 12, 07, 07, 09, 09, 07, 07,
2013 2013 2013 2013 2016 2017 2015 2016
DS DS DS DP
ADA 155 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP
EXCLUSIVITY CODE(S)
OXALIPLATIN - ELOXATIN N021759 002 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED 5716988 5716988*PED OXALIPLATIN - ELOXATIN N021759 003 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED 5716988 5716988*PED OXANDROLONE - OXANDRIN N013718 001 5872147 6090799 6576659 6670351 6828313 OXANDROLONE - OXANDRIN N013718 002 5872147 6090799 6576659 6670351 6828313 OXCARBAZEPINE - OXTELLAR XR N202810 001 7722898 7910131 OXCARBAZEPINE - OXTELLAR XR N202810 002 7722898 7910131 OXCARBAZEPINE - OXTELLAR XR N202810 003 7722898 7910131 OXCARBAZEPINE - TRILEPTAL N021014 001 7037525 7037525*PED OXCARBAZEPINE - TRILEPTAL N021014 002 7037525 7037525*PED OXCARBAZEPINE - TRILEPTAL N021014 003 7037525 7037525*PED OXCARBAZEPINE - TRILEPTAL N021285 001 7037525 7037525*PED 8119148 8119148*PED OXYBUTYNIN - ANTUROL N202513 001 7029694 7179483 7198801 8241662
12, 12, 07, 07, 09, 09, 07, 07,
2013 2013 2013 2013 2016 2017 2015 2016
12, 12, 07, 07, 09, 09, 07, 07,
2013 2013 2013 2013 2016 2017 2015 2016
DS DS DS DP
Dec Jul Dec Oct Dec
05, 18, 05, 20, 05,
2017 2017 2017 2012 2017
U-585 U-585 U-585 U-585 U-585
Dec Jul Dec Oct Dec
05, 18, 05, 20, 05,
2017 2017 2017 2012 2017
U-585 U-585 U-585 U-585 U-585
Apr Apr
13, 2027 13, 2027
DP U-1298
NDF
Oct
19, 2015
Apr Apr
13, 2027 13, 2027
DP U-1298
NDF
Oct
19, 2015
Apr Apr
13, 2027 13, 2027
DP U-1298
NDF
Oct
19, 2015
Feb Aug
12, 2018 12, 2018
U-724
Feb Aug
12, 2018 12, 2018
U-724
Feb Aug
12, 2018 12, 2018
U-724
Feb Aug Dec Jun
12, 12, 19, 19,
2018 2018 2020 2021
U-724 DP U-724
Apr Apr Jun Apr
26, 26, 25, 26,
2020 2020 2022 2020
DP DP
U-318 U-318 U-318
NP
Dec
07, 2014
ADA 156 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
OXYBUTYNIN - OXYTROL N021351 002 5601839 5834010 6743441 7081249 7081250 7081251 7081252 7179483 OXYBUTYNIN CHLORIDE - DITROPAN N020897 001 5674895 5674895*PED 5840754 5840754*PED 5912268 5912268*PED 6262115 6262115*PED OXYBUTYNIN CHLORIDE - DITROPAN N020897 002 5674895 5674895*PED 5840754 5840754*PED 5912268 5912268*PED 6262115 6262115*PED OXYBUTYNIN CHLORIDE - DITROPAN N020897 003 5674895 5674895*PED 5840754 5840754*PED 5912268 5912268*PED 6262115 6262115*PED
Apr Apr Apr Apr Apr Apr Apr Apr XL May Nov May Nov May Nov May Nov XL May Nov May Nov May Nov May Nov XL May Nov May Nov May Nov May Nov
26, 26, 26, 26, 26, 26, 26, 26,
2015 2015 2020 2020 2020 2020 2020 2020
DS
DP DP DP DP DP DP
U-318 U-318 U-318 U-318 U-318 U-318
22, 22, 22, 22, 22, 22, 22, 22,
2015 2015 2015 2015 2015 2015 2015 2015
U-393 U-393
22, 22, 22, 22, 22, 22, 22, 22,
2015 2015 2015 2015 2015 2015 2015 2015
U-393 U-393
22, 22, 22, 22, 22, 22, 22, 22,
2015 2015 2015 2015 2015 2015 2015 2015
U-393 U-393
OXYBUTYNIN CHLORIDE - GELNIQUE N022204 001 7029694 Apr 7179483 Apr 8241662 Apr OXYCODONE HYDROCHLORIDE - OXECTA N202080 001 7201920 Mar 7510726 Nov 7981439 Nov OXYCODONE HYDROCHLORIDE - OXECTA N202080 002 7201920 Mar 7510726 Nov 7981439 Nov
26, 2020 26, 2020 26, 2020
DP
U-318 U-318 U-318
16, 2025 26, 2023 26, 2023
DP DP DP
16, 2025 26, 2023 26, 2023
DP DP DP
OXYCODONE HYDROCHLORIDE - OXYCONTIN N020553 001 5508042 Apr 16, 2013 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN N020553 002 5508042 Apr 16, 2013 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025
U-443 DP DS DS
U-443 DP DS DS
ADA 157 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-443 DP DS DS
EXCLUSIVITY CODE(S)
OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 003 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 004 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 005 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 006 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 007 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 008 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 001 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 Oct 10, 2024 8114383 Nov 20, 2023 8309060 Aug 06, 2022 8337888 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 002 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 Oct 10, 2024 8114383 Nov 20, 2023 8309060 Aug 06, 2022 8337888 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N022272 003 5508042 Jun 24, 2017 6488963 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Apr 19, 2025 7776314 Oct 10, 2024 8114383 Nov 20, 2023 8309060 Aug 06, 2022 8337888
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DP DS DS DP DP DP DP
U-443
U-443
U-443
ADA 158 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 004 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 8114383 Oct 10, 2024 8309060 Nov 20, 2023 8337888 Aug 06, 2022 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 005 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 8114383 Oct 10, 2024 8309060 Nov 20, 2023 8337888 Aug 06, 2022 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 006 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 8114383 Oct 10, 2024 8309060 Nov 20, 2023 8337888 Aug 06, 2022 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 007 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 8114383 Oct 10, 2024 8309060 Nov 20, 2023 8337888 Aug 06, 2022 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 001 5662933 Sep 09, 2013 5958456 Sep 09, 2013 7276250 Feb 04, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 002 5662933 Sep 09, 2013 5958456 Sep 09, 2013 7276250 Feb 04, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 003 5662933 Sep 09, 2013 5958456 Sep 09, 2013 7276250 Feb 04, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 004 5662933 Sep 09, 2013 5958456 Sep 09, 2013 7276250 Feb 04, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 005 5662933 Sep 09, 2013 5958456 Sep 09, 2013 Feb 04, 2023 7276250
U-443
U-443
U-443
U-443
DP DP DP
U-826
DP DP DP
U-826
DP DP DP
U-826
DP DP DP
U-826
DP DP DP
U-826
ADA 159 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
OXYMORPHONE HYDROCHLORIDE - OPANA ER Sep 09, 2013 N021610 006 5662933 Sep 09, 2013 5958456 Feb 04, 2023 7276250 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 007 5662933 Sep 09, 2013 Sep 09, 2013 5958456 Feb 04, 2023 7276250 OXYMORPHONE HYDROCHLORIDE - OPANA ER Jul 10, N201655 001 7851482 Nov 20, 8075872 Aug 08, 8114383 Sep 15, 8192722 Nov 20, 8309060 Feb 04, 8309122 Feb 04, 8329216 OXYMORPHONE HYDROCHLORIDE - OPANA ER Jul 10, N201655 002 7851482 Nov 20, 8075872 Aug 08, 8114383 Sep 15, 8192722 Nov 20, 8309060 Feb 04, 8309122 Feb 04, 8329216 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 003 7851482 Jul 10, 8075872 Nov 20, 8114383 Aug 08, Sep 15, 8192722 Nov 20, 8309060 Feb 04, 8309122 Feb 04, 8329216 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 004 7851482 Jul 10, 8075872 Nov 20, 8114383 Aug 08, Sep 15, 8192722 Nov 20, 8309060 Feb 04, 8309122 Feb 04, 8329216 OXYMORPHONE HYDROCHLORIDE - OPANA ER Jul 10, N201655 005 7851482 Nov 20, 8075872 Aug 08, 8114383 Sep 15, 8192722 Nov 20, 8309060 Feb 04, 8309122 Feb 04, 8329216 OXYMORPHONE HYDROCHLORIDE - OPANA ER Jul 10, N201655 006 7851482 Nov 20, 8075872 Aug 08, 8114383 Sep 15, 8192722 Nov 20, 8309060 Feb 04, 8309122 Feb 04, 8329216
U-826
DP DP DP
U-826
2029 2023 2024 2025 2023 2023 2023
DS DP DP DP DP DP DP
2029 2023 2024 2025 2023 2023 2023
2029 2023 2024 2025 2023 2023 2023
2029 2023 2024 2025 2023 2023 2023
2029 2023 2024 2025 2023 2023 2023
2029 2023 2024 2025 2023 2023 2023
ADA 160 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 007 7851482 Jul 10, 8075872 Nov 20, 8114383 Aug 08, 8192722 Sep 15, 8309060 Nov 20, 8309122 Feb 04, 8329216 Feb 04,
2029 2023 2024 2025 2023 2023 2023
OXYMORPHONE HYDROCHLORIDE - OXYMORPHONE HYDROCHLORIDE A079087 001 OXYMORPHONE HYDROCHLORIDE - OXYMORPHONE HYDROCHLORIDE A079087 003 OXYMORPHONE HYDROCHLORIDE - OXYMORPHONE HYDROCHLORIDE A079087 005 OXYMORPHONE HYDROCHLORIDE - OXYMORPHONE HYDROCHLORIDE A079087 007 PACLITAXEL - ABRAXANE N021660 001 5439686 5439686 5498421 5498421 5498421 6096331 6096331 6096331 6506405 6506405 6506405 6537579 6537579 6537579 6749868 6753006 7820788 7820788 7923536 7923536 8034375 8138229 8138229 8268348 8314156 RE41884 RE41884 PALIPERIDONE - INVEGA N021999 001 Feb Feb Mar Mar Mar Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Mar Mar Dec Dec Aug Dec Dec Feb Dec Aug Aug 22, 22, 12, 12, 12, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 03, 03, 09, 09, 13, 09, 09, 21, 09, 14, 14, 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2024 2024 2023 2023 2026 2023 2023 2026 2023 2016 2016 DP DP DP DP DP DP DP DP DP DP DP U-1290 U-1092 U-634 U-1092 U-1290 U-1290 U-1092 U-633 U-633 U-1092 U-1290 U-1290 U-632 U-1092
PC
Jul
07, 2013
PC
Jul
07, 2013
PC
Jul
02, 2013
PC
Jul
07, 2013
I-658
Oct
11, 2015
DP DP DP DP
DP DP
U-1290 U-1092 U-1117 U-1290 U-1290 U-1092 U-1290 U-1290 U-1290 U-1290 U-1117
I-605 I-606 NPP PED PED PED
Jul Jul Apr Oct Jan Jan
31, 31, 06, 06, 31, 31,
2012 2012 2014 2014 2013 2013
PALIPERIDONE - INVEGA N021999 002
31, 31, 06, 06, 31, 31,
2012 2012 2014 2014 2013 2013
ADA 161 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PALIPERIDONE - INVEGA N021999 003
31, 31, 06, 06, 31, 31,
2012 2012 2014 2014 2013 2013
PALIPERIDONE - INVEGA N021999 004 PALIPERIDONE - INVEGA N021999 006
NPP PED
Apr Oct
06, 2014 06, 2014
I-605 I-606 NPP PED PED PED DS DP DP DP DP U-543 U-543 U-543
31, 31, 06, 06, 31, 31,
2012 2012 2014 2014 2013 2013
PALIPERIDONE PALMITATE - INVEGA SUSTENNA N022264 001 5254556 Oct 15, 2013 5254556*PED Apr 15, 2014 5352459 Dec 16, 2012 5352459*PED Jun 16, 2013 6077843 May 12, 2017 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 15, 2013 N022264 002 5254556 Apr 15, 2014 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 15, 2013 N022264 003 5254556 Apr 15, 2014 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 15, 2013 N022264 004 5254556 Apr 15, 2014 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED
M-119 NDF PED
Aug Jul Jan
29, 2015 31, 2012 31, 2013
DS
DP DP DP DP
U-543
M-119 NDF PED
Aug Jul Jan
29, 2015 31, 2012 31, 2013
U-543 U-543
DS
DP DP DP DP
U-543
M-119 NDF PED
Aug Jul Jan
29, 2015 31, 2012 31, 2013
U-543 U-543
DS
DP DP DP DP
U-543
M-119 NDF PED
Aug Jul Jan
29, 2015 31, 2012 31, 2013
U-543 U-543
ADA 162 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP DP U-543 U-543 U-543
EXCLUSIVITY CODE(S)
M-119 NDF PED
PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 15, 2013 N022264 005 5254556 Apr 15, 2014 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALONOSETRON HYDROCHLORIDE - ALOXI N021372 001 5202333 Apr 7947724 Jan 7947725 Jan 7960424 Jan PALONOSETRON HYDROCHLORIDE - ALOXI Apr N021372 002 5202333 Jan 7947724 Jan 7947725 Jan 7960424 PALONOSETRON HYDROCHLORIDE - ALOXI N022233 001 5202333 Apr
Aug Jul Jan
29, 2015 31, 2012 31, 2013
13, 30, 30, 30,
2015 2024 2024 2024
DS
DP DP DP DP
U-528
13, 30, 30, 30,
2015 2024 2024 2024
DS
DP DP DP DP
U-901
13, 2015
DS
DP
U-528
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - CREON N020725 001
I-625 M-93 NCE
Apr Jul Apr
30, 2013 29, 2013 30, 2014
I-625 M-93 NCE
Apr Jul Apr
30, 2013 29, 2013 30, 2014
I-625 M-93 NCE
Apr Jul Apr
30, 2013 29, 2013 30, 2014
I-625 M-93 NCE
Apr Jul Apr
30, 2013 29, 2019 30, 2014
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 001 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 002 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 003 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 004 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PERTZYE N022175 001 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PERTZYE N022175 002 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ULTRESA N022222 001 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ULTRESA N022222 002
NCE
Apr
12, 2015
NCE
Apr
12, 2015
NCE
Apr
12, 2015
NCE
Apr
12, 2015
NCE
May
17, 2017
NCE
May
17, 2017
NCE
Mar
01, 2017
NCE
Mar
01, 2017
ADA 163 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NCE
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ULTRESA N022222 003 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - VIOKACE N022542 001 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - VIOKACE N022542 002 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 001 7658918 Feb 20, 2028 8221747 Feb 20, 2028 8246950 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 002 7658918 Feb 20, 2028 8221747 Feb 20, 2028 8246950 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 003 7658918 Feb 20, 2028 8221747 Feb 20, 2028 8246950 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 004 7658918 Feb 20, 2028 8221747 Feb 20, 2028 8246950 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 005 8221747 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 006 8221747 Feb 20, 2028 PANTOPRAZOLE SODIUM - PROTONIX N020987 001 5997903 Dec 5997903*PED Jun
Mar
01, 2017
NCE
Mar
01, 2017
NCE DP DP U-1274
Mar
01, 2017
NCE
Aug
27, 2014
DP DP U-1274
NCE
Aug
27, 2014
DP DP U-1274
NCE
Aug
27, 2014
DP DP U-1274
NCE
Aug
27, 2014
DP
NCE
Aug
27, 2014
DP
NCE
Aug
27, 2014
07, 2016 07, 2017
I-614 M-54 PED PED
Nov Nov May May
12, 12, 12, 12,
2012 2012 2013 2013
PANTOPRAZOLE SODIUM - PROTONIX N020987 002 5997903 Dec 5997903*PED Jun
07, 2016 07, 2017
I-614 M-54 PED PED DP U-859 U-859 DP U-859
Nov Nov May May
12, 12, 12, 12,
2012 2012 2013 2013
PANTOPRAZOLE SODIUM - PROTONIX N022020 001 7544370 7544370*PED 7550153 7550153*PED 7553498 7553498*PED 7838027 7838027*PED PANTOPRAZOLE SODIUM - PROTONIX N020988 001 6780881 6780881*PED 7351723 7351723*PED
Jun Dec Sep Mar Sep Mar Sep Mar IV Nov May Nov May
07, 07, 30, 30, 30, 30, 30, 30,
2026 2026 2024 2025 2024 2025 2024 2025
I-614 M-54 PED PED
Nov Nov May May
12, 12, 12, 12,
2012 2012 2013 2013
17, 17, 17, 17,
2021 2022 2021 2022
DP DP
ADA 164 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PARICALCITOL - ZEMPLAR N020819 001 5246925*PED 5587497 5587497*PED 5597815 5597815*PED 6136799 6136799*PED 6361758 6361758*PED PARICALCITOL - ZEMPLAR N020819 002 5246925*PED 5587497 5587497*PED 5597815 5597815*PED 6136799 6136799*PED 6361758 6361758*PED PARICALCITOL - ZEMPLAR N021606 001 5246925*PED 5587497 5587497*PED 5597815 5597815*PED PARICALCITOL - ZEMPLAR N021606 002 5246925*PED 5587497 5587497*PED 5597815 5597815*PED PARICALCITOL - ZEMPLAR N021606 003 5246925*PED 5587497 5587497*PED 5597815 5597815*PED
Oct Dec Jun Jul Jan Apr Oct Apr Oct
17, 24, 24, 13, 13, 08, 08, 08, 08,
2012 2013 2014 2015 2016 2018 2018 2018 2018
U-1195
DP
Oct Dec Jun Jul Jan Apr Oct Apr Oct
17, 24, 24, 13, 13, 08, 08, 08, 08,
2012 2013 2014 2015 2016 2018 2018 2018 2018
U-1195
DP
Oct Dec Jun Jul Jan
17, 24, 24, 13, 13,
2012 2013 2014 2015 2016
DS U-1195
Oct Dec Jun Jul Jan
17, 24, 24, 13, 13,
2012 2013 2014 2015 2016
DS U-1195
Oct Dec Jun Jul Jan
17, 24, 24, 13, 13,
2012 2013 2014 2015 2016
DS U-1195
PAROXETINE HYDROCHLORIDE - PAXIL May N020031 001 5872132 Nov 5872132*PED May 5900423 Nov 5900423*PED Dec 6113944 Jun 6113944*PED Mar 6121291 Mar 6121291 Sep 6121291*PED Sep 6121291*PED May 6133289 Nov 6133289*PED PAROXETINE HYDROCHLORIDE - PAXIL N020031 002 5872132 May Nov 5872132*PED May 5900423 Nov 5900423*PED Dec 6113944 Jun 6113944*PED Mar 6121291 Mar 6121291 Sep 6121291*PED Sep 6121291*PED May 6133289 Nov 6133289*PED
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
U-286 U-431 U-431 U-286 U-358 U-358
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
U-286 U-431 U-286 U-431 U-358 U-358
ADA 165 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PAROXETINE HYDROCHLORIDE - PAXIL N020031 003 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020031 004 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020031 005 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020710 001 5811436 Sep 5811436*PED Mar 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
U-286 U-431 U-286 U-431 U-358 U-358
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
U-286 U-431 U-286 U-431 U-358 U-358
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
U-286 U-431 U-431 U-286 U-358 U-358
22, 22, 19, 19, 19, 19, 17, 17, 17, 17, 19, 19,
2015 2016 2015 2015 2015 2015 2017 2017 2017 2017 2015 2015
U-431 U-286 U-286 U-431 U-358 U-358
ADA 166 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PAROXETINE HYDROCHLORIDE - PAXIL N020885 001 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6063927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul PAROXETINE HYDROCHLORIDE - PAXIL N020885 002 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6063927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul PAROXETINE HYDROCHLORIDE - PAXIL N020885 003 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6063927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
U-431 U-286 U-286 U-431 U-358 U-358
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
U-431 U-286 U-431 U-286 U-358 U-358
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
U-286 U-431 U-431 U-286 U-358 U-358
ADA 167 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PAROXETINE HYDROCHLORIDE - PAXIL N020885 004 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6063927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul PAROXETINE HYDROCHLORIDE - PAXIL CR N020936 001 5422123*PED Dec 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6121291 Mar 6121291*PED Sep 6133289 May 6133289*PED Nov 6548084 Jul 6548084*PED Jan 7229640 Jul 7229640*PED Jan PAROXETINE HYDROCHLORIDE - PAXIL CR N020936 002 5422123*PED Dec 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6121291 Mar 6121291*PED Sep 6133289 May 6133289*PED Nov 6548084 Jul 6548084*PED Jan 7229640 Jul 7229640*PED Jan PAROXETINE HYDROCHLORIDE - PAXIL CR N020936 003 5422123*PED Dec 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6121291 Mar 6121291*PED Sep 6133289 May 6133289*PED Nov 6548084 Jul 6548084*PED Jan 7229640 Jul 7229640*PED Jan PAROXETINE MESYLATE - PEXEVA N021299 001 5874447 5874447 5874447
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
U-286 U-431 U-286 U-431 U-358 U-358
06, 19, 19, 19, 19, 17, 17, 19, 19, 19, 19, 19, 19,
2012 2015 2015 2015 2015 2017 2017 2015 2015 2016 2017 2016 2017
U-286 U-286 U-286 U-286
DP
U-816
06, 19, 19, 19, 19, 17, 17, 19, 19, 19, 19, 19, 19,
2012 2015 2015 2015 2015 2017 2017 2015 2015 2016 2017 2016 2017
U-286 U-286 U-286 U-286
DP
U-816
06, 19, 19, 19, 19, 17, 17, 19, 19, 19, 19, 19, 19,
2012 2015 2015 2015 2015 2017 2017 2015 2015 2016 2017 2016 2017
U-286 U-286 U-286 U-286
DP
U-816
Jun Jun Jun
10, 2017 10, 2017 10, 2017
U-46 U-518 U-286
ADA 168 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-518 U-46 U-286
EXCLUSIVITY CODE(S)
PAROXETINE MESYLATE - PEXEVA N021299 002 5874447 5874447 5874447 PAROXETINE MESYLATE - PEXEVA N021299 003 5874447 5874447 5874447 PAROXETINE MESYLATE - PEXEVA N021299 004 5874447 5874447 5874447
Jun Jun Jun
10, 2017 10, 2017 10, 2017
Jun Jun Jun
10, 2017 10, 2017 10, 2017
U-286 U-46 U-518
Jun Jun Jun
10, 2017 10, 2017 10, 2017
U-46 U-286 U-518
PASIREOTIDE DIASPARTATE - SIGNIFOR N200677 001 6225284 Jun 7473761 Jul 8299209 Dec PASIREOTIDE DIASPARTATE - SIGNIFOR N200677 002 6225284 Jun 7473761 Jul 8299209 Dec PASIREOTIDE DIASPARTATE - SIGNIFOR N200677 003 6225284 Jun 7473761 Jul 8299209 Dec PAZOPANIB HYDROCHLORIDE - VOTRIENT N022465 001 7105530 Oct 7262203 Dec 8114885 Dec PAZOPANIB HYDROCHLORIDE - VOTRIENT N022465 002 7105530 Oct 7262203 Dec 8114885 Dec PEGAPTANIB SODIUM - MACUGEN N021756 001 5919455 5932462 6011020 6051698 6113906
28, 2016 29, 2025 27, 2025
DS DS DS
DP DP DP
NCE ODE
Dec Dec
14, 2017 14, 2019
28, 2016 29, 2025 27, 2025
DS DS DS
DP DP DP
NCE ODE
Dec Dec
14, 2017 14, 2019
28, 2016 29, 2025 27, 2025
DS DS DS
DP DP DP
NCE ODE
Dec Dec
14, 2017 14, 2019
19, 2023 19, 2021 19, 2021
DS DS DS
DP DP DP
I-649 NCE ODE
Apr Oct Apr
26, 2015 19, 2014 26, 2019
19, 2023 19, 2021 19, 2021
DS DS DS
DP DP DP
I-649 NCE ODE
Apr Oct Apr
26, 2015 19, 2014 26, 2019
Oct Aug Jan May Oct
27, 03, 04, 19, 27,
2013 2016 2017 2015 2013
DS DS DS DS DS
U-622
PEGINESATIDE ACETATE - OMONTYS N202799 007 7084245 May 7414105 May 7528104 May 7550433 Jun 7919118 May 7919461 Jun PEGINESATIDE ACETATE - OMONTYS N202799 008 7084245 May 7414105 May 7528104 May 7550433 Jun 7919118 May 7919461 Jun
12, 12, 12, 02, 12, 02,
2024 2024 2024 2026 2024 2026
DS DS DS DS
DP DP DP DP
U-1238 U-1238 U-1238 U-1238
12, 12, 12, 02, 12, 02,
2024 2024 2024 2026 2024 2026
DS DS DS DS
DP DP DP DP
U-1238 U-1238 U-1238 U-1238
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE N202799 001 7084245 May 12, 2024 DS 7414105 May 12, 2024 DS DS 7528104 May 12, 2024 7550433 Jun 02, 2026 DS 7919118 May 12, 2024 7919461 Jun 02, 2026
DP DP DP DP
U-1238 U-1238 U-1238 U-1238
NCE
Mar
27, 2017
ADA 169 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP U-1238 U-1238 U-1238 U-1238
EXCLUSIVITY CODE(S)
NCE
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE N202799 002 7084245 May 12, 2024 DS DS 7414105 May 12, 2024 DS 7528104 May 12, 2024 7550433 Jun 02, 2026 7919118 May 12, 2024 DS 7919461 Jun 02, 2026 PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE N202799 003 7084245 May 12, 2024 DS 7414105 May 12, 2024 DS DS 7528104 May 12, 2024 7550433 Jun 02, 2026 DS 7919118 May 12, 2024 7919461 Jun 02, 2026 PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE N202799 004 7084245 May 12, 2024 DS DS 7414105 May 12, 2024 7528104 May 12, 2024 DS 7550433 Jun 02, 2026 DS 7919118 May 12, 2024 7919461 Jun 02, 2026 PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE N202799 005 7084245 May 12, 2024 DS DS 7414105 May 12, 2024 DS 7528104 May 12, 2024 7550433 Jun 02, 2026 7919118 May 12, 2024 DS 7919461 Jun 02, 2026 PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE N202799 006 7084245 May 12, 2024 DS DS 7414105 May 12, 2024 DS 7528104 May 12, 2024 7550433 Jun 02, 2026 DS 7919118 May 12, 2024 7919461 Jun 02, 2026 PEGVISOMANT - SOMAVERT N021106 001 5849535 6057292 PEGVISOMANT - SOMAVERT N021106 002 5849535 6057292 PEGVISOMANT - SOMAVERT N021106 003 5849535 6057292 PEMETREXED DISODIUM - ALIMTA N021462 001 5344932 5344932*PED 7772209 7772209 7772209*PED PEMETREXED DISODIUM - ALIMTA N021462 002 5344932 5344932*PED 7772209 7772209*PED
Mar
27, 2017
DP DP DP DP
U-1238 U-1238 U-1238 U-1238
NCE
Mar
27, 2017
DP DP DP DP
U-1238 U-1238 U-1238 U-1238
NCE
Mar
27, 2017
DP DP DP DP
U-1238 U-1238 U-1238 U-1238
NCE
Mar
27, 2017
DP DP DP DP
U-1238 U-1238 U-1238 U-1238
NCE
Mar
27, 2017
Mar Sep
25, 2017 21, 2015
DS U-507
Mar Sep
25, 2017 21, 2015
DS U-507
Mar Sep
25, 2017 21, 2015
DS U-507
Jul Jan Nov Nov May
24, 24, 24, 24, 24,
2016 2017 2021 2021 2022
DS
DP U-1296 U-1077
I-601 M-122 M-61 PED PED
Jul Oct Mar Sep Jan
02, 17, 17, 17, 02,
2012 2015 2014 2014 2013
Jul Jan Nov May
24, 24, 24, 24,
2016 2017 2021 2022
DS
DP U-1296
I-601 M-122 M-61 PED PED
Jul Oct Mar Sep Jan
02, 17, 17, 17, 02,
2012 2015 2014 2014 2013
ADA 170 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-501 U-501 U-501 U-501 U-501 U-501
EXCLUSIVITY CODE(S)
PENCICLOVIR SODIUM - DENAVIR N020629 001 5840763 5866581 5916893 6124304 6469015 6579981 PERAMPANEL - FYCOMPA N202834 001 6949571 PERAMPANEL - FYCOMPA N202834 002 6949571 PERAMPANEL - FYCOMPA N202834 003 6949571 PERAMPANEL - FYCOMPA N202834 004 6949571 PERAMPANEL - FYCOMPA N202834 005 6949571 PERAMPANEL - FYCOMPA N202834 006 6949571
Sep Oct Sep Oct Oct Jun
01, 04, 01, 04, 22, 17,
2015 2014 2015 2014 2019 2020
Jun
08, 2021
DS
DP
U-106
NCE
Oct
22, 2017
Jun
08, 2021
DS
DP
U-106
NCE
Oct
22, 2017
Jun
08, 2021
DS
DP
U-106
NCE
Oct
22, 2017
Jun
08, 2021
DS
DP
U-106
NCE
Oct
22, 2017
Jun
08, 2021
DS
DP
U-106
NCE
Oct
22, 2017
Jun
08, 2021
DS
DP
U-106
NCE
Oct
22, 2017
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE - SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS N021084 001 5607979 May 30, 2015 PERFLUTREN - DEFINITY N021064 001 5527521 5585112 6033645
Feb Dec Jun
22, 2015 17, 2013 19, 2016
DP DP
U-665 U-665
PHENTERMINE HYDROCHLORIDE - SUPRENZA N202088 001 6149938 Jul 23, 2018 PHENTERMINE HYDROCHLORIDE - SUPRENZA N202088 002 6149938 Jul 23, 2018 PHENTERMINE HYDROCHLORIDE - SUPRENZA N202088 003 6149938 Jul 23, 2018 PHENTERMINE HYDROCHLORIDE; TOPIRAMATE N022580 001 7056890 Jun 14, 7553818 Jun 14, 7659256 Jun 14, 7674776 Jun 14, PHENTERMINE HYDROCHLORIDE; TOPIRAMATE N022580 002 7056890 Jun 14, 7553818 Jun 14, 7659256 Jun 14, 7674776 Jun 14, PHENTERMINE HYDROCHLORIDE; TOPIRAMATE N022580 003 7056890 Jun 14, 7553818 Jun 14, 7659256 Jun 14, 7674776 Jun 14, PHENTERMINE HYDROCHLORIDE; TOPIRAMATE N022580 004 7056890 Jun 14, 7553818 Jun 14, 7659256 Jun 14, 7674776 Jun 14, QSYMIA 2020 2020 2020 2020 QSYMIA 2020 2020 2020 2020 QSYMIA 2020 2020 2020 2020 QSYMIA 2020 2020 2020 2020
DP
DP
DP
U-1243
DP DP DP
U-1262 U-1262 U-1262 U-1262
NC
Jul
17, 2015
DP DP DP
U-1262 U-1262 U-1262 U-1262
NC
Jul
17, 2015
DP DP DP
U-1262 U-1262 U-1262 U-1262
NC
Jul
17, 2015
DP DP DP
U-1262 U-1262 U-1262 U-1262
NC
Jul
17, 2015
ADA 171 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-967 DP DP U-967 DP
EXCLUSIVITY CODE(S)
PHENTOLAMINE MESYLATE - ORAVERSE N022159 001 6764678 May 6872390 May 7229630 Jun 7569230 Oct 7575757 Apr PIMECROLIMUS - ELIDEL N021302 001 5912238 5912238*PED 6352998 6352998*PED 6423722 6423722*PED
11, 11, 20, 17, 21,
2021 2021 2023 2023 2025
Jun Dec Oct Apr Jun Dec
15, 15, 26, 26, 26, 26,
2016 2016 2015 2016 2018 2018
PIOGLITAZONE HYDROCHLORIDE - ACTOS N021073 001 5965584 Jun 6150383 Jun 6150384 Jun 6166042 Jun 6166043 Jun 6172090 Jun 6211205 Jun 6271243 Jun 6303640 Aug 6329404 Jun PIOGLITAZONE HYDROCHLORIDE - ACTOS N021073 002 5965584 Jun 6150383 Jun 6150384 Jun 6166042 Jun 6166043 Jun 6172090 Jun 6211205 Jun 6271243 Jun 6303640 Aug 6329404 Jun PIOGLITAZONE HYDROCHLORIDE - ACTOS N021073 003 5965584 Jun 6150383 Jun 6150384 Jun 6166042 Jun 6166043 Jun 6172090 Jun 6211205 Jun 6271243 Jun 6303640 Aug 6329404 Jun
19, 19, 19, 19, 19, 19, 19, 19, 09, 19,
2016 2016 2016 2016 2016 2016 2016 2016 2016 2016
U-753 U-418 U-419 U-414 U-415 U-416 U-410 U-411 U-425 U-753
19, 19, 19, 19, 19, 19, 19, 19, 09, 19,
2016 2016 2016 2016 2016 2016 2016 2016 2016 2016
U-753 U-418 U-419 U-414 U-415 U-416 U-410 U-411 U-425 U-753
19, 19, 19, 19, 19, 19, 19, 19, 09, 19,
2016 2016 2016 2016 2016 2016 2016 2016 2016 2016
U-753 U-418 U-419 U-414 U-415 U-416 U-410 U-411 U-425 U-753
PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE A076801 001 PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE A076801 002 PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE A076801 003 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 001 6900184 Apr 14, 2023 7915229 Apr 14, 2023 8133883 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 002 6900184 Apr 14, 2023 7915229 Apr 14, 2023 8133883 Apr 14, 2023
PC
Feb
13, 2013
PC
Feb
13, 2013
PC U-282 U-282
Feb
13, 2013
DP DP DP
DP DP DP
U-282 U-282
ADA 172 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 003 6900184 Apr 14, 2023 7915229 Apr 14, 2023 8133883 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 004 6900184 Apr 14, 2023 7915229 Apr 14, 2023 8133883 Apr 14, 2023
DP DP DP
U-282 U-282
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER DP N050750 001 6207661 Feb 22, 2019 DP U-282 6900184 Apr 14, 2023 DP 7915229 Apr 14, 2023 DP U-282 8133883 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER N050750 002 6207661 Feb 22, 2019 DP DP U-282 6900184 Apr 14, 2023 7915229 Apr 14, 2023 DP DP U-282 8133883 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER DP N050750 003 6207661 Feb 22, 2019 6900184 Apr 14, 2023 DP U-282 DP 7915229 Apr 14, 2023 DP U-282 8133883 Apr 14, 2023 PITAVASTATIN CALCIUM - LIVALO N022363 001 5753675 5854259 5856336 6465477 7022713 PITAVASTATIN CALCIUM - LIVALO N022363 002 5753675 5854259 5856336 6465477 7022713 PITAVASTATIN CALCIUM - LIVALO N022363 003 5753675 5854259 5856336 6465477 7022713 PLERIXAFOR - MOZOBIL N022311 001 6987102 7897590 RE42152 POLIDOCANOL - ASCLERA N021201 001 POLIDOCANOL - ASCLERA N021201 002 PONATINIB HYDROCHLORIDE - ICLUSIG N203469 001 8114874 Dec PONATINIB HYDROCHLORIDE - ICLUSIG N203469 002 8114874 Dec PORFIMER SODIUM - PHOTOFRIN N020451 001 5438071
May Dec Jan Dec Feb
19, 29, 05, 20, 19,
2015 2015 2016 2016 2024
DS DS
DP DP DP
U-998 U-998 U-998
NCE
Aug
03, 2014
May Dec Jan Dec Feb
19, 29, 05, 20, 19,
2015 2015 2016 2016 2024
DS DS
DP DP DP
U-998 U-998 U-998
NCE
Aug
03, 2014
May Dec Jan Dec Feb
19, 29, 05, 20, 19,
2015 2015 2016 2016 2024
DS DS
DP DP DP
U-998 U-998 U-998
NCE
Aug
03, 2014
Jul Jul Dec
22, 2023 22, 2023 10, 2013
U-936 U-936 DP
NCE ODE
Dec Dec
15, 2013 15, 2015
NCE
Mar
30, 2015
NCE 22, 2026 DS DP
Mar
30, 2015
NCE
Dec
14, 2017
22, 2026
DS
DP
NCE
Dec
14, 2017
Aug
01, 2012
ADA 173 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP DP DP DP U-760 U-760 U-760
EXCLUSIVITY CODE(S)
POSACONAZOLE - NOXAFIL N022003 001 5661151 5703079 6958337 8263600 PRALATREXATE - FOLOTYN N022468 001 6028071 7622470 8299078 PRALATREXATE - FOLOTYN N022468 002 6028071 7622470 8299078
Jul Aug Oct Apr
19, 26, 05, 01,
2019 2014 2018 2022
Jul May May
16, 2017 31, 2025 31, 2025
DS
DP
U-1004 U-1015 U-1004
NCE ODE
Sep Sep
24, 2014 24, 2016
Jul May May
16, 2017 31, 2025 31, 2025
DS
DP
U-1004 U-1015 U-1004
NCE ODE
Sep Sep
24, 2014 24, 2016
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 001 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 002 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 003 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 005 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 006 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 007 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 001 7695734 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 002 7695734 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 003 7695734 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 004 7695734 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 005 7695734 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 006 7695734 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 007 7695734
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
DP
I-623 NDF
Mar Feb
19, 2013 19, 2013
DP
I-623 NDF
Mar Feb
19, 2013 19, 2013
DP
I-623 NDF
Mar Feb
19, 2013 19, 2013
DP
I-623 NDF
Mar Feb
19, 2013 19, 2013
DP
I-623 NDF
Mar Feb
19, 2013 19, 2013
DP
I-623 NDF
Mar Feb
19, 2013 19, 2013
DP
I-623 NDF
Mar Feb
19, 2013 19, 2013
ADA 174 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-638 U-639 U-640 U-641
EXCLUSIVITY CODE(S)
PRAMLINTIDE ACETATE - SYMLIN N021332 001 5686411 5814600 6114304 6608029 PRAMLINTIDE ACETATE - SYMLIN N021332 002 5686411 5814600 5814600 5814600 6114304 6114304 6608029 6608029 6608029 PRAMLINTIDE ACETATE - SYMLIN N021332 003 5686411 5814600 5814600 5814600 6114304 6114304 6608029 6608029 6608029
Mar Sep Sep Sep
16, 29, 05, 07,
2019 2015 2017 2013
Mar Sep Sep Sep Sep Sep Sep Sep Sep
16, 29, 29, 29, 05, 05, 07, 07, 07,
2019 2015 2015 2015 2017 2017 2013 2013 2013
DS
DP
U-638 U-639 U-638 U-637 U-637 U-640 U-637 U-640 U-641
Mar Sep Sep Sep Sep Sep Sep Sep Sep
16, 29, 29, 29, 05, 05, 07, 07, 07,
2019 2015 2015 2015 2017 2017 2013 2013 2013
DS
DP
U-638 U-639 U-638 U-637 U-640 U-637 U-637 U-641 U-640
PRASUGREL HYDROCHLORIDE - EFFIENT Apr N022307 001 5288726 Jul 6693115 PRASUGREL HYDROCHLORIDE - EFFIENT N022307 002 5288726 Apr 6693115 Jul PRAVASTATIN SODIUM - PRAVACHOL Apr N019898 002 5622985 Oct 5622985*PED PRAVASTATIN SODIUM - PRAVACHOL N019898 003 5622985 Apr 5622985*PED Oct PRAVASTATIN SODIUM - PRAVACHOL Apr N019898 004 5622985 Oct 5622985*PED PRAVASTATIN SODIUM - PRAVACHOL Apr N019898 008 5622985 Oct 5622985*PED PREDNISOLONE ACETATE - FLO-PRED N022067 001 5881926 Mar 6071523 Jun 6102254 Mar 6399079 Jun 6656482 Jun 7799331 Oct 7799331 Oct PREDNISOLONE ACETATE - FLO-PRED N022067 002 5881926 Mar 6071523 Jun 6102254 Mar 6399079 Jun 6656482 Jun 7799331 Oct 7799331 Oct
14, 2017 03, 2021
DS DS
DP DP
U-991 U-991
NCE
Jul
10, 2014
14, 2017 03, 2021
DS DS
DP DP
U-991 U-991
NCE
Jul
10, 2014
22, 2014 22, 2014
U-335 U-335
22, 2014 22, 2014
U-335 U-335
22, 2014 22, 2014
U-335 U-335
22, 2014 22, 2014
U-335 U-335
16, 03, 11, 03, 03, 11, 11,
2016 2018 2013 2018 2018 2028 2028
U-1068 U-139
16, 03, 11, 03, 03, 11, 11,
2016 2018 2013 2018 2018 2028 2028
U-1068 U-139
ADA 175 of 227

ODT 2018 2018 2019 ODT 2018 2018 2019 ODT 2018 2018 2019
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
PREDNISOLONE SODIUM PHOSPHATE - ORAPRED Apr 09, N021959 001 6024981 Apr 09, 6221392 Nov 24, 6740341 PREDNISOLONE SODIUM PHOSPHATE - ORAPRED N021959 002 6024981 Apr 09, 6221392 Apr 09, Nov 24, 6740341 PREDNISOLONE SODIUM PHOSPHATE - ORAPRED Apr 09, N021959 003 6024981 Apr 09, 6221392 Nov 24, 6740341 PREDNISONE - RAYOS N202020 001 6488960 6677326 8309124 PREDNISONE - RAYOS N202020 002 6488960 6677326 8309124 PREDNISONE - RAYOS N202020 003 8168218 8309124 PREGABALIN - LYRICA N021446 001 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 002 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 003 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 004 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 005 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 006 5563175 6001876 6001876 6197819 RE41920
Y Y
DP DP DP
Y Y
DP DP DP
Y Y
Mar Mar Apr
14, 2020 14, 2020 23, 2024
DP DP
U-1267 U-1268 U-1292
Mar Mar Apr
14, 2020 14, 2020 23, 2024
DP DP
U-1267 U-1268
Jan Apr
07, 2028 23, 2024
DP
U-1269 U-1292
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-55 U-819 DS DP U-1250
I-651 Y Y
Jun
20, 2015
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-819 U-55 DS DP U-1250
I-651 Y Y
Jun
20, 2015
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-55 U-819 DS DP U-1250
I-651 Y Y
Jun
20, 2015
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-819 U-55 DS DP U-1250
I-651 Y Y
Jun
20, 2015
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-55 U-819 DS DP U-1250
I-651 Y Y
Jun
20, 2015
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-55 U-819 DS DP U-1250
I-651 Y Y
Jun
20, 2015
ADA 176 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-661 U-819 U-55 DS DP U-1250
EXCLUSIVITY CODE(S)
I-651
PREGABALIN - LYRICA N021446 007 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 008 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N022488 001 5563175 6001876 6001876 6197819 RE41920
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
Jun
20, 2015
Y Y
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-819 U-55 DS DP U-1250
I-651 Y Y
Jun
20, 2015
Oct Dec Dec Dec Dec
08, 30, 30, 30, 30,
2013 2018 2018 2018 2018
U-661 U-819 U-55 DS DP U-1250
Y Y
PROCAINAMIDE HYDROCHLORIDE - PROCANBID N020545 001 5656296 Aug 12, 2014 PROCAINAMIDE HYDROCHLORIDE - PROCANBID Aug 12, 2014 N020545 002 5656296 PROGESTERONE - CRINONE N020701 001 5543150 PROGESTERONE - CRINONE N020701 002 5543150 PROGESTERONE - ENDOMETRIN N022057 001 7300664 7320800 7393543
Sep
15, 2013
U-209
Sep
15, 2013
U-209
Nov Nov Nov
17, 2019 17, 2019 17, 2019
DP
U-856 U-856 U-880
PROPAFENONE HYDROCHLORIDE - RYTHMOL SR N021416 001 5681588 Oct 28, 2014 PROPAFENONE HYDROCHLORIDE - RYTHMOL SR N021416 002 5681588 Oct 28, 2014 PROPAFENONE HYDROCHLORIDE - RYTHMOL SR N021416 003 5681588 Oct 28, 2014 PROPOFOL - DIPRIVAN N019627 002 5714520 5714520*PED 5731355 5731355*PED 5731356 5731356*PED 5908869 5908869*PED
Mar Sep Mar Sep Mar Sep Mar Sep
22, 22, 22, 22, 22, 22, 22, 22,
2015 2015 2015 2015 2015 2015 2015 2015
U-217 U-217 U-218 U-218 U-270 U-270
PROPRANOLOL HYDROCHLORIDE - INNOPRAN XL N021438 001 6500454 Oct 04, 2021 PROPRANOLOL HYDROCHLORIDE - INNOPRAN XL N021438 002 6500454 Oct 04, 2021 QUAZEPAM - DORAL N018708 001 7608616 QUAZEPAM - DORAL N018708 003 7608616
DP
DP
Jun
03, 2028
U-1012
Jun
03, 2028
U-1012
ADA 177 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NPP NPP PED PED
QUETIAPINE FUMARATE - SEROQUEL N020639 001
Dec Dec Jun Jun
02, 02, 02, 02,
2012 2012 2013 2013
NPP NPP PED PED
Dec Dec Jun Jun
02, 02, 02, 02,
2012 2012 2013 2013
NPP NPP PED PED
Dec Dec Jun Jun
02, 02, 02, 02,
2012 2012 2013 2013
NPP NPP PED PED
Dec Dec Jun Jun
02, 02, 02, 02,
2012 2012 2013 2013
NPP NPP PED PED
Dec Dec Jun Jun
02, 02, 02, 02,
2012 2012 2013 2013
NPP NPP PED PED
Dec Dec Jun Jun
02, 02, 02, 02,
2012 2012 2013 2013
NPP NPP PED PED XR May May May Nov XR May May May Nov XR May May May Nov XR May May May Nov 28, 28, 28, 28, 2017 2017 2017 2017 DP DP DP U-814 U-601 U-839
Dec Dec Jun Jun
02, 02, 02, 02,
2012 2012 2013 2013
QUETIAPINE FUMARATE - SEROQUEL N022047 001 5948437 5948437 5948437 5948437*PED QUETIAPINE FUMARATE - SEROQUEL N022047 002 5948437 5948437 5948437 5948437*PED QUETIAPINE FUMARATE - SEROQUEL N022047 003 5948437 5948437 5948437 5948437*PED QUETIAPINE FUMARATE - SEROQUEL N022047 004 5948437 5948437 5948437 5948437*PED
I-618
Dec
02, 2012
28, 28, 28, 28,
2017 2017 2017 2017
DP DP DP
U-839 U-601 U-814
I-618
Dec
02, 2012
28, 28, 28, 28,
2017 2017 2017 2017
DP DP DP
U-814 U-601 U-839
I-618
Dec
02, 2012
28, 28, 28, 28,
2017 2017 2017 2017
DP DP DP
U-601 U-814 U-839
I-618
Dec
02, 2012
ADA 178 of 227

XR May May May Nov
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP U-814 U-839 U-601
EXCLUSIVITY CODE(S)
I-618
QUETIAPINE FUMARATE - SEROQUEL N022047 005 5948437 5948437 5948437 5948437*PED
28, 28, 28, 28,
2017 2017 2017 2017
Dec
02, 2012
QUINAPRIL HYDROCHLORIDE - ACCUPRIL Nov N019885 001 5684016 May 5684016*PED QUINAPRIL HYDROCHLORIDE - ACCUPRIL Nov N019885 002 5684016 May 5684016*PED QUINAPRIL HYDROCHLORIDE - ACCUPRIL Nov N019885 003 5684016 May 5684016*PED QUINAPRIL HYDROCHLORIDE - ACCUPRIL N019885 004 5684016 Nov 5684016*PED May QUININE SULFATE - QUALAQUIN N021799 001 RABEPRAZOLE SODIUM - ACIPHEX N020973 001 5045552 5045552*PED RABEPRAZOLE SODIUM - ACIPHEX N020973 002 5045552 5045552*PED
04, 2014 04, 2015
U-210 U-210
04, 2014 04, 2015
U-210 U-210
04, 2014 04, 2015
U-210 U-210
04, 2014 04, 2015
U-210 U-210
ODE May Nov 08, 2013 08, 2013 U-385
Aug
12, 2012
May Nov
08, 2013 08, 2013
U-385
RALOXIFENE HYDROCHLORIDE - EVISTA N020815 001 5393763 Jul 5457117 Jul 5478847 Mar 5811120 Mar 5972383 Mar 6458811 Mar 6797719 Mar 6894064 Mar 6906086 Jul 6906086 Jul 8030330 Mar RE38968 Jul RE38968 Jul RE39049 Jul RE39049 Jul RE39050 Mar RE39050 Mar RALTEGRAVIR POTASSIUM - ISENTRESS N022145 001 7169780 Oct 7217713 Oct 7435734 Oct 7435734 Oct 7754731 Mar RALTEGRAVIR POTASSIUM - ISENTRESS N203045 001 7169780 Oct 7217713 Oct 7435734 Oct 7754731 Mar RALTEGRAVIR POTASSIUM - ISENTRESS N203045 002 7169780 Oct 7217713 Oct 7435734 Oct 7754731 Mar
28, 28, 02, 02, 02, 10, 10, 10, 28, 28, 10, 28, 28, 28, 28, 02, 02,
2012 2012 2014 2014 2014 2017 2017 2017 2012 2012 2017 2012 2012 2012 2012 2014 2014
U-114 U-114 U-114 U-287 U-825 U-657 U-657 U-662 U-657 U-662 U-662 U-657 U-662 U-657
Y Y Y
ODE
Sep
13, 2014
DS
DP DP DP
DP
03, 21, 21, 21, 11,
2023 2022 2022 2022 2029
DS
DP U-257 U-257 U-900 U-257
M-114 NPP NCE
Mar Dec Oct
28, 2015 21, 2014 12, 2012
DS
DP
03, 21, 21, 11,
2023 2022 2022 2029
DS
DP U-257 U-257 U-257
M-114 NDF
Mar Dec
28, 2015 21, 2014
DS
DP
03, 21, 21, 11,
2023 2022 2022 2029
DS
DP U-257 U-257 U-257
M-114 NDF
Mar Dec
28, 2015 21, 2014
DS
DP
ADA 179 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-674
EXCLUSIVITY CODE(S)
RAMELTEON - ROZEREM N021782 001 6034239 RAMIPRIL - ALTACE N019901 001 7368469 RAMIPRIL - ALTACE N019901 002 7368469 RAMIPRIL - ALTACE N019901 003 7368469 RAMIPRIL - ALTACE N019901 004 7368469 RAMIPRIL - ALTACE N022021 001 7368469 RAMIPRIL - ALTACE N022021 002 7368469 RAMIPRIL - ALTACE N022021 003 7368469 RAMIPRIL - ALTACE N022021 004 7368469
Jul
22, 2019
Aug
30, 2020
U-871
Aug
30, 2020
U-871
Aug
30, 2020
U-871
Aug
30, 2020
U-871
Aug
30, 2020
U-871
Aug
30, 2020
U-871
Aug
30, 2020
U-871
Aug
30, 2020
U-871
RANITIDINE BISMUTH CITRATE - TRITEC N020559 001 5456925 Oct 10, 2012 5601848 Feb 11, 2014 5629297 May 13, 2014 RANOLAZINE - RANEXA N021526 001 6303607 6369062 6479496 6503911 6525057 6562826 6617328 6620814 6852724 6864258 RANOLAZINE - RANEXA N021526 002 6303607 6369062 6479496 6503911 6525057 6562826 6617328 6620814 6852724 6864258 RAPACURONIUM BROMIDE - RAPLON N020984 001 5418226 RAPACURONIUM BROMIDE - RAPLON N020984 002 5418226 RASAGILINE MESYLATE - AZILECT N021641 001 5453446 5532415 6126968 7572834 7815942
U-202 U-186
27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
U-705 DP U-705 DP U-705 U-705 DP U-705 U-705 U-705 Y
27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
U-705 DP U-705 DP U-705 U-705 DP U-705 U-705 U-705
Apr
14, 2013
Apr
14, 2013
Feb Jul Sep Dec Aug
07, 02, 18, 05, 27,
2017 2013 2016 2026 2027
U-219 DS DP DP DP
DS
U-219
ADA 180 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-219 DS DP DP DP
EXCLUSIVITY CODE(S)
RASAGILINE MESYLATE - AZILECT N021641 002 5453446 5532415 6126968 7572834 7815942 REGADENOSON - LEXISCAN N022161 001 6403567 6642210 7144872 7144872 7144872 7183264 7183264 7183264 7582617 7655636 7655637 7683037 8106029 8106183 8133879 8183226 REGORAFENIB - STIVARGA N203085 001 7351834
Feb Jul Sep Dec Aug
07, 02, 18, 05, 27,
2017 2013 2016 2026 2027
DS
U-219
Apr Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Feb Jun Jun
10, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 02, 22, 22,
2022 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2027 2019 2019
DS DS DS DS DS
DS
DP
U-869 U-869 U-116 U-870 U-869 U-870 U-869 U-116 U-1003 U-869 U-869 U-1042 U-1042
NCE
Apr
10, 2013
DS DP U-116
Jan
12, 2020
DS
NCE
Sep
27, 2017
REMIFENTANIL HYDROCHLORIDE - ULTIVA Sep 10, 2017 N020630 001 5866591 Mar 10, 2018 5866591*PED REMIFENTANIL HYDROCHLORIDE - ULTIVA N020630 002 5866591 Sep 10, 2017 Mar 10, 2018 5866591*PED REMIFENTANIL HYDROCHLORIDE - ULTIVA Sep 10, 2017 N020630 003 5866591 Mar 10, 2018 5866591*PED REPAGLINIDE - PRANDIN N020741 001 6677358 REPAGLINIDE - PRANDIN N020741 002 6677358 REPAGLINIDE - PRANDIN N020741 003 6677358 RETAPAMULIN - ALTABAX N022055 001 7875630 RE39128 RE43390 RIBAVIRIN - COPEGUS N021511 001
DP
DP
DP
Jun
12, 2018
DS
DP
U-1265
Jun
12, 2018
DS
DP
U-1265
Jun
12, 2018
DS
DP
U-1265
Feb Apr Apr
14, 2027 12, 2021 12, 2021
DS DS DS
DP DP
U-805 U-805
NPP
Aug
09, 2014
ADA 181 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
RIBAVIRIN - REBETOL N020903 001 6172046 6172046 6172046*PED 6177074 6177074 6177074*PED 6461605 6461605 6461605*PED 6472373 6472373 6472373*PED 6524570 6524570 6524570*PED RIBAVIRIN - REBETOL N020903 002 6172046 6172046 6172046*PED 6177074 6177074 6177074*PED 6461605 6461605 6461605*PED 6472373 6472373 6472373*PED 6524570 6524570 6524570*PED RIBAVIRIN - REBETOL N021546 001 6172046 6172046 6172046*PED 6177074 6177074*PED 6461605 6461605 6461605*PED 6472373 6472373*PED 6524570 6524570*PED 6790837 6790837*PED RIBAVIRIN - VIRAZOLE N018859 001 6150337 RIFAXIMIN - XIFAXAN N021361 001 7045620 7612199 7902206 7906542 7928115 8158644 8158781 8193196
Sep Sep Mar Nov Nov May Nov Nov May Sep Sep Mar Nov Nov May
21, 21, 21, 01, 01, 01, 01, 01, 01, 21, 21, 21, 01, 01, 01,
2017 2017 2018 2016 2016 2017 2016 2016 2017 2017 2017 2018 2016 2016 2017
Sep Sep Mar Nov Nov May Nov Nov May Sep Sep Mar Nov Nov May
21, 21, 21, 01, 01, 01, 01, 01, 01, 21, 21, 21, 01, 01, 01,
2017 2017 2018 2016 2016 2017 2016 2016 2017 2017 2017 2018 2016 2016 2017
Sep Sep Mar Nov May Nov Nov May Sep Mar Nov May Apr Oct
21, 21, 21, 01, 01, 01, 01, 01, 21, 21, 01, 01, 05, 05,
2017 2017 2018 2016 2017 2016 2016 2017 2017 2018 2016 2017 2023 2023
U-1014 U-521 U-521 U-1013 U-521 U-1013 U-521 U-521 U-521 U-1013 DP U-1014
Nov
21, 2017
U-400
Jun Jun Jun Jun Jul Jun Jun Sep
19, 19, 19, 01, 24, 19, 19, 02,
2024 2024 2024 2025 2029 2024 2024 2027
DS DS DS DS
DP DP DP DP U-1121 DP
DS DS
DP
ADA 182 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DS
EXCLUSIVITY CODE(S)
NP ODE
RIFAXIMIN - XIFAXAN N022554 001 7045620 7612199 7902206 7906542 8158644 8158781 8193196
Jun Jun Jun Jun Jun Jun Sep
19, 19, 19, 01, 19, 19, 02,
2024 2024 2024 2025 2024 2024 2027
DP DP DP DP DP
Mar Mar
24, 2013 24, 2017
RILPIVIRINE HYDROCHLORIDE - EDURANT N202022 001 6838464 Feb 26, 2021 7067522 Dec 20, 2019 7125879 Apr 14, 2023 Apr 14, 2023 7125879 Apr 14, 2023 7638522 Apr 11, 2023 8080551 Aug 09, 2022 8101629 RILUZOLE - RILUTEK N020599 001 5527814 RISEDRONATE SODIUM - ACTONEL N020835 001 5583122 5583122*PED 6165513 6165513*PED RISEDRONATE SODIUM - ACTONEL N020835 002 5583122 5583122*PED 6165513 6165513*PED RISEDRONATE SODIUM - ACTONEL N020835 003 5583122 5583122 5583122*PED 5994329 5994329*PED 6015801 6015801*PED 6165513 6165513*PED 6432932 6432932*PED 6465443 6465443*PED RISEDRONATE SODIUM - ACTONEL N020835 004 5583122 5583122*PED 6165513 6165513*PED RISEDRONATE SODIUM - ACTONEL N020835 005 5583122 5583122*PED 6165513 6165513*PED 7192938 7192938*PED 7718634 7718634*PED
DS DS DS DS DS
NCE U-1153 U-1307
May
20, 2016
Jun
18, 2013
Dec Jun Jun Dec
10, 10, 10, 10,
2013 2014 2018 2018
U-222
M-61 PED
Jul Jan
23, 2012 23, 2013
Dec Jun Jun Dec
10, 10, 10, 10,
2013 2014 2018 2018
U-222
M-61 PED
Jul Jan
23, 2012 23, 2013
Dec Dec Jun Jul Jan Jul Jan Jun Dec Jul Jan Aug Feb
10, 10, 10, 17, 17, 17, 17, 10, 10, 17, 17, 14, 14,
2013 2013 2014 2018 2019 2018 2019 2018 2018 2018 2019 2018 2019
DS DS
DP DP
U-222 U-756 U-353 U-353
M-61 PED
Jul Jan
23, 2012 23, 2013
DP U-595 DP
Dec Jun Jun Dec
10, 10, 10, 10,
2013 2014 2018 2018
DS
DP DP
U-353
M-61 PED
Jul Jan
23, 2012 23, 2013
Dec Jun Jun Dec May Nov May Nov
10, 10, 10, 10, 06, 06, 06, 06,
2013 2014 2018 2018 2023 2023 2023 2023
DS
DP DP
U-353
M-61 PED
Jul Jan
23, 2012 23, 2013
U-353 U-662
ADA 183 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP DP DP U-662 U-662 U-662 U-662
EXCLUSIVITY CODE(S)
NDF
RISEDRONATE SODIUM - ATELVIA N022560 001 5583122 5583122*PED 5622721 7645459 7645460 8246989 RISPERIDONE - RISPERDAL N020588 001 5453425 5453425*PED RE39181 RE39181*PED RISPERIDONE - RISPERDAL N021444 001 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 002 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 003 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 004 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 005 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL CONSTA N021346 001 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 6667061 6667061*PED 7547452 7547452*PED
Dec Jun Apr Jan Jan Jan
10, 10, 21, 09, 09, 16,
2013 2014 2014 2028 2028 2026
Oct
08, 2013
Jul Jan Jul Jan
11, 11, 11, 11,
2014 2015 2014 2015
DP DP
Jul Jan Jun Dec
15, 15, 10, 10,
2014 2015 2017 2017
DP DP
Jul Jan Jun Dec
15, 15, 10, 10,
2014 2015 2017 2017
DP DP
Jul Jan Jun Dec
15, 15, 10, 10,
2014 2015 2017 2017
DP DP
Jul Jan Jun Dec
15, 15, 10, 10,
2014 2015 2017 2017
DP DP
Jul Jan Jun Dec
15, 15, 10, 10,
2014 2015 2017 2017
DP DP
Nov Nov May May Nov May Nov Nov May Nov May Dec Jun Nov May Dec Jun May Nov Dec Jun May Nov Nov May
18, 18, 18, 02, 02, 02, 02, 19, 19, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 25, 25, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2020 2020 2013 2014
U-972 U-543 DP DP DP U-543 DP U-543 DP DP DP DP DP
ADA 184 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
RISPERIDONE - RISPERDAL CONSTA N021346 002 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 6667061 6667061*PED 7547452 7547452*PED RISPERIDONE - RISPERDAL CONSTA N021346 003 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 6667061 6667061*PED 7547452 7547452*PED
18, 18, 18, 02, 02, 02, 02, 19, 19, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 25, 25, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2020 2020 2013 2014
18, 18, 18, 02, 02, 02, 02, 19, 19, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 25, 25, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2020 2020 2013 2014
ADA 185 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-972 U-543 DP DP DP U-543 DP U-543 DP DP DP DP
EXCLUSIVITY CODE(S)
RISPERIDONE - RISPERDAL CONSTA N021346 004 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 7547452 7547452*PED RITONAVIR - NORVIR N020659 001 5484801 5484801*PED 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5674882 5674882*PED 5948436 5948436*PED 6037157 6037157*PED 6703403 6703403*PED RITONAVIR - NORVIR N020680 001 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5948436 5948436*PED
Nov Nov May May Nov May Nov Nov May Nov May Dec Jun Nov May Dec Jun May Nov Dec Jun Nov May
18, 18, 18, 02, 02, 02, 02, 19, 19, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2013 2014
Jan Jul Jul Jan Jul Jan Jul Jan Jul Jan Sep Mar Jun Dec Jun Dec
28, 28, 30, 30, 30, 30, 15, 15, 30, 30, 13, 13, 26, 26, 26, 26,
2014 2014 2013 2014 2013 2014 2014 2015 2013 2014 2013 2014 2016 2016 2016 2016
U-140 U-190
U-688 DP
U-564
Jul Jan Jun Dec Jul Jan Sep Mar
30, 30, 03, 03, 15, 15, 13, 13,
2013 2014 2014 2014 2014 2015 2013 2014
U-140 U-190
ADA 186 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-348 U-347
EXCLUSIVITY CODE(S)
RITONAVIR - NORVIR N020945 001 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5674882 5674882*PED 5948436 5948436*PED 6037157 6037157*PED 6232333 6232333*PED 6703403 6703403*PED 7141593 7141593*PED 7432294 7432294*PED RITONAVIR - NORVIR N022417 001 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5674882 5674882*PED 6037157 6037157*PED 6703403 6703403*PED 7148359 7148359*PED 7364752 7364752*PED 8268349 8268349*PED RIVAROXABAN - XARELTO N022406 001 7157456 7157456 7585860 7592339 7592339 7592339 7592339 7592339 RIVAROXABAN - XARELTO N022406 002 7157456 7157456 7585860 7592339 7592339 7592339 7592339 7592339
Jul Jan Jul Jan Jul Jan Jul Jan Sep Mar Jun Dec Nov May Jun Dec May Nov May Nov
30, 30, 30, 30, 15, 15, 30, 30, 13, 13, 26, 26, 07, 07, 26, 26, 22, 22, 22, 22,
2013 2014 2013 2014 2014 2015 2013 2014 2013 2014 2016 2016 2017 2018 2016 2016 2020 2020 2020 2020
U-895 DP U-895
U-564 DP DP
Jul Jan Jul Jan Jul Jan Jul Jan Jun Dec Jun Dec Jul Jan Nov May Aug Feb
30, 30, 30, 30, 15, 15, 30, 30, 26, 26, 26, 26, 19, 19, 10, 10, 25, 25,
2013 2014 2013 2014 2014 2015 2013 2014 2016 2016 2016 2016 2019 2020 2020 2021 2024 2025
DS
DP
U-688 U-688
DS U-688 U-688 U-688 DP DP DP U-688
Feb Feb Dec Dec Dec Dec Dec Dec
08, 08, 11, 11, 11, 11, 11, 11,
2021 2021 2020 2020 2020 2020 2020 2020
DS DS DS
DP DP
U-1302 U-1301 U-1303 U-1302 U-1301 U-1200 U-1167 U-1303
I-662 I-661 I-660 NCE
Nov Nov Nov Jul
02, 02, 02, 01,
2015 2015 2015 2016
08, 08, 11, 11, 11, 11, 11, 11,
2021 2021 2020 2020 2020 2020 2020 2020
DS DS DS
DP DP
U-1302 U-1301 U-1303 U-1303 U-1302 U-1301 U-1200 U-1167
I-662 I-661 I-660 I-643 NCE
Nov Nov Nov Nov Jul
02, 02, 02, 04, 01,
2015 2015 2015 2014 2016
ADA 187 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP DP U-1302 U-1301 U-1303 U-1302 U-1303 U-1167 U-1301 U-1200
EXCLUSIVITY CODE(S)
I-662 I-661 I-660 I-643 NCE
RIVAROXABAN - XARELTO N022406 003 7157456 7157456 7585860 7592339 7592339 7592339 7592339 7592339 RIVASTIGMINE - EXELON N022083 001 4948807 5602176 6316023 6335031 RIVASTIGMINE - EXELON N022083 002 4948807 5602176 6316023 6335031 RIVASTIGMINE - EXELON N022083 005 5602176 6316023 6335031
08, 08, 11, 11, 11, 11, 11, 11,
2021 2021 2020 2020 2020 2020 2020 2020
Nov Nov Nov Nov Jul
02, 02, 02, 04, 01,
2015 2015 2015 2014 2016
Aug Feb Jan Jan
14, 11, 08, 08,
2012 2014 2019 2019
DS DS
DP DP DP
U-322 U-322
Aug Feb Jan Jan
14, 11, 08, 08,
2012 2014 2019 2019
DS DS
DP DP DP
U-322 U-322
Feb Jan Jan
11, 2014 08, 2019 08, 2019
DS
DP DP DP
U-322
NS
Aug
31, 2015
RIVASTIGMINE TARTRATE - EXELON N020823 003 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON N020823 004 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON N020823 005 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON N020823 006 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON N021025 001 4948807 Aug Feb 5602176 RIZATRIPTAN BENZOATE - MAXALT N020864 001 5298520*PED 5602162*PED RIZATRIPTAN BENZOATE - MAXALT N020864 002 5298520*PED 5602162*PED
14, 2012 11, 2014
DS
U-322 U-322
14, 2012 11, 2014
DS
U-322 U-322
14, 2012 11, 2014
DS
U-322 U-322
14, 2012 11, 2014
DS
U-322 U-322
14, 2012 11, 2014
DS
U-322 U-322
Dec Jul
29, 2012 28, 2012
NPP PED
Dec Jun
15, 2014 15, 2015
Dec Jul
29, 2012 28, 2012
NPP PED
Dec Jun
15, 2014 15, 2015
RIZATRIPTAN BENZOATE - MAXALT-MLT N020865 001 5298520*PED Dec 5457895 Oct 5457895*PED Apr 5602162*PED Jul RIZATRIPTAN BENZOATE - MAXALT-MLT N020865 002 5298520*PED Dec 5457895 Oct 5457895*PED Apr Jul 5602162*PED
29, 01, 01, 28,
2012 2013 2014 2012
DP
NPP PED
Dec Jun
15, 2014 15, 2015
29, 01, 01, 28,
2012 2013 2014 2012
DP
NPP PED
Dec Jun
15, 2014 15, 2015
ADA 188 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-602
EXCLUSIVITY CODE(S)
ROFECOXIB - VIOXX N021042 001 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021042 002 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021042 003 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021052 001 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021052 002 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFLUMILAST - DALIRESP N022522 001 5712298 ROMIDEPSIN - ISTODAX N022393 001 4977138 7608280 7611724
Jun Dec May Nov May Nov Jun Dec
24, 24, 18, 18, 06, 06, 24, 24,
2013 2013 2015 2015 2017 2017 2013 2013
U-602 DS DP U-602
24, 24, 18, 18, 06, 06, 24, 24,
2013 2013 2015 2015 2017 2017 2013 2013
DS
DP
U-602
U-602 DS DP U-602
24, 24, 18, 18, 06, 06, 24, 24,
2013 2013 2015 2015 2017 2017 2013 2013
DS
DP
U-602
U-602 DS DP U-602
24, 24, 18, 18, 06, 06, 24, 24,
2013 2013 2015 2015 2017 2017 2013 2013
U-266
U-266
24, 24, 18, 18, 06, 06, 24, 24,
2013 2013 2015 2015 2017 2017 2013 2013
U-266
U-266
Jan
27, 2015
DS
DP
U-1115
NCE
Feb
28, 2016
Aug Aug Aug
22, 2013 22, 2021 22, 2021
DS DS DS
DP
NCE ODE ODE U-20
Nov Jun Nov
05, 2014 16, 2018 05, 2016
ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 001 7927624 Dec 02, 2021 8303986 Apr 12, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL Dec 02, 2021 N022008 002 7927624 Apr 12, 2021 8303986 ROPINIROLE HYDROCHLORIDE - REQUIP XL Dec 02, 2021 N022008 003 7927624 Apr 12, 2021 8303986
DP DP
DP DP
U-20
DP DP
U-20
ADA 189 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-20
EXCLUSIVITY CODE(S)
ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 004 7927624 Dec 02, 2021 8303986 Apr 12, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 005 7927624 Dec 02, 2021 8303986 Apr 12, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 006 7927624 Dec 02, 2021 8303986 Apr 12, 2021 ROPIVACAINE HYDROCHLORIDE - NAROPIN N020533 001 5670524 May 26, 2014 5834489 May 26, 2014 ROPIVACAINE HYDROCHLORIDE - NAROPIN N020533 003 5670524 May 26, 2014 5834489 May 26, 2014 ROPIVACAINE HYDROCHLORIDE - NAROPIN N020533 004 5670524 May 26, 2014 5834489 May 26, 2014 ROPIVACAINE HYDROCHLORIDE - NAROPIN N020533 005 5670524 May 26, 2014 5834489 May 26, 2014 ROSIGLITAZONE MALEATE - AVANDIA N021071 002 5741803 Apr 5741803 Apr 5741803*PED Oct 6288095 Feb 6288095*PED Aug 7358366 Apr 7358366*PED Oct ROSIGLITAZONE MALEATE - AVANDIA N021071 003 5741803 Apr 5741803 Apr 5741803*PED Oct 6288095 Feb 6288095*PED Aug 7358366 Apr 7358366*PED Oct ROSIGLITAZONE MALEATE - AVANDIA N021071 004 5741803 Apr 5741803 Apr 5741803*PED Oct 6288095 Feb 6288095*PED Aug 7358366 Apr 7358366*PED Oct ROSUVASTATIN CALCIUM - CRESTOR N021366 002 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED
DP DP
U-20
DP DP
U-20
DS DS
DP DP
U-833 U-838
DS DS
DP DP
U-833 U-838
DS DS
DP DP
U-833 U-838
DS DS
DP DP
U-833 U-838
21, 21, 21, 11, 11, 19, 19,
2015 2015 2015 2017 2017 2020 2020
DS DS
DP DP
U-628 U-329 U-420
Y Y Y
DS
21, 21, 21, 11, 11, 19, 19,
2015 2015 2015 2017 2017 2020 2020
DS DS
DP DP
U-329 U-628 U-420
Y Y Y
DS
21, 21, 21, 11, 11, 19, 19,
2015 2015 2015 2017 2017 2020 2020
DS DS
DP DP
U-329 U-628 U-420
Y Y Y
DS
Aug Feb Dec Jun Apr Oct Apr Oct Jan Jul
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
DP U-618 U-1032 U-1032 DS
I-621 I-611 PED
Feb Oct Apr
08, 2013 16, 2012 16, 2013
ADA 190 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP U-618 U-1032 U-1032 DS
EXCLUSIVITY CODE(S)
I-621 I-611 PED
ROSUVASTATIN CALCIUM - CRESTOR N021366 003 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED ROSUVASTATIN CALCIUM - CRESTOR N021366 004 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED ROSUVASTATIN CALCIUM - CRESTOR N021366 005 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED ROTIGOTINE - NEUPRO N021829 001 6699498 6884434 7413747 8246979 8246979 8246980 ROTIGOTINE - NEUPRO N021829 002 6699498 6884434 7413747 8246979 8246979 8246980 ROTIGOTINE - NEUPRO N021829 003 6699498 6884434 7413747 8246979 8246979 8246980 ROTIGOTINE - NEUPRO N021829 004 6699498 6884434 7413747 8246979 8246979 8246980
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
Feb Oct Apr
08, 2013 16, 2012 16, 2013
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
DP U-618 U-1032 U-1032 DS
I-621 I-611 PED
Feb Oct Apr
08, 2013 16, 2012 16, 2013
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
DP U-618 U-1032 U-1032 DS
I-621 I-611 PED
Feb Oct Apr
08, 2013 16, 2012 16, 2013
Nov Mar Mar Sep Sep Nov
27, 30, 18, 01, 01, 27,
2020 2021 2019 2027 2027 2025
DP DP DP DP DP DP
I-647 I-646 U-1273 U-1272
Apr Apr
02, 2015 02, 2015
27, 30, 18, 01, 01, 27,
2020 2021 2019 2027 2027 2025
DP DP DP DP DP DP
I-647 I-646 U-1272 U-1273
Apr Apr
02, 2015 02, 2015
27, 30, 18, 01, 01, 27,
2020 2021 2019 2027 2027 2025
DP DP DP DP DP DP
I-647 I-646 U-1273 U-1272
Apr Apr
02, 2015 02, 2015
27, 30, 18, 01, 01, 27,
2020 2021 2019 2027 2027 2025
DP DP DP DP DP DP
I-646 I-647 U-1273 U-1272
Apr Apr
02, 2015 02, 2015
ADA 191 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP
EXCLUSIVITY CODE(S)
I-646 I-647
ROTIGOTINE - NEUPRO N021829 005 6699498 6884434 7413747 8246979 8246979 8246980 ROTIGOTINE - NEUPRO N021829 006 6699498 6884434 7413747 8246979 8246979 8246980 RUFINAMIDE - BANZEL N021911 001 6740669 7750028 8076362 RUFINAMIDE - BANZEL N021911 002 6740669 7750028 8076362 RUFINAMIDE - BANZEL N021911 003 6740669 7750028 8076362 RUFINAMIDE - BANZEL N201367 001 6740669 7750028
27, 30, 18, 01, 01, 27,
2020 2021 2019 2027 2027 2025
Apr Apr
02, 2015 02, 2015
U-1272 U-1273
27, 30, 18, 01, 01, 27,
2020 2021 2019 2027 2027 2025
DP DP DP DP DP DP
I-646 I-647 U-1273 U-1272
Apr Apr
02, 2015 02, 2015
Nov Oct Jun
14, 2022 19, 2018 08, 2018
DS
DP U-106 DP
NCE ODE
Nov Nov
14, 2013 14, 2015
Nov Oct Jun
14, 2022 19, 2018 08, 2018
DS
DP U-106 DP
NCE ODE
Nov Nov
14, 2013 14, 2015
Nov Oct Jun
14, 2022 19, 2018 08, 2018
DS
DP U-106 DP
NCE ODE
Nov Nov
14, 2013 14, 2015
Nov Oct
14, 2022 19, 2018
DS
DP U-106
NCE ODE
Nov Nov
14, 2013 14, 2015
RUXOLITINIB PHOSPHATE - JAKAFI N202192 001 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 002 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 003 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 004 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 005 7598257 Dec SALMETEROL XINAFOATE - SEREVENT N020692 001 5873360 Feb 5873360*PED Aug
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
16, 2016 16, 2018
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
16, 2016 16, 2018
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
16, 2016 16, 2018
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
16, 2016 16, 2018
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
16, 2016 16, 2018
23, 2016 23, 2016
DP
SAPROPTERIN DIHYDROCHLORIDE - KUVAN N022181 001 7566462 Nov 16, 2025 7566714 Nov 17, 2024 7612073 Nov 17, 2024 7727987 Nov 17, 2024 7947681 Nov 17, 2024 8003126 Nov 16, 2025 8067416 Nov 17, 2024 RE43797 Nov 17, 2024
DP U-989 U-1010 DP U-1156 U-989 U-1156
NCE ODE
Dec Dec
13, 2012 13, 2014
ADA 192 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
SAQUINAVIR - FORTOVASE N020828 001 6008228 6008228*PED 6352717 6352717*PED
Jun Dec Nov May
06, 06, 16, 16,
2015 2015 2019 2020
SAXAGLIPTIN HYDROCHLORIDE - ONGLYZA N022350 001 6395767 Feb 16, 2021 7951400 Nov 30, 2028 SAXAGLIPTIN HYDROCHLORIDE - ONGLYZA N022350 002 6395767 Feb 16, 2021 7951400 Nov 30, 2028 SELEGILINE - EMSAM N021336 001 7070808 7150881 7638140 SELEGILINE - EMSAM N021336 002 7070808 7150881 7638140 SELEGILINE - EMSAM N021336 003 7070808 7150881 7638140
DS
DP DP
U-995
M-108 NCE
Dec Jul
16, 2014 31, 2014
DS
DP DP
U-995
M-108 NCE
Dec Jul
16, 2014 31, 2014
May Jun May
10, 2018 12, 2018 10, 2018
DS DS
DP DP DP
May Jun May
10, 2018 12, 2018 10, 2018
DS DS
DP DP DP
May Jun May
10, 2018 12, 2018 10, 2018
DS DS
DP DP DP
SELEGILINE HYDROCHLORIDE - ZELAPAR N021479 001 5648093 Jul 6423342 Mar SERTACONAZOLE NITRATE - ERTACZO May N021385 001 5135943 SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 001 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 002 5248699 5248699*PED Feb SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 003 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 004 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 005 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N020990 001 5248699 Feb 5248699*PED Oct 6727283 Apr 6727283*PED Nov 7067555 May 7067555*PED
15, 2014 01, 2016
DP DP
31, 2014
DS
DP
U-786
13, 2012 13, 2013
13, 2012 13, 2013
13, 2012 13, 2013
13, 2012 13, 2013
13, 2012 13, 2013
13, 13, 11, 11, 10, 10,
2012 2013 2019 2020 2019 2020
DP DP
U-580
ADA 193 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP U-246 U-246 U-246 U-246 U-246
EXCLUSIVITY CODE(S)
SEVELAMER CARBONATE - RENVELA N022127 001 5496545 5667775 6509013 6858203 7014846 7459151 7985418 SEVELAMER CARBONATE - RENVELA N022318 001 5496545 5667775 6509013 6858203 7014846 7459151 SEVELAMER CARBONATE - RENVELA N022318 002 5496545 5667775 6509013 6858203 7014846 7459151
Aug Sep Aug Aug Aug Aug Oct
11, 16, 11, 11, 11, 11, 27,
2013 2014 2013 2013 2013 2013 2025
Aug Sep Aug Aug Aug Aug
11, 16, 11, 11, 11, 11,
2013 2014 2013 2013 2013 2013
DP DP DP DP
U-246 U-246 U-246 U-246 U-246
NDF
Aug
12, 2012
Aug Sep Aug Aug Aug Aug
11, 16, 11, 11, 11, 11,
2013 2014 2013 2013 2013 2013
DP DP DP DP
U-246 U-246 U-246 U-246 U-246
NDF
Aug
12, 2012
SEVELAMER HYDROCHLORIDE - RENAGEL Aug N020926 001 5496545 Sep 5667775 Aug 6509013 SEVELAMER HYDROCHLORIDE - RENAGEL Aug N021179 001 5496545 Sep 5667775 Aug 6509013 Oct 6733780 Aug 7014846 Aug 7459151 SEVELAMER HYDROCHLORIDE - RENAGEL Aug N021179 002 5496545 Sep 5667775 Aug 6509013 Oct 6733780 Aug 7014846 Aug 7459151 SEVOFLURANE - ULTANE N020478 001 5990176 5990176*PED 6074668 6074668*PED 6288127 6288127*PED 6444859 6444859*PED
11, 2013 16, 2014 11, 2013
U-246 U-246
11, 16, 11, 18, 11, 11,
2013 2014 2013 2020 2013 2013
U-246 U-246 DP DP
U-246 U-246
11, 16, 11, 18, 11, 11,
2013 2014 2013 2020 2013 2013
U-246 U-246 DP DP
U-246 U-246
Jan Jul Jan Jul Jan Jul Jan Jul
27, 27, 09, 09, 27, 27, 27, 27,
2017 2017 2018 2018 2017 2017 2017 2017
SIBUTRAMINE HYDROCHLORIDE - MERIDIA N020632 001 5436272 Jul 25, 2012 5436272*PED Jan 25, 2013 SIBUTRAMINE HYDROCHLORIDE - MERIDIA N020632 002 5436272 Jul 25, 2012 5436272*PED Jan 25, 2013 SIBUTRAMINE HYDROCHLORIDE - MERIDIA N020632 003 5436272 Jul 25, 2012 5436272*PED Jan 25, 2013
U-439
U-439
U-439
ADA 194 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
M-61 PED PED
SILDENAFIL CITRATE - REVATIO N021845 001 5250534*PED
Sep
27, 2012
Aug Mar Nov
30, 2015 01, 2016 07, 2012
SILDENAFIL CITRATE - REVATIO N022473 001 5250534*PED
Sep
27, 2012
M-61 NDF PED PED
Aug Nov Mar May
30, 20, 01, 20,
2015 2012 2016 2013
SILDENAFIL CITRATE - REVATIO N203109 001 SILDENAFIL CITRATE - VIAGRA N020895 001 5250534*PED 6469012 6469012*PED SILDENAFIL CITRATE - VIAGRA N020895 002 5250534*PED 6469012 6469012*PED SILDENAFIL CITRATE - VIAGRA N020895 003 5250534*PED 6469012 6469012*PED SILODOSIN - RAPAFLO N022206 001 5387603 5403847 5780485 6015819 SILODOSIN - RAPAFLO N022206 002 5387603 5403847 5780485 6015819
NDF PED Sep Oct Apr 27, 2012 22, 2019 22, 2020
Aug Mar
30, 2015 01, 2016
U-155
Sep Oct Apr
27, 2012 22, 2019 22, 2020
U-155
Sep Oct Apr
27, 2012 22, 2019 22, 2020
U-155
Dec Nov Nov Nov
01, 13, 13, 13,
2018 2012 2012 2012
DS
DP U-902 U-902 U-902
NCE
Oct
08, 2013
Dec Nov Nov Nov
01, 13, 13, 13,
2018 2012 2012 2012
DS
DP U-902 U-902 U-902
NCE
Oct
08, 2013
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC Apr 24, 2017 N202343 001 6303661 Jul 26, 2022 6699871 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Apr 11, 2026 7326708 Feb 02, 2019 7459428 Jun 26, 2022 8168637
DS
DP
DS
DP DP DP DP DP DP
U-1188 U-1188 U-1189 U-1191 U-1190 U-1188 U-1193 U-1189 U-1192 U-1190 U-1188 U-1189 U-1188
ADA 195 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1188 U-1188 U-1191 U-1190 U-1189 U-1188 U-1190 U-1192 U-1193 U-1189 U-1188 U-1189 U-1188
EXCLUSIVITY CODE(S)
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC Apr 24, 2017 N202343 002 6303661 Jul 26, 2022 6699871 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Apr 11, 2026 7326708 Feb 02, 2019 7459428 Jun 26, 2022 8168637 SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC Apr 24, 2017 N202343 003 6303661 Jul 26, 2022 6699871 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Apr 11, 2026 7326708 Feb 02, 2019 7459428 Jun 26, 2022 8168637 SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC Apr 24, 2017 N202343 004 6303661 Jul 26, 2022 6699871 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Apr 11, 2026 7326708 Feb 02, 2019 7459428 Jun 26, 2022 8168637 SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC N202343 005 6303661 Apr 24, 2017 6699871 Jul 26, 2022 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Feb 02, 2019 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7326708 Apr 11, 2026 Feb 02, 2019 7459428 Jun 26, 2022 8168637
DS
DP
DS
DP DP DP DP DP DP
DS
DP
DS
DP DP DP DP DP DP
U-1188 U-1188 U-1189 U-1190 U-1191 U-1188 U-1193 U-1192 U-1190 U-1189 U-1188 U-1189 U-1188
DS
DP
DS
DP DP DP DP DP DP
U-1188 U-1188 U-1190 U-1191 U-1189 U-1188 U-1190 U-1192 U-1193 U-1189 U-1188 U-1189 U-1188
DS
DP
DS
DP DP DP DP DP DP
U-1188 U-1188 U-1189 U-1191 U-1190 U-1188 U-1190 U-1192 U-1193 U-1189 U-1188 U-1189 U-1188
ADA 196 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1188 U-1188 U-1189 U-1190 U-1191 U-1188 U-1189 U-1193 U-1192 U-1190 U-1188 U-1189 U-1188
EXCLUSIVITY CODE(S)
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC Apr 24, 2017 N202343 006 6303661 Jul 26, 2022 6699871 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Apr 11, 2026 7326708 Feb 02, 2019 7459428 Jun 26, 2022 8168637 SINCALIDE - KINEVAC N017697 001 6803046 SINECATECHINS - VEREGEN N021902 001 5795911 5968973 7858662 SIROLIMUS - RAPAMUNE N021083 001 5100899 5100899*PED 5403833*PED 5536729 5536729*PED SIROLIMUS - RAPAMUNE N021110 001 5100899 5100899*PED 5403833*PED 5989591 5989591*PED SIROLIMUS - RAPAMUNE N021110 002 5100899 5100899*PED 5403833*PED 5989591 5989591*PED SIROLIMUS - RAPAMUNE N021110 003 5100899 5100899*PED 5403833*PED 5989591 5989591*PED SIROLIMUS - RAPAMUNE N021110 004 5100899 5100899*PED 5403833*PED 5989591 5989591*PED
DS
DP
DS
DP DP DP DP DP DP
Aug
16, 2022
DP
Oct Apr Oct
31, 2020 10, 2017 02, 2026
DP
U-172 U-172 U-172
Jul Jan Oct Sep Mar
07, 07, 04, 30, 30,
2013 2014 2012 2013 2014
U-290
DP
Jul Jan Oct Mar Sep
07, 07, 04, 11, 11,
2013 2014 2012 2018 2018
U-290
DP
Jul Jan Oct Mar Sep
07, 07, 04, 11, 11,
2013 2014 2012 2018 2018
U-290
DP
Jul Jan Oct Mar Sep
07, 07, 04, 11, 11,
2013 2014 2012 2018 2018
U-290
DP
Jul Jan Oct Mar Sep
07, 07, 04, 11, 11,
2013 2014 2012 2018 2018
U-290
DP
ADA 197 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-774 U-774 U-1039 U-775 U-1036 U-775 U-1037 U-1036 U-1038 U-1037 U-1036 U-775 U-1038 U-802
EXCLUSIVITY CODE(S)
SITAGLIPTIN PHOSPHATE - JANUVIA Apr N021995 001 6303661 Jul 6699871 Feb 6890898 Feb 6890898 Feb 6890898 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7078381 Jul 7125873 Jul 7125873 Jul 7125873 Jul 7125873 Apr 7326708 SITAGLIPTIN PHOSPHATE - JANUVIA Apr N021995 002 6303661 Jul 6699871 Feb 6890898 Feb 6890898 Feb 6890898 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7078381 Jul 7125873 Jul 7125873 Jul 7125873 Jul 7125873 Apr 7326708 SITAGLIPTIN PHOSPHATE - JANUVIA N021995 003 6303661 Apr 6699871 Jul 6890898 Feb 6890898 Feb 6890898 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7125873 Jul 7125873 Jul 7125873 Jul 7125873 Jul 7326708 Apr SODIUM NITRITE - SODIUM NITRITE N203922 001
24, 26, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 26, 11,
2017 2022 2019 2019 2019 2019 2019 2019 2019 2022 2022 2022 2022 2026
DS
DP
DS
DP
24, 26, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 26, 11,
2017 2022 2019 2019 2019 2019 2019 2019 2019 2022 2022 2022 2022 2026
DS
DP
DS
DP
U-774 U-774 U-1036 U-775 U-1039 U-775 U-1037 U-1038 U-1036 U-775 U-1038 U-1037 U-1036 U-802
24, 26, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 26, 11,
2017 2022 2019 2019 2019 2019 2019 2019 2019 2022 2022 2022 2022 2026
DS
DP
DS
DP
U-774 U-774 U-775 U-1036 U-1039 U-1038 U-1036 U-1037 U-775 U-1038 U-1036 U-775 U-1037 U-802
ODE
Jan
14, 2018
SODIUM NITRITE; SODIUM THIOSULFATE - NITHIODOTE N201444 001 SODIUM OXYBATE - XYREM N021196 001 6780889 7262219 7668730 7765106 7765107 7851506 7851506 7895059 8263650 8263650 8324275 8324275
ODE DP DP U-1110 U-1069 U-1070 U-1102 U-1101 U-1110 U-1102 U-1101 U-1102 U-1101
Jan
14, 2018
Jul Jul Jun Jun Jun Dec Dec Dec Dec Dec Dec Dec
04, 04, 16, 16, 16, 22, 22, 17, 22, 22, 22, 22,
2020 2020 2024 2024 2024 2019 2019 2022 2019 2019 2019 2019
ODE
Nov
18, 2012
DP DP
SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE - VISICOL N021097 001 5616346 May 18, 2013 U-359
ADA 198 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE - OSMOPREP May 18, 2013 DP U-715 N021892 001 5616346 Jun 22, 2028 DS DP 7687075 SODIUM THIOSULFATE - SODIUM THIOSULFATE N203923 001 SOLIFENACIN SUCCINATE - VESICARE N021518 001 6017927 Nov SOLIFENACIN SUCCINATE - VESICARE N021518 002 6017927 Nov
ODE DS DP
Jan
14, 2018
19, 2018
19, 2018
DS
DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 001 5435076 Apr 16, 2013 DP 5501673 Apr 16, 2013 DP DP 5716338 Feb 10, 2015 DP 6152897 Nov 20, 2018 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 002 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 DP Feb 10, 2015 5716338 DP Nov 20, 2018 6152897 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE Apr 16, 2013 DP N020280 003 5435076 DP Apr 16, 2013 5501673 DP Feb 10, 2015 5716338 DP Nov 20, 2018 6152897 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 005 5435076 Apr 16, 2013 DP 5501673 Apr 16, 2013 DP DP 5716338 Feb 10, 2015 DP 6152897 Nov 20, 2018 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 008 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 DP Feb 10, 2015 5716338 DP Nov 20, 2018 6152897 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE Apr 16, 2013 DP N020280 009 5435076 DP Apr 16, 2013 5501673 DP Feb 10, 2015 5716338 DP Nov 20, 2018 6152897 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 010 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 Feb 10, 2015 DP 5716338 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE Apr 16, 2013 DP N020280 011 5435076 DP Apr 16, 2013 5501673 Feb 10, 2015 DP 5716338 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE Apr 16, 2013 DP N020280 012 5435076 Apr 16, 2013 DP 5501673 DP Feb 10, 2015 5716338 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 013 5435076 Apr 16, 2013 DP 5501673 Apr 16, 2013 DP DP 5716338 Feb 10, 2015 SOMATROPIN RECOMBINANT - HUMATROPE N019640 001
ODE
Nov
01, 2013
ADA 199 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ODE
SOMATROPIN RECOMBINANT - HUMATROPE N019640 004 SOMATROPIN RECOMBINANT - HUMATROPE N019640 005 SOMATROPIN RECOMBINANT - HUMATROPE N019640 006 SOMATROPIN RECOMBINANT - HUMATROPE N019640 007 SOMATROPIN RECOMBINANT - NORDITROPIN N021148 001 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN N021148 002 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN N021148 003 5633352 May 27, 2014 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO N021148 008 5849700 Dec 15, 2015 5849704 Dec 15, 2015 6716198 Jun 05, 2021 6899699 Jan 02, 2022 7686786 Aug 03, 2026 SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO N021148 009 5849700 Dec 15, 2015 5849704 Dec 15, 2015 6716198 Jun 05, 2021 6899699 Jan 02, 2022 7686786 Aug 03, 2026 SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO N021148 010 5849700 Dec 15, 2015 5849704 Dec 15, 2015 6716198 Jun 05, 2021 6899699 Jan 02, 2022 7686786 Aug 03, 2026 SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 004 5849700 Dec 15, 2015 5849704 Dec 15, 2015 6004297 Jan 28, 2019 6235004 Jan 28, 2019 RE41956 Jan 21, 2021 SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 005 5849700 Dec 15, 2015 5849704 Dec 15, 2015 6004297 Jan 28, 2019 6235004 Jan 28, 2019 RE41956 Jan 21, 2021 SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 006 5849700 Dec 15, 2015 5849704 Dec 15, 2015 6004297 Jan 28, 2019 6235004 Jan 28, 2019 RE41956 Jan 21, 2021
Nov
01, 2013
ODE
Nov
01, 2013
ODE
Nov
01, 2013
ODE U-340
Nov
01, 2013
ODE
May
31, 2014
U-340
ODE
May
31, 2014
ODE U-340
May
31, 2014
DP DP DP DP
U-1041 U-1041
ODE
May
31, 2014
DP DP DP DP
U-1041 U-1041
ODE
May
31, 2014
DP DP DP DP
U-1041 U-1041
ODE
May
31, 2014
DP DP DP DP
U-340 U-340
ODE
May
31, 2014
DP DP DP DP
U-340 U-340
ODE
May
31, 2014
DP DP DP DP
U-340 U-340
ODE
May
31, 2014
ADA 200 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-340 U-340
EXCLUSIVITY CODE(S)
ODE
SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 007 5849700 Dec 15, 2015 5849704 Dec 15, 2015 6004297 Jan 28, 2019 RE41956 Jan 21, 2021 RE43834 Jan 28, 2019 SOMATROPIN RECOMBINANT - NUTROPIN AQ N020522 001 5763394 Jun 09, 2015 SOMATROPIN RECOMBINANT - NUTROPIN AQ PEN N020522 002 5763394 Jun 09, 2015 SOMATROPIN RECOMBINANT - NUTROPIN DEPOT N021075 001 5654010 Aug 05, 2014 5656297 Jul 25, 2014 6051259 Dec 02, 2012 SOMATROPIN RECOMBINANT - NUTROPIN DEPOT N021075 002 5654010 Aug 05, 2014 Jul 25, 2014 5656297 Dec 02, 2012 6051259 SOMATROPIN RECOMBINANT - NUTROPIN DEPOT N021075 003 5654010 Aug 05, 2014 Jul 25, 2014 5656297 Dec 02, 2012 6051259 SOMATROPIN RECOMBINANT - SAIZEN Apr N019764 002 5898030 SOMATROPIN RECOMBINANT - SAIZEN Apr N019764 003 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 001 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 002 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 003 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 004 5898030 SOMATROPIN RECOMBINANT - ZORBTIVE Apr N021597 004 5898030 SORAFENIB TOSYLATE - NEXAVAR N021923 001 7235576 7351834 7897623
May
31, 2014
DP DP DP DP
DP
DP
U-340
U-340
U-340
27, 2016
DP
27, 2016
DP
27, 2016
DP
27, 2016
DP
27, 2016
DP
27, 2016
DP
27, 2016
DP
Jan Jan Jan
12, 2020 12, 2020 12, 2020
DS DS
DP DP
ODE ODE
Nov Dec
16, 2014 20, 2012
SOTALOL HYDROCHLORIDE - SOTALOL HYDROCHLORIDE N022306 001 SPINOSAD - NATROBA N022408 001 5496931 6063771 6342482 7030095 STAVUDINE - ZERIT XR N021453 001 7135465 7135465*PED STAVUDINE - ZERIT XR N021453 002 7135465 7135465*PED
ODE DS DP DP DP U-1105 U-1105 U-1105 U-1105
Jul
02, 2016
Mar Jun Jun Jul
05, 22, 22, 02,
2013 2019 2019 2021
NCE
Jan
18, 2016
Feb Aug
18, 2023 18, 2023
DP
U-167
Feb Aug
18, 2023 18, 2023
DP
U-167
ADA 201 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP U-167
EXCLUSIVITY CODE(S)
STAVUDINE - ZERIT XR N021453 003 7135465 7135465*PED STAVUDINE - ZERIT XR N021453 004 7135465 7135465*PED SUMATRIPTAN - IMITREX N020626 001 5307953 5307953*PED 5554639 5554639*PED SUMATRIPTAN - IMITREX N020626 002 5307953 5307953*PED 5554639 5554639*PED SUMATRIPTAN - IMITREX N020626 003 5307953 5307953*PED 5554639 5554639*PED
Feb Aug
18, 2023 18, 2023
Feb Aug
18, 2023 18, 2023
DP
U-167
Dec Jun Sep Mar
02, 02, 10, 10,
2012 2013 2013 2014
U-232
Dec Jun Sep Mar
02, 02, 10, 10,
2012 2013 2013 2014
U-232
Dec Jun Sep Mar
02, 02, 10, 10,
2012 2013 2013 2014
U-232
SUMATRIPTAN SUCCINATE - ALSUMA N022377 001 7811254 Aug
26, 2027
DP
U-1083
SUMATRIPTAN SUCCINATE - SUMAVEL DOSEPRO N022239 001 5891086 Jul 27, 5957886 Mar 08, 6135979 Mar 21, 7776007 Nov 22, 7901385 Jul 31, 8118771 Aug 10, Dec 25, 8241243 Nov 21, 8241244 Mar 18, 8267903 Dec 06, 8287489 SUNITINIB MALATE - SUTENT N021938 001 6573293 7125905 7211600 SUNITINIB MALATE - SUTENT N021938 002 6573293 7125905 7211600 SUNITINIB MALATE - SUTENT N021938 003 6573293 7125905 7211600 SUNITINIB MALATE - SUTENT N021938 004 6573293 7125905 7211600 TACROLIMUS - PROGRAF N050708 001 TACROLIMUS - PROGRAF N050708 002 TACROLIMUS - PROGRAF N050708 003
2014 2016 2017 2026 2026 2023 2025 2022 2023 2024
Feb Feb Dec
15, 2021 15, 2021 22, 2020
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
Feb Feb Dec
15, 2021 15, 2021 22, 2020
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
Feb Feb Dec
15, 2021 15, 2021 22, 2020
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
Feb Feb Dec
15, 2021 15, 2021 22, 2020
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
ODE
Mar
29, 2013
ODE
Mar
29, 2013
ODE
Mar
29, 2013
ADA 202 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ODE
TACROLIMUS - PROGRAF N050709 001 TACROLIMUS - PROTOPIC N050777 001 5665727 TACROLIMUS - PROTOPIC N050777 002 5665727 TADALAFIL - ADCIRCA N022332 001 5859006 6821975 7182958 TADALAFIL - CIALIS N021368 001 5859006 6140329 6140329 6821975 6821975 6821975 6943166 6943166 6943166 7182958 7182958 TADALAFIL - CIALIS N021368 002 5859006 6140329 6821975 6821975 6943166 6943166 7182958 TADALAFIL - CIALIS N021368 003 5859006 6140329 6821975 6821975 6943166 7182958 TADALAFIL - CIALIS N021368 004 5859006 6140329 6821975 6821975 6943166 7182958 TAFLUPROST - ZIOPTAN N202514 001 5886035 TALIGLUCERASE ALFA - ELELYSO N022458 001 8227230 TAMOXIFEN CITRATE - SOLTAMOX N021807 001 6127425
Mar
29, 2013
Sep
09, 2014
U-919
Sep
09, 2014
U-919
Nov Nov Apr
21, 2017 19, 2020 26, 2020
DS DS
DP DP DP
U-975
ODE
May
22, 2016
Nov Jul Jul Nov Nov Nov Apr Apr Apr Apr Apr
21, 11, 11, 19, 19, 19, 26, 26, 26, 26, 26,
2017 2016 2016 2020 2020 2020 2020 2020 2020 2020 2020
DS
DS DS DS
DP DP DP DP DP DP
DP DP
U-1184 U-155 U-1184 U-614 U-533 U-614 U-1184 U-155 U-1184 U-155
I-642 I-641
Oct Oct
06, 2014 06, 2014
Nov Jul Nov Nov Apr Apr Apr
21, 11, 19, 19, 26, 26, 26,
2017 2016 2020 2020 2020 2020 2020
DS DS DS
DP DP DP DP
DP
U-155 U-614 U-533 U-155 U-614 U-155
I-642 I-641
Oct Oct
06, 2014 06, 2014
Nov Jul Nov Nov Apr Apr
21, 11, 19, 19, 26, 26,
2017 2016 2020 2020 2020 2020
DS DS DS
DP DP DP DP DP
U-155 U-614 U-533 U-614 U-155
I-642 I-641
Oct Oct
06, 2014 06, 2014
Nov Jul Nov Nov Apr Apr
21, 11, 19, 19, 26, 26,
2017 2016 2020 2020 2020 2020
DS DS DS
DP DP DP DP DP
U-155 U-614 U-533 U-155 U-155
I-642 I-641
Oct Oct
06, 2014 06, 2014
Dec
18, 2017
DS
DP
U-778
NCE
Feb
10, 2017
Feb
24, 2024
DS
DP
NCE
May
01, 2017
Jun
26, 2018
DP
TAMSULOSIN HYDROCHLORIDE - FLOMAX N020579 001 TAPENTADOL HYDROCHLORIDE - NUCYNTA Jun N022304 001 6071970 Jun 7994364 Aug RE39593
M-54 PED 06, 2017 27, 2025 05, 2022 U-931 U-931 U-931
Dec Jun
22, 2012 22, 2013
NCE
Nov
20, 2013
DS DS
DP DP
ADA 203 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-931 U-931 U-931
EXCLUSIVITY CODE(S)
NCE
TAPENTADOL HYDROCHLORIDE - NUCYNTA Jun N022304 002 6071970 Jun 7994364 Aug RE39593 TAPENTADOL HYDROCHLORIDE - NUCYNTA N022304 003 6071970 Jun 7994364 Jun RE39593 Aug TAPENTADOL HYDROCHLORIDE - NUCYNTA N203794 001 6071970 Jun 7994364 Jun RE39593 Aug
06, 2017 27, 2025 05, 2022
Nov
20, 2013
DS DS
DP DP
06, 2017 27, 2025 05, 2022
DS DS
DP DP
U-931 U-931 U-931
NCE
Nov
20, 2013
06, 2017 27, 2025 05, 2022
DS DS
DP DP
U-1289 U-1289 U-1289
NCE
Nov
20, 2013
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 001 6071970 Jun 06, 6071970 Jun 06, 7994364 Jun 27, 7994364 Jun 27, 8075872 Nov 20, 8114383 Oct 10, 8309060 Nov 20, 8309060 Nov 20, RE39593 Aug 05, Aug 05, RE39593 TAPENTADOL HYDROCHLORIDE - NUCYNTA ER Jun 06, N200533 002 6071970 Jun 06, 6071970 Jun 27, 7994364 Jun 27, 7994364 Nov 20, 8075872 Oct 10, 8114383 Nov 20, 8309060 Nov 20, 8309060 Aug 05, RE39593 Aug 05, RE39593 TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 003 6071970 Jun 06, 6071970 Jun 06, 7994364 Jun 27, 7994364 Jun 27, 8075872 Nov 20, 8114383 Oct 10, 8309060 Nov 20, 8309060 Nov 20, RE39593 Aug 05, Aug 05, RE39593 TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 004 6071970 Jun 06, 6071970 Jun 06, 7994364 Jun 27, 7994364 Jun 27, 8075872 Nov 20, 8114383 Oct 10, 8309060 Nov 20, 8309060 Nov 20, RE39593 Aug 05, Aug 05, RE39593
2017 2017 2025 2025 2023 2024 2023 2023 2022 2022
DS DS
DS DS
U-1276 U-1178 U-1178 U-1276
I-656 NDF NCE
Aug Aug Nov
28, 2015 25, 2014 20, 2013
U-1178 U-1276 U-1178 U-1276
2017 2017 2025 2025 2023 2024 2023 2023 2022 2022
DS DS
DS DS
U-1178 U-1276 U-1178 U-1276
I-656 NDF NCE
Aug Aug Nov
28, 2015 25, 2014 20, 2013
U-1276 U-1178 U-1276 U-1178
2017 2017 2025 2025 2023 2024 2023 2023 2022 2022
DS DS
DS DS
U-1276 U-1178 U-1276 U-1178
I-656 NDF NCE
Aug Aug Nov
28, 2015 25, 2014 20, 2013
U-1178 U-1276 U-1276 U-1178
2017 2017 2025 2025 2023 2024 2023 2023 2022 2022
DS DS
DS DS
U-1276 U-1178 U-1178 U-1276
I-656 NDF NCE
Aug Aug Nov
28, 2015 25, 2014 20, 2013
U-1276 U-1178 U-1178 U-1276
ADA 204 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-1178 U-1276 U-1178 U-1276
EXCLUSIVITY CODE(S)
I-656 NDF NCE
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER Jun 06, N200533 005 6071970 Jun 06, 6071970 Jun 27, 7994364 Jun 27, 7994364 Nov 20, 8075872 Oct 10, 8114383 Nov 20, 8309060 Nov 20, 8309060 Aug 05, RE39593 Aug 05, RE39593 TAZAROTENE - FABIOR N202428 001 TAZAROTENE - TAZORAC N020600 001 5914334 6258830 TAZAROTENE - TAZORAC N020600 002 5914334 6258830
2017 2017 2025 2025 2023 2024 2023 2023 2022 2022
DS DS
DS DS
Aug Aug Nov
28, 2015 25, 2014 20, 2013
U-1276 U-1178 U-1178 U-1276
NDF Jun Jun 07, 2014 07, 2014 U-517 U-517
May
11, 2015
Jun Jun
07, 2014 07, 2014
U-517 U-517
TECHNETIUM TC-99M APCITIDE - ACUTECT Aug 22, 2012 N020887 001 5443815 Apr 16, 2013 5508020 Jul 08, 2014 5645815 TECHNETIUM TC-99M BICISATE KIT - NEUROLITE N020256 001 5431900 Jul 11, 2012 TECHNETIUM TC-99M MERTIATIDE KIT - TECHNESCAN MAG3 N019882 001 5573748 Nov 12, 2013
U-336
DP
TECHNETIUM TC-99M SULFUR COLLOID KIT - AN-SULFUR COLLOID N017858 001 TECHNETIUM TC-99M TEBOROXIME KIT - CARDIOTEC N019928 001 6056941 Jul 28, 2019 TEDUGLUTIDE - GATTEX KIT N203441 001 TEGASEROD MALEATE - ZELNORM N021200 001 5510353 TEGASEROD MALEATE - ZELNORM N021200 002 5510353 TELAPREVIR - INCIVEK N201917 001 7820671
ODE
Aug
13, 2019
DP
NCE Apr 26, 2013 U-466
Dec
21, 2017
Apr
26, 2013
U-466
Feb
25, 2025
DS
DP
NCE
May
23, 2016
TELAVANCIN HYDROCHLORIDE - VIBATIV Sep N022110 001 6635618 Aug 6858584 Jun 6872701 May 7008923 May 7208471 May 7351691 Jan 7531623 May 7544364 May 7700550 May 8101575 May 8158580
22, 24, 05, 06, 01, 01, 01, 01, 01, 01, 01,
2021 2022 2021 2021 2021 2021 2027 2021 2021 2021 2021
DS
DP DP DP DP DP DP
U-728
NCE
Sep
11, 2014
U-1005 DS DS DS U-728
U-282 DP DP
ADA 205 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP DP DP DP U-282 DP DP U-728
EXCLUSIVITY CODE(S)
NCE
TELAVANCIN HYDROCHLORIDE - VIBATIV Sep N022110 002 6635618 Aug 6858584 Jun 6872701 May 7008923 May 7208471 May 7351691 Jan 7531623 May 7544364 May 7700550 May 8101575 May 8158580 TELBIVUDINE - TYZEKA N022011 001 6395716 6444652 6566344 6569837 6569837 7589079 7795238 7858594 TELBIVUDINE - TYZEKA N022154 001 6395716 6444652 6566344 6569837 7795238 7858594 TELITHROMYCIN - KETEK N021144 001 5635485 D459798 TELITHROMYCIN - KETEK N021144 002 5635485 D459798 TELMISARTAN - MICARDIS N020850 001 5591762 6358986 TELMISARTAN - MICARDIS N020850 002 5591762 6358986 7998953 8003679 TELMISARTAN - MICARDIS N020850 003 5591762 6358986 TEMOZOLOMIDE - TEMODAR N021029 001 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 002 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 003 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 004 5260291 5260291*PED
22, 24, 05, 06, 01, 01, 01, 01, 01, 01, 01,
2021 2022 2021 2021 2021 2021 2027 2021 2021 2021 2021
Sep
11, 2014
U-1005 DS DS DS U-728
Aug Aug Aug Oct Oct Sep Aug Sep
10, 10, 10, 25, 25, 11, 10, 11,
2019 2019 2019 2020 2020 2023 2019 2023
DS DS
DP DP
U-782 U-782 U-782 U-782 U-999 U-999 U-999 U-999
Aug Aug Aug Oct Aug Sep
10, 10, 10, 25, 10, 11,
2019 2019 2019 2020 2019 2023
DS
DP
U-999 U-999 U-999 U-999 U-999 U-999
Apr Sep
01, 2018 24, 2015
DS
DP DP
U-578
Apr Sep
01, 2018 24, 2015
DS
DP DP
U-578
Jan Jan
07, 2014 10, 2020
U-3
Jan Jan Jun Oct
07, 10, 06, 06,
2014 2020 2020 2022
DS
DP
U-3 U-1177 U-1176
I-612
Oct
16, 2012
Jan Jan
07, 2014 10, 2020
U-3
Aug Feb
11, 2013 11, 2014
DS
DP
U-619
Aug Feb
11, 2013 11, 2014
DS
DP
U-619
Aug Feb
11, 2013 11, 2014
DS
DP
U-619
Aug Feb
11, 2013 11, 2014
DS
DP
U-619
ADA 206 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-619
EXCLUSIVITY CODE(S)
TEMOZOLOMIDE - TEMODAR N021029 005 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 006 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N022277 001 5260291 5260291*PED 6987108 7786118 TEMSIROLIMUS - TORISEL N022088 001 5362718 5362718*PED 8026276 8026276*PED 8299116 8299116*PED
Aug Feb
11, 2013 11, 2014
Aug Feb
11, 2013 11, 2014
DS
DP
U-619
Aug Feb Sep Feb
11, 11, 08, 21,
2013 2014 2023 2023
DS
DP DP DP
U-619
Apr Oct Jan Jul Jul Jan
18, 18, 20, 20, 25, 25,
2014 2014 2026 2026 2023 2024
DS
DP DP DP
M-61 M-92 M-91 ODE PED PED PED PED U-999 U-256 U-248 U-250 U-1275
May Jul Apr May Nov Nov Jan Oct
30, 09, 26, 30, 30, 30, 09, 26,
2015 2013 2013 2014 2015 2014 2014 2013
TENOFOVIR DISOPROXIL FUMARATE - VIREAD N021356 001 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695*PED Jan 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946*PED Jan 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089*PED Jan 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230*PED Jan 25,
2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018
DS DS DS DS DS DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP DP
U-999 U-256 U-248 U-250 U-1275 U-256 U-250 U-999 U-248 U-1275 U-999 U-248 U-250 U-256
M-95 NPP NPP NPP ODE PED PED PED PED
Oct Aug Jan Mar Mar Jul Apr Sep Sep
01, 16, 18, 24, 24, 18, 01, 24, 24,
2013 2015 2015 2013 2017 2015 2014 2013 2017
ADA 207 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP DP U-248 U-999 U-256 U-1275 U-250 U-248 U-256 U-999 U-250 U-256 U-1275 U-999 U-248 U-250 U-250 U-999 U-248 U-256 U-1275
EXCLUSIVITY CODE(S)
TENOFOVIR DISOPROXIL FUMARATE - VIREAD N021356 002 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695*PED Jan 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946*PED Jan 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089*PED Jan 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230*PED Jan 25, TENOFOVIR DISOPROXIL FUMARATE - VIREAD N021356 003 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695*PED Jan 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946*PED Jan 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089*PED Jan 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230*PED Jan 25,
2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018
Oct Aug Jan Mar Mar Apr Jul Sep Sep
01, 16, 18, 24, 24, 01, 18, 24, 24,
2013 2015 2015 2013 2017 2014 2015 2017 2013
2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018
DS DS DS DS DS DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP DP
U-248 U-250 U-256 U-1275 U-999 U-999 U-250 U-248 U-256 U-250 U-1275 U-256 U-248 U-999 U-256 U-248 U-250 U-999 U-1275
01, 16, 18, 24, 24, 01, 18, 24, 24,
2013 2015 2015 2013 2017 2014 2015 2017 2013
ADA 208 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP DP U-999 U-248 U-250 U-1275 U-256 U-999 U-248 U-256 U-250 U-248 U-1275 U-250 U-256 U-999 U-256 U-999 U-250 U-248 U-1275
EXCLUSIVITY CODE(S)
TENOFOVIR DISOPROXIL FUMARATE - VIREAD N021356 004 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695*PED Jan 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946*PED Jan 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089*PED Jan 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230*PED Jan 25, TENOFOVIR DISOPROXIL FUMARATE - VIREAD N022577 001 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695*PED Jan 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946*PED Jan 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089*PED Jan 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230*PED Jan 25, TERAZOSIN HYDROCHLORIDE - HYTRIN N019057 001 5294615 Apr 5294615 Apr 5412095 Apr TERAZOSIN HYDROCHLORIDE - HYTRIN Apr N019057 002 5294615 Apr 5294615 Apr 5412095 TERAZOSIN HYDROCHLORIDE - HYTRIN N019057 003 5294615 Apr 5294615 Apr Apr 5412095 TERAZOSIN HYDROCHLORIDE - HYTRIN Apr N019057 004 5294615 Apr 5294615 Apr 5412095
2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018
01, 16, 18, 24, 24, 01, 18, 24, 24,
2013 2015 2015 2013 2017 2014 2015 2017 2013
2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018 2017 2017 2017 2017 2017 2018
DS DS DS DS DS DS DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP DP DP
U-256 U-248 U-250 U-999 U-1275 U-999 U-256 U-250 U-248 U-1275 U-248 U-999 U-256 U-1275 U-250 U-256 U-250 U-1275 U-999 U-248
M-95 NPP NPP NDF ODE PED PED PED PED
Oct Aug Mar Jan Mar Apr Sep Sep Jul
01, 16, 24, 18, 24, 01, 24, 24, 18,
2013 2015 2013 2015 2017 2014 2017 2013 2015
29, 2013 29, 2013 29, 2013
U-165 U-3
29, 2013 29, 2013 29, 2013
U-3 U-165
29, 2013 29, 2013 29, 2013
U-165 U-3
29, 2013 29, 2013 29, 2013
U-3 U-165
ADA 209 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-165 U-3
EXCLUSIVITY CODE(S)
TERAZOSIN HYDROCHLORIDE - HYTRIN N020347 001 5294615 Apr 5294615 Apr 5412095 Apr TERAZOSIN HYDROCHLORIDE - HYTRIN N020347 002 5294615 Apr 5294615 Apr 5412095 Apr TERAZOSIN HYDROCHLORIDE - HYTRIN N020347 003 5294615 Apr 5294615 Apr 5412095 Apr TERAZOSIN HYDROCHLORIDE - HYTRIN N020347 004 5294615 Apr 5294615 Apr Apr 5412095 TERBINAFINE - LAMISIL N020846 001 5681849 5681849*PED 5856355*PED 6005001*PED TERBINAFINE - LAMISIL AT N021958 001 5681849 5681849*PED 5856355*PED
29, 2013 29, 2013 29, 2013
29, 2013 29, 2013 29, 2013
U-3 U-165
29, 2013 29, 2013 29, 2013
U-3 U-165
29, 2013 29, 2013 29, 2013
U-165 U-3
Oct Apr Nov Nov
28, 28, 18, 18,
2014 2015 2012 2012
DP
Oct Apr Nov
28, 2014 28, 2015 18, 2012
DP
TERBINAFINE HYDROCHLORIDE - LAMISIL AT N021124 001 5681849 Oct 28, 2014 5681849*PED Apr 28, 2015 TERBINAFINE HYDROCHLORIDE - LAMISIL AT N021124 002 5681849 Oct 28, 2014 5681849*PED Apr 28, 2015 TERIFLUNOMIDE - AUBAGIO N202992 001 5459163 5679709 TERIFLUNOMIDE - AUBAGIO N202992 002 5459163 5679709
Oct Oct
17, 2012 21, 2014
DP DP
NCE U-1285
Sep
12, 2017
Oct Oct
17, 2012 21, 2014
DP DP
NCE U-1285
Sep
12, 2017
TERIPARATIDE RECOMBINANT HUMAN - FORTEO N021318 001 6770623 Dec 08, 6977077 Aug 19, 7144861 Dec 08, 7163684 Aug 19, 7351414 Aug 19, 7550434 Dec 08, TERIPARATIDE RECOMBINANT HUMAN - FORTEO Dec 08, N021318 002 6770623 Aug 19, 6977077 Aug 19, 6977077 Dec 08, 7144861 Aug 19, 7163684 Aug 19, 7163684 Aug 19, 7351414 Aug 19, 7351414 Dec 08, 7550434
2018 2019 2018 2019 2019 2018
DP DP
U-597 U-597 U-790 U-865 U-982
I-602
Jul
22, 2012
DP
2018 2019 2019 2018 2019 2019 2019 2019 2018
DP
U-982 U-994 U-982 U-983 U-994 U-994 U-984 U-982
I-602
Jul
22, 2012
DP
DP
ADA 210 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-1100 U-1100 U-1100 U-1100
EXCLUSIVITY CODE(S)
NCE
TESAMORELIN ACETATE - EGRIFTA N022505 001 5861379 6020311 7144577 7316997 TESAMORELIN ACETATE - EGRIFTA N022505 002 5861379 6020311 7144577 7316997 TESTOSTERONE - ANDRODERM N020489 003 TESTOSTERONE - ANDRODERM N020489 004 TESTOSTERONE - ANDROGEL N021015 001 6503894 6503894*PED TESTOSTERONE - ANDROGEL N021015 002 6503894 6503894*PED TESTOSTERONE - ANDROGEL N021015 003 6503894 6503894*PED TESTOSTERONE - ANDROGEL N022309 001 6503894 TESTOSTERONE - ANDROGEL N022309 002 TESTOSTERONE - ANDROGEL N022309 003 TESTOSTERONE - AXIRON N022504 001 6299900 6818226 6923983 8071075 TESTOSTERONE - FORTESTA N021463 001 6319913 6579865 TESTOSTERONE - STRIANT N021543 001 6248358 TESTOSTERONE - TESTIM N021454 001 7320968 7608605 7608606 7608607 7608608 7608609 7608610 7935690 8063029 8178518 TESTOSTERONE - TESTODERM N019762 001 5840327 TESTOSTERONE - TESTODERM N019762 002 5840327
May May Jul Aug
26, 26, 14, 14,
2015 2015 2020 2023
Nov
10, 2015
May May Jul Aug
26, 26, 14, 14,
2015 2015 2020 2023
DS DS
DP DP
U-1100 U-1100 U-1100 U-1100
NCE
Nov
10, 2015
NS
Oct
20, 2014
NS Aug Mar 30, 2020 01, 2021 U-490
Oct
20, 2014
Aug Mar
30, 2020 01, 2021
U-490
Aug Mar
30, 2020 01, 2021
U-490
Aug
30, 2020
U-1103
NP
Apr
29, 2014
NP
Apr
29, 2014
NP Feb Feb Feb Feb 19, 19, 19, 19, 2017 2017 2017 2017 DP DP DP DP U-1103 U-1103 U-1103 U-1103
Apr
29, 2014
NP
Nov
23, 2013
Nov Nov
09, 2018 09, 2018
U-490 DP
NP
Dec
29, 2013
Aug
23, 2019
U-527
Jan Apr Apr Apr Apr Apr Apr Apr Apr Apr
18, 21, 21, 21, 21, 21, 21, 21, 21, 21,
2025 2023 2023 2023 2023 2023 2023 2023 2023 2023
U-843 U-1009 U-1009 U-1009 U-1009 U-1009 U-1009 U-1009 U-843 DP
Aug
15, 2016
Aug
15, 2016
ADA 211 of 227

See report footnote for information regarding report content PATENT EXPIRATION DATE PATENT
DELIST
REQUESTED EXCLUSIVITY
EXPIRATION
DATE
APPL/PROD NO
PATENT NO
PATENT CODES
U-440
EXCLUSIVITY CODE(S)
TESTOSTERONE - TESTODERM TTS

N020791 001 6348210
TESTOSTERONE - TESTOSTERONE N202763 001 TETRABENAZINE - XENAZINE N021894 001 TETRABENAZINE - XENAZINE N021894 002 THALIDOMIDE - THALOMID
N020785 001 5629327
6045501
6045501
6235756
6315720
6315720
6561976
6561976
6561977
6561977
6755784
6755784
6869399
6869399
6869399
6869399
6908432
6908432
7141018
7141018
7141018
7141018
7230012
7435745
7723361
7874984
7874984
7874984
7874984
7874984
7959566
8143283
8204763
8315886
Nov
10, 2019
NP
Feb
14, 2015
NCE ODE
Aug Aug
15, 2013 15, 2015
NCE ODE May Aug Aug Mar Oct Oct Aug Aug Oct Oct Oct Oct Oct Oct Oct Oct Aug Aug Oct Oct Oct Oct Dec Nov Mar Aug Aug Aug Aug Aug Oct Mar Aug Oct 13, 28, 28, 01, 23, 23, 28, 28, 23, 23, 23, 23, 23, 23, 23, 23, 28, 28, 23, 23, 23, 23, 09, 03, 01, 28, 28, 28, 28, 28, 23, 01, 28, 23, 2014 2018 2018 2013 2020 2020 2018 2018 2020 2020 2020 2020 2020 2020 2020 2020 2018 2018 2020 2020 2020 2020 2023 2017 2013 2018 2018 2018 2018 2018 2020 2013 2018 2020 U-731 U-371
U-731
U-731
U-442
U-731
U-371
U-731
U-731
U-371
U-731
U-371
U-733
U-371
U-732
U-731
U-731
U-371
U-733
U-371
U-731
U-732
DP
U-899
U-1058
U-442
U-1109
U-732
U-371
U-733
U-1155
U-1236
U-1249
U-1249
ODE
Aug Aug
15, 2013 15, 2015
May
25, 2013
ADA 212 of 227

See report footnote for information regarding report content PATENT
EXPIRATION
DATE
PATENT DELIST REQUESTED EXCLUSIVITY EXPIRATION DATE
APPL/PROD NO
PATENT NO
PATENT CODES
U-731 U-371 U-731 U-731 U-731 U-442 U-731 U-371 U-731 U-371 U-371 U-731 U-733 U-732 U-731 U-371 U-731 U-371 U-371 U-731 U-733 U-732 DP
U-899
U-1058
U-733
U-732
U-371
U-442
U-1109
U-1155
U-1236
U-1249
U-1249
EXCLUSIVITY CODE(S)
ODE
THALIDOMIDE - THALOMID N020785 002 5629327 6045501 6045501 6235756 6315720 6315720 6561976 6561976 6561977 6561977 6755784 6755784 6869399 6869399 6869399 6869399 6908432 6908432 7141018 7141018 7141018 7141018 7230012 7435745 7723361 7874984 7874984 7874984 7874984 7874984 7959566 8143283 8204763 8315886
May Aug Aug Mar Oct Oct Aug Aug Oct Oct Oct Oct Oct Oct Oct Oct Aug Aug Oct Oct Oct Oct Dec Nov Mar Aug Aug Aug Aug Aug Oct Mar Aug Oct
13, 28, 28, 01, 23, 23, 28, 28, 23, 23, 23, 23, 23, 23, 23, 23, 28, 28, 23, 23, 23, 23, 09, 03, 01, 28, 28, 28, 28, 28, 23, 01, 28, 23,
2014 2018 2018 2013 2020 2020 2018 2018 2020 2020 2020 2020 2020 2020 2020 2020 2018 2018 2020 2020 2020 2020 2023 2017 2013 2018 2018 2018 2018 2018 2020 2013 2018 2020
May
25, 2013
ADA 213 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-731 U-371 U-731 U-731 U-731 U-442 U-731 U-371 U-731 U-371 U-731 U-371 U-731 U-733 U-732 U-371 U-731 U-371 U-731 U-733 U-371 U-732 DP U-899 U-1058 U-733 U-371 U-442 U-1109 U-732 U-1155 U-1236 U-1249 U-1249
EXCLUSIVITY CODE(S)
ODE
THALIDOMIDE - THALOMID N020785 003 5629327 6045501 6045501 6235756 6315720 6315720 6561976 6561976 6561977 6561977 6755784 6755784 6869399 6869399 6869399 6869399 6908432 6908432 7141018 7141018 7141018 7141018 7230012 7435745 7723361 7874984 7874984 7874984 7874984 7874984 7959566 8143283 8204763 8315886 THALIDOMIDE - THALOMID N020785 004 5629327 6045501 6235756 6315720 6561976 6561977 6755784 6869399 6908432 7141018 7435745 7723361 7874984 7874984 7874984 7874984 7874984 7959566 8143283 8204763 8315886 THYROTROPIN ALFA - THYROGEN N020898 001 5840566 6365127
May Aug Aug Mar Oct Oct Aug Aug Oct Oct Oct Oct Oct Oct Oct Oct Aug Aug Oct Oct Oct Oct Dec Nov Mar Aug Aug Aug Aug Aug Oct Mar Aug Oct
13, 28, 28, 01, 23, 23, 28, 28, 23, 23, 23, 23, 23, 23, 23, 23, 28, 28, 23, 23, 23, 23, 09, 03, 01, 28, 28, 28, 28, 28, 23, 01, 28, 23,
2014 2018 2018 2013 2020 2020 2018 2018 2020 2020 2020 2020 2020 2020 2020 2020 2018 2018 2020 2020 2020 2020 2023 2017 2013 2018 2018 2018 2018 2018 2020 2013 2018 2020
May
25, 2013
May Aug Mar Oct Aug Oct Oct Oct Aug Oct Nov Mar Aug Aug Aug Aug Aug Oct Mar Aug Oct
13, 28, 01, 23, 28, 23, 23, 23, 28, 23, 03, 01, 28, 28, 28, 28, 28, 23, 01, 28, 23,
2014 2018 2013 2020 2018 2020 2020 2020 2018 2020 2017 2013 2018 2018 2018 2018 2018 2020 2013 2018 2020
U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-899 U-1058 U-733 U-1109 U-371 U-732 U-442 U-1155 U-1236 U-1249 U-1249
ODE
May
23, 2013
Nov Nov
24, 2015 24, 2015
ODE DS DP U-556
Dec
14, 2014
TIAGABINE HYDROCHLORIDE - GABITRIL N020646 001 5866590 Apr 5958951 Jun TIAGABINE HYDROCHLORIDE - GABITRIL N020646 002 5866590 Apr 5958951 Jun
29, 2016 10, 2017
29, 2016 10, 2017
ADA 214 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
TIAGABINE HYDROCHLORIDE - GABITRIL N020646 003 5866590 Apr 5958951 Jun TIAGABINE HYDROCHLORIDE - GABITRIL N020646 004 5866590 Apr 5958951 Jun TIAGABINE HYDROCHLORIDE - GABITRIL Apr N020646 005 5866590 Jun 5958951 TICAGRELOR - BRILINTA N022433 001 6251910 6525060 7250419 7265124 TIGECYCLINE - TYGACIL N021821 001 7879828 RE40086 RE40183 TIMOLOL MALEATE - ISTALOL N021516 001 6335335
29, 2016 10, 2017
29, 2016 10, 2017
29, 2016 10, 2017
Jul Dec Dec Jul
15, 02, 02, 09,
2018 2019 2019 2021
DS DS DS DS
NCE DP DP DP U-1171 U-1171 U-1171
Jul
20, 2016
Feb Jun Apr
05, 2029 25, 2013 09, 2016
DP U-282 DS DP
Nov
02, 2018
DP
TIMOLOL MALEATE - TIMOLOL MALEATE N020963 001 6174524 Mar 6174524*PED Sep TIMOLOL MALEATE - TIMOLOL MALEATE N020963 002 6174524 Mar 6174524*PED Sep TIOTROPIUM BROMIDE MONOHYDRATE N021395 001 5478578 6777423 6908928 6908928 7070800 7309707 7642268 7694676 8022082 RE38912 RE39820 TIPRANAVIR - APTIVUS N021814 001 5852195 5852195*PED 6147095 6147095*PED 6169181 6169181*PED 6231887 6231887*PED TIPRANAVIR - APTIVUS N022292 001 5852195 5852195*PED 6147095 6147095*PED 6169181 6169181*PED
26, 2019 26, 2019
DP
26, 2019 26, 2019
DP
- SPIRIVA Dec 26, 2012 Sep 24, 2021 Sep 24, 2021 Sep 24, 2021 Jan 22, 2022 Sep 24, 2021 Sep 24, 2021 Mar 12, 2027 Jan 19, 2026 Oct 11, 2021 Jan 30, 2018
DS DS DS DS DS
DS
DP DP DP DP DP DP DP DP DP DP DP
M-89 U-762 U-566 U-566
Dec
17, 2012
U-1186 U-566
Jun Dec Oct Apr May Nov Jul Jan
22, 22, 29, 29, 06, 06, 27, 27,
2019 2019 2019 2020 2014 2014 2018 2019
DS U-670 DS DP
Jun Dec Oct Apr May Nov
22, 22, 29, 29, 06, 06,
2019 2019 2019 2020 2014 2014
DS U-670 DS
ADA 215 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020912 001 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020913 001 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020913 002 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020913 003 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TOBRAMYCIN - TOBI N050753 001 5508269 TOFACITINIB CITRATE - XELJANZ N203214 001 6956041 6965027 7091208 7265221 7301023 RE41783 TOLCAPONE - TASMAR N020697 001 5476875 TOLCAPONE - TASMAR N020697 002 5476875 TOLTERODINE TARTRATE - DETROL N020771 001 5382600*PED TOLTERODINE TARTRATE - DETROL N020771 002 5382600*PED
Oct
19, 2014
DP
U-909
Dec Mar Dec Dec May Dec
08, 25, 08, 08, 23, 08,
2020 2023 2020 2020 2022 2020
DP DS U-247 DS DS DS
NCE
Nov
06, 2017
Dec
19, 2012
U-219
Dec
19, 2012
U-219
Sep
25, 2012
Sep
25, 2012
TOLTERODINE TARTRATE - DETROL LA N021228 001 5382600*PED Sep 6630162 Nov 6630162*PED May 6770295 Aug 6770295*PED Feb 6911217 Aug 6911217*PED Feb TOLTERODINE TARTRATE - DETROL LA N021228 002 5382600*PED Sep Nov 6630162 May 6630162*PED Aug 6770295 Feb 6770295*PED Aug 6911217 Feb 6911217*PED
25, 11, 11, 26, 26, 26, 26,
2012 2019 2020 2019 2020 2019 2020
DP DP DP DP
U-544 U-544 U-544 U-544
25, 11, 11, 26, 26, 26, 26,
2012 2019 2020 2019 2020 2019 2020
DP DP DP DP
U-544 U-544 U-544 U-544
ADA 216 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-978
EXCLUSIVITY CODE(S)
NCE
TOLVAPTAN - SAMSCA N022275 001 5258510 5753677 TOLVAPTAN - SAMSCA N022275 002 5258510 5753677 TOLVAPTAN - SAMSCA N022275 003 5258510 5753677 TOPIRAMATE - TOPAMAX N020505 001 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 002 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 003 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 004 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 005 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED
Nov May
02, 2012 19, 2015
May
19, 2014
Nov May
02, 2012 19, 2015
DS
DP U-978
NCE
May
19, 2014
Nov May
02, 2012 19, 2015
DS
DP U-978
NCE
May
19, 2014
Oct Apr Oct Apr Oct Apr Oct Apr
13, 13, 13, 13, 13, 13, 13, 13,
2015 2016 2015 2016 2015 2016 2015 2016
U-598 U-598 U-723 U-955
M-54 NPP PED
Dec Jul Jun
22, 2012 15, 2014 22, 2013
13, 13, 13, 13, 13, 13, 13, 13,
2015 2016 2015 2016 2015 2016 2015 2016
U-598 U-598 U-723 U-955
M-54 NPP PED
Dec Jul Jun
22, 2012 15, 2014 22, 2013
13, 13, 13, 13, 13, 13, 13, 13,
2015 2016 2015 2016 2015 2016 2015 2016
U-598 U-598 U-723 U-955
M-54 PED
Dec Jun
22, 2012 22, 2013
13, 13, 13, 13, 13, 13, 13, 13,
2015 2016 2015 2016 2015 2016 2015 2016
U-598 U-598 U-723 U-955
M-54 NPP PED
Dec Jul Jun
22, 2012 15, 2014 22, 2013
13, 13, 13, 13, 13, 13, 13, 13,
2015 2016 2015 2016 2015 2016 2015 2016
U-598 U-598 U-723 U-955
M-54 NPP PED
Dec Jul Jun
22, 2012 15, 2014 22, 2013
ADA 217 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-598 U-598 U-723 U-955
EXCLUSIVITY CODE(S)
M-54 PED
TOPIRAMATE - TOPAMAX N020505 006 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020844 001 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7125560 7125560*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020844 002 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7125560 7125560*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX SPRINKLE N020844 003 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7125560 7125560*PED 7498311 7498311*PED
13, 13, 13, 13, 13, 13, 13, 13,
2015 2016 2015 2016 2015 2016 2015 2016
Dec Jun
22, 2012 22, 2013
Oct Apr Oct Apr Oct Apr Mar Sep Oct Apr
13, 13, 13, 13, 13, 13, 01, 01, 13, 13,
2015 2016 2015 2016 2015 2016 2019 2019 2015 2016
U-598 U-598 U-723 U-766 U-955
M-54 NPP PED
Dec Jul Jun
22, 2012 15, 2014 22, 2013
13, 13, 13, 13, 13, 13, 01, 01, 13, 13,
2015 2016 2015 2016 2015 2016 2019 2019 2015 2016
U-598 U-598 U-723 U-766 U-955
M-54 NPP PED
Dec Jul Jun
22, 2012 15, 2014 22, 2013
13, 13, 13, 13, 13, 13, 01, 01, 13, 13,
2015 2016 2015 2016 2015 2016 2019 2019 2015 2016
U-598 U-598 U-723 U-766 U-955
M-54 PED
Dec Jun
22, 2012 22, 2013
TOPOTECAN HYDROCHLORIDE - HYCAMTIN N020671 001 5674872 Oct 5674872*PED Apr TOPOTECAN HYDROCHLORIDE - HYCAMTIN N020981 001 8158645 Dec TOPOTECAN HYDROCHLORIDE - HYCAMTIN N020981 002 8158645 Dec TRAMADOL HYDROCHLORIDE - CONZIP N022370 001 7858118 Apr TRAMADOL HYDROCHLORIDE - CONZIP N022370 002 7858118 Apr TRAMADOL HYDROCHLORIDE - CONZIP N022370 003 7858118 Apr TRAMADOL HYDROCHLORIDE - RYBIX ODT N021693 001 5464632 Mar 6106861 Dec
07, 2014 07, 2015
U-910
10, 2024
DP
10, 2024
DP
11, 2022
DP
U-1104
11, 2022
DP
U-1104
11, 2022
DP
U-1104
22, 2013 05, 2017
DP DP
ADA 218 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP
EXCLUSIVITY CODE(S)
TRAMADOL HYDROCHLORIDE - RYZOLT May N021745 001 5591452 May 6254887 Jun 6607748 Oct 7988998 TRAMADOL HYDROCHLORIDE - RYZOLT May N021745 002 5591452 May 6254887 Jun 6607748 Oct 7988998 TRAMADOL HYDROCHLORIDE - RYZOLT May N021745 003 5591452 May 6254887 Jun 6607748 Oct 7988998 TRAMADOL HYDROCHLORIDE - ULTRAM Oct N020281 001 6339105 Apr 6339105*PED TRAMADOL HYDROCHLORIDE - ULTRAM Oct N020281 002 6339105 Apr 6339105*PED TRANDOLAPRIL - MAVIK N020528 001 5744496 TRANDOLAPRIL - MAVIK N020528 002 5744496 TRANDOLAPRIL - MAVIK N020528 003 5744496
10, 10, 29, 27,
2014 2014 2020 2023
10, 10, 29, 27,
2014 2014 2020 2023
DP DP DP DP
10, 10, 29, 27,
2014 2014 2020 2023
DP DP DP DP
12, 2019 12, 2020
U-435 U-435
12, 2019 12, 2020
U-435 U-435
Apr
28, 2015
U-229
Apr
28, 2015
U-229
Apr
28, 2015
U-229
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 001 5721244 Feb 24, 2015 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 002 5721244 Feb 24, 2015 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 003 5721244 Feb 24, 2015 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 004 5721244 Feb 24, 2015 TRANEXAMIC ACID - LYSTEDA N022430 001 7947739 8022106 8273795 TRAVOPROST - TRAVATAN N021257 001 5510383 5631287 5849792 5889052 6011062 TRAVOPROST - TRAVATAN Z N021994 001 5510383 5889052 8268299 8323630
Mar Mar Mar
04, 2025 04, 2025 04, 2025
DP U-1182 U-1182
NDF
Nov
13, 2012
Aug Dec Dec Dec Dec
03, 22, 22, 02, 22,
2013 2014 2014 2014 2014
DP DP DP DP
U-383 U-382 U-383 U-383
Aug Dec Oct Sep
03, 02, 13, 20,
2013 2014 2029 2027
DP DP DP DP
U-383 U-383
TRAZODONE HYDROCHLORIDE - OLEPTRO N022411 001 6607748 Jun 7829120 Mar 8133893 Mar
29, 2020 27, 2027 13, 2029
DS
DP DP DP
NDF U-796
Feb
02, 2013
ADA 219 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
NDF
TRAZODONE HYDROCHLORIDE - OLEPTRO N022411 002 6607748 Jun 7829120 Mar 8133893 Mar TREPROSTINIL SODIUM - REMODULIN N021272 001 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - REMODULIN N021272 002 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - REMODULIN N021272 003 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - REMODULIN N021272 004 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - TYVASO N022387 001 5153222 6521212 6756033 6765117 TRETINOIN - ATRALIN N022070 001 5670547 TRETINOIN - RENOVA N021108 001 6531141 TRETINOIN - RETIN-A MICRO N020475 001 5955109 TRETINOIN - RETIN-A MICRO N020475 002 5955109
29, 2020 27, 2027 13, 2029
Feb
02, 2013
U-796
DS
06, 2014 24, 2017 29, 2029
U-455 DS DP U-1174
06, 2014 24, 2017 29, 2029
U-455 DS DP U-1174
06, 2014 24, 2017 29, 2029
U-455 DS DP U-1174
06, 2014 24, 2017 29, 2029
U-455 DS DP U-1174
Oct Nov Nov Oct
16, 13, 13, 24,
2014 2018 2018 2017
U-1019 U-1018 U-1018 DS
NDF ODE
Jul Jul
30, 2012 30, 2016
Sep
23, 2014
DP
Mar
07, 2020
Sep
21, 2016
DP
U-134
Sep
21, 2016
U-134
TRIAMCINOLONE ACETONIDE - NASACORT AQ N020468 001 5976573 Jul 03, 5976573 Jul 03, 6143329 Jul 03, 7977045 Jul 03,
2016 2016 2016 2016
DP DP DP DP
U-896 U-295 U-896 U-896
TRIAMCINOLONE ACETONIDE - TRIESENCE N022048 001 6395294 Jan 13, 2020 8128960 Dec 17, 2029 8211880 Mar 10, 2029 8211880 Mar 10, 2029 TRIMETHOPRIM HYDROCHLORIDE - PRIMSOL A074973 001 5763449 Aug 07, 2016 5962461 Aug 07, 2016 TRIMETREXATE GLUCURONATE - NEUTREXIN N020326 001 6017922 May 18, 2018 TRIMETREXATE GLUCURONATE - NEUTREXIN N020326 002 6017922 May 18, 2018 TRIPTORELIN PAMOATE - TRELSTAR N020715 001 5776885 Jul TRIPTORELIN PAMOATE - TRELSTAR N021288 001 5776885 Jul
DP DP
U-846 U-1257 U-1258
07, 2015
07, 2015
DP
ADA 220 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
NP
TRIPTORELIN PAMOATE - TRELSTAR N022437 001 5776885 Jul TROGLITAZONE - PRELAY N020719 001 5602133 5859037 6011049 6046202 TROGLITAZONE - PRELAY N020719 002 5602133 5859037 6011049 6046202 TROGLITAZONE - PRELAY N020719 003 5602133 5859037 6011049 6046202 TROGLITAZONE - REZULIN N020720 001 5602133 5859037 6011049 6046202 TROGLITAZONE - REZULIN N020720 002 5602133 5859037 6011049 6046202 TROGLITAZONE - REZULIN N020720 003 5602133 5859037 6011049 6046202
07, 2015
Mar
10, 2013
Sep Nov Nov Sep
15, 13, 13, 15,
2013 2017 2017 2013
U-173 U-251 U-301 U-317
Sep Nov Nov Sep
15, 13, 13, 15,
2013 2017 2017 2013
U-173 U-251 U-301 U-317
Sep Nov Nov Sep
15, 13, 13, 15,
2013 2017 2017 2013
U-173 U-251 U-301 U-317
Sep Nov Nov Sep
15, 13, 13, 15,
2013 2017 2017 2013
U-173 U-251 U-301 U-317
Sep Nov Nov Sep
15, 13, 13, 15,
2013 2017 2017 2013
U-173 U-251 U-301 U-317
Sep Nov Nov Sep
15, 13, 13, 15,
2013 2017 2017 2013
U-173 U-251 U-301 U-317
TROSPIUM CHLORIDE - SANCTURA XR N022103 001 7410978 Feb 7759359 Nov 7763635 Nov 7781448 Nov 7781449 Nov TROVAFLOXACIN MESYLATE - TROVAN N020759 001 5763454 Jun 6187341 Jan TROVAFLOXACIN MESYLATE - TROVAN N020759 002 5763454 Jun 6187341 Jan TRYPAN BLUE - MEMBRANEBLUE N022278 001 ULIPRISTAL ACETATE - ELLA N022474 001 UNOPROSTONE ISOPROPYL - RESCULA N021214 001 5221763 Jul 6458836 Jul 6458836 Jul UROFOLLITROPIN - FERTINEX N019415 004 5767067 UROFOLLITROPIN - FERTINEX N019415 005 5767067
01, 04, 04, 04, 04,
2025 2024 2024 2024 2024
DP U-1071 U-1071 U-1071 U-1071
15, 2015 20, 2019
U-282
15, 2015 20, 2019
U-282
ODE
Feb
20, 2016
NCE 15, 2012 09, 2021 09, 2021 DS U-333 U-1315
Aug
13, 2015
Jun
16, 2015
Jun
16, 2015
ADA 221 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DS DS U-894 U-530 U-894 U-530
EXCLUSIVITY CODE(S)
VALACYCLOVIR HYDROCHLORIDE - VALTREX N020487 001 5879706 Jan 19, 2016 5879706 Jan 19, 2016 5879706*PED Jul 19, 2016 6107302 Jan 19, 2016 6107302 Jan 19, 2016 6107302*PED Jul 19, 2016 VALACYCLOVIR HYDROCHLORIDE - VALTREX N020487 002 5879706 Jan 19, 2016 5879706 Jan 19, 2016 5879706*PED Jul 19, 2016 6107302 Jan 19, 2016 6107302 Jan 19, 2016 6107302*PED Jul 19, 2016 VALDECOXIB - BEXTRA N021341 002 5633272 VALDECOXIB - BEXTRA N021341 003 5633272
DP DP DS DS
U-894 U-530 U-530 U-894
Feb
13, 2015
U-462
Feb
13, 2015
U-462
VALGANCICLOVIR HYDROCHLORIDE - VALCYTE Mar 29, 2015 N021304 001 6083953 Mar 29, 2015 6083953 Sep 29, 2015 6083953*PED VALGANCICLOVIR HYDROCHLORIDE - VALCYTE N022257 001 6083953 Mar 29, 2015 6083953 Mar 29, 2015 VALSARTAN - DIOVAN N020665 001 5399578*PED VALSARTAN - DIOVAN N020665 002 5399578*PED VALSARTAN - DIOVAN N021283 001 5399578*PED 5972990 5972990*PED 6294197 6294197*PED VALSARTAN - DIOVAN N021283 002 5399578*PED 5972990 5972990*PED 6294197 6294197*PED VALSARTAN - DIOVAN N021283 003 5399578*PED 5972990 5972990*PED 6294197 6294197*PED VALSARTAN - DIOVAN N021283 004 5399578*PED 5972990 5972990*PED 6294197 6294197*PED VANDETANIB - CAPRELSA N022405 001 7173038 8067427 RE42353
DS DS
DP DP
U-854 U-384
D-125 I-604 PED
Aug Aug Feb
05, 2013 28, 2012 28, 2013
DS DS
DP DP
U-854 U-384
NDF PED
Aug Feb
28, 2012 28, 2013
Sep
21, 2012
Sep
21, 2012
Sep Oct Apr Jun Dec
21, 26, 26, 18, 18,
2012 2016 2017 2017 2017
U-692 U-3
Sep Oct Apr Jun Dec
21, 26, 26, 18, 18,
2012 2016 2017 2017 2017
U-692 U-3
Sep Oct Apr Jun Dec
21, 26, 26, 18, 18,
2012 2016 2017 2017 2017
U-692 U-3
Sep Oct Apr Jun Dec
21, 26, 26, 18, 18,
2012 2016 2017 2017 2017
U-692 U-3
Aug Aug Sep
14, 2021 08, 2028 23, 2017
DS DS
DP DP DP
NCE ODE
Apr Apr
06, 2016 06, 2018
ADA 222 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP DP
EXCLUSIVITY CODE(S)
NCE ODE
VANDETANIB - CAPRELSA N022405 002 7173038 8067427 RE42353
Aug Aug Sep
14, 2021 08, 2028 23, 2017
Apr Apr
06, 2016 06, 2018
VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 001 6362178 Oct 7696206 Oct 8273876 Jul VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 002 6362178 Oct 7696206 Oct 8273876 Jul VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 003 6362178 Oct 7696206 Oct 8273876 Jul VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 004 6362178 Oct 7696206 Oct 8273876 Jul VARDENAFIL HYDROCHLORIDE - STAXYN N200179 001 6362178 Oct 7696206 Oct VARENICLINE TARTRATE - CHANTIX May N021928 001 6410550 May 6890927 Aug 7265119 VARENICLINE TARTRATE - CHANTIX N021928 002 6410550 May May 6890927 Aug 7265119 VELAGLUCERASE ALFA - VPRIV N022575 001 VELAGLUCERASE ALFA - VPRIV N022575 002 VEMURAFENIB - ZELBORAF N202429 001 7504509 7863288 8143271
31, 2018 31, 2018 23, 2027
DS DS
DP DP
U-533 U-533 U-1288
31, 2018 31, 2018 23, 2027
DS DS
DP DP
U-533 U-533 U-1288
31, 2018 31, 2018 23, 2027
DS DS
DP DP
U-533 U-533 U-1288
31, 2018 31, 2018 23, 2027
DS DS
DP DP
U-533 U-533 U-1288
31, 2018 31, 2018
U-155 U-155
NDF
Jun
17, 2013
10, 2020 06, 2022 03, 2022
DS DS DS
DP DP DP
U-56 U-56 U-56
M-105
Jul
22, 2014
10, 2020 06, 2022 03, 2022
DS DS DS
DP DP DP
U-56 U-56 U-56
M-105
Jul
22, 2014
NCE
Feb
26, 2015
NCE Oct Jun Jun 22, 2026 20, 2029 21, 2026 DS DS DS DP DP DP
Feb
26, 2015
NCE ODE
Aug Aug
17, 2016 17, 2018
VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 001 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 Jun 28, 2013 6310101 Mar 20, 2017 6403120 Mar 20, 2017 6403120 Sep 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Mar 20, 2017 6419958 Mar 20, 2017 6419958 Sep 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Jun 28, 2013 6444708 Dec 28, 2013 6444708*PED
U-398 U-398
U-46 U-535 U-451 U-535 U-451 U-535 U-459 U-535 U-459 U-398 U-398
ADA 223 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-398 U-398
EXCLUSIVITY CODE(S)
VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 002 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 6310101 Jun 28, 2013 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Sep 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Sep 20, 2017 6444708 Jun 28, 2013 6444708*PED Dec 28, 2013 VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 003 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Sep 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Sep 20, 2017 6444708 Jun 28, 2013 6444708*PED Dec 28, 2013 VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 004 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 6310101 Jun 28, 2013 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Sep 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Sep 20, 2017 6444708 Jun 28, 2013 6444708*PED Dec 28, 2013 VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 001 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 002 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 003 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017
U-46 U-451 U-535 U-451 U-535 U-459 U-535 U-535 U-459 U-398 U-398
U-398 U-398
U-535 U-451 U-451 U-535 U-535 U-459 U-459 U-535 U-398 U-398
U-398 U-398
U-46 U-535 U-451 U-451 U-535 U-459 U-535 U-459 U-535 U-398 U-398
U-535 U-839 U-535 U-839
U-839 U-535 U-839 U-535
U-839 U-535 U-535 U-839
ADA 224 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-839 U-535 U-839 U-535
EXCLUSIVITY CODE(S)
VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 004 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 VERAPAMIL HYDROCHLORIDE - COVERA-HS Apr 04, 2017 N020552 001 6096339 VERAPAMIL HYDROCHLORIDE - COVERA-HS N020552 002 6096339 Apr 04, 2017 VERTEPORFIN - VISUDYNE N021119 001 5707608 5756541 5770619 5798349 VIGABATRIN - SABRIL N020427 001 VIGABATRIN - SABRIL N022006 001 VILAZODONE HYDROCHLORIDE - VIIBRYD Sep N022567 001 5532241 Jun 7834020 Jun 8193195 Jun 8236804 VILAZODONE HYDROCHLORIDE - VIIBRYD Sep N022567 002 5532241 Jun 7834020 Jun 8193195 Jun 8236804 VILAZODONE HYDROCHLORIDE - VIIBRYD N022567 003 5532241 Sep Jun 7834020 Jun 8193195 Jun 8236804 VINCRISTINE SULFATE - MARQIBO KIT N202497 001 5543152 Jun 5741516 Jun 5814335 Jun 6723338 Mar 7247316 Sep Mar 7887836 VISMODEGIB - ERIVEDGE N203388 001 7888364 VORICONAZOLE - VFEND N021266 001 5567817 VORICONAZOLE - VFEND N021266 002 5567817 VORICONAZOLE - VFEND N021267 001 5567817 6632803 VORICONAZOLE - VFEND N021630 001 5567817
U-365
U-365
Aug Mar Jan Aug
02, 11, 06, 25,
2015 2016 2015 2015
U-357 U-357 U-357
NCE
Aug
21, 2014
NCE ODE 29, 05, 05, 05, 2014 2022 2022 2022 DS DS DP DP
Aug Aug
21, 2014 21, 2016
NCE U-839 U-839 U-839
Jan
21, 2016
29, 05, 05, 05,
2014 2022 2022 2022
DS DS
DP DP
NCE U-839 U-839 U-839
Jan
21, 2016
29, 05, 05, 05,
2014 2022 2022 2022
DS DS
DP DP
NCE U-839 U-839 U-839
Jan
21, 2016
20, 20, 20, 31, 25, 31,
2014 2014 2014 2020 2020 2020
DP DP DP U-1271 DP U-1271
NP ODE
Aug Aug
09, 2015 09, 2019
Nov
11, 2028
DS
DP
NCE
Jan
30, 2017
May
24, 2016
DS
DP
U-540
May
24, 2016
DS
DP
U-540
May Jun
24, 2016 02, 2018
DS
DP DP
U-540
May
24, 2016
DS
DP
U-540
ADA 225 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
U-892 DS DP DP DP U-892 DS DP U-892 U-892 U-892
EXCLUSIVITY CODE(S)
ODE
VORINOSTAT - ZOLINZA N021991 001 7399787 7456219 7652069 7732490 7851509 8067472 8093295 8101663 RE38506 ZAFIRLUKAST - ACCOLATE N020547 001 5482963 5612367 ZAFIRLUKAST - ACCOLATE N020547 003 5482963 5612367 ZANAMIVIR - RELENZA N021036 001 5360817 5648379 5648379 5648379 6294572 ZICONOTIDE - PRIALT N021060 003 5364842 5364842 5795864 ZICONOTIDE ACETATE - PRIALT N021060 001 5364842 5364842 5795864 ZICONOTIDE ACETATE - PRIALT N021060 002 5364842 5364842 5795864 ZICONOTIDE ACETATE - PRIALT N021060 004 5364842 5364842 5795864 ZILEUTON - ZYFLO CR N022052 001 6183778
Feb Mar Mar Mar Feb Mar May Mar Nov
09, 11, 04, 04, 21, 04, 16, 04, 29,
2025 2027 2023 2023 2024 2023 2026 2023 2013
Oct
06, 2013
Jan Mar
09, 2013 18, 2014
U-189
Jan Mar
09, 2013 18, 2014
U-189
Jul Jul Jul Jul Dec
26, 15, 15, 15, 15,
2013 2014 2014 2014 2014
DS
DP U-721 U-274 U-722
DS
DP
Dec Dec Jun
30, 2016 30, 2016 27, 2015
U-48 U-55 DP
Dec Dec Jun
30, 2016 30, 2016 27, 2015
U-55 U-48 DP
Dec Dec Jun
30, 2016 30, 2016 27, 2015
U-55 U-48 DP
Dec Dec Jun
30, 2016 30, 2016 27, 2015
U-55 U-48 DP
Sep
21, 2013
DP
ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 001 5312925 Sep May 6150366 Dec 6245766 ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 002 5312925 Sep May 6150366 Dec 6245766 ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 003 5312925 Sep 6150366 May Dec 6245766 ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 004 5312925 Sep 6150366 May 6245766 Dec
01, 2012 27, 2019 18, 2018
DS
DP DP U-601
I-615
Nov
20, 2012
01, 2012 27, 2019 18, 2018
DS
DP DP U-601
I-615
Nov
20, 2012
01, 2012 27, 2019 18, 2018
DS
DP DP U-601
I-615
Nov
20, 2012
01, 2012 27, 2019 18, 2018
DS
DP DP U-601
I-615
Nov
20, 2012
ADA 226 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP U-720 U-719 U-601
EXCLUSIVITY CODE(S)
ZIPRASIDONE HYDROCHLORIDE - GEODON Sep N021483 001 5312925 May 6150366 Dec 6245766 May 7175855
01, 27, 18, 18,
2012 2019 2018 2020
ZIPRASIDONE HYDROCHLORIDE - ZIPRASIDONE HYDROCHLORIDE A077560 001 ZIPRASIDONE HYDROCHLORIDE - ZIPRASIDONE HYDROCHLORIDE A077560 002 ZIPRASIDONE HYDROCHLORIDE - ZIPRASIDONE HYDROCHLORIDE A077560 003 ZIPRASIDONE HYDROCHLORIDE - ZIPRASIDONE HYDROCHLORIDE A077560 004 ZIPRASIDONE MESYLATE - GEODON N020919 001 6110918 6232304 6399777 ZOLEDRONIC ACID - RECLAST N021817 001 4939130 4939130*PED 7932241 7932241*PED 8052987 ZOLEDRONIC ACID - ZOMETA N021223 001 4939130 4939130*PED ZOLEDRONIC ACID - ZOMETA N021223 002 4939130 4939130*PED 8324189 8324189 8324189 8324189*PED ZOLEDRONIC ACID - ZOMETA N021223 003 4939130 4939130*PED 7932241 8324189 8324189 8324189 8324189*PED ZOLMITRIPTAN - ZOMIG N020768 001 5466699 5466699*PED 5863935 5863935*PED ZOLMITRIPTAN - ZOMIG N020768 002 5466699 5466699*PED 5863935 5863935*PED ZOLMITRIPTAN - ZOMIG N021450 004 5466699 5466699*PED 6750237 6750237*PED 7220767 7220767*PED
PC
Aug
29, 2012
PC
Aug
29, 2012
PC
Aug
29, 2012
PC
Aug
29, 2012
Mar Apr Apr
26, 2017 01, 2017 01, 2017
Sep Mar Feb Aug Mar
02, 02, 05, 05, 19,
2012 2013 2028 2028 2024
DS
DP DP
U-662
U-1199
Sep Mar
02, 2012 02, 2013
DS
DP
U-53
Sep Mar May May May Nov
02, 02, 29, 29, 29, 29,
2012 2013 2025 2025 2025 2025
DS
DP
U-53 U-53 U-1308 U-1309
Sep Mar Feb May May May Nov
02, 02, 05, 29, 29, 29, 29,
2012 2013 2028 2025 2025 2025 2025
DS
DP DP
U-53
U-53 U-1308 U-1309
Nov May Nov May
14, 14, 14, 14,
2012 2013 2012 2013
Nov May Nov May
14, 14, 14, 14,
2012 2013 2012 2013
Nov May Nov May Nov May
14, 14, 28, 28, 28, 28,
2012 2013 2020 2021 2020 2021
U-436 DP DP
ADA 227 of 227

APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ZOLMITRIPTAN - ZOMIG-ZMT N021231 001 5466699 5466699*PED ZOLMITRIPTAN - ZOMIG-ZMT N021231 002 5466699 5466699*PED ZOLPIDEM TARTRATE - AMBIEN CR N021774 001 6514531 6514531*PED ZOLPIDEM TARTRATE - AMBIEN CR N021774 002 6514531 6514531*PED ZOLPIDEM TARTRATE - EDLUAR N021997 001 6761910 ZOLPIDEM TARTRATE - EDLUAR N021997 002 6761910 ZOLPIDEM TARTRATE - INTERMEZZO N022328 001 7658945 7682628 8242131 8252809 ZOLPIDEM TARTRATE - INTERMEZZO N022328 002 7658945 7682628 8242131 8252809 ZOLPIDEM TARTRATE - ZOLPIMIST N022196 001 7632517
Nov May
14, 2012 14, 2013
Nov May
14, 2012 14, 2013
Dec Jun
01, 2019 01, 2020
DP
Dec Jun
01, 2019 01, 2020
DP
Sep
24, 2019
DP
U-674
Sep
24, 2019
DP
U-674
Apr Feb Aug Feb
15, 16, 20, 16,
2027 2025 2029 2025
DP
U-1194 U-1194 U-1266
NP
Nov
23, 2014
DP
Apr Feb Aug Feb
15, 16, 20, 16,
2027 2025 2029 2025
DP
U-1194 U-1194 U-1266
NP
Nov
23, 2014
DP
Oct
01, 2017
U-70
Footnote: 1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5). 2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. They may not be flagged with respect to other claims which may apply.
PATENT AND EXCLUSIVITY TERMS

PATENT & EXCLUSIVITY ABBREVIATIONS
D I M NC NCE NDF NE NP NP* NPP NR NS ODE PC PED RTO U W
ADB 1 of 55
NEW DOSING SCHEDULE (SEE INDIVIDUAL REFERENCES) NEW INDICATION (SEE INDIVIDUAL REFERENCES) MISCELLANEOUS EXCLUSIVITY CODES (SEE INDIVIDUAL REFERENCES) NEW COMBINATION NEW CHEMICAL ENTITY NEW DOSAGE FORM NEW ESTER OR SALT OF AN ACTIVE INGREDIENT NEW PRODUCT NEW PRODUCT (MINT FLAVORED) NEW PATIENT POPULATION NEW ROUTE NEW STRENGTH ORPHAN DRUG EXCLUSIVITY PATENT CHALLENGE PEDIATRIC EXCLUSIVITY RX TO OTC SWITCH OR OTC USE PATENT USE CODE (SEE INDIVIDUAL REFERENCES) EXCLUSIVITY ON THIS APPLICATION EXPIRING ON THIS DATE HAS BEEN WAIVED BY SPONSOR - SEE SECTION 1.8 OF ORANGE BOOK PREFACE WAIVED EXCLUSIVITY
EXCLUSIVITY DOSING SCHEDULE

D-1 D-2 D-3 D-4 D-5 D-6 D-7 D-8 D-9 D-10 D-11 D-12 D-13 D-14 D-15 D-16 D-17 D-18 D-19 D-20 D-21 D-22 D-23 D-24 D-25 D-26 D-27 D-28 D-29 D-30 D-31 D-32 D-33 D-34 D-35 D-36 ONCE A DAY APPLICATION ONCE DAILY DOSING SEVEN DAYS/SEVEN DAYS/SEVEN DAYS DOSING SCHEDULE SEVEN DAYS/FOURTEEN DAYS DOSING SCHEDULE TEN DAYS/ELEVEN DAYS DOSING SCHEDULE SEVEN DAYS/NINE DAYS/FIVE DAYS DOSING SCHEDULE BID DOSING INTRAVENOUS, EPIDURAL AND INTRATHECAL DOSING NARCOTIC OVERDOSE IN ADULTS NARCOTIC OVERDOSE IN CHILDREN POSTOPERATIVE NARCOTIC DEPRESSION IN CHILDREN BEDTIME DOSING OF 800MG FOR TREATMENT OF ACTIVE DUODENAL ULCER INCREASED MAXIMUM DAILY DOSAGE RECOMMENDATION BEDTIME DOSING OF 800MG FOR TREATMENT OF ACTIVE BENIGN GASTRIC ULCER SINGLE DAILY DOSE OF 25MG/37.5MG CONTINUOUS INTRAVENOUS INFUSION 400MG EVERY 12 HOURS FOR THREE DAYS FOR UNCOMPLICATED URINARY TRACT INFECTIONS LOWER RECOMMENDED STARTING DOSE GUIDELINES BOLUS DOSING GUIDELINES SINGLE 32MG DOSE ALTERNATIVE DOSAGE OF 300MG ONCE DAILY AFTER THE EVENING MEAL REDUCTION IN INFUSION TIME FROM 24 TO 4 HOURS FOR THE 60MG DOSE INCREASE MAXIMUM DOSE AND VARIATIONS IN THE DOSING REGIMEN FOR OVARIAN CANCER THE RECOMMENDED REGIMEN IS 135MG/M2 OR 175MG/M2 INTRAVENOUSLY OVER THREE HOURS EVERY THREE WEEKS ADDITIONAL DOSAGE REGIMEN EQUAL TO HALF THE ORIGINAL DOSING REGIMEN ONCE WEEKLY APPLICATION BID DOSING IN PATIENTS 12 YEARS OF AGE AND OLDER FOR PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATE EMETOGENIC CANCER CHEMOTHERAPY USE OF ISOVUE-370 IN EXCRETORY UROGRAPHY AT EQUIVALENT GRAMS OF IODINE TO THE CURRENTLY APPROVED ISOVUE-250 AND ISOVUE-300 INCREASE OF CUMULATIVE DOSE TO 0.3MMOL/KG FOR MRI OF CNS IN ADULTS 5000 IU DOSE FOR PHOPHYLAXIX AGAINST DEEP VEIN THROMBOSIS CHANGE IN RECOMMENDED TOTAL DAILY DOSE TO 80MG (40MG BID) REMOVAL OF THE RESTRICTIONS LIMITING TREATMENT TO TWO CONSECUTIVE WEEKS AND TO SMALL AREAS ONCE DAILY DOSING FOR PLAQUE PSORIASIS EVERY FOUR MONTHS DOSAGE REGIMEN FOR A ONE WEEK DOSING OF INTERDIGITAL TINEA PEDIS FOR A SINGLE 2MG DOSE AS AN ALTERNATIVE TO THE 1MG DOSE GIVEN TWICE DAILY

D-37 D-38 D-39
ADB 2 of 55
D-40 D-41 D-42 D-43 D-44
D-45 D-46 D-47 D-48 D-49 D-50 D-51 D-52 D-53 D-54 D-55 D-56 D-57 D-58 D-59 D-60 D-61 D-62 D-63 D-64 D-65 D-66 D-67 D-68 D-69 D-70 D-71 D-72 D-73 D-74 D-75 D-76 D-77 D-78 D-79
DOSING REGIMEN FOR ADMINISTRATION EITHER ONCE DAILY (QD) OR TWICE DAILY (BID) CONTINUOUS INFUSION AS AN ALTERNATE METHOD OF ADMINISTRATION CHANGE IN TIME TO TAKE THE DRUG PRIOR TO A MEAL TO PREVENT MEAL-INDUCED HEARTBURN SYMPTOMS FROM "..1/2 TO 1 HOUR BEFORE EATING" TO ".. RIGHT BEFORE EATING OR UP TO 60MIN BEFORE CONSUMING..." ONCE-A-DAY DOSING REGIMEN DRUG MAY BE DOSED RIGHT BEFORE A MEAL OR ANY TIME UP TO 30MIN BEFORE EATING OR DRINKING FOOD AND BEVERAGES THAT WOULD BE EXPECTED TO CAUSE SYMPTOMS TEN DAY DOSING REGIMEN FOR TRIPLE THERAPY, PREVACID IN COMBINATION WITH CLARITHROMYCIN AND AMOXICILLIN, FOR THE ERADICATION OF H.PYLORI IN PATIENTS WITH DUODENAL ULCER DISEASE INITIATION OF TREATMENT WITH 900MG/DAY BY DELETION OF THE REQUIREMENT TO TITRATE TO 900MG/DAY OVER A 3-DAY PERIOD IN A CLINICAL TRIAL, FEWER DISCONTINUATIONS DUE TO ADVERSE EVENTS, ESPECIALLY DIZZINESS AND VERTIGO, WERE OBSERVED WHEN TITRATING THE DOSE IN INCREMENTS OF 50MG/DAY EVERY 3 DAYS UNTIL AN EFFECTIVE DOSE (NOT EXCEEDING 400MG/DAY) WAS REACHED ONCE DAILY DOSING FOR MAINTENANCE ONLY NEW DOSING REGIMEN OF 80MG DAILY PREVENTION OF HEARTBURN SYMPTOMS WHEN ADMINISTERED FROM 15 MINUTES UP TO, BUT NOT INCLUDING, 1 HOUR PRIOR TO A PROVOCATIVE MEAL ADIMISTRATION OF CISATRICURIUM A NEUROMUSCULAR BLOCKING AGENT AT DOSES OF 3 AND 4X THE ED95 OF CISATRICURIUM FOLLOWING INDUCTION WITH THIOPENTAL PEDIATRIC DOSING GUIDELINES INFORMATION FOR USE OF CORVERT IN POST-CARDIAC SURGERY PATIENTS OPTIONAL STARTING DOSE OF 40MG/DAY ALTERNATE DOSING REGIMEN OF 1250MG TWICE DAILY USE IN PEDIATRIC PATIENTS FROM 1 MONTH TO 16 YEARS OF AGE USE OF ZYBAN FOR MAINTENANCE THERAPY. TREATMENT UP TO 6 MONTHS WAS SHOWN EFFICACIOUS ADDITION OF A HIGHER DOSE OF NUTROPIN FOR PUBERTAL PATIENTS (PUBERTAL DOSE LESS THAN OR EQUAL TO 0.7MG/KG/WEEK) ADDITION OF POSTPRANDIAL DOSING 3-HOUR INFUSION OF TAXOL GIVEN EVERY THREE WEEKS AT A DOSE OF 175MG/M2 FOLLOWED BY CISPLATIN AT A DOSE OF 75MG/M2 FOR THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN CANCER CHANGE IN DOSING INTERVAL TO ONCE-DAILY ADMINISTRATION REDUCTION OF ELEVATED LDL-C IN A NEW, HIGHER STRENGTH TABLET, 0.8MG, AND FOR EXTENSION OF THE DOSAGE RANGE TO 0.8MG DAILY ADDITION OF A POST-OPERATIVE DOSING REGIMEN ONCE WEEKLY DOSING FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS ONCE WEEKLY DOSING FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS TO ALLOW A TITRATION DOSING REGIMEN USING A 25MG DOSE INCREASING DOSAGE FOR NERVE BLOCK ANESTHESIA USING NAROPIN 7.5MG/ML AND FOR EXTENDING THE DURATION OF TREATMENT FOR POSTOPERATIVE ANALGESIA USING NAROPIN 2MG/ML CHANGE DOSING AND ADMINISTRATION TO INDICATE MAINTENANCE OF WEIGHT LOSS OVER AN 18 MONTH PERIOD THUS EXTENDING THE USE OF THIS DRUG FROM ONE TO TWO YEARS DOSING RECOMMENDATIONS FOR PATIENTS UNDERGOING PCI SHORTER TREATMENT COURSE OF THREE DAYS IN THE TREATMENT OF RECURRENT EPISODES OF GENITAL HERPES CHANGE OF ADMIN RATE FOR INFUSION OF AREDIA FOR TREATMENT OF MODERATE AND SEVERE HYPERCALCEMIA OF MALIGNANCY FROM 24 HOURS TO 2 HOURS UP TO BUT NOT INCLUDING 24 HOURS SHORTENED DOSING REGIMEN TO 5 DAYS FOR THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC BRONCHITIS 80MG ONCE DAILY DOSING REGIMEN EIGHT WEEK DOSING REGIMEN INFORMATION REGARDING INCREASED RATE OF INFUSION FOR DEPACON ONCE A WEEK DOSING FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS ONCE A WEEK DOSING FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS INTERMITTENT DOSING REGIMEN, STARTING DAILY DOSE 14 DAYS PRIOR TO THE ANTICIPATED ONSET OF MENSTRUATION THROUGH THE FIRST FULL DAY OF MENSES AND REPEATING WITH EACH NEW CYCLE FOR USE ON AN "AS NEEDED" OR PRN BASIS FOR THE MANAGEMENT OF NASAL SYMPTOMS IN PATIENTS FOR WHOM THE DRUG IS INDICATED ADDITION OF 20MG AND 40MG DAILY AS OPTIONAL STARTING DOSES WITH 40MG INTENDED FOR PATIENTS WHO REQUIRE A LARGE REDUCTION IN LDL-C (MORE THAN 45%) USE OF FLEXERIL 5MG FOR THE RELIEF OF MUSCLE SPASM ASSOCIATED WITH ACUTE, PAINFUL, MUSCULOSKELETAL CONDITIONS NEW LOWER STARTING DOSE FOR TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS AND/OR MODERATE TO SEVERE SYMPTOMS OF VULVAR AND VAGINAL ATROPHY ASSOCIATED W/ THE MENOPAUSE

D-80 D-81 D-82 D-83 D-84
ADB 3 of 55
D-85 D-86 D-87 D-88 D-89 D-90 D-91 D-92 D-93 D-94 D-95 D-96 D-97
D-98 D-99 D-100 D-101 D-102 D-103
D-104 D-105 D-106
D-107
D-108 D-109
D-110 D-111 D-112 D-113 D-114 D-115 D-116
CHANGE OF DOSING SCHEDULE FOR LANTUS FROM ONCE DAILY AT BEDTIME TO FLEXIBLE DAILY DOSING NEW LOWER STARTING DOSE FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPORSIS USE OF PREMARIN 0.3 MG AND 0.45 MG FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS 750 MG, ONCE DAILY FOR 5 DAYS FOR COMMUNITY ACQUIRED PNEUMONIA (CAP) ONCE-A-DAY DOSING OF FLOXACIN OTIC FOR THE TREATMENT OF ADULTS AND PEDIATRIC PATIENTS(AGES 6 MO & OLDER) W/ OTITIS EXTERNA CAUSED BY SUSCEPTIBLE STRAINS OF E.COLI, P.AERUGINOSA AND S.AUREUS LOWER RECOMMENDED STARTING DOSE GUIDELINES FOR TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH THE MENOPAUSE FOR USE IN SELECT EXTERNAL INSULIN PUMPS ADDITION OF ONCE-WEEKLY DOSING FOR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS NEW DOSING RANGE OF 200-400MG PER DAY IN TWO DIVIDED DOSES FOR ADULTS WITH PARTIAL SEIZURES USE OF REYATAZ 300 MG/RITONAVIR 100 MG ONCE DAILY FOR TREATMENT IN HIV-INFECTED ANTIRETROVIRAL-EXPERIENCED PATIENTS ADDITION OF DAYTIME ADMINISTRATION TO TREAT VULVOVAGINAL CANDIDIASIS ALTERNATE INTERMITTENT DOSING REGIMEN ALTERNATIVE DOSAGE OF 1000MG ONCE DAILY AT BEDTIME ALTERNATE TWO OR THREE TIMES DAILY DOSING REGIMENS NEW MAXIMUM DOSAGE OF 72 MG/DAY IN ADOLESCENTS 13-17 YEARS OF AGE WITH ATTENTION DEFECIT HYPERACTIVITY DISORDER (ADHD) BROADENED INITIAL STARTING DOSE FOR HYPERTENSION FROM 50 MG TO 100 MG TO 25 MG TO 100 MG DOSE RANGE ONCE-MONTHLY TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH BONIVA (IBANDRONATE SODIUM) 150 MG TABLETS PED CANCER PT POPULATION EXPANDED TO INCLUDE PTS 6 MOS UP TO BUT NOT INCLUDING 4 YRS AND DOSING INSTRUCTIONS TO ADMIN 30 MIN BEFPRE CHEMO WITH SECOND AND THIRD DOSES 4 & 8 HOURS AFTER FIRST DOSE DOSING FOR PED SURGICAL PTS EXPANDED TO INCLUDE PTS 1 MONTH UP TO BUT NOT INCLUDING 2 YEARS OF AGE ONCE DAILY ADMINISTRATION FOR THE TREATMENT OF HIV INFECTION IN THERAPY NAIVE ADULT PATIENTS 750 MG ONCE DAILY FOR FIVE DAYS FOR THE TREATMENT OF ACUTE BACTERIAL SINUSITIS ONCE DAILY IN CHRONIC IDIOPATHIC UTICARIA FOR ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER NEW DOSING REGIMEN OF ONE SPRAY TWICE DAILY FOR SEASONAL ALLERIC RHINITIS IN PATIENTS 12 YRS OF AGE AND OLDER NEW DOSING RECOMMENDATION FOR THE TREATMENT OF RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT PATIENTS, SPECIFICALLY A REDUCTION IN COURSE OF THERAPY FROM FAMCICLOVIR 125 MG TWICE-A-DAY FOR 5 DAYS TO 1000 MG TWICE-A-DAY FOR 1 DAY. 0.5MG/0.1MG FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE IN WOMEN WHO HAVE A UTERUS USE OF ACTONEL 75MG TWO CONSECUTIVE DAYS PER MONTH FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS FIVE DAY TREATMENT OF SELECTED SUSCEPTIBLE STRAINS OF STREPTOCOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZA, MYCOPLASMA PNEUMONIAE, AND CHLAMYDIA PNEUMONIAE FOR COMMUNITYACQUIRED PNEUMONIA PROVIDES FOR THE COMBINATION TABLET OF 70MG ALENDRONATE AND 5600 IU OF VITAMIN D3 FOR THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AND TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS TREATMENT OF COMPLICATED URINARY TRACT INFECTION AND ACUTE PYELONEPHRITIS WITH LEVAQUIN 750MG ONCE DAILY FOR FIVE DAYS PROVIDE FOR THE USE OF A LOWER DOSE FOR THE TREATMENT OF ADULTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB MESYLATE TREATMENT OF SCHIZOPHRENIA IN ADOLESCENTS AGED 13-17 PROVIDES FOR ONCE DAILY USE OF CIALIS, 2.5 MG AND 5 MG, FOR THE TREAMTENT OF ERECTILE DYSFUNCTION PROVIDES FOR PEDIATRIC PUMP USE ONCE DAILY DOSING REGIMEN FOR PATIENTS WHO BECOME CONSTIPATED ON TWICE DAILY REGIMEN NEW DOSING RECOMMENDATIONS FOR USE OF SIROLIMUS IN COMBINATION WITH CYCLOSPORINE FOR THE PROPHYLAXIS OF REJECTION IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS STARTING DOSE OF 15MG/DAY FOR MONOTHERAPY IN ACUTE TREATMENT OF BIPOLAR DISORDER, MANIC OR MIXED ALTERNATIVE DOSING REGIMEN ATAZANAVIR SULATE CO-ADMINISTERED WITH RITONAVIR FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT NAIVE PATIENTS

D-117 D-118 D-119 D-120 D-121 D-122 D-123 D-124 D-125
ADB 4 of 55
D-126 D-127 D-128
D-129 D-130
D-131 D-132 D-133
D-134
50 MG TABLET FOR INITIATION OF DOSE TITRATION FOR BIPOLAR DISORDER TWO 400MG TABLETS ONCE DAILY, CO-ADMINISTERED WITH 100MG RITONAVIR DOSING RECOMMENDATIONS FOR HIV INFECTED PEDIATRIC PATIENTS 6 TO LESS THAN 18 YEARS OF AGE DOSING REGIMEN ADJUSTMENTS CHANGE TO REMOVE 20 MG MAXIMUM DOSAGE RESTRICTION USE OF VAGIFEM 10 MCG FOR THE TREATMENT OF ATROPHIC VAGINITIS DUE TO MENOPAUSE ALTERNATIVE DOSING REGIMEN DOSE OF 20 MG/METER SQUARE BY CONTINUOUS INTRAVENOUS INFUSION OVER 1 HOUR REPEATED DAILY FOR 5 DAYS ONCE DAILY DOSING REGIMEN IN ADULT PATIENTS WITH LESS THAN THREE LOPINAVIR RESISTANCEASSOCIATED SUBSTITUTIONS EXTEND CURRENT DOSING REGIMEN TO 900MG (2-450MG TABLETS) ONCE A DAY WITHIN 10 DAYS OF TRANSPLANTATION UNTIL 200 DAYS POST-TRANSPLANTATION FOR THE PREVENTION OF CYTOMEGALOVIRUS (CMV) DISEASE IN ADULT KIDNEY TRANSPLANT PATIENTS AT HIGH RISK. CHANGE DOSAGE REGIMEN FROM 250MG TO 500MG DOSING REGIMEN FOR ADULT PATIENTS WITH CHRONIC HEPATITIS B (CHB) AND DECOMPENSATED LIVER DESEASE SINGLE IV DOSE OF FOSAPREPITANT 150MG, DOSED CONCOMITANTLY WITH 5HT3 RECEPTOR ANTAGONIST & CORTICOSTEROID, FOR PREVENTION OF ACUTE & DELAYED NAUSEA & VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY EMETOGENIC CANCER CHEMO 800/100 MG DARUNAVIR/RITONAVIR, ONCE DAILY, IN TREATMENT -EXPERIENCED HIV-1 INFECTED PATIENTS WITH NO DARUNIVIR RESISTANCE ASSOCIATED SUBSITUTIONS DOSING RECOMMENDATIONS FOR TREATMENT OF HIV-1 INFECTION DURING PREGNANCY BASED ON DATA FROM STUDY AI424-182, A STUDY OF ATAZANAVIR/RITONAVIR IN COMBINATION WITH ZIDOVUDINE/LAMIVUDINE IN HIV INFECTED PREGNANT WOMEN EVERY 6 TO 8 WEEKS FOR THE 120MG STRENGTH FOR PATIENTS WHO ARE CONTROLLED ON SOMATULINE DEPOT 60MG OR 90MG 45MG FOR 6 MONTH ADMINISTRATION NEW EFFICACY DATA AND DOSING REGIMEN FOR PREGNANCY IN NORMAL OVULATORY WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION AS PART OF AN IVF OR INTRACYTOPLASMIC SPERM INJECTION (ICSI) CYCLE INCREASING MAXIMUM DOSING OF PATIENTS WITH SCHIZOPHRENIA TO 160 MG/DAY
EXCLUSIVITY INDICATION
I-1 I-2 I-3 I-4 I-5 I-6 I-7 I-8 I-9 I-10 I-11 I-12 I-13 I-14 I-15 I-16 I-17 I-18 I-19 I-20 I-21 DYSMENORRHEA CHOLANGIOPANCREATOGRAPHY INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY PERIPHERAL VENOGRAPHY (PHLEBOGRAPHY) HYSTEROSALPINGOGRAPHY TREATMENT OF JUVENILE ARTHRITIS BIOPSY PROVEN MINIMAL CHANGE NEPHROTIC SYNDROME IN CHILDREN ADULT INTRAVENOUS CONTRAST-ENHANCED COMPUTED TOMOGRAPHY OF THE HEAD AND BODY PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING PREVENTION OF POSTOPERATIVE DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN TOTAL HIP REPLACEMENT SURGERY RELIEF OF MILD TO MODERATE PAIN TREATMENT OF CUTANEOUS CANDIDIASIS URINARY TRACT INFECTION (UTI) PREVENTION FOR PERIODS UP TO FIVE MONTHS IN WOMEN WITH A HISTORY OF RECURRENT UTI SEBORRHEIC DERMATITIS PHOTOPHERESIS IN THE PALLIATIVE TREATMENT OF SKIN MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PERSONS NOT RESPONSIVE TO OTHER TREATMENT STIMULATE THE DEVELOPMENT OF MULTIPLE FOLLICLES/OOCYTES IN OVULATORY PATIENTS PARTICIPATING IN AN IN VITRO FERTILIZATION PROGRAM MANAGEMENT OF CONGESTIVE HEART FAILURE ENDOSCOPIC RETROGRADE PANCREATOGRAPHY HERNIOGRAPHY KNEE ARTHROGRAPHY HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE IN COMBINATION WITH OTHER CHEMOTHERAPEUTIC AGENTS TO DELAY RECURRENCE IN PATIENTS WITH NONMETASTATIC OSTEOSARCOMA WHO HAVE UNDERGONE SURGICAL RESECTION OR AMPUTATION FOR THE PRIMARY TUMOR RESCUE AFTER HIGH-DOSE METHOTREXATE THERAPY IN OSTEOSARCOMA SHORT-TERM TREATMENT OF ACTIVE BENIGN GASTRIC ULCER TREATMENT OF RHEUMATOID ARTHRITIS
I-22 I-23 I-24

I-25 I-26 I-27 I-28 I-29 I-30 I-31 I-32 I-33 I-34 I-35 I-36 I-37 I-38 I-39 I-40 I-41 I-42 I-43 I-44 I-45 I-46 I-47 I-48 I-49 I-50 I-51 I-52 I-53 I-54 I-55 I-56 I-57 I-58 I-59 I-60 I-61 I-62 I-63 I-64 I-65 I-66 I-67 I-68 I-69
ADB 5 of 55
I-70 I-71 I-72 I-73 I-74
ADULT INTRA-ARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY OF THE HEAD, NECK, ABDOMINAL, RENAL AND PERIPHERAL VESSELS TREATMENT OF LIVER FLUKES ADJUNCTIVE THERAPY TO DIET TO REDUCE THE RISK OF CORONARY ARTERY DISEASE SELECTIVE ADULT VISCERAL ARTERIOGRAPHY METASTATIC BREAST CANCER IN PREMENOPAUSAL WOMEN AS AN ALTERNATIVE TO OOPHORECTOMY OR OVARIAN IRRADIATION TREATMENT OF TINEA PEDIS CONTRAST ENHANCEMENT AGENT TO FACILITATE VISUALIZATION OF LESIONS IN THE SPINE AND ASSOCIATED TISSUES PEDIATRIC MYELOGRAPHY ORAL USE OF DILUTED OMNIPAQUE INJECTION IN ADULTS FOR CONTRAST ENHANCED COMPUTED TOMOGRAPHY OF THE ABDOMEN ORAL USE IN ADULTS FOR PASS-THROUGH EXAMINATION OF THE GASTROINTESTINAL TRACT PEDIATRIC CONTRAST ENHANCEMENT OF COMPUTED TOMOGRAPHIC HEAD IMAGING ARTHROGRAPHY OF THE SHOULDER JOINTS IN ADULTS RADIOGRAPHY OF THE TEMPOROMANDIBULAR JOINT IN ADULTS CONTRAST ENHANCEMENT AGENT TO FACILITATE VISUALIZATION OF LESIONS OF THE CENTRAL NERVOUS SYSTEM IN CHILDREN (2 YEARS OF AGE AND OLDER) TREATMENT OF ACUTE MYOCARDIAL INFARCTION PRIMARY NOCTURNAL ENURESIS MIGRAINE HEADACHE PROPHYLAXIS HERPES ZOSTER HERPES SIMPLEX ENCEPHALITIS MAINTENANCE THERAPY IN HEALED DUODENAL ULCER PATIENTS AT DOSE OF 1 GRAM TWICE DAILY ACUTE TREATMENT OF VARICELLA ZOSTER VIRUS USE IN PEDIATRIC COMPUTED TOMOGRAPHIC HEAD AND BODY IMAGING TREATMENT OF PEDIATRIC PATIENTS WITH SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE PEDIATRIC ANGIOCARDIOGRAPHY TREATMENT OF TRAVELERS' DIARRHEA DUE TO SUSCEPTIBLE STRAINS OF ENTEROTOXIGENIC ESCHERICHIA COLI FOR USE IN WOMEN WITH AXILLARY NODE-NEGATIVE BREAST CANCER TREATMENT OF PRIMARY DYSMENORRHEA AND FOR THE TREATMENT OF IDIOPATHIC HEAVY MENSTRUAL BLOOD LOSS PEDIATRIC EXCRETORY UROGRAPHY TREATMENT OF PANIC DISORDER, WITH OR WITHOUT AGORAPHOBIA RENAL CONCENTRATION CAPACITY TEST HYPERTENSION EROSIVE GASTROESOPHAGEAL REFLUX DISEASE SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER INITIAL TREATMENT OF ADVANCED OVARIAN CARCINOMA IN COMBINATION WITH OTHER APPROVED CHEMOTHERAPEUTIC AGENTS ENDOSCOPICALLY DIAGNOSED ESOPHAGITIS, INCLUDING EROSIVE AND ULCERATIVE ESOPHAGITIS, AND ASSOCIATED HEARTBURN DUE TO GASTROESOPHAGEAL REFLUX DISEASE SINGLE APPLICATION TREATMENT OF HEAD LICE IN CHILDREN TWO MONTHS TO TWO YEARS IN AGE FEMALE ANDROGENETIC ALOPECIA PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS ONCE DAILY TREATMENT AS INITIAL THERAPY IN THE TREATMENT OF HYPERTENSION PREVENTION OF SUPRAVENTRICULAR TACHYCARDIAS PREVENTION OF UPPER GASTROINTESTINAL BLEEDING IN CRITICALLY ILL PATIENTS UNCOMPLICATED GONORRHEA TREATMENT OF ACUTE ASTHMATIC ATTACKS IN CHILDREN SIX YEARS OF AGE AND OLDER CENTRAL PRECOCIOUS PUBERTY SHORT TERM TREATMENT OF PATIENTS WITH SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE (GERD), AND FOR THE SHORT TERM TREATMENT OF ESOPHAGITIS DUE TO GERD INCLUDING ULCERATIVE DISEASE DIAGNOSED BY ENDOSCOPY USE IN COMBINATION WITH 5-FLUOROURACIL TO PROLONG SURVIVAL IN THE PALLIATIVE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL CANCER VARICELLA INFECTIONS (CHICKENPOX) PREVENTION OF CMV DISEASE IN TRANSPLANT PATIENTS AT RISK FOR CMV DISEASE INITIATE AND MAINTAIN MONITORED ANESTHESIA CARE (MAC) SEDATION DURING DIAGNOSTIC PROCEDURES INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY

I-75 I-76 I-77 I-78 I-79 I-80 I-81 I-82 I-83 I-84 I-85 I-86 I-87 I-88 I-89 I-90 I-91 I-92 I-93 I-94 I-95 I-96 I-97 I-98 I-99 I-100 I-101 I-102 I-103
ADB 6 of 55
I-104 I-105 I-106 I-107 I-108 I-109 I-110 I-111 I-112 I-113 I-114 I-115 I-116 I-117 I-118 I-119 I-120 I-121 I-122 I-123
TREATMENT OF ENDOSCOPICALLY DIAGNOSED EROSIVE ESOPHAGITIS PREVENTION OF OSTEOPOROSIS DERMAL INFECTIONS-TINEA PEDIS, TINEA CORPORIS, TINEA CRURIS DUE TO EPIDERMOPHYTON FLOCCOSUM CONTRAST ENHANCED COMPUTED TOMOGRAPHIC IMAGING OF THE HEAD AND BODY AND INTRAVENOUS EXCRETORY UROGRAPHY MANAGEMENT OF CHRONIC STABLE ANGINA AND ANGINA DUE TO CORONARY ARTERY SPASM DIAGNOSIS AND LOCALIZATION OF ISCHEMIA AND CORONARY HEART DISEASE PROPHYLAXIS IN DESIGNATED IMMUNOCOMPROMISED CONDITIONS TO REDUCE THE INCIDENCE OF OROPHARYNGEAL CANDIDIASIS TREATMENT OF TRAVELERS' DIARRHEA ANGIOCARDIOGRAPHY, CONTRAST ENHANCED COMPUTED TOMOGRAPHIC IMAGING OF THE HEAD AND BODY, AND INTRAVENOUS EXCRETORY UROGRAPHY IN CHILDREN INTRAOPERATIVE AND POSTOPERATIVE TACHYCARDIA AND/OR HYPERTENSION TREATMENT OF ANOREXIA ASSOCIATED WITH WEIGHT LOSS IN PATIENTS WITH AIDS TREATMENT OF SECONDARY CARNITINE DEFICIENCY RENAL IMAGING AGENT FOR USE IN CHILDREN MANAGEMENT OF ENDOMETRIOSIS EPIDURAL USE IN LABOR AND DELIVERY AS AN ANALGESIC ADJUNCT TO BUPIVACAINE INTENSIVE CARE UNIT SEDATION MONOTHERAPY USE FOR HYPERTENSION ADJUNCTIVE THERAPY IN THE MANAGEMENT OF HEART FAILURE PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN CHILDREN AGES 4-11 YEARS USE WITH MRI IN ADULTS TO PROVIDE CONTRAST ENHANCEMENT AND FACILITATE VISUALIZATION OF LESIONS IN THE BODY [EXCLUDING THE HEART] TREATMENT OF LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA ORAL OR RECTAL USE IN CHILDREN FOR THE EXAMINATION OF THE GASTROINTESTINAL TRACT TREATMENT OF CHILDREN WHO HAVE GROWTH FAILURE ASSOCIATED WITH CHRONIC RENAL INSUFFICIENCY PEDIATRIC ANESTHESIA IN CHILDREN 3 YEARS AND OLDER TO DECREASE THE INCIDENCE OF CANDIDIASIS IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION WHO RECEIVE CYTOTOXIC CHEMOTHERAPY AND/OR RADIATION THERAPY TREATMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I INSULIN-DEPENDENT DIABETES MELLITUS AND RETINOPATHY TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER PROPHYLAXIS AGAINST PNEUMOCYSTIS CARINII PNEUMONIA IN INDIVIDUALS WHO ARE IMMUNOCOMPROMISED AND CONSIDERED TO BE AT RISK OF DEVELOPING PNEUMOCYSTIS CARINII PNEUMONIA TREATMENT OF PULMONARY AND EXTRAPULMONARY ASPERGILLOSIS IN PATENTS WHO ARE INTOLERANT OF OR WHO ARE REFRACTORY TO AMPHOTERICIN B THERAPY TREATMENT OF METASTATIC CARCINOMA OF THE BREAST AFTER FAILURE OF FIRST-LINE OR SUBSEQUENT CHEMOTHERAPY TREATMENT OF ACROMEGALY VAGINAL CANDIDIASIS EXPANDED USE-FOR ICU PATIENTS UNDERGOING LONG-TERM INFUSION DURING MECHANICAL VENTILATION TYPHOID FEVER PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH RADIOTHERAPY TREATMENT OF PAGET'S DISEASE OF BONE MANAGEMENT OF MODERATE TO SEVERE PAIN TREATMENT OF PROSTATITIS USE IN CHILDREN TO VISUALIZE LESIONS WITH ABNORMAL VASCULARITY IN THE BRAIN (INTRACRANIAL LESIONS), SPINE, AND ASSOCIATED TISSUE USE IN MRI IN ADULTS TO VISUALIZE LESIONS IN THE HEAD AND NECK MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS TO SLOW THE PROGRESSION FO CORONANY ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE PREVENTION OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM FOLLOWING KNEE REPLACEMENT SURGERY TREATMENT OF ANEMIA CAUSED BY UTERINE LEIOMYOMATA IN WOMEN WHO FAIL IRON THERAPY MAINTENANCE THERAPY FOR GASTRIC ULCER PATIENTS AT REDUCED DOSAGE AFTER HEALING ACUTE ULCERS EXPANDED PATIENT POPULATION -- USE IN ICU PATIENTS PSORIASIS OF THE SCALP RELIEF OF MILD TO MODERATE PAIN IN PATIENTS AGED 6 MONTHS AND OLDER

I-124 I-125 I-126 I-127 I-128
ADB 7 of 55
I-129 I-130 I-131 I-132 I-133 I-134 I-135 I-136 I-137 I-138 I-139 I-140 I-141 I-142 I-143 I-144 I-145 I-146 I-147 I-148 I-149 I-150 I-151 I-152 I-153 I-154 I-155 I-156 I-157 I-158 I-159
I-160 I-161 I-162 I-163 I-164 I-165
I-166 I-167 I-168 I-169
LEUCOCYTE LABELED SCINTIGRAPHY AS AN ADJUNCT IN THE LOCALIZATION OF INTRA-ABDOMINAL INFECTION AND INFLAMMATORY BOWEL DISEASE EXPANSION OF CONSCIOUS SEDATION INDICATION TO INCLUDE SHORT THERAPEUTIC PROCEDURES ADJUNCT TO THALLIUM- 201 MYOCARDIAL PERFUSION IN PATIENTS UNABLE TO EXERCISE ADEQUATELY TREATMENT OF ACYCLOVIR-RESISTANT HERPES IN IMMUNOCOMPROMISED PATIENTS IN PT W/ CH DISEASE AND HYPERCHOLESTEROLEMIA: REDUCE RISK TOTAL MORTALITY BY REDUCING CORONARY DEATH; REDUCE RISK NON-FATAL MI; REDUCE RISK UNDERGOING MYOCARDIAL REVASCULARIZATION PROCEDURES; REDUCTION ELEVATED TOTAL AND LDL CHOL LEVELS... TREATMENT OF ALCOHOL DEPENDENCE MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS PERIPHERAL ARTERIOGRAPHY TREATMENT OF MANIC PHASE OF BIPOLAR DISORDER MANAGEMENT OF CHRONIC STABLE ANGINA HEART FAILURE POST MYOCARDIAL INFARCTION BONE METASTASES ASSOCIATED WITH MULTIPLE MYELOMA IDIOPATHIC CHRONIC URTICARIA PREVENTION OF METAL-INDUCED HEART BURN, ACID INDIGESTION, AND SOUR STOMACH WHEN TAKEN 30 MINUTES PRIOR TO CONSUMING FOOD OR BEVERAGES TREATMENT OF ACUTE RECURRENT GENITAL HERPES PALLIATIVE TREATMENT OF ADVANCED BREAST CANCER IN PRE- AND PERIMENOPAUSAL WOMEN PREVENTION OF CYTOMEGALOVIRUS (CMV) DISEASE IN INDIVIDUALS WITH HIV INFECTION AT RISK FOR DEVELOPING CMV DISEASE TREATMENT OF HEMODYNAMICALLY STABLE PATIENTS WITHIN 24 HOURS OF ACUTE MYOCARDIAL INFARCTION TO IMPROVE SURVIVAL LOCALIZE MYOCARDIAL ISCHEMIA(REVERSIBLE DEFECT) AND INFARCTION (NON-REVERSIBLE DEFECTS) IN EVALUATING MYOCARDIAL FUNCTION EPISODIC TREATMENT OF RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT ADULTS ENHANCEMENT OF MRI OF THE ADULT BODY INTERNAL ORGANS 0.1MMOL/KG AS A SINGLE INTRAVEOUS BOLUS FOR MRI OF THE CNS IN CHILDREN CONTRAST ENHANCEMENT AND FACILITATION OF VISUALIZATION OF EXTRACRANIAL HEAD AND NECK LESIONS PREVENTION OF GALLSTONE FORMATION IN OBESE PATIENTS EXPERIENCING RAPID WEIGHT LOSS TREATMENT OF ACUTE PNEUMOCYSTIC CARINI PNEUMONIA (PCP) IN HIV-INFECTED PATIENTS WHOSE ALVEOLAR-ARTERIAL OXYGEN DIFFERENCE (AaDO2) IS LESS THAN OR EQUAL TO 55 TORR TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER TREATMENT OF OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER PREVENTION OF AND PREVENTION OF FURTHER POSTOPERATIVE NAUSEA AND VOMITING IN PEDIATRIC PATIENTS RECEIVING GENERAL ANESTHESIA SLOWING THE PROGRESSION OF CORONARY ATHEROSCLEROSIS AND REDUCING THE RISK OF ACUTE CORONARY EVENTS MANAGEMENT OF SEVERE SPASTICITY [ENCOMPASES SPINAL AND CEREBRAL ORIGIN] PATIENT POPULATION ALTERED TO INCLUDE PEDIATRIC USE TREATMENT OF ONCHOMYCOSIS DUE TO DERMATOPHYTES (TINEA UNGUIUM) OF THE TOENAIL WITH OR WITHOUT FINGERNAIL INVOLVEMENT ADDITIONAL DATA REGARDING THE SAFE USE OF NORVASC IN PATIENTS WITH HEART FAILURE TREATMENT OF ACUTE UNCOMPLICATED CYSTITIS IN FEMALES TREATMENT OF OSTEOLYTIC BONE METASTASES OF BREAST CANCER FOR HYPERCHOLESTEROLEMIC PATIENTS WITHOUT CLINICALLY EVIDENT HEART DISEASE REDUCE THE RISK OF MYOCARDIAL INFARCTION, REVASCULARIZATION, AND DEATH DUE TO CARDIOVASCULAR CAUSES WITH NO INCREASE IN DEATH FROM NON-CARDIOVASCULAR CAUSES TREATMENT OF BACTERIAL CORNEAL ULCERS TREATMENT OF ADULT-ONSET OR CHILDHOOD-ONSET ADULT GROWTH HORMONE DEFICIENCY FOR USE IN PATIENTS 6-11 YEARS OF AGE TREATMENT OF PHOTOPHOBIA CHRONIC BACTERIAL PROSTATITIS MANAGEMENT OF ADULTS WITH ACTIVE, CLASSIC AND DEFINITIVE RHEUMATOID ARTHRITIS WHO HAVE HAD INSUFFICIENT THERAPEUTIC RESPONSE TO OR ARE INTOLERANT OF AN ADEQUATE TRIAL OF FULL DOSES OF ONE OR MORE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS TREATMENT OF BULIMIA COMPLICATED INTRA-ABDOMINAL INFECTIONS (USED IN COMBINATION WITH METRONIDAZOLE) CAUSED BY MIXED AEROBIC/ANAEROBIC PATHOGENS MANAGEMENT OF LOCALLY CONFINED STAGE B2-C METASTATIC CARCINOMA OF THE PROSTATE (IN COMBINATION WITH LHRH AGONISTS) USE IN COMBINATION WITH CORTICOSTEROIDS AS INITIAL CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH PAIN RELATED TO ADVANCED HORMONE-REFRACTORY PROSTATE CANCER

I-170 I-171 I-172 I-173 I-174 I-175 I-176 I-177
ADB 8 of 55
I-178 I-179 I-180 I-181 I-182 I-183 I-184 I-185 I-186 I-187 I-188 I-189 I-190
I-191 I-192
I-193 I-194 I-195
I-196 I-197 I-198
I-199 I-200 I-201 I-202 I-203 I-204 I-205 I-206 I-207 I-208 I-209 I-210
I-211 I-212
PROPHYLACTIC USE DURING HEAD LICE EPIDEMICS RELIEF OF SYMPTOMS OF THE COMMON COLD TREATMENT OF INITIAL EPISODE OF GENITAL HERPES PREOPERATIVELY FOR THE PREVENTION OF INFECTION IN TRANSRECTAL PROSTATE BIOPSY PELVIC INFLAMMATORY DISEASE TREATMENT OF TINEA CORPORIS AND TINEA CRURIS TREATMENT OF POSTOPERATIVE INFLAMMATION IN PATIENTS WHO HAVE UNDERGONE CATARACT EXTRACTION TX OF MODERATE ACNE VULGARIS IN FEMALES,GREATER OR EQUAL TO 15YRS OF AGE,WHO HAVE NO KNOWN CONTRAINDICATIONS TO ORAL CONTRACEPTIVE THERAPY,DESIRE CONTRACEPTION,HAVE ACHIEVED MENARCHE AND ARE UNRESPONSIVE TO TOPICAL ANTI-ACNE MEDICATIONS TREATMENT OF ONCHOMYCOSIS OF THE FINGERNAIL WITHOUT CONCOMITANT ONCHOMYCOSIS OF THE TOENAIL WITH A PULSE DOSING REGIMEN NOSOCOMIAL PNEUMONIA-MILD TO MODERATE AND SEVERE CAUSED BY HAEMOPHILUS INFLUENZAE OR KLEBSIELLA PNEUMONIAE TREATMENT OF PLANTAR TINEA PEDIS (MOCCASIN TYPE) TREATMENT OF PATIENTS WITH COMPLEX PARTIAL SEIZURES WITH AND WITHOUT SECONDARY GENERALIZATION TREATMENT OF GROWTH FAILURE ASSOCIATED WITH TURNER SYNDROME MAINTENANCE THERAPY IN THE MANAGEMENT OF MILD TO MODERATE ASTHMA IN PEDIATRIC PATIENTS AGES 6-11 TREATMENT OF PANIC DISORDER AT A RECOMMENDED DOSE RANGE OF 1 TO 2MG/DAY (MAXIMUM OF 4MG) PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR CAUSED BY OR PRESUMED TO BE CAUSED BY PITYROSPORUM ORBICULARE (ALSO KNOWN AS MALASSEZIA FURFUR OR M. ORBICULARE) PREVENTION OF FRACTURES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT OF ACUTE SINUSITIS AND ACUTE EXACERBATION OF CHRONIC SINUSITIS TREATMENT OF ACUTE OTITIS MEDIA IN PEDIATRIC PATIENTS PLANAR IMAGING AS A SECOND LINE DIAGNOSTIC DRUG AFTER MAMMOGRAPHY TO ASSIST IN THE EVALUATION OF BREAST LESIONS IN PATIENTS WITH AN ABNORMAL MAMMOGRAM OR A PALPABLE BREAST MASS ENDOMETRIAL THINNING AGENT PRIOR TO ENDOMETRIAL ABLATION FOR DYSFUNCTIONAL UTERINE BLEEDING THE PREVENTION OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM, IN PATIENTS UNDERGOING ABDOMINAL SURGERY WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS AND A NEW DOSAGE REGIMEN, 40MG ONCE DAILY, FOR THIS INDICATION TREATMENT OF PANIC DISORDER IN A RECOMMENDED DOSE RANGE OF 50 TO 200MG/DAY CONGESTIVE HEART FAILURE FOR USE OF LANSOPRAZOLE IN COMBINATION WITH CLARITHROMYCIN AND AMOXICILLIN FOR THE ERADICATION OF HELICOBACTER PYLORI IN PATIENTS WITH ACTIVE DUODENAL ULCER DISEASE OR A ONE-YEAR HISTORY OF DUODENAL ULCER ACUTE TREATMENT OF ACTIVE BENIGN GASTRIC ULCER MAINTENANCE OF HEALING OF DUODENAL ULCER FOR THE USE OF LANSOPRAZOLE IN COMBINATION WITH AMOXICILLIN FOR THE ERADICATION OF HELICOBACTER PYLORI IN PATIENTS WITH ACTIVE DUODENAL ULCER DISEASE OR A ONE-YEAR HISTORY OF A DUODENAL ULCER MONOTHERAPY AND COMBINATION THERAPY WITH SULFONYL UREAS IN THE TREATMENT OF TYPE II DIABETES TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC PATIENTS SECOND-LINE TREAMENT OF AIDS-RELATED KAPOSI'S SARCOMA MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS USE IN PEDIATRIC PATIENTS BETWEEN THE AGES OF 6 AND 11 FOR THE TREATMENT OF THE NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS INITIAL ANTICONVULSANT TREATMENT OF STATUS EPILEPTICUS TREATMENT OF EDEMA ASSOCIATED WITH CHRONIC RENAL FAILURE FOR THE SUPPRESSION OF RECURRENT EPISODES OF GENITAL HERPES IN IMMUNOCOMPETENT ADULTS TREATMENT OF OBSESSIVE COMPULSIVE DISORDER IN THE PEDIATRIC POPULATION PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) TO SLOW THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE AS PART OF A TREATMENT STRATEGY TO LOWER TOTAL AND LDL CHOLESTEROL TO TARGET LEVELS FOR USE IN PEDIATRIC POPULATION TREATMENT OF SYMPTOMS OF DRY MOUTH IN PATIENTS WITH SJOGREN'S SYNDROME

I-213 I-214 I-215 I-216
ADB 9 of 55
I-217 I-218 I-219 I-220 I-221
I-222 I-223 I-224 I-225 I-226 I-227 I-228 I-229 I-230
I-231 I-232 I-233
I-234
I-235 I-236 I-237 I-238 I-239 I-240
I-241
I-242 I-243 I-244 I-245 I-246 I-247
TEMPORARY RELIEF OF PAIN AND PHOTOPHOBIA IN PATIENTS UNDERGOING CORNEAL REFRACTIVE SURGERY TREATMENT OF OSTEOPOROSIS PRE-PROCEDURAL APPLICATION TO ADULT MALE GENITAL SKIN PRIOR TO SITE-SPECIFIC SUBCUTANEOUS INFILTRATION WITH LIDOCAINE FOR THE REMOVAL OF GENITAL WARTS FOR THE LONG-TERM TWICE-DAILY (MORNING AND EVENING) ADMINISTRATION IN THE MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD, INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA PREVENTION (DURING AND FOLLOWING HOSPITALIZATION) OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM, IN PATIENTS UNDERGOING HIP REPLACEMENT SURGERY USE OF LIPITOR AS AN ADJUNCTIVE THERAPY TO DIET FOR THE TREATMENT OF PATIENTS WITH ELEVATED SERUM TRIGLYCERIDE LEVELS (FREDERICKSON TYPE IV) USE OF LIPITOR BY PATIENTS WITH PRIMARY DYSBETALIPOPROTEINEMIA (FREDERICKSON TYPE III) WHO DO NOT RESPOND ADEQUATELY TO DIET TREATMENT OF EPISODIC- HEARTBURN, ACID INDIGESTION AND SOUR STOMACH TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN MEN WITH AN ENLARGED PROSTATE TO IMPROVE SYMPTOMS, REDUCE THE RISK OF ACUTE URINARY RETENTION AND REDUCE THE RISK OF THE NEED OF SURGERY PREVENTION OF ISCHEMIC COMPLICATIONS OF UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL INFARCTION, WHEN CONCURRENTLY ADMINISTERED WITH ASPIRIN USE IN THE SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH ALLERGIC AND NONALLERGICPERENNIAL RHINITIS IN CHILDREN AGE 6-11 YEARS FOR THE USE IN PEDIATRIC PATIENTS 4 TO 11 YEARS OF AGE FOR THE MANAGEMENT OF THE NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS USE IN PATIENTS WITH PREVIOUS MI AND NORMAL CHOLESTEROL LEVELS, TO REDUCE RISK OF RECURRENT MI, MYOCARDIAL REVASCULARIZATION, AND CEREBROVASCULAR DISEASE EVENTS FIRST-LINE THERAPY FOR THE TREATMENT OF ADVANCED CARCINOMA OF THE OVARY IN COMBINATION WITH CISPLATIN SHORT-TERM TREATMENT OF SYMPTOMATIC GASTROESPHAGEAL REFLUX DISEASE (GERD) PREVENTION OF MEAL INDUCED HEARTBURN AT A DOSE OF 75MG TAKEN 30-60MIN PRIOR TO A MEAL PRILOSEC (OMEPRAZOLE), AMOXICILLIN, AND CLARITHROMYCIN FOR THE ERADICATION OF H. PYLORI IN PATIENTS WITH DUODENAL ULCER DISEASE IN COMBINATION WITH CIS-PLATIN, FOR THE FIRST LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN PATIENTS WHO ARE NOT CANDIDATES FOR POTENTIALLY CURATIVE SURGERY AND/OR RADIATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER FAILURE OF PRIOR CHEMOTHERAPY TREATMENT OF RECURRENT MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN HIV-AFFECTED PATIENTS AT A DOSE OF 500MG TWICE DAILY PROPHYLACTIC USE TO REDUCE PERIOPERATIVE BLOOD LOSS AND THE NEED FOR BLOOD TRANSUFSION IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS IN THE COURSE OF CORONARY ARTERY BYPASS GRAFT SURGERY FOR USE IN COMBINATION WITH CISPLATIN FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH INOPERABLE LOCALLY ADVANCED (STAGE IIIA OR IIIB) OR METASTATIC (STAGE IV) NON-SMALL CELL LUNG CANCER PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN PATIENTS 12 YEARS OF AGE AND OLDER PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER MAINTENANCE TREATMENT OF ASTHMA AND PREVENTION OF BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER ADJUNCTIVE TREATMENT OF LENNOX-GASTAUT SYNDROME IN PEDIATRIC AND ADULT PATIENTS TREATMENT OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM AND RESULTANT METABOLIC BONE DISEASE IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENAL FAILURE (CCR 15 TO 55ML/MIN) NOT YET ON DIALYSIS USE IN PHOTODYNAMIC THERAPY (PDT) FOR REDUCTION OF OBSTRUCTION AND PALLIATION OF SYMPTOMS IN PATIENTS WITH COMPLETELY OR PARTIALLY OBSTRUCTING ENDOBRONCHIAL NONSMALL CELL LUNG CANCER TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH THE MENOPAUSE AND IN THE TREATMENT OF VULVAR AND VAGINAL ATROPHY IN WOMEN WITH AN INTACT UTERUS USE IN THE SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH THE COMMON COLD IN CHILDREN AGE 5 TO 11 YEARS REDUCE THE INCIDENCE OF BREAST CANCER IN WOMEN AT HIGH RISK FOR BREAST CANCER TREATMENT OF ACUTE SINUSITIS TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS USE IN CONVERSION TO MONOTHERAPY IN ADULTS WITH PARTIAL SEIZURES WHO ARE RECEIVING TREATMENT WITH A SINGLE ENZYME-INDUCING ANTIEPILEPTIC DRUG

I-248
ADB 10 of 55
I-249 I-250
I-251 I-252 I-253 I-254 I-255 I-256 I-257 I-258 I-259 I-260 I-261 I-262 I-263 I-264 I-265 I-266 I-267 I-268 I-269 I-270 I-271 I-272
I-273
I-274 I-275 I-276 I-277 I-278 I-279 I-280 I-281 I-282 I-283
I-284
INPATIENT TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITH/WITHOUT PULMONARY EMBOLISM WHEN ADMIN WITH WARFARIN SODIM AND OUTPATIENT TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITHOUT PULMONARY EMBOLISM WHEN ADMIN WITH WARFARIN SODIUM TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON THERAPY PRIMARY PREVENTION OF CORONARY HEART DISEASE IN PATIENTS WITHOUT SYMPATOMATIC CARDIOVASCULAR DISEASE WHO HAVE AVERAGE TO MODERATELY ELEVATED TOTAL-C AND LDL-C AND BELOW AVERAGE HDL-C TREATMENT OF GENERALIZED ANXIETY DISORDER NEW COMBINATION USE OF PRECOSE FOR PATIENTS WITH TYPE 2 DIABETES TREATED WITH DIET PLUS METFORMIN COMBINATION USE OF PRECOSE FOR PATIENTS WITH TYPE 2 DIABETES TREATED WITH DIET PLUS INSULIN PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS (LOSS OF BONE MASS) PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA (PCP) USE IN TREATMENT OF SMALL CELL LUNG CANCER SENSITIVE DISEASE AFTER FAILURE OF FIRST-LINE CHEMOTHERAPY TREATMENT OF CHRONIC HEPATITIS B ASSOCIATED WITH EVIDENCE OF HEPATITIS B VIRAL REPLICATION AND ACTIVE LIVER INFLAMATION FOR PERENNIAL NONALLERGIC RHINITIS FOR AGES 4 AND ABOVE PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT), WHICH MAY LEAD TO PULMONARY EMBOLISM, IN PATIENTS UNDERGOING HIP REPLACEMENT SURGERY EXPANDED PEDIATRIC USE IN CHILDREN YOUNGER THAN ONE MONTH OF AGE TO BIRTH (WITH A GESTATIONAL AGE OF 37 WEEKS OR GREATER) TREATMENT OF SOCIAL ANXIETY DISORDER TREATMENT OR PREVENTION OF BRONCHOSPASM WITH REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE AND FOR THE PREVENTION OF EXERCISE INDUCED BRONCHOSPASM IN CHILDREN AGES 4-12 TREATMENT OF UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL INFARCTION FOR THE PREVENTION OF ISCHEMIC COMPLICATIONS IN PATIENTS ON CONCURRENT ASPIRIN THERAPY PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH RADIATION, INCLUDING TOTAL BODY IRRADIATION (TBI) AND FRACTIONATED ABDOMINAL RADIATION TREATMENT OF ATOPIC DERMATITIS IN PEDIATRIC PATIENTS 6 YEARS AND OLDER USE OF TOPAMAX AS ADJUNCTIVE THERAPY IN PEDIATRIC PATIENTS AGES 2-16 YEARS WITH PARTIAL ONSET SEIZURES USE IN PEDIATRIC PATIENTS 3 MONTHS OLD AND OLDER - FOR CORTICOSTEROID-RESPONSIVE DERMATOSES PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA IN PATIENTS 7-11 YEARS OF AGE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH HIGHLY EMETOGENIC CANCER CHEMOTHERAPY, INCLUDING CISPLATIN ADJUVANT TREATMENT OF NODE-POSITIVE BREAST CANCER ADMINISTRERED SEQUENTIALLY TO STANDARD DOXORUBICIN-CONTAINING COMBINATION CHEMOTHERAPY TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN MEN AND WOMEN RECEIVING GLUCOCORTICOIDS IN A DAILY DOSE EQUIVALENT TO 7.5MG OR GREATER OF PREDNISONE AND WHO HAVE LOW BONE MINERAL DENSITY ADJUNCT TO DIET TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA (HETEROZYGOUS FAMILIAL AND NON FAMILIAL) AND MIXED DYSLIPIDEMIA (FREDERICKSON TYPES IIA AND IIB) USE OF TOPAMAX AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONICCLONIC SEIZURES USE IN COMBINATION WITH METFORMIN AND SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES USE OF REZULIN IN COMBINATION WITH METFORMIN AND SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES TREATMENT OF TYPE III HYPERLIPOPROTEINEMIA TREATMENT OF PATIENTS WITH ISOLATED HYPERTRIGLYCERIDEMIA (FREDERICKSON TYPE IV) TREATMENT OF POST-TRAUMATIC STRESS DISORDER USE OF CARNITOR INJECTION FOR THE PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS INCREASING HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA (HETEROZYGOUS FAMILIAL AND NONFAMILIAL) AND MIXED DYSLIPIDEMIA (FREDERICKSON TYPES IIA AND IIB) TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER AFTER FAILURE OF PRIOR PLATINUM-BASED CHEMOTHERAPY TO REDUCE THE INCIDENCE OF MODERATE TO SEVERE XEROSTOMIA IN PATIENTS UNDERGOING POSTOPERATIVE RADIATION TREATMENT FOR HEAD AND NECK CANCER, WHERE THE RADIATION PORT INCLUDES A SUBSTANTIAL PORTION OF THE PAROTID GLANDS TO REDUCE THE NUMBER OF ADENOMATOUS COLORECTAL POLYPS IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS AS AN ADJUNCT TO USUAL CARE

I-285 I-286 I-287 I-288
ADB 11 of 55
I-289
I-290 I-291 I-292 I-293 I-294 I-295 I-296
I-297 I-298 I-299 I-300 I-301 I-302 I-303 I-304 I-305 I-306 I-307 I-308 I-309 I-310 I-311 I-312 I-313 I-314 I-315
I-316
I-317 I-318 I-319 I-320 I-321 I-322 I-323 I-324
I-325
TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL RHINITIS IN ADULTS AND CHILDREN 3 YEARS OF AGE AND OLDER TREATMENT OF PATIENTS WITH FREDERICKSON TYPE III USE OF PRAVASTATIN IN PATIENTS WITH EVIDENT CORONARY HEART DISEASE TO REDUCE THE RISK OF TOTAL MORTALITY BY REDUCING CORONARY DEATH CHANGES IN SEVERAL SECTIONS OF THE INSERT TO INCORPORATE STATEMENTS CONCERNING THE USE OF HIGH DOSES OF LISINOPRIL TO REDUCE THE RISK OF THE COMBINED OUTCOMES OF MORTALITY AND HOSPITALIZATION IN PATIENTS WITH CONGESTIVE HEART FAILURE USE OF AVANDIA IN COMBINATION WITH A SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLLITUS WHEN DIET AND EXERCISE WITH EITHER SINGLE AGENT DOES NOT ACHIEVE ADEQUATE GLYCEMIC CONTROL PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS TREATMENT OF UNCOMPLICATED ACUTE ILLNESS DUE TO INFLUENZA A AND B IN PEDIATRIC PATIENTS 7 YEARS AND OLDER WHO HAVE BEEN SYMPTOMATIC FOR NO MORE THAN 2 DAYS PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR WOMEN WITH AN INTACT UTERUS LONG-TERM INTRAVENOUS TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH THE SCLERODERMA SPECTRUM OF DISEASE IN NYHA CLASS III AND CLASS IV PATIENTS WHO DO NOT RESPOND TO CONVENTIONAL THERAPY SHORT-TERM TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER TREATMENT OF PATIENTS WITH FREDERICKSON TYPE IIA AND IIB HYPERLIPOPROTEINEMIA USE OF CAMPTOSAR AS A COMPONENT OF FIRST-LINE THERAPY IN COMBINATION WITH 5-FLUROURACIL AND LEUCOVARIN FOR PATIENTS WITH METASTATIC CARCINOMA OF THE COLON OR RECTUM PROPHYLAXIS FOR ASTHMA IN CHILDREN 2-5 YEARS OF AGE TREATMENT OF SIGNS AND SYMPTOMS OF ALLERGIC CONJUNCTIVITIS TREATMENT OF PEDIATRIC PATIENTS WITH PRADER-WILLI SYNDROME INCREASING HDL-CHOLESTEROL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIAS TREATMENT OF PATIENTS WITH FREDERICKSON TYPE IV TREATMENT OF LEVOFLOXACIN SUSCEPTIBLE STRAINS OF PENICILLIN-RESISTANT STREPTOCOCCUS PNEUMONIAE IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA INDUCTION OF SPERMATOGENESIS IN MEN WITH PRIMARY AND SECONDARY HYPOGONADOTROPIC HYPOGONADISM IN WHOM THE CAUSE OF INFERTILITY IS NOT DUE TO PRIMARY TESTICULAR FAILURE NEW COMBINATION USE OF METFORMIN AND INSULIN IN TYPE 2 DIABETES TREATMENT OF PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE RHEUMOTOID ARTHRITIS WHO RESPONDED INADEQUATELY TO SALICYLATES OR OTHER NSAIDS USE OF ACTONEL 35MG ONCE A WEEK TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS REDUCTION IN RISK OF MYOCARDIAL INFARCTION, STROKE, AND DEATH FROM CARDIOVASCULAR CAUSES ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES IN PEDIATRIC PATIENTS AGE 3 TO 12 YEARS FIRST LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER EXTENSION OF INDICATION TO PROVIDE FOR MAINTENANCE OF RESPONSE TOPICAL ANESTHETIC FOR SUPERFICIAL MINOR SURGERY OF GENITAL MUCOUS MEMBRANES AND AS AN ADJUNCT FOR LOCAL INFILTRATION ANESTHESIA IN GENITAL MUCOUS MEMBRANES THROMBOPROPHYLAXIS OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM,IN MEDICAL PATIENTS WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS DUE TO SEVERELY RESTRICTED MOBILITY DURING ACUTE ILLNESS TREATMENT OF NSAID-ASSOCIATED GASTRIC ULCER PATIENTS WHO CONTINUE NSAID USE AND REDUCING RISK OF NSAID-ASSOCIATED GASTRIC ULCERS IN PATIENTS WITH HISTORY OF DOCUMENTED GASTRIC ULCER WHO REQUIRE USE OF AN NSAID PROPHYLAXIS OF INFLUENZA IN ADULTS AND ADOLESCENTS 13 YEARS AND OLDER FIRSTLINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER USE FOR SUSPECTED OR CONFIRMED METHANOL POISONING, EITHER ALONE OR IN COMBINATION WITH HEMODIALYSIS TREATMENT OF TYPE 2 DIABETES IN PEDIATRIC PATIENTS (AGES 10-16 YEARS) JUVENILE RHEUMATOID ARTHRITIS USE OF DIPRIVAN IN PATIENTS 3 MONTHS TO 16 YEARS COLORECTAL CANCER REDUCING NEUROLOGIC DISABILITY AND/OR FREQUENCY OF CLINICAL RELAPSES IN PATIENTS WITH SECONDARY (CHRONIC) PROGRESSIVE, PROGRESSIVE RELAPSING, OR WORSENING RELAPSING-REMITTING MULTIPLE SCLEROSIS PREVENTION OF RELAPSE AND RECURRENCE OF DEPRESSION

I-326 I-327 I-328 I-329 I-330 I-331 I-332 I-333 I-334 I-335 I-336
ADB 12 of 55
I-337 I-338 I-339 I-340 I-341 I-342
I-343 I-344 I-345 I-346 I-347 I-348 I-349 I-350
I-351 I-352 I-353 I-354 I-355 I-356 I-357 I-358 I-359 I-360 I-361
I-362 I-363 I-364 I-365 I-366 I-367
I-368
GENERALIZED ANXIETY DISORDER SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN PATIENTS 5 YEARS AND OLDER PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA IN PATIENTS 5-6 YEARS OF AGE UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND CONTROL OF DAYTIME AND NIGHTTIME HEARTBURN SYSTOMS IN PATIENTS WITH GERD TREATMENT OF MODERATE ACNE VULGARIS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH SUSPECTED FUNGAL INFECTIONS (EFTN) TOPICAL TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR DUE TO MALASSEZIA FURFUR (FORMERLY PITYROSPORUM ORBICULARE) LONG-TERM TREATMENT OF GROWTH FAILURE IN CHILDREN BORN SMALL FOR GESTATIONAL AGE WHO FAIL TO MANIFEST CATCH-UP GROWTH BY TWO YEARS OF AGE ADJUNCTIVE THERAPY IN PATIENTS TWO YEARS AND OLDER WITH SEIZURES ASSOCIATED WITH LENNOXGASTAUT SYNDROME EXPANSION OF INDICATION TO INCLUDE THE TREATMENT OF PATIENTS WITH PREDOMINATELY CLASSIC SUBFOVEAL CHOROIDAL NEOVASCULARIZATION DUE TO PATHOLOGIC MYOPIA OR PRESUMED OCULAR HISTOPLASMOSIS PATHOLOGICAL HYPERSECRETION ASSOCIATED WITH ZOLLINGER-ELLISON SNYDROME MANAGEMENT OF ACUTE PAIN IN ADULTS AND TREATMENT OF PRIMARY DYSMENORRHEA TREATMENT OF HEPATITIS B IN PEDIATRIC PATIENTS AGES 2-17 YEARS ATOPIC DERMATITIS IN PEDIATRIC PATIENTS AGES 2-5 BREAST CANCER COMBINATION THERAPY USE OF FORADIL FOR LONG-TERM, TWICE DAILY (MORNING AND EVENING) ADMINISTRATION IN THE MAINTENANCE TREATMENT OF BRONCHO-CONSTRICTION IN PATIENTS WITH COPD INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA USE OF COREG FOR SEVERE HEART FAILURE ACNE VULGARIS TREATMENT OF POSTTRAUMATIC STRESS DISORDER TREATMENT OF SYMPTOMATIC GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT OR PREVENTION OF BRONCHOSPASM IN CHILDREN 6 YEARS OF AGE AND OLDER WITH OBSTRUCTIVE AIRWAY DISEASE LONG-TERM, TWICE-DAILY (MORNING AND EVENING) ADMINISTRATION IN THE MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD (INCLUDING EMPHYSEMA AND CHRONIC BRONCHITIS) ACUTE CORONARY SYNDROME TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN ADOLESCENT BOYS AND GIRLS AT LEAST ONE YEAR POSTMENARCHAL, AGES 10 TO 17 YEARS, WITH A RECOMMENDED DOSING RANGE OF 10 TO 40MG ONCE DAILY PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR ALL STRENGTHS ANTICOAGULANT IN PATIENTS WITH OR AT RISK FOR HEPARIN-INDUCED THROMBOCYTOPENIA UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS (PCI) TREATMENT OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS MANAGEMENT OF POST HERPETIC NEURALGIA PREMENSTRUAL DYSPHORIC DISORDER TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS, INCLUDING ZOLLINGER-ELLISON SYNDROME TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS TREATMENT OF PANIC DISORDER TREATMENT OF VULVAR AND VAGINAL ATROPHY ASSOCIATED WITH THE MENOPAUSE TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL RHINITIS IN CHILDREN AGES TWO UP TO AGE THREE TREATMENT OF MULTIPLE MYELOMA AND DOCUMENTED BONE METASTASES FROM SOLID TUMORS, IN CONJUNCTION WITH STANDARD ANTINEOPLASTIC THERAPY. PROSTATE CANCER SHOULD HAVE PROGRESSED AFTER TREATMENT WITH AT LEAST ONE HORMONAL THERAPY TREATMENT OF PANIC DISORDER, WITH OR WITHOUT AGORAPHOBIA ADJUVANT TREATMENT OF POST MENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS TREATMENT OF HEART FAILURE (NYHA CLASS II-IV) IN PATIENTS WHO ARE INTOLERANT TO AN ACE INHIBITOR PREVENTION OF RELAPSE FOLLOWING LONG-TERM TREATMENT OF MAJOR DEPRESSIVE DISORDER COMBINATION THERAPY WITH THIAZOLIDINEDIONE TO LOWER BLOOD GLUCOSE IN PTS WHOSE HYPERGLYCEMIA CANNOT BE CONTROLLED BY DIET/EXERCISE PLUS MONOTHERAPY WITH ANY OF THE FOLLOWING AGENTS:METFORMIN,SULFONYLUREAS,REPAGLINIDE,OR THIAZOLIDINEDIONES USE OF GLUCOVANCE WITH A THIAZOLIDINEDIONE WHEN GLYCEMIC CONTROL IS NOT OBTAINED WITH GLUCOVANCE ALONE

I-369 I-370
ADB 13 of 55
I-371 I-372 I-373 I-374 I-375 I-376 I-377
I-378 I-379
I-380 I-381 I-382 I-383 I-384 I-385 I-386
I-387 I-388 I-389 I-390
I-391 I-392
I-393 I-394 I-395 I-396 I-397 I-398 I-399 I-400 I-401 I-402 I-403
I-404
PREVENTION AND TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN, AGES 8-13 YEARS, WITH RECOMMENDED DOSE OF 20MG ONCE DAILY AND IN ADOLESCENTS, AGES 14-18 WITH A RECOMMENDED DOSE OF 40MG ONCE DAILY HELICOBACTER PYLORI ERADICATION TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE NOSOCOMIAL PNEUMONIA TREATMENT OF TYPE 2 DIABETIC NEPHROPATHY SHORT TERM TOPICAL TREATMENT OF MILD TO MODERATE PLAQUE-TYPE PSORIASIS OF NON SCALP REGIONS FIRST LINE THERAPY FOR THE REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (CML) USE OF BRAVELLE FOR MULTIPLE FOLLICULAR DEVELOPMENT (CONTROLLED OVARIAN STIMULATION) DURING ASSISTED REPRODUCTIVE TECHNOLOGY CYCLES IN PATIENTS WHO HAVE PREVIOUSLY RECEIVED PITUITARY SUPPRESSION RELIEF OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER USE TAXOTERE IN COMBINATION WITH CISPLATIN FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHO HAVE NOT PREVIOUSLY RECEIVED CHEMOTHERAPY FOR THIS CONDITION TO TREAT PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER AT RISK FOR EMERGENT SUICIDAL BEHAVIOR TREATMENT OF COLD SORES (HERPES LABIALIS) IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER FOR NEWLY-DIAGNOSED HIGH GRADE MALIGNANT GLIOMA PATIENTS AS AN ADJUNCT TO SURGERY AND RADIATION TREATMENT OF TYPE 2 DIABETIC NEPHROPATHY USE IN COMBINATION WITH INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS MODIFICATION OF THE INDICATION FOR COMMUNITY ACQUIRED PNEUMONIA TO ADD"INCLUDING PENICILLIN-RESISTANT STRAINS, MIC PENICILLIN>=2MCG/ML TO STREPTOCOCCUS PNEUMONIAE RAPAMUNE (SIROLIMUS) WITHIN AN IMMUNOSUPPRESSIVE REGIMEN THAT WOULD ALLOW FOR THE WITHDRAWAL OF CYCLOSPORINE 2 TO 4 MONTHS AFTER RENAL TRANSPLANTATION IN PATIENTS CONSIDERED AT LOW TO MODERATE IMMUNOLOGIC RISK FOR RENAL TRANSPLANT REJECTION ADJUNCTIVE THERAPY OF PARTIAL SEIZURES IN PEDIATRIC PATIENTS GREATER THAT OR EQUAL TO 2 YEARS OF AGE TREATMENT OF PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION SUPRESSION OF RECURRENT GENITAL HERPES IN HIV-INFECTED INDIVIDUALS USE IN PTS AT HIGH RISK CORONARY EVENTS DUE TO EXISTING CORONARY HEART DISEASE,DIABETES,PERIPHERAL VESSEL DISEASE,STROKE HISTORY,OTHER CV DISEASE TO REDUCE RISK TOTAL MORTALITY BY REDUCING CORONARY DEATH,REDUCE NONFATAL MI & STROKE..... ABLATION OF HIGH-GRADE DYSPLASIA IN BARRETT'S ESOPHAGUS PATIENTS WHO DO NOT UNDERGO ESOPHAGECTOMY TX OF PED PATIENTS W/PH+ CHRONIC PHASE CML DISEASE RECUR AFTER STEM CELL TRNSPLT OR RESIST TO INTERFERON ALPHA THERAPY.NO CONTROLLED TRIALS DEMONSTRATING A CLINICAL BENEFIT SUCH AS IMPROVE IN DISEASE RELATED SX OR INCREASED SURVIVAL CHRONIC BACTERIAL PROSTATITIS USE IN PATIENTS WITH CORONARY HEART DISEASE TO REDUCE THE RISK OF UNDERGOING CORONARY REVASCULARIZATION PROCEDURES TO IMPROVE PHYSICAL FUNCTION EXPANDED INDICATION TO INCLUDE THE ASSESSMENT OF VENTRICULAR FUNCTION IN SUBJECTS BEING EVALUATED FOR HEART DISEASE AND/OR VENTRICULAR FUNCTION EXTENDED PROPHYLAXIS IN PATIENTS UNDERGOING HIP FRACTURE SURGERY IDIOPATHIC SHORT STATURE TREATMENT OF CANDIDEMIA AND THE FOLLOWING CANDIDA INFECTIONS: INTRA-ABDOMINAL ABSCESSES, PERITONITIS AND PLEURAL SPACE INFECTIONS USE OF OLANZAPINE IN COMBINATION WITH LITHIUM OR VALPROATE FOR THE TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR DISORDER LONGER-TERM EFFICACY OF ARIPIPRAZOLE IN THE TREATMENT OF SCHIZOPHRENIA DIABETIC FOOT INFECTIONS WITHOUT CONCOMITANT OSTEOMYELITIS USE OF VALTREX IN COMBINATION WITH SAFER SEX PRACTICES FOR THE REDUCTION OF THE RISK OF TRANSMISSION OF GENITAL HERPES DURING SUPPRESIVE THERAPY OF THE SOURCE PARTNER IN A HETEROSEXUAL COUPLE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER TO DELAY THE TIME TO OCCURRENCE OF MOOD EPISODES (DEPRESSION, MANIA, HYPOMANIA, MIXED EPISODES) IN PATIENTS TREATED FOR ACUTE MOOD EPISODES WITH STANDARD THERAPY

I-405 I-406 I-407
ADB 14 of 55
I-408 I-409 I-410 I-411 I-412 I-413 I-414
I-415 I-416 I-417 I-418 I-419 I-420 I-421 I-422 I-423 I-424 I-425 I-426 I-427 I-428
I-429 I-430 I-431 I-432 I-433
I-434
I-435 I-436 I-437 I-438 I-439 I-440
TREATMENT OF PREMENSTRUAL DYSPHORIC DISORDER (PMDD) USING AN INTERMITTENT DOSING REGIMEN PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY, HEART, AND KIDNEY-PANCREAS TRANSPLANT PATIENTS AT HIGH RISK (DONOR CMV SEROPOSITIVE/RECIPIENT CMV SERONEGATIVE) IMPROVE SURVIVAL OF STABLE PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (EJECTION FRACTION<=40%) AND CLINICAL EVIDENCE OF CONGESTIVE HEART FAILURE AFTER AN ACUTE MYOCARDIAL INFARCTION STIMULATION OF PANCREATIC SECRETIONS TO FACILITATE THE INDENTIFICATION OF THE AMPULLA OF VATER AND ACCESSORY PAPILLA DURING ENDOSCOPIC RETROGRADE CHOLANGIO-PANCREATOGRAPHY (ERCP) ESOPHAGEAL CANDIDIASIS USE OF ADVAIR DISKUS 250/50 FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ASSOCIATED WITH CHRONIC BRONCHITIS EXPANDED INDICATION FOR USE IN COMBINATION WITH ANTIDIABETIC DRUGS IN THE THIAZOLIDINEDIONE CLASS MONOTHERAPY FOR THE SHORT TERM TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER ADJUNCTIVE THERAPY FOR THE SHORT TERM TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT), WHICH MAY LEAD TO PULMONARY EMBOLISM (PE) IN MEDICAL PATIENTS WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS DUE TO SEVERELY RESTRICTED MOBILITY DURING ACUTE ILLNESS SEVERE HYPERTENSION WHEN THE VALUE OF ACHIEVING PROMPT BLOOD PRESSURE CONTROL EXCEEDS THE RISK OF INITIATING COMBINATION THERAPY THE USE OF CIPRO XR FOR COMPLICATED URINARY TRACT INFECTIONS AND ACUTE UNCOMPLICATED PYELONEPHRITIS USE IN THE LONG TERM TREATMENT OF BIPOLAR I DISORDER ADJUNCTIVE THERAPY W/ MOOD STABILIZERS (LITHIUM OR DIVALPROEX) IN THE TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDERS MONOTHERAPY IN THE TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER TOPICAL TREATMENT OF CLINICALLY TYPICAL, NONHYPERKERATOTIC, NONHYPERTROPHIC ACTINIC KERATOSES ON THE FACE OR SCALP IN IMMUNOCOMPETENT ADULTS TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS AND PYELONEPHRITIS DUE TO E.COLI FOR PED PATIENTS (1-17) NOT AS FIRST CHOICE INDICATED FOR THE IN-HOSPITAL SHORT-TERM (UP TO 4 HOURS) REDUCTION IN BLOOD PRESSURE IN PEDIATRIC PATIENTS ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENAL INSUFFICIENCY NOT YET ON DIALYSIS FLOXATIN IN COMBINATION WITH INFUSIONAL 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) FOR THE TREATMENT OF PATIENTS PREVIOUSLY UNTREATED FOR ADVANCED COLORECTAL CANCER TREATMENT OF ACUTE PULMONARY EMBOLISM WHEN ADMINISTERED IN CONJUNCTION WITH WARFARIN SODIUM TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITHOUT PULMONARY EMBOLISM WHEN ADMINISTERED IN CONJUNCTION WITH WARFARIN SODIUM FOR USE IN COMBINATION WITH PACLITAXEL FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER AFTER FAILURE OF PRIOR ANTHRACYCLINE CONTAINING ADJUVANT CHEMOTHERAPY UNLESS ANTHRACYCLINES WERE CLINICALLY CONTRAINDICATED FOR USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH ANDROGEN INDEPENDENT (HORMONE REFRACTORY) METASTATIC PROSTATE CANCER FOR USE IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN ADULTS NOSOCOMIAL PNEUMONIA AND COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY STREPTOCOCCUS PNEUMONIAE INDICATION EXPANDED TO INCLUDE MULTI-DRUG RESISTANT STRAINS TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA CAUSED BY MULTI-DRUG RESISTANT STREPTOCOCCUS PNEUMONIAE TREATMENT OF BIOPSY-CONFIRMED, PRIMARY SUPERFICIAL BASAL CELL CARCINOMA IN IMMUNOCOMPETENT ADULTS, WITH A MAXIMUM TUMOR DIAMETER OF 2.0CM, LOCATED ON THE TRUNK (EXCLUDING ANOGENITAL SKIN), NECK, OR EXTREMITIES (EXCLUDING HANDS AND FEET) PREVENTION OF CARDIOVASCULAR DISEASE IN ADULT PATIENTS WITHOUT CLINICALLY EVIDENT HEART DISEASE, BUT WITH MULTIPLE RISK FACTORS FOR CORONARY HEART DISEASE TO REDUCE RISK OF MI AND RISK FOR REVASCULARIZATION PROCEDURES AND ANGINA CHRONIC IDIOPATHIC CONSTIPATION FOR USE IN COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR THE ADJUVANT TREATMENT OF PATIENTS WITH OPERABLE NODE-POSITIVE BREAST CANCER TREATMENT OF ACUTE MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR DISORDER EMPIRICAL THERAPY FOR PRESUMED FUNGAL INFECTIONS IN FEBRILE, NEUTROPENIC PATIENTS USED TO TREAT ADULTS WITH GROWTH HORMONE DEFICIENCY FOR THE REPLACEMENT OF ENDOGENOUS GROWTH HORMONE IN ADULTS WITH GROWTH HORMONE DEFICIENCY

I-441
ADB 15 of 55
I-442 I-443 I-444 I-445
I-446
I-447 I-448 I-449 I-450 I-451 I-452 I-453 I-454 I-455
I-456
I-457 I-458
I-459 I-460 I-461
I-462 I-463 I-464 I-465 I-466 I-467 I-468 I-469 I-470 I-471
I-472 I-473 I-474
USE COMBINATION WITH INFUSIONAL 5-FU/LV FOR ADJUVANT TREATMENT STAGE III COLON CANCER PTS WHO HAVE UNDERGONE COMPLETE RESECTION PRIMARY TUMOR-BASED ON IMPROVEMENT IN DISEASE FREE SURVIVAL, NO DEMONSTRATED BENEFIT OVERALL SURVIVAL AFTER 4YRS USED FOR CANDIDEMIA IN NONNEUTROPENIC PATIENTS AND THE FOLLOWING CANDIDA INFECTIONS: DISSEMINATED INFECTIONS IN SKIN & INFECTIONS IN ABDOMEN, KIDNEY, BLADDER WALL, AND WOUNDS TREATMENT OF NASAL POLYPS IN PATIENTS 18 YEARS OF AGE AND OLDER USE OF PROTONIX IV FOR INJECTION AS STAND ALONE THERAPY FOR THE SHORT-TERM TREATMENT OF PATIENTS HAVING GASTROESOPHAGEAL REFLUX (GERD) WITH A HISTORY OF EROSIVE ESOPHAGITIS TO IMPROVE (COMPARED TO 4.25% DEXTROSE) LONG-DWELL ULTRAFILTRATION AND CLEARANCE OF CREATININE AND UREA NITROGEN IN PATIENTS WITH HIGH AVERAGE OR GREATER TRANSPORT CHARACTERISTICS, AS DEFINED USING THE PERITONEAL EQUILIBRATION TEST (PET) EXTENDED ADJUVANT TREATMENT OF EARLY BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE RECEIVED 5 YRS ADJUVANT TAMOXIFEN THERAPY-EFFECTIVENESS BASED ON AN ANALYSIS OF DISEASE FREE SURVIVAL IN PATIENTS TREATED FOR A MEDIAN 24 MONTHS USE OF COPEGUS (RIBAVIRIN) FOR TREATMENT OF CHRONIC HEPATITIS C IN ADULT PATIENTS COINFECTED WITH HIV IN COMBINATION WITH PEGASYS (PEGINTERFERON ALFA-2A) TREATMENT OF HEART FAILURE (NYHA CLASS II-IV AND EJECTION FRACTION <=40%) TO REDUCE THE RISK OF DEATH FROM CARDIOVASCULAR CAUSES AND TO REDUCE HOSPITALIZATIONS FOR HEART FAILURE TO IMPROVE WAKEFULNESS IN TWO NEW PATIENT POPULATIONS WITH EXCESSIVE SLEEPINESS: THOSE WITH OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME AND THOSE WITH SHIFT WORK SLEEP DISORDER TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMAS CONCOMITANTLY WITH RADIOTHERAPY AND THEN AS ADJUVANT TREATMENT MANAGEMENT OF ENDOMETRIOSIS ASSOCIATED PAIN EXPANDED INDICATION TO INCLUDE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST 1 PRIOR THERAPY USE IN COMBINATION WITH A SULFONYLUREA PLUS METFORMIN WHEN DIET, EXERCISE AND BOTH AGENTS DO NOT RESULT IN ADEQUATE GLYCEMIC CONTROL (TRIPLE THERAPY) MAINTENANCE OF CLINICAL REMISSION OF MILD TO MODERATE CHRON'S DISEASE INVOLVING THE ILEUM AND/OR THE ASCENDING COLON FOR UP TO 3 MONTHS MODIFIED HEART FAILURE INDICATION TO INCLUDE TREATMENT OF HEART FAILURE IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (NYHA CLASS II-IV; EJECTION FRACTION LESS THAN OR EQUAL TO 40% TO REDUCE CARDIOVASCULAR DEATH AND TO REDUCE HEART FAILURE HOSPITALIZATIONS. INCLUDES ADDITIONAL INFORMATION ON THE ADDED EFFECT ON THESE OUTCOMES WHEN USED WITH AN ACE INHIBITOR TREATMENT OF PATIENTS UNDERGOING ABDOMINAL SUREGERY WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLIATIONS USE OF BIVALIRUDIN FOR INJECTION WITH PROVISIONAL USE OF GLYCOPROTEIN IIB/IIA INHIBITOR (GPI) AS LISTED IN THE CLINICAL TRIALS REPLACE-2 SECTION FOR USE AS AN ANTICOAGULANT IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) PATIENTS RECEIVING OR NOT RECEIVING AN ERYTHROPOIETIN TREATMENT OF DIARRHEA CAUSED BY CRYPTOSPORIDIUM PARVUM IN NON-HIV INFECTED PATIENTS 12 YEARS OF AGE AND OLDER USE AS A SINGLE AGENT FOR ADJUVANT TREATMENT IN PATIENTS WITH DUKES' C COLON CANCER WHO HAVE UNDERGONE COMPLETE RESECTION OF THE PRIMARY TUMOR WHEN TREATMENT WITH FLUOROPYRIMIDINE THERAPY ALONE IS PREFERRED LONG TERM TREATMENT OF IDIOPATHIC SHORT STATURE TREATMENT OF PATIENTS POST MYOCARDIAL INFARCTION TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME PERENNIAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 6 MONTHS OF AGE AND OLDER FOR RELIEF OF THE SIGNS AND SYMPTOMS OF ANKYLOSING SPONDYLITIS USE OF TOPIRAMATE AS INITIAL MONOTHERAPY IN PATIENTS 10 YEARS OF AGE AND OLDER WITH PARTIAL ONSET OR PRIMARY GENERALIZED TONIC CLONIC SEIZURES USE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE TO REDUSE THE RISK OF CARDIOVASCULAR MORTALITY OR NON-FATAL MYOCARDIAL INFECTION RELIEF OF THE SIGNS AND SYMPTOMS OF PAUCIARTICULAR OR POLYARTICULAR COURSE JUVENILE RHEUMATOID ARTHRITIS IN PATIENTS 2 YEARS OF AGE AND OLDER DIABETIC PERIPHERAL NEUROPATHIC PAIN INDICATED TO REDUCE THE RISK OF MYOCARDIAL INFARCTION AND STROKE IN PATIENTS WITH TYPE 2 DIABETES AND WITHOUT CLINICALLY EVIDENT CORONARY HEART DISEASE BUT WITH MULTIPLE RISK FACTORS FOR CORONARY HEART DISEASE USE IN PATIENTS WITH ANGIOGRAPHICALLY DOCUMENTED CORONARY ARTERY DISEASE USE IN COMBINATION WITH GEMCITABINE FOR THE FIRST LINE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PANCREATIC CANCER TREATMENT OF IRON DEFICIENCY ANEMIA IN PERITONEAL DIALYSIS DEPENDANT CHRONIC KIDNEY DISEASE IN PATIENTS RECIEVING AN ERYTHROPOIETIN

I-475 I-476 I-477
ADB 16 of 55
I-478 I-479
I-480 I-481 I-482 I-483 I-484 I-485 I-486 I-487 I-488 I-489 I-490
I-491 I-492 I-493
I-494
I-495
I-496 I-497 I-498 I-499
I-500 I-501 I-502
I-503 I-504 I-505
I-506 I-507
I-508 I-509
PREVENTION OF NAUSEA AND VOMITTING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF MODERATELY EMETOGENIC CANCER CHEMOTHERAPY TREATMENT OF DIABETIC FOOT INFECTIONS WITHOUT OSTEOMYELITIS TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS CAUSED BY METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS, ESCHERICHIA COLI, KLEBSIELLA PNEUMONIAE, OR ENTEROBACTER CLOACAE FOR USE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES IN CHILDREN WITH EPILEPSY AGED 2-4 YEARS TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS CAUSED BY E.COLI, B. FRAGILIS, S.ANGINOSUS, S.CONSTELLATUS, E. FAECALIS, P. MIRABILIS, C. PERFRINGENS, B. THETAIOTAOMICRON OR PEPTOSTREPTOCOCCUS SPECIES PROPHYLAXIS OF INFLUENZA FOR PATIENTS BETWEEN 1-12 YEARS OF AGE INDICATED FOR THE ADJUVANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER WITH OR WITHOUT PSYCHOTIC FEATURES PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR THE RISK REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCERS TREATMENT OF POSTOPERATIVE INFLAMMATION AND REDUCTION OF OCULAR PAIN IN PATIENTS WHO HAVE UNDERGONE CATARACT EXTRACTION ANGIOMAX IS INDICATED FOR PATIENTS WITH, OR AT RISK OF, HIT/HITTS UNDERGOING PCI INDICATED FOR THE RELIEF OF THE INFAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YRS OF AGE OR OLDER MAINTENANCE THERAPY IN BIPOLAR I DISORDER FOR USE IN PEDIATRIC PATIENTS WITH TYPE I DIABETES FOR USE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE TREATMENT OF PATIENTS WITH ADVANCED GASTRIC ADENOCARCINOMA, INCLUDING ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION, WHO HAVE NOT RECEIVED PRIOR CHEMOTHERAPY FOR ADVANCED DISEASE INFLUENZA PROPHYLAXIS MONOTHERAPY IN THE TREATMENT OF ACUTE MANIC OR MIXED EPISODES IN BIPOLAR I DISORDER, WITH OR WITHOUT PSYCHOTIC FEATURES ADMINISTERED IN COMBINATION WITH FENOFIBRATE, AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF ELEVATED TOTAL-C, LDL-C, APO B, AND NON-HDL-C IN PATIENTS WITH MIXED HYPERLIPIDEMIA CLINICAL DATA IN SUPPORT OF AVANDAMET AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH DUAL ROSIGLITAZONE AND METFORMIN THERAPY IS APPROPRIATE ADJUVANT TX OF POSTMENOPAUSAL WOMEN WITH ESTROGEN-RECEPTOR POSITIVE EARLY BREAST CANCER WHO HAVE RECEIVED 2 TO 3 YRS OF TAMOXIFEN AND ARE SWITCHED TO AROMASIN FOR COMPLETION OF A TOTAL OF 5 CONSECUTIVE YRS OF ADJUVANT HORMONAL THERAPY LONG TERM TREATMENT OF GROWTH FAILURE ASSOCIATED WITH TURNER SYNDROME IN PATIENTS WHO HAVE OPEN EPIPHYSES PREVENTION OF SEASONAL MAJOR DEPRESSIVE EPISODES IN PATIENTS WITH SEASONAL AFFECTIVE DISORDER PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING USE OF GEMZAR IN COMBINATION WITH CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED OVARIAN CANCER THAT HAS RELAPSED AT LEAST 6 MONTHS AFTER COMPLETION OF PLATINUMBASED THERAPY FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN IMMUNOCOMPETANT PATIENTS WITH A SINGLE DOSE OF FAMCICLOVIR 1500 MG. FOR PTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION, PLAVIX TO REDUCE RATE OF DEATH FROM ANY CAUSE AND THE RATE OF A COMBINED ENDPOINT OF DEATH, REINFARCTION OR STROKE. NOT KNOWN TO PERTAIN TO PTS WHO RECEIVE PRIMARY ANGIOPLASTY TREATMENT OF MAJOR DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS INCLUDING ZOLLINGER-ELLISON SYNDROME TREATMENT OF STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA), INCLUDING THOSE WITH RIGHT SIDED INFECTIVE ENDOCARDITIS, CAUSED BY METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT ISOLATES ADJUNCTIVE THERAPY OF MYOCLONIC SEIZURES IN ADULTS AND ADOLESCENTS AGE 12 AND OVER WITH JUVENILE MYOCLONIC EPILEPSY ADJUNCT TO DIET TO REDUCE TOTAL-C, LDL-C AND APO B LEVELS IN ADOLESCENT BOYS AND GIRLS WHO ARE AT LEAST ONE YEAR POST-MENARCHE, 10-16 YEARS OF AGE, WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PREMENSTRUAL DYSPHONIC DISORDER TREATMENT OF IRRATABILITY ASSOCIATED WITH AUTISTIC DISORDER

I-510 I-511 I-512 I-513 I-514 I-515 I-516 I-517 I-518 I-519
ADB 17 of 55
I-520
I-521 I-522
I-523
I-524 I-525 I-526 I-527 I-528 I-529 I-530 I-531 I-532 I-533 I-534 I-535 I-536 I-537 I-538 I-539 I-540 I-541 I-542 I-543 I-544 I-545 I-546 I-547 I-548 I-549 I-550 I-551 I-552
ADULT DERMAFIBROSARCOMA PROTUBERANS (DFSP) ADULT MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE DISEASES (MDS/MDP) ADULT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) MONOTHERAPY ADULT AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM) ADULT HYPEREOSINOPHILIC SYNDROME/CHRONIC EOSINOPHILIC LEUKEMIA (HES/CEL) PROPHYLAXIS OF SURGICAL SITE INFECTION FOLLOWING ELECTIVE COLORECTAL SURGERY PRIMARY GENERALIZED TONIC CLONIC SEIZURES IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEG SYNDROME (RLS) TREATMENT OF SHORT STATURE OR GROWTH FAILURE IN CHILDREN WITH SHOX (SHORT STATURE HOMEOBOX CONTAINING GENE) DEFICIENCY WHOSE EPIPHYSES ARE NOT CLOSED USE OF TAXOTERE (DOCETAXEL) INJECTION CONCENTRATE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE INDUCTION OF PATIENTS WITH INOPERABLE LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) USE OF EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO ARE USING A THIAZOLIDINEDIONE ALONE OR IN COMBINATION WITH METFORMIN BUT HAVE NOT ACHIEVED ADEQUATE GLYCEMIC CONTROL TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST 1 YEAR PRIOR THERAPY TREATMENT OF MODERATE ACNE VULGARIS IN WOMEN AT LEAST 14 YRS OF AGE, WHO HAVE NO KNOWN CONTRAINDICATIONS TO ORAL CONTRACEPTIVE THERAPY, AND HAVE ACHIEVED MENARCHE, IF THE PATIENT DESIRES AN ORAL CONTRACEPTIVE FOR BIRTH CONTROL. USE IN ADULT PATIENTS WITH CLINICALLY EVIDENT CORONARY HEART DISEASE TO REDUCE THE RISK OF NONFATAL MYOCARDIAL INFARCTION, FATAL AND NONFATAL STROKE, ANGINA, REVASCULARIZATION PROCEDURES AND HOSPITALIZATION FOR CONGESTIVE HEART FAILURE GENERALIZED ANXIETY DISORDER (GAD) USE OF 0.5MG/0.1MG FOR PREVENTION OF POST-MENOPAUSAL OSTEOPOROSIS TREATMENT OF HYPONATREMIA IN HOSPITALIZED PATIENTS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER WITH IDIOPATHIC GENERALIZED EPILEPSY TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY ASSOCIATED WITH MENOPAUSE TREATMENT OF DEMENTIA OF THE ALZHEIMER'S TYPE IN PATIENTS WITH SEVERE ALZHEIMER'S DISEASE PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION IN PATIENTS 15 YEARS OF AGE AND OLDER MAINTENANCE TREATMENT OF SCHIZOPHRENIA TREATMENT OF BACTERIAL VAGINOSIS IN NON-PREGNANT FEMALES ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) EXTENDED TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE) AND/OR PULMONARY EMBOLISM TO REDUCE THE RECCURENCE OF VTE IN PATIENTS WITH CANCER MANAGEMENT OF FIBROMYALGIA FOR THE TREATMENT OF SHORT STATURE IN CHILDREN WITH NOONAN SYNDROME LONG TERM TREATMENT OF PANIC DISORDER SHORT TERM TREATMENT OF PANIC DISORDER REDUCTION IN RISK OF INVASIVE BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS OR AT HIGH RISK FOR INVASIVE BREAST CANCER TREATMENT OF SCHIZOPHRENIA IN ADOLESCENTS AGES 13-17 TREATMENT OF BIPOLAR I DISORDER IN CHILDREN AGES 10-12 AND ADOLESCENTS AGES 13-17 EXPANSION OF PATIENT POPULATION FOR HEAD AND NECK CANCER FROM "INOPERABLE" PATIENTS TO ALL PATIENTS USE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE INDUCTION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) ADJUNCTIVE THERAPY OF MYOCLONIC SEIZURES IN ADULTS AND ADOLESCENTS AGE 16 AND OVER WITH JUVENILE MYOCLONIC EPILEPSY ADJUNCTIVE TREATMENT TO TREAT PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA ADJUNCTIVE THERAPY TO DIET TO SLOW THE PROGRESSION OF ARTHEROSCLEROSIS IN ADULT PATIENTS AS PART OF A TREATMENT STRATEGY TO LOWER TOTAL-C AND LDL-C TO TARGET LEVELS SEASONAL ALLERGIC RHINITIS IN PATIENTS 6 THROUGH LESS THAN 12 YEARS OF AGE USE OF AVALIDE TABLETS AS INITIAL THERAPY IN PATIENTS WHO ARE LIKELY TO NEED MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD PRESSURE GOALS TREATMENT OF HYPERTENSION IN PEDIATRIC PATIENTS 6-16 YEARS OF AGE TREATMENT OF SHORT STATURE IN CHILDREN WITH TURNER'S SYNDROME ADJUNCTIVE TREATMENT FOR RADIOIODINE ABLATION OF THYROID TISSUE REMNANTS IN PATIENTS WHO HAVE UNDERGONE THYROIDECTOMY FOR WELL-DIFFERENTIATED THYROID CANCER AND WHO DO NOT HAVE EVIDENCE OF METASTATIC THYROID CANCER

I-553 I-554 I-555 I-556 I-557 I-558 I-559 I-560 I-561 I-562 I-563 I-564 I-565 I-566 I-567 I-568
ADB 18 of 55
I-569 I-570 I-571 I-572 I-573 I-574 I-575 I-576 I-577 I-578 I-579 I-580 I-581 I-582 I-583 I-584 I-585 I-586 I-587 I-588 I-589 I-590 I-591 I-592 I-593 I-594 I-595
FOR USE AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA PERITONIS AND ABSCESSES TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER IN PEDIATRIC PATIENTS AGED 10-17 YEARS PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOR UP TO 24 HOURS FOLLOWING SURGERY USE OF AMITIZA (LUBIPROSTONE) 8 MCG TWICE DAILY FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN WOMEN GREATER THAN OR EQUAL TO 18 YEARS OLD MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION AND REDUCING EXACERATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA ADJUNCTIVE THERAPY ADDED TO LITHIUM OR VALPROATE IN SHORT TERM TREATMENT OF BIPOLAR DISORDER, MANIC OR MIXED MAINTENANCE TREATMENT FOR BIPOLAR I DISORDER, AS ADJUNCTIVE THERAPY TO LITHIUM OR DIVALPROEX LONG-TERM TREATMENT OF SOCIAL ANXIETY DISORDER MAINTENANCE TREATMENT OF ATTENTION-DEFICIT DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SIEZURES IN ADULTS AND CHILDREN 16 YEARS OF AGE AND OLDER WITH IDIOPATHIC GENERALIZED EPILEPSY TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA USE OF DUTASTERIDE IN COMBINATION WITH TAMSULOSIN FOR THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH) MANAGEMENT OF FIBROMYALGIA INITIAL THERAPY IN PATIENTS LIKELY TO NEED MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD PRESSURE GOALS USE OF APTIVUS, CO-ADMINISTERED W/RITONAVIR, FOR COMBINATION ANTIRETROVIRAL TREATMENT OF HIV-1 INFECTED PED (AGE 2-18 YRS) PATIENTS WHO ARE TREATMENT-EXPERIENCED AND INFECTED W/HIV-1 STRAINS RESISTANT TO MORE THAN ONE PROTEASE INHIBITOR TREATMENT OF CHRONIC HEPATITIS B TREATMENT OF CHICKEN POX IN IMMUNOCOMPETENT PEDIATRIC PATIENTS 2 TO <18 YEARS OF AGE NON-SMALL CELL LUNG CANCER IN COMBINATION WITH CISPLATIN AND AS SINGLE AGENT FOR NONSQAUMOUS NON-SMALL CELL LUNG CANCER TREATMENT OF GROWTH FAILURE IN CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA) WITH NO CATCH-UP BY AGE 2-4 YRS. TO TREAT PATIENTS WITH PRIMARY DYSBETALIPOPROTEINEMIA (FREDICKSON TYPE III HYPERLIPOPROTEINEMIA) AS AN ADJUNCT TO DIET MONOTHERAPY IN THE TREATMENT OF BIPOLAR DEPRESSION MONOTHERAPY IN THE TREATMENT OF BIPOLAR MANIA ADJUNCTIVE THERAPY IN THE TREATMENT OF BIPOLAR MANIA SEDATION OF NON-INTUBATED PATIENTS PRIOR TO AND/OR DURING SURGICAL AND OTHER PROCUDURES EXPANSION OF INDICATION TO INCLUDE TREATMENT OF HIV IN TREATMENT NAIVE ADULTS TREATMENT OF MODERATE TO SEVERE DYSPAREUNIA, A SYMPTOM OF VULVAR AND VAGINAL ATROPHY, DUE TO MENOPAUSE AND NEW TWICE WEEKLY DOSING REGIMEN FOR THIS INDICATION INDOLENT B-CELL NON-HODGKINS LYMPHOMA (NHL) THAT HAS PROGRESSED DURING OR WITHIN SIX MONTHS OF TREATMENT WITH RITUXIMAB OR A RITUXIMAB CONTAINING REGIMEN TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ADJUVANT TREATMENT OF ADULT PATIENTS FOLLOWING COMPLETE GROSS RESECTION OF KIT (CD117) POSITIVE GASTOINTESTINAL STROMAL TUMORS (GIST) TREATMENT AND PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN PATIENTS EXPECTED TO BE ON GLUCOCORTICOIDS FOR AT LEAST 12 MONTHS TREATMENT OF SHORT STATURE IN PEDIATRIC PATIENTS SMALL FOR GESTATIONAL AGE WHO DO NOT MANIFEST CATCH UP GROWTH BY AGE 2 TO 4 YEARS COMMUNITY ACQUIRED BACTERIAL PNEUMONIA ADDITIONAL PATHOGENS TO COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS INDICATION ADDITIONAL PATHOGENS TO COMPLICATED INTRA-ABDOMINAL INFECTIONS INDICATION TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) IN COMBINATION WITH OLANZAPINE ACUTE TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER (IN COMBINATION WITH OLANZAPINE) TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) IN COMBINATION WITH FLUOXETINE ACUTE TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER (IN COMBINATION WITH FLUOXETINE) TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) INDICATION EXPANDED TO INCLUDE PATIENTS WHO HAVE EXPERIENCED A FIRST CLINICAL EPISODE AND HAVE MRI FEATURES CONSISTENT WITH MULTIPLE SCLEROSIS PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN

I-596 I-597 I-598 I-599 I-600 I-601
ADB 19 of 55
I-602 I-603 I-604 I-605 I-606 I-607 I-608
I-610 I-611
I-612
I-613 I-614 I-615 I-616 I-617 I-618 I-619 I-620
I-621
I-622 I-623 I-624
I-625 I-626 I-627 I-628 I-629 I-630
I-631 I-632
USE AS ADJUNCTIVE THERAPY WITH LITHIUM OR VALPROATE FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER MONOTHERAPY FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER TREATMENT OF PULMONARY ARTERIAL HYPERTENSION INDICATION EXPANDED TO INCLUDE DELAY IN CLINICAL WORSENING PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 5 IN PATIENTS ON HEMODIALYSIS OR PERITONEAL DIALYSIS FOR USE AS INITIAL THERAPY IN PATIENTS WHO ARE LIKELY TO NEED MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD PRESSURE GOALS MAINTENANCE TREATMENT IN PATIENTS WITH ADVANCED OR METASTATIC NONSQUAMOUS NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES OF PLATINUM-BASED FIRST LINE CHEMOTHERAPY TREATMENT OF MEN AND WOMEN WITH OSTEOPOROSIS ASSOCIATED WITH SUSTAINED SYSTEMIC GLUCOCORTICOID THERAPY AT HIGH RISK FOR FRACTURE GOUT FLARES PREVENTION OF CMV DISEASE IN KIDNEY AND HEART TRANSPLANT PATIENTS 4 MONTHS TO 16 YEARS AT HIGH RISK ADJUNCT TO MOOD STABILIZERS AND/OR ANTIDEPRESSANTS FOR SCHIZOAFFECTIVE DISORDER TREATMENT OF SCHIZOAFFECTIVE DISORDER AS MONOTHERAPY INDICATION EXPANDED TO INCLUDE TREATMENT OF PULMONARY ARTENAL HYPERTENSION (WHO GROUP I) IN PATIENTS WITH CLASS II SYMPTOMS REDUCE LDL-C LEVELS IN BOYS AND POSTMENARCHAL GIRLS, 10 TO 17 YEARS OF AGE, WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AS MONOTHERAPY OR IN COMBINATION WITH A STATIN AFTER FAILING AN ADEQUATE TRIAL OF DIET THERAPY TREATMENT OF HEAVY MENSTRUAL BLEEDING FOR WOMEN WHO CHOOSE TO USE INTRAUTERINE CONTRACEPTION AS THEIR METHOD OF CONTRACEPTION TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN ADOLESCENT BOYS AND POSTMENARCHAL GIRLS, AGES 10 TO 17 YEARS, WITH A RECOMMENDATION DOSING RANGE OF 5 TO 20 MG ONCE DAILY MICARDIS 80 MG FOR REDUCTION OF THE RISK OF MYOCARDIAL INFARCTION, STROKE, OR DEATH FROM CARDIOVASCULAR CAUSES IN PATIENTS 55 YEARS OF AGE OR OLDER AT HIGH RISK OF DEVELOPING MAJOR CARDIOVASCULAR EVENTS WHO ARE UNABLE TO TAKE ACE INHIBITORS MILD TO MODERATE ATOPIC DERMATITIS IN PATIENTS 3 MONTHS OF AGE TO LESS THAN 18 YEARS OF AGE SHORT TERM TREATMENT OF EROSIVE ESOPHAGITIS ASSOCIATED WITH GERD IN PEDIATRIC PATIENTS AGES FIVE YEARS AND OLDER MAINTENANCE TREATMENT OF BIPOLAR DISORDER AS AN ADJUNCT TO LITHIUM OR VALPROATE TREATMENT OF IRRITABILITY ASSOCIATED WITH AUTISTIC DISORDER IN PEDIATRIC PATIENTS AGES 617 YEARS OF AGE MAINTENANCE OF GENERALIZED ANXIETY DISORDER (GAD) ADJUNCTIVE THERAPY IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) INTRAVENOUS CONTRAST ENHANCED COMPUTER TOMOGRAPHY OF THE HEAD AND BODY FOR USE IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER THAT OVEREXPRESSES THE HER2 RECEPTOR FOR WHOM HORMONAL THERAPY IS INDICATED PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE, BASED ON THE RESULTS OF JUSTIFICATION FOR THE USE OF STATINS IN PRIMARY PREVENTION; AN INTERVENTION TRIAL EVALUATING ROSUVASTATIN (JUPITER) ADJUNCTIVE THERAPY FOR PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN PATIENTS THIRTEEN YEARS OF AGE AND OLDER TREATMENT OF SIGNS AND SYMPTOMS OF ADVANCED IDIOPATHIC PARKINSON'S DISEASE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES OF PLATINUM-BASED FIRSTLINE CHEMOTHERAPY PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMY RELIEF OF NASAL CONGESTION ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATENTS 2 YEARS OF AGE AND OLDER TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH & CML) IN CHRONIC PHASE. MAINTENANCE TREATMENT OF SCHIZOPHRENIA IN ADULTS ADJUNCTIVE THERAPY WITH EITHER LITHIUM OR VALPROATE FOR THE ACUTE TREATMENT OF MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER TREATMENT OF PATIENTS WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) ASSOCIATED WITH TUBEROUS SCLEROSIS (TS) WHO REQUIRE THERAPEUTIC INTERVENTION BUT ARE NOT CANDIDATES FOR CURATIVE SURGICAL RESECTION. PREVENTION OF RELAPSE TO OPIOID DEPENDENCE FOLLOWING OPIOID DETOXIFICATION MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN

I-633 I-634 I-635 I-636 I-637 I-638 I-639 I-640 I-641 I-642 I-643 I-644 I-645 I-646 I-647 I-648 I-649 I-650 I-651 I-652 I-653 I-654 I-655
ADB 20 of 55
I-656
I-657 I-658
I-659 I-660 I-661 I-662 I-663 I-664
MAINTENANCE TREATMENT OF BIPOLAR I DISORDER AS AN ADJUNCT TO LITHIUM OR VALPROATE TREATMENT OF SEVERE HYPERCALCEMIA IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM WHO ARE UNABLE TO UNDERGO PARATHYROIDECTOMY ADJUNCTIVE TREATMENT WITH LONG-ACTING ORAL PSYCHOSTIMULANTS FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) TREATMENT OF EXTERNAL GENITAL AND PERIANAL WARTS/CONDYLOMA ACUMINATA IN PATIENTS 12 YEARS OR OLDER USE IN COMBINATION CHEMOTHERAPY WITH 5-FLUOROURACIL IN THE PALLIATIVE TREATMENT OF PATIENTS WITH ADVANCED METASTATIC COLORECTAL CANCER FOR PATIENTS WITH PROGRESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC. TREATMENT OF PROGRESSIVE, WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMORS IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC DISEASE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS TREATMENT OF THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT OF ERECTILE DYSFUNCTION (ED) AND THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH) REDUCE THE RISK OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION. MONOTHERAPY IN PATIENTS 13 YEARS OF AGE AND OLDER WITH PARTIAL SEIZURES WHO ARE RECEIVING THERAPY WITH A SINGLE ANTIEPILEPTIC DRUG (AED) MAINTENANCE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS SIGNS AND SYMPTOMS OF ADVANCED PARKINSON'S DISEASE (APD) SIGNS AND SYMPTOMS OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME (RLS) TREATMENT OF HEAVY MENSTRUAL BLEEDING IN WOMEN WITHOUT ORGANIC PATHOLOGY WHO CHOOSE TO USE AN ORAL CONTRACEPTIVE AS THEIR METHOD OF CONTRACEPTION TREATMENT OF PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA (STS) WHO HAVE RECEIVED PRIOR CHEMOTHERAPY TREATMENT OF ADULTS WITH RENAL ANGIOMYOLIPOMA AND TUBEROUS SCLEROSIS COMPLEX (TSC), NOT REQUIRING IMMEDIATE SURGERY MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH SPINAL CORD INJURY MANAGEMENT OF POSTHERPETIC NEURALGIA TREATMENT OF ENDOGENOUS ANTERIOR UVEITIS MAGNETIC RESONANCE ANGIOGRAPHY (MRA) TO EVALUATE ADULTS WITH KNOWN OR SUSPECTED RENAL OR AORTO-ILIO-FEMORAL OCCLUSIVE VASCULAR DISEASE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED HORMONE RECEPTOR-POSITIVE,HER2-NEGATIVE BREAST CANCER (ADVANCED HR+BC) IN COMBINATION WITH EXEMESTANE, AFTER FAILURE OF TREATMENT WITH LETROZOLE OR ANASTROZOLE MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY (DPN) IN ADULTS WHEN A CONTINUOUS, AROUND-THE-CLOCK OPIOID ANALGESIC IS NEEDED FOR AN EXTENDED PERIOD OF TIME PLAQUE PSORIASIS OF THE SCALP FIRST-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, IN COMBINATION WITH CARBOPLATIN, IN PATIENTS WHO ARE NOT CANDIDATES FOR CURATIVE SURGERY OR RADIATION THERAPY PLAQUE PSORIASIS OF THE BODY TREATMENT OF DEEP VEIN THROMBOSIS TREATMENT OF PULMONARY EMBOLISM REDUCTION IN RISK FOR DEEP VEIN THROMBOSIS AND THE REDUCTION IN RISK FOR PULMONARY EMBOLISM IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATIONRESISTANT PROSTATE CANCER TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY
EXCLUSIVITY MISCELLANEOUS
M-1 M-2 INFORMATION REGARDING SUPERIORITY CLAIM OVER RANITIDINE FOR DAY AND NIGHT HEARTBURN ADDED TO CLINICAL STUDIES SECTION APPROVAL FOR ADDTION TO CLINICAL PHARMACOLOGY SECTION OF THE LABEL REGARDING (1) IMPROVEMENT IN BONE MINERAL DENSITY IN CHILDHOOD-ONSET ADULT GROWTH HORMONE DEFICIENT PATIENTS AND (2) INCREASES IN SERUM ALKALINE PHOSPHATASE ADDITION OF EFFICACY AND SAFETY INFORMATION IN WHICH FOSAMAX WAS USED CONCOMITANTLY WITH ESTROGEN ALONE OR WITH ESTROGEN PLUS PROGESTIN CHANGES TO PEDIATRIC USE SECTION TO PROVIDE INFORMATION REGARDING SAFETY AND EFFICACY IN PEDIATRIC PATIENTS AS YOUNG AS 2 YEARS OLD
M-3 M-4

M-5 M-6 M-7 M-8 M-9
ADB 21 of 55
M-10 M-11 M-12 M-13 M-14 M-15 M-16 M-17 M-18 M-19 M-20 M-21 M-22 M-23 M-24 M-25 M-26
M-27 M-28 M-29 M-30 M-31 M-32 M-33 M-34 M-35 M-36 M-37 M-38 M-39 M-40 M-41
M-42
INFORMATION REGARDING EFFECTS IN PATIENTS WITH ASTHMA ON CONCOMITANT INHALED CORTICOSTEROIDS IN CLINICAL PHARMACOLOGY SECTION ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES DONE WITH GLUCOPHAGE/GLYBURIDE COMBINATION ADDED TO CLINICAL PHARMACOLOGY AND DOSING AND ADMINISTRATION CLINICAL PHARMACOLOGY IN PEDIATRIC PATIENTS; DOSAGE AND ADMINISTRATION INFORMATION ADDITIONAL INFORMATION FOR THE USE OF SONATA CAPSULES FOR UP TO 5 WEEKS (35 NIGHTS) OF TREATMENT IN A CONTROLLED TRIAL SETTING ADDITION TO THE CLINICAL STUDIES SECTION OF THE LABELING OF TEXT AND TWO TABLES CONTAINING INFORMATION FOR THE PRESCRIBING PHYSICIAN ON BLOOD PRESSURE, HEART RATE, AND HEART RATE VARIABILITY INFORMATION REGARDING MAINTENANCE OF AN ANTIDEPRESSANT EFFECT UP TO 1 YEAR OF DOSING USE FOR LONG-TERM TREATMENT OF POSTTRAUMATIC STRESS DISORDER NEW LANGUAGE FOR PEDIATRIC USE INFORMATION FROM PEDIATRIC STUDIES ADDED TO CLINICAL PHARMACOLOGY, PRECAUTIONS, AND DOSAGE AND ADMINISTRATION ADDITIONAL CLINICAL TRIAL INFORMATION ADDED TO PEDIATRIC USE SUBSECTION LONGER TERM EFFICACY INFORMATION FOR RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA CHANGE IN WORDING OF THE PEDIATRIC SECTION OF THE PACKAGE INSERT INFORMATION REGARDING USE OF ULTANE IN PEDIATRIC PATIENTS WITH CONGENITAL HEART DISEASE INFORMATION DENOTING THE EFFICACY OF REMERON IN MAINTAINING A RESPONSE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) INFORMATION REGARDING USE IN PEDIATRIC PATIENTS TWO YEARS OF AGE AND OLDER LABELING REVISIONS RELATED TO MCCUNE ALBRIGHT SYNDROME COMPARISON DATA ON THE ANTIHYPERTENSIVE EFFECTS OF ATACAND AND COZAAR CHANGE IN TIME TO ONSET OF ACTION INFORMATION REGARDING ELIMINATION ADDED TO CLINICAL PHARMACOLOGY, STUDY RESULTS IN PATIENTS WITH HEPATIC AND RENAL IMPAIRMENT INFORMATION ON RESULTS OF A LONG TERM LONGITUDINAL GROWTH STUDY AND PEDIATRIC SAFETY INFORMATION ADDITIONAL SAFETY & PK INFORMATION IN CHILDREN 6 MONTHS TO LESS THAN 6 YEARS OF AGE ADDED TO PKG INSERT INCORPORATION OF INFORMATION CONTAINED IN THE PEG-INTRON PACKAGE INSERT INTO THE REBETOL PACKAGE INSERT AND MEDGUIDE-PEG-INTRON WAS APPROVED FOR USE IN COMBINATION WITH REBETOL FOR TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION ON 8/7/01 INFORMATION DESCRIBING ASPIRIN ENDOSCOPY STUDY AND THE MAXIMUM RECOMMENDED DOSE FOR PATIENTS WITH MODERATE HEPATIC INSUFFICIENCY INFORMATION FROM A STUDY IN PEDIATRIC PATIENTS IN ASSOCIATION WITH A NEUROLOGICAL CONDITION LABELING CHANGES TO PROVIDE INFORMATION IN THE MANAGEMENT OF OBESITY IN ADOLESCENTS AGED 12 TO 16 YEARS CHANGES TO CLINICAL PHARMACOLOGY, PRECAUTIONS, AND DOSAGE AND ADMINISTRATION SECTIONS OF LABELING CONCERNING USE OF LOTENSIN IN PEDIATRIC PATIENTS WITH HYPERTENSION INFORMATION FOR USE IN PEDIATRIC PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5 (END-STAGE RENAL DISEASE) ADDITIONAL LANGUAGE TO CLINICAL PHARMACOLOGY AND CLINICAL STUDIES INFORMATION FOR USE OF ADVAIR DISKUS 100/50 IN CHILDREN 4 TO 11 YEARS OF AGE WITH ASTHMA EXPANDED INFORMATION TO PEDIATRIC USE SUBSECTION OF LABELING IN RESPONSE TO PEDIATRIC WRITTEN REQUEST ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES DONE WITH ACTOS IN COMBINATION WITH METFORMIN, A SULFONYLUREA, OR INSULIN ADDED TO CLINICAL PHARMACOLOGY ADDITION OF INFORMATION TO CLINICAL STUDIES REGARDING PREVENTION OF CARDIOVASCULAR DISEASE INFORMATION ADDED TO THE LABELING THAT DETAILS INFORMATION RELATIVE TO STUDIES DONE IN PEDIATRIC POPULATIONS IN THE CLINICAL PHARMACOLOGY AND PEDIATRIC USE SUBSECTIONS SAFETY AND IOP-LOWERING EFFECTS OF TRUSOPT HAVE BEEN DEMONSTRATED IN PEDIATRIC PATIENTS IN A 3 MONTH, MULTI-CENTER DOUBLE MASKED ACTIVE-TREATMENT-CONTROLLED TRIAL FOR LABELING CHANGES BASED ON RESULTS OF THE SPD422-202 CLINICAL STUDY REPORT (CSR) SUBMITTED IN RESPONSE TO THE WRITTEN REQUEST ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES PERFORMED IN PEDIATRIC PATIENTS WITH LEUKEMIA ADDED TO PRECAUTIONS REVISION TO THE PEDIATRIC USE PRECAUTIONS OF THE PRESCRIBING INFORMATION TO INCORPORATE THE RESULTS FROM THE CAPPS-169 STUDY ENTITLED "THE EFFECT OF ORTHO TRICYCLEN ON BONE MINERAL DENISTY IN PEDIATRIC SUBJECTS WITH ANOREXIA NERVOSA" ADDITION OF A GERIATRIC USE SUBSECTION TO THE PRECAUTIONS SECTION OF THE PACKAGE INSERT AND GERIATRIC DOSING INFORMATION

M-43
ADB 22 of 55
M-44 M-45 M-46 M-47 M-48 M-49 M-50
M-51 M-52
M-53 M-54 M-55 M-56 M-57 M-58
M-59
M-60
M-61 M-62
M-63 M-64 M-65 M-66 M-67 M-68 M-69 M-70 M-71 M-72 M-73 M-74 M-75 M-76
INCLUSION OF RESULTS OF STUDY-"PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY AND PILOT EFFICACY OF ILOPROST AS ADD ON THERAPY WITH BOSENTAN IN SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION CLINICAL INFORMATION ADDED TO THE PEDIATRIC USE SUBSECTION OF PRECAUTIONS REGARDING THE USE OF NOVOLOG IN ADOLESCENTS WITH TYPE I DIABETES AGE 6 TO 18 INFORMATION ADDED TO CLINICAL TRIALS SECTION OF LABELING - EFFECTS OF HUMATROPE TREATMENT IN ADULTS WITH GROWTH HORMONE DEFICIENCY PROVISION OF RESULTS OF STUDY AND PROPOSED REVISIONS TO PACKAGE INSERT SEE SECTION ON CARDIAC ELECTROPHYSIOLOGY PROVIDES FOR USE OF ANTARA WITHOUT REGARD TO MEALS CHANGES TO THE LABELING DESCRIBING THE RESULTS OF A STUDY OF THE USE OF NOVOLOG MIX 70/30 WITH ORAL ANTIDIABETIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES CLINICAL DATA ADDED TO THE CLINICAL PHARMACOLOGY SECTION REGARDING EFFECT OF SINGULAIR ON GROWTH RATES IN PREPUBERTAL CHILDREN NEW INFO TO THE CLINICAL STUDIES, ADULT GROWTH HORMONE DEFICIENCY (GHD) SUBSECTION OF THE NUTROPIN AQ PACKAGE INSERT DESCRIBING THE EFFECTS OF SOMATROPIN ON VISCERAL ADIPOSE TISSUE IN THE ADULT GROWTH HORMONE DEFICIENT PATIENT POPULATION INFORMATION ADDED TO LABELING REGARDING OSTEOGENESIS IMPERFECTA STUDY INFORMATION ADDED TO THE CLINICAL PHARMACOLOGY/CLINICAL STUDIES SECTION REGARDING THE USE OF RISEDRONATE ADMINISTERED ONCE A WEEK IN THE PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN FOR LABELING CHANGES TO THE QUALITY OF LIFE (QOL) STATEMENT IN THE APPROVED PACKAGE INSERT INFORMATION FROM PEDIATRIC STUDIES ADDED TO LABEL INFORMATION ON RESULTS OF A STUDY OF THE USE OF SANDOSTATIN LAR DEPOT IN PEDIATRIC PATIENTS WITH HYPOTHALAMIC OBESITY. INFORMATION ADDED TO CLINICAL TRIAL SECTION WITH INFORMATION ON "GEMINI" TRIAL CLINICAL DATA ADDED TO THE CLINICAL PHARMACOLOGY SECTION REGARDING THE PHARMACOKINETICS OF EZETIMIBE IN ASIAN SUBJECTS CHANGES TO THE CLINICAL STUDIES, PRIMARY HYPERCHOLESTEROLEMIA, VYTORIN SUBSECTION OF THE PACKAGE INSERT TO ADD EFFICACY DATA FOR THE EZETIMIBE/SIMVASTATIN COMBINATION PRODUCT AND FOR AN ATORVASTATIN PRODUCT ON LDL-C AND OTHER LIPID PRMTRS RESULTS OF THE T20-310 STUDY WHICH EVALUATED THE PHARMACOKINETICS, SAFETY, AND ANTIVIRAL ACTIVITY OF FUZEON IN TREATMENT EXPERIENCED PEDIATRIC SUBJECTS AND ADOLSCENTS WAS ADDED TO THE PEDIATRIC SUBSECTION OF PRECAUTIONS CHANGES TO CLINICAL STUDIES, PRIMARY HYPERCHOLESTEROLEMIA, TO ADD EFFICACY DATA FOR THE EZETIMIBE/SIMVASTATIN COMBINATION PRODUCT AND FOR A ROSUVASTATIN PRODUCT ON LDL-C AND OTHER LIPID PARAMETERS IN PATIENTS WTH HYPERCHOLESTEROLEMIA REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST CLINICAL INFORMATION FROM ONE CLINICAL STUDY INVESTIGATING THE USE OF AVANDAMET PLUS INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE NOT ACHIEVED ADEQUATE GLYCEMIC CONTROL WITH PREVIOUS ANTI-DIABETIC THERAPIES DETAILED INFORMATION ON AN INCONCLUSIVE PEDIATRIC STUDY CHANGES TO CLINICAL PHARMACOLOGY DETAILING STUDY RESULTS ADDITION OF INFORMATION TO LABEL TO INCLUDE INFORMATION REGARDING USE IN PATIENTS WITH HIV-ASSOCIATED ADIPOSE REDISTRIBUTION SYNDROME (HARS) USE IN SPECIFIC POPULATIONS - PATIENTS WITH CONCOMITANT ILLNESS SUBSECTION OF THE LABELING REGARDING USE OF STRATTERA IN PATIENTS WITH ADHD WHO HAVE COMORBID TIC DISORDER INDICATION EXPANDED TO INCLUDE PATIENTS ON PERITONEAL DIALYSIS DESCRIPTION OF RESULTS OF STUDY OF INITIAL THERAPY IN COMBINATION WITH METFORMIN WHEN DIET AND EXERCISE DO NOT PROVIDE GLYCEMIC CONTROL RESULTS OF STUDY OF COMBINATION THERAPY AND NON-INFERIORITY STUDY PROVISION OF INFORMATION OF THE RESULTS OF A PHASE 2 RANDOMIZED TRIAL OF SPRYCEL 70MG TWICE DAILY OR IMATINIB 800MG DAILY REVISIONS TO PROVIDE FOR RESULTS OF MAINTENANCE DATA IN ADULT PATIENTS WITH MAJOR DEPRESSIVE DISORDER INFORMATION ABOUT USE OF INSPRA (EPLERENONE) FOR HYPERTENSION IN PEDIATRIC PATIENTS NEW INFORMATION ADDED REGARDING THE TUMOR SHRINKING POTENTIAL OF SANDOSTATIN LAR DEPOT INJECTION ON GH - SECRETING PITUITARY ADENOMAS REVISIONS TO CLINICAL STUDIES - CHILDREN AND ADOLSCENTS BASED ON CLINICAL TRIAL DATA TO SUPPORT A DURATION OF ACTION CLAIM UP TO 12 HOURS PROVISION FOR USE OF ARGAGATROBAN IN CERTAIN PEDIATRIC PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) OR HEPARIN-INDUCED THROMBOCYTOPENIA WITH THROMBOSIS (HITTS) REMOVAL OF SCREEN REQUIREMENT IN PTS WITH G6PD DEFICIENCY PRIOR TO INITIATING ACZONE TREATMENT; REMOVAL OF BLOOD COUNT & RETICULOCYTE MONITORING DURING TREATMENT IN G6PD DEFICIENT PTS AND IN PATIENTS WITH HISTORY OF ANEMIA

M-77
ADB 23 of 55
M-78 M-79 M-80 M-81
M-82 M-83 M-84 M-85 M-86
M-87 M-88 M-89 M-90 M-91
M-92
M-93
M-94 M-95 M-96
M-97 M-98 M-99
M-100 M-101 M-102
M-103
M-104 M-105
M-106
USE IN COMBINATION WITH THE NEW AKTILITE CL128 LAMP FOR THE TREATMENT OF THIN AND MODERATELY THICK, NON-HYPERKERATOTIC, NON-PIGMENTED ACTINIC KERATOSES OF THE FACE AND SCALP IN IMMUNOCOMPETENT PATIENTS CLINICAL TRIAL INFO ON USE OF STRATTERA IN PATIENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AND COMORBID ANXIETY DISORDER WITHOUT CAUSING WORSENING OF ANXIETY LABELING REVISIONS RELATED TO SMOKING AND ERLOTIMB EXPOSURE ADDITIONAL TIME POINT OF 30 MINUTES (0.5 HOUR) IN CHILDREN AGED 6-12 YEARS WITH A DIAGNOSIS OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) ADDITIONAL INFO FOR PEDIATRIC USE FOR CASODEX (STUDIED IN COMBINATION WITH ARIMIDEX) IN THE PEDIATRIC POPULATION, SPECIFICALLY BOYS WITH FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY (TESTOXICOSIS) LABELING REVISIONS RELATED TO CLINICAL STUDIES ADDITIONAL INFORMATION ADDED TO LABELING REGARDING ESTABLISHMENT OF EFFICACY IN ADDITIONAL CLINICAL TRIALS AND ONE MAINTENANCE TRIAL STUDY INFORMATION ADDED TO LABEL REGARDING BONE MINERAL DENSITY INFORMATION ADDED TO LABELING REGARDING USE OF PREVACID IN PATIENTS LESS THAN 1 YEAR WITH SYMPTOMATIC GERD LABELING CHANGES SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST FOR INFANTS AGES BIRTH TO 11 MONTH INCLUSIVE REFLECTING LACK OF EFFICACY FOR GERD INDICATION FOR THIS PATIENT POPULATION INCLUSION OF RESULTS FROM TWO DRUG INTERACTION STUDIES WITH LIPITOR AND CRESTOR IN CLINICAL PHARMACOLOGY SECTION ADDITION OF INFORMATION REGARDING ABUSE POTENTIAL OF CONCERTA VERSUS IMMEDIATE-RELEASE METHYLPHENIDATE PROVIDES FOR REVISIONS TO MULTIPLE SECTIONS OF THE PACKAGE INSERT TO REFLECT RESULTS OF CLINICAL TRIALS 205.235 (UPLIFT) AND 205.266 (VA STUDY) IN SUPPORT OF EXACERBATION CLAIM LABELING CHANGES BASED ON DATA FROM CLINICAL STUDIES NV20235 AND NV20236 STUDIES OF SEASONAL PROPHYLAXIS OF INFLUENZA IN IMMUNOCOMPROMISED PATIENTS AND CHILDREN AGES 1-12 UPDATED LABELING BASED UPON STUDY: A SINGLE-DOSE, SINGLE-BLIND, PLACEBO-AND MOXIFLOXACIN-CONTROLLED 2-PERIOD, RANDOMIZED, CROSSOVER, 3RD PERIOD SEQUENTIAL STUDY OF SIDE EFFECTS OF TEMSIROLIMUS ON CARDIAC REPOLARIZATION IN HEALTHY SUBJECTS UPDATES TO THE PACKAGE INSERT BASED UPON THE TRIAL ENTITLED "A PHASE I PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF TEMSIROLIMUS IN PATIENTS WITH ADVANCED MALIGNANCIES AND NORMAL AND IMPAIRED LIVER FUNCTION EXPANSION OF LABELING TO INCLUDE INFORMATION ON SAFETY AND EFFICACY OF CREON IN PATIENTS AGES 7 YEARS THROUGH 11 YEARS WITH PANCREATIC EXOCRINE INSUFFICIENCY DUE TO CYSTIC FIBROSIS INFO ADDED TO LABEL RELATED TO NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE (PH+) CHRONIC MYELOID LEUKEMIA IC CHRONIC PHASE INFORMATION FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN ADULT PATIENTS WITH DECOMPENSATED LIVER DISEASE BASED ON DATA FROM CLINICAL TRIAL GS-US-174-0108 UPDATED INFORMATION IN THE CLINICAL STUDIES SECTION RELATED TO THE LOSS AND RECOVERY OF BONE MINERAL DENSITY IN ADOLESCENT GIRLS DURING AND FOLLOWING THE USE OF DEPO-PROVERA CONTRACEPTIVE INJECTION LABELING CHANGES IN RESPONSE TO PEDIATRIC STUDIES - NOT INDICATED FOR USE IN PEDIATRIC POPULATION NEW INFORMATION FROM A STUDY WHICH EVALUATED THE SAFETY AND EFFICACY OF FAMVIR IN TREATING RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT BLACK/AFRICAN AMERICAN SUBJECTS. ADDITION OF FINDINGS FROM A SINGLE PEDIATRIC CLINICAL TRIAL (P04292) OF NASONEX NASAL SPRAY IN THE TREATMENT OF NASAL POLYPS IN PATENTS 6 TO <18 YEARS OF AGE TO THE PACKAGE INSERT. INFORMATION ADDED TO LABEL BASED UPON COMPLETED CLINICAL TRIAL REPORTS INCLUSION OF DATA FROM AN ADDITIONAL 19 SUBJECTS WITH HYPERCALCEMIA FROM PARATHYROID CARCINOMA TO THE INFORMATION CURRENTLY PRESENTED IN THE LABEL INFORMATION FROM PEDIATRIC STUDY REPORT ML16633, "INTRAVENOUS GRANISETRON (KYTRIL) IN THE PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING (PONV) IN PEDIATRIC SUBJECTS UNDERGOING TONSILLECTOMY OR ADENOTONSILLECTOMY." SAFETY, EFFICACY AND PHARMACOKINETIC INFO FOR FASLODEX IN THE PEDIATRIC POPULATION, SPECIFICALLY FOR GIRLS WITH PROGRESSIVE PRECOCIOUS PUBERTY ASSOCIATED WITH MCCUNEALBRIGHT SYNDROME ADDED TO THE PEDIATRIC USE SECTION OF THE LABELING INFORMATION ADDED TO DOSING AND ADMINISTRATION REGARDING A 26 WEEK STUDY NEW LANGUAGE ADDED TO CLINICAL STUDIES REGARDING USE IN SMOKERS WITH CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND USE ACCORDING TO AN ALTERNATIVE SET OF DIRECTIONS FOR SETTING A QUIT DATE ADDITION OF THE T1-WEIGHTED GD-ENHANCED LESION EFFICACY VARIABLE IN THE CLINICAL STUDIES SECTION 14 OF THE PACKAGE INSERT

M-107
ADB 24 of 55
M-108 M-109 M-110 M-111
M-112
M-113
M-114 M-115
M-116 M-117 M-118 M-119 M-120 M-121 M-122 M-123
INFORMATION TO THE CLINICAL STUDIES SECTION OF THE LUPRON DEPOT-PED,1-MONTH,BASED UPON THE PHASE 3/4 COMPLETED CLINICAL STUDY REPORT FOR STUDY M90-516, ENTITLED "STUDY OF LUPRON DEPOT IN THE TREATMENT OF CENTRAL PRECOCIOUS PUBERTY". CHANGES ARE BASED ON RESULTS FROM STUDY CV181057 CHANGES TO THE PACKAGE INSERT TO REFLECT THE RESULTS OF THE STUDY OF HEART AND RENAL PROTECTION (SHARP) TRIAL CHANGES TO THE PACKAGE INSERT TO REFLECT THE RESULTS OF THE STUDY OF HEART AND RENAL PROTECTION (SHARP) TRIAL LABELING CHANGES BASED ON STUDY HW80-EW-GWCI ENTITLED A PLACEBO AND POSITIVE CONTROLLED STUDY OF THE ELECTROPHYSIOLOGICAL EFFECTS OF A SINGLE 10 MCG DOSE OF EXENATIDE ON THE 12 LEAD ELECTROCARDIOGRAM QT INTERVAL IN HEALTHY SUBJECTS REVISIONS TO THE PEDIATRIC USE SECTION OF THE PACKAGE INSERT TO ADD INFORMATION FROM A PEDIATRIC STUDY IN PATIENTS AGED 12 YEARS TO LESS THAN 18 YEARS OF AGE WITH RECURRENT HERPES LABIALIS LABELING CHANGES BASED ON STUDY H80-US-GWCO ENTITLED A RANDOMIZED TRIAL COMPARING EXENATIDE WITH PLACEBO IN SUBJECTS WITH TYPE 2 DIABETES ON INSULIN GLARGINE WITH OR WITHOUT ORAL ANTIHYPERGLYCEMIC MEDICATIONS CHANGES IN SECTION 14 OF THE PACKAGE INSERT TO INCLUDE DATA FROM THE SWITCHMRK STUDIES (SWITCH OF SUPPRESSED SUBJECTS FROM LOPINAVIR/RITONAVIR TO RALTEGRAVIR) REVISIONS TO THE PI BASED ON RESULTS FROM STUDY NN2211-1842, ENTITLED THE EFFECT OF INSULIN DETEMIR IN COMBINATION WITH LIRAGLUTIDE AND METFORMIN COMPARED TO LIRAGLUTIDE AND METFORMIN IN SUBJECTS WITH TYPE 2 DIABETES LABELING CHANGES BASED ON RESULTS FROM CLINICAL STUDY 01-06-TL-OPIMET-008 ADDITION OF RESULTS OF PEDIATRIC TRIAL TO LABEL LABELING CHANGES BASED UPON SAFETY AND EFFICACY RESULTS FROM TRIAL 1218.36 LABELING CHANGES REGARDING MISSED DOSES CHANGES TO CLINICAL TRIALS DETAILING STUDY RESULTS LABELING CHANGES BASED UPON SAFETY AND EFFICACY RESULTS FROM TRIAL 1218.43 LABELING CHANGES TO INCLUDE THE RESULTS OF THE PARAMOUNT TRIAL UPDATED RESULTS OF OVERALL SURVIVAL FROM 'CONFIRM' STUDY
PATENT USE
U-1 U-2 U-3 U-4 U-5 U-6 U-7 U-8 U-9 U-10 U-11 U-12 U-13 U-14 U-15 U-16 U-17 U-18 U-19 U-20 U-21 U-22 PREVENTION OF PREGNANCY TREATMENT OR PROPHYLAXIS OF ANGINA PECTORIS AND ARRHYTHMIA TREATMENT OF HYPERTENSION PROVIDING PREVENTION AND TREATMENT OF EMESIS AND NAUSEA IN MAMMALS METHOD OF PRODUCING BRONCHODILATION METHOD OF PRODUCING SYMPATHOMIMETIC EFFECTS INCREASING CARDIAC CONTRACTILITY ACUTE MYOCARDIAL INFARCTION CONTROL OF EMESIS ASSOCIATED WITH ANY CANCER CHEMOTHERAPY AGENT DIAGNOSTIC METHOD FOR DISTINGUISHING BETWEEN HYPOTHALMIC MALFUNCTIONS OR LESIONS IN HUMANS TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS METHOD OF TREATING [A] HUMAN SUFFERING FROM DEPRESSION A METHOD FOR TREATING ANXIETY IN A HUMAN SUBJECT IN NEED OF SUCH TREATMENT ADJUNCTIVE THERAPY FOR THE PREVENTION AND TREATMENT OF HYPERAMMONEMIA IN THE CHRONIC MANAGEMENT OF PATIENTS WITH UREA CYCLE ENZYMOPATHIES METHOD OF LOWERING INTRAOCULAR PRESSURE USE IN LUNG SCANNING PROCEDURES TREATMENT OF VENTRICULAR AND SUPRAVENTRICULAR ARRHYTHMIAS METHOD FOR INHIBITING GASTRIC SECRETION IN MAMMALS TREATMENT OF INFLAMMATION A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSON'S SYNDROME AND IN NEED OF TREATMENT TREATMENT OF HUMANS SUFFERING UNDESIRED UROTOXIC SIDE EFFECTS CAUSED BY CYTOSTATICALLY ACTIVE ALKYLATING AGENTS METHOD OF COMBATTING PATHOLOGICALLY REDUCED CEREBRAL FUNCTIONS AND PERFORMANCE WEAKNESSES, CEREBRAL INSUFFICIENCY AND DISORDERS IN CEREBRAL CIRCULATION AND METABOLISM IN WARM-BLOODED ANIMALS METHOD FOR TREATING PROSTATIC CARCINOMA COMPRISING ADMINISTERING FLUTAMIDE METHOD FOR TREATING PROSTATE ADENOCARCINOMA COMPRISING ADMINISTERING AN ANTIANDROGEN INCLUDING FLUTAMIDE AND AN LHRH AGONIST REDUCING CHOLESTEROL IN CHOLELITHIASIS PATIENTS
U-23 U-24 U-25

PATENT USE
U-26 U-27 U-28 U-29 U-30 U-31 U-32 U-33 U-34 U-35 U-36 U-37 U-38 U-39 U-40 U-41 U-42 U-43 U-44 U-45 U-46 U-47 U-48 U-49 U-50 U-51 U-52 U-53 U-54 U-55 U-56 U-57 U-58 U-59 U-60 U-61 U-62 U-63 U-64 U-65 U-66 U-67 U-68 U-69 U-70 U-71 U-72 U-73 U-74 U-75 U-76 U-77 U-78 U-79 U-80 U-81
ADB 25 of 55
REDUCING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF DISSOLVING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF CEREBRAL, CORONARY, PERIPHERAL, VISCERAL AND RENAL ARTERIOGRAPHY, AORTOGRAPHY AND LEFT VENTRICULOGRAPHY CT IMAGING OF THE HEAD AND BODY, AND INTRAVENOUS EXCRETORY UROGRAPHY CEREBRAL ANGIOGRAPHY, AND VENOGRAPHY INTRA-ARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY PALLIATIVE TREATMENT OF PATIENTS WITH OVARIAN CARCINOMA RECURRENT AFTER PRIOR CHEMOTHERAPY, INCLUDING PATIENTS WHO HAVE BEEN PREVIOUSLY TREATED WITH CISPLATIN TREATING VIRAL INFECTIONS IN A MAMMAL TREATING VIRAL INFECTIONS IN A WARM-BLOODED ANIMAL TREATING CYTOMEGALOVIRUS IN A HUMAN WITH AN INJECTABLE COMPOSITION METHODS OF TREATING BACTERIAL ILLNESSES METHOD OF TREATING GASTROINTESTINAL DISEASE TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ANGINA PECTORIS METHOD OF TREATMENT OF BURNS METHOD OF TREATING CARDIAC ARRHYTHMIAS ADJUVANT TREATMENT IN COMBINATION WITH FLUOROURACIL AFTER SURGICAL RESECTION IN PATIENTS WITH DUKES' STAGE C COLON CANCER MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA RELIEF OF NAUSEA AND VOMITING TREATMENT OF INFLAMMATION AND ANALGESIA TREATMENT OF PANIC DISORDER STIMULATION OF THE RELEASE OF GROWTH HORMONE ANALGESIA SYMPTOMATIC CANCER-RELATED HYPERCALCEMIA USE IN TREATING INFLAMMATORY DERMATOSES BLOOD POOL IMAGING, INCLUDING CARDIAC FIRST PASS AND GATED EQUILIBRIUM IMAGING AND FOR DETECTION OF SITES OF GASTROINTESTINAL BLEEDING TREATMENT OF ADULT AND PEDIATRIC PATIENTS(OVER SIX MONTHS OF AGE) WITH ADVANCED HIV INFECTION HYPERCALCEMIA OF MALIGNANCY REVERSAL AGENT OR ANTAGONIST OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS TREATMENT OF PAIN AID TO SMOKING CESSATION OPHTHALMIC USE OF NORFLOXACIN METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES METHOD OF TREATING HYPERCHOLESTEROLEMIA NASAL ADMINISTRATION OF BUTORPHANOL CEREBRAL AND PERIPHERAL ARTERIOGRAPHY AND CT IMAGING OF THE HEAD CORONARY ARTERIOGRAPHY, LEFT VENTRICULOGRAPHY, CT IMAGING OF THE BODY, INTRAVENOUS EXCRETORY UROGRAPHY, INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY AND VENOGRAPHY ISOPRENALINE ANTAGONISM ON THE HEART RATE OR BLOOD PRESSURE TREATMENT OF VIRAL INFECTIONS METHOD OF TREATMENT OF A PATIENT INFECTED WITH HIV TRIPHASIC REGIMEN METHOD OF INDUCING ANESTHESIA IN A WARM BLOODED ANIMAL TREATMENT OF ACTINIC KERATOSIS TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS TREATMENT OF TRANSIENT INSOMNIA METHOD OF TREATMENT OF HEART FAILURE TREATMENT OF MIGRAINE METHOD OF TREATING DISEASES OR INFECTIONS CAUSED BY MYCETES METHOD OF PROVIDING HYPNOTIC EFFECT RELIEF OF OCULAR ITCHING DUE TO SEASONAL ALLERGIC CONJUNCTIVITIS USE TO IMAGE A SUBJECT WITH A MAGNETIC RESONANCE IMAGING SYSTEM TREATMENT OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS ULCERATIVE COLITIS SYMPTOMATIC TREATMENT OF PATIENTS WITH NOCTURNAL HEARTBURNDUE TO GERD METHOD OF TREATING OCULAR BACTERIAL INFECTIONS RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS

PATENT USE
U-82 U-83 U-84 U-85 U-86 U-87 U-88 U-89 U-90 U-91 U-92 U-93 U-94
ADB 26 of 55
U-95 U-96 U-97 U-98 U-99 U-100 U-101 U-102 U-103 U-104 U-105 U-106 U-107 U-108
U-109
U-110 U-111 U-112 U-113 U-114 U-115 U-116 U-117 U-118 U-119 U-120 U-121 U-122 U-123 U-124 U-125 U-126 U-127 U-128 U-129 U-130 U-131
TREATMENT FOR DEMENTIA IN PATIENTS WITH ALZHEIMER'S DISEASE TREATMENT OF SEIZURES A METHOD OF BLOCKING THE UPTAKE OF MONOAMINES BY BRAIN NEURONS IN ANIMALS NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS METHOD OF TREATING CERTAIN FORMS OF EPILEPSY METHOD FOR NONINVASIVE ADMINISTRATION OF SEDATIVES, ANALGESICS, AND ANESTHETICS TREATMENT OF MODERATE PLAQUE PSORIASIS TREATMENT OR PROPHYLAXIS OF EMESIS TREATMENT OF PYSCHOTIC DISORDERS ALTERNATIVE THERAPY TO TRIMETHOPRIM-SULFAMETHOXAZOLE FOR TREATMENT OF MODERATE-TO-SEVERE PNEUMOCYSTIS CARINII PNEUMONIA IN IMMUNOCOMPROMISED AND AIDS PATIENTS TREATMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I INSULIN DEPENDENT DIABETES MELLITUS AND RETINOPATY USE AS AN ANTIHISTAMINE/DECONGESTANT TREATMENT-ADULTS W/ ADVANCED HIV,INTOLERANT OF APPROVED THERAPIES,INTOLERANT OF APPROVED THERAPIES W/PROVEN BENEFIT OR HAVE EXPERIENCED CLINICAL/IMMUNOLOGICAL DETERIORATION WHILE RECEIVING..OR FOR WHOM SUCH THERAPIES-CONTRAINDICATED SHORT TERM MANAGEMENT OF MODERATE PRURITIS IN ADULTS WITH ATOPIC DERMATITIS AND LICHEN SIMPLEX CHRONICUS METHOD OF TREATING VARICELLA ZOSTER (SHINGLES) INFECTIONS A METHOD OF TREATING A PATIENT IN NEED OF MEMORY ENHANCEMENT A METHOD OF INDUCING REGRESSION OF LEUKEMIA CELL GROWTH IN A MAMMAL METHOD OF PROVIDING POTASSIUM TO A SUBJECT IN NEED OF POTASSIUM METHOD OF TREATING OCULAR INFLAMMATION ADJUNCT TO CONVENTIONAL CT OR MRI IMAGING IN THE LOCALIZATION OF STROKE IN PATIENTS IN WHOM STROKE HAS ALREADY BEEN DIAGNOSED METHOD OF HORMONALLY TREATING MENOPAUSAL OR POST-MENOPAUSAL DISORDERS IN WOMEN TREATMENT OF OCULAR HYPERTENSION TREATMENT OF AQUEOUS HUMOR FORMATION AND INTRAOCULAR PRESSURE EMESIS TREATMENT OF EPILEPSY TREATMENT OF HYPERTENSION AND ANGINA PECTORIS SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER, GASTROESOPHAGEAL REFLUX DISEASE (GERD), SEVERE EROSIVE ESOPHAGITIS, POORLY RESPONSIVE SYMPTOMATIC GERD AND PATHOLOGIAL HYPERSECRETORY CONDITIONS AND MAINTENANCE HEALING OF EROSIVE ESOPHAGITIS ADJUNCT DIET IN THE TX OF ELEVATED TOTAL CHOLESTEROL AND LDL-C LEVELS IN PTS W/PRIMARY HYPERCHOLESTEROLEMIA WHOSE RESPONSE TO DIETARY RESTRICTION OF SAT FAT AND CHOLESTEROL AND OTHER NONPHARMACOLOGICAL MEASURES HAS NOT BEEN ADEQUATE USE AS A RETRIEVABLE PERSSARY DIABETES CONTRACEPTION METHOD OF CONDUCTING RADIOLOGICAL EXAMINATION OF A PATIENT BY ADMINISTERING TO SAID PATIENT A RADIOPAQUE AMOUNT OF IOPROMIDE USE FOR INHIBITING BONE RESORPTION USE OF VASODILATORS TO EFFECT AND ENHANCE AN ERECTION (AND THUS TREAT ERECTILE DYSFUNCTION), BY INJECTION INTO THE PENIS METHOD OF MYOCARDIAL IMAGING TREATMENT OF OCULAR ALLERGIC RESPONSE IN HUMAN EYES METHOD OF LOWERING BLOOD SUGAR LEVEL TREATMENT OF NASAL HYPERSECRETION CONTROLLING OR PREVENTING POST-OPERATIVE INTRAOCULAR PRESSURE RISES ASSOCIATED WITH OPHTHALMIC LASER SURGICAL PROCEDURES METHOD OF TREATING CONDITIONS MEDIATED THROUGH HISTAMINE H2-RECEPTORS A THERAPEUTIC METHOD FOR CONTROLLING THROMBOSIS METHOD FOR CONTROLLING THROMBOSIS AND DECREASING BLOOD HYPERCOAGULATION AND HEMORRHAGING RISKS TREATMENT OF ACNE TREATMENT NEUROGENERATIVE DISEASES TREATMENT OF GASTRITIS METHOD OF PRODUCING NEUROMUSCULAR BLOCKADE METHOD FOR TREATMENT OF TUMORS METHOD TO DESTROY OR IMPAIR TARGET CELLS MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS PHOTODAMAGED SKIN

PATENT USE
U-132 U-133 U-134 U-135 U-136 U-137 U-138 U-139 U-140 U-141 U-142 U-143 U-144 U-145 U-146 U-147 U-148 U-149 U-150 U-151 U-152 U-153 U-154 U-155 U-156 U-157 U-158 U-159 U-160 U-161 U-162 U-163 U-164 U-165 U-166 U-167 U-168 U-169 U-170 U-171 U-172 U-173 U-174 U-175 U-176 U-177 U-178 U-179 U-180 U-181 U-182
ADB 27 of 55
INHIBITING HIV PROTEASE MANAGEMENT OF OBESITY INCLUDING WEIGHT LOSS AND MAINTENANCE IN PATIENTS ON A REDUCEDCALORIE DIET TREATMENT OF ACNE VULGARIS ANTITUMOR AGENT PROCESS FOR WASTE NITROGEN REMOVAL METHOD OF TREATING BACTERIAL VAGINOSIS TREATMENT OF ALLERGIC RHINITIS TREATMENT OF ALLERGIC REACTIONS USE OF NORVIR TO INHIBIT HIV PROTEASE OR TO INHIBIT AN HIV INFECTION TREATMENT OF ULCERATIVE COLITIS METHOD OF TREATING ALLERGIC REACTIONS IN A MAMMAL BY USING THIS ACTIVE METABOLITE BIODEGRADABLE SUPERPARAMAGNETIC METAL OXIDES AS CONTRAST AGENTS FOR MR IMAGING BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC MATERIALS FOR USE IN CLINICAL APPLICATIONS BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC PARTICLES FOR USE AS NUCLEAR MAGNETIC RESONANCE IMAGING AGENTS METHOD OF TREATING SUSCEPTIBLE NEOPLASMS IN MAMMALS DETECTION OF GASTROINTESTINAL DISORDERS AND THE SUBSEQUENT BREATH COLLECTION AND MEASUREMENT OF 13CO2 DEVICE FOR COLLECTING A BREATH SAMPLE METHOD OF TREATING AN ANIMAL, INCLUDING A HUMAN SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS, ACUTE MANIA OR MILD ANXIETY STATES METHOD OF USE FOR CONTROLLING HYPERGLYCEMIA BY ADMINISTRATION OF THIS SUSTAINED RELEASE DOSAGE FORM OF GLIPIZIDE RELIEF OF SYMPTOMS OF THE COMMON COLD METHOD OF TREATING ANXIETY RELATED DISORDERS INCLUDING OBSESSIVE COMPULSIVE DISORDER TREATMENT OF INITIAL EPISODE GENITAL HERPES METHOD OF TREATING ANIMALS SUFFERING FROM AN APPETITE DISORDER TREATMENT OF ERECTILE DYSFUNCTION METHOD OF PROVIDING ANESTHESIA TREATMENT OF A HUMAN SUFFERING FROM VITAMIN B12 DEFICIENCY ANGINA TREATMENT OF INTERSTITIAL CYSTITIS TREATMENT OF BACTERIAL INFECTIOUS DISEASE METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS IN A PATIENT METHOD OF USE TO INHIBIT CHOLESTEROL SYNTHESIS IN A HUMAN SUFFERING FROM HYPERCHOLESTEROLEMIA METHOD OF USING TROGLITAZONE TO TREAT IMPAIRED GLUCOSE TOLERANCE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS METHOD OF USING TROGLITAZONE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS IN A DEFINED POPULATION OF PATIENTS TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA TREATMENT OF H.PYLORI-ASSOCIATED DUODENAL ULCER METHOD FOR TREATING HIV-1 INFECTION METHOD OF INHIBITING LIPOXYGENASE ACTIVITY IN A MAMMAL WHICH IS THE MODE OF ACTION IN THE TREATMENT OF ASTHMA METHODS OF USING THE COMPOUND/DRUG PRODUCT AS A CONTRAST AGENT IN MAGNETIC RESONANCE IMAGING METHOD OF OBTAINING AN MR IMAGE USING THE COMPOSITION/DRUG PRODUCT AS A CONTRAST AGENT METHODS OF USING THE COMPOUND/DRUG PRODUCT AS AN ORAL CONTRAST AGENT IN MAGNETIC RESONANCE IMAGING OF THE GASTROINTESTINAL TRACT TREATMENT OF GENITAL WARTS ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES USE AS AN ANTIHISTAMINE AGENT METHOD OF TREATING MALIGNANT TUMORS METHOD OF TREATING A PATIENT SUFFERING FROM LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOSES FUNGICIDE FACILITATED ADHERENCE OF AGENTS TO SKIN ENHANCED CUTANEOUS PENETRATION OF A DERMALLY-APPLIED PHARMACOLOGICALLY ACTIVE AGENT TREATMENT OF ADULT AND PEDIATRIC PATIENTS (OVER 6 MONTHS OF AGE) WITH ADVANCED HIV INFECTION PRODUCING ALPHA ADRENERGIC ANTAGONISTIC ACTION IN A HOST USE OF SALMETEROL IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTION

PATENT USE
ADB 28 of 55
TREATMENT OF CONDITIONS CAUSED BY DISTURBANCE OF NEURONAL 5HT FUNCTION TREATING ALLERGIC EYE DISEASES IN HUMANS METHOD OF TREATING HYPERTENSION METHOD FOR TREATING GI DISORDERS CAUSED BY H.RYLORI WHICH COMPRISES ADMINISTRATION OF RANITIDINE BISMUTH CITRATE AND CLARITHROMYCIN FOR A GREATER THAN ADDITIVE EFFECT THERAPEUTIC TREATMENT OF CALCIFIC TUMORS TREATMENT OF H.PYLORI ASSOCIATED DUODENAL ULCER ENHANCEMENT OF THE BIOAVAILABILITY OF THE DRUG SUBSTANCE USE OF RITONAVIR IN COMBINATION WITH ANY REVERSE TRANSCRIPTASE INHIBITOR METHOD OF TREATMENT FOR CONTROLLING AND LOWERING INTRAOCULAR PRESSURE IN A HUMAN USE IN TREATING ALLERGIC REACTIONS PSORIASIS TREATING ANGINA PECTORIS AND HIGH BLOOD PRESSURE METHOD FOR THE DIAGNOSIS OF GASTROINTESTINAL DISORDERS BY UREA ISOTOAC OR NITROGEN LABELED CARBON TREATMENT OF METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR POSITIVE TUMORS USE IN COMBINATION WITH CERTAIN LHRH ANALOGUES FOR THE TREATMENT OF ADVANCED PROSTATE CANCER TREATMENT METASTATIC CARCINOMA OF OVARY AFTER 1ST LINE FAILURE OR SUBSQUENT CHEMOTHERAPY, TREATMENT OF BREAST CANCER AFTER FAILURE OF COMBINATION CHEMOTHERAPY FOR METASTATIC DISEASE AND 2ND LINE TREATMENT OF AIDS RELATED KAPOSI'S SARCOMA METHOD OF TREATING INFECTIOUS UPPER GI TRACT DISORDERS CAUSED BY CAMPYLOBACTER PYLORIDIS INFECTION COMPRISING ADMINISTRATION OF A BISMUTH AGENT AND AN ANTIMICROBIAL AGENT METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF A BISMUTH-CONTAINING AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF CAMPYLOBACTER-INHIBITING ANTIMICROBIAL AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT METHOD OF TREATING PEPTIC ULCER DISEASE CAUSED BY CAMPYLOBACTER PYLORIDIS COMPRISING ORAL ADMINISTRATION OF 50 TO 5,000MG BISMUTH DAILY FOR 3-56 DAYS TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOWING ANTIESTROGEN THERAPY USE OF TAXOL IN COMBINATION WITH G-CSF FOR TREATMENT OF PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA METHOD FOR TREATING HEARTBURN METHOD OF USING FSH ALONE, WITHOUT THE PRESENCE OF EXOGENEOUS LH, IN IN VITRO FERTILIZATION USE AS NASAL SPRAY VAGINAL ADMINISTRATION USING SPECIFIED FORMULATION VAGINAL ADMINISTRATION OF PROGESTERONE USING SPECIFIED FORMULATION METHOD OF TREATING CONGESTIVE HEART FAILURE USE IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTION METHOD OF TREATMENT OF PARKINSON'S DISEASE METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA AND METHOD FOR TREATING HYPERLIPIDEMIA USE AS A BLOOD GLUCOSE-LOWERING AGENT TREATMENT OF EPILEPSY TWICE DAILY. TREATING A PATIENT BY ADMINISTERING CARBAMAZEPINE IN A DOSAGE FORM CAPABLE OF MAINTAINING BLOOD CONCENTRATION FROM 4-12MCG/ML OVER 12 HOURS TREATMENT OF ADENOCARCINOMA, INCLUDING STAGE B2-C BY ADMINISTERING AN AGONIST OF LH-RH AND FLUTAMIDE METHOD OF PRODUCING ANESTHESIA METHOD FOR LIMITING THE POTENTIAL FOR MICROBIAL GROWTH IN THE DRUG PRODUCT TREATMENT OF PARKINSON'S DISEASE METHOD OF DIAGNOSIS SELECTIVE VASODILATION BY CONTINUOUS ADENOSINE INFUSION METHOD OF TREATING PAGET'S DISEASE USING ACTONEL TREATMENT OF BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF MICROORGANISMS CONTROLLING INTRAOCULAR PRESSURE METHOD FOR DELIVERY METHOD OF ENHANCING THE DISSOLUTION PROFILE OF A PHARMACEUTICAL FROM A SOLID DOSAGE FORM CONTAINING THE PHARMACEUTICAL AND SIMETHICONE NASAL ADMINISTRATION ASTHMA CARDIAC INSUFFICIENCY (CONGESTIVE HEART FAILURE) PREVENTION OF ACUTE CARDIAC ISCHEMIC EVENTS

PATENT USE
U-231 U-232 U-233 U-234 U-235
ADB 29 of 55
U-236 U-237 U-238
U-239
U-240 U-241
U-242 U-243 U-244 U-245 U-246 U-247 U-248 U-249 U-250 U-251 U-252 U-253 U-254 U-255 U-256 U-257 U-258 U-259 U-260
U-261 U-262 U-263
U-264
U-265 U-266
U-267
U-268 U-269 U-270 U-271 U-272
USE IN PARKINSON'S DISEASE METHOD OF TREATING MIGRAINE DECREASING MORTALITY CAUSED BY CONGESTIVE HEART FAILURE METHOD OF USING RIBAVIRIN TO TREAT VIRAL INFECTIONS IN MAMMALS METHOD OF MODULATING TH1 AND TH2 RESPONSE IN ACTIVATED T CELLS OF A HUMAN COMPRISING ADMINISTERING RIBAVIRIN TO THE T CELLS IN A DOSAGE WHICH PROMOTES THE TH1 RESPONSE AND SUPPRESSES THE TH2 RESPONSE TREATING MALE PATTERN BALDNESS WITH 0.05 TO 3.0MG/DAY METHOD OF PERFORMING NMR IMAGING WITH A PATIENT COMPRISING ADMINISTERING TO THE PATIENT AN EFFECTIVE AMOUNT OF CONTRAST AGENT DISCLOSED IN THE CLAIMS IMAGING A BODY TISSUE AND SUBJECTING TO NMR TOMOGRAPHY, ADMINISTERING AN AMOUNT OF PHARMACEUTICAL AGENT FOR AFFECTING THE RELAXATION TIMES OF ATOMS IN BODY TISSUES UNDERGOING NMR DIAGNOSIS, WHEREBY THE IMAGE CONTRAST IN ENHANCED.... TREATING OR CONTROLLING OCULAR INFLAMATION WHICH COMPRISES TOPICALLY ADMINISTERING TO AFFECTED EYE A COMPOSITION COMPRISING AN NSAID, A POLYMERIC QUATERNARY AMMONIUM COMPOUND AND BORIC ACID TREATMENT OF ACUTE MIGRAINE ATTACKS FOR SHORT-TERM TREATMENT ACTIVE DUODENAL ULCER, MAINTENANCE THERAPY FOR DUODENAL ULCER PATIENTS AT REDUCED DOSAGE AFTER HEALING OF ACTIVE ULCER, SHORT-TERM TREATMENT ACTIVE BENIGN GASTRIC ULCER & GERD, PATHOLOGICAL HYPERSECRETORY CONDITIONS USE OF FOLLITROPIN ALPHA ALONE IN IN-VITRO FERTILIZATION TOPICAL ADMINISTRATION PLATELET AGGREGATION INHIBITORS TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS PHOSPHATE BINDING TREATMENT OF RHEUMATOID ARTHRITIS TREATMENT OF HIV METHOD OF TREATING ALLERGIC OR NON-ALLERGIC RHINITIS IN PATIENTS BY ADMINISTERING AEROSOLIZED PARTICLES OF MOMETASONE FUROATE TREATMENT OF HEPATITIS B INFECTION USE OF TROGLITAZONE IN COMBINATION WITH SULFONYLUREAS IN THE TREATMENT OF TYPE II DIABETES METHOD OF TREATING A HUMAN SUBJECT HAVING GAUCHER'S DISEASE ORAL TRANSMUCOSAL USE USE OF AGGRASTAT IN COMBINATION WITH HEPARIN IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY TREATMENT OF HIV INFECTION IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV ANTIVIRAL AGENTS TREATMENT OF HIV INFECTION TREATMENT OF NEURODEGENERATIVE DISEASES TREATMENT OF ANDROGENIC ALOPECIA BY ORAL ADMINISTRATION DRUG SUBSTANCE REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION WHO ARE INTOLERANT OF OTHER IOP LOWERING MEDICATIONS OR INSUFFICIENTLY RESPONSIVE TO ANOTHER IOP LOWERING MEDICATION TREATING BENIGN PROSTATIC HYPERPLASIA WITH A GENUS OF COMPOUNDS, INCLUDING FINASTERIDE TREATING BENIGN PROSTATIC HYPERTROPHY WITH FINASTERIDE METHOD OF TREATING A MALIGNANT CONDITION THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING LEUKEMIA OR LYMPHOMA IN A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVENOUS ADMINISTRATION OF BUSULFAN METHOD OF TREATING A MALIGNANT DISEASE THROUGH PARENTERAL ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN USE AS LAXATIVE RELIEF OF THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS; RELIEF OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN ADULTS; MANAGEMENT OF ACUTE PAIN IN ADULTS; TREATMENT OF PRIMARY DYSMENNORRHEA; ACUTE TREATMENT OF MIGRAINE ATTACKS IN ADULTS PREVENTING HEARTBURN EPISODES FOLLOWING INGESTION OF HEARTBURN-INDUCING FOOD/BEVERAGE, COMPRISING ADMIN TO PT, 30 MIN PRIOR TO CONSUMPTION BY THE PT THE FOOD/BEVERAGE, A COMPOSITION COMPRISING 10MG FAMOTIDINE ACROMEGALY EXCESS GH-SECRETION OR GASTRO-INTESTINAL DISORDERS METHOD OF IMPROVING THE TIME FOR ADMINISTRATION OR THE TIME BETWEEN CHANGES OF GIVING SETS FOR THE DRUG PRODUCT METHOD OF TREATING TUMORS METHOD OF TREATING CARCINOMA

PATENT USE
U-273 U-274 U-275 U-276 U-277 U-278 U-279 U-280 U-281 U-282 U-283 U-284 U-285 U-286 U-287 U-288 U-289 U-290 U-291 U-292 U-293 U-294 U-295 U-296
ADB 30 of 55
U-297 U-298 U-299 U-300 U-301 U-302 U-303 U-304 U-305 U-306 U-307 U-308
U-309 U-310 U-311 U-312 U-313 U-314 U-315 U-316 U-317 U-318 U-319 U-320
CUTANEOUS T-CELL LYMPHOMA ZANAMIVIR FOR INHALATION METHOD OF USE OF THE DRUG SUBSTANCE METHOD OF USE OF LEVOBUPIVACAINE NEUROLOGICAL AND OTHER DISORDERS (TREATMENT OF EPILEPSY, BID ORAL DOSING) METHOD OF USE OF THE INDICATION OF THE DRUG PRODUCT METHOD OF USE OF THE APPROVED PRODUCT TREATING PRECIPITATED ACUTE URINARY RETENTION WITH FINASTERIDE ANTIMYCOTIC USES, SPECIFICALLY TREATMENT OF ONYCHOMYCOSIS METHOD OF TREATING BACTERIAL INFECTIONS METHOD FOR TREATING MENOPAUSAL SYMPTOMS IN A POSTMENOPAUSAL FEMALE MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE, AND VULVAR AND VAGINAL ATROPHY) AND OSTEOPOROSIS DEPRESSION AND SOCIAL ANXIETY DISORDER/SOCIAL PHOBIA DEPRESSION TREATMENT OR PREVENTION OF OSTEOPOROSIS THERAPY OF INFLUENZA TREATMENT OF NON-HYPERKERATOTIC ACTINIC KERATOSES OF FACE AND SCALP INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH CYCLOSPORIN INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH AZATHIOPRINE INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH A CORTICOSTEROID TREATMENT OF HYPERPIGMENTARY DISORDERS TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS TREATING MIGRAINE PAIN AND ONE OR MORE OF A CLUSTER OF SYMPTOMS CHARACTERISTIC OF A MIGRAINE ATTACK SYMPTOMS BEING SELECTED FROM PHOTOPHOBIA, PHONOPHOBIA NAUSEA AND FUNCTIONAL DISABILITY PREVENTION OR TREATMENT OF REVERSIBLE VASOCONSTRICTION BY THE INHALATION OF NITRIC OXIDE WITH AN OXYGEN CONTAINING GAS METHOD OF COMBATING BACTERIA IN A PATIENT TREATMENT OF ADENOMATOUS POLYPS INDICATED FOR THE REDUCTION OF ELEVATED TOTAL AND LDL CHOLESTEROL LEVELS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA USE OF TROGLITAZONE IN COMBINATION WITH SULFONYLUREAS AND BIGUANIDES IN THE TREATMENT OF TYPE II DIABETES TO REDUCE THE RISK OF STROKE IN PATIENTS WHO HAVE HAD TRANSIENT ISCHEMIA OF THE BRAIN OR COMPLETED ISCHEMIC STROKE DUE TO THROMBOSIS METHOD OF USE PATENT-PRODUCT APPROVED FOR TREATMENT OF OSTEOPOROSIS, PAGET'S DISEASE, PREVENTION AND TREATMENT OF GLUCOCORTICOID INDUCED OSTEOPOROSIS A METHOD OF TREATMENT OF A CONDITION INVOLVING AN ANTIBODY ANTIGEN REACTION METHODS FOR USING THE DRUG PRODUCT TREATMENT OF POST-MENOPAUSAL UROGENITAL SYMPTOMS ASSOCIATED WITH ESTROGEN DEFICIENCY CLAIMS AN OLANZAPINE POLYMORPH USEFUL FOR TREATING ANY NUMBER OF LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOSES,EMPLOYING OLANZAPINE AS PER THE INDICATION OF THIS NDA CLAIMS A SOLID ORAL FORMULATION INCLUDING TABLETS AND GRANULES OF OLANZAPINE USEFUL FOR TREATING ANY NUMBER OF LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOLES, EMPLOYING OLANZAPINE AS PER THE INDICATIONS OF THIS NDA TREATING SJOEGREN SYNDROME TREATMENT OF XEROSTOMIA HORMONE REPLACEMENT PANIC DISORDER, OBSESSIVE-COMPULSIVE DISORDER, POSTTRAUMATIC STRESS DISORDER TREATMENT OF CONGESTIVE HEART FAILURE METHOD FOR TREATING HYPERPARATHYROIDISM WHICH COMPRISES SUPPRESSING PARATHYROID ACTIVITY METHOD FOR ADMINISTERING DRUG TO GASTROINTESTINAL TRACT METHOD OF TREATING A SUBJECT SUFFERING FROM PROSTATE CANCER METHOD OF USING TROGLITAZONE TO TREAT PATIENTS HAVING INSULIN RESISTANCE TREATMENT OF PATIENTS WITH AN OVERACTIVE BLADDER WITH SYMPTOMS OF URINARY FREQUENCY, URGENCY, OR URGE INCONTINENCE TREATMENT OF MICROBIAL INFECTIONS INHIBITING OR ELIMINATING ACUTE MYELOID LEUKEMIA

PATENT USE
U-321 U-322 U-323 U-324 U-325 U-326 U-327 U-328 U-329 U-330 U-331 U-332 U-333 U-334 U-335 U-336 U-337 U-338 U-339 U-340 U-341 U-342 U-343 U-344 U-345 U-346
ADB 31 of 55
U-347 U-348 U-349 U-350 U-351 U-352 U-353 U-354
U-355 U-356 U-357
U-358 U-359 U-360
U-361 U-362
REDUCTION OF ELEVATED IPTH LEVELS IN THE MGT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS UNDERGONG CHRONIC RENAL DIALYSIS TREATMENT OF ALZHEIMER'S DEMENTIA USE AS A BILE ACID SEQUESTRANT METHOD OF TREATING AN ANIMAL, INCLUDING A HUMAN, SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS OR ACUTE MANIA EMPLOYING OLANZAPINE METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED CONDITIONS, INCLUDING "BIPOLAR DISORDER NOS" EMPLOYING OLANZAPINE METHOD OF TREATING SCHIZOPHRENIA AND BIPOLAR DISORDER METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED PSYCHOTIC CONDITONS EMPLOYING OLANZAPINE METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED CONDITIONS INCLUDING "A PSYCHOTIC CONDITION" EMPLOYING AN OLANZAPINE POLYMORPH USE OF AVANDIA AS MONOTHERAPY, IN COMBINATION WITH METFORMIN, AND IN COMBINATION WITH SULFONYLUREAS TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATMENT OF NAUSEA AND VOMITING METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT TREATMENT OR PREVENTION OF BRONCHOSPASM METHOD OF TREATING OCULAR HYPERTENSION TREATMENT OF EXCESSIVE FEMALE FACIAL HAIR USE OF PRAVASTATIN SODIUM FOR SECONDARY PREVENTION OF CORONARY EVENTS IN MEN AND WOMEN WHO HAVE HAD A MYOCARDIAL INFARCTION AND HAVE NORMAL CHOLESTEROL LEVELS DIAGNOSTIC RADIOIMAGING USE OF CARDIOLITE/MIRALUMA KIT FOR THE PREPARATION OF TC99M SESTAMIBI METHODS FOR TREATING DISTURBANCES OF MOOD, DISTURBANCES OF APPETITE, DEPRESSED MOOD, OR CARBOHYDRATE CRAVING ALL ASSOCIATED WITH PREMENSTRUAL SYNDROME PREVENTION OF CARDIO-TOXICITY CAUSED BY THE ADMINISTRATION OF DOXORUBICIN THE LONG TERM TREATMENT OF GROWTH FAILURE DUE TO LACK OF ADEQUATE ENDOGENOUS GROWTH HORMONE SECRETION IN CHILDREN METHOD FOR ENHANCING THE TREATMENT OF ... LATE LUTEAL PHASE DYSPHORIC DISORDER METHOD FOR TREATMENT OF LATE LUTEAL PHASE DYSPHORIC DISORDER REDUCTION OF INTESTINAL GAS, CRAMPING AND ANORECTAL IRRITATION METHOD FOR INHIBITING HIV INFECTION BY ADMINISTERING RITONAVIR IN COMBINATION WITH ANOTHER HIV PROTEASE INHIBITOR RITONAVIR AND ANOTHER HIV PROTEASE INHIBITOR FOR CONCOMITANT ADMINISTRATION FOR THE TREATMENT OF AN HIV INFECTION METHOD FOR INHIBITING CYTOCHROME P450 MONOOXYGENASE WITH RITONAVIR AND A METHOD FOR IMPROVING THE PHARMCOKINETICS OF A DRUG THAT IS MTABOLIZED BY CYTOCHROME P450 MONOOXYGENASE BY ADMIN THE DRUG AND RITONAVIR METHOD OF USE IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS METHOD OF USE FOR INHIBITING HIV INFECTION METHOD OF USE WHICH IS SUBJECT OF THE APPLICATION PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR CONCOMITANT ADMIN WITH A REVERSE TRANSCRIPTASE INHIBITOR INHIBITING PROTEASE WITH LOPINAVIR AND INHIBITING AN HIV INFECTION WITH LOPINAVIIR INHIBITING HIV INFECTION BY ADMINISTERING RITONAVIR IN COMBINATION WITH A REVERSE TRANSCRIPTASE INHIBITOR PREVENTION AND TREATMENT OF OSTEOPOROSIS METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID WITHOUT CAUSING TREATMENT-LIMITING ELEVATIONS IN URIC ACID OR GLUCOSE LEVELS OR CAUSING LIVER DAMAGE, BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT METHOD OF ASSISTING PERSON TO QUIT SMOKING...TRANSDERMALLY ADMIN NICOTINE VIA..PATCH ADHERED TO SKIN AT DOSING RATE APPROX SAME AS ABSORBED FROM SMOKING DELIVERING A MEDICINAL AEROSOL FORMULATION USING CFC-FREE PROPELLANT 134A. USE OF THE DRUG PRODUCT IN PHOTODYNAMIC THERAPEUTIC PROTOCOLS FOR THE TREATMENT OF AGERELATED MACULAR DEGENERATION AND RELATED CONDITIONS INVOLVING UNWANTED NEOVASCULATURE IN THE EYE DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, PANIC DISORDER AND SOCIAL ANXIETY DISORDER METHOD OF USE OF VISICOL METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF PATHOLOGICAL PSYCHOLOGICAL CONDITIONS INCLUDING MENTAL DISORDERS EMPLOYING OLANZAPINE AS PER THE INDICATION WHICH IS THE SUBJECT MATTER OF THIS SNDA-011 MANAGEMENT OF ANXIETY DISORDERS AND THE SHORT-TERM RELIEF OF THE SYMPTOMS OF ANXIETY USE OF APPROVED FORMULATIONS TO TREAT ALL APPROVED DISEASE INDICATIONS

PATENT USE
U-363
ADB 32 of 55
U-364
U-365 U-366 U-367 U-368 U-369 U-370 U-371 U-372 U-373
U-374
U-375 U-376 U-377
U-378 U-379 U-380 U-381 U-382 U-383 U-384 U-385 U-386 U-387 U-388 U-389 U-390 U-391 U-392 U-393 U-394 U-395 U-396 U-397 U-398 U-399 U-400
U-401 U-402 U-403 U-404 U-405
METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF PATHOLOGICAL PSYCHOLOGICAL CONDITIONS THAT RELATE TO THE USE OF A PSYCHOACTIVE SUBSTANCE EMPLOYING OLANZAPINE AS PER THE INDICATION THE SUBJECT MATTER OF SUPPLEMENT 011 TREATING A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO ANY NUMBER OF LISTED CONDITIONS INCLUDING PSYCHOSIS, EMPLOYING OLANZAPINE AS PER THE INDICATION WHICH IS THE SUBJECT MATTER OF THIS SNDA-011 METHOD FOR THE TREATMENT OF CARDIOVASCULAR DISEASE THROUGH THE ADMINISTRATION OF A CALCIUM BLOCKING VASODILATOR IN OUR EXTENDED, CONTROLLED RELEASE FORMULATION METHOD FOR THE TREATMENT OF CARDIOVASCULAR DISEASE THROUGH THE ADMINISTRATION OF A CALCIUM BLOCKING VASODILATOR IN A DELAYED RELEASE FORMULATION TREATMENT OF CARDIOVASCULAR DISORDERS HEARTBURN METHOD OF CONTROLLING AND LOWERING INTRAOCULAR PRESSURE INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH BUFFERED METRONIDAZOLE COMPOSITIONS APPROVAL FOR MARKETING ONLY UNDER A SPECIAL RESTRICTION PROGRAM APPROVED BY FDA CALLED "SYSTEM FOR THALIDOMIDE EDUCATION AND PRESCRIBING SAFETY" (S.T.E.P.S.) METHOD FOR ADMINISTERING A BENEFICIAL DRUG TO THE GI TRACT OF AN ANIMAL, WHICH METHOD COMPRISES ADMITTING AN OSMOTIC DEVICE ORALLY INTO THE ANIMAL... GENERAL USE CLAIM SUBMITTED FOR 12 NEXIUM PATIENTS STATING "PERTINENT TO THE CAPSULE FORMULATION FOR NEXIUM AND ITS INDICATIONS FOR THE TREATMENT OF GERD AND ERADICATION OF H.PYLORI TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE KIT ADAPTED AND DESIGNED TO PROVIDE BOTH DATA ON THE CURRENT REPRODUCTIVE STATUS OF A PATIENT AND CONTRACEPTION FOR THOSE WHO ARE NOT PREGNANT, BUT RECENTLY ENGAGED IN UNPROTECTED SEX METHOD OF USING RIBAVIRIN FOR TREATING A DISEASE RESPONSIVE TO RIBAVIRIN, E.G. HEPATITIS C TREATMENT OF INFLUENZA METHOD OF TREATING PT WITH CHRONIC HEPATITIS C HAVING HCV GENOTYPE 1 AND VIRAL LOAD GREATER THAN 2 MILLION COPIES/ML TO ERADICATE DETECTABLE HCV-RNA BY ADMIN COMBINATION OF RIBAVIRIN AND INTERFERON ALFA-2B FOR A LEAST 24 WEEKS METHOD FOR TREATING INCONTINENCE METHOD OF TREATING ONYCHROMYCOSIS COMBINATIONS OF TAXOL (PACLITAXEL) AND CISPLATIN WHICH ARE SUITABLE FOR THE TREATMENT OF OVARIAN AND NON-SMALL CELL LUNG CARCINOMAS TREATMENT OF HYPERPHOSPHATEMIA METHOD OF STABLIZING PROSTAGLANDIN METHOD FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION TREATMENT OF CMV RETINITIS TREATMENT OF PEPTIC ULCERS TREATMENT OF PATIENTS SUFFERING FROM A LATE ASTHMATIC REACTION OR LATE PHASE ASTHMA TREATMENT OF PATIENTS WITH RESPIRATORY DISORDERS SMOKING CESSATION AID APPLIED TO THE SKIN SMOKING CESSATION AID APPLIED TO THE SKIN ON WAKING AND REMOVED PRIOR TO SLEEP AFTER ABOUT 16 HOURS METHOD OF USING THE DRUG TO TREAT NEUROIMMUNOLOGIC DISEASES (INCLUDING MULTIPLE SCLEROSIS) USE OF CASODEX IN COMBINATION WITH LHRH AGONISTS FOR THE TREATMENT OF PROSTATE CANCER TREATMENT OF PATIENTS FOR INFLAMMATION MANAGEMENT OF INCONTINENCE, MGT OF HORMONE REPLACEMENT THERAPY, TREATMENT OF INVOLUNTARY INCONTINENCE, MGT OVERACTIVE BLADDER AND INCREASING COMPLIANCE IN SUCH PT METHOD OF USE OF ALPHAGAN METHOD OF USE OF ALPHAGAN P METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA TREATMENT OF GENERALIZED ANXIETY DISORDER IN-THE-EYE USE OF CHLORINE DIOXIDE CONTAINING COMPOSITIONS USE OF RIBAVIRIN TO INCREASE TYPE 1 CYTOKINE RESPONSE AND SUPPRESS TYPE 2 CYTOKINE RESP0NSE TO LYMPHOCYTES, INCLUDING METHODS THAT TAKE ADVANTAGE OF SUCH MODULATION TO TREAT INFECTIONS AND INFESTATIONS USE OF LOPINAVIR IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR TREATING HIV INFECTION AND IN COMBO WITH OTHER HIV PROTEASE INHIBITORS TREATMENT OF ACTINIC KERATOSES ANTI-ALLERGIC FOR VARIOUS ALLERGIC DISEASES TREATMENT OF ALLERGIC CONJUNCTIVITIS FOR WOMEN WITH SEVERE DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS)

PATENT USE
U-406 U-407 U-408 U-409 U-410
ADB 33 of 55
U-411
U-412 U-413 U-414 U-415
U-416
U-417 U-418
U-419 U-420 U-421 U-422 U-423 U-424 U-425
U-426 U-427 U-428 U-429 U-430
U-431 U-432
U-433 U-434 U-435 U-436 U-437 U-438 U-439 U-440 U-441 U-442 U-443 U-444
METHOD OF USE OF ATOVAQUONE AND PROGUANIL METHOD OF TREATING OTOPATHY FOR INDUCING OVULATION IN CONJUNCTION WITH A GONADOTROPIN RELEASING FACTOR ANTAGONIST AND RECRUITING OOCYTES FOR IN-VITRO FERTILIZATION METHOD OF TREATING INFLAMMATION USING DRUG SUBSTANCE METHOD OF REDUCING AMOUNT OF RESPECTIVE ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA (INCLUDING PIOGLITAZONE) IN COMBINATION WITH AN INSULIN SECRETION ENHANCER METHOD OF REDUCING THE SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA (WHICH INCLUDES PIOGLITAZONE) IN COMBINATION WITH AN INSULIN PREPARATION TREATMENT OF TYPE 2 DIABETES USE OF THE ACTIVE INGREDIENT FOR INHIBITING THE BIOSYNTHESIS OF CHOLESTEROL AND TREATMENT OF ATHEROSCLEROSIS A METHOD OF TREATING GLYCOMETABOLISM DISORDERS BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE A METHOD FOR REDUCING THE AMOUNT OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE AS SAID ACTIVE COMPONENTS A METHOD FOR REDUCING SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE AS SAID ACTIVE COMPONENTS COMBINATION USE OF AD-4833 WITH A BIGUANIDE A METHOD OF TREATING LIPID METABOLISM DISORDERS BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA (WHICH INCLUDES PIOGLITAZONE) IN COMBINATION WITH AN INSULIN SECRETION ENHANCER A METHOD OF TREATING LIPID METABOLISM DISORDERS BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE METHOD OF TREATMENT OF TYPE II DIABETES USE FOR SEDATION METHOD OF TREATING AT LEAST ONE OF ATTENTION DEFICIT DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER METHOD OF TREATING AT LEAST ONE OF ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, OR AIDS RELATED DEMENTIA FOR ONCE DAILY, BOLUS ADMINISTRATION TO A PATIENT IN ORDER TO ENGENDER TREATMENT FOR A NERVOUS DISORDER FOR SUBSTANTIALLY AN ENTIRE DAY ON A CHRONIC BASIS METHOD OF REDUCING SIDE EFFECTS OF ACTIVE COMPONENTS ADMIN TO A DIABETIC BY ADMIN A CHEMICAL COMPOUND HAVING FORMULA (INCL PIOGLITAZONE) IN COMBINATION WITH AN INSULIN SECRETION ENHANCER PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION METHOD OF TREATING ALLERGIC REACTIONS IN MAMMALS METHOD OF TREATING ALLERGY IN A MAMMAL USING THIS ACTIVE METABOLITE METHOD OF USING DESLORATADINE TO TREAT ALLERGIC RHINITIS METHOD OF TREATING A DIABETIC BY ADMINISTERING AN INSULIN SENSITIZER IN COMBINATION WITH AN INSULIN SECRETION ENHANCER, AND A DRUG PRODUCT C0MPRISING AN INSULIN SENSITIZER AND AN INSULIN SECRETION ENHANCER POSTTRAUMATIC STRESS DISORDER REDUCTION OF ATHEROSCLEROTIC EVENTS (MYOCARDIAL INFARCTION, STROKE, AND VASCULAR DEATH) IN PATIENTS WITH ATHEROSCLEROSIS DOCUMENTED BY RECENT STROKE, RECENT MYOCARDIAL INFARCTION OR ESTABLISHED PERIPHERAL ARTERIAL DISEASE USE OF LEVOCARITINE IN PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS CONTROLLED SYMPTOMS OF DIARRHEA, BLOATING PRESSURE AND CRAMPS, COMMONLY REFERRED TO AS GAS A TITRATION DOSING REGIMEN FOR THE TREATMENT OF PAIN USING AN INITIAL DOSE OF ABOUT 25MG ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS METHOD OF USE EQUAL TO PROCESS OF PREPARATION TREATMENT/PREVENTION OF NEURODEGENERATIVE DISEASE TREATMENT OF OBESITY METHOD FOR TRANSDERMAL ADMINISTRATION OF A DRUG THROUGH NON-SCROTAL SKIN USING A TRANSDERMAL DRUG DELIVERY DEVICE CONTAINING THE DRUG AND HAVING AN ADHESIVE SURFACE METHOD OF TREATING MS BY ADMINISTERING COPAXONE METHOD FOR DELIVERING A DRUG TO A PATIENT IN NEED OF THE DRUG, WHILE AVOIDING THE OCCURENCE OF AN ADVERSE SIDE EFFECT KNOWN OR SUSPECTED OF BEING CAUSED BY SAID DRUG MANAGEMENT OF MODERATE TO SEVERE PAIN WHEN A CONTINUOUS, AROUND-THE-CLOCK ANALGESIC IS NEEDED FOR AN EXTENDED PERIOD OF TIME TREATMENT OF MIGRAINE

PATENT USE
U-445 U-446 U-447 U-448
ADB 34 of 55
U-449 U-450
U-451 U-452 U-453 U-454
U-475 U-476
U-477
U-478
U-479 U-480 U-481 U-482 U-483
USE AS AN ANTIMYCOTIC AGENT TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID WITHOUT CAUSING TREATMENT-LIMITING ELEVATIONS IN URIC ACID OR GLUCOSE LEVELS OR CAUSING LIVER DAMAGE, BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT USE IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER WHERE THE DOSE OF LEUCOVORIN IS AT LEAST 200MG PER SQUARE METER INTERMEDIATE REL NICOTINIC ACID FORMULATIONS HAVING UNIQUE URINARY METAB PROFILES RESULTING FROM ABSORPTION PROFILES OF NICOTINIC ACID FROM THE INTERMEDIATE NICOTINIC ACID FORMULATIONS,SUITABLE FOR TX HYPERLIPIDEMIA FOLLOWING QD DOSING TREATMENT OF DEPRESSION AND GENERALIZED ANXIETY DISORDER USE OF LANSOPRAZOLE FOR COMBATTING DISEASES CAUSED BY THE GENUS CAMPYLOBACTER (C.PYLORI=H.PYLORI) TREATMENT OF PLATELET ASSOCIATED ISCHEMIC DISORDERS METHOD OF TX A PT SUSPECTED OF HAVING HEPATITIS C BY ADMIN, IN COMBINATION, A CONJUGATE COMPRISING PEG 12000 & INTERFERON ALFA-2B IN AN AMT OF FROM 0.5MCG/KG TO 2MCG/KG, ONCE WEEKLY, AND RIBAVIRIN TREATMENT OF PULMONARY HYPERTENSION WITH UT-15 METHOD OF DECREASING THE PRODUCTION OF A-BETA USING A COMPOSITION WHICH DECREASES BLOOD CHOLESTEROL IN PATIENTS AT RISK OF OR EXHIBITING SYMPTOMS OF ALZHEIMER'S DISEASE METHOD OF TREATING A VAGINAL FUNGAL INFECTION IN A FEMALE HUMAN METHOD OF USE OF IMAGENT TREATMENT OF DEPRESSION AND GENERALIZED ANXIETY DISORDER METHOD OF TREATING PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PREMENSTRUAL DISORDERS USING SERTRALINE METHOD OF TREATMENT OF LATE LUTEAL PHASE DYSPHORIC DISORDER (PMDD) USING SERTRALINE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS AND ADULT RHEUMATOID ARTHRITIS AND TREATMENT OF PRIMARY DYSMENORRHEA VENOGRAPHY PERIPHERAL ARTERIOGRAPHY CT IMAGING OF THE HEAD TREATMENT OF IRRITABLE BOWEL SYNDROME USE OF EPLERENONE IN COMBINATION WITH AN ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR FOR TREATING HYPERTENSION METHOD OF USING FEXOFENADINE HCL IN TREATING ALLERGIC RHINITIS TREATMENT OF GASTROESOPHAGEAL REFLEX DISEASE (GERD) AND ERADICATION OF H.PYLORI TO REDUCE RISK OF DUODENAL ULCER RECURRENCE THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTION METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER USING METHYLPHENIDATE BI-MODAL RELEASE PROFILE EXTENDED-RELEASE CAPSULES TO REDUCE PLASMA CHOLESTEROL LEVELS IN A MAMMAL TO REDUCE PLASMA CHOLESTEROL LEVELS BY ADMIN EZETIMIBE IN COMBO WITH CHOLESTEROL BIOSYNTHESIS INHIB SELECTED FROM GROUP CONSISTING OF HMG COA REDUCTASE INHIBITORS INCL SIMVASTATIN TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY METHOD OF TREATING ANDROGEN RESPONSIVE/MEDIATED CONDITION IN MAMMAL BY ADMIN A SAFE, EFFECTIVE AMOUNT OF DUTASTERIDE OR PHARMACEUTICALLY ACCEPTABLE DERIVATIVE THEREOF..CONDITIONS INCLUDE BENIGN PROSTATIC HYPERTROPHY METHOD OF INHIBITING 5 ALPHA TESTOSTERONE REDUCTASE ENZYME WITH DUTASTERIDE OR ITS DERIVATIVE AND TREATING ANDROGEN RESPONSIVE/MEDIATED DISEASE INCLUDING BENIGN PROSTATIC HYPERPLASIA METHOD OF TREATING HEPATITIS C VIRAL INFECTION BY CONTINUOUS PARENTERAL ADMIN INTERFERON ALPHA 2-10 MILLION IU WEEKLY, SUBCUTANEOUSLY, INJECTION OF POLYMER-INTERFERON ALPHA CONJUGATE-POLYMER IS PEG-INTERFERON IS ALPHA 2B METHOD OF USING PEG-INTRON/REBETOL COMBINATION THERAPY AND INTRON/REBETOL COMBINATION THERAPY CONTRAST AGENT FOR MRI DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY METHOD OF IN VITRO FERTILIZATION THERAPY INCLUDING MEANS FOR INDUCING OVULATION.... METHOD FOR THE ADMINISTRATION OF DRUGS USING THAT COMPOUND

PATENT USE
U-484 U-485 U-486 U-487 U-488 U-489 U-490 U-491 U-492
ADB 35 of 55
U-493 U-494 U-495 U-496 U-497 U-498 U-499
U-500 U-501 U-502 U-503 U-504 U-505 U-506
U-507 U-508 U-509 U-510
U-511 U-512 U-513 U-514 U-515 U-516 U-517 U-518 U-519 U-520 U-521 U-522 U-523 U-524 U-525 U-526 U-527 U-528
METHOD OF TREATING A SKIN DISEASE WITH A CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION METHOD AND COMPOSITION FOR REDUCING NERVE INJURY PAIN ASSOCIATED WITH SHINGLES (HERPES ZOSTER AND POST-HERPETIC NEURALGIA) EXTERNAL PREPARATION FOR APPLICATION TO THE SKIN CONTAINING LIDOCAINE-DRUG RETAINING LAYER PLACED ON SUPPORT AND COMPRISES ADHESIVE GEL BASE 1-10% BY WEIGHT OF LIDOCAINE METHOD AND COMPOSITION FOR REDUCING NERVE INJURY PAIN ASSOCIATED WITH SHINGLES (HERPES ZOSTER AND POST-HERPETIC NEURALGIA) METHOD FOR REDUCING THE PAIN ASSOCIATED WITH HERPES-ZOSTER AND POST-HERPETIC NEURALGIA EXPECTORANT TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE METHOD OF DELIVERING A DRUG TO THE LUNG METHOD FOR THE TREATMENT OF SKIN, SUFFERING FROM A CONDITION SELECTED FROM A GROUP CONSISTING OF NONACNE INFLAMMATORY DERMATOSES... COMPRISING APPLYING TO AFFECTED AREA. A THERAPEUTICALLY EFFECTIVE AMT AZELAIC ACID TREATMENT OF TYPE 2 DIABETES MELLITUS TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER PERITONEAL DIALYSIS SOLUTION METHOD FOR TREATING CHRONIC RENAL FAILURE RELIEF OF THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS INTRA-ARTERIAL AND INTRAVENOUS USES OF ULTRAVIST METHOD OF USING REBETOL CAPSULES IN COMBINATION WITH A CONJUGATE COMPRISING POLYETHYLENE GLYCOL(PEG) AND AN ALPHA INTERFERON, INCLUDING, FOR EXAMPLE, PEG-INTRON POWDER FOR INJECTION USE AS AN ANTIHYPERTENSIVE AGENT TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN ADULTS PITYRIASIS VERSICOLOR GENERATOR MUST BE USED WITH INFUSION SYSTEM SPECIFICALLY LABELED FOR USE WITH GENERATOR TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS ULTRASOUND CONTRAST AGENT PHARM PRODUCT CONTAINER 1ST CHAMBER IS DISPOSED AQUEOUS DILUENT SOL 2ND CHAMBER PHARM ACTIVE AGENT COMPRISING ACETYLCHOLINE,BUFFER IN 1ST CHAM IS SUFFICIENT TO BUFFER PH OF MIXED SOL RESULTING MIXTURE OF AQUEOUS DILUENT SOL & PHARM ACTIVE.. ACROMEGALY IN PATIENTS W/INADEQUATE RESPONSE TO SURGERY AND/OR RADIATION THERAPY AND/OR MEDICAL THERAPIES, OR FOR WHOM THESE THERAPIES ARE NOT APPROPRIATE METHOD OF RELEASING 17-BETA OESTRADIOL PRECURSOR IN A SUBSTANTIALLY ZERO ORDER PATTERN FOR AT LEAST THREE WEEKS TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (STAGE IA AND IB) WHO HAVE REFRACTORY OR PERSISTENT DISEASE AFTER OTHER THERAPIES OR WHO HAVE NOT TOLERATED OTHER THERAPIES USE OF QUINOLONE COMPOUNDS AGAINST ANAEROBIC PATHOGENIC BACTERIA USE OF QUINOLONE COMPOUNDS AGAINST ATYPICAL UPPER RESPIRATORY PATHOGENIC BACTERIA METHODS OF USE OF ANTIMICROBIAL COMPOUNDS AGAINST PATHOGENIC AMYCOPLASMA BACTERIA PREVENTION OF OVULATION IN A WOMAN TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES AND HAVE DEMONSTRATED DISEASE PROGRESSION ON THE LAST THERAPY METHOD OF TREATING A PSYCHOTIC DISEASE STABLE GEL FORMULATION FOR TOPICAL TREATMENT OF SKIN CONDITIONS OBSESSIVE COMPULSIVE DISORDER POST OPERATIVE NAUSEA AND VOMITING PREMENOPAUSAL OSTEOPOROSIS METHOD OF USING RIBAVIRIN IN COMBINATION WITH INTRON A (INTERFERON ALPHA-2 B RECOMBINANT) INJECTION TO TREAT PATIENTS WITH CHRONIC HEPATITIS C TREATMENT OF CMV RETINITIS BY INTRAVITREAL ADMIN OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE CAPABLE OF HYBRIDIZING WITH CMV MRNA METHOD OF TREATING INFECTION BY CRYPTOSPORIDIUM PARVUM IN AN IMMUNOCOMPROMISED MAMMAL METHOD OF TREATING DIARRHEA METHOD OF TREATING PARASITIC INFECTIONS METHOD OF PROVIDING CONTROLLED RELEASE OF A TREATING AGENT USING A CONTROLLED RELEASE COMPOSITION METHOD OF DELIVERING AN ACTIVE INGREDIENT USING A PROGRESSIVE HYDRATION BIOADHESIVE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

PATENT USE
U-529 U-530
ADB 36 of 55
U-531 U-532 U-533 U-534 U-535 U-536 U-537 U-538
U-539 U-540 U-541 U-542 U-543 U-544 U-545
U-546 U-547 U-548 U-549 U-550 U-551 U-552 U-553
U-554 U-555 U-556 U-557 U-558 U-559
U-560 U-561
U-562 U-563 U-564 U-565 U-566 U-567 U-568 U-569 U-570 U-571
ONCE DAILY TREATMENT OF ASTHMA WITH NEBULIZED BUDESONIDE TREATMENT OF HERPES ZOSTER, TREATMENT OF GENITAL HERPES, TREATMENT OF COLD SORES, SUPPRESSION OF GENITAL HERPES IN IMMUNOCOPETENT AND HIV-INFECTED INDIVIDUALS, REDUCTION OF RISK OF HETEROSEXUAL TRANSMISSION OF GENITAL HERPES TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION. MAY BE USED ALONE OR GIVEN WITH OTHER CLASSES OF ANTIHYPERTENSIVES, ESPECIALLY THIAZIDE DERIVATIVES TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD IN PATIENTS REQUIRING MORE THAN ONE BRONCHO DILATOR ERECTILE DYSFUNCTION HUMALOG IS AN INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS FOR THE CONTROL OF HYPERGLYCEMIA TREATMENT OF SOCIAL ANXIETY DISORDER CONTRAST AGENT FOR MAGNETIC RESONACE IMAGING TREATMENT OF CONDITIONS RELATED TO HYPERALDOSTERONISM SUCH AS HYPERTENSION AND CARDIAC INSUFFICIENCY, WITH EPLERENONE FIRST LINE TREATMENT OF SEVERE HYPERTENSION, IN PATIENTS WITH HYPERTENSION SEVERE ENOUGH THAT THE VALUE OF ACHIEVING PROMPT BLOOD PRESSURE CONTROL EXCEEDS THE RISK OF INITIATING COMBINATION THERAPY IN THESE PATIENTS TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE TREATMENT OF FUNGAL INFECTIONS METHOD OF TREATMENT OF ADULTS INFECTED WITH HIV-1 METHOD OF TREATING PATIENT WITH TYPE 2 DIABETES BY ONCE DAILY ADMINISTRATION TREATMENT OF SCHIZOPHRENIA TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE. METHOD FOR THE PREVENTION AND/OR TREATMENT OF THROMBOTIC EPISODES, SUCH AS MYOCARDIAL INFARCTION, IN A HUMAN PATIENT AND METHOD FOR THE PREVENTION OF VENOUS THROMBOSIS IN A POSTOPERATIVE HUMAN PATIENT USE OF REPAGLINIDE IN COMBINATION WITH METFORMIN TO LOWER BLOOD GLUCOSE MAINTENANCE MONOTHERAPY FOR BIPOLAR DISORDER A METHOD OF REDUCING FLUSH IN AN INDIVIDUAL BEING TREATED FOR A LIPIDEMIC DISORDER AND EFFECTIVELY TREATING THE LIPIDEMIC DISORDER USE IN THE TREATMENT OF MEN WITH ADVANCED SYMPTOMATIC PROSTATE CANCER TREATMENT OF BIPOLAR DISORDER AND SCHIZOPHRENIA METHOD FOR REDUCING TOXICITY OF ALIMTA TREATED PATIENTS BY ADMINISTERING FOLIC ACID TREATMENT OF HYPERTENSION AND HYPERLIPIDEMIA WITH A SINGLE COMPOSITION MANAGEMENT OF PAIN AND DISCOMFORT ASSOCIATED WITH PERIDONTAL SCALING AND ROOT PLANNING PROCEDURES BY APPLICATION OF AN EUTECTIC MIXTURE OF LOCAL ANESTHETICS TO PERIDONTAL POCKETS TREATING HIV INFECTION WITH INDINAVIR SULFATE IN COMBINATION WITH ANTIRETROVIRAL AGENTS TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS AND ACUTE UNCOMPLICATED PYELONEPHRITIS USE AS ADJUNCT DIAGNOSTIC FOR SERUM THYROGLOBULIN (TG) TESTING NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS INDICATED FOR THE RELIEF OF BRONCHOSPASM IN PATIENTS 2-12 YEARS OF AGE WITH ASTHMA (REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE) METHOD OF DECREASING OR REDUCING PARATHYROID HORMONE LEVEL; METHOD OF MODULATING PARATHYROID HORMONE SECRETION;METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF REDUCING SERUM IONIZED CALCIUM LEVEL METHOD OF DECREASING PARATHYROID HORMONE LEVEL;METHOD OF TREATING HYPERPARATHYROIDISM COSOPT IS INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION WHO ARE INSUFFICIENTLY RESPONSIVE TO BETA BLOCKERS TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA MARINOL IS INDICATED FOR, INTER ALIA, ANOREXIA ASSOCIATED WITH WEIGHT LOSS IN PATIENTS WITH AIDS TREATMENT OF HIV IN CONCOMITANT THERAPY TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS, AND CHRONIC URTICARIA FOR THE LONG-TERM, ONCE-DAILY, MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA METHOD OF TREATING INFERTILITY METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION AND WHEREIN THEREAFTER AN OVULATORY INDUCING AMOUNT OF HCG IS ADMINISTERED METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION AND WHEREIN THE DAILY AMOUNT OF FSH IS ABOUT 5-10 IU/KG TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA AND BIPOLAR I MANIA

PATENT USE
U-572 U-573 U-574
ADB 37 of 55
U-575 U-576 U-577 U-578
U-579 U-580 U-581 U-582
U-583
U-584 U-585 U-586
U-587 U-588
U-589
U-590
U-591 U-592 U-593 U-594 U-595 U-596 U-597 U-598 U-599 U-600 U-601 U-602
U-603 U-604 U-605
INTENSIVE CARE UNIT SEDATION TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL) PROPHYLAXIS AND TREATMENT OF THE NASAL SYMPTOMS OF SEASONAL ALLERGIC RHINITIS AND TREATMENT OF THE NASAL SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER LOTEMAX OPTHALMIC SUSPENSION IS INDICATED FOR THE TREATMENT OF STEROID RESPONSIVE CONDITIONS OF THE PALPEBRAL BULBAR CONJUNCTIVA, CORNEA AND ANTERIOR SEGMENT OF THE GLOBE. ALREX OPTHALMIC SUSPENSION IS INDICATED FOR THE TEMPORARY RELIEF OF THE SIGNS AND SYMPTOMS OF SEASONAL ALLERGIC CONJUNCTIVITIS. TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH FINASTERIDE IN COMBINATION WITH DOXAZOSIN TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER. TREATMENT OF EPILEPSY AND/OR MIGRAINE. TREATMENT OF DISORDERS OF THE SEROTONERGIC SYSTEM SUCH AS DEPRESSION AND ANXIETY-RELATED DISORDERS METHOD OF TREATING A CONDITION CAPABLE OF TREATMENT BY INHALATION, E.G. ASTHMA, COMPRISING ADMINISTRATION OF A FORMULATION CLAIMED IN US PATENT NO. 6743413 METHOD FOR THE TREATMENT OF A RESPIRATORY DISORDER, E.G. ASTHMA, COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF AN AEROSOL COMPOSITION TO A PATIENT FROM A METERED DOSE INHALER SYSTEM AS CLAIMED IN US PATENT NO. 6253762 METHOD FOR THE TREATMENT OF A RESPIRATORY DISORDER, E.G. ASTHMA, COMPRISING ADMINISTERING TO A PATIENT BY INHALATION, A METERED AEROSOL DOSE OF A DRUG FORMULATION FROM THE METERED DOSE INHALER SYSTEM CLAIMED IN US 6546928 SINGLE-DOSE ADMINISTRATION BY THE EPIDURAL ROUTE, AT THE LUMBAR LEVEL, FOR THE TREATMENT OF PAIN FOLLOWING MAJOR SURGERY TO PROMOTE WEIGHT GAIN AFTER WEIGHT LOSS IN CERTAIN TYPES OF PATIENTS AN INTERMEDIATE RELEASE NICOTINIC ACID FORMULATION SUITABLE FOR ORAL ADMINISTRATION ONCEA-DAY AS A SINGLE DOSE FOR TREATING HYPERLIPIDEMIA WITHOUT CAUSING DRUG-INDUCED HEPATOTOXICITY OR ELEVATIONS IN URIC ACID OR GLUCOSE OR BOTH USE OF EPLERENONE IN COMBINATION WITH AN ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR (AND OPTIONALLY A DIURETIC) FOR TREATING CONGESTIVE HEART FAILURE AND HYPERTENSION SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER; TREATMENT OF HEARTBURN AND OTHER SYMPTOMS ASSOCIATED WITH GERD; SHORT-TERM TREATMENT OF EROSIVE ESOPHAGITIS; MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS METHOD FOR TREATMENT OF A RESPIRATORY DISORDER, E.G., BRONCHOSPASM, COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF AN AEROSOL COMPOSITION TO A PATIENT FROM A METERED DOSE INHALER SYSTEM AS CLAIMED IN U.S. PATENT NO. 6131966 METHOD FOR TREATMENT OF A RESPIRATORY DISORDER,E.G.,BRONCHOSPASM,COMPRISING ADMINISTERING TO A PATIENT BY ORAL OR NASAL INHALATION A DRUG FORMULATION BY USING THE METERED DOSE INHALER SYSTEM AS CLAIMED IN US PATENT NO.6532955 TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER USING A DOSAGE FORM WHICH PROVIDES ONCE-DAILY ORAL ADMINISTRATION OF A PHENIDATE DRUG TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA, MIXED HYPERLIPIDEMIA AND/OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA, MIXED HYPERLIPIDEMIA AND/OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS 35 MG ORALLY ONCE A WEEK FOR PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN; 35 MG ORALLY ONCE A WEEK FOR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOWING ANTIESTROGEN THERAPY FORTEO IS INDICATED FOR THE TREATMENT OF POST MENOPAUSAL WOMEN WITH OSTEOPOROSIS WHO ARE AT HIGH RISK FOR FRACTURE PROPHYLACTIC TREATMENT OF MIGRAINE METHOD FOR TREATING ALLERGIC CONJUNCTIVITIS A METHOD OF TREATING A PATIENT IN NEED OF OPHTHALMIC ANTIMICROBIAL THERAPY WITH LEVOFLOXACIN TREATMENT OF BIPOLAR DISORDER SIGNS AND SYMPTOMS OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS IN ADULTS, AND/OR PAUCIARTICULAR OR POLYARTICULAR COURSE JUVENILE RHEUMATOID ARTHRITIS, ACUTE PAIN IN ADULTS; PRIMARY DYSMENORRHEA; AND/OR ACUTE MIGRAINE ATTACKS IN ADULTS METHOD OF TREATING INFECTIONS COMPRISING ORALLY ADMINISTERING AN EFFECTIVE AMOUNT OF THE FDA APPROVED ORAL SUSPENSION METHOD OF LOWERING BLOOD GLUCOSE BY ONCE DAILY ADMINISTRATION TREATMENT OF MAJOR DEPRESSIVE DISORDER(MDD);ALTHOUGH THE MEHCHANISM OF THE ANTIDEPRESSANT ACTION OF DULOXETINE IN HUMANS IS UNKNOWN, IT IS BELIEVED TO BE RELATED TO ITS POTENTIATION OF SERATONERGIC AND NORADRENERGIC ACTIVITY IN THE CNS

PATENT USE
U-606 U-607 U-608 U-609 U-610
ADB 38 of 55
U-611 U-612 U-613 U-614 U-615
U-616
U-617 U-618
U-634
U-635 U-636 U-637 U-638 U-639 U-640 U-641 U-642 U-643
U-644 U-645 U-646
USE OF IRINOTECAN IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLRECTAL CANCER CANCIDAS IS INDICATED FOR EMPIRICAL THERAPY FOR PRESUMED FUNGAL INFECTIONS IN FEBRILE, NEUTROPENIC PATIENTS. USE OF QUINOLONE COMPOUNDS AGAINST PNEUMOCOCCAL PATHOGENIC BACTERIA USE OF QUINOLONE COMPOUNDS AGAINST QUINOLONE-RESISTANT PNEUMOCOCCAL PATHOGENIC BACTERIA ATROVENT HFA (IPRATROPIUM BROMIDE HFA) INHALATION AEROSOL IS INDICATED AS A BRONCHODILATOR FOR MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA. METHOD OF USING DESLORATADINE TO TREAT SEASONAL AND PERENNIAL ALLERGIC RHINITIS, PRURITIS, AND CHRONIC IDIOPATHIC URTICARIA IN PATIENTS 2 YEARS OF AGE AND OLDER TREATMENT OF SEASONAL ALLERGY SYMPTOMS WITH NASAL CONGESTION IN ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER REDUCTION OF SERUM PHOSPHATE TREATMENT OF SEXUAL DYSFUNCTION ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V) MANAGEMENT OF PERSISTENT, MODERATE TO SEVERE PAIN IN PATIENTS REQUIRING CONTINUOUS, AROUND-THE-CLOCK ANALGESIA WITH A HIGH POTENCY OPIOID FOR AN EXTENDED PERIOD OF TIME GENERALLY WEEKS TO MONTHS OR LONGER TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL) USE OF ROSUVASTATIN CALCIUM TO REDUCE ELEVATED TOTAL-C, LDL-C, APOB, NONHDL-C OR TG LEVELS; TO INCREASE HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA; AND TO SLOW THE PROGRESSION OF ATHEROSCLEROSIS. TREATMENT OF MALIGNANT NEOPLASM TREATMENT OF INSOMNIA METHOD OF TREATING CANCER TREATMENT OF VEGF MEDIATED OCULAR DISEASE. SHORT TERM TREATMENT OF ACTIVE BENIGN GASTRIC ULCER REDUCTION OF RISK OF UPPER GASTROINTESTINAL BLEEDING IN CRITICALLY ILL PATIENTS ALLERGIC RHINITIS OR NASAL POLYPS CLOLAR IS INDICATED FOR THE TREATMENT OF PEDIATRIC PATIENTS 1 TO 21 YEARS OLD WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA AFTER AT LEAST TWO PRIOR REGIMENS TREATMENT OF PATIENTS USING EXTENDED-RELEASE CARBAMAZEPINE USE OF AVANDIA IN COMBINATION WITH A SULFONYLUREA, AND IN COMBINATION WITH METFORMIN AND A SULFONYLUREA TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS METHOD OF INDUCING A HYPNOTIC OR SEDATIVE EFFECT IN A HUMAN BY ADMINISTERING ESZOPICLONE TREATING URINARY INCONTINENCE BY ADMINISTERING AN EXTENDED-RELEASE FORM OF DARIFENACIN TREATING A DISEASE OF ALTERED MOTILITY OR TONE OF SMOOTH MUSCLE BY ADMINISTERING A MUSCARINIC RECEPTOR ANTAGONIZING AMOUNT OF DARIFENACIN METHOD OF TREATMENT OF CANCER BY ADMINISTERING PARTICLES OF PACLITAXEL THAT HAVE A PROTEIN COATING METHOD FOR TREATMENT OF TUMORS BY ADMINISTERING PACLITAXEL AT A DOSE IN THE RANGE OF ABOUT 30MG/METER SQUARE TO ABOUT 100MG/METER SQUARE IN A PHARMACEUTICALLY ACCEPTABLE FORMULATION THAT DOES NOT CONTAIN CREMOPHOR METHOD FOR DELIVERY OF A BIOLOGIC (INCLUDING ANTINEOPLASTIC AGENTS) BY ADMINISTERING TO A PATIENT AN EFFECTIVE AMOUNT OF A BIOLOGIC AS A SOLID OR LIQUID WITH A POLYMERIC BIOCOMPATIBLE MATERIAL TREATMENT OF GERD, MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND RISK REDUCTION OF NSAID ASSOCIATED GASTRIC ULCERS TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS TREATMENT OF DIABETES WITH AN AMYLIN AGONIST TREATMENT OF DIABETES WITH AN AMYLIN AGONIST, INCLUDING WITH INSULIN TREATMENT OF A MAMMAL HAVING A NEED OF OR REDUCED ABILITY TO PRODUCE INSULIN WITH AN INSULIN AND AN AMYLIN SUCH AS PRAMLINTIDE USE OF AN AMYLIN AGONIST TO REDUCE GASTRIC MOTILITY AND TREAT POST PRANDIAL HYPERGYLCEMIA USE OF AN AMYLIN AGONIST HAVING SPECIFIED BINDING ACTIVITY TO REDUCE GASTRIC MOTILITY, INCLUDING USE THROUGH PARENTERAL ADMINISTRATION TREATMENT AND PREVENTION OF OSTEOPOROSIS THE SHORT TERM TREATMENT (UP TO 10 DAYS) IN PTS HAVING GASTROESOPHAGEAL REFLUX DISEASE (GERD) AS AN ALTERNATIVE TO ORAL THERAPY IN PTS WHEN THERAPY WITH NEXIUM CAPSULES IS NOT POSSIBLE OR APPROPRIATE TREATMENT OF SEASONAL ALLERGIC RHINITIS TREATMENT OF ASTHMA METHOD OF TREATING OTITIS

PATENT USE
U-647 U-648 U-649 U-650 U-651 U-652 U-653 U-654 U-655
ADB 39 of 55
U-681 U-682 U-683 U-684 U-685 U-686 U-687 U-688 U-689 U-690
TREATMENT OF OSTEOPOROSIS IN POST MENOPAUSAL WOMEN AND/OR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AND/OR THE TREATMENT TO INCREASE BONE MASS IN MEN A METHOD FOR TREATING A TUMOR DISEASE TREATMENT OF ESOPHAGEAL CANDIDIASIS AND PROPHYLAXIS OF CANDIDA INFECTIONS IN HSCT PATIENTS TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATMENT OF CARDIAC ARRHYTHMIA STIMULATING INSULIN RELEASE BY ADMINISTERING EXENATIDE LOWERING PLASMA GLUCAGON IN A SUBJECT IN NEED THEREOF, INCLUDING ONE WITH TYPE 2 DIABETES, BY ADMINISTERING AN EXEDIN OR ANALOG, SUCH AS EXENDIN-4 TREATMENT OF MILD TO MODERATE ACTIVE CHROHN'S DISEASE INVOLVING THE ILEUM AND/OR THE ASCENDING COLON AND THE MAINTENANCE OF CLINICAL REMISSION OF MILD TO MODERATE CROHN'S DISEASE INVOLVING THE ILEUM AND/OR ASCENDING COLON FOR UP TO 3 MONTHS REDUCING GASTRIC MOTILITY OR DELAYING GASTRIC EMPTYING BY ADMINISTERING AN EXENDIN, SUCH AS EXENDIN-4 PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF ADVANCED HORMONE-DEPENDENT BREAST CANCER TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON SMALL-CELL LUNG CANCER (NSCLC) AFTER FAILURE OF AT LEAST ONE PRIOR CHEMOTHERAPY REGIMEN TREATMENT OF HYPERTENSION AND TREATMENT OF HEART FAILURE TREATMENT OF SEIZURE DISORDER TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN THE TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS TREATMENT OF CONDITIONS FOR WHICH AN ALDOSTERONE RECEPTOR BLOCKER IS INDICATED, SUCH AS HYPERTENSION, HEART FAILURE, AND POST-MYOCARDIAL INFARCTION METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING METHOD OF TREATING ADHD MANAGEMENT OF INCONTINENCE; METHOD FOR TREATING INCONTINENCE LEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS INDICATION OF TYPE II DIABETES TREATMENT OF HIV-1 INFECTION BY THE CO-ADMINISTRATION OF TIPRANAVIR AND RITONAVIR. PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 3 AND 4 TREATMENT OF INFLAMMATION OR AN INFLAMMATION-ASSOCIATED DISORDER METHOD OF TREATMENT WITH ONCE-DAILY DOSES OF 625MG/5ML METHOD OF TREATING INSOMNIA CHARACHTERIZED BY DIFFICULTY WITH SLEEP ONSET PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA; RELIEF OF SYMPTOMS OF ALLERGIC RHINITIS METHOD OF TREATING ATTENTION DEFICIT DISORDER USING ORAL ADMINISTRATION OF A BI-MODAL OR PULSATILE RELEASE COMPOSITION A METHOD OF TREATING DISEASE AMENABLE TO TREATMENT WITH A PHENIDATE DRUG BY ONCE DAILY ORAL ADMINISTRATION OF AN EXTENDED RELEASE DOSAGE FORM METHOD OF TREATING ATTENTION DEFICIT DISORDER AND/OR ATTENTION DEFICIT HYPERACTIVITY DISORDER ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES WHO ARE ALREADY TREATED WITH A PIOGLITAZONE AND METFORMIN A METHOD OF TREATING DYSLIPIDEMIA AND DYSLIPOPROTEINEMIA USING A DOSAGE FORM THAT CAN PROVIDE AN EFFECTIVE AMOUNT OF FENOFIBRATE TO A PATIENT IN A FASTED STATE WHICH IS AT LEAST 90% OF THE AUC AMOUNT PROVIDED BY THE DOSAGE FORM TREATMENT OF PRIMARY IGF-1 DEFICIENCY NON-BENZODIAZEPINE HYPNOTIC AGENT INDICATED FOR TREATMENT OF INSOMNIA, CHARACTERIZED BY DIFFICULTIES WITH SLEEP ONSET AND/OR SLEEP MAINTENANCE PREVENTION OR TREATMENT OF ISCHEMIC HEART DISEASE TREATMENT OF UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER EXPECTORANT AND COUGH SUPPRESSANT EXPECTORANT AND NASAL DECONGESTANT REDUCING FOOD INTAKE IN A SUBJECT WITH TYPE 2 DIABETES BY ADMINISTERING AN EXENDIN, SUCH AS EXENDIN-4 TREATMENT OF HIV-INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS TREATMENT OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WHOSE DISEASE HAS NOT RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY REGIMENS TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

PATENT USE
U-691
ADB 40 of 55
U-692 U-693
U-694
U-695
U-711 U-712 U-713 U-714 U-715 U-716
USE AS A MONOTHERAPY, IN COMBINATION WITH A SULFONYLUREA, METFORMIN OR INSULIN OR IN COMBINATION WITH A SULFONYLUREA PLUS METFORMIN TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USE OF VALSARTAN TO REDUCE CARDIOVASCULAR MORTALITY IN CLINICALLY STABLE PATIENTS WITH LEFT VENTRICULAR FAILURE OR LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION THE RECOMMENDED INITIAL DOSE OF EQUETRO IS 400MG/DAY GIVEN IN DIVIDED DOSES, TWICE DAILY. THE DOSE SHOULD BE ADJUSTED IN 200MG DAILY INCREMENTS TO ACHIEVE OPTIMAL CLINICAL RESPONSE. LENALIDOMIDE IS AN ANALOGUE OF THALIDOMIDE. THALIDOMIDE IS A KNOWN HUMAN TERATOGEN THAT CAUSES SEVERE LIFE-THREATENING HUMAN BIRTH DEFECTS. IF LENALIDOMIDE IS TAKEN DURING PREGNANCY, IT MAY CAUSE BIRTH DEFECTS OR DEATH TO AN UNBORN BABY. TREATMENT OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND T-CELL LYMPHOBLASTIC LYMPHOMA WHOSE DISEASE HAS NOT RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY REGIMENS TREATMENT OF PATIENTS WITH T-CELL LYMPHOBLASTIC LYMPHOMA WHOSE DISEASE HAS NOT RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY REGIMENS A METHOD OF USING RINFABATE RECOMBINANT (RHIGFBP-3) WITH MECASERMIN RECOMBINANT (RHIGF1) TO PROMOTE LINEAR GROWTH IN THE TRATMENT OF PRIMARY IGF-1 DEFICIENCY METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR INTRAVENOUS TREATMENT OF PATEINTS WITH EUVOLEMIC HYPONATREMIA NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF HYPERCHOLESTEROLEMIA AND/OR HYPERTRIGLYCERIDEMIA TOPICAL AEROSOL HAIR REGROWTH TREATMENT TREATMENT OF PROTEIN KINASE RELATED DISORDERS, SUCH AS GASTROINTESTINAL STROMAL TUMOR AND RENAL CELL CARCINOMA WITH SUNITINIB METHOD OF ADMINISTERING INSULIN VIA INHALATION TREATING CHRONIC ANGINA BY ADMINISTERING AN EXTENDED RELEASE FORM OF RANOLAZINE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ALLERGIC RHINITIS TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE METHOD OF COMBATING BACTERIA IN A PATIENT A METHOD OF TREATING RESPIRATORY DISORDERS, E.G., ASTHMA, WHICH COMPRISES ADMINISTRATION BY INHALATION OF AN EFFECTIVE AMOUNT OF A PHARMACEUTICAL FORMULATION AS CLAIMED IN US PATENT NO. 5658549 ACUTE AND LONGER-TERM TREATMENT OF MAJOR DEPRESSIVE DISORDER A METHOD OF USING A NICOTINIC ACID FORMULATION TO REDUCE ELEVATED TC, LDL-C AND TG LEVELS, AND RAISE HDL-C LEVELS IN PATIENTS WITH HYPERLIPIDEMIA TREATMENT OF MILD TO MODERATE DEMENTIA OF THE ALZHEIMER'S TYPE TOPICAL TREATMENT OF INTERDIGITAL TINEA PEDIS AND TINEA CORPORIS DUE TO TRICHOPHYTON RUBRUM, TRICHOPHYTON MENTAGROPHYTES OR EPIDERMOPHYTON FLOCCOSUM FOR CLEANSING THE BOWEL IN PREPARATION FOR COLONOSCOPY, IN ADULTS 18 YEARS OF AGE OR OLDER THE TREATMENT OR PREVENTION OF BRONCHOSPASM IN ADULTS AND CHILDREN 4 YEARS OF AGE AND OLDER WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE AND THE PREVENTION OF EXERCISEDINDUCED BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER METHOD OF RELIEVING OR PREVENTING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT TREATMENT OF FUNGAL INFECTIONS TREATENT OF PSYCHOSIS TREATMENT OF NEUROLEPTIC DISEASES TREATMENT OF INFLUENZA PROPHYLAXIS OF INFLUENZA PROPHYLACTIC TREATMENT OF MIGRAINE METHOD OF TREATING SEIZURES ALLERGIC RHINITIS AND URTICARIA ALLERGIC RHINITIS FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) METHOD FOR TREATING BACTERIAL INFECTION TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD), RISK-REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER, H. PYLORI ERADICATION TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE USE AS A NASAL SPRAY FOR TREATMENT OF THE SYMPTOMS OF SEASONAL ALLERGIC RHINITIS AND VASOMOTOR RHINITIS USE IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA ACUTE TREATMENT OF THE CUTANEOUS MANIFESTATIONS OF MODERATE TO SEVERE ERYTHEMA NODOSUM LEPROSUM (ENL)

PATENT USE
U-733 U-734 U-735 U-736 U-737 U-738 U-739 U-740 U-741 U-742 U-743 U-744 U-745 U-746 U-747 U-748 U-749 U-750 U-751 U-752 U-753 U-754 U-755 U-756 U-757 U-758 U-759 U-760 U-761 U-762 U-763 U-764 U-765 U-766 U-767 U-768
ADB 41 of 55
U-769 U-770 U-771 U-772
U-773 U-774 U-775 U-776
U-777 U-778 U-779 U-780
MAINTENANCE THERAPY FOR PREVENTION AND SUPRESSION OF THE CUTANEOUS MANIFESTATIONS OF ENL RECURRENCE FIRST LINE THERAPY FOR TYPE 2 DIABETES MELLITUS METHOD OF TREATING CHRONIC IRON OVERLOAD METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE DISINFECTION OF PATIENT SKIN PRIOR TO AN INVASIVE PROCEDURE INDICATED FOR THE LONG-TERM, TWICE-DAILY MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS 12 YEARS OF AGE OR OLDER METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMALIAN SUBJECT FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS COMBINATION THERAPY WITH CISPLATIN FOR THE TREATMENT OF LATE STAGE CERVICAL CANCER TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS. ONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA TREATMENT OF HIV INFECTION IN ANTIRETROVIRAL TREATMENT-EXPERIENCED ADULT PATIENTS TREATMENT OR PREVENTION OF EMESIS PREVENTION OR TREATMENT OF NAUSEA OR EMESIS INDUCED BY A CANCER CHEMOTHERAPEUTIC AGENT PREVENTION OR TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING A METHOD FOR THE TREATMENT OF A PROTEIN TYROSINE KINASE-ASSOCIATED DISORDER METHOD OF CONTRACEPTION TREATMENT OF HIV-1 INFECTION IN ADULTS ONCE DAILY DOSING OF BUDESONIDE VIA NEBULIZER FOR THE TREATMENT OF ASTHMA SUNSCREEN AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES USE FOR THE LONG-TERM MAINTENANCE TREATMENT OF ASTHMA TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) ADDITION OF ONCE-WEEKLY DOSING FOR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS USE AS A BILE ACID SEQUESTRANT FOR LOWERING CHOLESTEROL TREATMENT OF SYMPTOMS OF PREMENSTRUAL DYSPHORIC DISORDER METHOD OF USE OF ADMINISTERING LEVOTHYROXINE PROPHYLAXIS OF INVASIVE ASPERGILLUS AND CANDIDA INFECTIONS AND TREATMENT OF OROPHARYNGEAL CANDIDAIASIS TREATMENT OF SCHIZOPHRENIA INCLUDING MAINTAINING STABILITY IN PATIENTS WITH SCHIZOPHRENIA TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ADMINISTRATION OF ARIPIPRAZOLE BY INJECTION TREATMENT OF SCHIZOPHRENIA METHOD OF TREATING ALLERGIC CONJUNCTIVITIS TREATMENT OF SEIZURES MANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER A METHOD OF REDUCING THE CAPACITY OF EXTENDED RELEASE NICOTINIC ACID TO PROVOKE A FLUSHING REACTION BY PRETREATING AN INDIVIDUAL WITH A FLUSH INHIBITING AGENT PRIOR TO THE ADMINISTRATION OF THE EXTENDED RELEASE NICOTINIC ACID REVLIMID (LENALIDOMIDE) IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEASET ONE PRIOR THERAPY LONG-TERM TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS METHOD FOR THE TREATMENT OF DIABETES MELLITUS, SUCH AS TYPE 1 DIABETES MELLITUS OR TYPE 2 DIABETES MELITUS, IN A HUMAN PATIENT RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN CHILDREN 2 TO 11 YEARS AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN CHILDREN 6 MONTHS TO 11 YEARS PATHOLOGICAL HYPERSECRETORY CONDITIONS METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASTE-IV INHIBITOR METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN AND/OR A SULFONYLUREA TREATMENT OF CUTANEOUS MANIFESTATION IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL) WHO HAVE PROGRESSIVE, PERSISTENT OR RECURRENT DISEASE ON OR FOLLOWING TWO SYSTEMIC THERAPIES. DECREASING MORTALITY CAUSED BY CONGESTIVE HEART FAILURE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATEINTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION A METHOD FOR TREATMENT OF A CANCER, WHEREIN THE CANCER IS CHRONIC MYELOGENOUS LEUKEMIA A METHOD FOR THE TREATMENT OF CANCER

PATENT USE
U-781 U-782
ADB 42 of 55
U-783 U-784 U-785 U-786 U-787
U-788 U-789 U-790
U-791 U-792 U-793
U-794
U-795 U-796 U-797 U-798 U-799 U-800
FOR TREATMENT OF ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO ARE NAIVE TO PHARMACOLOGIC THERAPY TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS WITH EVIDENCE OF VIRAL REPLICATION AND EITHER EVIDENCE OF PERSISTANT ELEVATIONS IN SERUM AMINOTRANSFERASES (ALT OR AST) OR HISTOLOGICALLY ACTIVE DISEASE DESONATE GEL IS INDICATED FOR THE TREATMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN PATIENTS 3 MONTHS OF AGE AND OLDER TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME (RLS) USE AS REPLACEMENT SOLUTION, HEMOFILTRATION SOLUTION OR HEMODIAFILTRATION SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY PRODUCT IS APPROVED FOR THE TOPICAL TREATMENT OF TINEA PEDIS MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND PEDIATRIC PATIENTS SIX YEARS OF AGE OR OLDER, INCLUDING PATIENTS REQUIRING ORAL CORTICOSTEROID THERAPY FOR ASTHMA METHOD OF TREATING PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PREMENSTRUAL DISORDERS USING PAROXETINE TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING FORTEO IS INDICATED FOR THE TREATMENT OF POST MENOPAUSAL WOMEN WITH OSTEOPOROSIS WHO ARE AT RISK FOR FRACTURE. FORTEO CAN BE USED BY PEOPLE WHO HAVE HAD A FRACTURE RELATED TO OSTEOPOROSIS GLEEVEC IS ALSO INDICATED FOR THE TREATMENT OF PATIENTS WITH KIT (CD117) POSITIVE UNRESECTABLE AND/OR METASTATIC MALIGNANT GASTROINTESTINAL STROMAL TUMORS (GIST) TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS FOR THE LONG TERM TREATMENT, TWICE DAILY (MORNING AND EVENING) MAINTENANCE TREATMENT OF BRONCHOCONSTRICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA CLOSURE OF A CLNICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS IN PREMATURE INFANTS WEIGHING BETWEEN 500 AND 1500G, WHO ARE NO MORE THAN 32 WEEKS GESTATIONAL AGE WHEN USUAL MEDICAL MANAGEMENT IS INEFFECTIVE METHOD FOR INHIBITING NOREPINEPHRINE UPTAKE METHOD OF TREATING DEPRESSION METHOD OF TREATING ANXIETY TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN BY ONCE-MONTHLY ORAL ADMINISTRATION OF IBANDRONATE SODIUM MONOHYDRATE EQUIVALENT TO 150MG OF IBANDRONIC ACID METHOD FOR INHIBITING SEROTONIN UPTAKE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER WHOSE TUMORS OVEREXPRESS HER2 AND WHO HAVE RECEIVED PRIOR THERAPY INCLUDING ANTHRACYCLINE, A TAXANE AND TRASTUZUMAB METHOD OF TREATING CANCER METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN TREATMENT OF ACTINIC KERATOSES BY PHOTODYNAMIC THERAPY TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES INTRATHECAL TREATMENT OF LYMPHOMATOUS MENINGITIS PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION THE TREATMENT OF THE SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN PATIENTS 2 YEARS OF AGE AND OLDER TREATMENT OF CHRONIC IDIOPATHIC URTICARIA METHOD OF TREATMENT TO ALLEVIATE INFLAMMATION OF THE EYE RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS AND TREATMENT OF THE UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS MAINTENANCE TREATMENT OF BRONCHOCONSTRICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT OF SCHIZOPHRENIA TREATS COLD SORES/FEVER BLISTERS ON THE FACE OR LIPS. SHORTENS HEALING TIME AND DURATION OF SYMPTOMS: TINGLING, PAIN, BURNING AND/OR ITCHING DEPRESSION, PANIC DISORDER, PREMENSTRUAL DISORDERS AND SOCIAL ANXIETY DISORDER NASAL ADMINISTRATION OF CYANOCOBALAMIN TOPICAL TREATMENT OF ACNE VULGARIS MANAGEMENT OF FIBROMYALGIA IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY, OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME, AND SHIFT WORK SLEEP DISORDER

PATENT USE
U-821 U-822 U-823
ADB 43 of 55
U-824 U-825 U-826 U-827 U-828 U-829 U-830 U-831 U-832 U-833 U-834 U-835 U-836 U-837 U-838 U-839 U-840 U-841 U-842 U-843 U-844
U-845 U-846 U-847
U-848 U-849
U-850 U-851 U-852 U-853 U-854 U-855 U-856
U-857 U-858 U-859
U-860 U-861
METHOD OF INHIBITING ENTHOTHELIN RECEPTORS BY ADMINISTERING AMBRISENTAN TO A PATIENT TO TREAT PULMONARY ARTERIAL HYPERTENSION. USE IN LIPID MANAGEMENT RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS AND FOR THE TREATMENT OF UNCOMPLCATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN CHILDREN 6 TO 11 YEARS OF AGE METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 USE FOR PREVENTION OF BREAST CANCER RELIEF OF MODERATE TO SEVERE PAIN USE FOR TREATMENT OF DIABETES, PARTICULARLY TYPE 2 DIABETES PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION TREATMENT OF EXTRAVASATION RESULTING FROM IV ANTHRACYCLINE CHEMOTHERAPY TREATMENT OF RELAPSED SMALL CELL LUNG CANCER METHOD OF ADMINISTERING LANREOTIDE ACETATE ZINGO IS INDICATED FOR THE USE ON INTACT SKIN TO PROVIDE LOCAL ANALGESIA PRIOR TO VENIPUNCTURE OR INTRAVENOUS CANNULATION. METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.25% BY WEIGHT OF ROPIVACAINE INVIRASE IN COMBINATION WITH RITONAVIR AND OTHER ANTIRETROVIRAL AGENTS IS INDICATED FOR THE TREATMENT OF HIV INFECTION RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF ATOPIC DERMATITIS IN PATIENTS ONE YEAR OF AGE OR OLDER A METHOD FOR THE TREATMENT OF LEUKEMIAS GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN ADULTS METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.5% BY WEIGHT OF ROPIVACAINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) TREATMENT FOR TYPE 2 DIABETES MELLITUS INDICATED FOR THE LONG-TERM, MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS 12 YEARS OF AGE AND OLDER INDICATED FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) METHOD FOR ADMINISTRATION OF TESTOSTERONE PREFEST IS INDICATED IN WOMEN WHO HAVE A UTERUS FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE; TREATMENT OF VULVAR AND VAGINAL ATROPHY; PREVENTION OF OSTEOPOROSIS TREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA PERITONITIS AND ABCESSES USE FOR DELINEATION (VISUALIZATION) DURING A VITRECTOMY SURGICAL PROCEDURE ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V) ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP. DOSE IS ONE DROP OF COMBIGAN IN THE AFFECTED EYE TWICE DAILY PREVENTION OR TREATMENT OF NAUSEA OR EMESIS INDUCED BY A CANCER CHEMOTHERAPEUTIC AGENT TREATMENT OF TYPE 2 DIABETES MELLITUS RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS TREATMENT OR PREVENTION OF EMESIS PREVENTION OF CMV DISEASE IN KIDNEY, HEART, AND KIDNEY-PANCREAS TRANSPLANT PATIENTS AT HIGH RISK (DONOR CMV SEROPOSITIVE/RECIPIENT CMV SERONEGATIVE) METHOD TO INDUCE NATRIURESIS, DIURESIS AND/OR VASODILATION SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED REPORDUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN INHIBITION OF TRANSPLANT REJECTION PEDIATRIC USE AGED 1-11 YEARS, GERD AND EROSIVE ESOPHAGITIS EROSIVE ESOPHAGITIS, HYPERSECRETORY CONDITIONS INCLUDING ZOLLINGER-ELLISON SYNDROME, MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND REDUCTION OF SYMPTOMS IN PATIENTS WITH GERD FOR THE APPROVED USES AND CONDITIONS OF USE, INCLUDING DEPRESSION RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YEARS OF AGE OR OLDER

PATENT USE
U-862
ADB 44 of 55
U-863 U-864 U-865 U-866 U-867 U-868 U-869 U-870 U-871 U-872
U-873 U-874 U-875 U-876 U-877 U-878 U-879 U-880
ADJUNCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, NON-HDL-C, APO B, TG, AND LP(A) LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA, AND HYPERTRIGLYCERIDEMIA TAKING ASPIRIN OR NON-STEROIDAL ANTI-INFLAMMATORY MEDICATIONS APPROXIMATELY 30 MINUTES BEFORE DOSING CAN MINIMIZE FLUSHING, A COMMON SIDE EFFECT OF NIACIN THERAPY PEDIATRIC USE AGES 1-2 YEARS, GERD AND EROSIVE ESOPHAGITIS TREATMENT OF A WOMAN WITH OSTEOPOROSIS AND A HIGH RISK FOR BONE FRACTURE BY REDUCING THE RISK OF VERTEBRAL AND NONVERTEBRAL BONE FRACTURE THE LABEL REFERENCES THE EFFECTS OF THE ACTIVE INGREDIENT OF REVLIMID UPON CYTOKINES TREATMENT OF MIGRAINE METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR INTRAVENOUS TREATMENT OF PATIENTS WITH HYPERVOLEMIC HYPONATREMIA METHOD FOR STIMULATING CORONOARY VASODILATION FOR PURPOSES OF IMAGING THE HEART METHOD OF PRODUCING CORONARY VASODILATION WITHOUT PERIPHERAL VASODILATION METHOD OF REDUCING RISK OF MYOCARDIAL INFARCTION, STROKE AND DEATH TWICE DAILY MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA. TO REDUCE EXACERBATIONS OF COPD IN PATIENTS WITH A HISTORY OF EXACERBATIONS METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME BY OPENING CHLORIDE CHANNELS (CIC) METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME FIRST-LINE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PANCREATIC CANCER, IN COMBINATION WITH GEMCITABINE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA FOR USE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PEPTIC ULCER A METHOD FOR BINDING A PERIPHERAL OPIOID RECEPTOR A METHOD OF TREATING OR PREVENTING ILEUS ENDOMETRIN IS A PROGESTERONE INDICATED TO SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN TREATMENT OF NON-SMALL CELL LUNG CANCER MANAGEMENT OF FIBROMYALGIA (FM) TREATMENT OF GASTROINTESTINAL STROMAL TUMOR WITH SUNITINIB TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST 1 PRIOR THERAPY ADMINISTERING DESLORATADINE TO TREAT THE SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS, SEASONAL ALLERGIC RHINITIS, OR CHRONIC IDIOPATHIC URTICARIA TREATMENT AND PREVENTION OF OSTEOPOROSIS FEMALE HORMONE REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCCIATED WITH MENOPAUSE) REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE USE AS AN INTRAOCULAR IRRIGATING SOLUTION DURING SURGICAL PROCEDURES INVOLVING PERFUSION OF THE EYE TREATMENT OF CUTANEOUS MANIFESTATIONS IN PATIENTS WTIH CUTANEOUS T-CELL LYMPHOMA (CTCL) CLEVIPREX IS A DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER INDICATED FOR THE REDUCTION OF BLOOD PRESSURE WHEN ORAL THERAPY IS NOT FEASIBLE OR NOT DESIRABLE TREATMENT OF COLD SORES IN PEDIATRIC PATIENTS TWELVE YEARS OF AGE AND OLDER TREATMENT OF HIV INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN TWO YEARS OF AGE AND OLDER METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT USE OF GLUTAMINE TOGETHER WITH GROWTH HORMONE FOR THE TREATMENT OF PATIENTS WITH SHORT BOWEL SYNDROME USE OF THALIDOMIDE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA INTEGRASE INHIBITION FOR THE TREATMENT OF HIV INFECTION PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING USE IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN ADULT PATIENTS TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY, ASSOCIATED WITH MENOPAUSE

PATENT USE
U-906
ADB 45 of 55
U-907 U-908 U-909 U-910 U-911 U-912 U-913 U-914 U-915 U-916 U-917 U-918 U-919 U-920
U-921 U-922 U-923 U-924 U-925 U-926
U-927 U-928 U-929 U-930 U-931 U-932
U-933
U-934
U-935
U-936
U-937 U-938 U-939 U-940 U-941 U-942 U-943 U-944 U-945 U-946
PROPHYLAXIS OF ORGAN REJECTION IN KIDNEY, LIVER AND HEART ALLOGENIC TRANSPLANTS; TREATMENT OF PATIENTS WITH SEVERE ACTIVE, RHEUMATOID ARTHRITIS; TREATMENT OF ADULT, NONIMMUNOCOMPROMISED PATIENTS WITH SEVERE, RECALCITRANT, PLAQUE PSORIASIS FOR THE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS IN SUBJECTS 18 YEARS OF AGE AND OLDER PROPHYLAXIS OF ORGAN REJECTION IN PATIENTS RECEIVING ALLOGENEIC RENAL TRANSPLANTS TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA TREATMENT OF METASTATIC CARCINOMA OF THE OVARY AFTER FAILURE OF INITIAL OR SUBSEQUENT CHEMOTHERAPY METHOD OF TREATING, AS ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS AND OLDER WHEN ORAL TREATMENT IS TEMPORARILY NOT FEASIBLE SEDATION OF NON-INTUBATED PATIENTS PRIOR TO AND/OR DURING SURGICAL AND OTHER PROCEDURES TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY, AND FREQUENCY METHOD OF TREATING, AS ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS AND OLDER TREATMENT OF MUSCULOSKELETAL CONDITIONS TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OR OLDER TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET FOR THE TREATMENT OF DERMATITIS STEROID-RESPONSIVE INFLAMMATORY OCULAR CONDITIONS FOR WHICH A CORTICOSTEROID IS INDICATED AND WHERE SUPERFICIAL BACTERIAL OCULAR INFECTION OR A RISK OF BACTERIAL OCULAR INFECTION EXISTS TREATMENT OF ACNE VULGARIS FOR THE TREATMENT OF FUNGAL INFECTIONS METHOD OF TREATING OPHTHALMIC INFLAMMATION AND INFECTION TREATMENT OF MILD TO MODERATE INFECTION CAUSED ABY SUSCEPTIBLE STRAINS TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTILES) OF ROSACEA MGT SPECIFIC BACTERIAL INFECTIONS. TREATMENT PTS W/ COMMUNITY ACQUIRED PNEUMONIA OR BACTERIAL SINUSITIS DUE TO CONFIRMED, OR SUSPECTED B-LACTAMASE PRODUCING PATHOGENS & S. PNEUMONIAE WITH REDUCED SUSCEPTIBILITY TO PENICILLIN (MIC=2MC/ML) METHOD FOR INCREASING TEAR PRODUCTION TREATMENT OF BACTERIAL INFECTIOUS DISEASE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER TREATABLE WITH AN SSRI TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) RELIEF OF MODERATE TO SEVERE ACUTE PAIN PYLERA CAPSULES, IN COMBINATION WITH OMEPRAZOLE ARE INDICATED FOR THE TREATMENT OF PATIENTS WITH HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE TO ERADICATE H. PYLORI FOR THE TREATMENT OF PATIENTS WITH HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE TO ERADICATE H. PYLORI. THE ERADICATION OF HELICOBACTER PYLORI HAS BEEN SHOWN TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE IN COMBINATION WITH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) TO MOBILIZE HEMATOPOIETIC STEM CELL TO THE PERIPHERAL BLOOD FOR COLLECTION AND SUBSEQUENT AUTOLOGOUS TRANSPLANTATION WITH NON-HODGKINS LYMPHOMA AND MULTIPLE MYELOMA TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN ADULT PATIENTS, AND TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN PEDIATRIC PATIENTS 6 YEARS OF AGE AND OLDER USE IN COMBINATION WITH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) TO MOBILIZE HEMATOPOIETIC STEM CELLS TO PERIPHERAL BLOOD FOR COLLECTION & SUBSEQUENT AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA & MULTIPLE MYELOMA TREATMENT OF PROSTATE CANCER TREATMENT OF HAIR LOSS AND HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING AND STIMULATING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS METHOD TO TREAT AIDS-RELATED KAPOSI'S SARCOMA METHOD TO TREAT OVARIAN CANCER METHOD TO TREAT MULTIPLE MYELOMA GNRH ANTAGONIST INDICATED FOR TREATMENT OF PATIENTS WITH ADVANCED PROSTATE CANCER TREATMENT OF PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) SEDATIVE-HYPNOTIC AGENT INDICATED FOR MONITORED ANESTHESIA CARE (MAC) SEDATION TREATMENT OF BREAST CANCER

PATENT USE
U-947
ADB 46 of 55
U-948 U-949 U-950 U-951 U-952 U-953 U-954 U-955 U-956 U-957 U-958
U-959
U-960 U-961 U-962 U-963 U-964 U-965 U-966 U-967
U-968 U-969 U-970 U-971 U-972 U-973
U-974 U-975 U-976 U-977 U-978 U-979 U-980 U-981
U-982 U-983 U-984 U-985 U-986
WHEN PATIENTS ARE UNABLE TO TAKE THE ORAL FORMULATIONS, PREVACID IV, FOR INJECTION IS INDICATED AS AN ALTERNATIVE FOR THE SHORT-TERM TREATMENT (UP TO 7 DAYS) OF ALL GRADES OF EROSIVE ESOPHAGITIS TREATMENT OF DIABETES MELLITUS HEALING OF ALL GRADES OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 8 WEEKS MAINTAIN HEALING OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 6 MONTHS TREATMENT OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (GERD) FOR 4 WEEKS USE AS AN ANALGESIC METHOD OF TREATING OPHTHALMIC INFLAMMATION AND INFECTION CHRONIC MANAGEMENT OF HYPERURICEMIA IN PATIENTS WITH GOUT. NOT RECOMMENDED FOR THE TREATMENT OF ASYMPTOMATIC HYPERURICEMIA PROPHYLACTIC TREATMENT OF MIGRAINE TREATMENT OF PATIENTS WITH H. PYLORI INFECTION AND DUODENAL ULCER DISEASE A METHOD OF TREATING CANCER IN A PATIENT COMPRISING ADMINISTERING IXABEPILONE OR PHARMACEUTICAL COMPOSITIONS COMPRISING IXABEPILONE METHOD OF TREATING PATIENT COMPRISING MIXING FIRST AND SECOND VIALS OF PRODUCT COMPRISING LYOPHILIZED IXABEPILONE TO PROVIDE AN EPOTHILONE ANALOG SOLUTION, DILUTING SOLUTION WITH A SUITABLE DILUENT TO PREPARE INTRAVENOUS FORMULATION FOR PT METHOD OF TREATING CANCER, IV ADMIN, LYOPHYLIZED IXABEPILONE DILUTED, EVERY WEEK OR 3 WEEKS; LYOPHILIZED IXABEPILONE WITH SOLVENT(DEHYDRATED ETHANOL) DILUTED TO CONCENTRATION OF 0.1MG/ML TO 0.9MG/ML METHOD OF TREATING CANCER IN A PATIENT COMPRISING INTRAVENOUSLY ADMINISTERING TO THE PATIENT IXABEPILONE DILUTED IN A PARENTERAL DILUENT METHOD OF TREATING BREAST CANCER BY ADMINISTERING IXABEPILONE; A METHOD OF TREATING A CANCER RESPONSIBLE TO MICROTUBULE STABILIZATION BY ADMINISTERING IXABEPILONE SYMBYAX IS INDICATED FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS PROZAC AND OLANZAPINE IN COMBINATION FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS ZYPREXA ZYDIS AND FLUOXETINE IN COMBINATION FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS USE OF IXABEPILONE IN COMBINATION WITH CAPECITABINE IN TREATMENT OF METASTASIS BREAST CANCER TREATMENT OF ASTHMA (MAINTENANCE AND PROPHYLACTIC THERAPY) A METHOD OF REVERSING SOFT-TISSUE ANESTHESIA I.E. ANESTHESIA OF THE LIP AND TONGUE, AND THE ASSOCIATED FUNCTIONAL DEFICITS RESULTING FROM AN INTRAORAL SUBMUCOSAL INJECTION OF A LOCAL ANESTHETIC A METHOD FOR IMPROVING GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATMENT OF MIGRAINE TOPICAL TREATMENT OF LICE INFESTATIONS INDICATED FOR THE ACUTE TREATMENT OF ADULTS WITH SCHIZOPHRENIA MONOTHERAPY OR AS ADJUNCTIVE THERAPY TO LITHIUM OR VALPROATE FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHO ARE ALREADY TREATED WITH PIOGLITAZONE AND METFORMIN OR WHO HAVE INADEQUATE GLYCEMIC CONTROL ON PIOGLITAZONE OR METFORMIN ALONE ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES WHO ARE ALREADY TREATED WITH A PIOGLITAZONE AND METFORMIN TREATMENT OF PULMONARY HYPERTENSION IMPROVEMENT OF GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES TREATMENT OF ACUTE, UNCOMPLICATED MALARIA INFECTION DUE TO PLASMODIUM FALCIPARUM IN PATIENTS OF 5KG BODYWEIGHT AND ABOVE METHOD OF TREATING HYPONATREMIA RELIEF OF MUSCLE SPASM NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN MANAGEMENT OF MILD TO MODERATE PAIN, MANAGEMENT OF MODERATE TO SEVERE PAIN AS AN ADJUNCT TO OPIOID ANALGESICS, REDUCTION IN FEVER THROUGH ANTI-INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC ACTIVITY A METHOD OF TREATING OSTEOPOROSIS METHOD OF TREATING OSTEOPOROSIS IN A POST-MENOPAUSAL WOMAN AT RISK FOR FRACTURE METHOD FOR THE TREATMENT OF A WOMAN WITH OSTEOPOROSIS AND AT RISK FOR BONE FRACTURE TREATMENT OF MACULAR EDEMA FOLLOWING BRANCH RETINAL VEIN OCCLUSION (BRVO) OR CENTRAL RETINAL VEIN OCCLUSION (CRVO) TREATMENT OF PATIENTS INFECTED WITH PEDICULUS HUMANUS CAPITIS (HEAD LICE AND THEIR OVA) OF THE SCALP HAIR

PATENT USE
U-987 U-988 U-989 U-990 U-991 U-992 U-993 U-994 U-995 U-996
ADB 47 of 55
U-997 U-998
U-999 U-1000 U-1001
U-1002 U-1003 U-1004 U-1005 U-1006
U-1007 U-1008 U-1009 U-1010
U-1011 U-1012 U-1013 U-1014 U-1015 U-1016
U-1017 U-1018 U-1019 U-1020 U-1021 U-1022 U-1023 U-1024
U-1025 U-1026 U-1027 U-1028 U-1029 U-1030
TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS TREATMENT OF RHINITIS COMPRISING THE NASAL APPLICATION OF A PHARMACEUTICAL FORMULATION AS CLAIMED IN US PATENT 7541350 FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA TREATMENT OF PROTOZOAL INFECTION TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISMS REDUCTION OF THE RISK OF CARDIOVASCULAR HOSPITALIZATION METHOD OF TREATING INFERTILITY METHOD OF TREATMENT OF OSTEOPOROSIS WHEREIN THE OSTEOPOROSIS IS STEROID-INDUCED METHOD FOR TREATING TYPE II DIABETES BY ADMINISTERING SAXAGLIPTIN AN ADJUNCTIVE THERAPY TO DIET TO REDUCT ELEVATED TOTAL CHLORESTEROL (TC), LOW-DENSITY LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN B, TRIGLYCERIDES, AND TO INCREASE HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIX DYSLIPIDEMIA TREATMENT OF MAJOR DEPRESSIVE DISORDER BY DOSING AT INTERVALS OF 24 HOURS ADJUNCITVE THERAPY TO DIET TO REDUCE ELEVATED TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, APOLIPOPRTEIN B, TRIGLYCERIDES AND TO INCREASE HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS METHOD FOR DELIVERING DRUG TO LUNG OF MAMMAL, COMPRISING ADMINISTERING DRUG PRODUCT BY INHALATION. TREATING A MAMMAL HAVING A CONDITION CAPABLE OF TREATMENT BY INHALATION, COMPRISING ADMINISTERING TO THE LUNG THE DRUG PRODUCT BY INHALATION METHOD OF TREATING INFLAMMATORY CONDITIONS A METHOD OF MYOCARDIAL PERFUSION IMAGING AND INCREASING CORONARY BLOOD FLOW TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA METHOD OF TREATING A STAPHYLOCOCCAL INFECTION NEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER) METHOD OF TREATING GOUT FLARES APPLICATION OF ANTISEPTIC WITH MOISTURIZERS FOR SURGICAL AND HEALTHCARE PERSONNEL SKIN DISINFECTION METHOD FOR ADMINISTRATION OF TESTOSTERONE TO REDUCE BLOOD PHENYLALANINE LEVELS IN PATIENTS WITH HYPERPHENYLALANINEMIA DUE TO TETRA HYDROBIOPTERIN RESPONSIVE PHENYLKETONURIA. KUVAN SHOULD BE TAKEN ORALLY WITH FOOD TO INCREASE ABSORPTION USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING METHOD FOR TREATING INSOMNIA WHILE REDUCING THE RISK OF AN ADVERSE DRUG INTERACTION METHOD OF USING RIBAVIRIN IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2B TO TREAT PATIENTS WITH CHRONIC HEPATITIS C METHOD OF USING RIBAVIRIN IN COMBINATION WITH INTERFERON ALPHA-2B(PEGYLATED AND NONPEGYLATED) TO TREAT PATIENTS WITH CHRONIC HEPATITIS C TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-EXPERIENCED ADULT PATIENTS, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO AN NNRTI AND OTHER ANTIRETROVIRAL AGENTS A METHOD OF TREATING NASAL AND NON-NASAL SYMPTOMS OF SEASONAL ALLERGIC RHINITIS TREATMENT OF PULMONARY HYPERTENSION BY INHALATION TREATMENT OF PULMONARY HYPERTENSION METHOD OF USING COLCHICINE FOR THE PROPHYLAXIS OF GOUT FLARES SHORT-TERM TREATMENT (4-8 WEEKS) OF ACTIVE BENIGN GASTRIC ULCER FOR THE PREPARATION OF SKIN PRIOR TO SURGERY; HELPS REDUCE BACTERIA THAT CAN POTENTIALLY CAUSE SKIN INFECTION TREATMENT OF ATROPHIC VAGINITIS DUE TO MENOPAUSE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP TREATING FREQUENT HEARTBURN A METHOD OF TREATING HUMAN SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS. REDUCTION OF ELEVATED PLASMA STEROL AND/OR STANOL LEVELS IN A MAMMAL A METHOD OF DISTRIBUTING SODIUM OXYBATE UNDER CONTROL OF A CENTRAL PHARMACY METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF IMPROVEMENT OF WALKING IN PATIENTS WITH MULTIPLE SCLEROSIS (MS)

PATENT USE
ADB 48 of 55
U-1031 IMPROVE RESPIRATORY SYMPTOMS IN CYSTIC FIBROSIS IN PATIENTS WITH PSEUDOMONAS AERUGINOSA U-1032 USE OF ROSUVASTATIN CALCIUM FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN INDIVIDUALS WITHOUT CLINICALLY EVIDENT CORONARY HEART DISEASE BUT WITH INCREASED RISK FACTORS U-1033 TOPICAL TREATMENT OF ACNE VULGARIS U-1034 TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS U-1035 NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN U-1036 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH INSULIN U-1037 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH A PPAR-GAMMA AGONIST U-1038 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN AND A PPAR-GAMMA AGONIST U-1039 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN U-1040 INHIBITION OF THROMBIN IN A PATIENT U-1041 TREATMENT OF DISORDERS RESPONSIVE TO GROWTH HORMONE U-1042 METHOD FOR STIMULATING CORONARY VASODILATION FOR PURPOSES OF IMAGING THE HEART U-1043 MANAGEMENT OF MODERATE TO SEVERE PAIN U-1044 TOPICAL TREATMENT OF SCALP PSORIASIS U-1045 MAINTENANCE TREATMENT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC WHO HAVE NOT PROGRESSED ON 1ST-LINE TREATMENT WTH PLATINUM-BASED CHEMOTHERAPY U-1046 MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES PLATINUM-BASED CHEMOTHERAPY U-1047 TREATMENT OF BIOPSY-CONFIRMED, PRIMARY SUPERFICIAL BASAL CELL CARCINOMA (SBCC) U-1048 WORKS THROUGH THE INDUCTION OF INTERFERON AND OTHER CYTOKINES U-1049 PROPHYLAXIS OF ORGAN REJECTION IN ADULT PATIENTS AT LOW-MODERATE IMMUNOLOGIC RISK RECEIVING A RENAL TRANSPLANT U-1050 USE OF METAXALONE FOR TREATMENT OF MUSCULSKELETAL CONDITIONS U-1051 TREATMENT OF OROPHARYNGEAL CANDIDIASIS U-1052 RELIEF OF SIGNS AND SYMPTOMS OF ARTHRITIS AND RISK-REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER U-1053 RISK-REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER U-1054 ONYCHOMYCOSIS OF THE TOENAIL CAUSED BY TRICOPHYTON RUBRUM OR TRICHOPHYTON MENTAGROPHYTES, ONCE DAILY USE FOR 12 CONSECUTIVE WEEKS U-1055 AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHO ARE ALREADY TREATED WITH A THIAZOLIDINEDIONE (TZD) AND METFORMIN OR WHO HAVE INADEQUATE GLYCEMIC CONTROL ON A TZD OR METFORMIN ALONE U-1056 TREATMENT OF PAIN USING A NASAL SPRAY OF KETOROLAC TROMETHAMINE U-1057 TREATMENT OF INFLAMMATION AND PAIN USING A NASAL SPRAY OF KETOROLAC TROMETHAMINE U-1058 USE OF THALIDOMIDE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA U-1059 ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA U-1060 ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH ELEVATED CHOLESTEROL AND/OR LIPID LEVELS U-1061 ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA U-1062 ADMINISTRATION OF APPROVED PRODUCT FOR TREATMENT OF ALZHEIMER'S DISEASE U-1063 TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA U-1064 TREATMENT OF BIPOLAR DISORDER AND SCHIZOPHRENIA U-1065 METHOD OF TREATING ANDROGEN RESPONSIVE OR MEDICATED CONDITION IN A MAMMAL BY ADMINISTERING A SAFE & EFFECTIVE AMOUNT OF DUTASTERIDE OR A PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF.. CONDITIONS INCLUDE BENIGN PROSTATIC HYPERTROPHY U-1066 METHOD OF TREATING AN ANDROGEN RESPONSE OR MEDIATED DISEASE IN A MAMMAL BY ADMININSTERING AN EFFECTIVE ANDROGEN RESPONSIVE OR MEDICATED DISEASE AMOUNT OF DUTASTERIDE..CONDITIONS INCLUDE BENIGN PROSTATIC HYPERPLASIA U-1067 TREATMENT OF CANCER U-1068 TREATMENT OF ASTHMA U-1069 A METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING AN EXCLUSIVE COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION U-1070 A METHOD TO CONTROL ABUSE OF A SENSITIVE DRUG BY CONTROLLING WITH A COMPUTER PROCESSOR THE DISTRIBUTION OF THE SENSITIVE DRUG VIA AN EXCLUSIVITY CENTRAL PHARMACY THAT MAINTAINS A CENTRAL DATABASE U-1071 METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION U-1072 THE MANAGEMENT OF MODERATE TO SEVERE CHRONIC PAIN IN PATIENTS REQUIRING A CONTINUOUS, AROUND-THE-CLOCK OPIOID ANALGESIC FOR AN EXTENDED PERIOD OF TIME U-1073 USE FOR THE TREATMENT OF ASTHMA AND COPD

PATENT USE
ADB 49 of 55
U-1074 USE OF EXENATIDE MAY RESULT IN REDUCTION IN BODY WEIGHT U-1075 USE FOR THE TREATMENT OF ASTHMA U-1076 REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA) IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING U-1077 PRETREATMENT OF PATIENTS WITH VITAMIN B12 AND FOLIC ACID PRIOR TO PEMETREXED DISODIUM ADMINISTRATION U-1078 TREATMENT OF ACNE U-1079 REVLIMID (LENALIDOMIDE) IS INDICATED FOR THE TREATMENT OF PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS) U-1080 METHOD TO TREAT PULMONARY HYPERTENSION BY ADMINISTERING AMBRISENTAN TO A PATIENT U-1081 LUMIGAN IS A PROSTAGLANDIN ANALOG INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION U-1082 USE OF A COMBINATION OF TOBRAMYCIN AND DEXAMETHASONE TO TREAT OCULAR INFLAMMATION WHERE AN INFECTION OR RISK OF INFECTION EXISTS U-1083 ACUTE TREATMENT OF MIGRAINE ATTACKS, WITH OR WITHOUT AURA, AND THE TREATMENT OF CLUSTER HEADACHE EPISODES U-1084 RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YEARS OF AGE OR OLDER U-1085 METHOD FOR TREATING IRRITABLE BOWEL SYNDROME AND METHOD FOR TREATING ABDOMINAL DISCOMFORT ASSOCIATED WITH IRRITABLE BOWEL SYNDROME U-1086 TREATMENT OF AUTOIMMUNE DISEASE U-1087 DETECTION OF NON-MUSCLE INVASIVE PAPILLARY CANCER OF THE BLADDER BY PHOTODYNAMIC CYSTOSCOPY U-1088 RELIEF OF MUSCLE SPASM U-1089 INHIBITION OF THROMBIN U-1090 LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION U-1091 ASSESSMENT OF BRONCHIAL HYPERRESPONSIVENESS IN PATIENTS 6 YEARS OF AGE OR OLDER WHO DO NOT HAVE CLINICALLY APPARENT ASTHMA U-1092 TREATMENT OF BREAST CANCER U-1093 TREATMENT OF PSEUDOBULBAR AFFECT U-1094 MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN U-1095 METHOD OF TREATING OCULAR INFLAMMATION U-1096 TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER U-1097 ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH BOTH SAXAGLIPTIN AND METFORMIN IS APPROPRIATE U-1098 METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF TREATING HYPERCALCEMIA U-1099 TREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA U-1100 REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY U-1101 METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH NARCOLEPSY U-1102 METHOD OF TREATING CATAPLEXY IN PATIENTS WITH NARCOLEPSY U-1103 TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE U-1104 USE OF TRAMADOL FOR THE MANAGEMENT OF MODERATE TO MODERATELY SEVERE CHRONIC PAIN U-1105 TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER U-1106 TREATING HYPERTRIGLYCERIDEMIAS WITH REDUCTION OF FOOD EFFECT U-1107 TREATING HYPERCHOLESTEROLEMIAS WITH REDUCTION OF FOOD EFFECT U-1108 TREATING TYPE 2 DIABETES MELLITUS WITH EXENATIDE BY STIMULATING INSULIN RELEASE U-1109 TREATMENT OF CUTANEOUS MANIFESTATIONS OF ERYTHEMA NODOSUM LEPROSUM (ENL) IN CONNECTION WITH A SPECIAL PROGRAM APPROVED BY FDA CALLED "SYSTEM FOR THALIDOMIDE EDUCATION AND PRESCRIBING SAFETY" (S.T.E.P.S.) U-1110 METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING A COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION U-1111 NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN U-1112 METHOD OF MR IMAGING OF A MAMMAL U-1113 TREATMENT AND PROPHYLAXIS OF INFLUENZA U-1114 TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA U-1115 TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS U-1116 METHOD OF ADMINISTERING COLCHICINE TO FAMILIAL MEDITERRANEAN FEVER PATIENTS U-1117 TREATMENT OF BREAST CANCER U-1118 USE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA

PATENT USE
ADB 50 of 55
U-1119 CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING U-1120 TO REDUCE GASTROINTESTINAL SIDE EFFECTS ADMINISTER WITH A MEAL; AS STARTING DOSE ADMINISTER ONCE DAILY WITH EVENING MEAL U-1121 METHOD OF TREATING TRAVELERS' DIARRHEA U-1122 TREATMENT OF SECONDARILY INFECTED TRAUMATIC SKIN LESIONS DUE TO S. AUREUS AND S. PYOGENES U-1123 TREATMENT OF ALCOHOL DEPENDENCE U-1124 PREVENTION OF RELAPSE TO OPIOID DEPENDENCE, FOLLOWING OPIOID DETOXIFICATION U-1125 METHOD FOR THE DETECTION OF NEUROENDOCRINE TUMORS U-1126 USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO HAVE RECEIVED PRIOR CHEMOTHERAPY CONTAINING DOCETAXEL U-1127 TREATMENT OF PATENT DUCTUS ARTERIOSUS U-1128 TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION IN COMBINATION WITH PEGINTERFERON ALFA AND RIBAVIRIN IN ADULT PATIENTS (>=18 YEARS OF AGE) WITH COMPENSATED LIVER DISEASE U-1129 TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1130 SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE EVENING OR A NIGHT WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1131 TREATMENT OF HYPERTRIGLYDERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1132 TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1133 SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1134 TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1135 TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A) AND INCREASE OF HDL-C U-1136 SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1137 TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1138 TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1139 REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1140 REDUCTION IN ELEVATED TC AND LDL-C BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1141 REDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1142 TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1143 REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER DAY IN THE EVENING OR A T NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1144 REDUCTION IN ELEVATED TC AND LDL-C BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1145 REDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1146 REDUCTION IN TG WITH REDUCED FLUSHING BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1147 TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1148 REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTINO OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1149 TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1150 TRETMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION IN TOTAL-C, LDL-C, TG, LP(A), AND INCREASE OF HDL-C U-1151 TREATMENT OF HYPERTRIGLYCDERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION IN TOTAL-C, LDL-C, LP(A), AND INCREASE OF HDL-C U-1152 CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION U-1153 IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS, IS INDICATED FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN ANTIRETROVIRAL TREATMENT-NAIVE ADULT PATIENTS, AS SET FORTH IN THE LABELING, INCLUDING I&U SECTION U-1154 TREATMENT OF PROTEIN KINASE RELATED DISORDERS, SUCH AS GASTROINTESTINAL STROMAL TUMORS, RENAL CELL CARCINOMA AND ADVANCED PANCREATIC NEUROENDOCRINE TUMORS, WITH SUNITINIB U-1155 USE OF THALIDOMIDE IN TREATMENT OF CUTANEOUS MANIFESTATIONS OF ERYTHEMA NODOSUM LEPROSUM (ENL) U-1156 TO REDUCE BLOOD PHENYLALANINE (PHE) LEVELS IN PATINETS WITH HYPERPHENYLALANINEMIA (HPA)

PATENT USE
ADB 51 of 55
U-1157 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES IN ADULTS AND CHILDREN 2 YEARS OF AGE AND OLDER AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER U-1158 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER U-1159 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES, SWELLING OF THE NASAL PASSAGES AND SINUS CONGESTION AND PRESSURE IN ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER U-1160 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER AND 12 YEARS OF AGE AND OLDER U-1161 FOR THE TREATMENT AND PROPHYLAXIS OF GOUT FLARES & THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER U-1162 TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP U-1163 METHOD OF TREATING THROMBOSIS U-1164 METHOD OF TREATING AN ARGATROBAN TREATABLE CONDITION U-1165 USE FOR THE TREATMENT OF MULTIPLE MYELOMA U-1166 A METHOD FOR TREATMENT OF GOUT FLARES DURING PROPHYLAXIS U-1167 PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) U-1168 THE LONG TERM, ONCE-DAILY MAINTENANCE BROCHODILATOR TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA U-1169 MANAGEMENT OF BREAKTHROUGH PAIN IN CANCER PATIENTS 18 YEARS OF AGE AND OLDER WHO ARE RECEIVING AND TOLERANT TO OPIOID THERAPY FOR THEIR UNDERLYING PERSISTENT CANCER PAIN U-1170 TREATMENT OF HIV-1 INFECTION IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER U-1171 REDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME U-1172 TO REDUCE ELEVATED TOTAL-C, APO B, AND NON-HDL-C IN PATIENTS WIHT PRIMARY HYPERLIPIDEMIA BY ADMINISTRATION OF EZETIMIBE IN COMBINATION WITH A STATIN U-1173 TO REDUCE ELEVATED TOTAL-C, LDL-C, APO B AND NON-HDL-C IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA BY ADMINISTRATION OF EZETIMIBE ALONE OR IN COMBINATION WITH A STATIN OR WITH FENOFIBRATE U-1174 ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE WATER FOR INJECTION, 0.9% SODIUM CHLORIDE INJECTION, OR FLOLAN STERIILE DILUENT FOR INJECTION PRIOR TO ADMINISTRATION U-1175 REDUCTION OF CARDIAC TISSUE DAMAGE ASSOCIATED WITH MYOCARDIAL INFARCTION U-1176 TREATMENT OR PREVENTION OF STROKE U-1177 REDUCTION OF CARDIAC TISSUE DAMAGE ASSOCIATED WITH MYOCARDIAL INFARCTION U-1178 RELIEF OF MODERATE TO SEVERE CHRONIC PAIN U-1179 TREATMENT OF A CANCER MEDIATED BY AN ANAPLASTIC LYMPHOMA KINASE (ALK) U-1180 TREATMENT OF THE FOLLOWING INFECTIONS: COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS AND STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA) INCLUDING THOSE WITH RIGHTSIDED INFECTIVE ENDOCARDITIS U-1181 A METHOD OF TREATING OR PREVENTING OCULAR PAIN IN A PATIENT U-1182 TREATMENT OF CYCLIC HEAVY MENSTRUAL BLEEDING U-1183 A METHOD FOR ADMINISTERING FOLLICLE STIMULATING HORMONE (FSH) FOR OVARIAN FOLLICLE OR TESTICULAR STIMULATION IN THE HUMAN U-1184 TREATMENT OF ERECTILE DYSFUNCTION AND THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA U-1185 TREATMENT OF OPIOID-INDUCED CONSTIPATION U-1186 ADMINISTRATION OF AN INHALABLE POWDER COMPRISING TIOTROPIUM VIA DEVICE U-1187 TREATMENT OF PATHOLOGICAL STATE BY ANTAGONIZING BRADYKININ RECEPTOR INCLUDING TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) U-1188 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE U-1189 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH METFORMIN U-1190 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH INSULIN U-1191 METHOD OF TX TYPE 2 DM IN PTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBO WITH AN AGENT ACTING ON AN ATP-DEPENDENT CHANNEL IN BETA CELLS SUCH AS A SULFYONYLUREA(INCL GLIPIZIDE, GLIMEPIRIIDE & GLYBURIDE) U-1192 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH A SULFONYLUREA (SUCH AS GLIPIZIDE, GLIMEPIRIDE AND GLYBURIDE) U-1193 METHOD OF TREATING TYPE 2 DIABETES MELITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH A PPAR-GAMMA AGONIST (SUCH AS PIOGLITAZONE AND ROSIGLITAZONE) U-1194 METHOD FOR TREATING INSOMNIA

PATENT USE
ADB 52 of 55
U-1195 PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 5, WHICH MAY RESULT IN RENAL OSTEODYSTROPHY, WHILE AVOIDING HYPERPHOSPHATEMIA U-1196 RELIEF OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS AND TO DECREASE RISK OF DEVELOPING UPPER GASTROINTESTINAL ULCERS IN PATIENTS WHO ARE TAKING IBUPROFEN FOR THOSE INDICATIONS U-1197 METHOD OF TREATMENT OF CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY U-1198 RECTIV IS A NITRATE VASODILATOR INDICATED FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH CHRONIC ANAL FISSURE U-1199 TREATMENT AND PREVENTION OF POSTMENOPAUSAL OR GLUCOCORTICOID-INDUCED OSTEOPOROSIS AND TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS U-1200 REDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM U-1201 FOR THE TREATMENT OF INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS U-1202 METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME U-1203 METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT U-1204 TREATMENT OF UVEITIS U-1205 TREATMENT OF MACULAR EDEMA U-1206 DELIVERING AN OCULAR IMPLANT AS DESCRIBED IN THE DOSAGE AND ADMINISTRATION SECTION OF THE APPROVED LABELING OF OZURDEX U-1207 INFANT USE AGED 1 MONTH TO LESS THAN ONE YEAR, GERD AND EROSIVE ESOPHAGITIS U-1208 TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS U-1209 TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN ADULT PATIENTS, AND TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN PEDIATRIC PATIENTS 3 YEARS OF AGE AND OLDER U-1210 USE OF REVLIMID (LENALIDOMIDE) WHILE PREVENTING THE EXPOSURE OF A FETUS OR OTHER CONTRAINDICATED INDIVIDUAL TO REVLIMID (LENALIDOMIDE) U-1211 USE OF REVLIMID (LENALIDOMIDE) TO INHIBIT THE SECRETION OF PRO-INFLAMMATORY CYTOKINES, INCLUDING TUMOR NECROSIS FACTOR ALPHA U-1212 USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF MULTIPLE MYELOMA AND TRANSFUSIONDEPENDENT ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS) U-1213 TOPICAL TREATMENT OF SEBORRHEIC DERMATITIS IN IMMUNOCOMPETETENT PATIENTS 12 YEARS OF AGE AND OLDER U-1214 METHOF FOR RELIEVING CONSTIPATION IN A HUMAN PATIENT THAT COMPRISES ADMINISTERING TO THE PATIENT A DOSAGE UNIT COMPRISING (I) 24MCG+/- 10% OF A DRUG SUBSTANCE AND (II) A PHARMACEUTICALLY SUITABLE EXCIPIENT U-1215 USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF TRANSFUSION-DEPENDENT ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS) U-1216 USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF MULTIPLE MYELOMA U-1217 METHOD OF INCREASING HAIR GROWTH U-1218 METHOD OF STIMULATING HAIR GROWTH U-1219 METHOD OF INCREASING THE NUMBER OF HAIRS U-1220 TREATMENT OF RENAL CELL CARCINOMA U-1221 TO STIMULATE THE IMMUNE SYSTEM TO INDUCE T CELL PROLIFERATION U-1222 TO INHIBIT THE PROLIFERATIVE ACTIVITY OF NEOPLASTIC CELLS U-1223 METHOD FOR TREATING TYPE 2 DIABETES USING A SUSTAINED-RELEASE COMPOSITION CONTAINING EXENATIDE U-1224 REDUCTIONS IN BODY WEIGHT ARE OBSERVED WITH EXENATIDE U-1225 ACCELERATING THE TIME TO UPPER AND LOWER GASTROINTESTINAL RECOVERY FOLLOWING PARTIAL LARGE OR SMALL BOWEL RESECTION SURGERY WITH PRIMARY ANASTOMOSIS U-1226 A METHOD OF PROVIDING A PREDETERMINED CONCENTRATION OF NITRIC OXIDE TO A PATIENT U-1227 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND METFORMIN HCL EXTENDED RELEASE IS APPROPRIATE U-1228 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND METFORMIN HCL EXTENDED RELEASE IS APPROPRIATE ALONE OR IN COMBINATION WITH INSULIN U-1229 TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS U-1230 A METHOD OF PROVIDING NITRIC OXIDE THERAPY TO A PATIENT U-1231 TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS U-1232 USE AS ANTICOAGULANT IN PTS W/ UNSTABLE ANGINA UNDERGOING PTCA; W/ PROVISIONAL USE OF GLYCOPROTEIN IIB/IIIA INHIBITOR, AS ANTICOAGULANT IN PTS UNDERGOING PCI AND FOR PTS W/, OR AT RISK OF, HIT/HITTS UNDERGOING PCI.INTENTED FOR USE W/ASPIRIN U-1233 TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION, ADMINISTERED WITH FOOD U-1234 FOR REDUCING TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES, AND TREATING HYPERTRIGLYCERIDEMIA

PATENT USE
ADB 53 of 55
U-1235 REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION U-1236 USE OF THALOMID (THALIDOMIDE) FOR THE TREATMENT OF MULTIPLE MYELOMA U-1237 COMBO W/ OTHER ANTIRETROVIRALS FOR TX OF HIV-1 IN ANTIRETROVIRAL TX-EXPERIENCED PT 6 YEARS UP, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND OTHER ANTIRETROVIRALS U-1238 TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE U-1239 MAGNETIC RESONANCE IMAGING OF THE LIVER U-1240 TREATMENT OF HEAVY MENSTRUAL BLEEDING IN WOMEN WITHOUT ORGANIC PATHOLOGY WHO CHOOSE TO USE AN ORAL CONTRACEPTIVE AS THEIR METHOD OF CONTRACEPTION U-1241 MANAGEMENT OF MODERATE TO SEVERE PAIN BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIMED U-1242 PREVENTION OF RESPIRATORY DISTRESS (RDS) IN PREMATURE INFANTS U-1243 WITH DRY HANDS, GENTLY REMOVE THE SUPRENZA (PHENTERMINE HYDROCHLORIDE ODT) TABLET FROM THE BOTTLE. IMMEDIATELY PLACE THE SUPRENZA TABLET ON TOP OF THE TONGUE WHERE IT WILL DISSOLVE, THEN SWALLOW WITH OR WITHOUT WATER U-1244 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH SULFONLYUREA U-1245 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH PIOGLITAZONE U-1246 SINGLE DOSE ADMINISTRATION INTO THE SURGICAL SITE TO PRODUCE POSTSURGICAL ANALGESIA U-1247 MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS U-1248 USE OF TOPICAL DICLOFENAC ON THE KNEE AND A SECOND TOPICAL MEDICATION ON THE SAME KNEE U-1249 TREATMENT OF MALE PATIENT HAVING A DISEASE OR CONDITION RESPONSIVE TO A TERATOGENIC DRUG U-1250 TREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY OR SPINAL CORD INJURY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA U-1251 A METHOD OF CONTROLLING POSTOPERATIVE OCULAR PAIN AND BURNING/STINGING IN A PATIENT U-1252 METHOD FOR CHRONIC WEIGHT MANAGEMENT BY DECREASING FOOD INTAKE U-1253 METHOD FOR CHRONIC WEIGHT MANAGEMENT BY INDUCING SATIETY U-1254 METHOD FOR CHRONIC WIEGHT MANAGEMENT BY CONTROLLING WEIGHT GAIN U-1255 METHOD FOR CHRONIC WEIGHT MANAGEMENT BY TREATING OBESITY U-1256 TREATMENT OF SEBORRHEIC DERMATITIS U-1257 TREATMENT OF OPHTHALMIC DISORDERS U-1258 VISUALIZATION DURING VITRECTOMY PROCEDURES U-1259 PROPHYLAXIS OF HIV-1 INFECTION U-1260 TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE DEMONSTRATED DISEASE PROGRESSION ON OR WITHIN 60 DAYS OF COMPLETION OF THE LAST THERAPY U-1261 REDUCTION OF THE RISK OF HOSPITALIZATION FOR ATRIAL FIBRILLATION U-1262 USE OF QSYMIA (PHENTERMINE AND TOPIRAMATE) FOR WEIGHT MANAGEMENT, INCLUDING, BUT NOT LIMITED TO EFFECTING WEIGHT LOSS, TREATING OBESITY, AND/OR TREATING OVERWEIGHT U-1263 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) OR CHRONIC BRONCHITIS U-1264 TREATMENT OF A RESPIRATORY DISEASE U-1265 PATENTED METHOD OF USING REPAGLINIDE IN COMBINATION WITH METFORMIN AS INDICATED FOR IMPROVING GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS U-1266 METHOD OF TREATING MIDDLE-OF-THE-NIGHT INSOMNIA U-1267 TREATMENT OF RHEUMATOID ARTHRITIS BY DELAYED RELEASE FORMULATION OF 1MG OR 2MG OF PREDNISONE U-1268 TREATMENT OF PULMONARY, GASTROINTESTINAL AND/OR RHEUMATOLOGICAL DISEASES OR CONDITIONS BY USE OF DELAYED RELEASE FORMULATIONS OF 1MG OR 2MG PREDNISONE U-1269 TREATMENT OF RHEUMATOLOGIC, ALLERGIC, PULMONARY, GASTROINTESTINAL, DERMATOLOGIC DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 5MG PREDNISONE TABLET U-1270 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH INSULIN (WITH OR WITHOUT METFORMIN AND/OR PIOGLITAZONE) U-1271 TREATMENT OF ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE(PH-) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN SECOND OR GREATER RELAPSE OR WHOSE DISEASE HAS PROGRESSED FOLLOWING TWO OR MOR ANTI-LEUKEMIA THERAPIES U-1272 TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM U-1273 TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM U-1274 TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS OR OTHER CONDITIONS U-1275 TREATMENT OF CHRONIC HEPATITIS B IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER U-1276 MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY U-1277 METHOD OF INCREASING EYELASH GROWTH INCLUDING LENGTH, THICKNESS, DARKNESS AND/OR NUMBER OF EYELASHES BY ADMINISTERING BIMATOPROST TO AN EYELID MARGIN

PATENT USE
ADB 54 of 55
U-1278 METHOD OF TREATING IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN ADULTS U-1279 TREATMENT OF HIV INFECTION USING A COMPOSITION CONTAINING A PHARMACOKNIETIC ENHANCER THAT INHIBITS CYTOCHROME P450 MONOOXYGENASE U-1280 USE OF A CALCIPOTRIENE CONTAINING FOAM FOR THE TREATMENT OF PSORIASIS U-1281 THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO HAVE PREVIOUSLY RECEIVED DOCETAXEL U-1282 PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING U-1283 A METHOD OF TREATING CHRONIC MYELOGENOUS LEUKEMIA U-1284 A METHOD OF TREATING A NEOPLASM U-1285 TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS U-1286 A METHOD OF REDUCING THE RISK OF PULMONARY EDEMA IN PATIENTS IN NEED OF TREATMENT WITH INHALED NITRIC OXIDE U-1287 METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA U-1288 TREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET U-1289 MANAGEMENT OF MODERATE TO SEVERE ACUTE PAIN U-1290 TREATMENT OF LUNG CANCER U-1291 TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN PATIENTS WHOSE APL IS CHARACTERIZED BY THE PRESENCE OF THE (15;17) TRANSLOCATION OR PML/RAR-ALPHA GENE EXPRESSION U-1292 TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 1, 2, OR 5 MG PREDNISONE TABLET U-1293 A METHOD OF LOWERING INTRAOCULAR PRESSURE IN A PATIENT WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION U-1294 METHOD OF TREATING GLAUCOMA IN A PATIENT U-1295 A METHOD OF TREATING A PATIENT WITH GLAUCOMA OR OCULAR HYPERTENSION U-1296 USE OF PEMETREXED WITH PRIOR AND/OR REPEATED VITAMIN B12 AND FOLIC ACID ADMINISTRATION U-1297 TREATMENT OF PULMONARY ARTERIAL HYPERTENSION BY INHIBITING ENDOTHELIN RECEPTORS U-1298 ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES U-1299 TREATMENT OF PATIENTS WITH LEUKEMIA INCLUDING CHRONIC MYELOID/MYELOGENOUS LEUKEMIA (CML) U-1300 TREATMENT OF PATIENTS WITH TYROSINE KINASE INHIBITOR (TKI) RESISTANT OR INTOLERANT CHRONIC MYELOID/MYELOGENOUS LEUKEMIA (CML) U-1301 TREATMENT OF DEEP VEIN THROMBOSIS (DVT) U-1302 TREATMENT OF PULMONARY EMBOLISM (PE) U-1303 REDUCTION IN THE RISK OF RECURRENCE OF DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM U-1304 USE OF ONCE-A-DAY AMOXICILLIN PRODUCT TO TREAT TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES U-1305 TREATMENT OF HIV-1INFECTION IN ADULT PATIENTS, AND TREATMENT OF HIV-1 INFECTION IN PEDIATRIC PATIENTS 3 YEARS OF AGE AND OLDER, CO-ADMINISTERED WITH RITONAVIR (PREZISTA/RITONAVIR) AND WITH OTHER ANTIRETROVIRAL AGENTS U-1306 TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY U-1307 IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-NAIVE ADULT PATIENTS WITH HIV-1 RNA LESS THAN OR EQUAL TO 100,000 AT THE START OF THERAPY U-1308 MULTIPLE MYELOMA U-1309 BONE METASTASES U-1310 FOR THE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS U-1311 METHOD OF TREATING CYSTIC FIBROSIS U-1312 USE FOR THE TREATMENT OF HYPERGLYCEMIA U-1313 AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS U-1314 USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER U-1315 THE LONG TERM TREATMENT OF PROPHYLACTIC MANAGEMENT OF OCULAR HYPERTENSION AND GLAUCOMA U-1316 A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES U-1317 TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA U-1318 TREATMENT OF HYPERCHOLESTEROLEMIA BY DECREASING THE AMOUNT OR ACTIVITY OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IN PATINETS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA U-1319 SYMPTOMATIC RELIEF OF NON-INFECTIOUS DIARRHEA U-1320 TREATMENT OF ADULT PATIENTS WITH SHORT BOWEL SYNDROME WHO ARE DEPENDENT ON PARENTERAL SUPPORT U-1321 TREATMENT OF PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS U-1322 METHOD OF REDUCING OCULAR HYPERTENSION

PATENT USE
ADB 55 of 55
U-1323 REDUCING THE RISK OF STROKE U-1324 MANAGEMENT OF CYSTIC FIBROSIS PATIENTS U-1325 INDUCTION OF REMISSION IN PATIENTS WITH ACTIVE, MILD TO MODERATE ULCERATIVE COLITIS

Orange Book 33rd Edition

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Orange Book 33rd Edition

Uploaded by

Copyright:

Available Formats

APPROVED

FOOD AND DRUG ADMINISTRATION

APPROVED DRUG PRODUCTS

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

FOOD AND DRUG ADMINISTRATION

PREFACE TO THIRTY THIRD EDITION..................iv

DRUG PRODUCT LISTS

FOOD AND DRUG ADMINISTRATION

PREFACE TO THIRTY THIRD EDITION

SYNTHROID LEVOTHYROXINE SODIUM LEVO-T UNITHROID LEVOTHYROXINE SODIUM

ABBOTT MYLAN ALARA PHARM STEVENS J MERCK KGAA

0.025MG 0.025MG 0.025MG 0.025MG 0.025MG

AB2 AB2 AB2 AB2 AB2

021402 076187 021342 021210 076752

001 001 001 001 001

LEVOXYL LEVO-T UNITHROID LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM

KING PHARMS ALARA PHARM STEVENS J MYLAN MERCK KGAA

0.025MG 0.025MG 0.025MG 0.025MG 0.025MG

AB3 AB3 AB3 AB3 AB3

021301 021342 021210 076187 076752

001 001 001 001 001

LEVOTHROID LEVOTHYROXINE SODIUM

2. HOW TO USE THE DRUG PRODUCT LISTS

DRUG PRODUCT ILLUSTRATION

ACTIVE INGREDIENT DOSAGE FORM; ROUTE OF ADMINISTRATION TRADE OR GENERIC NAMES

REFERENCE LISTED DRUG

THERAPEUTIC EQUIVALENCE (TE) CODE FOR MULTISOURCE PRODUCT

25MG/ML 50MG/ML 75MG/ML 100MG/ML

A064890 A064890 A064890 A064890

001 002 003 004

FEB FEB FEB MAR

29, 29, 29, 08,

1987 1987 1987 1992

SINGLE SOURCE PRODUCT (NO TE CODE) AP

MULTIPLE INGREDIENTS WITH PRODUCT INFORMATION ALPHABETICALLY SORTED BY ACTIVE INGREDIENT

IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE

THERAPEUTIC EQUIVALENCE EVALUATIONS ILLUSTRATION

NOTE: BOLD FONT EQUIVALENT.

IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE

33RD EDITION - 2013 - APPROVED DRUG PRODUCTS LIST

PRESCRIPTION DRUG PRODUCT LIST

Dec 17, 1998

EQ 300MG BASE EQ 300MG BASE EQ 300MG BASE EQ 300MG BASE

A201570 A077844 A091294 N020977

001 001 001 001

ABACAVIR SULFATE; LAMIVUDINE

Aug 02, 2004

ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

Nov 14, 2000

Apr 28, 2011

Jul 29, 2004

May 29, 1997 Sep 06, 1995 Sep 06, 1995

Dec 30, 1999

33RD EDITION - 2013 - APPROVED DRUG PRODUCTS LIST

PRESCRIPTION DRUG PRODUCT LIST

400MG 200MG 400MG 200MG 400MG

BASE BASE BASE BASE BASE

A075047 A074288 A074288 A074007 A074007 N018917 N018917

002 001 002 001 002 001 003

Dec Apr Apr Oct Oct

30, 24, 24, 18, 18,

1999 1995 1995 1995 1995

200MG BASE 400MG BASE